<SEC-DOCUMENT>0001564590-21-010945.txt : 20210304
<SEC-HEADER>0001564590-21-010945.hdr.sgml : 20210304
<ACCEPTANCE-DATETIME>20210304161146
ACCESSION NUMBER:		0001564590-21-010945
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210304
DATE AS OF CHANGE:		20210304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NantKwest, Inc.
		CENTRAL INDEX KEY:			0001326110
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				431979754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37507
		FILM NUMBER:		21714261

	BUSINESS ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 633-0300

	MAIL ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Conkwest, Inc.
		DATE OF NAME CHANGE:	20140416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZelleRx Corp
		DATE OF NAME CHANGE:	20050504
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nk-10k_20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3486398+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:nk="http://www.nantkwest.com/20201231" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
nk-10k_20201231.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001326110_20200101_20201231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001326110_20200101_20201231">2020-12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001326110_20200101_20201231">2020</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001326110_20200101_20201231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0001326110_20200101_20201231">0001326110</ix:nonNumeric>
			<ix:nonNumeric id="F_000008" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001326110_20200101_20201231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000009" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0001326110_20200101_20201231">No</ix:nonNumeric>
			<ix:nonNumeric id="F_000010" name="dei:EntityCurrentReportingStatus" contextRef="C_0001326110_20200101_20201231">Yes</ix:nonNumeric>
			<ix:nonNumeric id="F_000011" name="dei:EntityVoluntaryFilers" contextRef="C_0001326110_20200101_20201231">No</ix:nonNumeric>
			<ix:nonNumeric id="F_000023" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001326110_20200101_20201231">Yes</ix:nonNumeric>
			<ix:nonNumeric id="F_000547" name="us-gaap:LeasePracticalExpedientsPackage" contextRef="C_0001326110_20200101_20201231">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000528" name="nk:CashAndCashEquivalentsOriginalMaturities" contextRef="C_0001326110_20200101_20201231">P3M</ix:nonNumeric>
			<ix:nonNumeric id="F_000684" name="us-gaap:DebtInstrumentTerm" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000685" name="us-gaap:DebtInstrumentTerm" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000735" name="nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20200101_20201231">P12M</ix:nonNumeric>
			<ix:nonNumeric id="F_000734" name="nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20200101_20201231">P12M</ix:nonNumeric>
			<ix:nonNumeric id="F_000806" name="nk:TermOfAgreement" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000807" name="nk:AdditionalTermOfAgreementRenewableUponMutualAgreement" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000812" name="nk:RelatedPartyAgreementRenewalTerm" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20150601_20150630">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000848" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20201231">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000847" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20201231">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000850" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20201231">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000849" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20201231">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000884" name="nk:PeriodOfExtendedLeaseTerm" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000888" name="nk:AnnualPercentageIncreasesToFixedChargeCommencementDate" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930">2020-11-30</ix:nonNumeric>
			<ix:nonNumeric id="F_000892" name="nk:RelatedPartyTransactionInitialTermOfAgreement" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000896" name="nk:PeriodOfExtendedLeaseTerm" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000899" name="nk:AnnualPercentageIncreasesToBaseRentCommencementDate" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930">2017-07-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000908" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190831">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000917" name="nk:AnnualPercentageIncreasesToBaseRentCommencementDate" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130">2017-01-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000926" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630">P7Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000953" name="nk:InitialTermOfAgreement" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000982" name="nk:RelatedPartyTransactionInitialTermOfAgreement" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000983" name="nk:RelatedPartyAgreementRenewalTerm" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000995" name="nk:AnnualPercentageIncreasesToBaseRentCommencementDate" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930">2017-07-31</ix:nonNumeric>
			<ix:nonNumeric id="F_001004" name="nk:RelatedPartyTransactionInitialTermOfAgreement" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001006" name="nk:RelatedPartyTransactionInitialTermOfAgreement" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160301_20160331">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001018" name="nk:RelatedPartyTransactionInitialTermOfAgreement" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001019" name="nk:RelatedPartyAgreementRenewalTerm" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331">P1Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001052" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140101_20140331">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001314" name="nk:PeriodOfCumulativeOwnershipChange" contextRef="C_0001326110_20200101_20201231">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001337" name="nk:NetOperatingLossCarrybacksPeriod" contextRef="C_0001326110_20200101_20201231">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001406" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001405" name="nk:LeaseAgreementExtendedPeriod" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228">2030-12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000737" name="nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20190101_20191231">P12M</ix:nonNumeric>
			<ix:nonNumeric id="F_000736" name="nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20190101_20191231">P12M</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001326110_20201231" decimals="-3">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001326110_20191231" decimals="-3">0</ix:nonFraction>
			<ix:nonNumeric id="F_000703" name="nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20200101_20201231">P3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000704" name="nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20200101_20201231">P3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000705" name="nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod" contextRef="C_0001326110_20200101_20201231">P3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001109" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20170101_20171231">P5Y3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001110" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">P4Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001111" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">P5Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001112" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P5Y6M</ix:nonNumeric>
			<ix:nonNumeric id="F_001113" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P4Y8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001143" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231">P3Y10M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_001157" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231">P3Y10M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_001144" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001158" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001145" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231">P4Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001159" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231">P4Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001146" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231">P7Y8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231">P7Y8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001147" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231">P9Y4M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_001161" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231">P0Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001148" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231">P4Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001162" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231">P4Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001149" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P5Y6M</ix:nonNumeric>
			<ix:nonNumeric id="F_001163" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P4Y8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001164" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">P5Y6M</ix:nonNumeric>
			<ix:nonNumeric id="F_001165" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">P6Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001166" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">P6Y1M6D</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="nk-20201231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001326110_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_20210303">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-03</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nk:ProposedMergerWithImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-28</xbrli:startDate>
					<xbrli:endDate>2020-06-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMinimumMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMaximumMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkLaboratoryEquipmentMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nk:LaboratoryEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkITEquipmentMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nk:ITEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20151130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-02-01</xbrli:startDate>
					<xbrli:endDate>2010-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nkProduct">
				<xbrli:measure>nk:Product</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20201221_20201221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-21</xbrli:startDate>
					<xbrli:endDate>2020-12-21</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-21</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtOwnershipAxis_nkNantKwestMember_20201221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:OwnershipAxis">nk:NantKwestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-21</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtTitleOfIndividualAxis_nkExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_20201221_20201221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">nk:ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-21</xbrli:startDate>
					<xbrli:endDate>2020-12-21</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20170331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-06-01</xbrli:startDate>
					<xbrli:endDate>2018-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-09-01</xbrli:startDate>
					<xbrli:endDate>2018-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-09-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesBPreferredStockMember_20190131">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-01-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_nkOtherIncomeAndExpenseNetMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nk:OtherIncomeAndExpenseNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nkSecurity">
				<xbrli:measure>nk:Security</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">nk:ProgramEquipmentRelatedCostsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">nk:NetProgramRelatedCostsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20150601_20150630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-06-01</xbrli:startDate>
					<xbrli:endDate>2015-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMinimumMember_20170501_20170531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-05-01</xbrli:startDate>
					<xbrli:endDate>2017-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_20170501_20170531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-05-01</xbrli:startDate>
					<xbrli:endDate>2017-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_20170501_20170531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-05-01</xbrli:startDate>
					<xbrli:endDate>2017-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">nk:RushUniversityMedicalCenterLicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2004-01-01</xbrli:startDate>
					<xbrli:endDate>2004-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkINDFilingMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:INDFilingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-02-01</xbrli:startDate>
					<xbrli:endDate>2010-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseTwoMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:PhaseTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-02-01</xbrli:startDate>
					<xbrli:endDate>2010-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseThreeMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:PhaseThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-02-01</xbrli:startDate>
					<xbrli:endDate>2010-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkCommercialSaleRelatedToLicensedProductsMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:CommercialSaleRelatedToLicensedProductsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-02-01</xbrli:startDate>
					<xbrli:endDate>2010-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapReinsurancePolicyTypeAxis_nkDirectorsAndOfficersInsurancePolicyMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">nk:DirectorsAndOfficersInsurancePolicyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20190809_20190809">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-09</xbrli:startDate>
					<xbrli:endDate>2019-08-09</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">nk:DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtCumulativeEffectPeriodOfAdoptionAxis_srtCumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrsqft">
				<xbrli:measure>utr:sqft</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-01</xbrli:startDate>
					<xbrli:endDate>2020-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-08-01</xbrli:startDate>
					<xbrli:endDate>2018-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-09-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-09-01</xbrli:startDate>
					<xbrli:endDate>2016-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160301_20160331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-03-01</xbrli:startDate>
					<xbrli:endDate>2016-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_utrsqft">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>utr:sqft</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190701_20190930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-07-01</xbrli:startDate>
					<xbrli:endDate>2019-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-06-01</xbrli:startDate>
					<xbrli:endDate>2021-06-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-11-01</xbrli:startDate>
					<xbrli:endDate>2015-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-01</xbrli:startDate>
					<xbrli:endDate>2020-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-01</xbrli:startDate>
					<xbrli:endDate>2020-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentSanDiegoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentSanDiegoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-06-01</xbrli:startDate>
					<xbrli:endDate>2015-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nkOfficer">
				<xbrli:measure>nk:Officer</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-07-01</xbrli:startDate>
					<xbrli:endDate>2019-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-07-01</xbrli:startDate>
					<xbrli:endDate>2019-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191001_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-07-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221_20201221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-21</xbrli:startDate>
					<xbrli:endDate>2020-12-21</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_us-gaapCollaborativeArrangementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-11-01</xbrli:startDate>
					<xbrli:endDate>2018-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-06-01</xbrli:startDate>
					<xbrli:endDate>2015-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160301_20160331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-03-01</xbrli:startDate>
					<xbrli:endDate>2016-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160401_20160430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-04-01</xbrli:startDate>
					<xbrli:endDate>2016-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20170401_20170430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-04-01</xbrli:startDate>
					<xbrli:endDate>2017-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190501_20190531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-05-01</xbrli:startDate>
					<xbrli:endDate>2019-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-03-01</xbrli:startDate>
					<xbrli:endDate>2018-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:PublicMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-28</xbrli:startDate>
					<xbrli:endDate>2020-06-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:PublicMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-29</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-28</xbrli:startDate>
					<xbrli:endDate>2020-06-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-29</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:ExecutiveChairmanAndPrincipalStockholderMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-28</xbrli:startDate>
					<xbrli:endDate>2020-06-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:ExecutiveChairmanAndPrincipalStockholderMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-29</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20151102_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-11-02</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140101_20140331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-01-01</xbrli:startDate>
					<xbrli:endDate>2014-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20190601_20190630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-06-01</xbrli:startDate>
					<xbrli:endDate>2019-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200601_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20170101_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-01-01</xbrli:startDate>
					<xbrli:endDate>2017-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeSixMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeSixMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTaxPeriodAxis_us-gaapTaxYear2020Member_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2020Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapTaxPeriodAxis_nkTaxYear2021AndThereafterMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nk:TaxYear2021AndThereafterMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20200101_20200331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20200401_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20200701_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20201001_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-10-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20190101_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20190401_20190630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-04-01</xbrli:startDate>
					<xbrli:endDate>2019-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20190701_20190930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-07-01</xbrli:startDate>
					<xbrli:endDate>2019-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_20191001_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-02-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-28</xbrli:startDate>
					<xbrli:endDate>2021-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-02-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001326110_20200101_20201231">10-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark&#160;One)</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Segoe UI Symbol;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000031" name="dei:DocumentAnnualReport" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended December&#160;31, 2020</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OR</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Segoe UI Symbol;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000032" name="dei:DocumentTransitionReport" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934 </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE TRANSITION PERIOD FROM&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; TO &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:4.54%;text-indent:-4.54%;font-weight:bold;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission file number:&#160;<ix:nonNumeric id="F_000020" name="dei:EntityFileNumber" contextRef="C_0001326110_20200101_20201231">001-37507</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0001326110_20200101_20201231">NANTKWEST, INC.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as specified in its Charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001326110_20200101_20201231">43-1979754</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br />Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000025" name="dei:EntityAddressAddressLine1" contextRef="C_0001326110_20200101_20201231">3530 John Hopkins Court</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:EntityAddressCityOrTown" contextRef="C_0001326110_20200101_20201231">San Diego</ix:nonNumeric><span style="font-family:Times New Roman Bold;">, <ix:nonNumeric id="F_000027" name="dei:EntityAddressStateOrProvince" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></span></p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000028" name="dei:EntityAddressPostalZipCode" contextRef="C_0001326110_20200101_20201231">92121</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000029" name="dei:CityAreaCode" contextRef="C_0001326110_20200101_20201231">858</ix:nonNumeric>)&#160;<ix:nonNumeric id="F_000030" name="dei:LocalPhoneNumber" contextRef="C_0001326110_20200101_20201231">633-0300</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;width:41.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title&#160;of each class </p></td>
<td valign="top" style="background-color:#FFFFFF;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:14.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="top" style="background-color:#FFFFFF;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:41.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;width:41.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0001326110_20200101_20201231">Common Stock, par&#160;value&#160;$0.0001 per share</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:14.64%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0001326110_20200101_20201231">NK</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:41.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000024" name="dei:SecurityExchangeName" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Nasdaq Global Select Market)</p></td>
</tr>
</table></div>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act:&#160;<span style="font-weight:bold;">None</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;YES&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> NO&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;YES&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span>&#160;NO&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant:&#160;(1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of&#160;1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;YES&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;NO&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the Registrant was required to submit such files).&#160;YES&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> NO&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange&#160;Act.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:11.5pt;">
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr style="height:1.9pt;">
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:56.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:21.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityFilerCategory" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:entityfilercategoryen">Non-accelerated&#160;filer</ix:nonNumeric></p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntitySmallBusiness" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
</tr>
<tr style="height:1.9pt;">
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:19.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:55.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:20.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:2.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b) of the Sarbanes-Oxley Act&#160;(15&#160;U.S.C.&#160;7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000016" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;YES&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000015" name="dei:EntityShellCompany" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> NO&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate market value of the voting and non-voting common stock held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on the Nasdaq Global Select Market on June&#160;30, 2020, was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000018" name="dei:EntityPublicFloat" contextRef="C_0001326110_20200630" decimals="-5" scale="6">415.4</ix:nonFraction>&#160;million.</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of shares of the Registrant&#8217;s common stock outstanding as of March 3, 2021 was <ix:nonFraction unitRef="U_xbrlishares" id="F_000017" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001326110_20210303" decimals="INF" format="ixt:numdotdecimal">109,344,573</ix:nonFraction>.</p><ix:nonNumeric id="F_000447" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:2.5%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As noted herein, the information called for by Part&#160;III of this Annual Report on Form&#160;10&#8209;K is incorporated by reference to specified portions of the Registrant&#8217;s definitive proxy statement to be filed in conjunction with the Registrant&#8217;s 2021 Annual Meeting of Stockholders, which is expected to be filed not later than 120&#160;days after the Registrant&#8217;s fiscal year ended December&#160;31, 2020.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p></ix:nonNumeric>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Table of Contents</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:87.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_I"><span style="text-decoration:none;">PART&#160;I</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:none;">Business</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:none;">Risk Factors</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:none;">Unresolved Staff Comments</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:none;">Properties</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_LEGAL_PROCEEDINGS"><span style="text-decoration:none;">Legal Proceedings</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:none;">Mine Safety Disclosures</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_II"><span style="text-decoration:none;">PART&#160;II</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:none;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;6.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_SELECTED_FINANCIAL_DATA"><span style="text-decoration:none;">Selected Financial Data</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:none;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS"><span style="text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;8.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR"><span style="text-decoration:none;">Consolidated Financial Statements and Supplementary Data</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:none;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:none;">Controls and Procedures</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OTHER_INFORMATION"><span style="text-decoration:none;">Other Information</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_III"><span style="text-decoration:none;">PART&#160;III</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;10.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO"><span style="text-decoration:none;">Directors, Executive Officers and Corporate Governance</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;11.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11_EXECUTIVE_COMPENSATION"><span style="text-decoration:none;">Executive Compensation</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;12.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF"><span style="text-decoration:none;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;13.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR"><span style="text-decoration:none;">Certain Relationships and Related Transactions, and Director Independence</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;14.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC"><span style="text-decoration:none;">Principal Accounting Fees and Services</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_IV"><span style="text-decoration:none;">PART&#160;IV</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:none;">Exhibits, Financial Statement Schedules</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;16.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16_FORM_10K_SUMMARY"><span style="text-decoration:none;">Form 10-K Summary</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:87.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:none;">Signatures</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Explanatory Note</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As used in this Annual Report on Form&#160;10&#8209;K, or Annual Report, for the year ended December&#160;31, 2020, the terms &#8220;NantKwest,&#8221; &#8220;the company,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;we&#8221; refer to NantKwest, Inc. and/or its subsidiaries.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_I">PART I</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Annual Report on Form&#160;10-K, or this Annual Report, may contain &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Part&#160;I, Item&#160;1A,&#160;&#8220;<span style="font-style:italic;">Risk Factors</span>&#8221;, in this Annual Report. Except as required by law, we assume no obligation to update these forward-looking statements, whether as a result of new information, future events or otherwise. These statements, which represent our current expectations or beliefs concerning various future events, may contain words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;estimate&#8221; or other words indicating future results, though not all forward-looking statements necessarily contain these identifying words. Such statements may include, but are not limited to, statements concerning the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to pioneer immunotherapy, harness the power of the innate immune system, implement precision cancer medicine and change the current paradigm of cancer care&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to implement and support the Joint COVID&#8209;19 Collaboration&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to consummate the proposed merger with ImmunityBio, Inc.&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any impact of the coronavirus pandemic, or responses to the pandemic, on our business, clinical trials or personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding the potential benefits of our strategy and technology and the proposed merger with ImmunityBio,&#160;Inc.&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding the operation of our product candidates and related benefits&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to utilize multiple modes to induce cell death&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our beliefs regarding the benefits and perceived limitations of competing approaches, and the future of competing technologies and our industry&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">details regarding our strategic vision and planned product candidate pipeline, including that we eventually plan to advance therapies for virally induced infectious diseases&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our beliefs regarding the success, cost and timing of our product candidate development activities and current and future clinical trials and studies, including study design&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding our ability to utilize the phase&#160;I and II aNK and haNK clinical trials data to support the development of all of our product candidates, including our haNK, taNK, t&#8209;haNK, MSC and ceNK product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing or likelihood of regulatory filings or other actions and related regulatory authority responses, including any planned investigational new drug, or IND, filings or pursuit of accelerated regulatory approval pathways or orphan drug status and breakthrough therapy designations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to implement an integrated discovery ecosystem and the operation of that planned ecosystem, including being able to regularly add neoepitopes and subsequently formulate new product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability and willingness of strategic collaborators, including NantWorks,&#160;LLC, or NantWorks, and its affiliates, to share our vision and effectively work with us to achieve our goals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability and willingness of various third parties, as well as related parties, to engage in research and development activities involving our product candidates, and our ability to leverage those activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to attract additional third party collaborators&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding the ease of administration associated with our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding the patient compatibility associated with our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our beliefs regarding the potential markets for our product candidates and our ability to serve those markets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to produce an &#8220;off-the-shelf&#8221; therapy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our beliefs regarding the potential manufacturing and distribution benefits associated with our product candidates, and our ability to scale up the production of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our plans regarding our manufacturing facilities and our belief that our manufacturing is capable of being conducted in-house&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">our belief in the potential of our aNK</span><span style="color:#000000;">&#160;</span><span style="color:#000000;">cells as a technology platform, and </span><span style="color:#000000;">the fact that our business is based upon the success of our aNK</span><span style="color:#000000;">&#160;</span><span style="color:#000000;">cells as a technology platform&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our aNK platform and other product candidate families, including genetically modified haNK, taNK, t&#8209;haNK, MSC and ceNK product candidates, will require significant additional clinical testing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">even if we successfully develop and commercialize our haNK and t&#8209;haNK product candidates, we may not be successful in developing and commercializing our other product candidates either alone or in combination with other therapeutic agents&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability to obtain and maintain regulatory approval of any of our product candidates, and any related restrictions, limitations and/or warnings in the label of any approved product candidate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to commercialize any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the rate and degree of market acceptance of any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to attract and retain key personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the accuracy of our estimates regarding our future revenue, as well as our future operating expenses, capital requirements and needs for additional financing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain funding for our operations, including funding necessary to complete further development and any commercialization of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain and maintain intellectual property protection for our product candidates and not infringe upon the intellectual property of others&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory developments in the United States, or U.S., and foreign countries&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our expectations regarding the period during which we qualify as a &#8220;smaller reporting company,&#8221; as defined in Rule&#160;12b&#8209;2 of the Securities Exchange Act of 1934.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, you should refer to Part&#160;I, Item&#160;1A, &#8220;<span style="font-style:italic;">Risk Factors</span>&#8221; of this Annual Report for a discussion of other important factors that may cause actual results to differ materially from those expressed or implied by the forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this Annual Report will prove to be accurate. Furthermore, if one or more of these forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Annual Report also contains estimates, projections and other information concerning our industry, our business, and the markets for certain diseases, including data regarding the estimated size of those markets, and the incidence and prevalence of certain medical conditions. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">Item&#160;1. Business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a pioneering clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using our natural killer cells, or NK&#160;cells, to treat cancer and viral infectious diseases. NK&#160;cells are the body&#8217;s first line of defense due to their innate ability to rapidly seek and destroy abnormal cells, such as cancer or virally infected cells, without prior exposure or co-activation by other support molecules that are typically required to train and activate adaptive immune cells such as T&#8209;cells.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A critical aspect of our strategy is to invest significantly in innovating new therapeutic candidates, based upon our proprietary activated&#160;NK, or aNK, cell platform, and conducting clinical testing and scale manufacturing of our most promising biologic product candidates. We believe our aNK cell is capable of being manufactured as a cell-based &#8220;off-the-shelf&#8221; therapy that can be molecularly engineered in a variety of ways to boost its killing capabilities against cancers and virally infected cells.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We retain worldwide </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">commercial </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights to clinical and research data, intellectual property and know-how developed with our aNK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cells, as well as clinical grade master </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and working </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cell bank</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of aNK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, haNK and t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">haNK cell lines</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreement and Plan of Merger with ImmunityBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;21, 2020, NantKwest and ImmunityBio, Inc.&#160;(ImmunityBio) entered into an Agreement and Plan of Merger&#160;(the Merger Agreement), pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The Merger Agreement provides that a wholly owned subsidiary of NantKwest will merge with and into ImmunityBio&#160;(the Merger), with ImmunityBio continuing as the surviving company and being renamed NantCell,&#160;Inc., upon the terms and subject to the conditions therein. At the effective time of the Merger&#160;(the Effective Time), NantKwest&#8217;s name, as the parent of NantCell,&#160;Inc., will be changed to &#8220;ImmunityBio, Inc.&#8221;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Effective Time, each share of ImmunityBio common stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions as set forth in the Merger Agreement, will be converted automatically into a right to receive&#160;0.8190&#160;shares of NantKwest common stock. At the Effective Time, each share of NantKwest common stock issued and outstanding immediately prior to the Effective Time, will remain an issued and outstanding share of the combined company. At the Effective Time, each outstanding option, warrant or restricted stock unit to purchase ImmunityBio common stock will be converted (using the merger exchange ratio of 0.8190) into an option, warrant or restricted stock unit, respectively, on the same terms and conditions immediately prior to the Effective Time, to purchase shares of common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon consummation of the Merger, on a fully-diluted basis, ImmunityBio stockholders and NantKwest stockholders will own approximately 72% and 28%, respectively, of the outstanding shares of common stock of the combined company. It is estimated that, immediately following the closing date, Dr.&#160;Patrick Soon&#8209;Shiong, our Executive Chairman and principal stockholder, and his affiliates will beneficially own, in the aggregate, approximately 82% of the common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following consummation of the Merger, shares of common stock of the combined company are expected to be listed on the Nasdaq Global Select Market under the symbol &#8220;IBRX&#8221;.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms and subject to the conditions set forth in the Merger Agreement, the closing of the Merger depends on a number of conditions being satisfied, including approval of the Merger by holders of a majority of the outstanding shares of NantKwest common stock as of the NantKwest record date (excluding all shares of NantKwest common stock beneficially owned by Dr.&#160;Patrick Soon&#8209;Shiong and his affiliates Cambridge Equities,&#160;LP and Chan Soon&#8209;Shiong Family Foundation or any of their respective controlled affiliates or any of the directors or executive officers of NantKwest or ImmunityBio).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;1, 2021, our Registration Statement on Form&#160;S-4, which was filed with the Securities and Exchange Commission (SEC) in connection with the Merger, was declared effective by the SEC.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A special meeting of the stockholders of NantKwest will be held on March&#160;8, 2021 to consider and vote on a proposal to approve the issuance of shares of common stock of NantKwest to security holders of ImmunityBio, and to consider and vote on a proposal to approve the Merger. Only holders of record of NantKwest common stock at the close of January&#160;29, 2021, will be entitled to notice of and to vote at the special meeting.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect the Merger to close in the first quarter of 2021, subject to receipt of the requisite stockholder approvals and satisfaction of other customary closing conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger is expected to be accounted for as a transaction between entities under common control as Dr.&#160;Patrick Soon&#8209;Shiong is the controlling stockholder of each of NantKwest and ImmunityBio. Upon the closing of the Merger, the net assets of ImmunityBio will be combined with those of NantKwest at their historical carrying amounts and the companies will be presented on a combined basis for all historical periods presented.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Off-the-Shelf Approach</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Multiple Modes of aNK Directed Tumor Cell Killing.<span style="font-weight:normal;font-style:normal;">&#160;&#160; Our NK platform has demonstrated the ability to induce cell death in cancers and virally infected cells through a variety of concurrent mechanisms including:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Innate Killing</span><span style="color:#000000;">, whereby all of our NK platforms, aNK, haNK, taNK and t&#8209;haNK, recognize the abnormal proteins typically found on the surfaces of metabolically stressed cells, which upon binding, release toxic granules to immediately kill their targets&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Antibody</span><span style="font-style:italic;color:#000000;">-</span><span style="font-style:italic;color:#000000;">Mediated Killing</span><span style="color:#000000;"> with our haNK</span><span style="color:#000000;"> and t</span><span style="color:#000000;">&#8209;</span><span style="color:#000000;">haNK platforms</span><span style="color:#000000;">, which are </span><span style="color:#000000;">a</span><span style="color:#000000;">NK&#160;cells engineered to express antibody receptors that can bind to therapeutically administered antibody products or to antibodies naturally produced in the body, thereby enhancing the cancer cell killing effects of those antibodies</span><span style="color:#000000;"> through Antibody Dependent Cell</span><span style="color:#000000;">ular Cytotoxicity, or ADCC&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">iii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">CAR-Directed Killing</span><span style="color:#000000;"> with our taNK and t</span><span style="color:#000000;">&#8209;</span><span style="color:#000000;">haNK platforms, which are aNK&#160;cells engineered to express chimeric antigen receptors, or CARs, that target tumor-specific proteins commonly found only on the surfaces of cancer cells and upon binding, induce cell death through the release of toxic granules directly into their targets and by the release of cytokines and chemokines, which recruit additional innate and adaptive immune responses, including the recruitment of cytotoxic T&#8209;cells.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All three modes of killing&#59; <span style="font-style:italic;">Innate Killing, Antibody-Mediated Killing, and CAR-Directed Killing</span>, are employed by our proprietary t&#8209;haNK platform, which combines all the enhanced NK killing functions of aNK, haNK and taNK into a single product platform.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our primary target therapeutic area is cancer, with a heavy emphasis on solid tumors. According to the National Cancer Institute, almost 1.9&#160;million new cancer cases are expected to be diagnosed in the U.S. during 2021, adding to the 16.9&#160;million already living with cancer. In addition, we plan to advance therapies for hematologic malignancies and virally induced infectious diseases.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Innate Killing&#8212;the aNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have developed a unique NK&#160;cell platform, which we believe is capable of being manufactured as a cell-based &#8220;off-the-shelf&#8221; therapy that can be molecularly engineered in a variety of ways to boost its killing capabilities against cancers and virally infected cells. Unlike normal natural killer cells, our NK&#160;cells do not express the key inhibitory receptors that diseased cells often exploit to turn off the killing function of natural killer cells and escape elimination. We have developed a unique aNK&#160;cell, which omits key inhibitory receptors, while preserving critical activation receptors that enable selective innate targeting and killing of distressed and diseased cells. They do so through the recognition and binding of stress-proteins that are overexpressed on the surfaces of</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">rapidly growing cancer cells due to oxidative and metabolic stress, nutrient deprivation and waste accumulation that typically occurs when cell growth outpaces the capacity of local circulation&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">virally infected cells where the cellular machinery is hijacked to produce an abundance of viral proteins and virions.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our aNK&#160;cells are also designed to deliver a more lethal blow to their target by delivering a larger payload of lytic enzymes and cytokines responsible for both direct and indirect killing when compared to other natural killer cells isolated from healthy donors. This is due to the higher density of lytic granules and larger cell volume possessed by aNK&#160;cells when compared to that of donor-derived natural killer cells. We believe that our aNK&#160;cells can be produced at commercial scale as a &#8216;living drug&#8217; using our proprietary manufacturing and distribution processes to adequately address select global cancer markets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Several phase&#160;I safety studies with unmodified aNK&#160;cells have been conducted in a variety of bulky hematological cancers and solid tumors, enrolling 46&#160;patients in a range of dose levels and schedules with encouraging evidence of single-agent activity and a durable remission, including some complete responses in liquid tumors. Based on these earlier clinical trials, we have further modified our aNK platform through virus-free molecular engineering designed to leverage additional modes of killing available to aNKs, including antibody-mediated killing, the haNK platform, and both antibody-mediated and CAR-directed antigen targeted killing, the t&#8209;haNK platform.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Antibody-Mediated Killing&#8212;the haNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have genetically engineered our aNK&#160;cell platform using a virus-free method to overexpress high-affinity CD16 receptors, which bind to antibodies. These antibody-targeted haNK&#160;cells are designed to directly bind to IgG1-type antibodies, such as avelumab, trastuzumab, cetuximab and rituximab with the intention of enhancing the cancer-killing efficacy of these antibodies by boosting the population of competent natural killer cells that can kill cancer cells through ADCC. Antibody products are abundantly utilized to treat cancer and it is estimated that they generate over $100&#160;billion in reported annual sales. A growing number of studies suggest that clinically meaningful responses to these antibody therapies correlate directly with the overall health of a patient&#8217;s natural killer cell population and whether they express the high-affinity variant of the CD16 receptor. Currently available literature estimates that only approximately 10% to 15% of the addressable patient population eligible for antibody therapies carry high-affinity CD16 receptors. This implies that our haNK product candidate may have significant market potential as a combination therapy to potentially address a large number of patients who do not carry high-affinity CD16 receptors and, as a result, exhibit a poorer response to antibody therapies. We therefore intend to develop our haNK product candidate as a combination therapy with widely-used U.S.&#160;Food and Drug Administration, or FDA, approved antibody products such as avelumab, trastuzumab, cetuximab and rituximab. Current Good Manufacturing Practice, or cGMP, master and working cell banks of our haNK product candidate have been successfully established and will serve as our source for product for our clinical trials and, if approved, commercialization going forward. We have optimized our manufacturing process partly by designing our haNK product candidate to not require IL&#8209;2 cytokine supplementation to the growth media every few days, thereby enabling us to overcome a technically challenging and costly limitation that many other natural killer cell-based therapies face. We have also successfully established processes for large-scale production, cryopreservation and long-term storage of final dose forms, thereby optimizing production efficiencies and allowing for on-demand availability with minimal handling at the infusion sites. Our cryopreserved haNK product candidate has been cleared for clinical testing in several phase&#160;Ib/II clinical trials, including our phase&#160;II Merkel cell cancer study.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed Killing&#8212;the taNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have genetically engineered our aNK platform to express CARs that target tumor-specific antigens found on the surfaces of cancers and virally infected cells. Our taNK&#160;cells are designed to bind directly to these surface antigens and induce cell death through the release of toxic granules directly into the tumor cells and release of cytokines and chemokines to recruit additional innate and adaptive immune responses, including the recruitment of cytotoxic T&#8209;cells. These tumor antigens include checkpoint ligands, such as PD&#8209;L1 and B7&#8209;H4 as well as well-established tumor proteins such as CD19, HER2 and EGFR, all of which can be targeted individually by our engineered taNK products.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical evidence has been mounting which indicates that taNK&#160;cell activation through the binding of its CAR receptors to these cancer specific proteins may be potent enough to override many of the pre-existing inhibitory signals and immunosuppressive factors present in the tumor microenvironment that may be responsible for tumor resistance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed and Antibody-Mediated Killing&#8212;the t&#8209;haNK Platform.<span style="font-weight:normal;font-style:normal;">   Our newest and most promising platform for the development of therapeutic product candidates is an innovative, bioengineered combination of our haNK and taNK platforms that incorporates all the features of our haNK platform together with a CAR. The resulting line of product candidates under this platform avails itself to all three modes of killing:&#160;</span><span style="font-weight:normal;">innate</span><span style="font-weight:normal;font-style:normal;">, </span><span style="font-weight:normal;">antibody-mediated</span><span style="font-weight:normal;font-style:normal;"> and </span><span style="font-weight:normal;">CAR-directed killing</span><span style="font-weight:normal;font-style:normal;">. These product candidates also include one or more additional expression elements such as functional cytokines, chemokines and trafficking factors, making them amongst the most versatile in our portfolio. These product candidates are intended to be combined with commercially available therapeutic antibodies to effectively target either two different epitopes of the same cancer specific protein or two entirely different cancer specific proteins. In addition to our two t&#8209;haNK product candidates, PD&#8209;L1.t&#8209;haNK, currently in phase&#160;II testing, and CD19.t&#8209;haNK, cleared to commence phase&#160;I testing, we believe a pipeline of prominent CARs for t&#8209;haNK, including HER2 and EGFR, which are nearing IND submission, and others that are advancing through clinical enabling studies, will enable us to potentially address an even broader range of cancers as part of a chemotherapy-free combination regimen.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The Nant Cancer Vaccine.<span style="font-weight:normal;font-style:normal;">&#160;&#160; The Nant Cancer Vaccine, or NCV, program is a personalized therapy regimen, which utilizes our &#8220;off-the-shelf&#8221; NK&#160;cell platform as the backbone of the regimen. NCV consists of an initial tumor-conditioning regimen followed by a molecularly-informed immunologic conditioning therapy. More specifically, NCV combines the novel delivery of metronomic, albumin-linked low-dose chemotherapy in conjunction with certain other agents, followed by a sequenced administration of tumor-associated antigen vaccines and an IL&#8209;15 superagonist fusion protein, all of which potentiate our NK&#160;cell therapy to potentially drive immunogenic cell death while avoiding the ravages of toxic high-dose chemotherapy. By inducing immunogenic cell death and enhancing a patient&#8217;s innate and adaptive immune system, NCV is designed to attain a long-term, durable response in multiple cancer types with a potential for lower toxicity and improved efficacy and quality of life in comparison with current standards of care. We believe ultimately that employing our NK&#160;cell therapy in the context of NCV will be a highly effective combination for long term clinical success over available standards of care that employ maximum tolerated dose, tolerogenic cell death and immune system compromise.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Potential Advantages of Our aNK Platform Over T&#8209;Cell and Other Current Immunotherapies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The immune system has two components:&#160;innate immune cells, such as natural killer cells, which are always primed and ready to attack diseased cells, and adaptive immune cells, such as T&#8209;cells, which are recruited and educated through a series of antigen presentation and clonal expansion, eventually mounting a delayed response. Our proprietary aNK platform is specifically designed to potentially address many of the limitations associated with current adaptive autologous cellular immunotherapies. We believe key limitations of adaptive autologous immunotherapy are the need to isolate adequate amounts of naive T&#8209;cells from a cancer patient in a lengthy procedure called leukapheresis and the requirement for a complex individualized genetic transfection and expansion campaign to manufacture each patient&#8217;s therapy. As a consequence, current autologous CAR&#8209;T&#160;cell therapies, in large part, are limited to patients from highly selected hematological cancers and leave many patients ineligible for treatment. Additionally, patients must undergo lympho-depleting chemotherapy prior to receiving CAR&#8209;T therapy and rely on engraftment, thereby exposing themselves to life-threatening serious adverse events for extended periods. For instance, recipients of CD19 CAR&#8209;T therapy develop life-long B&#8209;cell aplasia and hypogammaglobulinemia, requiring immunoglobulin infusion therapy. Acutely, patients may develop cytokine release syndrome or acute or chronic neurotoxicities. Due to these and other events, treatment with CAR&#8209;T requires intensive inpatient and long term monitoring. In contrast, our allogeneic &#8220;off-the-shelf&#8221; NK&#160;cells can be infused in the outpatient setting and do not rely on the patient as the source of suitable immune cells for processing, thereby availing every cancer patient as a potential candidate for on-demand treatment. In addition, our NK&#160;cell therapy is intended to be combined with immune potentiating agents, rather than immuno-depleting agents with the interest of driving a more natural and long-lasting adaptive immune response. This is largely due to the unique versatility of our cell products, which more closely approximates the characteristics of a drug rather than a transplant. Most cell-based immunotherapies are limited to one or a constrained number of doses due to product limitations and cost burdens, thereby </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">driving the need for immune-ablative therapies and reliance on long-term engraftment to achieve clinically meaningful results. In comparison, our NK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cell based therapies can be re-dosed regularly throughout the year and at much higher dose levels without the same product limitations, cost burdens, reliance on long-term engraftment and potential exposure to long-term toxicities.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For these reasons, we believe that our approach includes the following advantages:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Innate immune response.</span><span style="color:#000000;">  aNK platform products are always activated and can naturally detect and rapidly destroy a wide variety of diseased cells without prior exposure to antigens or activation by stimulatory molecules.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Promotion of adaptive immune response.</span><span style="color:#000000;">  aNK platform products stimulate the adaptive component of the immune system by producing chemokines and other molecules that recruit and activate T&#8209;cells directly and through dendritic cells to attack cancers.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Enhancement of ADCC effect with CD16 expressing haNK cells.</span><span style="color:#000000;">  Our haNK product candidates may have significant market potential as a combination therapy with approved monoclonal antibodies, or mAbs, targeting tumor associated antigens, as well as neoepitope induced antibodies, potentially addressing a large number of patients who have poor responses to antibody products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Wide therapeutic potential across multiple tumor types and even late-stage disease.</span><span style="color:#000000;">  In preclinical studies and phase&#160;I and II clinical trials to date, aNK, haNK and t&#8209;haNK&#160;cells have demonstrated activity in a spectrum of cancers, including bulky hematological cancers and solid tumors, as well as late-stage cancer patients who have failed multiple rounds of chemotherapy, radiation and stem cell transplantation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Ability to attack cancer stem cells.</span><span style="color:#000000;">  aNK&#160;cells have been shown in preclinical studies to preferentially attack cancer stem cells, which have demonstrated resistance to conventional chemotherapy.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Applications in diseases beyond cancer.</span><span style="color:#000000;">  We believe aNK platform products have the potential to treat diseases beyond cancer, such as viral infectious diseases because of the inherent ability of natural killer cells to kill virally infected cells. Preclinical studies in HIV, HCV, EBV and Ebola viruses demonstrate this capability.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Well tolerated.</span><span style="color:#000000;">  aNK&#160;platform products are hypo-immunogenic and have shown no dose limiting toxicities in over 900&#160;patient infusions, including in recipients who have received long-term repeat infusions beyond a year.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Ease of administration.</span><span style="color:#000000;">  aNK platform products have been administered in outpatient facilities, potentially offering physicians the flexibility to re-dose therapy in the ambulatory setting for extended periods and in large practices.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Virtually universal patient compatibility.</span><span style="color:#000000;">  aNK platform products do not require patient-donor matching or a minimum level of patient immuno-competence.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Low-cost, efficient and scalable manufacturing.</span><span style="color:#000000;">  aNK, haNK, taNK and t&#8209;haNK&#160;cells have the potential to be expanded on a large scale and readily supplied on demand from what we believe is the world&#8217;s only cGMP compliant aNK, haNK and t&#8209;haNK&#160;cell banks, proprietary assets of our company.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Experienced Management Team</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since the founding of our company in 2002, we have assembled a team of proven, experienced and visionary leaders in biotechnology. Our team is led by Patrick Soon&#8209;Shiong, MBBch, FRCS (C), FACS, who has served as our Chairman since March&#160;2015. Dr.&#160;Soon&#8209;Shiong was first introduced to us in 2007 when our technology was at a very early stage of development and he provided us with advice and scientific development strategies, including demonstration of activity in the clinical setting following irradiation of the cells and demonstration of safety and activity following multiple infusions in patients with both end-stage solid and liquid tumors. Dr.&#160;Soon&#8209;Shiong made an equity investment in our company in December&#160;2014 and joined as our Chief Medical Officer in January&#160;2015. Dr.&#160;Soon&#8209;Shiong became our Chairman in March&#160;2015 and served as our Chief Executive Officer, or CEO, from March&#160;2015 until October&#160;2020. Effective October&#160;2020, Dr.&#160;Soon&#8209;Shiong has served as our Executive Chairman of the board of directors. Dr.&#160;Soon&#8209;Shiong, a renowned surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers in the U.S., and has been issued over 230 worldwide patents on groundbreaking advancements spanning a myriad of fields. He performed the first encapsulated islet stem cell transplant in a diabetic patient in the U.S. He invented, developed and launched the first nanoparticle delivery system of human albumin, abraxane. Dr.&#160;Soon&#8209;Shiong was founder, Chairman and CEO of American Pharmaceutical Partners (sold to Fresenius SE for approximately $4.6&#160;billion in 2008), Abraxis BioScience (sold to Celgene Corporation for approximately $3.8&#160;billion in 2010), and NantWorks, an ecosystem of companies to create a transformative global health information and next generation pharmaceutical development network.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Richard Adcock </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was appointed as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our C</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EO</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in October&#160;2020. Prior to joining NantKwest, Mr.&#160;Adcock served as CEO of Verity Health from January&#160;2018 to September&#160;2020. Verity Health was previously affiliated with </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dr.&#160;Soon</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shiong</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> until 2018. Prior to Verity Health, Mr.&#160;Adcock served in various capacities at Sanford Health, including as its Chief Innovation Officer, President, Executive Vice President and Director from 2004 to 2017. Prior to Sanford Health, Mr.&#160;Adcock served as Global Engineering Director at GE Healthcare from 1999 to 2003.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Barry Simon, M.D., our President and Chief Administrative Officer, who was our CEO from May&#160;2007 until March&#160;2015 and our President and Chief Operating Officer from March&#160;2015 to December&#160;2016, brings decades of drug development and executive leadership experience from Roche Labs, F.&#160;Hoffmann&#8209;La Roche, Connetics Corp. and Immunomedics, having successfully contributed to Biologics License Applications, or BLAs, and commercial drug launches for Xeloda, Pegasys, Kytril, Fortovase, Valcyte, Fuzeon and Tamiflu.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have experienced executives leading our research and development, manufacturing, preclinical and clinical development, regulatory and medical affairs, finance and other critical areas of our business, and we continue to build our manufacturing and administrative infrastructure.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Company Vision</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We aspire to be the premier immunotherapy company, with the ultimate goal of harnessing the power of the innate immune system&#8212;with the NK&#160;cell at its core&#8212;to pioneer precision medicine in treatments for cancers and viral infectious diseases.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Core Strategies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our goal of becoming the world leader in immunotherapy for cancers and other diseases can be realized through a major reframing of how we apply the collective knowledge amassed in this field to date. This starts with precisely determining the &#8216;molecular address&#8217; of the target disease and leveraging this knowledge in the selection and staging of both tumor and immune conditioning agents in accordance with our understanding of biological mechanisms of action and the natural order of immune biology. Metronomic, low-doses of certain agents would be utilized to potentiate cellular stress and boost tumor immunogenicity, while an array of other agents would be applied selectively and sequentially to propagate a meaningful and lasting adaptive immune response. We believe that by utilizing the NK&#160;cell as the backbone and central coordinator as we engage and sequentially orchestrate the entire ecosystem of immune cells, we can effectively empower the patient&#8217;s own immune system to regain control by becoming its own &#8216;drug factory&#8217; that can establish and once again maintain a cancer-free environment in the body. The key elements of our strategy include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Pursuit of both accelerated regulatory pathways and large market opportunities.</span><span style="color:#000000;">  We are pursuing a comprehensive clinical development plan designed to maximize the commercial potential of our haNK and t&#8209;haNK platforms as the backbone in the treatment of cancers in a streamlined combination with a PD&#8209;L1 checkpoint inhibitor and a highly selective and molecularly enhanced IL&#8209;15 superagonist fusion protein. We intend to pursue accelerated regulatory approval pathways and seek indications that can lead to orphan drug status and breakthrough therapy designation, as well as pursue large market opportunities in select solid tumors in the shortest feasible timeframe.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Advance our next-generation t&#8209;haNK products towards phase&#160;II and registration trials.</span><span style="color:#000000;">&#160;&#160;Our broadly applicable t&#8209;haNK product, PD&#8209;L1.t&#8209;haNK, is currently undergoing testing in a phase&#160;II trial in pancreatic cancers and has received FDA authorization to begin testing in non-small cell lung cancers with an additional phase&#160;II trial submission in triple negative breast cancers with concurrent chemotherapy in preparation for submission. Additionally, our CD19.t&#8209;haNK IND application has been approved by the FDA for a dose escalation phase&#160;I study in patients with CD19 expressing diffuse large&#160;B-cell lymphomas and our HER2.t&#8209;haNK IND application is nearing completion and being readied for submission with the FDA during the first half of 2021. Additions to our pipeline of near-term IND-ready t&#8209;haNK product candidates include an EGFR t&#8209;haNK product during the second half of 2021.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Progress our lead haNK product candidate through phase&#160;II and registration trials.</span><span style="color:#000000;">&#160;&#160;We are leveraging the combined human safety and activity data accumulated to date on haNK therapy to conduct our multi-center phase&#160;II trial in patients with Merkel cell carcinoma who have relapsed on checkpoint therapy.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Leverage our exclusive co-development agreement with ImmunityBio for N-803.</span><span style="color:#000000;">&#160;&#160;As with the emergence of dozens of CAR</span><span style="color:#000000;">&#8209;T companies following the success of a select few, more and more </span><span style="color:#000000;">natural killer cell therapy</span><span style="color:#000000;"> companies are forging ahead into the cancer immunotherapy space. Due to the lack of market access to suitable companion products for co-development, suc</span><span style="color:#000000;">h as cytokine therapies, many natural killer cell therapy</span><span style="color:#000000;"> developers are following the path of CAR</span><span style="color:#000000;">&#8209;T sponsors in the use of myeloablative therapies that support engraftment, but at the same time suppresses immune recruitment and the recipient&#8217;s ability to mount an adaptive immune response. N</span><span style="color:#000000;">&#8209;803 </span><span style="color:#000000;">is an experimental IL</span><span style="color:#000000;">&#8209;15 superagonist</span><span style="color:#000000;"> fusion protein</span><span style="color:#000000;">, currently in late stage registration trials by ImmunityBio, Inc., an affiliated entity. Our utilization of N</span><span style="color:#000000;">&#8209;803 </span><span style="color:#000000;">in combination with our NK therapies across our clinical program affords us an additional distinction and competitive advantage where we combine systemic activation of recipient </span><span style="color:#000000;">natural killer</span><span style="color:#000000;"> and T</span><span style="color:#000000;">&#8209;cells with chemotherapy-free treatment regimens for maximal immune response and memory T</span><span style="color:#000000;">&#8209;cell formation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Pursue partnering opportunities with pharmaceutical companies for commercially approved antibodies and select late-stage antibodies in development.</span><span style="color:#000000;">&#160;&#160;Numerous biopharmaceutical companies have previously licensed our research-grade haNK&#160;cells through an affiliated entity for non-therapeutic applications that facilitate the discovery, selection and validation of their antibody candidates for development. A growing number of these biopharmaceutical companies have also licensed our cells for use in their antibody manufacturing and testing procedures in order to satisfy requirements by the FDA and comparable foreign regulatory agencies. There may be multiple opportunities to leverage these biopharmaceutical business relationships to forge therapeutic collaborations to conduct clinical studies with our haNK and t&#8209;haNK product candidates in combination with their late-stage and commercial antibody products to demonstrate enhanced activity when used in combination.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Accelerate clinical development of our t&#8209;haNK products by implementing phase&#160;Ib/II basket trials.</span><span style="color:#000000;">&#160;&#160;A growing number of antibody and other anti-cancer products are being marketed for multiple cancer types that share the same molecular abnormality. We plan to accelerate clinical development of our PD&#8209;L1.t&#8209;haNK, CD19.t&#8209;haNK and HER2.t&#8209;haNK product candidates by designing trials that permit the enrollment of patients whose cancers demonstrate high levels of PD&#8209;L1, CD19 and HER2, respectively, from a number of select cancer types. We believe this approach will enhance the development potential of our t&#8209;haNK product pipeline.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Employ an adaptive approach to our clinical trials designs.</span><span style="color:#000000;">&#160;&#160;As we explored complex combinations in our NCV trials that combined tumor conditioning agents, IL&#8209;15 cytokine activation, adenoviral and yeast vaccine driven dendritic cell activation and antibody therapy together with our haNK cell therapy across multiple tumor types, we continued to optimize the treatment design over time after accumulating sufficient outcome observations through IND amendments and new IND filings. By doing so, we were able to considerably condense the development time frame while providing patient access to the enhanced protocol designs much sooner than would have otherwise been possible.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Establish low-cost, scalable manufacturing capabilities to support late-stage clinical trials and global commercialization.</span><span style="color:#000000;">&#160;&#160;We believe our aNK platform product candidates offer unique advantages of a simplified, on-demand manufacturing process that is relatively easy to scale and requires minimal handling at the site of infusion. We opened our second state-of-the-art commercial production facility in El Segundo, California at the beginning of 2021 and transferred all of our t&#8209;haNK manufacturing operations from our first facility in El Segundo. We believe this new facility is capable of producing clinical product for all our clinical trials for multiple product lines. We have developed novel manufacturing methods, including the use of proprietary equipment that employs state-of-the-art optics, as well as proprietary media, designed to maximize the attributes of our NK product lines. We have eliminated the need for IL&#8209;2 media supplementation in all of our bioreactors and product lines, thereby simplifying the expansion process and shortening the culturing times while significantly reducing production costs. We have also implemented proprietary cryopreservation methods that enable large-scale production yields that can be easily processed into final frozen dose forms for long-term storage and simple, on-demand shipping. Cryopreservation allows for significant cost efficiencies and the establishment of a substantial commercial pipeline supply, much like shelf-stable pharmaceutical drugs. We have effectively eliminated reliance on third party contract manufacturers, with the associated risks to cost, time and reliability. We plan to continue to improve our costs as we scale up production to larger capacity bioreactors that can support serial harvests, the utilization of consumables that will support fully automated production lines from harvest to cryopreserved product and establish additional efficiencies across products pipelines.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Pursue opportunities with vaccine combination partnerships that drive in&#160;vivo production of anti-cancer antibodies for ADCC killing with haNK and t&#8209;haNK cells.</span><span style="color:#000000;">&#160;&#160;Upon achieving initially anticipated BLAs for our haNK and PD&#8209;L1.t&#8209;haNK products in simple combinations with N&#8209;803 and a monoclonal antibody, we plan to initiate a wide range of combination therapy studies that incorporate adenoviral and yeast vaccine platforms to deliver tumor associated antigens which induce the natural production of IgG1-type antibodies in patients, and when combined with our haNK and t&#8209;haNK products, would be expected to potentiate ADCC killing.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Extend our NK platform to address diseases beyond cancer.</span><span style="color:#000000;">&#160;&#160;We believe our aNK platform has the potential to address diseases beyond cancer such as viral infectious diseases because of the in</span><span style="color:#000000;">nate</span><span style="color:#000000;"> ability of </span><span style="color:#000000;">natural killer </span><span style="color:#000000;">cells to kill virally infected cells. Preclinical studies in HIV, HCV, EBV and Ebola viruses demonstrate this capability. </span><span style="color:#000000;">Pre</span><span style="color:#000000;">clinical</span><span style="color:#000000;"> e</span><span style="color:#000000;">fforts are underway to evaluate the role of </span><span style="color:#000000;">h</span><span style="color:#000000;">aNK </span><span style="color:#000000;">in combination with select broadly neutralizing antibody</span><span style="color:#000000;">, or bNAb,</span><span style="color:#000000;"> </span><span style="color:#000000;">candidates </span><span style="color:#000000;">in clearing HIV reservoirs as part of a novel immunotherapy combination regimen.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Therapeutic Platforms</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leveraging Our Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed a pre-clinical portfolio of t&#8209;haNK products based on the combined attributes of our existing haNK and taNK platforms. We have also advanced our haNK product candidate into clinical trials across several solid-tumor types, which incorporates a comprehensively orchestrated tumor and immune-conditioning regimen known as the Nant Cancer Vaccine, or NCV, and generated compelling safety and activity data. We now plan to advance our lead clinical candidates from the haNK and t&#8209;haNK platforms into checkpoint inhibitor and IL&#8209;15 superagonist fusion protein combination trials in select cancer indications.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our aNK Platform is the Foundation for Our haNK, taNK and t&#8209;haNK Product Candidates.<span style="font-weight:normal;font-style:normal;">&#160;&#160;Based on the unique characteristics of our aNK&#160;cells, we continue to expand the potential therapeutic applications of this platform through molecular engineering designed to leverage the multiple modes of killing available to aNK&#160;cells, including&#160;(1)&#160;innate plus antibody-mediated killing, the haNK platform&#59; (2)&#160;innate plus antigen targeted killing, the taNK platform&#59; and (3)&#160;a combination of all three, the t&#8209;haNK platform, as illustrated below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000001.jpg" title="" alt="" style="width:720px;height:550px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Antibody-Mediated Killing - the haNK Platform.<span style="font-weight:normal;font-style:normal;">  We have genetically engineered our aNK&#160;cells to both overexpress high-affinity CD16 receptors and the IL&#8209;2 cytokine. These haNK&#160;cells are well suited to directly bind to concurrently administered therapeutic antibodies such as avelumab, trastuzumab, cetuximab and rituximab to potentially enhance their targeted cancer killing effects through ADCC, as illustrated below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000002.jpg" title="" alt="" style="width:719px;height:532px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed Killing - the taNK Platform.<span style="font-weight:normal;font-style:normal;">  We have genetically modified our aNK&#160;cells to incorporate CARs that target cancer specific proteins typically found on the surface of cancer cells. These taNK&#160;cells are designed to directly bind to these surface proteins in a variety of solid and hematological cancers and induce cell death through the release of toxic granules directly into the tumor cell and the release of cytokines and chemokines, which recruit additional innate and adaptive immune responses, including the recruitment of cytotoxic T&#8209;cells. CARs are complex molecules that are designed to traverse the cell membrane and are comprised of four elements:&#160;(1)&#160;the antibody-derived single-chain Fv fragment, or scFv, which appears on the external membrane surface of the taNK&#160;cell, where it is exposed and available to bind to cancer specific antigens&#59; (2)&#160;a transmembrane hinge region&#59; (3)&#160;a CD28 co-stimulatory domain&#59; and (4)&#160;one of several signaling domain segments which resides on the internal surface of the membrane where, upon external scFv binding, it is available to signal the activation cascade to release cytotoxic compounds to destroy the targeted cancer cell. Unlike CAR&#8209;T and T&#8209;cell receptor therapies, taNK killing is human leukocyte antigen, or HLA, independent for &#8220;off-the-shelf&#8221; applications and does not depend on additional (second-generation) co-stimulatory domains, such as 4&#8209;1BB or OX40, which are often necessary in CAR&#8209;T cells for immune cell activation and survival.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000003.jpg" title="" alt="" style="width:720px;height:540px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed and Antibody-Mediated Killing - the t&#8209;haNK Platform.<span style="font-weight:normal;font-style:normal;">  We have genetically engineered our aNK&#160;cells to exhibit all three mechanisms of killing, thereby imparting CAR targeted killing via cancer specific antigens, ADCC based killing as mediated by antibody products, innate killing inherent to natural killer cells, as well as independence from IL&#8209;2 supplementation for expansion and viability. Based on this unique arrangement, t&#8209;haNK&#160;cells can target two distinct cancer antigens at once:&#160;one via its CD16 receptor together with an antibody such as rituximab&#160;(CD20), and the other through its CAR receptor&#160;(i.e.&#160;PD&#8209;L1), as illustrated below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000004.jpg" title="" alt="" style="width:719px;height:404px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the taNK and t&#8209;haNK&#160;cell lines, the activation signaling that results from the binding of the CARs to the tumor-specific antigens can be strong enough to overcome both cancer escape mechanisms and suppressive factors present in the tumor microenvironment. These tumor antigens encompass three categories of proteins, all of which can be targeted individually by our engineered taNK products:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Checkpoint ligands, such as PD&#8209;L1 and B7&#8209;H4&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Well-established tumor proteins such as CD19, HER2 and EGFR&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">iii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Novel surface antigens associated with cancer stem cells.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below is a partial list of CAR modified aNK products in the literature and their intended tumor types.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000005.jpg" title="" alt="" style="width:672px;height:290px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Non-Clinical Validation of Lenti- and Retroviral Generated taNK Cell Lines&#59; a Compelling Case for Virus-Free t&#8209;haNK-Based Therapies.<span style="font-weight:normal;font-style:normal;">&#160;&#160;We are preparing a novel lineup of virus-free t&#8209;haNK product candidates that are cryopreserved, CAR expressing cell lines based on our haNK&#160;cell therapeutic, one of which is progressing through a phase&#160;II clinical trial. Our rapid advancement of the virus-free t&#8209;haNK platform has enabled us to discontinue all use of viral vectors as a means to genetically enhance our platforms. These next-generation products avoid the safety concerns associated with the use of retro- and lentivirus sequences, incorporate the high-affinity CD16 receptor for enhanced antibody-mediated killing, as well as IL&#8209;2 for IL&#8209;2 growth independence, which can potentially reduce production costs and enhance clinical efficacy.</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000006.jpg" title="" alt="" style="width:720px;height:380px;" /></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Latest Addition to Our Platforms</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our GMP-in-a-Box Approach</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NantKwest is leading the efforts to generate allogeneic and autologous-sourced cell based products, the most advanced of which are our cytokine enriched memory-like NK, or ceNK, and mesenchymal stem cell, or MSC, therapeutics. We utilize a scalable GMP production process that combines the use of ImmunityBio&#8217;s (a related party) semi-automated manufacturing equipment and software, cytokine expansion and activation reagents, including ImmunityBio&#8217;s N&#8209;803, and unique user-friendly processing methods, all of which are proprietary. We have optimized processes for generating both fresh and cryopreserved clinical dose forms of ceNK&#160;cells with 100% purity (in the allogeneic setting) from a variety of sources, including cord blood and allogeneic and autologous peripheral blood. We have also optimized processes for generating fresh and cryopreserved clinical dose forms of MSCs from cord blood, cord tissue and allogeneic bone marrow sources. We avoid the use of both feeder-layers and feeder-layer derived substances for activation as well as other commonly applied additives that frequently create downstream issues in achieving a high-quality, operator-friendly reproducible final dose form and have been able to generate multiple dose forms from each donor product, both of which are critical features in achieving scalability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cytokine Enriched Natural Killer (ceNK) Cell Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; Cytokine-induced memory-like NK&#160;cells are a unique set of lymphocytes that differentiate after a brief pre-activation with interleukin&#8209;12&#160;(IL&#8209;12), IL&#8209;15, and IL&#8209;18 and exhibit enhanced responses to cytokine re-stimulation that include enhanced interferon&#8209;g production and cytotoxicity against leukemic cell lines. These cells have been isolated and characterized by their unique cell-surface marker profile and their highly desirable feature of immune-memory, marked by their pronounced anti-cancer activity for weeks to months in duration, which has made these cells a research focus for more than a decade.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on published literature, we believe the ability to generate these memory-like cells at clinically meaningful quantities has been limited to the work performed at Washington University by T.A.&#160;Fehniger,&#160;et&#160;al. Published data so far has been limited to the acute myeloid leukemia patient population in the post-allogeneic, haploidentical stem cell transplantation setting, for which the Fehniger group has generated enough cells to provide a one-time dose of these cytokine-activated, memory-like natural killer cells.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cytokine enriched natural killer cell program is based on the ability to enrich and expand donor-sourced natural killer cells in a GMP facility to a clinically relevant scale, which allows for the production of a pure cytokine activated and expanded NK&#160;cell population that possesses the unique phenotype we specifically refer to as M&#8209;ceNK&#160;cells.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed a unique ability to generate a portfolio of distinct ceNK&#160;cell products through the application of ImmunityBio&#8217;s proprietary GMP-in-a-Box bioreactors and cytokines and our proprietary methods and overall expertise in scale manufacturing of NK&#160;cell based products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Mesenchymal Stem Cell (MSC) Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; Bone marrow-derived allogeneic MSCs are considered to be a prominent cell type to treat degenerative diseases and autoimmune disorders. MSCs are reported to be immunoprivileged, allowing for transplantation of allogeneic MSCs without the risk of being rejected by the host immune system. MSCs have been found to be capable of modulating immune responses, thereby reducing inflammation as well as immunopathology and protecting alveolar epithelial cells during acute respiratory distress syndrome, or ARDS, including that triggered by cytokine storm. More importantly, MSCs demonstrated promising activity in reducing the non-productive inflammation and in promoting lung generation in a phase&#160;II clinical trial, as well as in patients with ARDS in clinical practice. As a result, we believe MSCs have the potential to alleviate the SARS&#8209;CoV&#8209;2-derived cytokine storm and ARDS, and thereby have an effect on the treatment of subsequent chronic respiratory dysfunction and lung fibrosis.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed and optimized procedures and proprietary protocols to generate multiple dose forms of MSC products from a single bone marrow or cord tissue sample, in a scalable format using ImmunityBio&#8217;s GMP-in-a-Box system.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000007.jpg" title="" alt="" style="width:719px;height:408px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Development Update on our Product Candidates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our leading programs reside in two core disease areas:&#160;Oncology, which includes our haNK and PD&#8209;L1.t&#8209;haNK programs, and COVID&#8209;19, which includes our joint BM&#8209;Allo&#8209;MSC therapeutic and hAd5 vaccine programs. We also have a pipeline of IND-ready t&#8209;haNK and ceNK projects in both solid and liquid cancers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Pancreatic Cancer</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pancreatic cancer is one of the deadliest cancers for patients in the U.S. Pancreatic cancer is the third leading cause of cancer-related death in the U.S., behind only lung cancer and colorectal cancer, and is expected to become the second-leading cause after lung cancer by the early 2020&#8217;s. The overall five-year survival rate is just 9%. In 2019, an estimated 56,770&#160;people were diagnosed with pancreatic cancer in the U.S., and approximately 45,750&#160;of those newly diagnosed will die from the disease. Pancreatic cancer is the ninth-most commonly diagnosed cancer in women and the tenth-most commonly diagnosed cancer in men. Only about 20% to 30% of cases are found early enough to treat surgically, before the cancer has spread, and surgery gives the only chance that this cancer can be eradicated. Treatment options for pancreatic cancer patients include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and clinical trials. Pancreatic cancer is uniformly accepted as an area of serious unmet medical need, with five-year relative survival rates by SEER stage at diagnosis of 37% for localized, 12% for regional, 3% for distant, and 9% for all SEER stages combined.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">QUILT&#160;88</span><span style="font-weight:normal;"> is a phase&#160;II, open-label, randomized, three-cohort comparative study of PD</span><span style="font-weight:normal;">&#8209;L1.t</span><span style="font-weight:normal;">&#8209;haNK, N</span><span style="font-weight:normal;">&#8209;803 and aldoxorubicin in combination with standard-of-care therapy versus standard-of-care therapy alone for front-line maintenance, second-line and third-line or greater treatment of 298&#160;subjects with locally advanced or metastatic pancreatic cancer. Each of the three cohorts are being conducted as standalone studies:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">A.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">as front-line maintenance therapy in patients that have achieved a clinical response after first-line standard-of-care therapy,</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">B.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">in second-line therapy, and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">C.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">in third-line therapy or greater.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cohorts&#160;A and B will have their own control arms while cohort&#160;C will be conducted as a single-arm, open-label study. Safety and progression-free survival for cohorts&#160;A and B will be compared within the groups using RECIST Version&#160;1.1 criteria based on blinded independent central review. Secondary objectives include initial safety and additional efficacy measures, including overall response rate, complete response rate, durability of response, disease control rate, and overall survival.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All three study cohorts of the trial are open and actively enrolling patients at Hoag Memorial Hospital Presbyterian in Orange County, California, the Immuno-Oncology Clinic,&#160;Inc. in Los Angeles County, California, and Avera McKennan Hospital and University Health Center in Sioux Falls, South Dakota, the latter serving patients in the tri-state area of Iowa, Nebraska and South Dakota. More than 50&#160;patients are currently enrolled in or being evaluated for the trial.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In our initial Cancer Moonshot QUILT trials of haNK and avelumab (PD&#8209;L1 checkpoint inhibitor) for patients with metastatic pancreatic cancer, we explored the hypothesis that by activating the patient&#8217;s own immune system, a paradigm change in cancer therapy could evolve to eradicate cancer cells without high-dose chemotherapy. From 2017 to 2020, multiple QUILT clinical trials exploring the combination of haNK cell therapy, immune-modulating antibodies, adenovirus-based cancer vaccines, and low-dose chemotherapy provided preliminary results showing the median survival rate can be more than doubled, compared to historical controls, from three&#160;months to eight&#160;months.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000008.jpg" title="" alt="" style="width:720px;height:408px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In an expanded access program for patients with advanced metastatic pancreatic cancer who had no available approved treatment options, a complete remission was achieved when replacing haNK and PD&#8209;L1 checkpoint inhibitor avelumab with PD&#8209;L1.t&#8209;haNK and four out of &#64257;ve&#160;patients are alive 8&#160;to&#160;16&#160;months since beginning treatment on these expanded protocols as of January&#160;12, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000009.jpg" title="" alt="" style="width:719px;height:354px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On the basis of these initial studies, we initiated our QUILT&#160;88 trials in metastatic pancreatic cancer in October&#160;2020. While the data are still early study in cohort&#160;C, for which the primary endpoint is overall survival, 15&#160;out&#160;of&#160;18&#160;(83%) of the patients enrolled with second-line or greater pancreatic cancer remain alive as of January&#160;12, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000010.jpg" title="" alt="" style="width:720px;height:378px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Triple Negative Breast Cancer</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Breast cancer is the most common cancer among women in the U.S., the second most common cause of cancer death, and the main cause of death in women ages 45 to 55&#160;years. In 2019, the latest year for which incidence data are available, 268,600&#160;women in the U.S. were diagnosed with breast cancer, and an estimated 41,760&#160;women died of the disease. Triple Negative Breast Cancer, or TNBC, accounts for approximately 15% of all breast cancers. Of these TNBC cases, about 75% are "basal-like." TNBC is a subtype of breast cancer that lacks expression of the estrogen receptor, or ER, and progesterone receptor, or PR, and does not overexpress the human epidermal growth factor&#160;2 receptor, or HER2, protein. TNBC is an important area of research for both researchers and clinicians alike because:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">TNBC is a poor prognostic factor for disease-free and overall survival&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">No effective specific targeted therapy is readily available for TNBC&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">iii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">There is a clustering of TNBC cases in premenopausal women and in women of African descent&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">iv.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The overlap of BRCA1-associated breast cancers with the TNBC phenotype is significant.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The prevalence of TNBC is highest in premenopausal African American women. A recent report notes that 39% of all African American premenopausal women diagnosed with breast cancer are diagnosed with TNBC. The prevalence of TNBC in this same age group in non-African American women is much lower, at approximately 15%. After adjusting for age and stage at diagnosis, African American women were almost three times more likely than white women to have triple-negative tumors. These ethnic or menopausal differences are not seen in either the ER+/HER2+ breast cancer subgroup or the ER+/HER2&#8211; subgroup. Five-year relative survival rates for TNBC by SEER stage at diagnosis are 91% for localized, 65% for regional, and 11% for distant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TNBC has fewer treatment options than other types of invasive breast cancer. This is because the cancer cells do not have the estrogen or progesterone receptors or enough of the HER2 protein to make hormone therapy or targeted drugs work. If the cancer has not spread to distant sites, surgery is an option. Chemotherapy might be given first to shrink a large tumor followed by surgery. Chemotherapy might also be given after surgery to reduce the chances of the cancer coming back. Radiation might also be an option depending on certain features of the tumor.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because hormone therapy and HER2 drugs are not choices for women with TNBC, chemotherapy is often used. In cases where the cancer has spread to other parts of the body (i.e., stage&#160;IV) chemotherapy and other treatments that can be considered include PARP inhibitors, platinum chemotherapy, or immunotherapy.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">QUILT&#160;3.067<span style="font-weight:normal;font-style:normal;"> is a phase&#160;II, open-label, single-arm trial evaluating the same novel triple combination of &#8220;off-the-shelf&#8221; haNK cell therapy with N&#8209;803 and avelumab following a tumor conditioning regimen in subjects that have progressed on or after standard-of-care therapy for TNBC. Patient follow-up concluded during the third quarter of 2020 for the long-term responders in the trial and final data is being collated for a final study report. We last reported an overall response rate by immune response RECIST criteria in 6&#160;of 9&#160;patients&#160;(67%), a complete response rate in 3&#160;of 9&#160;patients&#160;(33%)&#160;(one unconfirmed), a median progression-free survival by immune response RECIST criteria of 14.3&#160;months and a median overall survival of 20.2&#160;months.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the recent FDA approval of sacituzumab in patients with third-line TNBC, based on a 33% overall response rate, we believe that the addition of PD&#8209;L1.t&#8209;haNK and N&#8209;803 may result in meaningful improvements in clinical outcomes. As such, we are preparing for an open-label, randomized controlled phase&#160;III trial of PD&#8209;L1.t&#8209;haNK and N&#8209;803 in combination with sacituzumab versus sacituzumab alone. For the primary objective, we will compare the overall response rate between the two arms using RESIST criteria in solid tumors, Version&#160;1.1. Secondary objectives will include assessments of safety, event-free survival, overall survival and durability of response using the same RESIST Version&#160;1.1 criteria. The study will contain a safety lead-in phase in which the safety and tolerability of sacituzumab + PD&#8209;L1.t&#8209;haNK + N&#8209;803 will be assessed prior to the Phase&#160;III portion of the study. We anticipate filing an IND in the first quarter of 2021.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000011.jpg" title="" alt="" style="width:720px;height:442px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Non-Small Cell Lung Cancer</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lung cancer is the second most common cancer. The American Cancer Society estimates that about 235,760 new cases of lung cancer will be diagnosed in the U.S. in 2021 and an estimated 131,880 patients will die of the disease. Non-small cell lung cancer, or NSCLC, is often insidious, producing no symptoms until the disease is well advanced. NSCLC makes up about 80% to 85% of all lung cancers. The three main types of NSCLC are squamous cell carcinoma, and non-squamous cell carcinoma, consisting of adenocarcinoma and large cell carcinoma. Adenocarcinoma is the most common form of lung cancer in the U.S., among both men and women. Squamous cell carcinoma, is the second most prevalent, accounting for 25% of all lung cancers. Large cell carcinoma is the smallest, accounting for approximately 10% of NSCLC tumors. Early recognition of symptoms may be beneficial to outcome. At initial diagnosis, 20% of patients have localized disease, 25% of patients have regional metastasis, and 55% of patients have distant spread of disease. Symptoms depend on the location of cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The five-year survival rate for NSCLC is 24%. However, it is important to note that survival rates depend on several factors, including the subtype of lung cancer, and the stage of disease. For people with localized NSCLC, which means the cancer has not spread outside of the lung, the overall five-year survival rate is 61%. For regional NSCLC, which means the cancer has spread outside of the lung to nearby areas, the five-year survival rate is approximately 35%. If the cancer has spread to distant parts of the body, called metastatic lung cancer, the five-year survival rate is 6%. As a result of new effective treatments, this number is changing, although better therapies are acutely needed.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">QUILT&#160;3.055 <span style="font-weight:normal;font-style:normal;">is a phase&#160;IIb, open-label, multi-cohort study of combination immunotherapy in patients with NSCLC who have previously received treatment with immune checkpoint inhibitors. Patients are eligible to enter into the cohort designated to receive third-line combination immunotherapy consisting of PD&#8209;L1.t&#8209;haNK cell therapy, N&#8209;803 and a checkpoint inhibitor after progressing on one of four other treatment cohorts within the study. The primary efficacy endpoint of the study is overall response rate per RECIST Version&#160;1.1. Secondary endpoints include progression-free survival, overall survival and durability of response using RECIST Version&#160;1.1 criteria. The IND amendment to include this third-line study cohort has been authorized by the FDA. Observed responses in this trial will guide our plans to conduct a subsequent phase&#160;II trial in second-line NSCLC patients.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Merkel Cell Carcinoma</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Merkel cell carcinoma, or MCC, is a rare and aggressive skin cancer that arises from uncontrolled growth of cells in the skin. Increasing in incidence, approximately 2,000&#160;new cases are reported in the U.S. each year. Patients with metastatic or locally advanced MCC have an extremely poor prognosis, with less than 20% of patients surviving longer than five years. Typically, these patients are treated with a range of drugs, including chemotherapy, which can result in significant side effects. Although new immune therapies have the potential to improve survival, MCC is still fatal for a majority of patients who have progressed on or after treatment with a checkpoint inhibitor and represents an unmet medical need.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">QUILT&#160;3.063<span style="font-weight:normal;font-style:normal;"> is our phase&#160;II, open-label, single-arm trial evaluating the novel triple combination of &#8220;off-the-shelf&#8221; haNK cell therapy with N&#8209;803 and avelumab, without chemotherapy in subjects that have progressed after treatment with a checkpoint inhibitor for MCC. This trial is currently open at multiple centers across the U.S. As a rare disease, with approximately 2,000&#160;patients being diagnosed in the U.S. each year, MCC patients often require regional referral and additional travel to a clinical trial site. The ongoing COVID&#8209;19 pandemic has continued to have an impact on enrollment due in part to limitations in travel and study accessibility as well as a significant reduction in patient referrals. In response to this, we will continue to implement measures to increase local community awareness of the trial as we add new sites. While we remain cautiously optimistic, it may require additional time to reach our interim data readout.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Additional Oncology Programs Update</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate pursuing additional indications for our PD&#8209;L1.t&#8209;haNK product candidate, such as in the neoadjuvant setting in combination with N&#8209;803 and a checkpoint inhibitor for newly diagnosed patients with head and neck squamous cells cancers in collaboration with the National Cancer Institute. In the near future we also plan to initiate a series of phase&#160;I first-in-human trials with our IND-ready t&#8209;haNK products HER2.t&#8209;haNK, EGFR.t&#8209;haNK and the FDA authorized CD19.t&#8209;haNK. Likewise, we are nearing an IND filing for a phase&#160;I ceNK trial in locally advanced solid cancers.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">COVID&#8209;19 Programs Update</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">QUILT&#8209;COVID&#8209;19&#8209;MSC<span style="font-weight:normal;font-style:normal;"> is a randomized, double-blind placebo-controlled phase&#160;Ib study to assess the safety of therapeutic treatment with immunomodulatory bone marrow-derived MSC, or BM&#8209;Allo&#8209;MSC, in adults with severe COVID&#8209;19 infection. This clinical trial will evaluate the safety and efficacy of BM&#8209;Allo&#8209;MSC versus best supporting care in treating patients with severe disease requiring ventilator support during COVID&#8209;19 infection. A total of 45&#160;subjects receiving care in the critical care or ICU setting for COVID&#8209;19 will be enrolled in this study. Subjects will be randomized in a 2:1 fashion to the experimental and control arms, respectively. Primary endpoints include incidence of adverse events, mortality and number of ventilator-free days within 60&#160;days of randomization. All subjects will also be assessed using the standard National Early Warning Score, or NEWS score (Royal College of Physicians 2012).</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A second, more efficient commercial source of MSC&#160;cells has been developed in-house, using cord tissue. Consequently, we recently filed a second IND for CT&#8209;Allo&#8209;MSC&#160;cells using the same trial design and plan to shift our clinical trial effort to this new protocol, which we plan to open at several clinical sites in Southern California, including Hoag Hospital in Newport Beach, California.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">QUILT&#160;4001<span style="font-weight:normal;font-style:normal;"> is an hAd5 adenoviral COVID vaccine trial operated by our affiliate, ImmunityBio, under a Joint COVID&#8209;19 Collaboration Agreement, described below. This phase&#160;Ib, open-label study will evaluate the safety, reactogenicity and immunogenicity of prophylactic vaccination with a second generation E1, E2b and E3 deleted human adenovirus&#8209;5 vaccine in normal healthy volunteers. The test article is an hAd5&#8209;S&#8209;Fusion+N&#8209;ETSD vaccine which encodes for an optimized spike protein (S&#8209;Fusion), to enhance stability and cell surface expression of the receptor binding domain of the SARS&#8209;CoV&#8209;2 spike protein, and a Nucleocapsid protein with an enhanced T&#8209;cell stimulation domain (N&#8209;ETSD) to enhance cell-mediated immunity.</span><span style="font-size:9pt;font-weight:normal;font-style:normal;"> </span><span style="font-weight:normal;font-style:normal;">Two&#160;cohorts of ten&#160;subjects will receive either 5&#215;10<sup style="font-size:85%;line-height:120%;vertical-align:top">10</sup> or 1&#215;10<sup style="font-size:85%;line-height:120%;vertical-align:top">11</sup> virus particles per dose on days&#160;1 and&#160;22 and a third&#160;cohort of fifteen&#160;patients would receive the highest safe dose administered in the two initial cohorts. Safety and activity will be assessed for up to twelve&#160;months after the second dose. Toxicities will be graded using the Guidance for Industry - Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials&#160;(2007).</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the emergence of rapidly evolving resistance mutations in the spike protein, an IND amendment </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has been filed </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under the ongoing QUILT&#160;4001</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to incorporate a sublingual&#160;(SL) formulation of the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hAd5</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fusion+N</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ETSD vaccine</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, thereby expanding the trial to a total of 60</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patients across six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">study cohorts</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In addition, a second IND has been filed to test an</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> oral </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">formulation in a separate phase&#160;Ib trial in the U.S. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This trial, QUILT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4005, will study an additional 40</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patients across four</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cohorts.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> oral formulation </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">employed </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is stable at room temperatures, which may help alleviate cold-chain logistics </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issues </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that have slowed deployment</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of currently approved COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;19 vaccines</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Additionally, the oral and SL formulations are designed to enhance IgA secretion and may confer greater protection against infection. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11, 2021, we announced that the IND amendment for QUILT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4001 and the new IND for QUILT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4005 have been authorized by the FDA. These studies are now actively enrolling patients at Hoag Hospital, in Newport Beach, California. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Once these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">new </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">formulations have been tested for safety and immunogenicity</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> we will then proceed with a planned phase&#160;II/III trial using the most optimal combination.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our current development programs:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000012.jpg" title="" alt="" style="width:720px;height:366px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;margin-right:4.44%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N-803 is an&#160;IL-15R&#945;Fc Superagonist, a proprietary therapeutic cytokine designed to induce expansion of native NK and CD8+&#160;T&#8209;cells without concurrent stimulation of T&#8209;regulatory cells&#59; Aldoxorubicin (Aldox) is a proprietary albumin-bound doxorubicin complex that is designed to preferentially accumulate in a tumor&#8217;s low pH environment. Both agents are in late-stage clinical development by our affiliate, ImmunityBio, which has exclusive, worldwide rights to the agents. Avelumab is an FDA approved checkpoint inhibitor marketed by Pfizer.</p>
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:4.54%;margin-right:4.44%;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">* <span style="font-weight:normal;">Program owned by NantKwest and subject to Joint Development Agreement with ImmunityBio.</span></p>
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:4.54%;margin-right:4.44%;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8224; <span style="font-weight:normal;">Program owned by ImmunityBio and subject to Joint Development Agreement with NantKwest.</span></p>
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:4.54%;margin-right:4.44%;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8225;<span style="font-weight:normal;"> QUILT number not yet designated.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Joint COVID&#8209;19 Collaboration Agreement with ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a definitive agreement, which we refer to as the Collaboration Agreement, with ImmunityBio to pursue collaborative joint development, manufacturing and marketing of certain COVID&#8209;19 therapeutics and vaccines. The terms of the Collaboration Agreement supersede and replace the terms of the binding term sheet executed on May&#160;22, 2020. Through their efforts, the parties agreed to jointly develop ceNK, haNK, MSC, hAd5, and N&#8209;803, a novel IL&#8209;15 superagonist fusion protein, for the prevention and treatment of SARS&#8209;CoV&#8209;2 viral infections and associated conditions in humans, including without limitation, COVID&#8209;19. Pursuant to the Collaboration Agreement, we have contributed our ceNK, haNK, and MSC product candidates and certain of our manufacturing capabilities, and ImmunityBio has contributed their hAd5 and N&#8209;803 product candidates. hAd5 has been developed as a vaccine, and ceNK, haNK, MSC and N&#8209;803 have each been developed as therapeutics for treating COVID&#8209;19 at various stages of infection.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From and after the effective date of the Collaboration Agreement, the parties will share equally in all costs relating to developing and manufacturing of the product candidates globally with the exception of certain laboratory equipment purchases that will be borne solely by us. With the exception of N&#8209;803, we will be primarily responsible for the manufacture of each product. Each party will be responsible for the regulatory affairs and the commercialization relating to its contributed products. The global net profits from the collaboration products will be shared 60%/40% in favor of the party contributing the product on which the sales are based except if the parties mutually agree because of certain circumstances. All net profits from sales of combined collaboration products will be shared equally. This collaboration is supervised by a joint steering committee, which is comprised of an equal number of representatives from both parties. The term of the agreement will be five&#160;years and it is renewable for an additional five&#160;year period upon mutual agreement. Each party will also have a right to terminate in the event of material breach, bankruptcy, or insolvency.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In this Joint COVID&#8209;19 Collaboration, we contributed the following programs:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">MSC cells</span><span style="color:#000000;"> (as described above) as a therapeutic candidate for patients with severe symptoms of COVID&#8209;19 to modulate the immune system&#8217;s excessive response to COVID&#8209;19 infection, thereby potentially reducing the debilitating and sometimes fatal effects of the disease&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">ceNK and haNK cells</span><span style="color:#000000;"> (as described above) as a therapeutic candidate for moderate-risk, hospitalized adults with moderate to severe symptoms of COVID&#8209;19.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio contributed the following programs:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">N&#8209;803</span><span style="color:#000000;"> as a therapeutic candidate for patients with mild symptoms of COVID&#8209;19 prior to the onset of severe disease by potentially activating natural killer cells to mitigate viral replication&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Human adenovirus (hAd5)</span><span style="color:#000000;"> as a vaccine candidate for those individuals in an uninfected state to prevent the onset of COVID&#8209;19.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the above programs contributed by each party, we have contributed our manufacturing capabilities in the form of facilities, equipment, personnel and related know-how, including our GMP manufacturing facility in El Segundo, California, and ImmunityBio has contributed certain manufacturing equipment and related technology and know-how. To date, NantKwest and ImmunityBio have each prepared a GMP-ready manufacturing plant for COVID&#8209;19 vaccine production, which we and ImmunityBio expect will have a combined estimated capacity to produce sufficient clinical supply for our planned studies in 2021. We have prepared one of our GMP manufacturing facilities previously used to manufacture product for our oncology trials to manufacture and produce the hAd5&#160;vaccine candidate and have readied a new, well-equipped location to manufacture and produce clinical products for our oncology trials, which resulted in additional facilities and related facility operating costs starting in the third quarter of 2020. We have established a clinical product inventory to continue to supply clinical product for our ongoing oncology trials while this new facility was being readied. The new facility will resume clinical product supply for our oncology trial starting in early 2021. In addition, we have repurposed some of our personnel overseeing quality of our oncology programs to support the Joint COVID&#8209;19 Collaboration. We also expect to hire additional staff to support the Joint COVID&#8209;19 Collaboration. We believe the Joint COVID&#8209;19 Collaboration will have no material impact on our current oncology efforts and trials, and we expect that we will be able to continue to manufacture adequate product to continue our ongoing oncology trials.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Competition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biopharmaceutical industry is characterized by intense and dynamic competition to develop new technologies and proprietary therapies. Any product candidates that we successfully develop and commercialize will have to compete with existing therapies and new therapies that may become available in the future. We believe that our base proprietary aNK platform, differentiated haNK, taNK and t&#8209;haNK product candidates, strategic collaborations and cell-based immunotherapy expertise may provide us with competitive advantages. However, we face potential competition from various sources, including larger and better-funded pharmaceutical, specialty pharmaceutical and biotechnology companies, as well as from academic institutions, governmental agencies and public and private research institutions. The key competitive factors affecting the success of any approved product will include its efficacy, safety profile, pricing, and method of administration, as well as the level of promotional activity invested in it.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our haNK, taNK, t&#8209;haNK and ceNK product candidates compete with other cell and molecule-based immunotherapy approaches using or targeting natural killer cells, NKT cells, T&#8209;cells, and dendritic cells. Competitors focused on CAR&#8209;T related treatment approaches include AbbVie&#160;Inc., Atara&#160;Biotherapeutics,&#160;Inc., Precigen&#160;Corporation,&#160;Inc., Allogene&#160;Therapeutics,&#160;Inc., Bristol&#8209;Myers&#160;Squibb&#160;Company, Beijing Immunochina Pharmaceuticals Co., Ltd., Cellular Biomedicine Group,&#160;Inc., iCell Gene Therapeutics&#160;LLC, JW&#160;Therapeutics&#160;Co.,&#160;Ltd., Amgen,&#160;Inc., Leucid&#160;Bio&#160;Ltd., Bellicum&#160;Pharmaceuticals,&#160;Inc., Medisix&#160;Therapeutics&#160;Pte&#160;Ltd., Bluebird&#160;Bio,&#160;Inc., Mesoblast&#160;Ltd., Calibr/Scripps&#160;Research, Mustang&#160;Bio,&#160;Inc., Carina Biotech,&#160;Inc., CARsgen&#160;Therapeutics, CRISPR Therapeutics,&#160;Inc., GEMoaB Monoclonals&#160;GmbH, Nanjing&#160;Legend&#160;Biotechnology&#160;Co.,&#160;Ltd, Cartherics&#160;Pty&#160;Ltd, Novartis&#160;AG, Pfizer,&#160;Inc., Cellectis&#160;SA, Poseida&#160;Therapeutics,&#160;Inc., Prepromene Bio,&#160;Inc., Celularity,&#160;Inc., Servier&#160;Laboratories, Sorrento Therapeutics,&#160;Inc., Celyad&#160;SA, Takeda Pharmaceutical Company Limited, Fortress&#160;Biotech,&#160;Inc., TC&#160;BioPharm&#160;Ltd., Tessa Therapeutics&#160;Pte&#160;Ltd, Gilead&#160;Sciences,&#160;Inc., Tmunity Therapeutics,&#160;Inc., Transposagen Biopharmaceuticals,&#160;Inc., Humanigen,&#160;Inc., Immune&#160;Therapeutics,&#160;Inc., and Xyphos,&#160;Inc./Astellas.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on other T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;cell based approaches include Adaptimmune&#160;Ltd., Adicet&#160;Bio,&#160;Inc., Autolus&#160;Therapeutics,&#160;plc, Cell&#160;Medica&#160;Limited, Eureka Therapeutics,&#160;Inc., Formula Pharmaceuticals,&#160;Inc., GlaxoSmithKline&#160;plc., Green&#160;Cross&#160;LabCell&#160;Corp., Immatics Biotechnologies&#160;GmbH, Immunocore&#160;Limited, Iovance&#160;Biotherapeutics,&#160;Inc., Kiadis&#160;Pharma&#160;Netherlands&#160;B.V., Lion&#160;TCR&#160;Pte&#160;Ltd., MolMed,&#160;S.p.A., Precision&#160;Biosciences,&#160;Inc., Janssen&#160;Pharmaceuticals,&#160;Inc., Noile</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;Immune&#160;Biotech,&#160;Inc., Anixa&#160;Biosciences,&#160;Inc., Beam&#160;Therapeutics&#160;Inc., BioNTech&#160;SE, Cartesian&#160;Therapeutics,&#160;Inc., Marker Therapeutics,&#160;Inc., Refuge Biotechnologies,&#160;Inc., Repertoire Immune Medicines,&#160;Inc., Sensei Biotherapeutics,&#160;Inc., Senti&#160;Biosciences,&#160;Inc., TCR&#178; Therapeutics&#160;Inc., TScan Therapeutics,&#160;Inc., and Takara&#160;Bio,&#160;Inc.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on dendritic cell based approaches include Argos&#160;Therapeutics,&#160;Inc., Biovest&#160;International,&#160;Inc., ImmunoCellular&#160;Therapeutics,&#160;Ltd., Merck&#160;&#38;&#160;Co,&#160;Inc./Immune&#160;Design,&#160;Inc., Inovio&#160;Pharmaceuticals,&#160;Inc., Precigen&#160;Corporation,&#160;Inc., Medigene&#160;AG, and Northwest&#160;Biotherapeutics,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on natural killer cell based approaches include Acepodia,&#160;Inc., Carabou Biosciences,&#160;Inc., Catamaran Bio&#160;Inc., Celularity,&#160;Inc., Century&#160;Therapeutics,&#160;Inc., Cytovia Therapeutics,&#160;Inc., Glycostem&#160;Therapeutics&#160;BV, Kiadis&#160;Pharma Netherlands&#160;B.V./CytoSen Therapeutics,&#160;Inc., Dragonfly&#160;Therapeutics,&#160;Inc., Editas Medicine,&#160;Inc., EMERcell, Exacis&#160;Biotherapeutics,&#160;Inc., Fate&#160;Therapeutics,&#160;Inc., Gamida&#160;Cell,&#160;Ltd., INmune Bio Inc., Nkarta&#160;Therapeutics,&#160;Inc., Onkimmune&#160;Ltd., Oncternal Therapeutics,&#160;Inc., NKMax&#160;America, Artiva&#160;Biotherapeutics/Merck, HebeCell&#160;Corp., Vycellix,&#160;Inc., oNKo&#8209;innate&#160;Pty&#160;Ltd., ONK Therapeutics Limited, Sanofi,&#160;S.A., Shoreline Biosciences,&#160;Inc., Takeda Pharmaceutical Company Limited, XNK Therapeutics&#160;AB, Zelluna Immunotherapy&#160;AS, and Ziopharm&#160;Oncology,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on large molecule immunotherapy approaches, including those overlapping the natural killer cell space, include Cytomx&#160;Therapeutics,&#160;Inc., Compass Therapeutics,&#160;Inc., Innate&#160;Pharma&#160;SA, Nektar Therapeutics,&#160;Inc., and Sorrento&#160;Therapeutics,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other potential immunotherapy competitors include Affimed&#160;GmbH, AgenTus Therapeutics, Inc., Agios&#160;Pharmaceuticals,&#160;Inc., Codiak&#160;Biosciences, Glycostem&#160;Therapeutics&#160;BV, Kuur Therapeutics Limited, Triumvira&#160;Immunologics, Incysus&#160;Therapeutics,&#160;Inc., GammaDelta&#160;Therapeutics&#160;Ltd., Lyell&#160;Immunopharma,&#160;Inc., and GT&#160;Biopharma,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are currently four approved T&#8209;cell based treatments that are marketed by Novartis&#160;AG, Gilead&#160;Sciences/Kite&#160;Pharma (two therapeutics), and the Bristol&#8209;Myers&#160;Squibb&#160;Company. There is currently one approved dendritic cell-based cancer vaccine marketed by Dendron&#160;Pharmaceuticals,&#160;LLC for the treatment of metastatic castration resistant prostate cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on COVID&#8209;19 cell therapy currently include AstraZeneca plc, Athersys,&#160;Inc./Healios&#160;K.K., Capricor Therapeutics,&#160;Inc., CAR&#8209;T (Shanghai) Biotechnology, Cellavita Pesquisa Cient&#237;fica&#160;Ltda, Cellenkos,&#160;Inc., Cellular Biomedicine Group,&#160;Inc., Celularity,&#160;Inc., Sorrento Therapeutics,&#160;Inc., Chinese Academy of Sciences, Chongqing Sidemu Biotechnology Technology/ImmunCyte Life Sciences,&#160;Inc., Enlivex Therapeutics&#160;Ltd, Green Cross LabCell&#160;Corp., Hope Biosciences, Johnson &#38; Johnson, Mesoblast&#160;Limited, Moderna, Inc., NovaVax, Inc., Orbsen Therapeutics&#160;Limited, Pfizer, Inc./BioNTech SE, Pluristem Therapeutics,&#160;Inc., Rigshospitalet, Tianhe Stem Cell Biotechnologies&#160;Inc., University of Minnesota/Fate Therapeutics,&#160;Inc., and Xinjiang Medical University.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, a very large number of companies, government agencies and academic centers around the world are developing COVID&#8209;19 vaccines, and many of these entities are in more advanced stages of development than ImmunityBio, including some that have started Phase&#160;II and/or III clinical trials or already have emergency regulatory approval in some regions. Even if ImmunityBio&#8217;s COVID&#8209;19 vaccine candidate is ultimately approved for marketing, the value of our profit-sharing opportunity would be adversely impacted if other COVID&#8209;19 vaccines are approved earlier or show better efficacy or safety than ImmunityBio&#8217;s COVID&#8209;19 vaccine candidate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our competitors, either alone or with their strategic partners, have substantially greater financial, technical and human resources than we do, as well as significantly greater experience in the discovery and development of product candidates, obtaining FDA and other regulatory approvals of treatments and commercializing those treatments. Accordingly, our competitors may be more successful than us in obtaining approval for treatments and achieving widespread market acceptance. Our competitors&#8217; treatments may be more effective, or more effectively marketed and sold, than any treatment we may commercialize, and they may render our treatments obsolete or non-competitive before we can recover the expenses of developing and commercializing any of our treatments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated among a smaller number of our competitors. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel, and establishing clinical study sites and subject registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs. Smaller or clinical-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate that we will face intense and increasing competition as new therapies enter the market and advanced technologies become available. We expect any treatments that we develop and commercialize to compete on the basis of, among other things, efficacy, safety, convenience of administration and delivery, price, the level of generic competition and the availability of reimbursement from government and other third-party payors.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have a better safety profile, are more convenient or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. In addition, we expect that our therapeutic products, if approved, will be priced at a significant premium over competitive generic products and our ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Intellectual Property</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We strive to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to our business, including seeking, maintaining, and defending patent rights, whether developed internally or licensed from third parties. Our policy is to seek to protect our proprietary position by, among other methods, filing patent applications in the U.S. and in jurisdictions outside of the U.S. related to our proprietary technology, inventions, improvements, and product candidates that are important to the development and implementation of our business. We seek to consistently file follow-on patent applications on further improvements and features of our NK&#160;cell-based products, thereby adding additional layers of protection and reducing reliance on our original patents that would be the earliest to expire and may be subject to challenge. We also rely on trade secrets and know-how relating to our proprietary technology and product candidates, continuing innovation, and in-licensing opportunities to develop, strengthen, and maintain our proprietary position in the field of natural killer cell-based immunotherapy. We expect to rely on data exclusivity, market exclusivity, patent term adjustments and patent term extensions when available, as well as on regulatory protection afforded through orphan drug designations. Our commercial success may depend in part on our ability to obtain and maintain patent and other proprietary protection for our technology, inventions, and improvements&#59; to preserve the confidentiality of our trade secrets&#59; to maintain our licenses to use intellectual property owned by third parties&#59; to defend and enforce our proprietary rights, including our patents&#59; and to operate without infringing on the valid and enforceable patents and other proprietary rights of third parties.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have developed and in-licensed numerous patents and patent applications and we possess substantial know-how and trade secrets relating to the development and commercialization of natural killer cell-based immunotherapy product candidates, including related manufacturing processes and technology. As of December&#160;31, 2020, our owned and licensed patent portfolio consists of 66&#160;patents and pending patent applications and provisional filings in the U.S. disclosing subject matter directed to certain of our proprietary technology, inventions, and improvements and our most advanced product candidates, as well as 216&#160;licensed and owned patents and pending applications in 24&#160;jurisdictions outside of the U.S., including 26&#160;Patent Cooperation Treaty applications, that, in many cases, are counterparts to the foregoing U.S. patents and patent applications. For example, these patents and patent applications include claims directed to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Natural Killer Cell Line Compositions and Methods-of-Use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Treatment of Cancer using Natural Killer Cell Lines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Treatment of Specific Diseases using Natural Killer Cell Lines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Combination Therapy using Natural Killer Cell Lines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">CD16 Modified Natural Killer Cell Line Compositions and Methods-of-Use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">CD16 Modified Natural Killer Cell Line with Monoclonal Antibodies for Treatment of Cancer&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">CAR&#8209;Expressing Natural Killer Cell Line Compositions and Methods-of-Use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">CD16 Modified and CAR&#8209;Expressing Natural Killer Cell Line Compositions and Methods-of-Use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Homing and Cytokine Modified Natural Killer Cell Line Compositions and Methods-of-Use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Treatment of Viral and Bacterial Diseases using Natural Killer Cell Lines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Methods for Expansion, Cryopreservation and Commercial Manufacture&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Tumoricidal and Antimicrobial Compositions of Natural Killer Cell Line Derived Exosomes and Methods-of-Use.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As for the NK cell-based immunotherapy products and processes we develop and commercialize, in the normal course of business, we intend to pursue, when possible, composition, method of use, dosing and formulation patent protection. We may also pursue patent protection with respect to manufacturing and drug development processes and technology. The patents and patent applications outside of the U.S. in our portfolio are held primarily in Europe, Canada, Australia, China, Japan and Korea.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Individual patents extend for varying </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">periods</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of time</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, depending upon the date of filing of the patent application, the date of patent issuance, and the legal term of patents in the countries in which they are obtained. Generally, patents issued for applications filed in the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> are effective for 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years from the earliest effective filing date. The patent term may be adjusted to compensate for delayed patent issuance, when such delays are caused by the patent office or successful appeals against patent office actions. There is no limit on this patent term adjustment. In addition, in certain instances, a patent term can be extended to recapture a portion of the term effectively lost as a result of the FDA regulatory review period. The restoration period cannot be longer than five</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years and the total patent term, including the restoration period, must not exceed 14</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years following FDA approval.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The duration of patents outside of the U.S. varies in accordance with provisions of applicable local law, but typically is also 20&#160;years from the earliest effective filing date. Our issued patents </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are anticipated to expire</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">varying intervals through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2039</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. If patents are issued on our pending patent applications, the resulting patents are projected to expire at various dates through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2040</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">However, the actual protection afforded by a patent varies on a product-by-product basis, from country-to-country, and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country, and the validity and enforceability of the patent.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent positions of companies like ours are generally uncertain and involve complex legal and factual questions. No consistent policy regarding the scope of claims allowable in patents in the field of immunotherapy has emerged in the U.S. The patent situation outside of the U.S. is even more uncertain. Changes in either the patent laws or their interpretation in the U.S. and other countries may diminish our ability to protect our inventions and enforce our intellectual property rights, and more generally could affect the value of our intellectual property. In particular, our ability to stop third parties from making, using, selling, offering to sell, or importing products that infringe our intellectual property will depend in part on our success in obtaining and enforcing patent claims that cover our technology, inventions, and improvements. With respect to both licensed and company-owned intellectual property, we cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our existing patents or any patents that may be granted to us in the future will be commercially useful in protecting our products and the methods used to manufacture those products. Moreover, even our issued patents do not guarantee us the right to practice our technology in relation to the commercialization of our products. However, the area of patent and other intellectual property rights in biotechnology is an evolving one with many risks and uncertainties, and third parties may have blocking patents that could be used to prevent us from commercializing our patented product candidates and practicing our proprietary technology. Our issued patents and those that may issue in the future may be challenged, invalidated, or circumvented, which could limit our ability to stop competitors from marketing related products or limit the length of the term of patent protection that we may have for our product candidates. In addition, the rights granted under any issued patents may not provide us with protection or competitive advantages against competitors with similar technology. Furthermore, our competitors may independently develop similar technologies. For these reasons, we may have competition for our product candidates. Moreover, because of the extensive time required for development, testing and regulatory review of a potential product, it is possible that, before any particular product candidate can be commercialized, any related patent may expire or remain in force for only a short period following commercialization, thereby reducing any advantage of the patent.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, our worldwide trademark portfolio was comprised of&#160;(i)&#160;12&#160;U.S. trademark registrations&#59; (ii)&#160;two&#160;pending U.S. trademark application&#59; (iii)&#160;28&#160;foreign trademark registrations, six&#160;of which are Madrid Protocol International registrations&#59; and (iv)&#160;24&#160;pending foreign trademark applications.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also rely, in some circumstances, on trade secrets to protect our technology. However, trade secrets are difficult to protect. We seek to protect our technology and product candidates, in part, by entering into confidentiality agreements with those who have access to our confidential information, including our employees, contractors, consultants, collaborators, and advisors. We also seek to preserve the integrity and confidentiality of our proprietary technology and processes by maintaining physical security of our premises and physical and electronic security of our information technology systems. Although we have confidence in these individuals, organizations, and systems, agreements or security measures may be breached and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or may be independently discovered by competitors. To the extent that our employees, contractors, consultants, collaborators, and advisors use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. For risks related to our proprietary technology, inventions, improvements and products, please see Part&#160;I, Item&#160;1A, &#8220;<span style="font-style:italic;">Risk Factors &#8211; Risks Related to Intellectual Property</span>&#8221; and &#8220;<span style="font-style:italic;">Legal Proceedings</span>&#8221; of this Annual Report.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaboration Agreement</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">s</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Joint COVID&#8209;19 Collaboration Agreement.<span style="font-weight:normal;font-style:normal;">&#160;&#160;As discussed above, on August&#160;21, 2020, we entered into a definitive agreement, which we refer to as the Collaboration Agreement, with ImmunityBio to pursue collaborative joint development, manufacturing and marketing of certain COVID&#8209;19 therapeutics and vaccines.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cost Sharing Agreement.<span style="font-weight:normal;font-style:normal;">&#160;&#160;In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio and its subsidiaries to co-sponsor and conduct certain combination clinical trials (each a Joint Study) pursuant to clinical trial protocols wherein at least one investigational agent is a proprietary therapeutic drug candidate owned or controlled by NantKwest and at least one other investigational agent is a proprietary therapeutic drug candidate owned or controlled by ImmunityBio. Prior to initiating any activities for a Joint Study the parties agreed to enter into written work orders describing, amongst other things, development and management responsibilities, allocation of Joint Study costs and expenses, regulatory responsibilities, and any other matters relating to the Joint Study.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Cost Allocation Agreement, each of ImmunityBio and the company will receive exclusive rights to any new intellectual property developed that relates solely to its respective study drug, and the parties will have joint co-equal rights in any other intellectual property. The Cost Allocation Agreement expires on June&#160;22, 2022 with the option to renew for additional successive one-year terms, but work orders for any joint studies still in process at the time of termination will continue until the applicable study is completed.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and ImmunityBio are splitting certain costs related to these joint studies equally in accordance with the terms of the Cost Allocation Agreement and related work orders. Shared Joint Study costs include cost related to conducting the Joint Study development activities, such as personnel related costs, as well as all costs associated with regulatory matters. Costs and expenses incurred in connection with the development, manufacturing, supply, delivery, and pre-patient administration dosing mechanism of each party&#8217;s study drug, are excluded from the shared Joint Study costs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we executed Work Order Number One with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number One, the parties are conducting a clinical trial pursuant to the protocol titled QUILT&#160;3.063:<span style="font-style:italic;">&#160;A phase&#160;2 study of combination therapy with an IL&#8209;15 superagonist&#160;(N&#8209;803), off-the-shelf CD16&#8209;targeted natural killer cells&#160;(haNK), and avelumab without cytotoxic chemotherapy in subjects with Merkel Cell Carcinoma&#160;(MCC) that has progressed on or after treatment with a checkpoint inhibitor</span>. The ImmunityBio study drug included in this Joint Study is ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist known as N&#8209;803, and our study drug is our proprietary &#8220;off-the-shelf&#8221; CD16-targeted natural killer cell therapy known as haNK. We are the sponsor of this Joint Study for purposes of regulatory matters, including submissions, correspondence, and communications. Additionally, we are designated as the contracting party to execute agreements with third and related parties relating to the Joint Study.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2020, but effective on June&#160;22, 2020, we executed Work Order Number Two with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number Two, the parties are conducting a clinical trial pursuant to the protocol titled QUILT&#160;88:&#160;<span style="font-style:italic;">Open-label, randomized, comparative phase&#160;2 study of combination immunotherapy with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer</span>. The ImmunityBio study drugs included in the joint study are ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist&#160;(N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin), and our study drug is PD&#8209;L1.t&#8209;haNK. ImmunityBio is the sponsor of this Joint Study for purposes of regulatory matters, including submissions, correspondence, and communications with the FDA. Additionally, ImmunityBio is designated as the contracting party to execute agreements with third and related parties relating to this Joint Study.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Licenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Viracta Therapeutics, Inc.<span style="font-weight:normal;font-style:normal;">  In May&#160;2017, we entered into an agreement with Viracta Therapeutics, Inc., or Viracta, to grant us exclusive worldwide rights to Viracta&#8217;s phase&#160;II drug candidate, VRx&#8209;3996, for use in combination with our platform of NK&#160;cell therapies. In consideration for the license, we are obligated to pay to Viracta&#160;(i)&#160;mid-single digit percentage royalties of net sales of licensed products for therapeutic use, and (ii)&#160;milestone payments ranging from $10.0&#160;million to $25.0&#160;million for various regulatory approvals and cumulative net sales levels. We may terminate the agreement, in our sole discretion, in whole or on a product-by-product and/or country by country basis, at any time upon 90&#160;days&#8217; prior written notice. In addition, either party may terminate the agreement in the event of a material breach or for bankruptcy of the other party.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Hans G. Klingemann, M.D., Ph.D.</span><span style="font-weight:normal;font-style:normal;"> </span><span style="font-weight:normal;font-style:normal;"> </span><span style="font-weight:normal;font-style:normal;">We hold the worldwide rights, title and interest to the NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 cell line</span><span style="font-weight:normal;font-style:normal;">,</span><span style="font-weight:normal;font-style:normal;"> and we believe that we control commercial use of our NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 cells in key territories. We also maintain and exclusively control the only clinical grade master cell bank for NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92. The original NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 cell line was isolated by Hans G. Klingemann, M.D., Ph.D., our founder and Vice President of Research and Development, and all patents and patent applications pertaining to this cell line are now in the name of NantKwest, Inc. or ZelleRx Corporation, our former name. In February</span><span style="font-weight:normal;font-style:normal;">&#160;</span><span style="font-weight:normal;font-style:normal;">2003, we obtained an exclusive, worldwide license from Dr.&#160;Klingemann to the NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 cell line, and related NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 patents and know-how, that had been assigned to him by the British Columbia Cancer Agency, to manufacture, use and sell products covered by the scope of any valid claim in any of the licensed patents. Dr.&#160;Klingemann subsequently assigned the cell line and those patents to us, but we are still obligated to pay a single-digit royalty on sales of licensed products to Dr.&#160;Klingemann, as well as to pay the British Columbia Cancer Agency a small percentage of our profits from the sale of the NK</span><span style="font-weight:normal;font-style:normal;">&#8209;</span><span style="font-weight:normal;font-style:normal;">92 cell line that Dr.&#160;Klingemann obtained from them.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fox Chase Cancer Center.<span style="font-weight:normal;font-style:normal;">&#160;&#160;In July&#160;2004, we entered into an exclusive license agreement with Fox Chase Cancer Center, or Fox Chase, pursuant to which we were granted an exclusive, worldwide, sublicensable license under certain patents and know-how pertaining to CD16 receptors-bearing NK&#8209;92 cell lines. We agreed to pay Fox Chase low single-digit royalties on sales of licensed products. We are also obligated to pay Fox Chase a percentage of the royalties and other compensation we receive from sublicensees of our rights from Fox Chase. Fox Chase is obligated to assign the licensed patents to us if we commence a phase&#160;III clinical trial of a licensed product and, if this does not occur, our license expires when the last of the licensed patents expires. In late May&#160;2020, we received a letter from Fox Chase alleging breaches of our license. If the letter is found to be a proper notice of termination and the alleged breaches are confirmed and found to be material, we will lose the licensed rights. We do not consider these licensed rights to be material.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Rush University Medical Center.<span style="font-weight:normal;font-style:normal;">  In March&#160;2004, we entered into a license agreement with Rush University Medical Center, pursuant to which Rush&#160;University Medical Center granted us an exclusive, worldwide, sublicensable license to certain intellectual property related to clinical use of NK&#8209;92 to develop and commercialize products and processes for the treatment of melanoma and renal cancer, or for the diagnosis or treatment of non-melanoma and non-renal cancer. In consideration for the license, we were obligated to pay to Rush&#160;University Medical Center single-digit royalties on sales of licensed products with a minimum royalty payment of $25,000&#160;per year for 12&#160;years. The agreement also provided for payments upon completion of certain clinical, regulatory and commercialization milestones. We also agreed to pay to Rush&#160;University Medical Center a portion of certain payments that we receive under sublicensing arrangements. The license had a term of 12&#160;years from 2006, the year in which royalty payments were first made, and included customary termination rights for both parties. Beginning in 2018, this license converted to a perpetual, irrevocable, fully paid royalty-free, exclusive license.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">University Health Network.<span style="font-weight:normal;font-style:normal;">  In May&#160;2005, we entered into a license agreement with University Health Network, or UHN, pursuant to which we obtained from UHN an exclusive, worldwide, sublicensable license to certain intellectual property relating to NK&#8209;92 clinical trials data from UHN to develop and commercialize products and processes for the diagnosis and treatment of certain hematological malignancies. Our license from UHN will automatically expire if we have not filed for regulatory approval or launched a licensed product within specified periods of time, and also includes other customary termination rights for both parties.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Joint Development and License Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Precigen Corporation, Inc. (formerly known as Intrexon Corporation).<span style="font-weight:normal;font-style:normal;">  In February&#160;2010, we entered into a 17&#8209;year agreement with Precigen Corporation, Inc., or Precigen, pursuant to which we granted to Precigen a worldwide, sublicensable license which may be exclusive with respect to certain indications designated by Precigen, under certain patents relating to NK&#8209;92 cells to develop and commercialize modified NK&#8209;92 cells that express Precigen&#8217;s proprietary gene sequences for use as therapeutic and prophylactic agents in humans in specified therapeutic areas. Precigen paid us a one-time license fee and is also obligated to pay non-material milestone payments with respect to specific indications, a royalty on net sales of the licensed products and a portion of the revenue Precigen receives from third party sublicensees of its rights from us. Precigen has the right to terminate the agreement upon 180&#160;days&#8217; notice and both parties have the right to terminate the agreement for the other&#8217;s uncured breach of the agreement.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have licensed or sub-licensed our cell lines and intellectual property to numerous other pharmaceutical and biotechnology companies for non-clinical uses such as laboratory testing. Such licenses generally require the licensee to pay an upfront fee and annual research and commercial fees for products sold using our intellectual property and cell lines.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Supply Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have, and expect that we will continue, to enter into supply agreements with third parties and related parties to provide investigational agents to be used in our clinical trials.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Anticipated Agreements and Considerations</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the collaboration and license agreements discussed above, we may enter into a commercial agreement relating to an IL&#8209;15 superagonist product developed by ImmunityBio, if the proposed merger with ImmunityBio is not consummated, and we are also pursuing certain strategic research and/or license agreements with third parties to develop our product candidate pipeline. These types of agreements do not typically specify how sales will be apportioned between the parties upon successful commercialization of the product. As a result, we cannot guarantee that we will receive a percentage of the revenue that is at least proportional to the costs that we will incur in commercializing the product candidate. Furthermore, if Dr. Soon-Shiong was to cease his affiliation with us or with NantWorks, any affiliated entities may be unwilling to continue their relationships with us on commercially reasonable terms, or at all, which in turn may impede our ability to control the supply chain for our combination therapies.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Government Regulation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and other regulatory authorities at federal, state, and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring, and post-approval reporting of biologics such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process required by the FDA before biologic product candidates may be marketed in the U.S. generally involves the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA&#8217;s current Good Laboratory Practices, or cGLP, regulation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">submission to the FDA of an IND, which must become effective before clinical trials may begin and must be updated annually or when significant changes are made&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">approval by an independent Institutional Review Board, or IRB, or ethics committee for each clinical site before the clinical trial is begun&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">performance of adequate and well-controlled human clinical trials to establish the safety, purity and potency of the proposed biologic product candidate for its intended purpose&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">preparation of and submission to the FDA of a Biologics License Application, or BLA, after completion of all required clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a determination by the FDA within 60&#160;days of its receipt of a BLA to file the application for review&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">satisfactory completion of an FDA Advisory Committee review, if applicable&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMP and to assure that the facilities, methods and controls are adequate to preserve the biological product&#8217;s continued safety, purity and potency, and of selected clinical investigational sites to assess compliance with current Good Clinical Practices, or cGCPs&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">FDA review and approval of the BLA to permit commercial marketing of the product for particular indications for use in the U.S., which must be updated annually and when significant changes are made.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The testing and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all. Prior to beginning the first clinical trial with a product candidate, we must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for clinical studies. The IND also includes results of animal and <span style="font-style:italic;">in&#160;vitro</span> studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product&#59; chemistry, manufacturing, and controls information&#59; and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical trials may begin. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless the FDA, within the 30&#8209;day time period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When a clinical trial using genetically engineered cells is conducted at, or sponsored by, institutions receiving </span><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">National Institutes of Health, or </span><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIH</span><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> funding for recombinant DNA research, prior to the submission of an IND to the FDA, a protocol and related documentation is submitted to and the study is registered with the NIH Office of Biotechnology Activities, or OBA, pursuant to the NIH Guidelines for Research Involving Recombinant DNA Molecules, or NIH Guidelines. Compliance with the NIH Guidelines is mandatory for investigators at institutions receiving NIH funds for research involving recombinant DNA, and many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. The NIH is responsible for convening the Recombinant DNA Advisory Committee, or RAC, a federal advisory committee that discusses protocols that raise novel or particularly important scientific, safety, or ethical considerations at one of its quarterly public meetings. The OBA will notify the FDA of the RAC&#8217;s decision regarding the necessity for full public review of a protocol. RAC proceedings and reports are posted to the OBA web site and may be accessed by the public. If the FDA allows the IND to proceed, but the RAC decides that full public review of the protocol is warranted, the FDA will request at the completion of its IND review that sponsors delay initiation of the protocol until after completion of the RAC review process.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. Furthermore, an independent IRB, for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Phase&#160;I.</span><span style="color:#000000;">  The biological product is initially introduced into healthy human subjects and tested for safety. In the case of some products for severe or life-threatening diseases, the initial human testing is often conducted in patients.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Phase&#160;II.</span><span style="color:#000000;">  The biological product is evaluated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance, optimal dosage and dosing schedule.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Phase&#160;III.</span><span style="color:#000000;">  Clinical trials are undertaken to further evaluate dosage, clinical efficacy, potency, and safety in an expanded patient population at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk to benefit ratio of the product and provide an adequate basis for product labeling.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Phase&#160;IV.</span><span style="color:#000000;">  In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product. These so-called phase&#160;IV studies may be made a condition to approval of the BLA.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase&#160;I, phase&#160;II and phase&#160;III testing may not be completed successfully within a specified period, if at all, and there can be no assurance that the data collected will support FDA approval or licensure of the product. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the biological characteristics of the product candidate, and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. To help reduce the risk of the introduction of adventitious agents with use of biological products, the Public Health Service Act, or PHSA, emphasizes the importance of manufacturing control for products whose attributes cannot be precisely defined. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, as a result of the COVID&#8209;19 pandemic, we may be required to develop and implement additional clinical trial policies and procedures designed to help protect subjects from the COVID&#8209;19 virus. For example, the FDA has issued guidance on conducting clinical trials during the pandemic, which describes a number of considerations for sponsors of clinical trials impacted by the pandemic, including certain reporting requirements, and additional guidance on GMP considerations for responding to COVID&#8209;19 infection and other topics. We may be required to make further adjustments to our clinical trials or business operations based on current or future guidance and regulatory requirements as a result of the COVID&#8209;19 pandemic.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">BLA Submission and Review by the FDA</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The BLA must include all relevant data available from pertinent preclinical and clinical studies, including negative or ambiguous results, as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come from company-sponsored clinical studies intended to test the safety and effectiveness of a use of the product or from a number of alternative sources, including studies initiated by investigators. The submission of a BLA requires payment of a substantial user fee to the FDA, and the sponsor of an approved BLA is subject to annual product and establishment user fees. These fees typically increase annually. A waiver of user fees may be obtained under certain limited circumstances.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within 60 days following submission of the application, the FDA reviews a BLA to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the BLA must be resubmitted with the additional information. Once a BLA has been filed, the FDA&#8217;s goal is to review the application within ten&#160;months after it accepts the application for filing, or, if the application relates to an unmet medical need in a serious or life-threatening indication, six&#160;months after the FDA accepts the application for filing. The review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#8217;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities comply with cGMP requirements and are adequate to assure consistent production of the product within required specifications. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with cGCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The testing and approval process requires substantial time, effort and financial resources, and each may take several years to complete. The FDA may not grant approval on a timely basis, or at all, and we may encounter difficulties or unanticipated costs in our efforts to secure necessary governmental approvals, which could delay or preclude us from marketing our products. After the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter, a complete response letter, or a not approval letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A complete response letter indicates that the review cycle of the application is complete and the application is not ready for approval. A complete response letter may request additional information or clarification. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If regulatory approval of a product is granted, such approval may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy, or REMS, plan to mitigate risks, which could include medication guides, physician communication plans, or other restrictions to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing regulatory standards is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more phase&#160;IV post-market studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post-marketing studies. In addition, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A sponsor may seek approval of its product candidate under programs designed to accelerate </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA&#8217;s review and approval of new drugs and biological products that meet certain criteria. Specifically, new drugs and biological products are eligible for fast track designation if they are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. For a fast track product, the FDA may consider sections of the BLA for review on a rolling basis before the complete application is submitted if relevant criteria are met. A fast track designated product candidate may also qualify for priority review, under which the FDA sets the target date for FDA action on the BLA at six</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">months after the FDA accepts the application for filing. Priority review is granted when there is evidence that the proposed product would be a significant improvement in the safety or effectiveness of the treatment, diagnosis, or prevention of a serious condition. If criteria are not met for priority review, the application is subject to the standard FDA review period of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ten</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">months after </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA accepts the application for filing. Priority review designation does not change the scientific/medical standard for approval or the quality of evidence necessary to support approval.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the accelerated approval program, the FDA may approve a BLA on the basis of either a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. Post-marketing studies or completion of ongoing studies after marketing approval are generally required to verify the biologic&#8217;s clinical benefit in relationship to the surrogate endpoint or ultimate outcome in relationship to the clinical benefit. In addition, the Food and Drug Administration Safety and Innovation Act, or FDASIA, which was enacted and signed into law in 2012, established breakthrough therapy designation. A sponsor may seek FDA designation of its product candidate as a breakthrough therapy if the product candidate is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the therapy may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Sponsors may request the FDA to designate a breakthrough therapy at the time of, or any time after, the submission of an IND, but ideally before an end-of-phase&#160;II meeting with the FDA. If the FDA designates a breakthrough therapy, it may take actions appropriate to expedite the development and review of the application, which may include holding meetings with the sponsor and the review team throughout the development of the therapy&#59; providing timely advice to, and interactive communication with, the sponsor regarding the development of the drug to ensure that the development program to gather the nonclinical and clinical data necessary for approval is as efficient as practicable&#59; involving senior managers and experienced review staff, as appropriate, in a collaborative, cross-disciplinary review&#59; assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the review team and the sponsor&#59; and considering alternative clinical trial designs when scientifically appropriate, which may result in smaller or more efficient clinical trials that require less time to complete and may minimize the number of patients exposed to a potentially less efficacious treatment. Breakthrough designation also allows the sponsor to file sections of the BLA for review on a rolling basis. We may seek designation as a breakthrough therapy for some or all of our product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fast track designation, priority review and breakthrough therapy designation do not change the standards for approval but may expedite the development or approval process.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Orphan Drugs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, defined as a disease or condition with a patient population of fewer than 200,000 individuals in the U.S., or a patient population greater than 200,000 individuals in the U.S. and when there is no reasonable expectation that the cost of developing and making available the drug or biologic in the U.S. will be recovered from sales in the U.S. for that drug or biologic. Orphan drug designation must be requested before submitting a BLA. After the FDA grants orphan drug designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a full BLA, to market the same biologic for the same indication for seven&#160;years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. Orphan drug exclusivity does not prevent the FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA application user fee.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. In addition, orphan drug exclusive marketing rights in the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Post-Approval Requirements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record keeping, reporting of adverse experiences, periodic reporting, distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP, which impose certain procedural and documentation requirements upon us and any third-party manufacturers that we may decide to use. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us, and any third party manufacturers, that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance. We cannot be certain that we or our present or future suppliers will be able to comply with the cGMP regulations and other FDA regulatory requirements. If our present or future suppliers are not able to comply with these requirements, the FDA may, among other things, halt our clinical trials, require us to recall a product from distribution, or withdraw approval of the BLA.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future FDA and state inspections may identify compliance issues at our facilities or at the facilities of contract manufacturers that may disrupt production or distribution, or require substantial resources to correct. In addition, discovery of previously unknown problems with a product or the failure to comply with applicable requirements may result in restrictions on a product, manufacturer or holder of an approved BLA, including withdrawal or recall of the product from the market or other voluntary, FDA-initiated or judicial action that could delay or prohibit further marketing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information&#59; imposition of post-market studies or clinical studies to assess new safety risks&#59; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fines, warning letters or holds on post-approval clinical studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of product license approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product seizure or detention, or refusal to permit the import or export of products&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">injunctions or the imposition of civil or criminal penalties.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties, and exclusion from participation in governmental health programs, like Medicare and Medicaid. Physicians may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other Healthcare Laws and </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Compliance Requirements</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our sales, promotion, medical education, clinical research and other activities following product approval will be subject to regulation by numerous regulatory and law enforcement authorities in the U.S. in addition to the FDA, including potentially the Federal Trade Commission, the Department of Justice, the Centers for Medicare and Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services and state and local governments. Our promotional and scientific/educational programs must comply with the federal Anti-Kickback Statute, the False Claims Act, physician payment transparency laws, privacy laws, security laws, and additional federal and state laws similar to the foregoing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal Anti-Kickback Statute prohibits, among other things, the knowing and willing, direct or indirect offer, receipt, solicitation or payment of remuneration in exchange for or to induce the referral of patients, including the purchase, order or lease of any good, facility, item or service that would be paid for in whole or part by Medicare, Medicaid or other federal health care programs. Remuneration has been broadly defined to include anything of value, including cash, improper discounts, and free or reduced price items and services. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand and prescribers, purchasers, formulary managers, and beneficiaries on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the federal Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the federal Anti-Kickback Statute has been violated. The government has enforced the federal Anti-Kickback Statute to reach large settlements with healthcare companies based on sham research or consulting and other financial arrangements with physicians. Further, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act. Many states have similar laws that apply to their state health care programs, as well as private payors.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal false claims and false statement laws, including the federal civil False Claims Act, or FCA, imposes liability on persons or entities that, among other things, knowingly present or cause to be presented claims that are false or fraudulent or not provided as claimed for payment or approval by a federal health care program. The FCA has been used to prosecute persons or entities that &#8220;cause&#8221; the submission of claims for payment that are inaccurate or fraudulent, by, for example, providing inaccurate billing or coding information to customers, promoting a product off-label, submitting claims for services not provided as claimed, or submitting claims for services that were provided but not medically necessary. Actions under the FCA may be brought by the Attorney General, or as a qui tam action by a private individual, in the name of the government. Violations of the FCA can result in significant monetary penalties and treble damages. The federal government is using the FCA, and the accompanying threat of significant liability, in its investigation and prosecution of pharmaceutical and biotechnology companies throughout the country, for example, in connection with the promotion of products for unapproved uses and other illegal sales and marketing practices. The government has obtained multi-million and multi-billion dollar settlements under the FCA in addition to individual criminal convictions under applicable criminal statutes. In addition, certain companies that were found to be in violation of the FCA have been forced to implement extensive corrective action plans and have often become subject to consent decrees or corporate integrity agreements, restricting the manner in which they conduct their business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, created additional federal criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors&#59; knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services&#59; and willfully obstructing a criminal investigation of a healthcare offense. Like the federal Anti-Kickback Statute, the Affordable Care Act amended the intent standard for certain healthcare fraud statutes under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given the significant size of actual and potential settlements, it is expected that the government will continue to devote substantial resources to investigating healthcare providers&#8217; and manufacturers&#8217; compliance with applicable fraud and abuse laws. In addition, many states have similar fraud and abuse statutes or regulations that may be broader in scope and may apply regardless of payor, in addition to items and services reimbursed under Medicaid and other state programs. Additionally, to the extent that our products, once commercialized, are sold in a foreign country, we may be subject to similar foreign laws.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, there has been a recent trend of increased federal and state regulation of payments made to physicians and other healthcare providers. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Physician Payment Sunshine Act, or the Sunshine Act, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enacted as part of t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the Affordable Care Act, among other things, imposed new reporting requirements on certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, for payments </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> other transfers of value made by them to physicians and teaching hospitals, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as defined by law, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as well as ownership and investment interests held by physicians and their immediate family members. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1, 2022, these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">annual </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reporting obligations will extend to include payments and transfers of value made during the previous year to certain non-physician covered recipients, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">anesthesiologist assistants, and certified nurse-midwives. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Covered manufacturers are required to collect and report detailed payment data and submit legal attestation to the accuracy of such data to the government each year. Failure to submit required information may result in civil monetary penalties of up to an aggregate of $1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">495</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per year (or up to an aggregate of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,176,638</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per year for &#8220;knowing failures&#8221;)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, subject to adjustment for inflation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, for all payments, transfers of value or ownership or investment interests that are not timely, accurately and completely reported in an annual submission. Additionally, entities that do not comply with mandatory reporting requirements may be subject to a corporate integrity agreement. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-compliance under the Sunshine Act may increase government scrutiny and increase liability under other healthcare laws. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain states also mandate implementation of commercial compliance programs, impose restrictions on covered manufacturers&#8217; marketing practices and/or require the tracking and reporting of gifts, compensation and other remuneration to physicians and other healthcare professionals.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology and Clinical Health Act, or HITECH, and their respective implementing regulations, imposes specified requirements on certain health care providers, plans and clearinghouses (collectively, &#8220;covered entities&#8221;) and their &#8220;business associates,&#8221; relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. In addition, certain states have their own laws that govern the privacy and security of health information in certain circumstances, many of which differ from each other and/or HIPAA in significant ways and may not have the same effect, thus complicating compliance efforts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of our operations, exclusion from participation in federal and state healthcare programs, imprisonment, contractual damages, reputational harm, and diminished profits and future earnings, any of which could adversely affect our ability to operate our business and our financial results.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the foregoing health care laws, we are also subject to the U.S. Foreign Corrupt Practices Act, or FCPA, and similar worldwide anti-bribery laws, which generally prohibit companies and their intermediaries from making improper payments to government officials or private-sector recipients for the purpose of obtaining or retaining business. We also maintain an anti-corruption policy which mandates compliance with the FCPA and similar anti-bribery laws applicable to our business throughout the world. However, we cannot assure you that such a policy, or procedures implemented to enforce such a policy, will protect us from intentional, reckless or negligent acts committed by our employees, distributors, partners, collaborators or agents. Violations of these laws, or allegations of such violations, could result in fines, penalties or prosecution and have a negative impact on our business, results of operations and reputation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Coverage and Reimbursement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of pharmaceutical products depend significantly on the extent to which coverage and adequate reimbursement are provided by third-party payors. Third-party payors include state and federal government health care programs, managed care providers, private health insurers and other organizations. Although we currently believe that third-party payors will provide coverage and reimbursement for our product candidates, if approved, we cannot be certain of this. Third-party payors are increasingly challenging the price, examining the cost-effectiveness, and reducing reimbursement for medical products and services. In addition, significant uncertainty exists as to the reimbursement status of newly approved healthcare products. The U.S. government, state legislatures and foreign governments have continued implementing cost containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. Adoption of price controls and cost containment measures and adoption of more restrictive policies in jurisdictions with existing controls and measures could further limit our net revenue and results. We may need to conduct expensive clinical studies to demonstrate the comparative cost-effectiveness of our products. The product candidates that we develop may not be considered cost-effective and thus may not be covered or </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sufficiently reimbursed. It is time consuming and expensive for us to seek coverage and reimbursement from third-party payors, as each payor will make its own determination as to whether to cover a product and at what level of reimbursement. Thus, one payor&#8217;s decision to provide coverage and adequate reimbursement for a product does not assure that another payor will provide coverage or that the reimbursement levels will be adequate. Moreover, a payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Reimbursement may not be available or sufficient to allow us to sell our products on a competitive and profitable basis.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Healthcare Reform</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. and some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the U.S. and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the U.S., the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By way of example, in March&#160;2010, the Affordable Care Act was signed into law, intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. Among the provisions of the Affordable Care Act of importance to our potential drug candidates are:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare programs, not including orphan drug sales&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must agree to offer 70% point-of-sale discounts on negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part&#160;D&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">extension of manufacturers&#8217; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for certain individuals with income at or below 133% of the Federal Poverty Level, thereby potentially increasing manufacturers&#8217; Medicaid rebate liability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="letter-spacing:-0.1pt;color:#000000;">new requirements for certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, with specific exceptions to report annually certain financial arrangements with physicians, as defined by such law, and teaching hospitals, as defined in ACA and its implementing regulations, including reporting any payment or &#8220;transfer of value&#8221; provided to physicians and teaching hospitals and any ownership and investment interests held by physicians and their immediate family members during the preceding calendar year&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of healthcare fraud and abuse laws, including the U.S. federal False Claims Act and the U.S. federal Anti-Kickback Statute, new government investigative powers and enhanced penalties for noncompliance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.4%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.35%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. These changes include, among others, the Budget Control Act of 2011, which mandates aggregate reductions to Medicare payments to providers of up to 2%&#160;per fiscal year effective April&#160;1, 2013, and, will remain in effect through&#160;2030, with the exception of a temporary suspension implemented under various COVID&#8209;19 relief legislation from May&#160;1, 2020 through March&#160;31, 2021, unless additional Congressional action is taken. The American Taxpayer Relief Act of 2012, which, among other things, further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years. These new laws may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on customers for our product candidates, if approved, and, accordingly, our financial operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that the Affordable Care Act, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and lower reimbursement and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generate revenue</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">attain profitabili</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ty or commercialize our drugs. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, the current presidential administration and Congress </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may continue to attempt </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">broad sweeping changes to the current health care laws.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We face uncertainties that might result from modifications or repeal of any of the provisions of the Affordable Care Act, including as a result of current and future executive orders and legislative actions.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The impact of those changes on us and potential effect on the pharmaceutical and biotechnology industries as a whole is currently unknown.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">However</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, any changes to the Affordable Care Act are likely to have an impact on our results of operations and may have a material adverse effect on our results of operation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot predict what other healthcare programs and regulations will ultimately be implemented at the federal or state level or the effect any future legislat</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or regulation in the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may have on our business.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Foreign Regulation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to regulations in the U.S., we will be subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of our products to the extent we choose to develop or sell any products outside of the U.S. The approval process varies from country to country and the time may be longer or shorter than that required to obtain FDA approval. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employees</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, we had 171 employees. Among our employees, 23%&#160;are focused on research and development, 8%&#160;on clinical development and regulatory, 51%&#160;on manufacturing and quality, and 18%&#160;on general and administrative functions. Personnel of related companies who provide corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy and other administrative support services under our shared services agreement with NantWorks are not included in this number. For additional information, see Note&#160;10,<span style="font-style:italic;">&#160;Related Party Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report. We believe our ability to successfully achieve our vision depends on how effectively we manage our growth. Our leadership is focused on continuing to implement and improve our management systems, recruit and train new employees and cultivate and retain our existing team members. Our employees are a highly unique group of individuals across our drug discovery, preclinical development, clinical operations, regulatory affairs, manufacturing and quality, and executive leadership teams with deep experience in biotech across a breadth of novel scientific areas. We offer competitive compensation and benefits to all employees, as well as a host of other programs that enhance employee well-being in and outside of the workplace. We believe we have a positive relationship with our employees, and none of our employees are represented by a labor union or covered by collective bargaining agreements.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Corporate Information</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated on October&#160;7, 2002 in the state of Illinois under the name ZelleRx Corporation. On January&#160;22, 2010, we changed our name to Conkwest, Inc. In March&#160;2014, we formed Conkwest,&#160;Inc., our wholly owned subsidiary in the state of Delaware, or Conkwest Delaware, for the purposes of changing the state of our incorporation to the state of Delaware. In March&#160;2014, we merged with and into Conkwest Delaware, with Conkwest Delaware surviving the merger. On July&#160;10, 2015, we changed our name to NantKwest,&#160;Inc. Our website address is www.nantkwest.com. The contents of our website are not incorporated by reference into this Form&#160;10&#8209;K. We provide free of charge through a link on our website access to our Annual Reports on Form&#160;10&#8209;K, Quarterly Reports on Form&#160;10&#8209;Q and Current Reports on Form&#160;8&#8209;K, as well as amendments to those reports, as soon as reasonably practical after the reports are electronically filed with, or furnished to, the Securities and Exchange Commission.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1A_RISK_FACTORS">Item&#160;1A. Risk Factors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as other information included in this Annual Report on Form&#160;10&#8209;K, or Annual Report, including our financial statements and the related notes, and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; any of which may be relevant to decisions regarding an investment in or ownership of our stock. The occurrence of any of these risks could have a significant adverse effect on our reputation, business, financial condition, results of operations, growth and ability to accomplish our strategic objectives. We have organized the description of these risks into groupings in an effort to enhance readability, but many of the risks interrelate or could be grouped or ordered in other ways, so no special significance should be attributed to the groupings or order below.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risk Factor Summary</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Our Financial Condition and Capital Requirements:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We are a clinical-stage biopharmaceutical company with a limited operating history and have incurred significant losses since our inception, and we anticipate that we will continue to incur losses for the foreseeable future, which makes it difficult to assess our future viability.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We do not have any therapeutic products that are approved for commercial sale. Our ability to generate revenue from product sales and achieve and maintain profitability depends significantly on our success in a number of factors.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We will need to obtain substantial additional financing to complete the development and any commercialization of our product candidates, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our commercialization efforts, product development or other operations.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We expect our business to be adversely affected by outbreaks of epidemic, pandemic or contagious diseases, including the ongoing coronavirus pandemic.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may use our financial and human resources to pursue a particular type of treatment, or treatment for a particular type of cancer, and fail to capitalize on programs or treatment of other types of cancer that may be more profitable or for which there is a greater likelihood of success.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Business and Industry:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The foundation of our business is based upon the success of our aNK cells as a technology platform. Our aNK platform and product candidates derived thereof, including genetically modified haNK, taNK, t&#8209;haNK ceNK and MSC product candidates, will require significant additional clinical testing before we can potentially seek regulatory approval and launch commercial sales.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Utilizing haNK, taNK, t&#8209;haNK and ceNK cells represents a novel approach to immunotherapy, including cancer treatment, and we must overcome significant challenges in order to successfully develop, commercialize and manufacture our product candidates.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Even if we successfully develop and commercialize our haNK product candidate for Merkel cell carcinoma, we may not be successful in developing and commercializing our other product candidates, and our commercial opportunities may be limited.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not be able to file INDs to commence additional clinical trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed in a timely manner, or at all.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our plans to support the Joint COVID&#8209;19 Collaboration by moving some of our current manufacturing facilities or repurposing personnel may cause delays in our oncology trials.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our efforts regarding the Joint COVID&#8209;19 Collaboration may be difficult to integrate into our current operations and will require additional personnel who will require training, which may cause some of our employees to reallocate their time from our current operations or manufacturing duties, which could in turn cause delays in clinical supply of our products or trials.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We face significant competition in the biopharmaceutical industry, and many of our competitors have substantially greater experience and resources than we have.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Government Regulation:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may fail to obtain or may experience delays in obtaining regulatory approval to market our aNK platform product candidates, which will significantly harm our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Even if we obtain regulatory approvals for aNK related platform products, those approvals and ongoing regulation of our products may limit how we manufacture and market our products, which could prevent us from realizing the full benefit of our efforts.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may seek orphan drug status or breakthrough therapy designation for one or more of our product candidates, but even if either is granted, we may be unable to maintain any benefits associated with breakthrough therapy designation or orphan drug status, including market exclusivity.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We will need to obtain FDA approval of any proposed product brand names, and any failure or delay associated with such approval may adversely impact our business.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Intellectual Property:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">If our efforts to protect the intellectual property related to our product candidates are not adequate, we may not be able to compete effectively in our market.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not be able to protect our intellectual property rights throughout the world.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Obtaining and maintaining our patent protection depends on compliance with various procedural, documentary, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Third-party claims alleging intellectual property infringement may adversely affect our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property or the patents of our licensors, which could be expensive and time consuming.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to our Proposed Merger with ImmunityBio</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may suffer negative consequences if the proposed merger is not completed.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not consummate the proposed merger with ImmunityBio in the time frame anticipated or at all.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The combined company may not realize all of the anticipated benefits of the proposed merger.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Common Stock:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our Executive Chairman, and entities affiliated with him, collectively own a significant majority of our common stock and will exercise significant influence over matters requiring stockholder approval, regardless of the wishes of other stockholders.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The market price of our common stock has been and may continue to be volatile, and investors may have difficulty selling their shares.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plan, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We have incurred and will continue to incur costs as a result of operating as a public company and our management has been and will be required to devote substantial time to compliance initiatives and corporate governance practices, including maintaining an effective system of internal control over financial reporting.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">If a restatement of our financial statements were to occur, our shareholders&#8217; confidence in the company&#8217;s financial reporting in the future may be affected, which could in turn have a material adverse effect on our business and stock price.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Our Financial Condition and Capital Requirements</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are a clinical-stage biopharmaceutical company with a limited operating history and have incurred significant losses since our inception, and we anticipate that we will continue to incur losses for the foreseeable future, which makes it difficult to assess our future viability.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a clinical-stage biopharmaceutical company with a limited operating history upon which our business can be evaluated. To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property, and we have no products approved for commercial sale and have not generated any revenue from product sales. We have incurred operating losses on an annual basis since our formation and we may never become profitable. As of December&#160;31, 2020, we had an accumulated deficit of $754.6&#160;million. We incurred net losses of $92.4&#160;million, $65.8&#160;million, and $96.2&#160;million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Our losses have resulted principally from costs incurred in ongoing preclinical studies, clinical trials and operations, as well as other research and development expenses, and general and administrative expenses.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A critical aspect of our strategy is to invest significantly in expanding our haNK, taNK, t&#8209;haNK, MSC and ceNK platforms and the development of our product candidates. We expect to incur significant expenses as we continue to expand our business, including in connection with conducting research and development across multiple therapeutic areas, participating in clinical trial activities, continuing to acquire or in-license technologies, maintaining, protecting and expanding our intellectual property, seeking regulatory approvals and, upon successful receipt of U.S.&#160;Food and Drug Administration, or FDA, approval, commercializing our products. We will also incur costs as we hire additional personnel and increase our manufacturing capabilities, including the lease or purchase of a facility for the manufacturing of our product candidates for our ongoing and any future clinical trials and, upon receipt of any FDA approval, for our initial commercialization activities. Moreover, we do not expect to have any significant product sales or revenue for at least the next several years. These losses have had and, as our operating losses continue to increase significantly in the future due to these expenditures, will continue to have an adverse effect on our stockholders&#8217; equity and working capital. Because of the numerous risks and uncertainties associated with our product development efforts, we are unable to predict when we may become profitable, if at all. Additionally, our net losses may fluctuate significantly from quarter to quarter, and as a result, a period-to-period comparison of our results of operations may not be meaningful. For example, we expect our operating expenses to continue to increase in the year ended December&#160;31, 2021, due to increased research and development expenses including personnel related costs and capital and facility operating expenditures in continued efforts for our Joint COVID&#8209;19 Collaboration with ImmunityBio. Additionally, we also expect to incur increased costs associated with our proposed merger with ImmunityBio. Even if we do become profitable, we may not be able to sustain or increase our profitability on a quarterly or annual basis. In addition, we expect increased expenses in future quarters as a result of the Joint COVID-19 Collaboration.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We do not have any therapeutic products that are approved for commercial sale. Our ability to generate revenue from product sales and achieve and maintain profitability depends significantly on our success in a number of factors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently do not have any therapeutic products that are approved for commercial sale. We have not received, and do not expect to receive for at least the next several years, if at all, any revenues from the commercialization of our product candidates if approved. To obtain revenue from sales of our product candidates that are significant or large enough to achieve profitability, we must succeed, either alone or with third or related parties, in developing, obtaining regulatory approval for, manufacturing and marketing therapies with commercial potential. Our ability to generate revenue and achieve and maintain profitability depends significantly on our success in many areas, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our research and development efforts, including preclinical studies and clinical trials of our haNK, taNK, t&#8209;haNK, ceNK and MSC platforms and our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">continuing to develop sustainable, scalable, reliable and cost-effective manufacturing and distribution processes for our product candidates, if approved, including establishing and maintaining commercially viable supply relationships with third and related parties and establishing our own current Good Manufacturing Practices, or cGMP, manufacturing facilities and processes to support clinical development and meet the market demand for product candidates that we develop, if approved&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">addressing any competing therapies and technological and industry developments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">identifying, assessing, acquiring and developing new technology platforms and product candidates across numerous therapeutic areas&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">establishing and maintaining relationships with contract research organizations, or CROs, and clinical sites for the clinical development, both in the U.S. and internationally, of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">successful and timely completion of preclinical and clinical development of our product candidates and any other future product candidates&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">obtaining regulatory approvals and marketing authorizations for our current and future product candidates, including a continued acceptable safety profile both prior to and following any marketing approval of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">making any required post-marketing approval commitments to applicable regulatory authorities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">launching and commercializing any approved products, either directly or with a collaborator or distributor, including the development of a commercial infrastructure&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtaining market acceptance of and acceptable reimbursement for any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">completing collaborations, licenses and other strategic transactions on favorable terms, if at all&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">defending against third-party interference or infringement claims, if any&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">attracting, hiring and retaining qualified personnel.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if one or more of our product candidates is eventually approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate and we may not generate significant revenue from sales of such products, resulting in limited or no profitability in the future. Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital for the foreseeable future. Any failure to become and remain profitable may adversely affect the market price of our common stock, our ability to raise additional capital and our future viability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We will need to obtain substantial additional financing to complete the development and any commercialization of our product candidates, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our commercialization efforts, product development or other operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have used substantial amounts of cash to fund our operations and expect our expenses to increase substantially in the foreseeable future. Developing our product candidates and conducting clinical trials for the treatment of cancer, virally infectious diseases, and other diseases requires substantial amounts of capital. We will also require a significant additional amount of capital to commercialize any approved products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, we had cash and cash equivalents of $11.4&#160;million and marketable debt securities of $54.8&#160;million. We are using and expect to continue to use our existing cash and cash equivalents and marketable debt securities to fund expenses in connection with our ongoing and any future clinical trials, our manufacturing facilities and processes and the hiring of additional personnel, and for other research and development activities, working capital and general corporate purposes, including our previously announced share repurchase program. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#8217;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. Our estimate as to how long we expect our existing cash and cash equivalents to be available to fund our operations is based on assumptions that may be proved inaccurate, and we could deplete our available capital resources sooner than we currently expect. In addition, changing circumstances, including the completion of the proposed merger with ImmunityBio, may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. We may require additional capital for the further development and any commercialization of our product candidates and may need to raise additional funds sooner than we anticipate if we choose to expand more rapidly.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future capital requirements may depend on, and could increase significantly as a result of, many factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of, and the costs involved in, preclinical and clinical development and obtaining any regulatory approvals for our oncology product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of, and the costs involved with, the joint development, manufacturing and marketing of a vaccine and multiple therapeutics for COVID&#8209;19 with ImmunityBio&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs of manufacturing, distributing and processing our product candidates and any products for which we receive regulatory approval, if any&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number and characteristics of any other product candidates we develop or acquire&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to establish and maintain strategic collaborations, licensing or other commercialization arrangements and the terms and timing of such arrangements, including our arrangements with ImmunityBio and its subsidiaries and Viracta&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the degree and rate of market acceptance of any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the emergence, approval, availability, perceived advantages, relative cost, relative safety and relative efficacy of other products or treatments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the expenses needed to attract and retain skilled personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs associated with being a public company&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs associated with our proposed merger with ImmunityBio&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing intellectual property claims, including litigation costs and the outcome of such litigation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs related to commercializing product candidates independently&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing, receipt and amount of sales of, or royalties on, any approved products&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any product liability or other lawsuits related to our product candidates or the company.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our common stockholders&#8217; rights. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or licensing arrangements with pharmaceutical partners, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. Additional capital may not be available when we need it, on terms that are acceptable to us or at all. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market any approved products that we would otherwise prefer to develop and market ourselves, or be unable to continue or expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations and cause the price of our common stock to decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We expect our business to be adversely affected by outbreaks of epidemic, pandemic or contagious diseases, including the ongoing coronavirus pandemic.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outbreaks of epidemic, pandemic or contagious diseases, such as the coronavirus pandemic, may significantly disrupt our operations and adversely affect our business, financial condition and results of operations. In March&#160;2020, the World Health Organization declared the outbreak of COVID&#8209;19 a global pandemic as the novel coronavirus continued to spread throughout the world. The spread of this pandemic has caused significant volatility and uncertainty in the U.S. and international markets and has resulted in increased risks to our operations. We are monitoring a number of risks related to this pandemic, including the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Financial: While to date, the financial impact to our business has not been material, we anticipate that the pandemic could have an adverse financial impact in the short-term and potentially beyond. As a result of slower patient enrollment, we may not be able to complete our clinical trials as planned or in a timely manner. We expect to continue spending on research and development during the year ended December&#160;31, 2021 and beyond, and we could also have unexpected expenses related to the pandemic. The short-term continued expenses, as well as the overall uncertainty and disruption caused by the pandemic, will likely cause a delay in our ability to commercialize a product and adversely impact our financial results.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Supply Chain: While to date we have not experienced significant disruptions in our supply chain and distribution, an extended duration of this pandemic could result in disruptions in the future. For example, quarantines, shelter-in-place and similar government orders, travel restrictions and health impacts of the COVID&#8209;19 pandemic, could impact the availability or productivity of personnel at third-party laboratory supply manufacturers, distributors, freight carriers and other necessary components of our supply chain. In addition, there may be unfavorable changes in the availability or cost of raw materials, intermediates and other materials necessary for production, which may result in disruptions in our supply chain and adversely affect our ability to manufacture and distribute certain product candidates for clinical supply.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="text-decoration:none;Background-color:#auto;font-size:10pt;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Clinical Trials: This pandemic </span><span style="font-size:10pt;color:#000000;">did</span><span style="font-size:10pt;color:#000000;"> not significantly impact our business or financial results </span><span style="font-size:10pt;color:#000000;">during</span><span style="font-size:10pt;color:#000000;"> </span><span style="font-size:10pt;color:#000000;">the</span><span style="font-size:10pt;color:#000000;"> </span><span style="font-size:10pt;color:#000000;">year ended December&#160;31, 2020</span><span style="font-size:10pt;color:#000000;">, however, it is likely to adversely affect certain of our clinical trials, including our ability to initiate and complete our clinical trials within the anticipated timelines. Due to site and participant availability during the pandemic, new subject enrollment is expected to slow in the short-term for most of our clinical trials. For ongoing trials, we have seen an increasing number of clinical trial sites imposing restrictions on patient visits to limit risks of possible COVID</span><span style="font-size:10pt;color:#000000;">&#8209;19 exposure, and we may experience issues with participant compliance with clinical trial protocols as a result of quarantines, travel restrictions and interruptions to healthcare services. The current pressures on medical systems and the prioritization of healthcare resources toward the COVID</span><span style="font-size:10pt;color:#000000;">&#8209;19 pandemic have also resulted in interruptions in data collection and submissions for certain clinical trials and delayed starts for certain planned studies. As a result, our anticipated filing and marketing timelines may be adversely impacted.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Overall economic and capital markets decline: The impact of the COVID&#8209;19 pandemic could result in a prolonged recession or depression in the U.S. or globally that could harm the banking system, limit demand for all products and services and cause other seen and unforeseen events and circumstances, all of which could negatively impact us. The continued spread of COVID&#8209;19 has led to and could continue to lead to severe disruption and volatility in the U.S. and global capital markets, which could result in a decline in stock price, increase our cost of capital and adversely affect our ability to access the capital markets in the future. In addition, trading prices on the public stock market, including our common stock, have been highly volatile as a result of the COVID&#8209;19 pandemic.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Regulatory Reviews: The operations of the FDA or other regulatory agencies may be adversely affected. In response to COVID&#8209;19, federal, state and local governments are issuing new rules, regulations, orders and advisories on a regular basis. These government actions can impact us, our members and our suppliers. There is also the possibility that we may experience delays with obtaining approvals for our Investigational New Drug, or IND, applications.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing and other risks may have an adverse effect on our overall business, financial condition and results of operations. Additionally, the ongoing COVID&#8209;19 pandemic may also affect our operating and financial results in a manner that is not presently known to us or that we currently have not considered as significant risks to our operations. This pandemic may also amplify many of the other risks described throughout the &#8220;Risk Factors&#8221; section of this Annual Report. Any resulting financial impact cannot be reasonably estimated at this time. The extent to which the COVID&#8209;19 pandemic impacts our business and results will depend on future developments, which are uncertain and cannot be predicted with confidence, including the duration and scope of the outbreak, any potential future waves of the pandemic, new information which may emerge concerning the severity of COVID&#8209;19 and the ongoing and future actions to contain it or treat its impact, among others.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may use our financial and human resources to pursue a particular type of treatment, or treatment for a particular type of cancer, and fail to capitalize on programs or treatment of other types of cancer that may be more profitable or for which there is a greater likelihood of success.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we have limited resources, we must choose to pursue and fund the development of specific types of treatment, or treatment for a specific type of cancer or viral infectious diseases, and may forego or delay pursuit of opportunities with other programs, investigational medicines, or treatment for other types of cancer or viral infectious diseases, which could later prove to have greater commercial potential. Moreover, given the rapidly evolving competitive landscape and the time it takes to advance a product through clinical development, an incorrect decision to pursue a particular type of treatment or cancer may have a material adverse effect on our results of operation and negatively impact our future clinical strategies. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for investigational medicines or clinical trials may not yield any commercially viable products. If we do not accurately evaluate and anticipate the commercial potential or target market for a particular type of treatment or cancer or viral infectious disease, we may choose to spend our limited resources on a particular treatment, or treatment for a particular type of cancer or viral infectious disease, and then later learn that another type of treatment or cancer that we previously decided not to pursue would have been more advantageous.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We invest our cash on hand in various financial instruments which are subject to risks that could adversely affect our business, results of operations, liquidity and financial condition.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest our cash in a variety of financial instruments, principally commercial paper, corporate debt securities and foreign government bonds. All of these investments are subject to credit, liquidity, market and interest rate risk. Such risks, including the failure or severe financial distress of the financial institutions that hold our cash, cash equivalents and investments, may result in a loss of liquidity, impairment to our investments, realization of substantial future losses, or a complete loss of the investments in the long-term, which may have a material adverse effect on our business, results of operations, liquidity and financial condition. In order to manage the risk to our investments, we maintain an investment policy that, among other things, limits the amount that we may invest in any one issue or any single issuer and requires us to only invest in high credit quality securities to preserve liquidity.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Business and Industry</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The foundation of our business is based upon the success of our aNK cells as a technology platform. Our aNK platform and product candidates derived thereof, including genetically modified haNK, taNK, t<span style="font-weight:normal;">&#8209;</span>haNK, ceNK and MSC product candidates, will require significant additional clinical testing before we can potentially seek regulatory approval and launch commercial sales.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business and future success depend on our ability to utilize our aNK cells as a technology platform, and to obtain regulatory approval for one or more product candidates derived from it, and then successfully commercialize our product candidates addressing numerous therapeutic areas. Our aNK platform and our haNK, taNK, t&#8209;haNK, ceNK and MSC product candidates are in varying stages of development and may never become commercialized. All of our product candidates developed from our technology platform will require additional clinical and non-clinical development, regulatory review and approval in multiple jurisdictions, substantial investment, access to sufficient commercial manufacturing capacity and significant marketing efforts before they can be successfully commercialized. Because all of our product candidates are based on the same core aNK technology, if any of our product candidates encounter safety or efficacy problems, developmental delays or regulatory issues or other problems, these could impact the development plans for our other product candidates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Utilizing haNK, taNK, t<span style="font-weight:normal;">&#8209;</span>haNK and ceNK cells represents a novel approach to immunotherapy, including cancer treatment, and we must overcome significant challenges in order to successfully develop, commercialize and manufacture our product candidates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have concentrated our research and development efforts on utilizing aNK cells as an immunotherapy platform and genetically modified aNK cells as product candidates based on this platform. We believe that our product candidates represent a novel approach to immunotherapy, including cancer treatment. Advancing this novel immunotherapy creates significant challenges for us, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">educating medical personnel regarding the potential side effect profile of our cells&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">training a sufficient number of medical personnel how to properly administer our cells&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">enrolling sufficient numbers of patients in clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">developing a reliable, safe and effective means of genetically modifying our cells&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">manufacturing our cells on a large scale and in a cost-effective manner&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">submitting applications for and obtaining regulatory approval, as the FDA and other regulatory authorities have limited experience with commercial development of immunotherapies for cancer and viral associated infectious diseases&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">establishing sales and marketing capabilities, as well as developing a manufacturing process and distribution network to support the commercialization of any approved products.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We must be able to overcome these challenges in order for us to successfully develop, commercialize and manufacture our product candidates utilizing haNK, taNK, t&#8209;haNK and ceNK cells.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even if we successfully develop and commercialize our haNK product candidate for Merkel cell carcinoma, we may not be successful in developing and commercializing our other product candidates, and our commercial opportunities may be limited.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our ability to realize the full value of our aNK platform will depend on our ability to successfully develop and commercialize haNK and our other product candidates in a wider range of indications. We are simultaneously pursuing preclinical and clinical development of a number of product candidates spanning several types of cancers. For example, we are devoting substantial resources toward the development of haNK and t&#8209;haNK product candidates as combination therapies with commercially approved monoclonal antibodies and late-stage product candidates for solid tumors such as breast, pancreatic, lung, head and neck and hematologic malignancies such as diffuse large&#160;B&#8209;cell lymphoma, or DLBCL, and serious viral diseases such as COVID&#8209;19.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we are successful in continuing to build our pipeline of product candidates based on our technology platform, obtaining regulatory approvals and commercializing any approved product candidates will require substantial additional funding beyond our existing cash and cash equivalents and marketable debt securities, and are prone to numerous risks of failure. Investment in biopharmaceutical product development involves significant risks that any product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile to the satisfaction of regulatory authorities, gain regulatory approval or become commercially viable. We cannot assure you that we will be able to successfully advance any product candidates through the development process. Our research programs may initially show promise in identifying product candidates, but ultimately fail to yield product candidates for clinical development or commercialization for many reasons, including the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our product candidates may not succeed in preclinical or clinical testing due to failing to generate enough data to support the initiation or continuation of clinical trials or due to lack of patient enrollment in clinical trials&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">a product candidate may be shown to have harmful side effects or other characteristics in larger scale clinical studies that indicate it is unlikely to meet applicable regulatory criteria&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">competitors may develop alternatives that render our product candidates obsolete or less attractive&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may not be able or willing to assemble sufficient resources to acquire or discover additional product candidates from our technology platform&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other exclusive rights&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the market for a product candidate may change during our program so that the continued development of that product candidate is no longer reasonable&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a product candidate may not be capable of being manufactured in commercial quantities at an acceptable cost, or at all&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any of these events occur, we may be forced to abandon our development efforts for a product candidate or the entire platform, or we may not be able to identify, discover, develop or commercialize additional product candidates, which would have a material adverse effect on our business and could potentially cause us to cease operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not be able to file INDs to commence additional clinical trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed in a timely manner, or at all.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to commencing clinical trials in the U.S. for any of our product candidates, we may be required to have an allowed IND for each product candidate. As of the date of this filing, we have numerous INDs for clinical trials that have been authorized in the U.S. We are required to file additional INDs prior to initiating our planned clinical trials. Submission of an IND may not result in the FDA allowing further clinical trials to begin and, once begun, issues may arise that will require us to suspend or terminate such clinical trials. Additionally, even if relevant regulatory authorities agree with the design and implementation of the clinical trials set forth in an IND or clinical trial application, these regulatory authorities may change their requirements in the future. The fact that we are pursuing novel technologies may also exacerbate these risks with respect to our product candidates, and as a result, we may not meet our anticipated clinical development timelines.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our plans to support the Joint COVID&#8209;19 Collaboration by moving some of our current manufacturing facilities or repurposing personnel may cause delays in our oncology trials.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have prepared one of our GMP manufacturing facilities previously used to manufacture product for our oncology trials to manufacture and produce a COVID&#8209;19 vaccine candidate and we are in the process of readying a new, well-equipped location to manufacture and produce clinical products for our oncology trials. We cannot assure you that we will be able to achieve GMP qualifications for this new manufacturing facility, or the extent of costs or delays in timing to do so.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Failure to achieve GMP status could adversely impact our ability to successfully develop our oncology product candidates. In addition, we have repurposed some of our manufacturing facility in Culver City, California, and personnel to support the Joint COVD&#8209;19 Collaboration Agreement. While we believe we have sufficient product in our inventory to not incur any disruptions in our current or planned oncology trials, we cannot be certain that we will not experience any unforeseen circumstances that may cause delays in our ability to manufacture sufficient product for our current or planned trials. If this occurs, such trials could be significantly delayed which would have an adverse effect on our business, financial condition, results of operations and prospects.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our efforts regarding the Joint COVID&#8209;19 Collaboration may be difficult to integrate into our current operations and will require additional personnel who will require training which may cause some of our employees to reallocate their time from our current operations or manufacturing duties which could in turn cause delays in clinical supply of our products or trials.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After signing the binding term sheet regarding the Joint COVID&#8209;19 Collaboration in May&#160;2020, we have made significant investments related to the development and manufacture of our COVID&#8209;19 product candidates. We have repurposed some of our personnel to support our QUILT&#8209;COVID&#8209;19&#8209;MSC program and have repurposed some of our personnel overseeing quality of our oncology products to support the Joint COVID&#8209;19 Collaboration. We also plan to hire additional staff to support the Joint COVID&#8209;19 Collaboration, which will increase our expenses. Although we do not believe the Joint COVID&#8209;19 collaboration will have a material impact on our current oncology trials in the near term, if our current personnel fail to remain focused on our oncology drug candidates, or new personnel that we plan to hire to support the Joint COVID&#8209;19 Collaboration require extensive training, our current oncology operations may be adversely impacted.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We face significant competition in the biopharmaceutical industry, and many of our competitors have substantially greater experience and resource</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">s than we have.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if our aNK platform products prove successful, we might not be able to remain competitive because of the rapid pace of technological development in the biopharmaceutical field. Our haNK, taNK, t&#8209;haNK and ceNK product candidates compete with other cell and molecule-based immunotherapy approaches using or targeting natural killer cells, NKT&#160;cells, T&#8209;cells, and dendritic cells.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitors focused on CAR&#8209;T related treatment approaches include AbbVie&#160;Inc., Atara&#160;Biotherapeutics,&#160;Inc., Precigen&#160;Corporation,&#160;Inc., Allogene&#160;Therapeutics,&#160;Inc., Bristol&#8209;Myers&#160;Squibb&#160;Company, Beijing Immunochina Pharmaceuticals&#160;Co., Ltd., Cellular Biomedicine Group,&#160;Inc., iCell Gene Therapeutics&#160;LLC, JW&#160;Therapeutics&#160;Co.,&#160;Ltd., Amgen,&#160;Inc., Leucid&#160;Bio&#160;Ltd., Bellicum&#160;Pharmaceuticals,&#160;Inc., Medisix&#160;Therapeutics&#160;Pte&#160;Ltd., Bluebird&#160;Bio,&#160;Inc., Mesoblast&#160;Ltd., Calibr/Scripps&#160;Research, Mustang&#160;Bio,&#160;Inc., Carina Biotech,&#160;Inc., CARsgen&#160;Therapeutics, CRISPR Therapeutics,&#160;Inc., GEMoaB Monoclonals&#160;GmbH, Nanjing&#160;Legend&#160;Biotechnology&#160;Co.,&#160;Ltd, Cartherics&#160;Pty&#160;Ltd, Novartis&#160;AG, Pfizer,&#160;Inc., Cellectis&#160;SA, Poseida&#160;Therapeutics,&#160;Inc., Prepromene Bio,&#160;Inc., Celularity,&#160;Inc., Servier&#160;Laboratories, Sorrento Therapeutics,&#160;Inc., Celyad&#160;SA, Takeda Pharmaceutical Company Limited, Fortress Biotech,&#160;Inc., TC&#160;BioPharm&#160;Ltd., Tessa Therapeutics&#160;Pte&#160;Ltd, Gilead&#160;Sciences,&#160;Inc., Tmunity Therapeutics,&#160;Inc., Transposagen&#160;Biopharmaceuticals,&#160;Inc., Humanigen,&#160;Inc., Immune&#160;Therapeutics,&#160;Inc., and Xyphos,&#160;Inc./Astellas.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on other T&#8209;cell based approaches include Adaptimmune&#160;Ltd., Adicet&#160;Bio,&#160;Inc., Autolus&#160;Therapeutics,&#160;plc, Cell&#160;Medica&#160;Limited, Eureka Therapeutics,&#160;Inc., Formula Pharmaceuticals,&#160;Inc., GlaxoSmithKline&#160;plc., Green&#160;Cross&#160;LabCell&#160;Corp., Immatics Biotechnologies&#160;GmbH, Immunocore&#160;Limited, Iovance&#160;Biotherapeutics,&#160;Inc., Kiadis&#160;Pharma&#160;Netherlands&#160;B.V., Lion&#160;TCR&#160;Pte&#160;Ltd., MolMed,&#160;S.p.A., Precision&#160;Biosciences,&#160;Inc., Janssen&#160;Pharmaceuticals,&#160;Inc., Noile&#8209;Immune&#160;Biotech,&#160;Inc., Anixa&#160;Biosciences,&#160;Inc., Beam&#160;Therapeutics&#160;Inc., BioNTech&#160;SE, Cartesian&#160;Therapeutics,&#160;Inc., Marker Therapeutics,&#160;Inc., Refuge Biotechnologies,&#160;Inc., Repertoire Immune Medicines,&#160;Inc., Sensei Biotherapeutics,&#160;Inc., Senti&#160;Biosciences,&#160;Inc., TCR&#178; Therapeutics&#160;Inc., TScan Therapeutics,&#160;Inc., and Takara&#160;Bio,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on dendritic cell based approaches include Argos&#160;Therapeutics,&#160;Inc., Biovest&#160;International,&#160;Inc., ImmunoCellular&#160;Therapeutics,&#160;Ltd., Merck&#160;&#38;&#160;Co,&#160;Inc./Immune&#160;Design,&#160;Inc., Inovio&#160;Pharmaceuticals,&#160;Inc., Precigen&#160;Corporation,&#160;Inc., Medigene&#160;AG, and Northwest&#160;Biotherapeutics,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on natural killer cell based approaches include Acepodia,&#160;Inc., Carabou Biosciences,&#160;Inc., Catamaran Bio&#160;Inc., Celularity,&#160;Inc., Century&#160;Therapeutics,&#160;Inc., Cytovia Therapeutics,&#160;Inc., Glycostem&#160;Therapeutics&#160;BV, Kiadis&#160;Pharma Netherlands&#160;B.V./CytoSen Therapeutics,&#160;Inc., Dragonfly&#160;Therapeutics,&#160;Inc., Editas Medicine,&#160;Inc., EMERcell, Exacis&#160;Biotherapeutics,&#160;Inc., Fate&#160;Therapeutics,&#160;Inc., Gamida&#160;Cell,&#160;Ltd., INmune Bio Inc., Nkarta&#160;Therapeutics,&#160;Inc., Onkimmune&#160;Ltd., Oncternal Therapeutics,&#160;Inc., NKMax&#160;America, Artiva&#160;Biotherapeutics/Merck, HebeCell&#160;Corp., Vycellix,&#160;Inc., oNKo&#8209;innate&#160;Pty&#160;Ltd., ONK Therapeutics Limited, Sanofi,&#160;S.A., Shoreline Biosciences,&#160;Inc., Takeda Pharmaceutical Company Limited, XNK Therapeutics&#160;AB, Zelluna Immunotherapy&#160;AS, and Ziopharm&#160;Oncology,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on large molecule immunotherapy approaches, including those overlapping the natural killer cell space, include Cytomx&#160;Therapeutics,&#160;Inc., Compass Therapeutics,&#160;Inc., Innate&#160;Pharma&#160;SA, Nektar Therapeutics,&#160;Inc., and Sorrento&#160;Therapeutics,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other potential immunotherapy competitors include Affimed&#160;GmbH, AgenTus Therapeutics, Inc., Agios&#160;Pharmaceuticals,&#160;Inc., Codiak&#160;Biosciences, Glycostem&#160;Therapeutics&#160;BV, Kuur Therapeutics Limited, Triumvira&#160;Immunologics, Incysus&#160;Therapeutics,&#160;Inc., GammaDelta&#160;Therapeutics&#160;Ltd., Lyell&#160;Immunopharma,&#160;Inc., and GT&#160;Biopharma,&#160;Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are currently four approved T&#8209;cell based treatments that are marketed by Novartis&#160;AG, Gilead&#160;Sciences/Kite&#160;Pharma (two therapeutics), and the Bristol&#8209;Myers&#160;Squibb&#160;Company. There is currently one approved dendritic cell-based cancer vaccine marketed by Dendron&#160;Pharmaceuticals,&#160;LLC for the treatment of metastatic castration resistant prostate cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitor companies focused on COVID&#8209;19 cell therapy currently include AstraZeneca plc, Athersys,&#160;Inc./Healios&#160;K.K., Capricor Therapeutics,&#160;Inc., CAR&#8209;T (Shanghai) Biotechnology, Cellavita Pesquisa Cient&#237;fica&#160;Ltda, Cellenkos,&#160;Inc., Cellular Biomedicine Group,&#160;Inc., Celularity,&#160;Inc., Sorrento Therapeutics,&#160;Inc., Chinese Academy of Sciences, Chongqing Sidemu Biotechnology Technology/ImmunCyte Life Sciences,&#160;Inc., Enlivex Therapeutics&#160;Ltd, Green Cross LabCell&#160;Corp., Hope Biosciences, Johnson &#38; Johnson, Mesoblast&#160;Limited, Moderna, Inc., NovaVax, Inc., Orbsen Therapeutics&#160;Limited, Pfizer, Inc./BioNTech SE, Pluristem Therapeutics,&#160;Inc., Rigshospitalet, Tianhe Stem Cell Biotechnologies&#160;Inc., University of Minnesota/Fate Therapeutics,&#160;Inc., and Xinjiang Medical University.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, a very large number of companies, government agencies and academic centers around the world are developing COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19 vaccines, and many of these entities are in more advanced stages of development than ImmunityBio, including some that have started Phase</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">II and/or III clinical trials</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or already have emergency regulatory approval in some regions</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Even if ImmunityBio&#8217;s COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19 vaccine candidate is ultimately approved for marketing, the value of our profit-sharing opportunity would be adversely impacted if other COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19 vaccines are approved earlier or show better efficacy or safety than ImmunityBio&#8217;s COVID</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> vaccine candidate.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our current or potential competitors have greater financial and other resources, larger research and development staffs, and more experienced capabilities in researching, developing and testing products than we do. Many of these companies also have more experience in conducting clinical trials, obtaining FDA and other regulatory approvals, and manufacturing, marketing and distributing therapeutic products. Smaller or clinical-stage companies like us may successfully compete by establishing collaborative relationships with larger pharmaceutical companies or academic institutions. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Furthermore, currently approved products could be discovered to have application for treatment of cancer and other diseases, which could give such products significant regulatory and market timing advantages over any of our product candidates. In addition, large pharmaceutical companies or other companies with greater resources or experience than us may choose to forgo therapy opportunities that would have otherwise been complementary to our product development and collaboration plans. Our competitors may succeed in developing, obtaining patent protection for, or commercializing their products more rapidly than us, which could result in our competitors establishing a strong market position before we are able to enter the market. A competing company developing or acquiring rights to a more effective therapeutic product for the same diseases targeted by us, or one that offers significantly lower costs of treatment could render our products noncompetitive or obsolete. We may not be successful in marketing against competitors any product candidates we may develop.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our business plan involves the creation of a complex integrated ecosystem capable of addressing a wide range of indications. As a result, our future success depends on our ability to prioritize among many different opportunities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not have sufficient resources to pursue development of all or even a substantial portion of the potential opportunities that we believe will be afforded to us by our planned integrated ecosystem. Because we have limited resources and access to capital to fund our operations, our management must make significant prioritization decisions as to which product candidates to pursue and how much of our resources to allocate to each. Our management has broad discretion to suspend, scale down, or discontinue any or all of these development efforts, or to initiate new programs to treat other diseases. If we select and commit resources to opportunities that we are unable to successfully develop, or we forego more promising opportunities, our business, financial condition and results of operations will be adversely affected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We plan to develop our product candidates and potentially other programs in combination with other commercially available therapies or therapies we, or an affiliate of ours, have in development, which exposes us to additional risks. We do not know whether our attempts to use our product candidates in combination will be safe or effective.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We intend to develop cryopreserved PD&#8209;L1.t&#8209;haNK, haNK, and potentially other programs in combination with one or more currently approved cancer therapies or therapies in development. For Merkel cell carcinoma, we plan to evaluate haNK in combination with N&#8209;803 and avelumab. For pancreatic cancer, TNBC, and breast cancer indications, we plan to evaluate PD&#8209;L1.t&#8209;haNK in combination with N&#8209;803 and aldoxorubicin. For NSCLC indications, we plan to evaluate PD&#8209;L1.t&#8209;haNK in combination with N&#8209;803 and a checkpoint inhibitor.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patients may not be able to tolerate any of our other product candidates in combination with any other therapies or dosing of our product candidates in combination with other therapies may have serious or unexpected adverse events. Furthermore, we will be required to show with substantial evidence that the combination of drugs when used together are more effective than each of the individual drugs used separately. We can provide no assurance that we can establish that any of our product candidates, when used in combination with other drugs, will be more effective than each individual drug when used alone.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also evaluate our product candidates in combination with one or more other cancer therapies that have not yet been approved for marketing by the FDA, the European Medicines Agency, or EMA, or comparable foreign regulatory authorities. We will not be able to market and sell any product candidate in combination with any such unapproved cancer therapies that do not ultimately obtain marketing approval.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the FDA, EMA or other comparable foreign regulatory authorities do not approve or revoke their approval of these other therapies, or if safety, efficacy, purity, potency, commercial adoption, manufacturing or supply issues arise with the therapies we choose to evaluate in combination with any of our product candidates, we may be unable to obtain approval of or successfully market any one or all of the product candidates we develop.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, if the third-party providers of therapies or therapies in development used in combination with our product candidates are unable to produce sufficient quantities for clinical trials or for commercialization of our product candidates, or if the cost of combination therapies are prohibitive, our development and commercialization efforts would be impaired, which would have an adverse effect on our business, financial condition, results of operations and growth prospects. If clinical trial collaboration and supply agreement terminates or if we cannot negotiate favorable terms for combination therapies, our combination therapy development plans could be delayed or terminated, and the cost to us to conduct such trials may significantly increase.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Clinical development involves a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future clinical trial results. We may encounter substantial delays in clinical trials, or may not be able to conduct or complete clinical trials on the expected timelines, if at all. If our preclinical studies and clinical trials are not sufficient to support regulatory approval of any of our product candidates, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development of such product candidate.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is impossible to predict when or if any of our product candidates and therapies will prove safe, effective, or potent in humans or will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete extensive preclinical studies and clinical trials to demonstrate the safety, efficacy or potency of our product candidates in humans. A failure of one or more clinical trials can occur at any stage of testing. The outcome of early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. Our pre-clinical studies and future clinical trials may not be successful.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot be certain that our planned clinical trials will be sufficient to support regulatory approval of our product candidates. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Human clinical trials are expensive and difficult to design and implement, in part because they are subject to rigorous regulatory requirements. Failure or delay can occur at any time during the clinical trial process.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may experience delays in obtaining the FDA&#8217;s authorization to initiate clinical trials under future INDs, completing ongoing preclinical and clinical studies of our other future product candidates, and initiating our planned preclinical studies and clinical trials. Additionally, we cannot be certain that preclinical studies or clinical trials for our product candidates will begin on time, not require redesign, enroll an adequate number of research subjects or patients on time, or be completed on schedule, if at all. Clinical trials can be delayed or terminated for a variety of reasons, including delays or failures related to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA or comparable foreign regulatory authorities disagreeing with our tissue-agnostic anti-tumor development strategy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">delays in obtaining regulatory approval to commence a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtaining institutional review board, or IRB, approval at each clinical trial site&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">recruiting an adequate number of suitable patients to participate in a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">having subjects complete a clinical trial or return for post-treatment follow-up&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trial sites deviating from clinical trial protocol or dropping out of a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">addressing subject safety concerns that arise during the course of a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">adding a sufficient number of clinical trial sites&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtaining sufficient product supply of product candidates for use in preclinical studies or clinical trials from third-party suppliers.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may experience numerous adverse or unforeseen events during, or as a result of, preclinical studies and clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may receive feedback from regulatory authorities that requires us to modify the design of our clinical trials, including additional procedures and contingency measures in response to the COVID&#8209;19 pandemic or as required by clinical sites, IRB, or FDA&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon our research efforts for our other future product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials of our product candidates may not produce differentiated or clinically significant results across tumor types or indications&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate or participants may drop out of our clinical trials at a higher rate than we anticipate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our third-party contractors may fail to comply with regulatory requirements, fail to maintain adequate quality controls or be unable to provide us with sufficient product supply to conduct and complete preclinical studies or clinical trials of our product candidates in a timely manner, or at all&#59;</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We or our investigators might have to suspend or terminate clinical trials of our product candidates for various reasons, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">non-compliance with regulatory requirements, a finding that our product candidates have undesirable side effects or other unexpected characteristics or a finding that the participants are being exposed to unacceptable health risks&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost of clinical trials of our product candidates may be greater than we anticipate, for example, if we experience delays or challenges in identifying patients with the mutations required for our clinical trials, we may have to reimburse sites for genetic sequencing costs in order to encourage sequencing of additional patients&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the quality of our product candidates or other materials necessary to conduct preclinical studies or clinical trials of our product candidates may be insufficient or inadequate, and any transfer of manufacturing activities may require unforeseen manufacturing or formulation changes&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulators may revise the requirements for approving our product candidates, or such requirements may not be as we anticipate&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">future collaborators may conduct clinical trials in ways they view as advantageous to them but that are suboptimal for us.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have commenced studies that may provide the basis for regulatory approval, but we have not sought or obtained FDA input on the trial design, number of patients that will be enrolled in the studies, or statistical analysis plan. FDA may not accept the data generated from these studies and my reject any regulatory applications we submit with this data. If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only moderately positive or if there are safety concerns, our business and results of operations may be adversely affected and we may incur significant additional costs. We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such clinical trials are being conducted, by the Data Safety Monitoring Board, if any, for such clinical trial or by the FDA or other regulatory authorities. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical trial protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from the product candidates, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we experience delays in the completion, or termination, of any preclinical study or clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed, and our ability to generate revenues from any of these product candidates will be delayed or not realized at all. In addition, any delays in completing our preclinical studies or clinical trials may increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. If one or more of our product candidates generally prove to be ineffective, unsafe or commercially unviable, our entire pipeline and platform would have little, if any, value, which would have a material and adverse effect on our business, financial condition, results of operations and prospects.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Clinical drug development involves a lengthy and expensive process with an uncertain outcome, results of earlier studies and clinical trials may not be predictive of future clinical trial results, we may not be able to rely on the aNK and haNK phase</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">&#160;</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">I </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and II </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">clinical trials data for our other product candidates, and our clinical trials may fail to adequately demonstrate substantial evidence of safety and efficacy of our product candidates.</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> The results of our clinical trials may not satisfy the requirements of the FDA or other comparable foreign regulatory authorities, and we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of such product candidate.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. A failure of one or more of our clinical trials can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. There is a high failure rate for product candidates proceeding through clinical trials, and product candidates in later stages of clinical trials may fail to show the required safety and efficacy despite having progressed through preclinical studies and initial clinical trials. A number of companies in the pharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier clinical trials, and we cannot be certain that we will not face similar setbacks. Even if our clinical trials are completed, the results may not be sufficient to support obtaining regulatory approval for our product candidates. In addition, our strategy and anticipated timelines are predicated upon our ability to utilize the phase&#160;I and II clinical trial data for aNK, haNK, and t&#8209;haNK observed to date to support our planned clinical trials for all of our product candidates, including our haNK and t&#8209;haNK product candidates. To date, we have several INDs for our haNK and t&#8209;haNK product candidates, and we cannot offer assurances that the FDA will allow us to utilize the phase&#160;I and II aNK and haNK data to support other planned clinical trials or allow our anticipated INDs for&#160;(i)&#160;planned phase&#160;I or phase&#160;Ib/IIa clinical trials for our other product candidates, (ii)&#160;planned phase&#160;IIb/III clinical trials for our haNK and t&#8209;haNK product candidates as potential combination therapies, or (iii)&#160;any other planned clinical trials, including registration studies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have in the past experienced delays in our ongoing clinical trials and we may experience additional delays in the future. We do not know whether future clinical trials, if any, will begin on time, need to be redesigned, enroll an adequate number of patients on time or be completed on schedule, if at all. Clinical trials can be delayed, suspended or terminated by us, regulatory authorities, clinical trial investigators, and ethics committees for a variety of reasons, including failure to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">generate sufficient preclinical, toxicology, or other </span><span style="font-style:italic;color:#000000;">in&#160;vivo</span><span style="color:#000000;"> or </span><span style="font-style:italic;color:#000000;">in&#160;vitro</span><span style="color:#000000;"> data to support the initiation or continuation of clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtain regulatory authorization, or feedback on clinical trial design, to commence a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">identify, recruit and train suitable clinical investigators&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">reach agreement on acceptable terms with prospective Contract Research Organizations, or CROs, and clinical trial sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtain and maintain IRB approval at each clinical trial site&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">identify, recruit and enroll suitable patients to participate in a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">have a sufficient number of patients complete a clinical trial or return for post-treatment follow-up&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">ensure that our third-party contractors and clinical investigators comply with clinical trial protocols, comply with regulatory requirements, or meet their obligations to us in a timely manner&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">address any patient safety concerns that arise during the course of a clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">address any conflicts with new or existing laws or regulations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">add a sufficient number of clinical trial sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">timely manufacture sufficient quantities of product candidate for use in clinical trials&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">raise sufficient capital to fund a clinical trial.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient enrollment is a significant factor in the timing of clinical trials and is affected by many factors, including the size and nature of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the clinical trial, the design of the clinical trial, competing clinical trials and clinicians&#8217; and patients&#8217; or caregivers&#8217; perceptions as to the potential advantages of the drug candidate being studied in relation to other available therapies, including any new drugs or treatments that may be approved for the indications we are investigating.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We could also encounter delays if a clinical trial is suspended or terminated by us, by the data safety monitoring board for such clinical trial or by the FDA or any other regulatory authority, or if the IRBs of the institutions in which such clinical trials are being conducted suspend or terminate the participation of their clinical investigators and sites subject to their review. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements, including Good Clinical Practices, or GCP</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or our clinical protocols, inspection of the clinical trial operations or clinical trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our product candidates for approval. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Even if regulatory approval is secured for any of our product candidates, the terms of such approval may limit the scope and use of our product candidate, which may also limit its commercial potential.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we experience delays in the completion of, or termination of, any clinical trial of our product candidates for any reason, the commercial prospects of our product candidates may be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We use Immuno-Oncology Clinic, Inc., a related party, in some of our clinical trials which may expose us to significant regulatory risks. If our data for this site is not sufficiently robust or if there are any data integrity issues, we may be required to repeat such studies or required to contract with other clinical trial sites, and our clinical development plans will be significantly delayed, and we will incur additional costs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our Phase&#160;I and II clinical trials for our haNK, PD&#8209;L1.t&#8209;haNK and other t&#8209;haNK products have been conducted by Immuno-Oncology Clinic, Inc., which is a related party. Relying on a related party clinical site to develop data that is used as the basis to support regulatory approval can expose us to significant regulatory risks. For example, a study used to support regulatory approval that is conducted at a related party site can be rejected by the FDA if there are data integrity issues, or if there are significant good clinical practice violations at the site. If any data integrity, or regulatory non-compliance issues occur during the study, we may not be able to use the data for our regulatory approval. Furthermore, if the operations of the clinical site is disrupted or if the site experiences disruptions in its clinical supplies or resources, such as potential disruptions due to COVID&#8209;19, then we may be required to suspend or terminate the study at this site, and we may need to contract with other clinical sites for the study, which will delay our clinical development and regulatory approval for the product candidate. Failure of this site to comply with the regulations or to recruit a sufficient number of patients may require us to delay submission for regulatory approval or repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if the site violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Results for any patient who receives compassionate use access to our product candidates should not be viewed as representative of how the product candidate will perform in a well-controlled clinical trial, and cannot be used to establish safety or efficacy for regulatory approval.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We often receive requests for compassionate use access to our investigational drugs by patients that do not meet the entry criteria for enrollment into our clinical studies. Generally, patients requesting compassionate use have no other treatment alternatives for life threatening conditions. We evaluate each compassionate use request on an individual basis, and in some cases grant access to our investigational products outside of our sponsored clinical studies, and where a physician certifies the patient they are treating is critically ill and does not meet the entry criteria for one of our open clinical trials. Individual patient results from compassionate use access may not be used to support submission of a regulatory application, nor support approval of a product candidate. Although one patient with pancreatic cancer who was provided compassionate use access to our product candidates has experienced a six month complete remission after being treated, such results should not be considered to be indicative of results from any on-going or future well-controlled clinical trial. Before we can seek regulatory approval for any of our product candidates, we must demonstrate in well-controlled clinical trials statistically significant evidence that the product candidate is both safe and effective for the indication we are seeking approval. The results of our compassionate use program may not be used to establish safety or efficacy or regulatory approval.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may be unable to obtain regulatory approval for our product candidates. The denial or delay of any such approval would delay commercialization and have a material adverse effect on our potential to generate revenue, our business and our results of operations.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The research, development, testing, manufacturing, labeling, packaging, approval, promotion, advertising, storage, recordkeeping, marketing, distribution, post-approval monitoring and reporting, and export and import of biopharmaceutical products are subject to extensive regulation by the FDA, and by foreign regulatory authorities in other countries. These regulations differ from country to country. To gain approval to market our product candidates, we must provide regulatory authorities with substantial evidence of safety, purity and potency of the product for each indication we seek to commercialize. We have not yet obtained regulatory approval to market any of our product candidates in the U.S. or any other country. Our business depends upon obtaining these regulatory approvals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA can delay, limit or deny approval of our product candidates for many reasons, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our inability to satisfactorily demonstrate with substantial clinical evidence that the product candidates are safe, pure and potent for the requested indication&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="letter-spacing:-0.1pt;color:#000000;">the FDA&#8217;s disagreement with our clinical trial protocol or the interpretation of data from preclinical studies or clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the population studied in the clinical trial not being sufficiently broad or representative to assess safety in the full population for which we seek approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our inability to demonstrate that clinical or other benefits of our product candidates outweigh any safety or other perceived risks&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA&#8217;s determination that additional preclinical or clinical trials are required&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA&#8217;s non-approval of the labeling or the specifications of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA&#8217;s failure to accept the manufacturing processes or facilities of third-party manufacturers with which we may contract&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">for clinical trials conducted by the Immuno-Oncology Clinic, Inc., or the Clinic, a related party, the FDA or other regulatory authorities could view our study results as potentially biased even if we achieve such clinical trial endpoints&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the potential for approval policies or regulations of the FDA to significantly change in a manner rendering our clinical data insufficient for approval.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we eventually successfully complete clinical testing and receive approval of any regulatory filing for our product candidates, the FDA may only grant approval contingent on the performance of costly additional post-approval clinical trials. The FDA may also approve our product candidates for a more limited indication or a narrower patient population than we originally requested, and the FDA may not approve the labeling that we believe is necessary or desirable for the successful commercialization of our product candidates. To the extent we seek regulatory approval in foreign countries, we may face challenges similar to those described above with regulatory authorities in applicable jurisdictions. Any delay in obtaining, or our inability to obtain, applicable regulatory approval for any of our product candidates would delay or prevent commercialization of our product candidates and would materially adversely impact our business, results of operations, financial condition and prospects.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of our product candidates could be associated with side effects or adverse events.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As with most biopharmaceutical products, use of our product candidates could be associated with side effects or adverse events, which can vary in severity and frequency. Side effects or adverse events associated with the use of our product candidates may be observed at any time, including in clinical trials or once a product is commercialized, and any such side effects or adverse events may negatively affect our ability to obtain regulatory approval or market our product candidates. Side effects such as toxicity or other safety issues associated with the use of our product candidates could require us to perform additional studies or halt development or sale of these product candidates or expose us to product liability lawsuits, which will harm our business. We may be required by regulatory agencies to conduct additional preclinical or clinical trials regarding the safety and efficacy of our product candidates, which we have not planned or anticipated. We cannot provide any assurance that we will resolve any issues related to any product-related adverse events to the satisfaction of the FDA or any regulatory agency in a timely manner or ever, which could harm our business, prospects and financial condition.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we are successful in commercializing our product candidates, the FDA and other foreign regulatory agency regulations will require that we report certain information about adverse medical events if those products may have caused or contributed to those adverse events. The timing of our obligation to report would be triggered by the date we become aware of the adverse event</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as well as the nature of the event. We may inadvertently fail to report adverse events we become aware of within the prescribed timeframe. We may also fail to appreciate that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of our products. If we fail to comply with our reporting obligations, the FDA or other foreign regulatory agencies could take action including criminal prosecution, the imposition of civil monetary penalties, seizure of our products, or delay in approval or clearance of future products.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The clinical and commercial utility of our aNK, haNK, t&#8209;haNK, ceNK and MSC platforms are uncertain and may never be realized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our NK platforms are in the early stages of development. The company currently has multiple ongoing clinical trials to evaluate cryopreserved haNK and t&#8209;haNK cells in company sponsored clinical trials. Success in early clinical trials does not ensure that large-scale clinical trials will be successful nor does it predict final results. In addition, we will not be able to treat patients if we cannot manufacture a sufficient quantity of NK cells that meet our minimum specifications. In addition, our haNK product candidate has only been tested in a small number of patients. Results from these clinical trials may not necessarily be indicative of the safety and tolerability or efficacy of our products as we expand into larger clinical trials.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not ultimately be able to provide the FDA with substantial clinical evidence to support a claim of safety, purity and potency sufficient to enable the FDA to approve aNK platform product candidates for any indication. This may be because later clinical trials fail to reproduce favorable data obtained in earlier clinical trials, because the FDA disagrees with how we interpret the data from these clinical trials, or because the FDA does not accept these therapeutic effects as valid endpoints in pivotal clinical trials necessary for market approval. We will also need to demonstrate that aNK platform product candidates are safe. We do not have data on possible harmful long-term effects of aNK platform product candidates and do not expect to have this data in the near future. As a result, our ability to generate clinical safety and effectiveness data sufficient to support submission of a marketing application or commercialization of our aNK platform therapy is uncertain and is subject to significant risk.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have limited experience as a company conducting clinical trials and have relied and will rely on third parties and related parties to conduct many of our preclinical studies and clinical trials. Any failure by a third party, related party, or by us to conduct the clinical trials according to Good Clinical Practices and in a timely manner may delay or prevent our ability to seek or obtain regulatory approval for or commercialize our product candidates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, the only company sponsored studies to engage in patient enrollment have been for the following cancer indications:&#160;Merkel cell, pancreatic, triple negative breast, squamous head and neck, non-small cell lung, triple negative breast, colorectal, B&#8209;cell lymphoma, and advanced solid tumors, as well as COVID&#8209;19 infection. Our relative lack of experience conducting clinical trials may contribute to our planned clinical trials not beginning or completing on time, if at all. In addition, we have entered into an agreement with the Clinic, a related party, to continue to conduct and oversee certain of our clinical trials. Large-scale clinical trials will require significant additional resources and reliance on Contract Research Organizations, or CROs, clinical investigators, or consultants. Consequently, our reliance on outside parties may introduce delays beyond our control. Our CROs, the Clinic, and other third parties must communicate and coordinate with one another in order for our trials to be successful. Additionally, our CROs, the Clinic, and other third parties may also have relationships with other commercial entities, some of which may compete with us. If our CROs, the Clinic, or other third parties conducting our clinical trials do not perform their contractual duties or regulatory obligations, experience work stoppages, do not meet expected deadlines, terminate their agreements with us or need to be replaced, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical trial protocols, GCPs, or other regulatory requirements or for any other reason, we may need to conduct additional clinical trials or enter into new arrangements with alternative CROs, clinical investigators or other third parties. We may be unable to enter into arrangements with alternative CROs on commercially reasonable terms, or at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We, the Clinic, and the third parties upon which we rely are required to comply with GCPs. GCPs are regulations and guidelines enforced by regulatory authorities around the world, through periodic inspections, for products in clinical development. If we or these third parties fail to comply with applicable GCP regulations, the clinical data generated in our clinical trials may be deemed unreliable and have to be repeated, and our submission of marketing applications may be delayed or the regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We are subject to the risk that, upon inspection, a regulatory authority will determine that any of our clinical trials fail to comply or failed to comply with applicable GCP regulations. In addition, our clinical trials must be conducted with material produced under GMP and Good Tissue Practice, or GTP, regulations, which are enforced by regulatory authorities. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be significantly impacted if our CROs, the Clinic, clinical investigators or other third parties violate federal or state healthcare fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also anticipate that part of our strategy for pursuing the wide range of indications potentially addressed by our aNK, haNK, taNK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">haNK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, ceNK and MSC</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> platforms will involve further investigator-initiated clinical trials. While these trials generally provide us with valuable clinical data that can inform our future development strategy in a cost-efficient manner, we generally have less control over not only the conduct but also the design of these clinical trials. Third-party investigators may design clinical trials involving our product candidates with clinical endpoints that are more difficult to achieve or in other ways that increase the risk of negative clinical trial results compared to clinical trials we may design on our own. Negative results in investigator-initiated clinical trials, regardless of how the clinical trial was designed or conducted, could have a material adverse effect on our prospects and the perception of our product candidates.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. In addition, some of our trials are being run by the Clinic, which is controlled by one of our employees. Under certain circumstances, the company may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between the company, the Clinic and/or a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA and may ultimately lead to the denial of regulatory approval of one or more of our product candidates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We and ImmunityBio may not be successful in jointly developing and obtaining regulatory approval for any collaborative COVID&#8209;19 product candidates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The risks described in this section regarding the development and regulatory approval of our product candidates in oncology are also applicable to the product candidates that we and ImmunityBio intend to jointly develop under the Joint COVID&#8209;19 Collaboration, including ImmunityBio&#8217;s COVID&#8209;19 vaccine candidate. In particular, while the second generation adenovirus used in ImmunityBio&#8217;s COVID&#8209;19 vaccine candidate is being tested in Phase&#160;I trials for SARS&#8209;CoV&#8209;2 and has been generally well-tolerated in those studies to date, the COVID&#8209;19 vaccine candidate uses a different construct directed towards the SARS&#8209;CoV&#8209;2 virus. This vaccine candidate has not previously been tested in humans and very limited preclinical data has been generated to date. In addition, the biology of the SARS&#8209;CoV&#8209;2 virus and pathology of COVID&#8209;19 disease are not fully understood and new information is constantly emerging. Thus, there remains substantial uncertainty about how ImmunityBio&#8217;s COVID&#8209;19 vaccine candidate will perform in clinical trials, the timelines to complete development of the vaccine candidate and whether the FDA or other regulatory agencies will approve the vaccine candidate for registrational studies or subsequent marketing. If we and ImmunityBio are unable to successfully develop, obtain regulatory approval for, manufacture at scale and commercialize product candidates for COVID&#8209;19, or if the Joint COVID&#8209;19 Collaboration is terminated, we may not be able to realize any share of net sales of resulting products or recoup the substantial investments we expect to make in our joint development efforts.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are heavily dependent on our senior management, particularly Mr.&#160;Richard Adcock, Dr.&#160;Patrick Soon-Shiong and Dr.&#160;Barry Simon, and a loss of a member of our senior management team in the future, even if only temporary, could harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we lose members of our senior management for a short or an extended time, we may not be able to find appropriate replacements on a timely basis, and our business could be adversely affected. Our existing operations and continued future development depend to a significant extent upon the performance and active participation of certain key individuals, including Mr.&#160;Adcock, our CEO, Dr.&#160;Soon-Shiong, our Executive Chairman and our principal stockholder, and Dr.&#160;Simon, our President and Chief Administrative Officer. The risks related to our dependence upon Dr.&#160;Soon-Shiong are particularly acute given his ownership percentage, the commercial and other relationships that we have with entities affiliated with him, his role in our company and reputation. We may also be dependent on additional funding from Dr.&#160;Soon&#8209;Shiong and his affiliates, which may not be available when needed. If we were to lose Mr.&#160;Adcock, Dr.&#160;Soon-Shiong or Dr.&#160;Simon for a short or an extended time, for any reason, including the contraction of COVID&#8209;19, we may not be able to find appropriate replacements on a timely basis and our financial condition and results of operations could be materially adversely affected.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competition for qualified personnel in the biotechnology and pharmaceuticals industry is intense due to the limited number of individuals who possess the skills and experience required. To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided stock options and restricted stock units that vest over time. The value to employees of stock options and restricted stock units that vest over time may be significantly affected by movements in our stock price that are beyond our control, and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. We face significant competition for employees, particularly scientific personnel, from other biopharmaceutical companies, which include both publicly traded and privately held companies, and we may not be able to hire new employees quickly enough to meet our needs. Although we have employment agreements with our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. Except with respect to Dr.&#160;Simon, we do not maintain &#8220;key man&#8221; insurance policies on the lives of these individuals or the lives of any of our other employees. We may not be able to attract and retain quality personnel on acceptable terms, or at all, which may cause our business and operating results to suffer.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Dr.&#160;</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Patrick </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Soon-Shiong, our </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Executive </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Chairman and principal stockholder, has significant interests in other </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">companies which</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> may conflict with our interests.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong, is the founder of NantWorks. The various NantWorks companies are currently exploring opportunities in the immunotherapy, infectious disease and inflammatory disease fields. In particular, we have agreements with a number of related parties that provide services, technology and equipment for use in our efforts to develop our product pipeline. Dr.&#160;Soon-Shiong holds a controlling interest, either directly or indirectly, in these entities. Consequently, Dr.&#160;Soon-Shiong&#8217;s interests may not be aligned with our other stockholders and he may from time to time be incentivized to take certain actions that benefit his other interests and that our other stockholders do not view as being in their interest as investors in our company. In addition, other companies affiliated with Dr.&#160;Soon-Shiong may compete with us for business opportunities or, in the future, develop products that are competitive with ours (including products in other therapeutic fields which we may target in the future). Moreover, even if they do not directly relate to us, actions taken by Dr.&#160;Soon-Shiong and the companies with which he is involved could impact us.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also pursue supply arrangements for various investigational agents controlled by affiliates to be used in our clinical trials. If Dr.&#160;Soon-Shiong was to cease his affiliation with us, ImmunityBio, or with NantWorks, these entities may be unwilling to continue these relationships with us on commercially reasonable terms, or at all, and as a result may impede our ability to control the supply chain for our combination therapies. These supply and collaboration agreements do not typically specify how sales will be apportioned between the parties upon successful commercialization of the product. As a result, we cannot guarantee that we will receive a percentage of the revenue that is at least proportional to the costs that we will incur in commercializing the product candidate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, in November&#160;2015, we entered into a Shared Services Agreement with NantWorks, pursuant to which NantWorks and/or any of its affiliates provides corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy, and other support services to us and our subsidiaries. If Dr.&#160;Soon-Shiong was to cease his affiliation with us or with NantWorks, we may be unable to establish or maintain this relationship with NantWorks on a commercially reasonable basis, if at all. As a result, we could experience a lack of business continuity due to loss of historical and institutional knowledge and a lack of familiarity of new employees and/or new service providers with business processes, operating requirements, policies and procedures, and we may incur additional costs as new employees and/or service providers gain necessary experience, particularly in connection with issues or concerns we may have as a public company. In addition, the loss of the services of NantWorks might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management&#8217;s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business and results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We will need to grow the size and capabilities of our organization, and we may experience difficulties in managing this growth.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To effect our business plan, we will need to add other management, administrative, regulatory, manufacturing and scientific staff. As of December&#160;31, 2020, we had 171 employees. We will need to attract, retain and motivate a significant number of new additional managerial, operational, sales, marketing, financial, and other personnel, as well as highly skilled scientific and medical personnel, and to expand our capabilities to successfully pursue our research, development, manufacturing and commercialization efforts and secure collaborations to market and distribute our products. This growth may strain our existing managerial, operational, financial and other resources. We also intend to add personnel in our research and development and manufacturing departments as we expand our clinical trial and research capabilities. Moreover, we may need to hire additional accounting and other personnel and augment our infrastructure as a result of operating as a public company. Any inability to attract and retain qualified employees to enable our planned growth and establish additional capabilities or our failure to manage our growth effectively could delay or curtail our product development and commercialization efforts and harm our business.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have limited manufacturing experience and may not be able to manufacture our haNK, taNK, t<span style="font-weight:normal;">&#8209;</span>haNK or ceNK cells on a large scale or in a cost-effective manner.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">haNK, taNK, t&#8209;haNK and ceNK cells have been grown in various quantities in closed cell culture systems and intermediate to larger-scale bioreactors. With all manufacturing efforts being conducted in-house, we will need to develop the ability to grow haNK, taNK, t&#8209;haNK and ceNK cells on a large-scale basis in a cost efficient manner. While we have made great strides with our haNK and t&#8209;haNK production, including a validated cryopreserved form of the product, we have not demonstrated the ability to manufacture these cells beyond quantities sufficient for our clinical programs. We have not demonstrated the ability to manufacture our taNK, t&#8209;haNK and ceNK cells beyond quantities sufficient for research and development and limited clinical activities. We have also experienced increases in manufacturing costs and sporadic decreases in manufacturing yield of haNK, taNK, t&#8209;haNK and ceNK cells. In addition, we have no experience manufacturing our NK cells specifically at the capacity that will be necessary to support commercial sales. The novel nature of our technology also increases the complexity and risk in the manufacturing process. In addition, we may encounter difficulties in obtaining the approvals for, and designing, constructing, validating and operating, any new </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">manufacturing facility. We may also be unable to hire the qualified personnel that we will require to accommodate the expansion of our operations and manufacturing capabilities. If we relocate our manufacturing activities to a new facility during or after a pivotal clinical trial, we may be unable to obtain regulatory approval unless and until we demonstrate to the FDA&#8217;s satisfaction the similarity of our haNK, taNK, t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;haNK and ceNK cells manufactured in the new facility to our cells manufactured in prior facilities. If we cannot adequately demonstrate similarity to the FDA, we could be required to repeat clinical trials, which would be expensive, and would substantially delay regulatory approval.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because our product candidates are cell-based, their manufacture is complicated. In addition, we rely on certain third party suppliers for manufacturing supplies such as X&#8209;VIVO&#160;10 media to grow and produce our cells. Reliance on such third-party suppliers exposes us to supply interruptions and shortages that could have an adverse effect on our ability to produce product. Moreover, our present production process may not meet our initial expectations as to reproducibility, yield, purity or other measurements of performance. Any supply interruption from third parties and entities that are affiliated with Dr.&#160;Soon&#8209;Shiong and/or NantWorks could materially harm our ability to manufacture our product candidates until a new source of supply, if any, could be identified and qualified. We may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms. In addition, we may have to customize a bioreactor system to our manufacturing process. Because our manufacturing process is unproven, we may never successfully commercialize our products. In addition, because the clinical trials were conducted using a system that will not be sufficient for commercial quantities, we may have to show comparability of the different versions of systems we have used. For these and other reasons, we may not be able to manufacture haNK, taNK, t&#8209;haNK, ceNK and MSC cells on a large scale or in a cost-effective manner.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aNK platform cells have been produced at academic institutions associated with our other clinical trial sites. In the past, the lack of production of aNK platform cells has caused delays in the commencement of our clinical trials. We have been establishing NK cell production capacity to meet anticipated demand for our planned clinical trials but may not be able to successfully build out our capacity to meet our current and anticipated future needs. Any damage to or destruction of our facility and equipment, prolonged power outage, contamination or shut down by the FDA or other regulatory authority could significantly impair or curtail our ability to produce haNK, taNK, t&#8209;haNK and ceNK cells.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are dependent on third parties to store our aNK, haNK, taNK, t<span style="font-weight:normal;">&#8209;</span>haNK and ceNK cells, and any damage or loss to our master cell bank would cause delays in replacement, and our business could suffer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aNK cells of our master and working cell banks are stored in freezers at a third party biorepository and also stored in our freezers at one of our production facilities. If these cells are damaged at these facilities, including by the loss or malfunction of these freezers or back-up power systems, as well as by damage from fire, loss of power, or other natural disasters, we would need to establish replacement master and working cell banks, which would impact clinical supply and delay our patients&#8217; treatments. If we are unable to establish replacement cell banks, we could incur significant additional expenses and liability to patients whose treatment is delayed, and our business could suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we or any of our third party manufacturers that we may use do not maintain high standards of manufacturing, our ability to develop and commercialize haNK, taNK, t&#8209;haNK or ceNK cells could be delayed or curtailed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and any third parties that we may use in the future to manufacture our products must continuously adhere to cGMP regulations rigorously enforced by the FDA through its facilities inspection program. If our facilities or the facilities of third parties who we may use in the future to produce our products do not pass a pre-approval inspection, the FDA will not grant market approval for haNK, taNK, t&#8209;haNK or ceNK cells. In complying with cGMP, we and any third-party manufacturers must expend significant time, money and effort in production, record keeping and quality control to assure that each component of our haNK, taNK, t&#8209;haNK and ceNK cell therapies meets applicable specifications and other requirements. We or any of these third-party manufacturers may also be subject to comparable or more stringent regulations of foreign regulatory authorities. If we or any of our third-party manufacturers fail to comply with these requirements, we may be subject to regulatory action, which could delay or curtail our ability to develop, obtain regulatory approval of, and commercialize haNK, taNK, t&#8209;haNK or ceNK cells. If our component part manufacturers and suppliers fail to provide components of sufficient quality to meet our required specifications, our clinical trials or commercialization of haNK, taNK, t&#8209;haNK or ceNK cells could be delayed or halted, and we could face product liability claims.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we or any of our third-party manufacturers that we may engage use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development activities involve the controlled use of potentially hazardous substances, including chemical and biological materials, by us and any third-party manufacturers that we may use in the future. We and any of our third party manufacturers that we may engage are subject to federal, state and local laws and regulations in the U.S. governing the use, manufacture, storage, handling and disposal of medical and hazardous materials. Although we believe that our procedures for using, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. We do not have any insurance for liabilities arising from medical or hazardous materials. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have not yet developed a validated methodology for freezing and thawing large quantities of taNK and t<span style="font-weight:normal;">&#8209;</span>haNK cells, which we believe will be required for the storage and distribution of our taNK and t<span style="font-weight:normal;">&#8209;</span>haNK product candidates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not demonstrated that taNK and t&#8209;haNK cells can be frozen and thawed in large quantities without damage, in a cost-efficient manner and without degradation over time. We may encounter difficulties not only in developing freezing and thawing methodologies, but also in obtaining the necessary regulatory approvals for using such methodologies in treatment. If we cannot adequately demonstrate similarity of our frozen product to the unfrozen form to the satisfaction of the FDA, we could face substantial delays in our regulatory approvals. If we are unable to freeze taNK and t&#8209;haNK cells for shipping purposes, our ability to promote adoption and standardization of our products, as well as achieve economies of scale by centralizing our production facility, will be limited. Even if we are able to successfully freeze and thaw taNK and t&#8209;haNK cells in large quantities, we will still need to develop a cost-effective and reliable distribution and logistics network, which we may be unable to accomplish. For these and other reasons, we may not be able to commercialize haNK, taNK or t&#8209;haNK cells on a large scale or in a cost-effective manner.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely on third party healthcare professionals to administer haNK, taNK, t<span style="font-weight:normal;">&#8209;</span>haNK or ceNK cells to patients, and our business could be harmed if these third parties administer these cells incorrectly.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on the expertise of physicians, nurses and other associated medical personnel to administer haNK, t&#8209;haNK, MSC or ceNK cells to clinical trial patients. If these medical personnel are not properly trained to administer, or do not properly administer, haNK, taNK, t&#8209;haNK, MSC or ceNK cells, the therapeutic effect of haNK, taNK, t&#8209;haNK, MSC or ceNK cells may be diminished or the patient may suffer injury.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, if we achieve the ability to freeze and thaw our haNK, t&#8209;haNK, MSC and ceNK cells, third party medical personnel will have to be trained on proper methodology for thawing haNK, t&#8209;haNK, MSC and ceNK cells received from us. If this thawing is not performed correctly, the cells may become damaged and/or the patient may suffer injury. While we intend to provide training materials and other resources to these third-party medical personnel, the thawing of haNK, t&#8209;haNK, MSC or ceNK cells will occur outside our supervision and may not be administered properly. If, due to a third-party error, people believe that haNK, t&#8209;haNK, MSC or ceNK cells are ineffective or harmful, the desire to use haNK, t&#8209;haNK, MSC or ceNK cells may decline, which would negatively impact our business, reputation and prospects. We may also face significant liability even though we may not be responsible for the actions of these third parties.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even if any of our product candidates receive regulatory approvals, they may fail to achieve the broad degree of market acceptance and use necessary for commercial success.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any potential future commercial success of any of our product candidates will depend, among other things, on its acceptance by physicians, patients, healthcare payors, and other members of the medical community as a therapeutic and cost-effective alternative to commercially available products. Because only a few cell-based therapy products have been commercialized, we do not know to what extent cell-based immunotherapy products will be accepted as therapeutic alternatives. If we fail to gain market acceptance, we may not be able to earn sufficient revenues to continue our business. Market acceptance of, and demand for, any product that we may develop, if approved for commercial sale, will depend on many factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to provide substantial evidence of safety and efficacy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">convenience and ease of administration&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">prevalence and severity of adverse side effects associated with our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">availability of alternative and competing treatments&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost effectiveness of any approved product and competing treatments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability to offer appropriate patient access programs, such as co-pay assistance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the extent to which physicians recommend our products to their patients&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">effectiveness of our marketing and distribution strategy and pricing of any product that we may develop&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">publicity concerning our products or competitive products&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to obtain sufficient third-party coverage and adequate reimbursement.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If haNK, taNK, t&#8209;haNK and ceNK cells are approved for use, but fail to achieve the broad degree of market acceptance necessary for commercial success, our operating results and financial condition will be adversely affected. In addition, even if haNK, taNK, t&#8209;haNK and ceNK cells gain acceptance, the markets for treatment of patients with our target indications may not be as significant as we estimate.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even if we are able to commercialize any product candidates, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The regulations that govern marketing approvals, pricing and reimbursement for new drugs vary widely from country to country. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay the commercial launch of the product and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to successfully commercialize any products that we may develop also will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. Government authorities also impose mandatory discounts for certain patient groups and may seek to increase such discounts at any time. Future regulation may negatively impact the price of our products, if approved. It may be difficult to promptly obtain coverage and profitable payment rates from both the government-funded and private payors for any of our approved product candidates, and this may have a material adverse effect on our operating results, our ability to raise capital and our overall financial condition.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">There are risks inherent in our business that may subject us to potential product liability suits and other claims, which may require us to engage in expensive and time-consuming litigation or pay substantial damages and may harm our reputation and reduce the demand for our product.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business exposes us to product liability risks, which are inherent in the testing, manufacturing, marketing and sale of biopharmaceutical products. We will face an even greater risk of product liability if we commercialize haNK, taNK, t&#8209;haNK and ceNK cells. For example, we may be sued if any product we develop allegedly causes or is perceived to cause injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability and a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our products. Even a successful defense would require significant financial and management resources.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain aspects of how haNK, taNK, t&#8209;haNK and ceNK cells are processed and administered may increase our exposure to liability. Medical personnel administer haNK, taNK, t&#8209;haNK and ceNK cells to patients intravenously in an outpatient procedure. This procedure poses risks to the patient similar to those occurring with infusions of other cell products, such as T&#8209;cells and stem cells, including blood clots, infection and mild to severe allergic reactions. Additionally, haNK, taNK, t&#8209;haNK and ceNK cells or components of our haNK, taNK, t&#8209;haNK and ceNK cell therapy may cause unforeseen harmful side effects. For example, a patient receiving haNK, taNK, t&#8209;haNK and ceNK cells could have a severe allergic reaction or could develop an autoimmune condition to materials infused with the haNK, taNK, t&#8209;haNK and ceNK cells.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we have not conducted studies on the long-term effects associated with the media that we use to grow our haNK, taNK, t&#8209;haNK and ceNK cells. Similarly, we expect to use media in freezing our haNK, taNK, t&#8209;haNK and ceNK cells for shipment. These media could contain substances that have proved harmful if used in certain quantities. As we continue to develop our haNK, taNK, t&#8209;haNK and ceNK cell therapy, we may encounter harmful side effects that we did not previously observe in our prior studies and clinical trials. Additionally, the discovery of unforeseen side effects of haNK, taNK, t&#8209;haNK and ceNK cells could also lead to lawsuits against us.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regardless of merit or eventual outcome, product liability or other claims may, among other things, result in:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">decreased demand for any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">injury to our reputation and significant negative media attention&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">withdrawal of clinical trial participants or cancellation of clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">costs to defend the related litigation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a diversion of management&#8217;s time and our resources&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">substantial monetary awards to clinical trial participants or patients&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory investigations, product recalls, withdrawals or labeling, marketing or promotional restrictions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">exhaustion of any available insurance and our capital resources&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">loss of revenue&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a potential decrease in our share price&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability to commercialize any products we develop.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our inability to obtain and maintain sufficient product liability insurance at an acceptable cost and scope of coverage to protect against potential product liability claims could prevent or inhibit the commercialization of our products. We obtained product liability insurance covering our clinical trials with policy limits that we believe are customary for similarly situated companies and adequate to provide us with coverage for foreseeable risks. Although we maintain such insurance, any claim that may be brought against us could result in a court judgment or settlement in an amount that is not covered, in whole or in part, by our insurance or that is in excess of the limits of our insurance coverage. If we determine that it is prudent to increase our product liability coverage due to the commercial launch of any approved product, we may be unable to obtain such increased coverage on acceptable terms, or at all. Our insurance policies also have various exclusions and deductibles, and we may be subject to a product liability claim for which we have no coverage. We will have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Moreover, in the future, we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses. If and when we obtain approval for marketing our product candidates, we intend to expand our insurance coverage to include the sale of the applicable products&#59; however, we may be unable to obtain this liability insurance on commercially reasonable terms. If a successful product liability or other claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover these claims and our business operations could suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We currently have no marketing and sales organization and have no experience in marketing products. If we are unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to generate product revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently have no sales, marketing or distribution capabilities and have no experience as a company in marketing products. If we develop an internal sales, marketing and distribution organization, this would require significant capital expenditures, management resources and time, and we would have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we are unable or decide not to establish internal sales, marketing and distribution capabilities, we expect to pursue collaborative arrangements regarding the sales, marketing and distribution of our products. However, we may not be able to establish or maintain such collaborative arrangements, or if we are able to do so, their sales forces may not be successful in marketing our products. Any revenue we receive would depend upon the efforts of such third parties, which may not be successful. We may have little or no control over the sales, marketing and distribution efforts of such third parties and our revenue from product sales may be lower than if we had commercialized our product candidates ourselves. We also face competition in our search for third parties to assist us with the sales, marketing and distribution efforts of our product candidates. There can be no assurance that we will be able to develop internal sales, marketing and distribution capabilities or establish or maintain relationships with third-party collaborators to commercialize any product in the U.S. or overseas.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">A variety of risks associated with marketing our product candidates internationally could materially adversely affect our business.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to seek regulatory approval of our product candidates outside of the U.S. and, accordingly, we expect that we will be subject to additional risks related to operating in foreign countries if we obtain the necessary approvals, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">differing regulatory requirements in foreign countries&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">economic weakness, including inflation, or political instability in particular foreign economies and markets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">foreign taxes, including withholding of payroll taxes&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties staffing and managing foreign operations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">workforce uncertainty in countries where labor unrest is more common than in the U.S.&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">differing payor reimbursement regimes, governmental payors or patient self-pay systems, and price controls&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the U.S.&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the impact of public health epidemics on the global economy, such as the coronavirus pandemic currently having an impact throughout the world&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">business interruptions resulting from geo-political actions, including war and terrorism.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have formed, and may in the future form or seek, strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such alliances or licensing arrangements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have formed, and may in the future form or seek, strategic alliances, create joint ventures or collaborations or enter into additional licensing arrangements with third and related parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. For example, during the third quarter of 2020, we entered into a Joint COVID&#8209;19 Collaboration Agreement with ImmunityBio, a related party, as further described above. In addition, we entered into an agreement whereby Viracta granted to us exclusive world-wide rights to Viracta&#8217;s phase&#160;II drug candidate, VRx&#8209;3996, for use in combination with our platform of NK&#160;cell therapies. However, if Viracta fails to raise sufficient capital to complete their pivotal phase&#160;II trial, if their trial is unsuccessful, or if our future clinical trial of NK&#160;cell therapy in combination with VRx&#8209;3996 fails, the value of the Viracta license would be adversely affected.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. If we license products or acquire businesses, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction. Any delays in entering into new strategic partnership agreements related to our product candidates could delay the development and commercialization of our product candidates in certain geographies for certain indications, which would harm our business prospects, financial condition and results of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our internal computer systems, or those used by our contractors or consultants, may fail or suffer security breaches.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business model involves the storage and transmission of clinical trial and other data on our systems and on the systems of our consultants and contractors, and security breaches expose us to a risk of loss of this information, governmental fines and penalties, litigation and/or potential liability, in addition to negative publicity. Despite the implementation of security measures, our internal computer systems and those of our contractors and consultants are vulnerable to damage from computer viruses and unauthorized access. Our security measures and those of our contractors and consultants may also be breached due to employee error, malfeasance or otherwise. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on affiliated entities and third parties for research and development of our product candidates and to conduct clinical trials and may rely on third parties for the manufacture of our product candidates and similar events relating to their computer systems could have a material adverse effect on our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that these risks and exposures related to our internal computer systems will remain high for the foreseeable future due to the rapidly evolving nature and sophistication of cyber threats to our internal computer systems. Moreover, as the use of technology has become more prevalent in the course of business as a result of COVID&#8209;19, we may become more susceptible to operational, financial and information security risks resulting from cyber-attacks and/or technological malfunctions. There can be no assurance that our efforts to implement adequate security measures will remain sufficient to protect the company against future cyber-attacks. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability, suffer damage to our reputation, the further development and commercialization of our product candidates could be delayed, and our stock price could decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Future acquisitions and investments could disrupt our business and harm our financial condition and operating results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success may depend, in part, on our ability to expand our products and services. In some circumstances, we may determine to do so through the acquisition of complementary businesses and technologies rather than through, or in conjunction with, internal development. The identification of suitable acquisition candidates can be difficult, time-consuming and costly, and we may not be able to successfully complete identified acquisitions. The risks we face in connection with acquisitions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">diversion of management time and focus from operating our business to addressing acquisition integration challenges&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">retention of key employees from the acquired company&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">coordination of research and development functions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">integration of the acquired company&#8217;s accounting, management information, human resources and other administrative systems&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">liability for activities of the acquired company before the acquisition, including intellectual property infringement claims, employee disputes, and alleged violations of laws&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">unanticipated write-offs or charges.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our failure to address these risks or other problems encountered in connection with our past or future acquisitions and investments could cause us to fail to realize the anticipated benefits of these acquisitions or investments, cause us to incur unanticipated liabilities, and harm our business generally. Future acquisitions could also result in dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities, amortization expenses, incremental operating expenses or the write-off of goodwill, any of which could harm our financial condition or operating results.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operations, and those of our contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and pandemics, acts of terrorism, acts of war and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. We may rely on third-party manufacturers to produce and process our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster, pandemics, epidemics, or other business interruption, including the continuing coronavirus pandemic. The extent to which coronavirus pandemic impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID&#8209;19 and the actions to contain SARS&#8209;CoV&#8209;2 or treat its impact, among others. If any disaster were to occur, our ability to operate our clinical trials could be seriously, or potentially completely, impaired. Our corporate headquarters are in California near major earthquake faults and fire zones. Our operations and financial condition could suffer in the event of a major earthquake, fire or other natural disaster.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">A coronavirus pandemic is ongoing in many parts of the world and may result in significant disruptions to our clinical trials, preclinical studies and supply chain which could have a material adverse effect on our business.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A coronavirus pandemic exists as of the filing of this report. As the pandemic continues to evolve, much of its impact remains unknown, and it is impossible to predict the impact it may have on the development of our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The coronavirus pandemic may result in significant delays or disruptions in our clinical trials, which could affect or delay the regulatory approval process of our product candidates. If the patients involved with these clinical trials become infected with the coronavirus disease, we may have more adverse events and deaths in our clinical trials as a result. We may also face difficulties enrolling patients in our clinical trials if the patient populations that are eligible for our clinical trials are impacted by the coronavirus pandemic.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, if our clinical trial patients are unable to travel to our clinical trial sites as a result of quarantines or other restrictions resulting from the coronavirus pandemic, we may experience higher drop-out rates or delays in our clinical trials.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The severity of the coronavirus pandemic could also make access to our existing supply chain difficult or impossible by delaying the delivery of key raw materials used in our product candidates and therefore delay the delivery of such products for use in our clinical trials. Any of these results could have a material adverse effect on our business.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our manufacturing facilities may be negatively impacted by the ongoing coronavirus pandemic.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The coronavirus pandemic, including any actions we have taken in response, may disrupt our internal operations, including by heightening the risk that a significant portion of our workforce could suffer illness or otherwise not be permitted or be unable to work, and required that certain of our employees work remotely, which has heightened certain risks, including those related to cybersecurity and internal controls. Additionally the coronavirus pandemic has impacted, and may continue to impact, our office and manufacturing locations, as well as our analytical, process development, and transitional research teams, including through the effects of facility closures, reductions in operating hours and other social distancing efforts. For example, if even a small number of our employees in our working clusters related to manufacturing, analytical, process development, or translational research, tested positive for COVID&#8209;19, it would require us to temporarily close a number of our offices or manufacturing facilities and temporarily suspend operations in order to conduct a deep clean of the facilities in order to ensure the safety of our employees. Additionally, we cannot predict whether these conditions and concerns will continue or whether we will experience more significant or frequent disruptions in the future, including the complete closure of one or more of our facilities. In addition, in the event demand for our products is significantly reduced as a result of the coronavirus pandemic and related economic impacts, we may need to assess different corporate actions and cost-cutting measures, including reducing our workforce or closing one or more facilities, and these actions could cause us to incur costs and expose us to other risks and inefficiencies, including whether we would be able to rehire our workforce or recommence operations at a given facility if our business experiences a subsequent recovery.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our employees, affiliates, independent contractors, clinical investigators, CROs, data safety and monitoring boards, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, and insider trading.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to the risk of employee fraud, misconduct or other illegal activity by our employees, affiliates, independent contractors, clinical investigators, CROs, data safety and monitoring boards, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless or negligent conduct that fails to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">comply with the laws and requirements of the FDA and other similar foreign regulatory bodies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">provide true, complete and accurate information to the FDA and other similar foreign regulatory bodies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">comply with manufacturing standards we have established&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">comply with healthcare fraud and abuse, privacy and security and other laws in the U.S. and similar foreign fraudulent misconduct laws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">comply with federal securities laws regulating insider trading&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">report financial information or data accurately or to disclose unauthorized activities to us.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our current and future business operations may subject us to fraud and abuse, transparency, health information privacy and security, and other healthcare laws and regulations. Failure to comply with such laws and regulations may result in substantial penalties.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current and future business operations may subject us to fraud and abuse, transparency, health information privacy and security, and other healthcare laws and regulations. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the U.S., our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws are also likely to increase. These laws may impact, among other things, our current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also include the collection and/or use of information obtained in the course of patient recruitment for clinical trials. The healthcare laws that may affect our ability to operate include, but are not limited to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting, receiving, offering or providing any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">federal civil and criminal false claims laws, including the civil False Claims Act, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval from the federal government including Medicare and Medicaid, that are false or fraudulent or knowingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional U.S. federal criminal statutes that prohibit, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private), and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements, including mandatory contractual terms, on certain covered healthcare providers, health plans, and healthcare clearinghouses, as well as their respective business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the U.S. federal Physician Payments Sunshine Act, created under the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, which we refer to collectively as ACA, and its implementing regulations, which require certain manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the U.S. Department of Health and Human Services, or HHS, information related to payments or other transfers of value made to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members by the 90th&#160;day of each subsequent calendar year, and disclosure of such information will be made by HHS on a publicly available website&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, we are subject to state and foreign laws and regulations that are analogous to the healthcare laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payor. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and relevant compliance guidance promulgated by the federal government&#59; some state laws require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures&#59; some state and local laws that require the registration of pharmaceutical sales representatives&#59; and some state and foreign laws govern the privacy and security of health information in ways that differ, and in certain cases are more stringent than, HIPAA, thus complicating compliance efforts.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have adopted a code of business conduct and ethics, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is possible that governmental and enforcement authorities will conclude that our business practices do not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and/or administrative penalties, damages, disgorgement, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Defending against any such actions can be costly, time-consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Competing generic medicinal products or biosimilars may be approved.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the European Union, or E.U., there exists a process for approval of generic biological medicinal products once patent protection and other forms of data and market exclusivity have expired. Arrangements for approval of biosimilar products exist in the U.S., as well. Other jurisdictions are considering adopting legislation that would allow the approval of generic biological medicinal products. If generic medicinal products are approved, competition from such products may substantially reduce sales of our products.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Public opinion and scrutiny of cell-based immunotherapy approaches may impact public perception of our company and product candidates, or may adversely affect our ability to conduct our business and our business plans.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our platform utilizes a relatively novel technology involving the genetic modification of human cells and utilization of those modified cells in other individuals, and no natural killer cell-based immunotherapy has been approved to date. Public perception may be influenced by claims, such as claims that cell-based immunotherapy is unsafe, unethical, or immoral and, consequently, our approach may not gain the acceptance of the public or the medical community. Negative public reaction to cell-based immunotherapy in general could result in greater government regulation and stricter labeling requirements of cell-based immunotherapy products, including any of our product candidates, and could cause a decrease in the demand for any products we may develop. Adverse public attitudes may adversely impact our ability to enroll clinical trials. Moreover, our success will depend upon physicians specializing in the treatment of those diseases that our product candidates target prescribing, and their patients being willing to receive, treatments that involve the use of our product candidates in lieu of, or in addition to, existing treatments they are already familiar with and for which greater clinical data may be available. More restrictive government regulations or negative public opinion could have an adverse effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for any products we may develop. Adverse events in our clinical trials, even if not ultimately attributable to our product candidates, and the resulting publicity could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of our potential product candidates, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Government Regulation</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may fail to obtain or may experience delays in obtaining regulatory approval to market our aNK platform product candidates, which will significantly harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not have the necessary approval to market or sell aNK platform products in the U.S. or any foreign market. Before marketing aNK platform product candidates, we must successfully complete extensive preclinical studies and clinical trials and rigorous regulatory approval procedures. We cannot offer assurances that we will apply for or obtain the necessary regulatory approval to commercialize aNK platform product candidates in a timely manner, or at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conducting clinical trials is uncertain and expensive and often takes many years to complete. The results from preclinical testing and early clinical trials are often not predictive of results obtained in later clinical trials. In conducting clinical trials, we may fail to establish the effectiveness of haNK, t&#8209;haNK, MSC and ceNK cells for the targeted indication or we may discover unforeseen side effects. Moreover, clinical trials may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Clinical trials are also often subject to unanticipated delays. In addition, haNK, t&#8209;haNK, MSC and ceNK cells are produced in small-scale cell culture systems and we may be unable to adapt the production method to large-scale production systems. In addition, patients participating in the trials may die before completion of the clinical trial or suffer adverse medical effects unrelated to treatment with haNK, t&#8209;haNK, MSC and ceNK cells. This could delay or lead to termination of our clinical trials. A number of companies in the biotechnology industry have suffered significant setbacks in every stage of clinical trials, even in advanced clinical trials after positive results in earlier clinical trials.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, the FDA has approved only a few cell-based therapies for commercialization. The processes and requirements imposed by the FDA may cause delays and additional costs in obtaining regulatory approvals for our product candidates. Because our aNK platform product is novel, and cell-based therapies are relatively new, regulatory agencies may lack experience in evaluating product candidates like our aNK platform products. This inexperience may lengthen the regulatory review process, increase our development costs and delay or prevent commercialization of our aNK platform products. In addition, the following factors may impede or delay our ability to obtain timely regulatory approvals, if at all:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">potential delays in or failure to reach agreement on acceptable terms with prospective CROs and clinical sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our failure to obtain sufficient enrollment in our clinical trials or participants may fail to complete our clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulators may require us to perform additional or unanticipated clinical trials to obtain approval or we may be subject to additional post-marketing testing requirements to maintain regulatory approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulators may revise the requirements for approving our product candidates, or such requirements may not be as we anticipate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost of clinical trials of our product candidates may be greater than we anticipate, and we may need to delay or suspend one or more trials until we complete additional financing transactions or otherwise receive adequate funding&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate or may be delayed&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our product candidates may have undesirable side effects or other unexpected characteristics, causing us or our investigators, regulators or institutional review boards to suspend or terminate trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory authorities may suspend or withdraw their approval of a product or impose restrictions on its distribution&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our limited experience in filing and pursuing Biologics License Applications, or BLAs, necessary to gain regulatory approvals related to genetically modified cancer cell line therapies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any failure to develop substantial evidence of clinical efficacy and safety, and to develop quality standards and manufacturing processes to demonstrate consistent safety, purity, identity, and potency standards&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a decision by us, institutional review boards, or regulators to suspend or terminate our clinical trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory inspections of our clinical trials, clinical trial sites or manufacturing facilities, which may, among other things, require us to undertake corrective action or suspend or terminate our clinical trials if regulators find us not to be in compliance with applicable regulatory requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to produce sufficient quantities of haNK, taNK, t&#8209;haNK and ceNK cells to complete our clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">varying interpretations of the data generated from our clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">timely coordination with our related party, ImmunityBio, in connection with the filing of our BLA as a combined therapy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability of our related party, ImmunityBio, being commercially ready with a fully completed CMC package, and compliant with cGMP, for the manufacture of N&#8209;803 and aldoxorubicin&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in governmental regulations or administrative action.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any delays in, or termination of, our clinical trials could materially and adversely affect our development and collaboration timelines, which may cause our stock price to decline. If we do not complete clinical trials for haNK, taNK, t&#8209;haNK and ceNK cells and seek and obtain regulatory approvals, we may not be able to recover any of the substantial costs we have invested in the development of haNK, taNK, t&#8209;haNK and ceNK cells.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even if we obtain regulatory approvals for aNK related platform products, those approvals and ongoing regulation of our products may limit how we manufacture and market our products, which could prevent us from realizing the full benefit of our efforts.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we obtain regulatory approvals, our aNK platform products, and our manufacturing facilities will be subject to continual regulatory review, including periodic unannounced inspections, by the FDA and other U.S. and foreign regulatory authorities. In addition, regulatory authorities may impose significant restrictions on the indicated uses or impose ongoing requirements for potentially costly post-approval studies. aNK platform product candidates would also be subject to ongoing FDA requirements governing the labeling, packaging, storage, advertising, promotion, recordkeeping and submission of safety and other post-market information. These and other factors may significantly restrict our ability to successfully commercialize haNK, taNK, t&#8209;haNK and ceNK cell therapies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturers of biopharmaceutical products and their facilities, vendors and suppliers are subject to continual review and periodic unannounced inspections by the FDA and other regulatory authorities for compliance with cGMP regulations, which include requirements relating to quality control and quality assurance, as well as to the corresponding maintenance of records and documentation. Furthermore, our manufacturing facilities must be approved by regulatory agencies before these facilities can be used to manufacture aNK platform products, and they will also be subject to additional regulatory inspections. Any material changes we may make to our manufacturing process or to the components used in our products may require additional prior approval by the FDA and state or foreign regulatory authorities. Failure to comply with FDA or other applicable regulatory requirements may result in criminal prosecution, civil penalties, recall or seizure of products, partial or total suspension of production or withdrawal of a product from the market.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We must also report adverse events that occur when our products are used. The discovery of previously unknown problems with aNK, haNK, taNK, t&#8209;haNK and ceNK cells and therapies or our manufacturing facilities may result in restrictions or sanctions on our products or manufacturing facilities, including withdrawal of our products from the market or suspension of manufacturing. Regulatory agencies may also require us to reformulate our products, conduct additional clinical trials, make changes in the labeling of our product or obtain further approvals. This may harm our business and results of operations or cause our reputation in the market place to suffer or subject us to lawsuits, including class action suits.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects or adverse events caused by such products, a number of potentially significant negative consequences could result, including but not limited to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory authorities may withdraw approvals of such product or require additional warnings on the label&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may be required to change the way the product is administered or conduct additional clinical trials or post-approval studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may be required to create a Risk Evaluation and Mitigation Strategy, or REMS, plan, which could include a medication guide outlining the risks of such side effects for distribution to patients, a communication plan for healthcare providers, or other elements to assure safe use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we could be sued and held liable for harm caused to patients&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our reputation may suffer.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could significantly harm our business, results of operations, and prospects.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, if we, our product candidates or the manufacturing facilities for our product candidates fail to comply with applicable regulatory requirements, a regulatory agency may:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">issue warning letters that can produce adverse publicity&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">impose civil or criminal penalties&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">suspend regulatory approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">suspend any ongoing clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">refuse to approve pending applications or supplements to applications filed by us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">impose restrictions on operations, including costly new manufacturing requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seize or detain products or request us to initiate a product recall&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">pursue and obtain an injunction.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the product, manufacturing, and in many cases reimbursement of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the U.S., including additional preclinical studies or clinical trials as clinical studies conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In some cases, the price that we intend to charge for our products is also subject to approval by regulatory authorities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the U.S. have requirements for approval of product candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may seek orphan drug status or breakthrough therapy designation for one or more of our product candidates, but even if either is granted, we may be unable to maintain any benefits associated with breakthrough therapy designation or orphan drug status, including market exclusivity.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition or for which there is no reasonable expectation that the cost of developing and making available in the U.S. a drug or biologic for a disease or condition will be recovered from sales in the U.S. for that drug or biologic. If a product that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a full BLA to market the same drug or biologic for the same indication for seven&#160;years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. In 2012, the FDA established a Breakthrough Therapy Designation, which is intended to expedite the development and review of products that treat serious or life-threatening conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may seek orphan drug status for one or more of our product candidates, but exclusive marketing rights in the U.S. may be lost if we seek approval for an indication broader than the orphan designated indication and may be lost if the FDA later determines that the request for designation was materially defective or if we are unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, we may seek breakthrough therapy designation for one or more of our product candidates, but there can be no assurance that we will receive such designation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We will need to obtain FDA approval of any proposed product brand names, and any failure or delay associated with such approval may adversely impact our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A biopharmaceutical product cannot be marketed in the U.S. or other countries until we have completed rigorous and extensive regulatory review processes, including review and approval of a brand name. Any brand names we intend to use for our product candidates will require approval from the FDA regardless of whether we have secured a formal trademark registration from the U.S. Patent and Trademark Office, or the USPTO. The FDA may object to a product brand name if they believe the name creates potential for confusion or inappropriately implies medical claims. If the FDA objects to any of our proposed product brand names, we may be required to adopt an alternative brand name for our product candidates. If we adopt an alternative brand name, we would lose the benefit of our existing trademark applications for such product candidate and may be required to expend significant additional resources in an effort to identify a suitable product brand name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. We may be unable to build a successful brand identity for a new trademark in a timely manner or at all, which would limit our ability to commercialize our product candidates.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Coverage and reimbursement decisions by third-party payors may have an adverse effect on pricing and market acceptance.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is significant uncertainty related to the third-party coverage and reimbursement of newly approved drugs. Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Therefore, market acceptance and sales of our products, if approved, in both domestic and international markets will depend significantly on the availability of adequate coverage and reimbursement from third party and/or government payors for any of our products and may be affected by existing and future healthcare reform measures. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which drugs they will cover and establish approved lists, known as formularies, and establish payment levels for such drugs. Formularies may not include all FDA-approved drugs for a particular indication. Private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment under Medicare Part&#160;D may result in a similar reduction in payments from non-governmental payors. We cannot be certain that coverage and adequate reimbursement will be available for any of our products, if approved, or that such coverage and reimbursement will be authorized in a timely fashion. In addition, we cannot be certain that reimbursement policies will not reduce the demand for, or the price paid for, any of our products, if approved. If reimbursement is not available or is available on a limited basis for any of our products, if approved, we may not be able to successfully commercialize any such products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reimbursement by a third party or government payor may depend upon a number of factors, including, without limitation, the third-party or government payor&#8217;s determination that use of a product is:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a covered benefit under its health plan&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">safe, effective and medically necessary&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">appropriate for the specific patient&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">cost-effective&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">neither experimental nor investigational.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Obtaining coverage and reimbursement approval for a product from a government or other third-party payor is a time consuming and costly process that could require us to provide supporting scientific, clinical and cost-effectiveness data for the use of our products to the payor. We may not be able to provide data sufficient to gain acceptance with respect to coverage and reimbursement or to have pricing set at a satisfactory level. If reimbursement of our products, if any, is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels such as may result where alternative or generic treatments are available, we may be unable to achieve or sustain profitability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assuming we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate or may require co-payments that patients find unacceptably high. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the U.S., third-party payors include federal and state healthcare programs, government authorities, private managed care providers, private health insurers, and other organizations. No uniform policy of coverage and reimbursement for products exists among third-party payors, and third-party payors are increasingly challenging the price, examining the medical necessity, and reviewing the cost-effectiveness of medical drug products and medical services, in addition to questioning their safety and efficacy. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained. We or our collaborators may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain the FDA approvals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In some foreign countries, particularly in Europe, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct additional clinical trials that compare the cost-effectiveness of our products to other available therapies. If reimbursement of any of our products, if approved, is unavailable or limited in scope or amount in a particular country, or if pricing is set at unsatisfactory levels, we may be unable to achieve or sustain profitability of our products in such country.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recent legislative and regulatory activity may exert downward pressure on potential pricing and reimbursement for our products, if approved, that could materially affect the opportunity to commercialize.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. and several other jurisdictions are considering, or have already enacted, a number of legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell any of our products profitably, if approved. Among policy-makers and payors in the U.S. and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access to healthcare. In the U.S., the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. There have been, and likely will continue to be, legislative and regulatory proposals at the federal and state levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare may adversely affect:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the demand for any of our products, if approved&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to set a price that we believe is fair for any of our products, if approved&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to generate revenues and achieve or maintain profitability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the level of taxes that we are required to pay&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the availability of capital.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2010, ACA became law in the U.S. The goal of ACA is to reduce the cost of healthcare, broaden access to health insurance, constrain healthcare spending, enhance remedies against fraud and abuse, add transparency requirements for the healthcare and health insurance industries, impose taxes and fees on the health industry, impose additional health policy reforms, and substantially change the way healthcare is financed by both governmental and private insurers. While we cannot predict what impact on federal reimbursement policies this legislation will have in general or on our business specifically, ACA may result in downward pressure on pharmaceutical reimbursement, which could negatively affect market acceptance of any of our products, if they are approved. Provisions of ACA relevant to the pharmaceutical industry include the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare programs, not including orphan drug sales&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must agree to offer 70% point-of-sale discounts on negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part&#160;D&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">extension of manufacturers&#8217; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for certain individuals with income at or below 133% of the Federal Poverty Level, thereby potentially increasing manufacturers&#8217; Medicaid rebate liability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="letter-spacing:-0.1pt;color:#000000;">new requirements for certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, with specific exceptions to report annually certain financial arrangements with physicians, as defined by such law, and teaching hospitals, as defined in ACA and its implementing regulations, including reporting any payment or &#8220;transfer of value&#8221; provided to physicians and teaching hospitals and any ownership and investment interests held by physicians and their immediate family members during the preceding calendar year&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expansion of healthcare fraud and abuse laws, including the U.S. federal False Claims Act and the U.S. federal Anti-Kickback Statute, new government investigative powers and enhanced penalties for noncompliance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ACA has been modified and amended recently, including the elimination of the individual mandate that individuals purchase healthcare insurance. Furthermore, the current presidential administration and Congress may continue to attempt broad sweeping changes to the current health care laws. We face uncertainties that might result from modification or repeal of any of the provisions of the ACA, including as a result of current and future executive orders, legislative actions, and litigation, including the pending review by the U.S. Supreme Court of the constitutionality of the ACA. The impact of those changes on us and potential effect on the pharmaceutical and biotechnology industry as a whole is currently unknown. However, any changes to the ACA are likely to have an impact on our results of operations, and may have a material adverse effect on our results of operations. We cannot predict what other healthcare programs and regulations will ultimately be implemented at the federal or state level or the effect of any future legislation or regulation in the U.S. may have on our business.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are subject to governmental export and import controls that could impair our ability to compete in international markets due to licensing requirements and subject us to liability if we are not in compliance with applicable laws. Compliance with these legal requirements could limit our ability to compete in foreign markets and subject us to liability if we violate them.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our products and solutions are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Controls. Exports of our products and solutions outside of the U.S. must be made in compliance with these laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges&#59; fines, which may be imposed on us and responsible employees or managers&#59; and, in extreme cases, the incarceration of responsible employees or managers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, changes in our products or solutions or changes in applicable export or import laws and regulations may create delays in the introduction, provision, or sale of our products and solutions in international markets, prevent customers from using our products and solutions or, in some cases, prevent the export or import of our products and solutions to certain countries, governments or persons altogether. Any limitation on our ability to export, provide, or sell our products and solutions could adversely affect our business, financial condition and results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are subject to U.S. and foreign anti-corruption and anti-money laundering laws with respect to our operations and non-compliance with such laws can subject us to criminal and/or civil liability and harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, the U.S. domestic bribery statute contained in 18&#160;U.S.C.&#160;&#167;201, the U.S. Travel Act, the USA PATRIOT Act, and possibly other state and national anti-bribery and anti-money laundering laws in countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, third-party intermediaries, joint venture partners and collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. We have used contract research organizations abroad for clinical trials. In addition, we may engage third party intermediaries to sell our products and solutions abroad once we enter a commercialization phase for our product candidates and/or to obtain necessary permits, licenses, and other regulatory approvals. We or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize or have actual knowledge of such activities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have adopted an anti-corruption policy which mandates compliance with the FCPA and other anti-corruption laws applicable to our business throughout the world. However, there can be no assurance that our employees and third party intermediaries will comply with this policy or such anti-corruption laws. Noncompliance with anti-corruption and anti-money laundering laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other investigations, or other enforcement actions. If such actions are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, results of operations and financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management&#8217;s attention and resources and significant defense and compliance costs and other professional fees. In certain cases, enforcement authorities may even cause us to appoint an independent compliance monitor, which can result in added costs and administrative burdens.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in funding for the FDA, the SEC and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the FDA, the Securities and Exchange Commission, or SEC, and other government agencies on which our operations may rely is inherently fluid and unpredictable.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including beginning on December&#160;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could potentially impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may be, or may become, subject to data protection laws and regulations, and our failure to comply with such laws and regulations could lead to government enforcement actions and significant penalties against us, and adversely impact our operating results.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The E.U. has adopted data protection laws and regulations which may apply to us in certain circumstances, or in the future. These laws, which impose significant compliance obligations, are commonly known as the General Data Protection Regulation, or GDPR. The GDPR, which is wide-ranging in scope and applicability, imposes several requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the individuals, the security and confidentiality of the personal data, data breach notification and the use of third party processors in connection with the processing of personal data, including clinical trials. The GDPR also imposes strict rules on the transfer of personal data out of the E.U. to the U.S., provides an enforcement authority, and imposes large penalties for noncompliance, including the potential for fines of up to &#8364;20&#160;million or 4% of the annual global revenues of the noncompliant company, whichever is greater. Implementation of the GDPR, as applicable to us, will increase our responsibility and liability in relation to personal data that we process, including in clinical trials, and we may in the future be required to put in place additional mechanisms to ensure compliance with the GDPR, which could divert management&#8217;s attention and increase our cost of doing business. In addition, other new regulation or legislative actions regarding data privacy and security (together with applicable industry standards) may increase our costs of doing business. In this regard, we expect that there will continue to be new proposed laws, regulations and industry standards relating to privacy and data protection in the U.S., the E.U. and other jurisdictions, and we cannot determine the impact such future laws, regulations and standards may have on our business.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Intellectual Property</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If our efforts to protect the intellectual property related to our product candidates are not adequate, we may not be able to compete effectively in our market.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely upon a combination of patents, trade secret protection and contractual agreements, including confidentiality agreements to protect the intellectual property related to our product candidates and technology. Any disclosure to or misappropriation by third parties of our confidential proprietary information could enable competitors to quickly duplicate or surpass our technological achievements, eroding our competitive position in the market. We believe that we have worldwide commercial rights to the NK&#8209;92 cell line and we believe that we control commercial use of our haNK, taNK, t&#8209;haNK, MSC and ceNK cells in key territories. We have developed and in-licensed numerous patents and patent applications and we possess substantial know-how and trade secrets relating to the development and commercialization of natural killer cell-based immunotherapy product candidates, including related manufacturing processes and technology. Our owned and licensed patent portfolio consists of patents and pending patent applications in the U.S. disclosing subject matter directed to certain of our proprietary technology, inventions, and improvements and our most advanced product candidates, as well as licensed and owned patents and pending applications in jurisdictions outside of the U.S., that, in many cases, are counterparts to the foregoing U.S. patents and patent applications. We believe we have intellectual property rights that are necessary to commercialize haNK, taNK, t&#8209;haNK, MSC and ceNK cells. However, our patent applications may not result in issued patents, and, even if issued, the patents may be challenged and invalidated. Moreover, our patents and patent applications may not be sufficiently broad to prevent others from practicing our technologies or developing competing products. We also face the risk that others may independently develop similar or alternative technologies or may design around our proprietary property.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent application process, also known as patent prosecution, is expensive and time-consuming, and we and our current or future licensors and licensees may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our current licensors, or any future licensors or licensees, will fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, these and any of our patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. Defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, etc. If we or our current licensors, or any future licensors or licensees, fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our current licensors, or any future licensors or licensees, are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form or preparation of our patents or patent applications, such patents or applications may be invalid and unenforceable. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The strength of patents in the biopharmaceutical field involves complex legal and scientific questions and can be uncertain. This uncertainty includes changes to the patent laws through either legislative action to change statutory patent law or court action that may reinterpret existing law or rules in ways affecting the scope or validity of issued patents. The patent applications that we own or in-license may fail to result in issued patents in the U.S. or foreign countries with claims that cover our product candidates. Even if patents do successfully issue from the patent applications that we own or in-license, third parties may challenge the validity, enforceability or scope of such patents, which may result in such patents being narrowed, invalidated or held unenforceable.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any successful challenge to our patents could deprive us of exclusive rights necessary for the successful commercialization of our product candidates. Furthermore, even if they are unchallenged, our patents may not adequately protect our product candidates, provide exclusivity for our product candidates, or prevent others from designing around our claims. If the breadth or strength of protection provided by the patents we hold or pursue with respect to our product candidates is challenged, it could dissuade companies from collaborating with us to develop, or threaten our ability to commercialize our product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20&#160;years after its earliest effective non-provisional filing date. Various extensions may be available&#59; however, the life of a patent, and the protection it affords, is limited. Without patent protection for our product candidates, we may be open to competition from generic versions of our product candidates. Further, if we encounter delays in our development efforts, including our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the protection afforded by patents, we also rely on trade secret protection to protect proprietary know-how that may not be patentable or that we elect not to patent, processes for which patents may be difficult to obtain or enforce, and any other elements of our product candidates, and our product development processes (such as a manufacturing and formulation technologies) that involve proprietary know-how, information or technology that is not covered by patents. However, trade secrets can be difficult to protect. If the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating any trade secrets. Misappropriation or unauthorized disclosure of our trade secrets could significantly affect our competitive position and may have a material adverse effect on our business. Furthermore, trade secret protection does not prevent competitors from independently developing substantially equivalent information and techniques and we cannot guarantee that our competitors will not independently develop substantially equivalent information and techniques. The FDA, as part of its Transparency Initiative, is currently considering whether to make additional information publicly available on a routine basis, including information that we may consider to be trade secrets or other proprietary information, and it is not clear at the present time how the FDA&#8217;s disclosure policies may change in the future, if at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In an effort to protect our trade secrets and other confidential information, we require our employees, consultants, advisors, and any other third parties that have access to our proprietary know-how, information or technology, for example, third parties involved in the formulation and manufacture of our product candidates, and third parties involved in our clinical trials to execute confidentiality agreements upon the commencement of their relationships with us. These agreements require that all confidential information developed by the individual or made known to the individual by us during the course of the individual&#8217;s relationship with us be kept confidential and not disclosed to third parties. However, we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed despite having such confidentiality agreements. Adequate remedies may not exist in the event of unauthorized use or disclosure of our trade secrets. In addition, in some situations, these confidentiality agreements may conflict with, or be subject to, the rights of third parties with whom our employees, consultants, or advisors have previous employment or consulting relationships. To the extent that our employees, consultants or contractors use any intellectual property owned by third parties in their work for us, disputes may arise as to the rights in any related or resulting know-how and inventions. If we are unable to prevent unauthorized material disclosure of our trade secrets to third parties, we may not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results and financial condition.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly on obtaining and enforcing patents. Obtaining and enforcing patents in the pharmaceutical industry involves both technological and legal complexity, and therefore, is costly, time-consuming and inherently uncertain. In addition, the U.S. had previously enacted and implemented wide-ranging patent reform legislation (e.g., the Leahy-Smith America Invents Act in September 2011) and are currently considering additional legislation that may materially impact our ability to obtain or enforce our patents. Further, recent U.S. Supreme Court rulings and recent decisions from the United States Court of Appeals for the Federal Circuit have either narrowed the scope of patent protection available in certain circumstances or weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, changes to U.S. patent laws provide additional procedures for third parties to challenge the validity of issued patents based on patent applications filed after March&#160;15, 2013. If the breadth or strength of protection provided by the patents and patent applications we hold or pursue with respect to our current or future product candidates is challenged, then it could threaten our ability to commercialize our current or future product candidates and could threaten our ability to prevent competitive products from being marketed. Further, if we encounter delays in our clinical trials, the period of time during which we could market our current or future product candidates under patent protection would be reduced. Since U.S. patent applications are confidential for a period of time after filing, we cannot be certain that we were the first to either&#160;(i)&#160;file any patent application related to our product candidates, or (ii)&#160;invent any of the inventions claimed in our patents or patent applications. Furthermore, for applications filed before March&#160;16, 2013, or patents issuing from such applications, an interference proceeding can be provoked by a third party or instituted by the U.S. Patent and Trademark Office, or USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications and patents. As of March&#160;16, 2013, the U.S. transitioned to a &#8220;first-to-file&#8221; system for deciding which party should be granted a patent when two or more patent applications are filed by different parties claiming the same invention. A third party that files a patent application with the USPTO before us could, therefore, be awarded a patent covering an invention of ours even if we had made the invention before it was made by the third party. The change to &#8220;first-to-file&#8221; from &#8220;first-to-invent&#8221; is one of the changes to the U.S. patent laws resulting from the Leahy-Smith America Invents Act, or the Leahy-Smith Act, signed into law on September&#160;16, 2011.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Among some of the other significant changes to the patent laws are changes that limit where a patentee may file a patent infringement suit and provide opportunities for third parties to challenge any issued patent in the USPTO. This applies to all of our U.S. patents, even those issued before March&#160;16, 2013. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in U.S. federal court necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. It is not yet clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not be able to protect our intellectual property rights throughout the world.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We strive to control cell line distribution, as well as limit commercial use through licenses and material transfer agreements with third parties in addition to our patents and patent applications. However, a company may illicitly obtain our cells or create their own modified variants and attempt to commercialize them in foreign countries where we do not have any patents or patent applications where legal recourse may be limited. For example, we believe that certain companies, including at least one in China, may be using our NK&#8209;92 cell line without our permission. This may have a significant commercial impact on our foreign business operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filing, prosecuting and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. The requirements for patentability may differ in certain countries, particularly developing countries. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. and in some cases, may even force us to grant a compulsory license to competitors or other third parties. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but enforcement on infringing activities is inadequate or not as strong as that in the U.S. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patents granted by the European Patent Office may be opposed by any person within nine months from the publication of their grant and, in addition, may be challenged before national courts at any time. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our intellectual property or prevent others from designing around our claims. If the breadth or strength of protection provided by the patents and patent applications we hold, license or pursue with respect to our product candidates is threatened, it could threaten our ability to commercialize our product candidates.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to pharmaceuticals or biopharmaceuticals, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, certain countries in Europe and certain developing countries, including India and China, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In those countries, we may have limited remedies if our patents are infringed or if we are compelled to grant a license to our patents to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finally, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property laws.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Obtaining and maintaining our patent protection depends on compliance with various procedural, documentary, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent prosecution process. Periodic maintenance fees and various other governmental fees on any issued patent and/or pending patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of a patent or patent application. We have systems in place to remind us to pay these fees, and we employ an outside firm and rely on our outside counsel to pay these fees. While an inadvertent lapse may sometimes be cured by payment of a late fee or by other means in accordance with the applicable rules, there are many situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If we fail to maintain the patents and patent applications directed to our product candidates, our competitors might be able to enter the market earlier than should otherwise have been the case, which would have a material adverse effect on our business.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Third-party claims alleging intellectual property infringement may adversely affect our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties, for example, the intellectual property rights of competitors. Our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents owned or controlled by third parties. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our activities related to our product candidates may give rise to claims of infringement of the patent rights of others. We cannot assure you that our product candidates will not infringe existing or future patents. We may not be aware of patents that have already issued that a third party, for example a competitor in our market, might assert are infringed by our product candidates. It is also possible that patents of which we are aware, but which we do not believe are relevant to our product candidates, could nevertheless be found to be infringed by our product candidates. Nevertheless, we are not aware of any issued patents that we believe would prevent us from marketing our product candidates, if approved. There may also be patent applications that have been filed but not published that, when issued as patents, could be asserted against us.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties making claims against us for infringement or misappropriation of their intellectual property rights may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates. Further, if a patent infringement suit were brought against us, we could be forced to stop or delay research, development, manufacturing or sales of the product or product candidate that is the subject of the suit. Defense of these claims, regardless of their merit, would cause us to incur substantial expenses, and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us by a third party, we may have to</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)&#160;pay substantial damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed the third party&#8217;s patents&#59; (2)&#160;obtain one or more licenses from the third party&#59; (3)&#160;pay royalties to the third party&#59; and/or (4)&#160;redesign any infringing products. Redesigning any infringing products may be impossible or require substantial time and monetary expenditure. Further, we cannot predict whether any required license would be available at all or whether it would be available on commercially reasonable terms. In the event that we could not obtain a license, we may be unable to further develop and commercialize our product candidates, which could harm our business significantly. Even if we are able to obtain a license, the license would likely obligate us to pay license fees or royalties or both, and the rights granted to us might be nonexclusive, which could result in our competitors gaining access to the same intellectual property. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations, if, as a result of actual or threatened patent infringement claims, we are unable to enter into licenses on acceptable terms.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Defending ourselves or our licensors in litigation is very expensive, particularly for a company of our size, and time-consuming. Some of our competitors may be able to sustain the costs of litigation or administrative proceedings more effectively than we can because of greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could impair our ability to compete in the marketplace. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition or results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property or the patents of our licensors, which could be expensive and time consuming.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties may infringe or misappropriate our intellectual property, including our existing patents, patents that may issue to us in the future, or the patents of our licensors to which we have a license. As a result, we may be required to file infringement claims to stop third-party infringement or unauthorized use. Further, we may not be able to prevent, alone or with our licensors, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the U.S.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Generic drug manufacturers may develop, seek approval for, and launch generic versions of our products. If we file an infringement action against such a generic drug manufacturer, that company may challenge the scope, validity or enforceability of our or our licensors&#8217; patents, requiring us and/or our licensors to engage in complex, lengthy and costly litigation or other proceedings.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, if we or one of our licensors initiated legal proceedings against a third party to enforce a patent covering our product candidates, the defendant could counterclaim that the patent covering our product candidates is invalid and/or unenforceable. In patent litigation in the U.S., defendant counterclaims alleging invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, within and outside of the U.S., there has been a substantial amount of litigation and administrative proceedings, including interference and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in various foreign jurisdictions, regarding patent and other intellectual property rights in the biopharmaceutical industry. The Leahy-Smith Act introduced procedures including inter partes review and post grant review. The implementation of these procedures brings uncertainty to the possibility of challenges to our patents in the future, including those that patents perceived by our competitors as blocking entry into the market for their products, and the outcome of such challenges.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such litigation and administrative proceedings could result in revocation of our patents or amendment of our patents such that they do not cover our product candidates. They may also put our pending patent applications at risk of not issuing, or issuing with limited and potentially inadequate scope to cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. Additionally, it is also possible that prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, may, nonetheless, ultimately be found by a court of law or an administrative panel to affect the validity or enforceability of a claim, for example if a priority claim is found to be improper. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse impact on our business.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Enforcing our or our licensor&#8217;s intellectual property rights through litigation is very expensive, particularly for a company of our size, and time-consuming. Some of our competitors may be able to sustain the costs of litigation more effectively than we can because of greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could impair our ability to compete in the marketplace. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition or results of operations.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, during the course of litigation or administrative proceedings, there could be public announcements of the results of hearings, motions or other interim proceedings or developments or public access to related documents. If investors perceive these results to be negative, the market price for our common stock could be significantly harmed.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to comply with our obligation in any of the agreements under which we license intellectual property rights from third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Licensing of intellectual property rights is of critical importance to our business and involves complex legal, business and scientific issues. We rely on our exclusive license from Hans Klingemann, M.D., Ph.D., one of our founders and the inventor of our aNK and related platform product cell therapies, and subject to our freedom to operate we may or may not rely on our exclusive licenses from Rush University Medical Center, Fox Chase Cancer Center, the University Health Network, and other current and future licensors, including ImmunityBio with respect to the Joint COVID&#8209;19 Collaboration. If we fail to comply with the diligence obligations or otherwise materially breach our license agreement and fail to remedy such failure or cure such breach, the licensor may have the right to terminate the license.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our obligation to pay royalties to Dr.&#160;Klingemann under the license agreement, as amended, runs until the expiration of the underlying patents and the license agreement may be terminated earlier by either party for material breach. Under the license agreement, we have the right to enforce the licensed patents.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disputes may arise between us and our licensors regarding intellectual property rights subject to a license agreement, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the scope of rights granted under the license agreement and other interpretation-related issues&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our right to sublicense intellectual property rights to third parties under collaborative development relationships&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">While we would expect to exercise all rights and remedies available to us, including seeking to cure any breach by us, and otherwise seek to preserve our rights under the patents licensed to us, we may not be able to do so in a timely manner, at an acceptable cost, or at all. Generally, the loss of any one of our current licenses, or any other license we may acquire in the future, could materially harm our business, prospects, financial condition and results of operations. In late May&#160;2020, we received a letter from Fox Chase Cancer Center alleging breaches of our license. If the letter is found to be a proper notice of termination and the alleged breaches are confirmed and found to be material, we will lose the licensed rights. We do not consider these licensed rights to be material.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">One of NantKwest&#8217;s ten issued U.S. patents is subject to a claim challenging the inventorship.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September&#160;10, 2020, a legal complaint was filed in a California court where Institute for Cancer Research (d/b/a Fox Chase Cancer Center) argued that it has a co-ownership interest in U.S.&#160;Patent No.&#160;10,456,420 and its underlying U.S.&#160;Patent Application No.&#160;15/529,848, as well as in certain related patent applications or issued patents that include claimed subject matter allegedly invented by one of the claimant&#8217;s employees. On September&#160;30, 2020, NantKwest filed motion with the court asking that the complaint be dismissed. NantKwest disagrees that this claim for co-ownership has merit and intends to vigorously defend its position. All of the existing named inventors have assigned their rights in this patent to NantKwest. NantKwest will continue to have an undivided ownership interest in the technology covered by this patent even if claimant succeeds in this suit. Litigating this matter could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Confidentiality agreements with employees and others may not adequately prevent disclosure of our trade secrets and other proprietary information and may not adequately protect our intellectual property, which could limit our ability to compete.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we operate in the highly technical field of research and development, we rely in part on trade secret protection and confidentiality agreements, including those with our employees and consultants, in order to protect our proprietary trade secrets and unpatented know-how. However, trade secrets are difficult to protect, and we cannot be certain that others will not develop the same or similar technologies on their own. We have taken steps, including entering into confidentiality agreements with our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors, to protect our trade secrets and unpatented know-how. These agreements generally require that the other party keep confidential and not disclose to third parties all confidential information developed by the party or made known to the party by us during the course of the party&#8217;s relationship with us. We also typically obtain agreements from these parties, which provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, these agreements may not be honored and may not effectively assign intellectual property rights to us. Adequate remedies may not exist in the event of unauthorized use or disclosure of our confidential intellectual property. Enforcing a claim that a party illegally obtained and is using our trade secrets or know-how is difficult, expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the U.S. may be less willing to protect trade secrets or know-how. The failure to obtain or maintain trade secret protection could adversely affect our competitive position. Also, third parties, including our competitors, may independently develop substantially equivalent proprietary information and technologies or otherwise lawfully gain access to our trade secrets and other confidential information. In such a case, we would have no right to prevent such third parties from using such proprietary information or technologies to compete with us, which could harm our competitive position.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have received confidential and proprietary information from third parties. In addition, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise improperly used or disclosed intellectual property, including trade secrets, confidential information, or other proprietary information, of these third parties or our employees&#8217; or consultants&#8217; or independent contractors&#8217; former or other employers. Further, we may be subject to ownership disputes in the future arising, for example, from conflicting obligations of consultants or others who are involved in developing our product candidates. We may also be subject to claims that former employees, consultants, independent contractors, collaborators or other third parties have an ownership interest in our patents or other intellectual property. Litigation may be necessary to defend against these and other claims challenging our right to and use of confidential and proprietary information. If we fail in defending any such claims, in addition to paying monetary damages, we may lose our rights therein. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to our Proposed Merger with ImmunityBio</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may suffer negative consequences if the proposed merger is not completed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the merger is not completed for any reason, we may suffer negative consequences and be subject to material risks, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the market price of our common stock may decline to the extent that the current market price of such shares reflects a market assumption that the merger will be completed, or for other reasons&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">costs related to the merger, such as legal and accounting fees, must be paid even if the merger is not completed&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the diversion of management attention from the day-to-day business of our company and the unavoidable disruption to our employees during the period before completion of the merger may make it difficult for us to regain our financial position and strategic focus if the merger does not occur&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">employees important to our success as a stand-alone company may have left in anticipation of the merger&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">business opportunities important to us as a stand-alone company may have been terminated or not pursued by either us or third parties in anticipation of the merger.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not consummate the proposed merger with ImmunityBio in the time frame anticipated or at all.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order for the merger to be completed, our stockholders must approve the merger. Due to the related party nature of the merger, we are required to obtain the affirmative vote of a majority of the minority of stockholders. If the required votes are not obtained by September&#160;20, 2021, <span style="color:#000000;">the merger will not be consummated. In addition, the merger is subject to the satisfaction of other customary closing conditions, and the merger agreement may be terminated by the parties under certain specified circumstances. As a result, we cannot assure you that the proposed merger with ImmunityBio will be completed, or that, if completed, it will be within the expected time frame.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The combined company may not realize all of the anticipated benefits of the proposed merger.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The success of the merger will depend, in part, on the ability of the combined company to realize the anticipated synergies, cost savings and growth opportunities from integrating our business with the business of ImmunityBio. The combined company&#8217;s success in realizing these benefits and the timing of this realization depends upon the successful integration of the operations of ImmunityBio. The integration of two independent companies is a complex, costly and time-consuming process. The difficulties of combining the operations of the companies and realizing the expected benefits of the merger include, among others:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">coordinating commercial and clinical development initiatives and staffs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">raising sufficient capital to fund the significant expenditures that are needed to launch and successfully commercialize our products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">retaining key employees&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">consolidating research and development operations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">consolidating corporate and administrative infrastructures and physical offices&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">integrating and managing the technology of two companies&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">minimizing the diversion of management&#8217;s attention from ongoing business concerns.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot assure you that the integration of ImmunityBio with us will result in the realization of the full benefits anticipated to result from the merger.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The cash resources of the combined company could be materially depleted if a substantial number of ImmunityBio stockholders exercise their dissenters&#8217; or appraisal rights under applicable state law.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of ImmunityBio capital stock who dissent and do not consent to the approval and adoption of the merger agreement may be entitled to certain dissenters&#8217; or appraisal rights under applicable state law in connection with the merger. If the merger is consummated, a holder of record of ImmunityBio stock who complies with the statutory procedures will be entitled to have those shares appraised by the Delaware Court of Chancery under Section&#160;262 of the Delaware General Corporation Law and to receive payment for the &#8220;fair value&#8221; of those shares instead of the consideration provided for in the merger agreement. If a substantial number of ImmunityBio stockholders exercise their dissenters&#8217; or appraisal rights under applicable state law, the combined company may be required to make substantial payments in cash to these stockholders, thereby materially depleting the cash resources of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are expected to incur substantial expenses related to the proposed merger with ImmunityBio.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are expected to incur substantial expenses in connection with the merger with ImmunityBio. We will incur significant fees and expenses relating to legal, accounting, financial advisory and other transaction fees and costs associated with the merger. Actual transaction costs may substantially exceed our estimates and may have an adverse effect on the combined company&#8217;s financial condition and operating results.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We and ImmunityBio may become involved in securities litigation or stockholder derivative litigation in connection with the proposed merger, and this could divert the attention of our management and harm the combined company&#8217;s business, and insurance coverage may not be sufficient to cover all related costs and damages.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities litigation or stockholder derivative litigation frequently follows the announcement of certain significant business transactions, such as the sale of a business division or announcement of a business combination transaction. We are involved in this type of litigation in connection with the merger as described in Part&#160;I, Item&#160;3. &#8220;<span style="font-style:italic;">Legal Proceedings&#8211;Litigation Related to the Merger with ImmunityBio</span>&#8221; in this Annual Report, and we and/or the combined company may become involved in this type of litigation in the future. Litigation often is expensive and diverts management&#8217;s attention and resources, which could adversely affect our business and the combined company.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Relating to Our Common Stock</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our Executive Chairman, and entities affiliated with him, collectively own a significant majority of our common stock and will exercise significant influence over matters requiring stockholder approval, regardless of the wishes of other stockholders.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, our Executive Chairman, Dr.&#160;Patrick Soon-Shiong, and entities affiliated with him, collectively own approximately 64.4% of the outstanding shares of our common stock. Additionally, Dr.&#160;Soon&#8209;Shiong holds vested options to purchase an aggregate of 900,000 additional shares of our common stock, which would give him and his affiliates ownership of approximately 64.7% of our outstanding shares of common stock if they were exercised in full. In addition, pursuant to the Nominating Agreement between us and Cambridge Equities, LP, or Cambridge, an entity that Dr.&#160;Soon&#8209;Shiong controls, Cambridge has the ability to designate one director to be nominated for election to our board of directors for as long as Cambridge continues to hold at least 20% of the issued and outstanding shares of our common stock. Dr.&#160;Soon-Shiong was selected by Cambridge to hold this board seat. Dr.&#160;Soon-Shiong and his affiliates will therefore have significant influence over management and significant control over matters requiring stockholder approval, including the annual election of directors and significant corporate transactions, such as a merger or other sale of our company or its assets, for the foreseeable future. Finally, if the proposed merger with ImmunityBio is completed, Dr.&#160;Soon-Shiong will then hold approximately<span style="Background-color:#FFFFFF;color:#000000;"> 82% of the shares of the combined company&#8217;s common stock outstanding. </span>This concentrated control will limit stockholders&#8217; ability to influence corporate matters and, as a result, we may take actions that our stockholders do not view as beneficial. As a result, the market price of our common stock could be adversely affected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The market price of our common stock has been and may continue to be volatile, and investors may have difficulty selling their shares.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although our common stock is listed on The Nasdaq Global Select Market, the market for our shares has demonstrated varying levels of trading activity. You may not be able to sell your shares quickly or at the market price if trading in shares of our common stock is not active. Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to enter into strategic partnerships or acquire companies or products by using our shares of common stock as consideration.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The stock market in general and the market for biopharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. The market price of our common stock has been and may continue to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the commencement, enrollment or results of the planned clinical trials of our product candidates or any future clinical trials we may conduct, or changes in the development status of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any delay in our regulatory filings for our product candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#8217;s review of such filings, including without limitation the FDA&#8217;s issuance of a &#8220;refusal to file&#8221; letter or a request for additional information&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">adverse results or delays in clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">adverse regulatory decisions, including failure to receive regulatory approval of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in laws or regulations applicable to our products, including but not limited to clinical trial requirements for approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our failure to commercialize our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">additions or departures of key scientific or management personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">unanticipated serious safety concerns related to the use of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures or capital commitments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to effectively manage our growth&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">variations in our quarterly operating results&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our cash position and the amount and nature of any debt we may incur&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements that our revenue or income are below or that costs or losses are greater than analysts&#8217; expectations&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">publication of research reports about us or our industry, or immunotherapy in particular, or positive or negative recommendations or withdrawal of research coverage by securities analysts&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in the market valuations of similar companies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">sales of large blocks of our common stock&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in stock market prices and volumes&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">significant lawsuits, including patent or stockholder litigation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the perception of our clinical trial results by retail investors, which investors may be subject to the influence of information provided by third party investor websites and independent authors distributing information on the internet&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">general economic slowdowns&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">investors' perceptions regarding the viability, timing, and availability of COVID&#8209;19 vaccines&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the other factors described in this &#8220;</span><span style="font-style:italic;color:#000000;">Risk Factors</span><span style="color:#000000;">&#8221; section.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation could result in substantial costs and a diversion of management&#8217;s attention and resources, which would harm our business, operating results or financial condition.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plan, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. If our stockholders sell, or the market perceives that our stockholders intend to sell substantial amounts of our common stock in the public market, the market price of our common stock could decline significantly. In addition, as of December&#160;31, 2020 our Executive Chairman, Dr.&#160;Patrick Soon&#8209;Shiong, and his affiliates beneficially owned approximately 64.7% of our outstanding shares of common stock. Sales of stock by Dr.&#160;Soon&#8209;Shiong and his affiliates could have an adverse effect on the trading price of our common stock.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain holders of approximately 46.2&#160;million shares of our common stock are entitled to certain rights with respect to the registration of their shares under the Securities Act. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by our affiliates as defined in Rule&#160;144 under the Securities Act. Any sales of securities by these stockholders could have an adverse effect on the market price of our common stock.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we expect that additional capital may be needed in the future to continue our planned operations, including conducting clinical trials, commercialization efforts, expanded research and development activities and costs associated with operating a public company. To raise capital, we may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time to time. If we sell common stock, convertible securities or other equity securities, investors may be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new investors could gain rights, preferences and privileges senior to the holders of our common stock.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have incurred and will continue to incur costs as a result of operating as a public company and our management has been and will be required to devote substantial time to compliance initiatives and corporate governance practices, including maintaining an effective system of internal control over financial reporting.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a public company listed in the U.S., and increasingly after we no longer qualify as a &#8220;smaller reporting company,&#8221; we have incurred and will continue to incur significant additional legal, accounting and other expenses as a result of operating as a public company. In addition, changing laws, regulations and standards relating to corporate governance and public disclosure, including Sarbanes-Oxley and regulations implemented by the SEC and Nasdaq, may increase legal and financial compliance costs and make some activities more time consuming. These laws, regulations and standards are subject to varying interpretations and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. We intend to invest resources to create a larger finance function with additional personnel to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If, notwithstanding our efforts to comply with new laws, regulations and standards, we fail to comply, regulatory authorities may initiate legal proceedings against us and our business may be harmed.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a public company in the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may be</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> required, pursuant to Section&#160;404 of Sarbanes-Oxley, or Section</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The controls and other procedures are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is disclosed accurately and is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, w</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are required to </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disclose any material weaknesses identified by our management in our internal control over financial reporting, and, when we no longer </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">qualify</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">smaller reporting company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,&#8221;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we will </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">be required </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to provide a statement that our independent registered public accounting firm has issued an opinion on our internal control over financial reporting.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> To date, we have </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">not engage</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> our independent registered public accounting firm to perform an audit of, and give an opinion on, our internal control over financial reporting. There can be no assurance that we will not discover deficiencies or a material weakness in our internal control over financial reporting or that our auditor will agree with management&#8217;s assessment of our internal control over financial reporting if or when our auditor conducts such audit and delivers an opinion.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the normal course of business our controls and procedures may become inadequate because of changes in conditions or the degree of compliance with these policies or procedures may deteriorate and material weaknesses in our internal control over financial reporting may be discovered. We may err in the design or operation of our controls, and all internal control systems, no matter how well designed and operated, can provide only reasonable assurance that the objectives of the control system are met. Because there are inherent limitations in all control systems, there can be no absolute assurance that all control issues have been or will be detected. If we are unable, or are perceived as unable, to produce reliable financial reports due to internal control deficiencies, investors could lose confidence in our reported financial information and operating results, which could result in a negative market reaction.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To fully comply with Section&#160;404, we will need to retain additional employees to supplement our current finance staff, and we may not be able to do so in a timely manner, or at all. In addition, in the process of evaluating our internal control over financial reporting, we expect that certain of our internal control practices will need to be updated to comply with the requirements of Section&#160;404 and the regulations promulgated thereunder, and we may not be able to do so on a timely basis, or at all. In the event that we are not able to demonstrate compliance with Section&#160;404 in a timely manner, or are unable to produce timely or accurate financial statements, we may be subject to sanctions or investigations by regulatory authorities, such as the SEC or Nasdaq, and investors may lose confidence in our operating results and the price of our common stock could decline. Furthermore, if we are unable to certify that our internal control over financial reporting is effective and in compliance with Section&#160;404, we may be subject to sanctions or investigations by regulatory authorities, such as the SEC or stock exchanges, and investors could lose confidence in the accuracy and completeness of our financial reports, which could hurt our business, the price of our common stock and our ability to access the capital markets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating as a public company makes it more expensive for us to obtain directors&#8217; and officers&#8217; liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors, or as members of senior management.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If a restatement of our financial statements were to occur, our shareholders&#8217; confidence in the company&#8217;s financial reporting in the future may be affected, which could in turn have a material adverse effect on our business and stock price.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any material weaknesses in our internal control over financial reporting are discovered or occur in the future, our consolidated financial statements may contain material misstatements, and we could be required to restate our financial results. In addition, if we are unable to successfully remediate any future material weaknesses in our internal controls or if we are unable to produce accurate and timely financial statements, our stock price may be adversely affected, and we may be unable to maintain compliance with applicable stock exchange listing requirements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have not paid cash dividends in the past and do not expect to pay dividends in the future. Any return on investment may be limited to the value of our common stock.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have never paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition and other business and economic factors affecting us at such time as the board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if our stock price appreciates.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Because we are relying on the exemptions from corporate governance requirements as a result of being a &#8220;controlled company&#8221; within the meaning of the </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Nasdaq</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> listing standards, you do not have the same protections afforded to stockholders of companies that are subject to such requirements.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Executive Chairman, Dr.&#160;Patrick Soon-Shiong, and entities affiliated with him, control a majority of our common stock. As a result, we are a &#8220;controlled company&#8221; within the meaning of the Nasdaq listing standards. Under these rules, a company of which more than 50% of the voting power is held by an individual, a group or another company is a &#8220;controlled company&#8221; and may elect not to comply with certain Nasdaq corporate governance requirements, including&#160;(1)&#160;the requirement that a majority of the board of directors consist of independent directors, and (2)&#160;the requirement that we have a nominating and corporate governance committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities. Accordingly, you do not have the same protections afforded to stockholders of companies that are subject to all of the Nasdaq corporate governance requirements. However, our board of directors is currently comprised of a majority of independent directors. In addition, although not required by the rules of Nasdaq, in August&#160;2019, our board of directors established a nominating and corporate governance committee comprised of two directors, which are independent.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are a &#8220;smaller reporting company,&#8221; and the reduced disclosure requirements applicable to smaller reporting companies could make our common stock less attractive to investors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although we no longer qualify as an emerging growth company, we qualify as a &#8220;smaller reporting company&#8221; during fiscal year&#160;2021, which allows us to take advantage of many of the same exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. These exemptions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#8220;Management&#8217;s discussion and analysis of financial condition and results of operations&#8221; disclosure&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">reduced disclosure obligations regarding executive compensation.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investors may find our common stock less attractive as a result of our reliance on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and the market price of our common stock may be reduced or more volatile.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our ability to use our net operating loss carryforwards, or NOLs, and certain other tax attributes to offset future taxable income may be subject to certain limitations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 we had U.S. federal, state and foreign NOLs of $389.8&#160;million, $350.3&#160;million and $0.2&#160;million, respectively. Of the $389.8&#160;million in federal NOLs, $226.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. Of the $350.3&#160;million in state NOLs, $4.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. The remaining federal NOL carryforwards begin to expire in 2024, the remaining state NOL carryforwards begin to expire in 2030 and the foreign NOL carryforwards begin to expire in 2022. As of December&#160;31, 2020, we also had federal and state research and development tax credit carryforwards of $11.1&#160;million and state research tax credits of $7.8&#160;million, respectively. The federal research tax credit carryforwards begin to expire in 2034 and certain state research tax credit carryforwards begin to expire in 2031. The California research tax credits can be carried forward indefinitely. These net operating loss and research and development tax credit carryforwards could expire unused and be unavailable to offset future income tax liabilities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Sections&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change NOLs and other pre-change tax attributes, such as research tax credits, to offset its future post-change income and taxes may be limited. In general, an &#8220;ownership change&#8221; occurs if there is a cumulative change in our ownership by &#8220;5% shareholders&#8221; that exceeds 50&#160;percentage points over a rolling three-year period. Similar rules may apply under state tax laws. We completed an Internal Revenue Code&#160;Section&#160;382/383 analysis through March&#160;2019 regarding the limitation of net operating loss and research and development credit carryforwards. The analysis concluded that the federal and state carryforwards associated with the NOLs were reduced by the amount of tax attributes estimated to expire during their respective carryforward periods. The reduction in the NOLs was offset by a similar change in the valuation allowance.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since we will need to raise substantial additional funding to finance our operations, we may experience further ownership changes in the future, some of which may be outside of our control. Limits on our ability to use our pre-change NOLs or credits to offset U.S. federal taxable income could potentially result in increased future tax liability to us if we earn net taxable income in the future. In addition, under the legislation commonly referred to as the Tax Cuts and Jobs Act of 2017, or TCJA, as modified by the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the amount of NOLs generated in taxable periods beginning after December 31, 2017, that we are permitted to deduct in any taxable year beginning after December&#160;31, 2020 is limited to 80% of our taxable income in such year, where taxable income is determined without regard to the NOL deduction itself. The TCJA allows post-2017 unused NOLs to be carried forward indefinitely. Similar rules may apply under state tax laws.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We could be subject to additional income tax liabilities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a U.S.-based company subject to tax in the U.S. and in Korea. Significant judgment is required in determining our global provision for income taxes, deferred tax assets or liabilities, and in evaluating our tax positions on a worldwide basis. While we believe our tax positions are consistent with the tax laws in the jurisdictions in which we conduct our business, it is possible that these positions may be overturned by jurisdictional tax authorities, which may have a significant impact on our global provision for income taxes.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our business may be materially affected by changes to fiscal and tax policies. Negative or unexpected tax consequences could adversely affect our results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our domestic and international business operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Cuts and Jobs Act of 2017, or TCJA, which was approved by Congress on December&#160;20, 2017 significantly changed the U.S. Internal Revenue Code. Such changes include a reduction in the corporate tax rate and limitations on certain corporate deductions and credits, among other changes. We have generally accounted for such changes in accordance with our understanding of the TCJA and guidance available as of the date of this filing as described in more detail in our financial statements. The CARES Act, which was signed into law on March&#160;27, 2020, further modified the TCJA and we will continue to monitor and assess the impact of the federal legislation on our business and the extent to which various states conform to the newly enacted federal tax law. In addition, adverse changes in the financial outlook of our operations or further changes in tax laws or regulations could lead to changes in our valuation allowances against deferred tax assets on our consolidated balance sheets, which could materially affect our results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our share price and trading volume could decline.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The trading market for our common stock will depend on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. There can be no assurance that analysts will cover us or provide favorable coverage. If one or more of the analysts who cover us downgrade our stock or change their opinion of our stock, our share price would likely decline. If one or more of these analysts&#8217; cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are not subject to the provisions of Section&#160;203 of the Delaware General Corporation Law, which could negatively affect your investment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We elected in our amended and restated certificate of incorporation to not be subject to the provisions of Section&#160;203 of the Delaware General Corporation Law. In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes a merger, asset sale or other transaction resulting in a financial benefit to the interested stockholder. An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns (or, in certain cases, within three years prior, did own) 15% or more of the corporation&#8217;s voting stock. Our decision not to be subject to Section&#160;203 will allow, for example, our Executive Chairman (who with members of his immediate family and entities affiliated with him owned approximately 64.4% of our common stock as of December&#160;31, 2020) to transfer shares in excess of 15% of our voting stock to a third-party free of the restrictions imposed by Section&#160;203. This may make us more vulnerable to takeovers that are completed without the approval of our board of directors and/or without giving us the ability to prohibit or delay such takeovers as effectively.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Some provisions of our charter documents and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders, and may prevent attempts by our stockholders to replace or remove our current management.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders. These provisions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a requirement that special meetings of stockholders be called only by the board of directors, the president or the chief executive officer&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">advance notice requirements for stockholder proposals and nominations for election to our board of directors&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the authority of the board of directors to issue preferred stock on terms determined by the board of directors without stockholder approval and which preferred stock may include rights superior to the rights of the holders of common stock.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These anti-takeover provisions and other provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation and amended and restated bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. In addition, as permitted by Section&#160;145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We are not obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not retroactively amend our bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that a claim for indemnification is brought by any of our directors or officers, it would reduce the amount of funds available for use in our business.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">Item&#160;1B. Unresolved Staff Comments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_PROPERTIES">Item&#160;2. Properties.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our principal properties leased as of December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Principal Properties Leased:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lease Expiration Dates</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Diego, California</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,681</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research, Office</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2023</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">El Segundo, California*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,250</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research &#38; Manufacturing</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2023</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Culver City, California*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,500</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research &#38; Manufacturing</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2021</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Woburn, Massachusetts</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,153</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research, Office</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">El Segundo, California*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,901</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research &#38; Manufacturing</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Torrance, California**</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,034</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory - Research</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2027</p></td>
</tr>
<tr>
<td colspan="4" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">*&#160;&#160;&#160;&#160;Property leased from a related party.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="7" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">** Represents square footage dedicated to us within the facility, however, the lease also permits</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160; our non-exclusive use of the third party's vivarium premises.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our principal property owned as of December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.88%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Principal Property Owned:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.7%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.88%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">El Segundo, California</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,434</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.7%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Distribution Warehouse</p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information, see Note&#160;9,<span style="font-style:italic;">&#160;Commitments and Contingencies, Contractual Obligations &#8211; Leases</span>, and Note&#160;10,<span style="font-style:italic;">&#160;Related Party Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_LEGAL_PROCEEDINGS">Item&#160;3. Legal Proceedings.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fox Chase Litigation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July&#160;21, 2020, we filed a declaratory judgment lawsuit in the Superior Court for San Diego County, California, naming Fox Chase Cancer Center Foundation and Institute for Cancer Research as the defendants (&#8220;Fox Chase&#8221;). This litigation relates to an exclusive license agreement by which Fox Chase granted us various intellectual property rights (including patent rights) for certain modified NK&#8209;92 cell technologies dating back to 2004 (&#8220;2004&#160;License&#8221;). We requested the Court to grant declarations that we have not breached any material obligation under the 2004 License and that Fox Chase has not and cannot terminate the 2004 License. Fox Chase has answered the Complaint, lodged a Cross-Complaint raising a patent inventorship challenge, and moved the case to federal court (See Part&#160;I, Item&#160;1A,&#160;&#8220;<span style="font-style:italic;">Risk Factors</span>&#8221; of this Annual Report for a more detailed discussion). While the litigation is in the early stage, its outcome cannot be predicted. We do not consider the Fox Chase license agreement to be material to our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation Related to the Merger with ImmunityBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our merger (the Merger) with <span style="letter-spacing:-0.05pt;">ImmunityBio,&#160;Inc., a Delaware corporation (ImmunityBio), via a wholly owned subsidiary of NantKwest (the Merger Sub), </span>seven complaints have been filed as individual actions in United States District Courts. Three complaints have been filed in the United States District Court for the District of Delaware against NantKwest and its directors and are captioned <span style="font-style:italic;">Hargett v. NantKwest, Inc., et al.</span>, 1:21&#8209;cv&#8209;00197 (filed February&#160;11, 2021) (the Hargett Complaint), <span style="font-style:italic;">Franchi v. NantKwest, Inc., et al.</span>, 1:21&#8209;cv&#8209;00218 (filed February&#160;16, 2021) (the Franchi Complaint), and <span style="font-style:italic;">Gross v. NantKwest, Inc., et al.</span>, 1:21&#8209;cv&#8209;00223 (filed February&#160;17, 2021) (the Gross Complaint). One complaint has been filed in the United States District Court for the Southern District of New York and is captioned <span style="font-style:italic;">Leaman v. NantKwest, Inc., et al.</span>, 1:21&#8209;cv&#8209;01351 (filed February&#160;16, 2021) (the Leaman Complaint). Two complaints has been filed in the United States District Court for the Southern District of California and are captioned <span style="font-style:italic;">Weiss v. NantKwest, Inc., et al.</span>, 3:21&#8209;cv&#8209;00280 (filed February&#160;16, 2021) (the Weiss Complaint) and Carlisle v. NantKwest, Inc., et al., 3:21&#8209;cv&#8209;00304 (filed February&#160;19, 2021) (the Carlisle Complaint). One complaint has been filed in the United States District Court for the Eastern District of New York and is captioned <span style="font-style:italic;">Shenk v. NantKwest, Inc., et al.</span>, 1:21&#8209;cv&#8209;00871 (filed February&#160;18, 2021) (the Shenk Complaint, and collectively with the Hargett Complaint, the Franchi Complaint, the Gross Complaint, the Leaman Complaint, the Weiss Complaint, and the Carlisle Complaint, the Merger Actions). The Hargett Complaint and the Gross Complaint also bring claims against ImmunityBio, and Merger Sub. The Merger Actions generally allege that the Definitive Proxy Statement filed with the SEC on February&#160;2, 2021 misrepresents and/or omits certain purportedly material information relating to financial projections, analysis performed by the financial advisor to NantKwest&#8217;s Special Committee, alleged past engagements of the Special Committee&#8217;s financial advisor and industry consultant, and the terms of the engagement of such consultant. The Merger Actions assert violations of Sections&#160;14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule&#160;14a-9 promulgated thereunder against all defendants and violations of Section&#160;20(a) of the Exchange Act against NantKwest&#8217;s directors. The Merger Actions seek, among other things, an injunction enjoining the stockholder vote on the Merger and the consummation of the Merger unless and until certain additional information is disclosed to NantKwest&#8217;s stockholders, costs of the action, including plaintiffs&#8217; attorneys&#8217; fees and experts&#8217; fees, and other relief the Court may deem just and proper. NantKwest cannot predict the outcome of the Merger Actions. NantKwest believes the Merger Actions are without merit and NantKwest and the individual defendants intend to vigorously defend against the Merger Actions and any subsequently filed similar actions. If additional similar complaints are filed, absent new or significantly different allegations, NantKwest will not necessarily disclose such additional filings.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Item&#160;4. Mine Safety Disclosures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" />

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_II">PART II</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">Item&#160;5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Market Information for Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock began trading on the Nasdaq Global Select Market under the symbol &#8220;NK&#8221; on July&#160;28, 2015. Prior to that date, there was no public trading market for our common stock.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Holders of Record</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 3, 2021, we had 30 holders of record of our common stock. The actual number of stockholders is greater than the number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust or by other entities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dividend Policy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have not declared or paid any cash dividends. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common stock in the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on, among other factors, our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Securities Authorized for Issuance Under Our Equity Compensation Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information regarding our equity compensation plans is incorporated by reference to Item&#160;12, &#8220;<span style="font-style:italic;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span>&#8221; of Part&#160;III of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Sales of Unregistered Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Repurchases of Equity Securities by the Issuer</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We did not repurchase any shares of our common stock during the three months ended December&#160;31, 2020. At December&#160;31, 2020, $18.3&#160;million remained authorized for repurchase under our stock repurchase program. For additional information regarding our stock repurchase program, see Note&#160;11,<span style="font-style:italic;">&#160;Stockholders Equity</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Performance Graph</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following graph compares the cumulative total return on our common stock, the Russell 2000 Index, and the Nasdaq Biotechnology Index over the five-year period ending December&#160;31, 2020. The graph assumes that $100&#160;was invested in our common stock and in each of the comparative indices as of the market close on December&#160;31, 2015. The returns shown are based on historical results and are not indicative of, or intended to forecast, future performance of our common stock or the comparative indices. This performance graph shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference into any filing of NantKwest, Inc. under the Securities Act of 1933, as amended, or the Securities Act.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gtl21rgcbjm5000013.jpg" title="" alt="" style="width:528px;height:590px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_SELECTED_FINANCIAL_DATA">Item&#160;6. Selected Financial Data.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following selected consolidated financial data should be read in conjunction with &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; the consolidated financial statements and related notes, and other financial information included in this Annual Report on Form&#160;10&#8209;K, or Annual Report.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The selected consolidated statements of operations data for the years ended December&#160;31, 2020, 2019 and 2018 and the selected consolidated balance sheet data as of December&#160;31, 2020 and 2019 are derived from our audited consolidated financial statements included elsewhere in this Annual Report. The following selected consolidated statements of operations data for the years ended December&#160;31, 2017 and 2016 and the selected consolidated balance sheet data as of December&#160;31, 2018, 2017 and 2016 are derived from our audited consolidated financial statements not included in this Annual Report.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except share and per share amounts)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development (including</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,483</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,785</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,718</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,044</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,153</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,254</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,065</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,718</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,121</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,391</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,737</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,850</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,436</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,165</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124,544</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,626</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,807</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,389</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(99,120</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(124,500</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,642</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,857</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,665</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,097</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense (including amounts</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(433</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(618</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income, net (including</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">298</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other (expense) income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(752</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,921</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,660</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,204</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,119</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,378</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,886</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,729</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,916</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(121,381</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">493</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">572</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,383</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,789</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,226</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,423</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(120,809</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.89</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.70</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.22</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.20</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.47</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; during the period:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,550,936</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,210,087</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,132,220</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,979,005</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,979,005</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Data:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,821</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,872</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,083</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Working capital</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,847</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,198</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,512</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,590</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,592</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,858</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,123</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,950</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,440</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">317,496</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,465</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,444</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,944</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,596</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,078</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders' equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,393</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,679</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146,006</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">218,844</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293,418</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The following discussion and analysis of our financial condition and results of operations should be read together with Item&#160;6,&#160;&#8220;Selected Financial Data,&#8221; the description of the business appearing in Item&#160;1,&#160;&#8220;Business,&#8221; of this report, and the Consolidated Financial Statements in Item&#160;8 of this Annual Report on Form&#160;10&#8209;K and the related notes included elsewhere in this report. This discussion contains forward-looking statements as a result of many factors, including those set forth under Item&#160;1,&#160;&#8220;Business &#8211; Forward-Looking Statements&#8221; and Item&#160;1A,&#160;"Risk Factors", and elsewhere in this Annual Report on Form&#160;10&#8209;K. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those discussed in or implied by forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this report, particularly in Item&#160;1A,&#160;&#8220;Risk Factors&#8221;.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a pioneering clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using our natural killer cells, or NK&#160;cells, to treat cancer and viral infectious diseases. NK&#160;cells are the body&#8217;s first line of defense due to their innate ability to rapidly seek and destroy abnormal cells, such as cancer or virally infected cells, without prior exposure or co-activation by other support molecules that are typically required to train and activate adaptive immune cells such as T&#8209;cells.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A critical aspect of our strategy is to invest significantly in innovating new therapeutic candidates, based upon our proprietary activated&#160;NK, or aNK, cell platform, and conducting clinical testing and scale manufacturing of our most promising biologic product candidates. We believe our aNK cell is capable of being manufactured as a cell-based &#8220;off-the-shelf&#8221; therapy that can be molecularly engineered in a variety of ways to boost its killing capabilities against cancers and virally infected cells.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We retain worldwide commercial rights to clinical and research data, intellectual property and know-how developed with our aNK&#160;cells, as well as clinical grade master and working cell banks of aNK, haNK and t&#8209;haNK cell lines.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreement and Plan of Merger with ImmunityBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;21, 2020, NantKwest and ImmunityBio, Inc.&#160;(ImmunityBio) entered into an Agreement and Plan of Merger&#160;(the Merger Agreement), pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The Merger Agreement provides that a wholly owned subsidiary of NantKwest will merge with and into ImmunityBio&#160;(the Merger), with ImmunityBio continuing as the surviving company and being renamed NantCell,&#160;Inc., upon the terms and subject to the conditions therein. At the effective time of the Merger&#160;(the Effective Time), NantKwest&#8217;s name, as the parent of NantCell,&#160;Inc., will be changed to &#8220;ImmunityBio, Inc.&#8221;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Effective Time, each share of ImmunityBio common stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions as set forth in the Merger Agreement, will be converted automatically into a right to receive&#160;0.8190&#160;shares of NantKwest common stock. At the Effective Time, each share of NantKwest common stock issued and outstanding immediately prior to the Effective Time, will remain an issued and outstanding share of the combined company. At the Effective Time, each outstanding option, warrant or restricted stock unit to purchase ImmunityBio common stock will be converted (using the merger exchange ratio of 0.8190) into an option, warrant or restricted stock unit, respectively, on the same terms and conditions immediately prior to the Effective Time, to purchase shares of common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon consummation of the Merger, on a fully-diluted basis, ImmunityBio stockholders and NantKwest stockholders will own approximately 72% and 28%, respectively, of the outstanding shares of common stock of the combined company. It is estimated that, immediately following the closing date, Dr.&#160;Patrick Soon&#8209;Shiong, our Executive Chairman and principal stockholder, and his affiliates will beneficially own, in the aggregate, approximately 82% of the common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following consummation of the Merger, shares of common stock of the combined company are expected to be listed on the Nasdaq Global Select Market under the symbol &#8220;IBRX&#8221;.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms and subject to the conditions set forth in the Merger Agreement, the closing of the Merger depends on a number of conditions being satisfied, including approval of the Merger by holders of a majority of the outstanding shares of NantKwest common stock as of the NantKwest record date (excluding all shares of NantKwest common stock beneficially owned by Dr.&#160;Patrick Soon&#8209;Shiong and his affiliates Cambridge Equities,&#160;LP and Chan Soon&#8209;Shiong Family Foundation or any of their respective controlled affiliates or any of the directors or executive officers of NantKwest or ImmunityBio).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;1, 2021, our Registration Statement on Form&#160;S-4, which was filed with the Securities and Exchange Commission (SEC) in connection with the Merger, was declared effective by the SEC.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A special meeting of the stockholders of NantKwest will be held on March&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021 to consider and vote on a proposal to approve the issuance of shares of common stock of NantKwest to security holders of ImmunityBio, and to consider and vote on a proposal to approve the Merger. Only holders of record of NantKwest common stock at the close of January&#160;29, 2021, will be entitled to notice of and to vote at the special meeting.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect the Merger to close in the first quarter of 2021, subject to receipt of the requisite stockholder approvals and satisfaction of other customary closing conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger is expected to be accounted for as a transaction between entities under common control as Dr.&#160;Patrick Soon&#8209;Shiong is the controlling stockholder of each of NantKwest and ImmunityBio. Upon the closing of the Merger, the net assets of ImmunityBio will be combined with those of NantKwest at their historical carrying amounts and the companies will be presented on a combined basis for all historical periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, we incurred costs of $6.2&#160;million in connection with our proposed merger with ImmunityBio, consisting of financial advisory, legal and other professional fees.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Off-the-Shelf Approach</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Multiple Modes of aNK Directed Tumor Cell Killing.<span style="font-weight:normal;font-style:normal;">&#160;&#160; Our NK platform has demonstrated the ability to induce cell death in cancers and virally infected cells through a variety of concurrent mechanisms including:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Innate Killing</span><span style="color:#000000;">, whereby all of our NK platforms, aNK, haNK, taNK and t&#8209;haNK, recognize the abnormal proteins typically found on the surfaces of metabolically stressed cells, which upon binding, release toxic granules to immediately kill their targets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">Antibody-Mediated Killing</span><span style="color:#000000;"> with our haNK</span><span style="color:#000000;"> and t</span><span style="color:#000000;">&#8209;</span><span style="color:#000000;">haNK platforms</span><span style="color:#000000;">, which are aNK&#160;cells engineered to express antibody receptors that can bind to therapeutically administered antibody products or to antibodies naturally produced in the body, thereby enhancing the cancer cell killing effects of those antibodies through Antibody Dependent Cellular Cytotoxicity, or ADCC&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">iii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-style:italic;color:#000000;">CAR-Directed Killing</span><span style="color:#000000;"> with our taNK and t</span><span style="color:#000000;">&#8209;</span><span style="color:#000000;">haNK platforms, which are aNK&#160;cells engineered to express chimeric antigen receptors, or CARs, that target tumor-specific proteins commonly found only on the surfaces of cancer cells and upon binding, induce cell death through the release of toxic granules directly into their targets and by the release of cytokines and chemokines, which recruit additional innate and adaptive immune responses, including the recruitment of cytotoxic T&#8209;cells.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All three modes of killing&#59; <span style="font-style:italic;">Innate Killing, Antibody-Mediated Killing, and CAR-Directed Killing</span>, are employed by our proprietary t&#8209;haNK platform, which combines all the enhanced NK killing functions of aNK, haNK and taNK into a single product platform.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our primary target therapeutic area is cancer, with a heavy emphasis on solid tumors. According to the National Cancer Institute, almost 1.9&#160;million new cancer cases are expected to be diagnosed in the U.S. during 2021, adding to the 16.9&#160;million already living with cancer. In addition, we plan to advance therapies for hematologic malignancies and virally induced infectious diseases.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Innate Killing&#8212;the aNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have developed a unique NK&#160;cell platform, which we believe is capable of being manufactured as a cell-based &#8220;off-the-shelf&#8221; therapy that can be molecularly engineered in a variety of ways to boost its killing capabilities against cancers and virally infected cells. Unlike normal natural killer cells, our NK&#160;cells do not express the key inhibitory receptors that diseased cells often exploit to turn off the killing function of natural killer cells and escape elimination. We have developed a unique aNK&#160;cell, which omits key inhibitory receptors, while preserving critical activation receptors that enable selective innate targeting and killing of distressed and diseased cells. They do so through the recognition and binding of stress-proteins that are overexpressed on the surfaces of</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">i.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">rapidly growing cancer cells due to oxidative and metabolic stress, nutrient deprivation and waste accumulation that typically occurs when cell growth outpaces the capacity of local circulation&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">ii.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">virally infected cells where the cellular machinery is hijacked to produce an abundance of viral proteins and virions.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our aNK&#160;cells are also designed to deliver a more lethal blow to their target by delivering a larger payload of lytic enzymes and cytokines responsible for both direct and indirect killing when compared to other natural killer cells isolated from healthy donors. This is due to the higher density of lytic granules and larger cell volume possessed by aNK&#160;cells when compared to that of donor-derived natural killer cells. We believe that our aNK&#160;cells can be produced at commercial scale as a &#8216;living drug&#8217; using our proprietary manufacturing and distribution processes to adequately address select global cancer markets.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Several phase&#160;I safety studies with </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unmodified </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aNK&#160;cells have been conducted in a variety of bulky hematological </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cancers and solid tumors</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, enrolling 46&#160;patients in a range of dose levels and schedules with encouraging evidence of single-agent activity and a durable remission, including </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">some complete responses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in liquid tumors. Based on these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">earlier </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clinical trials, we have further modified </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> aNK platform through virus-free molecular engineering designed to leverage additional modes of killing available to aNKs, including antibody</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mediated killing, the haNK platform, and both antibody</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mediated and CAR</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-directed</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> antigen targeted killing, the t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">haNK platform.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Antibody-Mediated Killing&#8212;the haNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have genetically engineered our aNK&#160;cell platform using a virus-free method to overexpress high-affinity CD16 receptors, which bind to antibodies. These antibody-targeted haNK&#160;cells are designed to directly bind to IgG1-type antibodies, such as avelumab, trastuzumab, cetuximab and rituximab with the intention of enhancing the cancer-killing efficacy of these antibodies by boosting the population of competent natural killer cells that can kill cancer cells through ADCC. Antibody products are abundantly utilized to treat cancer and it is estimated that they generate over $100&#160;billion in reported annual sales. A growing number of studies suggest that clinically meaningful responses to these antibody therapies correlate directly with the overall health of a patient&#8217;s natural killer cell population and whether they express the high-affinity variant of the CD16 receptor. Currently available literature estimates that only approximately 10% to 15% of the addressable patient population eligible for antibody therapies carry high-affinity CD16 receptors. This implies that our haNK product candidate may have significant market potential as a combination therapy to potentially address a large number of patients who do not carry high-affinity CD16 receptors and, as a result, exhibit a poorer response to antibody therapies. We therefore intend to develop our haNK product candidate as a combination therapy with widely-used U.S.&#160;Food and Drug Administration, or FDA, approved antibody products such as avelumab, trastuzumab, cetuximab and rituximab. Current Good Manufacturing Practice, or cGMP, master and working cell banks of our haNK product candidate have been successfully established and will serve as our source for product for our clinical trials and, if approved, commercialization going forward. We have optimized our manufacturing process partly by designing our haNK product candidate to not require IL&#8209;2 cytokine supplementation to the growth media every few days, thereby enabling us to overcome a technically challenging and costly limitation that many other natural killer cell-based therapies face. We have also successfully established processes for large-scale production, cryopreservation and long-term storage of final dose forms, thereby optimizing production efficiencies and allowing for on-demand availability with minimal handling at the infusion sites. Our cryopreserved haNK product candidate has been cleared for clinical testing in several phase&#160;Ib/II clinical trials, including our phase&#160;II Merkel cell cancer study.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed Killing&#8212;the taNK Platform.<span style="font-weight:normal;font-style:normal;">&#160;&#160; We have genetically engineered our aNK platform to express CARs that target tumor-specific antigens found on the surfaces of cancers and virally infected cells. Our taNK&#160;cells are designed to bind directly to these surface antigens and induce cell death through the release of toxic granules directly into the tumor cells and release of cytokines and chemokines to recruit additional innate and adaptive immune responses, including the recruitment of cytotoxic T&#8209;cells. These tumor antigens include checkpoint ligands, such as PD&#8209;L1 and B7&#8209;H4 as well as well-established tumor proteins such as CD19, HER2 and EGFR, all of which can be targeted individually by our engineered taNK products.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical evidence has been mounting which indicates that taNK&#160;cell activation through the binding of its CAR receptors to these cancer specific proteins may be potent enough to override many of the pre-existing inhibitory signals and immunosuppressive factors present in the tumor microenvironment that may be responsible for tumor resistance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">CAR-Directed and Antibody-Mediated Killing&#8212;the t&#8209;haNK Platform.<span style="font-weight:normal;font-style:normal;">   Our newest and most promising platform for the development of therapeutic product candidates is an innovative, bioengineered combination of our haNK and taNK platforms that incorporates all the features of our haNK platform together with a CAR. The resulting line of product candidates under this platform avails itself to all three modes of killing:&#160;</span><span style="font-weight:normal;">innate</span><span style="font-weight:normal;font-style:normal;">, </span><span style="font-weight:normal;">antibody-mediated</span><span style="font-weight:normal;font-style:normal;"> and </span><span style="font-weight:normal;">CAR-directed killing</span><span style="font-weight:normal;font-style:normal;">. These product candidates also include one or more additional expression elements such as functional cytokines, chemokines and trafficking factors, making them amongst the most versatile in our portfolio. These product candidates are intended to be combined with commercially available therapeutic antibodies to effectively target either two different epitopes of the same cancer specific protein or two entirely different cancer specific proteins. In addition to our two t&#8209;haNK product candidates, PD&#8209;L1.t&#8209;haNK, currently in phase&#160;II testing, and CD19.t&#8209;haNK, cleared to commence phase&#160;I testing, we believe a pipeline of prominent CARs for t&#8209;haNK, including HER2 and EGFR, which are nearing IND submission, and others that are advancing through clinical enabling studies, will enable us to potentially address an even broader range of cancers as part of a chemotherapy-free combination regimen.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The Nant Cancer Vaccine.<span style="font-weight:normal;font-style:normal;">&#160;&#160; The Nant Cancer Vaccine, or NCV, program is a personalized therapy regimen, which utilizes our &#8220;off-the-shelf&#8221; NK&#160;cell platform as the backbone of the regimen. NCV consists of an initial tumor-conditioning regimen followed by a molecularly-informed immunologic conditioning therapy. More specifically, NCV combines the novel delivery of metronomic, albumin-linked low-dose chemotherapy in conjunction with certain other agents, followed by a sequenced administration of tumor-associated antigen vaccines and an IL&#8209;15 superagonist fusion protein, all of which potentiate our NK&#160;cell therapy to potentially drive immunogenic cell death while avoiding the ravages of toxic high-dose chemotherapy. By inducing immunogenic cell death and enhancing a patient&#8217;s innate and adaptive immune system, NCV is designed to attain a long-term, durable response in multiple cancer types with a potential for lower toxicity and improved efficacy and quality of life in comparison with current standards of care. We believe ultimately that employing our NK&#160;cell therapy in the context of NCV will be a highly effective combination for long term clinical success over available standards of care that employ maximum tolerated dose, tolerogenic cell death and immune system compromise.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Coronavirus Pandemic</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#8209;CoV&#8209;2) a pandemic. In the same month, the President of the United States declared a State of National Emergency due to the pandemic. Many jurisdictions, particularly in North America, Europe and Asia, as well as U.S. states in which we operate, including California, have adopted or continue to consider laws, rules, regulations or decrees intended to address the pandemic, including travel restrictions, closing or re-opening of non-essential businesses or restricting daily activities. However, due to the pandemic new restrictions might be imposed by various governmental authorities. For example, many communities have limited, and may continue to limit, social mobility and gatherings in response to the continued rise in coronavirus cases and fatalities in the U.S. Such restrictions and other impacts from the pandemic may have an impact on our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given the unprecedented and continuously evolving nature of the pandemic, the future impact of these changes and potential changes on our company are unknown at this time. To date, we have seen no material adverse impact to our business from the pandemic. We anticipate, however, that enrollment of patients in certain studies will likely take longer than forecasted in prior SEC filings and that our clinical trials may require additional time to complete which would in turn impact the timeline in which we were previously forecasting BLA submissions of our product candidates and subsequent revenue generation. These factors have been accounted for in the company&#8217;s anticipated upcoming milestones. During any such delays in our clinical trials, we will continue to incur fixed costs such as selling, general and administrative expenses and operating expenses related to our laboratory, GMP manufacturing, and office facilities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our office-based employees have been working from home since mid-March&#160;2020, while ensuring essential staffing levels for our research and development operations remain in place, including maintaining key personnel in our laboratory and GMP manufacturing facilities. While we have not previously experienced or been notified of any anticipated impact amongst our third party vendors, it is likely that the pandemic and resulting mitigation efforts could have an impact in the future on our third-party suppliers who manufacture laboratory supplies required for our in-house manufacturing process, which in turn could have an impact on having sufficient clinical product supply available for our clinical trials. We have addressed this in part by ensuring that we have sufficient supplies on hand to weather interruptions in our supply chain.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is significant uncertainty about the progression and ultimate impact of the pandemic on our business and operations. While the pandemic did not materially impact our results during the year ended December&#160;31, 2020 outside of the Joint COVID-19 Collaboration Agreement as described above, we anticipate that it could impact our business in the short-term due to factors such as fewer patients accessing treatment for cancer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Results</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have not generated any revenue from product sales. We have incurred net losses in each year since our inception and, as of December&#160;31, 2020, we had an accumulated deficit of $754.6&#160;million. Our net losses were $92.4&#160;million, $65.8&#160;million and $96.2&#160;million for the years ended December&#160;31, 2020, 2019 and 2018, respectively. Substantially all of our net losses resulted principally from costs incurred in connection with our ongoing clinical trials and operations, our research and development programs, and from selling, general and administrative costs associated with our operations including stock-based compensation expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, we had 171 employees. Personnel of related companies who provide corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy and other support services under our shared services agreement with NantWorks are not included in this number. For additional information, see Note&#160;10,<span style="font-style:italic;">&#160;Related Party Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future, which may fluctuate significantly from quarter-to-quarter and year-to-year. We anticipate that our expenses will increase substantially as we:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">continue research and development, including preclinical and clinical development of our existing product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">potentially seek regulatory approval for our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seek to discover and develop additional product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">establish a commercialization infrastructure and scale up our manufacturing and distribution capabilities to commercialize any of our product candidates for which we may obtain regulatory approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seek to comply with regulatory standards and laws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">maintain, leverage and expand our intellectual property portfolio&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">hire clinical, manufacturing, scientific and other personnel to support our product candidates&#8217; development and future commercialization efforts&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">add operational, financial and management information systems and personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">incur additional legal, accounting and other expenses in operating as a public company&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">incur additional costs associated with our proposed merger with ImmunityBio, including a higher expense rate for the operations of the combined company if the merger closes.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not expect to generate any revenue from product sales unless and until we successfully complete development and obtain marketing approval for one or more of our product candidates, which we do not expect to happen for at least the next several years, if ever. Until such time that we can generate substantial revenue from product sales, if ever, we expect to finance our operating activities through a combination of equity offerings, debt financings, government or other third-party funding, marketing and distribution arrangements and other collaborations, strategic alliances and licensing arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all, which would have a negative impact on our financial condition and could force us to delay, limit, reduce or terminate our research and development programs or commercialization efforts. Failure to receive additional funding could cause us to cease operations, in part or in full.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Viracta Investment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2017, we participated in a Series&#160;B convertible preferred stock financing and invested $8.5&#160;million in Viracta Therapeutics, Inc., or Viracta, a clinical stage drug development company, which was initially recorded at cost. In May&#160;2017, we executed an exclusive worldwide license with Viracta to develop and commercialize Viracta&#8217;s proprietary histone deacetylase inhibitor drug candidate for use in combination with NK&#160;cell therapy and possibly additional therapies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We measure our equity securities without readily determinable fair values at cost, less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions. At December&#160;31, 2020, our fair value assessment indicated that the recent offering of Viracta&#8217;s Series&#160;E preferred shares, at a lower offering price per share than the per share carrying amount of our investment in Viracta, is a directional indicator representing an observable price change in an orderly transaction for a similar investment. On December&#160;31, 2020, we reduced the carrying value by $1.4&#160;million due to the observable price change, which has been included in other income and expense, net, on the consolidated statements of operations. On a cumulative basis, we have recognized a reduction in carrying value of $1.4&#160;million. As of December&#160;31, 2020, the carrying value of our investment in Viracta totaled $7.8&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information, see Note&#160;5,&#160;<span style="font-style:italic;">Viracta Investment</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Collaboration Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate that strategic collaborations will become an integral part of our operations, providing opportunities to leverage our partners&#8217; expertise and capabilities to further expand the potential of our technologies and product candidates. We believe we are well positioned to become a leader in cell-based immunotherapy due to our broad and vertically integrated platform and through complementary strategic partnerships.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the collaboration and license agreements discussed below, we may enter into a commercial agreement relating to an IL&#8209;15 superagonist product developed by an affiliate, and we are also pursuing supply arrangements for various investigational agents controlled by affiliates and third parties to be used in our clinical trials. These collaboration and supply agreements do not typically specify how sales will be apportioned between the parties upon successful commercialization of the product. As a result, we cannot guarantee that we will receive a percentage of the revenue that is at least proportional to the costs that we will incur in commercializing the product candidate. Furthermore, if Dr.&#160;Soon-Shiong was to cease his affiliation with us, ImmunityBio, or with NantWorks, these entities may be unwilling to continue these relationships with us on commercially reasonable terms, or at all, and as a result may impede our ability to control the supply chain for our combination therapies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report for a more detailed discussion regarding our collaboration and license agreements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreements with </span><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Related Parties</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Executive Chairman, and principal stockholder, founded and has a controlling interest in NantWorks, which is a collection of multiple companies in the healthcare and technology space. As described below, we have entered into arrangements with NantWorks, and certain affiliates of NantWorks, to facilitate the development of new genetically modified NK&#160;cells for our product pipeline. Affiliates of NantWorks are also affiliates of the company due to the common control by and/or common ownership interest of our Executive Chairman.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantWorks</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the NantWorks shared services agreement executed in November&#160;2015, but effective August&#160;2015, NantWorks provides corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy, and other support services. We are charged for the services at cost plus reasonable allocations for indirect costs that relate to the employees providing the services. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded $2.5&#160;million, $2.1&#160;million and $2.8&#160;million, respectively, in selling, general and administrative expense, and $1.5&#160;million, $1.5&#160;million and $3.3&#160;million, respectively, in research and development expense under this arrangement on the consolidated statements of operations. These amounts exclude certain general and administrative expenses provided by third party vendors directly for our benefit, which have been reimbursed to NantWorks based on those vendors&#8217; invoiced amounts without markup by NantWorks.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, we amended the existing shared services agreement with NantWorks whereby we can provide support services to NantWorks and/or any of its affiliates. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded expense reimbursements of $1.4&#160;million, $1.2&#160;million and $0.6&#160;million, respectively, in selling, general and administrative expense and $1.6&#160;million, $2.3&#160;million and $2.6&#160;million, respectively, in research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, we entered into a facility license agreement with NantWorks, which became effective in May&#160;2015, for approximately 9,500&#160;square feet in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. In September&#160;2020, we amended this agreement to extend the term of this lease through December&#160;31, 2021, as further described in Note&#160;9,<span style="font-style:italic;">&#160;Commitments and Contingencies</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.6&#160;million, $0.6&#160;million, and $0.2&#160;million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Immuno-Oncology Clinic, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning in 2017, we entered into multiple agreements with Immuno-Oncology Clinic, Inc., or the Clinic (dba&#160;Chan Soon-Shiong Institutes for Medicine, in El Segundo, California), to conduct clinical trials related to certain of our product candidates. The Clinic is a related party as it is owned by one officer of NantKwest and NantWorks manages the administrative operations of the Clinic. Prior to June&#160;30, 2019, one of the company&#8217;s officers was an investigator or sub-investigator for all of the company&#8217;s trials conducted at the Clinic.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we entered into a new agreement with the Clinic (the Clinic Agreement), which became effective on July&#160;1, 2019. The Clinic Agreement, as amended on March&#160;31, 2020, covers clinical trial and research related activities on a non-exclusive basis relating to our existing clinical trials, commenced prior to July&#160;1, 2019, and prospective clinical trials and research projects. The Clinic Agreement also specifies certain services and related costs that are excluded from the Clinic Agreement. Prior to commencing any work under the Clinic Agreement, the parties have agreed to execute written work orders setting forth the terms and conditions related to specific services to be performed, including financial terms. For clinical trials that commenced prior to July&#160;1, 2019, fees incurred for services performed after July&#160;1, 2019 are covered under the Clinic Agreement and applied towards the below-mentioned prepayments. The Clinic Agreement allows for an automatic renewal and additional extensions beyond the initial one&#160;year term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In consideration of the services to be performed under the Clinic Agreement, as amended on March&#160;31, 2020, we agreed to make payments of up to $7.5&#160;million to the Clinic, of which $3.75&#160;million and $1.875&#160;million were paid in July&#160;2019 and October&#160;2019, respectively. As amended, a conditional payment of $1.875&#160;million shall be due and payable at such time, if any, that the payments made in July&#160;2019 and October&#160;2019 have been earned by the Clinic through performance of services. On a quarterly basis, our prepayment is increased by an interest credit computed in accordance with terms specified in the Clinic Agreement.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">extend the term of the Clinic Agreement for up to three additional one</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within 60&#160;days of expiration. The Clinic may terminate this agreement upon each anniversary date upon sixty&#160;(60)&#160;days prior written notice and reimbursement in full to us of any outstanding unearned balance of the prepayments, provided that any such termination by the Clinic will not apply with respect to any work orders still in effect at the time of such termination.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we executed a clinical trial work order under the Clinic Agreement for an open-label, phase&#160;I study of PD&#8209;L1.t&#8209;haNK for infusion in subjects with locally advanced or metastatic solid cancers. In July&#160;2020, but effective on June&#160;22, 2020, we and ImmunityBio executed a clinical trial work order under our existing master agreement with the Clinic for an open-label, randomized, comparative phase&#160;II study of ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist (N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin) and our PD&#8209;L1.t&#8209;haNK with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, $0.6&#160;million, $1.1&#160;million, and $2.7&#160;million, respectively, was recognized in research and development expense on the consolidated statements of operations related to clinical trial and research related activities conducted for us by the Clinic.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio, Inc., or ImmunityBio, is a related party, as it is controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;21, 2020, we entered into a merger agreement with ImmunityBio pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The proposed merger is discussed in additional detail above under Agreement and Plan of Merger with ImmunityBio, Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a subsidiary of ImmunityBio, whereby we leased approximately 6,901&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in November&#160;2020. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. Lease expense for this facility is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million during the year ended December&#160;31, 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a Collaboration Agreement with ImmunityBio as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report. As of December&#160;31, 2020, the joint research activity under the Collaboration Agreement totaled $8.4&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $5.0&#160;million, to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#8209;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#8209;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio, which (together with related work orders) is described further in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report. During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $1.1&#160;million and $35,700, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, we entered into an agreement with Etubics Corporation, or Etubics, a subsidiary of ImmunityBio. Pursuant to this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">agreement</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> we sold used laboratory equipment to Etubics for $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;million. In conjunction with this sale, we recognized a loss on disposal of related laboratory equipment of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;million, which was included in other income, net on the consoli</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dated statements of operations.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2015, we entered into a supply agreement with ImmunityBio pursuant to which we have the right to purchase ImmunityBio&#8217;s proprietary bioreactors, made according to specifications mutually agreed to with ImmunityBio. We also have the right to purchase reagents and consumables associated with such equipment from ImmunityBio. When an upfront payment is made, it is included in prepaid expenses on the consolidated balance sheets until the product is received. The agreement had an initial term of five&#160;years and renews automatically for successive one-year periods unless terminated earlier.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020 and 2019, we had $3.2&#160;million and $1.8&#160;million, respectively, in equipment purchased from ImmunityBio pursuant to our supply agreement, which has been included in property, plant and equipment, net, on the consolidated balance sheets. During the years ended December&#160;31, 2020, 2019 and 2018, we recorded research and development expense associated with reagents and consumables purchased from ImmunityBio pursuant to our supply agreement of $0.3&#160;million, $0.1&#160;million and $0.1&#160;million, respectively, on the consolidated statements of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">605&#160;Doug&#160;St,&#160;LLC</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2016, we entered into a lease agreement with 605&#160;Doug&#160;St,&#160;LLC, an entity owned by our Executive Chairman and principal stockholder, for approximately 24,250&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP laboratory manufacturing facility. The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional three-year term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in July&#160;2017. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million, $0.9&#160;million and $0.2&#160;million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August&#160;2018, NantBio, Inc., or NantBio, assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#8217;s laboratory and vivarium premises. NantBio is a related party as it is an affiliate of NantWorks. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $0.9&#160;million, and paid $0.5&#160;million directly to the third party for an aggregate value of $1.4&#160;million. The assigned agreement is for a term of ten&#160;years and expires in June&#160;2027. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, NantBio and the National Cancer Institute entered into a cooperative research and development agreement. The initial five-year agreement covers NantBio and its affiliates, including us. Under the agreement, the parties are collaborating on the preclinical and clinical development of proprietary recombinant natural killer cells and monoclonal antibodies in monotherapy and in combination immunotherapies. We benefited from the preclinical and clinical research conducted during the first four years under this agreement. In each of the contractual years under the agreement we paid $0.6&#160;million to the National Cancer Institute as a prepayment for services under the agreement. We recognize research and development expense related to this agreement ratably over a 12-month period for each funding year and recorded $0.6&#160;million of expense related to this agreement in each of the years ended December&#160;31, 2020, 2019 and 2018.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantHealth Labs, Inc.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2018, we entered into an agreement with NantHealth Labs, Inc., or NantHealth Labs, to obtain blood-based tumor profiling services. NantHealth Labs is a related party, as it is a wholly owned subsidiary of NantHealth, Inc., a majority owned subsidiary of NantWorks. We are obligated to pay NantHealth Labs fixed, per-patient fees. The agreement has an initial term of five&#160;years and renews automatically for successive one-year periods, unless terminated earlier. During the years ended December&#160;31, 2019 and 2018, $10,000 and $0.3&#160;million, respectively, has been recognized in research and development expense on the consolidated statements of operations. There were no expenses associated with this agreement during the year ended December&#160;31, 2020.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Components of our Results of Operations</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have derived substantially all of our revenue from non-exclusive license agreements with several pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of our licensee&#8217;s products developed or manufactured using our intellectual property and cell lines. Our license agreements may also include milestone payments, although to date, we have not generated any revenue from milestone payments. To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have no products approved for commercial sale and have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We classify our operating expenses into research and development and selling, general and administrative expenses. Personnel costs, including salaries, benefits, bonuses, and stock-based compensation expense comprise a significant component of our research and development and selling, general and administrative expense categories. We allocate expenses associated with our facilities and information technology costs between these two categories based on the nature of each cost.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense consists of expenses incurred while performing research and development activities to discover and develop our product candidates, including collaborative arrangements. This includes conducting preclinical studies and clinical trials, manufacturing development efforts and activities related to regulatory filings for product candidates. We recognize research and development expenses as they are incurred. Our research and development expense primarily consists of:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical trial and regulatory-related costs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expenses incurred under agreements with investigative sites and consultants that conduct our clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">expenses incurred under collaborative agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">manufacturing and testing costs and related supplies and materials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">employee-related expenses, including salaries, benefits, travel and stock-based compensation&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">facility expenses dedicated to research and development.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We typically use our employee, consultant and infrastructure resources across our development programs. We track outsourced development costs by product candidate or development program, but we do not allocate personnel costs, other internal costs or external consultant costs to specific product candidates or development programs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Substantially all of our research and development expenses to date have been incurred in connection with our product candidates. We expect our research and development expenses to continue to increase significantly for the foreseeable future as we advance our product candidates through clinical development, including the conduct of our ongoing and any future clinical trials as well as product candidates pursued as part of our collaboration efforts. The process of conducting clinical trials necessary to obtain regulatory approval is costly and time consuming. The successful development of product candidates is highly uncertain. At this time, we cannot reasonably estimate the nature, timing or costs required to complete the remaining development of any product candidates. This is due to the numerous risks and uncertainties associated with the development of product candidates as discussed in greater detail in Part&#160;I, Item&#160;1A,&#160;&#8220;<span style="font-style:italic;">Risk Factors</span>&#8221; of this Annual Report.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The costs of clinical trials may vary significantly over the life of a project owing to, but not limited to, the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">per patient trial costs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of sites included in the clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the countries in which the clinical trials are conducted&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the length of time required to enroll eligible patients&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of patients that participate in the clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number of doses that patients receive&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost of comparative agents used in clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the drop-out or discontinuation rates of patients&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">potential additional safety monitoring or other studies requested by regulatory agencies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the duration of patient follow-up&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the efficacy and safety profile of the product candidate.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not expect any of our product candidates to be commercially available for at least the next several years, if ever.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we expect our research and development expenses to continue to increase significantly for the foreseeable future as we advance our product candidates through clinical development and conduct our ongoing and planned clinical trials.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Selling, General and Administrative</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expense consists primarily of salaries and personnel-related costs, including employee benefits and any stock-based compensation, for employees performing functions other than research and development. This includes personnel in executive, finance, human resources, information technology, legal, and administrative support functions. Other selling, general and administrative expenses include facility-related costs not otherwise allocated to research and development expense, professional fees for auditing, tax and legal services, advertising costs, expenses associated with strategic business transactions and business development efforts, obtaining and maintaining patents, consulting costs, royalties and licensing costs, and costs of our information systems.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that our selling, general and administrative expenses for the year ended December&#160;31, 2021 will increase as compared to the year ended December&#160;31, 2020. We have incurred and expect that we will continue to incur in the future, additional costs associated with operating as a public company, including costs to comply with stock exchange listing and SEC requirements, future funding efforts, corporate governance, internal controls, investor relations, disclosure and similar requirements applicable to public companies. Additionally, if and when we believe that a regulatory approval of a product candidate appears likely, we expect to incur significant increases in our selling, general and administrative expenses relating to the sales and marketing of the approved product candidate. Furthermore, we expect to continue to incur additional costs associated with our proposed merger with ImmunityBio and the operations of the combined company after closing.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Income and Expense</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income and expense consists primarily of income from our investments in marketable debt securities, sublease rental income, unrealized losses related to observable price changes associated with our equity investment in Viracta, and foreign currency gains and losses.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes consists of U.S. federal and state income taxes and foreign income taxes associated with our Korean subsidiary. To date, we have not been required to pay U.S. federal income taxes because of our current and accumulated net operating losses. Our income tax expense to date primarily relates to minimum income taxes in the State of California. Our income tax benefit to date relates primarily to the amortization of deferred tax liabilities at our Korean subsidiary.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Results of Operations</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comparison of the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.12%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020 vs. 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019 vs. 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development (including</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,483</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,785</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,718</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,698</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,933</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative (including</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,254</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,065</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,718</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,189</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,653</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,737</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,850</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,436</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,887</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,586</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,626</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,807</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,389</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,819</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,582</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,642</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,857</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,276</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(215</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense (including amounts</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(433</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income, net (including</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">298</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,375</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other (expense) income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(752</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,921</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,660</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,673</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,378</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,886</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,729</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,492</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,843</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(406</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,383</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,789</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,226</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,594</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,437</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The change in revenue was minimal during the comparative periods and consisted of license fees and royalties.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense increased $14.7&#160;million during the year ended December&#160;31, 2020, as compared to the year ended December&#160;31, 2019. The increase in research and development expense was primarily attributable to $8.4&#160;million of expenses related to our Joint COVID&#8209;19 Collaboration Agreement with ImmunityBio, including the acquisition of $5.0&#160;million of equipment to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. In addition, research and development expenses increased by $4.0&#160;million due to higher laboratory and supplies expense mainly driven by our COVID&#8209;19 programs, including additional expenses related to readying our new El&#160;Segundo manufacturing facility leased during the third quarter of 2020. We also experienced a $3.2&#160;million increase related to higher lease and facility operating costs, including an increase of $1.6&#160;million related to our new El&#160;Segundo facility, and an increase of $1.6&#160;million for other manufacturing and facility related expenses including higher depreciation expense and higher facilities and equipment maintenance costs. Our new El&#160;Segundo facility is used to manufacture and produce clinical products for our oncology product candidate trials. In addition, we incurred higher shared services costs of $0.6&#160;million driven mainly by manufacturing services, and higher third party research agreement costs of $0.5&#160;million. These increases in research and development expenses were partially offset by a decrease of $0.9&#160;million related to impairment of laboratory equipment during the year ended December&#160;31, 2019, a decrease of $0.6&#160;million in amortization expense due to the underlying asset being fully amortized as of March&#160;2019, and a decrease of $0.5&#160;million in clinical trial costs mainly driven by decreased activity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our research and development expense to increase significantly for the foreseeable future as we advance our product candidates, including collaboration product candidates, through clinical development and conduct our ongoing and planned clinical trials and those of ImmunityBio if the proposed merger closes.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense decreased $5.9&#160;million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the year ended December&#160;31, 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as compared to the year ended December&#160;31, 2018. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The decrease in research and development expense was primarily attributable to decreases of $4.7&#160;million in compensation and related expenses due to decreased staff and to fees for shared services rendered under our shared services agreement with NantWorks as a result of less clinical trial support activities, $2.0&#160;million for pre-clinical and clinical trial costs mainly driven by decreased activity related to investigator sponsored trials and research agreements, and $1.7&#160;million of intangible asset amortization expense due to the underlying asset being fully amortized as of March&#160;2019. These decreases were partially offset by a net increase of $1.6&#160;million for laboratory and manufacturing facility related expenses, including increases related to third-party facility and manufacturing process validation and qualification costs, depreciation expense, and lease expense, mainly driven and associated with our El Segundo cGMP facility, and decreases related to third party testing services and laboratory supplies. In addition, we recorded $0.9&#160;million of expense related to impairment of laboratory equipment.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Selling, General and Administrative</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expense increased $9.2&#160;million during the year ended December&#160;31, 2020, as compared to the year ended December&#160;31, 2019. The increase in selling, general and administrative expense was primarily attributable to higher financial advisory, legal and other professional fees of $7.1&#160;million driven primarily by strategic initiatives, including our proposed merger with ImmunityBio, as well as by higher costs associated with contracting, trademark, and patent related legal fees and other matters. Selling, general and administrative expense also increased by $1.0&#160;million due to higher compensation and related expenses, and higher insurance expense of $1.0&#160;million which was driven by increases in directors&#8217; and officers&#8217; insurance rates. In addition, we incurred higher shared services costs of $0.5&#160;million driven mainly by legal and information technology related activities, an increase of $0.4&#160;million due to higher software license fees, and higher corporate relations costs of $0.2&#160;million driven by an increase in corporate communications, including press releases. These increases in selling, general and administrative expense were offset in part by decreases in travel and tradeshow related expenses of $0.6&#160;million and $0.4&#160;million, respectively, due mainly to a decline in activity as a result of the ongoing COVID&#8209;19 pandemic.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expense decreased $24.7&#160;million during the year ended December&#160;31, 2019, as compared to the year ended December&#160;31, 2018. The decrease in selling, general and administrative expense was primarily attributable to a decrease of $20.8&#160;million in stock-based compensation expense, which was primarily driven by a decrease due to vesting completed in July&#160;2018 and March&#160;2019 related to service-based equity awards issued to our Executive Chairman in 2015. In addition, selling, general and administrative expense decreased by $2.3&#160;million due to lower costs associated with litigation, $1.1&#160;million due to decreased activity in shared services provided by NantWorks, and $0.6&#160;million due to lower headcount related expenses. These decreases in selling, general and administrative expense were partially offset by a $0.2&#160;million increase in other administrative costs.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other Income and Expense</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income decreased by $2.7&#160;million during the year ended December&#160;31, 2020, as compared to the year ended December&#160;31, 2019. The decrease in other income resulted primarily from a $1.4&#160;million unrealized loss attributable to an observable price change associated with our equity investment in Viracta, and a decrease of $1.3&#160;million in investment income associated with our investments in marketable debt securities. Investment income from our marketable debt securities decreased due primarily to a decline in the average yield on our marketable debt securities which was driven in part by shorter contractual securities lives and broader economic and market conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income increased by $0.3&#160;million during the year ended December&#160;31, 2019, as compared to the year ended December&#160;31, 2018. The increase in other income resulted primarily from lower interest expense of $0.4&#160;million, offset in part by a decrease in investment income related to use of our investments for operations of $0.2&#160;million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The change in income taxes was immaterial during the year ended December&#160;31, 2020, as compared to the year ended December&#160;31, 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit decreased by $0.4&#160;million for the year ended December&#160;31, 2019, as compared to the year ended December&#160;31, 2018. The decrease was due primarily to lower income tax benefits related to losses at our Korean subsidiary.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Capital Resources</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Sources of Liquidity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our principal sources of liquidity are our existing cash, cash equivalents, and marketable debt securities. We have historically invested our cash primarily in investment grade short- to intermediate-term corporate debt securities, commercial paper, government sponsored securities, U.S. treasury securities, and foreign government bonds and classify these investments as available-for-sale. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the company closed an underwritten public offering of an aggregate of 8,521,500&#160;shares of common stock, which included 4,811,500&#160;shares issued to the public at a price of $9.50&#160;per share (which included 1,111,500&#160;shares sold to the public upon full exercise of the underwriters&#8217; option to purchase additional shares at a public offering price of $9.50&#160;per share), less underwriting discounts and commissions, and 3,710,000&#160;shares issued to our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong, at a price of $12.12&#160;per share, less underwriting discounts and commissions. All of the shares were offered by the company. Including the underwriters&#8217; option exercise, the aggregate gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, we had cash and cash equivalents, and restricted cash of $11.6&#160;million compared to $15.7&#160;million as of December&#160;31, 2019. The decrease was attributable to cash used in operating and investing activities of $70.5&#160;million and $20.6&#160;million, respectively, partially offset cash flows provided by financing activities of $87.0&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments in marketable debt securities were $54.8&#160;million as of December&#160;31, 2020, all of which were short-term investments, as compared to $37.6&#160;million as of December&#160;31, 2019, of which $36.1&#160;million were short-term investments.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash Flows</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth our primary sources and uses of cash for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided by (used in):</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(70,453</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61,362</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(63,381</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,589</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,456</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,101</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,975</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,593</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net decrease in cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,067</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,313</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,051</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Operating Activities</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, our net cash used in operating activities of $70.5&#160;million consisted of a net loss of $92.4&#160;million, partially offset by $16.7&#160;million in adjustments for non-cash items, and $5.3&#160;million of cash provided by net working capital changes. Adjustments for non-cash items primarily consisted of $9.1&#160;million in depreciation and amortization, $3.4&#160;million of non-cash lease expense related to operating lease right-of-use assets, $2.1&#160;million in stock compensation expense, $1.4&#160;million of unrealized losses attributable to an observable price change associated with our equity investment in Viracta, and $0.8&#160;million in amortization of premiums on marketable debt securities, reduced by $0.3&#160;million in non-cash interest. The change in net working capital consisted primarily of increases in amounts due to related parties of $5.0&#160;million, accrued expenses of $3.7&#160;million, and accounts payable of $2.1&#160;million, partially offset by decreases related to operating lease liabilities of $3.9&#160;million, other current assets of $1.3&#160;million, and other long-term assets of $0.3&#160;million. The $9.1&#160;million increase in cash used in operating activities, as compared to the year ended December&#160;31, 2019, was primarily due to costs incurred in ongoing clinical trials, ramp-up of manufacturing, and Joint COVID&#8209;19 Collaboration Agreement related activities as well as costs associated with our proposed merger with ImmunityBio.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2019, our net cash used in operating activities of $61.4&#160;million consisted of a net loss of $65.8&#160;million, and $10.9&#160;million of cash used by net working capital changes, partially offset by $15.4&#160;million in adjustments for non-cash items. Adjustments for non-cash items primarily consisted of $9.0&#160;million in depreciation and amortization, $2.6&#160;million in stock compensation expense, $2.6&#160;million of non-cash lease expense related to operating lease right-of-use assets, $0.9&#160;million of impairment related to laboratory equipment, and $0.2&#160;million in non-cash interest. The decrease in net working capital consisted primarily of decreases related to accrued expenses of $12.0&#160;million, other long-term assets of $4.0&#160;million, operating lease liabilities of $3.1&#160;million, and due to related parties of $1.1&#160;million, partially offset by an increase related to prepaid expenses and other current assets of $9.3&#160;million. The $2.0&#160;million decrease in cash used in operating activities, as compared to the year ended December&#160;31, 2018, was primarily due to lower laboratory and manufacturing related costs and lower headcount and compensation costs including shared services, partially offset by higher clinical trial and related operational costs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2018, our net cash used in operating activities of $63.4&#160;million consisted of a net loss of $96.2&#160;million, offset by $33.4&#160;million in adjustments for non-cash items, primarily attributable to $23.4&#160;million in stock-based compensation expense, as well as research and development and selling, general and administrative expenses, and a $0.6&#160;million decrease of cash related to changes in working capital. Adjustments for non-cash items primarily consisted of the $23.4&#160;million in stock-based compensation expense, $9.6&#160;million in depreciation and amortization, $0.5&#160;million in amortization of premiums on marketable debt securities, $0.3&#160;million in non-cash interest related to our marketable debt securities, and $0.2&#160;million related to loss on disposal of assets, reduced by $0.5&#160;million of deferred income tax benefit. Changes in net working capital consisted primarily of increases related to prepaid and other current assets of $9.8&#160;million, other assets of $1.2&#160;million, accounts payable of $1.1&#160;million, due to related parties of $0.7&#160;million, and deferred rent of $0.5&#160;million, partially offset by an increase in accrued expenses of $12.7&#160;million.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investing Activities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, net cash used in investing activities was $20.6&#160;million, which included cash outflows of $91.6&#160;million for purchases of marketable debt securities, and $2.6&#160;million for purchases of property, plant and equipment, partially offset by cash inflows of $65.4&#160;million and $8.3&#160;million from maturities and sales of marketable debt securities, respectively. Our investments in property, plant and equipment for the year ended December&#160;31, 2020, related primarily to acquisitions of equipment which will be used to manufacture our ceNK and MSC product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2019, net cash provided by investing activities was $21.5&#160;million, which was primarily attributable to cash inflows of $109.7&#160;million and $2.5&#160;million from maturities and sales of marketable debt securities, respectively, partially offset by cash outflows of $86.6&#160;million for purchases of marketable debt securities, and $4.2&#160;million for purchases of property, plant and equipment. During the year ended December&#160;31, 2019, our purchases of marketable debt securities included our investment of $39.2&#160;million of cash proceeds received in March&#160;2019 from the exercise of stock options and warrants, together with reinvestment of excess cash related to maturing securities. Our investments in property, plant and equipment during the year ended December&#160;31, 2019 mainly related to our El Segundo, California, facilities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2018, net cash provided by investing activities was $57.1&#160;million, which was primarily attributable to cash inflows of $165.3&#160;million from maturities of marketable debt securities and $0.4&#160;million from sales of laboratory equipment, partially offset by cash outflows of $94.8&#160;million for purchases of marketable debt securities, driven by the reinvestment of excess cash resources, $13.1&#160;million for purchases of property, plant and equipment, mainly related to our laboratory and cGMP build out in El Segundo, California, and $0.7&#160;million for purchases of Viracta convertible notes.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Financing Activities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, net cash provided by financing activities was $87.0&#160;million, which consisted of proceeds from the issuance of 8,521,500&#160;shares of common stock, net of issuance cost paid, of $86.3&#160;million, and proceeds of $1.2&#160;million resulting from exercises of stock options. Net cash used in financing activities for the year ended December&#160;31, 2020, consisted of $0.5&#160;million related to net share settlement of vested RSUs for payment of employee payroll taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2019, net cash provided by financing activities was $38.6&#160;million, which primarily consisted of cash proceeds of $35.2&#160;million and $4.1&#160;million resulting from the exercise of warrants and stock options, respectively, by our Executive Chairman during March&#160;2019, partially offset by $0.5&#160;million used for stock repurchases, including commissions, and $0.1&#160;million related to net share settlement of vested RSUs and option exercises for payment of employee payroll taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2018, net cash used in financing activities was $0.8&#160;million, which primarily related to $0.5&#160;million of principal payments on our financing obligations, $0.2&#160;million used for stock repurchases, and $0.1&#160;million in net share settlement of exercised warrants and vesting of RSUs for payment of employee payroll taxes, partially offset by $0.1&#160;million in proceeds from the exercise of warrants.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Future Funding Requirements</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property, and we have no products approved for commercial sale and have not generated any revenue from product sales. We do not expect to generate significant revenue unless and until we obtain regulatory approval of and commercialize any of our product candidates, and we do not know when, or if, this will occur. In addition, we expect our expenses to significantly increase in connection with our ongoing development activities, particularly as we continue the research, development and clinical trials of, and seek regulatory approval for, our product candidates. We have also incurred and expect that we will continue to incur in the future additional costs associated with operating as a public company as well as costs related to future fundraising efforts and our proposed merger with ImmunityBio. In addition, subject to obtaining regulatory approval of our product candidates, we expect to incur significant commercialization expenses for product sales, marketing, manufacturing and distribution. We anticipate that we will need substantial additional funding in connection with our continuing operations. We expect that our expenses will increase substantially if and as we:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">continue research and development, including preclinical and clinical development of our existing product candidates including those related to our Joint CVOID-19 Collaboration agreement with ImmunityBio&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">potentially seek regulatory approval for our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seek to discover and develop additional product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">establish a commercialization infrastructure and scale up our manufacturing and distribution capabilities to commercialize any of our product candidates for which we may obtain regulatory approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">seek to comply with regulatory standards and laws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">maintain, leverage and expand our intellectual property portfolio&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">hire clinical, manufacturing, scientific and other personnel to support our product candidates&#8217; development and future commercialization efforts&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">add operational, financial and management information systems and personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">incur additional legal, accounting and other expenses in operating as a public company&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">complete our proposed merger with ImmunityBio.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#8217;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We have based this estimate on assumptions that may prove to be incorrect, and we may use our available capital resources sooner than we currently expect. The successful development of any product candidate is highly uncertain. Due to the numerous risks and uncertainties associated with the development and commercialization of our product candidates, if approved, we are unable to estimate the amounts of increased capital outlays and operating expenses associated with completing the development of our product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future capital requirements will depend on many factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of, and the costs involved in, preclinical and clinical development and obtaining any regulatory approvals for our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the impacts of COVID&#8209;19 on our operations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs of manufacturing, distributing and processing our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the number and characteristics of any other product candidates we develop or acquire&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to establish and maintain strategic collaborations, licensing or other commercialization arrangements and the terms and timing of such arrangements including our arrangements with ImmunityBio and its subsidiaries and Viracta&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the degree and rate of market acceptance of any approved products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the emergence, approval, availability, perceived advantages, relative cost, relative safety and relative efficacy of other products or treatments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the expenses needed to attract and retain skilled personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs associated with being a public company&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs associated with our proposed merger with ImmunityBio and costs of operations for the combined company if the merger closes&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing intellectual property claims, including litigation costs and the outcome of such litigation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing, receipt and amount of sales of, or royalties on, any approved products&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any product liability or other lawsuits related to our product candidates or the company.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because all of our product candidates are in various stages of preclinical and clinical development and the outcome of these efforts is uncertain, we cannot estimate the actual amounts necessary to successfully complete the development and commercialization of any of our product candidates or whether, or when, we may achieve profitability. Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or licensing arrangements with pharmaceutical partners, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market our product candidates that we would otherwise prefer to develop and market ourselves.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contractual Obligations, Commitments and Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contractual Obligations and Commitments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note&#160;9,<span style="font-style:italic;">&#160;Commitments and Contingencies, Contractual Obligations &#8211; Leases</span>,<span style="font-style:italic;"> and </span>Note&#160;10,<span style="font-style:italic;">&#160;Related Party Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Off-Balance Sheet Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the periods presented, we did not have, nor do we currently have, any off-balance sheet arrangements as defined under SEC rules.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies, Significant Judgements and Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management&#8217;s discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which are prepared in accordance with U.S.&#160;GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, related disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments, the most critical of which are those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#8217;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates and judgments on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is not intended to be a comprehensive discussion of all of our significant accounting policies. See the notes accompanying our financial statements appearing in this Annual Report for a summary of all of our significant accounting policies and other disclosures required by U.S.&#160;GAAP.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Transactions with Related Parties</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed in additional detail above, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaboration Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We analyze our collaboration arrangements to assess whether they are within the scope of Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC,&#160;Topic&#160;808, <span style="font-style:italic;">Collaborative Arrangements,</span> or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements are further discussed within Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Preclinical and Clinical Trial Accruals</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. In accruing clinical and research related fees, we estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Costs</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Restricted Cash</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents include highly liquid investments with an original maturity of three&#160;months or less from the date of purchase.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We minimize the credit risk associated with cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, management believes we are not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Marketable Debt Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of 12&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than 12&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#8217; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were no other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investment in Equity Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#8217; earnings performance and clinical trial performance, change in the investees&#8217; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record our available-for-sale investments at fair value. At December&#160;31, 2020, our cash equivalents and investments in marketable debt securities totaled $54.8&#160;million. FASB ASC Topic 820,&#160;<span style="font-style:italic;">Fair Value Measurements and Disclosures</span>, or ASC&#160;820, establishes three levels of inputs that may be used to measure fair value. Each level of input represents varying degrees of subjectivity and difficulty involved in determining fair value. Valuations using Level&#160;1 and&#160;2 inputs are generally based on price quotations and other observable inputs in active markets and do not require significant management judgment or estimation. We utilize a third-party pricing service to assist us in obtaining fair value pricing for these investments. While pricing for these securities is based on proprietary models, the inputs used are based on observable market information&#59; therefore, we have classified our inputs as Level&#160;1 and Level&#160;2. For additional information, see Note&#160;7,<span style="font-style:italic;">&#160;Fair Value Measurements</span>, of the &#8220;Notes to Consolidated Financial Statements&#8221; included in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December&#160;31, 2019, we determined that certain bioreactor laboratory equipment could no longer be utilized in the production process. As a result, we recorded an impairment charge totaling $0.9&#160;million, which is included in research and development expense on the consolidated statements of operations. There were no impairment losses recognized during the years ended December 31, 2020 and 2018.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, <span style="font-style:italic;">Leases</span>, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset&#59; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period&#59; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, <span style="font-style:italic;">Leases</span>, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term&#59; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised&#59; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset&#59; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset&#59; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p>
<hr style="page-break-after:always" />
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception. Such leases are expensed on a straight-line basis over the lease term.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation</span>, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Repurchases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, the board of directors approved a share repurchase program, or the 2015 Share Repurchase Program, allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Utilization of Net Operating Loss Carryforwards, or NOLs, and Research and Development Credits</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, we had federal, state and foreign income tax NOLs of $389.8&#160;million, $350.3&#160;million and $0.2&#160;million, respectively. Of the $389.8&#160;million in federal NOLs, $226.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. Of the $350.3&#160;million in state NOLs, $4.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. The remaining federal NOL carryforwards begin to expire in 2024, the remaining state NOL carryforwards begin to expire in 2030 and the foreign NOL carryforwards begin to expire in 2022. As of December&#160;31, 2020, we also had federal and state research and development tax credit carryforwards of $11.1&#160;million and state research tax credits of $7.8&#160;million, respectively. The federal research tax credit carryforwards begin to expire in 2034 and certain state research tax credit carryforwards begin to expire in 2031. The California research tax credits can be carried forward indefinitely. These net operating loss and research and development tax credit carryforwards could expire unused and be unavailable to offset future income tax liabilities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Sections&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period), the corporation&#8217;s ability to use its pre-change net operating loss carry forwards and other pre-change tax attributes to offset its post-change income may be limited. We have completed a study through March&#160;2019 to determine the impact of ownership changes on our NOLs and we have undergone significant ownership changes in previous years. Accordingly, some of our NOLs and research and development credits have been derecognized.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Not Yet Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, the FASB issued Accounting Standards Update, or ASU, 2016&#8209;13,&#160;<span style="font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments</span>. The FASB subsequently issued amendments to ASU&#160;2016&#8209;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reducing the carrying amount under the current, other-than-temporary-impairment model. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For public business entities that meet the definition of a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities and Exchange Commission, or SEC,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;15, 2018. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">continue to evaluate</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the impact that this new standard and its related amendments will have on our consolidated financial statements</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and we do not intend to early adopt this new standard</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the SEC during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our exposure to market risk for changes in interest rates relates primarily to interest earned on our cash equivalents and investments. The primary objective of our investment activities is to preserve our capital to fund operations. A secondary objective is to maximize income from our investments without assuming significant risk. Our investment policy provides for investments in low-risk, investment-grade debt instruments. As of December&#160;31, 2020, we had $11.4&#160;million in cash and cash equivalents and $54.8&#160;million in our investment portfolio. Our cash equivalents are short-term investments with maturities of 90&#160;days or less at the time of purchase. We maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits. However, we believe that we are not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. As of December&#160;31, 2020, we did not hold or issue financial instruments for trading purposes. To date, we have not realized any significant loss of principal on our investments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Interest rate risk &#8211; cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the cash discussed above, our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of U.S interest rates. However, we do not believe a sudden change in the interest rates would have a material impact on our financial condition or results of operations due to the short-term maturities on our cash equivalents. A hypothetical 100&#160;basis point change in interest rates during any of the periods presented would not have had a material impact on our consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Interest rate risk &#8211; cash equivalents and investment portfolio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest a portion of our cash in a number of diversified fixed and floating rate securities, consisting of marketable debt securities and debt funds that are subject to interest rate risk. Changes in the general level of interest rates can affect the fair value of our investment portfolio. If interest rates in the general economy were to rise, our holdings could lose value. At December&#160;31, 2020, a hypothetical increase in interest rates of 100 basis points across the entire yield curve on our holdings would not have resulted in a material impact on the fair value of our portfolio.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Foreign currency exchange risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We contract with clinical research organizations, investigational sites and suppliers in foreign countries</span> and we have a bank account in Korea<span style="Background-color:#FFFFFF;">. We are, therefore, subject to fluctuations in foreign currency rates in connection with these agreements. We have not entered into any material foreign currency hedging contracts although we may do so in the future. To date we have not incurred any material effects from foreign currency changes on these contracts. The effect of a 10% adverse change in exchange rates on foreign currency denominated cash and payables as of December&#160;31, 2020 would not have been material. However, fluctuations in currency exchange rates could harm our business in the future.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Inflation risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Inflation may affect us by increasing our cost of labor, clinical trial, and other costs. We do not believe that inflation has had a material effect on our business, financial condition or results of operations for any period presented herein.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">Item&#160;8. Financial Statements and Supplementary Data.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><span style="text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_BALANCE_SHEETS"><span style="text-decoration:none;">Consolidated Balance Sheets as of December&#160;31, 2020 and 2019</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STMTS_OPERATIONS"><span style="text-decoration:none;">Consolidated Statements of Operations for the years ended December&#160;31, 2020, 2019 and 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STMTS_COMPREHENSIVE_LOSS"><span style="text-decoration:none;">Consolidated Statements of Comprehensive Loss for the years ended December&#160;31, 2020, 2019 and 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STMTS_STOCKHODLERS_EQUITY"><span style="text-decoration:none;">Consolidated Statements of Stockholders&#8217; Equity for the years ended December&#160;31, 2020, 2019 and 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STMTS_CASH_FLOWS"><span style="text-decoration:none;">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2020, 2019 and 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><span style="text-decoration:none;">Notes to Consolidated Financial Statements</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">Report of Independent Registered Public Accounting Firm</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Stockholders and the Board of Directors of NantKwest, Inc.</p>
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Opinion on the Financial Statements</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying consolidated balance sheets of NantKwest, Inc.&#160;(the Company) as of December&#160;31, 2020 and 2019, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes&#160;(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2020, in conformity with U.S. generally accepted accounting principles.</p>
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis for Opinion</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board&#160;(United States)&#160;(PCAOB) and are required to be independent with respect to the Company in accordance with the U.S.&#160;federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Critical Audit Matter</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that:&#160;(1)&#160;relates to accounts or disclosures that are material to the financial statements and (2)&#160;involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p>
<hr style="page-break-after:always" />
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Related party transactions</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and disclosures</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;width:21.42%;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;margin-right:1.85%;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Description of the Matter</p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;width:auto;">
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed in Note&#160;10 to the consolidated financial statements, the Company&#8217;s Executive Chairman of the Board of Directors and former CEO founded and has a controlling interest in NantWorks&#160;LLC, which is a collection of multiple companies in the healthcare and technology space. Affiliates of NantWorks&#160;LLC are also affiliates of the Company due to the common control by and/or common ownership interest of the Company&#8217;s Executive Chairman of the Board of Directors and former CEO. The Company has entered into multiple transactions with related parties, including shared services provided by/to NantWorks&#160;LLC, agreements with Immuno&#8209;Oncology Clinic,&#160;Inc. to conduct various clinical trials, and multiple agreements with ImmunityBio,&#160;Inc. including a collaboration agreement with ImmunityBio,&#160;Inc. for the joint development, manufacturing, and marketing of a vaccine/treatment for COVID&#8209;19.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assessing the sufficiency of procedures performed to identify related parties and related party transactions and determining the identified related party transactions were properly recorded, presented and disclosed was challenging due to the nature, volume and the significance of related party transactions.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;width:21.42%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.93%;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">How We Addressed the Matter in Our Audit</p></td>
<td valign="top" style="width:auto;">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The audit procedures we performed included, among others, testing the completeness and accuracy of the listing of significant related parties identified and related party transactions provided by management, testing the manner in which related party transactions were recorded, presented and disclosed, and performing journal entry searches of identified related parties to verify completeness and accuracy of the Company&#8217;s related party transactions. We also inspected questionnaires received from the Company&#8217;s directors and officers, read employment and compensation contracts, proxy statements and other relevant filings with the Securities and Exchange Commission and other regulatory agencies that relate to the Company&#8217;s financial relationships and transactions with the Company&#8217;s executive officers and with other entities controlled by the Company&#8217;s Executive Chairman of the Board of Directors and former CEO. We confirmed management fees payable to NantWorks&#160;LLC and other related party affiliates and agreed such fees to subsequent payments made by the Company. We designed and executed our tests of account balances and transaction details to assess potential effects on the Company&#8217;s identified related parties and related party transactions. We inquired of management and members of the Company's audit committee regarding the completeness of the related party transactions identified. We assessed the adequacy of financial statement footnote disclosure pertaining to related party transactions.</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:right;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ernst&#160;&#38;&#160;Young&#160;LLP</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 2016.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Los Angeles, California</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March&#160;4, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_BALANCE_SHEETS">Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ASSETS</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000033" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000034" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000035" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,285</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000036" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable debt securities, available-for-sale</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000037" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000038" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:AssetsCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:AssetsCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">55,757</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable debt securities, noncurrent</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment, net (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">53,927</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">60,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets, net (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,729</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity investment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,253</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,121</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,386</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:Assets" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">151,858</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:Assets" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">143,123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,749</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to related parties</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">486</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,206</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,438</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">775</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,559</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, less current portion (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,814</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,885</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:Liabilities" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,465</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:Liabilities" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,444</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 9)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000069">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000070">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000083" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001326110_20201231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000084" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001326110_20191231" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction> par value&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000085" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000086" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001326110_20191231" decimals="INF" format="ixt:numdotdecimal">500,000,000</ix:nonFraction></ix:nonFraction> shares authorized&#59;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000087" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000089" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal">108,726,551</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_000088" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_20191231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000090" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001326110_20191231" decimals="INF" format="ixt:numdotdecimal">98,460,404</ix:nonFraction></ix:nonFraction> issued and outstanding as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2020 and December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:CommonStockValue" contextRef="C_0001326110_20201231" decimals="-3" scale="3">11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:CommonStockValue" contextRef="C_0001326110_20191231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">872,078</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">782,965</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001326110_20201231" decimals="-3" sign="-" scale="3">122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001326110_20191231" decimals="-3" sign="-" scale="3">105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001326110_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">754,574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001326110_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">662,191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">117,393</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">120,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">151,858</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000082" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">143,123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STMTS_OPERATIONS">Consolidated Statements of Operations</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:Revenues" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="us-gaap:Revenues" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">43</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="us-gaap:Revenues" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000094" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">64,483</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000095" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,785</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000096" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">55,718</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000097" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,718</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">91,737</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">67,850</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000102" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,436</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000103" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">91,626</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000104" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">67,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000105" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">98,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000106" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">366</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000107" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,642</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000108" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,857</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000109" name="us-gaap:FinanceLeaseInterestExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">41</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000110" name="us-gaap:FinanceLeaseInterestExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000111" name="us-gaap:FinanceLeaseInterestExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">433</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income, net (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000112" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,077</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000113" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000114" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">236</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other (expense) income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000115" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">752</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000116" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,921</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000117" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000118" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,378</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000119" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000120" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,729</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000121" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000122" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">97</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000123" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000127" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20200101_20201231" decimals="2" sign="-">0.89</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000128" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20190101_20191231" decimals="2" sign="-">0.70</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000129" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20180101_20181231" decimals="2" sign="-">1.22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average number of shares during the period:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000130" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20200101_20201231" decimals="0" format="ixt:numdotdecimal">103,550,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000131" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20190101_20191231" decimals="0" format="ixt:numdotdecimal">94,210,087</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000132" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20180101_20181231" decimals="0" format="ixt:numdotdecimal">79,132,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STMTS_COMPREHENSIVE_LOSS">Consolidated Statements of Comprehensive Loss</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive (loss) income, net of income taxes:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net unrealized (losses) gains on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">158</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">114</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of net realized losses on available-for-sale</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities included in net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive (loss) income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">114</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,112</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STMTS_STOCKHODLERS_EQUITY">Consolidated Statements of Stockholders&#8217; Equity</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.96%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2017</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000148" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231" decimals="INF" format="ixt:numdotdecimal">79,021,878</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">717,930</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231" decimals="-3" sign="-" scale="3">381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">498,713</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">218,844</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of warrants</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000159" name="nk:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">93,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" scale="3">57</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000162" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">57</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of restricted stock units (RSUs)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000165" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">172,330</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000166" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000167" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000168" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000169" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000170" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net share settlement for RSU vesting and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; warrant exercises</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000171" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">61,379</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000173" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" scale="3">123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000174" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repurchase of common stock</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000177" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">138,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000178" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000179" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000180" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" scale="3">228</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">228</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative effect of the adoption of the new</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; revenue standard</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000185" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" scale="3">186</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000187" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20180101_20181231" decimals="-3" scale="3">186</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000188" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000190" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" scale="3">114</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000192" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">114</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000193" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2018</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000198" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="INF" format="ixt:numdotdecimal">79,087,734</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">741,246</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231" decimals="-3" sign="-" scale="3">267</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">594,981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">146,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000204" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of warrants</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000209" name="nk:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">17,589,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000210" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,149</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000212" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000213" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,151</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of stock options</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000215" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,986,300</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,070</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,070</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of RSUs</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000221" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">395,051</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000225" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000226" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net share settlement for RSU vesting and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; warrant exercises</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000227" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">124,345</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" scale="3">127</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000230" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000231" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">127</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repurchase of common stock</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000233" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">473,586</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000234" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000235" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000236" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000237" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" scale="3">501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000238" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative effect of the adoption of the new</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; lease standard</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000240" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000241" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000242" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" scale="3">920</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="us-gaap:PriorPeriodReclassificationAdjustment" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101_20191231" decimals="-3" sign="-" scale="3">920</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000244" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000246" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" scale="3">162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">162</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000249" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000250" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000251" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000252" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000253" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000254" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal">98,460,404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000255" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000256" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">782,965</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000257" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" sign="-" scale="3">105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">662,191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000259" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">120,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock, net of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="nk:StockOfferingCosts" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,373</ix:nonFraction> in offering</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; costs</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000260" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">8,521,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000261" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000262" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,301</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000263" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000264" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000265" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000266" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000267" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,139</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000269" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000270" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,139</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of stock options</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000271" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,272,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,176</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000275" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,176</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting of RSUs</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000277" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">648,336</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000279" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net share settlement for RSU vesting and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; option exercises</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000283" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">175,962</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000287" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000290" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" sign="-" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000298" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000299" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">108,726,551</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" scale="3">11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">872,078</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231" decimals="-3" sign="-" scale="3">122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">754,574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:StockholdersEquity" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">117,393</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STMTS_CASH_FLOWS">Consolidated Statements of Cash Flows</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000306" name="us-gaap:ProfitLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:ProfitLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:ProfitLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,012</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000311" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,555</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash lease expense related to operating lease right-of-use assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,430</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,604</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000314" name="nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000315" name="us-gaap:ShareBasedCompensation" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,139</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000316" name="us-gaap:ShareBasedCompensation" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000317" name="us-gaap:ShareBasedCompensation" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized loss on equity investment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000318" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,405</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000319" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of net premiums and discounts on marketable debt</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000321" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">794</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Losses (gains) on sales of marketable debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:MarketableSecuritiesGainLoss" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="us-gaap:MarketableSecuritiesGainLoss" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:MarketableSecuritiesGainLoss" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on disposal of assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">209</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash interest items, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="nk:NonCashInterestIncomeExpenseFromOperatingActivities" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="nk:NonCashInterestIncomeExpenseFromOperatingActivities" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">246</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="nk:NonCashInterestIncomeExpenseFromOperatingActivities" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">291</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on impairment of assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:AssetImpairmentCharges" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:AssetImpairmentCharges" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">869</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="us-gaap:AssetImpairmentCharges" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income tax benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,328</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,276</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000341" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,818</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">339</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,063</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,151</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="nk:IncreaseDecreaseInAccountsPayableCurrent" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000346" name="nk:IncreaseDecreaseInAccountsPayableCurrent" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">41</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000347" name="nk:IncreaseDecreaseInAccountsPayableCurrent" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,100</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000348" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000349" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">12,020</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000350" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,708</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to related parties</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000351" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,034</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000352" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000353" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">685</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="nk:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,941</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="nk:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,076</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000356" name="nk:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred rent</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000357" name="nk:IncreaseDecreaseInDeferredRent" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000358" name="nk:IncreaseDecreaseInDeferredRent" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000359" name="nk:IncreaseDecreaseInDeferredRent" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000360" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">70,453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000361" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">61,362</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000362" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">63,381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investing activities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property, plant and equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000363" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,639</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000364" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,182</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000365" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sales of property, plant and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000366" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000367" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000368" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">412</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of debt securities, held-to-maturity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000369" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000370" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000371" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">723</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of investments in equity securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000372" name="nk:PaymentsToAcquireInvestmentsInEquitySecurities" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000373" name="nk:PaymentsToAcquireInvestmentsInEquitySecurities" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000374" name="nk:PaymentsToAcquireInvestmentsInEquitySecurities" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of marketable debt securities, available-for-sale</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000375" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">91,572</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000376" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,618</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000377" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">94,770</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maturities of marketable debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000378" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">65,350</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000379" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">109,730</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000380" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">165,284</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of marketable debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000381" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,272</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000382" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,529</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000383" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000384" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,589</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000385" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,456</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000386" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">57,101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financing activities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from equity offering, net of issuance cost paid</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000387" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000388" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000389" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from exercises of stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000390" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,176</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000391" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,070</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000392" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from exercises of warrants</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000393" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000394" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,151</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000395" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">57</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal payments of financing obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000396" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000397" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000398" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">477</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repurchases of common stock with commissions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000399" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000400" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000401" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">228</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net share settlement for restricted stock unit vesting and warrant and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; option exercises</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000402" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000403" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">127</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000404" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000405" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,975</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000406" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,593</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000407" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">771</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net decrease in cash, cash equivalents, and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000408" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,067</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000409" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,313</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000410" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">7,051</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash, beginning of period</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000411" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000412" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000413" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,051</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash, end of period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000414" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,620</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000415" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000416" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Cash Flows (Continued)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reconciliation of cash, cash equivalents, and restricted cash at end of period:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000417" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000418" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000419" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,821</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash included in other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000420" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000421" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000422" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001326110_20181231" decimals="-3" scale="3">179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents, and restricted cash, end of period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000423" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,620</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000424" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000425" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of cash flow information:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid during the period for:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000426" name="us-gaap:InterestPaidNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">40</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000427" name="us-gaap:InterestPaidNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000428" name="us-gaap:InterestPaidNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">475</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000429" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000430" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000431" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of non-cash activities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets obtained in exchange for operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000432" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,164</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000433" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">800</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000434" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cashless exercise of stock options and warrants</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000435" name="us-gaap:StockIssued1" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000436" name="us-gaap:StockIssued1" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">29</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000437" name="us-gaap:StockIssued1" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">94</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment purchases included in accounts payable, accrued</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; expenses, and other liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000438" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000439" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">74</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000440" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,664</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion of Viracta convertible notes and accrued interest into</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; investment in equity securities of Viracta (Note 5)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000441" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000442" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">751</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000443" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized (losses) gains on marketable debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000444" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000445" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">258</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000446" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">123</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">Notes to Consolidated Financial Statements</p><ix:nonNumeric id="F_000448" name="nk:DescriptionOfBusinessDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000448_dcnt_0ba21880-7168-40e2-9d8d-4f398af2e987">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. &#160;&#160;&#160;&#160;Description of Business</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Organization</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc., or NantKwest, was incorporated in Illinois on October&#160;7, 2002 under the name ZelleRx Corporation. On January&#160;22, 2010, the company changed its name to Conkwest, Inc., and on July&#160;10, 2015, the company changed its name to NantKwest, Inc. In March&#160;2014, the company redomesticated from the State of Illinois to the State of Delaware and the Illinois company ceased to exist. We are a pioneering clinical-stage immunotherapy biotechnology company headquartered in San Diego, California with certain operations in Culver City and El Segundo, California and Woburn, Massachusetts. In these notes, the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;the company&#8221; and &#8220;us&#8221; refer to NantKwest.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are focused on harnessing the power of the innate immune system by using our natural killer cells, or NK&#160;cells, to treat cancer and viral infectious diseases. A critical aspect of our strategy is to invest significantly in innovating new therapeutic candidates, based upon our proprietary activated NK, or aNK, cell platform, and conducting clinical testing and scale manufacturing of our most promising biologic product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We hold the exclusive right to commercialize aNK&#160;cells, a commercially viable NK&#160;cell line, and a wide range of genetically modified derivatives capable of killing cancer and virally infected cells. We own corresponding United States, or U.S., and foreign composition and methods-of-use patents and applications covering the cells, improvements, methods of expansion and manufacture and use of aNK&#160;cells and their improvements as therapeutics to treat a spectrum of clinical conditions.</p><ix:nonNumeric id="F_000464" name="nk:LiquidityPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000464_dcnt_00985f60-a056-45c6-af1a-d106dd6886f3">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the company closed an underwritten public offering of common stock as discussed further in Note&#160;11,<span style="font-style:italic;">&#160;Stockholders Equity</span>. Gross proceeds from the offering were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000522" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="-5" scale="6">90.7</ix:nonFraction>&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000523" name="nk:UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="-5" scale="6">4.4</ix:nonFraction>&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, the company had an accumulated deficit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000524" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001326110_20201231" decimals="-5" sign="-" scale="6">754.6</ix:nonFraction>&#160;million. We also had negative cash flow from operations of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000525" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001326110_20200101_20201231" decimals="-5" sign="-" scale="6">70.5</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020. The company will likely need additional capital to further fund development of, and seek regulatory approvals for, our product candidates, and to begin to commercialize any approved products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently focused primarily on the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer and viral killing cell lines, and we believe such activities will result in the company&#8217;s continued incurrence of significant research and development and other expenses related to those programs. If the clinical trials for any of the company&#8217;s product candidates fail or produce unsuccessful results and those product candidates do not gain regulatory approval, or if any of our product candidates, if approved, fail to achieve market acceptance, we may never become profitable. Even if the company achieves profitability in the future, it may not be able to sustain profitability in subsequent periods. We intend to cover our future operating expenses through cash and cash equivalents and marketable debt securities on hand and through a combination of equity offerings, debt financings, government or other third party funding, marketing and distribution arrangements and other collaborations, strategic alliances, and licensing arrangements. Additional financing may not be available to us when needed and, if available, financing may not be obtained on terms favorable to the company or its stockholders.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we expect our existing cash, and cash equivalents and marketable debt securities, together with the ability to borrow from affiliated entities, will enable us to fund operations and capital expenditure requirements for at least the next 12&#160;months, we may not have sufficient funds to reach commercialization. Failure to obtain adequate financing when needed may require us to delay, reduce, limit, or terminate some or all of our development programs or future commercialization efforts or grant rights to develop and market product candidates that we might otherwise prefer to develop and market ourselves, which could adversely affect our ability to operate as a going concern. If we raise additional funds from the issuance of equity securities, substantial dilution to existing stockholders may result. If we raise additional funds by incurring debt financing, the terms of the debt may involve significant cash payment obligations, as well as covenants and specific financial ratios that may restrict our ability to operate our business.</p>
</ix:nonNumeric></ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000448_dcnt_0ba21880-7168-40e2-9d8d-4f398af2e987"><ix:continuation id="F_000464_dcnt_00985f60-a056-45c6-af1a-d106dd6886f3">
</ix:continuation></ix:continuation><ix:nonNumeric id="F_000449" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000449_dcnt_fae80fee-b270-438e-9312-5d6804ac136b">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</p><ix:nonNumeric id="F_000465" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S.&#160;GAAP.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared assuming the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of the uncertainty discussed in the Liquidity section of Note&#160;1. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#8217;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We may also seek to sell additional equity, through one or more follow-on public offerings, or in separate financings, or obtain a credit facility. However, we may not be able to secure such financing in a timely manner or on favorable terms. Without additional funds, we may choose to delay or reduce our operating or investment expenditures. Further, because of the risk and uncertainties associated with the commercialization of the company&#8217;s product candidates in development, we may need additional funds to meet our needs sooner than planned.</p></ix:nonNumeric><ix:nonNumeric id="F_000466" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000466_dcnt_c2ee4a96-f226-4987-8f7c-0feebaf08f20">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of NantKwest and its wholly owned subsidiaries. All intercompany amounts have been eliminated.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We apply the variable interest model under Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic&#160;810,&#160;<span style="font-style:italic;">Consolidation</span>, to any entity in which we hold an equity investment or to which we have the power to direct the entity's most significant economic activities and the ability to participate in the entity's economics. If the entity is within the scope of the variable interest model and meets the definition of a variable interest entity, or VIE, we consider whether we must consolidate the VIE or provide additional disclosures regarding our involvement with the VIE. If we determine that we are the primary beneficiary of the VIE, we will consolidate the VIE. This analysis is performed at the initial investment in the entity or upon any reconsideration event.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For entities we hold as an equity investment that are not consolidated under the VIE model, we consider whether our investment constitutes ownership of a majority of the voting interests in the entity and therefore should be considered for consolidation under the voting interest model.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unconsolidated equity investments in the common stock or in-substance common stock of an entity under which we are able to exercise significant influence, but not control, are accounted for using the equity method. Our ability to exercise significant influence is generally indicated by ownership of <ix:nonFraction unitRef="U_xbrlipure" id="F_000526" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMinimumMember_20201231" decimals="INF" scale="-2">20</ix:nonFraction> to <ix:nonFraction unitRef="U_xbrlipure" id="F_000527" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMaximumMember_20201231" decimals="INF" scale="-2">50</ix:nonFraction> percent interest in the voting securities of the entity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other unconsolidated equity investments on which we are not able to exercise significant influence will be subsequently measured at fair value with unrealized holding gains and losses included in other income and expense, net, on the consolidated statements of operations. In the instance the equity investment does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, <span style="font-style:italic;">Fair Value Measurement</span>, or ASC&#160;820, we will apply the measurement alternative under ASC&#160;321, <span style="font-style:italic;">Investments&#8212;Equity Securities</span>, or ASC&#160;321, pursuant to which we will measure the investment at its cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#8217; earnings performance and clinical trial performance, change in the investees&#8217; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include:&#160;the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.</p>
</ix:nonNumeric></ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_fae80fee-b270-438e-9312-5d6804ac136b" continuedAt="F_000449_dcnt_e3ffbaee-d749-4394-b077-da09f7335f26"><ix:continuation id="F_000466_dcnt_c2ee4a96-f226-4987-8f7c-0feebaf08f20">
</ix:continuation><ix:nonNumeric id="F_000467" name="us-gaap:UseOfEstimates" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#8217;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates. Actual results could differ from those estimates.</p></ix:nonNumeric><ix:nonNumeric id="F_000468" name="us-gaap:UnusualRisksAndUncertaintiesTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#8209;CoV&#8209;2) outbreak a pandemic. To date, our operations have not been significantly impacted by the pandemic. However, we cannot at this time predict the specific extent, duration, or full impact that this pandemic may have on our financial condition and results of operations, including ongoing and planned clinical trials. More specifically, the pandemic may result in prolonged impacts that we cannot predict at this time and we expect that such uncertainties will continue to exist until such time a vaccine is broadly available and in use. The impact of the pandemic on the financial performance of the company will depend on future developments, including the duration and spread of the outbreak and related governmental advisories and restrictions. These developments and the impact of the ongoing pandemic on the financial markets and the overall economy are highly uncertain. If the financial markets and/or the overall economy are impacted for an extended period, our results may be adversely affected.</p></ix:nonNumeric><ix:nonNumeric id="F_000469" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p></ix:nonNumeric><ix:nonNumeric id="F_000470" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea. We minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe that we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.</p></ix:nonNumeric><ix:nonNumeric id="F_000471" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000471_dcnt_fa95d516-0973-473f-acd1-f6e8cc9e570e">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents include highly liquid investments with an original maturity of <span style="-sec-ix-hidden:F_000528">three&#160;months</span> or less from the date of purchase.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of cash, cash equivalents, and restricted cash is included on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_e3ffbaee-d749-4394-b077-da09f7335f26" continuedAt="F_000449_dcnt_2dbc7685-58b2-41b4-9379-1f0fa688ab37"><ix:continuation id="F_000471_dcnt_fa95d516-0973-473f-acd1-f6e8cc9e570e">
</ix:continuation><ix:nonNumeric id="F_000472" name="us-gaap:MarketableSecuritiesPolicy" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Marketable Debt Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of <ix:nonNumeric id="F_000529" name="nk:MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:durmonth">12</ix:nonNumeric>&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than <ix:nonNumeric id="F_000530" name="nk:MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:durmonth">12</ix:nonNumeric>&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#8217; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were <ix:nonFraction unitRef="U_iso4217USD" id="F_000531" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" contextRef="C_0001326110_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000532" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" contextRef="C_0001326110_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000533" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" contextRef="C_0001326110_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.</p></ix:nonNumeric><ix:nonNumeric id="F_000473" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property, Plant and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment is stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. All repairs and maintenance are charged to net loss during the financial period in which they are incurred. <ix:nonNumeric id="F_000493" name="nk:PropertyPlantAndEquipmentUsefulLifeTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000493_cnt_1">Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:</ix:nonNumeric></p><ix:continuation id="F_000493_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000534" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231" format="ixt-sec:duryear">39</ix:nonNumeric> years</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000535" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20200101_20201231" format="ixt-sec:duryear">3</ix:nonNumeric> years</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000536" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkLaboratoryEquipmentMember_20200101_20201231" format="ixt-sec:duryear">5</ix:nonNumeric> years</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &#38; fixtures</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000537" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20200101_20201231" format="ixt-sec:duryear">5</ix:nonNumeric> years</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IT equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000538" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkITEquipmentMember_20200101_20201231" format="ixt-sec:duryear">3</ix:nonNumeric> years</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <ix:nonNumeric id="F_000539" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20200101_20201231">The lesser of the lease term or the life of the asset</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon disposal or impairment of property, plant and equipment, the cost and related accumulated depreciation is removed from the consolidated financial statements and the net amount, less any proceeds, is included in the consolidated statements of operations.</p></ix:nonNumeric><ix:nonNumeric id="F_000474" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, which consisted of the cost of reacquiring a technology license during 2015, were amortized using the straight-line method over an estimated useful life of <ix:nonNumeric id="F_000540" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_0001326110_20200101_20201231" format="ixt-sec:duryear">4</ix:nonNumeric>&#160;years. As of December&#160;31, 2019, our intangible assets were fully amortized.</p></ix:nonNumeric><ix:nonNumeric id="F_000475" name="us-gaap:LegalCostsPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Patents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patent costs, including related legal costs, are expensed as incurred and recorded in selling, general and administrative expenses on the consolidated statements of operations.</p></ix:nonNumeric><ix:nonNumeric id="F_000476" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000476_dcnt_5e1671c5-32b7-40a7-8d81-8f56585e765a">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_2dbc7685-58b2-41b4-9379-1f0fa688ab37" continuedAt="F_000449_dcnt_017c1c6a-04bd-4099-8e8b-33cf1e202339"><ix:continuation id="F_000476_dcnt_5e1671c5-32b7-40a7-8d81-8f56585e765a">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year ended December&#160;31, 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we determined that certain bioreactor laboratory equipment could no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> longer</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be utilized in the production process. As a result, we recorded an impairment charge </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">totaling</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000541" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231" decimals="-5" scale="6">0.9</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">million, which is included in research and development expense on the consolidated statements of operations. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000542" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment losses recognized during the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years ended December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 2018</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></ix:continuation><ix:nonNumeric id="F_000477" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in absence of a principal, most advantageous market for the specific asset or liability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The three tiers are defined as follows:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;1&#8212; Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets at the measurement date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Our Level 1 assets consist of bank deposits and money market funds.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;2&#8212; Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities. Our Level 2 assets consist of corporate debt securities including commercial paper, government sponsored securities and corporate bonds, as well as foreign municipal securities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;3&#8212; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, <ix:nonFraction unitRef="U_iso4217USD" id="F_000544" name="nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" contextRef="C_0001326110_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000545" name="nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" contextRef="C_0001326110_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000546" name="nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" contextRef="C_0001326110_20181231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers were made into or out of the Level&#160;1,&#160;2 or 3 categories. We will continue to review the fair value inputs on a quarterly basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We utilize a third-party pricing service to assist in obtaining fair value pricing for our investments in marketable debt securities. Inputs are documented in accordance with the fair value disclosure hierarchy.</p></ix:nonNumeric><ix:nonNumeric id="F_000478" name="us-gaap:CollaborativeArrangementAccountingPolicy" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaboration Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We analyze our collaboration arrangements to assess whether they are within the scope of FASB ASC&#160;Topic&#160;808, <span style="font-style:italic;">Collaborative Arrangements,</span> or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements are further discussed within Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>.</p></ix:nonNumeric><ix:nonNumeric id="F_000479" name="nk:PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000479_dcnt_8a366148-f439-43c0-96d3-04a1ea14f0d1">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Preclinical and Clinical Trial Accruals</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_017c1c6a-04bd-4099-8e8b-33cf1e202339" continuedAt="F_000449_dcnt_4edfdf08-dcf8-4858-9934-0612618daec0"><ix:continuation id="F_000479_dcnt_8a366148-f439-43c0-96d3-04a1ea14f0d1">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> behalf.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accruing clinical and research related fees, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.</span></p></ix:continuation><ix:nonNumeric id="F_000480" name="nk:RelatedPartyTransactionsPolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Transactions with Related Parties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As outlined in Note&#160;10,&#160;<span style="font-style:italic;">Related Party Agreements</span>, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.</p></ix:nonNumeric><ix:nonNumeric id="F_000481" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, <span style="font-style:italic;">Leases</span>, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset&#59; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period&#59; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, <span style="font-style:italic;">Leases</span>, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term&#59; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised&#59; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset&#59; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset&#59; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also <ix:nonNumeric id="F_000548" name="us-gaap:LesseeOperatingLeaseDescription" contextRef="C_0001326110_20200101_20201231">elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception</ix:nonNumeric>. Such leases are expensed on a straight-line basis over the lease term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.</p></ix:nonNumeric><ix:nonNumeric id="F_000482" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000482_dcnt_f38fefbd-2d8c-4c12-9892-6f0f4fed6c3c">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, as well as for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances to reduce deferred tax assets to the amount we believe is more likely than not to be realized.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_4edfdf08-dcf8-4858-9934-0612618daec0" continuedAt="F_000449_dcnt_95fd75b2-2521-4762-a09b-b5871ef33453"><ix:continuation id="F_000482_dcnt_f38fefbd-2d8c-4c12-9892-6f0f4fed6c3c">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize uncertain tax positions when the position will be more likely than not upheld on examination by the taxing authorities based solely upon the technical merits of the positions. We recognize interest and penalties, if any, related to unrecognized income tax uncertainties in income tax expense. We did <ix:nonFraction unitRef="U_iso4217USD" id="F_000549" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001326110_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001326110_20191231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t have any accrued interest or penalties associated with uncertain tax positions as of December&#160;31, 2020 and 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to U.S. federal income tax, as well as income tax in Korea, California and other states. To date, we have not been required to pay U.S. federal and state income taxes because of current and accumulated net operating losses. The federal returns for tax years <ix:nonNumeric id="F_000551" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">2017</ix:nonNumeric> through <ix:nonNumeric id="F_000552" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">2020</ix:nonNumeric> remain open to examination and the state returns remain subject to examination for tax years <ix:nonNumeric id="F_000553" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2016</ix:nonNumeric> through <ix:nonNumeric id="F_000554" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2020</ix:nonNumeric>. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination. No income tax returns are currently under examination by taxing authorities.</p></ix:continuation><ix:nonNumeric id="F_000483" name="nk:StockRepurchasesPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Repurchases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, the board of directors approved the 2015 Share Repurchase Program (Note&#160;11) allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000555" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="C_0001326110_20151130" decimals="INF" scale="6">50.0</ix:nonFraction>&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.</p></ix:nonNumeric><ix:nonNumeric id="F_000484" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000484_dcnt_0b335123-5cd7-4f85-8e4b-110f162d1743">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2018, we adopted the provisions of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. This guidance requires that entities recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted ASC&#160;606 on January&#160;1, 2018 by recording the cumulative effect of the adoption to accumulated deficit. We applied the new guidance to contracts that were not complete as of January&#160;1, 2018. Implementation of ASC&#160;606 did not have a material impact on our consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive substantially all of our revenue from non-exclusive license agreements with a limited number of pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of the licensee products developed or manufactured using our intellectual property and cell lines.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC&#160;606. A contract&#8217;s transaction price is allocated to each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the company&#8217;s license agreements with customers, the company typically promises to provide a license to use certain cell lines and related patents, the related know-how, and future research and development data that affect the license. We have concluded that these promises represent one performance obligation due to the highly interrelated nature of the promises. We provide the cell lines and know-how immediately upon entering into the contracts. The research and development data is provided throughout the term of the contract when and if available.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our license agreement with Precigen&#160;(Note&#160;8) included a nonrefundable upfront payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000556" name="nk:NonrefundableUpfrontPayment" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million, received when we entered into the contract in 2010. In this instance, we determined that under ASC&#160;606 it would be appropriate to recognize the initial milestone payment at a point in time, when we transferred the license. In this case, the intellectual property provided under the contract is functional intellectual property under ASC&#160;606 and was determined to be a distinct performance obligation in the context of the arrangement. Prior to adoption, the upfront payment had been initially recorded as deferred revenue and was being recognized into revenue on a straight-line basis. As a result, upon adoption of ASC&#160;606, we adjusted our accumulated deficit for the effects of recognizing revenue upfront for the initial milestone. The adjustment to accumulated deficit upon adoption was not material.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_95fd75b2-2521-4762-a09b-b5871ef33453" continuedAt="F_000449_dcnt_f586180e-b004-44c9-b681-1c90241d51ef"><ix:continuation id="F_000484_dcnt_0b335123-5cd7-4f85-8e4b-110f162d1743">

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The license agreements may include nonrefundable upfront payments, event-based milestone payments, sales-based royalty payments, or some combination of these. The event-based milestone payments represent variable consideration and we use the most likely amount method to estimate this variable consideration. Given the high degree of uncertainly around achievement of these milestones, we do not recognize revenue from these milestone payments until the uncertainty associated with these payments is resolved. We currently estimate variable consideration related to milestone payments to be <ix:nonFraction unitRef="U_iso4217USD" id="F_000557" name="nk:VariableConsiderationRelatedToMilestonePayment" contextRef="C_0001326110_20200101_20201231" decimals="-6" format="ixt-sec:numwordsen" scale="6">zero</ix:nonFraction> and, as such, <ix:nonFraction unitRef="U_iso4217USD" id="F_000558" name="us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized" contextRef="C_0001326110_20200101_20201231" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> revenue has been recognized for milestone payments. We recognize revenue from sales-based royalty payments when or as the sales occur. On a quarterly basis, we re-evaluate our estimate of milestone variable consideration to determine whether any amount should be included in the transaction price and recorded in revenue prospectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption, we changed our accounting policy from accounting for milestones payments under the milestone method to accounting for variable consideration as discussed above. The change in accounting policy did not change any amounts in the financial statements because of the significant uncertainty surrounding the estimate of variable consideration for milestone payments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have <ix:nonFraction unitRef="U_nkProduct" id="F_000559" name="nk:NumberOfProductsApprovedForCommercialSale" contextRef="C_0001326110_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> products approved for commercial sale and we have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.</p></ix:continuation><ix:nonNumeric id="F_000485" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Costs</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.</p></ix:nonNumeric><ix:nonNumeric id="F_000486" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation</span>, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.</p></ix:nonNumeric><ix:nonNumeric id="F_000487" name="nk:LitigationCostsPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000487_dcnt_7494abf8-358d-46c6-9986-f7d68fd2c84b">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expense legal fees as they are incurred.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_f586180e-b004-44c9-b681-1c90241d51ef" continuedAt="F_000449_dcnt_480c1d6b-f541-4cda-932d-d430c2819605"><ix:continuation id="F_000487_dcnt_7494abf8-358d-46c6-9986-f7d68fd2c84b">
</ix:continuation><ix:nonNumeric id="F_000488" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income or loss is composed of net income (loss) and other comprehensive income (loss). Our other comprehensive income or loss consists of unrealized gains and losses on marketable debt securities classified as available-for-sale, net of income taxes.</p></ix:nonNumeric><ix:nonNumeric id="F_000489" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and Diluted Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all periods presented, potentially dilutive securities are excluded from the computation of fully diluted loss per share as their effect is anti-dilutive. <ix:nonNumeric id="F_000494" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000494_cnt_1">The following table details those securities that have been excluded from the computation of potentially dilutive securities:</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000494_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000560" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">3,518,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000561" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">4,506,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000562" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">6,493,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000563" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">466,842</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000564" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,139,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000565" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">867,911</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding warrants</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000566" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231" decimals="INF" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000567" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231" decimals="INF" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000568" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">17,589,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000569" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">3,984,852</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000570" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">5,646,378</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000571" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001326110_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">24,950,411</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts in the table above reflect the common stock equivalents of the noted instruments.</p></ix:continuation></ix:nonNumeric><ix:nonNumeric id="F_000490" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment and Geographic Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating segments are defined as components of an enterprise (business activity from which it earns revenue and incurs expenses) for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the company&#8217;s CEO. We view our operations and manage our business as a single operating and reporting segment. As of December&#160;31, 2020 and 2019, the majority of our assets were held in the U.S. For the years ended December&#160;31, 2020, 2019 and 2018, all of our revenue was derived in the U.S.</p></ix:nonNumeric><ix:nonNumeric id="F_000491" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000491_dcnt_6c8134fa-f750-49d9-b728-630ae9abdfe5">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, the FASB issued Accounting Standards Update, or ASU, No.&#160;2018-18, <span style="font-style:italic;">Collaborative Arrangements&#160;(Topic&#160;808):&#160;Clarifying the Interaction between Topic&#160;808 and Topic&#160;606</span> (ASU&#160;2018-18). ASU&#160;2018-18 clarifies when certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic&#160;606. It also specifically addresses when the participant should be considered a customer in the context of a unit of account&#59; adds unit of account guidance in ASC&#160;808 to align with guidance in ASC&#160;606&#59; and precludes presenting revenue from a collaborative arrangement together with revenue recognized under ASC&#160;606 if the collaborative arrangement participant is not a customer. This standard is effective for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years with early adoption permitted. We adopted ASU&#160;2018-18, as required, in the quarter ended March&#160;31, 2020. We are a party to several collaboration arrangements as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, however, adoption of ASU&#160;2018-18 did not have an impact on our consolidated financial statements because the counterparties to our collaboration agreements do not meet the definition of a customer.</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000449_dcnt_480c1d6b-f541-4cda-932d-d430c2819605"><ix:continuation id="F_000491_dcnt_6c8134fa-f750-49d9-b728-630ae9abdfe5">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December&#160;2019, the FASB issued ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12,&#160;</span><span style="font-style:italic;">Simplifying the Accounting for Income Taxes</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12. The amendments in ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 include removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (e.g., discontinued operations or other comprehensive income), and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 also amends other aspects of accounting for income taxes to help simplify and promote consistent application of U.S.&#160;GAAP. The guidance is effective for interim and annual periods beginning after December&#160;15, 2020, with early adoption permitted. We early adopted ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 effective January&#160;1, 2020, and it did not have a material impact on our consolidated financial statements. Although our adoption of ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 did not have a material impact on our consolidated financial statements during the year ended December&#160;31, 2020, it may have a material impact on our consolidated financial statements in future periods due to the removal of the exceptions discussed above. The amendments related to intraperiod tax allocation and the amendment related to calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applied prospectively.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Not Yet Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, the FASB issued ASU&#160;2016&#8209;13,&#160;<span style="font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments</span>. The FASB subsequently issued amendments to ASU&#160;2016&#8209;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. For public business entities that meet the definition of a Securities and Exchange Commission, or SEC, filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December&#160;15, 2018. With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We continue to evaluate the impact that this new standard and its related amendments will have on our consolidated financial statements and we do not intend to early adopt this new standard.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.</p></ix:continuation></ix:continuation><ix:nonNumeric id="F_000450" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000450_dcnt_53f435f9-659e-47c8-b0d6-dba07e3729f1">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3. &#160;&#160;&#160;&#160;Financial Statement Details</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p><ix:nonNumeric id="F_000495" name="nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000495_dcnt_c78ac9ac-8ee0-42ce-9746-64c0294939a5">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, prepaid expenses and other current assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000572" name="nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,626</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000573" name="nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,021</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance premium financing asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000574" name="nk:InsurancePremiumFinancingAsset" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,421</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000575" name="nk:InsurancePremiumFinancingAsset" contextRef="C_0001326110_20191231" decimals="-3" scale="3">757</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000576" name="us-gaap:PrepaidInsurance" contextRef="C_0001326110_20201231" decimals="-3" scale="3">657</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000577" name="us-gaap:PrepaidInsurance" contextRef="C_0001326110_20191231" decimals="-3" scale="3">372</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000578" name="nk:PrepaidServices" contextRef="C_0001326110_20201231" decimals="-3" scale="3">607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000579" name="nk:PrepaidServices" contextRef="C_0001326110_20191231" decimals="-3" scale="3">440</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid rent</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000580" name="us-gaap:PrepaidRent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">589</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000581" name="us-gaap:PrepaidRent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">392</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest receivable - marketable debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000582" name="us-gaap:InterestReceivableCurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">473</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000583" name="us-gaap:InterestReceivableCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid supplies - with related party (Note 10)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000584" name="nk:PrepaidSuppliesWithRelatedParty" contextRef="C_0001326110_20201231" decimals="-3" scale="3">281</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000585" name="nk:PrepaidSuppliesWithRelatedParty" contextRef="C_0001326110_20191231" decimals="-3" scale="3">467</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid equipment maintenance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000586" name="nk:PrepaidEquipmentMaintenance" contextRef="C_0001326110_20201231" decimals="-3" scale="3">243</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="nk:PrepaidEquipmentMaintenance" contextRef="C_0001326110_20191231" decimals="-3" scale="3">251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid license fees</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="nk:PrepaidLicenseFees" contextRef="C_0001326110_20201231" decimals="-3" scale="3">233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="nk:PrepaidLicenseFees" contextRef="C_0001326110_20191231" decimals="-3" scale="3">78</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment deposit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="nk:LaboratoryEquipmentDeposit" contextRef="C_0001326110_20201231" decimals="-3" scale="3">66</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="nk:LaboratoryEquipmentDeposit" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related parties</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:DueFromRelatedPartiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:DueFromRelatedPartiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance claim receivables</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:InsuranceSettlementsReceivableCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:InsuranceSettlementsReceivableCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:OtherAssetsCurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">44</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="us-gaap:OtherAssetsCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">24</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,285</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
</ix:nonNumeric></ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000450_dcnt_53f435f9-659e-47c8-b0d6-dba07e3729f1" continuedAt="F_000450_dcnt_8ae87125-892b-4271-85c5-d8007b938a98"><ix:continuation id="F_000495_dcnt_c78ac9ac-8ee0-42ce-9746-64c0294939a5">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p><ix:nonNumeric id="F_000496" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, property, plant and equipment, net, consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">33,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">33,406</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,069</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,434</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,690</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000605" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,690</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,190</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,195</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &#38; fixtures</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000608" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231" decimals="-3" scale="3">415</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000609" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20191231" decimals="-3" scale="3">383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000610" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">81,044</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000611" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">79,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000612" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,117</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000613" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000614" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">53,927</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000615" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">60,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense related to property, plant and equipment was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000616" name="us-gaap:Depreciation" contextRef="C_0001326110_20200101_20201231" decimals="-5" scale="6">9.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000617" name="us-gaap:Depreciation" contextRef="C_0001326110_20190101_20191231" decimals="-5" scale="6">8.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000618" name="us-gaap:Depreciation" contextRef="C_0001326110_20180101_20181231" decimals="-5" scale="6">7.3</ix:nonFraction>&#160;million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Intangible assets, net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our intangible assets were fully amortized as of March&#160;31, 2019. Amortization expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000619" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001326110_20190101_20191231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000620" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_0001326110_20180101_20181231" decimals="-5" scale="6">2.3</ix:nonFraction>&#160;million for the years ended December&#160;31, 2019 and 2018, respectively, and is included in research and development expense on the consolidated statements of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other assets</p><ix:nonNumeric id="F_000497" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Security deposits</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000621" name="us-gaap:SecurityDeposit" contextRef="C_0001326110_20201231" decimals="-3" scale="3">481</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000622" name="us-gaap:SecurityDeposit" contextRef="C_0001326110_20191231" decimals="-3" scale="3">113</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid software license fees</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000623" name="nk:PrepaidSoftwareLicenseFeesInOtherAssets" contextRef="C_0001326110_20201231" decimals="-3" scale="3">318</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000624" name="nk:PrepaidSoftwareLicenseFeesInOtherAssets" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000625" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000626" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000627" name="nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" contextRef="C_0001326110_20201231" decimals="-3" scale="3">92</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000628" name="nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,075</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related party</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000629" name="us-gaap:DueFromRelatedPartiesNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">51</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000630" name="us-gaap:DueFromRelatedPartiesNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000631" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,121</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000632" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,386</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash is comprised of a certificate of deposit that serves as collateral for a letter of credit required by our landlord as a security deposit related to our facility in San Diego, California.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued expenses</p><ix:nonNumeric id="F_000498" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000498_dcnt_5b805fa3-3ab3-41fa-9554-33e817a15a36">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, accrued expenses consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and service fees</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000633" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,920</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000634" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">975</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued bonus</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000635" name="us-gaap:AccruedBonusesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,236</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000636" name="us-gaap:AccruedBonusesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,002</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000637" name="us-gaap:AccruedSalariesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,368</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000638" name="us-gaap:AccruedSalariesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,064</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued laboratory equipment and supplies</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000639" name="nk:AccruedLaboratoryEquipmentAndSupplies" contextRef="C_0001326110_20201231" decimals="-3" scale="3">641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000640" name="nk:AccruedLaboratoryEquipmentAndSupplies" contextRef="C_0001326110_20191231" decimals="-3" scale="3">640</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued preclinical and clinical trial costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000641" name="nk:AccruedPreclinicalAndClinicalTrialCosts" contextRef="C_0001326110_20201231" decimals="-3" scale="3">638</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000642" name="nk:AccruedPreclinicalAndClinicalTrialCosts" contextRef="C_0001326110_20191231" decimals="-3" scale="3">281</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued capital expenditures</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000643" name="nk:AccruedCapitalExpenditures" contextRef="C_0001326110_20201231" decimals="-3" scale="3">337</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000644" name="nk:AccruedCapitalExpenditures" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued franchise, sales/use and property taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000645" name="nk:AccruedFranchiseSalesUseAndPropertyTaxes" contextRef="C_0001326110_20201231" decimals="-3" scale="3">103</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000646" name="nk:AccruedFranchiseSalesUseAndPropertyTaxes" contextRef="C_0001326110_20191231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000647" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">100</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000648" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">181</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000649" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000650" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000450_dcnt_8ae87125-892b-4271-85c5-d8007b938a98"><ix:continuation id="F_000498_dcnt_5b805fa3-3ab3-41fa-9554-33e817a15a36">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other current liabilities</p><ix:nonNumeric id="F_000499" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other current liabilities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing obligation - current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000651" name="nk:FinancingObligationCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,421</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000652" name="nk:FinancingObligationCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">757</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000653" name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000654" name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000655" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,438</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000656" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001326110_20191231" decimals="-3" scale="3">775</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investment income, net</p><ix:nonNumeric id="F_000500" name="us-gaap:InvestmentIncomeTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net investment income included the following for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000657" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000658" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,643</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000659" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,317</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment (amortization expense) accretion income, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000660" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">858</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000661" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000662" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net realized (losses) gains on investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000663" name="us-gaap:RealizedInvestmentGainsLosses" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000664" name="us-gaap:RealizedInvestmentGainsLosses" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000665" name="us-gaap:RealizedInvestmentGainsLosses" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000666" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">366</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000667" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,642</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000668" name="us-gaap:InvestmentIncomeNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,857</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income includes interest from marketable debt securities, notes receivable, other assets, and interest from bank deposits. We did <ix:nonFraction unitRef="U_iso4217USD" id="F_000669" name="us-gaap:ImpairmentOfInvestments" contextRef="C_0001326110_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000670" name="us-gaap:ImpairmentOfInvestments" contextRef="C_0001326110_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000671" name="us-gaap:ImpairmentOfInvestments" contextRef="C_0001326110_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize an impairment loss on any investments during the years ended December&#160;31, 2020, 2019 and 2018.</p></ix:continuation><ix:nonNumeric id="F_000451" name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231" escape="true" continuedAt="F_000451_dcnt_88026b68-9385-4b83-8b01-a65c83f7479a">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4. &#160;&#160;&#160;&#160;Agreement and Plan of Merger with ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On <ix:nonNumeric id="F_000672" name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" contextRef="C_0001326110_20201221_20201221" format="ixt:datemonthdayyearen">December&#160;21, 2020</ix:nonNumeric>, NantKwest and ImmunityBio, Inc.&#160;(ImmunityBio) entered into an Agreement and Plan of Merger&#160;(the Merger Agreement), pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The Merger Agreement provides that a wholly owned subsidiary of NantKwest will merge with and into ImmunityBio&#160;(the Merger), with ImmunityBio continuing as the surviving company and being renamed NantCell,&#160;Inc., upon the terms and subject to the conditions therein. At the effective time of the Merger&#160;(the Effective Time), NantKwest&#8217;s name, as the parent of NantCell,&#160;Inc., will be changed to &#8220;ImmunityBio, Inc.&#8221;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Effective Time, each share of ImmunityBio common stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions as set forth in the Merger Agreement, will be converted automatically into a right to receive&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_000673" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="C_0001326110_20201221_20201221" decimals="4">0.8190</ix:nonFraction>&#160;shares of NantKwest common stock. At the Effective Time, each share of NantKwest common stock issued and outstanding immediately prior to the Effective Time, will remain an issued and outstanding share of the combined company. At the Effective Time, each outstanding option, warrant or restricted stock unit to purchase ImmunityBio common stock will be converted (using the merger exchange ratio of <ix:nonFraction unitRef="U_xbrlipure" id="F_000674" name="nk:MergerExchangeRatio" contextRef="C_0001326110_20201221_20201221" decimals="6" scale="-2">0.8190</ix:nonFraction>) into an option, warrant or restricted stock unit, respectively, on the same terms and conditions immediately prior to the Effective Time, to purchase shares of common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon consummation of the Merger, on a fully-diluted basis, ImmunityBio stockholders and NantKwest stockholders will own approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_000675" name="nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221" decimals="2" scale="-2">72</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000676" name="nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" contextRef="C_0001326110_srtOwnershipAxis_nkNantKwestMember_20201221" decimals="2" scale="-2">28</ix:nonFraction>%, respectively, of the outstanding shares of common stock of the combined company. It is estimated that, immediately following the closing date, Dr.&#160;Patrick Soon-Shiong, our Executive Chairman and principal stockholder, and his affiliates will beneficially own, in the aggregate, approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_000677" name="nk:OwnershipPercentageByKeyExecutives" contextRef="C_0001326110_srtTitleOfIndividualAxis_nkExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_20201221_20201221" decimals="2" scale="-2">82</ix:nonFraction>% of the common stock of the combined company. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following consummation of the Merger, shares of common stock of the combined company are expected to be listed on the Nasdaq Global Select Market under the symbol &#8220;IBRX&#8221;.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms and subject to the conditions set forth in the Merger Agreement, the closing of the Merger depends on a number of conditions being satisfied, including approval of the Merger by holders of a majority of the outstanding shares of NantKwest common stock as of the NantKwest record date (excluding all shares of NantKwest common stock beneficially owned by Dr.&#160;Patrick Soon&#8209;Shiong and his affiliates Cambridge Equities,&#160;LP and Chan Soon&#8209;Shiong Family Foundation or any of their respective controlled affiliates or any of the directors or executive officers of NantKwest or ImmunityBio).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;1, 2021, our Registration Statement on Form&#160;S-4, which was filed with the Securities and Exchange Commission (SEC) in connection with the Merger, was declared effective by the SEC.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000451_dcnt_88026b68-9385-4b83-8b01-a65c83f7479a">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A special meeting of the stockholders of NantKwest will be held on March&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to consider and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">vot</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on a proposal to approve the issuance of shares of common stock of NantKwest to security holders of ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to consider and vote </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on a proposal to approve the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">M</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erger.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Only holders of record of NantKwest common stock at the close of January&#160;29, 2021, will be entitled to notice of and to vote at the special meeting.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect the Merger to close in the first quarter of 2021, subject to receipt of the requisite stockholder approvals and satisfaction of other customary closing conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger is expected to be accounted for as a transaction between entities under common control as Dr.&#160;Patrick Soon-Shiong is the controlling stockholder of each of NantKwest and ImmunityBio. Upon the closing of the Merger, the net assets of ImmunityBio will be combined with those of NantKwest at their historical carrying amounts and the companies will be presented on a combined basis for all historical periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, we incurred costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000678" name="us-gaap:PaymentsForMergerRelatedCosts" contextRef="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231" decimals="-5" scale="6">6.2</ix:nonFraction>&#160;million in connection with our proposed merger with ImmunityBio, consisting of financial advisory, legal and other professional fees.</p></ix:continuation><ix:nonNumeric id="F_000452" name="us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000452_dcnt_ba554fd1-9f57-4e7f-ae10-cdbb35612c66">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5. &#160;&#160;&#160;&#160;Viracta Investment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2017, we participated in a Series&#160;B convertible preferred stock financing and invested $<ix:nonFraction unitRef="U_iso4217USD" id="F_000679" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="C_0001326110_20170331" decimals="-5" scale="6">8.5</ix:nonFraction>&#160;million in Viracta Therapeutics, Inc., or Viracta, a clinical stage drug development company, which was initially recorded at cost. In May&#160;2017, we executed an exclusive worldwide license with Viracta to develop and commercialize Viracta&#8217;s proprietary histone deacetylase inhibitor drug candidate for use in combination with natural killer cell therapy and possibly additional therapies. See Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements &#8211; Royalties and In-licensing Agreements &#8211; Viracta License Agreement</span>, for further information.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2018, Viracta executed a 2018&#160;Note and Warrant Purchase Agreement with existing and new investors, including us. The initial closing under the Purchase Agreement occurred in June&#160;2018, at which point we purchased a convertible note for $<ix:nonFraction unitRef="U_iso4217USD" id="F_000680" name="nk:PurchaseOfConvertibleNoteUponConversion" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#8217;s common shares. The convertible note accrued interest at <ix:nonFraction unitRef="U_xbrlipure" id="F_000682" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180630" decimals="2" scale="-2">8</ix:nonFraction>% and had a <span style="-sec-ix-hidden:F_000684">one-year</span> maturity date. In September&#160;2018, a milestone closing under the Purchase Agreement occurred, at which point we purchased an additional convertible note for $<ix:nonFraction unitRef="U_iso4217USD" id="F_000681" name="nk:PurchaseOfConvertibleNoteUponConversion" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#8217;s common shares. The convertible note accrued interest at <ix:nonFraction unitRef="U_xbrlipure" id="F_000683" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180930" decimals="2" scale="-2">8</ix:nonFraction>% and had a <span style="-sec-ix-hidden:F_000685">one-year</span> maturity date. We classified the convertible notes as held-to-maturity notes receivable on the consolidated balance sheets. Effective January&#160;31, 2019, the notes, together with accrued interest then outstanding, were converted to Series&#160;B preferred stock resulting in an increase to our investment in Viracta&#8217;s Series&#160;B convertible preferred stock of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000686" name="us-gaap:PreferredStockValue" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesBPreferredStockMember_20190131" decimals="-5" scale="6">0.8</ix:nonFraction>&#160;million. In May&#160;2019, we exercised warrants to acquire <ix:nonFraction unitRef="U_xbrlishares" id="F_000687" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190531" decimals="INF" format="ixt:numdotdecimal">253,120</ix:nonFraction>&#160;shares of Viracta common stock.</p><ix:nonNumeric id="F_000492" name="us-gaap:InvestmentPolicyTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the level of equity investment at risk, Viracta is not a VIE and therefore is not consolidated under the VIE model. In addition, we do not hold a controlling financial interest in Viracta, and therefore we do not consolidate Viracta under the voting interest model. As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, we have elected to apply the measurement alternative under ASC&#160;321, pursuant to which we measure our investment in Viracta at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions.</p></ix:nonNumeric>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, our fair value assessment indicated that the recent offering of Viracta&#8217;s Series&#160;E preferred shares, at a lower offering price per share than the per share carrying amount of our investment in Viracta, is a directional indicator representing an observable price change in an orderly transaction for a similar investment. On December&#160;31, 2020, we reduced the carrying value by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000688" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_nkOtherIncomeAndExpenseNetMember_20200101_20201231" decimals="-5" scale="6">1.4</ix:nonFraction>&#160;million due to the observable price change, which has been included in other income and expense, net, on the consolidated statements of operations. On a cumulative basis, we have recognized a reduction in carrying value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000689" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" contextRef="C_0001326110_20201231" decimals="-5" scale="6">1.4</ix:nonFraction>&#160;million. At December&#160;31, 2020, the carrying value of our investment in Viracta, which is reflected in equity investment on the consolidated balance sheets, totaled $<ix:nonFraction unitRef="U_iso4217USD" id="F_000690" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="C_0001326110_20201231" decimals="-5" scale="6">7.8</ix:nonFraction>&#160;million.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000452_dcnt_ba554fd1-9f57-4e7f-ae10-cdbb35612c66">
</ix:continuation><ix:nonNumeric id="F_000453" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000453_dcnt_fb7e9665-2994-420c-9b6c-71b35fdc75cd">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6. &#160;&#160;&#160;&#160;Financial Instruments &#8211; Investments in Marketable Debt Securities</p><ix:nonNumeric id="F_000501" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000703">0.3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000691" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000694" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000697" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000700" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000704">0.3</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000692" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000695" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000698" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000701" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">0.3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000693" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000696" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000699" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_20201231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000702" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2019, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000706" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000713" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000720" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000727" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000707" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,007</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000714" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000721" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000728" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,007</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000708" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,752</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000715" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000722" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000729" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000709" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000716" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000723" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000730" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000710" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000717" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000724" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000731" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000711" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000718" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000725" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000732" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000712" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,642</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000719" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001326110_20191231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000726" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001326110_20191231" decimals="-3" scale="3">11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000733" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000502" name="us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated unrealized losses on debt securities classified as available-for-sale that have been in a continuous loss position for less than <span style="-sec-ix-hidden:F_000734"><span style="-sec-ix-hidden:F_000736">12&#160;months and for more than 12&#160;months</span></span> at December&#160;31, 2020 and 2019, were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000738" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,762</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000740" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000742" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000744" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000739" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,762</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000741" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001326110_20201231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000743" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000745" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000746" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,021</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000749" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000752" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000755" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000747" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000750" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000753" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000756" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000748" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,021</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000751" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" contextRef="C_0001326110_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000754" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,245</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000757" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" contextRef="C_0001326110_20191231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, <ix:nonFraction unitRef="U_nkSecurity" id="F_000758" name="us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231" decimals="INF">34</ix:nonFraction> of the securities were in an unrealized loss position. We evaluated our securities for other-than-temporary impairment and concluded that the decline in value was primarily caused by current economic and market conditions. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases. Therefore, we did not recognize any other-than-temporary impairment loss during the years ended December&#160;31, 2020, 2019 and 2018.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000453_dcnt_fb7e9665-2994-420c-9b6c-71b35fdc75cd">
<ix:nonNumeric id="F_000503" name="us-gaap:ScheduleOfRealizedGainLossTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized realized gains and losses on sales of available-for-sale debt securities as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains (Losses)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000759" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGains" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000762" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">13</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000765" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000760" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGains" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000763" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000766" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000761" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGains" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000764" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000767" name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000454" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7. &#160;&#160;&#160;&#160;Fair Value Measurements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as an exit price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Authoritative guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recurring Valuations</p><ix:nonNumeric id="F_000504" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities measured at fair value on a recurring basis are summarized below at December&#160;31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000768" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000769" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000770" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000771" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000772" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000773" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000774" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000775" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000776" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">66,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000777" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000778" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000779" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000780" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000781" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000782" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000783" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000784" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000785" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000786" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000787" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000788" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,007</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000789" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000790" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,007</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000791" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000792" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000793" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000794" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,748</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000795" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000796" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000797" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000798" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000799" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000800" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">53,149</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000801" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,508</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000802" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000803" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Non-recurring Valuations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-financial assets and liabilities are recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. There were no material non-financial assets and liabilities deemed to be other-than-temporarily impaired and measured at fair value on a non-recurring basis for the years ended December&#160;31, 2020, 2019 and 2018.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p><ix:nonNumeric id="F_000455" name="nk:CollaborationAndLicenseAgreementsTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000455_dcnt_772a0b76-52d0-46ae-b791-89d1e04b9512">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8. &#160;&#160;&#160;&#160;Collaboration and License Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaborative Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are&#160;(i)&#160;active participants in the activity, and (ii)&#160;exposed to significant risks and rewards dependent on the commercial success of the activity.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000455_dcnt_772a0b76-52d0-46ae-b791-89d1e04b9512" continuedAt="F_000455_dcnt_27c02df7-c790-455c-849a-1aaef6bab31e">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into the following collaborative arrangements with ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inc., </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as described below. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio is a related party, as it is </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Joint COVID&#8209;19 Collaboration Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a definitive agreement, which we refer to as the Collaboration Agreement, with ImmunityBio to pursue collaborative joint development, manufacturing and marketing of certain COVID&#8209;19 therapeutics and vaccines. The terms of the Collaboration Agreement supersede and replace the terms of the binding term sheet executed on May&#160;22, 2020. Through their efforts, the parties agreed to jointly develop ceNK, haNK, mesenchymal stem cells&#160;(MSC), adenovirus constructs&#160;(hAd5), and N&#8209;803, a novel IL&#8209;15 superagonist fusion protein, for the prevention and treatment of SARS&#8209;CoV&#8209;2 viral infections and associated conditions in humans, including without limitation, COVID&#8209;19. Pursuant to the Collaboration Agreement, we have contributed our ceNK, haNK, and MSC product candidates and certain of our manufacturing capabilities, and ImmunityBio has contributed their hAd5 and N&#8209;803 product candidates. hAd5 has been developed as a vaccine, and ceNK, haNK, MSC and N&#8209;803 have each been developed as therapeutics for treating COVID&#8209;19 at various stages of infection.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From and after the effective date of the Collaboration Agreement, the parties will share equally in all costs relating to developing and manufacturing of the product candidates globally with the exception of certain laboratory equipment purchases that will be borne solely by us. With the exception of N&#8209;803, we will be primarily responsible for the manufacture of each product. Each party will be responsible for the regulatory affairs and the commercialization relating to its contributed products. The global net profits from the collaboration products will be shared <ix:nonFraction unitRef="U_xbrlipure" id="F_000804" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="2" scale="-2">60</ix:nonFraction>%/<ix:nonFraction unitRef="U_xbrlipure" id="F_000805" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="2" scale="-2">40</ix:nonFraction>% in favor of the party contributing the product on which the sales are based except if the parties mutually agree because of certain circumstances. All net profits from sales of combined collaboration products will be shared equally. This collaboration is supervised by a joint steering committee, which is comprised of an equal number of representatives from both parties. The term of the agreement will be <span style="-sec-ix-hidden:F_000806">five&#160;years</span> and it is renewable for an additional <span style="-sec-ix-hidden:F_000807">five&#160;year</span> period upon mutual agreement. Each party will also have a right to terminate in the event of material breach, bankruptcy, or insolvency.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, joint research activity under the Collaboration Agreement totaled $<ix:nonFraction unitRef="U_iso4217USD" id="F_000808" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">8.4</ix:nonFraction>&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000809" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">5.0</ix:nonFraction>&#160;million to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000810" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">3.4</ix:nonFraction>&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#8209;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#8209;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $<ix:nonFraction unitRef="U_iso4217USD" id="F_000811" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231" decimals="-5" scale="6">3.3</ix:nonFraction>&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cost Sharing Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio and its subsidiaries to co-sponsor and conduct certain combination clinical trials (each a Joint Study) pursuant to clinical trial protocols wherein at least one investigational agent is a proprietary therapeutic drug candidate owned or controlled by NantKwest and at least one other investigational agent is a proprietary therapeutic drug candidate owned or controlled by ImmunityBio. Prior to initiating any activities for a Joint Study the parties agreed to enter into written work orders describing, amongst other things, development and management responsibilities, allocation of Joint Study costs and expenses, regulatory responsibilities, and any other matters relating to the Joint Study.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Cost Allocation Agreement, each of ImmunityBio and the company will receive exclusive rights to any new intellectual property developed that relates solely to its respective study drug, and the parties will have joint co-equal rights in any other intellectual property. The Cost Allocation Agreement expires on June&#160;22, 2022 with the option to renew for additional successive <span style="-sec-ix-hidden:F_000812">one-year</span> terms, but work orders for any joint studies still in process at the time of termination will continue until the applicable study is completed.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and ImmunityBio are splitting certain costs related to these joint studies equally in accordance with the terms of the Cost Allocation Agreement and related work orders. Shared Joint Study costs include cost related to conducting the Joint Study development activities, such as personnel related costs, as well as all costs associated with regulatory matters. Costs and expenses incurred in connection with the development, manufacturing, supply, delivery, and pre-patient administration dosing mechanism of each party&#8217;s study drug, are excluded from the shared Joint Study costs.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000455_dcnt_27c02df7-c790-455c-849a-1aaef6bab31e" continuedAt="F_000455_dcnt_ddaf8f91-4a2b-4b55-8434-2f81627b50ae">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we executed Work Order Number One with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number One, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the parties </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> conduct</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a clinical trial pursuant to the protocol titled QUILT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.063:</span><span style="font-style:italic;">&#160;A phase&#160;2 study of combination therapy with an IL</span><span style="font-style:italic;">&#8209;</span><span style="font-style:italic;">15 superagonist&#160;(N</span><span style="font-style:italic;">&#8209;803), off-the-shelf CD16</span><span style="font-style:italic;">&#8209;targeted natural killer cells&#160;(haNK), and avelumab without cytotoxic chemotherapy in subjects with Merkel Cell Carcinoma&#160;(MCC) that has progressed on or after treatment with a checkpoint inhibitor</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The ImmunityBio study drug included in th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">J</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oint </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tudy is ImmunityBio&#8217;s proprietary IL</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15 superagonist known as N</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">803</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and our study drug is our proprietary </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">off-the-shelf</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> CD16-targeted natural kil</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ler cell therapy known as haNK. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the sponsor of this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">J</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oint </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tudy for purposes of regulatory matters, including submissions, correspondence, and communications. Additionally, we are </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designated as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the contracting party to execute agreements with third and related part</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ies relating to the Joint Study</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2020, but effective on June&#160;22, 2020, we executed Work Order Number Two with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number Two, the parties are conducting a clinical trial pursuant to the protocol titled QUILT&#160;88:&#160;<span style="font-style:italic;">Open-label, randomized, comparative phase&#160;2 study of combination immunotherapy with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer</span>. The ImmunityBio study drugs included in the joint study are ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist&#160;(N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin), and our study drug is PD&#8209;L1.t&#8209;haNK. ImmunityBio is the sponsor of this Joint Study for purposes of regulatory matters, including submissions, correspondence, and communications with the FDA. Additionally, ImmunityBio is designated as the contracting party to execute agreements with third and related parties relating to this Joint Study.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000813" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231" decimals="-5" scale="6">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000814" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231" decimals="0" format="ixt:numdotdecimal">35,700</ix:nonFraction>, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, we owed ImmunityBio $<ix:nonFraction unitRef="U_iso4217USD" id="F_000815" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20201231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million related to the Cost Allocation Agreement. As of December&#160;31, 2019, <ix:nonFraction unitRef="U_iso4217USD" id="F_000816" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20191231" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> balances were due between the parties with respect to the Cost Allocation Agreement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Royalties and In-licensing Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Viracta License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May&#160;2017, we entered into an agreement with Viracta under which we were granted exclusive worldwide rights to Viracta&#8217;s phase&#160;II drug candidate, VRx&#8209;3996, for use in combination with our platform of NK&#160;cell therapies. In consideration for the license, we are obligated to pay to Viracta&#160;(i)&#160;mid-single digit percentage royalties of net sales of licensed products for therapeutic use&#59; and (ii)&#160;milestone payments ranging from $<ix:nonFraction unitRef="U_iso4217USD" id="F_000817" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMinimumMember_20170501_20170531" decimals="INF" scale="6">10.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000818" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_20170501_20170531" decimals="INF" scale="6">25.0</ix:nonFraction>&#160;million for various regulatory approvals and cumulative net sales levels. We may terminate the agreement, at our sole discretion, in whole or on a product by product and/or country by country basis, at any time upon <ix:nonNumeric id="F_000819" name="nk:LicenseAgreementTerminationNoticePeriod" contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_20170501_20170531" format="ixt-sec:durday">90</ix:nonNumeric>&#160;days&#8217;&#160;prior written notice. In addition, either party may terminate the agreement in the event of a material breach or for bankruptcy of the other party.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fox Chase Cancer Center License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2004 and amended in 2008, we entered into an exclusive license agreement with Fox Chase Cancer Center, or Fox Chase, for the exclusive, worldwide right to certain patents and know-how pertaining to CD16 receptor bearing NK&#8209;92&#160;cell lines. In consideration for this exclusive license, we agreed to pay Fox Chase&#160;(i)&#160;low single-digit percentage royalties on net sales of licensed products for therapeutic and diagnostic use&#59; and (ii)&#160;mid-twenties percentage royalties on any compensation we receive from sublicensees.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Rush University Medical Center License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2004, we entered into a <ix:nonNumeric id="F_000820" name="nk:PeriodOfLicenseAgreement" contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231" format="ixt-sec:duryear">12</ix:nonNumeric>-year licensing agreement with Rush University Medical Center for the exclusive rights to license and grant sublicenses of certain intellectual property related to clinical use of NK&#8209;92. We are required to pay low to mid-single digit percentage royalties on net sales depending upon the various fields of studies and other factors. We were required to pay a minimum annual royalty of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000821" name="nk:MinimumAnnualRoyaltyPayment" contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231" decimals="INF" format="ixt:numdotdecimal">25,000</ix:nonFraction>. The Rush University Medical Center License Agreement also provides for payments in the aggregate amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000822" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231" decimals="-5" scale="6">2.5</ix:nonFraction>&#160;million upon the company achieving various milestones, including upon&#160;(i)&#160;the completion of phase&#160;II clinical trial associated with the licensed intellectual property&#59; (ii)&#160;the approval by the FDA of a new drug application for a licensed product&#59; and (iii)&#160;the first year that sales of the licensed product equals or exceeds $<ix:nonFraction unitRef="U_iso4217USD" id="F_000823" name="nk:MinimumSalesMilestoneOfLicenseForFirstYear" contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231" decimals="INF" scale="6">0.3</ix:nonFraction>&#160;million. The license had a term of 12&#160;years from 2006, the year in which royalty payments were first made, and included customary termination rights for both parties. Beginning in 2018, this license converted to a perpetual, irrevocable, fully paid, royalty-free, exclusive license. No milestones were met during the years ended December&#160;31, 2020, 2019 and 2018.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000455_dcnt_ddaf8f91-4a2b-4b55-8434-2f81627b50ae">

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Out-Licensing Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Precigen (formerly known as Intrexon) License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February&#160;2010, we entered into a <ix:nonNumeric id="F_000824" name="nk:LicenseAgreementTerm" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" format="ixt-sec:duryear">17</ix:nonNumeric>-year license agreement with Precigen Corporation, Inc., or Precigen, pursuant to which we granted to Precigen a non-exclusive, worldwide, sublicensable license to research and sell products under certain patents relating to modified NK&#8209;92&#160;cells that express Precigen&#8217;s proprietary gene sequences for use as a therapeutic and prophylactic agent in humans in specified therapeutic areas. In consideration for the license agreement, Precigen paid us a one-time fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000825" name="nk:AgreementOneTimeFee" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million. Prior to our adoption of ASC&#160;606 at the beginning of 2018, this upfront payment had initially been recorded as deferred revenue and was being recognized into revenue on a straight-line basis. Upon our adoption of ASC&#160;606, we adjusted our accumulated deficit in an amount equal to the then remaining deferred revenue after concluding that under ASC&#160;606 the upfront payment would have been recognized when the license was transferred in 2010. Precigen will pay the following milestone payments:&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000832" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkINDFilingMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million upon the first IND filing&#59; $<ix:nonFraction unitRef="U_iso4217USD" id="F_000833" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseTwoMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million upon the commencement of the first phase&#160;II clinical trial&#59; $<ix:nonFraction unitRef="U_iso4217USD" id="F_000834" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseThreeMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million upon the commencement of the first phase&#160;III clinical trial&#59; and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000835" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkCommercialSaleRelatedToLicensedProductsMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million upon the first commercial sale relating to the licensed products. Precigen is obligated to pay us a low single digit percentage royalty based on net sales of the licensed products by Precigen and a mid-teen percentage royalty based on revenues received by Precigen in connection with sublicenses of the licensed products. <ix:nonFraction unitRef="U_iso4217USD" id="F_000826" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000827" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000828" name="nk:MilestonePaymentAmount" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> milestone payments were due or received in the years ended December&#160;31, 2020, 2019 and 2018, and, therefore, we did <ix:nonFraction unitRef="U_iso4217USD" id="F_000829" name="us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000830" name="us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000831" name="us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized" contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t record any milestone revenue for any of those years on the consolidated statements of operations.</p></ix:continuation><ix:nonNumeric id="F_000456" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000456_dcnt_37623d3a-09be-4304-a592-342429b4ff39">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9. &#160;&#160;&#160;&#160;Commitments and Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Securities Litigation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, a putative securities class action complaint captioned <span style="font-style:italic;">Sudunagunta v. NantKwest, Inc., et al.</span>, No. 16&#8209;cv&#8209;01947 was filed in federal district court for the Central District of California related to the company&#8217;s restatement of certain interim financial statements for the periods ended June&#160;30, 2015 and September&#160;30, 2015. A number of similar putative class actions were filed in federal and state court in California. The actions originally filed in state court were removed to federal court, and the various related actions were consolidated. Plaintiffs asserted causes of action for alleged violations of Sections&#160;11 and 15 of the Securities Act of 1933 and Sections&#160;10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule&#160;10b&#8209;5 promulgated thereunder. Plaintiffs sought unspecified damages, costs and attorneys&#8217; fees, and equitable/injunctive or other relief on behalf of putative classes of persons who purchased or acquired the company&#8217;s securities during various time periods from July&#160;28, 2015 through March&#160;11, 2016. In September&#160;2017, the court denied defendants' motion to dismiss the third amended consolidated complaint. On August&#160;13, 2018, the district court granted plaintiffs&#8217; motions for class certification and to strike plaintiffs&#8217; claims under the Securities Exchange Act of 1934 and Rule&#160;10b&#8209;5. On August&#160;24, 2018, at the district court&#8217;s direction, plaintiffs filed a fourth amended consolidated complaint. On August&#160;27, 2018, defendants petitioned the U.S. Court of Appeals for the Ninth Circuit to authorize interlocutory appeal of the class certification order. On September&#160;7, 2018, defendants answered the fourth amended consolidated complaint. On September&#160;21, 2018, the parties informed the Ninth Circuit that they had reached a settlement in principle, and the parties moved to stay appellate proceedings. On September&#160;24, 2018, the parties notified the district court that they had reached a settlement in principle. On November&#160;9, 2018, the plaintiffs filed an unopposed motion for preliminary approval of the settlement and notice to class members. On January&#160;9, 2019, the district court granted the motion for preliminary approval. A final approval hearing was held on April&#160;29, 2019, and the district court granted final approval and entered judgment on May&#160;31, 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the settlement, we paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_000836" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" contextRef="C_0001326110_20190101_20191231" decimals="-5" scale="6">12.0</ix:nonFraction>&#160;million to the plaintiffs as full and complete settlement of the litigation. We were responsible for $<ix:nonFraction unitRef="U_iso4217USD" id="F_000837" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million of the settlement amount, which was recognized in selling, general and administrative expense during the year ended December&#160;31, 2018, while the remaining $<ix:nonFraction unitRef="U_iso4217USD" id="F_000838" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" contextRef="C_0001326110_us-gaapReinsurancePolicyTypeAxis_nkDirectorsAndOfficersInsurancePolicyMember_20190101_20191231" decimals="-5" scale="6">10.8</ix:nonFraction>&#160;million was fully funded by our insurance carriers under our directors&#8217; and officers&#8217; insurance policy. We and the insurance carriers paid the settlement amount into a settlement fund during the year ended December&#160;31, 2019. Subsequent to receiving final approval of the settlement on May&#160;31, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000456_dcnt_37623d3a-09be-4304-a592-342429b4ff39" continuedAt="F_000456_dcnt_e980b6b1-a995-48e8-b9b2-207a69c8122b">

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stipulation of Settlement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In early April&#160;2019, following board approval, we entered into a settlement agreement, or the Stipulation of Settlement, with three&#160;stockholders of the company, each of whom had submitted a stockholder demand for the board to take action to remedy purported harm to the company resulting from certain alleged wrongful conduct concerning, among other things, disclosures about Dr.&#160;Soon-Shiong&#8217;s compensation and a related-party lease agreement. The Stipulation of Settlement called for us to adopt certain governance changes, and for the three&#160;stockholders to file a stockholder derivative action in the Superior Court of the State of California, County of San Diego, followed by an application for court approval of the Stipulation of Settlement. On May&#160;31, 2019, the court entered an order preliminarily approving the Stipulation of Settlement and scheduling the final settlement hearing for August&#160;9, 2019. Pursuant to the Stipulation of Settlement, we have provided stockholders with notice of the settlement and the final settlement hearing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the Stipulation of Settlement, which received final approval by the court on August&#160;9, 2019, we paid an attorney&#8217;s fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000839" name="us-gaap:LegalFees" contextRef="C_0001326110_20190809_20190809" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million to the plaintiffs as part of the settlement. Of that amount, we were responsible for half, which was recognized in selling, general and administrative expense on the consolidated statements of operations during the year ended December&#160;31, 2019, while the other half was funded by our insurance carrier. We and the insurance carrier paid the settlement amount into a settlement fund in June&#160;2019. Subsequent to receiving final approval of the settlement on August&#160;9, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Insurance Recoveries</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have reflected our right to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund. The amount of such receivable recorded at December&#160;31, 2019 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000841" name="us-gaap:InsuranceSettlementsReceivable" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20191231" decimals="0" format="ixt:numdotdecimal">34,000</ix:nonFraction>, which is included in prepaid expenses and other current assets on our consolidated balance sheets. There were <ix:nonFraction unitRef="U_iso4217USD" id="F_000840" name="us-gaap:InsuranceSettlementsReceivable" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> such receivables recorded as of December&#160;31, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contractual Obligations - Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted the new lease accounting guidance as discussed in further detail in Note&#160;2. The most significant change requires us to record the present value of operating lease payments as right-of-use assets and lease liabilities on our balance sheets. We adopted the new guidance using the simplified transition approach. As a result, reporting periods beginning on January&#160;1, 2019 are presented under the new guidance, while periods prior to January&#160;1, 2019 continue to be reported in accordance with our historical accounting.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adoption of the new lease accounting guidance had a substantial impact on our balance sheet. The most significant impacts were&#160;(1)&#160;the recognition of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000842" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101" decimals="-5" scale="6">13.5</ix:nonFraction>&#160;million of operating lease right-of-use assets, net, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000843" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101" decimals="-5" scale="6">16.4</ix:nonFraction>&#160;million of operating lease liabilities, and (2)&#160;the derecognition of assets and liabilities associated with build-to-suit leases under ASC&#160;840, resulting in the derecognition of property, plant and equipment, net, of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000844" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101" decimals="-5" sign="-" scale="6">6.6</ix:nonFraction>&#160;million and net adjustments to related liabilities of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000845" name="us-gaap:Liabilities" contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101" decimals="-5" sign="-" scale="6">5.7</ix:nonFraction>&#160;million). The build-to-suit leases were recorded as normal operating leases under ASC&#160;842. The difference between the excess of build-to-suit related liabilities and assets of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000846" name="us-gaap:AssetsNet" contextRef="C_0001326110_srtCumulativeEffectPeriodOfAdoptionAxis_srtCumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101" decimals="-5" sign="-" scale="6">0.9</ix:nonFraction>&#160;million was recorded as an increase to our accumulated deficit. The cumulative-effect adjustment had no tax impact due to the valuation allowance against the gross deferred tax asset less reversing deferred tax liabilities. Adoption of this standard had no material impact on our results of operations and cash flows.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Substantially all of our operating lease right-of-use assets and operating lease liabilities relate to facilities leases. As of December&#160;31, 2020, we lease:&#160;(i)&#160;a&#160;research facility and office space in San Diego, California&#59; (ii)&#160;a research and manufacturing space in Culver City, California, from a related party&#59; (iii)&#160;research and manufacturing facilities in El Segundo, California, also from related parties&#59; (iv)&#160;a research facility in Torrance, California, and (v)&#160;a research facility in Woburn, Massachusetts. See Note&#160;10,&#160;<span style="font-style:italic;">Related Party Agreements</span>, for further information.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our leases generally have initial terms ranging from <span style="-sec-ix-hidden:F_000847">two to ten&#160;years</span> and often include one or more options to renew. These renewal terms can extend the lease term from <span style="-sec-ix-hidden:F_000849">one to three&#160;years</span>, and are included in the lease term when it is reasonably certain that we will exercise the option. These operating leases are included in operating lease right-of-use assets, net, on the consolidated balance sheets, and represent the right to use the underlying asset for the lease term. Our obligations to make lease payments are included in current and non-current operating lease liabilities on the consolidated balance sheets.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000456_dcnt_e980b6b1-a995-48e8-b9b2-207a69c8122b" continuedAt="F_000456_dcnt_0398c4c5-13fd-4dd5-98e8-8748d216dfbe">
<ix:nonNumeric id="F_000505" name="nk:ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operating right-of-use assets and lease liabilities as of December&#160;31, 2020 and 2019, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease right-of-use assets, net (including amounts</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000851" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000852" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,729</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Short-term lease liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000853" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000854" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,206</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000855" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,814</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000856" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,885</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000857" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,314</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000858" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,091</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000506" name="us-gaap:LeaseCostTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of lease expense for the years ended December&#160;31, 2020 and 2019 consist of (in&#160;thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000859" name="us-gaap:OperatingLeaseCost" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,655</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000860" name="us-gaap:OperatingLeaseCost" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,898</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000861" name="us-gaap:VariableLeaseCost" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,566</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000862" name="us-gaap:VariableLeaseCost" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Total lease costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000863" name="us-gaap:LeaseCost" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,221</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000864" name="us-gaap:LeaseCost" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,113</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rental expenses for operating leases during the year ended December&#160;31, 2018, excluding common-area maintenance, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000865" name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="C_0001326110_20180101_20181231" decimals="-5" scale="6">2.8</ix:nonFraction>&#160;million.</p><ix:nonNumeric id="F_000507" name="nk:ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid during the years ended December&#160;31, 2020 and 2019 for amounts included in the measurement of lease liabilities is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating cash flows for operating leases</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000866" name="us-gaap:OperatingLeasePayments" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,345</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000867" name="us-gaap:OperatingLeasePayments" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average remaining lease term as of December&#160;31, 2020 and 2019 was <ix:nonNumeric id="F_000868" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001326110_20201231" format="ixt-sec:duryear">3.2</ix:nonNumeric>&#160;years and <ix:nonNumeric id="F_000869" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001326110_20191231" format="ixt-sec:duryear">4.5</ix:nonNumeric>&#160;years, respectively. The weighted-average discount rate used in determining the present value of operating lease liabilities as of December&#160;31, 2020 and 2019 was <span><ix:nonFraction unitRef="U_xbrlipure" id="F_000870" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001326110_20201231" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000871" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001326110_20191231" decimals="2" scale="-2">9</ix:nonFraction></ix:nonFraction>%</span>.</p><ix:nonNumeric id="F_000508" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000508_dcnt_fc1b3489-447d-4158-84a7-9d4194babf06">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum lease payments as of December&#160;31, 2020, including $<ix:nonFraction unitRef="U_iso4217USD" id="F_000872" name="nk:OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" contextRef="C_0001326110_20200101_20201231" decimals="-5" scale="6">3.9</ix:nonFraction>&#160;million related to options to extend lease terms that are reasonably certain of being exercised, are presented in the following table (in thousands). Common area maintenance costs and taxes are not included in these payments.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years ending December 31:</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases (a)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000873" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,563</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000874" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000875" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000876" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,083</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000877" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000878" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="C_0001326110_20201231" decimals="-3" scale="3">614</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000879" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,527</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000880" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000881" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,314</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
</ix:nonNumeric></ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000456_dcnt_0398c4c5-13fd-4dd5-98e8-8748d216dfbe"><ix:continuation id="F_000508_dcnt_fc1b3489-447d-4158-84a7-9d4194babf06">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a related party&#160;(Note&#160;10), whereby we leased approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000882" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930" decimals="INF" format="ixt:numdotdecimal">6,901</ix:nonFraction>&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. <ix:nonNumeric id="F_000883" name="us-gaap:LesseeOperatingLeaseDescription" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231">The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional <span style="-sec-ix-hidden:F_000884">one-year</span> term through July&#160;2023. The monthly fixed charge related to the agreement is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000885" name="nk:MonthlyFixedCharge" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million, a portion of which is subject to annual increases of <ix:nonFraction unitRef="U_xbrlipure" id="F_000886" name="nk:AnnualPercentageIncreasesToMonthlyFixedCharge" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930" decimals="2" scale="-2">3</ix:nonFraction>% which began in <span style="-sec-ix-hidden:F_000888">November&#160;2020</span>.</ix:nonNumeric> In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. At inception of the lease we recognized an increase of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000887" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930" decimals="-5" scale="6">4.0</ix:nonFraction>&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August&#160;2018, NantBio, Inc., or NantBio, a&#160;related party (Note&#160;10), assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#8217;s laboratory and vivarium premises. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000889" name="nk:RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">0.9</ix:nonFraction>&#160;million, and paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_000890" name="nk:RelatedPartyTransactionAmountPaidToRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million directly to the third party for an aggregate value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000891" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">1.4</ix:nonFraction>&#160;million. The assigned agreement is for a term of <span style="-sec-ix-hidden:F_000892">ten&#160;years</span> and expires in <ix:nonNumeric id="F_000893" name="nk:RelatedPartyAgreementExpirationMonthAndYear" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" format="ixt:datemonthyearen">June&#160;2027</ix:nonNumeric>. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2016, we entered into a lease agreement with 605&#160;Doug St,&#160;LLC, a related party&#160;(Note&#160;10), for approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000894" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930" decimals="INF" format="ixt:numdotdecimal">24,250</ix:nonFraction>&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. <ix:nonNumeric id="F_000895" name="us-gaap:LesseeOperatingLeaseDescription" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional <span style="-sec-ix-hidden:F_000896">three&#160;year</span> term through July&#160;2026. The monthly rent is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000897" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million with annual increases of <ix:nonFraction unitRef="U_xbrlipure" id="F_000898" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930" decimals="2" scale="-2">3</ix:nonFraction>% beginning in <span style="-sec-ix-hidden:F_000899">July&#160;2017</span>.</ix:nonNumeric></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, we entered into a lease agreement for an approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000900" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331" decimals="INF" format="ixt:numdotdecimal">7,893</ix:nonFraction>&#160;square foot facility in Woburn, Massachusetts, for a research and development laboratory, related office and other related uses. The initial lease term ran for <ix:nonNumeric id="F_000901" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331" format="ixt-sec:durmonth">48</ix:nonNumeric>&#160;months from <ix:nonNumeric id="F_000902" name="nk:LeaseCommencementDate" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160301_20160331" format="ixt:datemonthdayyearen">April&#160;29, 2016</ix:nonNumeric> through May&#160;31, 2020. <ix:nonNumeric id="F_000907" name="nk:PeriodOfLicenseAgreementDescription" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20200101_20201231">In June&#160;2016, the lease was amended to add <ix:nonFraction unitRef="U_utrsqft" id="F_000903" name="nk:AdditionToNumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630" decimals="INF">260</ix:nonFraction>&#160;square feet, for a total of <ix:nonFraction unitRef="U_utrsqft" id="F_000904" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630" decimals="INF" format="ixt:numdotdecimal">8,153</ix:nonFraction>&#160;square feet. Base rent for the initial term of the lease was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000905" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630" decimals="0" format="ixt:numdotdecimal">19,000</ix:nonFraction>&#160;per&#160;month with a $<ix:nonFraction unitRef="U_iso4217USD_utrsqft" id="F_000906" name="nk:AnnualBaseRentIncreasePerSquareFoot" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630" decimals="INF">1</ix:nonFraction>&#160;per&#160;square foot annual increase on each anniversary date.</ix:nonNumeric> In August&#160;2019, we exercised our right pursuant to the lease agreement to extend the term of the lease for an additional <span style="-sec-ix-hidden:F_000908">two&#160;years</span> through <ix:nonNumeric id="F_000909" name="nk:LeaseAgreementExtendedPeriod" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190801_20190831" format="ixt:datemonthdayyearen">May&#160;31, 2022</ix:nonNumeric>. Consequently, in August&#160;2019 we recognized an increase of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000910" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190701_20190930" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets. Base rent for the extended term of the lease is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000911" name="nk:BaseMonthlyRent" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601" decimals="0" format="ixt:numdotdecimal">25,800</ix:nonFraction>&#160;per&#160;month with an annual increase of <ix:nonFraction unitRef="U_xbrlipure" id="F_000912" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601" decimals="2" scale="-2">3</ix:nonFraction>% on June&#160;1,&#160;2021.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, we entered into a facility license agreement with NantWorks LLC, or NantWorks, a related party&#160;(Note&#160;10), for approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000913" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130" decimals="INF" format="ixt:numdotdecimal">9,500</ix:nonFraction>&#160;square feet of office space in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. <ix:nonNumeric id="F_000914" name="nk:PeriodOfLicenseAgreementDescription" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231">The initial license was effective from May&#160;2015 through December&#160;2020. Base monthly rent for the initial lease term was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000915" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130" decimals="0" format="ixt:numdotdecimal">47,000</ix:nonFraction>, with annual increases of <ix:nonFraction unitRef="U_xbrlipure" id="F_000916" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130" decimals="2" scale="-2">3</ix:nonFraction>% beginning in <span style="-sec-ix-hidden:F_000917">January&#160;2017</span></ix:nonNumeric>. In September&#160;2020, we entered into an amendment to extend the term of this lease through <ix:nonNumeric id="F_000918" name="nk:LeaseAgreementExtendedPeriod" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930" format="ixt:datemonthdayyearen">December&#160;31, 2021</ix:nonNumeric>. Commencing on <ix:nonNumeric id="F_000919" name="nk:AnnualPercentageIncreasesToBaseRentCommencementDate" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930" format="ixt:datemonthdayyearen">January&#160;1, 2021</ix:nonNumeric>, the monthly rent will increase by <ix:nonFraction unitRef="U_xbrlipure" id="F_000920" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101" decimals="2" scale="-2">3</ix:nonFraction>% to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000921" name="nk:BaseMonthlyRent" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101" decimals="0" format="ixt:numdotdecimal">54,500</ix:nonFraction>. Subsequent to December&#160;31, 2021, the lease term will automatically renew on a month-to-month basis, terminable by either party with at least <ix:nonNumeric id="F_000922" name="nk:NumberOfDaysPriorToWrittenNoticeToTerminateLease" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101" format="ixt-sec:durwordsen">thirty days</ix:nonNumeric>&#8217; prior written notice to the other party. In addition, we will have a one-time option to extend the lease term through December&#160;31, 2022. If we exercise the option to extend the lease through December&#160;31, 2022, or continue on a month-to-month basis, the monthly rent will increase by <ix:nonFraction unitRef="U_xbrlipure" id="F_000923" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101" decimals="2" scale="-2">3</ix:nonFraction>% annually commencing on January&#160;1 of each year. On the date of amendment we recognized an increase of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000924" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets, which reflects our belief that we will extend the term of this lease through December&#160;31, 2022.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2015, we entered into a lease agreement for an approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000925" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630" decimals="INF" format="ixt:numdotdecimal">44,700</ix:nonFraction>&#160;square foot facility in San Diego, California, for a research and development laboratory, related office and other related uses. The term of the lease extends for <span style="-sec-ix-hidden:F_000926">seven&#160;years</span> commencing on August&#160;1, 2016. The base rent is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000927" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million per month with <ix:nonFraction unitRef="U_xbrlipure" id="F_000928" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630" decimals="2" scale="-2">3</ix:nonFraction>% annual increases on each anniversary date.</p></ix:continuation>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unconditional Purchase Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unconditional purchase obligations are defined as an agreement to purchase goods or services that is enforceable and legally binding (non-cancelable, or cancelable only in certain circumstances). We estimate our total unconditional purchase obligation commitment (for those contracts with terms in excess of one year) as of December&#160;31, 2020, at $<ix:nonFraction unitRef="U_iso4217USD" id="F_000929" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" contextRef="C_0001326110_20201231" decimals="-5" scale="6">2.7</ix:nonFraction>&#160;million. Payments by year are estimated as follows:&#160;2021&#160;($<ix:nonFraction unitRef="U_iso4217USD" id="F_000930" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" contextRef="C_0001326110_20201231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million), 2022&#160;($<ix:nonFraction unitRef="U_iso4217USD" id="F_000931" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" contextRef="C_0001326110_20201231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million) and 2023&#160;($<ix:nonFraction unitRef="U_iso4217USD" id="F_000932" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" contextRef="C_0001326110_20201231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million). These commitments relate primarily to hosted software license subscription fees and related implementation costs and our pro-rata share is passed-through to us without any markup under the shared services agreement with NantWorks (as further described in Note&#160;10 below). The purchase obligation amounts do not represent the entire anticipated purchases in the future, but represent only those items for which we are contractually obligated. The majority of our goods and services are purchased as needed, with no unconditional commitment. For this reason, these amounts do not provide an indication of our expected future cash outflows related to purchases.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</p>
<hr style="page-break-after:always" />
<ix:nonNumeric id="F_000457" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000457_dcnt_aa7da05c-e0d5-4fa1-a867-b4c7678aa64b">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. &#160;&#160;&#160;&#160;Related Party Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Executive Chairman, and principal stockholder, founded and has a controlling interest in NantWorks, which is a collection of multiple companies in the healthcare and technology space. As described below, we have entered into arrangements with NantWorks, and certain affiliates of NantWorks, to facilitate the development of new genetically modified NK&#160;cells for our product pipeline. Affiliates of NantWorks are also affiliates of the company due to the common control by and/or common ownership interest of our Executive Chairman.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantWorks</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the NantWorks shared services agreement executed in November&#160;2015, but effective August&#160;2015, NantWorks provides corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy, and other support services. We are charged for the services at cost plus reasonable allocations for indirect costs that relate to the employees providing the services. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded $<ix:nonFraction unitRef="U_iso4217USD" id="F_000933" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231" decimals="-5" scale="6">2.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000934" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231" decimals="-5" scale="6">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000935" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231" decimals="-5" scale="6">2.8</ix:nonFraction>&#160;million, respectively, in selling, general and administrative expense, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000936" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231" decimals="-5" scale="6">1.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000937" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231" decimals="-5" scale="6">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000938" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231" decimals="-5" scale="6">3.3</ix:nonFraction>&#160;million, respectively, in research and development expense under this arrangement on the consolidated statements of operations. These amounts exclude certain general and administrative expenses provided by third party vendors directly for our benefit, which have been reimbursed to NantWorks based on those vendors&#8217; invoiced amounts without markup by NantWorks.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, we amended the existing shared services agreement with NantWorks whereby we can provide support services to NantWorks and/or any of its affiliates. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded expense reimbursements of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000939" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231" decimals="-5" scale="6">1.4</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000940" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000941" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million, respectively, in selling, general and administrative expense and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000942" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231" decimals="-5" scale="6">1.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000943" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231" decimals="-5" scale="6">2.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000944" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231" decimals="-5" scale="6">2.6</ix:nonFraction>&#160;million, respectively, in research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020 and 2019, we owed NantWorks a net amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000945" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20201231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000946" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20191231" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million, respectively, for all agreements between the two affiliates, which is included in due to related parties on the consolidated balance sheets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, we entered into a facility license agreement with NantWorks, which became effective in May&#160;2015, for approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000947" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130" decimals="INF" format="ixt:numdotdecimal">9,500</ix:nonFraction>&#160;square feet in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. In September&#160;2020, we amended this agreement to extend the term of this lease through <ix:nonNumeric id="F_000948" name="nk:LeaseAgreementExtendedPeriod" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930" format="ixt:datemonthdayyearen">December&#160;31, 2021</ix:nonNumeric>, as further described in Note&#160;9,&#160;<span style="font-style:italic;">Commitments and Contingencies</span>. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000949" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000950" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20190101_20191231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000951" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20180101_20181231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Immuno-Oncology Clinic, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning in 2017, we entered into multiple agreements with Immuno-Oncology Clinic, Inc., or the Clinic (dba&#160;Chan Soon-Shiong Institutes for Medicine, in El Segundo, California), to conduct clinical trials related to certain of our product candidates. The Clinic is a related party as it is owned by <ix:nonFraction unitRef="U_nkOfficer" id="F_000952" name="nk:NumberOfOfficers" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> officer of NantKwest and NantWorks manages the administrative operations of the Clinic. Prior to June&#160;30, 2019, one of the company&#8217;s officers was an investigator or sub-investigator for all of the company&#8217;s trials conducted at the Clinic.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we entered into a new agreement with the Clinic (the Clinic Agreement), which became effective on July&#160;1, 2019. The Clinic Agreement, as amended on March&#160;31, 2020, covers clinical trial and research related activities on a non-exclusive basis relating to our existing clinical trials, commenced prior to July&#160;1, 2019, and prospective clinical trials and research projects. The Clinic Agreement also specifies certain services and related costs that are excluded from the Clinic Agreement. Prior to commencing any work under the Clinic Agreement, the parties have agreed to execute written work orders setting forth the terms and conditions related to specific services to be performed, including financial terms. For clinical trials that commenced prior to July&#160;1, 2019, fees incurred for services performed after July&#160;1, 2019 are covered under the Clinic Agreement and applied towards the below-mentioned prepayments. The Clinic Agreement allows for an automatic renewal and additional extensions beyond the initial <span style="-sec-ix-hidden:F_000953">one&#160;year</span> term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In consideration of the services to be performed under the Clinic Agreement, as amended on March&#160;31, 2020, we agreed to make payments of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000954" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731" decimals="-5" scale="6">7.5</ix:nonFraction>&#160;million to the Clinic, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000955" name="nk:RelatedPartyInstallmentPayment" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731" decimals="-4" scale="6">3.75</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000956" name="nk:RelatedPartyInstallmentPayment" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191001_20191031" decimals="-3" scale="6">1.875</ix:nonFraction>&#160;million were paid in July&#160;2019 and October&#160;2019, respectively. As amended, a conditional payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000957" name="nk:RelatedPartyTransactionConditionalPayment" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190731" decimals="-3" scale="6">1.875</ix:nonFraction>&#160;million shall be due and payable at such time, if any, that the payments made in July&#160;2019 and October&#160;2019 have been earned by the Clinic through performance of services. On a quarterly basis, our prepayment is increased by an interest credit computed in accordance with terms specified in the Clinic Agreement.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000457_dcnt_aa7da05c-e0d5-4fa1-a867-b4c7678aa64b" continuedAt="F_000457_dcnt_7e977a90-c7f3-4028-9083-935a83aa612a">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000958" name="nk:RelatedPartyTransactionAgreementExtensionDescription" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231">To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to&#160;(i)&#160;not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)&#160;extend the term of the Clinic Agreement for up to three additional one&#160;year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within <ix:nonNumeric id="F_000959" name="nk:NewAgreementTerminationNoticePeriod" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231" format="ixt-sec:durday">60</ix:nonNumeric>&#160;days of expiration.</ix:nonNumeric> The Clinic may terminate this agreement upon each anniversary date upon sixty&#160;(60)&#160;days prior written notice and reimbursement in full to us of any outstanding unearned balance of the prepayments, provided that any such termination by the Clinic will not apply with respect to any work orders still in effect at the time of such termination.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we executed a clinical trial work order under the Clinic Agreement for an open-label, phase&#160;I study of PD&#8209;L1.t&#8209;haNK for infusion in subjects with locally advanced or metastatic solid cancers. In July&#160;2020, but effective on June&#160;22, 2020, we and ImmunityBio executed a clinical trial work order under our existing master agreement with the Clinic for an open-label, randomized, comparative phase&#160;II study of ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist (N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin) and our PD&#8209;L1.t&#8209;haNK with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000960" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000961" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190101_20191231" decimals="-5" scale="6">1.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000962" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20180101_20181231" decimals="-5" scale="6">2.7</ix:nonFraction>&#160;million, respectively, was recognized in research and development expense on the consolidated statements of operations related to clinical trial and research related activities conducted for us by the Clinic. As of December&#160;31, 2020 and 2019, we owed the Clinic $<ix:nonFraction unitRef="U_iso4217USD" id="F_000963" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000964" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million, respectively, for services excluded from the Clinic Agreement, which are included in due to related parties on the consolidated balance sheets. As of December&#160;31, 2020 and 2019, we had prepaid balances related to the Clinic Agreement of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000965" name="nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231" decimals="-5" scale="6">4.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000966" name="nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231" decimals="-5" scale="6">5.1</ix:nonFraction>&#160;million, respectively, which are included in prepaid expenses and other currents assets, and other assets, on the consolidated balance sheets. We anticipate that the remaining prepayment amount as of December&#160;31, 2020 will be utilized in future periods as the Clinic provides additional services pursuant to the Clinic Agreement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio, Inc., or ImmunityBio, is a related party, as it is controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On <ix:nonNumeric id="F_000967" name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221_20201221" format="ixt:datemonthdayyearen">December&#160;21, 2020</ix:nonNumeric>, we entered into a merger agreement with ImmunityBio pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The proposed merger is discussed in additional detail in Note&#160;4, <span style="font-style:italic;">Agreement and Plan of Merger with ImmunityBio</span>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a subsidiary of ImmunityBio, whereby we leased approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000968" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930" decimals="INF" format="ixt:numdotdecimal">6,901</ix:nonFraction>&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000969" name="nk:MonthlyFixedCharge" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million, a portion of which is subject to annual increases of <ix:nonFraction unitRef="U_xbrlipure" id="F_000970" name="nk:AnnualPercentageIncreasesToMonthlyFixedCharge" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231" decimals="2" scale="-2">3</ix:nonFraction>% which began in November&#160;2020. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. Lease expense for this facility is recorded in research and development expense on the consolidated statements of operations and was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000971" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231" decimals="-5" scale="6">0.9</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020. As of December&#160;31, 2020, we owed $<ix:nonFraction unitRef="U_iso4217USD" id="F_000972" name="nk:FixedAndVariableLeaseCosts" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million under this agreement related to variable lease costs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a Collaboration Agreement with ImmunityBio as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>. As of December&#160;31, 2020, the joint research activity under the Collaboration Agreement totaled $<ix:nonFraction unitRef="U_iso4217USD" id="F_000973" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">8.4</ix:nonFraction>&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000974" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">5.0</ix:nonFraction>&#160;million, to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000975" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231" decimals="-5" scale="6">3.4</ix:nonFraction>&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#8209;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#8209;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $<ix:nonFraction unitRef="U_iso4217USD" id="F_000976" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231" decimals="-5" scale="6">3.3</ix:nonFraction>&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000457_dcnt_7e977a90-c7f3-4028-9083-935a83aa612a" continuedAt="F_000457_dcnt_952285c3-6a67-4785-a480-66e1ff77b2fc">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio, which (together with related work orders) is described further in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>. During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000977" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231" decimals="-5" scale="6">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000978" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231" decimals="0" format="ixt:numdotdecimal">35,700</ix:nonFraction>, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, our balance owed to ImmunityBio related to the Cost Allocation Agreement was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000979" name="us-gaap:DueFromRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_us-gaapCollaborativeArrangementMember_20201231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million. As of December&#160;31, 2019, no balances were due between the parties with respect to the Cost Allocation Agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, we entered into an agreement with Etubics Corporation, or Etubics, a subsidiary of ImmunityBio. Pursuant to this agreement we sold used laboratory equipment to Etubics for $<ix:nonFraction unitRef="U_iso4217USD" id="F_000980" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million. In conjunction with this sale, we recognized a loss on disposal of related laboratory equipment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000981" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million, which was included in other income, net on the consolidated statements of operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2015, we entered into a supply agreement with ImmunityBio pursuant to which we have the right to purchase ImmunityBio&#8217;s proprietary bioreactors, made according to specifications mutually agreed to with ImmunityBio. We also have the right to purchase reagents and consumables associated with such equipment from ImmunityBio. When an upfront payment is made, it is included in prepaid expenses on the consolidated balance sheets until the product is received. The agreement had an initial term of <span style="-sec-ix-hidden:F_000982">five&#160;years</span> and renews automatically for successive <span style="-sec-ix-hidden:F_000983">one-year</span> periods unless terminated earlier.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020 and 2019, we had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000984" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231" decimals="-5" scale="6">3.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000985" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million, respectively, in equipment purchased from ImmunityBio pursuant to our supply agreement, which has been included in property, plant and equipment, net, on the consolidated balance sheets. During the years ended December&#160;31, 2020, 2019 and 2018, we recorded research and development expense associated with reagents and consumables purchased from ImmunityBio pursuant to our supply agreement of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000986" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000987" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000988" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20180101_20181231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million, respectively, on the consolidated statements of operations. At December&#160;31, 2020 and 2019, we had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000989" name="nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000990" name="nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20191231" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million, respectively, included in prepaid expenses and other current assets on the consolidated balance sheets related to consumables purchased from ImmunityBio.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">605&#160;Doug&#160;St,&#160;LLC</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2016, we entered into a lease agreement with 605&#160;Doug&#160;St,&#160;LLC, an entity owned by our Executive Chairman, and principal stockholder, for approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000991" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930" decimals="INF" format="ixt:numdotdecimal">24,250</ix:nonFraction>&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP laboratory manufacturing facility. <ix:nonNumeric id="F_000992" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">The lease runs from July&#160;2016 through July&#160;2023.</ix:nonNumeric> We have the option to extend the lease for an additional three-year term through July&#160;2026. The monthly rent is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000993" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million with annual increases of <ix:nonFraction unitRef="U_xbrlipure" id="F_000994" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930" decimals="2" scale="-2">3</ix:nonFraction>% beginning in <span style="-sec-ix-hidden:F_000995">July&#160;2017</span>. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000996" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231" decimals="-5" scale="6">0.9</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000997" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20190101_20191231" decimals="-5" scale="6">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000998" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20180101_20181231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million, respectively. At December&#160;31, 2020 and 2019, <ix:nonFraction unitRef="U_iso4217USD" id="F_000999" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20201231" decimals="INF" format="ixt-sec:numwordsen" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001000" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20191231" decimals="INF" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction></ix:nonFraction> balances were due between the parties.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August&#160;2018, NantBio assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#8217;s laboratory and vivarium premises. NantBio is a related party as it is an affiliate of NantWorks. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001001" name="nk:RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">0.9</ix:nonFraction>&#160;million and paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_001002" name="nk:RelatedPartyTransactionAmountPaidToThirdParty" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million directly to the third party for an aggregate value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001003" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6">1.4</ix:nonFraction>&#160;million. The assigned agreement is for a term of <span style="-sec-ix-hidden:F_001004">ten&#160;years</span> and expires in <ix:nonNumeric id="F_001005" name="nk:RelatedPartyAgreementExpirationMonthAndYear" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" format="ixt:datemonthyearen">June&#160;2027</ix:nonNumeric>. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, NantBio and the National Cancer Institute entered into a cooperative research and development agreement. The initial <span style="-sec-ix-hidden:F_001006">five-year</span> agreement covers NantBio and its affiliates, including us. Under the agreement, the parties are collaborating on the preclinical and clinical development of proprietary recombinant natural killer cells and monoclonal antibodies in monotherapy and in combination immunotherapies. We benefited from the preclinical and clinical research conducted during the first four years under this agreement. In each of the contractual years under the agreement we paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_001008" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001009" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001014" name="nk:PrepaymentOfFundingAmount" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190501_20190531" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001013" name="nk:PrepaymentOfFundingAmount" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001015" name="nk:PrepaymentOfFundingAmount" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200401_20200430" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001011" name="nk:PrepaymentOfFundingAmount" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160401_20160430" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001012" name="nk:PrepaymentOfFundingAmount" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20170401_20170430" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001010" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180101_20181231" decimals="-5" scale="6">0.6</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million to the National Cancer Institute as a prepayment for services under the agreement. We recognize research and development expense related to this agreement ratably over a <ix:nonNumeric id="F_001007" name="nk:ResearchAndDevelopmentExpenseRatablePaymentPeriod" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231" format="ixt-sec:durmonth">12</ix:nonNumeric>-month period for each funding year and recorded $0.6&#160;million of expense related to this agreement in each of the years ended December&#160;31, 2020, 2019 and 2018. At December&#160;31, 2020 and 2019, we had balances of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001016" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001017" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million, respectively, included in prepaid expenses and other current assets related to this agreement on the consolidated balance sheets.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000457_dcnt_952285c3-6a67-4785-a480-66e1ff77b2fc">

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantHealth Labs, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2018, we entered into an agreement with NantHealth Labs, Inc., or NantHealth Labs, to obtain blood-based tumor profiling services. NantHealth Labs is a related party, as it is a wholly owned subsidiary of NantHealth, Inc., a majority owned subsidiary of NantWorks. We are obligated to pay NantHealth Labs fixed, per-patient fees. The agreement has an initial term of <span style="-sec-ix-hidden:F_001018">five&#160;years</span> and renews automatically for successive <span style="-sec-ix-hidden:F_001019">one-year</span> periods, unless terminated earlier. During the years ended December&#160;31, 2019 and 2018, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001021" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20190101_20191231" decimals="0" format="ixt:numdotdecimal">10,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001022" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180101_20181231" decimals="-5" scale="6">0.3</ix:nonFraction>&#160;million, respectively, has been recognized in research and development expense on the consolidated statements of operations. There were <ix:nonFraction unitRef="U_iso4217USD" id="F_001020" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20200101_20201231" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> expenses associated with this agreement during the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, <ix:nonFraction unitRef="U_iso4217USD" id="F_001024" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_001023" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> balances were due between the parties.</p></ix:continuation><ix:nonNumeric id="F_000458" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. &#160;&#160;&#160;&#160;Stockholders&#8217; Equity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Issuance of Common Stock &#8211; <span style="font-style:normal;">On June&#160;29, 2020, the company closed an underwritten public offering of an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001025" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="INF" format="ixt:numdotdecimal">8,521,500</ix:nonFraction>&#160;shares of common stock, which included <ix:nonFraction unitRef="U_xbrlishares" id="F_001026" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="INF" format="ixt:numdotdecimal">4,811,500</ix:nonFraction>&#160;shares issued to the public at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001027" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629" decimals="2">9.50</ix:nonFraction>&#160;per share (which includes <ix:nonFraction unitRef="U_xbrlishares" id="F_001028" name="nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="INF" format="ixt:numdotdecimal">1,111,500</ix:nonFraction>&#160;shares sold to the public upon full exercise of the underwriters&#8217; option to purchase additional shares at a public offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001029" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629" decimals="2">9.50</ix:nonFraction>&#160;per share), less underwriting discounts and commissions, and <ix:nonFraction unitRef="U_xbrlishares" id="F_001030" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="INF" format="ixt:numdotdecimal">3,710,000</ix:nonFraction>&#160;shares issued to our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong, at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001031" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629" decimals="2">12.12</ix:nonFraction>&#160;per share, less underwriting discounts and commissions. All of the shares were offered by the company. Including the underwriters&#8217; option exercise, the aggregate gross proceeds from the offering were $<ix:nonFraction unitRef="U_iso4217USD" id="F_001032" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="-5" scale="6">90.7</ix:nonFraction>&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001033" name="nk:UnderwritingDiscountsCommissionsAndOfferingExpenses" contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629" decimals="-5" scale="6">4.4</ix:nonFraction>&#160;million.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock Repurchase &#8211; <span style="font-style:normal;">In November&#160;2015, the board of directors approved a share repurchase program, or the 2015 Share Repurchase Program, allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_001034" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="C_0001326110_20151130" decimals="INF" scale="6">50.0</ix:nonFraction>&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015&#160;Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified, or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. The shares are formally retired through board approval upon repurchase.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have repurchased <ix:nonFraction unitRef="U_xbrlishares" id="F_001035" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_20151102_20201231" decimals="INF" format="ixt:numdotdecimal">6,403,489</ix:nonFraction>&#160;shares of our common stock under the 2015&#160;Share Repurchase Program at a total cost of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001036" name="nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" contextRef="C_0001326110_20151102_20201231" decimals="-5" scale="6">31.7</ix:nonFraction>&#160;million. In addition, we have paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_001037" name="us-gaap:SalesCommissionsAndFees" contextRef="C_0001326110_20151102_20201231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million of broker commissions on repurchases. We did <ix:nonFraction unitRef="U_xbrlishares" id="F_001038" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction>t repurchase any shares during the year ended December&#160;31, 2020. During the years ended December&#160;31, 2019 and 2018, we repurchased <ix:nonFraction unitRef="U_xbrlishares" id="F_001039" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">473,586</ix:nonFraction>&#160;shares for $<ix:nonFraction unitRef="U_iso4217USD" id="F_001041" name="nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" contextRef="C_0001326110_20190101_20191231" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="U_xbrlishares" id="F_001040" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="C_0001326110_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">138,349</ix:nonFraction>&#160;shares for $<ix:nonFraction unitRef="U_iso4217USD" id="F_001042" name="nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" contextRef="C_0001326110_20180101_20181231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million, respectively. At December&#160;31, 2020, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001043" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="C_0001326110_20201231" decimals="INF" scale="6">18.3</ix:nonFraction>&#160;million remained authorized for repurchase under the 2015 Share Repurchase Program.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Common Stock Reserved for Future Issuance</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are authorized to issue up to <ix:nonFraction unitRef="U_xbrlishares" id="F_001044" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal">500,000,000</ix:nonFraction>&#160;shares of our common stock, par value $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001045" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001326110_20201231" decimals="INF">0.0001</ix:nonFraction>&#160;per share at December&#160;31, 2020. As of December&#160;31, 2020, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_001046" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_001047" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal">108,726,551</ix:nonFraction></ix:nonFraction>&#160;shares of our common stock issued and outstanding.</p><ix:nonNumeric id="F_000509" name="nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the common shares reserved for issuance on exercise or vesting of various awards at December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:78.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001048" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">3,518,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001049" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="INF" format="ixt:numdotdecimal">466,842</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares reserved for future issuance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001050" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001326110_20201231" decimals="INF" format="ixt:numdotdecimal">3,984,852</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000459" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000459_dcnt_a6ef08d2-ad71-423a-b270-9edd79ef2545">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12. &#160;&#160;&#160;&#160;Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2014 Equity Incentive Plan &#8211; <span style="font-style:normal;">In March&#160;2014, the company&#8217;s board of directors and stockholders approved the 2014 Equity Incentive Plan, or 2014&#160;Plan, under which <ix:nonFraction unitRef="U_xbrlishares" id="F_001051" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140331" decimals="INF" format="ixt:numdotdecimal">11,109,000</ix:nonFraction>&#160;shares of common stock were reserved for the granting of incentive stock options, within the meaning of Section&#160;422 of the Internal Revenue Code, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and performance awards to employees, directors and consultants. The maximum term of awards granted under the 2014&#160;Plan is <span style="-sec-ix-hidden:F_001052">ten&#160;years</span>. Recipients of stock awards are eligible to purchase shares of our common stock at an exercise price equal to no less than the estimated fair market value of such stock on the date of grant. As of December&#160;31, 2020, there were approximately&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_001053" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20201231" decimals="-5" scale="6">1.1</ix:nonFraction>&#160;million vested and exercisable options outstanding under the 2014&#160;Plan, and there were <ix:nonFraction unitRef="U_xbrlishares" id="F_001054" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> additional shares available for future grant.</span></p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000459_dcnt_a6ef08d2-ad71-423a-b270-9edd79ef2545" continuedAt="F_000459_dcnt_b1685fb9-c3a4-4979-a7b3-2ae6c72305be">

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2015 Equity Incentive Plan &#8211; <span style="font-style:normal;">In July&#160;2015, the company&#8217;s board of directors adopted and the company&#8217;s stockholders approved the 2015 Equity Incentive Plan, or 2015&#160;Plan. The 2015&#160;Plan, as amended, permits the grant of incentive stock options to the company&#8217;s employees, and for the grant of non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to the company&#8217;s employees, directors and consultants. The 2015&#160;Plan is the only equity plan of the company available for future grant of equity awards to employees, directors and consultants of the company. In April&#160;2019, the company&#8217;s board of directors adopted, and in June&#160;2019 the company&#8217;s stockholders approved, a first amendment to the 2015&#160;Plan to reserve a further <ix:nonFraction unitRef="U_xbrlishares" id="F_001055" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20190601_20190630" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction>&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. In March&#160;2020, the company&#8217;s board of directors adopted, and in June&#160;2020 the company&#8217;s stockholders approved, a second amendment to the 2015&#160;Plan to reserve a further <ix:nonFraction unitRef="U_xbrlishares" id="F_001056" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200601_20200630" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction>&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. As of December&#160;31, 2020, a total of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_001057" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231" decimals="INF" scale="6">10.2</ix:nonFraction>&#160;million shares of common stock were reserved for issuance pursuant to the 2015&#160;Plan and a total of approximately&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_001058" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231" decimals="INF" scale="6">7.2</ix:nonFraction>&#160;million shares were available for future grant. In addition, the number of shares reserved for future grant under the 2015&#160;Plan include shares subject to stock options granted under the 2014&#160;Plan that expire or terminate without having been exercised in full and shares issued pursuant to awards granted under the 2014&#160;Plan that are forfeited to or repurchased by us (provided that the maximum number of shares that may be added to the 2015&#160;Plan pursuant to this provision is approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_001059" name="nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200101_20201231" decimals="INF" scale="6">1.1</ix:nonFraction>&#160;million shares as of December&#160;31, 2020).</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p><ix:nonNumeric id="F_000510" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents all stock-based compensation as included on the consolidated statements of operations (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants for common stock to an officer</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001060" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001061" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001062" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,817</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001063" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,388</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001064" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,309</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001065" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee RSUs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001066" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231" decimals="-3" scale="3">629</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001067" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20190101_20191231" decimals="-3" scale="3">938</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001068" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,193</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employee RSUs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001069" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231" decimals="-3" scale="3">122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001070" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231" decimals="-3" scale="3">380</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001071" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231" decimals="-3" scale="3">315</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001072" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,139</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001073" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001074" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense in operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001075" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" scale="3">220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001076" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231" decimals="-3" scale="3">499</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001077" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231" decimals="-3" scale="3">460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001078" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001079" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,128</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001080" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,922</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001081" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,139</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001082" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001083" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,382</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock Options</p><ix:nonNumeric id="F_000511" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity and related information under all equity incentive plans for the years ended December&#160;31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001084" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231" decimals="INF" format="ixt:numdotdecimal">5,693,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001094" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231" decimals="2">7.71</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,920</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001109">5.3</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001085" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">800,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001095" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="2">3.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001086" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="INF" format="ixt:numdotdecimal">6,493,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001096" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="2">7.14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="-3" scale="3">563</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001110">4.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001087" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,986,300</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001097" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="2">2.06</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001088" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231" decimals="INF" format="ixt:numdotdecimal">4,506,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001098" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231" decimals="2">9.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001106" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,710</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001111">5.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001089" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">400,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001099" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="2">6.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001090" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,272,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001100" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="2">1.89</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">116,667</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001101" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="2">3.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001092" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">3,518,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001102" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="2">11.93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001107" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,922</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001112">5.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and Exercisable as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001093" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,868,008</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="2">13.50</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001108" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,509</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001113">4.7</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, the unrecognized compensation cost related to outstanding stock options was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001114" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="-5" scale="6">1.3</ix:nonFraction>&#160;million, which is expected to be recognized over a remaining weighted-average period of <ix:nonNumeric id="F_001115" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" format="ixt-sec:duryear">0.9</ix:nonNumeric>&#160;years.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000459_dcnt_b1685fb9-c3a4-4979-a7b3-2ae6c72305be" continuedAt="F_000459_dcnt_2680d56b-7944-46b7-acd7-f6e6c1a52a93">

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the years ended December&#160;31, 2020, 2019 and 2018, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_001116" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">166,667</ix:nonFraction>, <ix:nonFraction unitRef="U_xbrlishares" id="F_001117" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">343,810</ix:nonFraction>, and <ix:nonFraction unitRef="U_xbrlishares" id="F_001118" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">462,875</ix:nonFraction> stock options vested, respectively, with weighted-average exercises prices of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001119" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="2">2.09</ix:nonFraction>, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001120" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="2">3.51</ix:nonFraction>, and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001121" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="2">8.45</ix:nonFraction>, respectively. The total intrinsic value of stock options exercised during the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="-5" scale="6">12.7</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001123" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001124" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash proceeds received from stock option exercises for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001125" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="-5" scale="6">1.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001126" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="-5" scale="6">4.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001127" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="-6" scale="6">0</ix:nonFraction>, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2019 and 2018, a total of <ix:nonFraction unitRef="U_xbrlishares" id="F_001128" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231" decimals="INF" format="ixt:numdotdecimal">3,973,614</ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_001129" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="INF" format="ixt:numdotdecimal">5,577,531</ix:nonFraction> vested and exercisable shares were outstanding, respectively.</p><ix:nonNumeric id="F_000512" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of options outstanding and vested as of December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Prices</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001130" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231" decimals="4">0.4213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001136" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231" decimals="INF" format="ixt:numdotdecimal">512,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001143">3.9</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001150" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231" decimals="INF" format="ixt:numdotdecimal">512,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001157">3.9</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001131" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231" decimals="4">1.7554</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001137" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231" decimals="INF" format="ixt:numdotdecimal">288,404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001144">4.0</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001151" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231" decimals="INF" format="ixt:numdotdecimal">288,404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001158">4.0</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001132" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231" decimals="4">1.9984</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001138" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231" decimals="INF" format="ixt:numdotdecimal">262,120</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001145">4.1</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001152" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231" decimals="INF" format="ixt:numdotdecimal">262,120</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001159">4.1</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001133" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231" decimals="2">3.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001139" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231" decimals="INF" format="ixt:numdotdecimal">600,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001146">7.7</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001153" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231" decimals="INF" format="ixt:numdotdecimal">349,998</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001160">7.7</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001134" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231" decimals="2">6.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001140" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231" decimals="INF" format="ixt:numdotdecimal">400,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001147">9.4</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001154" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231" decimals="INF" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001161">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001135" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231" decimals="2">25.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001141" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231" decimals="INF" format="ixt:numdotdecimal">1,455,450</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001148">4.6</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001155" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231" decimals="INF" format="ixt:numdotdecimal">1,455,450</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001162">4.6</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001142" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">3,518,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001149">5.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001156" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,868,008</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001163">4.7</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000513" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may grant stock options to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#8217;s shared services agreement with NantWorks&#160;(Note&#160;10). The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001164">5.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 - 6.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001167" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="3" scale="-2">0.4</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001168" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="3" scale="-2">2.8</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001169" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="3" scale="-2">96.8</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001170" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="3" scale="-2">75.9</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001171" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="3" scale="-2">0.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001172" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231" decimals="3" scale="-2">0.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average grant date fair value</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001173" name="nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="2">4.64</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001174" name="nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="2">2.09</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected term was estimated using the average of the contractual term and the weighted-average vesting term of the options. The risk-free interest rate was based on the U.S.&#160;Treasury&#8217;s rates for U.S.&#160;Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. For grants issued during 2020, the expected volatility was estimated based on the historical volatility of our common stock. For grants issued during 2018, the expected volatility was based on a weighted-average calculation of the company&#8217;s common stock together with a peer group of comparable companies whose share prices are publicly available. The assumed dividend yield was based on the company&#8217;s expectation of not paying dividends in the foreseeable future. There were <ix:nonFraction unitRef="U_xbrlishares" id="F_001175" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> grants issued during 2019.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000459_dcnt_2680d56b-7944-46b7-acd7-f6e6c1a52a93">

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p><ix:nonNumeric id="F_000514" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the restricted stock units, or RSUs, activity under the 2015&#160;Plan:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RSUs</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2017</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001176" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231" decimals="INF" format="ixt:numdotdecimal">888,189</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001189" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231" decimals="2">8.14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001177" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">487,472</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001190" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="2">3.57</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001178" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">172,330</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001191" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="2">6.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001179" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">335,420</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001192" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231" decimals="2">6.27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001180" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231" decimals="INF" format="ixt:numdotdecimal">867,911</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001193" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231" decimals="2">6.69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001181" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">749,793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001194" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">1.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001182" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">395,051</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001195" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">8.83</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001183" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">83,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001196" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">7.29</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001184" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231" decimals="INF" format="ixt:numdotdecimal">1,139,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001197" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231" decimals="2">2.23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001185" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">33,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001198" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">6.43</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001186" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">648,336</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001199" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">2.04</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001187" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">57,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001200" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">4.47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001188" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="INF" format="ixt:numdotdecimal">466,842</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001201" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="2">2.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may grant RSUs to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#8217;s shared services agreement with NantWorks (Note&#160;10). During the year ended December&#160;31, 2018, we granted <ix:nonFraction unitRef="U_xbrlishares" id="F_001204" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">90,906</ix:nonFraction>&#160;RSUs to employees of related companies under our shared services agreement with NantWorks&#160;(Note&#160;10). There were <ix:nonFraction unitRef="U_xbrlishares" id="F_001203" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001202" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> grants made to non-employees during the years ended December&#160;31, 2020 and 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001205" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million of unrecognized stock-based compensation expense related to RSUs that is expected to be recognized over a weighted-average period of <ix:nonNumeric id="F_001206" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" format="ixt-sec:duryear">1.8</ix:nonNumeric>&#160;years. Of that amount, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001207" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20201231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million of unrecognized expense is related to employee grants with a remaining weighted-average period of <ix:nonNumeric id="F_001208" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231" format="ixt-sec:duryear">1.9</ix:nonNumeric>&#160;years and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001209" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20201231" decimals="0" format="ixt:numdotdecimal">6,400</ix:nonFraction>&#160;of unrecognized expense is related to non-employee grants with a remaining weighted-average period of <ix:nonNumeric id="F_001210" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231" format="ixt-sec:duryear">0.2</ix:nonNumeric>&#160;years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warrants</p><ix:nonNumeric id="F_000515" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the company&#8217;s warrant activity:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001211" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20171231" decimals="INF" format="ixt:numdotdecimal">17,721,088</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001212" name="nk:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">93,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants expired</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001213" name="nk:StockIssuedDuringPeriodSharesWarrantsExpired" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">38,584</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001214" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20181231" decimals="INF" format="ixt:numdotdecimal">17,589,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001215" name="nk:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">17,589,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001216" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20191231" decimals="INF" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash proceeds recognized from exercises of warrants during the years ended December&#160;31, 2019 and 2018, were $<ix:nonFraction unitRef="U_iso4217USD" id="F_001217" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001326110_20190101_20191231" decimals="-5" scale="6">35.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001218" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001326110_20180101_20181231" decimals="-5" scale="6">0.1</ix:nonFraction>&#160;million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001219" name="nk:ClassOfWarrantOrRightsIssued" contextRef="C_0001326110_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001220" name="nk:ClassOfWarrantOrRightsIssued" contextRef="C_0001326110_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001221" name="nk:ClassOfWarrantOrRightsIssued" contextRef="C_0001326110_20180101_20181231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> warrants were issued during the years ended December&#160;31, 2020, 2019 and 2018, and as of December&#160;31, 2020 and 2019 there were <ix:nonFraction unitRef="U_xbrlishares" id="F_001222" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001223" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001224" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0001326110_20181231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> warrants outstanding. </p></ix:continuation><ix:nonNumeric id="F_000460" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000460_dcnt_753450f3-30ee-4cf1-a4f0-07a0ef1cf6cb">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13. &#160;&#160;&#160;&#160;Income Taxes</p><ix:nonNumeric id="F_000516" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000516_dcnt_dfab1352-5fd5-4c51-bf65-ce1060312794">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of loss before taxes is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. loss before taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001225" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,412</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001226" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001227" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">94,423</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income (loss) before taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001228" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001229" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" scale="3">600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001230" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,306</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001231" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">92,378</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001232" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">65,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001233" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,729</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
</ix:nonNumeric></ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000460_dcnt_753450f3-30ee-4cf1-a4f0-07a0ef1cf6cb" continuedAt="F_000460_dcnt_dd5bb452-706c-4d6a-b8f9-391779ef297b"><ix:continuation id="F_000516_dcnt_dfab1352-5fd5-4c51-bf65-ce1060312794">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000517" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit for the years ended December&#160;31, 2020, 2019 and 2018 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001234" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001235" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001236" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001237" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001238" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001239" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001240" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001241" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001242" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001243" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001244" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001245" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001246" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001247" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">79</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001248" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001249" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001250" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001251" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001252" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001253" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001254" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001255" name="nk:DeferredIncomeTaxExpenseBenefitNet" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001256" name="nk:DeferredIncomeTaxExpenseBenefitNet" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" scale="3">100</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001257" name="nk:DeferredIncomeTaxExpenseBenefitNet" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">506</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001258" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001259" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20190101_20191231" decimals="-3" sign="-" scale="3">97</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001260" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001326110_20180101_20181231" decimals="-3" sign="-" scale="3">503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000518" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components that comprise the company&#8217;s net deferred tax assets at December&#160;31, 2020 and 2019 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001261" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">105,537</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001262" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">78,377</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001263" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001264" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,536</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001265" name="nk:DeferredTaxAssetsOperatingLeaseLiabilities" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001266" name="nk:DeferredTaxAssetsOperatingLeaseLiabilities" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001267" name="nk:DeferredTaxAssetsDeferredDepreciationAndAmortization" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,128</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001268" name="nk:DeferredTaxAssetsDeferredDepreciationAndAmortization" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001269" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_0001326110_20201231" decimals="-3" scale="3">898</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001270" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_0001326110_20191231" decimals="-3" scale="3">898</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001271" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" contextRef="C_0001326110_20201231" decimals="-3" scale="3">762</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001272" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" contextRef="C_0001326110_20191231" decimals="-3" scale="3">775</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leases and other accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001273" name="nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" contextRef="C_0001326110_20201231" decimals="-3" scale="3">451</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001274" name="nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" contextRef="C_0001326110_20191231" decimals="-3" scale="3">453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001275" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,419</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001276" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001277" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">125,148</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001278" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">94,965</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001279" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001280" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001281" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001282" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001283" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">121,409</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001284" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">91,732</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001285" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">121,409</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001286" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">91,732</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001287" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001288" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000519" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the federal statutory income tax rate to the company&#8217;s effective income tax rate for the years ended December&#160;31, 2020, 2019 and 2018 is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax computed at federal statutory rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001289" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001326110_20200101_20201231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001290" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001326110_20190101_20191231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001291" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001326110_20180101_20181231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income taxes, net of federal tax benefit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001292" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001326110_20200101_20201231" decimals="3" scale="-2">7.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001293" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001326110_20190101_20191231" decimals="3" sign="-" scale="-2">19.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001294" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001326110_20180101_20181231" decimals="3" scale="-2">6.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax rate adjustment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001295" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" contextRef="C_0001326110_20200101_20201231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001296" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" contextRef="C_0001326110_20190101_20191231" decimals="3" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001297" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" contextRef="C_0001326110_20180101_20181231" decimals="3" sign="-" scale="-2">0.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001298" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="C_0001326110_20200101_20201231" decimals="3" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001299" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="C_0001326110_20190101_20191231" decimals="3" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001300" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="C_0001326110_20180101_20181231" decimals="3" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001301" name="nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" contextRef="C_0001326110_20200101_20201231" decimals="3" scale="-2">3.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001302" name="nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" contextRef="C_0001326110_20190101_20191231" decimals="3" sign="-" scale="-2">82.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001303" name="nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" contextRef="C_0001326110_20180101_20181231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001304" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" contextRef="C_0001326110_20200101_20201231" decimals="3" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001305" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" contextRef="C_0001326110_20190101_20191231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001306" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" contextRef="C_0001326110_20180101_20181231" decimals="3" scale="-2">0.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001307" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20200101_20201231" decimals="3" sign="-" scale="-2">32.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001308" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20190101_20191231" decimals="3" scale="-2">80.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001309" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20180101_20181231" decimals="3" sign="-" scale="-2">26.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001310" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001326110_20200101_20201231" decimals="2" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001311" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001326110_20190101_20191231" decimals="3" sign="-" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001312" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001326110_20180101_20181231" decimals="3" scale="-2">0.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000460_dcnt_dd5bb452-706c-4d6a-b8f9-391779ef297b" continuedAt="F_000460_dcnt_6029f054-f0c7-4dd6-86d3-8f7b5d3eda50">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Internal Revenue Code&#160;Sections&#160;382 and 383, annual use of the company's net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than <ix:nonFraction unitRef="U_xbrlipure" id="F_001313" name="nk:ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" contextRef="C_0001326110_20200101_20201231" decimals="2" scale="-2">50</ix:nonFraction>% occurs within a <span style="-sec-ix-hidden:F_001314">three-year</span> period. We completed an Internal Revenue Code&#160;Section&#160;382/383 analysis through March&#160;2019 regarding the limitation of net operating loss and research and development credit carryforwards. As a result, we derecognized a portion of the deferred tax assets for net operating losses and federal and state research and development credits of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001315" name="nk:DerecognizedDeferredTaxAssets" contextRef="C_0001326110_20201231" decimals="-5" scale="6">0.8</ix:nonFraction>&#160;million from our deferred tax asset schedule as of December&#160;31, 2020. There is no impact to tax expense for the derecognition of the net operating losses and federal and state research and development credits due to the valuation allowance recorded against the deferred tax assets. Additionally, we have not recognized the deferred tax asset for research and development credit carryforwards as of December&#160;31, 2020 and 2019 because we are a part of a controlled group of affiliated companies with common ownership and cannot complete our calculation of the credit until the time that all members of the controlled group complete their analysis and calculation of qualified research expenditures.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, we have recorded a full valuation allowance of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001316" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001326110_20201231" decimals="-5" scale="6">121.4</ix:nonFraction>&#160;million at December&#160;31, 2020. The change in the valuation allowance for the year ended December&#160;31, 2020 was an increase of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001317" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001326110_20200101_20201231" decimals="-5" scale="6">29.7</ix:nonFraction>&#160;million which was mainly driven by losses for which the company cannot benefit. The portion of the valuation allowance for deferred tax assets for which subsequently recognized tax benefits will be credited directly to contributed capital is $<ix:nonFraction unitRef="U_iso4217USD" id="F_001318" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" contextRef="C_0001326110_20200101_20201231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, the company has federal net operating losses, or NOLs, of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001319" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231" decimals="-5" scale="6">389.8</ix:nonFraction>&#160;million, state NOLs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001320" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231" decimals="-5" scale="6">350.3</ix:nonFraction>&#160;million, and foreign NOLs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001321" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20201231" decimals="-5" scale="6">0.2</ix:nonFraction>&#160;million. Of the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001322" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231" decimals="-5" scale="6">389.8</ix:nonFraction>&#160;million in federal NOLs, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001324" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231" decimals="-5" scale="6">226.4</ix:nonFraction>&#160;million will not expire and will be able to offset <ix:nonFraction unitRef="U_xbrlipure" id="F_001326" name="nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231" decimals="2" scale="-2">80</ix:nonFraction>% of taxable income in future years. Of the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001323" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231" decimals="-5" scale="6">350.3</ix:nonFraction>&#160;million in state NOLs, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001325" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231" decimals="-5" scale="6">4.4</ix:nonFraction>&#160;million will not expire and will be able to offset <ix:nonFraction unitRef="U_xbrlipure" id="F_001327" name="nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231" decimals="2" scale="-2">80</ix:nonFraction>% of taxable income in future years. The remaining federal NOL carryforwards begin to expire in <ix:nonNumeric id="F_001328" name="nk:NetOperatingLossCarryforwardsExpirationDate" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">2024</ix:nonNumeric>, the remaining state NOL carryforwards begin to expire in <ix:nonNumeric id="F_001329" name="nk:NetOperatingLossCarryforwardsExpirationDate" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2030</ix:nonNumeric> and the foreign NOL carryforwards begin to expire in <ix:nonNumeric id="F_001330" name="nk:NetOperatingLossCarryforwardsExpirationDate" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20200101_20201231">2022</ix:nonNumeric>. At December&#160;31, 2020, the company also had federal research tax credit carryforwards of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001331" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231" decimals="-5" scale="6">11.1</ix:nonFraction>&#160;million and state research tax credits of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001332" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231" decimals="-5" scale="6">7.8</ix:nonFraction>&#160;million. The federal research tax credit carryforwards begin to expire in <ix:nonNumeric id="F_001333" name="nk:TaxCreditCarryforwardExpirationPeriod" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">2034</ix:nonNumeric> and certain state research tax credit carryforwards begin to expire in <ix:nonNumeric id="F_001334" name="nk:TaxCreditCarryforwardExpirationPeriod" contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">2031</ix:nonNumeric>. The California research tax credits can be carried forward indefinitely.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;27, 2020, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, was signed into law in response to the economic challenges facing U.S. businesses. Under the CARES Act, the Internal Revenue Code was amended to allow for federal&#160;NOL carrybacks for <span style="-sec-ix-hidden:F_001337">five&#160;years</span> to offset previous years income, or the federal NOLs can be carried forward indefinitely to offset <ix:nonFraction unitRef="U_xbrlipure" id="F_001335" name="nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" contextRef="C_0001326110_us-gaapTaxPeriodAxis_us-gaapTaxYear2020Member_20200101_20201231" decimals="INF" scale="-2">100</ix:nonFraction>% of taxable income for tax year 2020 and <ix:nonFraction unitRef="U_xbrlipure" id="F_001336" name="nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" contextRef="C_0001326110_us-gaapTaxPeriodAxis_nkTaxYear2021AndThereafterMember_20200101_20201231" decimals="2" scale="-2">80</ix:nonFraction>% of taxable income for tax years 2021 and thereafter.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the state of California enacted Assembly Bill No.&#160;85&#160;(AB&#160;85) suspending California net operating loss utilization and imposing a cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020, 2021 and 2022. There was no material impact from the provisions of AB&#160;85 in 2020.</p><ix:nonNumeric id="F_000520" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes to the amount of unrecognized tax benefits (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001338" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001326110_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,983</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001339" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001326110_20190101_20191231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001340" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001326110_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001341" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001326110_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,656</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001342" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001326110_20200101_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001343" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001326110_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,763</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001344" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001326110_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,413</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in the balance of unrecognized tax benefits at December&#160;31, 2020, is $<ix:nonFraction unitRef="U_iso4217USD" id="F_001345" name="nk:UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" contextRef="C_0001326110_20201231" decimals="-5" scale="6">18.3</ix:nonFraction>&#160;million that, if recognized, would not impact our income tax benefit or effective tax rate as long as the deferred tax asset remains subject to a full valuation allowance. We do not expect that the unrecognized tax benefits will change within 12&#160;months of this reporting date. Due to the existence of the valuation allowance, future changes in our unrecognized tax benefits will not impact the company's effective tax rate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not incurred any material interest or penalties as of the current reporting date with respect to income tax matters.</p>
</ix:continuation><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000460_dcnt_6029f054-f0c7-4dd6-86d3-8f7b5d3eda50">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to U.S. federal income tax and various state income taxes. The federal returns for tax years </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001346" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">2017</ix:nonNumeric></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001347" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">2020</ix:nonNumeric></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> remain open to examination and the state returns remain subject to examination for tax years </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001348" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2016</ix:nonNumeric></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001349" name="us-gaap:OpenTaxYear" contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2020</ix:nonNumeric></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the adoption of ASU&#160;2019&#8209;12 in the first quarter of 2020, as described in Note&#160;2, intraperiod tax allocation rules required us to allocate the provision for income taxes between continuing operations and other categories of earnings, such as other comprehensive income. In periods in which we had a year-to-date pre-tax loss from continuing operations and pre-tax income in other categories of earnings, such as other comprehensive income, we had to allocate the tax provision to the other categories of earnings. We then recorded a related tax benefit in continuing operations. However, with the adoption of ASU&#160;2019&#8209;12, we are no longer required to allocate the tax provision to the other categories of earnings and related benefit to continuing operations under these circumstances.</p></ix:continuation><ix:nonNumeric id="F_000461" name="us-gaap:QuarterlyFinancialInformationTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">14. &#160;&#160;&#160;&#160;Summarized Quarterly Data (Unaudited)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair statement of the results of the interim periods.</p><ix:nonNumeric id="F_000521" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below presents unaudited quarterly data for years ended December&#160;31, 2020 and 2019 (in thousands, except for share and per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001350" name="us-gaap:Revenues" contextRef="C_0001326110_20200101_20200331" decimals="-3" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001351" name="us-gaap:Revenues" contextRef="C_0001326110_20200401_20200630" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001352" name="us-gaap:Revenues" contextRef="C_0001326110_20200701_20200930" decimals="-3" scale="3">68</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001353" name="us-gaap:Revenues" contextRef="C_0001326110_20201001_20201231" decimals="-3" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001354" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20200101_20200331" decimals="-3" format="ixt:numdotdecimal" scale="3">18,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001355" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20200401_20200630" decimals="-3" format="ixt:numdotdecimal" scale="3">20,228</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001356" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20200701_20200930" decimals="-3" format="ixt:numdotdecimal" scale="3">21,995</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001357" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20201001_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,907</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001358" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20200101_20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">18,586</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001359" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001360" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20200701_20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,927</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001361" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20201001_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">30,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001362" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200101_20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">18,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001363" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200401_20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,092</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001364" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20200701_20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001365" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20201001_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">32,132</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001366" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20200101_20200331" decimals="2" sign="-">0.19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001367" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20200401_20200630" decimals="2" sign="-">0.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001368" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20200701_20200930" decimals="2" sign="-">0.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001369" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20201001_20201231" decimals="2" sign="-">0.30</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001370" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20200101_20200331" decimals="0" format="ixt:numdotdecimal">98,472,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001371" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20200401_20200630" decimals="0" format="ixt:numdotdecimal">98,769,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001372" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20200701_20200930" decimals="0" format="ixt:numdotdecimal">108,246,579</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001373" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20201001_20201231" decimals="0" format="ixt:numdotdecimal">108,607,715</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001374" name="us-gaap:Revenues" contextRef="C_0001326110_20190101_20190331" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001375" name="us-gaap:Revenues" contextRef="C_0001326110_20190401_20190630" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001376" name="us-gaap:Revenues" contextRef="C_0001326110_20190701_20190930" decimals="-3" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001377" name="us-gaap:Revenues" contextRef="C_0001326110_20191001_20191231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001378" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20190101_20190331" decimals="-3" format="ixt:numdotdecimal" scale="3">18,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001379" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20190401_20190630" decimals="-3" format="ixt:numdotdecimal" scale="3">17,313</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001380" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20190701_20190930" decimals="-3" format="ixt:numdotdecimal" scale="3">16,077</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001381" name="us-gaap:OperatingExpenses" contextRef="C_0001326110_20191001_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,120</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001382" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20190101_20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">18,335</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001383" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20190401_20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001384" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20190701_20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">16,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001385" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001326110_20191001_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">16,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001386" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190101_20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,885</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001387" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190401_20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">16,682</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001388" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20190701_20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">15,581</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001389" name="us-gaap:NetIncomeLoss" contextRef="C_0001326110_20191001_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">15,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001390" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20190101_20190331" decimals="2" sign="-">0.22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001391" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20190401_20190630" decimals="2" sign="-">0.17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001392" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20190701_20190930" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001393" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001326110_20191001_20191231" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001394" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20190101_20190331" decimals="0" format="ixt:numdotdecimal">81,261,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001395" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20190401_20190630" decimals="0" format="ixt:numdotdecimal">98,594,355</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001396" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20190701_20190930" decimals="0" format="ixt:numdotdecimal">98,331,695</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001397" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001326110_20191001_20191231" decimals="0" format="ixt:numdotdecimal">98,419,166</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric id="F_000462" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000462_dcnt_ed2ee6dc-74bc-4212-8a03-6d94cccdb638">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">15. &#160;&#160;&#160;&#160;Employee Benefits</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Defined Contribution Benefit Plan &#8211; <span style="font-style:normal;">In December&#160;2015, the company adopted a 401(k) retirement and savings plan, or the 401(k) Plan, covering all employees. The 401(k)&#160;Plan allows employees to make pre- and post-tax contributions up to the maximum allowable amount set by the Internal Revenue Service. The company, at its discretion, may make certain contributions to the 401(k)&#160;Plan. We made contributions of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001398" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001399" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20190101_20191231" decimals="-5" scale="6">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001400" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20180101_20181231" decimals="-5" scale="6">0.5</ix:nonFraction>&#160;million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Compensated Absences &#8211; <span style="font-style:normal;">Under our vacation policy, salaried employees are provided unlimited vacation leave. Therefore, we do not record an accrual for paid leave related to these employees since we are unable to reasonably estimate the compensated absences that these employees will take.</span></p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000462_dcnt_ed2ee6dc-74bc-4212-8a03-6d94cccdb638">
</ix:continuation><ix:nonNumeric id="F_000463" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_0001326110_20200101_20201231" escape="true" continuedAt="F_000463_dcnt_ee49f49a-570c-4a88-8a3e-25a1eacd04a4">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">16. &#160;&#160;&#160;&#160;Subsequent Event</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Related Party Lease Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February&#160;2021, but effective on January&#160;1, 2021, we entered into a lease agreement with 605&#160;Nash, LLC, whereby we leased approximately <ix:nonFraction unitRef="U_utrsqft" id="F_001401" name="nk:NumberOfSquareFootOfFacilityLeased" contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228" decimals="INF" format="ixt:numdotdecimal">6,883</ix:nonFraction>&#160;square feet in El&#160;Segundo, California. 605&#160;Nash, LLC is a related party, as it is owned by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon&#8209;Shiong. This facility will be used primarily for pharmaceutical development and manufacturing purposes. <ix:nonNumeric id="F_001402" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231">The lease runs from January&#160;2021 through December&#160;2027</ix:nonNumeric>, and includes an option to extend the lease for an additional <span style="-sec-ix-hidden:F_001406">three&#160;year</span>&#160;term through <span style="-sec-ix-hidden:F_001405">December&#160;2030</span>. Base rent for the term of the lease is approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001403" name="nk:BaseMonthlyRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228" decimals="0" format="ixt:numdotdecimal">20,300</ix:nonFraction>&#160;per month with an annual increase of <ix:nonFraction unitRef="U_xbrlipure" id="F_001404" name="nk:AnnualPercentageIncreasesToBaseRent" contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228" decimals="2" scale="-2">3</ix:nonFraction>% on January&#160;1 of each year during the initial term and, if applicable, during the option term. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses.</p>
</ix:nonNumeric><p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000463_dcnt_ee49f49a-570c-4a88-8a3e-25a1eacd04a4">
</ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9A_CONTROLS_PROCEDURES">Item&#160;9A. Controls and Procedures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management, with the participation of its Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2020. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rule&#160;13a-15(e) of the Securities Exchange Act of 1934, or the Exchange Act, means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December&#160;31, 2020, our CEO and CFO have concluded that, as of December&#160;31, 2020, our disclosure controls and procedures were effective at the reasonable assurance level.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Management's Report on Internal Control Over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rule&#160;13a-15(f) under the Exchange Act. Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our CEO and CFO, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that&#160;(i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets&#59; (ii)&#160;provide reasonable assurance (a)&#160;transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, (b)&#160;our receipts and expenditures are being made only in accordance with authorizations of our management and directors&#59; and (c)&#160;regarding the prevention or timely detection of the unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, our management conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control - Integrated Framework&#160;(2013). Based on this evaluation, our management concluded that, as of December&#160;31, 2020, our internal control over financial reporting was effective.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management&#8217;s report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management&#8217;s report in this annual report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in Internal Control over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been no changes in our internal control over financial reporting that occurred during the last fiscal quarter ended December&#160;31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p>
<hr style="page-break-after:always" />
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Inherent Limitations on Effectiveness of Controls</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions&#59; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9B_OTHER_INFORMATION">Item&#160;9B. Other Information.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152</p>
<hr style="page-break-after:always" />

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_III">PART III</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO">Item&#160;10. Directors, Executive Officers and Corporate Governance.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this item will be contained in our definitive proxy statement to be filed with the Securities and Exchange Commission on Schedule&#160;14A in connection with our 2021 Annual Meeting of Stockholders, or the Proxy Statement, which is expected to be filed not later than 120&#160;days after the end of our fiscal year ended December&#160;31, 2020, and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_11_EXECUTIVE_COMPENSATION">Item&#160;11. Executive Compensation.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Executive Compensation&#8221; and &#8220;Board of Directors and Corporate Governance &#8211; Director Compensation,&#8221; and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">Item&#160;12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Executive Compensation &#8211; Equity Compensation Plan Information,&#8221; and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Certain Relationships and Related Party Transactions&#8221; and &#8220;Board of Directors and Corporate Governance,&#8221; and is incorporated herein by reference.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC">Item&#160;14. Principal Accounting Fees and Services.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this item will be contained in the Proxy Statement under the heading &#8220;Ratification of Appointment of Independent Registered Public Accounting Firm &#8211; Fees Paid to the Independent Registered Public Accounting Firm&#8221; and is incorporated herein by reference.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153</p>
<hr style="page-break-after:always" />

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART IV</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">Item&#160;15. Exhibits, Financial Statement Schedules.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements schedules and exhibits filed as part of this Annual Report on Form&#160;10&#8209;K, or Annual Report, are as follows:</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(1)<span style="font-weight:normal;"> </span>Consolidated financial statements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to the consolidated financial statements identified in the &#8220;Index to Financial Statements&#8221; under Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(2)<span style="font-weight:normal;"> </span>Financial Statement Schedules</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is otherwise on the consolidated financial statements or notes thereto.</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(3)<span style="font-weight:normal;"> </span>Exhibits</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The documents listed in the Exhibit Index of this Annual Report are incorporated by reference or are filed with this Annual Report, in each case as indicated therein (numbered in accordance with Item&#160;601 of Regulation&#160;S-K).</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Index</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td rowspan="2" valign="bottom" style="width:7.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="7" valign="bottom" style="width:43.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference Herein</p></td>
</tr>
<tr>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:0.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:10.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:0.68%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:0.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:15.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;2.1</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312520323766/d21044dex21.htm"><span style="text-decoration:none;">Agreement and Plan of Merger, dated December&#160;21, 2020, by and among NantKwest, Inc., ImmunityBio, Inc. and Nectarine Merger Sub, Inc.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;22, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515275314/d158803dex31.htm"><span style="text-decoration:none;">Amended and Restated Certificate of Incorporation of NantKwest, Inc</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;4, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312520174073/d949400dex31.htm"><span style="text-decoration:none;">Amended and Restated Bylaws of NantKwest, Inc., effective as of June&#160;18, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.1</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex41.htm"><span style="text-decoration:none;">Nominating Agreement by and between the Registrant and Cambridge Equities, LP, dated June&#160;18, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.2</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.15pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex42.htm"><span style="text-decoration:none;">Form of Registration Rights Agreement by and between the Company and the Purchasers of Common Stock, dated June 2015</span></a><span style="letter-spacing:-0.15pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.3</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex43.htm"><span style="text-decoration:none;">Registration Rights Agreement by and between the Company and Cambridge Equities LP, dated December&#160;23, 2014</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.4</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex45.htm"><span style="text-decoration:none;">Form of Subscription and Securities Purchase Agreement among the Company and the Subscribers of Series C Preferred Stock, dated as of April&#160;1, 2014</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.5</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.15pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex46.htm"><span style="text-decoration:none;">Registration Rights Agreement, among the Company and the purchasers of Series B Preferred Stock, dated as of June&#160;20, 2013</span></a><span style="letter-spacing:-0.15pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.6</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515252847/d917371dex47.htm"><span style="text-decoration:none;">Specimen common stock certificate</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July&#160;15, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.7</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020012816/nk-ex48_1107.htm"><span style="text-decoration:none;">Description of the Registrant&#8217;s Securities</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.26</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March&#160;25, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex101.htm"><span style="text-decoration:none;">Form of Indemnification Agreement between the Company and each of its directors and executive officers</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex102.htm"><span style="text-decoration:none;">2014 Equity Incentive Plan and forms of agreements thereunder</span></a><span style="letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020038096/nk-ex101_858.htm"><span style="text-decoration:none;">2015&#160;Equity Incentive Plan (as Amended and Restated June&#160;10, 2020) and all forms and agreements thereunder</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;7, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515252847/d917371dex104.htm"><span style="text-decoration:none;">Executive Incentive Compensation Plan</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 15, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515252847/d917371dex105.htm"><span style="text-decoration:none;">Amended and Restated Executive Employment Agreement between the Company and Patrick Soon-Shiong, effective March&#160;24, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 15, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154</p>
<hr style="page-break-after:always" />
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td rowspan="2" valign="bottom" style="width:7.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="7" valign="bottom" style="width:43.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference Herein</p></td>
</tr>
<tr>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:0.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:10.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:0.68%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:0.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:15.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.6+</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex106.htm"><span style="text-decoration:none;">Executive Employment Agreement between the Company and Barry J. Simon, M.D., dated January&#160;1, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex107.htm"><span style="text-decoration:none;">License Agreement between the Company and Brink Biologics, Inc., dated June&#160;9, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex108.htm"><span style="text-decoration:none;">License Agreement between the Company and Coneksis, Inc., dated June&#160;9, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex1010.htm"><span style="text-decoration:none;">License Agreement between the Company and Intrexon Corporation, dated February&#160;23, 2010</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.10</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.10</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex1011.htm"><span style="text-decoration:none;">UHN-ZelleRx License Agreement between University Health Network and the Company, dated May&#160;9, 2005</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.11</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex1012.htm"><span style="text-decoration:none;">License Agreement, as amended, between Fox Chase Cancer Center and the Company, dated as of July&#160;10, 2004</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.12</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex1013.htm"><span style="text-decoration:none;">Rush-ZelleRx License Agreement, between Rush University Medical Center and the Registrant, dated as of March&#160;24, 2004</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.13</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.13</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515263882/d917371dex1014.htm"><span style="text-decoration:none;">License Agreement, as amended, between Hans G. Klingemann and the Company, dated February&#160;10, 2003</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.14</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 27, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:5pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.14</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000119312515229037/d917371dex1018.htm"><span style="text-decoration:none;">Genomic and Proteomic Services Agreement by and between the Company and NantOmics, LLC, dated June&#160;18, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 19, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.15</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000095012315007692/d917371dex1019.htm"><span style="text-decoration:none;">Lease Agreement by and between ARE - John Hopkins Court, LLC and the Company, dated June&#160;19, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333-205124</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.19</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 27, 2015</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.16</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459016015596/nk-ex1022_1730.htm"><span style="text-decoration:none;">Shared Services Agreement by and between the Company and NantWorks, LLC, dated November&#160;10, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:3.4pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.22</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 30, 2016</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459016015596/nk-ex1023_1729.htm"><span style="text-decoration:none;">Facility License Agreement by and between the Company and NantWorks, LLC, dated November&#160;10, 2015</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.23</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 30, 2016</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459016019464/nk-ex101_452.htm"><span style="text-decoration:none;">Offer Letter between Sonja Nelson and the Company, dated April&#160;7, 2016</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 16, 2016</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459016024275/nk-ex101_112.htm"><span style="text-decoration:none;">Amended and Restated Shared Services Agreement by and between the Company and NantWorks LLC, dated June&#160;28, 2016</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 15, 2016</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.20</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459016028905/nk-ex101_159.htm"><span style="text-decoration:none;">Lease agreement by and between the Company and 605 Doug Street, LLC, dated June&#160;28, 2016</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 10, 2016</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.21+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459018019420/nk-ex101_64.htm"><span style="text-decoration:none;">Letter Agreement with Barry Simon dated May&#160;3, 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 06, 2018</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.22+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1326110/000156459018019420/nk-ex102_65.htm"><span style="text-decoration:none;">Offer of Employment Letter with Sonja Nelson dated June&#160;11, 2018</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 06, 2018</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.23</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312519169172/d723718dex991.htm"><span style="text-decoration:none;">Notice of Pendency of Proposed Settlement of Stockholder Derivative Action dated May&#160;31, 2019.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;10, 2019</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.24</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312519169172/d723718dex992.htm"><span style="text-decoration:none;">Stipulation and Agreement of Settlement dated April&#160;10, 2019.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;10, 2019</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.25</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459019029330/nk-ex104_267.htm"><span style="text-decoration:none;">Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated July&#160;5, 2019.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;6, 2019</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.26</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020012816/nk-ex1026_1106.htm"><span style="text-decoration:none;">Cost Allocation Agreement between the Company and ImmunityBio, Inc. and its subsidiaries, dated January&#160;29, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.26</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March&#160;25, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.27</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020024168/nk-ex101_98.htm"><span style="text-decoration:none;">First Amendment to the July&#160;1, 2019 Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated March 31, 2020</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May&#160;5, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.28</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020038096/nk-ex102_317.htm"><span style="text-decoration:none;">COVID Joint Development, Manufacturing, and Marketing Agreement between NantKwest, Inc. and ImmunityBio, Inc. Binding Term Sheet, dated May&#160;22, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;7, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155</p>
<hr style="page-break-after:always" />
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td rowspan="2" valign="bottom" style="width:7.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td colspan="7" valign="bottom" style="width:43.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by Reference Herein</p></td>
</tr>
<tr>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:48.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="width:0.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="width:0.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:10.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File No.</p></td>
<td valign="bottom" style="width:0.68%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:7.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="bottom" style="width:0.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:15.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filing Date</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.29</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020052488/nk-ex101_92.htm"><span style="text-decoration:none;">COVID Joint Development, Manufacturing, and Marketing Agreement between NantKwest, Inc. and ImmunityBio, Inc., dated August&#160;21, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;9, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.30</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020052488/nk-ex102_93.htm"><span style="text-decoration:none;">First Amendment to Facility License Agreement by and between &#160;&#160;NantWorks, LLC and NantKwest, Inc., dated September&#160;14, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;9, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.31</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020052488/nk-ex103_94.htm"><span style="text-decoration:none;">Sublease Agreement between Altor Bioscience Manufacturing Company, LLC and NantKwest, Inc., dated September&#160;14, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;9, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.32+</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000156459020052488/nk-ex104_390.htm"><span style="text-decoration:none;">Offer Letter between the Company and Richard Adcock, dated October&#160;26, 2020</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;9, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.33</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312520323766/d21044dex101.htm"><span style="text-decoration:none;">Voting Agreement, dated December&#160;21, 2020, by and among ImmunityBio, Inc., NantKwest, Inc., and the NantKwest, Inc. stockholders party thereto.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;22, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.34</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001326110/000119312520323766/d21044dex102.htm"><span style="text-decoration:none;">Voting Agreement, dated December&#160;21, 2020, by and among NantKwest, Inc., ImmunityBio, Inc. and the ImmunityBio, Inc. stockholders party thereto</span></a><span style="text-decoration:none;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">001-37507</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;22, 2020</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.35*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex1035_433.htm"><span style="text-decoration:none;">Lease Agreement between 605 Nash, LLC and NantKwest, Inc., dated February&#160;11, 2021</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;21.1*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex211_10.htm"><span style="text-decoration:none;">Subsidiaries.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;23.1*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex231_7.htm"><span style="text-decoration:none;">Consent of Ernst &#38; Young LLP, Independent Registered Public Accounting Firm.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;24.1*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#POWER_ATTORNEY"><span style="text-decoration:none;">Power of Attorney (Contained on Signature Page to this Annual Report on Form 10-K).</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex311_8.htm"><span style="text-decoration:none;">Rule 13a-14(a) / 15d-14(a) Certification of Principal Executive Officer.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2*</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex312_6.htm"><span style="text-decoration:none;">Rule 13a-14(a) / 15d-14(a) Certification of Principal Financial Officer.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1**</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex321_9.htm"><span style="text-decoration:none;">Section 1350 Certification of Chief Executive Officer.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.2**</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nk-ex322_11.htm"><span style="text-decoration:none;">Section 1350 Certification of Chief Financial Officer.</span></a></p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Labels Linkbase Document.</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</p></td>
<td valign="top" style="width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:10.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:7.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:15.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:86.67%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Filed herewith.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report, are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of NantKwest, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report, irrespective of any general incorporation language contained in such filing.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Indicates a management contract or compensatory plan.</p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_16_FORM_10K_SUMMARY">Item&#160;16. Form&#160;10-K Summary.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Annual Report on Form&#160;10-K to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:59%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc.</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:59%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:37%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:59%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 4, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:37%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Richard Adcock</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:59%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:37%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Richard Adcock</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:59%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:37%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="POWER_ATTORNEY">POWER OF ATTORNEY</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each person whose signature appears below constitutes and appoints Richard Adcock and Sonja Nelson, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form&#160;10-K has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Patrick Soon-Shiong</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Chairman of the Board of Directors</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Patrick Soon-Shiong</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Richard Adcock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Richard Adcock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Barry J. Simon</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President, Chief Administrative Officer and Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Barry J. Simon</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Sonja Nelson</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Sonja Nelson</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Michael D. Blaszyk</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Michael D. Blaszyk</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Frederick W. Driscoll</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Frederick W. Driscoll</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;John C. Thomas, Jr.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">John C. Thomas, Jr.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Cheryl L. Cohen</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:17.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cheryl L. Cohen</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:17.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.35
<SEQUENCE>2
<FILENAME>nk-ex1035_433.htm
<DESCRIPTION>EX-10.35
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex1035_433.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;10.35</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">COMMERCIAL LEASE</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(605-607 Nash Street)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(6,883 rsf)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Commercial Lease (this &#8220;<font style="text-decoration:underline;">Lease</font>&#8221;) dated February 11, 2021, but made effective as of January 1, 2021 (the &#8220;<font style="text-decoration:underline;">Effective Date</font>&#8221;), is made by and between <font style="color:#000000;text-transform:uppercase;">605 NASH, LLC</font><font style="color:#000000;">, a California limited liability company (</font>&#8220;<font style="text-decoration:underline;">Landlord</font>&#8221;) and <font style="text-transform:uppercase;">NANTKWEST, inc.</font>, a Delaware corporation (&#8220;<font style="text-decoration:underline;">Tenant</font>&#8221;).</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="_Toc330199813"></a><font style="text-decoration:none;">ARTICLE 1</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">Basic Provisions</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="_DV_M48"></a><font style="text-decoration:none;">1.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Premises, Project and Common Areas.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Premises</font>.  That certain real property, including all improvements therein, consisting of approximately 6,883 rentable square feet (the &#8220;<font style="text-decoration:underline;">Premises</font>&#8221;) in the building commonly known as 605-607 Nash Street, El Segundo California (the &#8220;<font style="text-decoration:underline;">Building</font>&#8221;) all as depicted on <font style="text-decoration:underline;">Exhibit A</font> attached hereto.&nbsp;&nbsp;The Building is a two story mixed use building containing consisting of approximately 65,000 rentable square feet.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Project</font>.  The Building and Premises is set on approximately 87,120 square feet of land in the City of El Segundo (the &#8220;<font style="text-decoration:underline;">Project</font>&#8221;).&nbsp;&nbsp;The term "Project" as used in this Lease, shall mean, collectively: (i) the Building; (ii) all Common Areas (as defined below); (iii) any additional improvements, facilities and common areas which Landlord may add thereto from time to time within or as part of the Project, including landscaping and hardscaping; and (iv) the land upon which any of the foregoing are situated. Notwithstanding the foregoing or anything contained in this Lease to the contrary, (A) Landlord has no obligation to expand or otherwise make any improvements within the Project, and (B) Landlord shall have the right from time to time to include or exclude any improvements or facilities within the Project. Landlord reserves the right to close temporarily, make alterations or additions to, or change the location, dimensions, identities and types of any buildings, signs or other improvements that constitute the Project and the Common Areas.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Common Areas</font>.&nbsp;&nbsp;Tenant shall have the non-exclusive right to use in common with the Landlord or other tenants in the Project, those portions of the Project which are provided, from time to time, for use in common by Landlord, Tenant and any other tenants of the Project, including certain walkways, driveways, courtyards, landscaped and hardscaped areas and other improvements and facilities now or hereafter constructed surrounding, which are designated from time to time by Landlord, in its absolute discretion, as common areas to be shared by Landlord, Tenant and other tenants of the Project (collectively, the "<font style="text-decoration:underline;">Common Areas</font>").&nbsp;&nbsp;The manner in which the Common Areas are maintained and operated shall be at the reasonable discretion of Landlord and the use thereof shall be subject to such reasonable and customary rules, regulations and restrictions as Landlord may make from time to time.&nbsp;&nbsp;Landlord reserves the right to (i) make any changes, additions, improvements, repairs and/or replacements in or to the Project or the Common Areas, including, without limitation, expanding or decreasing the size of the Project and any Common Areas and other elements thereof, including adding, deleting and/or excluding buildings thereon and therefrom; (ii) close temporarily any of the common areas while engaged in making repairs, improvements or alterations to the Project, as long as such changes do not prevent Tenant&#8217;s ingress to or egress from the Premises; or (iii) perform such other acts and make such other changes with respect to the Project as Landlord may, in the exercise of good faith business judgment, deem to be appropriate.  Subject to Landlord's reasonable rules, regulations and requirements and applicable laws, Tenant shall have the non-exclusive right to use the Building's shafts, risers or conduits for the installation and maintenance of conduits and cables for communications, data processing devices and other facilities consistent with Tenant&#8217;s use of its Premises.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Term</font><font style="text-decoration:none;color:#000000;">; Option Ter</font><font style="text-decoration:none;color:#000000;">m</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>The term of this lease (&#8220;<font style="text-decoration:underline;">Term</font>&#8221;) shall commence January 1, 2021 (&#8220;<font style="text-decoration:underline;">Commencement Date</font>&#8221;).&nbsp;&nbsp;The term of this lease shall expire seven (7) years following the Commencement Date (i.e., December 31, 2027), subject to the Options set forth below (&#8220;<font style="text-decoration:underline;">Expiration Date</font>&#8221;). At any time during the Lease Term, Landlord may deliver to Tenant a Notice of Lease Term Dates in the form as set forth in <font style="text-decoration:underline;">Exhibit&#160;C</font>, attached hereto, as a confirmation only of the information set forth therein, which Tenant shall execute and return to Landlord within five&#160;(5) days of receipt thereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font>Subject to the terms hereof, Landlord hereby grants to Tenant one (1) option to extend the Term (the &#8220;<font style="text-decoration:underline;">Option</font>&#8221;) with respect to all of the then Premises for an additional three (3) year (the &#8220;<font style="text-decoration:underline;">Option Term</font>&#8221;), under the terms of this Lease, which Option shall be exercisable only by written notice delivered by Tenant to Landlord as provided below, provided that, as of the date of delivery of such notice, no uncured Default exists under this Lease.&nbsp;&nbsp;Notwithstanding the foregoing or anything to the contrary herein, the extension of the Term by the written agreement of Landlord and Tenant shall not serve to extinguish or cancel a then unexercised Option, but rather the unexercised Option shall apply to the end of such Term as extended by written agreement. Upon the proper exercise of the Option, and provided that, as of the end of the initial Term no uncured Default exists under this Lease, the Term, as it applies to the Premises, shall be extended for the Option Term.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;"></font>The monthly base rent payable by Tenant during the first year of the Option Term shall initially be 103% of the base rent payable under this Lease immediately prior to the commencement of the Option Term and thereafter such monthly Base Rent shall be subject to the Annual Increase (as defined below) set forth in Section 1.3 below. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;"></font>The Option contained in this Section 1.2 shall be exercised by Tenant, if at all, only in the manner set forth in this Section 1.2.&nbsp;&nbsp;In order to exercise the Option, Tenant shall deliver an irrevocable written notice (the <font style="text-decoration:underline;">&#8220;Exercise Notice</font>&#8221;) to Landlord not less than twelve (12) months and no earlier than eighteen (18) months prior the expiration of the Term, stating that Tenant has elected to exercise its Option.&nbsp;&nbsp;Nothing herein shall be deemed to entitle Tenant to extend the Lease Term beyond the Option Term.&nbsp;&nbsp;If Tenant does not exercise the Option during the exercise periods set forth above in strict accordance with the provisions hereof, the Option shall forever terminate and be of no further force or effect.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Base Rent.&nbsp;&nbsp;The initial monthly base rent for the lease of the Premises shall be $2.95 per rentable square foot of the Premises as set forth below (&#8220;</font><font style="text-decoration:underline;color:#000000;">Base Rent</font><font style="text-decoration:none;color:#000000;">&#8221;) (subject to abatement of rent pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 4.3</font><font style="text-decoration:none;color:#000000;">) and shall be increased by three percent (3%) annually commencing on the Commencement </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">Date</font><font style="text-decoration:none;color:#000000;"> and each year thereafter during the initial Term and, if applicable, during the Option Terms (the &#8220;</font><font style="text-decoration:underline;color:#000000;">Annual Increase</font><font style="text-decoration:none;color:#000000;">&#8221;), all as set forth below:</font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:7.61%;width:84.85%;">
<tr>
<td style="width:42.88%;"></td>
<td style="width:41.97%;"></td>
</tr>
<tr style="height:9.3pt;">
<td valign="bottom"  BGCOLOR="#BFBFBF" style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:12pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Period</p></td>
<td valign="bottom"  BGCOLOR="#BFBFBF" style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:12pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monthly Installment of Base Rent</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:12pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2021 &#8211;December 31, 2021</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:12pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$20,304.85*</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2022 &#8211;December 31, 2022</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$20,914.00</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2023 &#8211;December 31, 2023</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$21,541.42</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2024 &#8211;December 31, 2024</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$22,187.66</p></td>
</tr>
<tr style="height:1.2pt;">
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2025 &#8211;December 31, 2025</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$22,853.29</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2026 &#8211;December 31, 2026</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$23,538.89</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2027 &#8211;December 31, 2027</p></td>
<td valign="top"  style="padding-left:1.5pt;padding-Right:1.5pt;padding-Top:6pt;padding-Bottom:1.5pt; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$24,245.05</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*The monthly Base Rent shall be subject to rent abatement as set forth in <font style="text-decoration:underline;">Section 4.3</font> of this Lease.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Parking</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Commencing on Commencement Date, Tenant shall have the right to use up to five (5) unreserved parking spaces at the Project free of charge.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Payment by Tenant Upon Execution</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Upon execution of this Lease, Tenant shall pay the Security Deposit (defined below).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Security Deposit</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;One (1) month&#8217;s Base Rent (&#8220;</font><font style="text-decoration:underline;color:#000000;">Security Deposit</font><font style="text-decoration:none;color:#000000;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Agreed Use</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The Premises shall be used for pharmaceutical development and manufacturing, ancillary office, and other related uses consistent with the character of the Premises and otherwise in compliance with the provisions of Section 6 hereof (&#8220;</font><font style="text-decoration:underline;color:#000000;">Agreed Use</font><font style="text-decoration:none;color:#000000;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Tenant Improvement Allowance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;$313,176.50 (based on $6.50 per rentable square foot of the Premises per year of lease Term) (&#8220;</font><font style="text-decoration:underline;color:#000000;">Tenant Improvement Allowance</font><font style="text-decoration:none;color:#000000;">&#8221;) for costs and expenses associated with the construction of the initial tenant improvements in the Premises that are to be constructed by Tenant pursuant to the terms and conditions set forth in the Work Letter, attached hereto as </font><font style="text-decoration:underline;color:#000000;">Exhibit B</font><font style="text-decoration:none;color:#000000;"> (the &#8220;</font><font style="text-decoration:underline;color:#000000;">Work Letter</font><font style="text-decoration:none;color:#000000;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">1.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Base Rent Abatement Period. Seven (7) months (&#8220;Base Rent Abatement Period&#8221;). See Section 4.3.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 2</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">PREMISES</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Letting</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord hereby leases to Tenant, and Tenant hereby leases from Landlord, the Premises, for the Term, at the rental, and upon all of the terms, covenants and conditions set forth in this Lease.&nbsp;&nbsp;Unless otherwise provided herein, any statement of size set forth in this Lease, or that may have been used in calculating rental, is an approximation that the parties agree is reasonable and the rental based thereon is not subject to revision whether or not the actual size is more or less.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Condition</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">L</font><font style="text-decoration:none;color:#000000;">andlord </font><font style="text-decoration:none;color:#000000;">shall deliver the Premises to </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> broom clean and free of debris o</font><font style="text-decoration:none;color:#000000;">n the Commencement Date.&nbsp;&nbsp;Landlord</font><font style="text-decoration:none;color:#000000;"> represents that the existing electrical, plumbing, fire sprinkler, lighting, heating, ventilating and air conditioning systems (</font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">HVAC</font><font style="text-decoration:none;color:#000000;">&#8221;</font><font style="text-decoration:none;color:#000000;">) shall be in good operating condition on the Commencement Date and that the structural elements of the roof, bearing walls and foundation of </font><font style="text-decoration:none;color:#000000;">the </font><font style="text-decoration:none;color:#000000;">buildings </font><font style="text-decoration:none;color:#000000;">in which the Premises is located</font><font style="text-decoration:none;color:#000000;"> (the </font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Building</font><font style="text-decoration:none;color:#000000;">&#8221;</font><font style="text-decoration:none;color:#000000;">) shall be free of material defects</font><font style="text-decoration:none;color:#000000;"> on the Commencement Date</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">T</font><font style="text-decoration:none;color:#000000;">he taking of possession of the Premises by Tenant shall conclusively establish that the Premises, the Building and the Project were at such time complete and in good, sanitary and satisfactory condition and without any obligation on Landlord's part to make any alterations, upgrades or improvements thereto.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Compliance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord warrants that to its actual knowledge the improvements on the Premises comply with the building codes, applicable laws, covenants or restrictions of record, regulations, and ordinances (&#8220;</font><font style="text-decoration:underline;color:#000000;">Applicable Requirements</font><font style="text-decoration:none;color:#000000;">&#8221;) that were in effect at the time that each improvement, or portion thereof, was constructed.  Said warranty does not apply to the use to which Tenant will put the Premises, modifications which may be required by the Americans with Disabilities Act or any similar laws as a result of Tenant&#8217;s use, any installation of Improvements made pursuant to the Work Letter or to any Alterations made or to be made by Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Acknowledgments</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Except as specifically set forth in this Lease and in the Work Letter, Tenant shall accept the Premises, including the base, shell, and core of the Building (collectively, the "</font><font style="text-decoration:underline;color:#000000;">Base, Shell, and Core</font><font style="text-decoration:none;color:#000000;">") in their "AS-IS" condition as of the Commencement Date and Landlord shall not be obligated to provide or pay for any improvement work or services related to the improvement of the Premises.&nbsp;&nbsp;Tenant also acknowledges that Landlord has made no representation or warranty regarding the condition of the Premises or with respect to the suitability of any of the foregoing for the conduct of Tenant's business, except as specifically set forth in this Lease and the Work Letter.&nbsp;&nbsp;The taking of possession of the Premises by Tenant shall conclusively establish that the Premises is at such time in good and sanitary order, condition and repair.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Net Lease</font><font style="text-decoration:none;color:#000000;">. The obligations of Tenant hereunder shall be separate and independent covenants.  This is a net lease and Rent and all other sums payable hereunder by Tenant shall be paid without notice or demand, and without setoff, counterclaim, recoupment, abatement, suspension or reduction, or defense.&nbsp;&nbsp;This Lease is the absolute and unconditional obligation of Tenant, and the obligations of Tenant under this Lease shall not be affected by any interference with Tenant&#8217;s use of the premises for any reason subject only to: (i) any damage to or destruction of the Premises, as provided in Article&#160;9 of this Lease, or (ii) any condemnation or eminent domain, as provided in Article&#160;14 of this Lease.  All costs and expenses of every kind and nature whatsoever relating to the Premises (other than depreciation, interest on or amortization of debt incurred by Landlord, and costs incurred by Landlord in financing or refinancing the Premises) and the appurtenances thereto and the use and occupancy thereof which may arise or become due and payable with respect to the period which ends on the expiration or earlier termination of the Term in accordance with the provisions hereof (whether or not the same shall become payable during the Term or thereafter) shall be paid by Tenant.&nbsp;&nbsp;Tenant shall pay all expenses related to the maintenance, repair, management, or operations of the Premises as set forth in this Lease.&nbsp;&nbsp;Except as provided in Section 4.3, Tenant shall not have any right to abate Rent or other sums payable hereunder by Tenant during the Term.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">2.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Expansion Option</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Provided Tenant is not in Default under any term or provision contained in this Lease (beyond any applicable notice and cure period), Tenant shall have the right, exercisable by delivering written notice to Landlord, to expand the Premises (the &#8220;</font><font style="text-decoration:underline;color:#000000;">Expansion Option</font><font style="text-decoration:none;color:#000000;">&#8221;) to include all or any portion of the remainder of the Building (&#8220;</font><font style="text-decoration:underline;color:#000000;">Expansion Premises</font><font style="text-decoration:none;color:#000000;">&#8221;), which Expansion Premises; provided, however, the Expansion Option shall terminate and be of no further force and affect upon the earlier to occur of: (a) eighteen (18) months following the Commencement Date of this Lease (i.e., June 30, 2022), and (b) thirty (30) days following the date Landlord notifies Tenant that Landlord has either </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">countered a bona fide offer or responded to a request for proposal to lease the Expansion Premises to a third-party tenant.&nbsp;&nbsp;If Tenant exercises the Expansion Option then </font><font style="text-decoration:none;color:#000000;">(x) </font><font style="text-decoration:none;color:#000000;">the Base Rent for the </font><font style="text-decoration:none;color:#000000;">Expansion Premises </font><font style="text-decoration:none;color:#000000;">shall be $2.</font><font style="text-decoration:none;color:#000000;">9</font><font style="text-decoration:none;color:#000000;">5 per rentable square foot per month on a triple net basis with </font><font style="text-decoration:none;color:#000000;">pro-rated </font><font style="text-decoration:none;color:#000000;">initial Premises concessions (i.e. </font><font style="text-decoration:none;color:#000000;">Base Rent A</font><font style="text-decoration:none;color:#000000;">batement</font><font style="text-decoration:none;color:#000000;">, T</font><font style="text-decoration:none;color:#000000;">enant Improvement </font><font style="text-decoration:none;color:#000000;">Allowance</font><font style="text-decoration:none;color:#000000;">)</font><font style="text-decoration:none;color:#000000;"> and proportionate increases in the parking allotment and security deposit,</font><font style="text-decoration:none;color:#000000;"> and (y) the Tenant and Landlord shall enter into an amendment to this Lease to memorialize the terms of the expansion of the Premises.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 3</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">TERM</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">3.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Term</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The Commencement Date, Expiration Date and Term of this Lease are as specified in Section&#160;1.2 above.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">3.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Delay in Possession</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord agrees to use its commercially reasonable efforts to deliver possession of the Premises to Tenant by the Commencement Date.&nbsp;&nbsp;If, despite said efforts, Landlord is unable to deliver possession by such date, Landlord shall not be subject to any liability therefor, nor shall such failure affect the validity of this Lease or change the Expiration Date.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 4</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">RENT</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Rent Defined</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;All monetary obligations of Tenant to Landlord under the terms of this Lease, including without limitation, Base Rent and Operating Expenses, and all taxes, costs, expenses and other amounts that Tenant is required to pay pursuant to this Lease to any other party, together with every fine, penalty, interest and costs which may be added for late payment thereof (except for the Security Deposit), are deemed to be rent (&#8220;</font><font style="text-decoration:underline;color:#000000;">Rent</font><font style="text-decoration:none;color:#000000;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Payment</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall cause payment of Rent to be received by Landlord in lawful money of the United States, without offset or deduction, on or before the day on which it is due; provided, however, that monthly Base Rent and any other Rent payable on a monthly basis shall be payable in advance on or before the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) day of each month during the Term.&nbsp;&nbsp;Rent for any period during the term hereof which is for less than one (1) full calendar month shall be prorated based upon the actual number of days of said month.&nbsp;&nbsp;Payment of Rent shall be made to Landlord at its address stated herein or to such other persons or place as Landlord may from time to time designate in writing.&nbsp;&nbsp;Acceptance of a payment which is less than the amount then due shall not be a waiver of Landlord&#8217;s rights to the balance of such Rent, regardless of Landlord&#8217;s endorsement of any check so stating.&nbsp;&nbsp;In the event that any check, draft, or other instrument of payment given by Tenant to Landlord is dishonored for any reason, Tenant agrees to pay to Landlord the sum of $25 in addition to any late charge and Landlord, at its option, may require all future Rent be paid by cashier&#8217;s check.&nbsp;&nbsp;Payments will be applied first to accrued late charges and attorneys&#8217; fees, second to accrued interest, then to Base Rent, insurance and Real Property Taxes, and any remaining amount to any other outstanding charges or costs.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Monthly Base Rent Abatement</font><font style="text-decoration:none;color:#000000;">.&#160; Notwithstanding anything in Section 4.1 above to the contrary and provided that Tenant is not then in default under this Lease (beyond any applicable notice and cure period), Landlord hereby agrees to abate Tenant&#8217;s obligation to pay monthly Base Rent due under this Lease for the Premises (the &#8220;</font><font style="text-decoration:underline;color:#000000;">Base Rent Abatement</font><font style="text-decoration:none;color:#000000;">&#8221;) for the Base Rent Abatement Period.&#160;&#160; Tenant acknowledges and agrees that the Base Rent Abatement has been granted to Tenant as additional consideration for entering into this Lease, and for agreeing to pay the rental and performing the terms and conditions otherwise required under this Lease.&#160; If Tenant shall be in default under this Lease, and shall fail to cure such default within the notice and cure period, if any, permitted for cure pursuant to this Lease, or if this Lease is terminated for any reason other than Landlord&#8217;s breach of the Lease, then Tenant shall </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">immediately become obligated to pay to Landlord </font><font style="text-decoration:none;color:#000000;">all of the Base Rent Abatement a</font><font style="text-decoration:none;color:#000000;">mount abated hereunder during the Base Rent Abatement Period with interest as provided in this Lease from the</font><font style="text-decoration:none;color:#000000;"> date such Base Rent Abatement a</font><font style="text-decoration:none;color:#000000;">mount would have otherwise been due under this Lease but for the Base Rent Aba</font><font style="text-decoration:none;color:#000000;">tement Period provided herein.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Operating Expenses</font><font style="text-decoration:none;color:#000000;">.  Tenant shall be responsible for, and shall pay to Landlord, as additional rent, Tenant&#8217;s Pro Rata Share of Operating Expenses (as defined below) for the Project.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Operating Expenses</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean all expenses, costs and amounts of every kind and nature which Landlord pays or accrues because of or in connection with the ownership, management, insurance maintenance, security, repair, replacement, restoration or operation of the Building and the Project, or any portion thereof, including, without limitation, (i) the cost of supplying all utilities, the cost of operating, repairing, maintaining, and renovating the utility, telephone, mechanical, sanitary, and storm drainage; (ii) the cost of licenses, certificates, permits and inspections; (iii) the cost of all insurance carried by Landlord or the property manager of Landlord in connection with the Project as set forth in Article 8t; (iv) the cost of landscaping, relamping, all supplies, tools, equipment and materials used in the operation, repair and maintenance of the Project, or any portion thereof; (v) costs incurred in connection with the parking areas servicing the Project; (vi) fees and other costs, including management fees, consulting fees, legal fees and accounting fees, of all contractors and consultants in connection with the management, operation, maintenance or security of the Project; (vii) payments under any equipment rental agreements and the fair rental value of any management office space and the cost of furnishings in such management office space; (viii) wages, salaries and other compensation and benefits, including taxes levied thereon, of all persons engaged in the operation, maintenance and security of the Project; (ix) operation, repair, maintenance and replacement of all systems and equipment and components thereof of the Building and/or the Project; (x) the cost of janitorial, alarm, security and other services; (xi) the cost for maintenance and replacement of curbs and walkways, repair to roofs and re-roofing; (xii) amortization of the cost of acquiring or the rental expense of personal property used in the maintenance, operation and repair of the Project, or any portion thereof; and (xiii) the cost of capital improvements or other costs incurred in connection with the Project (A) which are intended to effect economies in the operation or maintenance of the Project, or any portion thereof, or (B) that are required under any governmental law or regulation; provided, however, that any capital expenditure shall be amortized with interest over the lesser of its useful life or, if applicable, the period of time in which the savings from such capital expenditure is equal to or greater than the cost of the capital expenditure, as Landlord shall reasonably determine.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Pro Rata Share</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean the percentage of the square footage of the Premises as compared to the square footage of the Project.  Landlord shall have the right from time to time, including when the physical size of the Building, the Premises and/or the Project has changed, to re-determine the rentable square feet of the Premises and/or Building, and Tenant's Pro Rata Share shall be adjusted to reflect any such redetermination, which redetermination shall be in a manner that fairly and equitably allocates Operating Expenses among tenants of the Project.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">4.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Payment of Operating Expenses</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;All payments of Operating Expenses shall be made within thirty (30) days of request by Landlord.&nbsp;&nbsp;Landlord may, at Landlord&#8217;s sole discretion, estimate the Operating Expenses, and require that Tenant&#8217;s Pro Rata Share of the Operating Expenses be paid in advance to Landlord by Tenant, either: (i) quarterly, (ii) monthly in advance along with the payment of the Base Rent, or (iii) in such other manner as the parties shall agree.&nbsp;&nbsp;If Landlord elects to require payment monthly in advance, the monthly payment shall be an amount equal to the estimated amount of Operating Expenses for such calendar year divided by twelve.&nbsp;&nbsp;If the total amount collected by Landlord is less than Tenant&#8217;s actual Pro Rata Share of Operating Expenses for any calendar year, as reasonably determined by Landlord, Tenant shall pay Landlord within thirty (30) days of request, such additional sums.&nbsp;&nbsp;If the total amount collected by Landlord is more than Tenant&#8217;s actual Pro Rata Share of Operating Expenses for any calendar </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">year, as reasonably determined by Landlord</font><font style="text-decoration:none;color:#000000;"> (an "</font><font style="text-decoration:underline;color:#000000;">Overage</font><font style="text-decoration:none;color:#000000;">"), Tenant shall receive a credit against the Rent next due under this Lease in the amount of such Overage (or, in the event that this Lease shall have terminated, Tenant shall receive a refund from Landlord in the amount of such Overage).</font><font style="text-decoration:none;color:#000000;"> </font><font style="text-decoration:none;color:#000000;"> </font><font style="text-decoration:none;color:#000000;">The terms of this Section 4.4 shall survive the early terminati</font><font style="text-decoration:none;color:#000000;">on or expiration of this Lease.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 5</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">security deposit</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">Tenant shall deposit with Landlord upon execution hereof the Security Deposit as security for Tenant&#8217;s faithful performance of its obligations under this Lease.&nbsp;&nbsp;If Tenant fails to pay Rent, or otherwise Defaults under this Lease, Landlord may, in addition to all other remedies available to Landlord at law or in equity, use, apply or retain all or any portion of the Security Deposit for the payment of any amount due Landlord, for Rents which will be due in the future and/or to reimburse or compensate Landlord for any liability, cost, expense, loss or damage which Landlord may suffer or incur by reason thereof.&nbsp;&nbsp;If Landlord uses or applies all or any portion of the Security Deposit, Tenant shall within ten (10) days after written request therefor deposit monies with Landlord sufficient to restore the Security Deposit to the full amount required by this Lease.  Within ninety (90) days after the expiration or termination of this Lease, Landlord shall return that portion of the Security Deposit not used or applied by Landlord.&nbsp;&nbsp;No part of the Security Deposit shall be considered to be held in trust, to bear interest or to be prepayment for any monies to be paid by Tenant under this Lease.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 6</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">USE</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Use</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall use and occupy the Premises only for the Agreed Use, and for no other purpose.&nbsp;&nbsp;Tenant shall not use or permit the Premises to be used for any other purpose without Landlord&#8217;s prior written consent, which may be granted or withheld in Landlord&#8217;s sole discretion.&nbsp;&nbsp;Tenant shall not use or permit the use of the Premises, or suffer or permit any person or persons to use the Premises or any part thereof for any purposes or in a manner that is unlawful, creates damage, waste or disturbs owners and/or occupants of, causes damage to, neighboring properties, or in any way that is contrary to any rules and regulations Landlord may require of Tenant, as the same may be amended by Landlord from time to time, or in violation of the laws of the United States of America, the State of California, the ordinances, regulations or requirements of the local municipal or county governing body or other lawful authorities having jurisdiction over the Project, including, without limitation, any such laws, ordinances, regulations or requirements relating to hazardous materials or substances, as those terms are defined by applicable laws now or hereafter in effect (collectively, the &#8220;</font><font style="text-decoration:underline;color:#000000;"></font></a>Applicable Requirements<font style="text-decoration:none;color:#000000;">&#8221;).&nbsp;&nbsp;Tenant shall not do or permit anything to be done in or about the Premises which will in any way damage the reputation of the Project or obstruct or interfere with the rights of other tenants or occupants of the Building, or injure or annoy them or use or allow the Premises to be used for any improper, unlawful or objectionable purpose, nor shall Tenant cause, maintain or permit any nuisance in, on or about the Premises.&nbsp;&nbsp;Tenant shall comply with, and Tenant&#8217;s rights and obligations under the Lease and Tenant&#8217;s use of the Premises shall be subject and subordinate to, all recorded easements, covenants, conditions, and restrictions now or hereafter affecting the Project. At its sole cost and expense, Tenant shall promptly comply with all such Applicable Requirements, including, without limitation, Applicable Requirements in effect to limit the spread of Infectious Conditions for itself and its employees, agents, contractors and invitees.&nbsp;&nbsp; Tenant will obtain and pay for all licenses and permits (including any business licenses) required for Tenant&#8217;s use and occupancy of the Premises.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Hazardous Substances.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Reportable Uses Require Consent</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Hazardous Substance</font><font style="text-decoration:none;color:#000000;">&#8221; as used in this Lease shall mean any product, substance, or waste whose presence, use, manufacture, disposal, transportation, or release, either by itself or in combination with other materials expected to be on the Premises, is either: (i) potentially injurious to the public health, safety or welfare, the environment or the Premises, (ii) regulated or monitored by any governmental authority or (iii) a basis for potential liability of Landlord to any governmental agency or third party under any applicable statute or common law theory.&nbsp;&nbsp;Hazardous Substances shall include, but not be limited to, hydrocarbons, petroleum, gasoline, and/or crude oil or any products, by-products or fractions thereof.&nbsp;&nbsp;Tenant shall not engage in any activity in or on the Premises that constitutes a Reportable Use of Hazardous Substances.  &#8220;</font><font style="text-decoration:underline;color:#000000;">Reportable Use</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean (i) the installation or use of any above or below ground storage tank, (ii) the generation, possession, storage, use, transportation, or disposal of a Hazardous Substance that requires a permit from, or with respect to which a report, notice, registration or business plan is required to be filed with, any governmental authority, and/or (iii) the presence at the Premises of a Hazardous Substance with respect to which any Applicable Requirements requires that a notice be given to persons entering or occupying the Premises or neighboring properties.&nbsp;&nbsp;Notwithstanding the foregoing, Tenant may use any ordinary and customary materials reasonably required to be used in the normal course of the Agreed Use, ordinary office supplies (copier, toner, liquid paper, glue, etc.) and common household cleaning materials, so long as such use is in compliance with all Applicable Requirements and does not expose the Premises or neighboring property to any material risk of contamination or damage or expose Landlord to any liability therefor.&nbsp;&nbsp; Landlord may require such additional assurances as Landlord reasonably deems necessary in Landlord&#8217;s sole and absolute judgment to protect itself, the public, the Premises and/or the environment against damage, contamination, injury and/or liability, including, but not limited to, the installation (and removal on or before Lease expiration or termination) of protective modifications (such as concrete encasements) and/or increasing the Security Deposit.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Duty to Inform Landlord</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If Tenant knows, or has reasonable cause to believe, that a Hazardous Substance has come to be located in, on, under or about the Premises in violation of Applicable Requirements, Tenant shall immediately give written notice of such fact to Landlord, and provide Landlord with a copy of any report, notice, claim or other documentation which it has concerning the presence of such Hazardous Substance.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Tenant Remediation</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall not cause or permit any Hazardous Substance to be spilled or released in, on, under, or about the Premises (including through the plumbing or sanitary sewer system) and shall promptly, at Tenant&#8217;s expense, comply with Applicable Requirements and take all necessary or reasonably recommended investigatory and/or remedial action, whether or not formally ordered or required, for the cleanup of any contamination of, and for the maintenance, security and/or monitoring of the Premises or neighboring properties, that was caused or materially contributed to by Tenant, or pertaining to or involving any Hazardous Substance brought onto the Premises at any time during the term of this Lease, by or for Tenant, or any third party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Tenant Indemnification</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall be solely responsible for and shall indemnify, defend, reimburse and hold Landlord, its agents, lenders and employees, if any, harmless from and against any and all loss of rents and/or damages, losses, liabilities, judgments, claims, costs, expenses, penalties, and attorneys&#8217; and consultants&#8217; fees arising out of or involving any Hazardous Substance brought, spilled or released in, on, under or about the Premises by or for Tenant, or any third party (provided, that Tenant shall have no liability under this Lease with respect to underground migration of any Hazardous Substance under the Premises from adjacent properties not caused or contributed to by Tenant).&nbsp;&nbsp;Tenant&#8217;s obligations shall include, but not be limited to, the effects of any contamination or injury to person, property or the environment created or suffered by Tenant, and the cost of investigation, removal, remediation, restoration </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">and/or abatement, and shall survive the expiration or termination of this Lease.&nbsp;&nbsp;No expiration, termination or cancellation of this Lease and no release agreement entered into by Landlord and Tenant shall release Tenant from its obligations under this Lease with respect to Hazardous Substances, unless specifically so agreed by Landlord in writing at the time of such agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Compliance with Applicable Requirements</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall, at Tenant&#8217;s sole expense, fully, diligently and in a timely manner, comply with all Applicable Requirements, the requirements of any applicable fire insurance underwriter or rating bureau, and the recommendations of Landlord&#8217;s engineers and/or consultants which relate in any manner to the Premises, without regard to whether said requirements are now in effect or become effective after the Commencement Date.&nbsp;&nbsp;Tenant shall, within ten (10) days after receipt of Landlord&#8217;s written request, provide Landlord with copies of all permits and other documents, and other information evidencing Tenant&#8217;s compliance with any Applicable Requirements specified by Landlord, and shall immediately upon receipt, notify Landlord in writing (with copies of any documents involved) of any threatened or actual claim, notice, citation, warning, complaint or report pertaining to or involving the failure of Tenant or the Premises to comply with any Applicable Requirements.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">6.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Inspection; Compliance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord and Landlord&#8217;s &#8220;</font><font style="text-decoration:underline;color:#000000;">Lender</font><font style="text-decoration:none;color:#000000;">&#8221; (as defined in Section&#160;17.13(a) below), if applicable, and consultants shall have the right to enter into Premises at any time, in the case of an emergency, and otherwise at reasonable times, for the purpose of inspecting the condition of the Premises and for verifying compliance by Tenant with this Lease.&nbsp;&nbsp;The cost of any such inspections shall be paid by Landlord, unless a violation of Applicable Requirements, or a Hazardous Substance condition is found to exist or be imminent, or the inspection is requested or ordered by a governmental authority.  In such case, Tenant shall upon request reimburse Landlord for the cost of such inspections, so long as such inspection is reasonably related to the violation or contamination.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 7</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">maintenance; repairs; utility installations; fixtures and alternations</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant&#8217;s Obligations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">In General</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Except as provided in Section 7.2, it is expressly understood and agreed that Landlord is under no obligation to provide Tenant with any services (including, without limitation, any security services or janitorial services). Tenant shall, at Tenant&#8217;s sole expense, keep the Premises, Trade Fixtures, Utility Installations and Alterations in good order, condition, appearance and repair (whether or not the portion of the Premises requiring repairs, or the means of repairing the same, are reasonably or readily accessible to Tenant, whether or not the need for such repairs occurs as a result of Tenant&#8217;s use, any prior use, the elements or the age of such portion of the Premises, and whether such maintenance or repair is foreseen or unforeseen), Tenant, in keeping the Premises in good order, condition and repair, shall exercise and perform good maintenance practices.  Tenant&#8217;s obligations shall include restorations, replacements or renewals when necessary to keep the Premises and all improvements thereon or a part thereof in good order, condition and state of repair.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Failure to Perform</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If Tenant fails to perform Tenant&#8217;s obligations under this Section&#160;7.1, Landlord may enter upon the Premises after ten (10) days&#8217; prior written notice to Tenant (except in the case of an emergency, in which case no notice shall be required), perform such obligations on Tenant&#8217;s behalf, and put the Premises in good order, condition and repair, and Tenant shall promptly pay to Landlord a sum equal to 110% of the cost thereof.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Landlord&#8217;s Obligations</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Subject to reimbursement pursuant to Section 4.4, Landlord shall repair and maintain the exterior roof, structural portions of the Building and Premises, base building systems (including HVAC, electrical and plumbing systems) and the Common Areas. </font><font style="font-weight:bold;text-decoration:none;color:#000000;"> </font><font style="text-decoration:none;color:#000000;">Landlord shall not be required </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">to make any repair, replacement, maintenance or other work whatsoever </font><font style="text-decoration:none;color:#000000;">in the interior of the Premises</font><font style="text-decoration:none;color:#000000;">, and </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> waives the right to make repairs, replacements or to perform maintenance or other work at the expense of </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;">, which right may be provided for in any Applicable </font><font style="text-decoration:none;color:#000000;">Requirement</font><font style="text-decoration:none;color:#000000;">s.&nbsp;&nbsp;It is the intention of the </font><font style="text-decoration:none;color:#000000;">parties</font><font style="text-decoration:none;color:#000000;"> that the terms of this Lease govern the respective obligations of the </font><font style="text-decoration:none;color:#000000;">parties</font><font style="text-decoration:none;color:#000000;"> as to maintenance and repair of the Premises, and they expressly waive the benefit of any statute now or hereafter in effect to the extent it is inconsistent with the terms of thi</font><font style="text-decoration:none;color:#000000;">s Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Utility Installations; Trade Fixtures; Alterations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Definitions</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Utility Installations</font><font style="text-decoration:none;color:#000000;">&#8221; refers to all floor and window coverings, air lines, steam lines, power panels, electrical distribution, security and fire protection systems, communication systems, information technology infrastructure, lighting fixtures, HVAC and other air-handling equipment, plumbing, and fencing in or on the Premises.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Trade Fixtures</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean Tenant&#8217;s machinery and equipment that can be removed without doing material damage to the Premises.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Alterations</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean any modification or improvements, other than Utility Installations or Trade Fixtures, whether by addition or deletion.&nbsp;&nbsp;&#8220;</font><font style="text-decoration:underline;color:#000000;">Tenant Owned Alterations</font><font style="text-decoration:none;color:#000000;"> and/or </font><font style="text-decoration:underline;color:#000000;">Utility Installations</font><font style="text-decoration:none;color:#000000;">&#8221; are defined as Alterations and/or Utility Installations made by Tenant that are not yet owned by Landlord pursuant to Section&#160;7.4(a).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Consent</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Except for any Improvements to be constructed by Tenant pursuant to the Work Letter, Tenant shall not make any Alterations or Utility Installations to the Premises without Landlord&#8217;s prior consent.&nbsp;&nbsp;Tenant may, however, make non-structural Utility Installations to the interior of the Premises (excluding the roof) without such consent but upon notice to Landlord, as long as they are not visible from the outside, do not involve puncturing, relocating or removing the roof or any existing walls, will not affect the electrical, plumbing, HVAC, and/or life safety systems, and the cumulative cost thereof during this Lease for each building comprising a portion of the Premises does not exceed $100,000.00 in the aggregate.&nbsp;&nbsp;Notwithstanding the foregoing, Tenant shall not make or permit any roof penetrations and/or install anything on the roof without the prior approval of Landlord.&nbsp;&nbsp;Any Alterations or Utility Installations that Tenant shall desire to make and which require the consent of Landlord shall be made in accordance with the Work Letter.&nbsp;&nbsp;Each of the parties hereto shall perform the obligations imposed upon such party in the Work Letter at the times and in the manner therein provided. Consent shall be deemed conditioned upon Tenant&#8217;s: (i) acquiring all applicable governmental permits, (ii) furnishing Landlord with copies of both the permits and the plans and specifications prior to commencement of the work, and (iii) compliance with all conditions of said permits and other Applicable Requirements in a prompt and expeditious manner.&nbsp;&nbsp;Any Alterations or Utility Installations shall be performed in a workmanlike manner with good and sufficient materials.&nbsp;&nbsp;Tenant shall, promptly upon completion, furnish Landlord with as-built plans and specifications.&nbsp;&nbsp;For work which costs an amount equal to the greater of one (1) month&#8217;s Base Rent, Landlord may condition its consent upon Tenant providing a lien and completion bond in an amount equal to one and one-half times the estimated cost of such Alteration or Utility Installation or upon Tenant&#8217;s posting an additional Security Deposit with Landlord equal to such amount, which additional Security Deposit shall be returned to Tenant upon completion of the work.&nbsp;&nbsp;Tenant must reimburse Landlord within ten (10) days after Tenant&#8217;s receipt of Landlord&#8217;s invoice for Landlord&#8217;s actual and reasonable costs incurred relating to any Utility Installations, Trade Fixtures or Alterations, including but not limited to all management, engineering, consulting, construction and legal fees incurred by Landlord for the review and approval of Tenant&#8217;s plans and specifications or for monitoring Tenant&#8217;s construction of any Utility Installations, Trade Fixtures or Alterations. In the event that Tenant makes any Alterations, then prior to the commencement of such Alterations, Tenant shall provide Landlord with evidence that Tenant carries &#8220;</font></a>Builder&#8217;s All Risk&#8221; insurance in an amount approved by Landlord covering the construction of such Alterations, and such other insurance as Landlord may reasonably require, it being understood and agreed that all of such Alterations shall be insured by Tenant pursuant to Article 8 of this Lease immediately upon completion thereof.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Liens; Bonds</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> shall pay, when due, all claims for labor or materials furnished or alleged to have been furnished to or for </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> at or for use on the Premises, which claims are or may be secured by any mechanic</font><font style="text-decoration:none;color:#000000;">&#8217;</font><font style="text-decoration:none;color:#000000;">s or materialmen</font><font style="text-decoration:none;color:#000000;">&#8217;</font><font style="text-decoration:none;color:#000000;">s lien against the Premises or any interest therein.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> shall give </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> not less than ten (10) days</font><font style="text-decoration:none;color:#000000;">&#8217;</font><font style="text-decoration:none;color:#000000;"> notice prior to the commencement of any work in, on or about the Premises, and </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> shall have the right to post notices of non-responsibility.&nbsp;&nbsp;If </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> shall contest the validity of any such lien, claim or demand, then </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> shall, at its sole expense, defend and protect itself, </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> and the Premises against the same and shall pay and satisfy any such adverse judgment that may be rendered thereon before the enforcement thereof.&nbsp;&nbsp;If </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> shall require, </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> shall furnish a surety bond in an amount equal to one and one-half times the amount of such contested lien, claim or demand, indemnifying </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> against liability for the same.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> shall not be liable for any labor, services or materials furnished to </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> or to any party holding any portion of the Premises through or under </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> and no mechanic</font><font style="text-decoration:none;color:#000000;">&#8217;</font><font style="text-decoration:none;color:#000000;">s liens or other liens for any labor, services or materials shall attach&#233; to the Premises or the leasehold estate created thereby.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Ownership; Removal; Surrender; and Restoration.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Ownership</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Subject to Landlord&#8217;s right to require removal or elect ownership as hereinafter provided, all Alterations and Utility Installations made by Tenant shall be the property of Tenant, but considered a part of the Premises.&nbsp;&nbsp;Landlord may, at any time, elect in writing to be the owner of all or any specified part of the Tenant Owned Alterations and Utility Installations.&nbsp;&nbsp;Unless otherwise instructed per Section&#160;7.4(b) hereof, all Tenant Owned Alterations and Utility Installations shall, at the expiration or termination of this Lease, become the property of Landlord and be surrendered by Tenant with the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Removal</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;By delivery to Tenant of written notice from Landlord no later than sixty (60) days prior to the end of the term of this Lease, Landlord may require that any or all Tenant Owned Alterations or Utility Installations installed by or for the benefit of Tenant after the date of this Lease be removed by the expiration or earlier termination of this Lease, or within thirty (30) days following delivery of such written notice, if given after expiration or termination of this Lease.&nbsp;&nbsp;Landlord may require the removal at any time of all or any part of any Tenant Owned Alterations or Utility Installations made without the required consent.&nbsp;&nbsp;Notwithstanding anything to the contrary in this Lease, Tenant shall not be required to remove any of the initial Improvements installed prior to Tenant&#8217;s initial occupancy of the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Surrender; Restoration</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall surrender the Premises by the Expiration Date or any earlier termination date, with all of the improvements, parts and surfaces thereof broom clean and free of debris, and in good operating order, condition and state of repair, normal wear and tear excepted.  Tenant shall perform all restorations, replacements or renewals required to deliver the Premises and all improvements thereon or a part thereof to Landlord in good order, condition and state of repair, normal wear and tear excepted. Tenant shall repair any damage occasioned by the installation, maintenance or removal of Trade Fixtures, Tenant Owned Alterations or Utility Installations, furnishings, and equipment as well as the removal of any storage tank installed by or for Tenant, and the removal, replacement, or remediation of any soil, material or groundwater contaminated by Tenant.&nbsp;&nbsp;Trade Fixtures shall remain the property of Tenant and shall be removed by Tenant.  Any personal property of Tenant not removed on or before the Expiration Date or any earlier termination date shall be deemed to have been abandoned by Tenant and may be disposed of or retained by Landlord at Landlord&#8217;s sole discretion.  The failure by Tenant to timely vacate the Premises pursuant to this Section&#160;7.4(c) without the express written consent of Landlord shall constitute a holdover under the provisions of Section&#160;17.9 below.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">7.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Tenant&#8217;s Default of Maintenance and Repair Obligations</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If Tenant shall be in default of any of the provisions of this Section&#160;7, Landlord may, after thirty (30) days&#8217; written notice to Tenant and failure of Tenant to cure during said period, but without notice in the case of an emergency, do whatever is </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">necessary to cure such default as may be appropriate under the circumstances for the account of and at the expense of </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;All reasonable sums so paid by </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> and all reasonable expenses (including without limitation reasonable attorneys</font><font style="text-decoration:none;color:#000000;">&#8217;</font><font style="text-decoration:none;color:#000000;"> fees and costs) so incurred, together with Interest from the date of payment or the incurring of such expenses, shall constitute Rent payable by </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> under this Lease and shall be paid by </font><font style="text-decoration:none;color:#000000;">Tenant</font><font style="text-decoration:none;color:#000000;"> to </font><font style="text-decoration:none;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;"> on demand.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 8</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">insurance; indemnity</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Payment for Insurance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall pay for all insurance required under Paragraph 8.&nbsp;&nbsp;Premiums for policy periods commencing prior to or extending beyond the Term shall be prorated to correspond to the Term.&nbsp;&nbsp;Payment for insurance held by Tenant shall be made by Tenant directly to the insurance carrier.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Liability Insurance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall obtain and keep in force during the term of this Lease (i) a Commercial General Liability policy of insurance protecting Tenant and Landlord as an additional insured against claims for bodily injury, property damage and personal injury based upon, relating to, involving, or arising out of the use, occupancy, or maintenance of the Premises and all areas appurtenant thereto with such insurance to be on an occurrence basis providing single limit coverage in an amount not less than $1,000,000 per occurrence with an annual aggregate of not less than $2,000,000, and (ii) excess (or umbrella) liability insurance in an amount not less than$ $1,000,000 per occurrence $3,000,000 aggregate limit, applying in excess over the limits and coverages noted in subsection (i) above.&nbsp;&nbsp;Tenant shall promptly provide Landlord with evidence of such insurance in the form of an endorsement to the policy.&nbsp;&nbsp;The insurance shall include an &#8220;Additional Insured &#8211; Managers, Landlords, of Premises&#8221; endorsement.&nbsp;&nbsp;The policy shall not contain any inter-insured exclusions as between insured persons or organizations, shall contain endorsements for cross-liability to ensure a severability of interests, but shall include coverage for liability assumed under this Lease as an &#8220;insured contract&#8221; for the performance of Tenant&#8217;s indemnity obligations under this Lease.&nbsp;&nbsp;The limits of said insurance required by this Lease or as carried by Tenant shall not, however, limit the liability of Tenant, nor relieve Tenant of any obligation hereunder.&nbsp;&nbsp;All insurance to be carried by Tenant shall be primary to and not contributory with any insurance carried by Landlord, whose insurance shall be considered excess insurance only and shall not insure Tenant. Tenant shall comply with and maintain, and shall require all its vendors and contractors who provide services to or upon the Premises to comply and maintain, reasonable insurance requirements as set forth by Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Property Insurance &#8211; Building and Improvements.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Building and Improvements</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Subject to reimbursement pursuant to Section 4.4, Landlord shall obtain and keep in force, at Tenant&#8217;s sole cost and expense, a policy or policies in the name of Landlord, with loss payable to Landlord insuring loss or damage to the Premises.&nbsp;&nbsp;The amount of such insurance shall be equal to the Replacement Cost of the Premises, as the same shall exist from time to time, but in no event more than the commercially reasonable and available insurable value thereof.&nbsp;&nbsp;If the coverage is available and commercially appropriate, such policy or policies shall insure against all risks of direct physical loss or damage, including coverage for debris removal and the enforcement of any Applicable Requirements requiring the upgrading, demolition, reconstruction or replacement of any portion of the Premises as the result of a covered loss.&nbsp;&nbsp;Said policy or policies shall not exclude flood coverage if the Premises are located in a flood zone, and may include earthquake coverage in Landlord&#8217;s discretion.  Said policy or policies shall also contain, if available and commercially appropriate, an agreed valuation provision in lieu of any coinsurance clause, waiver of subrogation, and inflation guard protection causing an increase in the annual property insurance coverage amount by a factor of not less than the adjusted U.S.&nbsp;&nbsp;Department of Labor Consumer Price Index for All Urban Consumers for the city nearest to where the Premises is located.&nbsp;&nbsp;Such insurance coverage may have a deductible clause, and such deductible amount </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">shall be an Operating</font><font style="text-decoration:none;color:#000000;"> Expense pursuant to Section 4.4</font><font style="text-decoration:none;color:#000000;">, </font><font style="text-decoration:none;color:#000000;">in the event of an Insured Loss.</font><font style="text-decoration:none;color:#000000;">&nbsp;&nbsp;Tenant, at Tenant&#8217;s option, by providing written notice to Landlord, shall have the right to obtain the insurance required in this section.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant&#8217;s Property; Business Interruption Insurance; Worker&#8217;s Compensation Insurance.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Property Damage</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall obtain and maintain insurance coverage on all of Tenant&#8217;s personal property, Trade Fixtures, and Tenant Owned Alterations and Utility Installations for the full replacement cost thereof.&nbsp;&nbsp;The proceeds from any such insurance shall be used by Tenant for the replacement of personal property, Trade Fixtures and Tenant Owned Alterations and Utility Installations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Business Interruption Insurance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall obtain and maintain loss of income and extra expense insurance in amounts as will reimburse Tenant for direct or indirect loss of earnings attributable to all perils commonly insured against by prudent Tenants in the business of Tenant or attributable to prevention of access to the Premises as a result of such perils.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Worker&#8217;s Compensation Insurance</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall obtain and maintain worker&#8217;s compensation insurance in such amount as may be required by Applicable Requirements.&nbsp;&nbsp;Such policy shall include a &#8220;Waiver of Subrogation&#8221; endorsement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">No Representation of Adequate Coverage</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord makes no representation that the limits or forms of coverage of insurance specified herein are adequate to cover Tenant&#8217;s property, business operations or obligations under this Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Additional Requirement. Landlord may require that Tenant&#8217;s licensees, vendors, or agents carry reasonable insurance coverage and list Landlord and any management company of the Property as additional insureds.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Insurance Policies</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Insurance required herein shall be by companies duly licensed or admitted to transact business in the state where the Premises are located, and maintaining during the policy term a &#8220;General Policyholders Rating&#8221; of at least A-, VII, as set forth in the most current issue of &#8220;Best&#8217;s Insurance Guide,&#8221; or such other rating as may be reasonably required by a Lender.&nbsp;&nbsp;Tenant shall not do or permit to be done anything that invalidates the required insurance policies.&nbsp;&nbsp;Tenant shall, prior to the Commencement Date, deliver to Landlord certified copies of policies of such insurance or endorsements evidencing the existence and amounts of the required insurance.&nbsp;&nbsp;Tenant shall, at least thirty (30) days prior to the expiration of such policies, furnish Landlord with evidence satisfactory to Landlord of renewals or &#8220;insurance binders&#8221; evidencing renewal thereof, or Landlord may order such insurance and charge the cost thereof to Tenant, which amount shall be payable by Tenant to Landlord upon demand.&nbsp;&nbsp;Such policies shall be for a term of at least one (1) year, or the length of the remaining term of this Lease, whichever is less.&nbsp;&nbsp;If Tenant shall fail to procure and maintain the insurance required to be carried by it, Landlord may, but shall not be required to, procure and maintain the same at Tenant&#8217;s expense, for which Tenant shall promptly reimburse Landlord together with Interest thereon from the date paid by Landlord.&nbsp;&nbsp;Tenant shall pay all premiums for the insurance required by this Section&#160;8 as they become due.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Waiver of Subrogation</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Without affecting any other rights or remedies, Tenant and Landlord each hereby release and relieve the other, and waive their entire right to recover damages against the other, for loss of or damage to its property arising out of or incident to the perils required to be insured against herein.&nbsp;&nbsp;The effect of such releases and waivers is not limited by the amount of insurance carried or required, or by any deductibles applicable hereto.&nbsp;&nbsp;The parties agree to have their respective property damage insurance carriers waive any right to subrogation that such companies may have against Landlord or Tenant, as the case may be, so long as the insurance is not invalidated thereby.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Indemnity</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Except for Landlord&#8217;s gross negligence or willful misconduct, Tenant shall indemnify, protect, defend and hold harmless the Premises, Landlord </font><font style="text-decoration:none;color:#000000;">and its agents and Lenders </font><font style="text-decoration:none;color:#000000;">from and against any and all claims, loss of rents and/or damages, liens, judgments, penalties, attorneys&#8217; and consultants&#8217; fees, expenses and/or liabilities arising out of, involving, or in connection with, the use and/or occupancy of the Premises or the Project by Tenant or Tenant&#8217;s agents, contractors, employees</font><font style="text-decoration:none;color:#000000;">, licensees</font><font style="text-decoration:none;color:#000000;"> or invitees (collectively, &#8220;</font><font style="text-decoration:underline;color:#000000;">Tenant </font><font style="text-decoration:underline;color:#000000;">P</font><font style="text-decoration:underline;color:#000000;">arties</font><font style="text-decoration:none;color:#000000;">&#8221;), </font><font style="text-decoration:none;color:#000000;">any act, omission or negligence of any Tenant </font><font style="text-decoration:none;color:#000000;">P</font><font style="text-decoration:none;color:#000000;">arties</font><font style="text-decoration:none;color:#000000;">, or any breach of this Lease by Tenant</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If any action or proceeding is brought against Landlord by reason of any of the foregoing matters, Tenant shall upon notice defend the same at Tenant&#8217;s expense by counsel reasonably satisfactory to Landlord and Landlord shall </font><font style="text-decoration:none;color:#000000;">reasonably </font><font style="text-decoration:none;color:#000000;">cooperate with Tenant in such defense.&nbsp;&nbsp;Landlord need not have first paid any such claim </font><font style="text-decoration:none;color:#000000;">in order</font><font style="text-decoration:none;color:#000000;"> to</font><font style="text-decoration:none;color:#000000;"> be defended or indemnified.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">8.14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Exemption of Landlord and its Agents from Liability</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Notwithstanding the negligence or breach of this Lease by Landlord or its agents, neither Landlord nor its agents shall be liable under any circumstances for injury or damage to the person or goods, wares, merchandise or other property of any Tenant Parties or any other person in or about the Premises, by reason of the condition of the Premises or the operation thereof or for any other reason, whether such damage or injury is caused by or results from fire, steam, electricity, gas, water or rain, or from the breakage, leakage, obstruction or other defects of pipes, fire sprinklers, wires, appliances, plumbing, HVAC or lighting fixtures, or from any other cause, whether the said injury or damage results from conditions arising upon the Premises or upon other portions of the Building of which the Premises are a part, or from other sources or places.&nbsp;&nbsp;Landlord and its agents shall not be liable for any damages arising from any act or neglect of any other tenant of Landlord.  Notwithstanding Landlord&#8217;s negligence or breach of this Lease, Landlord shall under no circumstances be liable for injury to Tenant&#8217;s business or for any loss of income or profit therefrom and Tenant waives any claim against Landlord for actual, consequential, incidental, exemplary or punitive damages.&nbsp;&nbsp;Instead, it is intended that Tenant&#8217;s sole recourse in the event of such damages or injury be to file a claim on the insurance policy(ies) that Tenant is required to maintain pursuant to the provisions of this Section&#160;8.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 9</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">damage or destruction</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Definitions.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Premises Partial Damage</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean damage or destruction to the improvements on the Building or Premises, other than Tenant Owned Alterations and Utility Installations, which can reasonably be repaired in six (6) months or less from the date of the damage or destruction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Premises Total Destruction</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean damage or destruction to the Building or Premises, other than Tenant Owned Alterations and Utility Installations and Trade Fixtures, which cannot reasonably be repaired in six (6) months or less from the date of the damage or destruction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Insured Loss</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean damage or destruction to improvements on the Premises, other than Tenant Owned Alterations and Utility Installations and Trade Fixtures, which was caused by an event required to be covered by the insurance described in Section&#160;8.3(a), irrespective of any deductible amounts or coverage limits involved.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Replacement Cost</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean the cost to repair or rebuild the improvements owned by Landlord at the time of the occurrence to their condition existing immediately prior thereto, including demolition, debris removal and upgrading required by the operation of Applicable Requirements, and without deduction for depreciation.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">&#8220;</font><font style="text-decoration:underline;color:#000000;">Hazardous Substance Condition</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean </font><font style="text-decoration:none;color:#000000;">the occurrence or discovery of a condition involving the presence of, or a contamination by, a Hazardous Substan</font><font style="text-decoration:none;color:#000000;">ce</font><font style="text-decoration:none;color:#000000;">, in, on, or under the Premises which requires remediation.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Notification</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Upon the occurrence of a casualty, damage or destruction to the Building or Premises, Landlord shall notify Tenant within thirty (30) days from the date of such event informing Tenant if such casualty, damage or destruction constitutes Premises Partial Damage or Premises Total Destruction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Partial Damage &#8211; Insured Loss</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If a Premises Partial Damage that is an Insured Loss occurs, then Landlord shall, at Tenant&#8217;s expense, repair such damage (but not Tenant&#8217;s Trade Fixtures or Tenant Owned Alterations and Utility Installations) as soon as reasonably possible and this Lease shall continue in full force and effect.&nbsp;&nbsp;Premises Partial Damage due to flood or earthquake shall be subject to Section&#160;9.4, notwithstanding that there may be some insurance coverage, but the net proceeds of any such insurance shall be made available for the repairs.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Partial Damage &#8211; Uninsured Loss</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If a Premises Partial Damage that is not an Insured Loss occurs, unless caused by a negligent or willful act of Tenant (in which event Tenant shall reimburse Landlord for the cost of the repairs), Landlord may either: (i) repair such damage as soon as reasonably possible at Landlord&#8217;s expense, in which event this Lease shall continue in full force and effect, or (ii) terminate this Lease by giving written notice to Tenant within thirty (30) days after receipt by Landlord of knowledge of the occurrence of such damage.  Such termination shall be effective sixty (60) days following the date of such notice. In the event Landlord elects to terminate this Lease, Tenant shall have the right within ten (10) days after receipt of the termination notice to give written notice to Landlord of Tenant&#8217;s commitment to pay for the repair of such damage without reimbursement from Landlord.&nbsp;&nbsp;Tenant shall provide Landlord with said funds or satisfactory assurance thereof within thirty (30) days after making such commitment. In such event this Lease shall continue in full force and effect, and Landlord shall proceed to make such repairs as soon as reasonably possible after the required funds are available.  If Tenant does not make the required commitment, this Lease shall terminate as of the date specified in the termination notice.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Total Destruction</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Notwithstanding any other provision hereof, if a Premises Total Destruction occurs, this Lease shall terminate sixty (60) days following such Destruction.&nbsp;&nbsp;If the damage or destruction was caused by the negligence or willful misconduct of Tenant, Landlord shall have the right to recover Landlord&#8217;s damages from Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Damage Near End of Term</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If at any time during the last six (6) months of this Lease there is damage for which the cost to repair exceeds one (1) month&#8217;s Base Rent, whether or not an Insured Loss, Landlord may terminate this Lease effective sixty (60) days following the date of occurrence of such damage by giving a written termination notice to Tenant within thirty (30) days after the date of occurrence of such damage.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Abatement of Rent; Tenant&#8217;s Remedies.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Abatement</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;In the event of Premises Partial Damage or Premises Total Destruction or a Hazardous Substance Condition for which Tenant is not responsible under this Lease, the Rent payable by Tenant for the period required for the repair, remediation or restoration of such damage shall be abated in proportion to the degree to which Tenant&#8217;s use of the Premises is impaired.  All other obligations of Tenant hereunder shall be performed by Tenant, and Landlord shall have no liability for any such damage, destruction, remediation, repair or restoration except as provided herein.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Remedies</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If Landlord is obligated to repair or restore the Premises and does not commence, in a substantial and meaningful way, such repair or restoration within 120 days after such </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">obligation shall accrue, Tenant may, at any time prior to the commencement of such repair or restoration, give written notice to Landlord of Tenant&#8217;s election to terminate this Lease on a date not less than </font><font style="text-decoration:none;color:#000000;">sixty (</font><font style="text-decoration:none;color:#000000;">60</font><font style="text-decoration:none;color:#000000;">)</font><font style="text-decoration:none;color:#000000;"> days following the giving of such notice.&nbsp;&nbsp;If Tenant gives such notice and such repair or restoration is not commenced within </font><font style="text-decoration:none;color:#000000;">thirty (</font><font style="text-decoration:none;color:#000000;">30</font><font style="text-decoration:none;color:#000000;">)</font><font style="text-decoration:none;color:#000000;"> days thereafter, this Lease shall terminate as of the date specified in said notice.&nbsp;&nbsp;If the repair or restoration is commenced within such </font><font style="text-decoration:none;color:#000000;">thirty (</font><font style="text-decoration:none;color:#000000;">30</font><font style="text-decoration:none;color:#000000;">)</font><font style="text-decoration:none;color:#000000;"> days, this Lease shall continue in full force and effect. &#8220;</font><font style="text-decoration:underline;color:#000000;">Commence</font><font style="text-decoration:none;color:#000000;">&#8221; shall mean either the unconditional authorization of the preparation of the required plans, or the beginning of the actual work on the Premises, whichever first occurs.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">9.15</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Waive Statutes</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord and Tenant agree that the terms of this Lease shall govern the effect of any damage to or destruction of the Premises with respect to the termination of this Lease and hereby waive the provisions of any present or future statute to the extent inconsistent herewith.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 10</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">real property taxes</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Definition</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;As used herein, the term &#8220;</font><font style="text-decoration:underline;color:#000000;">Real Property Taxes</font><font style="text-decoration:none;color:#000000;">&#8221; shall include any form of assessment; real estate, general, special, ordinary, unforeseen or extraordinary, or rental levy or tax (other than inheritance, personal income or estate taxes); improvement bond; and/or license fee imposed upon or levied against any legal or equitable interest of Landlord in the Premises or the Project, Landlord&#8217;s right to other income therefrom, and/or Landlord&#8217;s business of leasing, including, without limitation, gross rentals, taxes by any authority having the direct or indirect power to tax and where the funds are generated with reference to the Building address and where the proceeds so generated are to be applied by the city, county, state or other taxing authority of a jurisdiction within which the Premises are located.&nbsp;&nbsp;Real Property Taxes shall also include any tax, fee, levy, assessment or charge, or any increase therein, imposed by reason of events occurring prior to or during the term of this Lease, including but not limited to, renovations of the Premises, construction of the Improvements, escape assessments or a change in the ownership of the Premises or any other tax or assessment imposed in lieu of any other real property.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Payment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Payment of Taxes</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;In addition to Base Rent, Tenant shall pay Tenant&#8217;s Pro Rata Share of the Real Property Taxes.&nbsp;&nbsp;Subject to Section&#160;10.2(b), all such payments shall be made at least ten (10) days prior to any delinquency date.  Landlord shall receive invoices for taxes due and upon such receipt promptly deliver such invoices or bills directly to Tenant; provided, that Landlord&#8217;s failure to deliver any such bill or invoice shall not limit Tenant&#8217;s obligation to pay such tax.  Tenant shall promptly furnish Landlord with satisfactory evidence that such taxes have been paid.&nbsp;&nbsp;If any such taxes shall cover any period of time prior to or after the expiration or termination of this Lease, Tenant&#8217;s share of such taxes shall be prorated to cover only that portion of the tax bill applicable to the period that this Lease is in effect, and Landlord shall reimburse Tenant for any overpayment.&nbsp;&nbsp;If Tenant shall fail to pay any required Real Property Taxes, Landlord shall have the right to pay the same, and Tenant shall reimburse Landlord therefor promptly upon demand.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Advance Payment</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord may, at Landlord&#8217;s option, estimate the current Real Property Taxes, and require that Tenant&#8217;s Pro Rata Share of the Real Property Taxes be paid in advance to Landlord by Tenant, either: (i) in a lump sum amount equal to Pro Rata Share of the installment due, at least twenty (20) days prior to the applicable delinquency date, or (ii) monthly in advance with the payment of the Base Rent.&nbsp;&nbsp;If Landlord elects to require payment monthly in advance, the monthly payment shall be an amount equal to the amount of the estimated amount of taxes divided by the number of months remaining before the month in which said installment becomes delinquent.&nbsp;&nbsp;When the actual amount of the applicable tax bill is known, the amount of such equal monthly advance payments shall be adjusted as required to provide the funds needed to pay the applicable taxes.&nbsp;&nbsp;If the amount collected by Landlord is insufficient to pay Tenant&#8217;s </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">Pro Rata Share of</font><font style="text-decoration:none;color:#000000;"> such Real Property Taxes when due, Tenant shall pay Landlord, upon demand, such additional sums as are necessary to pay such obligations.&nbsp;&nbsp;All moneys paid to Landlord under this </font><font style="text-decoration:none;color:#000000;">Section</font><font style="text-decoration:none;color:#000000;"> may be intermingled with other moneys of Landlord and shall not bear interest.&nbsp;&nbsp;In the event of a Breach by Tenant in the performance of its obligations under this Lease, then any balance of funds paid to Landlord under the provisions of this </font><font style="text-decoration:none;color:#000000;">Section</font><font style="text-decoration:none;color:#000000;"> may at the option of Landlord, be treated as an additional Security Deposit.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Joint Assessment</font><font style="text-decoration:none;color:#000000;">. If the Premises are not separately assessed, Tenant&#8217;s liability shall be calculated in in accordance with Section 4.4 and in such proportion to be reasonably determined by Landlord from the respective valuations assigned in the assessor&#8217;s work sheets or such other information as may be reasonably available.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">10.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Personal Property Taxes</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant shall pay, prior to delinquency, all taxes assessed against and levied upon Tenant Owned Alterations, Utility Installations, Trade Fixtures, furnishings, equipment and all personal property of Tenant.&nbsp;&nbsp;When possible, Tenant shall cause such property to be assessed and billed separately from the real property of Landlord.&nbsp;&nbsp;If any of Tenant&#8217;s said personal property shall be assessed with Landlord&#8217;s real property, Tenant shall pay Landlord the taxes attributable to Tenant&#8217;s property within ten (10) days after receipt of a written statement.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 11</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">utilities</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall obtain and timely pay for all water, gas, heat, light, power, electricity, telephone and other information technology infrastructure, trash disposal and other utilities and services supplied to the Premises, together with any taxes thereon.&nbsp;&nbsp;If any such utilities are provided to Tenant in common with Landlord or other tenants of the Building, Tenant shall pay its reasonable share of such utility expenses based upon the percentage of the square footage of the Premises as compared to the square footage of the Building. If Tenant shall use an over standard amount of utilities or consume any such utility in excess of standard office use, Tenant shall pay Landlord for such excess costs, as reasonably determined by Landlord.&nbsp;&nbsp;It is expressly understood and agreed that Landlord shall have no liability for any provision, interruption or termination of utility services to the Premises and Tenant shall have no right to abatement of Rent or other charges hereunder nor any right to terminate this Lease in the event of any such failure to provide, interruption or termination of utility services.</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 12</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">assignment and subletting</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Landlord&#8217;s Consent Required.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Except as provided in Section 12.4, Tenant shall not voluntarily or by operation of law assign, transfer, mortgage or encumber (collectively, &#8220;</font><font style="text-decoration:underline;color:#000000;">assign or assignment</font><font style="text-decoration:none;color:#000000;">&#8221;) or sublet all or any part of Tenant&#8217;s interest in this Lease or in the Premises without Landlord&#8217;s prior written consent.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">An assignment or subletting without consent shall, at Landlord&#8217;s option, be a Default curable after notice per Section&#160;13.1(e), or a noncurable Breach without the necessity of any notice and grace period.&nbsp;&nbsp;If Landlord elects to treat such unapproved assignment or subletting as a noncurable Breach, in addition to all other rights and remedies of Landlord herein, Landlord may either: (i)&#160;terminate this Lease, or (ii)&#160;upon thirty (30) days written notice, increase the monthly Base Rent to one hundred ten percent (110%) of the Base Rent then in effect.&nbsp;&nbsp;Further, in the event of such Breach and rental adjustment, all fixed rental adjustments scheduled during the remainder of the Term, including, but not limited to the annual </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">increase in Base Rent pursuant to Section 1.3 herein,</font><font style="text-decoration:none;color:#000000;"> shall be increase</font><font style="text-decoration:none;color:#000000;">d to One Hundred Ten Percent (110</font><font style="text-decoration:none;color:#000000;">%) of the scheduled adjusted rent.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant&#8217;s remedy for any breach of Section&#160;12.1 by Landlord shall be limited to compensatory damages.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Terms and Conditions Applicable to Assignment and Subletting.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Regardless of Landlord&#8217;s consent, any assignment or subletting shall not: (i) be effective without the express written assumption by such assignee or sublessee of the obligations of Tenant under this Lease, (ii) release Tenant of any obligations hereunder, or (iii) alter the primary liability of Tenant for the payment of Rent or for the performance of any other obligations to be performed by Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Landlord may accept Rent or performance of Tenant&#8217;s obligations from any person other than Tenant pending approval or disapproval of an assignment.&nbsp;&nbsp;Neither a delay in the approval or disapproval of such assignment nor the acceptance of Rent or performance shall constitute a waiver or estoppel of Landlord&#8217;s right to exercise its remedies for Tenant&#8217;s Default or Breach.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Landlord&#8217;s consent to any assignment or subletting shall not constitute a consent to any subsequent assignment or subletting.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">In the event of any Default or Breach by Tenant, Landlord may proceed directly against Tenant or anyone else responsible for the performance of Tenant&#8217;s obligations under this Lease, including any assignee or sublessee, without first exhausting Landlord&#8217;s remedies against any other person or entity responsible therefore to Landlord, or any security held by Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Each request for consent to an assignment or subletting shall be in writing, accompanied by information relevant to Landlord&#8217;s determination as to the financial and operational responsibility and appropriateness of the proposed assignee or sublessee, including but not limited to the intended use and/or required modification of the Premises, if any, together with a fee of $1,000 as consideration for Landlord&#8217;s considering and processing said request.&nbsp;&nbsp;Tenant agrees to provide Landlord with such other or additional information and/or documentation as may be reasonably requested.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Any assignee of, or sublessee under, this Lease shall, by reason of accepting such assignment, entering into such sublease, or entering into possession of the Premises or any portion thereof, be deemed to have assumed and agreed to conform and comply with each and every term, covenant, condition and obligation herein to be observed or performed by Tenant during the term of said assignment or sublease, other than such obligations as are contrary to or inconsistent with provisions of an assignment or sublease to which Landlord has specifically consented to in writing.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Additional Terms and Conditions Applicable to Subletting</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The following terms and conditions shall apply to any subletting by Tenant of all or any part of the Premises and shall be deemed included in all subleases under this Lease whether or not expressly incorporated therein.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant hereby assigns and transfers to Landlord all of Tenant&#8217;s interest in all Rent payable on any sublease, and Landlord may collect such Rent and apply same toward Tenant&#8217;s obligations under this Lease; provided, that until a Breach shall occur in the performance of Tenant&#8217;s obligations, Tenant may collect said Rent.&nbsp;&nbsp;Landlord shall not, by reason of the foregoing or any assignment of such sublease, nor by reason of the collection of Rent, be deemed liable to the sublessee for any failure of Tenant to perform and comply with any of Tenant&#8217;s obligations to such sublessee.&nbsp;&nbsp;Tenant hereby irrevocably authorizes and directs any such sublessee, upon receipt of a written notice from Landlord stating that a Breach exists in </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">the performance of Tenant&#8217;s obligations under this Lease, to pay to Landlord all Rent due and to become due under the sublease.&nbsp;&nbsp;Sublessee shall rely upon any such notice from Landlord and shall pay all Rents to Landlord without any obligation or right to inquire as to whether such Breach exists, notwithstanding any claim from Tenant to the contrary.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">In the event of a Breach by Tenant, Landlord may, at its option, require sublessee to attorn to Landlord, in which event Landlord shall undertake the obligations of the sublessor under such sublease from the time of the exercise of said option to the expiration of such sublease; provided, that Landlord shall not be liable for any prepaid rents paid or security deposit paid by such sublessee to such sublessor or for any prior Defaults or Breaches of such sublessor.&nbsp;&nbsp;If Tenant does not require the sublessor to attorn to Landlord, the sublease shall be extinguished upon the termination of this Lease as a result of Tenant&#8217;s breach hereunder, and the sublessee shall have no further right to occupy the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.15</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Any matter requiring the consent of the sublessor under a sublease shall also require the consent of Landlord.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.16</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">No sublessee shall further assign or sublet all or any part of the Premises without Landlord&#8217;s prior written consent.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.17</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Affiliated Companies/Restructuring of Business Organization</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Neither (A) the assignment or subletting by Tenant of all or any portion of this Lease or the Premises to (i) a parent or subsidiary of Tenant, or (ii) any person or entity which controls, is controlled by or under common control with Tenant, or (iii) any entity which purchases all or substantially all of the assets of Tenant in one or a series of transactions, or (iv) any entity into which Tenant is merged or consolidated (all such persons or entities described in (i), (ii), (iii) and (iv) being sometimes hereinafter referred to as "</font><font style="text-decoration:underline;color:#000000;">Affiliates</font><font style="text-decoration:none;color:#000000;">"), nor (B) any transfer of the membership interest, stock or shares of Tenant, shall be deemed a Transfer under this Article 14, provided that</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.18</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Any such Affiliate was not formed, nor was such financing intended, as a subterfuge to avoid the obligations of this Article 12;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.19</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant gives Landlord notice of any such assignment, sublease, financing or public offering;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.20</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Any such Affiliate shall assume, upon or prior to the effective date of such assignment or sublease, all the obligations of Tenant under this Lease; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.21</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant shall remain fully liable for all obligations to be performed by Tenant under this Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">12.22</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Special Transferees</font><font style="text-decoration:none;color:#000000;">.  Tenant shall be permitted, upon prior written notice to Landlord (without otherwise triggering the provisions of this Article 12 to enter into any license/use agreement for Tenant's affiliates, subsidiaries or parents in connection with Tenant's business, and such licensees shall not be deemed a Transfer under this Article 12; provided that (a) Tenant shall, at the request of Landlord,  give Landlord any documents or information reasonably requested by Landlord regarding such licensees/users (including, but not limited to, applicable certificates of insurance), and (b) Tenant shall not be permitted to separately demise any such space nor shall such licensees/users be permitted to maintain a separate reception area in the premises.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 13</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">default; breach; remedies</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Default; Breach</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;A &#8220;</font><font style="text-decoration:underline;color:#000000;">Default</font><font style="text-decoration:none;color:#000000;">&#8221; is defined as a failure by Tenant timely to comply with or perform any of the terms, covenants, conditions or rules under this Lease.&nbsp;&nbsp;A &#8220;</font><font style="text-decoration:underline;color:#000000;">Breach</font><font style="text-decoration:none;color:#000000;">&#8221; is defined as the occurrence of one or more of the following Defaults, and the failure of Tenant to cure such Default within any applicable grace period:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The failure of Tenant to make any payment of Rent or any Security Deposit required to be made by Tenant hereunder, whether to Landlord or to a third party, within three (3) business days after written notice that such payment is overdue.&nbsp;&nbsp;THE ACCEPTANCE BY LANDLORD OF A PARTIAL PAYMENT OF RENT OR SECURITY DEPOSIT SHALL NOT CONSTITUTE A WAIVER OF ANY OF LANDLORD&#8217;S RIGHTS, INCLUDING LANDLORD&#8217;S RIGHT TO RECOVER POSSESSION OF THE PREMISES.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The failure of Tenant to allow Landlord and/or its agents access to the Premises or the commission of waste, act or acts constituting public or private nuisance, and/or an illegal activity on the Premises by Tenant, where such actions continue for a period of ten (10) business days following written notice to Tenant.&nbsp;&nbsp;In the event that Tenant commits waste, a nuisance or an illegal activity a second time then, Landlord may elect to treat such conduct as a non-curable Breach rather than a Default.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The failure by Tenant to provide (i) reasonable written evidence of compliance with Applicable Requirements, (ii)&#160;the rescission of an unauthorized assignment or sublease, or (iii)&#160;any other documentation or information which Landlord may reasonably require of Tenant under the terms of this Lease, where any such Default continues for a period of ten (10) business days after written notice.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">A Default by Tenant as to the terms, covenants, conditions or provisions of this Lease, other than those described in Section&#160;13.1(a), (b), (c) or (d) above, where such Default continues for a period of thirty (30) days after written notice; provided, that if the nature of Tenant&#8217;s Default is such that it is reasonably capable of cure but&nbsp;&nbsp;more than thirty (30) days are reasonably required for its cure, then it shall not be deemed to be a Breach if Tenant promptly (but in no event later than 30 days) commences such cure within said thirty (30) day period and thereafter diligently prosecutes such cure to completion.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The occurrence of any of the following events: (i) the making of any general arrangement or assignment for the benefit of creditors; (ii) becoming a &#8220;debtor&#8221; as defined in 11&#160;U.S.C.&#160;&#167;101 or any successor statute thereto (unless, in the case of a petition filed against Tenant, the same is dismissed within sixty (60) days); (iii) the appointment of a trustee or receiver to take possession of substantially all of Tenant&#8217;s assets located at the Premises or of Tenant&#8217;s interest in this Lease, where possession is not restored to Tenant within thirty (30) days; or (iv) the attachment, execution or other judicial seizure of substantially all of Tenant&#8217;s assets located at the Premises or of Tenant&#8217;s interest in this Lease, where such seizure is not discharged within thirty (30) days; provided, however, in the event that any provision of this Section&#160;13.1(f) is contrary to any applicable law, such provision shall be of no force or effect, and not affect the validity of the remaining provisions.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Tenant does or permits anything that creates a lien on the Premises or the Project, and Tenant fails to discharge the lien within thirty days of its filing.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">If a Default occurs more than four times within any period of twelve (12) months, then, notwithstanding that Tenant cured those prior Defaults, any further Default is a Breach of this Lease for which no notice is required or cure available.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Remedies</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">If Tenant fails to perform any of its affirmative duties or obligations, within </font><font style="text-decoration:none;color:#000000;">five (</font><font style="text-decoration:none;color:#000000;">5</font><font style="text-decoration:none;color:#000000;">)</font><font style="text-decoration:none;color:#000000;"> days after written notice (or in case of an emergency, without notice), Landlord may, at its option, perform such duty or obligation on Tenant&#8217;s behalf, including but not limited to the obtaining of reasonably required bonds, insurance policies, or governmental licenses, permits or approvals. Tenant shall pay to Landlord</font><font style="text-decoration:none;color:#000000;"> an amount equal to 11</font><font style="text-decoration:none;color:#000000;">0</font><font style="text-decoration:none;color:#000000;">% of the costs and expenses of any such performance by Landlord promptly upon receipt of invoice therefor. </font><font style="text-decoration:none;color:#000000;"> </font><font style="text-decoration:none;color:#000000;">In the event of a Breach, Landlord may, with or without further notice or demand, and without limiting Landlord in the exercise of any </font><font style="text-decoration:none;color:#000000;">other </font><font style="text-decoration:none;color:#000000;">right or remedy which Landlord may have by reason of such Breach:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Terminate Tenant&#8217;s right of possession, in which case this Lease shall immediately terminate and Tenant shall immediately surrender possession of the Premises to Landlord.&nbsp;&nbsp;In such event, Landlord shall be entitled to recover from Tenant:&nbsp;&nbsp;(i) the unpaid Rent which has been earned at the time of termination; (ii) the worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of award exceeds the amount of such rental loss that Tenant proves could have been reasonably avoided; (iii) the worth at the time of award of the amount by which the unpaid rent for the balance of the term after the time of award exceeds the amount of such rental loss that Tenant proves could be reasonably avoided; and (iv) any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant&#8217;s failure to perform its obligations under this Lease, including but not limited to the cost of recovering possession of the Premises, expenses of reletting, including necessary renovation and alteration of the Premises, and reasonable attorneys&#8217; fees.&nbsp;&nbsp;The worth at the time of award of the amount referred to in provision (iii) of the immediately preceding sentence shall be computed by discounting such amount at the discount rate of the prime rate of interest published in the Wall Street Journal, or a comparable publication if the prime rate is no longer available in the Wall Street Journal plus four percent.&nbsp;&nbsp;Efforts by Landlord to mitigate damages caused by Tenant&#8217;s Breach of this Lease shall not waive Landlord&#8217;s right to recover damages under this Article&#160;13 or otherwise.&nbsp;&nbsp;If termination of this Lease is obtained through the provisional remedy of unlawful detainer, Landlord shall have the right to recover in such proceeding any unpaid Rent and damage as are recoverable therein, or Landlord may reserve the right to recover all or any part thereof in a separate suit.&nbsp;&nbsp;If a notice and grace period are required under Section&#160;13.1 was not previously given, a notice to pay rent or quit, or to perform or quit given to Tenant under the unlawful detainer statute shall also constitute the notice required by Section&#160;13.1.&nbsp;&nbsp;In such case, the applicable grace period required by Section&#160;13.1 and the unlawful detainer statute shall run concurrently, and the failure of Tenant to cure the Default within the greater of the two such grace periods shall constitute both an unlawful detainer and a Breach of this Lease entitling Landlord to the remedies provided for in this Lease and/or by said statute.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Maintain Tenant&#8217;s right to possession, in which case this Lease shall continue in effect whether or not Tenant has abandoned the Premises.&nbsp;&nbsp;In such event, Landlord shall be entitled to enforce all of Landlord&#8217;s rights and remedies under this Lease, including the right to recover the rent as it becomes due.  Acts of maintenance, efforts to relet, and/or the appointment or a receiver to protect Landlord&#8217;s interests shall not constitute a termination of Tenant&#8217;s right to possession.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Pursue the remedy of specific performance and/or injunctive relief.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Change or alter the locks at the Premises and otherwise lock Tenant out of the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Pursue any other remedy now or hereafter available in equity under the laws or judicial decisions of the state wherein the Premises are located.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.15</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The expiration or termination of this Lease and/or the termination of Tenant&#8217;s right to possession shall not relieve Tenant from liability under any indemnity provisions of this Lease as to matters occurring or accruing prior to the expiration or earlier termination of this Lease.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.16</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">The acceptance by Landlord of any payments from Tenant after the expiration or earlier termination of this Lease shall not preclude Landlord from commencing and prosecuting a holdover or summary eviction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.17</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">If Tenant shall hold over or remain in possession of the Premises or any part thereof beyond the expiration or earlier termination of this Lease, then Tenant shall be subject to summary proceeding for eviction and liable for all damages related thereto.&nbsp;&nbsp;All damages of Landlord by reason of such holding over by Tenant may be the subject of a separate action and need not be asserted by Landlord in any summary proceedings against Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.18</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Late Charges</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant hereby acknowledges that late payment by Tenant of Rent will cause Landlord to incur costs not contemplated by this Lease, the exact amount of which will be extremely difficult to ascertain.&nbsp;&nbsp;Such costs include, but are not limited to, processing and accounting charges, and late charges which may be imposed upon Landlord by any Lender.&nbsp;&nbsp;Accordingly, if any Rent shall not be received by Landlord (or received by any other third party that Tenant is directed to pay, as provide herein), within five (5) days after such amount shall be due, then, without any requirement for notice to Tenant, Tenant shall pay to Landlord a one-time late charge equal to the greater of $250 or five percent (5%) of each such overdue amount.&nbsp;&nbsp;The parties hereby agree that such late charge represents a fair and reasonable estimate of the costs Landlord will incur by reason of such late payment.&nbsp;&nbsp;Acceptance of such late charge by Landlord shall in no event constitute a waiver of Tenant&#8217;s Default or Breach with respect to such overdue amount, nor prevent the exercise of any of the other rights and remedies granted hereunder.&nbsp;&nbsp;In the event that a late charge is payable hereunder, whether or not collected, for three (3) installments of Base Rent in any twelve (12) month period, then notwithstanding any provision of this Lease to the contrary, Base Rent shall, at Landlord&#8217;s option, become due and payable quarterly in advance.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">13.19</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Interest</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Any monetary payment due Landlord hereunder, other than late charges, not received by Landlord, when due as to scheduled payments (such as Base Rent) or within thirty (30) days following the date on which it was due for non-scheduled payment, shall bear interest from the date when due, as to scheduled payments, or the thirty-first (31st) day after it was due as to non-scheduled payments.&nbsp;&nbsp;The interest (&#8220;</font><font style="text-decoration:underline;color:#000000;">Interest</font><font style="text-decoration:none;color:#000000;">&#8221;) charged shall be equal to ten percent&#160;(10%) per annum, but shall not exceed the maximum rate allowed by law.&nbsp;&nbsp;Interest is payable in addition to the potential late charge provided for in Section&#160;13.3.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 14</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">condemnation</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">If the Premises or any portion thereof are taken under the power of eminent domain or sold under the threat of the exercise of said power (collectively &#8220;<font style="text-decoration:underline;">Condemnation</font>&#8221;), this Lease shall terminate as to the part taken as of the date the condemning authority takes title or possession, whichever first occurs.  If more than 25% of the Premises, is taken by Condemnation, Tenant may, at Tenant&#8217;s option, to be exercised in writing within ten (10) days after Landlord shall have given Tenant written notice of such taking (or in the absence of such notice, within ten (10) days after the condemning authority shall have taken possession) terminate this Lease as of the date the condemning authority takes such possession.  If Tenant does not terminate this Lease in accordance with the foregoing, this Lease shall remain in full force and effect as to the portion of the Premises remaining, except that the Base Rent shall be reduced in proportion to the reduction in utility of the Premises caused by such Condemnation.  Condemnation awards and/or payments shall be the property of Landlord, whether such award shall be made as compensation for diminution in value of the leasehold, the value of the part taken, or for severance damages; provided, that Tenant shall be entitled to any compensation paid by the condemnor for Tenant&#8217;s relocation expenses, loss of business goodwill and/or Trade Fixtures, without regard to whether or not this Lease is terminated pursuant to the provisions of this Article&#160;14.  All Alterations and Utility Installations made to the Premises by Tenant, for purposes of </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Condemnation only, shall be considered the property of </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Tenant</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> and </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Tenant</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> shall be entitled to </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">any and all</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> compensation which is payable therefor. </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">In the event that</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> this Lease is not terminated by reason of the Condemnation, </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Landlord</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> shall repair any damage</font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:normal;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to the Premises caused by such Condemnation.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 15</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">BROKERS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">Tenant and Landlord each represent and warrant to the other that it has had no dealings with any person, firm, broker or finder in connection with this Lease, and that no person is entitled to any commission or finder&#8217;s fee in connection herewith.&nbsp;&nbsp;Tenant and Landlord do each hereby agree to indemnify, protect, defend and hold the other harmless from and against liability for compensation or charges which may be claimed by any such unnamed broker, finder or other similar party by reason of any dealings or actions of the indemnifying Party, including any costs, expenses, attorneys&#8217; fees reasonably incurred with respect thereto.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 16</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">estoppel certificates</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">16.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Each party (as &#8220;</font><font style="text-decoration:underline;color:#000000;">Responding Party</font><font style="text-decoration:none;color:#000000;">&#8221;) shall within ten (10) business days after written notice from the other party (the &#8220;</font><font style="text-decoration:underline;color:#000000;">Requesting Party</font><font style="text-decoration:none;color:#000000;">&#8221;) execute, acknowledge and deliver to the Requesting Party a statement in writing in form similar to the then most current &#8220;Estoppel Certificate&#8221; form published by the American Industrial Real Estate Association, plus such additional information, confirmation and/or statements as may be reasonably requested by the Requesting Party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">16.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">If the Responding Party shall fail to execute or deliver the Estoppel Certificate within such ten (10) day period, the Requesting Party may execute an Estoppel Certificate stating that: (i) this Lease is in full force and effect without modification except as may be represented by the Requesting Party, (ii)&#160;there are no uncured defaults in the Requesting Party&#8217;s performance, and (iii) if Landlord is the Requesting Party, not more than one (1) month&#8217;s rent has been paid in advance.&nbsp;&nbsp;Prospective purchasers and encumbrancers may rely upon the Requesting Party&#8217;s Estoppel Certificate, and the Responding Party shall be estopped from denying the truth of the facts contained in said Certificate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">16.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">If Landlord desires to finance, refinance, or sell the Premises, or any part thereof, Tenant shall deliver to any potential lender or purchaser designated by Landlord such financial statements as may be reasonably required by such lender or purchaser.&nbsp;&nbsp;All such financial statements shall be received by Landlord and such lender or purchaser in confidence and shall be used only for the purposes herein set forth.</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">ARTICLE 17</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">miscellaneous</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.1</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Definition of Landlord</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Landlord</font><font style="text-decoration:none;color:#000000;">&#8221;</font><font style="font-weight:bold;text-decoration:none;color:#000000;"> </font><font style="text-decoration:none;color:#000000;">as used herein shall mean the owner or owners at the time in question of the fee title to the Premises.&nbsp;&nbsp;In the event of a transfer of Landlord&#8217;s title or interest in the Premises or this Lease, the prior Landlord shall fully be released from and relieved of all liability with respect to the obligations and/or covenants under this Lease thereafter to be performed by Landlord.&nbsp;&nbsp;Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by Landlord shall be binding only upon Landlord as hereinabove defined.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.2</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Severability</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The invalidity of any provision of this Lease, as determined by a court of competent jurisdiction, shall in no way affect the validity of any other provision hereof.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.3</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Day</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Unless otherwise specifically indicated to the contrary, the word &#8220;days&#8221; as used in this Lease shall mean and refer to calendar days.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Limitation on Liability</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The obligations of Landlord under this Lease shall not constitute personal obligations of Landlord or its affiliates, individual partners, directors, officers or shareholders.&nbsp;&nbsp;Tenant shall look to the Premises, and to no other assets of Landlord, for the satisfaction of any liability of Landlord with respect to this Lease, and shall not seek recourse against the individual partners of Landlord or its individual partners, directors, officers or shareholders, or any of their personal assets for such satisfaction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Time of Essence</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Time is of the essence with respect to the performance of all obligations to be performed or observed by the parties under this Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.6</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">No Prior or Other Agreements</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;This Lease constitutes the entire agreement between Landlord and Tenant with respect to the lease of the Premises and supersedes any and all other prior written or oral agreements or understandings with respect to this transaction.&nbsp;&nbsp;Except as expressly set forth in this Lease, no representations, inducements, understanding or anything of any nature whatsoever, made, stated or represented by Landlord or anyone acting on Landlord&#8217;s behalf, either orally or in writing have induced Tenant to enter into this Lease, and Tenant acknowledges, represents and warrants that Tenant has entered into this Lease under and by virtue of Tenant&#8217;s own independent investigation.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.7</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Notices.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.8</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Notice Requirements</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;All notices required or permitted by this Lease shall be in writing and may be delivered in person (by hand or by courier) or may be sent by regular, certified or registered mail or U.S. Postal Service Express Mail, with postage prepaid, or by facsimile transmission, and shall be deemed sufficiently given if served in a manner specified in this Section&#160;17.7.&nbsp;&nbsp;The addresses noted adjacent to a party&#8217;s signature on this Lease shall be that party&#8217;s address for delivery or mailing of notices.&nbsp;&nbsp;Either party may by written notice to the other specify a different address for notice.&nbsp;&nbsp;A copy of all notices to Landlord shall be concurrently transmitted to such party or parties at such addresses as Landlord may from time to time hereafter designate in writing.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.9</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Date of Notice</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Any notice sent by registered or certified mail, return receipt requested, shall be deemed given on the date of delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon.&nbsp;&nbsp;If sent by regular mail the notice shall be deemed given forty-eight (48) hours after the same is addressed as required herein and mailed with postage prepaid.&nbsp;&nbsp;Notices delivered by United States Express Mail or overnight courier that guarantee next day delivery shall be deemed given twenty-four (24) hours after delivery of the same to the Postal Service or courier.&nbsp;&nbsp;Notices transmitted by facsimile transmission or similar means shall be deemed delivered upon telephone confirmation of receipt, provided a copy is also delivered via delivery or mail.&nbsp;&nbsp;If notice is received on a Saturday, Sunday or legal holiday, it shall be deemed received on the next business day.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.10</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Waivers</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;No waiver by Landlord of the Default or Breach of any term, covenant or condition hereof by Tenant, shall be deemed a waiver of any other term, covenant or condition hereof, or of any subsequent Default or Breach by Tenant of the same or of any other term, covenant or condition hereof.&nbsp;&nbsp;Landlord&#8217;s consent to, or approval of, any act shall not be deemed to render unnecessary the obtaining of Landlord&#8217;s consent to, or approval of, any subsequent or similar act by Tenant, or be construed as the basis of an estoppel to enforce the provision or provisions of this Lease requiring such consent.&nbsp;&nbsp;The acceptance of Rent by Landlord shall not be a waiver of any Default or Breach by Tenant.&nbsp;&nbsp;Any payment by Tenant may be accepted by Landlord on account of moneys or damages due Landlord, notwithstanding any qualifying statements or conditions made by Tenant in connection therewith, which such statements </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">and/or conditions shall be of no force or effect whatsoever unless specifically agreed to in writing by Landlord at or before the time of deposit of such payment.</font><font style="text-decoration:none;color:#000000;">&nbsp;&nbsp;THE PARTIES AGREE THAT THE TERMS OF THIS LEASE SHALL GOVERN WITH REGARD TO ALL MATTERS RELATED THERETO AND HEREBY WAIVE THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE TO THE EXTENT THAT SUCH STATUTE IS INCONSISTENT WITH THIS LEASE.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.11</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">No Right to Holdover</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant has no right to retain possession of the Premises or any part thereof beyond the expiration or termination of this Lease.&nbsp;&nbsp;In the event that Tenant holds over, then such holdover shall be deemed a &#8220;</font><font style="text-decoration:underline;color:#000000;">Tenancy at Sufferance</font><font style="text-decoration:none;color:#000000;">&#8221; (with Tenant waiving, to the fullest extent permitted by applicable law, any required statutory notices to vacate the Premises) and the Base Rent shall be increased to one hundred fifty percent (150%) of the Base Rent applicable during the month immediately preceding the expiration or termination.&nbsp;&nbsp;Nothing contained herein shall be construed as consent by Landlord to any holding over by Tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.12</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Cumulative Remedies</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;No remedy or election hereunder shall be deemed exclusive but shall, wherever possible, be cumulative with all other remedies at law or in equity.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.13</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Covenants and Conditions; Construction of Agreement</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;All provisions of this Lease to be observed or performed by Tenant are both covenants and conditions.&nbsp;&nbsp;It is expressly understood and agreed that Tenant&#8217;s obligation to pay Rent and other charges due hereunder is an independent covenant.&nbsp;&nbsp;In construing this Lease, all headings and titles are for the convenience of the parties only and shall not be considered a part of this Lease.&nbsp;&nbsp;Whenever required by the context, the singular shall include the plural and vice versa.&nbsp;&nbsp;This Lease shall not be construed as if prepared by one of the parties, but rather according to its fair meaning as a whole, as if both parties had prepared it.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.14</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Binding Effect; Choice of Law</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;This Lease shall be binding upon the parties, their personal representatives, successors and assigns and be governed by the laws of the State of California.&nbsp;&nbsp;Any litigation between the parties hereto concerning this Lease shall be initiated only in the county of Los Angeles, California.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.15</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:none;color:#000000;">Subordination; Attornment; Non-Disturbance.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.16</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Subordination</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;This Lease shall be subject and subordinate to any ground lease, mortgage, deed of trust, or other hypothecation or security device (collectively, &#8220;</font><font style="text-decoration:underline;color:#000000;">Security Device</font><font style="text-decoration:none;color:#000000;">&#8221;), now or hereafter placed upon the Premises, to any and all advances made on the security thereof, and to all renewals, modifications, and extensions thereof, subject to Tenant&#8217;s receipt of a non-disturbance agreement in Lender&#8217;s standard form.&nbsp;&nbsp;Tenant agrees that the holders of any such Security Devices (in this Lease together referred to as &#8220;</font><font style="text-decoration:underline;color:#000000;">Lender</font><font style="text-decoration:none;color:#000000;">&#8221;) shall have no liability or obligation to perform any of the obligations of Landlord under this Lease.&nbsp;&nbsp;Any Lender may elect to have this Lease superior to the lien of its Security Device by giving written notice thereof to Tenant, whereupon this Lease shall be deemed prior to such Security Device, notwithstanding the relative dates of the documentation or recordation thereof.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.17</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Attornment</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;In the event that Landlord transfers title to the Premises, or the Premises are acquired by another upon the foreclosure or termination of a Security Device to which this Lease is subordinated (i) Tenant shall attorn to such new owner, and upon request, enter into a new lease, containing all of the terms and provisions of this Lease, with such new owner for the remainder of the term hereof, or, at the election of the new owner, this Lease will automatically become a new lease between Tenant and such new owner, and (ii) Landlord shall thereafter be relieved of any further obligations hereunder and such new owner shall assume all of Landlord&#8217;s obligations, except that such new owner shall not: (a) be liable for any act or omission of any prior lessor or with respect to events occurring prior to acquisition of ownership; (b) be subject to any offsets or defenses which Tenant might have against any prior lessor, (c) </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">be bound by prepayment of more than one</font><font style="text-decoration:none;color:#000000;"> (1)</font><font style="text-decoration:none;color:#000000;"> month&#8217;s rent, or (d) be liable for the return of any security deposit paid to any prior lessor which was not paid or credited to such new owner.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.18</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Self-Executing</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;The agreements contained in this Section&#160;17.13 shall be effective without the execution of any further documents; provided, however, that, upon written request from Landlord or a Lender in connection with a sale, financing or refinancing of the Premises, Tenant and Landlord shall execute such further writings as may be reasonably required to separately document any subordination or attornment agreement provided for herein.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.19</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Modifications Required by Lender</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If any Lender requires a modification of this Lease that will not increase Tenant&#8217;s cost or expense or materially or adversely change Tenant&#8217;s rights and obligations, this Lease shall be so modified and Tenant shall execute whatever documents are required and deliver them to Landlord within ten (10) business days after the request.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.20</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Infectious Disease Liability Waiver</font><font style="text-decoration:none;color:#000000;">.  Tenant acknowledges and agrees that measures and/or services implemented at the Project, if any, intended to encourage social distancing, promote and protect health and physical well-being and/or intended to limit the spread of communicable diseases and/or viruses of any kind or nature (&#8220;</font><font style="text-decoration:underline;color:#000000;">Infectious Conditions</font><font style="text-decoration:none;color:#000000;">&#8221;), may not prevent the spread of such Infectious Conditions. Neither Landlord nor any Landlord Parties shall have any liability and Tenant waives any claims against Landlord and the Landlord Parties with respect to any loss, damage or injury in connection with (x) the implementation, or failure of Landlord or any Landlord Parties to implement, any measures and/or services at the Project intended to encourage social distancing, promote and protect health and physical well-being and/or intended to limit the spread of Infectious Conditions, or (y) the failure of any measures and/or services implemented at the Project, if any, to limit the spread of any Infections Conditions.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.21</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Attorneys&#8217; Fees</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;If any party brings an action or proceeding involving the Premises to enforce the terms hereof or to declare rights hereunder, the Prevailing Party (as hereafter defined) in any such proceeding, action, or appeal thereon, shall be entitled to recover its reasonable attorneys&#8217; fees.&nbsp;&nbsp;Such fees may be awarded in the same suit or recovered in a separate suit, whether or not such action or proceeding is pursued to decision or judgment.&nbsp;&nbsp;The term &#8220;</font><font style="text-decoration:underline;color:#000000;">Prevailing Party</font><font style="text-decoration:none;color:#000000;">&#8221; shall include, without limitation, a party who substantially obtains or defeats the relief sought, as the case may be, whether by compromise, settlement, judgment, or the abandonment by the other party of its claim or defense.&nbsp;&nbsp;The attorneys&#8217; fees award shall not be computed in accordance with any court fee schedule, but shall be such as to fully reimburse all attorneys&#8217; fees reasonably incurred.&nbsp;&nbsp;In addition, Landlord shall be entitled to attorneys&#8217; fees, costs and expenses incurred in the preparation and service of notices of Default and consultations in connection therewith, whether or not a legal action is subsequently commenced in connection with such Default or resulting Breach.&nbsp;&nbsp;In addition, if, as a result of any action or request of Tenant, Landlord consults or retains attorneys, Tenant must reimburse Landlord for its attorneys&#8217; fee within ten (10) days following Tenant&#8217;s receipt of Landlord&#8217;s invoice for those attorneys&#8217; fees.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.22</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Landlord&#8217;s Access; Showing Premises; Repairs</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord and Landlord&#8217;s agents shall have the right to enter the Premises at any time, in the case of an emergency, and otherwise at reasonable times for the purpose of: (i) showing the same to prospective purchasers, lenders, or lessees; (ii) making such alterations, repairs, improvements or additions to the Premises as Landlord may deem necessary, so long as they do not interfere with Tenant&#8217;s business or use of the Premises; or, (iii) any other reason as Landlord shall deem necessary.&nbsp;&nbsp;All such activities shall be without abatement of rent or liability to Tenant.&nbsp;&nbsp;Landlord may at any time place on the Premises any ordinary &#8220;For Sale&#8221; signs and Landlord may during the last nine (9) months of the term hereof place on the Premises any ordinary &#8220;For Lease&#8221; signs.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.23</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Termination; Merger</font><font style="text-decoration:none;color:#000000;">.  Unless specifically stated otherwise in writing by Landlord, the voluntary or other surrender of this Lease by Tenant, the mutual termination or cancellation hereof, or a </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;color:#000000;">termination hereof by Landlord for Breach by Tenant, shall automatically terminate any sublease or lesser estate in the Premises; provided, that Landlord may elect to continue any one or all existing subtenancies.&nbsp;&nbsp;Landlord&#8217;s failure within ten (10) days following any such event to elect to the contrary by written notice to the holder of any such lesser interest shall constitute Landlord&#8217;s election to have such event constitute the termination of such interest.&nbsp;&nbsp;No payment of money by Tenant to Landlord after this Lease has expired or terminated will reinstate or extend the Term or make ineffective any notice given to Tenant prior to Tenant&#8217;s payment.&nbsp;&nbsp;If after Landlord</font><font style="text-decoration:none;color:#000000;"> has filed and served a law</font><font style="text-decoration:none;color:#000000;">suit against Tenant or after a final judgment granting Landlord possession of the Premises, Landlord may receive any sums due under this Lease and the payment will not make ineffective any notice, or in an</font><font style="text-decoration:none;color:#000000;">y manner affect any pending law</font><font style="text-decoration:none;color:#000000;">suit or previously obtained judgment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.24</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Consents</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Except as otherwise provided herein, wherever in this Lease the consent of a party is required to an act by or for the other Party, such consent shall not be unreasonably withheld or delayed.&nbsp;&nbsp;Landlord&#8217;s actual reasonable costs and expenses (including but not limited to architects&#8217;, attorneys&#8217;, engineers&#8217;, attorneys and other consultants&#8217; fees) incurred in the consideration of, or response to, a request by Tenant for any Landlord consent, including but not limited to consents to an assignment, a subletting or the presence or use of a Hazardous Substance, shall be paid by Tenant upon receipt of an invoice and supporting documentation therefor.&nbsp;&nbsp;Landlord&#8217;s consent to any act, assignment or subletting shall not constitute an acknowledgment that no Default or Breach by Tenant of this Lease exists, nor shall such consent be deemed a waiver of any then existing Default or Breach, except as may be otherwise specifically stated in writing by Landlord at the time of such consent.&nbsp;&nbsp;In the event that either party disagrees with any determination made by the other hereunder and reasonably requests the reasons for such determination, the determining party shall furnish its reasons in writing and in reasonable detail within ten (10) business days following such request.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.25</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Quiet Possession</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Subject to payment by Tenant of the Rent and performance of all of the covenants, conditions and provisions on Tenant&#8217;s part to be observed and performed under this Lease, Tenant shall have quiet possession and quiet enjoyment of the Premises during the term hereof.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.26</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Security Measures</font><font style="text-decoration:none;color:#000000;">.  Tenant hereby acknowledges that the Rent payable to Landlord hereunder does not include the cost of guard service or other security measures, and that Landlord shall have no obligation whatsoever to provide same.&nbsp;&nbsp;Tenant assumes all responsibility for the protection of the Premises, Tenant, its agents and invitees and their property from the acts of third parties.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.27</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Reservations</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord reserves to itself the right, from time to time, to grant, without the consent or joinder of Tenant, such easements, rights and dedications that Landlord deems necessary, and to cause the recordation of parcel maps and restrictions, so long as such easements, rights, dedications, maps and restrictions do not unreasonably interfere with the use of the Premises by Tenant.&nbsp;&nbsp;Tenant agrees to sign any documents reasonably requested by Landlord to effectuate any such easement rights, dedication, map or restrictions.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.28</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Relationship of Parties</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Nothing contained in this Lease shall be deemed or construed by the parties hereto or by any third party to create the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant, it being expressly understood and agreed that neither the method of computation of Rent nor any act of the parties hereto shall be deemed to create any relationship between Landlord and Tenant other than the relationship of landlord and tenant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.29</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Offer</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Preparation of this Lease by either party or its agent and submission of same to the other party shall not be deemed an offer to lease to the other party.&nbsp;&nbsp;This Lease is not intended to be binding until executed and delivered by all parties hereto.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.30</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Amendments</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;</font><font style="text-decoration:none;color:#000000;">This Lease may be modified only in writing, signed by the parties in interest at the time of </font><font style="text-decoration:none;color:#000000;">the modification.&nbsp;&nbsp;As long as they do not materially change Tenant&#8217;s obligations hereunder, Tenant agrees to make such reasonable non-monetary modifications to this Lease as may be reasonably required by a Lender in connection with the obtaining of normal financing or refinancing of the Premises.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.31</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Waiver of Trial By Jury</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Tenant hereby waives, to the fullest extent permitted by applicable law, the right to a trial by jury in any action brought by Landlord against Tenant in connection with this Lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.32</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Counterparts</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;This Lease may be executed in counterparts with the same effect as if both parties hereto had executed the same document.&nbsp;&nbsp;Both counterparts shall be construed together and shall constitute a single lease.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.33</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Governing Law</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;This Lease shall be construed and enforced in accordance with the laws of the State of California.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-weight:normal;text-transform:none;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:none;">17.34</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;">Civil Code Section 1938 Advisory</font><font style="text-decoration:none;color:#000000;">.&nbsp;&nbsp;Landlord and Tenant acknowledge and agree that the Premises have not been inspected by a Certified Access Specialist (&#8220;</font><font style="text-decoration:underline;color:#000000;">CASp</font><font style="text-decoration:none;color:#000000;">&#8221;) pursuant to Section 1938 of the Civil Code (&#8220;</font><font style="text-decoration:underline;color:#000000;">CASp Code</font><font style="text-decoration:none;color:#000000;">&#8221;).&nbsp;&nbsp;The parties further agree, that a CASp can inspect the Premises and determine whether the Premises comply with all of the applicable construction-related accessibility standards under state law.&nbsp;&nbsp;Although state law does not require a CASp inspection of the Premises, Landlord may not prohibit Tenant from obtaining a CASp inspection of the Premises for the occupancy or potential occupancy of Tenant, if requested by the Tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of the construction-related accessibility standards within the Premises.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page Follows]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD AND TENANT HAVE CAREFULLY READ AND REVIEWED THIS LEASE AND EACH TERM AND PROVISION CONTAINED HEREIN, AND BY THE EXECUTION OF THIS LEASE SHOW THEIR INFORMED AND VOLUNTARY CONSENT THERETO.  THE PARTIES HEREBY AGREE THAT ON THE EFFECTIVE DATE, THE TERMS OF THIS LEASE ARE COMMERCIALLY REASONABLE AND EFFECTUATE THE INTENT AND PURPOSE OF LANDLORD AND TENANT WITH RESPECT TO THE PREMISES.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the parties have executed this Lease as of the date first written above.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD:</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;font-variant: normal;">605 NASH, LLC<font style="text-transform:none;">,</font></p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;font-variant: normal;">NANTKWEST, inc.<font style="text-transform:none;">,</font></p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a California limited liability company</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/<font style="font-style:italic;">s/ Charles Kenworthy</font></p></td>
<td valign="top"  style="width:5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">/s/ Richard Adcock</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:&#160;Charles N. Kenworthy</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:&#160;Richard Adcock</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:&#160;&#160;&#160;Manager</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:&#160;&#160;&#160;CEO</p></td>
</tr>
<tr>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Address:</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Address:</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9922 Jefferson Blvd.</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3530 Johns Hopkins Court</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Culver City, CA 90232</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Diego, CA 92121</p></td>
</tr>
<tr>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Chuck Kenworthy</p></td>
<td valign="top"  style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:45%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">Exhibit A</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:11pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">Premises</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[OMITTTED]</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EXHIBIT B</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">WORK LETTER</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Tenant Build)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[OMITTED]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EXHIBIT C</font></p>
<p style="margin-top:0pt;text-align:center;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NOTICE OF LEASE TERM DATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[OMITTED]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>nk-ex211_10.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex211_10.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;text-indent:0%;">Exhibit 21.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">SUBSIDIARIES OF <font style="text-transform:uppercase;">NANTKWEST,</font> INC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:48.98%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name of Subsidiary</p></td>
<td valign="bottom"  style="width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:48.98%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jurisdiction of Organization</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:48.98%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inex Bio, Inc.</p></td>
<td valign="bottom"  style="width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:48.98%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Republic of Korea</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Infacell Therapeutics, Inc.</p></td>
<td valign="bottom"  style="width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nectarine Merger Sub, Inc.</p></td>
<td valign="bottom"  style="width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">557 Doug St, LLC</p></td>
<td valign="bottom"  style="width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="width:48.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">California</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>nk-ex231_7.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex231_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit 23.1</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:13.5pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in the following Registration Statements:</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.81%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.81%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;">Registration Statement (Form S-3 No.</font><font style="font-size:10pt;font-family:Times New Roman;color:#000000;"> </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;">333-233434) of NantKwest, Inc. for </font><font style="font-size:10pt;font-family:Times New Roman;color:#000000;">the registration of common stock, preferred stock, warrants, debt securities and units,</font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:-2.88%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.81%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Times New Roman;">Registration Statement (Form S-4 No.</font><font style="font-size:10pt;font-family:Times New Roman;color:#000000;"> </font><font style="font-size:10pt;font-family:Times New Roman;">333-252232) of NantKwest, Inc. for the registration of common stock to be issued in connection with the merger with ImmunityBio, Inc.,</font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:-2.88%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.81%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Times New Roman;">Registration Statement (Form S-8 No. 333-205942) pertaining to the 2014 Equity Incentive Plan and 2015 Equity Incentive Plan, </font></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:-2.88%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.81%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Times New Roman;">Registration Statement (Form S-8 No.333-233082) pertaining to the 2015 Equity Incentive Plan as Amended and Restated, and </font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:-2.88%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.81%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Times New Roman;">Registration Statement (Form S-8 No.</font><font style="font-size:10pt;font-family:Times New Roman;color:#000000;"> </font><font style="font-size:10pt;font-family:Times New Roman;">333-243725) pertaining to the 2015 Equity Incentive Plan as Amended and Restated; </font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:-0.96%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our report dated March 4, 2021, with respect to the consolidated financial statements of NantKwest, Inc. included in this Annual Report (Form 10-K) of NantKwest, Inc. for the year ended December 31, 2020.</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ernst&#160;&amp; Young LLP</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Los Angeles, California</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>nk-ex311_8.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex311_8.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Exhibit_31.1"></a>Exhibit 31.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Richard Adcock, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">I have reviewed this Annual Report on Form 10-K of NantKwest,</font><font style="font-size:10pt;letter-spacing:-1.05pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">Inc.;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this</font><font style="font-size:10pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and </font><font style="font-size:10pt;letter-spacing:-0.15pt;color:#000000;">for, </font><font style="font-size:10pt;color:#000000;">the periods presented in this</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting</font><font style="font-size:10pt;letter-spacing:-0.95pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and</font><font style="font-size:10pt;letter-spacing:-0.9pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">have:</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting</font><font style="font-size:10pt;letter-spacing:-0.9pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">principles;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">c)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered</font><font style="font-size:10pt;letter-spacing:-0.75pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">by this report based on such evaluation;</font><font style="font-size:10pt;letter-spacing:-0.25pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">d)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial</font><font style="font-size:10pt;letter-spacing:-0.85pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">reporting; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control</font><font style="font-size:10pt;letter-spacing:-0.55pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">functions):</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize</font><font style="font-size:10pt;letter-spacing:-1.2pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and report financial information;</font><font style="font-size:10pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">reporting.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:8.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top"  style="width:36.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4,<font style="letter-spacing:-0.1pt;"> </font>2021</p></td>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Richard Adcock</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Richard Adcock</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>nk-ex312_6.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex312_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Exhibit_31.2"></a>Exhibit 31.2</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.69%;text-indent:-4.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Sonja Nelson, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">I have reviewed this Annual Report on Form 10-K NantKwest,</font><font style="font-size:10pt;letter-spacing:-1.05pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">Inc.;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this</font><font style="font-size:10pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and </font><font style="font-size:10pt;letter-spacing:-0.15pt;color:#000000;">for, </font><font style="font-size:10pt;color:#000000;">the periods presented in this</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting</font><font style="font-size:10pt;letter-spacing:-0.95pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and</font><font style="font-size:10pt;letter-spacing:-0.9pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">have:</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting</font><font style="font-size:10pt;letter-spacing:-0.9pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">principles;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">c)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered</font><font style="font-size:10pt;letter-spacing:-0.75pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">by this report based on such evaluation;</font><font style="font-size:10pt;letter-spacing:-0.25pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">d)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial</font><font style="font-size:10pt;letter-spacing:-0.85pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">reporting; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.4pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control</font><font style="font-size:10pt;letter-spacing:-0.55pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">functions):</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">a)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize</font><font style="font-size:10pt;letter-spacing:-1.2pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and report financial information;</font><font style="font-size:10pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.45%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;">b)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial</font><font style="font-size:10pt;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-size:10pt;color:#000000;">reporting.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:8.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top"  style="width:36.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 4,<font style="letter-spacing:-0.1pt;"> </font>2021</p></td>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Sonja Nelson</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sonja Nelson</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr>
<td valign="top"  style="width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:41.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>nk-ex321_9.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex321_9.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Exhibit_32.1"></a>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS<font style="letter-spacing:-1.7pt;"> </font>ADOPTED PURSUANT TO SECTION 906 OF THE<font style="letter-spacing:-0.25pt;"> </font>SARBANES-OXLEY<font style="letter-spacing:-1pt;"> </font>ACT<font style="letter-spacing:-0.4pt;"> </font>OF<font style="letter-spacing:-0.55pt;"> </font>2002</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Richard Adcock, certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form&#160;10&#8209;K of NantKwest,&#160;Inc. for the fiscal year ended December&#160;31, 2020 fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form&#160;10-K fairly presents, in all material respects, the financial condition and results of operations of NantKwest,&#160;Inc.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 4, 2021</p></td>
<td valign="bottom"  style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  style="width:49%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Richard Adcock</p></td>
</tr>
<tr>
<td valign="top"  style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Richard Adcock</p></td>
</tr>
<tr>
<td valign="top"  style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>nk-ex322_11.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nk-ex322_11.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Exhibit_32.1"></a>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS<font style="letter-spacing:-1.7pt;"> </font>ADOPTED PURSUANT TO SECTION 906 OF THE<font style="letter-spacing:-0.25pt;"> </font>SARBANES-OXLEY<font style="letter-spacing:-1pt;"> </font>ACT<font style="letter-spacing:-0.4pt;"> </font>OF<font style="letter-spacing:-0.55pt;"> </font>2002</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Sonja Nelson, certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form&#160;10&#8209;K of NantKwest,&#160;Inc. for the fiscal year ended December&#160;31, 2020 fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form&#160;10&#8209;K fairly presents, in all material respects, the financial condition and results of operations of NantKwest,&#160;Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0%;width:100%;">
<tr>
<td valign="top"  style="width:48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 4, 2021</p></td>
<td valign="bottom"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  style="width:48%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Sonja Nelson</p></td>
</tr>
<tr>
<td valign="top"  style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Sonja Nelson</p></td>
</tr>
<tr>
<td valign="top"  style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gtl21rgcbjm5000011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 5F",H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M**Y38***,T %-DD6*-G;[JC)IU5-3_Y!MQ_N&FE=V$]C+7QCI#7HM!,WFDX
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MV23^][_C7H-17IJG4<%T*IR<HIL6BBBLBPHHHH **** "BBB@ HHHH ****
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M/GQ?]]5T_5L(M.<Q]K7_ )3U.W\9:/<N%CGY/J*VHKJ&8 QRHV1G 85X5/\
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MHHHKB.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** &2?ZI_H:^=?'G_(UW'T']:^BY/\ 5/\
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MIJ5Q$+:57VI@X-7OAKK]CI>C/%<S(C&0G!-<WXW\)KX=N%*S^9Y@W=*L>#?
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M/QYI.G'"RK/_ +C5YIXU\67.LZK]BM)CY&X+M!XSG%:NA?"UKNV6XO)]C-_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP$@/85M?%2[CO;G3IXF!5XB1^===/#^QQ2:V9A*KST7?='5_"3_D79O^NO\
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MN[.Y;'F'Q;T^)=+2]"#S"X7=69\'_P#D)77_ %S%=#\6V \+QCOYPKGO@_\
M\A*[_P"N8KU8-O NYQ226)1ZKJFG1ZG9R6TI(1Q@U@:'X*L-!O#<QR[GSD;A
MC%;6MZM%H^G2W4K ;%R!ZUXIJGC#6/$%ZT5KN5"<+Y>1Q^%<V&I5:D7&+M$V
MJSA!W:NSV^YU6SM!F691CWK%N_&^@Q1.DEUU&,8KS2U\">*=002M<-L;LTIS
M6I;?"VZ.6OI6V@9.'S6GU;#P^*=_0CVM66T3D=0O+:]\:K<69S"T@VD"O?\
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MIPG5YH&F'C*,+2"BBBN(Z#A/B?\ \B]+_NUXYHFAW.N78M[9=SD=*]C^)_\
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MB;4JT9NUK,U/$(_XI^__ .N+5XS\,_\ D-?\"%>S^(?^1>O_ /KBU>,?#/\
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M_P"NIKW+PK_R K?_ '%_E7AOC/\ Y&:Y_P"NIKW+PK_R K?_ '%_E7KX[^!
MXL/_ !)&+\3?^1<7_?KSSX::0NI:V\C#_48<5Z'\3?\ D7%_WZY7X.LO]H7P
M[^6/YTJ$G'!R:"HDZZ3/7P !@4V10\;*>XQ3Z2O).T^>O&6E_P!A^*55,C<P
MD_,YKVKPI>-?:!!,QR>E>5_%9E;Q;#M.?W:_TKTGP&"OA: 'U/\ 2O4Q?O8:
M$GN<='2K)(Q/BGJ7V32XH0W^NRI%2_##27T_1WG<8%P PKD?B#<OJ7BN/3@<
M[)< ?G7K&@6_V70K.$C!2/!K.M^[PL8=RH>]6;[&EVKPOXK_ /(T_P#;):]T
M->%_%?\ Y&G_ +9+1EO\;Y#Q?\,[WX8_\BK;_4UVYKB/AC_R*MO]37;FN;$_
MQI>IK1^!'SAXO_Y&BZ_Z[&O?/#W_ "!+7_KDO\J\#\7_ /(T77_78U[YX>_Y
M EK_ -<E_E7?C_X,#FPW\21J4445Y)VA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V3_ %3_
M $-?.GCS_D:[CZ#^M?14G^K8>QKP?QIH.JW7B:>6"QED0@88"O2RUI5'?L<F
M+3<58]5\ ?\ (E:=_P!<ZZ:N>\$6\UKX1L(9XS'(J893U%=#7%7_ (DO4Z*?
MP(I:M_R#)_\ </\ *OGO0?\ D:?^V_\ [-7T+J:-)I\RH"6*' 'TKPO1= U:
M+Q)YKV,RIYV=Q'O7?@))4YW9SXE-RB>_)_JU^@IU-3_5K]*4UY9UG@_Q(_Y&
M&+_/>O6?!_\ R H?]T?RKS7Q_HNI7FNQR6]G+(@[J/>O3O"L,MOHL22H48 9
M!^E>GB9)X:"3..BG[61Q7Q=_Y!L'_72L_P"%OB".W>2RN' 7 "9.*T/B[_R#
M8/\ KI7#Z1X:O[K3TU#3R3*@W!5'-;T81GA.6;M<SFY1K71]#JP9<J<@]#6#
MXIURWTC2)I'<;R,!0>>:\K3QEXITV/[/<><&7@9'2J$EKXE\5W*M<13/&3C<
M1P!7/3P#C+FG)6-98FZM%:D7A+2CKOB8G:=HD,N?QS7O=\NS2)E](L5A^#_"
M,'AVS5FVO<,,EP.F>U;^H*7T^=5&6*$ 5EBZZJU5R[(NC2<(.^[/GZU_Y'J+
M_KM7T%;#=8H/5:\.M]!U5?&<4YL91$)<EL<5[I:J5M8P1@@<UMF,D^6SZ$85
M-7N?/'B:PN-%\3-)(,;I/,!QVS7MGA77[?6-)B=9%\P *5)YXJIXQ\(0^(;<
MNNU;A1\K$?I7DT=AXE\,7+/:PS(H.-P'!K3W,722O:2(]ZA-NVC/H0FN/\:^
M,8M LBENX-TX.S'.#[UYV_CWQ+)'Y2M+YAXJC;^'O$/B;4(VO8I0KGF5AP*B
ME@5"7-5:LBIXAR5H+4[OP-XJUK7[S_2BI@!PV$Q7H]8?AGP[!X?L!#&!N;!8
MCN:W:X<1*$JC<%9'124E'WMPHHHK$T.0^)'_ "*-Y_N5Y]\*_P#D.)]#7HWC
M^UGN_"]U%;Q-)(R<*O4UP_PUT?4+'65>ZM)(EP>6%>I0DEA)*YQU$_;)GL5-
M=0ZE6&01R*=17EG8>*_$KPM]BN_[0M8SME)+E>U<%=ZA/>QPI,V1"NU?I7TS
MJNG1ZIITUK(!B1<9->!:UX.U2SU*:."REDB#?*5'&*]S XF,X\L]T>=B*3B[
MQV9Z1\)/^1<F_P"NO^-3?$_2)-0T-7A&61]S<=A3OA?8W5AH$T=U \3F7(#"
MNTN;=+JW>&095U((K@JU>3%.:[G5"'-146>)_#37DTO5)(+AL+* JY/2O<(Y
M4E7=&P93T(->+^*OA[=Z?>?:M+C+H6R$0?=JA:>*?%.C)Y$PF55X"D=*ZJ]"
M.)?M*3U,*=25+W9H]RN;J*TA:25U4 9Y->2:I\2M2;6O(T]E$6_9RN>^*P[S
M7/%/B$>2JS21GJH%=+X)^'S^<+_5$Q@\1,.<^M3##T\/%RK6;[#E5G5=H:'H
M^F&YN](7[809'7G Q7A_B^TFT3QA)<JA5%DRAQP:^@54(@51@ 8%<YXK\+0>
M(K/8VT2IDHQ[&N;"8B-.H[[,VK4G..FZ#PIXCM=5TB#,JB95 8$]ZZ"2XBB3
M<\BJOJ37@A\.>)= OI!803-M;AT'!JPTWCF^3R)HKDH>#\O_ ->MYX*$I<T)
MJQG'$22M*.IH_$[Q)!?N-/@;<JD-D'(J7X/_ /(2N_\ KF*Y_P 0^$9M&T-;
MZZ?,SN 01SS71?"!"+^Z;L8Q7544(X-Q@[I&,>9UTY&A\7YIX[:S2+.QL[\?
MC65\)XK5YYFF"F0/\H->D>*- CU[2Y(6 $NW",>QKQ0Z7X@\+:@TEO#*H1N)
M .#6.&E&KAW23LRZJ<*JFU='T,H &%  ]JR]=U:WTS3IGED56V' )[UY5%\0
M=?>(1+',TO3(IL6C^)O%MT!J?FQQ=<R+Q6"P+B^:I))&CQ%U:"U.4:_.H>)H
M[INK25]$:*=VD6Q]5KPK5_"&IZ3KC):V<LT49RKH.#7MGAAICH%H)XVCD"?,
MK=16V82C*$7!Z$85-2:9P'Q<3,D+>B5<^$L\2Z*\;. _F$XS6S\0/#\FL:0[
MP+NF48"@<UY':P^)-!F(MX)H6Z=*=%1K87V:=F*;=.MS6/HIV#1,001BOGCQ
MA_R.MU_OUZ]X(NM2NO#ZMJ(?SCG):O,O%6@ZK<>+[F:*QE>,OPP'%3@4J564
M9,K$/F@FCV3PS_R+5A_UR%:K#<C*>A&*S/#T4D/A^RCD4JZQX(/:M2O-J?&_
M4ZH_"CPCQWIAT7Q0EQ$,1@J_XYS5'Q)XGN/$I@L\_*I&T8[UZ9\2/#\FJZ2'
MMHR\P8=!SBO-_#'A'5)=;@:XM)(HXW#$L.M>UAZM.5)5)[Q."K"49N,=F>L^
M!M)&F^'K<E<2NGSUTTBAXF4]Q20Q+#$J*, =*?7BU)N<W)G?&/+&Q\Y>)-/D
MT7Q*S.I :7S/PSFO;_#&OVNLZ7$\3@,%"E2>>!5#QCX-A\0V[2)M2X4<,1^E
M>416?B?PQ<,UM#.B XW <$5ZGN8RDE>TD<?O4)MVT9]"9P,UQGC?Q>-"M-MI
M*AN&''?!KSZ3QYXEDB\E6E#GBJ5MX;U_Q)J"/>Q2J'/,C#BHI8%4Y<U9JR*G
MB')6@M3N? WB;7O$%Z'N'0VJG#X3'->DUB>&M @\/Z<+>(#<V"Y'<UMUPXB<
M)5&X*R.BDI*/O;A1116)H<)\3_\ D7I?]VN$^%\J1>(D+L%&T\DUZ%\1;*YO
M="DCMH6E<KT6O'[31O$5C+YEO8SHP[@5[.#49X9P;M<X*UU64K'T9]LMO^>\
M?_?5!O;8?\MX_P#OJO L^,/^?>X_*E"^,GX%M<G\/_KUC_9Z_G1I]:?\IZ[X
MF\3V.F:7*1.CR%> K5XAI]J_B'Q+M4?ZY]U7D\*^(=4N5%S:S+N/+,.E>H^#
MO L&A*MS/MDN>JL!]VMDZ6$INSO)F;4Z\E=61UUC#]GT^"+^Y&%_2O#_ (@_
M\CX/HE>[GI^%>+^.=%U*[\:">"SEDBPOS*.*YLODE5;?8UQ2]Q)'J/AC_D V
M_P!*V*RO#L4D.B0)(I5@.0:UJXJGQLZ(_"CQ[XKZ/,+R&_C'[I$PW'>K_P +
M?$,(L3I]Q(%?<6!8UZ#K6DV^LZ?):7"AE;UKQ76/!>L:#J32:?')*H.X-&.E
M>E1J0KT/8S=FCDJ1E3J>TCL>]!@PR#D&LS6M7@TG3YKB210R+D+GDUX[#XW\
M3V<7DS&;<.!Q5&ZE\4>)WQ)%/+'GTZ5$,NDG>;5BI8I6]U:G1Z7\0-;U77UM
M8'7R7;Y04Z"N_P#$TMPGAAW7_6E1NP/:L/P-X%CT:-;V[ :Y.&7CE*[:\M4N
M[5X6'# BLL14I>U7LUHBZ49\CYGJSY^\'Q6T_B<_:\;=Q(R>^:^A84C6)?+5
M0,=A7@WB'P;JVB:L\MG$\R[MX=!P.<U<LO'GB"TB$$RS.PXKLQ-!XFTZ;,*-
M14KQDCVNXN8K:(R2N%4=R:^?_'FM1ZOK?[KE8B5SZUKS7?B[Q,PA:.=+:3C)
M'&*KZ_\ #V_T^VBEMT:=V7+!!WHPM*&'G><M6%:<JD?=6AW_ ,,&W>&G]GK(
M\;^+];T'5VBMBHM\#!*=ZO\ PP@O;+1Y+:[MY(F,A(W"MCQEX87Q#II12%D3
MY@2.M<KE3CBGSZHU2DZ*Y=P\&>(QKFCPR7$BFZQ\X%=.R*XPRAOJ*^>XK+Q+
MX7N6:VAF11U8#@UICX@>(RGEYE\SUK2I@'*7-2:L*&)LK36ITOQ2AL!II<!%
MN !M"X%9OPDBG^TM)SY.&'XUS_\ 9/B3Q3?(][%-L/\ &PX KV#PKX=B\/Z6
MMNN"Q^8D5=:4:.']DW=LF"=2KSVLBYX@_P"1?O\ _KBU>*_#>9(]; =@,L,9
M->XZK;F[TJZMU^])&5%?/MSX=US0=0+0V\O[L_+(!P:G <LJ<Z;=FQXFZE&5
MCZ+5U;HP-/KRKP)JWB&XU1(M065H2WWF' KU6N&O1=*7*W<Z:<U-7"BBBL2S
MR+XH^&@DJZA:Q,2Y+2D<U!\//&26)_L^]8@,?E)X %>MWMG#?VLEO.@:-Q@@
MUX[XI^'%U9W#7&G*9%)R$0=*]3#UJ=6E[&K\CCJTY0G[2!['!>6]R@:*57!&
M>#FIF=57+$ >IKYZBU#Q9H0V*)X0/45(_C#Q;=CROM$K9XQBI>6RO[LE8:Q:
MMJCU;Q=XNL])TV1(Y5>=U(7:<X->,:387'B?Q"H=2WG/\[8X%7;7PMKVN7JM
M<V\J!SS(PXKU_P *^$;;P];\!6F;[S#UK;FI8.FU%WDS.TZ\KO1&BMJ=.T 0
M1]8XMO'TKYVSO\0_O22/M7.?]ZOIZ1!)&R'H1BO%/&7@6[M-2:ZTV!I$)WD(
M._6L\NK1C*2D]R\3!M)KH>P:;%;I8Q>0J;=HY4>U6WD2-2SL%4=2:\)T[QCX
MBTA!;2K-A>B^E6[C7_%VNKY5O#<+$W#<=JSE@)\UVU8I8F-M$)\4-=BU"_A@
MMV!6(%6P:W_A$?\ B5S#_II6!?\ P\O8="DOF!FNG&[8!R#6U\,8-1TZ1K6Z
MLY8E8EMS#BNJK[/ZJX0>QE#F]M>2W.Q\:?\ (!E^AKRSX9?\AZ;\/YUZOXM@
MEN-$DCA0NQ!X%>;?#S1M2LM;E>XLY8U..6'O6&&:6&FKEU4_;1/:*9+_ *I_
M]TT^F2Y,3@>AKS#L/FG4?^1G;_KY_P#9J^C; ;M.B'K&/Y5X)?\ A[5V\1-*
MMA,4^T9W8[;J]]L%*64*L,$(,C\*]7,9)QA9G'A4TY7/"O'UK-I_B^:["$(7
MRAQQ7K'@O7+?4M#MHPX\Y$ 89[TOB[PO%XAL=IP)$R5)'>O)!IWB7PI=R-:1
M3*BG_6 <&FG#%45"]I(34J-1RMHSZ )P,UYE\4M=1;%;*WFQ,'5LJU<R_CSQ
M+-%Y*&;S#QFHM)\(:UXEU59M25XE^\7D'!'I2HX149>TJM60ZE?VBY8([+X:
M_;KJQ:>Z<M$ZX&:X3Q]IL^F^)Y[K&$E?*&O<](TJ#2+".UMU"HOI67XK\+6_
MB.RV.%$J [&/8UG2Q<8UW-[,J=%NDH]44_ WB"WU+18(#(!+$H4@GK77]J^?
M'T3Q'X8OG>SBFVHW$BC@U?\ ^$]\2K%Y1:7S.F:NK@>>7-2DK,F&(Y5::U/3
M?%OBB'0-/,B.#,3@*#R*Y3P;XPUS7]2:*1T,2\GY.U<9_97B/Q->*]W#,58@
M;R.!7L'A+PI;^'+,* K7!&'<=Z52G1H4N5ZR80E.I.ZT1)XV_P"10U#_ *YU
MXS\/O^1TM?QKVOQA!+<^%;Z*%"\C1X"CJ:\D\#:%JEIXMMYI[*6.,9RS#BJP
M<DL---_U85=-U8V/=E^Z/I2TB_=%+7E':%%%% $<W^ID_P!TU\Y:[_R-(_Z[
M#_T*OHZ4$Q.!W4UX'K.@:M+XD$J6,S)YH.X#_:KT\MDE*5V<F+3:5CV[0_\
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M6]G'Y=O$L:^BU8HHHW *8T2,<LH-/HH 15"C &!12T4 1F%"<E13P,=*6B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N4\
M>_\ (OO]#75URGCW_D7W^AK;#_Q8D5?@9@?"7_CRG_W11\5_^/*/_=H^$O\
MQY3_ .Z*/BM_QY1_[M=S_P!].;_F'.!DTFZT:&WU:W)\L!=Q'O7L_A+Q!%KN
MDQRCB0?*5SZ5DZ!I<.K>#_L\J!@5!&1WQ7!:5>W?@GQ4UK-GRG. A/ !/6JJ
M+ZRG'[428?NFGT9Z]XE_Y%O4/^N)KS_X.==3^H_I7=:W<1W7A*]FB;<K0GFN
M%^#G74_J/Z5A25L+4]4:S_C1-_XG?\BI<?A6?\(_^1?D_P"NI_K6A\3O^14N
M/PK/^$7_ "+\G_74_P!:I?[D_43_ -X^1Z-BN?\ $_AVUUC390\2F4*=C'L:
MZ&D8 J0>AK@A)PES(Z914E9GBO@/4YM$\5/HK999)=I/ITKVH'(S7A5K\GQ9
MD [7'^%>YQ?ZI?I7;F"7-&7='/AGHUV'UC^*/^1=O?\ KD:V*Q_%'_(NWO\
MUR-<=/XT;S^%GF7PA_X_+S\*]DKYV\'^(KK09IGMK83E\9!/2NS_ .%G:O\
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M4I21RQ^)EF#_ *@?]]4A^)UF!DPC_OJNH/AK11R=.@_*O.O'%UI$$HTO3K"
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M.YATBWCNV+3A?F)[UHT5M4KRG!1ET,XTU&3:ZA1116)H%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSL(I6>1=NX#(%<Y\-"Y\0YD^_OYJZ-&4*$W+0FI-2J12/;J***\L[#E?'O\
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MMV.>46J*OW/7X/\ CWB_W!_*I:B@_P"/>/\ W!_*I:\AG<@K@/BI_P BX_\
MO"N_K@/BI_R+C_[PK?"?QHF5;^&R'X7V%I<>& \UM%(WF-RR@FNHU7PMINHV
MKQ?9HXR1U10#7/\ PI_Y%8?]=&KO*K$SE&O)I]14HITTF>$DW'@3Q&5VEK7?
MP6YXKV;2-2BU73XKF)@=R@D#M6'XZ\.1ZSI+R*@\^)3L('>N%^'WB";2=6;2
M+M]J,^"6[8KIFEB:/M%\2W,HMT9\KV9Z)XJ\2Q>'K!I#S)T Q7 VM]XL\4DS
M6B(D9/'S;:O?%*UFF6*[C!>$;>G-:/@GQ1ID>C)!(RQ2*3G) I4X*G052*NV
M$GS5.63LC%N/!WB&2WDEO;J1449(64U2^'D7D>)IHMQ;;(!DGK75^)_&MLUA
M-9V2O++(NT%.17%?#R=H_%&RX^65Y.0>*W@ZDZ$W-6,Y*"J143K_ (I?\@K\
M16Q\/4">&U '\58_Q1_Y!7XBMGX?_P#(N+]:Y9?[HO4V7\=^AL^(/^1?OO\
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M +@_F*Z,N_C_ "9GBOX9UF@^#-,NM*BED3YB!VK47P-I*G/E@_\  :O^&/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 53U'3K?4[8P7*;D/:KE%--IW0-7T9E:-H%CH<;)91>6&&#1K&@
MV.MH$O(MX Q6K13YY<W-?4GE5K%2PT^#3K<06Z;4':K=%%)MMW8TK%/4=-MM
M3MV@N8]Z$8Q5+0_#6G: )?L$/E^9][GK6S13YY<O+?07*KW*&JZ1:ZQ9M;7<
M>^)NHKG?^%:^'?\ GS'YUV-%5"M4@K1=A.$9.[1R"_#?PZ#S9 _C6G8^$M'T
MYP]M:A6'2MRBG*M4DK.3!4X+9#0H P!3J**R+"H+NUBO+:2WF7=&XP14]%"=
MM0,+1O"NF:$[O8P>67Z\UNT454I2D[R8E%15D%(ZAT93T(P:6BI&8,7A/2X=
M2-\EN!.3DMFK>K:)9ZS"(KR+>N,8K3HJW4FVG?5$\D;6L4=/TRWTRU^SVR;8
M\8Q5!?"FF#4OMX@'G_WLUNT4*I)-M/<.5%'4M)M=5M1;W2;XQVI-*TFUTBU6
MVM(]D:C %7Z*7-*W+?0?*KW$K"L_"6E6.KG4X;?;<DDEL^M;U%$9RC=)[@XI
M[F!XC\1P:!;+)/"71V"G!]:SH/#WAWQ/;+?&V#[^X-:GB;P_%XATTVSD*0<@
MX[UYTGAWQ9H0^SZ;-</ #P%Z5UT(PE#W9<LC"HY*6JNCK-3\.Z%X>T:YGA@6
M-PF1D]:Y3X:V[76M7%ZJ_()>M._X1KQ5KN(=2N+B.(\'<*]#\.>'K?P_8""$
M#<0-[ =36DZBI4I1<N9LF,>>::5DC;HHHKSCJ*>HZ;;ZG;-!<IO1A@BL0^!M
M%^R_9Q:C;C YKIZ*N-2<5:+)<(O='#P_#31TGWO"&3/"YKK;#3[;38!#;1A$
M':K=%.=:<_B=Q1A&.R$KS;XIWMN;6WM5 DF8D!0>0:Z7QC#JTVFQC2))$F#9
M.SJ17$Z-X*UG4M6BOM:DE_=MNPX^]73A80C^]E+;H95G)^XD==X!T@:;H,,F
MW:\R!F%=93(8E@A6)!A5& *DKEJ3<YN3ZFT(\L4@HHHJ"A",BL#5/!VD:JS/
M<6P:0]ZZ"BJC.47>+L)Q4M&<"/A?I?FYV+L],UKP>!-#MX#&EH!D8ZUT]%:R
MQ-66\B%2@NAYTGP_GTW6H[K3KE8H-^6CP>E>A1*4C"DY([T^BIJ5I5+<W0<8
M*&P5@:AX0TK4=06]N+<-,N,-GTK?HJ(SE%WB[%.*EN,10BA0. ,"GT45(PKG
M]7\'Z3K=RL]Y;B211@'-=!151G*#O%V$XJ2LSCO^%;>'?^?,?G2_\*V\._\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&ND?V7X6A8CYKE5D/Y5V#HLB%6&5(P15/1H/LVC6<.,;(@M/U*]2PT^>Y?\
MY9HS#\!0!SWB#5-#\$V4VH,L4,SJ0H[N?2O(/"%E?^.OB$/$DD+QVL<PE4'D
M8KB_$WBV;Q/XM,]_+*MBD@Q%@E>*]<\&?$;0;>>TT>PA1#(=F0A&: /8@ !@
M=!2TU&WH&'<4Z@#YJ^+/_)8;'_?A_G7TE%_J8_\ =%?-WQ81C\8+$A21OAY
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MEVMG9FUBB41'JN.*N44 <S/X$T.>X,S6L8)/0(,5M:?I=GID/EVD$<8Q@[5
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MHH;:&W&(HU3Z#%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 13/L7-4S?C.,U9N_P#55BG[QH T?MP]:7[<*SJ44 :'VVE^
MV5GBG"@"]]LI?M=412T 7?M=+]J-4Q3A0!:^TTOV@U4%.% %G[0:7SS5>EH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HIHD0G 89IU !12$@=31N![T +112;@.] "T4
MFX'O2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1129% "T444 %%&:* "BD#J>AH) &30 M%(K*W0YI: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O=_P"J
MK%/WC6U=_P"JK%/WC0 M**2E% "BG"FBG"@!12T@I: '"G"FBG"@ %.%-%.%
M #J6DI: %%% HH 6BBLO5M?L='C)N)D5NRDU48N3LA-I*[-6EK@F^)EB'VB,
M$>NZNAT;Q3I^L82*9/,/1 >:TGAZL%>42(U82=DS<I:2L;6/$^GZ,-LTR>9_
M<)YK.,92=HHMM)79MT5PD?Q,L'EVLBJN>N:ZS2]8L]6A\RUF5^.0O:KG0J4U
M>2)C4C+9FA137=40LQP!7$ZG\2+.QNFAAB$Y4X.&Z4J=*=1VBKCE.,=SN:6N
M3T'QS8ZS-Y3;89.RDUUE*=.5-VD@C)25T%+7*^)_&</AR2)##YS/V!Z5NZ7?
MG4;&.Y,1C#J" :;I3C!3:T8*<6^5%ZBBBLRA:44E** "EI*6@ I:2EH !2T@
MI: %H%% H 6BBB@ HHHH B_Y:5+47_+2I: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "F2RI#$TLAPBC)-/KGO&=S+#X9O(X%8S21$)@
M=Z /)5\8Z,_Q'N;O5KLQ1V,_[@[<Y%-3Q=HMM\3+.YT:Z+VDRL9AMP-Q(KOO
M /A"TBT**ZU*RAENKA S^8@)!_&F?$/P?9W/AN233;**&Z1U*F- #C\* ,7X
MS[;S0-./\,MU#^185O7W@G2(_"#R):Q"XC@WK,%^8' K@/'E_=W'@33WFCVS
M07<* $==I'^%=!-XTU.]T1=(2U/VN:/RS\AV@$<<XH @L-2GN?A!JMG.YD>"
MTY=CRW(K5^'?A/3!X5L[^:VCEG:(,KL.5^E.7PM<Z3\)KZSD7-\]MM<#G)R*
MZ/P1:RVW@FPAE4JZP $?G0!PWP^4+X=\3*HP!>O@?]]5T?PB_P"14G_Z^Y/_
M $(UD^!],NK;0_$22QE6EO'91CJ.:WOA;9S6/AF:*="K&ZD.".V30!V[ ,I#
M#(/6N.\5>,;?18?L%@%FU&3Y88/5O2MGQ1>S6.@W4ENI:;RSL '>O#?#NL7]
MCJ$VHZA9O-<R'< \98*?;B@#T;PCX4N-.M+W5;S<+R\)E*'^ XZ"H?@YC^R-
M7]?[0D_]"-:GACQ;=:],;>:V,:GY?N$5R\;:A\/M<G582^GSLTI*@L=Q]OQH
M G\=X_X2^RV?>\U,_G7I-[?6>DVDEY=.(XT7+M[5YMI%G?\ BSQ8VLW,6RQ5
M1LR,'</:N>^(>J:S>^+%M!%(+"VDS\@/SCT/K0!MR"^^(WB**18RFCV[8#KT
MD4]R*C\36ZVGQ5\/VP_U<=HRC\Q4FE>.[BPBCM;?3MB 8XA(_I6SXTT2YU.Q
MM?$%BF=0B0!5/ P>O\J .J\18_X1FX_Z]V_]!KF?@YG_ (02+_KO)_.L&^\6
MZKKFG1:3:6I^T';'+N0@8Z-SCZUZ%X1T)?#OA^&P7)P2YSZF@#=HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]XT +2BDI10 HIPIHIPH 44M(*6@!PIPIHIPH !3A313A0 ZEI*6@!110**
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M[7_GNGYT 6:*K?;[7_GNGYT?;[7_ )[I^= %FBJWV^U_Y[I^='V^U_Y[I^=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 56O_ /CRE_W:LU6O_P#CRE_W: (M)_Y!
M\7TJ]5'2?^0?%]*O4 %%%% !28I:* "BBB@!K(&&" ?K4+65J_WK>(_5!5BB
M@32>Y0DT>RD7'D1C/<(*RKGP;97!R)[A/]QR*Z2BIY493P]*?Q1./;P4$YBN
M[DXZ9E/^-*NE:_9?\>CQOC_GHV:Z^BER(Q^HTE\.GH<@U_XG@_UT=N?]T9IJ
M^+)[9P+Z(KGN$KKRH[@'\*X_Q#MO]:M=,0+MD!+$#IBDTUK<QKPJ48\T9MOS
M.NAE$L*2#HR@BI*B@B\F"./^ZH%2UH>BKVU*U_\ \>,W^[7@-];B>[UD[<L'
MXX]J]^O_ /CQF_W:\A\.6J7OBR_MY!E7FP?R%>C@9<D92['-B(\S2)K;Q'_Q
M;^YCW8EB=8P/SKB)+9K>^MBZX9Y4;IZD5-=PS1Z]<:<AQ$T^=OT-;_C>WCMM
M>TQ(UP/+A)^O%>C!*$K+[6IRR;E&[Z:'5>+/$T^G:3;V5H0)9<(2>P(%<Z=&
MU.RTE-634E:2-=[(;C/Z9J3QW9.!:7+*QB)7./I4HL-"_P"$>^VR7&[Y,F$2
M_-]*YJ:C"G%KKOI<UDW*3N=5H?C#SO"\U[.1NMU ; [UQNFV^L>,M2FNH[AD
M@1B %D*_2M>QTRWO? ^H1:;;RQ>< 1O.<U6^&VK6NDK<6%W(L;B0G+''2H2C
M",Y4UK<IMR<5)Z'-:U;WMEXLM;:];<ZNF#G/&:[SXD7,UMHM@T4C(2W.TX[5
MR/B^_BU'QS;36Y#1;T&X=.M=3\3_ /D!Z?\ [_\ 2M)7<Z7,B5I&=C<TZ6\D
M\ 0O;,#<M#\I<]ZXB;P]J9M9KN[U(++G(5;C'Z9K;N=5N=+^'-HULIW-#]['
M K&TW3],O](>]U2]5YR,A5DQ^E94DX\TNE^URIM2LO(T_A[K]S.MQITS[]N\
MAB<GC/>N?EU'5&\6S6MM,Q$@VD%C@9)J7X<&-=?ND0_*%DV\]N:=IBAO'\N>
MV/YFMG&,:D[+H0FW"-WU(_$>G:MX3GM;UKJ1@S]#(2*]:\/WC:AH-G=O]Z6/
M<:X?XN_\@VS_ -X_RKKO!O\ R*.F_P#7$?SKCQ#Y\/&;W-Z2Y:KBMB;Q+_R
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MY"[>BM5PL%7<2 HYS0 ZE%5X;ZUN&989T<K]X*>E-CU"TEF,,=Q&T@."H/-
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M*** "BBB@ HHHH **** "BBB@ HHHR/6@ HHHH **** "BBB@ HHHH ****
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M@\Z]F$28SDU!HWB72]>5FT^Y68*<'% &O11FB@ HHHH **** "BBB@ HHHH
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MM8(UPS@YKH-.T6[_ .$IM[F:(B&"#R@3WQ0!E>+M O8=6MM8LXVF*A%,:#G
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MN\MC''AT7I4_B;1M8M?$-EJ6GVK71A8L0>*M>([7Q#>QVUU!;NP"?O+?/!-
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MPX.7Q4\.JZ[X2U5([B63(/*ECC&:[CX)@&.ZR/\ EH/Y4WXS:?$EPERJ@-M
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M@ HHHH *R(?^0U<?A6O61#_R&KC\* ->BBB@ HHHH **** /-/C#_P BV_\
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M>@"UKNO:[J>C%;B%UL\##%<#%;'PA_Y#<O\ UP?^1JGK7C&UO/"$6DPPJKA
M&8'N*M?"-P-<E!//D/\ R- &#XF_Y'C_ (&/YU[+J5O$_P -)BRC*P$CCZ5X
MMXNE\CQ?)+C.P@X_&NEU#XDK<^$ETQ(-K,A5CF@#,^%Y(\;6:CH9.:RO%O\
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MFCS9O^2N1_\ 7Q6WXNTO2-4U5(VGC@N,'#LU;Y\$Q_\ "4+K7GC<)-^W%/\
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M!R_Q0N'735@!.UP,UT_AS2;.ST.W2*( 21AFR,Y)%9WCO0Y-7T:3R%+3*/E
M'-<QI?CR\TJR^Q7MFQEC&U2Q].* .Y@\,Z59W[ZA'#MF(Y.:X[6-9U?6O$LV
ME:5<B*.(C+$9&#4GAN[U[7]6FFG>6&R9,*IZ5FRO<^$O&-W<M;,]O*0 _04
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M444 %%%% &+XB\.6_B*R-M<.54D'(%4?#7@FS\-3F6WE9R1CD8KJ** "N?\
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M@"O=_P"JK%/WC6U=_P"KK&(.X\'\J "E%)M/H?RIP!]#0 "G"D /H:4 ^AH
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MCB]1&7#;3N]1715P7A_6M%T/PH+FQC5;;S-IP>,UK:%XVT[7;I[>!E#*,]:
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M2\1+XBTS[0%8,N V>YKH:YCP2-.32,:<JK&,;L&C6_'.E:+(8Y)T:0?PYYH
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M]K.OZW':WLJ-&V<X7%>P#I7SK\)/^1GA_&O>=5UJRT:V\Z[G2,#^\: -&BN
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M.H#4[1OB%I.K3B(2I&YZ MUH Z^BD!##(.12T %%%% !1110 4444 %5K_\
MX\I?]VK-5K__ (\I?]V@"+2?^0?%]*O51TG_ )!\7TJ]0 4444 %%%% !111
M0 4444 %(:6H;J40V[N3C"F@3=E<Y+6&.K^(TTP'Y(MLM=BB!$"CL*Y+PM";
MZ^FU9_O$M'S[&NOJ(=SDP:YE*J_M/\.@44459V!1110 4444 %%%% !1110
M4444 %%%% !15:"\2>XEB YC.#5F@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@!@C"GBGT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%9$/_(:N/PK7K(A_Y#5Q^% &O1110 4444 %%%% !1110 4444 (QPI/H*^<
M?B;J<VH^)E@WGRQ\FWWS7T:_^K;Z&OF#Q@K1^+QO_P">P/\ X]0!N1?#!O\
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M:*.WG;B0#<.XS4_A7P_K>M12G2IB@5L,!)MS6Y_PK'Q$;R.2<(S!@<M+SUH
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MAF\6R\$P3Y'RPC^5>*ZAKVM>)=?DMX9WC_>%0JO@8S0!2\4Z%!H%ZJVMT92
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MSH ](\#?#FZL+VTU2>1P0VXH17G?BC_D=K[_ *[G^E?3FF?\@^'Z5\Q^*?\
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MBU,:E;1EX<#(49.:]WKS?XE>*[C1 D,,1(."6*Y&* /)8/$GB"/1VTT0R"W
M))9#_.JO@K_D;M._Z["NBU/XB6EYIC6UO:-',XPS$#FE^&'AJ?4-:6]>,K'"
MP=6(X- '9?%+P;+J,27]HF6C!+CN:\QL]=\0:5I\VF103>6[<YC;-?4;(K+M
M8 CWJB^BV$DGF-;KN^@H \/^'?@NZU/51?WL;)""6^8$'.<U['XHTY;WPY<0
ME=Q2([1^%;,4$<"[8T"CV%/90RE2,@T ?)$.AWDFJ)9_99_F;;G8<5]0>&;+
M[!X<L[<C#)%@U<&EV8D\P0KN'? JV  ,#H* /F?QM:73^*]RVTS+YO4(2.M>
MTC3Y+WP3Y(4A_)X!_P!VNEDTRTE?>\*EO7 JRL:HFU0 OI0!\HQ1:KX?U@O'
M;2^;&^0?+)%>RWVF7GC3P'#/.FV\\K*@C'-=Y-H]C<2>9) I;UP*N10QPQB-
M% 4=!0!\NV,^O>#]186\$N]6Y^0E36U9:[XI\0:U YCE0AAGY2HQFO?Y]+L[
MDYEA4GZ"EMM-M+4YBA5?P% '$>/_  O<:]X<A* &XC 9OP KQRPU37O#8N+2
MWMY0)%VM^[/Z5]2$ C!&15&;1[&=]\D"EOH* /!? GAS5-:\1QW]RLJ1J^7W
MY&:O_%+PO>07T%U;QM)$B8.T$FO=(+6&V7;%&JCV%+/;Q7";)4# ^HH ^8X]
M=\03:,=)6UD\@'=_JCG^5:7PS:XL?$C--:SJ),+DQGUKZ BT>Q@)V0*,]>!3
MX],LXGWI"H;U % 'SU\2;6YD\:7C1VTSJ9."J$BO3[Z*0_"..,1N7\@?+MY[
M]J[>73;6>0O)$K,>I(J8V\1@\DH/+QC&* /GCX:VMS'XU1GMID7#<LA KZ+7
M[B_2JT6G6L$F^.)5;U JU0 5X[\:X)IOL'E0R28SG8I/K7L507%G!=8\Z,-C
MID4 >9_!N&6+P]J(EB>,E^ RD=J\JO+.[/BYF%K/M^U9SY9Q]ZOJ*"UAME*P
MH%!ZX%0G2[,OO,*[LYS@4 >6?%2XOO\ A'K.V@CE*C;G8IST'I7E6D7>JZ-<
M^?;64I?U:$G^E?5DUE;W"A98PP'3(J#^Q['_ )]T_(4 >+^%_'7B6^\1VEM<
MVSK"[88^41_2J?Q;M[F?7K1TMY7S$<E4)]*]WCTNSBD#I"H8=#@4Z?3[:X8-
M+$K$=,B@#@_@Y%)%X0998W0^<W#K@]:X_P",FDK;WZZ@ ,RMMKVJ40Z98321
M)A8U+X'L,U\Z^-_&,GBRY6VCC8*DGRJ>N: .@^#>DF>_N+IUXCP5->[5P_PQ
MT<Z;X;@EDC*2RH-P(YKN* $;[I^E?.?Q,M;F3QR62VF==J\JA(KZ-JI+IUK/
M)YDD2LWJ10!@^"("_@NVAE1EW @AA@UXYX]\)ZAH_B"6^@B9HI7+)Y8)(_*O
MHF.-(D"( %'84V:VAN%VRQJP]Q0!\OWVM:_K=I%836\QC50H_=G]:]7^&WA"
M?1M)ENKM0)V5MH'H0:[^/1K")]Z0*#]!5X*H7:  * /F7Q!:71\<JPM9BOF+
MR(SCK7T3H(*Z- ""#CH:G;3+1Y/,:%2WK@5:50B[0, 4 +7EOQAAEETO$<3R
M' X52:]2J&>UAN1B5 P]Q0!X]\(X)XK.X\R&1/D?[RD=C7$:[:73>-]PM9BN
M\<B,XZFOI>"S@MP1%&%SZ"HFTRT:3S&A4MZX% 'F?C2"9_ MHJQ2,PC.0%)-
M87P>MIX[^3S8)8P7_B0BO;Y+6&6,1N@*CMBF06-O;',4:J?84 >(_$KP1<6^
MH_VC8QLT9Y8#DYKGK+QKXGL=/-A%;R[.1DQG-?2LD22KM=0P]Q5$Z'IY?>;=
M<_04 >=?"UM=D>62]W>0R_+OSG]:Y/XJ>'[R#6FNTA>1)F+#8I.*]_BACA7;
M&@4#T%1W-G!=KMFC##W% 'BW@+4M7U2T;29X62#& 60CH*X>^L=6\.>()9%M
MI&?S"RD(2,9KZ=MM-M;0YAB"GV%)<Z9:7;;IH58^N!0!\PZ_?ZWKS+=7EI+S
MA1MB/;\*]-\$VLVJ^!I]-"30SI#A2P*\\5ZA_95EY83R$VCV%306D%MGRD"Y
MZX% 'S2LOB'P=K9=%GE:-N-P9U-5YTUCQ?K,<DEF8Y">HB*CK7TS<Z9:7?\
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M<:?:W1S+"K?@*9;Z396S;HH%!^@H @\/_;/['A^W8\_'S8K4HZ=** "BBB@
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M)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E%
M$?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2
MM'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2
MM244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)1
M0!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?
MDK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'
MDK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M2
M44 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!
M'Y*T>2M244 1^2M'DK4E% $?DK1Y*U)10!'Y*T>2M244 ,$:@Y%/HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R(?^0U<?A6O61#_
M ,AJX_"@#7HHHH **** "BBB@ HHHH **** "LO5O#^FZW'LOK991_M5J44
M<8/ACX:$F[^SHL>F*Z73-)LM(MU@LX5BC P *O44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 1SPK/ \3C*NI4CZUR5M\-]!M[T7/V.,N&W#CH:[&B@!D<:Q($084=!3Z**
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MWWO"8FSC::\VUO4-4U#4H8;0M&P&&13Q7HFA6\T&GH)Q^\QSFA; ]S4HHHH
M***3<,]10 M(>E&X9QD4'I0!C:9_R%+W_>K:K%TS_D*7O^]6U0 4444 %%%%
M !1110 445'-)Y<3-Z"DW97 DHJA!=F20#UZU?J834U= %%%%6 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5D0_\AJX_"M>LB'_D-7'X
M4 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,:GTQJ (9*K3_\
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M^)?"5S<>"1I%LS2R*JJ"!UQ6!\.? ^I>']?^U74;JGEE<D4 >N4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5D0_\AJX_"M>LB'_D-7'X4 :]
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %&*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM
M%FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7
M/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]
M%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJ
MVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM
M%FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7
M/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]
M%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJ
MVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBJVZY]%HW7/HM
M%FBJVZY]%HW7/HM %FBJVZY]%HW7/HM %FBH$,Y;Y@,5/0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5D0_\AJX_"M>LB'_D-7'X4 :]
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!=&-O,  '/'%:^T!<8Z4M(>E &-IG_(4O?\ >K:K%TS_ )"E[_O5M4 %%%%
M!1110 AZ5CS?Z;J8AZHHS^(K2NYO)MV?\*I:3"?+:5Q\Q8X^E<U;WYQI_-DO
M5V-,   4M%%=)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +1
M24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5D0_\ (:N/PK7K(A_Y#5Q^% &O1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 56O_P#CRE_W:LU6O_\ CRE_W: (M)_Y!\7TJ]5'
M2?\ D'Q?2KU !1110 4444 4M3NEM+&25S@ 8S6#X*M'2SGGF7YVF8@GT)-'
MC"=I(5L(S^\D(; ]JZ*QB6&RA15 ^09QZXJ-Y'$OWF)OTBOQ99HHHJSM"BBB
M@ HHHH **** "BBB@ K#\47LEEI$K1$J^W@CM6Y5'5--BU2S>WE)"L,9% 'E
M/G76H+NFG?:#G;ZUZ9X;N_M>EJVP+L.WCVK"_P"$-TN)L?;G!!Z;A_C74Z=:
M0V5L(H3E?6GT%U+E%%%(844AX%<O<>*6M=0\J6/$(X+8YH ZFD/2N5?QE!'J
M"1$'R7P V.YKJ!(I0-D<B@#(TS_D*7O^]6U6#I\\4>J7F^11ENYK;$B,NX,"
M/7- [.UQ]%0_:X-V/-3/^\*<\T<8R[JH/J:5T/E?8DHJ..>*7[CJV/0YILEU
M#&<-(H/IFAM6%RLS]3E,DR6J_P 7-:42!(E4#'%9-B/M-V]PYX1B :TQ=P9P
M)4SZ;A7-0]YNH^HHQ;U1/13'E1%RS #U)IJ7$4APDBM]#75<?*[7):*B>XAC
M.'D53[FG)*DB[E8$>H-%PY7:X^BH?M< ;;YJ9]-PIYD15W%@!ZYHN'*UT'T5
M$ES#(<+(I/L12R3Q1??=5^II70^5WM8DHIB31R#*.K#V-,:Z@5MIE0'TW"G<
M7*]K$U%-\Q-F_<-OKFF)<PNVU9%)] :+A9DM%1R3Q1??=5^II4FCD&4=6^AH
MN'*[7'T5"UU"C;6E0'T+"G^8FS?N&WUS1<.5CZ*A6Z@9MHE0GT#"GO-'&,NX
M4>YHN'*]K#Z*C2>*7[CJWT-(]S"C;6D4'T)%%PY7>UB6BF+(C+N# CUS3/M4
M&[;YJ9]-PHN'*V344QI41=S, /4FFI<12'"2*Q]C1<.5VN2T5$]Q%&</(J_4
MTY)$D&58$>QHN%G:X^BH?M4&[;YJ9]-PI[2(B[F8 >I-%PY6/HJ)+B*0X216
M/L:5[B*/AY%7ZFBX<KO:Q)13$E2091@1[&F&Z@#;3*F?]X47#E?8FHII=57<
M6 'KFF+<PN<+(A/LPH#E;):*CDFCB^^ZK]32I-'*,HX8>QH"SM<?14+74*-A
MI4!]"PJ02(5W!AM]<T7!Q:'45"MU S;1*A/IN%/>6.,9=POU-%PY7>UA]%1Q
MSQ2_<=6^AI'N88VVO(H/H32N'*[VL2T4P2HR;PP*^N:8MU S;5E0D]@PIW#E
M9-13'E2,9=@H]S2)/%)]QU;Z&BX6=KDE%1/<PQMM>10?0FG+(C)N5@5]0:+A
MRNUQ]%0_:H-VWS4SZ;A3VE1%W,P ]2:+AROL/HJ)+B*0X216/L:5YXHSAY%7
MZFBX<KO:Q)13$E21<JP(]0:8;N -M,J CMN%%PY7V)J*:9$"[BPV^N:8ES"[
M;5D4GT!HN'*R6BHWFCB^^ZK]30DT<@RCJV/0T7#E=KDE%0F[@#;3*@([;A4A
MD0+N+ +ZYHN#BT.HJ)+F%VVK(I/L:62:.+[[JN?4T7#E=[6)**CCFCESL<-C
MT.::UU APTJ ^["BX<KO:Q-13=Z[=VX8]<U&+J!FVB5"?3<*+@HMDU%,>5(Q
MEV"_4XI(YXI?N.K8]#0%G:Y)143W,,9P\B@^YIRR(Z[E8%?4&BX<KM<?14(N
MX"VWS4SZ;A3VD1%RS #U)HN#BUT'T5$EQ#(<)(K'V-$EQ%$</(JGW-%PY7>U
MB6BF+(C+N# KZYI@NX"VT2IGTW"BX<K9-136D1%W,P ]2:8EQ%(<)(K'V-%P
MY7:Y+143W$41P\BJ?<TY)4D7<C CU!HN'*[7'T5";J -M,J9]-PIYD14WE@%
M]<T7#E8^BH4N87;:LBD^@(ITDT<7WW5?J:+ARN]K#S7-:]KMUI]S%%;VXDWG
M!YKHDFCD&4<-]#7/:KI\=YJ,3O,J*C<_,*SJ7:]TZ\&H*K^]5T26?B2$QXNL
M1R?W:N+X@L6DVB4=,U2GTA#=021A3$JX9CWK)_LV9I)+=?*\LDMO##=]*CFF
MCI5'#5-5H;\GB;3HF^:8 4O_  D=AY2R><-K=#7$7HD7;9"-,;OOMUK4N= F
MN=*MHX"IDC.6 :H56;V-Y8'#047)VN=,_B"QC1"91\XXI9]<LX&C5Y &D&5'
MK7,OI]Q%8I'B$R@8^9AQ5N^L+V2W@*11,0HRQ/2KYY&/U3#W6NFO4UFUNVAG
M_>2@*5S3O^$BL!&',P&:YZ;3)YI5=3$651\N\4XZ-<R21W%PL<?S<J&XHYY]
M"OJN&TO(ZFQU2VU#=Y#AMO6KM8>DVRV]]<.A38_0*16V*UBVUJ>;7C&,[0V%
MHHHJC$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(A_P"0U<?A
M6O61#_R&KC\* ->BBB@!#33*BG!=1^-97B/4IM-TTRV\3R2$X 6O+KS7?$.X
MRS%U!/=:SG443S\7F$,-+E:;/9?.B_YZ+^=)YT7_ #T7\Z\-_P"$GU7_ )^/
MTH_X2?5?^?C]*CVZ.'^W:?\ *SW575AE2#]*1I$7[S ?4URW@2^N+_2I9+A]
MS!\ UE^.]5N["4"WDV]*T<TH\QZ$\;&.'6(MHSO/.B_YZ+^='G1?\]%_.O#/
M^$GU7_GX_2C_ (2?5?\ GX_2L_;H\_\ MVE_*SW02QL<!U)^M.R .37D?A77
M]0NM?@AFFW(>HQ7I^H2-'ITCJ<,$)_2M(S4E<]#"XV.(INHEL6O.B_YZ+^='
MG1?\]%_.O#YO$VJ+/(!<<!CV]Z9_PD^J_P#/Q^E9^W1Y_P#;M+^5GN?G1?\
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M^='G1?\ /1?SKPS_ (2?5?\ GX_2C_A)]5_Y^/TK/VZ//_MVE_*SW02(QPK
M_0TI8*,L0![UYMX&UB]OM0E2XEW*%&*ZSQ9<RVFB3RQ-M<+D&M%-./,>A1QL
M:M!UDM$;7G1?\]%_.E\Z+_GHOYUX9_PD^J_\_'Z4?\)/JO\ S\?I6?MT>?\
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M?Y%]Q0L-'L-,W?8[=8MW7;WJ2\TZUU"+R[J)9$/8U;HIV5K&GLX*/+;0Q/\
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M8IU@FY,:8)!QBFHM["<DC;HIJ-N0'VIU(84444 %%%% !1110 4444 %%%%
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M93D"D2]MI"P2>-BHRP#=* )Z*S7\0:1'+Y;ZC;*_]TR#-7XY$EC$D;!D89#
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M('4@5P_PV\07NN^'+B]OCND20X &..>*RKW5/%OB'7);71BMI;QC(-Q'U(H
M].!!Z&BO,O"WBG6+7Q/=:#KLJ2R1 !6C7 R:]-H *3(SC(SZ50U?6+;1[-[B
MX< *.F>37G/A+Q[?>)/B(]GY;Q6:PL0CK@DCO0!ZJ2!U(%+6+XG^UII37%HP
M5H 9&SW J+PAKHU[0H+EV'GLN73N/PH WZ*** "BBB@ HHHH **** "BBB@
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MR202"0''+=:N_P#"N] _YXO_ -]52=U<35BM_P +0T#UG_[]FC_A:&@>L_\
MW[-6?^%=Z!_SP?\ [ZH_X5WH'_/!_P#OJF(K?\+0T#UG_P"_9H_X6AH'K/\
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MV:L_\*[T#_G@_P#WU1_PKO0/^>#_ /?5 %;_ (6AH'K/_P!^S1_PM#0/6?\
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MS1_PM#0/6?\ []FK/_"N] _YX/\ ]]4?\*[T#_G@_P#WU0!6_P"%H:!ZS_\
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MH:!ZS_\ ?LT?\+0T#UG_ ._9JS_PKO0/^>#_ /?5'_"N] _YX/\ ]]4 5O\
MA:&@>L__ '[-'_"T- ]9_P#OV:L_\*[T#_G@_P#WU1_PKO0/^>#_ /?5 %;_
M (6AH'K/_P!^S1_PM#0/6?\ []FK/_"N] _YX/\ ]]4?\*[T#_G@_P#WU0!6
M_P"%H:!ZS_\ ?LT?\+0T#UG_ ._9JS_PKO0/^>#_ /?5'_"N] _YX/\ ]]4
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MKLZBBLZTUJQO$W13*V.N*O12I*N4.16;36YJFGL/HHHI#"BBB@ HHI"0!DT
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M HHHH **** "BBB@ K(A_P"0U<?A6O61#_R&KC\* ->BBB@#B?B3_P @,?\
M705Q?@G_ )#0_"NT^)/_ " Q_P!=!7%^"?\ D-#\*YI_Q#YC'?\ (QC\CVJB
MBBND^G"BBB@ HHHH ***:[JB[F8*!U).* '45##>6UR2(+B*4CKL<'^52LRH
MI9F"J.I)X% "T5!#>VMPQ6&YBD8=0C@XJ>@ HHHH **B>X@B=4DFC1W.%5F
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M%7.NA*3@G+<6BBBK-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMV@ HHHH **** *>I2M!IMQ*OWD0D5YCIWC2_GU"&)LX9L'FO2]9'_$EO/\
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M\B\_YYR5UW@**X364,BL!@]:(U6W:P\/F\ZM50<+7/4I9HX$W2NJ+ZDXJO\
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M -]BN6^("2O8J(P2=O:O,/(O/^><E$ZKB[6*QF:3P]7V:A<]X_M6Q_Y^H?\
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MQ<^JT8N?5:M44 5<7/JM&+GU6K5% %7%SZK1BY]5JU10!5Q<^JT8N?5:M44
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MBY]5HQ<^JU:HH JXN?5:,7/JM6J* *N+GU6C%SZK5JB@"KBY]5HQ<^JU:HH
MJXN?5:,7/JM6J* *N+GU6C%SZK5JB@"KBY]5HQ<^JU:HH JXN?5:-MQZK^56
MJ* *302N,,L9^JU2GT..X^^JC_=&*VJ*+L3BGNCE9?"8',$CJWNYJI)I/B"R
M1F@N(BH'0\FNUI" 1@U2FS&6'@]M#SRVUW4;2_BCO3]X\L!P*[:"6:>)7CD1
M@1VJ*^T.ROHG26('=UKGDDO?#=T(V#2VAZ;>BBJ=I;&<>>C\6J.JQ<_WEHQ<
M^JTEE?07T(>%U;U /2K=9G4FFKHJXN?5:,7/JM6J*!E7%SZK1BY]5JU10!5Q
M<^JT8N?5:M44 5<7/JM&+GU6K5% %7%SZK1BY]5JU10!5Q<^JT8N?5:M44 5
M<7/JM&+GU6K5% $""?=\Q&*GHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTH/5I%#^Q=._Y]4_*I[>RMK7_4Q*GTJQ119 J<$[I$%Q9P7:A9XE<#IFJ_\
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M:RN<5/\ >8B4^D="6BBBK.T**** "BBB@ HHHH **** "BBB@ HHHH ****
M$KG/&-G<7NCRPVQ99&7 8=JZ2FN%V_,,B@#A;'PMK8M8=VMS+A1E<?\ UJ[.
MQ@DM[=8Y93(P'WC7-2^,X5NG@A4,$;:>.E=+9W'VJW67&,TQ%FBBBD,****
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MXUG#*OS(K ^HK+O?"&EWW,L3 _[)Q6_-3ENK'#>+W1KPWUK,H*3Q'/\ MBK
M=3T8'Z&N,D\#BV!.G2M&W;>Q-9\EIXLTQMWVJ.6,?PJAS_.CV<9?#(.5/9GH
M>X>HHW#U'YUP5OXNGB(CO=/NB1U8# JX?&.F9QNV$=06YI.C-=!<C.QW#U'Y
MT;AZC\ZS+*ZM;Z!9(I5.1TW5<$ /0_K6336Y)/N'J/SHW#U'YU!]F'K^M'V8
M>OZT 3[AZC\Z-P]1^=0?9AZ_K1]F'K^M $^X>H_.C</4?G4'V8>OZT?9AZ_K
M0!/N'J/SHW#U'YU!]F'K^M'V8>OZT 3[AZC\Z-P]1^=0?9AZ_K1]F'K^M $^
MX>H_.C</4?G4'V8>OZT?9AZ_K0!/N'J/SHW#U'YU!]F'K^M'V8>OZT 3[AZC
M\Z-P]1^=0?9AZ_K1]F'K^M $^X>H_.C</4?G4'V8>OZT?9AZ_K0!/N'J/SHW
M#U'YU!]F'K^M'V8>OZT 3[AZC\Z"R_WA^=4+J6VLHC)/*J*/4UQVH>(+W5)_
ML>C1NA/'G,,K]:N%-RV*46SI]9\266CPEY7WMV6/YC^5<KC6/%T_SGR=/[8.
MQZTM+\%Q[UN]28S7'7(;C\JZA+-(U"H H'I6G-"G\.K[CNH[%#2/#]CI$(2,
M!V'\;\G\ZUP5]14/V8>OZT?9AZ_K6+DV[LAN^Y/N'J/SHW#U'YU!]F'K^M'V
M8>OZT@)]P]1^=&X>H_.H/LP]?UH^S#U_6@"?</4?G1N'J/SJ#[,/7]:/LP]?
MUH GW#U'YT;AZC\Z@^S#U_6C[,/7]: )]P]1^=&X>H_.H/LP]?UH^S#U_6@"
M?</4?G1N'J/SJ#[,/7]:/LP]?UH GW#U'YT;AZC\Z@^S#U_6C[,/7]: )]P]
M1^=&X>H_.H/LP]?UH^S#U_6@"?</4?G1N'J/SJ#[,/7]:/LP]?UH GW#U'YT
M;AZC\Z@^S#U_6C[,/7]: )]P]1^=&X>H_.H/LP]?UH^S#U_6@"?</4?G1N'J
M/SJ#[,/7]:/LP]?UH GW#U'YT;AZC\Z@^S#U_6C[,/7]: )]P]1^=&X>H_.H
M/LP]?UH^S#U_6@"?</4?G1N'J/SJ#[,/7]:/LP]?UH GW#U'YT;AZC\Z@^S#
MU_6C[,/7]: )]P]1^=&X>H_.H/LP]?UH^S#U_6@"?</4?G2$J>I%0_9AZ_K1
M]F'K^M &1K.@Q7H\^W/EW"<KM. 3[U3TG7Y;>X%AJ7RR X5@./SKH_LP]:S]
M2T&VU"/YUPX'!!Q5*71F$Z;3YX;_ )FLLB.H96!!]#2[AZC\ZXFWNKS0[K[-
M?9DMR?E91P!74VYAN8A)$X93Z&DU8NG54].I=W#U'YT;AZC\Z@^SCU/YT?9A
MZ_K2-"?</4?G1N'J/SJ#[,/7]:/LP]?UH GW#U'YT;AZC\Z@^S#U_6C[,/7]
M: )]P]1^=&X>H_.H/LP]?UH^S#U_6@"?</4?G1N'J/SJ#[,/7]:/LP]?UH G
MR/44M0I %;.:FH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *JRZ=:SR%Y(@6/4U:HH H_P!D67_/$4?V19?\\15ZB@"C_9%E_P \11_9
M%E_SQ%7J* */]D67_/$4?V19?\\15ZB@"C_9%E_SQ%']D67_ #Q%7J* */\
M9%E_SQ%']D67_/$5>HH H_V19?\ /$4?V19?\\15ZB@"C_9%E_SQ%']D67_/
M$5>HH H_V19?\\11_9%E_P \15ZB@"C_ &19?\\11_9%E_SQ%7J* */]D67_
M #Q%']D67_/$5>HH H_V19?\\11_9%E_SQ%7J* */]D67_/$4?V19?\ /$5>
MHH H_P!D67_/$4?V19?\\15ZB@"C_9%E_P \11_9%E_SQ%7J* */]D67_/$4
M?V19?\\15ZB@"C_9%E_SQ%']D67_ #Q%7J* */\ 9%E_SQ%']D67_/$5>HH
MH_V19?\ /$4?V19?\\15ZB@"C_9%E_SQ%']D67_/$5>HH H_V19?\\11_9%E
M_P \15ZB@"C_ &19?\\11_9%E_SQ%7J* */]D67_ #Q%']D67_/$5>HH H_V
M19?\\11_9%E_SQ%7J* */]D67_/$4?V19?\ /$5>HH H_P!D67_/$4?V19?\
M\15ZB@"C_9%E_P \11_9%E_SQ%7J* */]D67_/$4?V19?\\15ZB@"C_9%E_S
MQ%']D67_ #Q%7J* */\ 9%E_SQ%']D67_/$5>HH H_V19?\ /$4?V19?\\15
MZB@"C_9%E_SQ%']D67_/$5>HH H_V19?\\11_9%E_P \15ZB@"C_ &19?\\1
M1_9%E_SQ%7J* */]D67_ #Q%']D67_/$5>HH H_V19?\\11_9%E_SQ%7J* *
M/]D67_/$4?V19?\ /$5>HH H_P!D67_/$4?V19?\\15ZB@"C_9%E_P \11_9
M%E_SQ%7J* */]D67_/$4?V19?\\15ZB@"C_9%E_SQ%']D67_ #Q%7J* */\
M9%E_SQ%']D67_/$5>HH H_V19?\ /$4?V19?\\15ZB@"C_9%E_SQ%']D67_/
M$5>HH H_V19?\\11_9%E_P \15ZB@"C_ &19?\\11_9%E_SQ%7J* */]D67_
M #Q%']D67_/$5>HH H_V19?\\11_9%E_SQ%7J* */]D67_/$4?V19?\ /$5>
MHH H_P!D67_/$4?V19?\\15ZB@"C_9%E_P \11_9%E_SQ%7J* */]D67_/$4
M?V19?\\15ZB@"C_9%E_SQ%']D67_ #Q%7J* */\ 9%E_SQ%']D67_/$5>HH
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M?:%]#1]H7T- $M%1?:%]#1]H7T- $M%1?:%]#1]H7T- $M%1?:%]#1]H7T-
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M28="O%9NF:[/IUT+#40?]EP.,?6JLGJC)3E3?+/;N=C15=+N.10R'<#W%/\
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MH:J:3X-T_3[E;J2-)KE/N2$<K0!QVKZOJ</BC3?#UC=QVB?9 Q:1<C@"N?\
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M7F<#.N@+',"G]MKY2QGJ._\ 2O1XO %B)AY^V6W4Y2(C@&M.]\*:=>2V#&%
MMD^^(8^Z<4 <AXGA&A?"7[!$ LRP!1@?6KSS1>&OAU#=1J$:9$#^Y85U.KZ'
M;:Q L-PBL@&,&DU+0+34]'33)D4P(5PIZ<=* /']89=!\!6<0./M&H!W_P!U
MF!/\Z[Z^U/2++P++!:7$1$L)$:J?O-@<5A>+-!_M/7[?1U@W6L:HV.W&*Z2V
M^'^FQSQL\:/;QX,<..$/K0!P%GJ&HZ'H.D6D1^SS:DNW>XXC^OY5:\:W.I6/
M@Z07NLV]PQ PB#!->F:MX9L-5M8XI(4#1#]TQ'W*RI?A_IEW9&"^C2X88VLP
MZ4 >?ZWI;2^$]/TR+F2:2*<K[9!KM?&<PTSPE9P( OFA8B![@"NA7PY9B[MY
MV13Y$8C48Z 5+K&B6VLPP17"*RPN'4'U% ' 0R:9IWA+3M#U.(C[23&K$X )
MK-$VI>$=;L+"/4(KK3)CA($&2%]*]*U7POIFKP1I<6R,\7,3$?</K5&P\$V=
MO=I<W6VXDB.8R1]V@#B[*:WD^(UE=:B!'*$;R@_&%XJQ\3+Z+6A9Z38,)IDN
M(ICLYP P)KM-9\(:=JTL=SY*)=QC;'-CE12:3X0T_39OM+1))=XV^;CG% '
M:7 =2^,%Y#,-T<%G$R@]CS5[QLYOO'OAZ%!G[-=9..W!KO+/P]9V6L3:G'&O
MVF5 C/CD@4/X>LY-5_M!XU,P;<#CD&@#7HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JAJNH?V=:--Y;/@9P*OUSWBV0II,@W; 5Y?TH X."\^W7<TMW9R
M\R?+GTKT[2=OV%-JE1@<&L"ZM[-?#4<JNHDVJ=_K6GX7N9+G2]TF<AB!GTI^
M0O,VZ***0S-U31;;50!.I.!@8.*Y ^"KJ.[,<4RBW8YQBO0:* .%?PE>M=10
MB=1:1L'VX[UV?V6,QA6&<"IZ0]* ,/2X4&IW@ X#5M>4GI61IG_(4O?]ZMJ@
M!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI
M1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E+Z4
M^B@#+U>Q2YM&3;GZ5BV>GZC#)B&78ON*ZTC(H  Z"LI4E)W.FGBI0AR6NCG_
M "-6'_+PI_X#3=NJC_EIG_@-='24>R\Q_6>\5]QS9_M+&&R?^ U6D2])R8W)
M'M76T4*FUM(?UE?R(Y2*\U&'AX9& ]!4O]NNAVO9RYKIB,U#+:12_>09]:?)
M+^8/;TWO Q%ULMTLI33_ .VL=;*6KK6<D)W(Q(_NBD29,XGBV>YHY)])![2B
M_L?B5!K:=[204\:S!W@8?C6BL-K*,JJF@Z?:GK$M*U3N+GP_\IES:W;J  A!
M/O3;?7+=B5<<CWJ_-HUG*,"%0?6HX=!LX\[HE8FIM5ON:*6%Y=F,_MBT]/UH
M_MBT]/UJU_8]C_S[K1_8]C_S[K56J>1%\-V95_MBT]/UH_MBT]/UJU_8]C_S
M[K1_8]C_ ,^ZT6J>07PW9E7^V+3T_6C^V+3T_6K7]CV/_/NM']CV/_/NM%JG
MD%\-V95_MBT]/UH_MBT]/UJU_8]C_P ^ZT?V/8_\^ZT6J>07PW9E7^V+3T_6
MC^V+3T_6K7]CV/\ S[K2?V/8_P#/NM%JOD%\-V9F2:Y '^7@?6K":S:,@./U
MI\GA^T=\K&H'IBIUT:Q5<?9UJ4JI<I86RLF5_P"V+3T_6C^V+3T_6K7]CV/_
M #[K1_8]C_S[K56J>1%\-V95_MBT]/UH_MBT]/UJU_8]C_S[K1_8]C_S[K1:
MIY!?#=F5?[8M/3]:/[8M/3]:M?V/8_\ /NM']CV/_/NM%JGD%\-V95_MBT]/
MUH_MBT]/UJU_8]C_ ,^ZT?V/8_\ /NM%JGD%\-V93DUJT5<@?K5:+78-_P X
MR#TYK3?1;%EQY"U!%X?LT?+1JP["I:JWW+C+"VU3#^U[3T_6D_MBT]/UJU_8
M]C_S[K1_8]C_ ,^ZU5JOD1?#=F5?[8M/3]:/[8M/3]:M?V/8_P#/NM']CV/_
M #[K1:IY!?#=F5?[8M/3]:/[8M/3]:M?V/8_\^ZT?V/8_P#/NM%JGD%\-V95
M_MBT]/UH_MBT]/UJU_8]C_S[K1_8]C_S[K1:IY!?#=F5?[8M/3]:1M9M%4G'
M3WJW_8]C_P ^ZTUM&L2,?9UYI6J^07PW9E6TU!;F0D?=S6L(T(!QUJC;:3';
M2$I@*3]VM$# Q5PYK>\95G3;_=[#?*3TH\I/2GT59B,\I/2CRD]*?10 SRD]
M*/*3TI]% #/*3TH\I/2GT4 ,\I/2CRD]*?10 SRD]*/*3TI]% #/*3TH\I/2
MGT4 ,\I/2CRD]*?10 SRD]*/*3TI]% #/*3TH\I/2GT4 ,\I/2CRD]*?10 S
MRD]*/*3TI]% #/*3TH\I/2GT4 ,\I/2J.IZ/;:E;F.5,]P?>M&BA.PI)25F<
M3'+>>';@13!I;4G VCI756EQ;7L*RPL&!]#4MU:Q7<)CF4,I[&N2N;2]\.7/
MG6FZ2T)YC7H@J])>IS^]1\X_D=CY2>E'E)Z51TO5K?4X0T;C>!\RCM6C46L=
M$9*2NAGE)Z4>4GI3Z*!C1&H.0*=110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %0"SMUN3<")1,1@OCG%3T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% $)M8#/YYC7S<8W8YJ:BB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "JU_917]J\$HRK#%6:* ..7P2WVC
M+ZC.T(/$9Z5U5M;1VD"Q1* H':IZ* "BBB@ HIOF)NV[QN],TPW$0?894W>F
MX9H EI#TJ/SXM^SS4W>FX9J0]* ,;3/^0I>_[U;58NF?\A2]_P!ZMJ@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *C>%)/O*#4E% %&2R8<Q.1["FK<30<2I\OK6A2%58<@&G<=R&*ZCE'R
MFIZJ2V*N=RDJ?:H0;JW." 4'YT6"RZ&C156.]C<X.0?<59# C@BD*PM%%% !
M1110 4444 %%%% !1110 444G% "T444 %%%% !1110 4444 %%%% !1110
M44G!I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9)&DJ%'4,IZ@T^B@#D]4T
M.>SE^V:82&')C' -7]&U^*]'D2D+<+PR^];A (P17/:UX>6X;[5:$QSKT"G
M-6FGHSGE"5-\U/[CHATHKE])UZ2.3[%J(V3#H0.,?6NE616&0P(/O4M-&L*D
M9JZ'T444BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR?W3^5'GR?W3^56Z* *GGR?W3^5'GR?W3^56Z* *GGR?W3^5'GR?W3^56Z*
M.>UC3(]2@8F,B1>01QR*Q=)FU*W81SOG:>!BNZ(XJO\ 88#+YAC^;UJE+2QC
M*BG+F6@VVGDD52ZD9]JMT45)L%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M']EQ_P!]J/[+C_OM0!/]MM_^>@H^VV__ #T%0?V7'_?:C^RXO[[4 3_;;?\
MYZ"C[;;_ //05CZAIY69!&[8[UH)I<91<NW2@"Q]MM_^>@H^VV__ #T%0?V7
M'_?:C^RX_P"^U $_VVW_ .>@H^VV_P#ST%0?V7'_ 'VI&TN/:<.W2@"Q]MM_
M^>@H^VV__/05DV.G;G;>[5?_ ++C_OM0!/\ ;;?_ )Z"C[;;_P#/05!_9<?]
M]J/[+C_OM0!/]MM_^>@H^VV__/05!_9<?]]JHZEIVQ8O+=N6YH U?MMO_P ]
M!1]MM_\ GH*JQ:7&8QEVS3_[+C_OM0!/]MM_^>@H^VV__/05!_9<?]]J/[+C
M_OM0!/\ ;;?_ )Z"C[;;_P#/05!_9<?]]JS;73V;4;A6=M@/% &S]MM_^>@H
M^VV__/05!_9<?]]J/[+C_OM0!/\ ;;?_ )Z"C[;;_P#/05!_9<?]]J/[+C_O
MM0!/]MM_^>@H^VV__/05F:IIH33Y6B=MX'%/L--5K5"[MNQS0!H?;;?_ )Z"
MC[;;_P#/05!_9<?]]J/[+C_OM0!/]MM_^>@H^VV__/05!_9<?]]J/[+C_OM0
M!/\ ;;?_ )Z"C[;;_P#/05C76GE=2C57;9MYK2&EQX'SMTH G^VV_P#ST%'V
MVW_YZ"H/[+C_ +[4?V7'_?:@"?[;;_\ /04?;;?_ )Z"H/[+C_OM2/I<8C8A
MVS@T 6/MMO\ \]!1]MM_^>@K(TS3B\;>:[9W&M#^RX_[[4 3_;;?_GH*/MMO
M_P ]!4']EQ_WVH_LN/\ OM0!/]MM_P#GH*/MMO\ \]!4']EQ_P!]JHZEIVP0
M^6[<OS0!K+=P.P57!)J>J,&G(A5]QR*O4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 C,%!). .YJG#J-I+.8HW3?GH".:CUP2
M_P!CW'DY\S;QBN'TI81K5L8=WGX_><]Z%N'2YZ3138\[%SUQ3J "BBB@""YN
M(;>,M*R@>YI;:XCN8]\9RM<=X[2Z<(L4GEQXR6/3-7?!4TK:9ME.[#'YJ%J@
M>AU5%%% !4<T\4";I751ZL<5)6)XEL8[W32K@G# \'%# ORW]M#&)69<'C(-
M3V]Q'<QAXF#*?0UQ%S/8VF@!+P')8JOS8QZ5M^$8DCTI"D@<'T-/N(Z&BBBD
M,*KM>6ZR^494W_W=PS4Y&01ZUPVL:>D'B'[3&K[FP#@T=0Z'6G4[2.X^S^8@
M?.,9%70<C(KR*Z@N#XT\X3A4\P'RSU->KVIW6T9P1QT-'0.I-1110!'-,D,9
M=S@"J\%_:W0+(Z';UR1Q46L2VT-B[W/W #QG%<+:W$0MKZYL T@D7(C4Y(I
M>AV]Y!<LZQ2*Q0X.#FK%>;?#JZE>\OEDMIHRTO)?Z5Z35,2"BBBD,J7.H6]J
MZK*P&?>F2:E9V^W=(B[^1R.:YCQHL#PG;,$F X!/6L&Z6)K>U^VA]X3Y3G&:
M5P/44D61 R$$'T-.K&\-B0::-^>ORY]*V:;W!!2,P523T%+4-SL\AO,^[WH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVM95CFE"LW0'O33JEHLRQ&9=Y&0/:@"Y15--4M)+CR%F4R8SBK= "T4F:6@
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M47'D>:/,_NU(;N%91$7&\G&* )Z*** "BBB@ HIK.$&2<"A7#C(- #J*2C-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNZSJEO<72,L;@0+^5 'H%%4Y-5L(@QDNHU"'#9/2I8+VVNH3+!,LD8ZLIXH
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M5-<'X2\0:C?_ !"U?3[B;=;0Q*R+CH<F@#T:BBJUUJ%I9#-S<)%_O&@"S02
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M2[/D+CS8P.'-6]0D;PI\3VO;E2+?4)_OXZ 5H?%7QAIL_@^>RMI?,EGP5&*
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M1:!I^@2Z"+S4[][R5TW,LRYPV.E %;X9:VS^(;S28;_[79K$[JPZ=ZTO O\
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MYD6,#&WOBN2TV"[\4^,QJ:1GRD<.?I4X:G.DY2GHK#JR4DE$U_BH<OIOT/\
M6O0- _Y -E_UR%>?_%?Y'TXXX /]:TM*^(&CVNE6T$DY#H@!&VIG3G/#0Y5?
M<<9*-65SO7<(C.QPJC)-8#>-="5RAOXMP.,9INF>*-.\0M):6LI+.A!X[8KG
M7^$UC).TIOYLELXVBN>G3IQ;5:Z9I.4VKT]3H]3TJS\5VUK.LJO IR/1J\^U
M33X-.\76,%N@55)'%>J:/IB:1ID-E&Y=8Q@,>]>;>(P?^$WL^/XC6^%F^=Q3
MT29%:/NIO<]1M/\ CTB_W146I6YN;&6,/M)4\_A3HI!%IZ.>BIFLC2O$4&M"
M>.+JFY>GI7$HRUDNANVMF>2P:')+XKELQ=$,"/GQZFO75O;+POIMM;:A>*"!
M@.W\5>9S7T.E>.YI;DE4R.<?6N^UOP_8^.+*UN%NG2)1E"HZUZ6*?,X>T^&Q
MRT59/EW-"W\3:5J3&&UNXY)"#@"O*= TZ[U3Q3=VT%PT"F1R6'UKN]&^'UKH
M%U]KBNY)&4'AA7/> Q_Q5MV<?\M'_G4TG"$9ND[Z#FI2<5,S-7M[_P ,>)((
MHKQF5F7)'?-=YXB34-1T>)K2=X>/G(]*Y7XA _\ "2V_'\:4[QGJ%Y;V%G''
M+)%"S89D[C%6XNI[.74FZCS+H9.HVEK8Z8TRZVK7J+GR\<DUV_@?4;C4?#L[
M3R%R@P"?I7'WS:''X5(5_.O98^&9><UTGPX.?#MX/?\ H:>(2=%M]&%/2IH<
M';Z$^J2WLD(_>QS.W ]":Z?0?$+7?AN\TR?_ %L,;$L3_GTJ;X?QA]5OD8<-
M)(#^9K%\=:)/H=_)=VFZ.";Y3M[UK*:J5/92^1"3C#G1TGP]_P"1=F_ZY_U%
M<#/J-S8>)+PVH/G&7Y2.HKOOAZ#_ ,([-_US_P *YWPY9177CZ;SD#*)NA'T
MJ824:E5L;3<8)%#PS,D'BB.36(^9,MN>O=(BIB0I]TJ,?2O.OB'X;_<+J-G'
MM:( 845H^ /$8U*P%I<.?M*9X/H*YL4O;TU6CTW-:7[N3@SMSTKRG5M%O+OQ
M-?7&MZ@T&F*^84D'RD>U>I7+M';2.@RP&0*\0TV=M>\=ZS%K=_-##!(/+AZJ
M?:O..HRM8U;3?#OB&UGT'6$EV_?AC[G-='\2M2U![/37M9WBDG2/)'OBN7^(
MIT&UO+9-*@1F Q)($P0<UTGC?YK31"!_RSA_I0!HWOPZF'AQKZ34B]W'#YHD
M*\],XI?"/BF\M_AK<75S,TMQ;PLP8GDGBN_U+_D4+C_KS_\ 9:\J\*:=+J/P
MUOX(@3(T#!1ZG(H O>%?"=YXLL?[;U&[8B['F1*P^Y6-X?TF\TCXPV,%U.TJ
M['\O(Z#BNL^'7BVQL_#T.C7K^5<6""-QCO7/V&MPZW\9["2WY2)'7./<4 >V
MUYA\2HQ-=6L9Z-* :]/KS3XA@_VC9<?\MA77@OXR,<1\!S4*W/A#7(;@!DM)
MGQGL16G>7:7WC#3+F,@K(2PQ75ZUH*:SX77C,L:$IQWKS#P\EQ#XNMK:<L3"
MVT ]J]"G*-5.?VDFCFDG!J/1GM5WKVG:3'$EY<I$Q7(#5#%XATK5X)X+:[CD
M/EL6QV&*H:_X,M_$HAEFN7B*IC"BL^R\!0^'X+JXMKJ21VA9<$>QKSHQH..L
MGS'2W4OMH<=8S7]CK%XFAA[F/;SY?;FM'P=]GD\3SRZHX2_+C:C]<U'X*URQ
MT.:YCU >6^#SCKS5.Q#:O\1OMMDI-OYV[=CM7I33?/%JVF_<Y8NW*_/8M7Q\
M[X@Q*_(#&MSXC1JNAPN!\P9 #6-XK@ET7Q/;W[*2G))IOBSQ%!KL5K961,F=
MA;CH>*SC%RG3DMBFTE),[KPE%'>>&H1.H<9Z&L3QDVJP6DMII]I(MF 0S+TQ
M5Z:XO_#?A2%K2V$S]6#'H,5FP^/["Z\.2)>-LNV0@QX[US0A/G]I%75S63CR
M\K=F6OANEI%82"&56F('F =0:[+4+87EE)"3C(ZUYQ\-[>>:_O+I04A9P0!T
M->G/]QOH:QQBM6>I=!W@?/VC>&8Y/BP]L90%6)I<X].:W]1FU'Q3X]G\.VMX
M\5G:1K(<<ALY!'Z4[04+?&:9<'!M''Z5%#<KX/\ BU?W5YE;6YA2-'(ZG)_Q
MKF-BWXH\&77AK3GUK3+TQFT'F.B#[_M4'BWQ)=:C\+8[Z*1DN&@!8@\YYK>^
M('C#39/#-UIMM+YES>1F.-0.IKDM?TV6P^$D2S*1(T ROIR: .C\'> KE8+'
M5KO5#.[Q!@I7IGM7INS]SY?^SBLWPSQX8TW_ *]U_E6K0!X%XKT!)?B4B^9]
M^11T^M6OBIIMS!K/A6QL9S'.KE4D7J#S5OQE<1V'Q$M[BX)6(S+AL?6K?CVX
MBO?''@Z> [HGF)!_ T /U+X?W">'3>O?G[:%#&3'.:E\*>+KBU\!WUY?S&1[
M>5H59CZ9 KO-?_Y%V;_=KRGPUH\NL_#O5[:,'<MX[X^F: ,OP_?:1KT,M_K_
M (@C69G95BDZJ,\&K?AOQ9'H?C8:;;:J+ZRN7$<2C@+4W@&'PQ+I+6^JV\27
MD<C;@R=LUJ:9-H5SXR%II6EV\GV9P3+LP5]Z /7J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MH:SI%OKFES:?=9\F48;%7Z* ,;P[X:LO#-F]M8@B-VW'-;-%% &-XA\-67B6
MWCAO0=L;;ABK5AI5OIVE1Z=#GR8UVCZ5?HH Y_2_!^FZ3?S7EN#YDK;FR.]9
MFK_#71-7OQ>2*T4G?RQC-=G10!QTGPVT-Q#^[VM$P8,%&<BMJ^\.:?J.G?8K
MF)9$ P&9<D5KT4 <%;_";0+>Y67,CX.0C<BNTMK&VM+46\,2+&!C 7&:LT4
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MK[VL;V1M3_JRFS\,8J>B@#(T?P[9:+&R6P.UA@@BJ*^"=-37EU>,NDX?>0O
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M)8HU"HHP !TH I:9HUGI-I]GMHE48P6 P3]:K6/AJRT_4VOX0?.8$'\:V:*
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MR3+N.3&#\OY5VM% '/V7@_3;!F:!2I92IP/6L0?"K1%E>1))D9B2=IQ7=T4
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MN*\DN;W6O&WB^\TW3KZ:RM+-@6>+G>#5?7[+7?A_)%JHU>XO;-!NF1L ?RH
M]F+!>IQ31-&S[ X+=<5Y9\1/$E]%X,M=0L;AX9)Q&<H>F:M^#_".N130:K>^
M(+F821@^2X&.1GTH ]$O;D6=G+<,,B-=V*YCPKXO'B*\OHQ&8UAQMR:U/%%I
M)=>'KI(YVB81'YA7DOPKT"]_MJ\F_M67; 073 P_UH ZKP'XEU/5/$NOVU]<
MF2&VNMD0/\(P*]&CGBESY;AL>E?._AVPU?5/'VO6>GW4MK#)=GS)H_X>!6[K
M]KKO@/4;:\_MJXN[=F5&C; !)(]J /;ZB^TPF3R_,7?Z5YUX^\83V&FV-I8R
M%;NY*!BIY4,!S^M8\_A76;;2'OE\4737:+OV8&6]NE 'L6<=:C:>)/O.!7F?
MASQ=<ZKX0U"&25A?6* 2/GYLURWAC2/$GC>2\N#XBN[2.VFV!%P0P_*@#WC<
M-N[/'7-1)=02/M2568=A7GOB32_%$\]OIMC=7$=LL:[[M,<D8S7->*-'U3PU
M9PW\'B2XD=6RZ8 SCMTH ]L) &2:8\\4>-[A<],UYI?^)+Z\^%']KPRM%</
M6#*>0>*R?"?A;Q)XC\/V]]>>(+N+S4#)P#_2@#V0$$9!X- 8-T.:\I\(:[JE
MIK-QX;U">2>9PYBE<\X'_P"NIO >M:E:>)KK0-8GDDGR\R&0\[2210!Z@6"]
M3C-+7E_BK6=1U'QI::/I-Q(C6LJR7 0]4/K7IZC"@$YH 6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!YH)J"A:*2B@!:RI/#NG2:F=1:$FY)SNS6IF@&@!:*3/-% "T4E% "T4E+0
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M[MW&:V_B1?"X6RLCQ^\!/XUU<K6(C=(QYDZ;*O@+3;^SLUU%V=+5@&]B*O\
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MQSWA.SU6_DN9+%64,^3(IY%;N@>(-5TWQ$-.U)F<-D@N:UOAU<VD.C2?.B,
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MJ\Z\ >&+2]T".YNHB)A(?O+7H\,*P1"-/NBC&NG[1\N_4*"DHKF,WQ+<_9-
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MW_>NQKS\0HJH^78Z:5^17"BBBL30**** "BBB@ HHHH **** "BBB@ HHHH
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M8(<!$VCFM.BL_:2<5'HBN17N<QH/A.'1KQ[E>79B<Y]:K^)?!4.NWXN\D28
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MX^HD9+,6P3GK7:440J3@FHO<)04MSEO$/A&#7)4:3HN!UQTK8TW2HM,TM;*
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MA**EN5I[?S;%K<'&Y-GZ5C>'?#2:&\KJS,9!@Y;-=%10IR47%=0<4W<X?6_
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M/VL>;E.XS67JVO66D*/M$JJ[<*I[FKT[2);.T8S(%R![UXCXBU#5-2\4);O
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M,$BN=)7LS5[:'#7WQ-$5T\=G9BXC3JX:NC\,^*[;Q% 63:DJC+(#TKG=1L]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ4O:15#DOJWJ/E?M.:VQYGX?N1K'CBXE8?ZM3V]":U-?\27MYX@.EVBPX4@
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MCG/&<<EOH6GP\A/*7=Z5V/AMM/L_#>4DB V9.6'7%:.M:!;:SIQM95[8!S7
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MW 4 OVS4.K3M3UT70:A+WM-S*\ 20V7A2>1Y$4DLW+#T-<OH4AUWQM//][8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO;((K8^.L2P_#RQC4 !9%''T%<7X:9S\:)/M'_33&?K7<?'[_D1;7_KL/Z4
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MPN,"MOQ_X]N_$FL_\(_H\H6,OL9^V#[UZ!\-O!UAX7L-S312WLX!D.\,<^U
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MM:_]?)H ]P_L;2M,M&O+73;:.:-"0RQ@'I7B+?'?Q!]KN;6'3X'>*5D4*">
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M0*;R*;<D/.W/I7>? V*1/'.LQSE&;R!NV].IK/UJ.)?CQ;*8T$?VOD8&.AH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6M/K!F@4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ;'Y=HF>XJY2*H50HZ"EKIIQY(J/8M*RL%%%%6,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "E7[PI*5?O"@#7C_ -6M/ID?^K6G
MUSLT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ&9K=-[$+R:T--\?7MU\,[V^#,MQ:;4WYY.<UEZ]\0[WQ)H3Z/;62^?<)L8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2K]X4E*OWA0!KQ_ZM:?3(_]
M6M/KG9H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCVWFW,Y*AE."#7FWB5?L?QJ1;?Y%\]>%_&O?9K2)K4726L3W2C*LPYS0KM6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ H[444 >(_$SP_J>G>(8=?TU"T<8 8*,GJ/2LW6?BA>SVD
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MU%#B%SFO"'CNQU69;&UL9X%4X&Z+:/Y5O^-U9_"MVJ@DD=!5^ST'3K&3S+>
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M6;3+<1QL_P"_C^Z,]Q7JJ*$0*HP!TJM>Z;:Z@H6YC#@'(IM75A7.<\,V33^
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MO#,E@EE<_;)X]A_='&?RJMH/AZ[TSX<:O//&=]V@8+CG\J]2C\):/%="X2U
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MUZ4L30<>172\CD5&HG=ZLT]#UNTUNW>2T=61#@[:UJSM)T>UT>)X[9 JN<G
MQ6C7FSY>;W=CJC>VHAZ5QFDVMRGC?59GC(B?&T^O-=F>E<CI>HR3>,M3M2N%
MCQ@UK2ORRMV)G:ZN==2]J2E[5@C0R[K_ %QJ"I[K_7&H*WCL9L****8!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4A 88(I:* &+$BG*KBGT44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %)M&<XYI:* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** &&%&.2HS3P !@444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4J_>%)2K]
MX4 :\?\ JUI],C_U:T^N=F@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT-
M"44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AH
MVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44
MNT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT
M- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^
MAHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "
M44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHV
MGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44N
MT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT-
M "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^A
MHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "4
M4NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVGT- "44NT^AHVG
MT- "4J_>%&UO0TJJ=PX- &M'_JUI],C_ -6*?7.S0**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH
M9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4
M>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/
MHH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE
M)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2
M>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@
M!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI
M1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4
M^B@!GE)Z4>4GI3Z* &>4GI1Y2>E/HH 9Y2>E'E)Z4^B@!GE)Z4>4GI3Z* &>
M4GI1Y2>E/HH 9Y2>E'E)Z4^B@ Z4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gtl21rgcbjm5000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 3O",<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)']*<J4HJ[0E--V1HT445!04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!**JWNI6>G[3=W,<(;IO;&:J?\)-HO\ T$[;_OL4U%OH*Z-:BLG_ (2;1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME4<V56<5%11ZY\);$0>&Y;EA\\TIP?\ 9P/_ *]<O\7KXRZY:VBM\D462/\
M:R?Z5Z7X-LOL'A/3X"/F$>6^IKQ'QK=MJ7C*^9?F'F!$'X ?SHH>]7<@J:4T
MCU#X>:0/^$$9''_'Z')![=5KQV[@ET779(R"K6TYV_0'C]*^BO#UH++P_8P
M8VPJ3]2,UY%\5]*%GXD2[13MNDR>. 1Q1AZEZLD^HJL+03[%[XD:^-1T#1HT
M8%;A!.Q'9@,8_6MGX/V+Q:1>WC?=GD"K_P !SG^=>27%_+<VEK;2<K;A@GKR
M<U[Y\/;(V/@RR5NLB^;_ -]<U6(C[*CRKJ*D^>?,SB/C#?I)>V-BI^:)6=_Q
MQC^1KC8O#\\WA*768V8HDWENH_#G]:O_ !(O5O?&=WL_Y8@0GZC->E^"]!AD
M^'B6<PREZC.P/;<,?TJE/V-&(G'GFSS[X8:K;Z?XF\J=5_TE=BN1]UNWYU[P
M*^8;^VGT37)8#E)K:7Y2#TQR*^A?"NLQZYX?M;Q2-Y3:ZYR01QS_ #_&LL9"
M[51=33#R^RS:I:2EKA.D**** "BBB@ HHHH **** $KQOXP7ZRZK962GYH8V
M9_QQC^5>R5\]?$*]6_\ &EXR_P#+(B'_ +YXKJP<;U+]C#$.T3OOA7I\?_"*
M74^W#7$C(3Z@=/YUY9:3/I?B6&5AAH+D,1]#7O/@FT6R\(:=&%PS1!G^IZUX
M?XRC%OXQU-%&T+.<"NBA+FJ37<RJ*T(L]'^)?BG[+H\.FVTF)[I TF.R?_7Y
MK(^%/ALS7+ZU<1_NX\K#N'4XY/ZUQ,"7OBOQ#%&Q9IIF521R%4<9^E?0=I:P
M>'_#XBC4+%:PDD#O@9-15_<P]FMV.'ORYGLCPGQY?+J'C"]D3E%8(/P !_45
M[;X0LDL/"NGPH, Q"3\6&?ZUX#&1J7B=6QE9[O./8M7TA*!9Z4ZQC AA(4?0
M<48K2$8#HZR<CY^\<WC:AXQO6/)63RA_P'BO;_!UH;'PIIT3+M;R59AZ$CFO
MGIYVNM9,\IRTD^]C]6KZ)U+7=.T/2/M$T\814_=J&R6^@IXF+48P0J+7,VSR
M[XNZ@D^N6UFI!,$>X_C_ /JKK/A/9+!X7:Y*X>:8\^HP,?UKQ[6M5EUK5[B^
MF^]*Y('H/2OH+PA9BP\*:?!C#"(%OK177)1C *3YJCD>3_%6\%SXK$8;(AB"
M$>AR3_6O0OAGI_V+PA!)_%<DR$?CC^E>.^)KEM1\57TRY8R38 _(5]!Z%:"R
MT*RMP.$A'Z\_UI8CW:,8CI:S;/(OBU=QS^)(;=,;H(MK?4\_UKL_A7IT=OX3
M%R5&^XD9FR/0D"O*O&=V+[Q=?S \&3;S[#']*]U\+QVUEX9TZ..1 K0J?O#[
MQ&3^M%>\:,8BI^]4;9;UNY6QT.\N. $B)KYX\,69U'Q-86S$D23#<?:O9_B7
M>&U\'7"@X\\B/\^?Z5YQ\++(W/BU92N4AB+9]#D8HP_NTI2'5UFD>E^,?&2>
M$X;91!YTLV<#/0#'^-<A_P +DE_Z!J_G_P#7KT'6_"NE>('C?4+?S&C&%.XC
M^1K*_P"%:>&?^?$_]_&_QK&G*BH^\M2Y*I?0M>#O%+>*=/EN6M_)\N39P>#P
M#_6N)^+'B3>Z:);R'"_-/CU[#^1KN+MM-\$>&9I+:)8HHP2B<G<YZ?TKPFWM
M;_Q1KKI #)<W#%CD]._\JUP\(N;GT1%6;45'J=Y\+8-,L(IM4OKVUCGD^2-9
M)5!4>N":E^+%[I]]I]E):W<$\BR[2(Y Q P?2L#_ (59XA_YYQ_]]"J.K^ =
M9T;3I+ZZC3RH_O$,*V2INKS\Q%Y*'+8Z;X/7A2^OK+M(HD_+C^M>@>-;M;/P
MCJ,A?:S1%4^M>3?"V]6T\7HC?\MXC&OUR#_2NV^+EXD7AN*UW8>68,!Z@9S_
M #K&M"^(2+IR_=,\H\.Z-)X@UR"PC)'F'+L/X5[FOH6'3['1=%:&*!%@BB.X
M8Z@#O7E_P@T]9M7O+X]8$"K_ ,"S_A7HGC6^&G^$K^0]7C,8/NPP*,3-RJJ"
M"C%*#D> P1_:=?CB0<2W(5?Q:OI&3%IH[,^/W,&3GV6O!O -F+_QE9HPR%)D
M/U'->S>-[LV7A&_F4X)39^9Q_6JQ6LXP%1TBY'@<*?VEXE55Y\^ZS^!:OI:W
MMH[>WBB51B- HX]!7SWX#ACF\9Z>LK (').[_=-?1 D1B55P67J >E3C6[J(
M\.E9L\T^,-Z8].LK$'_6.9#^'']:I_!VRR^H7C+]W:BGZYS_ "K(^+-ZT_B>
M.U)^6WB&/^!8-=Q\+K1[;P<LCIM:61G&1U':G+W<,EW$K2K7/._B9J[ZCXJF
MM\D16G[M5]QU/\J]%^&F@0:?X=AOFC!N;H;RS#D#L*\A\5,[>*]2,@PYG;->
M^Z1?V$?ARUN%GC2V$0PQ8 "GB+QI1C$*=G-MG&_%[[(FD6H:)#<O)\C8Y XS
M6+\(+)9=7O+ME_U4853Z'_\ 56!X\\2_\)%K9,)_T6#Y(_\ :]Z]!^$EC]G\
M/3W)',\N0?; ']*<DZ>'L^HD^>K='-_%O6'GU6'3$;]W NYP/[Q_^L:S_!'B
MW2?"]M,UQ9R2W<A^^O8>E9OC]G;QI?E\Y!7\MHKT7PKX,\+ZIH%G>/9)+,R#
M>WF-][OWJI.,*"4D)7E4=CC_ !?X^?Q3:+I]K9&.+>&YY8GTX^M='\+_  I<
MV$LFL7L;Q,R;(D88.#UR/P%=S!HFAZ5%E+2UA1?XG X_$UJJR-&&5@RD9!!X
MKFG77)R05D;1I^]S2/%_BYJ#3Z_;V/\ #!'OS[M_^JK_ ,+?"L4Z/K5XB.N=
MD*,.GJ?UKCO'-Z;[QAJ$F<JCF-?H*]R\)V?V'POI\!7:5B&>.];59.G045U,
MZ:YJC;.-^,/EKI&GH%4,96Q@=.!69\'+1S?W]X1^[$8C!]\YJK\7;MI-?MK8
M/E$AW%?0Y-=7\)]/>U\,27#]+F4NOT'']*3]W#>H+6L=_2TE+7 =8E>$_%6\
M%QXM,2MN6&,#Z'O7NCL%5F/0#)KYK\47*W_BO4)HVW))<-M/MFNS!1O._8Y\
M0_=2/7/A58FV\)B9QAIY"P]UXQ6-\7]698+72D; <^9(/4=OY5W7A6Q?3O#&
MGVLGWXX@&^M>2?%DN?%Z[N@MUV_FU%'WZ]V*I[M*R-7X2Z!%<2SZM<1AQ&?+
MB##(!QR?UKN_&_V&+PG>R7D"2HJ84$=&/ /YXK&^%ES;?\(H5$B!TD/F#/3B
MN<^)_BV*\"Z-82J\:G,SJ<@GTS^5-J52N":C2.0\$VBWOC#3H77*&0D_@"?Z
M5[1X^O%L_!M^2V&= B>YR*\]^$-FDVO75PZ9\J'Y#Z'(_I6]\8+M$T:SM-V'
M>;?C/4 $?UJZWOXA1[$T_=I-GFGA?0V\0:_!9#.PG=(1V4=:^A[/1]/L;..U
M@M(ECC&%&T&O,?@]IJO<WVHG[T0$2CV//]*]<QQ6>+J-SY5T*P\$HW/#_BKJ
M[W?B%=/5P8+9>@[,>O\ (5U_PN\.Q6>B#5)HE-Q=<HQ[)V^G>O+_ !D2?&.K
M%LY^T-7MWA"\M4\&Z?(9XUC2'#$L,+]:TK7C1C&/4FGK4;9A?%G[*GAE/,B0
MSM(!$YZCD9_2N0^$UGY_B>2<K_J(MP/UX_K53XB>*E\0:JMO:MFSMCA3V=NY
MKK/@[:;=.O[LH0S2A 3W& :=G3PSOU%=2JZ%+XO:PYFM=*BD^0#S)0/7L#7/
M>!_$VE^&FN+B[M9)KE^$9?X13?B82?&]WGLJ?^@BNP\#>$?#>L^&K>[N;)9K
M@LP<F1@<@^@-/W84%?9BUE4T,#Q7\1V\0Z>VG6=FT44APQ?EC],5J?"WPK>V
MU\VL7D31*$*1JXP3GOC\*]!@T#0M*B+)96L2+R6D ./Q-:L+QR1*\+*T;#*E
M3D$>U<\JZ4.2"LC:-)\W-)GE_P 8;P"WL;-,9=F9_P!,?UI/@]8_N+^\9 0Y
M$8)'IS_6N=^*EZ;CQ:8A]V&(+CWYS7H'PS6WM?!T3^8@WN7<EAP>.M;3O'#)
M=S.-G5.SD*0Q.YP%4%C^%?-&HR'4_$TQ)SYUSM!^K8%?0GB6\BL_#=_.[@+Y
M#*ISW((%>#>#[(:GXNL87[R>8?P^;^E3A%:,I,=?5J)[R^S2_"Q#$*(+3;^(
M7%?.EK;RZOJZ01C,ES+Q^/->[_$.]2S\&WBEL/* B#U.1_2O+OACIZWOB^*1
MO^79#*/Y?UJL,^6G*8JJO)1/8M T"S\/Z1';0QH65?GDQRQ[UX#XF9)?%6I-
M$ $:Y;:!]:^B]5NA9:5=7#=(XR:^<M%@?5/$EI"_S-/. WOS1A&WS38ZZM:*
M/=$N#X=\!),^/,M;7(![D#@5X;I5G)XA\20P.S,UQ-EV[@9Y_2O:/B+N3P/<
M!>VT5Y9\.)88?&EHT[JJE6 )/<CBC#Z4Y36XJOQ*)[O96%OI]C':P1*L:+MP
M!UKP'Q]Y'_"8WXMU14##[G3.T5[5XH\46?A[2Y)7E1KAEQ%&#R3V_"OGQ/,U
M/5UW?ZRXG&?^!'_Z]&$B[N;"NUI%'OG@'3GTWP?912??93(?HQR/YUT]5]/@
M-KIUM;G_ )91*A_ 8JS7#-WDV=,59!1114E!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:
M\Y^)VBZWK;V4.FV;W$$8+.591ANG<^E>CTE73FX2YD3*/,K'GOPR\,WNAPWD
MVI6A@N)& 0,03M[]/PKT.DI:*DW.7,PA%15D%)2T5!1S'CNSU#4/"UQ:Z; T
MUQ(RC8"!QGGK7$_#SP;J^F>(A?:E8O D:'8693DD$=C7KE&*UC6<8."ZF<J:
M<N8J:FLSZ5=);H6F:)@@!Y)(XKQ'1O 7B-M=MI;S3I(HA*'DD9U.._8U[S11
M3K2III=0G34G=D,T0GMY(FZ.I4_C7@GB'P#J^DWT@MK:2XM=W[N5,'CW[YKZ
M!HIT:TJ3N@J4U/<\*TCP%XBUV:,:DT\-JO\ %-)NX]%&33+OX>:U)KSQ6^F2
M)8F0*LA=3A?7KFO>**T^MSO<CV$2JD;VVGK'&NYHX\!?4@5XE;^!O$EQXECN
M+C37CA-T)&=G7&W=GL?2O=Z,5E3K.%[=2YTU*PR-=D:H.BC KE/B!X;F\1Z$
ML=J ;F!_,C'][MC]:ZX"BHC-QES(IQ35CY\M?AYXFDNXTDTQXT+#<[.N /SK
MW>RM/L&EPVB<^3&$'O@5<HK2K7E5W)A24-CP75O!/BC4-=NKG^RI-LTI;=O7
M'/XU[9I-D-/TFVLQTAC"U>HI5*TJB2?0(4U%MH\N^)'@J^U34(=0TJU\Z1UV
MRHI /^]S_GBK/PRT?7M$DNX-2LV@MG 9=S Y;\#Z5Z113]O)PY&)4ES<P4M)
M2UB:A1110 4444 %%%% !1110!'+N\I]HRV#@5X3=>!_$M_X@EN9=+D1)IR[
M.77 !/UKWDT8K6G5=.]C.=-3M<AMXE@MXXD7:J+@#TKR7Q_X*UC4/$SWFF6#
MSPRH"S*RCYN<]3]*]@HI4ZLH2YD.=-25F>=_#?P;<Z();_4H/+NW^1$)!*K^
M%==XCBNIO#]Y#9Q&6>2,HJ XSGCO6M11*I*<^=@H)1Y4>*>#? VM6OB>UN=2
MTYX;:(EF+,I[''0^N*]GFC$T$D3?==2I^AJ2BBI5E4=V*$%!61\_>(O FKZ5
MJ4OV>TDFM2Q,<B<\=O?-6M%\!:_KDL)U!IH+1!PTKY('HH[5[OBC'M6WUN?+
M8CZO&]SPJ\^'FLOXB>*WTV1-/\W:DN]?N>O7->SW$<T.D/';)NF2$B-1W;'%
M7J*SJ5Y5+7Z%PIJ-['@VF^ _$;^(+>:YTUXX?M =W9UQC=D]#7NZ*$C51T48
M%.Q1BE5JRJ6N.%-0V/#O&?@75H=:N;NRM6N+65M^4QE2>O'UJ3P=X8\23:Q9
MR70NH;"%]Q#R?+^ S7MN*3%:O%2Y.5F:H+FO<X'XF:3K.LV=I;:9:-<1AM\F
MU@,$=.I]ZB^&/AC4=#6^FU*V,$DA4(I()P,YZ?A7HE%9>VE[/V9?LUS<P4'I
M1161H>:?$K2_$6MW%O:Z=8R36:+N9E91EOQ/TJQ\-_!UQH<<U[J4'EW<GRJI
M()5?PKT.BMO;RY.3H9>R7-S!VK"\8Z?/JGA6^L[5-\\B (N>IR*W:*QB[.Z-
M&KJQX=X3\&>(M/\ %&GW=SIDD4,4FYW+J<#'UKH_B;X?UK7;ZR_LZQDN(HD;
M)5E&"<>I]J].HKH>)DYJ9DJ*4>4XGX;^';K0M&E-]"8;J:3YD)!PHZ=/QJ;X
MBZ?J6J^'/L6FVK3N\@+!2!@#ZFNPHK/VKY^=[E\BY>4\M^&GA/4](U6YN]4L
MF@_=A8BQ!YYST-=UXFTHZWX?NK!6PTB_*?<<C^5:]+1.K*<N?J$8)1Y3YQF\
M'^(["["BPG64-\CQL/S!!KU7X=:+J^F65U/K#2^?.P*K))N( '?FNYQ16M3$
MRJ1Y6B(45%W/#_%/A+Q1K'B>\NQIDCQ-(5C<.O* \=_2O7/#UC)IOAZPLY0!
M)#"J,!Z@5IXI&.%)]!FLYUI3BHOH5&FHML\=\?>!=1?69M4TZ!KB*<EY%4_,
MK=_PK TOPAXHU55M0EQ#:9P?-D(1?^ Y_I6Y?_$[7+#6[I#$C6ZR'9$Z8('U
MQ4-W\6]7N(#'!:0P.W&\'=C\Q7=#VW(E9'-+DO<Y#7K"'2]8FL8)/-$&$,G9
MCU)_6O??!UC_ &=X4T^W[B/<3]23_6O'?"GA2_\ $NL+/<1.MJ)-\TCC&[OC
M\:]^BB6&%(D&%10H'L*RQ<]%"YI0B[\QYO\ $'P'<ZQ>?VGIBAYR )(LX+8[
MBO/X=,\6Z6Q@AAOH<'[B.<9_ XKZ+HK*&*E&/*U<N5%-W/"++PKXRUB6-+K[
M6MN6&XS3$KCZ9KVR&W^R::MO'EC''M7WXJW1BLZE9SL5"FHH\$C\!^);S6Q)
M=Z9(D4DV9'+K@#/UKW>%/*@1/[J@5)115K2J6OT"%-1O8\2\7^$?$NK>*;VZ
MATV66!W_ ';;UQMP/?ZUZMX7TU])\.65E*,/$GS#T))/]:UJ443K2G%1?0(T
MTG="T445D:%6_$C6,ZQ+ND*$*H[FO"+#X>^))-1A6XTV2*+>-TC,I 'YU] 4
M5K3K.FFEU,YTU+<9$NR-5]!BN ^)'@VYUT17^GIYES$NQH\X+#MC]:]"HQFI
MA-PES(J4%*-F?.ECX9\4F9[>TM+N(DX<*^T?CSS6YJ7PSU:ST> VT)N[V5\S
M!" $7'OCO7M]%=#QD[W2,EAXVL<)\-/#M[H6F71U"V,$\TF0K$$XQ[5C_$SP
M[K>N:M:OI]@\\,497<K*.21ZFO4\4?A62KR53GZENFG'E./^'6@7.A>'V2\A
M,5U+(6="02 .G2NO[4M(>!6<I.4KLJ,;*R/)?B'X&OKK57U73(/.64?O8T/(
M/KS7*:7X2\47W^B10W,-LQ^?=)A!]1G^E=)K?Q(UW2O$EY L:&UCD*HCH!D?
M7%5Y_B]JTL)2&R@B<\!P=WZ$5Z$/;*"22.27L^:YR7B/38-'U5M.A8O);J%F
M?/#/UX_ BO;OA]:?9/!MB"FUW!9O4\G^E>0Z!X;U3Q;K?FS(_EL^^>9P>E?0
M-K MK;10(/EC0(/P%1BY^ZH7+H1U<C@_B%X&FUUUU#3@OVI%P\?3S!_C7F\>
MD>+-(D:"&"]@.>5C?@_D<5]%48K"GB90CRM7-)45)W/!;;PQXTU<K'/]L$#'
M#-+/QCZ9KVO1M/&E:/:V"MO$$83=ZXJ_145:SJ=+%0IJ)Y+\1O!6I7NKG5-.
M@,ZR+AT4@$$=^:Y?1/"GB:[N8[40WD%H9!YI\S:H'<XS7T%16D<5)0Y;$NC%
MRYCD/'.EWU_X..GZ? UQ-^[&T, 2%(]?I7*_#GP9J>FZZ]]JED]N(D/E;F!R
MQX/0^AKUG%%9QKR4'!=2G23ES'!_$W1]4UO2[.WTVT><I-O<*P&!@CN:I_#+
MPI?:*]W>:E;-;SL!&BL0<KU/0^U>D8HQ0JTN3D6P>S3ES&!XQM[V[\+WEKI\
M!FN)DV!5(!_6O.O G@K6K'Q/#=ZEI[PP1*6#,RGYN,=#7LE%$*THP<5U"5-2
MES,S]:TR/6-(N+"7[LR%0?0^M>"W_@O7]+OO+6SE8!OW<L9Z^A'<5[3XUU:[
MT7PW/>6*YN 0JG;NQGOBO-+;XN:S"FVXM8)W'4GY?Y"NC#>T2;B95N1NS*0\
M%ZM_9UQJVORR1QPQG8LLFYF/8=3QFLKP38G4?%MC%CY0Y<GTQS_2KGB'QOJ_
MBJ 69A$<!()BB&<GWKN/AGX/N-+#ZIJ$>R:1<11GJH]371*<H4WS[F48J4ER
MGI0Z4M HKRCN"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I,4M% !24M% !1110 4444 %%%% !1110 E+110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %)2T4 %%%% "4M%% !1110 4444 %%%% !1110 44
M44 %%%% "4M%% !1110 4444 %%%% !1110 4444 %)BEHH R[WP_I.HR^;>
M:?;S28QO>,$U6C\'^'XF#+I-ID<C,0K<HJN>6UR>5#(XDB0)&H51T &*DHHJ
M2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@#,OM!
MTO4WWWMA;SMTW21@FJJ>#O#R-N&D6F?>(5N4M4IR6ER>5=B.*".",1Q(J(.B
MJ, 5)114O4H**** "BBB@ HHHH **** "BBB@ I*6B@!DD:2H4=0RD8((ZUC
M2>$/#\K%FTFTW'DD1"MO%&*:DUL)I/<S++P_I.G2>99Z?;PR?WTC /YUIXHI
M:&V]P22V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*
MX?Q9\5-#\':RNEZA%=/<-$LH\I 1@D^_M0!W-%>5_P#"^_#'_/GJ?_?H?XUO
M>%/B=H_C#4GL=/M[R.1$WDS( ,?G0!VU%)10 M%%)0 M%9VKZYINA637>IW<
M=M O5G/]*\^E^.WAM)2L5EJ4\8/^MCA!4_K0!ZE17.>%_&VB>+K<R:7=!I%&
M7A;AT^HKHB: %HKC?%?Q)T3P?J=M8:CYQFN%##RU!"C.,GFNLMKA+JVBN(F#
M1RH'4CN",B@":BL#Q;XML/!ND+J6HK*T+2","( G)!/?Z5Q8^/'AI@"++4R#
MW$(Q_.@#U.BO-[#XV^$[V[2":2XL]W :XCP/TS7H<%Q%<PI+"ZR1N-RLIR"*
M ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BLM?$6DOK?\ 8RWT1U$ DV_.[ &:74O$
M&E://;P:A>QV\EPP2%7SER> !0!IT4#D9HH ***1F"J6)  ZDT +17.7?CWP
MO8W36USK=I',IP5W$\_@*V;+4;34K=;BSN(YX6Z,AR* +5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124
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M6-[/K5QJNA3R;)EE!^0=\#)P>>#7HGQ*\0QZ;\-;Z\12WVN'R8P.N9!@?SH
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MAQ;65G="UFFLP@EV[MH(P>X[5Q>D:+\-O!6F_8]<O=+N]1R6FEN "['/8=J
M/1-!\7Z%XF#'2=1BN60995/*UN5\W6.H>'T^.&BR^#V,-I<%EN$1=J,=IZ =
MN,U]("@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3-% "T444
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MDURX)5!CD"F?\*O\$_\ 0N6?Y'_&KNE^!?#&B7ZWNFZ-;VUR@(61 <@'KWH
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MW"B9AW3(P#[9S7J]M;06END%O$L42#"HHP!7+_$R))?AYK(=0P%NS 'U .*
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MG&D6$5H)R#)Y>?F(_P#UT >1>)?^3E=(_P"O>'_T)JW_ (__ /).F_Z^$_\
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M *?6/XI_Y%?4R.UL_P#*FE=V$W97,V7XA>'8I&1KM\J<'$3$?RIO_"QO#?\
MS]2_]^6_PKQ55R<4_9[UZ4,O<U='G2QW*[,]G_X6-X;_ .?J7_ORW^%'_"QO
M#?\ S]2_]^6_PKQC9[T;/>K_ +-8O[01[/\ \+&\-_\ /U+_ -^6_P */^%C
M>&_^?J7_ +\M_A7C&SWHV>]']FL7]H(]G_X6-X;_ .?J7_ORW^%'_"QO#?\
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M-']C6'_/N/\ OHT?58=@^L3[FA_PM2\_Y\8?U_QH_P"%J7G_ #XQ?K_C6?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!(KC)OCGX\CGD1=2MPJL0/\ 1(_7Z5R8GXCJP^S/K.DS7R5_PO;Q[_T$K?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L?Q5_R*NI_]>S_RK8K'\5?\BKJG_7L_\J<=T3/X6>!I
MUJ2HTZU)7U6%?[L^;Q'QA11171=&-@HHHHN@"BBBBZ ****+H HHHHN@"BBB
MBZ ****+H HHHHN@"BBBBZ ****+H HHHHN@"BBBBZ ****+H HHHHN@"BBB
MBZ ****+H HHHHN@"BBBBZ"P5$WWJEJ)OO5R8SX#IPOQGN-AX,\,QQVUPF@Z
M:LRJKB06RA@W7.<=:V[S3[/4;1K6]MHKBW;&Z*5 RG'3@TZS_P"/*#_KFO\
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MBCZUY!]6\SP7_A)=4_Y[_I1_PDNJ?\]_TKWK[+!_SQC_ .^11]E@_P">,?\
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M_OD4?98/^>,?_?(H^M>0?5O,\%_X275/^>_Z4?\ "2ZI_P ]_P!*]Z^RP?\
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M<@_[^T?\*X\1_P!R#_O[7L]%'UF8?5H'C'_"N/$?]R#_ +^T?\*X\1_W(/\
MO[7L]%'UF8?5H'C'_"N/$7]R#_O[1_PKCQ%_<@_[^U[/11]9F'U:!XQ_PKCQ
M'_<@_P"_M'_"N/$?]R#_ +^U[/11]9F'U:!XQ_PKCQ'_ '(/^_M'_"N/$?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%<!X^U.]L+^T2UN'B5HB2%]<UR/_  D6K_\ /]+^E 'MM%>)
M?\)#J_\ S_2_I71^!]6O[WQ#Y5S=221^2QVMCKQ0!Z51110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\2O\ D(V/
M_7)OYUZ37FWQ)_Y"-C_UR;^= '$4444 =C\._P#D-R_]<S7I]>8?#O\ Y#<O
M_7,UZ?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MQ/Q)_P"039_]=_\ V4UYK7I7Q)_Y!-G_ -=__937FM !6OX7_P"1GT[_ *["
MLBM?PO\ \C/IW_784 >TT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 >;?$K_D)67_ %Q/\ZXBNW^)7_(2L?\ KB?YUQ% !75?
M#[_D9_\ M@_]*Y6NJ^'W_(S_ /;!_P"E 'JU%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7FWQ)_Y"-C_ -<F_G7I
M->;?$G_D(V/_ %R;^= '$4444 =C\._^0W+_ -<S7I]>8?#O_D-R_P#7,UZ?
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/Q)_Y
M!-G_ -=__937FM>E?$G_ )!-G_UW_P#937FM !6OX7_Y&?3O^NPK(K7\+_\
M(SZ=_P!=A0![31110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!YM\2O^0E8_]<3_ #KB*[?XE?\ (2L?^N)_G7$4 %=5\/O^1G_[
M8/\ TKE:ZKX??\C/_P!L'_I0!ZM1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5YM\2?\ D(V/_7)OYUZ37FWQ)_Y"
M-C_UR;^= '$4444 =C\._P#D-R_]<S7I]>8?#O\ Y#<O_7,UZ?0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/Q)_P"039_]=_\
MV4UYK7I7Q)_Y!-G_ -=__937FM !6OX7_P"1GT[_ *["LBM?PO\ \C/IW_78
M4 >TT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M >;?$K_D)6/_ %Q/\ZXBNW^)7_(2L?\ KB?YUQ% !75?#[_D9_\ M@_]*Y6N
MJ^'W_(S_ /;!_P"E 'JU%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7FWQ)_Y"-C_ -<F_G7I->;?$G_D(V/_ %Q/
M\Z .(HHHH ['X=_\AN7_ *YFO3Z\P^'?_(;E_P"N9KT^@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B?B3_R";/_ *[_ /LIKS6O
M2OB3_P @FT_Z[_\ LIKS6@ K7\+_ /(SZ=_UV%9%:_A?_D9]._Z["@#VFBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HY2ZQL8P"P&0#WJ2D(H X>[\?2V5P]O/IS)(IP03_ /7KE/$N
MO_V_<P2^3Y7E(5QZ\YKT/Q+X:@UNW+* ET@^1_7V->375I/97+P7"%'4X(-
M$-%%% &QX=US^PKUKCR?,W+MQ776OC^6]N4M[?36DD<X4 __ %Z\_M;6>]N4
MM[>,R2.<*HKUCPSX9AT2W\Q\/=N/G?T]A0!O1&1HE:10KD<@=JDHHH ****
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MZ4/=L,@'HG_UZZJ@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!KL5C9E4L0,A1U/M7(7'Q"M;6=X9].NDD0X()7_&NP(KFO%'A:'6H#+"
MEV@X./O>QH X7Q7X@A\07=O-!#)$(HRI#D<\^U<_4EQ;S6L[PS(4=3@@U'0
M5L>&=8BT/5OMDT;R)Y;)M3&><>M8].CC>618XU+,QP .] 'I4?Q%LY9%CCT^
MZ9F. !MR?UKK[>5IK=)'B:)F&2C$9'Y5ROA/PDFF(MY>*&NF&0IY\O\ ^O77
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@!#7/\ B7PU#KEL64;+I!\CCO[&NAHH \&N[.>QN7M[A"DB'!!I+2UGOKE+
M>W0O*YP%%>M>)/#4&N6^X )=+]Q\=?8TGAKPS#HEN'?:]VP^=\=/84 )X9\,
MPZ);[Y 'NV'SOCI["NAI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** *6I:;;ZI:/;W*!D(X..0?45Y'K^@W&A7AC?+0L<QR=B*]
MIJEJ6F6VJ6CV]R@96Z'N#ZB@#P^*)YY5CC4L[<!0*]1\*>%(]*B6ZND#7;#H
M>B?_ %ZG\/\ A"VT:5YW;SIMQV,1]T?XUTM !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!S/B?PO%K4!FB 2[0?*<?>]C7E-
MQ;S6D[PSHR2(<$&O>S7-^)_"T.M0&:(!+Q1\K?WO8T >31QO+(L<:EG8X %>
MG^$_"2:8B7EXH:[(X4](_P#Z]+X5\))I:+=WBAKP\@=D_P#KUUU !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !129%+0 444F10 M%%% !11FB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH 3%+BBB@ HHHH **** "BBB@ HHS10 449HH **** "BBDR* %HHR
M** "BBB@ HHHH **** "BBB@ HHHH ***,B@ HHHH ***,B@ HI,BEH ****
M "BC-% !1110 4444 %%&:* "BBB@ Q1110 4444 %%%% !1110 4444 %%&
M:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***,B@ HHHH **,T4 %%%% !129%+D4 %%%% !28S2Y%&: "BBB@ HHR**
M "BBB@ HHS1F@ HHI,B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** $-8NO^)]-\.VWFWLHWMPD2\LWX5KS2"*&20_P*6_*O)/#%FWC;QG>Z
MO??O;.V;"(QX&3\H_(&M:<%*[ELB)R:T1J?\+,OIP);7PY>21'^, D$?@*V?
M#WQ"T[6[O[%-$]G>$X$<AZ_CZ^U=:EO#&@5(D51V"X%<9XQ\#?VU-;WFEF.U
MO8V^:0#&1_\ 6JE*G+1JQ-IK6YVWO63XCUV'P[I$E_,I<(0 @."Q)Q5ZQ2>*
MRACN65YE4!V7H37G7Q!N7U?Q)I7A^###S%DEVG)'/(/X#-13AS2L]BIR:CH=
M-X1\90>*H[C;;FWEA/,;-DD>M=/7D\R'P7\2+=QA;*^14P/3&W^8KU@$%01T
M-.M%)WCLQ0DVM3B/$/Q!&A:^VE)IDUU(%5@4;KD9Z8JC_P +,O/^A9OOR/\
MA5#4@#\;+8$9&U.#_N5ZCY,7_/-/R%:2Y()71"YI-ZG!6GQ5L6NUM]0TZYLM
MW\3\_IBN^AFCGB66)@T;C*L#P17"_$^TTX>%Y)94C2X#CRBH 8FM7X?-,W@V
MQ\XDD+A2?2IG"+ASQT*C)\W*SJ*ANKJ&SMY+B=PD4:EF8GM4U<7\1-9-AH<E
MK]CGF%PI'F(/E3ZUE"/-)(N3Y5<Z72=7M=:LA=V;%H6)"L1C.#BK]>8?#7Q(
MRV5GHW]FW1#%O])"GRQU/7]*ZCQ'XWL/#LT=LT<ES=OT@A&6JYTFI\J)C-.-
MV=/17G;_ !1> &2X\.:C%%Q\SH0!^.*[+1=;M=>TQ+^T;,;<$'JI[BIE3E%7
M:*4XO8TJ*XFY^)%A;/J,4EM+YEG((@@89D)ST_*KGA?QHGB2>XB_L^>U,"AF
M,IXYS_A3=*:5VA*<6['545PNH_$RSM]0DL[#3[G47CX8P+D U"?BI8Q6DSW.
MG74%Q&1BWD&&8'N,TU1GV#VD>YZ!152SODN].BO<>7')&)/F/08S7(7OQ,M4
MOI+73=.N]1\LX9X%)&?RJ8TY-V2&Y)'=5!=W<%C:R7-S((X8QN9B> *Y/1_B
M)9:CJ*V%W:7&GW#?<6X&,FH/B5K1L]"EL!9SRBZB;]\BY6/&.OYTU2ES*+$Y
MJUT=9I6JVNL62WEFQ:%B0K$8S5ZO-?AKXA9K"VT?^SKD  M]IV_N^W>NG\2>
M,;#PVJ),&GN7^Y!']XT2I-3Y4)37+=G1T5Y[_P +0$.U[O0-0MX"?]:Z$ #\
MJ[;3=2MM5L8[NTE$D3C((_K2E3E'<I3C+8N53U:_&EZ5<7I0N(5W%0<9KGO$
M/CVPT*\6R2&6]NSUB@&2*Y_5?B#!J.BWMC>:;=Z?)+#^[,Z$!CD<=*J%&3L[
M:$RFD=GX7UY?$FB1ZBD+0J[,NQCD\'%;-<9\+/\ D1K?_KK)_P"A&NTJ)I*3
M14&W&YS_ (K\2KX8TY+M[=IPSA-JMCK6Q97/VNSBN NT2*&QZ5P_Q;_Y%N#_
M *[K746-Y!I_AJWN;F41PQP@LQ-6X+V::W)YGS-,UZYFW\7)/XRF\/"U8-%_
MRUW<'Y<]*/#GB\>)+B46VGSI;1DCSW(VGZ4VV\2V,WC2;15L-MTG6XP.?ES]
M:2@U>Z&Y)VLQ_B'Q:F@:M8V+6K2F[( 8-@+DXI/$OBY/#M_96S6KS&Z( 8-C
M;SBN6^(W_(WZ!_O+_P"AT?$__D/Z%_OC_P!"K6%.+Y?,SE-ZG5>*/%J>&I+-
M7M6F^T-M&UL8KI%.Y0:YGQ3XDL=!DLUO+'[29VVJ<#Y?SK1U[7(] T=]0DA:
M1%(&Q3@UDXMI61HGYFO17!2?$^T:" V6FW5Y-)&'>.)<^7GL>*LZ'\1;/5M5
M73KBTFL;AON+-QN/I1[&=KV!5(]SM**J:AJ-OIEC)>7<HCAC&237#_\ "TUE
M8M::#?W$"G_6HN0?TI1IREJD.4U'<]#I:X:V^)NG7FHV5E!;3-)<<-GCRSZ&
MNXS2E"4=PC)2V%HHHJ2@KC?&_BVZ\-36*V\,<@N&(;>#QC'^-=E7E?Q<_P"/
MG1_^NC?TK6C%2G9F=1M1NCN-=UB72_#<FI1HK2+&&"GIS2>$]9EU[0(+^=$2
M23.54<#G%9_C+_D09_\ KBO\J;\-?^1*L_Q_F:?*O9\WF*[Y['74445B:A6#
MXG\4V7AFS$MQEYGXCB4\L:WJY#7_  ?+K?B>PU*2YC^RVQ&Z!E)+>M7#EO[V
MQ,KVT,8^-/%,L0O8?#[?9>NUE.\BNC\+>,+/Q-%(J1M!=1?ZR%SR*Z+8JQ[<
M *!C '%>4>'#'-\7+R2P4_9E#[BOW>E:I1G%V5K&;O%K4]9J&]F>"QN)HUW/
M'&S*OJ0,U/5>_G-MI]S. &,43/@]#@9KG6YJ]C!\':]?Z]97$U_:_9WCEV*-
MI&1CWKIA7*^"/$DGB33[FXDMHH#%+L C'!XK%?XF-;ZG?V<MEYDD,AC@2($L
MY!Q6KIRE)I(A22BKGHE%>8W'CWQ1INVZU'0HTL2>2H;<![\\5WFB:U;Z[I46
MH6QQ&XY!ZJ>XJ94I15V.,U+8TJR/$VJ2Z+H-S?Q(KO$N0&Z5S.L_$"==5?2M
M!L/MMVAP[$$H#W''\ZPO$?B_4GT*ZTS7M,-K/*G[N2,$H?;OS6D*,FU<F51)
M:'H/A?5I=;\/VNH3(J/,N2J]!S6S7*_#XA? ^G$G@1GG\363J/Q"NI]1DT[P
M[IQO9XVPTC@[/Z5+IMS:B-32BFST"BO.X/B!J>F7T=OXETH6R2G"S19VCZ\F
MNPU;5OL.@3ZG;A90D8D7T;./\:F5.2=F4IIFI2UYI:_$C4M6M(X=*TM9]0;)
M<8/EH.W?^M6++X@7]CJ<>G^)=-%H\IPDL9^0?J<U3H3$JD6>A456NKV"TLGN
MYI D"+O9O:N!/C_6]8N77PYHXF@C.#)-G!^AR*F-.4MAN:B>CT5PNB>/Y)=3
M72M<L38WC'"M@A&/MFM;QAXDE\-:5'>11)*6<*0V<4.G)/E%SQM<Z2BO.Y/'
MVK:EM7P_I'V@*H,DLH(0G'('3H:G\-?$":_U?^Q]8LA:7Q)"X!"D^F#STJO8
MS2N'M(W.]HK)\0:_:^'M,:]NCD X5!U8^@KBXO'/BF[0WUMH"G3P<C(;>5_/
MG\J4:4I*Z"4TM#:F\5W47CZ/0!%'Y#(&WD'=785X[INLQ:[\5+2^A1X]T05D
M<<JP/(KTCQ'XEL_#6G_:;HEF8X2->K&KJT[-)(F$[IMFU17FR^,_&%Q$;VVT
M"+[%]X!PV\K],UTOA?QA:^)4DC6-H+J+_60OU'O42I2BKLI339TE%<7X@\=?
M\(_XC@L)X5-LZ%F?!+=. /QK)N/'/BF2)KVR\/@6(Y'FJV\CZ T*C-H3J13/
M2J*YSPEXMM_%%E)(D9AGB(62,GH?:H/%/C6V\.NELD37-])]R%!D_C2]G+FY
M>I7.K7.JHKS9O&WBS3XEO=2T&(6.?F,6=X'Y\5VNCZ]::UI*ZC;OMA(^;=_"
M1U!HE3E%78E-,U**\]N_B%?7]_)9>&],^UM&V&ED!V'^6*++X@7]CJ$=GXDT
MS[(TK826,'9^/6J]C,/:(]"HIJ.)%5U(*L,@CO3JR+%HHHH **** "BBB@ H
MHHH ***2@ /2O/M<^)46E:[+81VC310L%EESPI-=EK6I)I.CW-](1B&,M@]S
MZ5Y5X?\ #CZ[X1UK4IMS7-TQ*;AUV\C'YUO1C&SE+8RJ2=[(]@MIDN+:.9""
MKJ&&/>J.OZI_8VBW%^(_,\H [<]>:YKX::T=0\/?8I2!/9,8B,\D>OZX_"M/
MQW_R)M__ +H_F*CDM4Y6/F]RZ.4@^)VIW,8EM_#]Q+&>C(I(/XXJ0_%"\M1O
MOO#UU''W8@J!^8K8^&2*?!-H2H/S/V_VC767%G;W,3130HZ,,$,M:SE3C)QY
M24IM7N4-!\0V'B*Q%S8R9'\:'JI]ZT9YXK:!YII%CC099F. !7DUC$WA#XHK
M80/ML[LXV9X ;G]*U/BOJ\J6UII,#,#<L2^WN!CC]:3HWFDMF"J>Z[[DE[\3
M)+BYDM]!TJ>\*''FA20?P%4U^(GB#3'WZUH3K!_>2-D _$YKN/#>A6NAZ/;V
MT$:[PH+OCEC[UI7=G;WMN\%S$LD;C:58=12YZ:=N4.635[E71M:L]<T]+RSD
MW1L.1W4^AHUG6K+0K%KN^F"(/NC/+'T KG_"'A"Z\,7]ZYNTDM)S\D0!RO-<
MGKSMXL^)4&D.S?8[=N1V.!N/^%$:<92=MD-S:CYFA)\1-<U++:)H,KQYX>1&
M8'\L5)8?$NYMKJ.U\0:7+:,[8\S:5 _ ]:]#MK2"T@2&"-8T48 48K*\3^'(
M/$6D2VKJ@F(S%*PY0T<]-NUM!.,[7N;$$\=Q"DL3AXW&593D$5)6%X3T>ZT+
M1(["[N5N&C)VNH/3TYK=K&25]#5;&'XJUX^'-$?4!#YNUU7;G'6K>AZD=7T2
MUU IL,Z;MOI7-_%+_D2IO^NJ?UI-)\06GAWX>:==73C/D_(@/+G)X%:J%X*V
M]R.:TVGL;_B#Q#9>'M.>ZNW[81!U<^@K.\*>([[Q'$]U)IYM;4?<9CR_TKC]
M$T34/'>J#6]:9ET]6S# . 0.WTKU*&&.WA6*%%2-!A5 X HG&,%R]11<I._0
MYSP]XHGUG6;ZQDL7@2V+;9&_BPV*2[\6FV\:V^@"WR)0/WF>F1GI3/#?BN'6
M]<U"PCLA"UJ6S)Q\V&Q7.ZK_ ,EGT_Z+_P"@4XP3D[KH)R=KIG2W_BPV7C&S
MT+[/N%QC]YGIFI=4\236'B6QTI+)Y([E@&E'1,URNO\ _)7](_X#_*NGU?Q/
M#IWBG3]):S$CW+ "7CY<T<BTLN@*3=[G4 T5SOBSQ.OA?34NS;F8,X7:#BN>
MN?B+>W;;="T>6Z5?O2LAVGCMBHC2E)71;FEHST.EKBO"_CZ/6]0.F7EH]I?
M$[6!P<=?IQZUN^(/$5GX<T\W=V2<G"(.KGT%)TY*7+8:FFKFO17FR?$+79?]
M,3P](=.').UM^/;M6EI'Q%MM9\01:;;6KA9$!WMQ@XY&/:J=&:U)52+.XHI,
MYI:R- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>WM-+T^ROKN5\%!&" /J!6EXK68_#N]$L*12_9LO'&.%/H*EOX5:P[;C/AR
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MT;2+\[;ZT^7YCRZ_XUE:?_R6J]^A_P#1=9QBXN2?8IM-*POQ&_Y&_0/]Y?\
MT.CXG_\ (?T+_?'_ *%1\1O^1OT#_>7_ -#H^)W_ "']"_WQ_P"A5</L_,F7
M4=\5?^/C1_\ KH/YUN?$C_D2)_\ >'\C6'\5?]?H_P#UT'\ZW/B1_P B1/\
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MC^-^A"^'YBZ__P E?TCZK_*G^*_^2H:#_OK3-?\ ^2OZ1_P'^5.\5?\ )4-
M_P!]:(]/0'U]2U\7/^1;@_ZZC^E=9X:LH+'P_9PP1JJB,'@=:Y/XN?\ (MP?
M]=1_2NUT?_D#VG_7(5G)_ND:17OMGG>N1K;?%K3FB 1I$RVT8SU%'C9#JOQ
MT?39&/D !BO8D$FG>(_^2L:5_P!<A_,U-\1;"[LM6T[Q%:(SK;D+*JC.!G.?
MZ5K%ZQ]#-[,]%2&..(1*BB,#:% XQ7E=K80:?\8VAMU"1D!\#L6&3766_P 0
M_#\NG"Y>]5'VY:$J=P/ITKA/#VJ2:S\4Q?21-%YGW58<[>WZ5%*,DI7[%3E%
MVL>T4M)2URFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7,5Q<6T<DT7W'902OTJ[10FT.PQT612CJ&4\$$<&N?D\#^'I;X7;:='Y@.<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH**:9%!P6&?K5.WU)+BY>(#A3M!]Z5AW+]%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1132PS
MC(S]: %KA?BC).GAL>5C:6^>NZKS7XH:S8/IAL%G#3JV2JFJA?F)EL;_ ,.X
M4C\%63)_RT&]OJ:R/$%E?^&]<?7[ ;K23'GQC_"I_AAJ]I<^&(+(2K]HB)&P
M]<<5TGB:58?#UX[+O_=D8_"G]H.A0MO'6B30(\ETL;,.5;L:U[#6;#4U)M+E
M),=0#7S_ &>FR2RFXN;>0VS$[-C<$^]2P2^2[?8+LVMZK<1>:,'\Z<E&]A)L
M^B&=47+L%'J338[B&7_5RHWT.:\%U?QCJ&K6$=G>7_V1H6"N54DN>G:G+JT/
MASR775;N2YN5VQRG[B$=B,5+212;9[Q+*D,32R,%11DDGI7EWB?X@3ZA]IT[
M1(78H/GE49XKI(;FX\4>#GMY)XX;R2/!96!!/K7E^R?P]8W6FNX6Z<DO(%Y(
M[<^G6A60/4P#=ZC%>?-+(9DP^S)R*]W\#^)U\1Z.K,I6:$;7'K7A%G<V/]I?
M:-2,D<X7#E>C5Z;\)[94GOI[6X,EG( 5!'(-%[K4278]3HR/6N:\5>,+/PW;
M?.P>X8?*@//XUY?I_CZZB\4+>W$K?9I&PT>> *%%L;E9GNU%5K&^@O[2.YMW
M#QN,@@U9J1B4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?)CTVW$S/G?\P&!^)_E7%> ?%^K7GB:[74MZQRDDQL#\A]J0SV2BD!R :6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7Q?9^([52K!+@#YD)_E735\JZ=K4^B7:7,,I!1MP -?0/@[QA;^)['=CR[E
M-R$]?>F(ZFBD%+0(**** "BBB@ HHHH **** "BBB@ HHHH *2EI* %I"0.I
MHKE_&2ZHMK'<:>S;8B3(J]350CS2Y3.I/DBY6N=117GN@^.6:98-0..<;C7?
MQR++&'0Y5AD&JJTI4WJ11Q$*JO$?2'&.:YS_ (23RM3DAG4+$K8SGI6!XQ\;
M)ID,T2S;$DCQ&1]XGVJ5%LN4TD4-?U6*S\17%O!;(.0<Y^^<=!56WNMES-*Z
MNORAO+SP#]:\T.I7$-Q)=W$A+,N5.>23W%2_V_?26HBEF;YNV>0/>NRG2<]#
MS95I)W.\U/XAWEG:2VED^XG^-CG;]*\ZFGENYFFG<O(QRQ)SFDCF\S)<^WN:
M$3YB!GZUZ%.E&GL9.<JCO(:(MQZ5,EH">15B.'C/>KD,'/3)JF4B"&U /2M.
M*W5 ,CD^E$,1'.#BKL<((P#@]C4-C9#L!/!XJ=0NT*4^8_I4BP,/X<TOD/YR
MG'R <THM7U$R%+:(. [98]*O(N  !TJE+;2H^]#D9K07.T<<XYIS'$D1:G6/
MBHT%64Y'-8,T3&>3[57GL5D3&.M:2K[U)Y>>V#2N6<A<:44;='D$=Q5.=]16
M$QQG'^V>M=L]N"3Q^E4Y;%#VHM%[BU6QQ/D7%R&\YF9^Q-49+->0Z9;'7TKM
MY;%5;<!5633$E8MM&#6EE)6,)WO<Y?3X;A/D0M\YQ@=37I_AVU&G6,?[H;@2
M>.QKEK:SDM)%:,?=.<$5O:=J2N&%QE9%Y '0BN:I"2*I*/-=FOK=Y&NDS*00
M9/EQ_.L#2=??0KF,$_N6XSCBKL<3ZKJJQW),=H&"\<DD_P#ZQ7>'PSI<E@MH
MULICQUQS356%*'*U>Y,J%2O4YXZ6,R;QK;#3Q-"N^0C@9X%9>GZM?7^HI<3.
M8HR>.>M5M:\*Z?H<#3_:'(+92,FJFC07NLZA'Y2E(8_X@.!6M.%'V;E$YZ\\
M1[14WN>IH=R@@YXIU1Q)Y4:IG.T8J2O*>Y[\;V5Q:3-(:X-?%WV6WUB"X^VR
M3QS2".1(BRH-HP,]N:(Q;&Y)'>Y%&:XBS\3FT(:<7,\QM(V5=^0[,Y4#&.#G
M'-+JGBF\:SFA^Q3V=W"878!LY!D (''.0?Z57LY$\Z.VHK&T36WU26Z@FM'M
MI[9@&1FSD$9!Z>A%'B.\FM=,,=JQ6[N&$4)'][_]0-3RN]BKZ7-G(HS7'3:S
M?)X.O'@#RWMHQ@9W?#':<;_QK%GO=;M+Q(;DWRV]M;>=(5O1N8G'4[><5:IM
MDN:1Z7FC(KDI?&+6\TJG397M[8@3S[_NJ>^,<]ZK7GB&]2\1;"&21&U'R9#)
M+T&$/ QP.>E)4W>P^=';YHKGO^$D;[(&^Q-]I%RMN\ ?E<D9.<=@<UOCFH::
M&G<=1110,**** &.NY&!)&1U%>+Z[X>O=/\ $$WV+5)R96#+O;./4"O7M5OH
M].TV>ZER$C4DX'->(W_BNW\_S[2WS:7"-SM^<-T)_+% &-X:U*/2[B\BUZ9F
M2>4A QR-P[UE:E$JZNTH;SHI&.,#/RFK<J6ALE(C+H7,GS#.PU0L[B2663R@
M'4'Y>*0[&QX=\176B/+'83$ MPIXP*=J?B[7-2G6"6]EV'AB&.,5F^8T4#2M
M$&8Y'!QS4.GVC7<\:3DYD/S#':A:CV.TEU&&>PLGMG^9(PA(/.X#&:I1:G?&
M)K?4G?>A_=R-R'^OK3,PQ81%"K'\J"DA U&&1483+&1N51RI_K71-*UC&-[E
M.X\FX6:&0$;P5; ]>]365^UMJ^G6$.6ME4*S/U?)JCJ5Q<OMF2!843'[PG.:
MNZ'<6LEU$TD3[X_F5QRI]ZR<KK4M*S-XM::E.UY;S%);?*R1D\.G3'\ZP([4
M.YDE 1%<D(.F*TKAXXFQ;P[D9@-R<YYR<TUHDDV@J1SG!%240/;6][$8F0$'
MU[5C065YI]Y):NHD$F70#]#781PQ^62%&[' %*/W<>YL%AZB@15L(97BA6Z&
M9-@#9]:=/Y:YCA4'!Y-%Y<2Q2 M'(ROT$:Y(^M31V ,?FAG&[J#U% &6P#*[
M*,D#ICK7.:M=(+B"6.V!B/\ K Z_=^E=Y%IR,S;3CBJ%]IL5U:2V<BE5/1MO
M0^U '#6MG;OJ"E;CAF#% ,_A70RF%VD1""%QD9Z5)H^GVT-Y.I_X^(P  W4#
MUK0;3K<R%O)&YNIH&<E+=0NS6IM6\PGC:.#2V,CVDZK+;L)U;,;8[5N#3VAN
M61H T9Y60=JC>>29P@B,3H2-[C@_C2 I7,BVSO))&\4TW+,IP?SJ9[NUAL([
MB8B6ZW@H[\,J^YK0%B+P;[Q!YR#Y2&X-9FJ*ZE3/'\BC!91E: .N\*^+KW1W
M59)C/:9R5SGCVKJ?%<5QXPTNVETJ\7[(&!N(\X;'>O*H9BD&8@/+ R%7O71Z
M)J4-@EP?WR"2/(96Y!^E%PL7VU32M'DBTZTM2MQM(VA\ _7BN?UZWTZ>]6],
MIMU8JLL:<EFX%0:>SV^L3W6H1_N)HW$;,?F&01G\ZR]3N+ Q-% 90Z-N;>-V
M:J[%8]5\)^.(4U*W\/1PLR1KM\PC%=%\1) GA"Z&<%N!7E7A+7;))/M<L!6\
MA4$,1@, ,5+?>*M3\57LL!XMN2JYP /4FG%7=Q/0]0^'$?E^#;,$DDC)KK:X
MWP%>!=._LU]HD@ /!R"#W%=E2EN"V"BBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*": %HJLU]:H_EM<1AB< ;N:L T +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX5N =2>UD49"_*<=*[3RRYX?CH0*SQ-E*R"BG:[(+EUBBR!GGIZU3CNP=RI
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MY2_\(]!36@,Z.)/+B1/[H I]%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT@.T$]:6;8\&'XSTK>(,L13V=Y%B4[9$&1QUJC)$'D5H,LK'%-LTB\[8S'+
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M_.K7B?P9;W(6YBD*S$@-N8 'CK56V)3Q VX@L9S@8/K75>(X9;BRABB4EVD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9V4GYEO3-3AUB&9&7:0<;3W':N,\0:<NCRR,D(<D?N>,FETS4OL-\DBMP.&
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M1T-5=6A,NI*N[: .:B$=QO\ W.2B]36,XV=BXR>Y<G-VLI>-L$<@5NZ?>K-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCBH=UHRE9ZFLF7MTWA47KL48%7+;:[;Q^%4%MEN7"O(X [ \&G7=XFGW5K&
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MFB<,KC((J:D M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)"F[.?+')-=K44T$<Z;)4#*>QH ^4[JSU.WM'DF5Q'*V-K<YJ6]0:;IUO:'
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MS2;R3[>[QPW/293D GUIIM"9V4-NNII*ME=M:J[%-^.?PJ?2O"$\FB&RO[N
M.DX96#!N!].E<U$+_078).;JRB/)V\BNABO;BTA-_;0O=02?,53J/I52E<25
MCJ5TVSLYUEL@-Y($C*.H':KMW M[920E0=ZXK!T'Q'8ZHN(V*29P8W&&'X5L
MWS2P6K26W,H&57U-2,6;?!H4T3!MWDL@VC)R1@5P.@&&]MK^QMSB0-D;QTZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MACC"]ZY^2^?:))<MYCG"Y.<5H7!^TJS2D^7G@"LNZFV31E8P#C8._'TIH"W
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M=M '82Z:(=]W:_ZQVWN#W/\ D5K6LL>H66R158$893TK TK7K-S$BW22)(.
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M'9P<%L^OUI#NCSK3;".]U![,64RB)-BR>80)!UZ9]2:[O0/"R6EN$F4M;;"
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M+') ^M;D$0A@CB'1% %2TR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\*KS7N%9.,9I []#5_<3#9O5F!SP>:EC944+'PH["L&&X*RH5Z9K7+JZ[U
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M=&0G>&((8_X5WVD:2U[IX:ZU"8HI.Q$8!0.W:@#HKJ_:%';)?'8=:Y6.UO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M )XU0[ ?E8*?ZUV8I.+0T[BT444AB&N?\7:6E_HDW[GS)4!*;1S70TA&1@T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!!:NIKEO&W^HTO_K^3_P!!:NIIO8A;L6BBBD6%%%% !1110 4444 %%%%
M!1110 4444 %%%% 'GGC\SR74,6US$1P!ZUM^%](-KH^9TP\J\@]A7136L,Y
M'FQJV.F13;IQ!:2/V12:Z?;MP5-'#]52J2JR=SR^ROH[/4[C3Y8M\#2_NF7^
M$YKU.  6\8'3:*\ITRU^U^(5=5W!I<X'89YKUA1A !T J\7%1:(R^HYJ784@
M;<5Q<FG_ &K5YA&H!W8P.W-=K4:PQJY=5 8]37(G8[I1YAMK +>V2(=AS4V*
M*6D58\\\?:(9YH[U(P3C:W%6_#:_:?"=S:$GY,]O:NPNK2*\A,4JY4U!9Z7;
MV,3QPJ0K]<UU.NG1Y'NCA6&E'$>T6S/)VMGCN9(N&0]"1WIBQM&=N.G/UK8\
M93SZ3=K''&JJQR#MZU0AD2ZB24@'>1NP>A]*E.Y<DDSLO"+L))/E 5E&:I?$
M.9]MI!SY;'<U:7A1 DDZ@8  J3QEIS7ND%T&6B.[%.BTJRN+$J4L.^43P?;6
MXTI9DC <G!..>*V+W2K._&+B$-[]ZP?!$K?V<\# @(1UKK*G$-JJRL&HNBM#
M@_$WA];3RKFT3$:C#*!75:')+)I4!E3:VWI5]XUD4JX#*>H-*JA1@# I2K.4
M%%] IX94ZKJ1>XZEI!2UB=84444 %%%% !1110 444&@#AOAS][7_P#L(/\
MUKN:X;X<_>U__L(/_6NYIRW(A\(4444BPHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *BN+>*ZA:*9 Z,.014M% 'E'BWP,UFS76F1@PG[R8Y4UYV\<P9
MHSN5E/WG&,?2OIEE# @C(-><>//!_GQ?:].@&[^-5'6E8I,\KF6VGA&\Y=>K
M>E58B$N3Y.&(Z$MG-7+_ $T*5C=74@X89Z54<K8QB*./>P.<[>E(9>9)7@FE
M0[!$F]@HSGG''XFJC^:D4:W8Q(W*<\KZ<5MZ#=0K)<1W,X*S(OEJ5[[@2#^
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M0-;O'M S]UN,B@#C8YFE7##Z9IR,\;%&^Z::D#)= %?E[#-/DAD:<%2HQVH
MEB!1EVRX&>AI]Q]I$;NY0,3QGO5.9GC7YL#W4\UIV]DNHZ?#+CS&5\,-V,4
M1PP12+')DAEYV@\$U(8VFGY< 'J*LV^G7-O<QD0[@'^8+Z5N^(O#R1Z9:ZA9
MYBFEEVR*HS@$'^M(#GYQME40\!1T(JSI&G)+=1BX95DD;[Q_AJO,)+*X6WV-
MY[]-XY'U%)&TZQ&"[/ESF0&-_P#ZU 'OOA?PWH^DP@V;)/./ORY!.:Z:O,/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF]B%NQ:***184444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4E+10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M!HHH X;X<_>U_P#["#_UKN:X;X<_>U__ +"#_P!:[FG+<B'PA1112+"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N0^(46J/X?+:2I-RK
M@@ 9SS77TA /49H \]\)>!S::A'K=T%6:>(&6#' ?C)KT("C%+0 4444 %%%
M% !1110 4444 %<MXB\#Z?XAO;>\E9XIX&R&3O74T4 ,AC$4*1@YVC'-/HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !110: .&^'/WM?_P"P
M@_\ 6NYKAOAS][7_ /L(/_6NYIRW(A\(4444BPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .5\;
M?ZC2_P#K^3_T%JZFN6\;?ZC2_P#K^3_T%JZFF]B%NQ:***184444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !110: .&^'/WM?_P"P@_\ 6NYK
MAOAS][7_ /L(-_6NYIRW(A\(4444BPHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?CU_"KY=-2;W9] Q2"6,.O0CBI*HZ3;&TTV& EB47&6.35ZH*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'_\ 05KJ[B!+F"2&09212C#V(Q4S24K#B[JYSP\8V<_BBWT:T*SEP3)(#PF
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MO$OB/3= @G/A])((XE^99CG;CKC;3C3TVU$YZ[G2>'O$JZS+/:S6LEK>V_\
MK87[?3\ZWQ7&^#+2>[NKKQ'=30O->J%"0G*HHQQGUXKLA6<TE*R-(-M"T445
M!04E%'>@ S1FN+\3W7B>'Q#:1Z1!*]B57S65,@'<<_I5CQ?<>(8-/LVT2&22
M=F_?!%S@8_QJK$<_D=9FC-<KXCN/$$7AZSDTN&1[Y@OG*JY(^7GCZT+<>(/^
M$&DF,,G]L;3M3;\V=WI]*5@YO(ZK<,9HS7,Z'/KDOA2274(9%U,;]JLN#UXX
MJMX.N?$<]O?'789(Y%V^3O3&>#G^E%@YSK\T9KBO"%UXHGO[A=<@ECA _=ET
MQDU+87/B1O&]Q#<P2C1P6\MRGRGCCFGRAS^1V&ZC-<->W?BM?&"Q6]O*=+\U
M07V<;>,\U9\37/B2+7]/328)7L6"^>53('S<_I2Y0Y_([#=1FN1\9W'B*WBM
MO["ADD8G]YL3.*/$=QXBB\-Z?)I<,CW[;//54R1\O/ZT6!R.NS1FN9:?7!X+
M:812?VL(LA-OS;N.U1:3<>()/!UQ+>PR+JHW^6A7#>W%%@Y];6.KS1FN3\'7
M'B&>.Z.NPR1LN/*WKC/7/]*B\(7/B2>^OAK<$L<*X\DNF,\G/]*=@4[]#L<T
M9KBM+NO%#^,WAO+>4:3\^'*87[O'/UILUWXI'C9H8[>4Z1O&'V<8VCO]<T<H
M<^FQV^:,UQ_BBY\20ZU8)I$$LEFV//*ID#YN?TH\97/B2"6U&AP22*0?-V)G
M'-*P<YV&:6JFG-.VG6[7((G,:F0$?Q8YJT*12U%IK.$4LQPH&2:=5>\_X\YO
M]PTUJP8EG?6VH6XGM95EB)(#+TXILFIV<6H16#SHMU*I=(CU8#O^E<#X4\8:
M?I>B+:SPW;.CODQQ9'WCWS3DUJVUKXE:5-;),BI;.I\U-I_BK1TVFR.?0]&S
M1FN/FU[6M5U"YM]!MK<PVS[))YWQEL= ,5&/&=Q;Z5J'VVS2/4K+ :$/E6R0
M V<=.?2I5.3'SH[3-1FYB6=8&D42L"53/) KD;/5_$R3VTEU9VUS:W#@$VTF
M6C![XQR*S]1_M;_A9=MY @_U#[-Q_@RN<^_2FJ>NH.:M<]"S56]U*STV#SKR
MX2&/IN8U8&=N3U[UP5O'#XF^(.HQ7JF6WTM56*)N5W'.6Q^5*$4]QR=MCHX/
M&.@W,XACU"/>QPN01FMP," 1R#TKE_$%MX;N;633[Z6V@DV_(3C<A[$4MQK4
M/A_PO:21S_;W;$4+9QYAS@?Y]J;BG\(E+N=/NHS7$/X@\0:48[K5K6T-E(P5
MO)ERT6>F>.:EN?$>KSZ_=Z5I-K#*8XTD661MJ@$ ^ASUI>S8<Z.RS1FN5T?Q
M%>F:^LM:@CAN;- [-&V592.O08JA#XA\2:E;?VE86=HMB1NCCEEP\B^O3BCV
M;#G1W.ZC-<-=^-[B2QTB?3;9)9;YVC,3-T<8XS^-:)U/Q!9:&9;NPBFU!I0B
M1PO\NTXY)QQ0Z<D@YT=1G%1BXB,YA#@R!=Q7/.*XNXU_Q'H\MO+J5O9R6L\R
M1$12?,FX@>G/6JNE-K!^(>H'%OM,:E^?X,C&/>J5)VN+VB/0LT9KC[KQ!JVH
M:G<V>A0V_EVS;9)YY, MZ 8JUHOB5[B*^AU*)+>\LAF5%?<"/4&IY)6N5SJY
MTK.$4LQPH&2:@L=0M=2M1<V<RS0L<!UZ&N,77?$NI6$NIVFGV_\ 9Q5MD328
MD=?7I^E7?AJ=W@VW/^VW]*;IM1NQ*=W8Z[-4M0UBPTKROMUTD'FMM3?_ !&K
MIZ5YSJUJ/%WB;4+;>QM["V*1YZ><P/(^GRTH14GJ$Y-+0]$\Q3'YF1LQG/M4
M5I?6]_!YUK*LL9)&Y>F0<&N?\)ZM_:GAC;(Q:XME:&;(_B'_ -;%<WX8OO$3
MZ5)'I5E!Y%O-("\SX,GS$\#'O5*F]?(7/L>EYHS7&OXV_P"*::_2W47BS?9V
MB+_*KYQR<=*?I^K>)8]0MX]0LH+FUG/,UL^?+X[C%3[.5A\Z.OS6)>^(8;>Z
MDMD&Z6/&]1VST_E6T>E>7>*U/_"0W21NK+,B"8YP8L9VGWSD_E4Q5W8INR.D
MN_%CPHPB1'D7ID\-]*ICQK<*BF6.)&(Z;NGZ5P/]FE5D9KU2X'R8-5VMI@%W
MWJDGC&:U5-&?.SO+SQC>-,OE/;*HQG,A'U[>E<YXDURSN'CN!*9KA"2F[HA(
MP<5B#39"Q$MROOM.>*8VB1*\+?;E^]\XVYP/;GFJY4@NV5;;3=1URX"6\<DI
M)R<=!]:[K2?AF9=.D:\D,=R?N,AX3_&M71O$&DZ1%%91V[H H._RPJGWZUT\
M'B33YXO,69<9QU[UG*3+44>6ZQX,OXKB2 V[3J3F.5!_,=JP+/P-K%^6VV3P
MJAQ^^XS],9KT[6_'<,#A+1%EQD.2V N*YR#XE31S8D";0>@.*$Y"M&Y%I'PB
MDEESJ<@\@CA8R02?<UZ=H&@VF@:;'9VB!40=>Y^I[UR6C?$>*\U PW;00Q <
M-YF2?TKO+6[ANXA)"X=3W!J'?J4K%BBBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH:#XBNXX%#Z1<G>N6YC;O^'6NN%&**F4KC2L+1112&%%%% "4<4M% !24M%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% "5EZMH\%^OF,N94&5/H:U:0_2@#P7Q!H_VAI9 ?*N+>3848X+>A
M'KG%7_"?CBT\,6HL;JW\I3(69TR1SWQ7J&L^';/58_GC4.&W @8.1T/ZUQS_
M  T,[;;AHV!X9P/F^OIFM.9-6)M9GH=A>Q:A91W4)S'(,J:M51TFP73-,ALU
M8LL2[03UJ]6904444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 )1110 M)110 M%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 )032U5O;R*RMGFE<*JC.2:6P"W5Y#9
MPM+/(J*!R2:YN3QA&9H_)B_<MGYV./IP>:YW4-4^UNVJW^X0@%;: G@C^\1T
M.<#K6;9Z3>^*<RQ@!.FXM@#VXKAEB93GRTCH5))7D>H:1JD>J6QFC &#M(W
MX/X5H#I6%X5T631-)6VF9&ESEV1<;CZUO"NZ-[:G.]PHHHI@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HI*6@ HHI* %HHHH **** "BDI: "BBDH 6BDI: "BBB@
MHHHH **** "BBDS0 M%)GBC- "T4F:* %HI** %HI,T4 +1244 +129HS0 M
M%)10 M%)FC- "T4F:,T +129HS0 M%)D49H 6BDS1WH 6BBB@ HHI* %HI,T
M4 +29H) [U4O=0@L+=IY6^51DTK@6R:X7Q5=_;/$>G:08RT6#<2$'@A>-I'U
M(/X4[4/$EQ<7#K$YM;7R\B1UY8\'CVQ7-RZO&A=[=GDG;AIW;+$>F?2N#$XF
M+BX0U9TTJ3O=EGQ!9/>2"-6/'\*]OI7<>&].MM.TN*.'9P,,5/4]S7G7GS-
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MI:IX<LK*SE"W$(7>V[&<+@\_6E30=2'@.32#*/MS*0'W?[6>OTHL@YGV.KW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=$&"?6K]%+72E8\24G)\SW"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %)2TE "T4A..II-P]:!7%HHHH&%+110 44E+
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12TR1UC4
MLQP!0 [-)O7^\*Y+4?$LT[O%IR_)&^V29N%'7./4CTKF)/$\MKE!<SR3$_ZP
M(#D^@7-6H.US%UHIV/5<TM4=+N)+K3H9I8V1V&2K=:NBH-A:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2QJ/E48%25@VOBS3+R1%CE^]T)K<5@RAAR#633.M-/8=1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBN]0"Q;+>!PL600Q&!R:W;RPMK]%2ZA65%8,%;ID=*YGPPBIXI\1*BA5$R8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 )BBEHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BBEH :55A@C(J#[
M%;[L^4OY58HHU %4*,#@#M2T44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gtl21rgcbjm5000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" :W",H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MES\V/F'I5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 V1BL;,.H&:XNY\4ZC%<R1KY6U6P/EKLYO
M]2_^Z:\QOO\ C^F_WC0!K?\ "6ZE_P!,O^^*/^$MU+_IE_WQ69IUB=0NU@#A
M,]R*W_\ A"Y/^?M?^^: *8\6ZEGGRL?[E6;?Q?,)!Y\89?\ 9&*BN/"5S$"8
MY!)CT%8,T,D$ICD4JPZB@#TJQU&WU"(/"X)[KGD5;KS72;Y[&]1U8[2<,/:O
M1XI!+$L@Z,,B@#(\1ZI<:7! ]OMR[$'<,]JYX>+-2+ ?NN3_ '*U/&G_ !ZV
MO^^?Y5QR_?7ZT >GV$[W%E'*^-S#)Q5FJ6D_\@R'_=J[0 4444 %%%% !115
M;49&BTZXD0X94)!H AO]7M=/3,K@MV4'DU7T757U,RLP 5?NC%<#+-).Y>1R
MQ/J:ZWP?_J9?\]Z .HJ.>>.VA:61@JKW-25SOBV=DL%B!P&()H HWGBZ3S"+
M5 %'0L,U4'BW4L\^5C_<K!KH+#PM->6ZS-,(PPR 1F@#;T'6I]4ED21 -@SD
M"MZL70M(?2S)O8,6&,XK:H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M48H Y;5O$K$75C]G&.4W;JY6N@U;P_?">ZO"(_*R7^]SBN?H V=(UXZ5&R"
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MIJ3&0V<C9&,KD]*ZZ@#FK[Q4UG=/"+8-M/7=4FF^)_MUQY;P"->[;JYC6_\
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M?46/R2[?PI@\2ZH#DW&1]*L:7X9DOHA+,YC0],=:LWWA(P0M)!,TFT9PP H
M;9>+)ED N5W*>_I776US'=0++$V585Y8P*L0>H.*[#P?<%H9HF/W2-HH Z9V
MVHS>@S7+S^+VAG>/[*#M.,[JZ>;_ %+_ .Z:\QOO^/Z;_>- '::9XB2]65YH
MQ$L:[B<YS63?^*YFE*VORJ/XO6N=C,K?NH\G=Q@=ZZ.R\(O-$'N)3'D9 7!H
M H)XFU(-EI]P],5O:5XF2Y=8;D;7/0^M8FJ>'9K!/,0F2/N>]8H)4@C@B@#U
M@$$9!R*YJ_\ %$EC=-"UH#@\'=UJQX:U$W=EY<C9>/CZBL[Q=989+I1U^4T
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M$C&% KS=%+NJCJ3@5Z;IL0AT^!,8(09H PO&G_'K:_[Y_E7'+]]?K78^-/\
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M)/\ D!S_ (5?L_\ CQ@_ZYK_ "JAXD_Y <_X4 >>5W?A7_D&'ZBN$KN_"O\
MR##]10!O5YWXA_Y"S_2O1*\[\0_\A9_I0!!I'_(3A^M>D,=L!;T7/Z5YOI'_
M "$X?K7HTG_'L_\ N'^5 'FNH3-/?S2,<EFK2\+VB7.I;GZ(,CZUD7 *W#@]
MC6_X0(^WN,\[#0!VM(0&!!Z&EHH \YUZU6UU61$^[U%-T2X:WU2)E.,_+^=6
M?%!!UB09Y %4-,4MJ$(']X']: /3J\QU3_D*7/\ UT->G5YCJG_(4N?^NAH
MM^'8EEU>+< 0#G%>A]!BN \,?\A9*[^@#+\0('TB0'U!KSJO1]=_Y!,M><4
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M*\&_\A"?_KG_ %KM: .1\9H UNP')SFN7B.)D/HPKJO&G2U_&N4C_P!8OU%
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M53U= !^==O0!'.BR0.C#(*FO,;R+R;N2,?PFO4'_ -6WT->9ZD0=1F(.1NH
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ML6OA6\GY<B(>C"@!-7\0?VC#Y2Q@+Z]ZPJZ#4_#ZZ=9&5GW-[5S] 'I&@_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&4@C(- 'DY!!QW%=9X;UM$C%I<-C'W&-1Z[X=9':XM5RIY*^E<R5>-L$%2*
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MO'ZUV?@__CSF_P!X5QA^\?K79^#_ /CSF_WA0!TM>?>)?^0JWTKT&O/O$O\
MR%6^E $&@_\ (<M/]^O2*\WT'_D.6G^_7I% &+XI_P"0')_O+7 5W_BG_D!R
M?[RUP% '?^&/^06/K5?Q?_R#XO\ >/\ *K'AC_D%CZU7\7_\@^+_ 'C_ "H
MX@=:]&T#_D#P_C7G(ZUZ-H'_ "!X?QH T)?]4_\ NFO,K_\ X_YO]ZO39?\
M5/\ [IKS*_\ ^/\ F_WJ -OP;_R$)_\ KG_6NUKBO!O_ "$)_P#KG_6NUH Y
M/QITM?QKE(_]8OU%=7XTZ6OXURD?^L7ZB@#TW3O^0=!_NUD>+D+Z9'CL^:U]
M._Y!T'^[2:C9K?6<D+#DCY?8T >8UW7AS4X)+%8&<+(IZ&N/O+&:SF9)$/!X
M.*KAF0_*Q!]C0!Z9=ZA;6<9:611QP,UY[JEY]NOY)@,*3Q4 $\[!1YCD_4U9
MO-.EL88FF&&D&0/2@""R_P"/V'_>%>G0_P"H3_=%>8V7_'[#_O"O3H?]0G^Z
M* .2\8?ZZ+_/:N9C_P!:G^\*Z;QA_KHO\]JYF/\ UJ?[PH ]/L?^/*+Z58JO
M8_\ 'E%]*L4 >:ZS_P A2?\ WC4_AS_D,P_[U0:S_P A2?\ WC4_AS_D,P_[
MU 'H3#<C+ZC%>:ZM:-9ZA)&1QG@UZ765K.CQZE#D#$HZ&@#B]'U$Z=>K+_">
M&KT"UO[>[C#12*>.F:\YN]/N;.4I+&PQW J 22)P'9?H<4 >@:IK=O8P,%D#
M38X6O/Y9&EE:1NK'-)EY#SN8_G6OI.@SWLJM(I2(=2: -'PE8L96NVX X7WK
MKZBMK>.U@6*)<*HJ6@#S3601K%UGO(:L>'I$CU6,NP )%6/$MA)#?M,%)1^<
M@5A E3D9!H ]3^T1>8L>\;FZ"LWQ-_R YOJ*Y/0)9/[9MRS.5W<YR:ZOQ-_R
M IOJ* //J[WPM_R#/Q%<%7>^%O\ D&?B* -RN*\7_P#'ZGT%=K7%>+_^/U/H
M* .>B_UT?^\*]309A4'NHKRR+_71_P"\*]4C_P!4G^Z* //?$%H;;59>"%<Y
M6H=(OO[/OEE/W3PWTKM=:TE=2MOE&)5^Z:X.YLI[24QRQD$>U 'I%M?6]W&'
MBD4\9//2L?6_$'V/:EHZM)GYN,XKBA)(G =E^AI/G<_Q,?SH Z.'Q==;@)$#
M?0 5UMG.;FTCF*%"XSM/:N.T/09+B59IU*QCD ]Z[=5"*%48 H Y?QA_J8_K
M7'UV'C#_ %,?UKCZ /2]'_Y!L7TJ]5'1_P#D&Q?2KU '*>,B?W [8_K7)H=K
M@GL:]#US31J-D54?O%Y4UY_-;RV\A21""/:@#T+2+VVGL8EC==RJ,CTJ+5M9
MM[2VD59 9B, "O/U=U^Z[#Z&K5I8W6H3!$5F)[F@"J[;W9O4YKI?!_\ Q\25
MA:A9/87;0/\ > !K6\*7"QZCY;'&\&@#MIO]2_\ NFO,;[_C^F_WC7ITW^I?
M_=->8WW_ !_3?[QH =I]XUC>1SK_  G)'K7H5CJ=M>Q*R2#=CD9KSZQL7OG=
M(_O@9 ]:BDCGM9"C;T(]": .]U;6;>SMG42 RD8"UY\[EW+'J3069SR2Q]SF
MK^F:1/J$R@(1'W)% &WX0M&!DN2./NBNMJO9VD=E;+#&. /SJQ0!@^*;/[1I
M_FJO,6237"J2K@CJ#7JD\2SP/&PR&%>9WUNUK>21,,8- #+JY>ZF,CG)-=!X
M2LM]P]RR_*ORYKFE!9@HZDXKT;0K06FF1#&&89;ZT :5%%% !1110 R;_4O_
M +IKS&^_X_IO]XUZ=-_J7_W37F-]_P ?TW^\: -#PU_R%H_J*]!KS[PU_P A
M:/ZBO0: "BBB@ HHHH YCQI_QZVO^^?Y5QR_?7ZUV/C3_CUM?]\_RKCE^^OU
MH ]+TG_D&0_[M<)KQ/\ ;=WG_GH<5W>D_P#(,A_W:Y_Q-H\C2F[A7.?O >M
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MTHXUBC5$&% P*S?$7_(&E^HH \[KNO"?_(,?_>KA:[KPG_R#'_WJ -^JU_\
M\>4O^[5FJU__ ,>4O^[0!YC)_K7_ -XUTW@[_72_Y[5S,G^M?_>-=-X._P!=
M+_GM0!V-<7XO_P"/Y/\ =%=I7%^+_P#C^3_=% &#9?\ 'Y%_O5Z?%_J4_P!T
M5YA9?\?D7^]7I\7^I3_=% %#7?\ D%2UYQ7H^N_\@J6O.* .W\'_ /(,E_ZZ
M5T5<[X/_ .09+_UTKHJ *5SJ]C:3&*>X5) ,D&F1ZYITKA$ND+'H*Y#Q5_R'
M)/\ <6J.E_\ (0B^M 'IM%(.@I: "BBB@ HHHH **** "BBB@ HHHH ****
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M.:".XB,<J[D/450_X1[2_P#GT7\S6G10!!:V=O91F.WC"*3D@5/110 4444
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MJEB<DYK2HH HV^CV%K*)(;=4<="*O444 %%%% !1110!6N["VOE5;F(2!3D
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MBTTVTLB3;PA">N*MT4 %5+K3+.]</<0AV QDU;HH S4T'3$<,MJH8=#FM$
M #H*6B@".:".XB,<J[D/450_X1[2_P#GT7\S6G10!!:65O91F.WC"*3D@5/1
M10!1N=(L;R8S3VZO(1@DTR/0M-BD#I;*&'0UHT4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ",H92I[C%84OA2RFE:1I)<L<G!K>HH R=/\/VNG
M3^;$\A;_ &C6M110 4444 %5+_3XM1A$4Q.T'/%6Z* .>_X1"PSGS)?SJ[::
M#96C;E3>?5JU** $  &!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3C'<]<HKC?!?C:;Q8\^;%8$B(!8/FNRJ9P<':0U)25T%%%%2,**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIN?H>->&/ FK2^(;=-1L)K>)?WF9!P<$5Z%\4+M-.\)K!%A=SA H]*[S SG
MR.]>-?&#40^HV]DC9 3<WL<URPJ2KU5?H;2BJ<'8\OKZ%^&FG"P\)197#N[,
M3['FO K&V-Y?0VXZR-MKZCTNW6VTNUA48VQ*#]<"M<;*T5$B@M;D\[;+>5_[
MJ$_I7S#XBO#?Z_=W).2[]37T/XMO3I_AN[N V,+C/UKYFD;=(S'N2:G QWD/
M$/9'=_"C3A=^)S+(I,<<9(^M>\$@#)X KS'X/:=LTVYO&'+/A?IBNR\7ZE_9
MGAJ\F!PYC(3ZUCB7SUK(NE[L+GE/Q&\9RZEJ#Z=9R%;6/AL'[QZ&N!M[>:[N
M%A@0O(YP%'4TV:5IIGE8Y9V+&O4OA-X=CF>35;B/=M_U6>F>]=[Y:%/0YU>I
M(R+/X3ZU=6?GO+' V,B-U.:YJ\T_4O"FL1^>CQ2HVY6Z;@#7T[7#?%#2H+SP
MVUP4 FC88;':N6EBY2G:6S-IT4E='BNMZM)K-[]JE^^1S74?"JR-UXH\T+G[
M. Y]N:X2O7?@W:;5N[O'WUV9^AKIKM0I.QC3]Z9Z=J5ZFGZ?-=/]V-<U\TZ_
MK5UK6IRW%Q(6^8A1G@"OHCQ3:R7OAN\MX@2[)QBOF:=&CGD1@0RL0<UA@8JS
M?4UQ#>B.B\.>"-3\2(9+<".(''F..*W+WX1:S:PEX[B&X(_AC4YK+\*>/+WP
MS&T"H)+=B"5P,_G7I6E_%;1[W:MR#:L>N]L_RJZLZ\97BM"8*FUKN>'WEE<6
M%R]O<QM'(AP5:NT^&7B&73]>BL'D/D7!V\GA>]>GS^'_  SXINAJ)Q-(5QF-
M\ _A6I8>&M)TU@UO:(&'0L 2*SJ8J,H<LEJ5&BU*Z9K@Y&1T-%%%>>=(4444
M >&_%R^$WB-;56RL<:M^)%<5HMI]MU>V@'\3BK_C&\^V^)KN3=G:Y3\B:TOA
MM8B[\76SL,I&<G\J]F/[NC\CA?O3/H&VC$5K$B@ ! ,#Z5Y+\9+\?:+*S5@<
MH68>A!KUX<#'I7SW\2[P7/B^ZC!SY#%/Y5P82/-5N=%9V@<A&^R17QG!SS6_
M9Z?KGB^X1(4DF2,!<]505F:/ITFJZI;V<8/[QPI/I7TIH.BVVB:;%;01JK!1
MO;')-=N(K*GMN84J?-Z'BNJ_"_6-,TTWAECF &61%.17$$%6*D8(.#7U+K=P
M+71[F8@85#]X9%?+URVZZF;U<G]:6&K2J)\PZL%%Z'JWP>U28FYT]B3&3N7/
M; KUNO'O@W9N\]W=X^6-MI/U%>PUPXJWM78WH_ %%%%<YJ-=@D;.>B@DUX!X
M_P#%L^MZK);0R%;2(X50>OUKZ 90Z,K=",&N+U3PIX1@^>^_=YYSYE=&'G&$
MKM7,JL7)61X;I6D7FLWBVMG$TDAZX'0>M=J?A!K(MO-^U0%L9\O:<UUFF:GX
M"\,S2S6%XOG-U#,3^7%6)_BOHD0)C!EXZ!JZIUJK?N+0RC3@E[S/$=0T^XTR
M\>UN4*2(>A%=3\.-:FT[Q+! &;R9CAUS6)XFUA==UJ6]2,QJW 4FM#X?6GVO
MQA9*0=H8D_E73/6D^;L91TGH?1H.5!]12T@&% ]!2UXAWA1110!Y3\8]0 M[
M.S0_-O)?Z$5Y H!8 G )YKN?BK?+<^+'BC;<D<:\CUQS7# $G !)]J]G#QY:
M2.&J[S9[QX0\3^&M*\,65I+JUK'*B8<%N<^];C>.O# 4D:S:G'8-7S;Y,O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&=$AT+1X;6)<-MRQ]37 _"KPMY:'6+E/F/$0(Z5ZO7#BZO-+D70Z*,+*[$)
M!)Z"OF[QU>?:_%E]@Y"2%17T/JLH@TJ[E)QMB8_I7RY?W!NKZ:<_\M&+5>!C
MJY"Q#T2.D^'5E]K\7V;D9$+AS7T5T%>-?!VP#:A=WCKD"/"^QS7L4S!(78D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBMO:X>_-U(Y*FQY*D;SRA4!9V/YU[O\ #;PN^BZ8US=1[;B?!P1R*OZ%\/\
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MZ81458****S*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=1JNV)W+1_2MJ53GG*#(G'EBI(];^(.J*/!?GQ/\EP,#!Z@BO)_ -C]M\7V
M892.4,P]JGUCQ.^I^#[/3F?/V=@,?05O_![3Q+JMU=..$C&WZYI1C[*C*X-\
M\T>O:A<)8Z9-*1\J(:^7;V=I]1FF?YLR$_K7T)\0;Y;+PA>'=B1UP@]>:^>(
M();RY$4*%Y'/ %+!1M%R'7>J1HZEKUWJ5I;V>66VMUVI&/3.>:9X>N;>TURU
MENH]\0D&X&O5/!GPVAMK0W6J(&GD0@(?X<BO-_&.B/H7B">  B)F)C/M6T*L
M)MTXD2A))29]'6,D,UE#+;A1$Z@J%Z8JQ7G/PL\2"_TYM-F;]]",C)_AZ"O1
MJ\JI!PDXLZXRYE<****@H**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \9^,0D^WVA.=G./2JOPIN-+M[Z<WS1I,3^[:0@ #'/6O4?%7A>V\36'
MDS?+(GW''45Y;+\'];\X^5-;F//!9^<5Z%.I"5+DD['-*$E/F2N=3\0/&FGP
M:7-I]E*LD\GRL4Y&._(KRCPQ:_;?$MA!V>8 UZ'%\(9$TZ3=,K79'R@GY14/
MA[X9Z_I&N6EZ\EJ4BD#, _:KISI0@XQ8I1G*2;1Z=JLYTKP]/*IQY$7!_2OF
MI5:[UC Y,D^?S:OHWQ5IM]J_AVXL;-D6:9-I+' KS;1?A7K5EJ\%S=26QB1L
MMM?)K+"U(0BVWJ55BY-)'K.E6BV6F6\"'*J@KSWXNZ(9]/AU.-,M%A#CKR:]
M,1=J*OH,51UK35U;2I[-L9=2%SZXXKFIU.6:D:RC>-CY9KW3X2Z=]G\.-=,,
M222,/PKC7^$&O[SLEM=N>,O7KWAO2FT;18+.3!=!\VWIFNS%5HRA:+,:,&I7
M9PGQBOQ'86=JI^9V;</;%<O\*K 7'B9;AE!6('K[BNQ\>>"-8\3:HLUI) (%
M P';!SCFK_P^\&7?A=;IKXQ-)*1M*'.*E5(1P_*GJ-Q;J7.YKS_XH^'1J6D?
M;HES-!UP/X:] J*X@2ZMI()!E)%*M]*XZ<W"2DC:4>96/F7PYK,NA:U#=J2%
M5AO'J*^EK"\CO[&&YC8%9$!X^E>/:G\)-7EU&>2SDMQ SDH&?! KT#P/HVL:
M%IK6>IR1.JDE"C9KKQ4J<TI1>IC24HNS1U5%%%<)T!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%4K_5;+34#74ZIDX SS^56HI5FB
M61,[6&1D8IV=KA<?17GGBOXEOX=U8V4-BD^T'<S.1@UM^"_%5QXJL9+J2S6W
M16*C:Q.:T=&:CSM:$*<6['44445D6%%%% !1110 4444 %%%17%S#:Q-+/(J
M(HR2QQ0!+156PU"WU* S6SEHPVW..]6J&K %%%% !1110 4444 %%<QXR\6?
M\(K8+.L"SR,>$8XKG_"_Q+NO$>L+8?V9'&"I8L')QBM8T9RCSI:$.<4['H]%
M%174QM[:24#.P9Q619+17(MXRD#D?9$X./O&NATS4$U&U$RC![CTH NT45S.
MH>*9+*\D@%LK!#C):@#IJ*H:3J!U*S\]D"'., U?H **** "BBB@ HHJA?:Q
M8Z>RK<3J&8X"@Y/Y4TF]@+]%("&4$=",TM( HHHH **** "BBB@ HHHH ***
M* "BBO./$_Q/?0-7:RAL(YPHY9G(YJX4Y3=HDRDHJ[/1Z*YKP;XFN/%&F->R
MVBVZ[BHVMG.*Z6E*+B[,:::N@HJEJU^=-L&N50.5(&":Q;'Q5)=W20FV5=QZ
M[JD9T]%%5-0U"'3[=I9&&>P]: +=%<@?&<F["VBGGCYC6_I=]<7T/FS6XB4]
M.>M &A117F/B#XKR:/K5S81:=',('*%RY&:NG3E4=HDRDH[GIU%8?A779O$.
MD"]FME@); 56SQ7-^,/B.WAC6/L$5E'<$(K%BY'6G&E*4N1;@YI*[/0**Y3P
M7XMG\56\TTMFENJ8V[6)S4/C?QP?"36Z1VJ7#S G#-C&#1[*7/R=0YUR\QV-
M%<-X,\>W'BJ_>!]/2"-5)+JY/-=S2G"4':0XR4E=!1114#"BBB@ HHHH ***
M* "BBJE_J5IIENT]W,L:*,\GFA*^P%NBO--3^+UC;R,MC;_: .[Y6LR/XTS%
M\/I42KZB0UNL-5:O8S=6"ZGKU%<GX<\>Z7KY$0?RKC^XW _,UUE92A*+M(M-
M-704445(PHHHH **9-)Y4$DG]Q2WY"O*;OXQ3P7TD$6EQ.JMM5C(>:TITIU/
MA)E-1W/6:*H:+?R:GI%M>RQ")ID#E <XK@->^*\FD:M-91:=',L9P6+D40I3
MF^6(.:2NSTZBL+PGKLWB+1$U":V6W+.RA%;/2MVHE%Q=F-.ZN%%%%(84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=W.A*R"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7:?!S3U6SO+QU^8N-A]L<UI4:C0NE:Y$4W4U-KXJ7XM/"I16'F22 ;?:O*O
M%E]L\66AQD1.'-=;\9+W_2[.T5L@Q[B/<&H?@]8A]4N+MESB/:/KFHI^YAVR
MI>]5L>S]!@4445YIU&-XI_Y <G^\M>?UZ!XI_P"0')_O+7&Z3&LFHQ*PR,T
M7]/\.RW5F\\@*_+E!ZUD9DM+G@E71J]25550J@ #M7%^*=,\B874:X1^#]:
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MS/XT+W,-Z@_>JGK-%%%>:=04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7_CTA_ZYK_*I:BM?^/2'_KFO\JEK![FRV"BBBD,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_KB_P#2OJ[6-7M-#TV:^O) D42ECD]?I7R/\)K^WTSQQ'>7,@2**WD8DGT
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MN:_RJ6L'N;+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZN@=6!5AD'U% 'RE\;?#%KH/B@7%G$(HKGG8HP <<UW/[-?_ "#-=_Z[1_\
MH-<M\?M9@OO$T-C$ZLUL,MCW%=3^S7_R#-=_Z[1_^@T >[4444 %>9_%O_F#
M?]=C_2O3*\S^+?\ S!O^NQ_I71A/XR,,3_"9Z/:_\>D/_7-?Y5+45K_QZ0_]
M<U_E4M8/<V6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0LN6/OFO4:  !@# HH *\N^.T;R^!)5C1G.Y>%&>]>HTR2*.5=LD:NOHPR*
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M]ZQ;C4("ORCDUHJL?Y$<=2<D[*3,.R\3>-3+_H^F[V]/+_\ KUJ?\)+\1/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAX,F$\M]*J+'N;(5>@XKFM+\/W>JQ/)%A549!(ZUT?@J&2V:^BE4JZ'!!^E
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M****DT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLO7]8CT32)KQ\%D7*KG
M[QI2:BKL3:2NS4HK&\/^(K37[,30, _\29Y%;-$9*2N@335T%%%%,84444 %
M%%% !1110 445!+*$'6@"4N!49F4=ZRKG40F>:RYM8 /WJ .G^T+ZT?:%]:Y
M ZS_ +5)_;/^U0!V'VA?6D^T+ZUR']L_[5']L_[5 '1W<JLAYKCM63)-6GU?
M</O5EW=V) >: ,27*/D$@CH172:=XU:"V\F^MA<J!A>!_6N;N&R2:SY),<T
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ME:Y%&AS72>'[8RW:# QGG(K(A@YZ5TV@2QVD^Z0<5TQ@['+.2N=O;J(8L<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 56OK*+4+.2VF7*.I'TJS7G/C+Q_<:1J1L;%$
M9DX<MZUG5J1IQO/8BI.,(WD7?#?@0:'KLMVS!X<?N\]12_$@:G+8V<.FB7<T
MI#^6,\8[URMM\5M33 FMX2OJ <U8O_BC)<6#1P1F.<CAATKB]M0]FX1=CE]I
M2Y'&+L;/@+P=/I;MJ%_CSFY4>E>@UYYX4\?P36J1:E*1<$XSGBO0E8,H8=",
MBNG#>SY+0-Z/)RVB+11170;!1110 4A8"FNV!6?<WHCSS0!?,H'>D\Y?6N=E
MU8 _>JN=9']Z@#J?.7UH,JGO7*_VR/[U']LC^]0!TDH21"I/45R5[IZVMTSA
M<J>]6?[9']ZF2:G'(,/@TT[$3@I(Y2Z!>]VKW-3+&$;:S%?<5+J4D$3F9  :
MS6U$21ECVK2]SC<)19O6EVMN?]<6]C4FH:\/(*(HR1UKEX[Z-5+'FLZ?4O,D
M.#Q5TX)O4ISDEH6I(_M%P6/.3UITL4<8"A0<56@O1CFFW5X!T/6NV%F[').Z
M5SH_"]FKS/(0#[5T=SIL,RE9$5AZ&N9\&7A^U&/.<UV-S($;GK7-B$U4-:37
M)<YN3P[I^\L(A],5*BI:1A(DZ5H2,&YSBJDIP,CFL_:3>C9HX1W1%]IE,BG?
M@=\FK <NVXO63,X+=<8JRDP\G"\FI)1HB5=PYZ4R\N#MRO(JF$DD3&<9]*6;
M*1A<YI)#FVHD*SDGFE:7/%56<AN>*3S!FJL9J1>3:!\QK(\1/_Q+6P>U6S(
M,D\"N4\0ZJ)6%O"^1WP:TI1<IJP[Z7*E@3^M;,59-BN%%7V=E8!0:]1HXV]2
MS+#*W*-4MND@^^<TL18H,]:G7CK639K%('1B.*1-P'S4[SEZ9HR34:FMD1)=
M>1=*_H:[5'6_LDEB.>*XF2W5CDUI:3JCZ>_E]8^XKEQ=#VL/=W1UX+$NA._0
M9?Z;.;DM@X)I;72)I' / KI!?Z?>#)E5#Z$TKZAI]I&2)58^@->,J%5/EL?4
M_P!L0]GN26D(T^R=V8# XKC;B66YO'<1LP)["NBA:769#DE;<=AWJQ)-:Z>/
M*BA7=ZXKLIU(X16EJV>+4IU,?.\=CD7@?J8V7ZBJ;2%&Q7<17$4N1<11D'VK
M%UW1XEB-S;?=[BNJACH5'RO0Y<3EU2BK[HYYW#BH8WV2#ZTS)%-+<UWG%8]!
MTZ18]/$@QG%<QJ6HM]J8NYP#TK6T>4W.DLB'+BN7U6.43D.I'-?-8Z3=9W/M
M>'Z-/V9MZ5K89O+DX'8UIZW$MQIPD7G'>N/MH9'DC"*>HKK-2N5M-&$;'DBE
MA)255<I6=T*4:=T<F91!]:KRW+,?2JLUQN<G-0/<$\5].HGQ#9H0,T]PJ9ZF
MNN\^/3K1<X9R*X&.9XV#@X(KI]'E_M!"TYSLZ43E&$>:6QE*E.JU&&Y?B!FN
M%N54KW-2WNHL>-V,5:@EC:W8*H&*YF_9VN2,\9KQ,7B?;2TV/J\BRZ.';53X
MCI-,NSLW%LU-J5E'?(LBCYO:L"R=U7 SBM"756L;7(P6]ZYXTW-\J.O&5EAI
M^TBR_:6<5G'N?C'K69J<4VJSD0(=@Z$TNGWDNJN6F;$8["M&2[6W&V/"CVKI
MBOJTN[/)G.ICWJ]#D;C1+R!P=F?I4$H>(8D4@^]=2+X>=N,A)/;--U.V@N[4
MRA0& SQ732QCE*TT<V)R^5*/-%W.57[N0*8<]34C2[25"XQ32X<<C%=YY7.B
M'S 3@4!N*B:-E?(Z4FX XIV'<<^#59XEZC@U.:KNQ!JHD2&JQ<[3VJ.Y)4<4
MB2 2X-23D;>:OJ3T(X7WI@U6D!67BI8N#P:25AO&:9([;O4'O08CBI5 *9%2
MK@BBXBO"P23:U6W*E,5%)"&&X=:: Q3Z4 211$<K4DL6]?>HXI"$J4R\9I 5
MW+"/:PJN,'CO5V7#)FJ XDYH&CL/ FM-INJ+$S81SBO<UG0PB3/!&:^7XKDP
M7*R)P5.:]A\-^(9M2TI V<J,5Y^*I:\R.^C52C9G:3:FD=8EWJDTDN%.!55]
M\C<M2-'M3)/-<RBD9SK2D+/>2E.7-44NI58LI)J212\9S4EE"&B.1UJM##F<
MF1-J,SC&X\4D5Z7<"3FK,.D/+-A>A-;$?AN+"ENO>DY)&T:-66HS0]_VEBHQ
M'BNCJ"VM8[6,(@J>L3T(JRL%%%% PHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/;_ ,"7-YXNDU.22-[:
M27?L*G.*[^8E89&'4*2*\5U7Q=X@M-8N5A<B,/\ *#'GBN7%2@DN='/7E!)<
MQZ=<>#=%N!AK55_W0!7 ^.?!5MIL%O+I5O.[LY$G.0!BLV+XD>)8^'9"O_7&
MKD?Q.U%B!<VZ2#_<%<U2MAZD;6M\C&=2C-6M8L:=\,IKNQAN5N5BE/.&SQ7I
M^EV]Q::=%!<R+)*@P64<&N:U[QLGA^*S+6AD,ZABJD#&1FNBT;4AJ^EPWHB,
M0D&=A.<5TT(TH2<8;F]*-.+M'<OT445U&X444C=* *=W)M0UR6J7Q4D UT>I
M/A#7"ZI(=YH IS7K%CS4!NV]:NZ!90:EJ@@N 2A&< XK4\4>&8=-B6XLE;R^
MC G./>@#G?M;^M'VM_6NB\-Z#8ZEIDD]RCEU)QAL4[0= L+^VNGG1RT9;;AL
M=,T <W]K?UH^UOZU:TG1IM4OS%&"(U;YF]JV/$.G:'H]OY:)(]R1Q^\Z4 <A
M?W99=I-9$D[ 8S@5VNA^$AJ:?;M0?R[1?X>A(^M7$TCP%=WR627+M<.VQ4\T
M\FJ1E*-W<\SGO2%VJ:H&Y8-UKJ?&'@Z3P_<QM',LD,S84#JM=)8^ M TS24O
M?$4S!GP05<KC-;QDHHQ<&W8\Z^UE0.<4]K@NO7-=GXN\"V,6DQ:QH+LUMCYD
M+$EO?->?J_RUM2E?5&%:#6C.G\,:D+'44=OND\UZJ42\A21><CBO#;:0J<BO
M2/!^O,X^S3MP.A-:XFDY1YT84*B3Y&:UU"T9.<UGY< \9KI;C9,O !K,DM"O
MS 5P'2URG/W,+RGA2*NV=LWEXVU=V*,EEJ(NRO\ +PM,ERBM2RD9"8(Q[UGW
M)4.0#FK-Q,S( M9[$D\TT0W<B9 S<FH2H4U.QYJC>7L-JA,C &C=V0XPNM2.
M_N5AM7+-CBN*CB$MRS]<FK-_?27]P0I_=YJ2VMR!Q7I8>ER*[W,JL^B+MK&!
MC%::(H&2*RHXFCD!YK709CK69C >C G J8C<N*@0!.M3@UBSHBNY&MN V[-3
M< <5%-)L7BD1]RU+NS1)(59 7Q3BH+<55:!_,R#@5MZ'8">XW/RJ\FIG)0CS
M,J$7*7*D+9:#<7:^9]Q?4BK?_"-*QPTP)K2O]1C@3RHR% XXK!N-8,8Q&YW'
MWKQZF/J-^[H?0X;)5.-Y'20VIT^Q\N+YC7)ZW=R12EG.&K6T[69 %$W(-0^)
M-(-_$MQ$,>M<524F^9[GKX*E'#5%">QS]GJ,C-EG./K746S"\TZ13_=S7,V>
MCS @8./6NE^73=*<E@&(P*5%RE-);FN:RHJD['#3D17;H>QJ&0\\47#^9.SG
MJ3FHB:^J6Q\$]S2TG59-.N W)0]172M>:7JH&71'/9JX<TW>5.02/H:Y<1A*
M=?66YUX;&5<._<9W6W3].3S&F0XZ#-<KK>L&_F(3(C'05E27#G@NQ^IJI)*<
MX%+#8*%%WW9>+Q]7$_$6$4ROM'4U:;3"%W;Q]*ATP_.216@C?O?F)(/%>E&-
MT>+6K.$DD9A4 [>]:FB3O;2F.12%;H:G.D;#]H!&.N*IRO*_( R#Q@5$Z2J1
M<67'%.G-.)U$,RQ,58\-TJY%X<DU"42*,1GO2^&M)2]M8YKK.1@UVL9BC0)'
MP%&*\JM2I1?+'H>K0QV(NYR>YCV^@VEG'M(W-WKE?%NCRE@UHC%>^*[N90[?
M>Y/O56:6*W^60!L^M%.7LWS)&-2I.JWS,X/28IK>S*E"&I9S(5);.:[C]RZY
M6-.?0"LNZ2(L5VJ/PJ9KGES'1A\;]7C:QP[2.LHZ]:WK.;-LV\C&.]3G2HIY
MN1BJNK6DUC9MY:%@1U%2J5Y)(ZZ^9PJTCD[^Z NW"XQGM4 N"3BH91EV9N#4
M<:DL2#7M**2/F7-MFDA$B^XJK.C?>7M1$[J]66PU0]&;1=T51+E<'@TU^E.G
MC./E'-1(YVX8=*I>0[]R&6(,0RGFGD%DP?2E<AD.WJ*C@E#9!/(JB;%9]T3C
MTS4\T8>,..M170/:GPRJ8-I/.*;$AUM(&&VI=K(<CI5"-_*G]B:TPP8 TGHP
MM<=$^>#3F3;DCH:C8 $$4_?N6D%B.)L28/>B8X?V-12Y5@12YWD9JB28 A?4
M&JDZXEXJZ-NRJ,SYDVTD,K\[SFNR\&:V+>X^RMT8\5R:*&)!J33Y#:ZE')G@
M-6=6/-&QI%GN 8!=YZ4(XF^E9\%TL^FQN#U6KUH L6:\QJP=;#;PK'%@=ZLV
MH$=J&]>E9MPXEO%3/&:WOLZ^5&O:E+1&E%<TKFII<(6W#GJ:T*BMU"PJ!Z5+
M6)Z2V"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5 ]G;2#YX(SG_ &!4DTJP023-]V-2Q^@&
M:\MU?XJ.Y,6F6XVGI(<AORK*K6A37OF=2I&"]X[Z[TC1@I:XBA4 <Y(%<=J%
MSX,CO$@2W$LY;&!G%<@(O%/BJ7#&9E8\>9\H_/%=1H?POEBGCN=0N2KH<[$P
MP-<?M)57[D-/,YN>51^Y$Z_4?"VF:Y'!)<PY*HNSGH,5L6-G%86<=M",1H,
M5-&@CC5!T4 "G5WJ$4[I:G6HI.X4445104C=*6D;I0!BZG]QJX34_OFN\U,?
M(:X34U^=J )O"/\ R'%_W:[JXGM[VXFTJ?!+)GGTKA?"/_(<7_=J_P")+Y]/
M\4Q7"'[J@D>M &WH%D^G6=U;R+MPS%1[9XJ#P=MEM[Q<\%F'ZFMR*XBO=--U
M'@[TP2/6N7\$.5LM1*GE2Y'YF@3>MCI+.RMK&V>UMG438/(ZYKR?7)9HM;EM
M[IV:3S-I8]Z=IWBJYLO$0NKB0ON<JQ)]3BNE^(.B+JNF1:S8$,R+G([CKFFD
M1*5UH/\ %US+I_@2R6U./, 1B/3%>>Z3X7US5U%YIT8?8W#E\$&O0-%NK#Q?
MX0CTR6=4N(EV+N(!SCJ,UGZ5X0\9Z7.+>UOEM[(N<LD@)QZXQ5QT(:YG<YCQ
M-I/BJ%4OM94%4 "D.#C'3BJZ:IX@\73PZ8\C3*, 87 45WWQ%OK=M%M=/%R)
M[J0[/D(8YXSG'2MGPYX:/A_03]CBCDOY$R6<XR<<<U?/[MV3R7E9,PO%=Q'X
M7\!6^D>:);D*$Z]1SD_K7C<)(.#7>>*/"'BV[:74]2\AD3)P)@=H]JX%!MR2
M>M=%%*VYSUV[[&C;?,^.U=1I\3PJ)$.*YK3T#R*#TKL+?"Q *N1BNYO2QP):
MW'MJ]_"X*RG K5M/%,8B NC\WKBL.4%@>*R[I!TK)T83W1K&K*)W:ZY87 PL
MHR?6I_-M_+W%U_.O*9E=#E"01Z5$VI:CY?EK.X%8RP?\K-HUX]4>IB[MB2 Z
M_G5.XO;6,G,BC\:\I:YU*+)6X?FJPDOIG_>2N?K2^IR[FGM8-'?ZEXBLX<JC
MY;VKD;JZFU&XWLQVYX%1169;!;DUHPVP3H*Z:>'C#4YYUFU9!:P].*UH(L#I
M45O%@CBM*-!Q6LF8K4019[5808&*3(4=*()!)GVK)LUC&S(V@D>0?-A:LJNW
M I=U,W'=4-MFT8I$C ,,$4U=@X%-D;"U31WWD8-38NZ1=+5T^@H/L+LOWC7*
MKP*VM#U%+=S%*<*U<V*BY4FHG3A9J-52D1:LFU\N3FN>N68ME:[J]LDN^@!!
MZ$5E2^'W4\)D>M>!KL?<X7%TU%79FZ:9950$=ZZRXNX;.Q07)^4BJUIIJVL8
M>0A0O-<_XAU);J7RXS\B\5TX:BZLK/8\C-<=%?!N:$OB+3H%(A7<WTKGK[59
M+TG<W'85E2'TJ-9=C9(KV:.$ITM8H^<K8FI6^-DD@P<U 6Q3Y+@2' J)JZ48
M#NV:B<TTDXQ49:F CFJS, >:D=NU59FIH3-*SG$<@S]TUL":)2K;<^]<E#.Q
MX]*T(]2:)-K(&^M:Q=CEKTN;5'1MJ7FCR^0*DTRW6:^1'Z$U@VE^L\A!4+^-
M;6E3;=11NM%1VB['/"+4TI'ID$:6\"HF  .E-%TRO@55BN5DP6X-3&)).5;F
MO%OKJ>J]=BQG>P8G!K)UB="^S=5J:46T1RV36/*R3DN?SH$U9#;2]G@;85++
MV-2WXD=1*G6H!<+ X!(*FK,LRF(X(Y%48VNK&4NISPGE<U<AUH3?NY(L@\'(
MK--O+))E2,9]:U+2%47)4;J395.+*MQX8M=2<R1?NR>O%<_J_A6?2H_.1M\=
M>@0Y5?EIFKE&T:8S -@<5O2KS32)J4HGDJL0W-6E<8S5-I!YSXZ9XJ2-O?->
MA)'/%D[.=V>H]*CD ()Q4$KG/RG\*G5BT0W"IM8I-MD7EJ1G%5S:?/N6KNW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>M>/.#A*S/134XWB-F7S8OF.:J*(U0J<8J^J!1@D$&D6&!FVXYJ YM+,YZ>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2;I8B1)Y9VX]<5V22:=SJEMJ92Z3X=TA-Q2$ ?W\-5&[\:^&; $1- SC^%4
M_I7G$?A+Q+J4Y.UR,\EI,5M6OPIO)ES<W7EMZ  UP*K5?\.%CD52H_@C8Z+2
MOB/;:IK<%A%:-&DAQOW#%=WU&:\6ATQ?!'B&%M0@\^)VQ')G&*]DMY4GMTDC
M(*LH(Q6^&J3DFI[HUH3DTU/<>XR*Q=2@WJ>*W*KS0AQ74;GG5_9-N/%9#VC
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MTY*3E)ZCZ3%+176= PH#3#"#VJ:B@"O]G7TH^SKZ58HH K_9U]*/LZ^E6**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-GK3"XY+5#]H))P*B=RU4(9--N8XJN[<4H&7.:CE]* &@[A3<9.*D1"(\FF
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M-Y;>ZYKVY2&4,.A&:Z,-5=2/O;HVHU'..NZ%HHHKH-@HHHH *9)]VGTUAD4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT6>6S9DN(E+[F8D'':L?954^=:'J/'Y?4@J%1N2[M'H6B:[9:_8+=V4H93U
M/*GTK3KPGX07%U;^)KJSWL8Q'RN>,YKW:NNC4YXW9\[F6$6%KNG%W6X4445J
M< 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 07MJE[936TGW95*G\:Y6U\ :!
M8'?<HCD<@NV*[&O+/B!:ZY-K*06DD\EM(@^4#@&N?$<L5SN-S&MRI<S5SI;K
MQ'X:\/QF-/+W#H%7=^M<IJ/Q3GD?R["V$:YX8'K^%4M+^&.J7F)+V18HV[JP
M)_(U?UGX91:9I;W=K?3231\[64 5R2EB91O%61SRE6:NE9'H?AW47U71+>[D
M!#NN2",5J5YW\-]=O[L2V-X6<1\(S=J]$KNHSYX)G52ES03"BBBM30*@N;.W
MO(S'/$KJ?45/2-D*2.N.*'J!B-:Z'X?1K@I%#CW!/Y5Q?B+XF0R12VFG1;U<
M%=YX_2N6\6SW^I^+I[.:4X\[9&K' 7.*[CP_\,[*U5)]183R=3&<%?SKSG4J
M56X4E9(XN><VXTU9'DK^>TQ9PZ>8<Y.1FO7O!G@K^S!%J$ETSLX#!!T%:7B#
MPQH5Q!"UTT=M' <X&/F&.G-6_#VOZ3?L]AIS'%NH&",9[<44<,J=3WWZ#I45
M"?O'04445Z)V!1110 4444 (QP*HW-R(P>:LS-A37-:K=[0W- $6HZF#&ZYZ
MBO)M;N=MU)NZ$UUUY=LS'FN-UFQN;R8BWADE;N$4DUK1E9F-:/-$Q)[L[<9J
M!KH*F0>:DNM(U*"+S)+&Y1!U9HR *H003W<ODP1/+)V5!D_E7<IG$X%@7F>]
M*+OWJ,Z'K ;_ )!EY_WY;_"H)[.[L_\ CZMYH">GF(5S^=4JA+IEO[5[TANS
M6;YO%6GL;U+7[0]K.(?^>AC.W\ZKVC)]F2&\.>M.%Z0>M9P#2.%12S'H .M7
M'T?58XR[Z==*@&2QB8"CV@>S1=BO#NZUHPS@CK7+QRD'K6I:S$XJXR)<3=,O
M&:4.'&:JH^4J1,"K"]BR&Q5JPLFO[M8AT/6J 8&NF\)(OG22'DKTKGKS]G!R
M.FA#VDE$Z&.VMM'MQLC!<#DU1EUFXDD^1@J@^M.U2X>1& [5RMQ,Y;&:^:JS
ME)\S9][EV IJGJCM[?4$G0), V:SKW3&:YS ,J:R]/N=NU2<DUU37(M;'>WI
M6M'$RHNZ/.S+*X2DDMV8L>@HLN^XEV^U33^'K69<PS?-V&*S9-4-S*Y'04RW
MU*03C)QS5/'UW*Z8UPY2Y+-:F?J.EW%FQ$JG;V(K,#$G;TKT8O%J%F891DD<
M&N&O[,07+Q'CG@U[6"QBKJTMT?)YA@)86?D4)CG Q4;-L^5NAJR8@@RV#^-5
M)L[@,_2O03/-:"0* "*A+Y/R]:G()7:34>T*WS&FA#>9!AASZTW&TXIXQD_/
MQ02 >>:8%NQL3<$ESP.E3&!;<L2.>U3:1*K/Y+MMSTK5GT=YC@'<>QKYK-:M
M95;/8^]X96$5&[MS=>YAP3'?R.*T+K3HY[(S 8<#TJ];Z"T;#S2*35K^&RA^
MS1;78CDYZ5RX#VKJKD.[/\5A98=J6IRRJ4RO>D/EYP3S]*%W>8SL>#VIH(\W
MY5KZ\_--!8E^]Z5*F7C(4]*01,7X.%-3 >4N$P32;&A 6V;2.G>GA1LSGI3-
MS8^9<DTY%"-\^1GL!4LI$]M>/!*'C)4BNFMM:MI@JW?#>N*YF11'@JN:DA@#
MCS&_*N3$8>G67OHZ\-BJN'E>FSK)-0LT&Z#G';%4I=2>Z!+C:H[5F0QL#P?E
MJ.^N5MH"F!N-<U+!TJ3]U:G55QM>OI-Z&7J-QYUR<=!5(D"FO)R3ZTP'=76E
M8RN2YII--)P*8'IV%<DS36/%-9ZB:2BP7'LVT<FF;LBHV8M2;L<46"X\M4UG
M<^5.N[D9JH33"^WD4T)ZG:K=0O& RY!% ,$"EH^M<K!JLT8 8Y4>M7(=1$K;
M3QFMU-,XI49+4NSWYN+@1MTK,UB^\O$49[58$;K-YF,BL;5$+7.X&G)V1--7
M>I4$AW<U.'^7!Z56 PW-/W[C@=JR-_0E,&\96H1D'!JW"Y5>:J.V9":147=#
ML @TS@&DZT&F4+C)I2.**7.>*:$QO:G(,FEQZ4^):9(]/>I  *B9&J4+D"@0
MN#@U"8C@Y-6#(  HZTU\XI,:W.R\ .8Q(3TKT6V5;F8L>@KA/!L!2VWE>#7>
M63IRB]2*\VL_>9HE>6IH#J<?='2M/2 22W:L=F,2 'IBM'1;@-(5!KG>QU4_
MB1OT445!U!1110 4R65(8FDD.%49)I]5M1LQJ&GSVAD:,2KMWJ.10QQM=7V/
MGWQ#J.DW'Q 2_$S2V8<+)E<8(SG]:]\TO4+*]L87M9XW0H, ,,]*\>UOX-:A
M&\DNFW(GR2W[U@M<H+3Q9X4G_<BYAVGEHE)'YXK@C.=*3<H[GUM?#8;'TH1H
MU=8JVI]-U!>6PO+.:W8X$B%2?K7COA'XG:W=ZI#IMS;+.SG#.['</PKVFNNG
M4C45T?.XO!U<'44:F_0Y7PSX'LO#5]-=P.7DE&"2*ZJBBJC%15D85:TZTN>H
M[L****HR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;L:?RL;)"?NX[U4^#TR)X:OFX8QJ6*_3)JWX,\>2^+]:N]*N[:/[,0WE@*.
M!SFIG=R;:V*A9123W/#]6N+2XUBZFL(S':/(3$A&,"G6K\U?\<:='I?C#4;>
M$!81,=B@=!63;MR*[*;NE8XZBL;\+Y7%3J>.M4(&X%3[V4CTKI,"TK8ZUT'A
MK4([:Z,<APK]ZYK.1FE60J00<$=*SJTU4BXLVI5'3DI(])OK9I(28^0?2N8E
ML)_,/RFK.B>*4@C$%YDKT#&MHZMI#'?]IC'MFOG:^$JPE9*Y]G@,[A&'O&?I
MVFN9$=UQBM75?GM_+Z'%9=_XHM8DVVGS-Z@U9L;M-:M<[P)E[5E/"U8PYY(:
MS6G6Q"39SDG^AE@3R:ACG.[=6W?:/),>GSBF6VA2*1O'X5R<S/I%B:7)=O4U
MM%D\Q5W"L/7]AOVQS72!8M,LR[8W8XKC+N4W%RTC'J>*]K*J<N9S9\%G^(A.
M:C$IL2S[,5!(A#893^%7Q 68-G%03*Z,26!%>ZGJ?-M$'&S&&S22(P"L5R/>
MG!OFX'XU(49TP&%5>Q-BL8T+94XS2^6!WS3A&4.6P1[4\*&&5(HN%B-5((*'
M::U(-8O+:/:KAOJ:S0K#.5X]:1MS=.O:HG3C-6DKEPJ3IN\78T9=9OI@=TF,
M^AJ@T9D8NTF2>^:7?L3$F,U'YBD\ \T0IQA\*L%2<Y_$[C@(NF233E!_Y9K3
M#$.JG-/4[5."2WI5D#_NC+&HP<G/-*)5VX926J7!V @"D%@C7)&<U/MR<X)Q
M34''J?:I>2-N& K-LT2'1H7.3VJ6/A^O%,A8 GJ:LPKN&6&!6<F:11+O1$+=
M,5S.H71N9SCH*NZK> 9BC;ZXK-LHC/=QIURW-2K)7-XQZ%_3-"N-0PV-J=R:
MZ,>&-.AB EF.[VQ6A(Z6-BD287Y><5S[WYWL68D?6O$GC:M6KR0=D?3X;**:
MP[K5-;*Y'?>'H(_FCFROUK&FL BDQG.*UC+<7&=BDBHVS!%\Z_,>N:^AI4K1
MM)W9\?6Q#YVXJR,:WLVED^?*K6@FB1SJ3')T]:<W[Z/]W^E+;7T%HC))(-WU
MK3D21G[:<GH8EW UK*48=.]5"1UJUJM^MS+\G0=ZSMW:L6E<ZX-M:DA?-1DY
M-.[4P]*10K'BF*Y0Y!IHRQH-,1H1:I*HVL>*CDDCF));!JB>E,YS3NR'%%H0
M@MG=4B11QG<Q%4]Q'>D+$]S0*Q8GNAC8@P*K9SUHQS10/T'#I0,YIM.%,0X#
M)I>](#S4JC-,0HZ5*G IH%21IZTQ"YSQBG=\4;L/C%/[T"!(@?F/6D8<C'K4
M@.&JW8P+/>1H>A-3)V145J=_X;98M*3]W^E:R3".99!P*N:;I:+IR(B]JBDT
MR1)1D';7EMILJ<9+4TTE2\C%6+%!9W.X=#66&$   Q5J&665U &0:AHUA5MO
MN=7%=QR8 /-6*R+*S99 YR*UQP*S9W0;:NPHHHI%!7G/CSXCKH#FPL%$ET1R
MW9?_ *]=[J,YMM.N)UZQH6%>!^$[*W\2?$&X;46+A9-ZJQZ\]*YZ\Y*T8[L]
M?*\-2GSUZRO&"V[D#?$'Q7#(+F1Y1&>0"3MKO/!_Q(MO$;KINKPHLS\ _P )
MKOI= TJ:W\A[& IC'W!7A'CGP_'X7\5P/8L5CDD!4 \CFL9*I1]Z]T>E0J8/
M,;TE3Y)=&CV^#PKHMMJ2:A;6,,4P!&57KFMJJ6D3O<Z5;S.,,R#-7:[8I):'
MS564W*TW>V@4444S,**SM0U[2M*=4OKZ&W9C@!SC-7XY$EC62-@RL,@CO2NM
MBG"22DUHQU%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+4<Z0<C9=91N#*<Y]:'.<8Q@51^V97 J(7#EL$_+2]H/V9J*5;C(&/2E?;C
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M"BBBJ, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(ION/HHHKK/ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#">!Y@&_C/>M80<8G%4J*<[GA7C!'3Q7J.]&7,Q(R,9K"ZUZIK;6WQ'^(/\
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M*G5<TV)U(Z5."O2DP(V4YQ4HCPG%+CO3HP\K;5%2WH%KCH+<S,!VK?M8%AC
M I-,TV58]Q4\UN0:7(X'RUQ5:EV3-2;LBE$C2.%45T6FZ<L;H\HXS4EAHWD?
MO)*O*>"OITK!LUI4K:R.HM8HEA78HZ5/@>E<W:Z@]LP5SE:WX)UG0,M8M-'I
MPG&2T)0JCH!574[Y--TZ>\D!*Q(6P.]6Z;)&DL;(ZAE88(-)FL;)J^QY?X3^
M(%SXCUR73;RR$T#.0K%1A%SQFI/$WPRTO7%DNM)E2*XR<@'()^G:NEO/"\.F
MV.H3Z#;)'?W$>%;..<YKQ2TU_P 1>#-9D\[S0"Y,B-G:W/K7%-\J4:NI]+A8
M^WJ2JX%\C5M.Y0FT_7/!>L),\3Q2H>&QD$5Z1I7QGMS:!;^U(F4<MN^]6]HW
MBGP_XYL?LM['&LY&&1^.?J:Y'Q5\(I8BUUHC!TZ^42 !4J$X+FI.Z.B>(P^)
MDJ6/ARS74SKR'4?B7XIAN8[5H[1/EW'LN:]STZT6PTZWM%.1"@0'Z5S?P^T>
M\TCPY%'?$&1@"!@?*/2NMKHHPLN9[L\3,L5[22HP^"&B"BBL'QAJTVA^&[B_
M@YDC*X'XULW979Y].FZDU".[-ZO,_C-#*_AJ-U!*B5<XJ&W^,5A)HTDLL12]
M48$8!()^M;/AK55^(/AJ9+^T"*/D)SG)QUK"4X58\D7N>I0PM? U%B*L;*+,
MGX3>(K!]&.GNZ1W"MG:>,BN\UN:Q&CW+7CQF#9\V2*\-\1?#G6M!OFGTX-);
MYRK*>1^ JA'I_B_Q 4L7$[+G #Y45C&M.$>1QU/2JY=A\15^LTZJ47J_(W/A
M5 \OC"YFA_U"2$GZ9.*]XKEO!/A&#POI@3 :ZD&9']?:NIKHH0<(69Y&:XJ.
M(Q#E#9:!1116QYH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%*16$ I?* J?%#BIY4:*3(B@ JE.=IJ^>%K/N>M9ST-(:E-VJ%JFC_X^(_\
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MH%AJM@-3@=4E8*[R*"P]>M34DI1T'"+C+4S+P_"4WUQ]H63S_,;S.&^]GFN
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MK4KL5[:GS=114VH;!1113("BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** $(!&#7G_Q)M-7FM(_L88VH&&1.N?I7H-(R*Z[6
M (/8UG5I^TBXD5(<\;'F7@7P*(]FHZE'ENJ1D=*;\6+*VB@LKA$59F8J2.I
M'%>G@!5  P!T%>1_%>\\S48+3/\ J\-CZBN6O3A2P[BCGJPC3HM(P-(UW7]%
ML0UOYK6K_=Z[1]*AL=,U7Q/K0EDCD<R.&>1AQCZUZAX#L(9_!UJMU"D@RV X
MSCFNH6UM["WD:V@2/:I.%&.U9PPCG&+E+0F.'<HIMZ&5+JVF^%M+M[:XG'[I
M0H4'FFZ;XTT?4Y?*BGV-V\P@9KQ_5I9M<\7/#/*0))]@R>%!KHM:^'-QIEE]
MMT^8NT8W$ \_A36)J-MP6B&JTVWRK1'KP(8 @Y!Z&EKS7X>^+IIY?[(OV+2
MX1F/)/I7I5=M*JJD>9'33FIQN@I&4,I5AD'@BEHK0L\L\5>$]0TS5#JVB[AN
M.YE3KFH=#UO7+W419ZQ93W%I, CJZD@>]>LTQ88U;<J*#ZXKE>&M+FB[>1@Z
M'O7B[''P:/I/@JVN=4.26&5!'(]A7GMYXCU[Q/J;1V<LJHQ^6-#P*Z7XL74H
M2T@4D(6.?0\5L_#C1+>TT.._VAIINK'M6$XN=7V,-$C&2<I^SCHD<2;KQ1X3
MECGN)96@)Y!/RUZIX:UZ+Q!I:W*8#CAU]#47B_2)M9T&2UMPGF[@PW#TK ^'
M&D7^DPW27D3Q@/@!AUXZUI3C.E5Y%K%EPC*G4Y5JCO:*I-J^GI+Y;7<0?.-I
M/-7%8,H93D'H:[$T]CINF+1113&%%%% &-K.B1:C$2% ?L:\WU?0)K>4AE.!
MWKV&JEY80WD95T!)[UM3K.!C5HJ9X1<V1"GC.*R)+<ANE>JZWX6DA#/$,K[5
MQESI^ 0RD,*]&E631YM2BXLYDQ8/(J1(@3R*N2Q<D=Q4.7C/W:WO<QL-$&UL
M=0:8UNP/'2ITD+-\PJPA#\ 5-VBK&=Y8Z=ZC> @]*UVL&+9J-HF4[2O2CG#E
M,:6U<KD#BLZ:T=<DUT[GY-NVJQC613O%3)W-(Z'(2P&JS18-=+/:)DX-49;-
M<=.:RY6;*9C^6?2I0AC7.*U(+$L>1P*6:T8-PN12Y6#F8S#S.HQ43(0:V?LN
M>2,5 ]L"3BJ4&1SF0X-5WC)K6>VP#Q521-G6IE U@[[&:T= B8] :Z72M#;4
M%,@'RBMF/P_''@&/]*Y9-)FW,EH<,L$G9#^531V\V>$/Y5Z&/#T0C#8%)_8Z
M(?NBI4V#FCCHK&Y*@A#4A66(X="/PKN[6VC# ,HP*DETN"ZDPL8/X5M&NT8\
MR>YP/FCITIRL/6NIO/#*%L*N#61=>'IX1E.:VCB$]PY4UH58V'K3PWS52^>%
MRC<$5;B?(YK=2N92C8F)ST%-Q2Y'04X+D51 PC R*:FXGFI0!G%.P!3$-"4[
M8!3P.*8P8MQ3$2JHQDFI%D"K\O6HPF1\QQ4@C4=.:0AO+>M*JD'BIU7*_=JU
M!;Y()6B]@*B)N<9!JXD6U\@5;2 !L*G-6#%M7D FLW,I1(%A#88U*T((]J(@
MQ;D8%3+&\K[8P34-EI%*14QM7@U)%;2N JJ6S71:9X0NKZ97*$*>Y%>BZ3X2
ML[*(>8@9_>LIUXQ-H4)2W/(Y_#E]';K,T9"GGI4MKI\;(-RC>*]DUBQB?32@
M084<<5YZ]FL4A;&!FN5U7/<TG34-C!DL_*/(I0@7&*UY(4N>%/(J)K IUI(Y
MI^1F%/FX[TC*V[CH*T!8R-)A5))J4Z;-'U0_E5&-FRC&-J_6KT:!K1O7%.:R
MDQRA%.VM"F/7M2&GRLM:!=2VUP'SP#7IMG<BY@5QZ5Y98;E<^]=]X<E+V^TG
MI6<T=^&J75C=HHKF/&GBQ/"NF>?Y1>1N$],^]92DHJ[.^E2G6FJ<%=LZ>JFI
M:=;:K926EW&LD3C!!%8/@SQC;>*K#<"$ND'SQ_U^E=3234U=;%5*=3#U.66D
MD?.?C3P1>>%+_P"V6FYK4MN5QU7ZUW'@#XA0ZI;#2=8<>;C:KN>''O7I5_86
M^I6DEM<QK)&XP017A_B#X8ZEI^OPG2E>2"1\JRCE.>]<DJ<J4N:&Q]#0QE',
M*/L<4[26S.A\7?"A+V^2[T?;&LCC>G0#)[5Z)X=TC^Q-&@LO,+F-0"34VBV<
M]AI%M;7,QFFC3#N3G)J_71"G&+YDMSQL3C:U6"HSE=1"BBBM3A"F2RQP1F25
MU1!U9C@"G$A5+'@ 9->(^//%.HZ]XA.@Z2[B-&V,8S][W^G-9U:B@KG;@<'+
M%5.5.R6K?8]:&O:+=,;==1M79_EV"0$FO"_&N@:EX5\1/J=F72-W\Q)8_P"$
MFNG\)_"O4-/UN"^U">-D3Y\+G.?0UZ#XEU#0K>&.SU<PD2G:J/V]ZQE%U87G
MHSTJ%6G@<1RX=^TBUJ>._#_Q1HVCWMQ?:N)9;Q^5?;G!SUS1K-_)\0O&,*Z?
M"_D(P(8CIZYKNI_@_H-Y*MS#+.L<GS8#<8//%=7X>\(Z7X:C*V4>6/5VZU$:
M-1KDEL=-;,\'";Q%*[FU;79&K86JV5C#;KT10*LT45VGS#;;NPHHHH$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH!5SC+#PY:>K;*DG1C:&[9['I>JVNKV:W-K(&1AV[5>KRCQ#XA;PI%;:-I3
M-#CS3C/.<UV.@^*!=Z#'?ZBGV<%@H8_Q$UO3KQ;Y'NC6%9-\KW.FHID<B2QK
M(C!E89!%/KH-CEO&_AH^(-+'E?\ 'Q#DI[UYQIOBO7/"D;:=)%A4R K)DBO<
M*IW.EV5X<S6\;'UVC-<U7#N4N>#LS"I1;ES1=F<CX%\77NN2RP7L.6'(D48
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK)UW7[/0K)I[B0!L?*F>2:4
MI**NQ-I*[*7C#Q!%H6CR,2#-(-JKWYXS7FO@+1)M:UW[=<*6BC.XN?[W45"$
MU3QYKQ<*_D!N3V45['H^D6^C:?':6Z@!1@GN:X(IXBISOX4<B3K3YGLC0HHH
MKT#L"BBB@ HHHH 9+)Y43/@G:,X'6O!]7DOO$_BXPLC!V?8JGL!7O?4<U1&D
M6*WHNUMXUF'1@HS7/B*+JI*^AC6I.I97.*U_P#YNCVO]G )<0+GZFN,FT;Q=
M?N+2Y6[DC!P-X.VO=J*B>$A)W3L3+#QD]-#C/!O@Z/P] UU=E6N2.3_=%>>>
M,-0E\0>*3;PDG:WE(/6O;K^)Y[">*,X=T(!]Z\&>.\\->)1<7=LQ,<NX;A][
MWK#%14(1@MC+$148J*V/9M&L;?0?#<:. J(F]\^I S7D^NZYJ/BK73:6C/Y1
M;:D:].*]*\0W4UW\/[RY$91W@#!?RK@?AA#%)KLDDF/,3[N:JO[TH4HZ)CJZ
MN--;#IOAQK&GV1O(KA/-0;B$)S6KX!\874EY_9>HNSL?NLYY'M7I%]*D-C/)
M(0%$;=?I7A6B,;WQJDMOPK2AN/3(J:D%AYQ]GU%.*HSCR'L^O>(+3P]:I<78
M8J[;0%ZU%9^*])N[!;QKE(8F8J#(<<UPGQ8O?](M[+/\(?%9&@>!=2UW2//^
MU"&')V1OGKZUI/$5/:N$%<N5:?M'&*N>S6M[;7L?F6TR2IZJ<U,6 ZG&:\GO
MFN_ ?AU+99B]W<LRD]E Y&!6=INB^)]<L1J$&HS;6R0NYJKZTT^7ENQ^W=[6
MU/:J*\>T/Q+KVBZT+"_225-X1P_+ _C7KZ.'0,.A&:VHUE56AK3J*:T&301S
MH5D4$'UKF-6\(0W&YX0 U=9171&;CL5*"DM3QS4?#]U9L08R5'M6&8760AD-
M>\S6T,XQ(BGZBLB[\+V-QDB,*?:NN&*_F.2>%_E/&F@#?,5I/E^ZPKU";P-$
M<[&%8M_X(GC!>,;L>@K:.(@S!X::.&-HJG<!Q1O53M*YK5N].F@.QU*XJD+8
M@_-@UJI)F3BT,C<HZE1WKT'2I5N--0GKBN!"#?@$5U?ABX&XPLP]A65=7B73
M=F:=Q =AP,5GR^9&IV\\5OW41(V@5CZDCP63,!SBN-*^A>TCF9XYGE.Y]HSU
MJ[:):Q+F20.?<UAW,UQ(3@GK4<32*/F)KJ6&5M69^TU.@OWL6CR" ?:J]I<6
M\<942CGIDUC2_..2338[8[=QR*KZO&PU4=SJK5_O$G([5?@G7S!7/:3*[2"'
M!(]:Z2&S*29QQ7+.')*Q<I7BK#[Z3%JYZ<5P\C;Y6!YYKL-2MYWMV55)^E8$
M&A7LC?+"QS[5O0:2;9,DWL9RH-N,8IOED-78:=X+NYL-,I4>XKH[?P3:J 9.
M352KP3+CAYM'F,=M-(WRH35Z+PW?73#;$V#[5ZO;>'K&V^[$#]:T4MXHQA$4
M?A6,L5V1M'"?S,\ZTSP"Y*M.<#TKL=/\.65BHQ&"?<5LT5A.M.6[-X4H1V0U
M45!A0 *=1161J%%%% !1110 4444 %%,EECAB:21@J*,DGM7.V/CG1-2UI=,
ML[I)I""=RMQQ2<DMS2%&I--Q5TMSI:**AN+J"TC,D\JQH.I:F0DV[(FJ*3R8
M5,K[5 Y+&J-IX@TF^G\BUOX99<XVJ>:XOXO:Q=:;H<$%LQ07)*NR]0!43J*,
M7(Z</A)UJ\:+T;[EC7_BKH^D2M!!FXD'=,%:D\)?$BV\2WOV,6TJRX)SCCBO
M/O"K>#++2%N]5N%FOGSOB+\C\Q6G9_$?POH$TG]FZ/,2YR9 5_2N6-:5U*4E
M8]RIEM+DE2I4I.2Z[$OQ:\(8(UJSCZ\2A1^M7?A5XK34K%M$OV#,H^3?_$.@
M%=7H?B32O'>D30JFTLI5XG(+#WKQ/6K&]\#>,/,BRH1_,C]".PI3M"2JQV9>
M%4L50E@:^DX[&I\1/"4WAK6!J-D&%M(VX$?PGJ:],^'/B]/$.DK!.P^UPC##
M/7TK3MULO&_A)/.3*3)M8]PPQG%2>&?"&G>&(&2T0EV/+MR:UA3<9\T=F<6*
MQL*N%]C77[R+LB34O"6DZKJD-_=6ZO+$#P1P?<UM1QI#&L<:A448 ':GT5T*
M*6J/&E5G)*,G=+80@$Y(Z4M%%,@HZQ=S6.E3W%O$9947*H!G-?-&K:Q=^(?$
M(;5I61#(%*YX09KZD(!!!&0>M>0_$OX?&0/J^E1?,.98U'ZBN7%0E)71[V1X
MFC2J.%16;V9WWA?2=)T30XVL"AA*;FF_O>Y->1_%/Q/::WJ26=H0RPG#2>IK
ME[7Q;K46D'1HKAA"[ #D[A[ ^E=GH?PAN-3TU+R\NE1Y1N4'.?QK%U'5CR01
MZ-/"4\!6>)Q4[N^AU?@KQ+X?T30;>P?4(5<_.Q+< FNJO(M!\56A@>2"Y4C@
MJ<D?2O(-3^#>L6N6MIX[A>RHIS4'A[P/XM_M=+=Q=V4*GYI"2!C\#5QJ5%[D
MHG-5P>$J-XBE7L]_ZZG>#X-Z#]I,IGN,9R$R,5V^D:+8Z):+;V4*QJ.I P3]
M:GL+7[%91VYD:0H,%F.2:LUU0IQCJD>'B,97K>[4FVD%%%%6<H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML^?=KZ!1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5-2_Y!MQ_US-?-.I_\A.Y_P"NAKZ6U+_D&W'_ %S-?-.I_P#(
M3N?^NAKT\N^T>?CNA4HHHKTSSB2W_P"/F+_?'\Z],D_Y!MS_ -<F_E7F=O\
M\?,7^^/YUZ9)_P @VY_ZY-_*O-Q_QP/0P7PR/+Z***](\\*N:7_R$(OK5.KF
ME_\ (0B^M14^!EP^)'J>G]5KL-.^Z*X_3^JUV&G?=%?.'O&U'TI],CZ4^@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]T^%\J/;VS7#ZC\/_&/A#PQ+J\.MO=LZ;9+:3<V%88/4XZ5=_9SZZC_UT_\
M9: /H*O/_B)\3+3P:BV4*^=J<XPB@C]WW#,.XKOI%+QLH."1C-?(/Q1\,W6A
M>.);>XU!KIK@^:K'/R!LD#GTH ^N+"<W6G6T[8W2Q*YQZD U/D#J:\Q\&:#/
M\._"ESJFIZNUY%);K(H8M\F1D#GZUYMIZ>*?C)KMR\>J/8VEHQ4/'E0,],X/
M- 'TQD'H:*^:XM2\3_![Q9#IE]>O>V%ZX;?)D[AD+D$G@5]&6-Y'?V,-W$<Q
MRKN7Z4 6**** "BBB@"IJ7_(-N/^N9KYIU/_ )"=S_UT-?2VI?\ (-N/^N9K
MYIU/_D)W/_70UZ>7?://QW0J4445Z9YQ);_\?,7^^/YUZ9)_R#;G_KDW\J\S
MM_\ CYB_WQ_.O3)/^0;<_P#7)OY5YN/^.!Z&"^&1Y?1117I'GA5S2_\ D(1?
M6J=7-+_Y"$7UJ*GP,N'Q(]3T_JM=AIWW17'Z?U6NPT[[HKYP]XVH^E/ID?2G
MT %8^M^*]"\-F,:SJ<%D91E/-)^85L5X!^T:N^\T5,XW(PS_ ,"% 'I__"U/
M O\ T,UC_P!]'_"I;7XE>#+VZCMK;Q#9RS2MM1%8Y8_E7ANB_ DZOHUKJ'_"
M26D/VB,/Y;+ROMUKH-!^ S:9KMG?#Q):3>1*'\M4Y;'XT >^*P90RG((R#2U
MPGC_ .(47P\L;%Y;%[OSW\OY7"XP,YKE[[X_Z;!:P36>E3WA?[ZHV-GXXH ]
MCHKB/ 7Q)T[QS"_DQ&VN$^]"S9-6_&WC[3/!-FLEV?,N'&8X <%A0!UE%>.:
M7\?M/O#/]MTBXLE2(M&SMD2-V4<5T_P_^)4/CNXNHHM/>U\A<Y9PV><4 ;UE
MXT\-ZCJ9TVSU>VFO0Q4PJ3NR.W2MZO!_!>I>%)OB?+#8Z'=07_GL#.]SN4G)
MR=M=7XO^,-IX1\2#2;C39)%R TP<  'VH ]-HKQC5?V@["QU"6*VT6XNK16
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7RUXWL[2_\ C<EM?A3;2!!(&; Q
M@]Z^I:^??B)\(/%?B7QA/J>G1VAMW154O.%.1[8H [2/X8?#,Q(3!9Y*@G_2
MA_C72>%_#/A/PY-(-!%LDDG+*DX<G\,U\_?\*%\>?W;+_P "_P#ZU=?\,_A/
MXK\+^,H=3U1;86J1.IV7&XY/3B@#!^(?_):--_Z^5_\ 0J]>^*/_ "374/\
MK@:Y+Q;\,_$6L_$>SURT2V-E%,'8M-AL9STKT#QOH-[KW@V[TNR"&YEB**';
M S]: /*_@G')-X(U6./)8JV!_P "K.^!<\5OXRU>"9@LKRD*#U.":]"^$O@G
M5O!FDW%OK*P*SY_U<FX=:X?Q-\.KG_A,%U3P)K5BEV[$F/[4BE#WP.<T ;O[
M0EU;CPW#;EU\YF!5<\X!J+1_^2 Q_P#7M_0UPWQ&\(Z[IWAV'4_%.K-=ZH2
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MZA@?6O+_  O\'];O]=;6O'%Z)[J.0-&JN) _?)/&#D5[;&BQ1JB*%51@ =J
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M%?$7XJV7C/25T;PS;W-PTIQ)NA(.#7IWPI\+2^%/!5O:7('VB1C*Q[@-@@4
M=Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5-2_Y!MQ_US-?-.I_\A.Y_P"NAKZ6U+_D&W'_ %S-?-.I_P#(
M3N?^NAKT\N^T>?CNA4HHHKTSSB2W_P"/F+_?'\Z],D_Y!MS_ -<F_E7F=O\
M\?,7^^/YUZ9)_P @VY_ZY-_*O-Q_QP/0P7PR/+Z***](\\*N:7_R$(OK5.KF
ME_\ (0B^M14^!EP^)'J>G]5KL-.^Z*X_3^JUV&G?=%?.'O&U'TI],CZ4^@ K
M*U?PWHVO&,ZKIMO=F,83S5SBM6B@#E_^%<>#?^A<L/\ OW3X?A]X1MYEEB\/
MV*2(<JPCY!KI:* ,O5/#>C:U###J6G074<)S&LBY"\8XJ[;65M9V@M;>%(X
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M "(MA]&_G2Q:M22'1=YL\V^+7_(R1?[C?SKATNYQ:FU5SY;-N*CN:[CXM?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:V\&]FFD9@@W]>:['2/".CZ#\,;F]T^W,<]S8EI&+$Y)KA?@59Q:AJ?B.TF
M,<L&U@?]^@#W+0O%6B>)1(=(OX[KR_O[,\5)KGB32/#ENL^K7L=K&W1GS7@?
MPWGD\'_%:\T2X<JMW(< ],9)%6OC5J<VM^+]-T&U^81N!(H[Y(H ][TO5++6
M=/BOM/G6>VE&Y)%Z$4W669=&O&4D,(C@@]*B\/:8NC:#9Z>@ $,87@5)K?\
MR!+S_KDU 'R&D/B[Q%XDO[31KG4;F2.1F*1W+# S]:T)?!/Q0MXFFEM]75$&
M23<MQ_X]618^(]<\-^*M2N="9EG>1E;;'OXSZ5N7'Q5^(MQ;O%-+*8V&&_T3
M''Y4 >D_!'QUJFJ-/H>IDRF XC<]1ZY/4TGCNPMIOB#:ROXW33G%PA%D3)EO
MF'R\<<]/QJG\ 1HY-U*UQNU:5LO&1C;UKFOBK_R5VP_Z^X__ $-: /HC7?%&
MC>&H5FU>^CM8V. 7SS6=>?$7PI86\-Q<ZS!'%,H:-CGD&O.?VB/^0%:_]=%_
MF:J^!/A-HVK^!1>:PLD]U*-\3F0X12.!B@#V/0_$FD>)+4W.D7L=U$"063U%
M3:OK.GZ%I\E]J5TEO;1_>=^U?.GP9N)-+^(VH:;%*P@,ABV9X(#'_"I_BG?7
M?BOXF0^&HYV6UC*X . <CG- 'JFJ?$#PWKFAWT&CZS%-<B%R!&2#PIKA?V?-
M0O;UM0^U7EQ/B3CS9"V/E]ZN>*O@UHNG>#)+C2A)!?QH&:42'YAC)XK*_9SZ
MZC_UT_\ 9: /H%F"J6)P!UKP?XI_& 17+:'H%TA3.RZG Z>JCN"".M>\,H=2
MIZ'K7RC\8O#NFZ+X^$%C"8XYU660%LY9LDT ?1OA'Q3I'B/2X?[-OTNI(84$
MNW/!P <_C3M<\;^'/#DR1:MJD-L[_=#9.?RKEUTW1_AO\/+C6-+MFB9K5&DR
MY.20/ZFO,OAAX.@^(NHZAJOB(R7$*/\ (A<C.?Y4 >]:#XNT+Q,LC:/J,5T(
MCM?;V/XUMU\R>//#Q^%OC'3KW09GBLK@[VCW'"C<!CWKZ*T'4?[7T&RU ?\
M+Q$'_.@#1HHHH **** *FI?\@VX_ZYFOFG4_^0G<_P#70U]+:E_R#;C_ *YF
MOFG4_P#D)W/_ %T->GEWVCS\=T*E%%%>F><26_\ Q\Q?[X_G7IDG_(-N?^N3
M?RKS.W_X^8O]\?SKTR3_ )!MS_UR;^5>;C_C@>A@OAD>7T445Z1YX5<TO_D(
M1?6J=7-+_P"0A%]:BI\#+A\2/4]/ZK78:=]T5Q^G]5KL-.^Z*^</>-J/I3Z9
M'TI] !7DWQD\?Z[X*ET]=&D@03HS/YL0?D'%>LUX%^T3_P A#0_]T_\ H0H
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MUWWAGX1Z;X8L[ZUM]2NI4NXC&V]5^7/<5=\$?#6P\#7UY=VE[<7#72[6$J@
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M%ET_4(K[Q#,C/#)N6&(AE;ZT ;%UI\VF_L[:G%,,,UGOQ[';69\!/^17U/\
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MXCX>?#FQ\#6+;&,UY+R\K 97C&!CM7;T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHHHKG-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BJ.KZI!HVESW]Q_JXE+$9Q
MGCI7FWAKX[:/XCUJ+35TNZM6EX62612,^G% 'J]'48HHH \O_P"%%>&#K#:B
M\MTSM(9"A8;22<UZ5:VT-G;);P($C0850*FHH **YW7?&>DZ%>6UC+,LE]<2
M*B6RG#8)P6^@I?&/BN#P=HO]I3VLMRF[;LC(!_6@#H:*Y'P_X]M=?\'W'B**
MQGAA@)!A=@6./>J?@3XFV7CO4=0L[73[BU:R +-*X(;G'&* .ZHHHH ****
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M_D:Z:?\  G\CGG_&A\STJBBBN8Z HHHH **** "BBB@ HHHH **** "BBB@
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M<S7S3J?_ "$[G_KH:]/+OM'GX[H5****],\XDM_^/F+_ 'Q_.O3)/^0;<_\
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MI1F*!3RU<+IO[0-G<WT<5_HMQ8P.<&:1N!^E>9_$37)I?BM<//:M>1V<P\N
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M%%%%8&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y;XA_P"2RZ1_
MVS_D:]2KRWQ#_P EETC_ +9_R-=.%^*7HSGQ'PKU1ZE1117,= 4444 %%%%
M!1110 A^Z?I7E_PL_P"0[KW^_P#^S&O4#]T_2O+_ (6?\AW7O]__ -F-=-+^
M%/Y'/5_B0^9ZC1117,= 4444 %%!.!FOFKXO_$76+?Q:^GZ/J=Q:Q6_WC"^
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M<^] &K1110 4444 %%%% !1110 4444 %%%% %>^_P"0?<_]<F_D:\]^#_\
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MMD)*QKM!-9W_  E.A_\ 05M?^_@H_P"$IT/_ *"MK_W\%')/L'/'N;%%8_\
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M&\LHC)+:C?(%')7;V]:[2Z'@6^O(KNZ_LR6XB^Y(Q!*_2L/XA?$)O#^BPRZ
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M !1110 4444 %%<1XR^)^C>";N.WU&&Y=WZ>4N15GP1\0M+\=I=OIL4\8MB
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M&:^L/&/A'1O&6D#^TXY72,>8GER%>: /C;4[M;W5;J[12JS2M( >H!.:^C?
M7QFTJ]?3?#R:;=+.RB/S"R[<@?\ UJ^=-6MH[36;RVB!$<4S(H)R< U]/^!?
MA1X6M+;3M<B@N1>A X8SDKDCTH U?''Q4T[P-<V\%Y87-P9P2#$P&/SJ_P"
M?']EX_L;RZLK2>V6UD$;"4@DDC/&*\;_ &B1C6=- [*W]*Z/]FO_ )%[7/\
MK[3_ - H J_M%?\ 'K9_45C_  (U:RT5-4O;^X2"".')9S@=:V/VBO\ CUL_
MJ*\L^'?A2[\9:W_9L4[QVR@-/@D J3CM0![=?_M"^';.Z:&*PNKE0?\ 61NN
M#77>%/B5X?\ %C+%:7*Q7+#B!VRU<E>?L_>&&TQDM?/2\V\2-,Q7/TKY^O[6
M_P#!/BI[?S'CGMI <J2,C- 'V_63KOB32O#EI]HU.[CMT[;SC-9'A7Q6FJ^
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M_E7@/@#P5<^.=?$#2$0K\TLC9.<=L^M>V:I\ ?#PTQCI9N(KY5RKM,Q!/TH
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MF>1B>K'-0445V)6.4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBK-E:27EPL:#OR:3:BKL:3;LC<\,69,C7##I]VN\L$R16-IUHMO D2C@
M"NFTZ#D<5X%>K[2;D>W1I^S@HGGOCC27L]0%RJ_NY1DGWKDZ]XU[04UG1W@(
M_> 90^]>(7UE-I]W);S*0R''/>O4P=93ARO='FXJDX3NMF5J***[#E"BBB@
MHHHH **** "BBB@ HHHH **** $(##!&0>U5S86A.3;1?]\U9HI-)[C3:V&1
MPQPKMC147T Q3Z**>P@HHHH **** "BBB@ HHHH **** "BBB@ I&4,I5AD'
MJ#2T4 5OL%I_S[1?]\U-'%'$NV-%5?0"GT4E%+9#<F]PHHHIB"BBB@ HHHH
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M=+"2ZY/\/2N-_:$_Y'&/_KDG\J .X_9\A1?#EQ(!\[GD_C7I'C'_ )%34/\
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M%7QCX"\977@3Q$+AHV,1^2:)@01GOCUKVK6/V@/#_P#9+_V5]HDOF3Y5>$J
MWUH \6^*'D?\)U?>1C;N.['KDYKZ3^$/_)/++_?:ODG6+FZO=4FN[Q&26=C(
M0P]>:^MOA#_R3RR_WVH \U_:$\-%9;;6H(_E.1,WOT%/^#'C(6O@_5K*ZF >
MV0M ">P0G^=>M>/] 3Q'X0O;%E!.WS!_P'FOC6*[O-*N)HXG:)B"CCIP>* -
MBSCE\8^/%+*7^V7(+^P)K[,TFQ33-)M;)  L,808]A7SQ^S_ .&A=ZQ/K,RD
MQP@QJ".-W7-?2E !1110!X+^T;_JM-_W#_Z%7E7P[\%2>-/$*6F[; GSR'U
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MS_GD?RI^TAW#V<NQ3HIUPOV9MLI /IFH/M$?]ZJYDR>5DM%1?:(_[U'VB/\
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MT4 >/?\ #/6A?VA]L_M:^W^;YN-JXSG->LP6BP6*VJL2JIMR>M6** /(]7^
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M0!Q_]GGTH_L\^E=A_9Z^E']GKZ4 <?\ V>?2C^SSZ5V']GKZ4?V>OI0!Q_\
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MO85VU% 'QWX=\)^((?&=I-)HUZD0N"2YA. .:^MY$8Z*Z;3N^SD8[YVU=HH
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M'EBGT4 ,\L4>6*?10 SRQ1Y8I]% #/+%'EBGT4 ,\L4>6*?10 SRQ1Y8I]%
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M+P1NW>5??^!)_P *Z;0?AUX;\.,KV-D"Z]&EPY'XXKJZ*  <# HHHH ****
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M+1]C^)W_ #\Q_P#?Q:]2HH^LO^5?<'U=?S/[SRW['\3O^?F/_OXM'V/XG?\
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MG?\ /S'_ -_%KU*BCZR_Y5]P?5U_,_O/+?L?Q._Y^8_^_BT?8_B=_P _,?\
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MWY86^8G0F[<TK_(6BBBN4Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/Q7'D2:Q9K-G&PRC.: -FBFHZR('1@RGD$=ZSM0\0Z/I4XAU#4K:VE(W!)9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "D-+10!D:YIZZAID]NR@ET('UKYSU"T:QOY
MK9P08V*U]/NN17BOQ-T7['J:WL:XCEX/^]7H8"K:7(^IQ8VG>/,NAP-%%%>L
M>6=1X-U$V]^;=C\K\_E7K5A=!8]S'  R:\%LIVM[R*13C#"O4;C5U@T"2X#<
M.A"GZBO)QM+]XFNIZ>$J_NVGT.(\9ZJVJ>()V)RL1*+]*YVG2.TLC.YRS')-
M-KU(148J*/.E)RDVPK0T>U^U7Z*1\HY-9]==X9L]EN9B.7Z5CB:GLZ;9KAZ?
M/42.EM8LD"NGTVWZ<5C6$.6'%=9I\.%'%>">T:5M'A15P#BHXUP*EH ****
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M_"GQ%I/AWQK>W&K7L=K"97^9\XZFO:=6^,/@VVTR>2UUFWN9PAV1(3DG'N*
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M** "BBB@ HHHH **** "BBB@ HHHH 0]*Y#Q]I7]H^'IB%RT(+BNPJM=0+/
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M^$SS_$$>*/[44 $?N/+_ *UT_CSPDWC/PG)HBW0MB\B/YA7/W3Z5U%% ''>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0,'- 'U517B7@_XS:O=^+$T7Q/I\=HTQ"1A%((?/?/:O; 0P!!R#TH 6N?\
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MKT_PQJ9U&S2<P&('H":\&KAZE/62/:IUH3TB=C N%%6:K0,-M6!6!L+1110
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MGY@!BO6_C'86UUX%G:6-2T9W*<=,"O+O'^@ZUX%^(+^+-/@,EG+*"=JYVJ2
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M\"ACPAXE [1G_P! -97BOXF:SXZ\)7&G:?H5S!&B+]ID8YS]*U_@9#+%X/\
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M!D<4<2[8XU1?11@5&UE:NY=K:%F/)8Q@FIZ* (GM;>3&^")MO W(#BE>"&1
MCQ(RCHK*"!4E% $!L[5D"&VA*CD*8Q@4^*"*$8BB2,>B*!4E%  >1@U7-A9E
MMQM(,^OEBK%% " !0 H  Z 4V2*.9=LL:NOHPR*?10! MG:H"%MH5!Z@1@9I
M\=O#"I6*&- W4*H&:DHH BCMK>%MT4$2,>ZH :=+#%.NV6))%'9U!%/HH AC
ML[:)MT=M"C>JH :FHHH KM8V;-N:U@)/<QBI8XHX5VQ1JB^BK@4^B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *0]*6B@"I=0K+$R,,J1@BO!O&_AYM&U1I(U/D2G*
MGW[U] L,BN9\5:%'K&ERPLHWXRI]*Z,-6]E/R,,12]I#S/GL=*6IKNUDL;R2
MVE4JZ'!!J&O=3NKGC-6=@JU9P[WW$571"[8%;5C!DJ *XL;7Y(\BW9UX2CS2
MYGLC9TNVW,O%=YI%I@+Q6!HMEDKQ7>:=;!5'%>.>J:%K%M4<5= XID:X%24
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M$/'%>@>&/AW##XHAU3P1XGMI;&)QYJ%V9F'H<4 >^T4V/?Y:^807QSCIFG4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %03(&4U/2$9H \B^(_AKC^TK
M9.1_K !UKS$<G KZ8U*S2ZMI(G4%6!!S7BMSX4EMO$LEOL(MP2Z-Z@5Z>$Q*
M4'&70\[$X=N:E'J8EM:%4#$<FNATJT+.O%3R:>1+@+6[H^G_ #+Q7GU)N<G)
MG=""A%11O:-985>*ZNWBVJ*HZ?;!$'%:Z# J"Q12T44 %%%% !1110 4444
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M\LXN55-C-MQD?2@#RC]GO5K:&VO-+EF5+A6+[&X.,UB_'[6;.]U^SL8)5>6
MJ[X/0$5V'B'X#P:CK<NH:1JSZ8LO+H@/)]<@U6O_ -GNWNH+?R]79;I&S),X
M+;QZ<F@#U3PI_P BS8_]<E_D*V:I:38?V9ID%GOW^4@7=CK@5=H Y#XE_P#(
MCW__ %S/\C7G/[.O_(,O/]\UZ[XFT0^(=#N-.$WD^:I&_&<<5SGPY^'9\!VL
MT)OQ=>8Q.0FW% '$?M$:G>0:;I]G%(\<$DI#[3C<-O0TNE>%_!WASX<W.MJ$
MDFGA&]YFW@'V!'')KTOQOX+L/&VB-8W?R2IDP2_W&/?WKSG2OV?TM[E1J6N2
MWEESFW&Y0?3O0!C?L\LK:GJY7[ID!'TYK%O #^T3J61G_2__ (FO5? ?PKD\
M#ZS-=PZH)K>4G,/EX^G-03?"-I?B-<^*_P"U !--YOD>7TZ<9_"@#OO$-N]W
MX>O[=/O20LHKP+X)ZC;Z-X^U;3[QQ'+*/*3=QN;=TKZ,GE2"!Y9?N(,MQGBO
MGWQ'H?@GQEXMVZ-XB_L[4&?:X\LC+?7C% &C^T+KED=/L-,CE62Y#EG13]P$
M<$UBZOIT]W\ ;">)2RPL=P ]6K+^(?@W2?"7AJQB_M/^T=5GF97N/,W97C:,
M9.,5[1\.]&1_AG9Z=?Q!D=6W*1V- 'E_PR^'?@7Q=X7^U7QN#>P8%SMN2H!Y
M/3Z5UOA;PE\+[+Q1Y6BWTTFJ6YYB-PS8Q^%9U_\ L_%M1N)=*U^6QM96RL"A
MN/J<\UVW@3X::=X+!GWFYOV&'N&SSZ\4 >3_ !^B(\8V,N>#$HQ^=>_>'G5O
M#NF[6!Q:QYP?]D5R_P 1/AK;>.X(2+G[+=1G_6XSD>F*;\._A]=^!WN?/UA[
M])4"JK _)@Y[F@#NI9!%"\AZ(I8_A7R)XQFU3Q_\1KJ+1X9+J0,3#'&>0!UK
MZOUFQFU+2I[2"?R))5VB3&<5PWP_^%,?@K4[B_EOA>3R$E6V8V@]: /"IOA]
M\398#'-I^J/%CE&G)'Y9KH?@EK%QX=\:7&B:B#%O!C\INHDS7TY7E>L?!X7W
MC:+Q'9ZH+5DE\UHQ'G)S0!Q7[17_ !_V/U'\J]@@_P"2>1?]>:_^@BN?^('P
MMD\<&U9M4%NT &3Y>=V!BNT31]GAU=*\W.V$1;\>@QF@#P/X#?\ (WZA_P!=
M&_K6;\2(_+^-%JY(P]ZA^GS+7K/@+X5MX*UBXOSJ8N?.8G;Y>,9I/B!\([?Q
MIJ,5_!??8KA =S[2<G/6@"[\6V5_ =V58,,'H?:N(^#=J][\*M4MH_OR.ZC]
M*ZK3_A9=6W@J\\/W.MO<M/)O$[J3M&,8Y-:W@'P6OP^\/S6<M[]J7>9"X3'7
MVH \C^!>IVVD>.M;L;N0)-<GRHPW&2'.:V?V@]<LFL[33HI5DN.2P4_=K/U_
M0_!'C/Q<!H?B+^SM09RCCRR,L,YYXQSFL+XB^#=*\*:#8VXU+^T-3N&(,WF;
MMW/IDXH O^(M.GN?V?\ 0;N-2R1*JM@>KFM#X<_#GP%XK\)QW]XUP;J$!;DK
M<E0&QGI7IG@#0XI_A5IFE:A$'0P%74CU)_QKA[O]GQ_MMPVF>(9;*TD?*0*&
M^4>AYYH V/!OA;X9V?B4CP_>RRZE;GYD,[-C!^E<%\6?^2Y6O_7"'^1KV/P-
M\.=.\%PL\;>?>N,23G^*L;Q;\)V\3^.HO$@U,0"-$3R?+SG;GO\ C0!K?$#_
M ))A<_\ 7!/Y"O._V=YH;?2_$<MPP6%9%+DCC&#FO7_$'A\ZYX7ET83^5OC5
M/,QG&*YSX=?#8>!;74K>6^%XMZP)^3;@8Q0!QVK>"_AY\0KZ[ET#58TU:5B[
M$.0B^ORX%>9:YX>U7X8>*;"UM]9%Q(^)0MN653ST(SS7KWB7X%VNIZM]NT74
MWTK>#YJID[CZ\=*/"_P,M])UV/4M8U1]4\H9B1P1M;UY/Z4 >H:+/)=:)8SS
M?ZR2%6;ZD5?IJ(L:*B@!5& !3J "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@".1-PK$O[%9,G:,^N*WCS4,D0:@#B)-*_>9V]ZU=/T\1XXK9-H"<
MXJ:* +VH =!'M4"K%(HQ2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 C*'4JPR#U%>3>)O@1I&NZW
M)J5G?RZ;YG+QQ(""W=LFO6J* /'-(_9_TNRU.&ZO]5N-1AC;)@E3 ;\<UZ_!
M!%:P)#"@2-!A5'85)10 4444 %%%% !1110 4444 %%%% !1110 4$9&#110
M!Y'XC^ NCZSK,FH6-_+IHD.YHX4!&[N<D]S46B_ #2]/U>"\O]5N-1AB.?(F
M3 )[<YKV&B@"."".V@2&%0L:#"J.U2444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 )M%&*6B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8^'O_(E6'^Z?YUT]<DURR:-HNZN%%%%2,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ3YF2@   # %5]0_Y!MU_P!<7_D:LU%=1--9S1+C<\;*,^XKSEN=1Y-\*?\
MD.7OU/\ *G_%/_D8+#\*Z#P3X-U#P[J5Q<7<D3))G&PYI?&G@_4/$.J6MS:2
M1*D6-V\X-=GM(^WYKZ&'*_9V//=:EE\+^((YHLJLUM&V1[C-5Y;%D\$_VBPP
M;F5_KP:] \9> KW7X+'[(\*S0JJR%S@$ 8XJ76/ ][=^$[72K5XEDB)+%CQS
M6BKPM'77J2Z;NS8^'O\ R)5A_NG^==/6-X5TJ?1?#MK87!4RQ ABIXK9KAJ-
M.;:-XZ)!1114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_PEOCW_ * /_D(T?59]U]X?68]G]QZE17EO_"6^/?\ H _^0C1_PEOCW_H
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M_P#"6^/?^@#_ .0C1_PEOCW_ * /_D(T?59]U]X?68]G]QZE17EO_"6^/?\
MH _^0C1_PEOCW_H _P#D(T?59]U]X?68]G]QZE17EO\ PEOCW_H _P#D(T?\
M);X]_P"@#_Y"-'U6?=?>'UF/9_<>I45Y;_PEOCW_ * /_D(T?\);X]_Z /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y;X8_Y*[K/_ _
MZ5ZE7EOAC_DKNL_\#_I7J5=.*^)>B.?#?"_5A1117,= 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !4%[_QX7'_ %R;^53U!>_\>%Q_UR;^5-;B>QYW\(?^/;5_^NX_
MD:]+KS3X0_\ 'MJ__7<?R->EUOB_XS,<-_"04445SFX4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%(3@$T +17AWC+XZZGX9\37.E0Z-9S1PXP[R,"<_2L#_AI36?\
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M=9&)% 'OM%4[R\:UTN2[5 S+'OVGITKP9/VB=7;5EL_["L=IG$6[S7SC=C-
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MWTK5([BV$3><D+Y7<&XS[UZW\/=>G\7_  _22<@7,D3Q,Q^F :^:_B%X O?
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M_/1L5P?Q9^(O_"'Z8MM9X:^N,A3_ '/<UX#HNE>*OB1JDB1W$\BDY>1R2B4
M?5</C7PS<2B*'7+)W/15E&:VXY4F0/&X93T(KY<U7X%^)]"LFO[>\BN7C7<5
MMU8,!5;P#\4-8\,:Q'8ZG.\EHT@63SCDI^= 'U?45Q<P6L1EN)5CC'5F. *C
MM[ZWN-/CODD'V>1!('[8-?*OQ,^).I>(M>GM+*>2&RA8QA4;!8C@YQ0!]*CQ
MKX9:;R1K=D9,XV^:,UY?^T'+'-X;M)(G#HQ4AAT/S5Y_X9^"WB7Q!8)J7VE+
M(M\R^<IW'\JQ/&UOXF\/(-!UR5Y82=T3OGY@/3/:@#H_V>O^2AR?]>C_ -*^
MB;GQGX;L[AX+G6K**5#AD:4 @U\[?L]?\E#D_P"O1_Z4OQV\-G2_%"ZA"F(+
MA<L0.KGK0!]/VMW;WL"SVTR2Q-T=#D&I))$B1G=@JJ,DGM7DWP$\0?VEX3;3
MI9-UQ;.S$9Y"D@"NE^*FO?V#X'O9D;$S+M0>OK0!K#QQX7:41#7;$N6VA?-&
M<^E;ZLKJ&4@J>A%?''PP\/MXF\=6T;H3$K&5F[ CFOL=5"*%48 Z 4 +117/
M^+_%=MX/T9M2NK>2>-<_+&0#Q]: -R<E;>4@X(0D'\*^1]3\=^*H_%[6Z:[>
MK#]I"[!)QC=TKT^7]H[0I(70:+?@LI'WUKP"]U..Z\0'451A&9A)M/7&<T ?
M<&E2/+I=N[L69D!)/>KE>&6/[1.AVMC# VC7Q9%P2'6O2? GCJS\>:7/?V=K
M-;I#+Y964@DG&>U '54'D8HHH \Q\1?!'0O$FM3:I=7UXDLN,JF,#%<)X[^"
MNA^%_"T^J6E[=R2QLH"OC'-?1-<%\8?^2=W?_71/ZT ?+'A/1X=>\16NGW#N
MD<SA24ZC)KZ!_P"&<_#7_01O_P Q7B'PV_Y'C3O^NJ_S%?:5 '+^$/!VG> ]
M'>TM;F5X-Q<O,1QFK<_C3PU;/LGUNRC8=FE KR'XV:WXJ:^%AI]K=0Z>BAC-
M'QN)'(SFN*\-?!SQ'XPTW^T7O([96)P+@,2?RH ^F+/Q7H&H2".SU:TG<]%2
M0$UL5\5>(_#VM?#_ %A;:6X=),Y26(E0V/2OH;X)^+KOQ/X8GCOG+S63K$&/
M5N,YH [S4O$.CZ,ZIJ6HV]JS#($KXS38/$NBW-DUY#J=M);*2&E5\J/QKPC]
MHK_D+V7_ %R'\Z\Z\)6>O^*$3PWI<K1PAS(Y7.!GCG':@#ZWM?%_AZ^G$%KK
M%I-*3@(D@)K9R-N<\8SFO#?!/P-U'P]XCMM4O]3MY8XSN,<08$_G5WXS_$2?
MP_;IHVF2;;B08D<'E: /3;OQ;X?L)3%=ZO:0R#JKR &K=IK.FW\#36E[#-$H
MR61L@"OD3PIX(\0?$2ZDDBG;:AP\\V6 /6NBUCPEXR^&$/VI+W[3:,-C>7NV
M?D: /HH>,_#37/V9=;LC-NV[/-&<^E;BL'4,IRI&01WKX>T&X>[\96=P^-TE
MQN./>OM'[;#IV@1W<[!8HH%9B?H* +=S=V]G$9;B9(HQU9C@5BMXX\+K)Y;:
M[8A\XP91FOFCQCX]USQSXB:RT]ID@WE(XHS@MSC)Q6O%\ /$MQ9?;7OH%EQN
M\IE;>30!],6E_:7\?F6EQ',G]Y#D4E[J%IIMN;B]N(X(1U>0X KY%TKQ+XE^
M'7B<6]U+,!$^V2&4G!'? KZ)URR/Q)\ Q+I]Q%$US'NR_(4D=#B@#YP^*6LC
M6/&,\D5Z+FW &QE;([]*]I^#'BG0=-^'=G9WNJVL%R)I/W4D@#<GCBOG?Q)H
M$WAK69=-N)DEDCZL@.#7=>!O@YJGBS1K37K;4K6&$RG]W(K%OE/M0!]6JP90
MRG*D9!'>L^_U[2M+.+Z_@M_^NCXKDOB-XV7P+X8C5"K7LD82(>N!@FOGC1=&
M\4_$_5IV2XE9"W[R1R2B'TH ^J;;QCX<O)!';ZU9RN>BK(":VU974,I!4C((
MKY3U_P"#?B?PE8-J,-VMPL8W.;8,"H]371_!OXF7HU>/0-8N#)',0D#.<L&^
MOTH ^BJI7^L:=I:;KZ\AMU]9&Q6=XO\ $</ACPU=:I(<^6F57^]7R/J.N^(/
M'.O&/S9II)WPD*$X SZ4 ?7MEXKT#49O)L]7M)Y#_"D@)KYD^-__ "/4GT/\
MZV;;X'>+=-LO[2M-3CCG4;O)C#!_I7FGB6]U2ZU1H=8S]LMOW;[OO9]_>@#Z
M*_9Y_P"1 G_Z^W_I7KE>1_L\_P#(@3_]?;_TKUR@ KYV_:4_Y">A?]<9/_0J
M^B:^=OVE/^0GH7_7&3_T*@!?V=/^/R^^I_E78_%KXFQ>'-/;3M,F5M0D&UBI
M^X/\:\.\%>.&\'Z7?_9U)NI\JA] 1C-<EJ&H7.IWDEW=RM)+(<DL<T :NB:)
MJWC;7Q! KS3S/F20\A<]S7UCX#\":?X,TI(H8PUTPS+*1R3Z5RWP,CT%O"_F
M:?$!> D3%\%NWZ9KUB@#/UI=+;3)!K A^Q<;_.^[^-<MH\/PW74D.D+I'VS^
M'R2-U.^+7_)/;[ZK7S=\*O\ D?K3\?YB@#ZG\=_\B)K?_7H_\J^0_ 7_ "/>
MC?\ 7R/ZU]>>._\ D1-;_P"O1_Y5\A^ O^1[T;_KY']: /LC5O\ D7)O^N/]
M*^*(O^1GC_Z_1_Z'7VOJW_(N3?\ 7'^E?%$7_(SQ_P#7Z/\ T.@#[ECV?85\
MS&SRQNSTQCFN&N(/A?\ V@YG71?M>_YMQ&[=7:3_ /(&D_Z]S_Z#7Q9K?_([
MW7_7S0!]L68MQ9Q"TV?9]H\O9TQVQ6/)XW\,0S-#)KMBLB,593*,@^E6/"W_
M "*VF?\ 7NO\J^+/$9*^*M4(ZB\E/_CYH ^WKG5;"R@6>YNXHHF&X.[8!%9T
M'C/PU<RB*'6[*20G 59037SUI/AGQK\4($NS>FUL@@C0ONV':,=!7*>,? FM
M> +N'[1/N\S)6:($"@#[,1U= R$%3T(I:\,^ WC.^U,SZ-?S/,RC=&[G)  K
MTKQ]XK3PAX:FOR1YK96('NW:@#:U#6],TE<ZA?06P]9&Q5>Q\4:%J4@CLM5M
M9W/18Y 37R#]K\0_$'Q$+83S32W#X"9)5<^U=Q)\%_%_AVP_M.QU%&EC&[R8
M P:@#Z&O_%6@Z7<&"_U:UMY1U220 U>L;^TU*V6YLKB.>%QE7C.0:^(O$>MZ
MAK>H&74O^/E/E8X].*^I?@S_ ,DYT[_KF/ZT >@T444 %07O_'A<?]<F_E4]
M07O_ !X7'_7)OY4UN)['G?PA_P"/;5_^NX_D:]+KS3X0_P#'MJ__ %W'\C7I
M=;XO^,S'#?PD%%%%<YN%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y;
MX8_Y*[K/_ _Z5ZE7EOAC_DKNL_\  _Z5ZE73BOB7HCGPWPOU84445S'0%><?
M&7Q(-"\&2QQM^^N#Y>,\[3D&O1Z^6/COXC_M7Q=]@B?]W9 Q, >"<YH \_\
M#&K6NB>(;34KNV>Y2WD$@16P217N/_#26G!-@\.W.W&,><M<CX'^"<OB[01J
M4VIFTW-A4\O.1ZUTO_#-8_Z&$_\ ?F@#Q7Q'JEMK&N7%_9VS6T4IW"-CD@]Z
M^C/@+XC&I>%VTQV)DLB ,G).>:\U\=?!:7P?H3ZI'J1NTC^^OEXQ6;\&O$9T
M+QI#'(^VWG!#CU/04 ?0_P 4/^1%O?I_0U\M_#NS6]\<Z4C8VK.K$$=>:^I/
MB><^!+TCN/Z&OF3X7?\ (^:=_P!=5_G0!]F*H10JC"@8 %?)WQZ4+\4+D* !
M]FAZ#VKZRKY.^/?_ "5&Y_Z]H?Y4 >J? $D^$G!)P#_6N/\ VE/^0WH7_7M)
M_P"A5U_P _Y%)_K_ %KE/VDX7;5=%F ^1;=P3[[J )?V=/\ 77OU/\J];^)/
M_).-?_Z]&KQO]GR_M;2YO5N)XXB02-[ =O>O7OB!=0W?PSU^2"19$^R-RIR*
M /E?X=?\E T?_KO_ $-?7WB#_D6+K_K@?Y5\@_#K_DH&C_\ 7?\ H:^OO$'_
M "+%U_UP/\J /BNP02>);5&&5:\0'_OL5]S6=M'9V<5M"H6.-=J@= *^$DG^
MS:NMP!GRI]_Y-FOK_P $>/\ 2?$>A6\ANXX[E4_>H[ 8/XT <[\>[:&;P3&[
MH"Z39#8YZ5Y!\$;I[?Q];QKG$S*K8].:[GXZ^.-/O--BT2QF6682;W9>1CI6
M%\ - GNO$4^IM&1!"H*N1U8'D4 8'QLOIKOXB72NQV)&FU?3BO;/@=ID-M\/
M[6\15\RXR6('/!KR_P"/GAJ>T\4#640FWN5"<#H5%;WP1^(-A9Z>-!U"40LO
M^J+'@^M 'OS*'4JP!4C!!KXS^*%G#9^/M36!=BM,Q('2OJW6_&.C:)IDEY/?
M0L I*JCAB3V'%?(FNWMSXT\9W$]O&S-=SGRU Z T ?07A/5;B;X)W=QDB2"$
MJI/MBOG?0K=-1\8PPS\K+<$M^9-?6.A>%_LOP[31G&'FMP''H2!FODJ^AN/#
MWBJ82HR/#<,0#QQN- 'V[8QI#86\:*%58U  'M7C_P"T-81/X:@O2J^;$ZH#
MCG!:N[\(^.-'U_0;>XCNXHV6,!E=P",#WKQGXZ>.++6)HM'T^02I%_K7'0,#
MD4 9G[/7_)0Y/^O1_P"E>P_&7PZ-<\$3RJH,EF#,,#DX%>/?L]?\E#D_Z]'_
M *5]075M'=VLEO*H:.1=K ]Q0!\J?!+Q!_8GCA+.0D)?$0MD\+@DUT?[0?B+
M[3J-KI$4G$(W. >H(XKSKQ387/@[QY<!<K)'*9H_8$G%5KZ^N_&?BN&4J7FF
MV)C/8<4 >X_L_>&_L>BW&KS)EK@@Q''0=#7M=9'AC2(]#\.V>GQ !8D'ZUKT
M %<MX]\)R^,?#SZ9%=);LV?G=21S74T4 ?.<G[-NH1QL_P#PD%L=H)_U+5XW
M=:8UKK)TXR!F$HCWXXY.,U]V7'_'M+_N'^5?%^K:;?'QJS"RN2OVI3D1-C[W
MTH ]#M/V<[^[M(YQK]LH=<X,+<5ZU\,O DW@'1;FPGO8[MIIO-#(I4#C&.:Z
MK1P1I%L"""$'!J[0 4444 %<%\8?^2=W?_71/ZUWM<%\8?\ DG=W_P!=$_K0
M!\U?#;_D>-._ZZK_ #%?:5?%OPV_Y'C3O^NJ_P Q7VE0!R7B[QKX;\-+LU:2
M!IB/EB=02?TKS.^_:%LX,V^DZ+(%7HRE=OY8KQ_QWJ%YJ/C'4&O'<E)V10W9
M0Q KW/X>>%_ 8\-PWSM!)<XS(TD@!_(T >(>./&>H^,M0CN;^,1^6"$&S;P:
M]9_9P)^R:H,\></_ $&N'^,FJZ+?Z]!;Z,$\NV!5RBX%=O\ LX?\>NJ?]=A_
MZ#0!0_:*_P"0O9?]<A_.K/[.5GBYU&[,?WHMH8^S56_:*_Y"]E_UR'\ZVOV=
M?^07>?4_SH ]Q8X4GT%?'7Q=N9+GXC:DTC$X*@#L.*^QNHQ7RA\<= FT[QM-
M?["(+K!3C@8% 'M_P;L(K7X<:9.BJ'N(@[D#G.2.:Z'QK9Q7O@[5(I54_P"C
MN02.AQUKS/X(>.=/?0$T.[F6&:W 6/>V PZFM_XJ>/M,TGPS=6,-TDMU<QF,
M*C9P#WR* /F?P]'Y/B^RCSG;< 9KZ?\ BC=RVWPHNO*;:7M5!(_"OEWPP2?%
M.GD]3,,U]:^-M&?7?AK=6,0S,]JNSZX% 'R'HNK7NC:M%J%AM-U&25W)O'Y5
MZ"/CA\00,![?C_IS%<CX2U%/#/C*WN;N(,L$A1U=<^W0U]<:;JOAC4K!;N!M
M/\LKGYE0'\J /D'Q)KVL^*]1^WZI$&GP1F.#8#^5?1WP%N9[CP-()U8&*<HH
M8=@*W8O&W@B;4);))+3SHFVL#"H&?K76V36CVX>S6(1-R/+  /Y4 ?('Q7_Y
M'V\^@_F:]_\ @5_R2ZR_Z[2_SKP/XN1/%X^NPXP2H(^F37N'P2U:PM?AE:QS
MW<,<B3295G /+<<4 >=?M!W4LOB2U@9CLB5@HKB/"'C[Q)X.M;B'0_*$<[AY
M"\&\Y QU[5Z9^T)H4K2V.KP*7A*GS&';)XJA\"_%.D:?]KTG55@W3.'C>1 <
M #&,F@# O/C-X\O[.6UN# T4JE6'V,=*X[0I+R#Q-:7HAD$BS;\A".:^P-1U
MGPKI5D;NZ>P$0&3M1&/Y"H='\2>$M;:,:>;1V<_*#$H)H X'XXW<R^ =,4'
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MBMIG_7NO\J^+?$//BO4Q_P!/DG_H9K[2\+?\BMIG_7NO\J^+?$/_ "-FI_\
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MO^N8_K7R[XOUK_A(/$]YJ6,>:W'T%?47P9_Y)SIW_7,?UH ]!HHHH *@O?\
MCPN/^N3?RJ>H+W_CPN/^N3?RIK<3V/._A#_Q[:O_ -=Q_(UZ77FGPA_X]M7_
M .NX_D:]+K?%_P 9F.&_A(****YS<**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR->EUOB_XS,<-_"04445SFX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'EOAC_DKNL_\#_I7J5>6^&/^2NZS_P/^E>I5TXKXEZ(Y\-\+]6%%%%<QT!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %4-1T73-64#4+&"Y"]!*F<5?HH R;/PQH>GR"2STJU@<=&C
MC -:U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4C*'4JP!!Z@TM% &-<^$_#]VY>XTBTE8\DM&#3(?!OANWDWPZ)9(P[K$ :
MW** &111PQB.) B#H .!3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,^]T+2M1)-[803D]?,0&J \#^%P<C0;$'U\D5OT4 5K/3K/3TV6EM'"OHBX
MJS110 4444 %07O_ !X7'_7)OY5/4%[_ ,>%Q_UR;^5-;B>QYW\(?^/;5_\
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MC'_WR*/L\'_/&/\ [Y%'M:/\GXA[.K_/^!YO_P +:D_Z 5Q^?_UJ/^%M2?\
M0"N/S_\ K5Z1]G@_YXQ_]\BC[/!_SQC_ .^11[6C_)^(>SJ_S_@>;_\ "VI/
M^@%<?G_]:C_A;4G_ $ KC\__ *U>D?9X/^>,?_?(H^SP?\\8_P#OD4>UH_R?
MB'LZO\_X'F__  MJ3_H!7'Y__6H_X6U)_P! *X_/_P"M7I'V>#_GC'_WR*/L
M\'_/&/\ [Y%'M:/\GXA[.K_/^!YO_P +:D_Z 5Q^?_UJ/^%M2?\ 0"N/S_\
MK5Z1]G@_YXQ_]\BC[/!_SQC_ .^11[6C_)^(>SJ_S_@>;_\ "VI/^@%<?G_]
M:C_A;4G_ $ KC\__ *U>D?9X/^>,?_?(H^SP?\\8_P#OD4>UH_R?B'LZO\_X
M'F__  MJ3_H!7'Y__6H_X6U)_P! *X_/_P"M7I'V>#_GC'_WR*/L\'_/&/\
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M2?\ 0"N/S_\ K5Z1]G@_YXQ_]\BC[/!_SQC_ .^11[6C_)^(>SJ_S_@>;_\
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M?_?(H^SP?\\8_P#OD4>UH_R?B'LZO\_X'F__  MJ3_H!7'Y__6H_X6U)_P!
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MC'_WR*/L\'_/&/\ [Y%'M:/\GXA[.K_/^!YO_P +:D_Z 5Q^?_UJ/^%M2?\
M0"N/S_\ K5Z1]G@_YXQ_]\BC[/!_SQC_ .^11[6C_)^(>SJ_S_@>;_\ "VI/
M^@%<?G_]:C_A;4G_ $ KC\__ *U>D?9X/^>,?_?(H^SP?\\8_P#OD4>UH_R?
MB'LZO\_X'F__  MJ3_H!7'Y__6H_X6U)_P! *X_/_P"M7I'V>#_GC'_WR*/L
M\'_/&/\ [Y%'M:/\GXA[.K_/^!YO_P +:D_Z 5Q^?_UJ/^%M2?\ 0"N/S_\
MK5Z1]G@_YXQ_]\BC[/!_SQC_ .^11[6C_)^(>SJ_S_@>;_\ "VI/^@%<?G_]
M:HY_BM)-;R1?V%.-ZE<Y]1]*],^SP?\ /&/_ +Y%'V>#_GC'_P!\BCVM'^3\
M0]G5_G_ \\^$<,T=CJ;RQL@DF5EW#':O2*:J(@PBJOT&*=656I[2;D:4H<D%
M$****S- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gtl21rgcbjm5000010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2>",H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M._%$NFWSZ/?.0 Q"[OK7JVK,&TF<@Y!0_P JX*E%TJJ70ZH5%.&AY/\ #/\
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M)4#BND^)>HW>G6=D()61BX!([\552G_M-H/4B$[TKR1V^C6*:=IT5NC;E10
M<U?>5(QEV"CW-8/AN[=O#4-Q,^2(]Q)KSO6O%6J>(-8;3M*9@H;:64UA##RJ
M3:[&SJJ,4>M_VC:9QY\>?]X5821'&48$>QKR)O _B!;?SQ?RF3&<8J+0/&6H
M:)K TS5BQ!. 6-6\*G&].5R?;M/WE8]C9U098@ =S3!<1,I(D4@=\U@>*;QD
M\+7-S ^&\O((KR+P]XAUW4?,T^WDD=RYRV>@J:6%=2+E?8<ZZBTCW<ZA:AMI
MGCS_ +PJ=)$D&58$>QKQV]\'>(H;5KI;V5I%&2N*M?#_ ,6WDFH-I=^Q,BG
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MTX76%=Q2UK*QZD.E(WW3]*6D8_*?I7GG6>%:_P#\E'M_^NB_UKV2Y_Y <O\
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M\_ZY-_*N?$/_ &DUI?PCRWX26T;:G.Y4$AN./:O7=553IDX(XVUY1\(_^/\
MN/\ >_I7K&J_\@V?_=JL9?ZQ]PL/_#/'_A_QXTNP.!EOYUN?%S_CSA^H_G6'
MX _Y'6[^K?SK>^+B,=/B< X!&?SKHE_O43)+]RSK/ __ "+5O]*C\>_\BS/]
M#_*HO 5Y#+X:@"R+D=LU3^(^J00>'9(O,4NW& :XE%O$6\SH;2I'-_!C_CUN
M_P#>'\JR/B8@D\90(>A9?Y5K?!C_ (]+O_>'\JS/B1C_ (3:V_WE_D:[T_\
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M0Y*J=2HHQ+Q^)^F&#RRAVXQU%>:?V_%!XQ6]M?ECD?G\37MW_"#:'_SY1?\
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M#9R:]<UJW-UI-Q&.I1L?D:\=\ 7HT7Q)-:77R%GQS73AOX,TMS"LOWD6SW$
M!<8XKR7XOV$:QP7B !UP,CZUZLMQ&T8<.NTC.<UX_P#%C5DO+BWL+<[R<9 Y
MYS48)/VR+Q+2ILW="N7N/AN=[$D1GDURWPOLHY?$UU,P!(+8S]:Z[2K"2Q^'
M)25=K^6<BN<^%7_(:N_JW\ZZ4U[.I8QWE&Y[+@>E.%)3J\H[D%%%% !1110
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MJ3Z"GI7FVN^$[Z]\70W\:$QH^2:]*INVE2JRIMM#G#F1S^O: NM:*+1Q\P3
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M8\,?#QK>]&H:F?,FZX85Z1L&<[1^5.Q6DL7-JT58A8>-[MW,7Q'I[W^@W%I
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MM)TWKU*A/F0^BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /$OB\-VJVH/?_&L>VB.@Z[87:_*DC '\JV?BY_R&+/Z_UJQXGTDR
M^#K2]C'SQ MG\!7MTIVHPB^IYLXWJ2?8]9L9A<6<4H.=R@U@^.=6_LKP[/(K
M8<C J#P!JPU'P_&&;+QX4_A7(_$J\EU35K728#G)PP'UKSZ5']_ROH=4ZG[J
M_<\]N],,>DI?./FFD;D_G7O/@@[?#-N3V0?RKSKX@Z?'INAV-O&, <GZ[:[/
M1;W[#X%6;/(BX_*NO%2=6E%^9A17)-W+7B'QQ9:,YB!WR_W5KF?^%F7N=_V&
M7R_797->$X[7Q#XDGO-3D4HKY 8C%>K&'P^8/*_T?;C'4?XUE.%*C:+C=FD9
MSJ:IV*WAWQM9:V?*SLE[JU0^-]=?3;!HUA9PZGD"O-O$T,/AWQ;;W&ES+Y4A
M!8*1W(KU*[$.J>%C<31JS%,Y-*=*%.<9I:,(SE.+B]SQ[P9XBDTO5)Y%@=R[
M'@#WKWBSU)9M+2\E&P%-Q!KR+X;65O<:U=K+$K ,<9'^T:]3U_39KK1GM;,[
M&(P,''%/'.$JJ5K"PRDH7.7U/XDPPW#06<+S,#CY1FLT_$Z\@;,]C*J>I2M3
MPIX.M-'1I-1,;S'NQ%:6O0: ^F3+)Y .TXP1_C23H)\JC<;]I:[=BYX:\6V?
MB&+]TV)!U4GFKVN:[;:)9M<7#  #(&>M>+_#R;R/'DD,#GR2'P*Z#XP"Z\FW
M*AC#SG%$L)%5U#HP59NGS%R3XF7,KDVEG*\>>H3-7-,^)<4UTL%Y"\3$X^88
MJ+P;J?AM]*BA(19@ &W#'/YU;U[P5IFNRQS6DJ1.I!RA'/-.4:*DXRC;S",I
MM73N='K&NBQTK[;"AE&W("\UX1;:\\?B][[R7+$YVXYZU[YIVCQV^EI:3GSE
M48RU>-V-G ?B+)$8U\O=T_&KP4H)321.(4KQ/6O#>O-J]G)-)$T>P_Q#%9>N
M_$"TTR<V\0,LHXPO-=(]A'%8216J!"P[5PVC>!EM]9FO=49'!.5#D&N6G[)M
MRE]QM+G2215?XEWZG<;"79Z[*W?#GQ!L]9G%N^8YO1N*U[BWT%("D@@"X]1_
MC7C-V+6S^( ;3GQ&9#PO3M713ITZT6E&UC*4YTVKNYZCX[UY]/TR2)86<2KC
M('2O*_!/B*32]3FD2!WWL> .F:]FUZUAN/#$LDL89A%D$_A7FOPSLK>XUBZ6
M2)6 9L9%7AW!4)71-5-U5J>EW'B 0>&QJ4L9&5!*D4OA7Q!'KUF9XTV@$]L5
M2\>1)#X1G1% 4 8 K&^$_P#R!'/^TW\ZY.2+I.?F;<[511.LU[Q)::'!OF<;
MNPS7$R?$VYD8M;64K1COLS7/:Y)+XC\<"R9B84;!'T->L6'AO3K2S6%;9.!@
M\5JX4J,%SJ[9*E.I)\NB1SV@_$2VU&Z6VN%,4I.,-Q7=(X=0RG(/0UYEXH\
M37&IQ7>DHL;!LG!Q7H.D0S6^F017!S(J ,<UC7C2LI4^II3<[VD7JXKXF_\
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M?Y5XKX\18_'6Z/[QEY_,5Z]=$MX'F)Z^1_A7I8FTO9U.K..B[*4>QYO\*_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!XG\7/^0S9_7^M=U!8#4? H@QDM'@?I7$_%B"635[0I&S8/8>]>E^&$_P"*
M?MU8?P\@UZ-67+0IM''!7JRN>7^!-7.C:G?:?,VT*789JYX=A;7_ !U/?,-T
M<,AP?J*P?B!I=UI7B,S6B-B4<E1ZUZ!\--,:UTG[1*N))0"<BMZSC&G[5;LS
M@FY<CV1A_%P8M[<#LW]*TE1G^'"A>OE?TJC\6HI)88-B%OF/0>U=1X9L_M/@
M^."1<;HL8/TK!RY:$'YFG*W4D>0^"O#+ZW)*J3^6RGD<UVW_  K*Z_Y_&_6L
M!H=0\#^)9+B*%VMF;)P,UUX^)]G]FR8I/,QTQ6]>5:34J>J9G3C!*TS'D^&:
MK<QFXO 6!! (-=Y-9BQ\+O;@Y")C->61S:UXQ\3).AFAMT/&"5&,UZ]-9,FA
MM;9+,$QDG-<^(<XN*G*YK246FXH\O^&'_(<O/]YO_0C7H7C'Q"GA_1WN2?F)
MVK^->1:!J\WA77KHSV\A#.>B^YKMO'-M+XH\(1W-JK;OE?;^M:5J:E74I;,B
ME.U-I;G-Z9#XD\7 W*7#QPMR.*U9?AW<"TEFO;PMM7/>J7@GQC'H-@+*\A96
M08^[6OK7C>75K5[33H)"T@QG;5S]JI\L59"C[-QO)ZG%^ (EMOB"T2G*J' _
M2O:];L=.U*S,%\5VD8&:\4\$VUW8^-PUU$P8A@3CZ5V?Q,T?498DOK&64;>6
M5&-3B8\]>/O6'1?+2>A4U'X5'=YVG3E,\C&:P+R'Q/X.9)9))&MP1DXKIM!^
M) MK".WU"*02(-N2/2LSQ;XI;Q/ EA96SG<PR=OO5P=;GY:BNB9*GR\T-&>C
M>$=;.MZ1'.Q^8CFO+K#_ )*5)_O?UKTGP/I$FE:'''(,.1S7EVMM<^'_ !RU
MXT+M&3G('O66'4?:3C$NJWR1;/;-3OET_39+AN JUY!'JFO^+]2FCL9&2%3U
M S79+K/_  EWANY2)'5AQ@C':N$\(ZTWA+4)H+R!PI/7;[TL/3Y8RT]X*L[R
M6NAT,'PZU*X(-[>L1W&"*XJ^TN/2/&\=K&V[8^#^8KT>\^(L4D!2RAD>1A@8
M&:\SN+?4O^$JAO[R)\SOOZ=.:Z,/*KK[330RJJ"MRGN6K?\ (IS?]<1_2O./
MA;_R&KO_ 'FKTJYC-WX9=$'+1 #]*\9\.ZS-X5UZY\^WDPSMC"^]<V'7-2G%
M;FU5VG%GJWQ _P"15N?PK"^%()T&0#U;^=7_ !+?_P!L>!7N8T;]XH.,<U5^
M%,;QZ,P=2IW-U'O4+3#M/N4_XJL<AI)\GXCSB3N[?SKW%3E17C_C?0+S3=<7
M6+)"V#E@![UK:?\ $V!+)5NH7$H'(Q5UZ;K1C.&I-*:IMQD=QJFMZ?I"*U]<
M)"K' +5;LKR"^@6>VD$D;#(85XIK-[?^.]9A@@B=;8,.2,5['HE@--TJ"V[H
M@!KFK4%2BK[FU.HYR?8T:XKXF_\ (K2?0UVM<9\2HVD\,2!02<'@5.'_ (L2
MJOP,XOX6:'8:E8RM<PAR&[_2O1QX/T8'(M5KC/A!$\5A,'1E^;N/:O4Q6V+J
M259I,RH03IJZ,VTT6QLSF&!5/TJ[(PBB9^@4$U+BH;I/,M94'5D(_2N5MR>I
MO9):'CWB'Q?J>L>(#I6E,P^;;E>:M0> ]<O &N[UL-R1@US4D=UX4\:M=30L
M\8?.<9KT'_A95D;<&.)V?'0"O4J*48I4EH<,6I-^T9Y]XS\+QZ"UOF7?(S*3
MU]:]:\-G/A&+_<KR'Q=-JNO74=\\#K;JPVC;VS7K7A9BW@^+((.WI2Q-_8QY
MGJ51MSNQP'@@9\>WGX_S->TUXWX*@E7QU>,8V"G/)'O7LM<V-UFO0UPWPL\0
M^(?_ "/%O_OC^5=7XZC>3P)!L[*"?RKF/B!#*_C:!EC8KO'('M7IEQIHU/PN
MMJPY:' SZXK><U&-*1G&+;FCD?A#(IT>11UR/Y5Z82 ,FO"]&N=0\!ZO+!+"
M[6Y;J!75WWQ-@:R9;>*0RL.!CO48C#RJ5.:&J95*M&,+2Z'9+XCTIK_[%]KC
M^T?W.]>5>-1GX@6V>FX_SJ]X&T.]U#7)-8O%90Q.T&JWC&"5O'MLRQL1N/('
MO5T81IU;)]!5&Y0NT>NZ> +&'_='\J\E^+T3&>$GA3BO6[#_ (\HA_LC^5<O
MX^\-MKFE-Y0_>IR/PKGPU14ZUV:UHN5.R.(\/^ )M2T:WN8[LA77( S6HWPR
MN=IS>''XUD^%/%E[X7C_ +-U&"3RX_E4[:VM:^)23V3PV,4C2N,# KLG]8=2
MT=CGA[+EN]R?PSX%BTG5OM*W =AUX-)X^\7SV%RNG6+?OV.#BH?AYI6IO=2:
MC?2RX?)"LQQS[5C?$32KJU\2+JB1L\>XL<#-1%*6(M-W*;:I>ZK%BT\)>(]6
MB6:XO&17YP5-5/%'@<:3HCW,]P7D![YKIM,^(]DEA&DD;B15QC%<QXPUG4O%
M%JR6D$BVZ\G*]<5=*5;VJOHB)*GR::LZ#X0?\@AQ["L#XF_\C;:_5?Y5M_"(
MO'I\D4B%6&.HK,^*ME<IJ\%['$SHI'0>@I1LL9(;O[!'J>A_\@.T_P"N0KR3
M6_\ DJ0_ZZ5UG@OQDFI10:>875TCP21Z5R^LP2GXGAPC;?,ZXK.A!PJ34NS+
MJR4H1:-KXKHQT"R;^$,/Y5T'P\=6\-0[>RBK/BG1?[;\.^0!\ZIE?KBO./#/
MB.]\(3R6%]"YB!X(6E%>UP_)'=,;?)5YGL>U2.L:%W.%'4UE67B/2K^Z:VM[
MN-YEZJ.M<+K?Q&2ZLG@L8I&D<8'&:E^&_AVYMYI=3NU(>7. ?KFL'AN6FY3T
M9?ME*5HGIHJM?P?:K*6'^\,5:%(17*M#=K2Q\]Z3,_A_Q^R2?()),<^YKZ!B
MD66)74Y##(KS+XA^#);V8:G8#$R8.![5D:#\0;_1H1::E;R'9P#MKTZT/K$%
M.&YQTY>QDU+8]F)KC/''C-/#<44<3 SLPRH/.*Q+OXJQ>2?L\$ADQQ\M<C9Z
M/JWC;7UN[M&6$-W!'&:SHX7E?-5T2+J5U+W8;GJ6G^*//\-'4YUVC9GDUYS'
MK6O>,=4ECL79(5/4#->D:QX?'_")MIUJ,;4P/PKROPAK$OA'4YX;RW8*QQG;
M[UIAE!QE*"UZ$56[J,MCI8_AWJ<_S7EZQ'4C!%<7>:7'H_C6&W1MVU\$UZ3=
M_$6&6W*6<$CR,,#"YKS&\CU)_%$5_=0N/,?<..G-=&'E5N_::&550TY#V;Q;
M_P B@_\ UQ_H*Y3X0 >3=?\ 74UU?B?,OA!MH))@''X"N7^$D4D4-UO0K^]/
M45QP?^S31T27[V)ZA-_J)/\ =->"Z!Q\1Y/^NG]37O4Q_<2?[IKPG0K>8?$1
MW,;!?,ZX]S2P5N2?H.NM8FM\6D87-I(?N KG\Z] \%2*_ARVV_W:I>.?#O\
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M0M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*R8G"+W1!!;16T82) JCL*K3Z/97-R+B6!&D'1B*T,48I<S6H^5-#40(H '
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M1_\ GRB_*GP^&=+@E$D=I&K#H0*V:,4_:3[AR16MAJJ%& .!5&ZT:RNYA--
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MREN%%+28KF-A:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH 0BC%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%%  >E)BEHH 3'% I:* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI#
M2%AZT .HI,TM !124F>* '44@.:6@ HHI,T +13<\]:4&@!:**:6QU- #J*9
MO7^\/SI0P/0T .HI*6@ HHHH **0G%)N]Q0 ZBFAAZTZ@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **J:E>IIUC+=2?=C&37FA^->DB9X
MPDA*L5.(R>E 'JU%>;Z=\7M&O+I8&+H6.!N3%=CJ6O6VGZ#-JI;=#&NXD<T
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MN)@1)M/!_P!JL;PMX5C\1?"^8J@\^*9V5@.>*\^U77+R+2VT&\R6A=57/L:
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MXV9H<DE03]V@#3\!?$6#Q>&B*".=, KG-=]7SQ\*T$'Q!O(H^$\SH/I7T-0
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MKS>1$3\PSQ0!VM%0VTRSVT<JGAE!J;- !115'6+W^S]+GN?[B$T 3RW<$/\
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MNLHI[BV6-8B $5SSSGTKI[KPWJ<_PS33?)_?JA&*]C$: 8"C'TI=JXQM'Y4
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M-;K:.55AQU&*UO$L,%EXHTKRT6.,.>G Z5TEOX0M[;7+74D<!H(C$%QV-/\
M$GA>/7E0^8(Y8_NOCI0!S7CRYB+:<%=2V]> ?:N0M9KZ3Q=D6\,[*&""9L8'
MM7=_\*]::>&6\OO/:(@KE?2K>I>!8KJYBNK6<6]Q&NW?C- '%26^J_\ "1P7
M C@@(;++$_6I?AG;VUW;:I)J(5Y_/E&9.H&37:Z5X.-G??:[NZ^T2#H<8JG<
M^ 1]MDGL+H6JR9WJ!G.>M &;X'@MK?Q+JBVP79YW\/3I7>:PBOI=P&4,-O2L
M7PSX1C\/3S2B;S'E;<QQ72S1":)HV'##!H \0T,*GA/4O* #?;) <=<9KM-
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M&&Z$8E)+ICK0!YQX4DU"1[QA9VTQ+L"97P<;JZKX?V=U;ZS=._EI&[,2D;9
M-:DW@!DNI);&]%L)!\P"YS6QX=\,Q:"DA$GF2.V6;UH K^/_ /D4+OZ"N ^S
MQW.D:+'*H9#='(/?BO5M:TM-8TR6RD;:LG>L>/P; D%I%Y@Q;R>8..M &%XV
MTZSM=%LW@@2-EEC *CWKM=%);2("3GY:KZUH,>L6D=N[!0C*P./0UHVEN+6U
M2 '(48H R]2N[._,FEO<M#(RXR.O-><'1E\(^*XEM;EKO[2IW%R,C/':N[UK
MPBNIW@NX)_(G&/FQFH-,\%"VU);Z]N?M4R@A21C% %^/PY$VGS6[L<3 <^E9
M]OX4N$OHYI;ERD9&T9]*[  8I: ,S61MT:X'_3,_R-</\,9XH[>X#R(IST+
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M&H6TNBV[+*GRQ@$;AQQ6AJ%A#J%I);S*&1Q@YKBQ\/KBW:1;/4_)A<G*;<T
M=!!XEM+C6#80_.P)!(&1^=;PKFO#WA*#0V:7>)9F.6?UKI10 M%%% !1110
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MW#R*(\9W$T 3YI:X>\^)^@6MP8C.6(."0N:W]$\3:;KL>ZSG#'T[T ;-%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "8HQ2T4
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MN]6VE5HW?[N5(KK%(901T- !1BEHH 3%+110 F*,4M% "8HQ2T4 )BC%+10
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BFD\]:* '44E% "T4E+0 4444 %%%-SS0 ZBD%+0 4444 %%%% !11
M2$T +13:=0 4444 %%%% !1110 44F>>M% "T444 %%%% !1110 44E (]:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **8TBI]XXI58-R.E
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M1-BJ HXQ3Z* ,RX\/Z7=2>9-91.WJ15VWM(+5-D$2HH["IJ* "BBB@ HHHH
M***2@!:*C:9$X)Q3PV>E "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M4AH 0L ,D@4!L\@YKSGQWXHU6SD%KI]G*5# -,,8'-==X8GEN=$@EF.9#UH
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MI1T%0W'WEJ8?=% #J*** "BBB@ HHHH 1NE5[5B6;)JP>AJK:?>:@"W1110
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M%>D:OX%UVTD34IGWNI8G ZF@#ZE!R.*&^Z:QO"NH/J?A^UN9.7=,DUL/]PT
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M,HWO7FNN:SJOCOQQ)IMK=R10(VPA3Z'%5OB!X.U;PQI,8DOYI[9BI96Q@'-
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MTN[F2=5D 4OCUKZL\.?\@"R_ZXI_Z"* -6BBB@ HHHH **** "BBB@ HHHH
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MG/2H+G_5T 2Q?<'TI],B^X/I3Z "BBB@ HHHH **** *LO\ Q\+]:LBJTO\
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M444 %%%% "'H:K6H(+9%6:  .E "T444 %%%% !1110 5#<_ZAJFJ&Y_U#4
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M8 :^F&4,I4]",&N4D^'VC/KG]K!66XW;N!0!X'IDI\&_$B2;4%\N&63=O;@
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M/$AW7,0$G]Y1S6?H?PNT31[E;A(R\BG(W &@#R[XL6-U>/I^KS0.(V5-X]*
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M\ZJ1R)]L;YUZ>M%F%R]13/-C_OK^='FQ_P!\?G19CN/HIGFQ_P!\?G1YL?\
M?'YT687'T4SS8_[X_.CS8_[X_.BS"X\U!<_ZNI/-C_OC\Z@N9$V?>'YT6871
M/%]P?2GU'$?W8QZ5)0 "EHHH **** "BBB@"K+_Q\+]:LBJTO_'POUJR* %H
MHHH **** "BBB@!#TJK:?>?ZFK1Z55M/O/\ 4T 6J6DI: "BBB@ HHHH *KW
M'5/K5BJ]QU3ZT 3K]T?2EI%^Z/I2T %%%% !1110 4444 5/^7NK=5/^7NK=
M !1110 4444 %%%% $-S_J&HMO\ 5"BY_P!0U%M_JA0!-1110 4444 %%%%
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M)XFFI^SOJ=1FH;G_ %#4\'-,N?\ 4-5&X^+_ %8I],B_U8I] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !29I:R?$>H/I>@W5Y']
MZ)<B@#5S1FOGO1?C3J-WXCCL9UQ&TVS.!ZU[+X@UT:5X>;4%(^[D4 ;^X49K
MY\T/XSZGJ7B6WL&7]W))MZ"O?K>3S+:.0]64&@":DI-ZYQFH[B=+>%I7.%49
M)H EHKB]$\>VNMZY+86Z']V2"V<CBNSW>M #J*:'4G -+D4 +2&DWKGK02,9
MH 7-%<1?_$"TMO$D>CHI>5NI!''-=JK97- #Z3-)O7UIDTR0Q/*YPJ@DT 29
MH)KA],^(5IJ_B1]+M5)V-M+Y!%9GC7Q=K>C:U;VUA:22PN0&95!QQ0!Z72U1
MTFXDNM,@FF4K(Z L#VJYO7.,T +BBC(H- !FC->0?$KXCZCX7UB.SLT+;B1@
M &N9'Q8\6Q1>;)I<_EXSNV#I^= 'T+FE%>:> /B9%XI<VUPABN%X(8BO2=P
MSF@!U)B@.IZ&C(H 6DQ1N [T!@>AH 6DHR!2!U/0T +BC%&11O7UH 6BDR,9
MI-ZGH: '44F12%U'4T .I,T%A@G-<9JGCZRLM?CTE1NF8X.#TH [/- KC_&V
MO:AI&BQ76G0-+(W4*,]JTO"6IW>J:+%<WL9CE8 E2* -^BD+J.IH!!Z4 +29
MI:S-:UBVT2PDN[EPJH,\GK0!I'ZT@->!7WQAUW4KR1-$T^9XT8C(4'.*L:!\
M9;^'58[+7;62+><98 8H ]VS2U7M+J*\MTGA<,C#((J;>H[T .I,49%&X>M
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M/:3[G0_\)SXE_P"@O/\ G3!XV\1AMW]JSY^M8-%'L*?\J#VD^YT'_"<^)?\
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MP#D+]J\SY>:WOA1%Y'CZZC\XRD(X+'O5K7G2+XMQLY 7S3R: .N\2ZUJNC>
MK6>\CC:Y+$$'D8P,5T&@^*4MO 0U6[VQXCXQTS@U@_&"5)?!EJT;!A[?[HK
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M6,UZG\.H43PE98 _U8H ZR#=Y$>_[VT9^M2444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !4<TGE1,Y!(49XJ2D8 C!Y!H \:UCQ-)J_B&:TN+
M>\2SA?;\D1^;O7H7A;4+"XMO(LK>6((.=\>W-;)TZU+$F%<FI(K:&#_5QA?I
M0!/1110!S/C>VDN]"FAB7+LI %> R^"M9:5R+9N3Z&OIJ\&3']:F2--H^4=*
MZ\/BY4%9(YZV'55W9\N?\(3K7_/LW_?)H_X0G6O^?9OR-?4GEI_=%'EI_=%=
M7]JU>QC]1CW/EO\ X0G6O^?9OR-'_"$ZU_S[-^1KZD\M/[HH\M/[HH_M6KV#
MZC'N?+?_  A.M?\ /LWY&C_A"=:_Y]F_(U]2>6G]T4>6G]T4?VK5[!]1CW/E
MO_A"=:_Y]F_(TT>"]8+;?LS9^AKZF\M/[HJHD:?;&^4=*/[5J=@^HQ[GS-_P
MA.M?\^S?D:/^$)UK_GV;\C7U)Y:?W11Y:?W11_:M7L'U&/<^6_\ A"=:_P"?
M9OR-'_"$ZU_S[-^1KZD\M/[HH\M/[HH_M6KV#ZC'N?+?_"$ZU_S[-^1H_P"$
M)UK_ )]F_(U]2>6G]T4>6G]T4?VK5[!]1CW/EO\ X0G6O^?9OR-'_"%:R",V
M[?D:^I/+3^Z*KW,:;/NBC^U:G8/J4>YA^#-.EL/#\4$Z_-CD5->^%+*\G,I7
M!)R<"MR$80?2I:\R<N>3DSMBK*Q1T_38-.A$<*@>^*NBEHJ1A1110 4444 5
M9?\ CX7ZU9%5I?\ CX7ZU9% "T444 %%%% !1110 AZ55M/O/]35H]*JVGWG
M^IH M4M)2T %%%% !1110 57N.J?6K%5[CJGUH G7[H^E+2+]T?2EH ****
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M":HS ,&Q6$)2BK6/"PM3$T(<B@4];N_[=\1CR02I( KT0:,T_AY+0<,5%5-
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M[_A*HK:-)UC6$J1NSVKIO#^DG1=(ALMP;RUVY%:V*,4 +1110 4444 %%%%
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M468719I#5?\ M"R_Y^X/^_@H_M"R_P"?N#_OX*+,-"?:/2EJO_:%E_S]P?\
M?P4?VA9?\_<'_?P468:%FD-5_P"T++_G[@_[^"H)-3M!,H%U#@GG]X*+,+E[
M'M2X'I5;^T+/_G[@_P"_@I?[0LO^?N#_ +^"BP:%FBJW]H67_/W!_P!_!1_:
M%G_S]P?]_!19A=%FDJO_ &A9?\_<'_?P4G]H67_/W!_W\%%F.Z+&!Z48'I4'
M]H67_/W!_P!_!4<FHV80XNX/^_@HL+0M@"G51BU&S9.;N#/_ %T%2?VA9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHIA8#J<4 /HI <BD)Q0 ZBFJP;H<TN:
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MZF.65,5+2:]TZ 4M- Q3JV/=$/2JMI]Y_J:M'I56T^\_U- %JEI*6@ HHHH
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M@>F?W!1_P@>F?W!75T4>TEW#E1RG_"!Z9_<%'_"!Z9_<%=711[27<.5'*?\
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M_A3UI_SU;]*CE^$5HBY\UOTKUBJ]S_JZ/KM;^8/J]/L>8I\(+1ESYK?I3O\
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MJ-VQM]&;:^TK'PWI0!;-S &VF:,-Z;A69?:XEIJ$5KC)DSBO*-;OWMT>XCU
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MK/\ #^OMK$!G8(L?8YJCX]L?M7A\IOV[37%V_P!KMM+TW3+.X,9N8]Q8#T-
M'KJSQ2?<D1L>C US%EXQBNTNV"_\>\C(>/2N;N5O?"NJ66+HR13L R_AFL?P
MS)YVGZO)_>N)#0!ZUI^H1WFGQ718*KKGDXJRL\3C*RH0.N&%>5?;KV\BTK2+
M:<PI)$=Q'L:74X]2\/W:VD%VSK< *!CH>M 'J_F)MW;ACUS2>8F =ZX/?->3
M7?B6^3PE(BS'[6MP(_?%.T[Q%>74-AI[S'SE7]Z?<4 >LYXSFDW@C(8''O7*
M'Q?9S026T;CSE3&?>H?#=_/<:/J,DDA9E=MI].* .O,J8^^OYTB3Q.VU948^
M@85Y'K&KZF=+7[-<LLC8 (^M:-S;W_APV%Y]K+F8KO&/;- 'J-%5K&<W%G%,
M?XUS5F@ HHHH 0UD^(_^0)<_[AK6-9/B/_D"7/\ N&G'="EL4?!7_(%'X5TM
M<UX*_P"0*/PKI:JI\3%'8****@H**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "O-/B9_K;3_?7_T*O2ZX+Q[I5UJ$ML;=-VU@3^==&&:51-F59-PT
M->;2(=8\,+;2*"63 /I7F:ZG/X?M]1T:\)V&-]A/OTKV/3(VBTZ)'&&"\UQ?
MQ!\(?VO:&XM5_?CT[UMAZL>?DGL9U:;Y;QW,[X5)YOAG4%'<C_T&J_@NX73?
M&5]:S$*7P%SWYK;^%^D76DZ/<PW:;69Q@?A4?BWP?/+>?VKI;%+E3NP#C-7*
MI!U9P;T9"A)0C+L>A @C(Z5@>)?$]OX>@6252[,0 J]>M<5%XF\36D0ADLPS
M*,9R?\*CMM"UGQ3J<=SJ@\N%#P@.?YUE'#J+O-Z&CK.2M%:GIFEZ@-2L4N51
MD##HU<3\4?\ D&P_]=%KO+2V2TMDA0851BN0^(6F7.I6$:6Z;B'!K.@XJLGT
M+JIN%C7\&_\ (KV7_7,5B_$ZT:XT%95!(A)8_E70>%K:2T\/VD,HPZI@BK6M
M:>NIZ3<6C?\ +5-M'.HUN;S!Q;IV,OP9<+/X=MRI!VH :Y7X@2";6[&%>6R>
M/QJI92Z[X6:2TBMA+%N.TY-7-(T74=<UQ=3U*/8J'*KG-=$8J$W4;T,KN45"
MQVMMJ5E96MM!<7$<<C* JL<$\4Z^T:PU)"\L2ON7@X%<[XT\*R:G!#<V9(N(
M#N7''08K#A\1>([6T%FUF&=1M#9/^%91I\RYH/4MSM[LD4],+:'X\DL;=R;<
MOC;GI7H!BT2ZU!2[0O=8!VG!-<OX5\+7<FIOJ^I<3.=V,YJ+Q-X;U"RUE-6T
MS+$$;ESCI6M1PG.U];&<5*,;V.ZU'3[2339T>&/:(V_A'I7DGA(.E]JUM"28
M01@=JV[C7_$>H6WV1+,(SC:S9/?\*W_!_A(:192/<?-/,/GS2B_8TWS/<)+V
MDTTCE?AOIMO-JMZ\ZJSAFP&&?XC74^.]+LSX>ED\I$=""" !6%?:+JGAK69+
M[3$\R.3[RDX]^U07UQK_ (HV6;V_E0DC<03_ %%7*\ZBJ)Z$Q?+!Q:U-WX>:
MEL\)PR7DH5%!^=S[UU3+8ZQ#D,DT>>HY%9,?AB*/PN-+48^7&:XVQEU[PJ\E
MLMOYT18E22?Z5BX1JMR@[,U4G"*3V#QMIL6A7]M>6)\MBP!53C.37I6D3M<Z
M9#*X^8KS7FZ:7J_BK5(IKZ/RH$.<9]\]Z]0M8%MK=(E'"C%&(:Y(Q;NPI7<G
M)+0Y+XE_\BX/]ZI_ AV^$H".HC!_G3O'EA/J&A^5 NY]W2K'@RRFLO#T$$ZX
M<( 14N2^KI>86?M;GF>O:WJ'_"5M+/8SRP1-E0J\55\6>,Y]3TJ*V;3IH51@
M060 5[<VFV<C%GMT)/<BN/\ 'OAX7>EQI96R;Q("<>E;TL13<HIQV,YT9).S
M,;PCXKNI?#PMDLY08H]JMMX/%<SIGB"^L-9GO;O3;F:1C\IVY P:]8\+:3'9
MZ!;12P*) @#5J_V79'K;1_E4/$0C*24=RE2DTG<\$\4^*Y]4U>TN'LI8C&RD
M*RXS@U[%X2\02ZU9;I+:2';@?.,5RGC7PS)=:]926ELOEJZ%L?6O1[*VBMK=
M5CC"<<XIXBI3E2BHH*,)*;;99[5Y+*?^+FJ'_N''YUZW7E'B^V?2_%UKJ 4B
M-F52?J:RPN[7D776S.Z\66CWF@7$:#+8X%<C\+=0CCM)M.D8+-&['!]S7H<+
MI=VBL,%7%>>:YX0O--U5M4T8D,>60' -.C).#I2=@FFI*:/0[B]MK-0UQ,D:
MG@%CBN%^(^IVTNB^3#,DC2= I]ZYS6;[7M7M1:3V>&!X89//Y5B0Z!KEG-#=
M:@K30(<[2<UO1PT8OF<C*K6<E9(]#TNPD@^'CQ,#N*LV/KBJGPNG017L1.&6
M8C'X5UND31ZIHBJL912NT@C%<#=Z)K/AC6);S3$\R*0DE2V.M1&2FIP>C8W%
MQ:DCU=W 1B>!BO'[9A=?$Z5H_F"JN2/J:N2^)/$]Y$8$L@K-QG)_PK8\%>$I
MM/F?4+XYN).N><<YHA!4(R<GJQRE[1I1,;XM<-8?]=$_]"%=/?\ _(A-_P!<
MZR?B7HUYJCVGV:/=M="?^^JWKRQF?P<UJ%_>^7C%+F7LX>H6?/(P/A-_R"I_
M^NS_ ,Z]'S7B?A]O$?AZ.6&"T#*9&;DGN?I6VOB3Q06 -DN,_P!X_P"%/$4'
M.;DF@IU5&*BT>H$\5X[%_P E/?\ W1_.O4M'GN+G38Y+E LI'(%>?QZ%>CX@
M->>7^YP.?QK/#-1YD^Q59.7*T>@ZM]H&FR?9?]=CCBO-&_X3;<V"N,\?(:]:
M'2C%94ZWLU:URYT^;J>8^+;[4;?P]:PSL5EDD"N1QUK>\->&=/\ [%ADDB61
MY$R6(S5[Q?H']MZ=L3B1#N7ZUQUEK'B#1+<636@D"#:K9)_I70GST[0=F9-<
ML_>V(=6@'AOQ;:_8V*I-)@J#[4GBZ]FU#Q+8V#.4A=$9AG&:N:5H>I:]K::C
MJ2;%1MRKG-:/C'PM-=S0W]D/W\(  Z<"M.>*FE)ZV(Y).+ML;B^%-+%AY7D*
M<+UP*XSPU))H_B^;38I"T'&!G.,FI5\3>(EM_LQLAYF,;LG_  K1\(>&KJ.^
MDU34/]?)VSG'-1K",N=WN6O>:Y4=)XE(.A7!/]P_RKF?AD3_ &?)Z<8K8\;W
M:V^B,F?FD.T#ZU'X!T]K+0XBXPSJ":R3MAWYEO6JCKNU HH%<IN+1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%->18UW,P ]2:2.:.5=T;
M!AZ@T /HHHH JW?6/ZU.I^45D>)-1&EZ>UT1D1@FO.F^,42.5\E>..AK:EAZ
ME57@KF<ZL8;GKU%>0_\ "Y8O^>*_D:/^%RQ?\\5_(UM]1K]B/K-/N>O45Y#_
M ,+EB_YXK^1H_P"%RQ?\\5_(T?4:W87UJGW/7J*\A_X7+%_SQ7\C1_PN6+_G
MBOY&CZC6[!]:I]SUZJB?\?C?2O+/^%RQ?\\5_(U"OQ@B$Q?R5Y'H:/J-;L'U
MJGW/8Z6O(?\ A<L7_/%?R-'_  N6+_GBOY&CZC6[!]:I]SUZBO(?^%RQ?\\5
M_(T?\+EB_P">*_D:/J-;L'UJGW/7J*\A_P"%RQ?\\5_(T?\ "Y8O^>*_D:/J
M-;L'UJGW/7:@N?\ 5UY3_P +EA_YXK^1J.7XQ1.N/)7\C1]1K=@^M4^YZ]%]
MP?2I*\?3XR1*@'DK^1IW_"Y8O^>*_D:/J-;L'UJGW/7J*\A_X7+%_P \5_(T
M?\+EB_YXK^1H^HUNP?6:?<]>HKR'_A<L7_/%?R-'_"Y8O^>*_D:/J-;L'UJG
MW/7J2O(O^%RQ?\\5_(T?\+EA_P">*_D:/J-;L'UJGW/5)/\ CX7ZU9KQUOC#
M$9 WDKQ[&I?^%RQ?\\5_(T?4:W8/K5/N>O45Y#_PN6+_ )XK^1H_X7+%_P \
M5_(T?4:_8/K-/N>O45Y#_P +EB_YXK^1H_X7+%_SQ7\C1]1K=@^M4^YZ]17D
M/_"Y8O\ GBOY&C_A<L7_ #Q7\C1]1K=@^M4^YZZ:JVG5OJ:\K/QEB_YXK^1J
M*'XP11D_N5Y]C1]1K=@^M4^Y['2UY#_PN6+_ )XK^1H_X7+%_P \5_(T?4:W
M8/K5/N>O45Y#_P +EB_YXK^1H_X7+%_SQ7\C1]1K=@^M4^YZ]17D/_"Y8O\
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M&AC;[R _A4M%(+$:QJOW5 _"G4ZB@!C*&&",T!0HP!BGT4 -I&4,.0#3\44
M-  &,44ZB@",H"<D"G4ZB@!*P?%&BIJ^F,FW]XAW*?<5OTA (P:<).+NA25U
M8YKP@UW'IBVUVC!X@!D]ZZ,@$<C-"QJI^50/H*?3G+FE<4596(?(CSG8OY4C
MP1NNUD!'TJ>BINQV1#%"D*[8U 7T%.9%;J ?PJ2BB[&0B"('(C7\J?CTI]%
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M1^-KX11W<UBZVKG&XG@5H:AXKE6&)K&W:;S$W94US$VLQ:AX2@LK>TD,[_(
M%Z<#FJ,,5W'-;6M^DD<2Q?>7CF@#>'C6YOK.[MFMVCN(QC&>:K^'-5N)?#%U
M)>PN45Y.2>O-8NDVC_VU?>5;S^6Q&UG&<UK:7.TOA*]LQ;R+*KR'!'7F@#7G
M\81:?I]E!;1%Y98PRH#SBFP>/3&LB7<)CE4< GK7(WFE2PW6E7-S#,8!;[6V
M=02:6\TZ*:64V<-P^/XCR* .E3QW?30_:HK!S;*Q#.#QQ69XB\37UUJ>F26B
M-Y<B9*@^]:NGV3IX'GC\@B0EN-O-<_-!/:QZ7<O;2%(T"MA>G- 'K=C(\EI&
M\BE7*C(-6:JV,ZW%I'(@(! X-6J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** $-9/B/\ Y ES_N&M8UD^(_\ D"7/^X:<?B0I;%'P5_R!
M1^%=+7->"O\ D"C\*Z6JJ?$Q1V"BBBH*"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEI!&^](U#>HIZPQJY95 8]ZH6^O6%Q;M/'.I11ECGI58>*]*,RQ_:4RQP.:
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MDC\MX5*#L:S[?Q+IMP6"7"':,GFK#ZS9)9_:FF41 @;L^M %V.)(4"1J%4=
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M2,RK)\@^7UXH Q/#.IS>)_$"7@+"&$\?C7IH&*Y'P%H@TK2@3$$9QDCTKKZ
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MH^Q7G_/ROY5I44 9OV*\_P"?E?RH^Q7G_/ROY5I44 9OV*\_Y^5_*C[%>?\
M/ROY5I44 9OV*\_Y^5_*C[%>?\_*_E6E10!F_8KS_GY7\J/L5Y_S\K^5:5%
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MNWO%E P:K>(6*Z<Q']X5C:-.SL,F@#KU.12U'%]T5)0 4444 %%%% !1110
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M^$#UO_GV;_ODT?\ "!ZW_P ^S?\ ?)H^L4NX>REV.9HKIO\ A ];_P"?9O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &-XC_Y!;?[PK"T+[XK=\2?\
M@MO]X5A:#]\4 =E#]P5)4<7W14E !1110 4444 %%%% !1110 4444 %%%%
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M_P"H:BV_U0H EHI:* $HI:* $HI:* $JM<?Z^'_>JU56X_U\/^]0!9HH%+0
M4444 %%%% !2'I2TAZ4 06_?ZU8JO;]_K5B@ HHHH *9)'YB%3WI]% ')OX+
MA,[RQRE"QR<"C_A#1_S\M^5=916GM)$\J..F\(;8R1<M^5.C\'@KG[2WY5U-
MS_JC2Q?<%'M9!RHY?_A#A_S\M^0H_P"$.'_/RWY"NLI,T>UD'*CE/^$.'_/R
MWY"C_A#A_P _+?D*ZO-&:7M9!R(Y3_A#A_S\M^0H_P"$.'_/RWY"NKS1FG[6
M0<J.4_X0\?\ /RWY4QO!QWC%R^._%==FDS1[60<J.5'@X?\ /RWY4?\ "'#_
M )^6_(5U>:,TO:R#D1RG_"'#_GY;\A1_PAP_Y^6_(5U>:,T_:R#E1RG_  AP
M_P"?EOR%'_"'#_GY;\A75YHR*/:R#E1RG_"'#_GY;\A36\'?+Q<M^5=;FC-'
MM9!RHY)?!WR\W+9^E._X0X?\_+?E754N:/:R#E1RG_"'#_GY;\A1_P (</\
MGY;\A75Y%+2]K(.1')_\(</^?EOR%'_"'#_GY;\A75YHS1[60<B.4_X0X?\
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MJ5@]Q#R5[4,%J;>: :YK1/$?]I17#N OE.R]?2FZ)XG74]1O+<X"P2;<Y]J
M.HHJK]NM]I;S5P.O-"7MNYPLJG\: +5%5UNX&<H)%W#MFF&_ME;!F7/UH M4
M9K*U35H[.U:5"&(&<9J'1M<CU*R64LH<C.,T+4#;S1FJ$-V/F,C */>G27L;
M1[HG4\XZT@+U&:JK>0J@WR*#]:AU&^%G827*C<$7-,"_FC-<=;>,A<:=+="-
M<1MM(S5B+Q; =-6YD 5G&57UH ZG-&:YB/Q)*R,S08XR*G\/:Z=7:<%=OE/M
MZT(&=!FC-8^MZJ^E6WGB/<HZUEKXPAFT\7$"ACD@KGI0M0.LS1FL^ROC<Z>M
MRZ[05W8KGY/&D*W_ ) 4%,X+9HZV#I<[#-&:YFX\4PQ3(J@%2 2?2GWOB5+9
M8750T<G\6: .DS156UNDN;99AP"*!>0,2!*N1UYHZV M4F:KK>0,VU95)^M8
M7B/Q(FC^4%PQ<XZT =+FC-8-_KAL])BO-F=X!QFLF'QLI">=$$WKN7GK1U [
M3-&:XB#QL\ZO*MOF-.IS72Z7JL&IVWFPMGU% &GFDS7-77B5K?6EL/*SN)P<
MUL7MZMGI[W3CA%W$4=+AUL7<T9K)T76(]7MVECZ XJ=]5M8[P6ID'F'C% %_
M-+6'X@U@Z3:QS*N0QYYJY8:E#=64<^]?F7)YH!E_-&:Q=4UR.RMFFBQ(%ZX-
M9Z>+H9M,:ZA 8KG<N>F*!V.JS1FN,_X3,J\*M"!Y@R.:N6/B5KW57M4ARJG&
MZ@5SJ**:.13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "DS10: #-&:Y_7]?.C;/W>X,:OVFIQ2VR22NJ,PSC-
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M4?VSIW_/[!_W\%?)_P#:%U_SV:C^T+K_ )[-1_9']X/KWD?6']LZ=_S^P?\
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M)-G66=VEY LJ'@U:KC/!]\YO;VR<YV2D+]!79US5(<DK&T'="T445!04444
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M;?[PK"T'[XK=\2?\@MO]X5A:#]\4 =E%]T5)4<7W14E !1110 4444 %%%%
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M48^$/B4R% +;(_Z:BCZ]0_F%]7J=C@:*]"_X4WXG]+;_ +^BC_A3?B?TMO\
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MPHK>H%5&LD^:VH.FWI<YJXU>?3]66*>WW0'^/:/YUCZKN\0ZY EM 5CB8,7
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MA>32U%<?ZAJ )0<C(I:CA_U8J2@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *>H_\ 'O\ \"%36W^H6H=1_P"/?_@0J:V_U"T 34444 %17$9E
MA958J2.HJ6B@#GFT.Y).+N7GWIO]@W7_ #^2_G718I: .<_L&Z_Y_)?SH_L&
MZ_Y_)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_
M)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SK
MHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ*
M.<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ* .<_L&Z_Y_)?SH_L&Z_Y_)?SKHZ* .<_L
M&Z_Y_)?SH_L&Z_Y_)?SKHZ* .7?PS+(P9KAR1W)J4:!<@8%W+^=='10!SG]@
MW7_/Y+^=']@W7_/Y+^=='10!SG]@W7_/Y+^=']@W7_/Y+^=='10!SG]@W7_/
MY+^=']@W7_/Y+^=='10!SG]@W7_/Y+^=']@W7_/Y+^=='10!SG]@W7_/Y+^=
M']@W7_/Y+^=='10!SG]@W7_/Y+^=']@W7_/Y+^=='10!SG]@W7_/Y+^=']@W
M7_/Y+^=='10!SG]@W7_/Y+^=']@W7_/W+^=='10!SG]@W7_/Y+^=']@W7_/Y
M+^=='10!SG]@W7_/Y+^=']@W7_/Y+^=='10!SG]@W7_/Y+^=+_85U_S^2_G7
M144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144
M<[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_8
M5U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S
M^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G
M1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85
MU_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^
M2_G7144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7
M144 <[_85U_S^2_G1_85U_S^2_G7144 <[_85U_S^2_G1_85U_S^2_G7144
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M/<?^%RV?_/,_]\FE_P"%RV?_ #S/_?)KPVBC^S* ?6ZO<]R_X7+9_P#/,_\
M?)H_X7+9_P#/,_\ ?)KPVBC^S* ?6ZO<]R_X7+9_\\S_ -\FC_A<MG_SS/\
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MS_WR:/\ A<MG_P \S_WR:\-HH_LR@'UNKW/<O^%RV?\ SS/_ 'R:/^%S6?\
MSS/_ 'R:\-HH_LR@'UNKW/<O^%RV?_/,_P#?)H_X7+9_\\S_ -\FO#:*/[,H
M!];J]SVZ7XQ6;QE?+//^R:(OC'9HF/+/_?)KQ&BC^S* ?6ZI[E_PN6S_ .>9
M_P"^31_PN6S_ .>9_P"^37AM%']F4 ^MU>Y[E_PN6S_YYG_ODT?\+EL_^>9_
M[Y->&T4?V90#ZW5[GN7_  N:S_YYG_ODT?\ "Y;/_GF?^^37AM%']F4 ^MU>
MY[E_PN6S_P">9_[Y-0R?&&S>1#Y9^4Y^Z:\3HH_LR@'UNJ>X_P#"Y;+_ )YG
M_ODTO_"Y;/\ YYG_ +Y->&T4?V90#ZW5[GN7_"Y;/_GF?^^378:)XNM-9TQK
MR/<%7KQ7RZ:]C^'Q_P"*6NOHW\JX\;@J=&ESQ-*>*F[W/4-.URSU)<PRC(ZA
MN*TU((X-> P:A<6-V9(9"I!KT'PSXQDNW2WF4ECQG->!"JGHS+"9K&K+DGHS
MOZ#TIJ-N4'U%*>E;'LD-OW^M6*KV_?ZU8H **** "BBB@ HHHH AN?\ 5&G0
M_<%-N?\ 5&G0_<% $E%%% !1110 4444 %59O^/B/ZU:JI/_ ,?$?UH MCI1
M2"EH **** "BBB@ J*;_ %35+44W^J- "6W^J_&IJ@MS^Z_&IZ "BBB@ HHH
MH *2EI#0!!<?>6IEZ#Z5!<'YEJ=?NB@!U%%% !1110 4444 (W0U5M.K59/0
MU6M/O-0!;HHHH **** "BBB@ J&Y_P!0U35!<_ZAJ )(?]6*?4</^K%24 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!3U'_CW_ .!"IK;_ %"U
M#J/_ ![_ / A4UM_J%H FHHHH **** "BBB@ HHHH **** "BBC- !249%%
M!2TE% "T4F:,T +249HS0 4444 +12"EH *2C-&: %HI*,T %%%&: %HI.U
M/- "T444 %)1GBB@ I:3(S1Q0 M%)D44 +12<49% "T4F:* %HI :,T %+24
M4 %+249H 6BDS10 M%)10 M)11F@!:*2B@!:**3- "T4F:6@!**.** "EI**
M "BBB@!:2BB@!:*3-&: %HHS10 4E+FDH 6BDS10 M%)FC- "TE&:,T %+29
MHH 6BD[TM !1110 4444 %%%% !1110 4444 8WB3_D%M_O"L+0?OBMWQ)_R
M"V_WA6%H/WQ0!V47W14E1Q?=%24 %%%% !1110 4444 %%%% !1110 4444
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MC?\ /,?]\BC^U*78/J4SYOVM_=-&UO[IKZ0_X5KHW_/,?]\T?\*UT;_GF/\
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MU"YW2*4CSW%>CZ/X<L]+C79&"X[GFMB.)(EPB@#VJ0"O%C342L-E]*@[VNQ
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MUII.J?89XL2$X7+=:ZS3+[^T+1)]FT-VKQ#XG(H\>:;@#D'/_?0KVO2 J:5
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M9$S^=3U2'I9L]3M?'=FTR172B O]W<>M=7#,LR!T.5(R#7D?Q-M8X?"=M=Q
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M%5;0?,_U-/-[;X_UR?G56UO+<,W[U>I[T687-'%+BJ_VVWS_ *U/SI?MMO\
M\]D_.BS"Z)\48J#[;;_\]D_.C[;;_P#/9/SHLPNB?%&*@^VV_P#SV3\Z/MMO
M_P ]D_.BS"Z)\57N!RGUH^VV_P#SV3\Z@N+RWRG[U.OK19A<NJ/E%.Q5=;VW
MVC]\GYTOVVW_ .>R?G19A=$^*,5!]MM_^>R?G1]MM_\ GLGYT6871/BC%0?;
M;?\ Y[)^='VVW_Y[)^=%F%T3XHQ4'VVW_P">R?G2?;;?_GLGYT6870S'^E5;
MQ6=]LM_M7^M3\ZM?;;?_ )[)^=%F%T3XHQ4'VVW_ .>R?G1]MM_^>R?G19A=
M$^*,5!]MM_\ GLGYT?;;?_GLGYT6871/BC%0?;;?_GLGYT?;;?\ Y[)^=%F%
MT+<C]PU%N/W0J"YO;?R&_>K^=%O>6XB'[U?SHLPN7<48J#[;;_\ /9/SH^VV
M_P#SV3\Z+,+HGQ1BH/MMO_SV3\Z/MMO_ ,]D_.BS"Z)\48J#[;;_ //9/SH^
MVV__ #V3\Z+,+HGQ56X'[^'_ 'J?]MM_^>R?G56XO+?SX?WJ_>]:+,+HT,4N
M*KB\M_\ GLGYTOVVW_Y[)^=%F%T38HJ#[9;_ //9/SH^V6__ #V3\Z+,+EBB
MJXNX"<"52?K4N\8SFDT.Y)2'H::#GH:4]* (;?O]:L56M^I^M6: "BBB@ HH
MHH *BGB6>%XV^ZP(-2T4 >+?%#PQIVC:"9+6$+(V26KMO#T+7'@(0HVUGAV@
M_A57XGZ)=ZWHRP6B%FP>@K3TK1I_^$._L]V,<QBVY!Q@XH \M7X<ZO9+>WUM
M?[3DO@+Z"NI^$/BJZUN*[L+QB\MH.6]><5S4NG^-M$:ZTVW/GP3M@.REL#IU
MKM_AEX,D\+V4UQ<D&ZN1\^/KF@"Y\2]9GT7PQ)+ 2KOE01VXKS7P[X&D\0^%
MFUBXNV-RZ>8#D^A_PKU[Q?X?7Q)H<MF3AB"5/O7D-MIWC?0+&30K2-7MS\H?
M83QTZ_C0 WP?XFO;C0]<TBXD9_L<7RMG_:Q72?#*XDD\-:H7<DAI,$FKGA'X
M<G2M O3<'-[>IMD.>.N:Y72-(\7:!)?:;9PJ8)V<AF3/7WH I^'H'U2]UR&6
M1BHD..?]FH?A'X<BN_%5[*SD&V.X<_[6*Z?P+X.U73KG43?+\TQ/..#\M4O"
M.B>(_#'C*X\J &UN&P[%,\9)H ]@U>X:PT6YF3[T<3$?@*\,\+:-/X^U"^O+
MZY;"ME5R>.*]YNK87VFR02_\M8RI_$5XJ?#GBGP5JMR=%19;>9N 5+8'2@#,
MT:>[T/QA=>''N&DMI%"@9Z9/_P!:JWAOPO;W?Q)DB9CA"9!SZ&NQ\%^!-1EU
MB;7M:(^T.!M4<8P?2K?AWPO?V7Q FU"2,B!E8 X]: /4HX@D00= ,5Y]X]\*
MZ8-)OM2:$&X,9^;Z5Z**P/&5A+J/AVYMX!EW0@"@#D/A00GAZX)^ZI)/Y5P>
MHV][K/CN];0G,3JYWLHSGBO3OA_H-SI>BSVUTI4OD=/:N+U+PSXA\,>)KG4-
M'C66.=LX*[J (/A3-%8>*KVRO4S?X^9SWRQKVS4_^05=_P#7!_\ T$UY9\/O
M!.J0Z_/K^K;5EE& H&,8.>GXUZK?(9=/N8U^\\3*/Q!H ^:/"6I:S8^(+[^R
M[5YB7YVUU%AX-\0^)?%T6LZO&\2QE>&'I6_\.O"E]I.MWD]W#A'8$96O5O+4
M*0J@?04 >*^.TL4U:&">[\S:I A!(/6N5\/7,MOXVCM[</#!(V-I;-=7XH\,
MZU9>-!J]G"+F,AAM9-X&3Z57L_#&O3^+[?5;FW1$+Y*HF,4 <IK7A^,_%&WM
MBYQ)L8G/K6[XKC?2_&FEVL4C;$0CK_M"M/QEX5UI/&=IK.G1;PJH"-N>E.U?
MPSK6L^(]-U":'&U?WF%Z<B@#G?&&M2W_ (V%E<%FMH]OR X[4OA>ZU'3O&"K
M9I(+%U (SD5T_BOP;J=EXB36]-A28\%D9-W0>E2>%M U_4-?.HZA#%!$%P$$
M>WI0!SM]:7&M?$XV?GLD3%R1D^U&L:5)X2\>:9':3L([B4*RY/I776?A:_C^
M)/\ :)C/V?YN<>N*?XV\,7^I^+M)O((R8H9=S''M0!YSXNT",_$"R0N?WRHQ
M_&M[QWI&I:;'8K"DDMDB88*<=ZU?'GA/5I-;L=5TZ/>T2(I&W/2I-9TWQ3<V
MUIJ"(CNB?/$R9'7TH Y;PSJ.E'Q%:B.;[))O&49B<U]#6S@VT;!MPVCGUKPZ
M+PMK7B/7+2>:RCM$@<,Q6+9GC':O:$ADM=*$2?,Z1X'UQ0!XK\9O$"/J=OIQ
MDQ$#\X^AKD=4UW2++5],N]-=08V4R;?I7H>G>"+O6?&EQJ&L19@#G:".V*Z'
MQ9\.M,O-"FCL[5%G"':0HSF@#COB?J*:GX4TFY1LAI8C^M9/BB>6.#P^J.0"
MG.#[U9N?!^O77A>"PDB8M#=(5RI^Z*U?$'@[4[M-%$<1/D+A^.G- $7B 3^'
M?%6FZEO802K&&YXX7-9UQJ<_C'Q["()&,$$18X/&1S7HWCOPO)K?A>*&%?\
M2(XA@CKG %9/PM\#2Z#8W$E\N;B0D GK@B@#SO6-4?4/&L]M=[Y+>%\! V*U
M_ MW?V7C%H8(Y!8N% !.1U.:U-?\(ZOHGBF35]-@CGCE8L59-U:G@K1=<N-=
M?4]1ABA0@ ($V]#0!ZICS(L>HKYV^(OAZ)_B!;1ES^^D.:^C ,"O(?B7X;U:
MYUJVU738][Q,3C;F@#(\9&XTFTTO0;29DCF9=Q!_O"HO$/@AM \.P:S:W3"9
M2N[D\\UM:UX6UGQ)X?L]0D58]1MFR%VXZ# XK%N;'QKXDMX-'O8UCMD*[F$9
M&<'UH ],^'NL3:QX<@FG)+[>2:Z^L+PMH::!H\-FG51@FMV@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH IZC_Q[_P# A4UM_J%J'4?^/?\ X$*FMO\
M4+0!-1110 4444 %%%% !1110 4444 87B?0H]?T::R<?>Z5P7A2+4?!?FV=
MS 7AR=A&3W]J]9Q4;01O]Y%/U%):; ]3R:Y\.WWB_P 21W]Q%Y=M%C'O@^]4
M/B98W5W<65M9VQ=8.#P?6O:EB5!A5 ^@IC6T3G+(I/N*?9#OU,#PD5.C0 P^
M6ZJ >*X/XMVUYJ?D06L!D*LK'@]C7KRQ*@PJ@?04UK>-SED4_44/5W%'0\ET
M.Y73M)M6-DPNX5Q]P]:Z";7+Q=,BDEMV+ESP 3@5W'V2'_GDGY4XV\1&"BX^
ME-N[%:QS=WI=OXGT#RKB+EDXR.AQ6+X#\*3^'C?VSDB-B-AKT (%&  ![48
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M86@_?% '91?=%25'%]T5)0 4444 %%%% !1110 4444 %%%% !1110 4444
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MNXCO6E=^,KC3/&D.G70(MYDRK'IUXH ]$ZCFC %(C!E!!X-.H *0@&EHH 3
MHVBEHH 3%+110 4444 %%%% !1110 4444 %%%% !1110 4444 4]1_X]_\
M@0J:V_U"U#J/_'O_ ,"%36W^H6@":BBB@ HHHH **** "BBB@ HHHH ****
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M>QG$/]XIVK7M_%%M?:4]Y:9D*=4')IFIVT)\)LFT;1 /Y"O+?A?=W"^(M1M
M2;?<W';I3M>30KV29V6F?%&PN]9_LV>*2&3=M!<8%;NK>)S87,,:6TDJ28PR
MKD<UY_XQ\%/>V3ZMIPVW<66RHY)IO@GQL=3\G2=0!%W#)CG/0<4HZZ=1RT=^
MA[%:3&XMTD*E2PS@U8ID?W!3A0"%HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#&\2?\@MO]X5A:#]\5N^)/^06W^\*PM!^^* .RB^Z*DJ.
M+[HJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$+UG_GUD_P"^32_\(7K/_/J__?)KZB\F/^X*7R(_[HKI_M6IV,?J,>Y\N?\
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MK_\ ?)H_X0O6?^?5_P#ODU]1^1'_ '11Y$?]T4?VM4[!]1CW/ES_ (0O6?\
MGU?_ +Y-'_"%ZS_SZO\ ]\FOJ/R(_P"Z*/(C_NBC^UJG8/J,>Y\N?\(9K/\
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MS72)&L:850!["GXH/2N)12V-:5"%)6@B"V_B^M6:KV_?ZU8IFH4444 %%%%
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M;C5] CDNE(D4 '(KR&S35(+1=*/A^)I@Q'F$MFO:_"6GRV&CQK-$(Y" 2H-
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M **** "BBB@ HHHH **** *>H_\ 'O\ \"%36W^H6H=1_P"/?_@0J:V_U"T
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M^,_#.LZMXPMK^&V<Q0N&X'I6UK.AZMXFM;:QEB:*%-N[</2O4-D9/04H55[
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M(K*T%0GQ8E4?\]#_ "J?QZ"OQ TUB,#S$Y_"J7V?,3^T>EW,6IC0(W2ZD$Y
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MC8Z1]KD$88'.>Q-=]KT>JQ10?9[N13D!L=^:\NL<I\6&+<9VX_,U[+K)!2(
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MH [*+[HJ2HXONBI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!" 017F_B7P5J1U%M1T.=XYF'*K@9KTFL+Q)K\>@6L<\HRC-@G
MTH X/3?!7B+4KZ.77KF0QH<["00:]3MH%MX5B4851@5EZ?XETR_M8I4NX\N,
M@9K71E<!E.0: 'T444 %17$GDPO(>BC-2U',JO$RMT(P: /,K6?4O%&L:DR7
M;PPVTA5%!Z\9K;\%ZS<37=UIEW*9);<9W$]<FN>:QNM.UK4FTFY0I(Y,B@9V
MG%.^'%K<?\)%J4\T@?*C+ >] 'JM%%% '+>/)&C\.SLAPP4X(KYOFU:^$S_Z
M2_6OHWX@?\BU<?[AKYEG_P!>_P!:]W*XIP=SS<;)J2+7]KWW_/P]+_:]]_S\
M/5&C%>KR1['#S/N7O[7OO^?AZ/[7OO\ GX>J.*,4^2/8.9]R]_:]]_S\/1_:
M]]_S\/5'%&*.2/8.9]R]_:]]_P _#TG]JWN<_:'S5+%%')'L',^Y>_M>^_Y^
M'H_M>^_Y^'JC1BCDCV#F?<O?VO??\_#T?VO??\_#U1Q1BCDCV#F?<O?VO??\
M_#T?VO??\_#U1Q1BCDCV#F?<O?VO??\ /P](=6OCUN'JE11R1[!S/N7?[6OO
M^?AZ7^U[[_GX>J/%&*.2/8.9]R]_:]]_S\/1_:]]_P _#U1Q1BCDCV#F?<O?
MVO??\_#T?VO??\_#U1Q1BCDCV#F?<O?VO??\_#TG]K7W_/R]4L44<D>P<S[E
MW^UKW.?M#TO]KWW_ #\O5&BCDCV#F?<O?VO??\_#T?VO??\ /P]4<48HY(]@
MYGW+W]KWW_/P]']KWW_/P]4<48HY(]@YGW+W]KWW_/P]']KWW_/P]4<48HY(
M]@YGW+O]K7W_ #\/0-5O1TN'JE11R1[!S/N7O[7OO^?AZ/[7OO\ GX>J-&*.
M2/8.9]R]_:]]_P _#T?VO??\_#U1Q1BCDCV#F?<O?VO??\_#T?VO??\ /P]4
M<48HY(]@YGW+W]KWW_/P](=6O3UN'JEBBCDCV#F?<O?VO??\_#T?VO??\_#U
M1Q1BCDCV#F?<O?VO??\ /P]']KWW_/P]4<48HY(]@YGW+W]KWW_/P]']KWW_
M #\/5'%&*.2/8.9]R]_:]]_S\/1_:]]_S\/5'%%')'L',^Y=_M6]SG[0]+_:
M]]_S\/5&C%')'L',^Y>_M>^_Y^'H_M>^_P"?AZHXHQ1R1[!S/N7O[7OO^?AZ
M/[7OO^?AZHXHQ1R1[!S/N7O[7OO^?AZ/[7OO^?AZHXHQ1R1[!S/N73JU\1_Q
M\/0-6OA_R\/5*BCDCV#F?<O?VO??\_#T?VO??\_#U1Q1BCDCV#F?<O?VO??\
M_#T?VO??\_#U1Q1BCDCV#F?<O?VO??\ /P]']KWW_/P]4<48HY(]@YGW+W]K
MWW_/P])_:U\?^7AZI8HHY(]@YGW+W]KWW_/P]']KWW_/P]4<48HY(]@YGW+W
M]KWW_/P]']KWW_/P]4<44<D>P<S[FE!J]^)T(N7ZCO7ONEW<TO@5YG<EQ&>?
MRKYTA_UR?45]"Z-_R3^3_KF?Z5Y&;1BJ:LCHHR;C+7H<UI?C&[T^XVRN7CST
M)KT;1O$UEJZ8C<"3N*\?MM+NK^Z*PQL<GJ!7?>'/!DEHZW$[D,.<#(KYNE*5
M['%EU?%.=K7B=Q;'K5FJEHNU=OI5NN@^E"BD%+0 4444 %%%% $-S_JC3H?N
M"FW/^J-.A^X* )**** "BBB@ HHHH *JS?\ 'Q']:M55F_X^(_K0!:'2B@=*
M* "BBB@ HHHH *BF_P!4U2U%-_JFH 2V_P!5^-35#;?ZK\:FH **** "BBB@
M I*6DH @N/O+4P^Z*AN/O+4R]!]* '4444 %%%% !1110 AZ&JMIU:K1Z&JM
MIU:@"W1110 4444 %%%% !4-S_J&J:H;G_4-0 ^+_5BGTR+_ %8I] !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4]1_P"/?_@0J:V_U"U#J/\
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M6VM)-@ YYQ6\&4\@@T%D'5A^=#NP1E:7I\L&G"VNR).QR<U5T[PK::9J,MU
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M110!C>)/^06W^\*PM!^^*W?$G_(+;_>%86@_?% '91?=%25'%]T5)0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<KXYMK"XT-Q
M?NRQKDC;UKJJY#Q]I%UJNC!;1-[QMNV>M 'E^B)HPOX8UGU"./(VEAA:]VL5
M1;2,(Q9<<$UXE'%JFL"UTM='$#PE=T@;T->TZ9;O:V$43_>4<T 7:*** "FL
M,\4ZB@#BM4\#F[U"2YM[J:+S6RX5L UO:#H-OHEMY<1+,?O,>IK7HH ****
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M/_EZJUFO'/\ A<</F[_)/_?)J7_A=,'_ #Q/_?!H^HU^P?6:?<]>S1FO(?\
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MI4-Q]Y:F7[HH =1110 4444 %%%% "'H:JVG5JM'H:JVG5J +=%%% !1110
M4444 %0W/^H:IJAN?]0U #XO]6*?3(O]6*?0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %/4?^/?\ X$*FMO\ 4+4.H_\ 'O\ \"%36W^H6@":
MBBB@ HHHH **** "D-+2&@#&UOP[9ZY#Y=S$I/8D5FV?A1[-1&DY\L=%Q75T
M4+1 8=]H/VK36M%?:&&"<=:Y_0OAY%H4TDEM+M+]<#WKO**7F!YX_P -()-9
M_M(R_OLYSBI==^'<.O21O<RY,?3(KN#=VZOL,RAO3-.>>*-=S. OJ:.@7UN<
M;_PA#BQ%J+DB,#&,5?G\+[[*&W24J(\<XZXK?%_:G@3I^=)]OM,X\],_6G=B
M]##O/"=MJ$$"7*AVB'!(JGXC\#PZ]:QVTCXB08"X]JZDW]JO6=!^--_M&S)Q
M]H3\Z5AW,70_"T.E:6;!COBQ@ BJ:^"8K:9WLY/*5^H45U374"*&:50IZ$FG
M13Q2_P"K<-]*?6XNECGM*\(VEA=&Z90\Q_B(K0UK2?[5LFMM^U6&#6C)-'$,
MR.%'O217,$W^KD5OH:35QK<XWPSX!A\-WKSV\GWSE@!UK1\4>%4\1V_D3/A/
M3%=!+=00_P"LE5?J:='/'*N8W##VIO4#C-)\")I6FO90S8C88P![57T;X<Q:
M-J#W=O+AG.6P.M=Q)=V\)Q)*JGT)IAU&S'_+PGYT7ZATL</??#6"]U9=0DES
M*I!!Q6DWA"25T,ER2J]L5U!O;8+N,R8]<T"^M3TG3\Z 9Q.O?#FWUZ6-YY,B
M/[H(K0N/ ]K=Z(-.GPZJ, D=*Z47]H3@3IGZT&_M%ZSH/QI=+!UN<98^ !8:
M>;.*X(CXP,5O:?X?%GIKVI;=N&,XK56_M'.%G0GZTK7MM&</,@/N:>Z%U.&L
M_AM!9:LU_#+MD8Y.!3]4^'<6J:K'?S2YDC/RY'2NU6_M7;:LZ$^@-6 1CK0A
MLJV-J;2U2$MG:,9JEKNC'6+-K<OM5A@\5K,RJ,L<"EW#&<\4GJ"T.$\-_#N#
MPY=--;28W') '6NZ5<*!4+7UJC%6G0$=B:='=03?ZN56QZ&GN!*1E<5SZ>%+
M)-;;5!&OFLV2<5LM?6JMM:= ?3-2?:(O+\SS%V>M'6X=+%34K(WUD]N&VAAC
M-<5IWPSATR]DNH)MLDA))"^M>@1SQ3#,;AA[4V2Z@B.))54^YI;,.ECEX/"!
MCNC.\Y9NW%97_"L[<:W_ &GYO[[(.<5W/]HV?_/Q'^=3I*DB[D8,/44PL<;K
MGP_L]9,,CX$T>,-CGK5O_A$(WMH(Y)-S0CY6Q71/>VR-M>9 WH34P="NX,-O
MK1T#J<M_PA\4T\;W3^:(SE01TJ[K/A>RUBR6WEC7"8VG'3%:IU"T4X-P@Q[T
M^.[@F.(Y5;Z&BV@=3G=-\*FQC6+SRT:_PXK4OM'AOK(6S@;16I4$MW;PG$DR
MJ?<T-W#8YH^#U,:P&4F$?PXK?T[38=-M5@@0*H]*?_:-G_S\)^=.-[;!0QG3
M!Z'- C&U/PQ!J-Z+L\2@8!Q4,7A.,W*S7+>:5Z9%;XOK4YQ.AQ[T@U"T;I.A
M_&A(90UK1AJFG&TW;%(QTK"\,^!(O#ER\L$GWR20!ZUUAU"T!YG0?C0M_:.=
MJSH2>V:-M0>J,76O#AU:XCD,I4)VQ3M4\-1:GI/V&0C!7!.*Z#(ZU ]]:QMM
M>=%;T)I:6L!QVB> 4T2.5+>;"R Y 'K6WH6@'2"Y\TOO.3Q6I_:-GG_CX3\Z
M<;VV4#=,@STYIW$9][X?M+R_BO&C7S8SD-BN;\0_#N#7[M)YY,E"",CTKLQJ
M%HQP+A"?K4S2QJF]G 7UH&<;'X#A=(X[E_,CCZ*16KJ/AR.ZTY+. ^5&O8"M
M;^T;/_GX3\ZDBN[>8XCE5C[&@#(@\/K%I369;.5QG%<YI?PW@TK46O()-K,<
MG KO\@=:0,K=#FEUN'2QY]??#6"^UA=1DES,I&#CTJ_KW@"SUVRAAG WQ8P^
M/2NOEN(8/];(J_6HO[1L_P#GXC_.GOH!Q-S\.ENM-6QEN"T0&,$5)8_#V.SL
MOL:S?N<G*XKM/MUKC=YZ8]<T^.YAF_U<BM]*+@9VD:%:Z1;^5;QJN>N.]:/D
MH#PHISRI$NYV"CU-1"^MF'$R''O0P,'5?!UEJ%V+M4"3#^("JC>"(;F='O'\
MX)T#"NH.H68ZW"?G3DO+>3[DRM]#0M W,+6_"T.JZ7]@4A(2,$ 52\+>"(O#
M.Y;>3Y"22 *ZI;RW=MJS*6],T^2XBA&9)%4'UH#<5HU88(S44EM')&49 5/4
M4-?6JC<9T /?--_M&SQ_Q\1_G0P.8?P+:Q7S75F1"[')VBM>UT3RCND?>V,
MFM:*>*89BD5A[5)0#.8M_"WE:JUXTI;)Z8JCXG\!6_B.>.24@%,$<>E=<]Y;
M1MM>95/H34HD1EW!@5]:0)G&R^"/.T4::TY,0&,8I- \ VVB6\ENK!HI!@KC
MWKK&O[13AIT!'O2I?VLC;5G0D]@:>^H'$6WPWM['4);JUD\OS"<@#UJ$_#*#
M^V/[3$O[_.=V*]$!!Z4M =#D8_"+_;(II+@L(SD BNLB38@4=A3J!0 M%%%
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M 4]1_P"/?_@0J:V_U"U#J/\ Q[_\"%36W^H6@":BBB@ HHHH **** "BBB@
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M1W'PYTNYU 7DAE,H.0?,-=E+*L43.W0#)KGSXUT=;K[,9R)<XVXHZAT*>I^
M-.U946Y:5@G3YS2)X L8[7[,LLXC]!*:ZR&99HA(G0]*@O=2MK",O/(J@>]*
MX&1)X2M'T]+,-($4@\.<\5._AJSET]+.52Z*,#<<FF+XLTQF \Q@#T)&!6Q#
M<Q3Q"2-PRGN#3 P=7\'V.KVJ6TP?RU& H;%2Z'X5L]#MS!!N,9&-K-D5:O-?
ML+)]DDHW>B\FE@UZRGQAR,]-PQ0O(&9]QX-L)+AIX@T3MUV-M_E5C3?#%CIT
MQF5-\A_B<Y-;/F+MW9XJK!J=K<SM%%*&=>H!HZ@)J6FQZE:M!(6"MUVG%<]I
M/@#3M'OOM5L9%<G)^<\UT&HZM;:9%YMPQ51WQ5+3/%6FZM-Y=I*7;Z4+N@Z:
MBZWX;MM<@\FX9]F,$!L5F:;X"T_2X'AMFE5'ZC>:Z:ZNX[2!I920H&3@5BVO
MC32+NY^SQ3EI,XQBCR S;/X<Z79:A]LA,HE)R3YAHOOAUI=_>+=3&0RJ<@[S
M78&91%YA^[C-8,GC31X[O[,\Y$N<8(HOT#S*S>"+1RN^:<A>@,IIFJ^ --U=
M52X,A5>@WFM^YU:VM;1;F5B(V'!Q4ECJ,&H0B6 DJ?44/4#'@\'V$6EFP*EX
M2,88YJA:?#S3K*-XX'F1&/($AKL<X%4XM5M)KM[9)5,J'!7- ="IIN@0:;:/
M;QLY5ACYFS6&?AUI?]I&^'F"8G.0YKJ;[4(-/@,TY(0#)(%8L7CC1YB1',6(
MZX%'4"IJ'P_T[4[E9[@RLZ=/G/%=)I]@FGVJP(6*KTR<U'::S97L1>&96QU&
M>:S)O&NCP78MI)R)2<!2*/('W-/5-+CU2V:"4L%;KM.*YW2OAYIFD7?VBU\Q
M7)R?G-=#<:Q:VUH+F1B(R,YQ3].U6VU2'S;=B5]2*%IL#[%Q%VH%]*P=?\*V
MGB!=ET7*^@;%:<^JVEO<I;R2J)'. ,U/-<QP0F5_N@9XI 8V@^%K3P_%Y=J7
M"=@6S6O<VD-W T,R*Z,,$$9K(MO%^DW5W]F2X ESC#<5;OM>LM/*"=R-_3 S
M3O<25C*;P38[F\MI41CRJN0*TK#P_9:;;F*WB"[ARV.?SJV-2MS:BX,@6,C.
M6XJ@OBC37DV+(S8[@<4#MH8UQ\.=+N=2%])YAF!R#O-7M4\&:=JUM'#<*3LQ
MAL\_G6FVMV2P--YF449.*S(_&^CS.4CF9F'4 4>07ZFEHVC1:-:BWA9R@'&Y
MLU8U&P34;5H)"P5A@[3BJ5IXEL+PNL3L2G4$53;QQHRW!@,Y\P'&W%#N]P6F
MI4TOX?Z;I5\;NW,@D)R3O/-:FN^&K;78!#<E]F,$!L9J>S\06%Z^R.8;O1N*
MU,\4,+ZG*Z;X'L=+MY(+=I%1P01O-5[+X=:98WS7<1E$K').\UU-W?V]E%YD
M\BH/<UE+XMTQFQYK 'N1Q1?4+:&5??#C2[^]%W,93*.0=YJ9O EDYBWRSE8R
M"!YI[5T$FJ6J6OVGS T8&<KS61'XWT>61HTF+,O4 4>0;ZG000+;P)$GW5&!
M5#6=%AUFU,$Y8(>#M;%-L/$6GZC(8X)@7'\)X-:;R+'&7/0#-#\P7D<UH7@J
MPT"=I;0N-W4%\U-K_A&R\08%V7*CL&Q2OXSTB.[%L\^V0G !XK<^T1^3YNX;
M,9S2Z:@MS!T[P?8:=ITEB@9H'&-K-FJ5M\/M-LWD:!I4$F<@2$#FKR^--'>\
M^RK/F7.-H%%WXSTBQE$<\Q5CT!%/S#R,JW^&NEVURUQ$TJR,<DB0U>A\$V4=
MR9S),SXXS(3BK*>+]+<J/,<;NA*U9N_$5C9,JRNV6&1@9H KZ=X7MM.NWN(W
MD+/G.7)JCK/@+3=:O/M-QOW@Y!#8JPGCC1GE,2S,7'4 <UKV&JV^HJ3 Q./4
M8HM<"*UT>*UTS["C/Y>,9+<USJ?#C2X]2^WH91-G.[>:ZNZU"WLR@FD"[S@9
M-3I(KH'4Y4C.:+ZW![6,V_T6*_LQ;2.X4#'#$&H8O#=HEA]D?<\8)/S'-6+K
M7;*TE\N23+>B\T]-9LY(V=9,A1DTMP\C.U+PG9:CIZV3[UA  PK8JIIG@33]
M*MW@MFD5'&"-YJS<>--(M03-*R@'&2M26WB[3+LJ(I&(?H=O%,'H8T'PSTFV
MNWN8C*LK')(D-:-KX,L[:\^U>9*T@4@;I">M=&9T6+S"<+C.:AM=0M[PL(9
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M/RBL+Q;J$FF:1)=1 %HP2 :\>?XNZPDC*((L X^\:Z:&$J5E>!C4KQINTCZ
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ME?K5D&OGL_%S5RX;[/%Q_M&G_P#"X-8_Y]XO^^C1_9M?L'URF?06:,U\^_\
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M:OYF[R(_^^C3_P#A<&L?\\(_^^C1_9M?L'URF?06:,U\^_\ "X-8_P">$?\
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MAJFJ&Y_U#4 /B_U8I],B_P!6*?0 4444 %%%% !1110 4444 %%%% !1110
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M_"UE!-\3+F%T)3#X&:]QL],MM/W&!-N>37B/A9YH?B3/<O;R")BP#$>M>O\
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M%% !1110 4444 %%%% !1110!C>)/^06W^\*PM!^^*W?$G_(+;_>%86@_?%
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M/'N'*RO15C[!=_\ /O)^5'V"[_Y]Y/RHYX]PY65Z*L?8+O\ Y]Y/RH^P7?\
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MGCW#E97HJQ]@N_\ GWD_*C[!=_\ /O)^5'/'N'*RO15C[!=_\^\GY4?8+O\
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M>TGW#V<>QA3^&M)$1Q91?E3HO#6DE!_H47Y5JW'^J-.B^X*/:3[A[./8R_\
MA&=(_P"?*+\J/^$9TC_GRB_*MBBCVD^X>SCV,?\ X1G2/^?*+\J/^$9TC_GR
MB_*MBBCVD^X>SCV,?_A&=(_Y\HORH_X1K2?^?*+_ +YK8HH]I/N'LX]C'_X1
MK2?^?*+_ +YJ-=#TZVNXWAM8U;/4"MRJLW^OC^M'M)/J/D2+"@ 8 IV!2"EJ
M+%"T444 %%)10 M13?ZIJDS4<W^J:@!+;_5?C4U0VW^J_&IJ "BBB@ HHHH
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M>UV<9BM8XR<E5 S^%6!69HE^VH:='.Z%6(P016F*&"V%HHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-
MXD_Y!;?[PK"T'[XK=\2?\@MO]X5A:#]\4 =E%]T5)4<7W14E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q?Q$GNK?2(GMRX^?
MYMG7%=IVKRWXCZ_JUFT=O#8)+"6Y)8\T <!!_:MY?I?"6Z"QR!%!8X()KZ"T
M<R-IL)ESO*\YKQFWUW5+N*VMK?1[>'YE)97/K7M&E^9]@B\T8?'- %VBBB@
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M<EK%&VY8U!]A4]% #"@;J!2[01@CBG44 0?9("V[RES]*<8HV7:5&/3%2T4
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MUVC_ #!]7J=CS>BO2/\ A4NI>J_G2_\ "I=2]5_.CZ[1_F#ZO4['FU%>D?\
M"I-1]5_.FO\ "C447)*_G1]=H_S!]7J=CSFBO1U^$VHD9ROYTO\ PJ74O5?S
MH^NT?Y@^KU.QYO17I/\ PJ74O5?SI/\ A4NI>J_G1]=H_P P?5ZG8\WHKTC_
M (5+J7JOYT?\*EU+U7\Z/KM'^8/J]3L>;T5Z1_PJ74O5?SH_X5+J/JOYT?7:
M/\P?5ZG8\WHKT4_"C40X7*\^]/\ ^%2ZCZK^='UVC_,'U>IV/-Z*](_X5+J7
MJOYT?\*EU+U7\Z/KM'^8/J]3L>;T5Z1_PJ74O5?SH_X5+J7JOYT?7:/\P?5Z
MG8\WHKTC_A4NI>J_G1_PJ74O5?SH^NT?Y@^KU.QYO17I'_"I=2QU7\ZCC^%.
MHOG!7CWH^NT?Y@^KU.QYW17I'_"I=2]5_.C_ (5+J7JOYT?7:/\ ,'U>IV/-
MZ*](_P"%2ZEZK^='_"I=2]5_.CZ[1_F#ZO4['F]%>D?\*EU+U7\Z/^%2ZEZK
M^='UVC_,'U>IV/-Z*](_X5+J7JOYTU_A3J*8R5Y]Z/KM'^8/J]3L><T5Z0/A
M+J1'5?SH_P"%2ZEZK^='UVC_ #!]7J=CS>BO2/\ A4NI>J_G1_PJ74O5?SH^
MNT?Y@^KU.QYO17I'_"I=2]5_.C_A4NI>J_G1]=H_S!]7J=CS>BO2/^%2ZEZK
M^='_  J74L=5_.CZ[1_F#ZO4['F]%>B_\*IU'S-N5_.G_P#"I=2]5_.CZ[1_
MF#ZO4['F]%>D?\*EU+U7\Z/^%2ZEZK^='UVC_,'U>IV/-Z*](_X5+J7JOYT?
M\*EU+U7\Z/KM'^8/J]3L>;T5Z1_PJ74O5?SH_P"%2ZEZK^='UVC_ #!]7J=C
MS>BO1W^$^HHA;*\>](GPGU%ESE?SH^NT?Y@^KU.QYS17I'_"I=2]5_.C_A4N
MI>J_G1]=H_S!]7J=CS>BO2/^%2ZEZK^='_"I=2]5_.CZ[1_F#ZO4['F]%>D?
M\*EU+U7\Z/\ A4NI>J_G1]=H_P P?5ZG8\WHKTC_ (5+J7JOYTQ_A3J*LJY7
MD^M'UVC_ #!]7J=CSJBO2/\ A4NI>J_G1_PJ74O5?SH^NT?Y@^KU.QYO17I'
M_"I=2]5_.C_A4NI>J_G1]=H_S!]7J=CS>BO2/^%2ZEZK^='_  J74O5?SH^N
MT?Y@^KU.QYO17I'_  J74O5?SH_X5+J6.J_G1]=H_P P?5ZG8\WHKT9/A1J+
MYY7\Z=_PJ74O5?SH^NT?Y@^KU.QYO17I'_"I=2]5_.C_ (5+J7JOYT?7:/\
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MH **** "BBB@ HHHH **** "BBB@ HHHH IZC_Q[_P# A4UM_J%J'4?^/?\
MX$*EMO\ 4+0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;;_5?C4]06Q_=?C4U "T4E% !FC-%)0 N:*2B@""X^\M3C[HJ"?[RU.OW10
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M_L:7T-']C2^AH ZW^V;7_GH/SH_MFU_YZ#\ZY+^QI?0T?V-+Z&@#K?[9M?\
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MF4 ^MU#W#_A<UG_SR?\ [YH_X7-9_P#/)_\ OFO#Z*/[,H!];J'N'_"Y;/\
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MX?\ "YK/_GD__?-'_"Y;/_GDW_?->'T4?V90#ZW4/:_^%PV?F[_*;_OFI?\
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MS.>EFR55TZB/5I_O+4Z]!]*SXKG[5#')C&:OKT'TK8]J+4E=#Z***!A1110
M4444 (>AJK:=6JT>AJK:=6H MT444 %%%% !1110 5#<_P"H:IJAN?\ 4-0
M^+_5BGTR+_5BGT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AI
MC1!NU244 0?9T_NT?9T_NBIZ* (/LZ?W11]G3^Z*GHH @^SI_=%'V=/[HJ>B
M@"#[.G]T4?9T_NBIZ* (/LZ?W11]G3^Z*GHH @^SI_=%'V=/[HJ:C- $/V=/
M[HH^SI_=%344 0_9T_NBC[.G]T5-2T 0?9T_NBC[.G]T5/10!!]G3^Z*/LZ?
MW14V:* (?LZ?W11]G3^Z*FHH A^SI_=%'V=/[HJ>B@"#[.G]T4?9T_NBIZ*
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M[:=+F%94.589%<_%X"\/PR*Z:? &4Y!V"NCBB6&-8T "CH!0 ^BBB@ HHHH
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M5EH7_//_ ,=%(?AGH7_//_QT4?VK2[,/J,^Y\UT5]&O\-M$$ZKY?!_V14_\
MPK/0_P#GG_XZ*?\ :M(/J,^Y\UT5]*_\*RT+_GG_ ..BC_A66A?\\_\ QT4O
M[5I=F'U&?<^:J*^E?^%9:%_SS_\ '11_PK+0O^>?_CHH_M6EV8?49]SYJHKZ
M5_X5EH7_ #S_ /'11_PK+0O^>?\ XZ*/[5I=F'U&?<^:N**^E#\,]"_YY_\
MCHJO;_#?1'+9CZ'^Z*?]JTO,/J,^Y\YT5]*?\*ST+_GG_P".BE_X5EH7_//_
M ,=%+^U:7F'U&?<^:J*^E?\ A66A?\\__'11_P *RT+_ )Y_^.BC^U:79A]1
MGW/FJBOI7_A66A?\\_\ QT4?\*RT+_GG_P".BC^U:79A]1GW/FJBOI7_ (5G
MH7_//_QT5!-\-M#4KB/J?[HI_P!JTO,/J,^Y\XT5]*+\,]"VC]W_ ..BE_X5
MEH7_ #S_ /'12_M6EYA]1GW/FJBOI7_A66A?\\__ !T4?\*RT+_GG_XZ*/[5
MI=F'U&?<^:J*^E?^%9:%_P \_P#QT4?\*RT+_GG_ ..BC^U:79A]1GW/FJBO
MI7_A66A?\\__ !T4A^&6A?\ //\ \=%']JTNS#ZC/N?-=%?1G_"MM$^T;?+X
M_P!T59_X5EH7_//_ ,=%/^U:0?49]SYJHKZ5_P"%9:%_SS_\=%'_  K+0O\
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MI"0!S0 M%1-/$B;V<!?4T]'5U#*00>] #J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M=]8_K4Z_=%5[O[T?UJ=
M3\HH ?1244 +129HS0 M%)FC- "U33_C\;Z5;S5./_C\;Z4 7:*2C- "T4F:
M,T +129HS0 5!<_ZNIJ@NC^[H FB_P!6/I3ZBB^X/I4E "T4E&: %HI,T9H
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MW1110 4444 %%%% !4-S_J&J:H;G_4-0 ^+_ %8I],B_U8I] !1110 4444
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M#QG!<J&_*NZC.4!H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?V#I?_/E#_WS1_8.E_\ /E#_ -\T?VO_ '0^H^9\I_V9>_\ /M)^5']F7O\
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M#_WS1_:_]T/J/F?*?]F7O_/M)^5']F7O>VD_*OJS^P=+_P"?*'_OFJ]QH>F
MK_H4/7^[1_:_]T/J/F?+?]F7O_/M)^5']F7O_/M)^5?5:Z#I>T?Z%#_WS2_V
M#I?_ #Y0_P#?-']K_P!T/J/F?*?]F7O_ #[2?E1_9E[_ ,^TGY5]6?V#I?\
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MDA<HS%=F>G-=;\*-,M7\,22O C.9'Y90>]<UH4]A8_$^=;DQ1AF8*& '.>*
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MP<T>YMQ?<'TJ2L2/Q/H@09U2VZ?WZ=_PE&A_]!2U_P"^Z.2?8.:/<V:*QO\
MA*-#_P"@I:_]]T?\)1H?_04M?^^Z.2?8.:/<V:*QO^$HT/\ Z"EK_P!]T?\
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MA3^)M$++_P 32V_[[J5?$^A[1_Q-+;_ONCDGV#GCW-JBL;_A*-#_ .@I;?\
M?='_  E&A_\ 04MO^^Z.278.:/<V:*QO^$HT/_H*6W_?='_"4:'_ -!2V_[[
MHY)]@YH]S9HK&_X2C0_^@I;?]]T?\)1H?_04MO\ ONCDGV#FCW-ANAJK:=6J
MBWBC0]I_XFEM_P!]T[3M3LKO>UM<QRJ.NPYH<9+5H.9=S7HJK!>07!81R*Q4
MX(!J?-2--/8?124M PHHHH *AN?]0U35#<_ZAJ 'Q?ZL4^F1?ZL4^@ HHHH
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MPZNFZ7/!89,DZE2Q&#6SH.G_ -G::D1^^0"WUK2QD4HXH 6BDS1GF@!:***
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MOB(G^E6.T=N,?6N-DLM1'CZ=UO)+97CC","!SCWH ].T+Q:U[J!L;V,PSXR
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M UV/5]+6[8A2 -P/&*N#6M,^;_3H/EZ_..*\MT^_GTFZOM+N$,7VC=)&!T
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M.]*7_A4>J_WT_6O?HO\ 5CZ4^C^TJX?4Z9\_?\*CU7^^GZT?\*CU7^^GZU]
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MQU:I'EEL7'#0@[HAM]*MH)#(L:[B<Y(J\!CI3J*X;(V45'82G4E IE"T444
M%0W/^H:IJAN?]0U #XO]6*?3(O\ 5BGT %%%% !1110 4444 %%%% !1110
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M&/4@9KFO%&JW=DRI;-LSC+ \T =725YQX;\6WT_B3^S+F1I5<G:S'TKT<=*
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M4'CW]_*Q;><Y- 'K%4;O48+658W;YFZ"K@R(QGKBN"MY7U;QFZ.<I$K #Z4
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MRAJW7*_#_P#Y%F/_ 'C754 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M #R/Y"HI_AUHBID1'\A7;5!=?ZNCV]3N'LH=CE$^'.B% ?*_04[_ (5QH?\
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M"NPHH]O4[A[*'8X__A7&A_\ /(_D*/\ A7&A_P#/+]!7844>WJ=P]E#L</\
M\*[T3[1M\KCZ"K'_  KC0_\ GD?R%=-_R]U:H]O4[A[*'8X__A7&A_\ /(_D
M*/\ A7&A_P#/(_D*["BCV]3N'LH=CC_^%<:'_P \C^0H_P"%<:'_ ,\C^0KL
M**/;U.X>RAV./_X5QH?_ #R/Y"C_ (5QH?\ SR/Y"NPHH]O4[A[*'8XN?X=:
M(L3$1<_040_#K0VC!,7Z"NON?]0U);_ZH4>WJ=P]E#L<K_PKC0_^>1_(4?\
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M=P]E#L<?_P *XT/_ )Y'\A1_PKC0_P#GD?R%=A11[>IW#V4.QQ__  KC0_\
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M$:CHHXZ4XB@#A+?0Y'\</=S0$PF,C<1Q76RV$$=O)Y,2ABIZ"KFT YQS2]J
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M5$3#";<>U &%X+LYK'0(X9T*.&Z&NCIJ@#@4Z@ HHHH **** "BBB@ HHHH
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M:K_L_K1_9M</KE,^A:,U\]?\+6U7_9_6C_A:VJ_[/ZT?V;7#ZY3/H7-59_\
MCXC^M>"?\+6U7_9_6HV^*6J,X;CCZT_[-KA]<IGT2**^>?\ A:VJ^WZTO_"U
MM5_V?UI?V;7#ZY3/H6BOGK_A:VJ_[/ZT?\+6U7_9_6C^S:X?7*9]"T5\]?\
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MU-*BD!S1FK.L6H;G_4-4U0W/^H:@!\7^K%/ID7^K%/H **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!>0#-.2YBDC+JX*COF@#%7PEIH9&9-Q0@KD=,58G\.6,]W]I:,>8>IQUJ_\
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MLT25!&N)"2W'K5 >#]+#@F,'!^4$=*W?-CV;RPV^M1I=P2G"2*<>] $L:"-
MB] ,"JFHZ5:ZG$$N8PV#D$CI4GV^V'_+5>3CK2_;K;>%\U<GIS0!GV7ANQL)
MO-1 S]B14]YHEE?7,5Q-$IDC.5)%7GFCC7<[ #UJ!]0MQ"\HD4J@R>: (K_2
M;348!#/&K*O3(Z54MO#%A:OO"!F]2*K-XKMFL9[B,AO*)!&:M:)K]OJNG0W
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M)7PCIJS"3RQ@'(7'%: TNV%XMT$ D5-@..U67N8HQEW _&H_MUL5W"5<>N:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!0U&".X5(Y5#*QP0:ICPOI)Y-C#S_LUI7?WH_K4Z_=%4IR6PG%/<Q_^
M$6T?_GQA_P"^:/\ A%]'_P"?&'_OFMFBG[2?<7)$QO\ A%]'_P"?&'_OFC_A
M%]'_ .?&'_OFMFBCVD^X<D3&_P"$7T?_ )\8?^^:/^$7T?\ Y\8?^^:V:*7M
M)]PY(F-_PBVC_P#/C#_WS59/#.D_:F'V*'&/[M=%51/^/QOI3]I/N')$H_\
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MU/\ \(OI'_/C#_WS6A)_Q\K]:LT>TGW#DB8W_"+Z/_SXP_\ ?-'_  B^C_\
M/C#_ -\ULT4>TGW#DB8W_"+Z/_SXP_\ ?-'_  B^C_\ /C#_ -\ULT4>TGW#
MDB8W_"+Z/_SXP_\ ?-'_  B^C_\ /C#_ -\ULT4O:3[AR1,;_A%]'_Y\8?\
MOFJMKX9TEF;-E#U/\-=$1Q56T^\WU-/VD^X<D2C_ ,(OH_\ SXP_]\T?\(OH
M_P#SXP_]\ULXHH]I/N')$QO^$7T?_GQA_P"^:/\ A%]'_P"?&'_OFMFBCVD^
MX<D3&_X1?1_^?&'_ +YH_P"$7T?_ )\8?^^:V:*/:3[AR1,;_A%]'_Y\8?\
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MW,.JW5K!'<);-;2OF5B2#M..:Z34/!)=X+JW ^T( #DXR *FTSPO=QRSS7+
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M5OMUU_SW?\Z/MUU_SW?\Z/[)C_,'UY]CZI_X2;2/^?Z'_OJC_A)M(_Y_H?\
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MW77_ #W?\Z/MUU_SW?\ .C^R5_,'UY]CZI_X2;2/^?Z'_OJC_A)M(_Y_H?\
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M3BN)T[Q5>R:;-+<Q_O(\_,%P#BM"7Q')'X4BU7:-S[>,>IH W)+ZWCN5MVD
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M\*3U;_G\MOUH_P"%)ZM_S^6WZT?7L/\ S!]6J]CRVBO4O^%)ZM_S^6WZT?\
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MQY;17J7_  I/5O\ G\MOUH_X4GJW_/Y;?K1]>P_\P?5JO8\MHKU+_A2>K?\
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MQY;17J7_  I/5O\ G\MOUH_X4GJW_/Y;?K1]>P_\P?5JO8\MHKU+_A2>K?\
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M,:-6^\H/U% 'B%K\*;Q?#9'VJ4%T\PIQU(S46EP:K%X0OM'G@D+13H(R0>0
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MVQXW\06KO9F*WB=6).1T/N*[;4_ 1O\ 4!=K>2Q@'.Q0,5VZQQK]U%'T%/H
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MK/49;&^C(D>$(Q3>,'VXJ&;5+N7PC!I*6DGG(4#90]C7K@C4#A5'T%)Y,?\
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MHH **** "BBB@ HHHH **** "J=_J=KIL/FW4BHGJ3BK9Z5YY\6%W>'<>HH
MZ1?&6CL^W[2@XR#NZU8L?$NFZA<FWAG4R#MNZUYSKWA^P@M=%\FW1&D$9<@=
M<J*DU&P@TKQ5IIL8A$SVKEMHZF@#T.^\2:=82>7+,N[N,UEZWXPL[73H[FVF
M1PS[3@YKSN"&[O\ 7;OSX(I<8_UK8IFG:8BV,B3JKQB=CMSD#F@#U&#Q18KI
MD%S/.BF1<X)Y-6K'Q'IU^6$4ZY7J-U>:ZI-8O>:98P6T,LA@)"MPO!]:H:6A
M@\27$3A8%;&1$<XH ]3_ .$MTK[1Y(G4G.W.[O6!K_C@:?XLTW3H64P7$;,Y
M]P:XA+$:<TEQY,-Q#YQ;>S?,.?2K6LBQN?%OANY,"B-[1V;([YH ],N?%.FV
M@ DF4MC) -9VM^,+>WTD7EI*CC=@\YQ7(72P7]_.+>SMY%51EG;&*PM+C271
MKN*5%*K<-\O84 >C6&N/J4^ES?:(U$L19DSRW/:MN\\3:=82>5+,N_N >E><
M%(XM7\-BV4*/LDG"_6KGARSL=0UF_.JJCL%&/,[<T >E66H6]_#YMO('7V-5
M=0U^PTR58[F94=N@)QFL[PO_ &?&EQ%I[$QK(<C;@ UR7BN"SN/B!IL=[M,9
M#?*W0T =]8:_8:B6$$RDKR1FJL_B[2H)S$;A"5.TD-T-<1=FUTGQ%.]BH2!8
MU+B/IBN?G1+VPO;F"SM]ID),A;#9^E 'L$_B+3;>WCGDN$$;C*G=UJ.R\4:9
M?S^3#<(7]-U>0I&+W1]&AE^92G(/UK<U_38-)U>S?38%BD94^X,9XH ] N?%
M6EVMQY#SJ7!P<-TIUSXGTNU2)Y;F,"7[OS=:X;PG8:7>V^I3:K'&\ZS'F3J.
M.U9FKV-A?^(] M8?GM3NX*\4 >F'Q-IHMA.9U"DX'S=:?8^(M.O]PBG7<!DC
M->:>)[%K?6[>TMK=!;@+A"<*3BH! ^FZL)BD<*^6P*Q-D&@#TFX\7:5!*8VF
M7CJ=W%8_B/QDFGW%D+=T:.:0 GKP17%W<2WFD2W"65N(R,[RV&_*F&&":PTI
MYT5L76,GTH ])T_43-J*R-<QF-D+;<\U8D\6Z5'/Y1G4D'!(;@5P;$QZW(+?
MA1&X 7TQ6AH>FZ')X>DGNTB,F,N[?>'- 'HL4R31K(C JPR"*S-0\1Z=ITHB
MGF4.>V>:?I+0MI@^S$E!PN1BN$TRTLK_ ,3:F=65'*2,(Q)Z8H [Q=>L&LC=
M^>GE 9SNJO:>*M,O+CR(YUWGH"W6N(UF[TBSLEL[51(LA("%<*?QK >%K?Q!
M8.+>&#<R?ZMLY% 'JUUXITNTF>*2X02(<%=W-6(=>T^>S-TLZ>4HR3NZ5YSI
M6D6NI>,=6:[B64+(V P_V:QKL26R7=I#E+4 [@.@&: /6+7Q1IEW/Y,<Z[NW
MS=:6\\3Z993^3).A<'! ;I7*M9:%9Z7;3Q*B7!1<%!DDXKA],M[C4-9UEY88
MY66;@RM@CCM0![)-XETR"U2X>Y01N< [JFT[6;35%+6SA@.X->%WEI,UM8VL
MS;H6F88SD5[1H=AI^DZ7;B*..(L@R1QDT ;9[UYSJ%QJ>J>-+_3K>Z2&*WB1
MQN.,YKT8$%<@Y%>7R6/VWXD:L/MAMMMO&<@@9Y]Z -[2M)U2"\5YK^.1!U 8
MULWOB?3;"8PRS+O4X(#=*R['3DL7>5M4:4!3\I85Q6H/%J=[J$D%I!)M;YG<
MX- 'J<>MV,EB;Q9T\D#EMU48O%6FW1DCAF7>%)'S=:\KM))O^$:MH,D0-<.L
MP'3;7;'3_#]GIUO+&D:2F, ,@R30 S0_&D2:IJ<-_,H$3@(,UVUEJ%OJ$ FM
MY Z'N#7EWAS0["_U/79[F!)"K#;N'M73^ E$=I-$HPBR-@>G- $GB3Q5_9&J
M6]N" LF,Y^M:+^+]*AE\E[A!*.J[N:YWQG:VCZY9M/$A''+?45@6&D65]\1M
M2\R%'CC8;5QQTH ]'N?$^FVH4O.N6&<;JGAUW3Y[5KA+A-B]?FZ5Y$+6XN?$
MMW&]O$ZHF%61L #-+#(-,CN(Y@-CR#]VIRN: /3T\7Z5).(1.H). 2W6L5O&
MB)XL:P9U\CRPP/N:X76+8QPV\PM+>'G*F-\FM2&ULSXG9YHDW?8D*D^N* ._
ME\8Z1"Y1KE,@X/S=*<?%^D"14%RAW=PU>=66B65SI^LSS0(\BRG:2.GRU#I>
MC68^'YO'A5K@!L2$<CF@#UNYU>SM+1;F:9%C;H2>M5;/Q-IMZQ6*=<@9QNKR
MCQ--?31:7;XW6^].&/!..E6/[.FMM35TCBA'E-Q$^<T >D2^,-(B;:;E"<\X
M8<5A^+_&JZ3;64MI(C":958]>#7/>&]!L;K0KZYN;=))=IPS#D<UE:[;0MHN
MG[XP0M^J\^F: /9M.NUO+&*=3PZYJE?^)=.T^?R9IE\P=1GI5G3$A32X5A"A
M-G&VO+O$6F^9XGN[F'9<':-T<IP!0!Z@FLV3VAN1,GECOFJ=OXKTNYD,:7";
MNWS=:\BUS5;A_#\,%E'Y?^DA75.GO5AM,D5K&18H8CCK&^21F@#KI/'Z+K6J
M6P9?+MX5:/ZYJ;3O%#ZQI+RB9(W67&2<#%<ZNF:>OB+7$>WCR+*,KGUS4"0V
M\/A-_)15;[4.E 'HR>);"QM(EN;E#(1V;K5O3_$.GZDCM!.AV#+#=T%>8Z5I
M\&HZY9I<QB1 I^5A4%["=+\5ZU!IZ>5']D3")TZT >F/XOTF.9HVN$&W@G=Q
M6M9WL%];K- X=&&00:\M33]&E\(S3W"1?:>I8_>SBNK^'9!\)6F#D;* +/B#
M5&CO;:QMW'F.^&'< TS0[F1;^=)KJ.14SE0W(KG9C(WQ2G$A.P0QE1VSS69I
MKS)J^N&+);][C_ODT >@_P#"6:4MSY)N$W XSNK:CE26,.C J1D$5X/I^GSW
M'A]9W@A\T\F0O\W6O6O"\WEZ+"EQ*/,S@9- &U<S""VDE/\ "I/Z5Y;9^(;G
M6=7OV%VL<<)&S+8%>HW2+)9S*PR"AX_"O'[:RMHH->9(54C&"!0!Z)#XBLM-
ML8_MMU'N)P#NZU-)XMTI(E<SK\W(&[DUY=<6,=_=:;%.H9/-7(/>M7Q+X>MD
MU6V^Q*@=(R!"QVJ1F@#J/$7C*"S\.W-[92*TD:Y /-:_AC5QK6CQ7602PYQZ
MUY+JL\/]@:E:2VD<<P0#"<C\Z]0\%16\7ARW%NJJ-HR%]<4 4M0U>YB\7V]B
MK 1/"['ZBK]AJ\-I;O+=W497U#=*YW6O^1[M_P#KVEKE[J/SM#EC.?FW#]:
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ-VVJQ]!FDV YG5>I
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M",TN* .7/@G3O(MXMG^H8L#GN:U+W1H;RWAA9B!$01@^E:#2QH<,X!]S2ET
MSN% "0QB*%8QT48KF-5\$6FIZI)?[RDLBA6()Y KJ%=7^ZP/TIU '(V?@:WM
M9O,,S-QC&XTLO@.P>ZEE4[5E.77)YKJFD13AG /UIWF)C.X8H YZU\':=;:;
M)8A,Q29SSZU6L_ ]E;3;RQ=5&%&3Q74"5#T8''I0)4)P'4GV- &9I_A^VT][
MIXAS<'+U-INDP:8KB$8W$D_C5UI$3[S@?4U!>ZA;V-H]S*X\M1DG- %'6_#U
MMK:IYWWD((.?2H-,\+VFF:A)>)S+(?F.:UK*^AOK5;B)AY;#(.:F61'/RN#]
M#0!S^K>$;/4KK[2/W<IX)!ZBH5\#:9]B:!TW,S!BV>]=*\\: G<,CMFJ-CK,
M-Y<R0 %70XP>] &"/ %@^WSR7V?=Y/%6KWP78WES%/C;(@"YSV%=-2;L'&1F
M@#%MO#5I;6MQ H^68Y;\J;#X8LX=&_LU1^YYK<W+GJ,U0OM42REBCV,_F'&5
M&<4 4KSPK8WVG1VDJ96,[E/H:J6/@JRM)C*Y+M@J#D]#4S^+[-+%[HJ^U&*G
MCTK9TZ\34=/@O(L[)5W#- %*RT"UL;.2VC'R2#FJ=WX/T^]L/LDB94/Y@YZ&
MM^XF6WMWE;[JC)JCI^L6^H1LZ-MPQ7!H ETVP73K&.V4Y5%P*Q-4\&6>H7K7
M0)21_O')YKIMPQDGCUIJR1N<*X/T- &#%X0TV/3FLS$"K')/O5.T\!V%M=)*
MQ+"/[@W'BNMHR ,G@4 <W=^#[*YU1K[H[J%?GJ!4<?@FPCB>(?<9]^,]ZZ42
MQL<!P?QIP((X- &+9^&;2SN8YXUPR#BH+[P[;I>7>I1Q[YY8PA'J!70%U ^\
M,4TSQ%20P;'4 T >0:AH\=RDL2V4HE=_N[OUKT3P?IDFD^';6UE&'1<$5-IM
M_8ZE--Y<2AHG*DD=ZUPRA<@C% '+:_I936;;4H4)<L ^/05=T[P]:02S7:I\
MUP#O'UZUM2>65^<KCWIK7$,4#/O78@R<&@#EF\ :>9RRDB,G)3)JU>:"3>VI
MM\K'$1W]!6S8:E;ZC#YL#97US5D2QLV P)^M "[,PE#W&#6$OA6R5+I0.+C[
M];DDR1@EF X[FLRPUZWU#4+BSB!WP$;CVH JKX3LEEADV\Q,&'-&L^%+35ID
MG;*S(,!LGI705F?VNG]J+9>5)D@G=CCB@#)A\#Z<MK-#,F\S##MGK6IH>B1:
M':FWA.4W$@9K1,T8ZNH_&G%U"Y)&/6@#+N=!MKG4UOG'[Q49!]#5,^$;$VYB
M*_*:MW/B"UM]3AL3DO(I((K4,R #<P&?6@#+OM M;^SAMI1E(B"OX50O_!ME
M=^6R#RY(UVA@:Z3>@&2PQ2+*C'"N#^- &/HOANTT8L\0)D;JV:L:OHEMJXB\
M\9\MPX^HK0:5$^\P'UI=Z[<[AB@#'N/#=I<:G:WS#]Y;J57\:6Z\-V=U=M/*
MN2P -:PFC8X#J3Z9H:1%^\P'U- '(GX?V.9%!Q$Y)*Y-6;3P/IUG-;R1K@P*
M57FM'3]?MM1OI;6+.Z,D'\*U/-C#8WC/IF@#/L]$M[.[GN(Q\\JA6_"JB^%;
M(17$97*SL6;GN:W&D1>K ?6F-<1I&TA<%5&3S0!SI\$Z<VF?877,:C"\]*99
M>";.UF\QR7(&%Y/%7;WQ58V>G2WI):.,@''O6EI]_%J%HEQ'PKC(!H HZ5X<
MM-*MKN" 86Y<N_U-4;GP1IUS;&%D^ASTKIMPSC(S3@* ..3P#8>?#-*=[Q'*
MG)XK6TWPY:Z;<S31#YI<Y_&MEF5!DD >](LB/]UP?H: ,@>&[+_2 R!EG^\*
MR[;P+8V]R) 245MP7<>#75&:,-@N,^F:?VS0!S&H^"M/O;A;A!Y<H&,@]JAO
M?"<4'AZYM+0-YDBXR#S76]JC,T0."Z@^F: *FBV;V.FQ0N264#.:T::I!Z=*
M=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5#,,QN!W4U-3<4F!YOINK0:+JFH6]V1&2N5)[
M\UL>#4,DUQ<@?([D@^M;E[H%C?3>;+$-_<XZU=M+2*SC$<2A5'H*:"Q8I:2E
MH **** "D-+10!CZ^;<:<YN8]\>.1FN#U9]$GMK=-/4?:1)\H5N0:].F@CN(
MS'(H*GJ"*RX?#6GPW'G+$-P.1Q0@+FD"1=)MA+GS @W9J]2* JX'04M !111
M0 4444 ,90>HS7$:<F/B%JF!QA*[JJB6$"7DERJ#S'ZG% ' V5[#H&NWD=X0
M@<,REN^36EX38W6IWEV@_=M)E3Z\5T=]H=GJ$@>:,%AWQ5FSL8+&+RX4"CV%
M" M"EHHH **** "L#Q<@.@S< G([5OU#<VZ7,1CD&5/:D]AHX[3_ "%\'K]I
MC+Q[FR,US7B$Z-<V=HFFI_I0F3A6Y'->H"P@6U^SA!Y?IBJ,/AO3X9_.6%2V
M<\BF2M"YI0D7381+G>%YJ[VH50!@4M Q*6BB@!#TJK?7<=G:23RD!5!)S5NH
M+FUCNH&BD&58<T >8G7[3Q%J8^T7"+9HW"GO5O4'ATWQ;%?D@6K0HBMVX%=0
MG@[3(_N18^@K0N-&M+J!8I8P57ID4 <7H<O]K^.CJ$ S!$CIN'0YKT0#FJ5A
MI=MIRE8(PN3S@5>H 6BBB@ I#2TAH X[Q=XN@T4K:JP^T2#CV[54\,M9R)+<
M/.L]W(/F ZUTNH^'+#4YUFN(@SJ, XIUCH%G82%X5P:0'!2R^'?L5Y&L0CN#
M(WREN2U=9X*CECT2,2 @8&W-7)/#.GR7'G&%=Q.>E:L,*01B.-0%'0"F!-11
M10 4444 17#^7$SXSM&<5P&N:AHFL0R)>_+-%PJ[L<UZ&RAA@C@UCW'ANPN)
MS*T0W$Y.!0!YO"EVNDV5S,I\F&=CG'1>U:VK:G#K-Q8V]F1(RE6;';!KOGTR
MV>T^SF)?+],55L] LK*;S(HAN]<4 :-NNV!5/85-30*=0 4444 %96M:BFG6
MIDD7*$X/XUJU7NK2*[B,<JAE/8B@#RR_>QDURSNM'.ZX=B7P<UMW,VB)=G^T
MH@LQC&YF;K74VGAZPLYO-CB7<.G%.O="LKY]TL0SZXH XOX<PR)J>KO"&%F]
MQF/)R",=J])JI96$%C%Y<$85?85;H **** "FOG:<=:=2&@#RGQ#:ZXVL7-T
MUM)+ A(CP.,5%I\6HZIX$U6S>!U9XB%XZG->KR0I*A5E!!J&"QAMXC&B *>H
MQ2MT \S_ +9@7PM;Z:"#<*1&4[^E>A>'86M] LXG&&6/!%1CPWIXN?/\E=V<
M]*UU4(  , 4P'4444 %)2T4 8_B)+M]*D2S!,C#'%>67L6L:;IL4+V4F<C<Y
M'7FO:2,]:K7-C#= "1 0/:EU&<;?SV)@L'UBW((VX+'&.*SK$6LWBJ.32A^[
M"G<5/%=]>:5;7T*QS1@JO3CI3;'1;33SF&, ^N*?470OJ/E%/I!2T %%%% "
M5R?BIM-2>(ZA#N7^\3@#FNMJG?:=;W\>R= P]Q0!YA=Q6MYXDM#HH^4-^]*G
MCI5[2M5@T>WO8+M@DIW$ ]^:[FQT.SL&+0Q ,>^*9=>'K&[F\R2(;OI0!A>!
M89/(N[IE(6>0.OTQ79U#;VT=K"L42A54< "IZ "BBB@ IK_ZMN_%.I,<4 >=
M7\N@)>WJW$02<D\ENIQ5;0HTB\-3&\B9[0EL GMFNXN_#]C>3>;)$-V<DXJT
M--MA:?9O*7R\8QB@#RO7_P"R[D:<NC+BY6="P1N0N>:]9M-XMT#_ 'L<UGVW
MAS3[:?SDA7=VR*UP,4 +1110 4&BB@#B?B/82WVA*L:D[959L>@/-<:8=+6R
ML_[.S]M Y ;)S7L<\"3QE)%#*>QK+@\-Z?!/YR0KN!XXH0' *7T7QY)J=[\L
M,]I%&&/3(ZUL^&Y?M_B6:[B&8AN&X=#777VD6NH(JSQ@[>AQ4ECIEOIZ;8(P
MOT% %P4M HH **** &FO)]>T^WC\;)+J2D6KJQSG [8KUFL^_P!)M=1 \^,,
M1WQS2!GF=M':IJUR;%&DL2!O ;.15C4Y-#ETCRK1 MQO.%#<YKT*TT6SLXV2
M.)<-UR*@7PUIZS^;Y0SG.,4P&^%DECT"U6;.\(,YK;'2FQHL:A5& .F*?0 4
M444 %,8X&:?2$9H X62V_M;QB'DYCMR5Q4/B=#9:]97CC$*.,GT %=O%90Q3
M/*J@.QR3BFWFGP7T>R9 P]Q0!YR\XU_Q_:RV@W0QP?,XZ9%>I5FV&C6FG,6@
MB4,>^.:TJ "BBB@ I#TI:* ,K7K@6VDRMZC;^=97A"Q6'21.P^>49:NCN;:.
MZB\N097.:6&!((1'&,*.@I ><W<OA])+U)X1'<$'[S<GFMKP!'+'IUQNSY1D
M!CSZ8K:NO#MA=S^=)"N[OQ6C;6T5K$(XE"J.P%,"84M)2T %%%% !1110 44
M44 %%%% !1110 4444 %%%% "'I7(^/K_4+#1'ELMV0/F*GD5U]8'B>SU&YL
MP;!EWKU4KG- '"Z#X@\R99(]0G=E4%TD7:,]ZSI_&8O=3O//OKF$0N518TW
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M)V(QWKKJ /*[ES'\09W7J"_\J@U76]271=/^S3,LLUPZ$@UT-SX9NY/%,U\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH *,49S2T )2T44 %%%% !1110 4E+10 E%+10 4444 %%%% !1110 4444
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M"--=21J H&?X17G_ (PBD-YH.(V. <X'O5CQ)&^D^,-/U*[B9K79$"<9QA:
M.DTKXI7)U!+35;1H"XRIV8%;-AX^6X\13:9*H4(<*<=:X'Q7JUIXNUG3[?1X
MF9E*EGVD8PPS4/Q"T^\\-W=GJ5LC%VSN*B@#N-(^)\.HZS=V3*%6#/S8]\5H
M^$O&TGB75[VV2+$-O(4W[>O%>(W>G7NBZ1_:4,3^;>9#8'///]:]G^%6A_V7
MX9%PZXFN\2MD<YQ0!RGQ;FECU[30DC*"YS@UUGBUW7X>!E8AOLXY_P" BN8^
M,MA<+)9ZA%$72$EFP*H:_P#$*QU+P;'IUNKM<F,(5V'K@"@"[X.\2R:!X!EO
MWS(5=!SSU!J1OB[?M;"\CL'-J.6;RCTK)N=-ETWX3*TRD-*T;[3^-5[+Q9I:
M_#>;3FB/VID*J@0\G- 'L_AS7X/$.F)=P]^H]#6;XR\8P>%K925+S/\ <11D
MFL;X36%Q9^'RTRE=[LP!]#6!\5[2XAUS3]1,;26T2_/@9Q\U $]G\6KJ*_@C
MU6R>&"9L*_ED5J^+?B6- >W$$7FB95*X7/6N#\=Z]9>*=/T_3M)@:2YR5/RD
M8.*EUS3)HM3T."=&8J(L\=.E 'I_@SQ-?^(HY9+JU:% 1MW(5R,5P?Q8FEC\
M3:4$D909N@/L:]ALHDAM4"*!Q7D?QGL;B.:PU.&)G6&0LV![4 =1XP=U^'R,
MK$-Y(YS[5S/@WQ-)H/P_%ZV9"JKUYJAXA^(%AJ?@R#3[=7:Z*!"NP]<4ATJ>
MR^%5LLL;!Y%0E<>YH T9_B]?I:I>+8M]FR=S&,U#X]\;75UX7M[JQ#J)"I)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gtl21rgcbjm5000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 9_",<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML%R,QOF@"Q1103@4 %%9-SKMM;2E';!'M20:_:SRA%;D^U &O12*=R@CO2T
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M^JF#*PR"#0 M%%% !113'FCC'S.H^IH ?15?[;;_ //5/^^JE66-_NNI^AH
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MZ11]30!+15?[;;_\]D_[ZIZ7,+_=D4_C0!+11D'I10 44C,J_>('UIGGQ?\
M/1?SH DHI P89!!ICSQ1_>=1]30!)14"W<#' E0_C4P((R#F@!:**8TB+]Y@
M/J: 'T5'Y\7_ #T7\Z>"",@YH 6BBB@ HJ,S1@X+K^=*)HR<!U/XT /HHHH
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MO6K_ (AO3;6A"GEA7 NYD<L>230!8GU"YN&S))FHA-*IR'.?K6_HF@BZ'FS
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M@>M*_BR%>D9/XT ;E\0+5\GL:\TNN;IR*VM3\1R7:;(P47ZU@$DG)ZF@"[I
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MT4]Z]*TM EF@'H*\WM?^/N.O3+#_ (]$^@H LUQ?BW_7_E7:5Q?BW_7_ )4
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M>U>>Z#_Q_K]:]$C_ -6OTH KZ@,VCCVKS6Z&+E_J:]+OO^/5_I7FEW_Q\O\
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M\*J:?(8[Q"#CD5H?\(W=_P!UJDM_#MVDZL5. 10!VMLQ>V4GTKA_$W_'^?\
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M:I9R6MV^5."?2@#8\,7B(_EL<9-=EO7&<C\Z\JCE>)MR$@BKW]MWNS;NX^M
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M8K/TFP%E;*,?,:T: (+N(36[*1G@UYMJ,!@NW4C%>GD9&*XOQ/9[)O,4<$T
M8<5Y)%$8P>",5"JF24#N331TK0T:U:YO5P. : .TT.V$%FIQR16K4<*>7$JX
MZ"I* "BBB@ IK_<-.IK_ '#0!YWKW_(1;_>JG9?\?:?6KFO?\A%O]ZJ=E_Q]
MI]: /2K+_CV3Z58JO9?\>R?2K% !1110 4C?=-+2-]TT >=:Y_Q_M]346D?\
M?Z5)KG_'^WUJ/2/^/]* /1E_X]O^ ?TKSO69&>^?=7HL8S H]5KC/$FFNDQE
M120: ,G2]GVU?,Z9KT>V$8A79C'M7EJL48,,@BM6WU^Z@CV @_6@#M=3NHX+
M1]S#D5YS<N)+EV'0FK4UY=ZE)MY.?2JLUO);G$@P30!M>%?^/G\:[G^'\*\^
M\.W @O I[UZ"IW(#ZB@#AO$P/VDUAVYVW$9_VJZCQ3;$G>H-<H./PH ],T^9
M#91_,.GK5P,&&0:\QCU"X0J@<[?K7?:-(9+)"3DXH P_%GW1]*Y-/OK]:ZSQ
M9]T?2N33[Z_6@#T30O\ CS6M1AN4CU%9>A?\>2UJT <!XBM##=LV.":R;>8P
M3K(.QS7H6K::M] 1CYATK@[NPFLY2CJ<#VH [O2=3BNK91N&X#FM%I449+#'
MUKRZ&XE@.48C\:G?5+J1=I<X^M &YXCU9)088FS7+JI9@!U)I?F=N[$_C70Z
M'H3S2":9<** -SP]9F"T5B.35C6_^/%OI6A'&(D"J.!6?K?_ !XM]* /.7^^
MU=AX5_U1KCW^^U=AX5_U1H ZF@]**#TH X?Q7_Q\_E6%;?\ 'PGU%;GBO_CY
M_*L.V_X^$^HH ]*T[_CS2K$G^K;Z57T[_CS2K$G^K;Z4 >=ZW_Q_-]:CT?\
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M!R7_  B)SU'YU8B\*0@_O.?H:Z6B@#/MM&M+;[B?G5]551@ #\*6B@ HHHH
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MBTAN5VR*"#[5BW/A:WD),8(SZFNAHH Y(>$CNZC'UJ_:>&;6%@S@EA[UO44
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M0C(Q2T4 8EYX>ANYS(V<D^M11>&+>*0. <CWKH** &11B*,*.U/HHH ****
M"D(R*6B@#$N_#L%U,9&!R?>FVWAN"WF$BYR/>MVB@!%7:H'H*CGMX[B,I(,@
MU+10!S=UX6AD8M%QGU-0)X2PWSD8^M=710!FV.C6UE@JN6]Z@OM AO)=[#\C
M6S10!@0>&8(9A(N<CWK=1=B!?04ZB@"&YMH[J,I(,BN>N/"D;N3%P/<UT]%
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!129 ZD4;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3(]12T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45GZGK%II4#27$@7 KS[4_B@'=HM.C\Q^
M@RM:0I3GLB934=SU&BO%QXX\5!_,:QC\OZG_  K<TOXH1&58;]?+<]<+6CPT
MTM"55BSTRBJ=AJ5MJ,*RV\@8$5<K!JVYH%%%%( HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRO'M=B3S6:]RB[]2GK/0[6BBBN0V"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ7>W[3)L^[GBK]WJNJW"8N9Y64^IK,/S''<UTT*/LE:YE4GS,]4^%$;$LW;
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MO(?A7IQ>?S\=C7M Z5RXN7[S0UHKW3Q;7O#VH^&-3>\L5=K=FRRKTQ6KX?\
M&6A[P;FUB@N/XF)YS7J$]M#=(4FC5U/8UR.L?#K3-2;=%BW;U1:%6C-6J X-
M.\2ZWC/0VAP;N(C'3-</KGBO1%D;^SK&*2Z;HZGFM'_A4<.?^0E-CZ"M_1_A
M_IFEX9U6X8=W6A.C#5-L&IRT.*\,>%K[6M074-25PF?E5A^5>O6\"6\*QH,!
M1BEBAC@0)$@51V%25C5JNHRX044%%%%9%A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN"O)7GFO:X+."V7;%& ![4Z6VBG_ -8@-1+&2<O(I4$D?+J:'J,C@?9I.?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 44F:,T +13<TF: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9
MH =FC--S1F@!V:,TS-&: 'YHS3,T9H ?FC-,S1F@!^:,TS-&: 'YHS3<T9H
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MS40:G@T 29I:8#2T@'4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPC)2U0ZBBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M44 %%%% !1110 44F1ZTM !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 0TPT\TQJ (VJ!ZG:H6I@5I*J25<D
M%59!5("E(*J2+D$>M7G6JSK5(#Q[QO:/#JXDQ\N_K78^%KJ&73$0.,A>YK1U
M_0(M7MRI'[S'!KBH_!VL6<O[B3" \?/7=S1J4U%NS1R\LH3NE<W/%&N-I<.V
M,!F(XKE;V*\OM,:ZF;"\<;JZ#4O"UYJ%@JN090N/O5GMX5UE[3[.2FP?[553
M<(I6>HIJ4GL2>"Q_HTH] W]:R((UD\4,&&>?ZUU_AO0;C3('2;&2#T-48/"]
MVFN-=D#8?>E[2/-)W#DERQT,?QLBI+&%4#YNU2C?_P (J,9QLK8\3>&[K5)$
M:$#@]S6AIV@LFB&SN -VS Q1[6*A$?(W-F5X)^S_ &;!VA\#K69XX:3S0/X<
M5*?!^J6MV7MGPA/]^MZ[\./J&F"*?_7!< YHYH1J<]PM)PY;')V5MJ=YIOE1
MQH8SCG=6CI^E7.G:9+YXQG)ZU-;:'KFGJ8H?+*9XR:WET^\ETQHI@OF'THG4
M[-6"$#@?#MM'/K3&0 \]#]:]02%$B*1H%!&.!7):)X6N['4&FDQM/H:[4)TK
M/$34I:,NC%I:GEGB>!K/6EE(XWYKN=!O(KK3X\.,A?6DU_P\FK0Y _>#I7*P
M^$=9M7_<R84=/GJ^:%2"3=FB;2A-M*Z%\<%MZ]QBJEI:ZG>::(HXT\LXYW5U
M-SX;EU#2_*N/]<!@'-9MKH>N6"&*'RRF>,FJC4CR63U1,H/FOW)=/TR;3M#E
M$HY))ZUSGA7_ )#TOT-=W!I]Z^EO#<;?,;/0UB:%X4O+#57N)=NT^AI1J*TK
ML;@[QLC.U\?\5%'_ +XKT.P'^AQ_2N8U3PW=7FKK<QXV!@>M=?:0F*W1&Z@5
MC5DG&*1I3BU)W)T%6HQ42+5E%KF9L31BKD?2J\8JT@J6!.E3K4*5,M2!*M.'
M6FK3AUH =1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDR/44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*I5INCRQ81A+GNP^)6IM:Z5Y8[Y%>2^#;<W>O1.!G#@U[%XV\*WOB&,);[<
M]SBL?P9\/+S0;TSW00\C&&S44JD(46KZE3A*4ST>T39:QKZ"N#^)FB+>::UP
M =R+VKT.J6J6*ZA8R0$ [A7)3GRSYC:4;QL?*KC8S*>QQ7KWPIT]1%Y^.<FL
MV_\ A-J<]X\D/E["V?OUZ%X.\-S>'[+RIL;L]CFN_$5X2IVBSGI4Y*6I!\0;
MMK;0FVG&<BO!M*4W&M0'KF09KWWQEH%]KMIY%MMQGN<5QOASX7W^G:FL]UL*
M*01ALU&'JPA3=WJ.I"4I:'IVBQB+2X5 Q@5<GA6>%HW&5;K2Q1B*,(O04^N!
MO6YT=#YZ^(&@-IVIM,BX1B36A\-O$9LKU;65_E8]S7IOC#PQ_P )#9F.,#S,
M8!Z5YY:?"O6K.\6>(QC:>/GKT8UH3I<LV<SA*,[Q/:8W$D:N.A&:=5#2(+FW
ML4BNL;U '!J_7G/<ZD%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIU(*6@ HHHH *RM<MFN+%U49X-:M-D&8V'J* /FSQ%I@;56A*8;=5.Y\/+#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*1F"*68X ID<\4N=C XH DHJAJ>JV^EPF6X<*H]:QK;QSI-U.(H[B,L3T!JE
M"35TA.21U%%,BD$L8=>AI]2,**** "BBB@ HHHH **** "BBF>='NV[AGTH
M?1110 4444 %%%% !1110 450U/5K?2X?-N'"J/6L>T\;Z5>3B&*=&8G& :I
M0DU=(3DEH=/134<.@8=Z=4C"BH;BY2V3?(0!5!=>LV?;YJYH U:*;'(LB!E.
M0:=0 452N]3@LVQ(X'UIUIJ$-Y_JF!^E %NBBB@ HHHH **** "BBHI)XHR
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MK4;QYWS&N!ZT :ES=P@D@ UE-=Q23;5P#[5:TM49?WIR3ZU%J5B!)YD0Q]*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[^T710VS<!VKAX_BU>2:D+9;>(@G&:X8T)RO8Z'4BMSUZBJ>F7;7ME',X +
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M:S;.II&^XWTI:1ON-]*\PZCSO7B?MK<UM^%<^7^%8FO?\?K5L>&9%BMR['
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M4N5%#3_#VJZM\T43.#WJW>^"M8L(O-:!@HKZ$T_2;6PMDCCA08'7%3W%I#/
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M0:[NN?$RYJC-*2M$****P- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CFD$43.
M>PJ2N7\5>((;"R>-6!<CL: .*\;^+/.W6T9/!K$T/Q8MC:-%/G#9%8%TSW=U
M),P)R36;<P-*N"I&*DHZ*\ACO+HWMK(O)SBLS4[J[V[MA..X%9]I+/9KM5R!
MZ5J_VANM=L@RQ%.XK&;:R2W7+(=P]JNI--'( P.T>U:^DVD*Q&=B.><57O'C
MFN-J#% T,GO<Q KQBH[>]2?Y7(I\]D@AP""QJ"WT.<G<%//M0 ZZO+>!@I&<
M^E02R6[)N3&36JGAD3+F;&?<54OM&2R3>I'':@1EFRO9_GCSM^E-B9(9A%=#
MYO>M6PUB6.+9Y;8 J6?2XM60S;0)!TS0 R32&F@$ENXQBLR;2;X-N"L^/05W
M7A#0;QG*W)(@!ZD<8KIM0?1])A)_=R$=0#0!YE9WLMO$%EB88]14&IN]S%O0
MA?8UZ#IL>BZ\['RXUQG@FL;Q)X=B(9+!U4#DA10!YNMYL8J_7UIWVID4M&^3
M3[JQCM]T<K R5%9P01?-*1CWH +;4))I2ESG9FJ]]!'YP>W8"M3_ (E\SA?D
M%;%MH%A-%N$T?- &/$TQL""X.*P_,=9SP>M=5J.GI:+LBF4@]A3K30K=XO,E
M=03ZT <A>2M( "I I+:15&P*237976@6\L)$3J3CM7,?V=/8W15HRPSP: (_
M[/E\T2APHSGFKSQ3W,2PEP5QBECT^^N[@(I94SZ5=OM/O-,@#C<V!V%,11N-
M!:"VWJ<DC/%2Z1=BV)CF'.>]:6D:K%=+Y5S@$<<FEU:SL8T,J.F[TI#$N(S>
MH3'TK%FT^Y8D)G\J=8:U]GDV'A,XKI[*]LW =I%&:8''6\5[93[BC?E6S'K.
M[Y9E.:Z-VLYS@%36?=:);R'>@&: *AQ=0MCO6#+%<VLY* [<^E;,L%S9<QAB
MOM47VW=Q*ASWS0!#!>&1-K(<TR6)L[T4YK3C2U(RH&ZG6Z>7<[I5Q'CO0"*E
MKYEQ'B7*_6IOEM5.>?I3=7N4W_Z*0/I52*?S(L2<FD,M0NMU)E>*OVFH/83;
M>Q-8,4C6]P-H.":TV*S;6[T@*6MVYO+D31_>-/T'2M1-^A2&3'KBGOYL4ZN,
ME1VKN/#/B^SM)$CFM\8[DTQ6.\\-^&@(XY[I<O@=:[!V2V@+8PJBJ.E:S9ZE
M"I@D4\= :S/%NJRV5D4A4LS<<56Y.QS7B+Q\UO</!!D8KA[WQ/<7VY7D)![5
MUFC>$X-7B:ZOBJ,PS\XJQ_P@>E+,VR2)OH*U4HQV(Y7(Y+PGJB6&J"20X!;-
M>X:??17MLLD9!XKQ'Q)X8ETV7S+1MR]<**]&\ M-_9P$JD$8ZT3:DN9!%-.Q
MVE%%%8F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWXF8L?<5-)X=L7C)VK^5,#,T[7+5HUV1J&HUC7H?LK*Z Y'K5BWLK&SE(<*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** &-$C'YE!IRJJC"C%+10 8%&*** "H9;6&;_61AOK4U% $,=K!%_JXPOT
MJ:BB@ ICQI(,.H(I]% %=+&V1MRQ*#ZU/M'I2T47 0*!T%+110 4FT>E+10
M4444 %0R6D$QS)&&^M344 ,CB2)<(H ]J=M'I2T4 ( !TI2,C!HHH KO8VSM
MN:%2:ECB2(810!3Z*=V 5%+;0S?ZR,-]:EHI 0QVL$)S'&%^E3444 %->-)%
MPZ@BG44 5TLK:-MR1*#ZU/@>E+11<! H'04M%% !1110 4F!2T4 %%%% !@4
M8HHH *BEMH9O]9&&^M2T4 ,CACB&(U"CVIVT'J*6B@!  .E+110! ]G;RG+Q
M*3[T^.&.$8C4*/:I**+L!" PP1D5!]AMM^_REW>M6**+@(% & .*-H]*6B@
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:4_Y0Y*G\QQ__";S?\\/_'31_P )O-_SP_\ '378?8K7_GWB_P"^!1]BM?\
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M_GA_XZ:[#[%:_P#/O%_WP*/L5K_S[Q?]\"CVE/\ E#DJ?S''_P#";S?\\/\
MQTU%)\0!;NHGCV@_[-=K]BM?^?>+_O@5POQ#MX8[92D2+QV4"M*;ISDH\I%1
M5(1YKG:Z;?)J%HLZ=&&:N5A>%/\ D#1_05NUS35I-(W@[Q3"BBBI*"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% ''^-_\ 56W_ %TK>T'_ ) \
M'TK!\;_ZJV_ZZ5O:#_R!X/I6\OX2,8_Q&:5%%%8&P4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5P?Q&_X]5_W:[RN#^(W_'JO^[6^'_B(QK_PV;_A3_D#1_05NUA>%/\
MD#1_05NUG4^-ET_A04445!84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5E:[;PW5DT4V,,,<UJU5O;<3P
MD>@H \(\0>&M,TVZ:Z#QYSG%<UJ&M^=#]F@C(&,9!KTOQ3H3W/F'R<A:\ZM[
M",Z@86C"D'% RAI.OW&AS;ANR3FNBD\7MK,7ER@@XX)-<YKVG/%<J$0D8I;6
MV"!<##4"-);V9V,1DW*.0*CD=\X((44XI'#AAC-0RB:Z("@JM247(9E,9(Y
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M[&@"&/7K><(;=@N#T!K>B66^B1^=M>;6UG)IBL&B+,">*Z?0?%9MT$%PN,\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH X_QO_JK;_KI6]H/_ "!X/I6#XW_U5M_UTK>T'_D#P?2M
MY?PD8Q_B,TJ***P-AKML0L>PS7 ZQ\5=+T>]-M*%+ X^]7=W/_'O)_NFOCSX
MD?\ (U2?[Q_G0!]6>'?$MMXBM1/;XVGT-;E>3?!/_D K]37K- !1110 4444
M %%%% !1110 4444 %%%% !11534[DVFG3SJ,E$) H ?=7UM9*&N)EC!Z;J=
M;W,-U&)(7#J>A%?*GBSQ[J^K>*5M?M$D<*R?<SQ7T5X%);PY:LQR3&.: .GH
MHHH **** "BBB@ KG/$WB^S\,Q"2YQ@C/)Q71UXA\>O^0>O^X: .QT3XIZ7K
M=\MK"%WMT^:N]5MR*P[C-?'GPK_Y&ZW_ !_I7UT;B.UL%EE8*JQ@DGZ4 /N[
MN&RMVFF<*JC.37GM[\8M%L[EH=R/M[AJ\]^*GQ1:Y>33=.DPHZLIKS?PEX2O
M_%FJKA',9(+/CM0!]2>'/'EMXDDVVT!V_P!X&HO$GQ&T[PY<^1<!=V<<M5SP
M?X/M/#&FQPQHOF!<%L<FO,?B=\.]6\0ZOY]I%(R[B?E% 'IGAGQQ8^)FQ; =
M<<'-:>O:]!H-FUS/C:OJ:\W^%?@C4?#<I:\C=06S\PK8^+O_ "+$WX4 3:3\
M5]*U74!:1!0Y./O5WC3JML9_X0NZOC?X??\ (Y)_O?UKZ]F_Y 4G_7#^E '%
MWOQ:TJRU/[$X7>#C[U=MI6IQ:K9)<Q?=89%?'/B;_D>G_P"N@_F:^IOAY_R+
M%M_N4 )XE\?6'AJ39<@$GU.*E\,>.+'Q.2+8#@XX.:X'XH^ ]3\170DM(G<
MG[HJS\)_!&I>&7=KR-URV?F% 'K]%%% !1110 4444 %%%% !1110 4444 %
M<'\1O^/5?]VN\K@_B-_QZK_NUOA_XB,:_P##9O\ A3_D#1_05NUA>%/^0-']
M!6[6=3XV73^%!1114%A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <?XW_ -5;?]=*WM!_Y \'TK!\;_ZJV_ZZ
M5O:#_P @>#Z5O+^$C&/\1FE1116!L17/_'O)_NFOCSXD?\C5)_O'^=?8=S_Q
M[R?[IKX\^)'_ "-4G^\?YT >W_!/_D K]37/_'7[B_[U=!\$_P#D K]37/\
MQU^XO^]0!Q?P33/B-CZ$5]6U\K?!'_D8&^HKZIH ^1OC#_R-3?[QKUKX)_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=-J-GH:^CJ* ,V#2HO[(2QN%#H%VFO)O%GP2@OIY+G3RD;,<X->UT4 ?+R?
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M]!6[6%X4_P"0-']!6[6=3XV73^%!1114%A1110 4444 %%%% !1110 4444
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M (1+6?\ G[G_ ._AKT2BCZS,/81/._\ A$M9_P"?N?\ [^&C_A$M9_Y^Y_\
MOX:]$HH^LS#V$3SO_A$M9_Y^Y_\ OX:/^$2UG_G[G_[^&O1**/K,P]A$\[_X
M1+6?^?N?_OX:/^$2UG_G[G_[^&O1**/K,P]A$\[_ .$2UG_G[G_[^&C_ (1+
M6?\ G[G_ ._AKT2BCZS,/81/._\ A$M9_P"?N?\ [^&C_A$M9_Y^Y_\ OX:]
M$HH^LS#V$3SO_A$M9_Y^Y_\ OX:/^$2UG_G[G_[^&O1**/K,P]A$\[_X1+6?
M^?N?_OX:/^$2UG_G[G_[^&O1**/K,P]A$\[_ .$2UG_G[G_[^&C_ (1+6?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#+!$X
M)<#\:FK&\174UM8.802V#TH JZCI6ERYD?82.>HKSOQ5JHTY<694(.PK#O\
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M3?J/VM3@YS7IFC>/(K5X[2XW#G&3TKR+3KF3S=P/RBMFX$&JIMB.R9.02>]
MV?1-I>0WD"RQ.&!&>#5BO*?AU?WUL_V.Z8NHP <5ZJ#D9IDBT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444A8#J: %HI 0>E+0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#SAZT></6@">BH/.'K2^:/6@":BH?-'K0)1ZT 344P.#3@<T +1110 4444
M%%%% !111G% !143W$2?>8"H'U.V3K(*=F*Z+E%93Z_9H>9%I@\161_Y:K^=
M/DEV%SQ[FQ164NO6;''FK5I-2MGZ2"CE:'S)ENBHUFC?[K U)4C"BBB@ HHH
MH **** "BBB@ HHJO=S^1$6H!NPZ6Y2+[Q%8FHZRD?W6%4;J\>=B-Q%8]RH+
M;2^236L8G!5Q#>D3K='U/[6,5M5@>'K'R80Y[UOUG+<ZZ5^1<P4444C0****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXMV!4>9C@XH V;:[6YM%9#G(K"U_2OMEJX"98U)X;5HXV1R2.V:W9-H!R :
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M$?>J*UL+Z_;S7B48[9J74;.5(=DT*J<<$4 )96DB1>=&[+NY./>HKJWLU?\
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M=)0(XT4-72ZUH2QN?(.5/2N?N=/N;>'<5R /6GRNUQ<RN9UQ,TL@1138U9)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *1ONFEHH \<\>VT@O\ < =I)KEHHQ$FZO4/B)$B
MV&\#YMIKRJTD,Y*-TS2*+T$ (+@_K3K:U%Q/AJ;)FWCVISFK.E+^]WR,!]:
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M]CE(/7&^H;6TFL[9"R_,,=JKZOJEYM2+. 6Z8H QX]4G$NRYSM'?%7TGAN,
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M:4R \J:5F5>(SRR!D]*%VD]Z1YST(H\P,O'%*S&I(?M Y!-/CU"6 X5V'XU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHJ"YN8[6(O(V * *VL79LK"28=5!->:1_$027+V\^-O3DUJ>
M)?&=K*K6D;*Q;BO(];@$5QYBG:SGM0!TOB'Q<@?;;1@@^AK-C8WL'FF'YC7/
MO97'DB;!;C/-=!I%PT=H=Z#CUH LZ?;IYGS8!':KE])$8MA0$^M9,$TDM[N
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MJ">X2,?-Q0 H.VH9)PIJO]M29MD;9-2I''G]ZV#0!')=@*23BL.XUB,S^6C
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M 1@T ?/-QX/U.SO'N9RQQSC=FLJ2QN[^_P![H=B'-?1-]I<=RC#:.:R+7PK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;V]]I94 &1,GCK5CP!KTMC?_ &.;*C@#<*Y7P]J<CZK)R3&1TJSJ=V(-?22
M8RXZ5I!WT(EW/HAK:VOH=S(K!AZ5FP>%K*"[\](\-G-'A.Z:ZT>)V.3MK>J6
MVG8JR8BJ%4*.@I:**D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4.FP?:+0QR#G'>JUWH,L ,D1.#SC- ':>'YQ):[2>:CU?3QM:;TKG- ^W13
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSW@Z]N/MLD4A.T-@4@/2GDALXMQP,\URVIWMO*Y,9)-2:S<_:%\OYA@8KGD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN(IA\C@_2I:!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5VNZA3=./*W<ZZ4'!6;N%%%%;&@4444 ,=L"L^XNA&#S5FX?:IKF-3NRN>:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ7F-$*5FQL$H>_!/K74$+Y:'':N*MV_TE3GO79VQ#VR@GM4R.C#/<V;61#$
M"*LUS,,[PW0&[Y:Z.)PZ @]JR:L>A"5T/HIN>:7(]:18M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7(>*6@NH6AW!6/%=3<7$5O&6E8*/>O.?&$BA&NH)>!SQ0!SMUX7BM;22X
M#,3G(%>=:A=213L@!&#7H]CKYU'3I(%&Y@<=:XG4-/>6=MT>"6H JZ//</-E
MI"%]ZU]2O[O"I!<'KVJDMH+.#[_S5B27L\5Z%).,T6'<W#+<-"!*Q9O6I[6X
MEC&,&GVD$U]%^[C.<=:B%O?6]WY3P-@GK2&7$O(I)0LJ?-[UHS21BW^4 5S6
MHR_8I5+)\QJ?[3-/;A@I% &JJ[DRPS3#'@@_=K-@U"6W8"<';[UJK<PW294@
M4 6XFS'@2 TY"\;=<UG?</R/4T=YCY3R: +5PTDJ[ >M2VEF47+MUJJES\W2
MK#7X  H EF(A_C&*K%HG.?,%-N#Y\?WL5G",QMAFH TFEB48!!J)PR_O%/%0
M%40;MV:BDNV;Y%'% %LZ@B)\S#=41U*2)#(F2.N!5)Q$?O8SZ4])8L;6(Q0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS?='--"FKCK:^#C!/2H;QA.=H-4V_P!';##%78D5TW"F9)]&0066QMV:UHF
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MMOM5G)%CEA7AFK0WFD:ZRY/ELQ/)JTKHG9G.V$EUHVHE-FY23G-7M7O]Q#!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBF2N(HF<]%&: '%@!R15:>SM+Q"LL22 ^M>3>+O%E]+J36MF2 &Q\IJOX<
M\4:E9:G%'>EO+8_Q$UQO&0YN6QS/$QYN6QV6M?#VPO0SP$1MZ**T/"?A^71(
MC&^<9.,US?C'6K^W2*YM"?+*@G!KH?!?B%M9L@),;QP:(.E[6R5F$?9^TLEJ
M=911178=(4444 %%)NI-XH ;(F165=V?F \5K%Q4;;30!R%QI62>*I-I!_NU
MVK0J>U1FV3TH XLZ2?[M,_LD_P!VNU-JGH*;]D3TH X&\\-_:$.%Y^E<_+X<
MNK=R0A*U[ +5/04C6,+#E ?PIIF<J:>IXM)ICD\J0:K/8LG&VO:'T2U<Y*#\
MJY[Q#H]M;0%U&#]*T@[RL93IN*N>5SV9':J@M)!+]WC-=6L<;YIAAC5\8'/M
M7?&/0X9RZF&+,LG(J"2#RQA172/ -O '-9DL0\W::TA3N93J6,E+<DY-:$<>
MU:D$ W5=M;82'FNE)11S-N3+>F(QB^E2RL2Q7TI-RP#:E5F<[B<UG:[N:75K
M"R<<5 :<Y)YIKC]WNJA%FPL/M,XSTKIQ:I;1 8'2J'AQ XR>H-;5RFY3FO.Q
M55\W*>K@<.I+F9ED;FZU;A*XV]:I.-C\&K-N5R#7*YGL_4K*XS4M-26'S$49
MZUSWE["01TKNU426KY'&*Y"[0"Z<#UKLPE9R33/$QM!4YE5?O8J<# H5 *=7
M2V<T8V$QFFDKG!I_057F4XW"I+M9#R3T%.&<<U%"2PYJ8G I/0N.NHC<4F[B
MF,V:8<TK%$F:;N%-YZ5(MM)(/E%(HB8;C4J02..!5VVL4C&9#S5QF1%X J;B
MND9R:>[<D$586PC4?,:D-P ,"H6F8T69#FB7R8%'8T.(E7[BU &/4TCW.T8(
M%'*+G&_NRWW%I9/*QC:*J-*';*FD?)'6KY2>=D_EP=T6H9;2!Q]T#\*A)9#U
MS3S)N6CE&ILKOI43#*M5"?27&2N36J'*CK49D9^E&I2F<Y-:RQYRM49!SS78
MA%=3N K,O-,27)3K5*7<?,F<W(GRY%5'RO-:5Q9S0M@CBJ;)N< ^M:)B:+&E
M7&V3!'6M^1OER1P:R4MUAC5U'-:4$ZS0;&'(%;I61YM6HI2LB2+Y@2*V]%UL
MQ3""0\?6L5"$1L5@W5W+'<;D.,&LJM-35F:T)-.Z/:4F65 0>HIRH <YKSCP
M_P"*VWK#<-@>M>@VMS'<1AD8$&O*G!P=F>@TI*Z)F6(M\V*;-''&FY5!IS1%
MCD4X @889J2'?8Q+J-9VZ8I+>,H<$G%:<EMODRHXJ9;-0!ZT71*C-O0JJSD8
M45/#%(#GK5I;=47-9]]J\-@,;@6H2<G9&B7*KR9I>;';1EY<+@5Q/B7Q#]I8
MPPG*Y[5#K>N3W<&$X7VKEE+,<L237=1P_+[TC"5525HDRCC)ZT]<"F#@4X5T
M,F*0_)]:8Y.:<*"*@U0@'%*#S2@]J-O-(H7%1N<5(:KS/@TT3(&4.O-593Y0
MP*MJ<K5*[8"KB0T53RV13F7Y:C5N:D9AMJA #A:9@,IJ/?FI8E.W-,3(D*QO
M\U/F^8 CI4,@)>K6W]S^%,EC%;"@"A')DP:CBR9:?(-C@TQ(2=><U69N*GEE
M#+4 &X5++1T/A1P)\9YKT&.-G->8^'W:+4D5?XB!7M^FZ--+9K*5'(KSL0TI
M&JHN>J,3[,V.E-,!]*Z$Z=*&*[.:DBTB<GF,8KGYD/ZLV<VEJY/"U;CMAT/6
MNB_LN8+@1K3H-%<OEQBESE+"M&=::2)L=ZZ&RTF.  D5<MK1(%  JS4.39UT
MZ,8"*H48 I:**DV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "N#\8^'3=@S(O..U=Y3)8EE0JP!!JHNS$
MU<\%NK-K&,[^WK6;!82ZK.(HDZGL*[OX@Z5]FC,B<"D^'-M;R'<0"P)K:Z4;
MHRLV[&YX,\)'1HQ*X^8CUKIM=D,6E3,IP0AK2    %97B(%M)F [J:QO=FNR
M/GN9+V_\0R.DC85\_>-:NLK-:62NP+L%^M4%NFTW6)#(/E9N>*[F%M-U73QR
MN[;W-.::8HVL4[#PZVM>'S*1L(4>U<%JOA];6X8(^9 ?[V:]EL)A%I4EK&Z@
M=!BO(-8,EIKK%2223[U!1;\/7+JPMI2=Q/%>Q^$]',$8F<=1WKS+P_X?N+W4
MHKK:0..U>Z6,7DVB)C&!0!9HHHH QO$<8.FR/W5:\8N/$,L5W)%(H*@XZ9KV
MW7$:33957N*\!\1'[%=ON0Y)]* *VK7 F_>< 'M4>EZ<=2N%C0XR?7%216L.
MI0C>X7ZG%;&C00Z;>*=WR@=<TTFPN.\0Z(NDZ>OFNNX_[5<W;$&URR@CZ5M^
M,TNM5N%,+$QC%4[2V$%GL8?,!5PW)EL5%NAY/E1+@D8Z5F75NS, Y/-3?:C'
MJ!4J>O'%/DE:2?+*<9]*BVMAWT)+6,0[%7J:]_\ !08:.F[VKQ/P]I[ZEJL<
M>TE<U]":19+8V$<:C^$5I+2-B5J[E^BBBLBQ",C%<WKGAY;X[T4;CZUMWU_!
M80&69@% [FJ6E^(;/5F*V[9Q[T!<\O\ $_@6?[(S)&"V*/AUX;GTVZ::ZC"J
MK=2*]D>))!AE!'TK-U:SSILJP*%8CL* (8_$NG^?Y'FJ&''45KQ3),FY""#Z
M&OF?5Y;JPUXB21A\_J?6O;_!&IQW>EHH8E@.YIM$1G=V.MHHHI%A114<TR01
MEW("B@#B?B':H^G,Q'(%<OX!E%I#-(2< M6OXX\007-LT$# MC'7-<QH%VMK
MI\RN#N8G&*VBGRF3DKW)8)TU3Q9N(R ?3WKV:T18[9%4 #'I7D?A"Q7^UFN)
M".2<9/O7K\)!B7'3%*KV' DHHHK(T"BBB@ HHHH **3(I: "BBB@ HHHH **
M** "O-?B!(]W>6]I$WS%B,9KTJL6Y\,:?=:@MY*K&4-N'S<5K2FH2NR)Q<E9
M'GFJ>$;]?#RSR-D(G0-5JUO_ #O"DMNWWD*KBO3);.*:T-LXS&1C%8Z^$-+1
M'54?#G)^:M5735I$>SL]#GKK_D2F_P"NBU'!$TW@IE09(<FNQ?0K.33S9,K>
M23G&:DM=(M;.S:UC4^6V<@GUJ?:JWS'R.YQ'@RXC&BW4!8"0(V037.^&/^1E
MU'_='\Z])MO"&F6EQ)-$KAI!AOFXHL_".EV-Y)=0HPDD^]DU?MH>]YD^SEIY
M'F^B3K:>.;R28%4\T<D8%:Q7^U_$,HMLD&3[W:NSOO".EWY8RQL&;J5.*L:5
MX>L='&+9#GU8YHE7B]5N"IO8XGP]<II&JS0W7R98\FLAH&UKQ>9K8,456&>U
M>C:KX3TW5WWW".&]4;%3:3X=L-'7%LA^K'-+VT5[RW'[-[=#B]$NTTG7FCN?
ME^7J:SO$-['>^+XS"K,-R\XXKT#5?"FFZO*)+A&##'*MBB#PKIEL5=8VRO.2
M:%5A?FZB<)6L<5XO5K.1+E5(+'J!6[X(@%S;?;) =S &J'BVZ34+R'38%W%7
MP3C-=AH6GKI^F11 88+@T3E:DEU'%>^:=%%%<IL%%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#/UK;_ &9)NZ8KQ[2EG'B1GMB1&&.<?6O2O&.I?9-,=1C)%<#X
M6?B>9UP3NY_.M8KW3.6YJ>,-?E:%;6%SO. <&F>"?#LLDHNKF,\\Y-,T/3DU
M?66>8[@.>:]1MK:.UB$<:@ >E.3Y5RH$N9W9(BA%"CH*=116)H%%%% !1110
M 4444 %8^L^'[;5H2LB+DCKBMBBFG8+7/(-0\#76GSF6T#8!["J-VVJ);^7.
M7V#CFO:V17&& (K*U/0[>]MV0( <=A6BJ=R'#L>>>#=/M6N_-:4;_2O6$ "
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M!P:3U/IO2$-IIT8F.#CO5F74;6*,NTH %?.^L?%+4-0BV0_NO]UJY=_%.M3
MJUU+M/\ M4HX:3W-762V/HN\^(FB64QCDNHP0>YKSKQSXMTS7$"6DZ.<$<&O
M);AI[ER\DK$GU-,B5HVR&-:K#I/0RE4<XV9T!DPF&/%5VF#/@<"L]9) V221
M3BY8\<5HJ;.64'T-FW?9,C*W<5[+X5U!+324E:7+>E>!QO(KYW&KPUN^C7RX
MYG"^@-)T925F."Y9<Q]0Z9K,-Y '+@&M-)DD^ZV:^4(O$FK0#$=S(![-6_I'
MQ$U+3_\ 6NTG^\U92P<NATQQ6FJ/I.BO&-*^+ADN56Y1%3/)S7I&C>*]/U=
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MGO<]!;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFGN9/C=@-;D_WJYU)26IVL:J^J7IG<$$G/-5R2B!A7K05HI'B57U1H):>?\
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M\LSR\QR>,$ZN'=UV/6J*16#*&'<4M=A\X%%%% !1110 4444 %%%% !1110
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M11V0.1D4M-&$09/2D65'.%.:YSJ'T444 %%%% !1110 4444 %%%% !1110
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M,)'U]JXCP0YBL^?05W%F!+)N8=#7F5/B8WJ[%BS@V+ODY:M:P;,N#5 #)X/
MJYIPW3YK%G535K)'0#H*6D'04M9G8%%%% !1110!D>)+I[31YI(R0=I'Z5X?
MX7T]/$'B67[5$)%SU;ZFO2_B-KQTW3FA"AMP_G7D7A7Q0-&UAIY% 1CSFN*O
M./M$F?4950JK"3G!:O8]ZLO"&D6BC;9Q'CTJ^-$TT=+2/\JQ])\<Z1J42D7
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MW,X[$\4X3L_>%*/8QO!&BG3;$R,,,[%L?6MK5-"M-5P9U&X'(..:TD144*H
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M 9O6G>8WK3#TIN:8AY)/4TW%%+FF(3.*4444 *.M/!I@IZ@4Q,>!FI%&*CR
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MR?P0E\26I-11176?/A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0V1E.K*2LV>_> $8:8I)ZUVM<!\.+PS6 0GI7?UXN(5JC/5PMO9*P4445B=
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M44 %%%% !1110! ;.$R^9L&[UQ4_0444 %%%% !1110 4444 %%%% !1110
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MS(_^T*Y/P/X\U.XNTL9X\CIDYS7LL;%XU8]Q6U*-.?O)'FXZKC<,O85)W0X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\5T:S?4+R*%XG7&.<8KV;3K46EFD0[ 5Y.*LY7.O+W)Q:Z%NBBBN0]$****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSU7PP]KI&(6&-P)SS@UE^"=5T;6=)>QU-(U+8&7-=!+)X9\(:=/)I[P>8QR
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M5'#H9YC*.)P<<2U:1WJ1I&,* *?117:?,A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY=RZ^AJ/-+/+YL[/ZU'FOHDM#XNX[-&ZDH%.P7&,QS2C)I^!1F@-  HI,TM
MKA2 T%N:<H[T .6@D4M)@4"N&?2FX8FI !24[$MB A1S3=Q+>U*1FE"U5B6Q
MP3- V@\TJ\5($!Y- @0;CQ4\5OALFG1)@<"IQ$Q89Z5+&ACQY/RU+$J@?-4V
MU1P.U-)5CM J1E:56>0;>E2\1J/6G@$' %3>0,9:J)( I9<XJ6.,8S4D:DG&
M.*FV!.M)L:17$7S9Q2>3E\FI))8TY)JH+_?.J(/ESSQ4.=BU!LWM*T>74KE(
MXU.W/)KV+P_H$.EVJ_*-^.>*Q_ MK:_V>D@ ,FWFNUKSZU9R=D=]&DHJX444
M5SFX4444 ,>))!AE!_"J,VC6TO.T#Z"M&BG<EQ3W*5IIT5H?DJ>YM8;N(QS(
MK*?45-7&>*_'EKX?&P-F3'0#-1.22O(WP]"=2:A26IS/C/X:K,KW6G*=XYP.
M*\JWWVC:DOV@/E&'WLXX->IZ=\78;BZ$5ROR,<?<K?UKPMI7B_3_ +3;;?-(
MR-I KBE3A4]ZGN?3T,97PB5+&1]U]2QX,\866KV$<1D E Y!XK;UKP[8ZW:L
MDL:Y(X8#FOGW4=(U;PAJ.Y=X53P5)Q7I_@/QY)JVVTN%)<#J%K2G63]R:U.3
M&9<Z7^TX65X[F1:?"^XM/$2RQLPMU?((/:O7;6 6UM'""3M&,FI<#KBEK>%.
M,-CR<5C:N)M[1[!1116AR!5#4M7LM,A+W4H5:M7$HAMY')^ZI/Z5X'XEO-2\
M4>)'LH'8*".A(%95:G(M-ST,OP7UF;YG:*W.SOM;\%ZM?9EF8R9_N"FZKX#T
MC7K'S=,<;\9 &!7&:A\,-6LK3ST.2!DX;)K,T#Q'J?AG4UAF9]F[#!\_UKD<
M];5([GOPPJ<.?!U6VNA%?:/KGA:Z)'F*H/&TFM+PE8ZMKNN13RM+M4\DDU[7
MILMCXDTN.5XHWW+DY45HV>EVEB/W$2+]% K2.&UNGH<E7.GR.$X>_M<GM(C#
M:QQD\JH!J:BBNP^<;N[A1110(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH RM9UR#1H@\R,P) ^7WJ2'5XIM+:^"ML )QWXKFO'Y"V
M2D\ .M-L=8TY?"<D9O(@^QN-WM6ZIIP31GS/F:-71?%UIK,LL<4;KY8R=U:U
MOJ<%Q,T2?>7K7F7@&5/.OIL[HQ'DX[\UT.@:[IUSJ=TL,#(T?+$FJJ44F[="
M83;2N=S2.=JD^E>?WWBZ^N-5>UTY7(1MI(&:DT;Q?/?:@;&=6$@.TDU'L)6N
M5[17L;>E:^U_J<EL0<*Q'3TKHJ\FM]3N++79EMHW:0LQ^6M_PYXREN[\V=\&
M67)QNXJJE%[H4:BV9W58.O>*+30B@G5F+MC"UNE@$W=L9KRCQHO]JZLZ1'<(
MCNXJ*,%*5GL54DXK0]*TS4HM3LDN8P0K#/-86M^+X[&?[/;QO++G'R#-97AZ
M_FBT":*,'?%'7+:%=7LOB6:3:S.)/2M8T5=M]#-U'9'97/CM+6V4/#(9V&0H
M'/Y5=T'Q%=ZE+B:WE13T++BO.KZ:\E\61EU.\$X&*ZB/QI-9:I;Z?-$P++UQ
M5RHJWNH2J.^K/1QTHKE_$GB-])MHY(U9F<+@#WKFE\::I#<Q-/'((9& &17/
M&C*2NC5U$G8]#N[^*SV^9_$<"@7]N54EU&[H":Y;Q#KEG#:VTMQ"SEVPN#WK
MA]<U>_>_M6M2R1E_E6KA0<D3*I8]J!# $=#2UQ)UK4+#08[B4,2$R>*TH?$)
M?0FO#G> .*S=)E*:.DHK,T6_>_M3*X(YXS6G4-6=BD[A1112&%%%% !14-S<
MQVT1DD8 #UKS;6_B?%I]TT<>7QV4UI"E*>QE4JQI[GI_0<U4N=2MK9-SR*?8
M&O-M$\;:GXFN#':[XD.1\PKK;7PP9#OOW$N><"IE%Q=F7&2DKH;<^))KA_)L
M(9 YX#E<BF)HEY=GS]6F4J.?D.*Z2UL;>SC$<*!5%1ZE"\]E)'&<$C%2AO8\
MQ\8Z]9:5']GL>7 P><UQ\U^MW9%GX=A5SQ+X=GMK]I9CNR<UG1VT(*B08^M=
M<4DM#RZLY2EJ9,64D(/0FMBR4CG-17MFF]3%TQ4MOF(@8KHI3Y78YIIR1JQ;
MCQVJRL(IMN05R:NQ(&YKHDQ4ABP9%3K:#&<5.B^M6%'&!63DSK2*36X*$8JK
M#IV)"S#BMD1YI"A!QVI*;0^4Y_483D!%/Y58T[3L 2&MK[/'(OS+2K$(Q@=*
MIUO=LB?9Z@DH3BI!,.H-5I"F>E(D>><\5A8U3L71*#WI&Y'!JN4P.#1YNW@T
MK%<W<E7@\FG%Q5.24XRIYJ-)Y,_-FG8.8T,UEZO(57Y6J\),K6#JLA,N W>J
M@M2*TO=,MU)?>2<T'4'A8#/ IDTI P:R;FX(8BNFUSSTVGH=M:WBW$(P><42
MJ.M<GHVH%;D1D\$UV& \8/J*PG'E9W4Y.4=1L;#;S1)($7BJ\AVMBI"N^/-3
M8LAWN_S'I5>4ER<G@5.7Q\@JO)M4'/>J1+*$L@W8YXJN_/>K;A,' JD\3.V
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M$8>!BK"Q?N^1FI8U"C!%3 #'/%9-FB1GB!MV>U 7+\]JLS/M'RC-3V.GS7K
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M.G:;W8W3[..QM$AC4 **M445V;'SS;D[L****!!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <1X
MZUJ>T5;*W.'DP<U'H'@V)X%NKN68R-\WWSCUJGXXPNN6[,/EVC^8KN]-96L(
MBO38/Y5TMN%-<O4Q2YINYYQXLM@-:CM%DD$>5Z,:M:SX82QTV.]LY90Z?,<N
M:C\6_P#(SQ_[RUT^NR)'X9<.<;D(%7S-*-B;)ME/PWJ,VLZ'Y2M^^5.N:XCQ
M/;:AIFK6YEG;YB> YKJ/AO Z02.<[648K+^(O_(5L_J:J&E5Q0I:P39W5G?"
MT\.Q7,C=$!YKE4^V^*+IM\H2W5L?*VTT_P 2W$D/@R%8SC=$*K>'=-OY- DF
MCE0-G(J(Q2BY>93=VHG;:-I,>F0;$D9_<MFM6N \'>)+NXOI+&]8,REL$#TK
MO^U858N,M36#36@4445F4%%%% !1110 4444 %%%% !1110 4444 ,EB29"C
M@$&L=O"NFO*9&A7)_P!D5MT52DUL2XQEN4K/2K6Q/[E OT%7:**3;>XTDMA#
MT-<]>V=W).=I^7ZUT5)@>E"=@:N<N=&F<8;^=177A??;D@_-CUKKL#TIDBEH
MV ZD4^9DNFFCR:YTJXM)BA(*D^N:BEL9(X]^#7:7FDW+W18X*D^E7(='C\C,
MX&,5U0J\B/.E0<Y-(\P(*D[LBGPSJ&QFNIU?1;=F/D_SKG'T1@Q*FM77BRX4
M9K<MQ2@C@U:67BL=$E@.#VJ47..M"DI;%.+1KB6F3O\ )5%+L;N34DEPC+UJ
MTC&97B5/M09^F:TVU2.(!(\GBL65\GBIK'R%DWRGI[U<H76IF%S8/?2>:XXI
M;416G##]*T6NXW&(^@K.:VEN[C@$#Z5QM..YI\6VQ-! MU<Y&<&EU6SAMAE5
M!;Z58R+"/YOO8K/\Q[Z4[N16]%/XF9R2Z&5#%+-<;E'0U=DFEB.&'-7HUBL2
M2V,FJL]S$[%S73\1BK192GFD9:PM7+)%D'FMV2595.T=*Q;U#*I%5&-F5S7+
MO@TAB2XR>:[*2,8R*X_PGMAN-C]3FNXD@RN>U>?B%:HSOHM.!ASQY;-0A')P
MHK7>).2>U9KW:)*44=#6294HW"2T%W 890.1BO/]=T<Z;<%A]T\UZ&MTA;!.
M#6=X@L$N[%I>N!6^'J<L[="*D6XV9YW$?2IP,]:A.(Y&4=C5B(;Z]5HX;C=N
MYL"G&%ZGVK&<TV6Y4)U&:DCF?0KNK!:J-N9L&IEE>4E1WJ9+5QR1UJDPE+EW
M&Q0)LRU30HO).0*LP6#M_"3["M;3M.AGNEBF4JI]>*SJ5HP1DDY:&AX&N+9+
M\JXY((&171:UH#/>_:0OR''2J-_X4.E&*]L0=N5SCFO0]$>/5-(5)4._'<5Y
M-:7,^<]3#7C>FSC(8$C0 =:O6H"RJ#TS5W4M!DM9#(@ROM6%->-!(.#P?2LT
M[F[7*]3TW3$06RE5'3TJ]7+>'=?BN(UA8X8<<UU ((R*R9TIJQ#-:13'+J"?
MI4J((UVJ.*=12&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4UT5QAE!^HIU% &3KMB;K2988@
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M"A[CTKPKQ=X$O=-O#=V2EHR=PV#/O67#KWBD6PL%27RSQRAJ(594ER21TXK
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M    =!2UVI65CYB<G*3D^H4444R0HHHH **** "BBB@ HHHH **** "BBB@
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M6(!'/->@]J0  8%+43FYN[*C%15@HHHJ"@HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ:ZNSM&BMU;%<K;RB.9<#C->A6&R>Q4GTKEQ%TC6GJ94SLZ;<&BU@.,FM":
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:* $P/2@J&&"*6B@!BQ(G0"GT44 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7H^V^TE9G<?$2R$&GV\H'.U/Y"NJ^%]P;O1# [9R"*7QSHS7WAF*2.,NP5>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJS1561S\TMKA1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JGJ5I]LLWB]15RBFG9W$U=6/#=>T"]TN_#HC%2U>F^#I7?2HP
MXPV*V[FPM[K_ %L:GZBGV]K%;)MC4 >PKJJXGVD%%K4Y*.%]E4<D]">BBBN0
M[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *9,VV)B*?6=K5\EA822MV&:<5=V0I.RN>1^(/&5Y9>(A")"(P
M3WI-8\4OYD$\4I/"Y&:Y36[>ZUW6W-K&Q)8X.,5*OAW5+-XUNHR5./4U[$:<
M;I,\>4Y6;1[SX:U1=2TR.3.6Q6W7+>#-/-IIJ$D\]C74UY=9)3:1ZE%MP384
M445D:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2TAZ4 9>J?\
M>DO^Z:^>_$/_ "%Y?K7T)JG_ !Z2_P"Z:^>_$/\ R%Y?K7HY?\3.''?"C,HH
MHKU3S I/3ZTM)Z?6@#VCP!_R#UKT&/[M>?> /^0>M>@Q_=KY^O\ Q&>Y1_AH
MDHHHK$U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KG?%6N0Z3ITA9@&*\5T5<7XU\.2:W!M3W[5K147-<QE7<E!N)XEJ&OO
MJ6HR*3D,W%=1X#LK^/54DC5A&6R3BM32/A0?.$DS!<'NM>H:-HD&DVZQHHW#
MN*]"MB81BXK4\ZAAIRDI/0T8=WDINZXYJ2BBO*/6"BBB@ HHHH **** "BBB
M@ HHHH ***BGN(K>,O(P4#UHW"]B6BN&UWQ]:V#[(6#G/8U-I_C^PGMPTLBJ
MQ]36WU>I:]C#ZQ3YN6YV=,>5(QEV ^M4=.UBVU)=T#JWT-<UXQU"XA_=PL02
M<<4H4G*7*RIU5&/,CI[W4H(+-Y!(IP,]:\SEU74-3U<I;R':&QQ65>7NK)9$
M2&0H12>"]4\O6 C#)9J[*='V:;W.*I6]JTMCV+2$E2R03'+8%7Z9"VZ%&]13
MZ\^3N[GHQ5E8****0PHHHH **** "FNZQJ68X IU5[V!KBV>-3@D&FM]1.]M
M"&'5K2>8Q)*I8=LU>KQK5HM1\-ZP;G<YC)JY<?%!X8D(C8^O-=<L)*R<-4<<
M,9&[4]&>LT5S/A7Q(-=M1(1@XSR:Z:N6<'!V9UPFIJZ,?5/$=EI+!;B103ZF
MKMCJ$&H0"6%P5/H:\C^*NGW3RK)'N( [5B>'?&=_H\2PMO*@=,UUQPO/!..Y
MR2Q7).TMCZ"HKS#0O'>H:IJ2PFVD$9_BSQ7ID;%HU)ZD5S5*4J;M(Z:=6-17
MB/HHHK,T"BBB@ KSWQWXLN-'_=0;LG'2O03TKR/XD6D\NHH$C+*2HXKIPL8R
MJ6D<V*E*-.\3BKO5KS6E/FN2?>J^E7FIZ=J$44+,JEL=*]-T+P#!/8QSL55C
MUR*V%\!6PF23*Y4YZ5Z'UFBERGG_ %:LWS(W_#\LLNE0O*<L5YK6JO9VPM;=
M8EZ*,58KR)-.3:/7BFHI,****DH**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2TAZ4 9>
MJ?\ 'I+_ +IKY[\0_P#(7E^M?0FJ?\>DO^Z:^>_$/_(7E^M>CE_Q,X<=\*,R
MBBBO5/,"D]/K2TGI]: /:/ '_(/6O08_NUY]X _Y!ZUZ#']VOGZ_\1GN4?X:
M)****Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M(>E &7JG_'I+_NFOGOQ
M#_R%Y?K7T)JG_'I+_NFOGOQ#_P A>7ZUZ.7_ !,X<=\*,RBBBO5/,"D]/K2T
MGI]: /:/ '_(/6O08_NUY]X _P"0>M>@Q_=KY^O_ !&>Y1_AHDHHHK$U"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M(>E &7JG_ !Z2
M_P"Z:^>_$/\ R%Y?K7T)JG_'I+_NFOGOQ#_R%Y?K7HY?\3.''?"C,HHHKU3S
M I/3ZTM)Z?6@#VCP!_R#UKT&/[M>?> /^0>M>@Q_=KY^O_$9[E'^&B2BBBL3
M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:^A-4_X])?\ =-?/?B'_ )"\OUKT<O\ B9PX[X49E%%%>J>8%)Z?6EI/3ZT
M>T> /^0>M>@Q_=KS[P!_R#UKT&/[M?/U_P"(SW*/\-$E%%%8FH4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTX0,O[Q1\K=.E=910!\_M\)/$UJ#:VUV1;DXQYQZ?G7>^ OAT/#"^=<RN\[
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M''?"C,HHHKU3S I/3ZTM)Z?6@#VCP!_R#UKT&/[M>?> /^0>M>@Q_=KY^O\
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M2BBBL34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=&*(3M/TKC=(O?''BSR)+7[3Y(<993V%;?QFYL;$>JQ?TKTKX8VD4'A6%D0
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M28_-\V/,-==>C&4[R=C&G-J-DCV>R\0Z=?$"&8$GU(K4!!&0<BOEH3WVAZB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKJ?#OA*#2?WTHWW!.2<YKIL#TI:<JS:LM!*"6H4445D6%%%% !1110 4444
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M3Q(<-(H/N:>"",@Y%>'?$GQ3J>E^([2WMIRB-*H(KUG0+\2Z';RW$H#L.<T
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MPQ'/3B@#S/17\3^)K1[NV\0N) "1$!S7=?#N^\60W[VFKQ7#QK@"1^AKSE/
M7B?24DN-!O+E[=03N0 <?E6MX%^(6K6&NKI>J[Y9"P4F0\T ?1]%16\PGMTE
M ^\,U+0 4AZ4M(>E &7JG_'I+_NFOGOQ#_R%Y?K7T)JG_'I+_NFOGOQ#_P A
M>7ZUZ.7_ !,X<=\*,RBBBO5/,"D]/K2TGI]: /:/ '_(/6O08_NUY]X _P"0
M>M>@Q_=KY^O_ !&>Y1_AHDHHHK$U"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;\Z5Z'9CM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\
M"(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\
MGDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__
M (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F
M_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'
M_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9
M_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[H
MH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B
M]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3
M_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWY
MT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#
M2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^
M#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:
M9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_
M[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\
M"?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LP
MM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \
MF_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\
M"(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\
MGDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__
M (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F
M_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'
M_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9
M_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[H
MH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B
M]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3
M_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWY
MT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#
M2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^
M#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:
M9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_
M[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LPM6[HH?\
M"?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \F_.B]#LP
MM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\ "(:3_P \
MF_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\ GDWYT?\
M"(:3_P \F_.B]#LPM6[HH?\ "?:9_<F_[X-'_"?:9_<F_P"^#5__ (1#2?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<-\0O]7!_NFNYKAOB%_JX/
M]TUMA_XB,J_P,Z#PU_R"(?\ =%;-8WAK_D$0_P"Z*V:BI\3+A\*"BBBH*"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/Q9_R
M I:W*P_%G_("EJZ?QHBI\+.2^&/W)?\ ?;^9KTFO-OAC]R7_ 'V_F:])K7%?
MQ69X;^&@HHHKG-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D/2EI#TH R]4_X])?]TU\]^(?^0O+]:^A-4_X])?\ =-?/?B'_ )"\
MOUKT<O\ B9PX[X49E%%%>J>8%)Z?6EI/3ZT >T> /^0>M>@Q_=KS[P!_R#UK
MT&/[M?/U_P"(SW*/\-$E%%%8FH4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<-\0O]7!_NFNYKAOB%_JX/\ =-;8?^(C*O\  SH/#7_((A_W16S6
M-X:_Y!$/^Z*V:BI\3+A\*"BBBH*"BBB@ HKCO'WC!O">F&XC17DVY"L:\=B_
M:#U4W(5]/@"9Z[C0!])T5@>$_$2>(M*2Z& Q R!6_0 4444 %%%% !1139)%
MB0LYP!0 ZBN/U3XAZ/I^H+9?: 9F(&/K74VEP+JW69>C#(H GHKSCXC>/KSP
MC&&MK=)<G'S&N>^'WQ;U'Q7JWV6XLXHUW 95J /:**YGQKXBF\.:/)=P1+(R
MKG#&O(='^.>K:AKB63Z?"%9L9#&@#Z$HJKI]RUW913,,%U!(JU0 4444 %%%
M% !1110 4444 %%%>:_$;X@WOA$*;:VCER3]XT >E45XY\//BOJ/BS4?L]Q9
MQ1+N RIKV)3E0: %HHHH **** "BBB@ HK)\1ZG)I&D37<:!F3H#7A@^.^K_
M -K_ &7^SX=OF;<[CZT ?1-%9F@Z@^IZ7%<R*%9@#@?2KEW=1V=L\TK!549-
M $]%>$>+?CI-I>IO;:=;13JIQDG%6/!OQ1\2^*=02)-*B$61N8,>!0![?17&
M>-O%5WX9T,7:0*\H3<5)[UYQX6^->JZUK\=C+8PHC'&0QH ]ZHK/O;Y[?2?M
M2J"VS=C\*\*U#XZ:M::U]C73X2OF;<[CZXH ^A:*Q?#.KRZSI$5W*@1GZ@5Y
MU\2/BGJ'A#4S;6UI'*H;&6- 'K]%>??#GQQ=^+K0RW-ND1 !^4UH?$#Q7<>%
MM*:ZMX5D8+G#&@#L:*\&\)_&G5-=U^*QEL841SR0QKW:%S) CGJR@T /HHHH
M **** "BBB@ HHHH **** "BBB@ K#\6?\@*6MRL/Q9_R I:NG\:(J?"SDOA
MC]R7_?;^9KTFO-OAC]R7_?;^9KTFM<5_%9GAOX:"BBBN<W"BBB@ HHHH ***
M:SJBDL0 * '45F?V]8?:?($P,F<8K25@RAAT--IK<2:>PM%%%(84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4AZ4M(>E &7JO_'I+_NFOGOQ!_P A>7ZU[WXBN%MM-D<G
ML:^?-3G%QJ$CCN:]++T[MGGXYZ)%2BBBO4/."D[CZTM)W'UH ]H\ ?\ (/6O
M08_NUP7@),::IKO8_NU\]7_B,]RC_#1)11161J%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7#?$+_5P?[IKN:X;XA?ZN#_=-;8?^(C*O\#.@\-?
M\@B'_=%;-8WAK_D$0_[HK9J*GQ,N'PH****@H*1F"*6/04M8WB?4DTS0[J=F
MP0F10!\^_&GQ$+O4?LD<K$(2I&:\A:VF1!(R$+USBM[6KF3Q#XIE7.?,DXKU
MG7O L,/P]2?ROWHB!R!0!+\#O$V\?89F YX&:]\!R 1WKXM\%:N^A>*(V)*H
M&VD?C7V)I%\FH:;#.AR"@_E0!<DE2%=TC!1ZDXJO'J5G*VU+B-CZ!Q7)?%&2
M2+PP[1NR'GE3CM7R]HWBB]TC4VG-U<.0?E!=C0!]GW.HVMHNZ:9%'NPJM!X@
MTVXDV1W49;_>%?,-]/XN\; S1&5(1R-NY:XZZ;6_#]^/.N+E9$/=VQ0!]PJZ
MNN58$>H-<1\1]86R\/3"*=5D]FP:YGX2>.)]<L_LER^YU^4&O./BWIVJ_P!L
MO*&G\CG@$XH X_0K^6Y\5+)<S,W[WJS>]?7F@7UM+ID*I/&QVC@,/2OA^".:
M2?9$6\S/;K7L/PITO6H=962X>Y,6!C<S8H ]>\<^"[#Q.@%W<F+!S]X"L/P3
M\,])\-ZE]IM;TROD'&\'^M8OQNN9X+:/RIY8_F/W'(KB?@O>W<WB/;+=3R#>
M.'D)H ]F^+'_ "+$_P#US-?,OA;_ )&^+_>KZ:^+'_(L3_\ 7,U\J6=^VG:P
M;E!\RMQQ0!]H:=J-I9Z1 9YT7Y!U8>E6+?7].N7VQW,9/^\*^5Y1XK\7Q*T+
M2I&HP-NY:Y^X77_#5ZK337(92#RS8H ^VE8,,J01[4M>-?"OXEMK*+87SCS5
M'7%>L:GJ4.F6$EU*P"HN: +4DL<2[G=5 ]3BLV7Q%ID+;7NH\_[PKYQ\>_%G
M4=2OI;/3W(ASC@8.*XVUT3Q+JR-<QO=X//+-0!]DVVJ6=V/W-Q&WT85<Z]*^
M*K#7]>\)Z@"TL^Y3R)"Q'ZU]'?#CXB1>*+18IG G''I0!Z/5>YOK:T7=-,BC
MW85F^)M=AT'2)+N1AP#CZXKY3\6>/M7\2ZD\<<KK&6PHC)!_2@#ZRA\0Z9/)
MY:749;_>%>+_ !S96CC*L",GH:\RL/#/BL1)J$,ESM3Y@"S57\1>)]4O;=;+
M4@0\?'*F@#K?@A_R'#_UT']*^F&U&T@ 62XC4XZ%P*^:/@;C^W<'IY@_I5OX
MRZ9J&G:DMW'=3I&03A92/ZT ?24-U!<#,4J/_NL#4U?/'P1\23M<?9;BX=\D
M_?8G^=?0-Q*([220D#"$_I0 R:_M;<XEGC4^[ 4Z&\M[C_52H_\ NL#7R?\
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M71/14'VRU_Y^8?\ OL4?;+7_ )^8?^^Q19A=$]%0?;+7_GYA_P"^Q1]LM?\
MGYA_[[%%F%T3T5!]LM?^?F'_ +[%'VRU_P"?F'_OL46871/14'VRU_Y^8?\
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M1S@5U\?W:Q-)A\JWC7'0"MQ.E?.R?-)L]Z*LDA]%%%2,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N&^(7^K@_W37<UPWQ"_P!7!_NFML/_ !$9
M5_@9T'AK_D$0_P"Z*V:QO#7_ ""(?]T5LU%3XF7#X4%%%%04%>-_&SQ*MIIP
MLHFP[ JW->NWDXMK.68G&Q<U\C?%+7I-8\23(&)5'.!0!2^'L%G<>)(9KYU4
M*_5CBOI?4M;T.?PX;/[5 0$P!O%?*%CX>U^9!-9Z=<NIY#*M7?\ A'_%O_0,
MO/\ OF@"IXA$=MK\CV[#;YA((/O7TG\(/$3:GHB022 LO&/I7S+J&AZS9CS+
MZPGB'JZXKO?@]XA_LW6UMG;"MGOZT >Y_%3_ )%9_P ?Y5\IZ+;+=>(K>)QE
M3* 17U3\3G$GA#>#D$'^5?+_ (8_Y&FV_P"NHH ^O_"VE6ECH=ND4*CY>X%>
M._'72+2!([F.,+(RDG%>X:+_ ,@F#_=KQ[X]?\>,/^X?ZT <C\#'(UH#/!>O
M8/B?;Q-X8E<QKNQUQ7COP-_Y#B_[]>S_ !-&?"DWT% 'R[X856\4*&&1YO\
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ME&!.P'U-4Z*32>X[M%W^U[__ )[M^9H_M>__ .>[?F:I44<J[!S/N7?[7O\
M_GNWYFC^U[__ )[M^9JE11RKL',^Y=_M>_\ ^>[?F:/[7O\ _GNWYFJ5%'*N
MP<S[EW^U[_\ Y[M^9H_M>_\ ^>[?F:I44<J[!S/N7?[7O_\ GNWYFC^U[_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&^(7^K@_W37<UPWQ"_
MU<'^Z:VP_P#$1E7^!G0>&O\ D$0_[HK9K&\-?\@B'_=%;-14^)EP^%!1114%
M'%?$C7%TGP]+B8([J17R?:K+K7B2($ES+)@FOL[6O#MCKD0CO(DD4=F%8MC\
M-_#]A<K/#8PAU.00M %OP7HZZ;X>MHRO)C&:Z+R(_P"Z*='&L4:HHPH& *=0
M!P_Q)\/QZMX;F*Q@R+TKY0M)I=$\0!L%2LV/PW5]QS0I/$T<BAE/4&N0N?AI
MX>NK@S26,!8G.2M '*:[K,6L?#6.57#-@@_D*\ \,$?\)1;?]=17U[%X0TN+
M3_L0MX_)Y^7'%9MM\-/#]K<K/'8PAU.00M '1:+_ ,@F#_=KQ[X]?\>,/^X?
MZU[;#$L$2QH %7H!63KGAG3]?0+>P)( ,#<* /GCX&_\AQ?]^O=/'UC)>^%Y
MDC!+8Z#Z58T7P3I&A3>;9VL4;9SE1712PI-$8W4,I&"#0!\+R23Z/K328*ND
MI/ZU[G\/OBS/JMY%I;V[KMP-Q:NYUOX4Z)J\IE$$<3DY)"U+X=^&.DZ!<">.
M-&D'\6V@#A/CF<VT9]6-</\ !/\ Y&7_ (&*^DM:\+Z=KJA;RW20#^\*IZ-X
M%T;1+CS[2TBC?.<J* ,;XL?\BQ/_ -<S7RA!:SW>J-';@F0MP!7W!JFDVVK6
MQ@NHU=",$,*Y^S^'.@65V+F.QA#CN%H \-T7XIZQX.MA97MI-(,<9.*YCQA\
M0M0\83;2'1#C"$YKZ8UWX=:+K:_/:Q(X& VVL;3/@]HEC.)9(XY<'(!6@#S?
MX.^!+F6]&IW<3*F. PKW#Q9X?37-"DM> 0AV\5L65A;:? L-M$L:#H%JS0!\
M6:_X=U7PGK+.(I$$;?*^*[#0_CCJ&E6"VT\,DY48#;J^B]7\,Z7K496[M(Y"
M>["N'O/@MHMQ+OC5(QZ!: /GSQ%XIU;QIJ'/F.&.!'G->N?"'X>363+J-]$5
M?L&':N_T7X8:%I#K(+6*1QW*UVD,,<$8CC4*H& !0!R?CWPRNO: \*+F15R.
M/05\GW5IJ7A36RQ5XF1\Y]>:^WR 1@]#7,:_X$T;7@QGM8O,/\9'- 'AEE\=
MKZ'319FUE>7& ^[_ .O7"^)9M7UMVU.]201O\PW5]%:?\'-$L[GS7CCE .0"
MM=1<^"=%N;-;9K*'RU& ,4 ?/OP0(_MTC_IH/Z5]1KS&![5SFC>!]'T.?S;.
MTBC;.<J*Z"2XBA&'8"@#P?XX^'1C[;$O0#) KP.)7EN$B/.7"X_&OIGXQ>)-
M.CTA[;*/(V,9KP?P9I9U?Q+'&$RN\-^M 'T=\(_#Z:9H$4VS#,#7I59^BV2V
M&F0P*NW"C^5:% !1110!S7CK_D6+GZ5\@ C_ (24_P#7;^M?;=[90W]LT$ZA
MD;J#7*?\*R\/?://^P0;\YSMH U?!W_(O6_^Z/Y5IZG9)?V$MNZ@AE(J6TM(
MK*!885"HHP *GH ^._B5X6DT'792J$1LW!Q6_P#"/QP^DZBEC<2XB<A0">*^
MB-:\*:7KQS>VL<ASG+"L:#X8>'K>=)8[&!74Y!"T 8?Q<G2Y\*><A!5XB0?S
MKP;X>$?\)G!_O'^E?6E]X>L=0T];.XA1XE7: 1QBLBP^'6@Z=>+<P64*R+T(
M6@#3U7_D6O\ ME_2OC[6R/\ A*_^VW_LU?:TMM'+;^0R@IC&*Y.;X:^'Y[K[
M0]C"7SG.V@"?X?G/ABW^G]!7A?QW/_%0-_OU]*V%A!I]LL$"!$7H!6+K?@G2
M->N/.O;6*1R<Y84 ><? O_D&M_NBMKXTG_BG7_ZYG^M=QHOAO3]"CV64"1C&
M/E%3:QH=GK=OY-Y$LB8QAA0!\E?#8C_A,[?ZG^E?5FM?\BTW_7+^E9NG_#O0
MM-NUN;>RA61>A"UT\UK'-;>0Z@IC&* /B76_^1G/_7;_ -FKZQ^''_(J6W^?
M2F3?#/P_/<^>]C"7SG.VNHT_3X--M5M[= B+T H XGXMG'A=_P#=-?.WP[(_
MX2NW_P"N@KZ[U72;75[8P74:R(>S"L"P^'>@Z==+<064*NIR"%H V+G3X]3T
M 6L@!5TQS7RCX\\'WV@ZU+-';N(2Q8,!Q7U?K>I?V%HTMVD0<1+G;7DDWQ7\
M.ZY-):ZQ8VR -MRY)_K0!YAX>^*>N:):_9%FE<=  >E5==?Q'XE@;4;_ ,XP
M]MU>^Z5X1\%:I$MY;6UJRGGA:QOBG<:-H_AO[%:K%$V> M 'BOPZ&/%$8]&'
M\Z^Q[+_CT3Z5\@_#.V>Y\5J5&0&!_6OL&V4I;JI["@"6BBB@ K#\6?\ ("EK
M<K"\6_\ ("EJZ?QHBI\+//\ PA>SV.F7$EM$TC[GX7\:Y#7/$6LWL[I=22(F
M?N-7=?#G#03AAD;GX_.KVN>'[&]#?N45CW KT/;PIUGS(XO8SJ4ERL\7/)R:
M*Z75/"D]LS-!N=1[5SLL,D+%9%P17?3JPJ*\6<,Z<H/WD,HHHK0@**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH[XH *N:?I\M_.J
M(IP3R:LZ7H=QJ$@^4A/6O1]$T&*R10%!;UQ7)B,5&FK+<ZJ&&E4=WL2>'-$6
MRA7Y?F/6NWLX-JCBJME:8 XK8BC"BO&E)R=V>M&*BK(D48%/HHJ1A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<-\0O]7!_NFNYKAOB%_J
MX/\ =-;8?^(C*O\  SH/#7_((A_W16S6-X:_Y!$/^Z*V:BI\3+A\*"BBBH*"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "O)/C)%K M5?2Y95^3G8<5ZW4,]K!<KMFB1Q_M#-
M'QA_8/BC7)PDJRS,3CYS7N?PL^&DFAJMY?QE9B.AKU6/2;")MR6D*GU""K@
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M6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\
M")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA
M]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")
M6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\
M")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA
M]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")
M6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\
M")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA
M]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")
M6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\
M")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA
M]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")
M6O\ M?E1]?IA]2J'G5%>B_\ ")6O^U^5'_")6O\ M?E1]?IA]2J'G5%>B_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (T>P7\R#VS_ )6>D;T_O+^=&]/[R_G7F_V#QA_S]Q?]\G_&C[!XP_Y^XO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gtl21rgcbjm5000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 3[",<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ***Q- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .!^*_\ R+*_]=EKQJ&&9D>:
M(';'RQ':O9?BO_R+*_\ 79:Y;X;Z9#JUGJEK,H(=0*]O"5%2PO.^YP5H<]:Q
MU/P[\4)J-B+&YE_TE.@/]T5WM?/5Q'=^$O$G!*@/GZKFO<=!UB'6M,BNHCRR
MY*YY%<>-H*+]I#9F]"HVN66Z+&J_\@F[_P"N3?RKQ7P1_P C];_[QKVK5?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M336(I^WAOU-:4G3E[.1ZM7$?$O3WO= 4QIEHWW$^U=MFJ6K0?:=*N8MN2T9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .!^*_\ R+*_]=EK%^#_ /K-0_X#71_$G3KS
M4O#ZPV5N\TGF@[4ZXK*^%^CZCI;WIOK22#?C;O'6O3A*/U)J^IRR3]NF>DU1
MU?3(=5T^2VF4$,,9Q5ZE/2O-3:=T=+5U8^<]5L[[PSJ\T7,9;.-IZJ:T/ $A
MD\;6CGJ2:]*\=>%EUNQ,UO'_ *4G/ Z@=JX;P/X;UBQ\4VEQ=:?-%$I.68<"
MO<CB85</)MV=CSW2E"HK;'J7BAY$T"[,><^6>E>*>!UAE\76HNMI0YSOKWVX
M@2ZMI(9!E77::\;\1^!-2TO4FNM,1I8V;<HC'*UR8&I#DE3;LV;XB+YE-:V/
M9X]@10F-H'&*S->UFVTG3I999%SM( SS7E,6K^.XT$2038 P!L'^-:%CX3U[
MQ+*)]9E:)5_@<$9J/J<8/FJ35A^W<E:*U.0TFX-SXOMIC_%<9'YFOH8_\>Q_
MW37BVJ^$=3TGQ-')IFG3301;6#(.">]>P:<\TVCQ-/$T<S1_,C=0:TS"49J$
MHL6&3C=,\3U#_DH$7_70?UKW2S_X](O]VO'[[P[K#^-H[I-/F, D!+@<=Z]@
MM5*VT:L,$+R*C'33C"SZ#H)IRN3U\]>(O^1R?_KY'\Q7T+7B&N>&M:G\5-<1
M:=,\1G#;@.,9%/+I1C.5WT#$IM*Q[/9?\><7^Z/Y5Y#\4^/$UF?1!_,5Z_:*
M5M(U88(4 BN#^(?A&ZUATOK0[GC7;Y8')K+!5(PKWD57BY4[(Z/PE<POX=ML
M2IG'3<*3QA_R+\Q]C_*O)-.LO%FG2*D-C<A%/W<?_7KU?6(+N\\)I&(7:X:,
M;D[YQ5U:*IU5)23NR83<H-6/+OAU_P C/#_OU[M7C?@7P]J]CX@BFNK":*,/
MDLPXKV2C,9*571CPR:AJ5[VTBOK5[>90R.,$&O!/$^B3^&M;WH"$W;U/XU]!
M5S_BOP_#KFE2(R9E4%D]2>U1@\1[*=GLQUZ?/&ZW*'@;Q1'K6FI%*_\ I,8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@
M$8(I:* (_)BSG8N?I4F,444 %%%% !BBBB@ HHHH **** &[%SG:,TZBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I&56&& -+10 P0QJ<A *?110 4444
M ,:)&^\@-*L:)]U0/I3J*+@%%%% "$ CD4!%7H *6B@ HHHH **** "BBB@
MHHHH **** "D*AA@C-+10!&((@<A%S]*DHHH **** #&::$4'(44ZB@ HHHH
M **** &LBO\ >4&D6*-?NH!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "
MD(!&",TM% $?D19SY:Y^E/  & *6B@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2_1114%!125AWOB6VM-8ATWAII#@C/2JC&4G9"<DMS=HIJG*@^M.J1A1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML;B%0CGEB._-=+XHU*33_!\3(<-)"%S_ ,!%9U*,)\DJ>G,7&;7,I="KK'Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPJH"3^%)PC[!2ZW&I/VC1O45PMY\0@EY)!86HN=AP3DTVU^(@-VD-_:"VW'
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MA1114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\<0Z3IU_9VEA!%&Q="=G^\*[O6V#>"+HC_GA_A6U6W+2:VOU(A>\KF5\+O\
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M@6M3^9N?$C_D7I/I5FPADG\%-'%]\PX&/I5;XD?\B])]*OZ)>)8^%XYW^ZJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DP*6B@ HHHH **** "BBB@ HHHH
M **** "BBB@ I,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FDR
M/44 +13=Z_WA1O7U% #J*;O7U%+N7U% "T4FX>HHR/44 +129'J*,CUH 6BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+7T#^[<?]\4?5*_\K#VU/N=W17"?\+7T#^[<?]\4?\+7T#^[<?\ ?%'U2O\
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M_P#00N/^_AH_LJ7\P?VDOY3ZC\U/[PH\U/[PKY<_MS5?^@A<?]_#1_;FJ_\
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MXC_A6>C_ //):/\ A6>C_P#/):[>BCZU6_F8>RAV.(_X5GH__/):/^%9Z/\
M\\EKMZ*/K5;^9A[*'8XC_A6>C_\ /):/^%9Z/_SR6NWHH^M5OYF'LH=CB/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F7C>%9_&5BIZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM!_Y#-M_UT7^8KZA@_X]X_\ ='\J\3-?BB>OEOPR)****\D],**** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO'_NC^5>)FOQ1/7RWX9$E%%%>2>F%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!%<?ZEJQ6ZFMJX_P!2U8K=30 E%)2T %%)10 M%%%
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M\5[*&TGC$0/W1U->85]+@?X$3Y_&?QF%%%%=ARG9^ =.@N+F[NIXQ)]G@:1
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MTMC#?0L/[W- 'KT$OF1@]ZDJI8\P(WJ,U;H AN/NCZU(/NBHY_NCZU(/NB@
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MR&2WL8XI&!#,K')S7*W=RUW<O,_WF.34%%$*4(.\4*524E9L****T(-+0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M445Y)Z84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6-E;Y_U8_*JFIV< TNY(C&1&>U'OBYL/V?W_ / ,C0-:LHM+B1V?(7LM:O\
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M]J?7'6DMU>:U!<"4!'.=N*[ =.: %KS/Q!Q\283_ +"5Z97F?B/CXC0?[B4
M>C'K534_^07=?]<S5H]:JZE_R"[G_KF: ,_PW_R"H_H*V*Q_#?\ R#$^@K8H
M **** "EI*6@ I*6DH *6DI: $I.]+24 %%%% !7+^.O^0')_NUU-<QXY_Y
M<G^[0!Y!%]\U>CZ"J40^<U>CZ"@"+6O^/E?]P5DFM?6_^/A?]P5DF@!;S_CU
MC_WJK_PU9O/^/6/_ 'JK_P  H K_ /+0U87I4'_+0U.O2@!XI#3A2&@!M%!X
MK0MM'N+J/>/E!Z9% &?FIK;_ %PK0/AN['1@?PJJEK)!="-^HH A\0_\>9^E
M<KI__(.N/J:ZKQ",6K#VKEM/'_$NN/J:$!RK_?-7-(NWL]2AE0X.X _2JC_>
M-"<2*?0T ?0=C,+JSCF'\0S5E1S6-X4<R>'K4GKMK=4<UB45)AR:Y#4_^0F?
M]VNRF')KC]4'_$S/^Z*J.X,@/W:9BI,<4W%:$C:,4[%&* &TTBGXI"* &J.*
M:14BCBF$4 7M*_UQK;@_X^(_K7/V#2B4[!6I#)<^?'@'.?2JY1<QZ]9_\>4/
M^X*FKG[:YU/[+%A#C:,<5-]IU3^X?RHY0YC4N/NCZU(/NBL&:XU/ RAZ^E2?
M:-3Q]P_E1RAS&U25C?:=3_N'\J3[1J?]P_\ ?-'*',;5)6-]HU/^X?RI/M&I
M_P!P_E1R!S&S4UK_ ,?*5S_VC4_[A_*I;>XU3[0N$.?I1RAS'<#I2USGVG6/
M[I_[YH^TZQ_</_?-'*+F.BQ1BN=^T:Q_=/\ WS1]HUC^Z?\ OFCD#F.CI,5S
MOVC6/[I_[YH^T:Q_=/\ WS1RAS'1T5SGVG6/[A_[YH^T:Q_=/_?-'(',='17
M.?:-8_NG_OFC[1K']T_]\T<H<QT=%<Y]IUC^X?\ OFC[1K']T_\ ?-'(',=%
MBEKG/M&L?W#_ -\T?:-8_NG_ +YHY YCHZ*YW[3K']P_]\TGVC6/[I_[YHY0
MYCHZ*YS[3K']P_\ ?-'VG6/[A_[YHY0YCHZ*YS[1K']T_P#?-'VC6/[I_P"^
M:.4.8Z.BN<^T:Q_=/_?-'VC6/[I_[YHY0YCHZ*YS[1K']T_]\U)#/JQE4.IV
MYY^6CE#F-^BFIG8,]>].J2@HHHH **** "BBB@ HHHH \T^)^C7$PCU.$$F/
M P*M^ ?%T-Y8QV%TX6:,8!)ZUW5Q;1W4#PRJ&1A@@UY-XF\ 7FG7$E[I)9DS
ME8DSD5Z%&=.M3]C4T:V9S3C*$^>)Z\K!AD$$>QHKP^#QEXGT?$5VK*BC&UEY
MJW_PM.^_NG\A2>75?LV8UB8=3V6BO&O^%J7W]T_D*/\ A:E]_=/Y"E_9]?L'
MUJF>RT5XU_PM2^_NG\A1_P +4OO[I_(4?V?7[!]:IGLM%>-?\+4OO[I_(4?\
M+4OO[I_(4?V?7[!]:IGLM%>-?\+4OO[I_(4?\+4OO[I_(4?V?7[!]:IGLM%>
M-?\ "U+[^Z?R%'_"U+[^Z?R%']GU^P?6J9[+17C7_"U+[^Z?R%'_  M2^_NG
M\A1_9]?L'UJF>RT5XU_PM2^_NG\A1_PM2^_NG\A1_9]?L'UJF>RT5XU_PM2^
M_NG\A1_PM2^_NG\A1_9]?L'UJF>RT5XU_P +4OO[I_(4?\+4OO[I_(4?V?7[
M!]:IGLM%>-?\+4OO[I_(4?\ "U+[^Z?R%']GU^P?6J9[+17C7_"U+[^Z?R%'
M_"U+[^Z?R%']GU^P?6J9[+17C7_"U+[^Z?R%'_"U+[^Z?R%']GU^P?6J9[+1
M7C7_  M2^_NG\A1_PM2^_NG\A1_9]?L'UJF>RT5XU_PM2^_NG\A1_P +4OO[
MI_(4?V?7[!]:IGLM%>-?\+4OO[I_(4?\+4OO[I_(4?V?7[!]:IGLM%>-?\+4
MOO[I_(4?\+4OO[I_(4?V?7[!]:IGLM%>-?\ "U+[^Z?R%'_"U+[^Z?R%']GU
M^P?6J9[*6 &2<5Q_C7Q;;Z3I\D$,H-RXPNT]#7!3^._$>J'R[(,01C 7FI]!
M\#ZGKM\+K5MT<8.65P?F^E:4\(J3YZSVZ$RKN?NTT6OAQHLM[JLFK74>4.?O
M>M>NXJII^GP:=:I;P(%51BK=<F(K.M/F-J4.2-@HHHK T"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?8_K7TQY,?\ SS3_ +Y%'DQ_\\T_[Y%']JS[!_9L.Y\S_P#"):Q_S[']:/\
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MQ_\ /-/^^14?VK/L/^S8=SYH_P"$2UC_ )]C^M'_  B6L?\ /L?UKZ8\F/\
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M5NC!\A'F^_2M 7=N9-@E7=Z4 3T5"]U!&^QY5#>AI/MMMOV><NX]J )Z***
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M&3_PC.B_] RW_P"^*/\ A&=%_P"@9;_]\5K44>TGW8<L>QD_\(SHO_0,M_\
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M_P"^*/\ A&=%_P"@9;_]\5K44>TGW8<L>QD_\(SHO_0,M_\ OBC_ (1G1?\
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MJ$?<%:<6F_;H4!<+\W%5KZS^Q2>46SB@#-_Y:&IUJ#'[TU93I0 X4[%(*=0
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MQ6IA33Y1(Y9G.[WJK$FV*X*L5=I2/>NS^P6^V-=G$9ROM4)T:S,F_P OD^]
M',30-;OIT?F/Y4K$2-[4^Y7R+YXK>0O$823Z9KJIM/MYX!"Z94=*B@TBT@0J
MD?7@\T <I$TD>GVS1@[P.,57@BOW6.02*/WW/S_-UKMTTVVC"A8^%Z5 NA6*
M3>:(_FSGKWH Q(;9KK6;DS2.-C< 5G@3VLJN[@Q>=@'.6Z^E=LEG"DSRA?F<
MY)JHVAV33^:8_F!SU[T 7;=Q) CC.".]2TBJ%4 =!2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(6 [BEK/OB0>#0!=W>A'YTF3ZC\ZQO,?UI1*_\ >H UR3V(_.F_/ZC\ZR_/
MD_O4OVB3^]0!H$2>OZTTK)[53%S)_>IPNI/[U %@I)3"C^],^U2>M+]KD]:
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MT0^_:XZ[>AJK L]M=F6/YHU'.35:TTYX5<-,),]%%-@.JR91D:.($Y)'447
MN7-[<W%PLT# 1CKDXK4LM49H_+<J6'O63=6*RVZ-:2#<!\X'>L^(?9YM[2>Q
M%.[3"USM[75YK*5;@_P_W>37H'AC7SK$1RI!4=QBO'[/4XUG 891CS7K_A/[
M')9"2W0*Q'/-8XBSC<J&YTE%%%<9J%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC4@\1WJ]=QH [78WM1M;VKCAXHNAUC)_&I%\5S8Y@/YT =9AA2_-7++XM/>
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M4MJW#(S)*_ V^F37+>*+6ZUNY\1)HN021ETX#_0CK7JVJ>&=)UEPU]:+*P&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\K8[%JO&UF[7!'X41V=Q)*(Q=D$^U %.\O+RUD6.V4&, #I4(U6__BB!_P"
MUH7=@]J^)+T@GVJOM8=+PG\* (/[7N/XK;/_  "I;;4TN+A89+4#=W*4N^0?
M\M2U2PQW4IW1P&3% '->)_"EWJ%T);/8(^.#6(/!^J(.54X]*]*%Q=1?*UH0
M?K3Q?3][?'XT >9+X;U)9 #%GZ"K$?A'4YG^X%SZUZ5%?/NYCQ4TE](<;8=W
MXT <%;^ +AL&9U_!JU8/ ME'@RNQ_&NC+W4O_+,Q^],-M<$_-<GZ8H HP^']
M*M?X$/\ O8JPJ64',<"9']U14XLXNL@#GUIX@B3[J 4 0?:3(=J(P^HJ;L,T
M[H,"@122#$:DT 5+OY[:2,'YF&.*Y6^\++,_VAW"'W.*[I+)+<AYEW>K&L34
M[!K]6"7N[GA<40E-7UL4U$X^/PS:O/YDCEAGL>*=K&D*T*+:(N 1GBK$Z7.G
MNT8R .HK4@@N9;=;@1%%_G7-4>(A+GC*Z[&T%2DN5JQYIJNF7,*R+ 61CZ'%
M5M$^T02.;J1W4 \,<UZ5-;PSRGSHQN[YKF=0TU;34'<_-;LGIT-=6'QU.K)1
M>C,JN&G35]T<9K-J-2O%E9]L0/ !P:Z+2I_+B6W5P\..K')K-OHK:9MD!!(]
M.U8D\]QI[K#&"-[8SZ9KMORNYS;Z';R;X+I67F/MCI5.6YO'U-K4 >4RCYOK
M2R2RV>D6WFR&1F3G-5XK]NOIR#Z5;8D<]J_AMSK""'<\CMT/-?1/@#PY_P (
M[X=AA<#S&^8X]Z\KT^XS=P7WE>9-&0 ?K7N]A.+BRBD'=1_*N2M&STV-(O0L
MT445B6%9VN:K'HND7%]("5B3=@#K6C7"_$K5EBTI=(BC\R\U F&(9Y#=: 'Z
M#X[&I:O;V%Q$R/<Q&:([<#:/6NWKP;PC?/X=UB(^,)RM[$/)M5EZA#Z?C7NE
MO,L\"R)]UAD4 97B?Q#;^&M(:^N,E00H ZDFF>%/$,?B31HKU5*,W5&&"/PK
MA_'^KZ9?>)K70]0N%CM-HF9CR-RD'%1^$/$=E#X]U"QM)PUC.$2V4=,]\4 =
MQIWB:.^M[^4*1]E=E/'I5[0M636-'AOQ\JR>O%<3X:_Y!WB'_KK+_(UE6NHW
MR^'O#>C6-RUL^H,T9E7^&@#UM94?[CJWT-*TB)]Y@/J:\S\1-JG@AK/4SJ3W
M$$CI \&, L3C=4FFOJGBCQ)J>W4GAMK=AY<>,CF@#T@%3R"#2>;'NV[USZ9K
MR33O$6KZ1I^HK?7KSN'D2)V_@ZXJD-:NW\)1WD/B)WU4J#@+R30![275>K ?
MC2>:K(S(P; SP:\HEO\ 7=:\4VMC!J$EL@M8WD YW<<UK6#:GH7BIK&?4'N8
M+G<8U(P(P!TH ['1-2?4[.2>2-HRLK)AACH:T%EC9L*ZD^@->2V7B[48_!^9
M+AFN;O4I;1)>Z#=@?E726_AC6[9+29=;D>1%_?';_K#ZT =S138PPB0,<L%&
M3[TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** &R':A-<[=PV]XS";=^%=#+_JS7.O_K&^M &9
M)X<TYR2/,'XU WA2R;[LLH_X'6S10!@MX0@_AN)1_P!M#3#X08?<NY/QD-=#
M10!S1\*WB_<NV_&0TT^'M53[ET#]7-=/FC<1WH Y?^RM=C^[,A_&D^S^(H_[
MA_"NF:X9.C5LV;^= K'K0!Y\9?$$?6)3_P !IIU#6E^];9^B5Z44%5KJXMK1
M<SN%!H \\_MC4%^_9N?I'0-?F'W[*7_OW7<#4=-DZ2J:7?ITG\2F@#B/^$A3
M^*SF_P"^*>/$%J?O6T@_X#79FTT^3^%#4;:-ILG6%#0!R@UNQ;JC#ZBI!JFG
MM_%CZFNB?PSI<G6WCJ!O!VE/_P N\?Y4 8XO=/;_ );J/^!4X3V+=+I?^^ZO
M/X'TMND*#\*@;P'8G[H4?A0!$&M3TNU_[[IX$1^[=#_ONF'P'$/N28_"HSX)
MF7[ETP_"@"VD:GK/G_@57(D11P0:Q3X2U)/N7TGY4T^'M=C^Y>R_E0!TBU(*
MY;^R_$D?2YE--\GQ+'U:1OQH ZREKDOM'B*/K"[?C2_VKKD?WK%C_P "H ZR
MEKE!X@U-/OZ>?^^J</%-ROW[''XT =317,CQ<H^_;XJ1?%UJ?O+B@#HQUJQ'
M7,KXKT\GF0#\*LQ^*],'68?E0!THZ4R2L+_A+M, XE!_"H)?%]L1^Z7>: -Z
MBN7;7]1N.+>Q/U!I@C\07?\ RTDA!]#0!OWHMIH&CED5<]\XQ659ZY!;EK>>
M9&*_=(/:H!X:NY^;N\=_4$43^$+-8=Z*#(O/3K2:ZF-2+3YX[HGF\46Z'$<,
MK_[HS50Z_J%P<6]LZ_[R5J:5;V1A 6!5E3[X]*U5PHPHQ36II&2DKHY7R==O
M/O,B ^G%2)X9GD.;BY?\'-=.6)[TTT%&/!X;LXOO%W/^T<U>CT^TB'RPK^*B
MK-)0 @1%^ZBC\*7-!I* $HHHH 2BBDH *#124 (:*** $I#2TE !24M)0 E6
MK#_C[2JM6K#_ (^UH W:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ J-H49PY4%AWQ4E% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH3DJH!-/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!DO^K-<Z_^L;ZUT4G^K-<Z_P#K&^M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI\\44&GS2;^K(O YKN::T:,<LH- &196/VJW26<,I(R1G%:,=G#$,!<_7FK
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0O9,]#HHHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#?RCR_%7_/*W_[^4 =)]@MOL[0>4OEMG(Q56+0--A!"6ZX)SR*Q?+\5?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'N6Z@6TA68RJ@#GO4?\ :5K_ ,]5_.C^TK7_ )ZK^=%T)R@]V6Z*J?VE:_\
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MVP1A![4S^TK7_GJOYU9CD61-RG(H5GL)*#=UN.I:**984444 %%%% !1110
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M'O534);YUBN)G8PMAP#VK0L_#<\<MT\Y3]]&%&WM2/H.H3%(I)(_)3@ 'G%
M%.3Q'+)(SQ3%$C4$(/XJN3:O>7$]M%;;@9$W'%(WARYBF86_E>2PP=XYK1BT
MAX[^"?*XCCVD#UH U+82"!1*27[DU+110 4444 %%%% !1110 'I7):\LMK<
M;P#Y9[UUM075I%=Q%)%R#0!P(O\ />I!>^]:]SX2#,3"V/J:IMX3NEZ.OYT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML3PRM'(,,IP13*M:A?2:C=M<RJBLW4*,"JM=JO;4P>^@4444Q!1110 4444
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M %'5)6OMRR _</ 'X5=&O*M.T=EN3.FJ<==S(HHHKN.<**** "BBB@ HHHH
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MT_\ Z["OI2OFOPU_R,FG_P#785]*5XN:_''T._!_"PHHHKRCL"BBB@ HHHH
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %6=/_ .0G:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYH;:S=86D(S-(N5&35CP5XFNM8N;NSNI4N&MP/W\0PCY]*7,KV"QV=%%>?\
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M :=9) &+$#YCGJ:H2Z$9-=CU#>N%;.*IK05SC)]6O-6T2TM+,GS(+D12@'^
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MYC_WJZ2N;MO^/F/_ 'JZ2L:NY40HHHK(H**** "BBB@ HHHH **** "BBB@
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MTX_*CE87+_AC_D!6V.FQ<?E6Q4-K:Q6<"P0C$:C %352$%%%%,"6V_X^8_\
M>KI*YNV_X^8_]ZNDK&KN5$****R*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K@_B1>/;?V9&J@^;*0?RKO*\[^)Y"RZ.3VF/\
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M;J,FM=A566!GZ"J$83QMGK3/+:M<V3GM2"Q;OQ0!FQQ$=JN(!CE :LK9 =6
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MN%BCXA\7:9X:"_;WD&[H$3=63;_$[1+F=(DCO=SG S;,!7-?%QWCO+)TC,C
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MQ<RQ:3:PHQ"3.5?'IBM?3]!TBZ\'6<-W$GDM&K,W0Y^M#;O9 =-:W<-Y;K/
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M,$FM86T _P"6,?\ WR*D550850!Z 4)687%HHHJ@"BBB@ IT?^L7ZBFTZ/\
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M0N<GX6T.[TZ?7#<JH6[GW1X.>,8JC8Z?K7A^>XM[6"*2"3)B+-SN)R<UW5&
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MF/"R_P#/0?E2?\(OSQ,*?)+N+F1Q1\'3?\LYD_%Q33X4U%!\LT?_ '\%=O\
M\(RPZ34U_#[HN?/ _"BTA71P<N@:E$AW.A_X'6+-HMPSGY5S]:[R^@>%M@G#
M_2L\Q-Z5:NMR6D]CC3H=Q_=7\ZB.AW(/W5_.NU\D]Q1Y ]*=V%D<8NE7738*
MGCTZ>/JM=;Y7M2^7[4786.5^QSCH@IIL[@_PUUGE^U'E_P"S1<5CD/L,QZJ:
M!I[]T_2NO\OVIPASVIW86.);3I">$/Y5;LK##_O$./I76BV']VI!;#THYA.)
MUGA6-8]+PF<<5NUEZ$NVQQ6I0-*R"BBB@84444 %%%% !1110 4444 %%%%
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M&@#EUTO49#@S9_X%2MH4[?ZQV_.MIK6_:9_L<;%<_>%-FM-1A7=<W#1 ^HH
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M+01^^:6 JBX' JE#N9RJ/H=WX?)_L_FM>LG0"#85K5F]SHB[H****104444
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M+:[.,>E%@,+Q!-=:OXOL-,GO9K:$VL4C&-]N6(&:QM/TU-+^-=C!'=O<*'8
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M7\KD&V;@X)KM=)\/-:V8:1,L1GD=*F34=P2N<1I-B8H1+.K+MY (Q6H;U>[
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M=U_[ZIP^',W]]?\ OJO2:* /-?\ A74_9U_[ZIA^'5SV=?\ OJO3:* /+7\
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M]: ))_\ 65%4L_\ K*BH6P!1110 4444 %%%% !1110 4444 %(V=IQUI:*
M.8M?$LJ:S)8WR>6-Q\ML8!%4=;E.KZ_;6"9,<3AGQTP16MXFT0:G:^;$O^DI
M]QAUJGX2TN\MI9KJ^!$LB[>?:N=J;?(]CCDJCE[-ZKN=/!"MO D2#"J,"I**
M*Z#L"BBB@ HHHH **** "BBB@ HHHH **** '1_ZQ?K6C6='_K%^M:-3(:"B
MBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6#
MXE@$T< .>&-;U8OB D1PX]:&-'/?8HMO-,:&",$[SQ[U.5=^,X%1O# H_>8-
M245G>.0;1FD#BW7"J23[4R:ZMH?E1 35;[4\I.!QZ4"+;M(_W"HJN\D<',KY
M/UJ(R2 $9))%54LFF<R7#$J.QH D-S+=/L@0A?7%7;?3DC^>=N?K2"Y@LXOD
M &*R[C49;IBJ$@4 :-UJ"Y\FW ]SBEM(VD/S' K/@M&"[VX'K5C[;M'EQGZF
M@#=%RD:[5-(;@.V.HK ^T@<%JEBU&"+[TF2.U(HV)(X@,B)!]%%0R$>41M _
M"J0U3SI,=!VJ5[I3'@]J5@.3\3L\<8:,=37(6[2K*992,>E=3XCOX93]F1@9
M$Y(KDY<L"*CD5QW9>\^.24,A&>XK>L3E!7F=W>7&GW:RJ3LS\P]J[KP_JD5_
M;JR,,]Q5V)N=-&!BI,57C:IP<TQ#6'%9EP2,D#/M6HW0U0SB4TQ&#<S%B0L9
MR?45*B1H@W1DY'I6K<0IC>JC<*@B9)05[T 94FW?A8S^51JC8SL(Y[BMH0[,
M[ER11Y\((5X@<&@96@M7G8 9.?2NMT"PCT^3SY\%B.*S[6_M80"MNJU>35H2
M,&%6'7.:0&QJ6H3W!6* X4]2*V+#$42[F)XY&:YO3KK[7<8BA"(#V[UU]G;J
M<$QC..M,"Y'.K#A#^52 ;^Q%21JH/W0*D+ =Z!D)C(Z4Z GS,&G>8OK2Q,K2
M<4"+;?=/TKR/Q.N=?E^@KUQONGZ5Y/XE'_$^E^@HEL$3G9%^>@+4LJ_/0JUF
M6;6A<*P]ZZ",USVB\,16\AYIH3+L9JTC511JL(U,1>5JE4U41ZF5J +0:G'#
MJ5/>JX:GAZ8'F>N@1WDL9[DXKEXE"321/Z\5V7BRV6/40X/)&37)7D'[SS%[
MU+&4KM]XZ=.*C7]Y;X]*N/;[XP3QFH %C)C49(I 0+'QMQ3S&VT*@J;(/ ZB
MD21M^ :0R2U@*#<X_.F7FI);G9'\SGTI=<N9+;3T:/(9CC-<J;HPIYLAW2'I
MFDV5%7-&YOAM\R<Y8]%%94MXUPWHO8"L^6Y:64O(V30)0>E92;9T1BD6Z>*@
M1\U*K>M38TN2 X-3HW%5P1FK,>.* +MI,R.".U=987YD14?&/>N4A1L;@O J
M/^US!.$W8YJDF3)I'H\<?V4BYA(V]6%=9H;M-8L[=VKRVV\0/ 561=T3^IZU
MZ-X=U 7.FY1=@W=!6T5T.:HUN:]RG[E_I6)&G^ED8[5T,@S"WTK$08OS_NU2
M,60W$@AY*D_A4(N%8<*:SO&&HR:=9B2,]N:X!?&=VTB@,0,^M.UQ'J<?S#.*
ME4X'2F^&YA?Z1%,Z L5R32:EJ%O;'RT4%J)>ZKL2=W8L+,J]C3C?PQ#+&N;E
MUIN@X_&LB^OYW;(D.*Q=7L:<AT^I:P&7]V1Q7.76IS%""YY]#5/[2WEY8YK.
MGN,DDFLW)LM)(F^T$R_,QP?4U9^U&,8'2L?>6&:DBN?X6J1FB]V64@^E8KWS
M"1E]*T"V:P[D!;I\=Z+A8D^W,JL?>IC>ED%9,AX_&I@W%4F!>20AOK4S2-CM
M6>DI!J;S\T[B)O,;-+YCY[5!YH-'FYIW L^<_M3A(WM53S#FG+(: '2CYLFH
MXC^\Q0\O.#42M^]% %HMSB@-S4!;YZ,\T7 N/G8&%;_AOQ-+IEPJ2,6B)Y%<
M^C KM/<569O*DP>G:J3L)JY]%:5J,5Y;I-"P(/O6U%,&'->$^$O%#Z9<+#(V
M86.,$]*]@M+U+B!98VRK#(-;QE<RDK&[FBJ"7) ZU*+JJ$6J*K?:!3&N: )Y
M9 %Q6;.^<TZ2?/>J<LM %:X(K*N,'-7IY*SYFS2 SIUZUY]KVMC[4T>'&TXQ
M7H=PPCB9SV%>6ZO";G6,CH6_K344]RHF]X>E^U0LV&&!WKHU7Y:T/#?AZW&D
M1R@C<PY.*AFA\N5D'.#3@DM$95.YE7)=6^7-0XF(SS6A)&2W2F-N7@"M4C%N
MQ1/G#N:!)*.N:LDOZ51=[PL<1''UJN4CG)'G<#O55M1*L%YY-*3<]70@54F7
M,R\=ZG8I.YTUFQ>$,>]6U)%06"?Z,OTJV%JD2QO)IV*7:<T_%,EC,56N1Q5W
M%5;E>*&"W,RS7-V/]\5ZS8KBQ0>U>56"YN_^!BO6+08LU'M4O8/M%J'[E2U%
M#]P_6I:R>YUT_@04444BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *BN/\ 5U+45Q_JZ$!1IDL8EB:-NC#!I]%:$GDEYI/B'P7X
MBO=0TE(YK*\?<R;=S "KWA[2_$FK:A=:OJ\NR-X3&D*DK].*]-HHL,\7LOA_
MJ%Y8^)+=\))=2JT1/ XI]QI_B7Q#8VV@7$*)%;N [[, J..#Z\5[+12L%SR'
M7/"^HZ?#9V;VT4VG0(44QIF7'UJOH'P^U*?3]2>6>1;>>%DABD<Y5O<5[-13
ML!X3IWA76%%MHZ6X\R#"M)(F4.#FNDUG0=;T;Q<FO6*QR)-#' RA<D;1S7J5
M%*P'DOAGP_K2_$(:S?H@BEW,-HQC..M>L2+OC9<XR*=130CR2_C\4^'=6NP8
M8KVRNG+H&3S"O8#VJUX$\,7EK?ZCK>KB&"*[C"^6HV@8/<5ZC574K)-1L)K5
MSA9%VDT6&> :+HTM_P#$RYT])!+8/*T_R'*@KC%>A^/-*U*X>U9+>&6QC/SA
M8\R8QVKI/#G@[3?#C/);1+YKG)<#!KHJ5@/(?!WA'4H[B]NP\L=I)#)&L4K'
M.64@<4GASP[JS>%M6\+W$80M&523&%.3ZUZ_13L!X19^%M81X=,2W!DBF4EY
M$RFT'G\:Z6P\*WMK\1A?E!]G$@.0*]2HHL!Y5I'A>_M_%FJWCIB.:"5%..Y!
MQ6O\-M"O-&ANA=+@OC'%=]118#GO&'AT>)=&-IG$BG?&<X^;M7G*S>+](T]=
M#FL;:Z,8V1R-#O7\2:]GHHL!Y!IW@/5M/\)W$,_E&>=WDVQC@;N<8K#\2?#[
M5+[2O#L-N@5X8L3<=\U[W12L%SRR#PG>6_C1[M4_<_V=%%G'\0'-6? GA,V>
MLZ[/J5I#(L]P&B,D8/&!ZUZ513L!'#!#;ILAB2-?1%P*X_XDZ/=:UX>^SVJY
M?S$/3T-=I10(\G;PK?MXZL[\H/)CBB!..X'-:MKH%Y'\2TU(K_HX5QG'KBO0
MZ*+#,[7K>XN]"O+>U;;/)&0C9Z&O$Y?"FL76D36<D4CW*W*,9'!((!YP:]]H
MH:N!E^'HY(=%@CE4JZC!!%>9^)M&UFV\>Q:S8VZ2JD3)ATW#FO8**+ >.VOA
M[Q!XC\5:??WD-O;06<OF-Y:;"PQBI(])\0>#M5OOLL:3V]X[,-J[B"W S7KU
M%*P'D^FZ'K6AZ/J=\R*^HZA'A0JY52#W%9NE>"]:\+ZW!K5KM=[C'G*1G&[K
M7M5%.P#(GWQJV",CH:?110(**** "BBB@ HHHH !UJ:;M4(ZU--VH8$-%%%
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M^KE1OH:\O\3'_B:'\:H6^I7EH<PSLGTKH^J*44TQ0Q+BK-'LM+7G%EXUN[?
MF3S?4L:Z.T\8Z?,%$KB-CVKGGAZD>ATQKPEU.DHJ"&[AG0-'("#TYJ;.:PV-
MKW%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*<$QX%2U
M4OW9+?*G!S36X$7EM1Y;5F?:Y_\ GHU'VN?_ )ZM6O(R;FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
MYZM1]KG_ .>K4<C"YI^6U'EM69]KG_YZM1]KG_YZM1R,+FGY;4>6U9GVN?\
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MS2; L_:649#,/H:C,[W#!"S')[FJA<GBI;,_Z0N1T.:0&G):BW15))R/6J+
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MP1H\[%EN"/\ @(H'@'1P<M/N^JBJU)T.%;QJ&/RPD?45/_PFL%Q8LKQ.)P<
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M %%%% !1110 4444 %%%% !5+4O^/;\:NU2U+_CV_&G'= S#HHHKJ,PHHHH
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MU*"X9=[%1TYJA'IY6 R!VCR1[5;_ +1C";2G KR+_A.KN%@)%S^-7X/&\DW
MB4_C3YGT(E3B]T:>O2++?EE&!653GO#>MYI4#Z4VO<HN]-'DU%:;2"BBBM"
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MO% 0J1ON''2J&D6%[XNO=2NKG6I[7RVRD:D87\Z2;'8]/UC6[71K+[5.<IV
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M[EK^VY/\BC^W9?\ (JJ=,N,?<'YT?V7<_P!P?G5ZDZ%K^W)::=;E_P BJ_\
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M !1110 4444 %%%% !1110 4Z/\ UB_44VG1_P"L7ZBDP+%__P ?!JK5J_\
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M8HY5 YW2513Q3:RW1M[H&&?.""N!^9J6-&U13%<,H93D'H12YJ1BYHS3:,T
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M]:0'):*KIIJ)(VXK\N?I6C2M MN2BC SFFU+ 6BDHH&+29I,T'I0 9HS3":
M: %)IK$@<#-*:D#".(L1GZU,Y60):F?,VUE+?>8X45=M;9]P9YE.1TQTK,FE
M>;5K=6"[0_0&NB"A<L44 #J*FFKZLN>PU;<$_P"L%4M4D(NHXQTVT\7]H&QY
MI!%4+R[CN-00QG("8K61,>I)13,TFZ@@61]D;/UQ62TUW(6DCE"HO)!%:A.1
M@UB^(KB:PT>62UC4M@YI@6;.6YN4\Q) JGH"*LL5R"Y^<?K7&_#_ %F\U&*9
M9D 1,8-=H65Y.5''>D] +$;90$\&G9J,'TI<TACLTE-S29I@/JSI0_XFB?45
M4S5O2O\ D)I]10MQ,[D]#7,ZB/\ 3&^E=,WW3]*\N\2Z[-;ZQ)" 0H Y%5+8
M(G0ED4?,P%9^H:G;VL+-Y@+#H,USL6H27 +&4X ]:Q;VY:XG/)(["H*L.O\
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M=2U%<?ZNDAE/<:-YIM%:$CMYHWFFT4 .WFC>:;10 [>:-YIM% #MYHWFFT4
M.WFC>:;10 [>:-YIM% #MYHWFFT4 .WFC>:;10 [>:-YIM% #MYHWFFT4 .W
MFC>:;10 [>:-YIM% #MYHWFFT4 .WFC>:;10 [>:-YIM% #MYHWFFT4 .WFC
M>:;10 [>:-YIM% #MYHWFFT4 .WFC>:;10 [>:-YIM% #MYHWFFT4 .WFC>:
M;10 X,<U+*Q&*@'6IINU $>\T;S3:* ';S1O--HH =O-&\TVB@!V\T;S3:*
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M>:;10 [>:-YIM% $D;'S%^M7ZSH_]8OUK1J9#04445(PHHHH **** "BBB@
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MEC)-A>2:!&_I-S+<W6&.170S^5&@/&?2LK2;/[!:_:)L!FZ"GB;[1/C/&>:
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MQ]WTJ#27O/!M[>6MS [VTAQ;F-2Q_''2@!GPSAN(+V^CN&W,LS@'';)KTRN
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MC_UB_6M&LZ/_ %B_6M&ID-!1114C"BBB@ HHHH **** "BBB@ HHHH ****
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M,!S@=N*Y4CYJ=9LLEON4YI".:\W$OWCW<'&U-"@4TCFG]J,5Q-G>D, J1%H
MJ110F.PJCFI4!.3Z5&.M.C+8( )S75AY6FF<.,7[IH3<OK1D5$8#GJ:EALY'
M/%>Z?,$B*6.!6E;6IX)I+6P<8K9M[4C'% [#(+;VK4M]\)RA(IT4.!R*D;"B
M@9<CU1U&V8>8OI5ZTGL)3DA8B?4U@I&\SX12?H*OPV,O4H?RHLF%SIX8K9U
M2134CZ>&.0:Y[[+.HRI<?2IHKC4+09'S#_:YIM26P73-&?3V'(%4'MRAY%7+
M?Q#&YV7",&]=O%37$T$R9C(.?2A2>S!Q[&04YJ"7T!J^ZX&:HR#@FK,SD=4R
M;NGVNAZA>*&AMG93W%>A:5I=K)#YLD2LV>XK:CACB7$:*H] *V^M\L>6*,UA
MN9W;.&LO LCH'N)MA[J1716?AC3K51F%6<?Q5M8I:YYUZDMV;QHPCLAD<,<2
MA44 "GXHHK$U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"HKC_5U+45Q_JZ$!1HHHK0D****8!1110 4444@"BBB@ HHHI@%%%%( HHHH
M ****8!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZOUB07LC3HIQ@FMNHFFMQH****@84444 %%%% !1110 4444 %%%% !1110
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M 4444 *OWA]:N7O1?H*IK]X?6KE[T7Z"I?Q($4J***H HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *='_K%^
MHIM.C_UJ_44F!8O_ /CX-5:M7_\ Q\&JM*.P/<****H HHHH **** "BBB@
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M']&-:-RW^B2$'C;5)(6IVWPYA^SZ T><[6 KL:Y+X?G.C2?[XKK::$%%%%,
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M]WBJ,/)K2APT?7FI*(HQ\U)<<KDT]U*Y(J,L'3WH$9\HXS40)"\BII]S/@C
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M502!D$4 >A?#:43>'V<=V!KLZXSX; #P\0.S"NSJUL2PHHHI@%%%% !1110
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MCQ591M;6&KVR6A/"O&6;\\TMG<!?%\]M-HDR:4,3+<KYI0>_-='X8D@?0H#
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M(4445D4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>9" 3R.*QF%6-/8Q2^U SL;<AHB#Z5P^IOB\9/1LUV-E*&7'M7$ZSE=8<>U
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MR]Z+]!4O= BE1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "K]X?6KE[T7Z"J:_>'UJY>]
M%^@J7\2!%*BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "G1_ZU?J*;3H_P#6K]12>P%B_P#^/@U5JU?_
M /'P:JTH[ ]PHHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"6V_X^8_\ >KI*YNV_X^8_]ZNDK&KN5$**
M**R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@
M/B6<#3#_ --3_*N_K%\0>'X]=%N)&"^2Q89H \H#D'-2H^X9KNQX#M_^>B_E
M3QX&@'_+1?RI#N<"TN!59YF<X%>B/X$@?_EJOY4+X"MU_P"6B_E3$<##&2N2
M:L06WFMCL.]=U_PA$&,>8OY5/%X0AB'#C\J .*%I&G;\ZEW*@PG KM&\*Q,,
M;Q^51CPA /XQCZ4AG%@[STIKVRN.:[C_ (1*#'WA2CPI".KC\J N<"L/DY"C
M/UJ.1<\UZ$WA.$_QC\JB/@Z G[Z_E0%SSEU]!5*3.37J#>"H#_&OY5 _@*W<
M_P"L7\J+ >6-)M:M_19XCQCKUXKKC\.K4G/F+^56;;P+!;@[95_*BP7/)/&"
M#^T9"H&"!TKE+*5HKO;N.*]]U#X=6M_RTB@^N*RT^$-FDWF>>GY&BP'(:/?K
MY>UBV /2N9\97[R7J) Q"[>37M=O\/+6"(H)%Y'I69>_"6TNY=_GH#]#2L%S
MY\,4CX9R6'ZU-Y 50R8([@U[RWP?L1%MBE16[G!I/^%/6/E8\Y/,_O8-.P7/
M!Y"&7,?!'45ZW\/)(XM%;<1N+]JV5^#5B%.Z="_K@UM:1\/(M*B*)<*><\"@
M"2)@5R#3T!9JUD\/QI'C>"WK4\>CHBX+ T 8,K*950]#UJ4*3R<8%:G]@QF7
M>6!J?^R4QC<,4 83@R?*HJ&XMHEA)8X;VKI1I:*."*@ET-)6R6&/2@#C%)1C
MY<K$>C&HWF1W_>H$([H*Z]O#$!.<BFOX6B9=N\?E0!RD*-,_$BF/ON;FNGT:
M.*!P ,L?2H1X,B5]R3 5LV.E"S RX8B@#0?_ %;?0U\W^/=-CG\:7$TG("K@
M?G7TB1D$>M<5J_P\MM5U%[MY%#,,8(I25P3/$(HPN% P!7:Z(H6S5S]U>377
M#X6V@_Y;+^5:<'@:""T:!95PPQG%3RLKF1Y9=,;W4#W4' IFHGR@L X"<UZA
M;_#ZVADW^8I/TJ.Z^'5O<NS-,N6]J7*Q\R/&" SDU9B7Y*]67X76BC'FK^52
MK\-+11CS5_*CE8<R/))$^3.*JF,FO9F^&UJRX\U?RJ/_ (5C:?\ /5?RHY6+
MF1Y7IMN2S2,. #3W;<Y->M1_#RUCA,8D7GVJ'_A6MKG/FK^5/E8<R/+0*9/R
MM>KCX<6O_/5?RIK_  UM7&/-7\J.5AS(\:/4U'_%7L9^%MH3_KE_*F_\*KM,
MY\Y?RI<K"Z/)H^E2@UZNOPOM%'^N7\J=_P *QM/^>J_E1R,?,CRR,YJCK"_*
MI]J]C7X:6JG_ %J_E4=U\+K2Y !E48]J?*Q71X=']VI*]E'PELP,><GY&E_X
M5/9_\]D_(T<K%='C8J1:]B'PIL_^>R_E2CX56G_/9?RHY6.Z/(5'<T9YP*]@
M_P"%66F,><OY4T?"NT!SYR_E2Y6',CS.W;$8!ISM@Y%>IK\-;51CS5_*@_#6
MU/\ RU7\J.5AS(\L!RE+$VU@/4UZE_PK6UVX\U?RI5^&UJ#GS5_*GRL+H\OO
MG&X@5ERMD5['+\-K65LF5?RJ$_"VT/\ RV7\J.5A='BSFH5/S5[6?A19G_EL
MGY&FCX360_Y;)^1HY6%T>+OTI8EKV<_":S/_ "V3\C2K\)[-?^6R?D:.5A='
MCHXH)XKV3_A5-G_SV7\J3_A5-G_SV7\J.5A='B:)B1C[U.&KV,?":S!)\Y/R
M-+_PJBS_ .>R?E1RL.9'D<.!\S'@5:BFRF<8KU0_"JT*X\Y?RJ0?"^T"X\Y?
MRHY6/F1Y/YE.5]XZUZK_ ,*NM?\ GLOY4J?"^U7_ );+^5+E8<R/*\G% 8;L
M&O6/^%9VO_/5?RIO_"L;7/\ KE_*CE8<R/+3(8F!1L'VIUUJ,\\2QR.2J^]>
MH?\ "L;7_GLOY4UOA?:M_P ME_*CE8<R/(6FRVT432X4+7K:?"RT1MWG+^5(
M_P *K1VR9E_(T<K#F1XZ'YIQD%>O#X468_Y;+^5'_"J+/_GLOY4<K#F1Y%'\
M[5;&%3W->K1_"RTC'$R_E3S\,+4_\ME_*CE8<R/'+G*C(K/D)R!W/6O<)/A9
M:2#'G+^50?\ "H[/.?.3\C1R7%S'B:QY;O6C9V'F2*#DYKUX?">R!SYJ?E5Z
MU^'%I;'(=2?I2]D/F. O(TM] F10!^[->=6W^KKZ,NO =O<VSPF10&&.E8:?
M!^R1<><GY&KY78FYY)HO_(6MO]\5ZP7(2K=I\*K2UN4F$R$J<]#71_\ "+1$
M8WC\J.5A<X*1CYM7(F.T5UA\'P$YWC\JF3PM"@P''Y4687..9C498UVI\+0G
M^,?E33X4A_OC\J+,+G#-(PXJ%W>N^_X1*#^\/RH_X1*W_O#\J+,1YR^\]C5=
MUD88P:]-_P"$1M_[P_*D_P"$/MO[P_*G8#REX).N*@:)SVKUIO!ELW\2_E43
M>!K8_P :_E18#R*6W8U0D@(->T'P#;'_ ):+^50/\.+5S_K%_*BP'CB J:68
M_P"K_P!ZO73\,K3_ )ZK^5-;X86C;?WJ\'/2BP'F,!_TY?K79V4A"+S70+\-
MK591)YJ\>U:4/@V&(8$@_*ERL=S'MKACCTK4A4D@DUH1>&XHOX@:MKI2J,;A
M19A<S63C(JNP;:=^!]*W#IBD8W4QM(1ARPHY6%SE+E" <&L6YSCFN^?P^C#[
MXJI)X2BDZR#\J+,+GEE_\RL*X+4[4K=D@=:^@Y? 5O*3F1>?:L^?X6V<QR95
MS]*=@N7OAF,>&0/<?RKM*R]"T:/1+'[-&01[5J52)"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZE_P >WXU<JM>Q-+!M
M7KFFMP.?HJW_ &?-_=-']GS?W371S(SLRI15O^SYO[IH_L^;^Z:.9!9E2BK?
M]GS?W31_9\W]TT<R"S*E%6_[/F_NFC^SYO[IHYD%F5**M_V?-_=-']GS?W31
MS(+,J45;_L^;^Z:/[/F_NFCF0694HJW_ &?-_=-']GS?W31S(+,J45;_ +/F
M_NFC^SYO[IHYD%F5**M_V?-_=-']GS?W31S(+,J45;_L^;^Z:/[/F_NFCF06
M94HJW_9\W]TT?V?-_=-',@LRI15O^SYO[IH_L^;^Z:.9!9E2BK?]GS?W31_9
M\W]TT<R"S*E%6_[/F_NFC^SYO[IHYD%F5**M_P!GS?W31_9\W]TT<R"S*E%6
M_P"SYO[IH_L^;^Z:.9!9E2BK?]GS?W31_9\W]TT<R"S*E%6_[/F_NFC^SYO[
MIHYD%F5**M_V?-_=-']GS?W31S(+,J45;_L^;^Z:/[/F_NFCF0694HJW_9\W
M]TT?V?-_=-',@LRI15O^SYO[IH_L^;^Z:.9!9E2BK?\ 9\W]TT?V?-_=-',@
MLRI15O\ L^;^Z:/[/F_NFCF06957[P^M7+WHOT%(-/FR/E-6+JTDD"[0>!4N
M2NAV9ET5;_L^;^Z:/[/F_NFJYD*S*E%6_P"SYO[IH_L^;^Z:.9!9E2BK?]GS
M?W31_9\W]TT<R"S*E%6_[/F_NFC^SYO[IHYD%F5**M_V?-_=-']GS?W31S(+
M,J45;_L^;^Z:/[/F_NFCF0694HJW_9\W]TT?V?-_=-',@LRI15O^SYO[IH_L
M^;^Z:.9!9E2BK?\ 9\W]TT?V?-_=-',@LRI15O\ L^;^Z:/[/F_NFCF0694H
MJW_9\W]TT?V?-_=-',@LRI15O^SYO[IH_L^;^Z:.9!9E2BK?]GS?W31_9\W]
MTT<R"S*E%6_[/F_NFC^SYO[IHYD%F5*='_K5^HJS_9\W]TTY+"8.IVG@TN9#
MLQE__P ?!JK6G=V<LLI95.*K_P!GS?W31&2L%F5**M_V?-_=-']GS?W33YD*
MS*E%6_[/F_NFC^SYO[IHYD%F5**M_P!GS?W31_9\W]TT<R"S*E%6_P"SYO[I
MH_L^;^Z:.9!9E2BK?]GS?W31_9\W]TT<R"S*E%6_[/F_NFC^SYO[IHYD%F5*
M*M_V?-_=-']GS?W31S(+,J45;_L^;^Z:/[/F_NFCF0694HJW_9\W]TT?V?-_
M=-',@LRI15O^SYO[IH_L^;^Z:.9!9E2BK?\ 9\W]TT?V?-_=-',@LRI15O\
ML^;^Z:/[/F_NFCF0694HJW_9\W]TT?V?-_=-',@LRI15O^SYO[IH_L^;^Z:.
M9!9D-M_Q\Q_[U=)6+#8S),C%3@&MJLJC3>A40HHHK,H**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>gtl21rgcbjm5000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" :9",H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBD) ZF@!:*9YB?WA1YB?WA0 ^BF>8G]X4>8G]X4 /HIGF)_>%'
MF)_>% #Z*0.K=#F@G'6@!:*9YB?WA3@P;H: %HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***;YBCO0 ZBFB12< TZ@ HHHH **:74'!-'F(?XA0 ZBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBF-*B?>8"@!]%0&[@'604Y;F)CPX- $M%'444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !133(H.":!(I. : '4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 444A('6@!:*9YB?WA3@P;H<T +1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M >DJ<KFAONFD3[HI6&5(H X#4]3NH]0F19& #<<U)H^I7,M^B/(Q!/K5F_\
M#MQ<7LLJ@X9LBGZ9X?N+:\61@<"@#KDY0?2G4B#"@4M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9.OS/!8AHV(.>U:U8OB7_D'#ZT <;_:]
MY_SU;\ZZGPS=2W*-YCEN.]<3ZUU_A+[C?2@#JJ*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "L^^U>VLE(=QNQT-.U:5H;%F3K
M7G-Q/)/(QD<GGO0!WNDZJ=18G;@5KURGA/[E=70!0U:1HK&1D."%K@SJUWG_
M %K?G7=:U_R#I?\ =KS@]30!VOA>ZEN8Y3*Q;![UT=<KX/\ ]7-]:ZJ@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YWQ/=2VR)Y;%<CM715RWB
M_P"Y'_NT <[_ &O>?\]6_.C^U[S_ )ZM^=4:V-/T%[^'S 3U[4 5?[7O/^>K
M?G2C6;P?\M6_.M4^$Y@."U5+GP[=0(6520* 'VGB2YA<>82X]S76Z;JL6H1@
MJ1NQR!7F[*48JPP15[2;U[2]CP?E8\T >E5S?BB[FMO*\IBN1VKH()1-$KJ<
M@BN8\8?\LOH: .?&KW>X?O6_.N\TJ1I;-68Y.*\U7[PKTC1O^/%/H* -&BBB
M@ HHHH **** "D)"C)Z4M8/B2ZD@MB(R1GN* )]0UZWLQM5@S^E6-*O&O;7S
M2,9->;O(\C[G8DY[UWOAK_D&+]: -JF2R"*)G/11FGUG:S,8K%\=Q0!R^K:_
M++.R0L54'J#6.U]<DY,S5"YRY-;6@:4E^S&3H#0!1L[^Z>Y2-9FR:]$M-WV9
M-QR<<UFQ>';:&995/*^U;"KM4 =J %HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNBH **** "L7Q+_R#A]:VJQ?$O\ R#A]: . ]:Z_PE]QOI7(>M=?X2^XWTH
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M]6_LY0<#DXK)7Q9EU&!R:7Q=]Q?]ZN3C_P!<GUH ]1LY_M-LDG]X5/5#2/\
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M#?/BRZSPBU=M/%88XG 'T%9D/AB]EC#@*,CN:S;NQFLWVR+T[B@#T>UO8;M
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MQ%SXFO)7/E/M4]B*S7GO+I]QW,3Z4 =CK.HVC6CQ$AB1Q@UPKXWMCIGBK?\
M9]VR%V5L#U%5&!4D'J* .H\)L<D>]=:ZJ4.0#QZ5R/A/[Y^M=@WW&^E 'G6N
M8_M!L"H]&_Y""Y]14FN?\A!JCT;_ )""_44 >CHB[0=J_E2M]PT)]P4K_<-
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M5_Q[_A0!Q7<?6N^\-JITU<J#SZ5P/?\ &N_\-?\ (,7ZT ;(4 8  _"L;Q$
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M<,\UF^(-+-K.947Y&Y..U $_AS5S%(+>5N">":[-6#*".AKRA7*.&4X(KN]
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MH A(SQ7?>'+<PV62/O<URFCZ:]]=+E3L!YKT&"(0PJ@[#% %+6_^0<]><O\
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M@"U>?\>K_2O-+K_CZD_WC7I=[_QZO7FEU_Q]2?[QH V_"G_'W^==Q7#^%/\
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M* %JG?Z?%?0[' SZU<HH X2\\,W$3GRPS+]*SFTB[!QY)KTL@'J*;Y,9_@%
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MO,GY&ZUZ)2;5]* ,/P]8RV<&V12#CO6[2  =*6@#G_$EA->K%Y2DXZXKF_\
MA'KS'W&KT,@'J*-J^E %338FALHT88( J#7;:2[TUHHP2Q/:M.C&>M 'G?\
MPCUY_<:NKT"SEM+0)("#GO6QM7TH  Z4 +7,>(=,GO)08U)Y[5T](0#U% 'G
MR>'[P2J=C<&NWT^)H;2-&&"!5K:/2EH .U<9K.CW-S>;T0D5V=)M'I0!PMCH
M=W%=*[(V :[B,8C4'L*=M'I2T 1S0K/$R.,@BN/U/PU(LC/ "5] *[2D(!ZT
M >:G2+S./*:KEGX;N9W&]65?6N\\J/\ N"G!0O08H YR\T,1Z:8H5RY') K
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MM620$'/>MJD  Z4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3)?]4WTI]% 'FFJ(QU";Y3
M][TJUX=1AJL65(Y]*[EK*!V+&-23[4L=I#&VY8U!'H* )ATI:** "BBB@!",
MC%<#X@>:+4I LC@9[&N_K.O-&MKURTF<GTH \Y+N_P!YF;ZU-:V4UY*(XU/-
M=LGABR1L@L?K6G!9P6Z@(B\=\4 5M)L!8VH7'S'K6C110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%5KG4+2T!,]Q&F!G#-BN7O?B
M-I%G*4PTF.ZM5QA*6R$Y);G8T5RNG>/=)U!PH;RL_P!]JZ2"[M[E=T$R2#U4
MYI2A*.Z!23V)J***D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEN-?1O+(V$&O2>&IJ%V<OM9.5CZ,4Y7-+34&% IU>:=04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !69K6LPZ-:-/-T SUK3KS#XL7H6R$"G[R5
MI2ASS429RY8W+Q^*.G@D;3_WU2?\+1T_^X?^^J\)VCN*E6SG<92!F'J*]+ZI
M3.7VTCW)?BCIQ/*G_OJKMO\ $C2IF"DA<^K5X#]BN!UMVJ-HFC;YD*GWI?4Z
M;#V\CZGL=9L=00&"=&)[ U?KY=TGQ!?Z1<+)#,P7/(%>Z^#?%D>O6*AVQ,J_
M-D\UR5L,Z>JV-Z=52T.MHHHKE-0HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J][=I96LD\A^5!DU8K
MFO&\QB\/W"CJR$"J@N:20F[*YBR_$_3XY&7;G'^U6EH/C:VURY\F%#P<9S7S
MN\$IR3$<UZY\)=,58YIWCPP((S7?6P].$+G/"K*4K'K-%%%><=(4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5%<3K;V[RMT49J6L/Q7<B
MVT.X;.,H:<5=V$W9'/7/Q+L+>X:(J25_VJB_X6CI_P#</_?5>'7+B>X>0]Z:
ML#R?ZN,M]*]582G;4Y/;R/<_^%HZ?_</_?5/3XH:<>J_^/5X7]BN/^?=J#9S
M@9,# 4?5*0>VD?0EG\0M*NG"[U3/JU=-:W]M>H&@F5P?[IKY24&-LK\K"NH\
M+>+[W1[Z-'F9H6(&,^M95,$K7BRXUW?4^CJ*IZ;>K?V4<Z_Q"KE>>U8Z0HHH
MI %%%% !1110 4444 %%%% !1110 5S/BSQ3#H%FW.9CP%!YYKH+F=+>W>5V
M"J >37BSK+XQ\9>4[%X$)Y[<&MZ%-2=Y;(SJ2:5D,@LM:\9W1FN9C' 3QO%=
M59?#72HX@+EXY&]<U2\;WD_ARVAM].<Q#Y1\M4]-L_$VI6"W4=]+AN@Q72W)
MQNG9&223LU=FK?\ POLY8BUBZ(PZ5SD-YKG@>^6.9G>U)QP.,4G_  D_B'P_
MK$5O>RRM'OP0>]>EWEG;>*?#ADDA&Z1/ESVI.4H64]4QI*7PZ,T-"UJ#6K".
M>)ADKDC/2M6O&?!E[/HGB:;2Y)"(_,V@&O958,H(.<URUJ?)+38UA+F0M%%%
M9%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN'O?BS#"Y^S*I'NM4)/B_<L"%1/^^:Z)PKU-3.+IQ*_Q*\/VFG/'+;@+N8Y
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MT4VEH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 0]*^?/B-=/<:[MR2%!%?09&1BN6O_ NEZA<F>:%&8]R*Z,/4C3E=F=2+DK(
M^=,'THPWO^=?07_"N-&_Y]X_RH_X5QHW_/O'^5=OUR!A["1\^X;_ &OSHPW^
MU^=?07_"N-&_Y]X_RH_X5QHW_/O'^5'UR >PD?/;!@I^]^=>S?"G3%2S>Y8'
M<P!YK>_X5OHI_P"7>/\ *NBTG1[;2(!#;H%4#&!6-?$QG#E1=.DXRNSB_BK<
M[-),0/WDZ5X:0V!P>M?3VM>'+36]HN45L#'-8H^&^C9_X]X_RHH8B%.%F%2D
MY2N1?#>Q2WT0.%PQ.:[BJ>G:=#IMN(85"J.PJY7'4ES2;-HJRL(Z[D*GN,5X
M)\3--%KK<DJ+]XXKWRL'6?"MAK4F^YB5CG/-:8>JJ<KLFI#F5CYH".[!54EC
MP!7MGPU\+K968O9X_P!Y( PR.E;$7PZT:*9)!;QY0Y'%=9;VZ6T"Q1C"J, 5
MO7Q2G'EB13I<KNR6BBBN$W/.OBI>;-':W!Y;!Q7A^UBP&#R:^F]:\.6>MD&Y
MC5L#'-8P^'&C @_9X^#GI7?0Q$*<+,YZE*4I7(?AG8I!X?CD*X<DUU&N70M-
M)N)/1#4NG:?#IMJ((%"H.PI]]91WULT$H!5A@@UR2FI3YF;)6C8^7]5N6O=2
MEN"#\QKK/AE8R2ZT9=IVJP->E?\ "M]&_P"?>/\ *MC1?#-CHF[[-$JEO2NR
MIBH.'+$PC1DI79M+PHJAK=R+32IIB>@K0JKJ%E'J%F]M* 4;J#7 K7U.A['R
M_JCF74[AP.LA-=G\*K7S->\QUR IKT5OASH[,6-O'D^U:NC>%K#1'WVT2JWM
M7?4Q4)0<4<\:+4KLW!P *Q?$NBIK.F/"0-P!(SZUL2/Y<3.?X1FN,N?B-86E
MVUO* "OJU<=.,F[Q-Y-):GBNM:!>:/>/%+"VT'AL<&LV*2:!MT9*M7O7]M>'
M?$[B&=8I'8\ FIO^%=:(S;A;1[?3%>@L5RJTUJ<WL;_"SQ"!=7UF18%$D@/&
M0.E0:CIDNFR".5LL>H]*^C+70M)T"!IX+=(]O)(KP'Q7=_:]>N'#97><55&O
M[25DM!3I\JU,JRC,M[$@&<L/YU]/:';I;Z5;J@QF-2?RKY^\#:<-1\30(ZY3
M!)KZ.@C$4"(.BJ!6&.EJHFF'6C9)1117 = 5!>R>59RO_=&:GJ.>)9X6B;[K
M#!IK<#YI\5W)NM>N3R</6)@^E?0TWP]TB>=Y7MT+,<DXJ/\ X5QHW_/O'^5>
ME'%TTK'(Z,F[G@'F2CHS?G36,C=2Q_&OH'_A7&C?\^\?Y4Y?ASHH.3;1G\*?
MURF'L)'S['#-*VU(V8^@K>T;P;JFK7 0P/$G4LR\5[G:>"=#M&#I9(''>MV&
MWC@4+&NT"LYXW^5%1H=SF/"?@VUT"W4E%,Q'+"NLHHKAE)R=V="22LCA/B;?
M?9]$:$'F1#7@;AB"<')KZ@UKP_::VJK<HK!>F:P_^%;Z-_S[Q_E79A\1"G&S
M,*E.4G<SOA=8>3I32LN"6!KT2J6FZ;!IEN(8%"J/2KM<M6?/)R-HKE5@KF/'
M.DR:KH;1Q?>3+=*Z>D90RE6&0>#4QDXNZ&U=6/D^YM9;2=HI4*L#WJSI^L7N
MEL3:RE,]:][UGP#IFJR-+Y2)(W5B*QX?A38QN"[1L/3%>DL73:]XY?8R3T/*
MSJ.NZ_*(=SRAN.!2:UX>ET6&$SG,DJYQCD5[]I/A32](PUO;HKC^(5'K'A.P
MUJ59+F)7*],UFL7%2T6A7L7;7<^;[2)I;R- I.37TQX;M!::/ H&,H#^E9%O
M\/M'MYUE6W3<O3BNLBC6&)8U& HP*RQ-=5$DBZ5-QW%=0Z,IZ,,&O&/B#X*F
MAN6OK2,LC=54<UZ5XA\30: @>89&1WK%7XAZ->KY4I0*W!!:IH>T@^:*T'4Y
M9:,\%>*2-]KH58=C5J"_U!%$,#M@\8%>YQ^%O#FO+]I@AB;=W%7;/P%HEK()
M/LB%AT-=;QD+:HQ5&71GA;:#J#V<E[<*R*!N^8=:Q3Q7L_Q0O(++3H;.W8 $
M$%1VKQ@\CZUM1FYQYF9SBHNQZO\ ";3BQ>Z(^Z]>NR1K+$R,,@C%<?\ #K3C
M9:&K%<>8 U=G7F8B7-4;.NFK1/%/'G@::"Y:\LHRR'DJHKSDK/:R\JR.OK7U
M=)&DJ%'&5/45S&I^ M'OV+BV17/4UT4<796F9SHW=T>'6WB[6+5-B7)VCI5>
M^\0ZGJ(VSSEE]*];E^$]D[95XU_"I;;X5Z?$P,AC<>F*U^LT5K8CV4]CQ>RT
MR\U&=8K>%V+'&0.E>\>!?"BZ'8B211YT@!/UK:TKPQIFD ?9K=4;N16S7-7Q
M+J+E6QK3I<NK"BBBN0V"D)P"?2EI",@CUH \)^*&I-<:W):C)5,&N)TZV>YU
M*WC4')>OH74O ^F:G>-<SPHSMU)%1V?@'2;.Z2>.! RG((%>C#%0C#E1S2HR
M<KFOX=MVM=%MXF&"JUSGQ+N/*T&10>2AKMU4*H Z"LO6="MM:B$=R@90,8-<
M4)I3YF;R7NV1\NONY;!Y->Y?"VP$.DM+MP2P-:)^&VBD8^SQ_E73:7I=OI5M
MY%N@5?05U5\3&<.6)C3I.,KLO5PGQ0OY+3P^!&<%GP:[NLK6M!M=;A$5RBLH
M.<&N6E)1FFS::;5D?+[!F8\')->V?"O2VMM-%R1_K%Q6M_PKC1L@_9X^/:NG
MTS3H=+LTMH%"HO0"NJOB8SARQ,:=)Q=V7****X3H"BBB@#RWXG^&Y;I/MUNA
M;: " .:\=97B?# JRGO7UA-"D\9CD7<IZBN,U3X;:7?2L\4<<1/)XKNH8I1C
MRR.>I2;=T>)P>(M6@C\J&Y(7L*MV^E:OKT<US*'VQKN+$<&O6++X6Z=;RAIA
M'(!VQ77VVB65I8M:00JD;+M(%7/%P7P(F-&3^(^7)(V1BI!R*]2^#[*LEV&.
M"2,?I792?#O1I'+&WCY]JOZ1X2L-&E,EK&J$G)Q2JXF$X.(X4I1E<Z&BBBO/
M.D*#P,T4'D8H \3^*UX9;_R!G"D&O-<'TKZ2U7P;IVK71GN(49CW(JA_PKC1
MO^?>/\J]&EBH0@HG-.E*4KGS^'D484D4OFS?WF_.O?\ _A7&C?\ /O'^5'_"
MN-&_Y]X_RJ_KE,GV$CY^9I&ZEC^-"QR,<*K$U] CX<:+G_CVC_*KUOX$T" A
MOL,98=Z'C8=@]A(\*TCPKJ6K3JBP/&I/WF7BO<?"/A*W\/V:_*#,1DL*Z&VL
M;>S0+!&$ ]*L5R5L3*IIT-H4E'49-&)87C/1E(KP#Q]X;GTW5Y)TC)A8\$"O
MH*J.I:3::K;F*ZB#KVS4T*SI2N.I#G1\M0S26\@DB;:XY!K4_P"$BUN9?)%P
MS \  5ZY=?"O3YI2T7EHOIBM#2_AUI5A(LDD,<C+T.*[98JE:]C!49GBMYH.
MH16?VZY5@&&[D5BL#@<'K7U%J.@66HVBVTL2F-1@ U@GX;Z*?^7:/\JF&-C;
MWARH/H6O CJV@18/0"NG=0\;(>C BJ.E:3!I-OY,"A5]!6=XA\56_A]@)QG.
M.]<+7//W3H7NQU/,_B!X,GM[Q[RSB+1GJ%%><-')&^&4JP]:][7XA:-?+Y4Q
M3:W!!:GQ^$O#FN)]JMX(F#=Q7=#$2IQM41SRIJ3O%GAD%]J(7R878@\ "KDF
M@:A]C:]N%9!C=\PZU[K9> ]$M)!(+1"PZ&N4^*&H0V=C%90X&05(':JCB5.:
MC!"=+E5Y,\;)P,UZ[\)]*9(Y+D]V!KR,(9&"#J:^A_ %B]GH<988WJ#58N5J
M=NXJ*O(Z^BBBO).P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#24$TTFF $TA-
M(33": '9I,TPM3"] $NZDW5"7I-] $VZC=4&^CS* )]U&^H/,H\R@"??1OJ#
MS*/,H GWT;Z@\RCS* )]]&^H/,H\R@"??1OJ#S*/,H GWT;Z@\RCS* )]]&^
MH/,H\R@"?=1NJ#S*/,H GW4;J@WTN^@"?=2YJ#?3@] $^:7-0AJ<&H FS2@U
M&#3@: ) :6F TX4@%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!DR[X77U4BOG7Q_ICV?B*9C'B,XP:^C:Y[Q)X5M-
M>MRKJ%D_O8YKHP]54Y79G5AS(^<K"\EL+N.>%B"ASQ7J>F_%D16:1SVX9U'+
M%NM8^I_"J_M\M:^9+[8K ?P%XB5L?V>]=\G1J[LYESPV.C\2_$Z75+1K:VA,
M088)!KSIW>:4D_,[&NML_AQKEPX6:U>,'J:[;P[\+H[.X6>[=GP?NL*2J4:*
MM$?+.;U#X8>&FM8/MD\>')RI([&O4:AMK:*UA6*)0J@8P*FKS:M1U)<S.J$>
M56"BBBLR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** //OBAI$E]H_F1J258'CVKPDIL<C&&!KZQNK:.[@:*50RD8P:\Q\0?
M"Q+JX>:S=ESSM45WX7$1BN61SU:;;NCC_"'CB;P^/+D0RQXP,FNPN?B]'Y#"
M.T!8C@ANE<1=_#S7X)"L5F\BCO447@'Q#(V#8.!ZUO*%";YFS-2J)61G:[KM
MQK=XT\S':3D*3TJ?PIHDNLZQ"@C+1!L,>U=3IOPIO9RK71DB'<8KU+P[X7M-
M"MU6-%,F.6QS4U,3"$;0'"E*3O(U-.M5L["&!1C8H%6Z**\MNYUA1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7FWQ3T66]L?M* D+@5Z34%W:17MNT,RAE(Z&M*4^22D3./,K'R?MV,0.".*[
M?P?XZE\/1^1*AEC XR:ZK7_A6MQ</-9NPSSM45Q5U\/=?AD*QV3NH[UZGM:5
M6-FSDY)P=T=M=?%Z/R&6*T&XC@ANE>9:YK=QK5XT\['!.0#VK2B\ >(9&PU@
MX'K70Z9\*+R9D>Z:2,=QBIC["EJF-^TGHSF/"&AS:SK$("$Q*WS'TKZ-L+46
M=E% /X%Q67X?\,V>A6ZI$B[\<MCFMVN'$5O:2TV-Z<.5!1117.:A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4AI:;0 AIA-*:83Q3 0FHV:AC4+-0 XO49>F,U0L],"
M8O[TTR>]5FDIIDIV M>9[TGF>]5/,I/,]Z+ 6_,]Z/,]ZI^;[T>9[T6 N>9[
MT>9[U3\WWH\VBP%SS/>CS/>J?FT>;18"YYGO1YGO5/S:/-HL!<\SWH\SWJGY
MM'FT6 N>9[T>9[U3\VCS:+ 7/,]Z/,]ZI^;1YGO18"YYGO2^9[U2\WWH\VBP
M%WS/>E\SWJEYGO2B2BP%X2>]/#^]41)[U('HL!=5ZD#535ZF5J0%I6J0&JZF
MI5-("4&GU&*>* 'T4@I:0!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "$ ]12>6G]T4ZB@! JCH!2T44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 THIZJ*!&@Z**=10   =**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:44]5%.HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ&(*YXH L^*-1B&G/$C@LW'!KS32;2STJ\-]=2*68],\UR\WC*^%U(EQO[@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%(S!1DD 4 +2,ZJ,L0/J:I2:M:(
MK'SDRHS]ZO.O$GC:4W+P6S86DW8J,')G8ZKXKM-.DV%\G/;FN'\1>/9Y2L=E
MW/<5R<UR]U*TLK,2?>JZL&EQCH:AR9T1II#KRYO;G]]+*X8\\,:H-)-Y9);=
M]3FK]]*RP *O;TK-23"EGJ31%(VGVERSG'XTJ+L?9&,U(TJLWRTL;",[AUH
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M , I<4X"G8H :!3@*7%+B@ I:**0!1110 4444 %%%% !1110 4444 %%%%
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MOA_08KB.*20#*\T ='X<C>/3(@XYVULTR.-8D"*, 4^@!,48I:* &XHQ3J*
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M,D9-=^*ASPYXG/2ERRY6>N44@.1D4M>8=04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD56WC&>]27L:B3Y3UI4M2T? H&0>>Q&":KEY(Y@RDYK3%FJ#+'FF&.+>.G%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,EACGC*
M2*&4CH:?10!REYX"TF[F\SRE0D]EK0T[POING1%([>,Y&"=M;=%6ZDVK7)Y4
M<_/X.TF>4R-:Q[C_ +-:]I8PV5N(85"H!@ "K-%)RD]&QI)&#=^$M+O)FEFM
MXV8G))6M'3M+MM+A,5M&J*3D@"KM%#G)JS862"JE_IUOJ,'E7$:NOH15NBI3
ML,YZ'P;I$,HD6VC# Y'RUO)$L<>Q1A:?15.3>XDDMC#O?"NFW\[2SP(S$Y)*
MU:TS1+/20PM8E3=UP,5I44<\FK7#E5[A1114C,C4O#NGZI+YEQ C-C&2*AL_
M"NFV$_G00(C^H6MVBJYY6M<7*MQ ,#%+114C"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_O#\Z '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%&1ZT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !111F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,CUI: "BBB@ HHHH ****
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MD4$>]6)IE@B:1SA1UKQ/Q=XCNY]1>&WF/EY(.*3=BX0YF5_$FO7&K7[1*YV
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MR*?X<T6#4)C),023ZUKII<&O(&9U3'K5FWTZ'13\DZ$>U KDFJO#869MHV4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/7=6WHVGK?8++Q2N6HVW#3-)ENV615)'>NT;2U>R5(V*N,9 JY86EOIMO\V
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M]OMK*C9S6O80J,23D;.]6;K0+?6!OLV&Y?\ :HL'.KG(VUQ(96)Y&:K(=^H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<N3)T[<5FVTLHN "=W-;KSK'$-PQ3B[DSAREKE^E!VKUZU%:W"R+D&H9R7?
MID"RS 'K5NQ\N12[#D=*R)@4&6-=-X?L8;VW*@C=31,M$4(M0OKB<P1QGR^F
M=M7[700DQ>=LEATS5/5?$'_",W8M1"S D$L/>M./Q#8WT"LF!+U/-,R,O5M&
ME@)8?ZLUAOIF%\U#SUZUZ.)(M0TLK)@$ X)KBY8'MKADS\G:DT:QD9MJ[J^#
MVJ_)+(5PE/\ LR_?'>IH8\&D4%I'(1F2K6,&F/)L'M2K(&7(- ACN5?DTRX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ*KVW4$O8Z!?%]II<B6DB@!/EW9INJ_$&V$:B!P>.@-97B72+&[F,<3*)NG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[#8* (+R/*U#;1[EP16E-'O3I55#Y3X(H&4KVQ#)DK5:UCDME)ASGVK>G*O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#'J/JO]* ,#X):_J6H^+9XKJZED019 9R?6O:O'US+:^&9Y(7*L$."#BO
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M\.?\@B'_ '!_*NF7\!>ISQ_C,UZ***YCH"BBB@ HHHH **** "BBB@ HHHH
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M[60FFR B'FK5TFU5"^@JA=NPBP:!K4H%\2%CSBH3.LTX!]:G6,O&3ZTU+,!
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M@7#Y8G)!('\Z]+^/FC7=U+;7D4;-''$0Q KSCX=^-O\ A$-2'G(S19)91ZT
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M"TID::-P01\AS7AVN?$+6_$6N">S=QD[57'09KZ!^&$>MG0TEU:7<QZ K@T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$N)[@7-V1SV(KLH?!EG%<K-L&X8JS =H'AFVTTB:%<;AZUTU,C01H%'04^@
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M@7I=S,TEOY463G&*]@HH \T\/?!W1-)E$LT$4KXQD"K.J_"/P_J=WYYM8P<
M<BO0J* ,7PYX<M?#E@MI:JJQKT K/\6>!M-\518NHD+@Y#-7544 >*)\!;$7
M6YI(C'G[NVO5M!T2#0M.BLX% 2-=HQ6K10!RGB3P#H_B,$W-LA<C[QKS^X^
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MK#VM/N=517*_\+#\._\ /V?^^:/^%A^'?^?L_P#?-'L:G\K#VM/N=517*_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!/84N74OVC<;'044 Y&:*9F%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %,DC$L91NAI]% ')3_#[2KB=Y
M69PSG)P*C_X5QI/]]_RKL:*U]O4[F7L:?8X[_A7&D_WW_*C_ (5QI/\ ??\
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MMZG</8T^QQW_  KC2?[[_E1_PKC2?[[_ )5V-%'MZG</8T^QQW_"N-)_OO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#9K7SEW1D<4VW.Q2K"JNG7,LDI53\N>:NRM'OV]Z@W(&MEDDWBI7B!3:.M.
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M[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !4%Q:QW*;9%!^M3U#<W"6T+2.< #-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 A.!7/:CJ[P7.Q,$5O39\IL5QL\9^UL\G3FKBKG/B)
MN*5CH=.U1+D!6/S5JUY]#=K!<AE8]:[*PU".YB&#S2DK%TJG-$OT49HR*DU$
M8X7-<+XLOU&4%=7J%]'!$PW#.*\ZUB43RMSG-7%'-7GIRHXW4I@[Y7K5>"*6
M[N$@C&6:GZBICFSVK6\$>7-K\>X D ]:IF-/>QV.G^%],T6T2YU"0@D D$9Z
MU?.F:/K%JS6,G(!P, 5S/Q'N91J<<(9EC\M> ?85RVCZI?6%P?LY=@1@CDU!
MUIV=CLM(TT#6GM;@ [<>]=5<Q:'9S&&; <=1MKE_#,TMQK1DE!#$#.:3QC($
MUJ8E\<^M2:&_?^'[*_LVGLFRP&0!Q7-Z1HIO-0:"8[=C8/-:O@6^^T"YCW%@
MH'4UQ7B/Q)>Z3K]TMIM_UE5&+;L3*22N>CI#H(F6P,@\X\=!7">,[>30[Q5B
M^ZXW"JWA*POM1U7^U;V1HXE;+98BH?'.MQZI?HD1!6)=F?I6BA:5C.4_=N9<
M&K7!(RQ'T-;-M>S,H^8GZFN7MGPPXS726I7R@3C-=<(HXYS9?:=CC)I3N9/E
M-5WD3;WS3-[YX/%="@<TIDF2H^<U')< C%-=)'Z$?G48BQ]ZK449.;!70GJ1
M4I'RY4FHP5' ZTHSGVJK$\P]?0FE/RC@FD.U!F@2*>M*P[CE):FE79N*=YJ@
M\4XN#R*5AW(7AFR, 8^M2*"H^<5)YJJOO2"5&'-+4JZ(F@1^03FG^1\OO0Q/
M\.*C+LW&:+,=T/\ LY<4\VV%ID<IC4Y--^V'=STJ;2'S1)5C 7FD\K R:;]I
M63BF/(W:CE97,AX)ST&!3LH3QUJ(3%EVD4BD*V:3B-2'&=XFX)'TIW]J31C*
MRL/QJ.25&!!JC-;F4':3^=3R]RU+L:\>NW6,B4G_ (%5Z'7KJX'ELYQ]:XAO
M-M6.2<?6KFDWHDN-A/-34@N6Z+C*5SM$N0QV ]:01QQ2$LYJ@RF--P/7WJOY
MS,WS-^M<2(F]=3:%T6?$705JPAI(PPX8>E<W'>I!'@<FKEGJKJ<G&*;5R85.
M1G26^I7,#;3S]35]-==!\X%9,5Y;W" D@&J]S*(^1R*SY3L59)7N;4WBC P@
M!/TJA+KTTA)) 'UK'EOX57'?Z5FWET''[LTU SGB7T+U[?+*_+9-);2?O8_*
MZYK!#,6Y-=%X>@-Q=J,9 .:IZ(RIISE<]$TO<;)-_7%7:9$@CC"CM3ZP/46P
M4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***0G% "T54O-1ALHC)(&(']T9K/M?$=
MM?-MMTE!_P!I"* -NDR/6L6[U"_C;]TBD>XHB74+I-S;0?8XH VBZ@9)'YU%
M]JASC>*R?[.O9&P[87V:I4\/P*=QEESW^8T 6+S5[6R7=*S8]AFN/\2ZZEY:
M%K=G"#U&*[%-.@A4L07P/XN:\_\ '.K(T7V"&#:Q.,K'B@#R;Q%XBN3(+>W
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MJ4EY<J%8XQ3M #[!OYJ;ZFJC97':E:R7"GGBF:4_V<^3WK6OI%AC)/<5D:=
MTM\90#MI%K5&X\K1P989S[5G1VY:7SCP.M:\CQJF'[5AW]Q*S;(,@'CI38HB
MWUZF#%&,MTXK-2VN<EY/NU9AB2W=7E.7-7M1N0NGDJ.=M0U<TC+ET1D?VK%;
MMM .X>E3HMS>N'9@J^_%9=K:++=B5Q6O.L]S(D< VJ!Z54$^IG6DD]"PR_V=
MB2?YU/''-6?LEE):&^B3:WO534[F.WM4AF^8\9Q6E;QPW>BA8>.<D$U;6AC%
MZF5:WC2*Y8?*!Z5CLAN+]F ^4'-:4DD5HIAVD-T-0G$4)<#J*S.E:%&]E4.(
MTIT2);QAV&6/-1F-99-YK0,,<D2G^Z*"B(R1[02,9JO*D3=>]-9))9"/X5XI
MX2/HQY'O2 B,6V,[>!6-=RR/F*)L-6G?W2PC8&&#5!X!L,BL,^M5%7,JDK*P
M[3;/4@GRNK*.<=:]:\"+*UL/.4!@/2O(]+UB6VNBK,-HKM--\;FU=8H0?0X%
M:'/<]AP*3 ]!67HFJ_VC:J[ AB.]:M B(V\3')1?RJ0*%&  *6B@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ I#2U%(X H 5GQ5=[D+WJG=7H0'FL*YU7!(W4 =$;Y1WJK>O%>0,C$'-
M<J^K'/WJ;_:I_O4 U<J7</V.5E)^4YK'EG"EL5KWEPETOS=:YB_8Q.?2M%(Y
M*E#L.^V<G)IL=PK.>:RIYP@SFJ7VME;(-7<Y73L]3=GN!YF,U4GN .]9DE]N
M.<\U&TID'6FM1>R[$TLS.V <T+9LXR:CC&TC-7TN%"XS6T8)&B5BH]B2.!3?
MLK*N *UHG0CFK(C1A\HYK>,+F<JEC _LYF'-']G,O05TRVF!EEQ[T- BJ6)%
M5R&;JG-KIKMR:D2R"\5K*&+$ <4X6^YJKV1/MC&:P)Z4L&GD'+#%= MNJKTR
M?6F-"2:%3)=4I6]HW7'%7XX]HJ95*QX% 7CFMHJQC)W$4D<4NTFFA#NZU+T%
M438C*#%-2  YJ3KVH)H"PC' Z4T-NII8[L4N0.E QS&HSTH9Z9O[4["$;&*C
MP#UJ1O2HMI!ZU2(#;CI3&4YXJ4TF":8B/;Q32AJ_;Z?/<G$:,?I5\^'+L)NV
MM^51*K&+LV:1ISEJD883-3"W]Q5B6QGMR?,C(IBCC-%[["LUN-$07J0:=M#4
MC(2.*D2$A-Q-3<L9MQTH(.*EP *:3BD"*Y4D4T(0>:G8\5&6&*90C?=XJC(K
M[ZM%Z83FE8:8Z(_)MJO(N"<TN\JU2;T<8/6DT5<SG13(".M.:=EP*F>W/+"J
MSI@\UG.E&9<9OJ3Q7?.*T%N\)P:PBA!RM(TTJ#OBN66'DMBTD]C=^W&4[2:M
M0/QSTKDQ=2*V[!J8ZU(L94 @UG[*?8TC!7N:VHZJ+0$*>367%?&=LL<UB3SR
MW,VZ0G'O5B(E>1772I\L1SMT.A5E)R!6IIVJW-A*KQR$ 'I7-V\YXRU:"2Y/
M6G*-]&3%VU1[%X=\517T:QS-A^G)KJU=77*G(-?/MO=26[AXFPP]*[SP]XU"
M!8;IO;)-<-6@UK$[:==/21Z1156SOX+V,/$X;/I5JN6UCI"BBD9@HR3B@!:0
ML!U-9EYJT< (4@FLAM6>1LA\52BV9RJJ)U6X>M,\Z,'&\9K@=4\0WUFI*;V!
M]*XZ;QEJ/GL?,=<'IFFH,SEB(Q/</.CSC>,T^O%M)\77\VHQAY'9?3->O6ET
MKVB2,<944G&Q=.JI[%NBHHKB.;[K U+4FH4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $8U0NY=BGFKKGB
ML74I,(: ,'4[T@GFN9N+LECS5W4IB7(IFA:?_:6HJK?<!P: *L-G=W(W11LP
M]JCN+>YMC^]0K]:[B_UBRT0K;I#&2!R:A.K:5JVGOYP2.3M@4 <9;PSW1VPJ
M6/M4D^@7TR\V[5T/A..(7\F,,HW$9K2U'Q/!8W9A,*8'K0!Y+J^BW-N"&0C%
M<X$D\WR0"6)P!7O=\MGKV@27$,:>8%)X%<?X+\.0O<W%[=H&V , 15QVU,I0
M5S@6\.ZHL/GM;.(\9S5>*-MVTCYAVKW,:K"\DL4]C$MFO ?VKB-.L].U#QJ$
MAVM"TO3'%:QEH92@D<U%H.I2P^:ELQ7UK*F$D$Q23*L.U>PZAXML='U!-.^R
MQ;>G2N?^(&B6_P!FCU*W0(&0$A1ZU<)N^I,X*VC.(MI2Q S6Y9G'WA7,0S;6
M^E;-K<%B,&N^G=Z'FU-#<:<LN*BR"?FY]JU-)TO[2@=^AJQJ.A-"/,CR0*TO
M%.QC:35S%(3LH%,.=V /QH<E3M[BA6XYJ[$7)0 !UI<BH]X-+G-*Q0_?@4PM
MGI5BS@^T3!*T[K2D2+*'H*3:3*2T,<=*1C37.TXIADIA8?N%-+5$6II:JL)B
MM)@T;L\U$S@=::),]*I(ELE-(6 IJEG; %7%T]W3)R#BDVEN(J!Z4&FF%HW(
M-/$;MT%/05M2,@YJYI]JUW<K&HZGFH#%(.JUT?A2%3<DL.0:RK5.6#DC6C3Y
MJBBSI[*R@L;9?D&[')J?[0AXXI+A@05S65)NC?(->$YN3NSZW#X2/+8OW%C#
M>1D&,9/>N+U+3S8SE2.*[*QN&SAZS_%4(,0D ]*Z<+6:GRWW/-S'"**O;8Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM BTVT3*_/@&KUAH]M91(JQC<HZUI#@8K11L<U2KS:(****HR"BBB@ HHHH
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M7-BTZ* ZC/ K M+LQMU-=;9,+JR96'!%;4JCIS31Q9A@TH,X?3]2N+"4_,<
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MI;3RF$=,M7;4A&1BKC4E%6)<4]3S?QSJ%O)IT>E [[MU ''-=7X4TQ=.T>-
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MN1I:1LK CU%=744-M%;KMC4 5+0 4444 %%%% !1110 4444 %%%% !1110
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MW(D>22:Y5+-/$'C +;QD6]K+@GL14Z7EYI_@F"TBA</+'M8CM6IX-NK32K1
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M1>4L"A/2K=%.[%9$<4,<$82)0JCH!36M87E65HP77H?2IJ*5QD4]O%<Q&*5
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M5=6>C-:D(R,&E)P,UG3ZO;P3B-F')Q7/&+EL=DIQA\3.8\;LD$*D*.E>3ZD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKC[38Q2>JC^5:X>IS-IJS1I1GS-IK4MT445U&X444PN!0 ^BH3,!WIOGKZT
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M3 R@LH_*M&#2X8FSBKRJ%& *ERN;4Z"CN1Q0)$/E _*I:**DW"BBB@ HHHH
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MKFM7&K7K[W.T''!JO8VZ33K$W\1Q5"W<,-QZGFKMNY5PRGD<US[&K;;N=.?
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M 4'D444 <GXG\/)=P/.@&X"O-Q?7.AW>Y-P"FO<G02(589!KRCQU;6]NY**
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M'!-('R0<U<2Y&!QR*AQN[HWHXCV4>62+!@6*$*IY(YJK]G#'WJTK!QGO3E4
MY/%:P5E8YYU'.7,4VM!BDCM,M\U7OD<X!%3I$,@=:K07/(S);)NB"H7MWMUR
MRFNC=HK=!C!:J%X[31\J0*6XU*74P@N\],4X*4."*EXW=,4\E6&*A1-)5-;$
M)4;>*BQBK$B83(JO2D52V \C%.CBPVXDG\::#FGKG< !FE9,J5UL:=M>D,J
M$UT]C8W$VU@#@^U4O#^B+)B>8<>]=O:#RU"QC %>;7C%2]TT@VUJ4H].G@VN
MI((K036;Z(",.>*;=ZD\(VX(S5%+@2/N)R37/H::K8GNVEO)%>5LM7>>$[1H
M;;<>]<EI6GS7]VH"G8#S7IEE;"UMEC'85,GI8N$7>[+-%%%9FP4444 %%%%
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MLTR]L[#S+E&4,O&:]*K2G)RC=G)C:,*-9P@[I!1115G*%%%% !1110 4444
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M 4444 %%%% !1110 5!>2/%:2/&,L!P*GI" 1@C(H8'DM[I'B+7KV;F1(@W
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MZ4"P7TH XL:2?[M!TD_W:[86*^E!L5]* .(.DG^[3#I1_NUW)L%]*;_9Z^E
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M20GI5@KD>QJ#&UN.E68P6'0UE(VBS'NHS'(2"1GT-5 [AL;VQ]:V-2M6,#,
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M%X#WIK77H:T4D3R,T-V.]1.0:I-=\=::MUD]:I21/*T75?M6G:W&^+836*)
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MDG^K-/IDW^J:@:W/*[[P%8:YJ<TB31[RQR-W--_X4[#_ 'D_.N5N?$EWX?\
M&$DAW"+S#E?7FO;=!UJWUFPCGAD5B0,@'O7'3C3J-IK4^BQ=7&X2$91E>+1Y
MM+\&P3^[DC IG_"FW_Y[15ZY<74%K&7FD5%'<UP7B3XFV.FJT5J1*X_B1JJ=
M*C'5F.'S#,:[Y:;N0>&_AT-"U+SFGB)XX!YKTD<"O%O"?B[5/$'B1B\K>5P=
MIKVE>E70<7'W3FS2->-5>W=W86BBBMSRPHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K)UG5UTV'=U;T%:U<9XH3-R2W*YZ54%=D5)<L;F9+X^E7C8_P"5
M9[ZF-8<L00Q]:R[A(_M)&SC-36K16TNY1CFNF$G2=XG'4@J\>68^>%XC6>T[
MI)G)XK2N[]9#TK(GN(P26%=:QB:U1YZRUQ>C,VZU"9;K.>*4:DLHVL.:CN52
M7++6=*A3YLUU1M)71E+FA*S$U6YE3[K?+6*+I^2:LW=RS_*350H)$^4<UO W
M@^9:EJTN=V<]:G7S))<MTS5"SB99N16I))@;5'-6PM9Z$,_##9^-(B@L".M-
M(;D8Y-6[>T95W9Y-+8KH0R0.Y!S4\5OSG%68H&W<U;$2@5+=AHJ#;&.14JMF
M-@/2G&$.>14JHJC %0V,X_4<QW+?6K^BWI#;">M1:]&%FR/6JND$_:U'O4\V
MNIMRWIG:+C&6/6G* 3Q4?DNX7GBK"1;14W,PY[4N*>>*<H!;GI4@-$K!<*.:
MBS*'R0?RI\\ICF_=J<5)#J47G;)4Z\5@Z_*]COIX"52-XR(C>2#Y<'\JD1WE
MQGBI;JW&_P R+[I/:EAA<\UO&491NCAE&4)<K)4A  )YJ1T&SI3D&W[U2$IC
M)(Q4-C2*K!%CY%-C.Y=O2G2GS& 4<4KC8!@8H %78V*F\L@[J:%^4-UJQ&VY
M:&P2(9&"X.*@E^9=PJS,JE?I58N@0KWH0,SY2IZ]:J7$0$9(J>1&>;VS4SP!
MHL8K78Q>IR5S"8)Q*!7065V#;;V/04Z2R5TPPS5*2U9%*)P*NZ>QE*/,M2E?
M:G<7$I2-L+TK.>W=#O!YJ_\ 9BDG2I&@9TP>*M6''W=B.QUJ>QY))%:3>-I/
M+*H&!(]*P;JV>+MQ518OFYH<4:PA"6K1>NKZZOG+R/E3VJ%8CMW4A#1+R>*F
MB;?&1TK1;:$25B?3LM,*T+NW%LPE!J/38E#?C5[4X"\&0.E<N*I^T5BZ-3D=
MR-;D/$,FI;61A+O4<CH:PX!*9,-G&:Z6QC.T94@&L(4(4U>1G5Q-2;M F:]O
M;O\ =O)E1V%3VCR6<@)1ACOBNG\/:!:7;K(SINZD&M[7]%TR'3F;**RC.31]
M;I0?*D3]1KU(\TF6O"VK+<6^QW&<>M:U]KMG8$"5QS[UY#8:LUK<.MN_0\$4
MFI74VH-^\8L:REA(SGS)Z,TACY4H>SDM4>PPZU:3P&59%VCWJ>UU"&[SY3 X
M/K7CM@UXJ^0F[:>U=]X3LKBW4F4'DYYK&MA8TXMW.G#X]U9J-CIKF[2U3>X.
MT=Z@M-7M;Q=T<B_G5J>WCN8C'*NY3U%8[>&;6&$I9*(23UKA/3-M)$D&48,/
M:G5S'V+5;",)%<;@/05)%K]Q!B.XLY21]Y^U '1T51MM6L[D?+.F[NN>15U6
M5AE2#0 M9FKZ/!JELR2+EL<5IT4XR<7=$RBI*S/'KO0+O3II$&3&2<8%6_"D
M%Y9ZCD(=I]J].N+.&Y_UB TD-A;P?ZM *[WC>:'+):GGK N-12B]"="2@)ZX
MIU%%>>>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_#ZTN+716$X(RY*@^E=A7/4BHR:1K%W5V%%%%04%%%% !1110 4444 %%%%
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MI2(D,%[5R6GZ?J4%^JE3MSUS7GSJ2YF>WA<)1J4;MZG32VC)VJ'8=N"*VY4
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MM4^85OVJ_**S8(\'&*U8!@5TQC9''.5V74Z5,*KHU3!J)%P) Q%.!,AQ46:
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M;-,S0W)IM F-;[U*12D9YHI@-H%!I.: W'9%&WFF@8IU,3\A:**4=:8A1TH
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MC&:[X'(R*ZL)3<8\S>IOAX-*[%HHHKL.D**** "BBB@ IC-BG,<"J=S.$4T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \6:3+JVDF"%27+#I6_14
MRBI*S%)*2LSS+2_A=$I$MU,P;.2I%=C:^%-+M4"BVC..^*U+R]AL8&FG;:H%
M<>_Q'TY;ORA(-F<9Q7/R4*.C,>6E3,CQMX5D>59=.AVG=_"*ZCP7;WMMI$<5
MV""J]ZI>)M3:^T..ZTW]YP37+^$_&MU%?+9WRA0QVC-9<U.G6OW,[PA4OW/7
M**9%(LL:NIR".*?7>=84444 (PRI'J*\>\<>'KD>(5NHHBZ,P&*]BJM>QQ?9
MWE>)7*#<,BL:])58V9G5IJ<;,RO#EK':Z1$TENL3 <XJIKGC73M*1U\Q7E'1
M#WKS_P 2>,M0FNWM+=/+ ./ES5#2_"&K:Y(LTX<QMSN)YKDEB7\%)7.=UW\-
M-$]YX\O[[4XFBS&@/W%/!KU[0KQKS3(9'^\5&:\[U#X<+9::T\;N9$7-1>!-
M6OX-7&GS!C&6QDYXI49U*=2U3J*G*<)VGU/7**0<BEKTCM"BBB@ HHH/2@"*
M4X%8.IW!53S6U.<*:Y/5Y#\U &!?W1+GFLK[)/J9,,*EF-27;DL?K79:'!#I
M^C->%07[$B@#S:?X<ZZ[LRVC8-<?K>B7VC77DW411B<#-=]JGC[4;75OE4>4
M&P>>V:I^,/%=CKUI;*D:>>) 20.>U=4)2.6<8]#"T_P!KFIV2W%O:LT;="*E
M?X7>(U4M]C?BO2K6_FTWX?0SP?? ;O\ 2N T?XF:JNLP0W"J8Y'P<M34YN]A
M.$%N<3J%A=Z3<M;W491U.,&FZ?97.J7:6UJA=V. !7KOQ)TBWU'3[/4(T"LZ
MEF('UI?",GAW18[5=X>]E&0"HX-7[7W;D^R]ZQYGK/AO4=#C4WD+1[AD9JGI
M6DWFM70M[.(R.>PKTOXN2B2.!QT:/(K0^%6E(GA^:[CC5KC<0N1]:/:-0Y@]
MFG/E.&F^&GB*" RM9OM R:Y-TDMYFCD&UE."*]W2Y\66DEQ+/91O#AN"^>.?
M:O%_$MZ;W6I)3"L1Z%5%52G)O4FI"*6@EM+[UJ0OD5A6S<UJPO7;#4Y):,O;
MN:=OQ4&\8YIX8,*IB)P_%=YH3;])8+US7GF_'%;VA:T;.012'Y":XL91=2G:
M)W8*NJ55.1M:D,(<]:YQ^9/QKN9;6.^@WH<@BL=M%_>8P:^;FFM&?H6"QM+D
MW,ZRWF5%&<9KK+B0P:?@=0*J6VGQVJAG[5+>N&A#(<HU2T[7.?$8B%:M&*.3
M\^1[MBQ.,TR27][U[U-J">7\T8ZUF)O=N<YJ.9+0]NG%27,CJ=+NC@*#5G7X
M?,T\R$?,,<UE:/!+Y@X/6M37IQ'8^4>I KKP3;KQL?*Y_&$:<CD,XZBH)&))
M&.*D<[E./6F*JM%\Q-?5H^#*BCY^E2%<=:=L Z4H&X@GI5$D!!W$+31N#$$5
M8F55(9335.XYQ3N*Q#@L>*L6L[6LROCI32!]*!S2:4E9CBW%W1U=KJ%G=(/,
M*J0.:G:\TR(?*RY^E<CNV+\IQ2*#)_$37E2RF@Y7/:AGN*C!1O<V]4UX/'Y-
MNHQZBN?^:1LMR:E^Z>0*:\FT\"O0H4848\L$>7B,14KSYZC&,C-QT%/1%5<;
ML^M ?=4JJHP>YK6YA81<*,@4F=QR:5U8G &!2B/Y@#2&*J;FJ79B3@X%"*14
MK* O7FH;+41'7S> :F@ 3Y<9-$ 7D=\5(B'=FLV^A<5U+$<6#DBJVJ7 @AVJ
M>2*G>?R8RS=JYJ]NC<3,<_+GBLTKLWBB%Y"[$YZU)!97$Y^1":V=!T3[8WFR
MY$8-=0)+/3UV*BDCU%<F)Q\*+Y5JST\)EU7$ZK8X673KJ$?-&15-HI?[M=]-
M?PN#OC3'TK"NVA9\(HY/I73A)SK1YFK''CXQPL_9WNSFR2HYIH5Y/NC-:UQ8
M!VR.*$$=J N 3[BNI4W<XY8B-M#':&4=141&*[%(X9K/+( 2/2N5U%!!.P!X
MS2E!HJG54BMSFFLU-W\4WFH-K@S4@)'(---(7&,4R21;EU;K6M;W<4J 2$9K
M"]Z Q'(-4FT1*"DM3=O&0P[4.16$Z;.U/^U,.#S1]H#=0*')LA4[:(A*MLXJ
MQ% S+2B=/04U[H[2%XI#M?0?,PC7;GFJF>:82S-DFG4(JUAU&<TF:%ZTQ#LT
MOXT<9I=N33$/ R*<B#=2*.*>O!Q3$2[!BD5 #Q2A2:<$P.M @/ XZTB*Q.6J
M15XJ4_<XI,"**+S;E%]37JNB6)@T^/!.<5YGI]N\U]&%'.ZO5+:WFALH\YZ5
MQXA]#3H:-G.RS^6_0GO6E<)\F4KG?,8.-N=U;-G,^S]Y7(T.G4Z,GTN21;U0
MXP*[!#E1]*Y3='N#*<-6A!J+@A34--G93E&*L;E%,C8N@)I]0= 4444 ,EE2
M&,R2'"CJ:\_\2?%&QTIFBM/+N)%X*D]Z;\4]?DTO3EMXFVM,I&0:X[PG\/7U
MV'[;>._S_,#US7-5J2<N2&Y[F!P5"-'ZSBG[O1&I8_$_3-5E\O5;&WB0G&3S
M713>#O#_ (FM/-LO+C#?Q(M<IX@^$[V]LTUB7=E&<'BLKP#K]YH^N#3[AR4!
M(()K)2DGRU4=\J%*=-UL#-IKH>@>&/AM#X<UDWB7#R@J1@BN_' Q38G\R)7_
M +P!I]=D(1BK1/F\1B*M>?-5=V%%%%48!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %5;U(S;NS@<"K55-1!-C*!Z4X[BEL>?ZI>6RNX7&0
M:PI=>M;<'+ &F:RKI=/UZUR^H88XKV*>$@UJ>5.M),OZGXEA:%O)(W>U<9>7
M]Q=D[R<9]:O/;@YJA+'L?&*Z(X6G#8E8B3>I#&#G!%:]BV(<#TK/^[(.*TH&
M0+A:VBK(51IEF D\U8SQ4$! %2R@[,K3,&&G.(M6C<],UTNHWGG!%08&.U8^
MA:7)?W.X#.TUT\ND,N,CD5YV.FN9'3A8.S,:%RHP:NVP.[(JPMB-V"*T(-.5
M0#7"FF=,HM#Q\MF=WI7EWB>5)+\A3GFO2-=O([&P;<0,@BO()G-Q>L^20373
MA(.53F%5]VGJ7K1!M!-:<=N9@-M4K4849%:\4BI'E>M>O=GBM)L;]G>-0"*;
M/N$7"U.\S,!Q4=Q<+# 2X%--]2;)NR,6=MV0U4&B)?CKFIVG#S$GUJW!;[OF
M/2M#1-TUJ21:WJ5K;>0CN5^M9EU=7=RY,DC?3-:,T9)PHJ,VW'(K+V,+WL:0
MQ4DK&3M]>M(W+JOK5^2WP>*K^5^^0^]$H::&T,3=ZGH?AJR6TTSS!U89K7MY
MV,V,\5F:=< :7$O^S5NS :7KUK%+34\VO/FJNQ@ZD6BU'(YSFE >7!Z4:J-E
MYGK3;><G@U36ES:FS1B(4 5=C( YJE$N ":NQKNQ7-([H,L(,CBK4:<9--BB
MPM3J.*R;-D&]NG:I 1MIF!BI"!LH&(1D<4F*?C IH&#0A,B>(XK-GMQYF36M
M)( *HS?-FM87,9M&->)^\ 4<9J*1O+50.M7I<(QR,U2F +;JZ(G-*:6I%O)=
M0>E57AW3Y[9K42..2/.<$4T6V0VWK5)V)YDRBL2QR#!YJ;>K_*>M1364Z/OY
MQ4&)%;/>GN-HO62E;G<6(%=/;Q">1"O.2!7-:8H>3$AP:Z^WQ:6GF<<#(S7/
M7E8Z*$;G;Z3#'9VRH6Y K35U;H<UYA:Z[<W#LP8_G5X:_<PH5')^M>))-N[/
M8C)15D>AT5QNF>+5^Y.0&KI;+48[P94U#31HI)EVBBBD,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSIS@[25A]%(&5AE2#]#2TR HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#D,.*A6$KVKT'7])46Y8#D"N/C #E6'0UV4O>1#D4@AJ5(LFK<D(4Y XIT:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV8+!5,5/EATZG8^(? ND:R[F(K#-_LKUKS/6?AUJ^CRF:U21E4Y#5F37?B:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI3Q(=V35I+02XV<T-I\BMR*\BJ?9Y5*"23T%AF;/)KH-+;S04SP:QH-/D8X
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MW\SG"#FNMK%\,Z7_ &5HUO 1AE3!K:KK@FHJY\_BI1E6DX[7"BBBK.<****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBL36]>CTV!N?GJH0<W9$5*D:<>:1L--&O5U'XT
MW[3#_P ]%_.O(+W7[Z[G9HV;!],U#%<:J_S;I,#GJ:[UE[MJSRGFT;Z1/:59
M6&5(/TI:\NTOQC<6,J07'*@X)Q7<+XCLS:K,7X(S7+4P\X2M8[Z6*IU(\US9
MK(UO5+.RM6\]UZ5B:MXTMXX#]G;+8KRWQ!J]WJ,A^=L'MDUM1PDI:RT,*^/A
M'W8ZLZ*[6&]G9X_ND]JR[@?9QA!SFG>%H;RXC*,I(]2*N:A;;6([BO2BTGRG
M)K)<QE2Q^=;DN/FK":/$C+726L@:0Q,.*I:K8I"Q9,\UK%V=B7M<PRK+]WI5
MNQ@2]G6-^!G!Q38;624X -:]M9K:Q[_XZT;,9S44740:<-D+$@^]:*WI@LVE
M=N:PX6>6Y&[IFJ_B"\(A$49[=JEJ^AQTTYS*U[K<UY(RYPN<<52&,Y-4T:11
MD@5.D@=,],5=DMCO2)YIE@AW5EC5I#, ,8)IEW<;P5!JO9VQGG'L:5K%QBK-
MLZ=)"T*M4T3!QSU%1K%Y42K3T7"DBL[C2+4?-6^"H%4;:568KW%70FX@BHD6
MMC2MUVQ4Z%V,N#TI\"AH,9YINQ88V=SC'O6-R[%TND41=V  'K7#Z[JD-S=%
M5.<&JVO>(GD9H(6.T5SEN7FN .22:Z*-/E?,R*D7.)KNAE@_=KSCM6EX5^T1
MWZJQ;;FM?1-&"Q!Y1]X5O6VDPQ3^:@QSFG4K1LXF%.E)&LK\J*LA<BF0Q# -
M60,=:\UL]"*(2F>*;L %62N[I3&C(%"8RLRU7<CI5S&:KR1 '-4B65VX6HU*
MDX?I[T^1U7J152>:-UVA@#]:U43.4DBIJEG$PW1 53@ME1-S'I4\US&@\LMD
MGWK,O9&BA8QD\^M;P3M8Y)PC*5PU#4%^Y&>E1VEQN]S5-+'S$,DC'GWJ_86V
MR0'&0*VT2(DD:J1;D!88S3IXA'& #S4KS@@*!C ]*IW$VTY8\5FKLAQ1-!JL
M]HG7./4T_P#X2VZ0_*JUC33>9]SI51P0:?LH-W:-(U)Q5KFQ?>(KJ]7:3C/H
M:R%5I9N22QIA8XJS8X6<,_3-4HJ"T0TW)ZFH8W2T (]*[KP;I7EP><Z\D]ZY
MK2;?^T;M(\92O3["U6UME11VKS<75M'E/1PU.[YBUT%%%%>8>@%%%% !1110
M 4444 %%%% !112;ESC(S0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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MRQ. *LW!HT?G6H 1QYB_SKFFS> EUI%[9PK+/ Z(W0D51S7M/Q+AB3PE9,B
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9?.VI6P.:@WD FF())L]:4I);E*-R;[1SM7DT]8991D@BDMK0K)DY-:(1EX
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (*6D%+0 4444 %%%%
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M1TKKJNI3=.7*R*56-2/-$****S- HHHH **** "BBB@ HHHH **** "BBB@
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MHLC$$ YK0>V96P!Q5B*Q^3<W6@N+UL>=Z_HXMI?-C'!K'C0UZ9JFE"YMGZ'
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M)^\C-\.^$;#0(0(8_G[D\UT5%%=2BHJR/!J59U9<TW=A1113,PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** &2
MMLB9O09KS3Q'J O+ID8XP:[K6-22RMFSU(Q7E6I7 N;EY!WKNPF'YWS/8\O,
M,6J:Y([D<21+(&ZUJPNLC*H'!K(M('N&VQ*2:[70/#SDB2X'2N^;IT8GDTU6
MQ$K%*YL56TW8QQWK*T5+<ZLHF'?BNH\2301PB"+A@,=:Y6PLFEOT]340O.FY
M,UG:E64(ZGJ:2P6UF&R @'K7E?CW6X;YC% .01R!73Z[=^5IRVR/\^T=Z\VO
M+<M*<\]Z\N*:E='O2DN6QE1W4T2>U7;34PX 8X-1R1+LQBL6[S$3L.#75&O-
M;G.Z<6=E')'.N-RD_6JMQ;$/@"N8TZZN87#2-Q74P:E%*@SRU=U.;:YCCFHW
MY;E?R"IY%/%LN<J#NK4A'G#_ %3$?2E%N$EW 8^M:>T)]F4!;,,!Q5LZ>GE;
MDZ_6KK1I,F#C-5@S0-M!R*7.V/D2,MH'$F,&M.VT\(@=C^M6HS$X^[\U178E
M)PG I\[>AFX):DF0.%IIQ@YQ38$95^8<U6O'D4?+2M=V%>RN=1X?4 .12ZM=
M'=M6HO# 9K=LGDT:C"RRL2*\O$:5&>G0=X)F=]IQUI)=2@B WM^1J%X'E?"U
MS.J02+=[6;BBA0]J]2<17]BCT;1-5AG(C[5OWFT6I (P1ZUYMH#M$XQGI71W
M&J.$PS<5M/#I2T,:.)<HMR&M9QEF.1S[TQ(F23"*2/I5O1[-]2EW;AMKKXM'
M@MK9LKE@**E=0TW-*>'YM5H<%<WB6YVN.36.-3<7) !*D^E7=9BW:E*&!&&X
MJM;VBQGS91\@K+VTGL6Z:B7-/LIIYO,*D@GTKK8=%DDM^F*Y^P\8:;:2K#MX
M'7FNRL_$^GW&U$9<D=,UG-5-VBZ<J;TN<EJ]A-9= >OI6KX=DDCMGD)Z*3BN
MEO[*.^M\X!)&16-9Z;/$)EQA2I XK+F36IKRN+T.*UF_^VZLQ?L:[7PM;(T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]+\$!=KSDGV(KKK/2K6S4".)01WJ]17)*I*6YUQIQCL%%%%06%%%% !1110
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M;M%O%?4HXM3G_<(PX?IP:]5UOQEHEKX=^R6$D1+*5VK]*37OA3;7]TT]I*R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSFNCMM-M+1V:&%%9CDD+5E$1!A%"CV%.KJC&RL>%6K.I-R6EPHHHJC$****
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M HHHH **** "BBB@ HHHH *,YI#R*%&* %HHHH **** "BBB@ HHHH ****
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M"VM!B&,#\*LU=##^SNV[METJ/)J]PHHHKI-@HHHH **** "BBB@ HHHH :<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1VHH/2@"M.?D/TKQ3XB?\A$
M_A7M5Q]P_2O%/B)_R$#^%=F"_BG+C/X9Q%%%%>T>0%%%% '>_#7_ (^9/]^O
M9K?[@KQCX;?\?,G^_7L]O]P5XF-_BL]C"?PD6:***Y#I"BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+=SO2L%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%4KS5+:R1C+( 5[5'IFJQZD&,9! ]*KDE:Y'/&
M_+?4T:***DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR?[]>SV_W!7C'PV_X^9/]^O9[?[@KQ,;_%9[&$_A(LT445R'2%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHI"0HR> * %HJ".ZBE<JC@D'G%3T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!EW^B6U_('E0'%1#PU8(ZLD0!%;-
M%5SR2M<EPBW>PR.,1H%7H*?114E!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !0>E%!Z4 5;C[A^E>*?$3_D('
M\*]KN/N'Z5XI\1/^0@?PKLP7\4Y<9_#.(HHHKVCR HHHH [SX;?\?,G^_7L]
MO]P5XQ\-O^/F3_?KV>W^X*\3&_Q6>QA/X2+-%%%<ATA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% #)I!%$SGL,UP>M>-EC:6UC&'Z9!KO9
M$$B%#T-<?K7@J&[<RPC$AYX%;T'34O?,*ZJ./N">#C+.9)Y)"VXYP:[.N:\-
M:)/I:LLK,1VS72U%5IRT+I)J%F%%%%9F@4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4'I10>E %6X^X?I7BGQ$_Y"!_"O:[C[
MA^E>*?$3_D('\*[,%_%.7&?PSB****]H\@**** .\^&W_'S)_OU[/;_<%>,?
M#;_CYD_WZ]GM_N"O$QO\5GL83^$BS1117(=(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5[NZ2T@:5SPHS32N
M[";LKLL456L[Q+R/>AR*LT--.S!--704444AA1110 9 JC)JEO'<"'?\Y.,5
MA>*-5O+#_4)D$UR.EZIG4C<WCL&W9 KKI85RCSLXJN+49\B/6%.Y0?6EJK87
M275NKIT(XJU7*U9V.Q.ZN%%%%(84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A.!FN,U[Q<-
M.O!&I&.]7"#F[(B<U!79VE%9&CZW!J<"LK#.*UZEIIV92::N@HHHI#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2B@]* *MQ]P_2O%/B)_P A
M _A7M=Q]P_2O%/B)_P A _A79@OXIRXS^&<11117M'D!1110!WGPV_X^9/\
M?KV>W^X*\8^&W_'S)_OU[/;_ '!7B8W^*SV,)_"19HHHKD.D**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "HKD9MI!ZK4M(PW*0>] 'C&N
M),FJ2*BDY-:OA=+V.\C^\J$\UWLN@6DTWFO&I;Z59BTRWB*E$ QZ5VRQ2<.2
MQPQPK4^>Y:CSY:YZXI](!@8I:XCN"BBB@ HHHH **** "BBB@ HHHH ****
M"H;I7:W<(<-CBIJ*$)JZ/)=>TW5[B[DWB1XP>*N^#;^.PNC;2H%<MWKTEX(G
M^\@.:R3X;L_M?VA44-G/2N[ZU&4.22.!X.4:GM(,V$8.@8=#3J:B!$"CM3JX
M3T$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !0>E%!Z4 5;C[A^E>*?$3_D('\*]KN/N'Z5XI\1/^0@?
MPKLP7\4Y<9_#.(HHHKVCR HHHH [SX;?\?,G^_7L]O\ <%>,?#;_ (^9/]^O
M9[?[@KQ,;_%9[&$_A(LT445R'2%4;O1M.OVW75G%,WJZYJ]10!C_ /"*:#_T
M"K7_ +XI1X6T)3D:5; C_8K7HH J2Z993VXMY;:-X0,!".,4ZTT^SL$*6MO'
M"IZA!BK-% %"YT73+R027-E#*XZ%ES7)_$.ZU72M'\S2;1957 *9P,5W=,EA
MCG0I*BNI[$9H ^=-*^).G00.FJ:+:I=#/.PDYK'TZSO/&_CF&_MK;9;1R*_R
MCC%?1DGA319&W-I]N2?^F8JY9Z/86'_'M:Q1_P"Z@% "C3;::S6"YA250.C"
MGP:=9VT)A@MHXXR,%5'%6J* *5OI&GVLS2P6D4<C')95Y-27>GVE\FRZMXY5
M]'&:LT4 06UE;6<?EV\*1H?X5'%4+SPUH]\VZ>P@=_[Q7FM:B@#-LM TO3SN
MMK*&-O55Q5^6&.:,QR(&4C!!I]% &)+X1T*9P[:;;Y!S]SK6C9Z;96"[;2VC
MA![(,5:HH HW&CZ==RB6XLXI''1F7FKD<:1($C4*H& !VIU% $%S96UY'LN8
M4E4]F&:R_P#A$="\[S/[,ML_[E;=% $4%M!:QB.")8T'0**KWNDV&HC%W:Q3
M?[XS5VB@#)A\,Z-!&433K< C!PO6K5II5A89^R6L4.>NP8JY10 4UT61"KJ&
M4]0:=10!CGPMHIN//.G6Y?.<[*T9;*VG@$,L*/&!@*1Q4]% &&?"&@F?S?[,
MML_[E:MK96UE&([:!(D'91BIZ* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2
MB@]* *MQ]P_2O%/B)_R$#^%>UW'W#]*\4^(G_(0/X5V8+^*<N,_AG$4445[1
MY 4444 =Y\-O^/F3_?KV>W^X*\8^&W_'S)_OU[/;_<%>)C?XK/8PG\)%FBBB
MN0Z0KB/%GQ(TSPI<^3=[]V<?*N:[>OG3XRQ+/XLMX7^Z\P!H ZX?'O0,\I<8
M_P"N1KI_#?Q/T'Q)+Y5M(R29QB0;:P-!^%/AR]T.&62%S(Z\G=7E_P 0/!=Q
MX#U2+4-.D*1EBRC=0!],ZAJ$5AI\EVYS&@S\O-<?H/Q.TS7=<_LN!)A+DC+(
M0.*@\,^((M8\ B:\);9$/,Q7,^"K_P -2^,"EE#*MT&;D]* /:1R,T5Y[JOQ
M/T_2=9^P3;A\I.:I67Q<L=1UM;&W20@XYQQ0!Z?17,>(_&FG>'+,2W39=APH
M/-<59?&NPENU2:"=8V. Q7 _E0!ZY15'3-5M=6LTNK:161AG@URWBKXD:7X<
M<PN3)-TPAS0!V]-DD6-"[D!1W)KR;2_C7IUQ>+%<Q2QACP67%;?C_P 66]KX
M0DG@8GS4#*5/2@#J[?Q#875]]DAE#R?[)S6)XL\?Z=X4N4AN]^YRH&U<]:\!
M^&_C#^S?$I><RR>9(<<D]374?&^3S]1L91T<1-^>* /==&U:'6;!+N'.QNF1
M6C7DNF^,X/"GA6T:=6*LP7('TKT+P]K]OK^E)?0-\C>M &Q17!:[\2;'2=>C
MTH;GF:39\O-=K97!N;1)2"-PS@T 23S""%I&Z"O,=2^-FAZ;?2VL@F+QL5.$
MS7H^I_\ (/E^E?*5EI]GJ?Q5-I?L!;O*VXDX]* /6Q\>M SRESC_ *Y&NQ\+
M_$#1O%2_Z%(0WH_!KFIOAQX'^Q,PGC#!"?\ 7#TKQK0$GTOQ_P"3H[.T8<CY
M26&,T ?1OBSQK9>%(5DNED(9@!L7-:7AS7H/$6DQW]N&$;D@;A@UQ/Q!N](@
MTJV;6(W;.W[OK@5J>&]9TVP\$1WMDC+;+N(!Z\8H [FBO,['XOZ3<QSDA]R+
MD#N:HV7QJTZ;4EMIHI45FP"RXH ]:HK/&KVITM=0+@0E=P)/:O.=3^,^G6VH
M&W@BFDVG!V+F@#H_%?Q#TWPI>1V]WOW.,C:N:Z;2]1BU2RCN8L[7 (R/6OF7
MXH>)[7Q)JEG-;AE("@ANO45]!^"?^1<M?^N:_P J .DJAJ6KV>E0F6ZE5 .Q
M89J[(XCB9ST4$U\P_&+Q9)>ZV;2)Y$2-@< D4 ?2>EZI;ZO9)=VQ)C?H35VO
M(_@[XKBNM AT\A]T*\LW2N@\5?$W2_#LK0$F28'&$.: .\HKR;2?C3IMU=I#
M<1RQ[S@%A@5ZA97T%_;)/ ZLCC(P<T 6:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***.E !15>6_M(3B
M2XB4^A<"B._M)3B.YB8^@<&G9A<L44=>E%( HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M).@R&W=_RJM\1O#,^A>,Q?O;--:%ER5'!YYK4U+Q7X:CTF%K/2C]I/! 89H
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M4F\Q8G#,,]:[3X?Z[#K7@2301 RS)"0"3W-<+HFI:C\-O%EPL]M*T,C@,0,
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MZZ*5!SBY&<ZG*['T.K!E##H:6J]FZFUC (/%6*YV:!13&E1#AF I!/$3@.*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !2.<(32T=: /"_B%KM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2B@]* *MQ]P_2O%/B)_P A
M _A7M=Q]P_2O%/B)_P A _A79@OXIRXS^&<11117M'D!1110!WGPV_X^9/\
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MXACB8_>V&@#V(D*,GH*P_P#A+-*.L_V6MP#<[=VWVK+\4>+H+3P?)JELQ=6
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M>\<RJ &6WV_KBJ7BG1)?"OCO^TY;:26U,A<[4+<5JZK\1]'N+..+2-,F^U8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !0>E%!Z4 5;C[A^E>*?$3_D('\*]
MKN/N'Z5XI\1/^0@?PKLP7\4Y<9_#.(HHHKVCR HHHH [SX;?\?,G^_7L]O\
M<%>,?#;_ (^9/]^O9[?[@KQ,;_%9[&$_A(LT445R'2%(RAU*MT/6EHH YR7P
M/H<VI#4'MB;@-NW9[UT,<:Q($484=*=10!E:QX=TW78O+OH-ZXQQ6?8>!- T
MU&2WM,!CDY(/]*Z6B@##TWPEI.DS/+:0%&?.>?6HQX+T4:C]N^SGS_[V:Z"B
M@"-U*V[+'P0N!7A?C?Q/J^F:X\%]:O-8YZK'V^M>\5G:IHEAK$/E7L D3TH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ H/2B@]* *MQ]P_2O%/B)_P A _A7M=Q]P_2O%/B)_P A _A79@OX
MIRXS^&<11117M'D!1110!WGPV_X^9/\ ?KV>W^X*\8^&W_'S)_OU[/;_ '!7
MB8W^*SV,)_"19HHHKD.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM?\ ^@TWY4?\(MK_ /T&F_*N\HH^L2_I![")P?\ PBVO_P#0:;\J/^$6U_\
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MTKSV3_DH5K_NM_2O0AT%/$:M/R%0ZKS%HHHKG-PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YY)_R4*U_P!U
MOZ5Z$.@KSV3_ )*%:_[K?TKT(=!717^SZ&%'[7J+1117.;A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW6_I7H0Z"NBO]GT,*/VO46BBBN<W"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5\V?VA=?\]31_:%U_P ]31_9Z[A]>?8^D_[:L/\ GYC_ .^A1_;5A_S\Q_\
M?0KYL_M"Z_YZFC^T+K_GJ:/[/7</KS['TG_;5A_S\Q_]]"HI=:L,<7,?_?5?
M./\ :%U_SU-'V^Z_YZFC^SUW#Z\^QW/Q&O8;J7]U(K=.AS7GM223R2_?;-1U
MW4J?LX*)QU9\\N8.AR"1]*T].UZ_TR0-!,1CUYK,HJVDU9D)M.Z/5_#_ ,3U
M.V+40S,> 1P*]$L-:LM0B5X9DY'3=S7S)5_3]9O=,D#VTQ6N*K@82UCH==+&
M2CI+4^G 01D4M>1Z#\3W3;'?!FQQG->C:;XAT_4XU,4Z!B/NYYKS:F'G3W1Z
M%.M">S-:N=\9_P#(!E_W3_*NA!!&17/>,_\ D R_[I_E4TOC153X&8WPP_Y%
MV/\ WFKNZX3X8?\ (NQ_[S5W=7B/XK(H?PT%%%%8&P$ C!&:9Y4?]Q?RI]%
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MOAA+Z[*^87(^5<5Y=\>_]<O^_7<_ _\ Y$6+_KHU<-\>_P#7+_OT <]\"_\
MD8;CZ"O;OBA_R*%W_P!<C7B/P+_Y&&X^@KV[XH?\BA=_]<C0!\M>%?\ D;[7
M_?K[-T<XT:W/I'7QEX5_Y&^U_P!^OLW2/^0+!_USH ^?_$OQ>US3O$$UI"T0
M1)2HS'GO7M?@G69]:T..ZN,;SCH,5\H>-_\ D;[C_KN?YU]._"__ )%:+\/Y
M4 <_\4_'NJ>%)=MC(J].JYK"\*_&>:6PEFU>578(=H48.:H?'W_CX'_ :\X^
M'GA1O%&M"!AF),,1[4 =?JOQO\0273M9DI;Y^4,E:7A+XY7TFI1V^KMO21L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_NT>TGW#DCV.'_L"V_YY#\J/[ MO^>0_*NX_LT?W:/[-']VCVD^X<D>QP_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQNO^^#_A7<?V39_\\1^5']DV?_/$?E1[2C_*'LZO\QP__"QW_P"?&Z_[X/\
MA1_PL=_^?&Z_[X/^%=Q_9-G_ ,\1^5']DV?_ #Q'Y4>TH_RA[.K_ #'#_P#"
MQW_Y\;K_ +X/^%'_  L=_P#GQNO^^#_A7<?V39_\\1^5']DV?_/$?E1[2C_*
M'LZO\QP__"QW_P"?&Z_[X/\ A1_PL=_^?&Z_[X/^%=Q_9-G_ ,\1^5']DV?_
M #Q'Y4>TH_RA[.K_ #'#_P#"QW_Y\;K_ +X/^%'_  L=_P#GQNO^^#_A7<?V
M39_\\1^5']DV?_/$?E1[2C_*'LZO\QP__"QW_P"?&Z_[X/\ A1_PL=_^?&Z_
M[X/^%=Q_9-G_ ,\1^5']DV?_ #Q'Y4>TH_RA[.K_ #'#_P#"QW_Y\;K_ +X/
M^%'_  L=_P#GQNO^^#_A7<?V39_\\1^5']DV?_/$?E1[2C_*'LZO\QP__"QW
M_P"?&Z_[X/\ A1_PL=_^?&Z_[X/^%=Q_9-G_ ,\1^5']DV?_ #Q'Y4>TH_RA
M[.K_ #'#_P#"QW_Y\;K_ +X/^%'_  L=_P#GQNO^^#_A7<?V39_\\1^5']DV
M?_/$?E1[2C_*'LZO\QP__"QW_P"?&Z_[X/\ A1_PL=_^?&Z_[X/^%=Q_9-G_
M ,\1^5']DV?_ #Q'Y4>TH_RA[.K_ #'#_P#"QW_Y\;K_ +X/^%'_  L=_P#G
MQNO^^#_A7<?V39_\\1^5']DV?_/$?E1[2C_*'LZO\QP__"QW_P"?&Z_[X/\
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MQNO^^#_A7<?V39_\\1^5']DV?_/$?E1[2C_*'LZO\QP__"QW_P"?&Z_[X/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>gtl21rgcbjm5000009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 13",<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTJ48X:,I2DFVMD.;=9I)&=\9?^/>T_WE_P#0J[GP8!_PB.F\#_5>E</\9?\
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MSJ]X&_Y$*T_ZY-6)\0]2@U;X<&\MVS'*Z$?G6WX&_P"1"M/^N35QR36%2?\
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M1\9VJ3^0KD_"OBT:]J5[;"#R_(;&<#FNJN_^/*?_ *YM_*O*_AC_ ,C%J_\
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MIO,U;50N5C(+*I[9:MZE%2H2FX<K1G&HU445*Z9U?BKQ^FCZ@FF65N]S>/C
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M,!Z5X=\,<1>/-563AF<XS_OFNG!>["I-;I&.(UE&/1L]LM;2*SMTAA145!@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M34]1NDDU_5)IT0Y"E@P-:S6'J3]JY:=41%U81Y+?,2^U#5_%WPXO9KBV16<
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MEB=M=.'AAU748-W7XF-655TVY+1GKFGBU/@^,7IQ;>2/,^F!5;PC'X:1)O\
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M[>LP-MC.^O/OC!_R#K;_ 'A_.M>U_P"2:C_KG5^P7LHS[NQ/M7SN/8U6\;Z
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $->:?%_\
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M;2IY[4.Q5HX\]366$M[.4HVY_,NO?F2?PEFZ^&]UI^A7UWJVK37#1Q,RA)F
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MK(J4O:RBH[(YCXJ_\CWHG_ ?_0A7L5M_Q[Q_2O,_BGX>U"\O+/5["%II+<J
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MUPFECQ+X!U":RALY+RP=L@HA8C' J/Q+<>)_&-I)%_9\L%JG\#(06I+#_O\
MVB:Y;W'[7]URVU.R^%6/^$.M\>_\Z[FN-^&MC<Z?X4MX+J%XI%SE6&#UKLJX
M\2[UI6[G11_AH****P- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA6)/[JBMI5>:FH/=&:A:;DNI8 I:**Q-!#0!CM2T4 (0#U%  ':EHH ****
M"F[0>HIU% "8Q1BEHH 0#%+110 4TJ#U%.HH 3&*6BB@!I4'J*4# Z4M% "
M8HQS2T4 )1CFEHH **** $P/2C ]*6B@!,>U':EHH ;M'I2BEHH 3%&!Z4M%
M "8'I1CBEHH 0C-(% [4ZB@!*\U\;--XE\06GA^VSY2/F=ATVD5Z4>:JQ:;9
MP73W,5NB32##.!R:UHU%3ES=>AG4ASJPZQM4LK*&W0 "- O'L*LTE+65[ZLT
M"D Q2T4 %(1FEHH 0# H-+10 W:,]*6EHH #2;:6B@ I",TM% "8I:** $(S
M0!BEHH 0@'M0 !VI:* "D(S2T4 - QT%+@9I:* $I-HSTIU% "48YI:* "DP
M,]*6B@ II4'M3J* $ QT%+110 A /:D 'I3J* $ Q2T44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 44R65(8FED8*BC))/05Y+XA^.6G
M:;J4EEIUNUW)$2K'82,^Q'6@#UVBO+O"/QGTKQ!J*Z?=HUK=-]T%"!^9KT.Z
MU>QLI4BN;F.-W&5#,!F@"]163;>)=(N[O[-#?0-+V42#G]:L:CK%AI4:O>7,
M<0;IN8#- %ZBO*/$7C>?_A/-#L],O0]G<SJD@1P01M/I7JR'* ^U "T5A>+/
M$2>&-&?4)$WJIQC%9GP^\<1>.=,NKR*+RQ!*(R,$=L]Z .PHHKE/'7C ^#])
M^VB 2^V#_2@#JZ*Y_P &>)/^$K\-V^J^5Y7FD_+@\8^M=!0 4444 %%%% !1
M110 4444 %%%% !112$A022 !U)H 6BO-O&7Q@TCPQ<FS@_TFZ'!51E?S%<:
M/V@[Q9 9M&5(?[^UZ />Z*Y+P7\0-)\96Q:TDVS*/FC8;?RS76T %%%% !11
M10 4444 %%9FMZ]I_A^R:[U"81Q >O)^@[T:%K=MX@TT7UH6,)8J"PQTH TZ
M*** "BBB@ HHK/UO4O[(T>XOMN[R5W8- &A17AL/[043ZB+9[)%7>5+8:O:;
M:\2?3HKPD!)(Q)] 1F@"S17B.K_'V+3=6NK)+)'$,A3<0><5ZQX;UG^W]"M=
M2"!//C#X';- &M1110 45G:SKEAH5FUU?S".,#/7DU'X=UZT\2:0FHV18PNS
M*-RX/% &K1110 4444 %%%8'B3QAI/A>)'U";#.0%51DG)QTH WZ*AM+E;NU
MCG3[KC(J:@ HHK+USQ!I_AZP:\U"81Q*/Q/T% &I16;I.M6VLZ4NH6FXPNNY
M=PP2*XG2?B@=2\>7'AO[(%\HL/,P><8H ](HHHH **** "BO-?B!\5!X)U5;
M(VJR[D#9.>_TKDE_:$/4Z7\OKL:@#W>BO-?!OQAT;Q1>BQD)M[H\J&7:I_$]
MZ]*H **** "BBB@ HHHH **** "BBB@ HHHH **** "BHKFYBM('GG<)&@R2
M3BL+P[XRTOQ/=WL&G.S_ &1PCL5P,XSQZT =%17F?C+XJ'PKKR:;]C$NYPN[
M!_I7H]M-]HM8IL8\Q V/J* ):*** "BBJM_J%MIEG)=74@CB0$DDT 6J*\4U
MCX^VT-Z\.D6)NE4XRR-_2I- ^/=E>7Z6VKVAM-YP"B,<'\: /9Z*BMKF&[MT
MG@D5XW&0RG(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** *&LV!U31KNQ$AC\^(IN';-><^#/@YIOAVZF
MGU B]8YPTH P/PKU4D 9->0?%#XIQZ0CZ1I#>9>O\C%>J]J /,_B/;:3#\2K
M.#P_$$D2<"<1C^+</Z5U'Q:AN)O$GAJ%Y&61D(<CN,C(JU\)_AO>7-]_PE&O
MJ3))\T:./OY'7VY%>A>+/A]'XGUS3]2:\,)L\X3;G=SF@#S'XB>']/\ ".N>
M&KK18%M9ICEVC[\"GZ^A\1_&#2])U>8R:<B1,('^Z24YKTWQEX 3Q;<:5*UX
M8/L'0;<[JJ>*OAE#KUW9W]G>&QU"W 'GJN2<# H \X\0^'M+T#XQZ#%I2I#
M9H_W"= =IR?QKZ%3[B_2O,+7X1.OB'3]:O=9:YN[60,7*8W@# %>H 84#TH
M\_\ C%_R(\W^]_2N7_9O_P"15U7_ *^E_P#0:ZCXQ?\ (CS?[W]*Y?\ 9O\
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MS'">X_"O./\ A?FM"'SV\+J+?^_E^E<S\9;F6Y^(EI;RY,<<X50?3<*^@X=
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M)\=))JUS:>#O"Z2EN#*'^]S[T ;_ (0^-;Z]XCBT?4M+2RFF8(F"Q)/XUO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOIF6TMISF:WBD/\ MH#3HH(8!B*)(QZ(H% 'E/Q=T&8> ;#3["$R&%MN%]E
MJY\#M/N=-\%RPW4+12&<G!KTMXHY1B1%<>C#-$<<<2[8T5!Z*,4 /JMJ%E%J
M-A-:3 %)4*G/N,59HH ^9=8\!^*?A]K[ZGX>222V#$AE' %.E^*?CR[B^RP0
M.LS#;G8*^EGC21=LB*R^C#-0#3K$'(L[<'U$2_X4 ?/GP[^&WB2;Q?:>(M8B
M> 12>8=P^]_G-7/CIHE_J&KVIM+9Y57;DK_NU[^ %&%  ]!3)((93F2*-S_M
M*#0!0\.1M%X:TV-QAEMD!'H<"O#/B5X$U?2?%2>(]'MVGC#^8X4=#G-?0H
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M\*Z)J,/QRO[R2V=;=FDPYZ=!7T%'9VL+;HK:&,^JH!3A;PK)Y@AC#G^(*,T
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M$<:(/15 HDABF7;+$D@]&4&@#YDU+6O&GQ'O;>T@MKB*)2-^TX[]>*]"\?\
MAR\M/@U%I,8>XNHC&&/4M@FO5HK.V@.8;>&,^J(!4CQI(NV1%=?1AD4 >;?!
M>PN=/\(I%=1-&^!P:SOC)X!NO$5M#J&EPE[J EF4#EJ]:2..)=L:*@]%&*4@
M$8(R* /FN+XA^*+306T-](<WH7RUEVCCT_E7I'PRTSQ/_9=Q-K[;//4^7&4
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M%(?5T!I8K:"#_4P1Q_[B ?RH \]UKP%)!\*IO#NFY,HC&,=SU->2^"/$&N^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBF2%%%% !1110 4444 %%%% $(E)G*8X%3567_C[:K- !1110 4444 %%%%
M!1110 4444 %%%% !1110 5!+,8YHD &'.#4]5+G_C[MO]Z@"W1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ,D8I&S#L*2%S(FXT3_ZA_I3;;_4B
M@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @MYFE:4$ ;&P*GJ
MG8_ZRX_ZZ5<H **** "BBB@ HHHH **** "BBB@ HHHH **** "H#,PN5CP,
M&IZJ/_Q_Q_0T 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*XD
M,4+.!DBI%.4!]1FH+W_CT?Z5-'_JU^@H =1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5!<?>B_WJGJ"X^]%_O4 3T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% "-]T_2JUG_ ,M?]ZK+?=/T
MJM9_\M?]Z@"U1110 AY4CVKQWQ1\/M<U37IKJVB4QL!@EP*]C/ S7#:O\1[+
M2=1DM)(P63OFN?$1IRC^\=CV,FK8RE5;PD>9V.PL(FM].MH7^_'$JM]0*LU%
M;3"XM8IUZ2(&'XC-2UNMCR9MN3ON%%%%,D**** "BBB@ HHHH **** *R_\
M'VU6:K+_ ,?;59H **** "BBB@ HHHH **** "BBB@ HHHH **** "JES_Q]
MVW^]5NJES_Q]VW^]0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M (Y_]0_TIMM_J13I_P#4/]*;;?ZD4 34444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %.Q_P!9<?\ 72KE4['_ %EQ_P!=*N4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !51_P#C_C^AJW51_P#C_C^AH MT444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% %>]_P"/1_I4T?\ JU^@J&]_X]'^E31_
MZM?H* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDCV#F9=_M?4O^?\ N?\ OZ:/[7U+_G_N?^_IJE11R1[!S,N_VOJ7_/\ W/\
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M10 4444 %%%% !52Y_X^[;_>JW52Y_X^[;_>H MT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% $<_^H?Z4VV_U(IT_P#J'^E-MO\ 4B@":BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH IV/\ K+C_ *Z5<JG8_P"LN/\
MKI5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J/\ \?\ ']#5NJC_
M /'_ !_0T 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O>_P#'
MH_TJ:/\ U:_05#>_\>C_ $J:/_5K]!0 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK]!4-[_QZ/\ 2IH_]6OT% #J*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N:\>_\ (G:C_P!<372US7CW_D3M1_ZXFM*/
M\2/JB9_"SY</4_6DI3U/UI*^Q/GPHHHH$%%%% !1110 4444 %%%% !1110
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MU $]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=/TJM9_\M?\
M>JRWW3]*K6?_ "U_WJ +5%%%  >!FN+U7XCZ7I.H/9S0RLZ=2"*[,\@BO+?$
M7PSOM7UF6\CFB57 P":PKRJ*/[O<]7*:6"J56L9*T;'I]O,MQ;13J,+(@8?B
M,U)4%E";:QMX&.3'&J'\!BIZV6QYDK<SML%%%%,D**** "BBB@ HHHH ****
M *R_\?;59JLO_'VU6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JI<
M_P#'W;?[U6ZJ7/\ Q]VW^]0!;HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** (Y_\ 4/\ 2FVW^I%.G_U#_2FVW^I% $U%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!3L?]9<?]=*N53L?]9<?]=*N4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !51_^/^/Z&K=5'_X_X_H: +=%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!7O?^/1_I4T?^K7Z"H;W_CT?Z5-'_JU^
M@H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5!<?>B_WJGJ"X^]%_O4 3T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% "-]T_2JUG_RU_P!ZK+?=/TJM9_\ +7_>H M4444 (3@$UYGX@^)M
MQH^KRV:VT;!,<G->FGD8KA=7^&6GZQJ,EY+>2HS]0$!%85U4<?W>YZN4SP4*
MK>-5XVT_I'9V<YN;*"<C!DC5\?49J>HK:$6UK% IRL:! 3WP,5+6RV/,E;F=
MM@HHHIDA1110 4444 %%%% !1110!67_ (^VJS59?^/MJLT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !52Y_X^[;_>JW52Y_X^[;_>H MT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% $<_^H?Z4VV_U(IT_P#J'^E-MO\
M4B@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH IV/\ K+C_ *Z5
M<JG8_P"LN/\ KI5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J/\
M\?\ ']#5NJC_ /'_ !_0T 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"O>_P#'H_TJ:/\ U:_05#>_\>C_ $J:/_5K]!0 ZBBB@ HHHH ****
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M^M/ZO5[!S(ZC^Q=5_P"@[/\ ]\"C^Q=5_P"@[/\ ]\"N7_X7'X=_Y[#]:/\
MA<?AW_GL/UH^KU>P<R.H_L75?^@[/_WP*/[%U7_H.S_]\"N7_P"%Q^'?^>P_
M6C_A<?AW_GL/UH^KU>P<R.H_L75?^@[/_P!\"C^Q=5_Z#L__ 'P*Y?\ X7'X
M=_Y[#]:/^%Q^'?\ GL/UH^KU>P<R.H_L75?^@[/_ -\"C^Q=5_Z#L_\ WP*Y
M?_A<?AW_ )[#]:/^%R>'?^>P_6CZO5[!S(ZC^Q=5_P"@[/\ ]\"C^Q=5_P"@
M[/\ ]\"N7_X7'X=_Y[#]:/\ A<?AW_GL/UH^KU>P<R.H_L75?^@[/_WP*/[%
MU7_H.S_]\"N7_P"%R>'?^>P_6C_A<GAW_GL/UH^KU>P<R.H_L75?^@[/_P!\
M"C^Q=5_Z#L__ 'P*Y?\ X7)X=_Y[#]:/^%R>'?\ GL/UH^KU>P<R.H_L75?^
M@[/_ -\"C^Q=5_Z#L_\ WP*Y?_A<GAW_ )[#]:/^%R>'?^>P_6CZO5[!S(ZC
M^Q=5_P"@[/\ ]\"C^Q=5_P"@[/\ ]\"N7_X7)X=_Y[#]:/\ A<GAW_GL/UH^
MKU>P<R.H_L75?^@[/_WP*/[%U7_H.S_]\"N7_P"%R>'?^>P_6C_A<GAW_GL/
MUH^KU>P<R.H_L75?^@[/_P!\"C^Q=5_Z#L__ 'P*Y?\ X7)X=_Y[#]:/^%R>
M'?\ GL/UH^KU>P<R.H_L75?^@[/_ -\"C^Q=5_Z#L_\ WP*Y?_A<GAW_ )[#
M]:/^%R>'?^>P_6CZO5[!S(ZC^Q=5_P"@[/\ ]\"C^Q=5_P"@[/\ ]\"N7_X7
M)X=_Y[#]:/\ A<GAW_GL/UH^KU>P<R.H_L75?^@[/_WP*/[%U7_H.S_]\"N7
M_P"%R>'?^>P_6C_A<GAW_GL/UH^KU>P<R.H_L75?^@[/_P!\"C^Q=5_Z#L__
M 'P*Y?\ X7)X=_Y[#]:/^%R>'?\ GL/UH^KU>P<R.H_L75?^@[/_ -\"C^Q=
M5_Z#L_\ WP*Y?_A<GAW_ )[#]:/^%R>'?^>P_6CZO5[!S(ZC^Q=5_P"@[/\
M]\"C^Q=5_P"@[/\ ]\"N7_X7)X=_Y[#]:/\ A<GAW_GL/UH^KU>P<R.H_L75
M?^@[/_WP*/[%U7_H.S_]\"N7_P"%R>'?^>P_6C_A<GAW_GL/UH^KU>P<R.H_
ML75?^@[/_P!\"C^Q=5_Z#L__ 'P*Y?\ X7)X=_Y[#]:/^%R>'?\ GL/UH^KU
M>P<R.H_L75?^@[/_ -\"C^Q=5_Z#L_\ WP*Y?_A<GAW_ )[#]:/^%R>'?^>P
M_6CZO5[!S(ZC^Q=5_P"@[/\ ]\"C^Q=5_P"@[/\ ]\"N7_X7)X=_Y[#]:/\
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M5_Z#L_\ WP*Y?_A<?AW_ )[#]:/^%Q^'?^>P_6CZO5[!S(ZC^Q=5_P"@[/\
M]\"C^Q=5_P"@[/\ ]\"N7_X7'X=_Y[#]:/\ A<?AW_GL/UH^KU>P<R.H_L75
M?^@[/_WP*/[%U7_H.S_]\"N7_P"%Q^'?^>P_6C_A<?AW_GL/UH^KU>P<R.H_
ML75?^@[/_P!\"C^Q=5_Z#L__ 'P*Y?\ X7'X=_Y[#]:/^%Q^'?\ GL/UH^KU
M>P<R.H_L75?^@[/_ -\"C^Q=5_Z#L_\ WP*Y?_A<?AW_ )[#]:/^%R>'?^>P
M_6CZO5[!S(ZC^Q=5_P"@[/\ ]\"C^Q=5_P"@[/\ ]\"N7_X7'X=_Y[#]:/\
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M %%%% !1110 4444 %%%% $<_P#J'^E-MO\ 4BG3_P"H?Z4VV_U(H FHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *=C_K+C_KI5RJ=C_K+C_KI5
MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J/_ ,?\?T-6ZJ/_ ,?\
M?T- %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KWO_ !Z/]*FC
M_P!6OT%0WO\ QZ/]*FC_ -6OT% #J*** "BBB@ HHHH **** "BBB@ HHHH
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M[&0#A5]*KVTEHU_6I*C?^O(\QN?#E[]I:.T@:9 <9'K5/^QM0-Y]D^S/Y_\
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MYKZ_^Q6W_/!/RH^Q6W_/!/RI_P!H/L'LSY _X1K7/^@5<_\ ?-'_  C6N?\
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MJ/L5M_SP3\J/[0?8/9GR!_PC6N?] JY_[YH_X1K7/^@5<_\ ?-?7_P!BMO\
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MS\*_?TKDI/A>LV@KIDM^65/]6VW[O-.G4I_$]'=#LT2JH/PIEW<D0]_PK/\
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M'J?K24IZGZTE?8H^?"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5A+DHNW%5ZN16Z.@)KR\UGA84T\4KJY]#P[2S&I7DLODE*VM^WXE0G
M))]:2E888CT-)7IQMRJQX-2_.^;<****9 4444 %%%% !1110 4444 %%%%
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MLYHE&-KN^[=72$ C! /UH  Z #Z4^57N"PD54YUWN Z4M%%4=84444 %%%%
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M%LX/(JUX!\4W=SK]YHMS()8X2Q1^I(S@<USFA:5<>$?&MX-0L9)[:Z/R.B9
MRQ/->GZ5%I*W+SVFGB&0KEI F,U=3DC&R5TU^(G=NQYQJ7_)7H/]S^M;WQD_
MY%N#_KZB_P#0JYR^:=_BE%="TG,"C:7V<=:W/BW-+>:-;6]M;2RL9HW^1<X
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M'?VLBB46X=BP]JY3PU-XK\36-K=K=(ENDRLXP=Q%;FOW1E^&RPI;S-*;<1[
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MXR_]\4U? .OOG%C+QU^6OJ!ONGZ57L_^6O\ O4?VM5[(/J,.Y\T_\*^\0_\
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M9&.&&*] HQ6&(Q\ZT.1HTI86-.7,F-2-(\[$"Y.3@=:=117"=(4444 %%%%
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M\M1EC["E_MK3?^?V'_OJLG7-'NM1T"WM;9@DBH,Y..PKB_\ A -=_P">\?\
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MLG^K;Z&@#/T3_D'#_?;^=:59NB?\@X?[[?SK2H **** "BBB@ HHHH ****
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M10 4444 %%%% &+KO_'UI?\ U\?TK:K%UW_CZTO_ *^/Z5M4 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% $<_^H?Z4VV_U(IT_P#J'^E-MO\
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M:/\ A&M-_P">3?\ ?9HU#FK?RK[_ /@&GY\/_/5/^^A1Y\/_ #U3_OH5F?\
M"-:;_P \F_[[-'_"-:;_ ,\F_P"^S1J'-6_E7W_\ T_/A_YZI_WT*//A_P">
MJ?\ ?0K,_P"$:TW_ )Y-_P!]FC_A&M-_YY-_WV:-0YJW\J^__@&GY\/_ #U3
M_OH4>?#_ ,]4_P"^A69_PC6F_P#/)O\ OLT?\(UIO_/)O^^S1J'-6_E7W_\
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M\]4_[Z%'GP_\]4_[Z%9G_"-:;_SR;_OLT?\ "-:;_P \F_[[-&H<U;^5??\
M\ T_/A_YZI_WT*//A_YZI_WT*S/^$:TW_GDW_?9H_P"$:TW_ )Y-_P!]FC4.
M:M_*OO\ ^ :?GP_\]4_[Z%'GP_\ /5/^^A69_P (UIO_ #R;_OLT?\(UIO\
MSR;_ +[-&H<U;^5??_P#3\^'_GJG_?0H\^'_ )ZI_P!]"LS_ (1K3?\ GDW_
M 'V:/^$:TW_GDW_?9HU#FK?RK[_^ 7;JYC6W<I,FX=/F%2I<1%%)E3./[PK-
M_P"$:TS_ )XM_P!]FC_A&M-_YY-_WV:-0YJW\J^__@&GY\/_ #U3_OH4>?#_
M ,]4_P"^A69_PC6F_P#/)O\ OLT?\(UIO_/)O^^S1J'-6_E7W_\  -/SX?\
MGJG_ 'T*//A_YZI_WT*S/^$:TW_GDW_?9H_X1K3?^>3?]]FC4.:M_*OO_P"
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M+KO_ !]:7_U\?TK:K%UW_CZTO_KX_I6U0 4444 %%%% !1110 4444 %%%%
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MT*BHK=VDMHW<89E!(]ZEK(84444 %%%% !1110 4444 %%%% !1110 4444
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M= 'C_P#PD;_]"%-_X"K7I/AJY-UHT<IL#8Y8_N2FW'X5KXHH **** "BBB@
MHHHH *RO$G_(N7__ %R-:M97B3_D7+__ *Y&D]C*O_"EZ,L:1_R"+3_KDO\
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M "BBB@ HHHH Q==_X^M+_P"OC^E;58NN_P#'UI?_ %\?TK:H **** "BBB@
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M?..JV\A'_?)KG/!=OKC&YO=7C6#S7)BM]HRBGMD5TVH1&?3+J$=9(74?B"*
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MHHH *;)_JV^AIU-D_P!6WT- &?HG_(.'^^W\ZTJS=$_Y!P_WV_G6E0 4444
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MR>87.DHKF_/\0_\ 3/\ []T>?XA_Z9_]^Z.3S"YTE%<WY_B'_IG_ -^Z//\
M$/\ TS_[]T<GF%SI**YOS_$/_3/_ +]T>?XA_P"F?_?NCD\PN=)17-^?XA_Z
M9_\ ?NCS_$/_ $S_ ._=')YA<Z2BN;\_Q#_TS_[]T>?XA_Z9_P#?NCD\PN=)
M17-^?XA_Z9_]^Z//\0_],_\ OW1R>87.DHKF_/\ $/\ TS_[]T>?XA_Z9_\
M?NCD\PN=)17-^?XA_P"F?_?NCS_$/_3/_OW1R>87.DHKF_/\0_\ 3/\ []T>
M?XA_Z9_]^Z.3S"YTE%<WY_B'_IG_ -^Z//\ $/\ TS_[]T<GF%SI**YOS_$/
M_3/_ +]T>?XA_P"F?_?NCD\PN=)17-^?XA_Z9_\ ?NCS_$/_ $S_ ._=')YA
M<Z2BN;\_Q#_TS_[]T>?XA_Z9_P#?NCD\PN=)17-^?XA_Z9_]^Z//\0_],_\
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MQ-:4?XD?5$S^%GRX>I^M)2GJ?K25]BCY\****!!1110 4444 %%%% !1110
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MW^8H_MRZ_P"@-=_F*KF1M]8I_P!)FT !T%! /49K%_MRZ_Z UW^8H_MRZ_Z
MUW^8HYD'UBG_ $F;=(%4=% ^@K#7Q!.Y(72+HX.#R.*=_;EU_P! :[_,4<R#
MZQ3_ *3-L@$8(S0 !T&*Q/[<NO\ H#7?YBC^W+K_ * UW^8HYD'UBG_29M8'
MI2UB?VY=?] :[_,4?VY=?] :[_,4<R#ZQ3_I,VL#.<#-!56ZJ#]16+_;EU_T
M!KO\Q1_;EU_T!KO\Q1S(/K%/^DS; P,"DVKG.T9]<5B_VY=?] :[_,4?VY=?
M] :[_,4<R#ZQ3_I,VL#TH*J>H!^HK%_MRZ_Z UW^8H_MRZ_Z UW^8HYD'UBG
M_29M8&,8I>V*Q/[<NO\ H#7?YBC^W+K_ * UW^8HYD'UBG_29M8'I1L7.=HS
MZXK%_MRZ_P"@-=_F*/[<NO\ H#7?YBCF0?6*?])FW2;5SG:,_2L7^W+K_H#7
M?YBF_P!OSA@O]D76X]LBCF0?6*?])FZ !T%'7K6)_;EU_P! :[_,4?VY=?\
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MFL7^W+K_ * UW^8H_MRZ_P"@-=_F*.9!]8I_TF;6Q?[H_*@ #H,5B_VY=?\
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MN+2.TDCB,0V2A2&S5[3[2\L[>*PGM9'F$GF>;M)^7TS274;/0]3DF.CR21.
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M10 4444 4[+_ %EQ_P!=*N53L?\ 67'_ %TJY0 4444 %%%% !1110 4444
M%%%% !1110 4444 %5'_ ./^/Z&K=5'_ ./^/Z&@"W1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 5[W_ (]'^E31_P"K7Z"H;W_CT?Z5-'_JU^@H
M =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-"V54X.:M$)M[8KR>#59+=Q8BZFM8YAN,T2Y((IXU'5;S4K73H=6N5B /[_
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M?_C_ (_H:MU4?_C_ (_H: +=%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!7O?^/1_I4T?^K7Z"H;W_CT?Z5-'_JU^@H =1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:5J5UYMRL9E8!3EN2/2EN/#&F74<:M OR*%!'I7!3.T5Y<MK+/#<>8WDSY.
M,\<#VKI?^$GG1H;*QA-XZP"0NIQD4): ]&;<6@:;%Y:)$@9""!GGBD;P[IC7
MLEPT2>=*_F,<\D^M<<VOZD/$Z2Q6CL1:L[Q;NE2S>)VDUC3;UP8PUJY://\
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MHHH **** "BBB@ HHHH **** "BBB@#%UW_CZTO_ *^/Z5M5BZ[_ ,?6E_\
M7Q_2MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@O'>.RF>,9=4)7
MZU/45S/';6LL\IQ'&I9C[4 ?/7AOPQIWC;Q=KHUN?%VMPP2-CT&.M+<+KGP@
MUJ2,-)<Z)<!@!V] :[BPT#PIJ_B<Z]IE\J3LV95W$98UWVKZ9INN:>]I?+%+
M$X[D4 >-_![4(M3\8ZQ=P,3')("/RKW>O.?#/@S1? 6H7=[%?1+!*=VS/W:[
M?2M9L=;M?M-A,)822 P% %^H+C[T7^]4]07'WHO]Z@">BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 1ONGZ56L_^6O\ O59;[I^E5K/_ ):_[U %
MJBBB@!#R"*\^UOX7PZSJDEZU^T9?^'97H)X!->4^(_B/?:3K4MI'&2J 8YKG
MQ#IJ*]IL>QDT,;*JU@G:5M?0]1M8!;6D, .1$@3/K@8J:H+&8W%A;SMUDC5C
M^(S4];K8\F=^9WW"BBBF2%%%% !1110 4444 %%%% %9?^/MJLU67_C[:K-
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MK7H%%"=@>NYQMSX1N9K'4X!.H-W&$4[>G-8K_#6>.3;!=$1L@!'.,]S7IE%
M' W'@O491##]JC$<8'*I@_G747.E/-X>;3MX\PPE Y]<=:UJ*.E@ZW.!3P%,
M/"8TMKA3.75VDP><5U6CZ8VFZ!#IY8,T<6S=CK6I13N!S6D>&S8B]\[RI#/]
MTE.E8MCX*U'2EBEL[N-9E=F;*$@@]*[^BD!PJ^#M0A^SWL=W']OCE+L^PX([
M#%4+KPQJ%O+<:KJ%W&TRKF-@A 0^I]:])IKHLBE74,IZ@C-(%O<\FM]+OO$N
MLR^;=I-']EV++&N &KH?#O@FXTK4H[F6XWK&FS!SS7:QV\,/^JB1/]U0*EIW
M#<BFA6>)HW&0:Q?^$>/FY\P;,]*WZ*YJ^$HUVG45[ 16\"6\2QH/E%2T45T1
MBHJR ****8!1110 4444 %%%% !1110 4444 %%%% !1110!BZ[_ ,?6E_\
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M^^*S_P"Q4_Y^)OSH_L5/^?B;\Z -#S8_[XH\V/\ OBL_^Q4_Y^)OSH_L5/\
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MAYL?]\4>;'_?%9_]BI_S\3?G1_8J?\_$WYT :'FQ_P!\4>;'_?%9_P#8J?\
M/Q-^=']BI_S\3?G0!H>;'_?%'FQ_WQ6?_8J?\_$WYT?V*G_/Q-^= &AYL?\
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MX"OM!O[K4M8O4N+V4@Y20/GZXKU2O/? /A+7?#]Q,^JZE+=*Y&T.1Q^5>A4
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M44 %%%% !1110 4444 %%%% %.Q_UEQ_UTJY5.Q_UEQ_UTJY0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5'_X_P"/Z&K=5'_X_P"/Z&@"W1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 5[W_CT?Z5-'_JU^@J&]_X]'^E
M31_ZM?H* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[9L /EY^]CBNBM;6.UB"(/J:GHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVV_Y[+1]MMO^>RU\D_VIJ'_/]<?]_6_QH_M34/\ G^N/^_K?XT?V0_Y@^O\
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MO\:/[4U#_G^N/^_K?XT?V0_Y@^O^1];?;;;_ )[+1]MMO^>RU\D_VIJ'_/\
M7'_?UO\ &C^U-0_Y_KC_ +^M_C1_9#_F#Z_Y'UM]MMO^>RU5N;RW^U6Y\U>&
MKY3_ +4U#_G^N/\ OZW^-']IWY.?MMQQ_P!-6_QH_LA_S!]?\CZV^VVW_/9:
M/MMM_P ]EKY)_M34/^?ZX_[^M_C1_:FH?\_UQ_W];_&C^R'_ #!]?\CZV^VV
MW_/9:/MMM_SV6ODG^U-0_P"?ZX_[^M_C1_:FH?\ /]<?]_6_QH_LA_S!]?\
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M5EK=Q627$LQ"IYN,U=M;N"\C$MO*LB'NIKRSKYHWY;ZD]%%%!04444 %%%%
M!1110 4444 %%%% !1110 54?_C_ (_H:MU4?_C_ (_H: +=%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!7O?^/1_I4T?^K7Z"H;W_CT?Z5-'_JU
M^@H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHH KWO_ !Z/]*FC_P!6OT%0WO\ QZ/]*FC_ -6OT% #J*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** *.KZM:Z)ILE_>,RP1_>*C)KB3\:O!X)'VBXX_Z95?\ BO\
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M@H:TW1P*@8[V!P!0!ZEK6MV>@V#7M\S+"IP2HR:A\/>)-/\ $UDUWISNT2D
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M!^ES/^,==?HOB#3M?M!<:?<)(O=<C</J*\Z/PU\"7'AM)#;V,,S0J3*&&X'
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M4B)#D?=]Q7F_]D?%?_G_ #_WZ%;GQ \-^*/$VG66FV[,L0C7SW ^\VWYOUH
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M$ADUS34!P68@&OHVO(OBE\/]4\5ZO8W-DI*0OEN* .7M/@SKE_8PE]:E6*1
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MR <A1TYKE['PW\3].M$M;:]*1(,*/+% 'N^0>A!KS[XPJJ^ [S: /D;H*D\
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M=4\(HKW?_A3&G_\ /P/R-'_"F-/_ .?@?D:/[2P_</J=4\(HKW?_ (4QI_\
MS\#\C1_PIC3_ /GX'Y&C^TL/W#ZG5/"**]W_ .%,:?\ \_ _(T?\*8T__GX'
MY&C^TL/W#ZG5/"**]W_X4QI__/P/R-'_  IC3_\ GX'Y&C^TL/W#ZG5/"**]
MQ'P=L#,4\\<>QJ;_ (4QI_\ S\#\C1_:6'[A]3JGA%%>[_\ "F-/_P"?@?D:
M/^%,:?\ \_ _(T?VEA^X?4ZIX117N_\ PIC3_P#GX'Y&C_A3&G_\_ _(T?VE
MA^X?4ZIX117N_P#PIC3_ /GX'Y&C_A3&G_\ /P/R-']I8?N'U.J>$45[O_PI
MC3_^?@?D:/\ A3&G_P#/P/R-']I8?N'U.J>$45[O_P *8T__ )^!^1H_X4QI
M_P#S\#\C1_:6'[A]3JGA%%>[_P#"F-/_ .?@?D:/^%,:?_S\#\C1_:6'[A]3
MJGA%%>[_ /"F-/\ ^?@?D:/^%,:?_P _ _(T?VEA^X?4ZIX117N__"F-/_Y^
M!^1J"7X/6"3Q)YX^<XZ&C^TL/W#ZG5/#Z*]W_P"%,:?_ ,_ _(T?\*8T_P#Y
M^!^1H_M+#]P^IU3PBBO=_P#A3&G_ //P/R-'_"F-/_Y^!^1H_M+#]P^IU3PB
MBO=_^%,:?_S\#\C1_P *8T__ )^!^1H_M+#]P^IU3PBBO=_^%,:?_P _ _(T
M?\*8T_\ Y^!^1H_M+#]P^IU3PBBO=_\ A3&G_P#/P/R-'_"F-/\ ^?@?D:/[
M2P_</J=4\(HKW?\ X4QI_P#S\#\C1_PIC3_^?@?D:/[2P_</J=4\(HKW?_A3
M&G_\_ _(T?\ "F-/_P"?@?D:/[2P_</J=4\(HKW?_A3&G_\ /P/R-'_"F-/_
M .?@?D:/[2P_</J=4\(HKW23X-:>D;-YXX'H:2'X-V$D>XSC\C1_:6'[A]3J
MGAE%>[_\*8T__GX'Y&C_ (4QI_\ S\#\C1_:6'[A]3JGA%%>[_\ "F-/_P"?
M@?D:/^%,:?\ \_ _(T?VEA^X?4ZIX117N_\ PIC3_P#GX'Y&C_A3&G_\_ _(
MT?VEA^X?4ZIX117N_P#PIC3_ /GX'Y&C_A3&G_\ /P/R-']I8?N'U.J>$45[
MO_PIC3_^?@?D:/\ A3&G_P#/P/R-']I8?N'U.J>$45[O_P *8T__ )^!^1H_
MX4QI_P#S\#\C1_:6'[A]3JGA%%>[_P#"F-/_ .?@?D:/^%,:?_S\#\C1_:6'
M[A]3JGA%>J?!7_D-S_\ 7,UT?_"F-/\ ^?@?D:Z+PIX#MO"UV]Q#(&+*5Z5S
MXK'4:E%QB]6:T<+4A44F;$EA'J4%S;R_<,N35G3M(L],A$=M"J@"GV7^LN/^
MNE7*\"RO<]#V<.;G:U"BBBF6%%%% !1110 4444 %%%% !1110 4444 %5'_
M ./^/Z&K=5'_ ./^/Z&@"W1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 5[W_ (]'^E31_P"K7Z"H;W_CT?Z5-'_JU^@H =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBHP<4 ;]%4M*U*'5M/BO( 1'(H89]ZNT %%%% !1110 4444 %%%% !1110
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MK]!4-[_QZ/\ 2IH_]6OT% #J*** "BBB@ HHHH **** "BBB@ HHHH ****
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MWN$7]W(B@9/;-2_#7PEJ7@S0Y;;5+Q9AG<,,2%&*Z?7=?LM!TF6_NI5$:(6
MS][Z5RVF^/;+QGX1U6XTQ)E:*!P2ZXYVF@#"\4_&,66K2:5H5G)=W<9(;:NX
M'%)X6^,8N]273=?M'L[ISA2R[17,? 6VL+R_U.XU$(VIB7Y _P![;MYI/CM;
M6-MXAT62T5$NBV7"=2=PZT >A_$;XAMX)?3=L8D2[SDXSTKDM5^-.J6[1WEM
MI$RZ;@%I9(^#ZX-8'QK::;3?"9N1B0\$?E7H?CW3+2V^"]ZD<" )9JRX'0D"
M@#&U#XT3W5@DGA_2[BXD50TK>7N5>/\ &NE^'?Q&A\9I+;RQF*]AR73&,"N>
M^!>G6S_#EKAXE+RS2(Q(Z@$5ROP: 3XK>(%484;P /\ ?- &%8^((O#GQ;UB
M\DB>5C(ZHB#)+9XKN8/C5J-EJZ1ZYI4UK9RMA"T>TX/ -<=H<5A+\;+\7^S:
M+ABF[^]GBNX_: M[-?",<BH@N!*@4]]N: .B^(_B/3X_ :ZKY4=W:RNA4$!@
M<FBQ\61Z5\)+;7K6W5$" K&%X'/I7G?B$L?V=M*W9^[%C_OHULR?\FVVW_7-
M?YF@"6#XTWVHZ3OTW2IKF\&=PCCRJ_6MSX>_%5?%=])IM] 8;U#C&, \]*Q_
M@390#PU<3^4OF.#EL<UROA>)+;XX^7$H1#*"0/QH ]%\<_%!_#^J+I&F64MS
M?L >%W YZ"L+0_C)J"ZY!IWB'39+5IV"IF/;C/<U#XG\:BX\<1Z9X>T>SN-0
M#!3/,ARIY[BN'\=0^((_&.FRZ\+59RZ86%\X% &_\<_$M\\]O90K(MJV'#CH
MW-=9\/O$UU??#N5+VR9(;. HFY.'4*37-_&-$_X131Y-HW'R^:[_ $R&./X/
M0,B %K!B2._RF@#/^#VO6.K:3J4]M:QVL<3C?M4+GC-4_$_QD%MJ;Z;X?M'O
M;B,X9E7<I^E<Y\$"X\$>)"G7_P"P-5_@%;65SJNL/=JCW"R#R]W7WQ0!UOA/
MXQ+?ZHFEZ[:O:7;G W+M K4^)'Q'?P4MHT48D6=L9QGC&:X#X\V]C::II,NG
MK&EZTA\SROO>V:H?&MI'T'P^9L[R%SG_ *YB@#I]5^,^K1PPWECHTXL=@,DL
MD7&<<X->D>"?%UMXRT)=1MT9,-L<-_>KG];L+6/X+7.V%!C3@XP.^T<UC?L\
M_P#(BW'_ %]-0!ZY(6$;%/O8XKSS0/B,^H>/KSPS=QJDD!<!L8!V@?XUZ+7S
MO\286\%_$NVUV(D+=([N1VR0* .M\3_&./0O&#:(D6X1RB-VQW)'^-;_ ([^
M(47A/3[.5 'EN@-@ZUX/>Z?'XHC\0^*U9O-@NXB@'0@]?Y5>6];XC>(]!TG>
M?W).2>V* .^^(7BN&VTO1KG5+".:6X<D!D!V\9K$^-?B6_73-/TV".2*T:!'
MWJ,!MR#C\*?\>X1;0>'X1_RS?;^2U>^-L2?\*]T"3:-Y103_ -LQ0!#\.O$=
M]?\ @C5--FM'2"*U+K*5P&/UKE/AWXM?PWJ&HBVLYKJZ=FV)$N:]/\'PQ+\(
MKJ144,83DCZ"N0^!UC!+XEU"XDC5G!8 D=* .C\*_&*>]U\:5KMFUI,YP@*[
M>?2O8*^<OB]!%:_%;P^T"",R.A<J.IWBOHV@#S'XU>(KC1O"IMK9RDMQC# X
M/6LCX1?#[1YO#,>LWT N;F[R6$H# <]J7X_6,TVA6]VBDQP_>Q]:Z3X/ZA;7
M'P_L(DGC,J [D#<KSW% ',^)O@M)<^)(-4\/W"V6U@7 .W'';%'QXB>#P+I,
M,C;GC?:S>I"#)KK_ !5\3]$\*7L5K=,\LCG&V$;B/K7(_'N=;KP1I=P@(25R
MZYZX*@T 8^F_%'4=,\+VD>CZ5/<101*)9O+W*,#GFO1O /Q"M/&.G/(W[FXB
M_P!8K<=.I^E9WA;2K2T^%3K'"H$EMO;CJ2*\K^&K/%JWB1825VVLVT#UQ0!Z
M!XH^+\UMK$FE>'K&2\N8B0Y5-P..N*O^"?BJFNZD=(U2V>TU$=5==HXZUY!\
M,QXBDUR[ETB&SFN]QW&Y;#=.:Z=O"7B6\\=0ZI=3:5;72O\ O$AF^8\C/% '
M:^*/BLOAKQ9_9<T6Z'D9 Y]JY^[^-NI:=J4;WVDS0:=(?E9X\%A[5SGQ M$N
M_BS;03 ,I<9_2NF^.=I GA730L:C:O''3@4 2ZW\9K\1"[T72II;%5#23M'E
M1Z\_6N^\#^-+7QAH8OH_W;J2KJW8CK7':1IMO;_ R[C$:_-"Q/'KBN1^%\EQ
M#X*\0FU+"5(Y#'MZYW4 ==XI^,8LM2DTS0[.2[NXSAMJ[A2>%_C']JU)-,U^
MSDL[J0X4LNT5ROP/@L[KQ!?RWRH][EB0_7K1\<;:SMO$^ER6JJEU\I 7O\U
M'T*K*ZAE(*GH12UC>$WED\*Z:\^?-,(W9ZYK9H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (C<1BX\DG#8S
M4M<UKLC1:@K(<$ 5H:7JBW2".0XD'ZT :M%%% !1110 4444 %%%% !1110
M4444 %07'WHO]ZIZ@N/O1?[U $]%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 C?=/TJM9_\ +7_>JRWW3]*K6?\ RU_WJ +5%%% "'E2/:O'/%/@
M'5M3UZ:Z@*>6P&,U[(>!FN+U7XD:1I-^]G.LQD3KM7BN?$1IRBO:.Q[&3U\9
M1JMX2/,['5Z?$T&G6T+_ 'HXE4_4"K-16\RW%M%.F=LB!QGT(S4M;K8\F;;D
MV]PHHHIDA1110 4444 %%%% !1110!67_C[:K-5E_P"/MJLT %%%% !1110
M4444 %%%% !1110 4444 %%%% !52Y_X^[;_ 'JMU4N?^/NV_P!Z@"W1110
M4444 %%%% !1110 4444 %%%% !1110 4444 1S_ .H?Z4VV_P!2*=/_ *A_
MI3;;_4B@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH IV/^LN/^
MNE7*IV/^LN/^NE7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JH_\
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MU_"LGX5^#[WP7X;ET^^*&1IC(-K;N#7=T4 %<!\4O DOC71UCL]HO(V4*6(
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M4 %07'WHO]ZIZ@N/O1?[U $]%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 C?=/TJM9_\M?\ >JRWW3]*K6?_ "U_WJ +5%%% "'D$5YEX@^&<^L:
MO+>+-M#@<9%>FDX!->:Z]\49M&U:2R6PCD" ?,6(KGQ'L^7]YL>QDWU[VK^I
M?%;7T/1+.$VUC! 3DQQJGY#%3U#9S_:;*"<C'FQJ^/3(S4U;K8\F=^9WW"BB
MBF2%%%% !1110 4444 %%%% %9?^/MJLU67_ (^VJS0 4444 %%%% !1110
M4444 %%%% !1110 4444 %5+G_C[MO\ >JW52Y_X^[;_ 'J +=%%% !1110
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M17G>O>/Y]*\!6>O+ 6><#*Y]1FN<_P"%L:SJVDQW.A:1+<B./=<2*PPA'44
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M:BO'-3^,,VF^*+C2OL;2LO$2@CYVSTJC=?%[7M%U:W36M&EMK><@J&8<*>]
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M_P"NE7*IV/\ K+C_ *Z5<H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"JC_ /'_ !_0U;JH_P#Q_P ?T- %NBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH KWO\ QZ/]*FC_ -6OT%0WO_'H_P!*FC_U:_04 .HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %07'WHO]ZIZY_P :7$MIX7O;B!RDD<9*L.H-.,7*2BNH
MI.RN=!17RT?''B'/_(2G_P"^Z3_A.?$/_03G_P"^Z]7^R:G\R.+Z]#L?4U%?
M+/\ PG/B'_H)S_\ ?='_  G/B'_H)S_]]T?V34_F0?7X=CZFHKY9_P"$Y\0_
M]!.?_ONC_A.?$/\ T$Y_^^Z/[)J?S(/K\.Q]345\L_\ "<^(?^@G/_WW1_PG
M/B'_ *"<_P#WW1_9-3^9!]?AV/J:BOEG_A.?$/\ T$Y_^^Z/^$Y\0_\ 03G_
M .^Z/[)J?S(/K\.Q]345\L_\)SXA_P"@G/\ ]]T?\)SXA_Z"<_\ WW1_9-3^
M9!]?AV/J:BOEG_A.?$/_ $$Y_P#ONC_A.?$/_03G_P"^Z/[)J?S(/K\.Q]34
M5\L_\)SXA_Z"<_\ WW1_PG/B'_H)S_\ ?=']DU/YD'U^'8^I6^Z?I5:S_P"6
MO^]7S'_PG'B'_H)3_P#?=-7QMKZ9QJ4XS_MT?V34_F0?7X=CZHHKY9_X3GQ#
M_P!!.?\ [[H_X3GQ#_T$Y_\ ONC^R:G\R#Z_#L?4U8EVWAX7#?:OL?F]]X&:
M^=/^$X\0_P#02G_[[JN^KW5VWFSW+M(>I+5P9AA*F%@I6YKGN9%"ECZTJ<I\
MEE>Y]61[/*7R\;,#;CIBG5\L#QMK\8")J4X5> -_:E_X3GQ#_P!!.?\ [[KN
MCE51I.Z/%GC81DU8^IJ*^6?^$Y\0_P#03G_[[H_X3GQ#_P!!.?\ [[I_V34_
MF1/U^'8^IJ*^6?\ A.?$/_03G_[[H_X3GQ#_ -!.?_ONC^R:G\R#Z_#L?4U%
M?+/_  G/B'_H)S_]]T?\)SXA_P"@G/\ ]]T?V34_F0?7X=CZFHKY9_X3GQ#_
M -!.?_ONC_A.?$/_ $$Y_P#ONC^R:G\R#Z_#L?4U%?+/_"<^(?\ H)S_ /?=
M'_"<^(?^@G/_ -]T?V34_F0?7X=CZ=7_ (^VJS7RO_PFVO[MW]I3Y_WZ=_PG
M/B'_ *"<_P#WW1_9-3^9!]?AV/J:BOEG_A.?$/\ T$Y_^^Z/^$Y\0_\ 03G_
M .^Z/[)J?S(/K\.Q]345\L_\)SXA_P"@G/\ ]]T?\)SXA_Z"<_\ WW1_9-3^
M9!]?AV/J:BOEG_A.?$/_ $$Y_P#ONC_A.?$/_03G_P"^Z/[)J?S(/K\.Q]34
M5\L_\)SXA_Z"<_\ WW1_PG/B'_H)S_\ ?=']DU/YD'U^'8^IJ*^6?^$Y\0_]
M!.?_ +[H_P"$Y\0_]!.?_ONC^R:G\R#Z_#L?4U%?+/\ PG/B'_H)S_\ ?='_
M  G/B'_H)S_]]T?V34_F0?7X=CZFHKY9_P"$Y\0_]!.?_ONC_A.?$/\ T$Y_
M^^Z/[)J?S(/K\.Q]354N?^/NV_WC7S)_PG/B'_H)S_\ ?=-/C;7V96.I3Y'3
MYZ/[)J?S(/K\.Q]445\L_P#"<^(?^@G/_P!]T?\ "<^(?^@G/_WW1_9-3^9!
M]?AV/J:BOEG_ (3GQ#_T$Y_^^Z/^$Y\0_P#03G_[[H_LFI_,@^OP['U-17RS
M_P )SXA_Z"<__?='_"<^(?\ H)S_ /?=']DU/YD'U^'8^IJ*^6?^$Y\0_P#0
M3G_[[H_X3GQ#_P!!.?\ [[H_LFI_,@^OP['U-17RS_PG/B'_ *"<_P#WW1_P
MG/B'_H)S_P#?=']DU/YD'U^'8^IJ*^6?^$Y\0_\ 03G_ .^Z/^$Y\0_]!.?_
M +[H_LFI_,@^OP['U-17RS_PG/B'_H)S_P#?='_"<^(?^@G/_P!]T?V34_F0
M?7X=CZFHKY9_X3GQ#_T$Y_\ ONC_ (3GQ#_T$Y_^^Z/[)J?S(/K\.Q]13_ZA
M_I3;;_4BOEX^-_$!&#J4^#_MT#QOX@48&I3_ /?=']DU/YD'U^'8^IZ*^6?^
M$Y\0_P#03G_[[H_X3GQ#_P!!.?\ [[H_LFI_,@^OP['U-17RS_PG/B'_ *"<
M_P#WW1_PG/B'_H)S_P#?=']DU/YD'U^'8^IJ*^6?^$Y\0_\ 03G_ .^Z/^$Y
M\0_]!.?_ +[H_LFI_,@^OP['U-17RS_PG/B'_H)S_P#?='_"<^(?^@G/_P!]
MT?V34_F0?7X=CZFHKY9_X3GQ#_T$Y_\ ONC_ (3GQ#_T$Y_^^Z/[)J?S(/K\
M.Q]345\L_P#"<^(?^@G/_P!]T?\ "<^(?^@G/_WW1_9-3^9!]?AV/J:BOEG_
M (3GQ#_T$Y_^^Z/^$Y\0_P#03G_[[H_LFI_,@^OP['U-17RS_P )SXA_Z"<_
M_?='_"<>(?\ H)S_ /?=']DU/YD'U^'8^FK'_67'_72KE?*Z^-=?0L5U*<9.
M3\]._P"$Y\0_]!.?_ONC^R:G\R#Z_#L?4U%?+/\ PG/B'_H)S_\ ?='_  G/
MB'_H)S_]]T?V34_F0?7X=CZFHKY9_P"$Y\0_]!.?_ONC_A.?$/\ T$Y_^^Z/
M[)J?S(/K\.Q]345\L_\ "<^(?^@G/_WW1_PG/B'_ *"<_P#WW1_9-3^9!]?A
MV/J:BOEG_A.?$/\ T$Y_^^Z/^$Y\0_\ 03G_ .^Z/[)J?S(/K\.Q]345\L_\
M)SXA_P"@G/\ ]]T?\)SXA_Z"<_\ WW1_9-3^9!]?AV/J:BOEG_A.?$/_ $$Y
M_P#ONC_A.?$/_03G_P"^Z/[)J?S(/K\.Q]345\L_\)SXA_Z"<_\ WW1_PG/B
M'_H)S_\ ?=']DU/YD'U^'8^IJJ/_ ,?\?T-?,G_"<^(?^@G/_P!]TW_A-M?W
MAO[2GR/]NC^R:G\R#Z_#L?5%%?+/_"<^(?\ H)S_ /?='_"<^(?^@G/_ -]T
M?V34_F0?7X=CZFHKY9_X3GQ#_P!!.?\ [[H_X3GQ#_T$Y_\ ONC^R:G\R#Z_
M#L?4U%?+/_"<^(?^@G/_ -]T?\)SXA_Z"<__ 'W1_9-3^9!]?AV/J:BOEG_A
M.?$/_03G_P"^Z/\ A.?$/_03G_[[H_LFI_,@^OP['U-1FOEG_A.?$/\ T$[C
M_ONO:/A;JEYJN@^=>3O*^3RQSWK#$8"="'.V:4L5&I+E2.^HJM]MM_M)MS*@
ME SM)YJS7 =*:>P4444#"BBB@"O>_P#'H_TJ:/\ U:_05#>_\>C_ $J:/_5K
M]!0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .7^(?_(C:K_U[M_*
MOE/0=,DLUL->W%8(KR-&/XU]6?$/_D1M5_Z]V_E7@&D:/-JOP4O?LZY>&]$A
MQZ 4 =?\9M;35]-T73(7W+?F.08_W\5@?"W2O[#^,<VFYS]G#KG\!7/>"#=>
M-/%>D6,V2NGV[;"?13NKL_"X/_"_]5 ZYD_]!% '7>//BM<Z)KT>AZ%9)>7N
M<2!\C:>V,5F6_P 6=>T77;6S\4Z7#;6TY&98F9B/I7GVJIJB_&JX%C-Y-X7^
M1V8+V]36[XK\,>*==FLHM9U*)V1\Q;IU- $WQ\UG4+HV=L+91INT2Q39.6++
MR*Z;X7>*=83P_<'4=/"6-I;[T>,,S/CVK.^.,,D'@+0XI3ET.TD<]$%==H&N
M0:/\+&OE\N9[>WWF,-UP!UQ0!RT7Q+\;:Q+=S:7H$(M(&;#3,Z,0/8BMSX=?
M%*;Q/?W6F:I:I;7L 9BL>2-H'/6N3T#5O%WC:SN+S3[X:78;R&\N4<?@:QOA
M- 8OC#J<%Q<_:"(9E>8X^?CK0!U^H?%?7=0\87.A>'["SD\EF >>4QYQBKF@
M?$GQ$GBE='\0:+Y2$D&:V#R#/UQBN3\0^ ))?&%S>^%=7 OI&+-'N5=AXXJO
MIGC?Q=X.\3P:=XB<79=MG,@;';M0!6^/&JZE<^)K.WFM52UMVS;ODY?/K7IO
MA[QGK<'@JYU+5-,"-:0*8XXPS%^@'&*X_P#:$??+X9DQC<VX_I7H'BOQA:>&
MO D5TGEW$OV9=B Y!.T=<=* .(3XF>.[O2;C6(= MTLHBV?,=U; /IBMOPU\
M2[_Q3X.U"Y%E&FHP*V(5)P0.G-<M%+XO\2^%KC47U7^S],8-F..12"/3FD^!
MXVRZNA?>0KC=Z\]: .*\!ZWK5G\1;F[M+%);J=R)HR3A03S7IGCKQA_9WC'0
M;6XT2TN)KD+F20G=&2X'%<Y\+)(XOC'K)D=5'[P#<<=ZE^,!#?%/PX0002F"
M/^N@H ]4^(GCZ#P3IJL(_-O9<>5$0<$9QVKSQOBIXX@TV/5I= @^QN0>'?<!
MGTQ4'Q_##Q5X;D;/DJ!O/;_6"O4KS7/#EGX/2YO986L%5<H""?RH T/"?B-/
M$^APZ@L3Q,X^9'4KC\ZV+C_4/]*P_"6N:)KFG>=H886X]4*UN7'^H?Z4 ?,G
MPNMM)NOB)KJZNML81(^WSV"C/F'UK>^,\7@Z#1(8M,CMEO/,SNM\-D8]0:XS
MP7X.MO&?CK6K.YG:)8Y78%1GJY%>MV'P%T&UN4EGG:Y53DHZ#!H ?\.]7N]#
M^&+7M['+*47,"!2V1CCI6+:_$GQWJMG<ZC::!;I:P'GS7=&QC/0BO0?&&KVG
M@?P=YD%JIAC'EQQ]AQQ7F&GW/C+Q5H%QJ$>IC3=/:)FVQRJ<C!X.: .V^'/Q
M*D\8Z9?-=6R075J/N(20?ESWKE(OC1K$VKW>F6^EQ2W2OM@4%B&^OI6-\$!L
MN=:4OO(#?-Z_)2?"Z%'^*5W(R@LLAP?PH VO^%O^(]%\2P6'B'28+>"1AN=&
M9L ^GK7>^//B%:^#O#<=_M$MS<IFVC(.&; /..@Q7G/[1*JLNB.H 8RG)K*^
M.*R_V5X?9@?+,28^OEB@#9_X6IXY32UU9O#UO]E)X^=\_EBNZ'Q":[\ 2:_:
MVS":-#OCE4J-P'./:M"VU?1+3P!;3WT\+6L=FGF*&!)^49&*YG7=<T/7OAC?
MW&@ BU4,I!0KSB@#D['XU>)]95(]+T.*9_XVR^ ?3.*ZSQ3\4KOPUX>TL26<
M;ZY>1AC;@DJO.#SU]*J?L^6T2>$;N0(-YG'/X5P'Q8BOD^)=L0Q5F<F!B< ?
M,/ZT =;+\5?%VB/:7&M:'!'9W&/G5F.T9QSQQ7HNM^-8K+P8=>L('NMR HBH
M3G\J\J\3:+XRU;1?LNJ:I$UM(00#<(<^E;DVM3?#KX765I.B7-T5(C^;(//J
M* *!^)OCMM$DUO\ L&V2R3)(>1@V![8K?T_XB7OB;X;WFHV]F@U! X:$$[<
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M+%F;'' ]ZZWX=^*O$?B22[.KZ8EI'"P .6R<CW%>6V=C#J'[0VH0SH'42R.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'4'--DH]NUACH_P=MOLA\MV5067OR:\GT?Q#J.CWPN;6=PX]\UZCH5Y:>-O
M:>'6N%@NX@N"W.['-5]$^&$&D7;7NM7*-:Q9RO3=7DTJM.DIPJ[W?S.Z<)3<
M90VL<?I%G>>//%2M=ODN1YCXZ"NNNK/P+8:U%I$M@CR' :7<>#5'P_K^B:5X
M_D%F!%82D+N)R!CK6AJWPZNM1\6)>P3!K.4AC(.P/-55FN>TVXQMH*$?=O%7
M=]3!U[P5;Z3XKT^)/WEA=.N!['G%=#XAT/P=X;N[9;BQ1S*HS'D]^]1^*M9M
M+CQ9HNFVTJR"VD0,X]0,50^+3 ZY8X8']RO0U$)5*DJ<9-JZ8Y*$5)I%CQ7X
M3T73;+3]=LX EI(R!HAWR:Z;Q7=Z-'X#M7DM0;=XAY*[B-O7'ZUF>-'4_"S2
M &!.Z+O[U1\:L#\,]) 89\M.,_[1K**=3DYF_B:+;4>:RZ%)_#>F_P#"JX]6
M$)^U,%^?<>YK3T;PEX;3P)#K>HVJG:"9&)//-/9E_P"%(0C<,X3C/O4\[C_A
M1C@,,[>F?>J=2;5KOX[?(2C&][?9*?A30?"?BC6=22WL%^S01*4Y/7O3]%T;
MP;K6JW>E0Z>@DBX$N3USBJ?P48+<ZQD@?N5ZGWJO\-F \>ZD20/WA[_[9JJB
MDI5$I/W4K:B@XM0NEK<T[+0_!O\ ;[Z))9)++VER1@YZ5BV7@"&\\=3:<#MM
M8R7QCL#TI-)?/Q1<EN///?W-=78:S:Z=\2[B.XD5%E1E5B>Y-$I5*=^5M^[<
M$H2MS+J5%\.^%;K6+C1TTCRI$#*)^>HKD](\$++X\N-(N/FM;<MN?'7 !KOK
MJV\7/XANFCNX+;3QN=)S$#@#]:YCPOK_ )7Q O(+^\299MZ_:0N Q(Q2IU*G
M))QE?3O<<HPYE=6U-&UB\&Q^*5TVULTBF1L"<$]:YWXM #Q'@= !C\JWF\"R
MV7C+^TI[A5L=^1+V]JP/BP5/B(;6# *,$?2KP[BZ\>63>A-6ZINZMJ<]X(@2
MY\9Z7#( 4>8 @_2NL^+VIW$?B"/38Y&6WBA1E4''.*X70-2_L?7;/4-N[R)-
MV/6O7/$WABW\?1PZQIEVGG&-59?H.E;XAJ&(C.?PV_$SI)RI.,=[GF6G^+M6
MT[29=/@G;R)<[@>>M>I?"F-KOP1JL>[:TLC#/ID5E3^$-$\*>%ICK$B3WC@F
M, XP>PJ_\-94_P"$ UMD.P;G*C/(^6N;$SA4HMTUU6O<UHQE&:4GT*%A\,KV
M+4$O&U)O*B<.<'/ .:R?BSXAL]7U*WM[1@_V=2CMCOFH? OC.72=9:RO)&DL
M[@["&;N>!S^-+\3?"B:5J/\ :%HP:VN,L<'[OM6D(R6)7MGTT)DTZ+]G\SSR
MBBBO4.(****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\^3R?[FXX_*E_M"Z-M]G,\GD_P!S<<?E7HH^"FL&0I_:-KD?[)J3_A1^L_\
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M*/UG_H)6G_?)H_X4?K/_ $$K3_ODT?7L/_,/ZM5_E/+:*]2_X4?K/_02M/\
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MO\IY;17J7_"C]9_Z"5I_WR:/^%'ZS_T$K3_ODT?7L/\ S!]6J_RGEM%>I?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07'WHO\ >J>H
M+C[T7^]0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 (WW3]*K6
M?_+7_>JRWW3]*K6?_+7_ 'J +5%%% "'@'Z5Y#XG^(FKZ3KDUI L)C4#&1S7
MK_:N<OO!>DZA=-<3PJ9&ZG;6%>$Y1]QV/4RK$82A4<L5#F5C;L)FN-.MIG^]
M)$K''J15BF11K#"D2#"HH4?04^MEL>;)IR;04444R0HHHH **** "BBB@ HH
MHH K+_Q]M5FJR_\ 'VU6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJI<_\?=M_O5;JI<_\?=M_O4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@".?\ U#_2FVW^I%.G_P!0_P!*;;?ZD4 34444 %%%% !1110 4444
M %%%% !1110 4444 %%%% %.Q_UEQ_UTJY5.Q_UEQ_UTJY0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %5'_P"/^/Z&K=5'_P"/^/Z&@"W1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5[W_CT?Z5-'_JU^@J&]_P"/1_I4
MT?\ JU^@H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!2* )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"G8_P"LN/\
MKI5RJ=C_ *RX_P"NE7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JH
M_P#Q_P ?T-6ZJ/\ \?\ ']#0!;HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** *][_ ,>C_2IH_P#5K]!4-[_QZ/\ 2IH_]6OT% #J*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "JES_Q]VW^]5NH98?,FB?.-AS0!-1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 1S_ZA_I3;;_4BI)%WQLO3(I(H_+3;G- #Z*** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBN6UC7[XZVVC:2J_:T19'9URH4]* .IHKG_"WB$Z[
M;3B5"EQ;RF)P>Y'4CVKH* "BBB@ HHHH **** "BBB@ HHHH **** "BBD)
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M+B; 6$@;LDXIVF^);VWUF#2]9">==?ZAD7:#WH6NP/0Z^BBB@ HHHH ****
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MC$@7"R$]"M'F!UM%<5:^)]4MM2LX]4B407I/EE5QY8']ZNT!# $=#0 M%%%
M!1110 4444 %%%% !1110 4444 %%%4-4746MB--EACF[&5<B@"_17"VFN>(
M5\31Z9/=6=RJ'-P((\&,=B:2[\6ZM(MW?:=;[[&S!+@IDRD'!"GUH [NBJ>E
MWPU'3X;D*5WJ"5/4'TJY0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1U<YQ(Q=?H>16Y4<420QK'&H5%&%4= *DIMW$E8****!A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP: +-%%% !1110 44WS$R1N7(ZC-0Q7UM/,\,<R-(GWE!&10!8HHHH ****
M"BBB@ HHHH **** "BBD) ZD"@!:*** "BBDR!U(H 6BD!!Z&EH **** "BB
MB@ HHHH **** "BC(]:* "BBB@ HHHH **** "BBB@ HHHH **3('4TM !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3#)!N9CCIFG06EG=>%O"['44L]2%D!$\JEEQNYXH ]#E\8Z5-I-]=6MRQ^S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHI,T +129I: "BBB@ HHHH ***0T +124M !1129H 6BDS2
MT %%%% !129HS0 M%%)F@!:*2EH **** "BBB@ HI,TM !1124 +1249H 6B
MDS2T %%%% !1110 44F:,T +129HS0 M%)GFEH *RY['2I)BTT,)?N649K3/
M0UY;XB\$^(-1UF6YM=0,<3 87<U95I.*NHW/0R^C3JU&IU?9^9ZB@544+PH'
M&/2G5!91O#8V\4AW.D:JQ]2!4]:HX)*S844E&:!"T444 %%)FEH RM?\/:?X
METYK'4HV>!NRM@_G47AOPKI?A336L-+B=(&;<0[;CFMJB@#E-/\ AWX>TSQ+
M/K]M!*+^<DN6DRO/7 J]XD\):3XJM1!J<+,%Y5T;:P^AK=HH X_P]\-M \.7
MAO+9)Y;@_P 4\IDQ^=3^)?A_H?BF5)KZ*5)T^[)!)Y;?F*ZFB@#FO#7@;1?"
MP<V$4AD<89YGWM^9J/0/A]H'AO5;S4=/AF%Q>?ZWS)-P/.>GU-=310!S&F>
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MVZ"0?Q[1D_C5ZB@"E::59V,\DUM"L;2?>VC&:G-I ;@SF-3(5VEB.H]*FHH
MRSX?TUI'8VZG><LN!M/X5++HUA-;I ]NFQ!A,* 5'MZ5?HH I6NDV=G&R0PJ
M-XPQ(!)_&GV6G6NGJRVT0C4]0!@5:HH @6T@2X>X6-1*XPS8Y-4Y_#^FW,QD
MDMER?O   -]1WK3HH K&PM2(AY*8B.4^4<4J65O&DB+$FV0DN,#!S5BB@#,3
MP_IB3"06R$@Y"D @?05:N=/M;MT>>%'9/NEE!Q5FB@"J=.M#>+=^1'YZ]'VC
M/YU:HHH S;C0=.N;GSY;9#(>O Y^OK7.^*?"*Z@NCP64*);VUTTLB!.""*[2
MB@#-T_1+*P"O%"OF;<%B 2*TJ** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-5)RZ-ORMM]YZ3)=0PD"215)Z GK4@<$9!XKQ-=3FU>_OI+N?4,QNRQ+;IN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>gtl21rgcbjm5000008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 3[",H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ\ >*(M>T=$9\SQ (P/4UR7PGL8-1T.\M;A=T<B ,*Y^1+OX?>,Q(N?LTK'
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MY;C%LR;DP.U8=I\0=$NS.%G(\G<&RN.G6E\._P#)/;'_ *]O\:\8\(Z,-?\
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M>$!W8[UJW2^I*ZZ_B9I3^L&KXD\1:%I6IP6^IQAIY,;"4SU/%=1&ZF%67A2
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MU(]=SD2E&M&,NAV7QB_Y$]?^NPK/^%'AFR&DQ:M(BO-(,J2/NFM#XP@MX04
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MJ0 >.*[$# Q77B,3SQ@HO9:F%*CRRDVMR."&.WB6*)0J*, #M4M%%<1T'/\
MC3_D5;S_ ':\G^&F@Z9K.IW"ZA:I. 6X:O6/&?/A:\ Y^6O.?A$K#5;C*D<O
MU'UKTL/)QPLVG8XZJ3KQ3.__ .$ \,?] B#\JMVGA'0K&426VGQ1L.A K;%+
M7"ZU1Z.3.GV<%T$ V@ #  XKPKQO_P E"C_ZZFO=J\#^(DYM/&WV@JQ5)">!
MFNS+5>J_0PQ>D$>XZ9_R#+;_ *YBK=>3VGQ<L8+2*(Q2Y10#^[--N_B^LD++
M8VTCRD< Q&LW@:[?PE+$TTMQ/C'JXCAM]/0Y\Y>?;FMSPMI5YI_@1H;4-Y\B
METQUR1Q7#:%X=U7QMK_]HZFC);*^2&R"/H#7N=M;I;6T<*#Y44*/PK;$25&G
M&BM6M69T4YS=1['@YTKXF;CB.[QFNG\#6/C6#7XWUM;@6NTYW],]J]6HK.IC
MG.+CRHN.&47?F9XC\4_^1GM_]Y:]7\,_\BY9_P#7.O)?BRQC\0Q2;20I4\"M
M+2?BM96&EP6SQ2[HUP?W9KHJ49U<-#D5S*%2,*LN9GK]%>7?\+BL/^>4O_?H
MUU7A3Q=!XG$GDJXV+GYEQ7#/"U81YI+0Z8UZ<G9,Z>O-_C+_ ,BU:?\ 7P/Z
M5Z17F_QC!;PW:  G_2!T_"G@_P"/'U%B/X3.D\"?\B;8?[E=)7-^!>/!U@#Q
M\E=)6=;^)+U+I_ @KG?&_P#R*=Y_NUT5<[XWY\*7@ _AI4?XD?4*GP,Y;X/_
M /(#N/\ KX?^9KG_ !* ?BW8@]/M _D:Z'X0 C0[C((_TA^OU-8'B-6/Q<L3
MM./M YQ[&O4C_O53T9Q2_@P]4>S1@! !Z5Y7\:?^01:_]=J]47[HKRSXT G2
M;7 )_>]A7'@?]XB=&)_A,Z?P7_R3O3_^N->:?#@?\72N_P#MI7I?@P$?#W3P
M1SY->;?#E6'Q1NR5('[SG%=5)Z5_F8SWIGN]>%ZK_P E0C_ZZ'^E>Z5X9JJM
M_P +/0[3CS&YQ]*PP'Q2]#3%;+U.]^(?_(H+]!_*JWPG_P"18B_W:L_$($^$
M% !/ _E5;X4@KX9B!!'R]Z/^81^H?\OUZ'):60/BX<^DG]*]L7[H^E?.FO/>
MV_CN2:S1C(KL> >F>:](L/BII*V(6\$R3HN&'EGM6V+H3J*$H*^A%"K&+DI:
M:E#XR/&MA;JV-Y4[?SK7\+(R> 9P_>%B/^^37!ZSJ-U\2/$-O;6T+K:1L0KE
M2./>O6Y+%=/\*RVRCE+8@X]=M35_=484I;WN.'OU)36QYC\%?^0UJ_\ N#_T
M*CXT?\AW2O\ <_\ 9J=\%U8:UJ^5(^0=1_M5;^,=A-+/9WJ(6CA7YB!GO70V
MO[0_KL9)?[*>@Z6"?"RA>ODC'_?->7^$"L?Q%N4F_P!:91C-=/X,\=Z?J4$>
MF8D$RH <I@>E<MXOTB_\,>,EU^WC9XGDW@*"?SQ6-"$HSG2EHY;&E22<8S6J
M1[?7GGQ<*CP]%N_O''Y4ZP^*VBR60:?SEE4?,-AZUQ?B37KKX@:G!86$,GV-
M9,ARA%98;#5(55*:LD56K0E"T7=L['X=JZ^#V+9P8^*YWX5J/^$KU!N^^3^9
MKTG3-+&D>&(K/ W1Q;6QWKSGX6*P\4:AD$?/)V]S6D9J<*TD)QY94T>QT445
MY9V!7B'CL;?'-J9/N>8:]OKQ;XQ6DMO?65Y$I[DD=J[LO?[ZW<YL5_#N>O:=
MC^S;?'3RQ_*L#Q[K4&D^&KD22!9)D*Q^YK5\/3B?0+)\Y_<KG\J\I^*6HMK&
MN6VAPABZ2=<<<BHPU'GKV>R*K5.6E='+>'M"\67!;4-)CF4L<[TKH6TSXELI
M5I+L@\&O6?"NF#2_#]I;XPZQ@-]:VJZ*N8-S?NI_(RAA5RK5GS)/#K?A+Q#;
M:GJ<4@FW[LM_%7T5I5T-4T2"<_\ +:++#ZBN/^*FAIJ'A][S:2]LI88'6J7P
MCUN6ZTJ2SN2?,1L(#Z"GB)?6*"K=5HQ4E[&JX=&<W?K<^%OB:OV=3';W#*I(
MZ'K6C\3]5_M2]LM+M&W>8"' ^M;/Q5TB>XTZWOK- 98)"[-WP!7&?#JUN-?\
M2QWUTI98&YW5M3<9PCB'O%&<DXR=)=3UW3--ATSPKY,,83-OE@/7;7AFEZ9<
M:EXMGAAO&M9=W# <FOHTQJ8C'CY2,5XEXMTB]\+>+TUNTB9X#)NPH)Z>N*PP
M-6\IKJS7$PLHOHCHO^$ \0_]#%/_ -\__6JG?_"W5=2C$=YKDLJ@Y 9:V;#X
ML:+-9AKCSEF4?./+[UR&N^+M1\7ZO#9Z1Y\=MO'SJ"IK2E]:<M5:W6R(E[&V
MFOS/08=%;0/ [6!E,GE1[=V*X_X4_P#(9O/^NCUW4MC-8>"VMII&DE2/!9CD
MFN%^%:LNL7F01^\?J*RA*]&HVRY*U2"*OQ'X\9V9/_/4?RKUS2#G2+4C^Y7E
M_P 6=*NEFMM2@C9\29.T9Q@5;\/_ !3TBVT:"WO1,)HDVL!&>M.K3E5P\'!7
ML$)J%67-H/\ C21_PC<0_P"FHK;^&/\ R(UC_N5YA\0/%%QXE@5X()!8AAAF
M0@YKU#X8@CP-8Y&#LIUH.G@XQEO<5.2EB&UV/.?"(_XN_=?[\G]*]X/W#]*\
M(\(HP^+UT2IQOD[?2O=C]S\*SS#^)'T1>$^%^IX)!_R6N3_KX->^)_JU^E>"
M0*W_  NN0[3C[0><5[TG^K7Z4\P^QZ(6%^UZGAWB+_DM%K_UW7^1KU_7M9AT
M+2)+Z8C:GK7D/B)6_P"%S6QVG'GKSCV->A_$:QFO_!US% I9R0<"JKQC)T8R
MVLB:3:51KN>>OXC\8^+KEI-%$\5MNV_NSQQ6[:> _$>HPYU'7)X\CE&6L;X<
M^,+#PY8MINH1R)(KL<[/>NGUSXD6LUH]MI,<TERXPI$9(!^HK:K[:,^2E!)=
M[$0Y''FG*[.-^'%K]C^)<MOYGF&,2*6]:Z[XRX_L*RST\T_RKBOAVT]M\0_.
MO5*-*CDY&.37:?&13)H%EM!.93T^E.K_ +["_84/]WD=;X)*GP;I>WIY(_F:
MT]6(&D7A/3R6_E7D?@?QP= L(K35HY5A('E$(3Q5_P 5_$FWO[,V.CI+)++\
MIRAZ&N6>#JNL[+2^YO&O!4]64_A!A]<U9HS\N!_.O9>U>>_"_P ,2:-ISWLX
M(FN5^8'M7>S/Y<$CG^%2:RQLXSKOE+P\7&FKGA_C,$_%RTV]FCS7N@KQ#277
MQ1\2YKD D0@?H37MXK3':*$'ND1AM7*7=BUY%\;_ /D'V'_74_RKUVO(_C:I
M:PL, G]Z>@]JC ?[Q$K%?PF=CX=_Y)[8_P#7M_C7F?PG'_%?ZC])/YFO3/#P
M(^'MB,<_9O\ &O-/A0K#Q]J)*D<2=1[FNFD_W=<QG\=,]UKP9_\ DI__  )O
MYBO>:\'=&_X6=G:<;FYQ[BLL!O/T-,5]GU/=HO\ 4Q_[HI],B_U,?^Z*?7GL
MZC@?BY_R)_\ VU%5OA5&LWA41L,JRD$5:^+8)\(8 )_>CI4/PF!7PW&""..]
M>BO]R^9R/_>/D<EHT]QX>^)LT,H,=M-(S =CTJ[XMO)]?\<VFG6ZF2"(QRMC
MH*E^+=A/!=VVJ6J8\I"&*CN32?"NVN-0U.35[I,AH_+!(]*Z>:+I_6>MK?,Q
ML^;V/F;?Q0B6#PH\:#"JAP*@^%G_ ")=[C_:_D:M_%8$^&Y0 3\AZ5%\)(R?
M"TZ,"-TF#GZ&N:_^Q_,U_P"8CY'F6FZ;<:CXON(8;MK:7=PP'N:]#_X0#Q#_
M -#%/_WS_P#6KG_&.BWGAKQ4FM6<3- 7!PHST]<5UNG_ !8T::S!N?.291\X
M\L]:Z:TZTXQG15U;L94XPBW&H[,Q[_X7:KJ40BO-<EE0'.&6NV\/:$?#WAE-
M/,ID\M<;B*\R\0>,+_Q;JD5GHWGI;[QEU4J>M>LZ-ITUCH,5I-(TDJK@LQR3
M7-B75C3BJCWZ&U%0<FX+YGCO@G_DK-Q_O2?TKV'Q'KD6@Z4]W)@D [03U->'
M66IKX6^(US?7L<BQ!W PAYSBN\\67B^-?!"7NFARB.Q((P>/:ML51YZL)2^&
MR,Z,^6$DMSF%U[QKXNN3+I(GAMB>0AR!6Y_P@OB"ZTZ:;4=;G7;&S%&7T%4_
M 'CG3]'TT:??Q-%)& H(3!/UK:U_XD6]U:26>D0S2SR*5_U9(P>#55/;1J<E
M."2[V%'V;CS3E=G'_"R,1>)[I V[&!G\:]<\3^%[/Q+8F&X"K)C"R$<BO(OA
MQ#-IOBR>&Z4I(^."/4UTWQ0@UJVGM[ZPEF$"#,BQL<]?05.)BYXI<LK:;CHM
M1HNZN9-_\,=:T0&71;R65L\*BXK/M_%?BWPA<QG6UF>-C\J2&NTT;XJZ2UA'
M'>><LR*%;Y#V%<=XZUZ'QO>VEII$$C%&(+&,CK[UK2=:<N2O'3N1-4XKFI2U
M['L5KJ2:KX=:[3 \RW+$#M\IKQSX8?\ (YW_ /G^(UZSH.FR6'A9;9_]88,$
M>^*\7TC4AX,\87<E[&X5_12>YKGPL4XU80^1K6=I0E(]N\4:\GA[19[\H':,
M9"9ZUY-'KGC3Q?,;C2?/BM-VT[#D"NG\8WR>*O!,MWIXD90F=NWD_A6+\//&
MVG:)IC:??QO%,')X2G0I.G1<U&\DQ59\U11;M$O?\(+K]U822ZEK<RX7)1EK
M"^&EO]E\;RP;]_ELPW>M=3X@^(5OJ5G)IVD13R3RC;N\LX'XUR'PT\Z#QN8[
MI2LI+;LCO6T75="?M---B)<BJ1Y-3MOC#_R+$'_76M3X9?\ (F6/_7,51^+%
MM+<^&8Q$A?;(2<#-87PV\;6<%O9:'*LBSD!!\G'YUS1A*>"M'HS5R4<1=]BC
M\6O^1OTWZI_Z$*ZCXCK*?"$/EYP$^;Z8%<O\5P7\6Z:R@D93H/\ :%>H:IIO
M]J^%Y+0*"\D 5<]C@54IJ$*,F*,>:51(Y[X6-&WAQ0F,@#=7=,0BECP!R37A
MGA;7Y_ .HW.GZG%+]G+_ '@A/3TKK=9^*>DG3Y(K/SGFD4A1L/<5GB,+4G5<
MHJZ?4NE6A&%F]4=Q#K-A<7)MXIU:4<%:OUY1\--'O[J\FU:_,BA\,BG/\J]7
MKEQ%*-*?*G<VI3<XW:%KY]\701W/Q$>*5 R-*<@U]!5X%XG5C\220IQYQYQ7
M7ES]^7H88OX5ZGJ%EX"\,O90N^DP%F0$G%6D\">&HSE-*A!^E;5A_P @^W_Z
MYC^56:Y'7JW^)_>;JG"VQ6M+*WL8O*MHA&GH*YSQQXN7PMI@E2,22NVT+G&/
M>NLKRGXO:=<26D-U$C2*KC*@9Z5>%A&I62GL36DX4VXF'9S^._$[+=VTMS%9
M2\H5Y %:.J^!-5&CR7.HZW*^T9*,OM5WP9\0M(L_#]O9W(>.:%<, F!57Q;X
MR;Q-8R:=HL,Q'WF=HR!QUYKT+UE5Y8Q44NMCDM3Y+MW8?!M=LETN<X4C]:3X
MK 'Q)HX/]T_SJ/X-N4O+N&0%75.<_6I?BHK'Q)HY )^4]![T/3&OT_0?_,,>
MJ:=_R#+7_KDO\J\\^,?_ "![?ZG^5>B:=_R#;7_KDO\ *O._C$"=(M\ GD]*
MX<)_O$?4Z:_\)FQX.W?\(.-G7R?Z&N-^$;)_PDVI*?O_ #Y_[Z-=QX$C+^$H
MXR,;H@/T->;W5O>^ /%\EXL3M;2GYBJD\$Y-=5/WW5I+=[&$O=4)]$>[UGW&
MLV%K=K:S7"K,PR%-<B?BOH0L_-S-N(SC97&:1%J/C7Q>M\?-BMH\E3RN0#D5
MS4\'*SE4T2-I8B.BAJS8^,>&CTOT,Q_E7H/A<8\,:>!_SR%>??%V-A#I*@$[
M9<?I7H7ACCPUI^?^>0JJW^ZP]6*G_&D</\9U<^'8/[OG"L7PKX-UG4/#MK<V
MNN2PPNN5C5>!7HOC30O[>T*2WQEDRZ_6O,O!_B^?P=*^F:Q%*L*?*A"$BM\/
M.<L-RT]TS*K&*K7GLSHCX \0$8/B*?!_V12Z'\-+G3=:74)M1>9P1G*]:GU?
MXJZ2MBZV7G-.ZX4;#WK+^&]MKE_J,VHWTTPMG^XKL?7T-%\0J4I3]U>FX6I.
M:4=3;\?^.SX<\NUM4\R:4'Y@<%37)6%AX_UMA+-=74$$GS*>V#4?Q2L;FSUV
M"^\II(B2W3(%=AI'Q+T,:3"K&56C0*R[.X%.,73HQE2C=O?J)RYJC4W9(Y'Q
M=X*O;#17N[[5Y)W"DA&6NO\ A3_R+C_4?RKC/'/B&Z\76K?V;#,MI;Y9F9"N
M1_6NN^$DHDT"9.A5@,'Z55?G>%]_>X4N7V_N['&?$#_DJ5G]8Z]QB_X]A]*\
M.^)JRV?CV"_:)S#&$)8*<<5Z7X2\967B:"5+;>'A W;EQ66*A*5"G);)%T9*
M-6:?5GF_@7_DK5W_ -M:M_$'<OCNR:3_ %7FK57P,K#XL79*D#]YSBNO^)_A
MFYU73XKRR4>;;L7;'7&.U;SJ1CB8WZHRA%NB[=SNM-*MIT!3[I7BGW5Y!91>
M;<.$3U->7^%/B5:6&FQ:?JJS)-"NT?NS5#QGXX3Q+#'INC+,69QEMA%<7U&J
MZG*UIW.GZQ!0NGJ>NV=_;7\>^VD$B^HJU7+>!M&GT?0(8[EF,Y7YLG-=0*Y:
MD5&;47=&T&W%-F=X@@:YT&]B099HB *\:^%]Q_9'B>;3;CY)I) -IKW9@",$
M9!KQGQ]X4O=,UDZ]I:L6+%V"]1],5V8.<7&5&6G-^9SXB+351=#V>DKR;1?B
MY;V]ND.L12I(@Q\L9JSJGQ@TYK=ETR.9YR/E#1GK6;P-?FMREK$T[7N;'BOX
M@Q>'-4MK-(!.91\QSC:<ULZQXFM]'T%=2NL)O0%%)ZDC.*\K\(^'-1\5>(FU
MC4D80!\E7R,9] :[/XH:)<ZCX6BBM%SY+ D>P%;3HT8U(4KZ]69QJ5'"4_N.
M.&M>-O%L_P!HTH7$%JQS\AR *VAX#\07EA)+J&N3J50L49?:J7P_\<:;HVE1
MZ=?))'+&N/N5L>(/B3!<6DEKH\,TMPX(YC.,=^:Z*GMHU.2G!)+K8RA[-QYI
MRNSDOA?#Y'B^\BW;MJ@9]>36S\:_]9IO^Z?YU@?#8RVOBZX%RI5Y .H]2:Z#
MXU*QET[ )^4]![UI/_?HOR_0A?[LT>@^#P!X=ML?W%_E5/X@_P#(H7__ %R-
M7/"((\/6V?[B_P JJ?$ $^$+\ 9/E&O+B_\ :%ZG:_X7R.9^$7_(KZA]?Z&N
M2\)$)\0;GS>I;C/U-=C\'4/_  C]VK C,@'/TK"\;Z+=>'_%$>M641:#*[@H
MS]>E>@I)XBK3[G(T_90EV/:*IWFJ6=@P6YF$9;IFN+LOBQHDEF'N?.691\X$
M9KB]1U2_\>>*+<:>LJ6T9!+$%1@$5QT\%-M^TT2ZG3/$1M[NK-;XR$SV.GNK
M_NFE.&_"C0_!.N7>BVD]OKTT<3QY5 O %=-XZ\+OK'AF**(9DMEW#W.*Y'P=
MX^_X1Z+^R]9CE01?*A"'I752G.6'2I:M/8PG&*JWGLS7;X?>(&4JWB*<J1@C
M;5OPK\/)M U4WLE^TQ8@D%>M5?$/Q3L&L7M],$KW$BX'R'C-2_"^SUAHIKW4
MY92DH!C5V.1^!J).NJ,I3=EVMN4E2<THZG-?%,9\<:7G^X/_ $(5[19_\>-O
M_P!<U_E7C/Q15CXWTLA21M]/]H5[-9_\>5O_ -<U_E66*?[BEZ,NC_$F3T44
M5P'4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4E+10!B2^%-)GU;^TW@S=;MV_/>MI5"J
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MJWD=U=P[Y8QA3GI6NBA$5%Z*,"EHI.3:LV.R6H4445(PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA$RWD9C(R#3Y)6O8.9=S4HJ.&>.>,/&P93T(J2I&(:YN\\9Z?9ZXNDR)(9V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9&D7S'0J%^HQ7F7P@D!\37[?WER/S-=SIOPSM89/.O;F>X?:5Q(^X?K5W0_
M%EH.JR7MJ[Y<8()XJHU:%.C*G%W;ZB<*DYQFUL<1\;O^0II'^X?YUZKX>_Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .U-1PZY4Y
M%*_W&^E5K#_CV_X$: +5%%% !1110 4444 %%%% !1110 4UG5!ECBG53O\
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MC38;ZV.891E3FO#9;KQ/XB\,W^KOJ,XM=\D?D=L GFO2_A/_ ,DUT?\ ZY4
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MF,<*/6@#MZ*SM3UJQTC3)-0NYECMXUW,YZ 5S$OQ7\*1B/\ XF49,A&T>N:
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M ZE>)"3]T'O0!O45QNC_ !.\,:U="UMM1C:9ONJ.]:>M^,-&\/F(:C=I#YA
M7/?- &_17'6?Q+\-7^LQZ7;:A&]R[;0H]:=K?Q)\-Z%-Y%WJ$:R_W30!U]%8
M/A_QAHOB5"=-O$F*C) [4WQ#XST7PR%_M*\2%F&5![T =!17$:5\5?"VJW2V
MT6HQ^:QPJ^M<S\8_'4^@6D5OIEZT-R^02AY% 'K32QJC.S@*O4D]*IV.MZ7J
M<SPV5]!/(GWEC;)%<#X*\7V'B/PJ]M-J >Z,)\UCU!P<UB?"'1M!T[Q1JDNE
MZV+Z9U.^,+C;\QH ]HHKE]?\?^'_  Y)Y5_?)'-V0TF@?$#P_P"(YO)L+Y))
M<9VB@#J:0L%!). .II:\C^,/C:\T80:1ILK1W-TN0ZGD<XH ]"F\6Z!;RF*7
M5;57!P09*TK2^M;Z$36LZ31D9#(<BO K/X#W>L60U&_U:1;F5=X4H._-:?P_
MTOQ?X8\6#1Y5GFTE) OF-P M 'N5%8'B#QCHOAD#^T[Q(6(R W>L?2OBKX6U
M6\2UBU&/SG.U%]30!V]%8VN>*-*\/6ZSZC<K#&PR":P]1^*?A;3C&LNI1AG
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MZQX8M[R[??,Y.3BO/IU:<JCC%:GO8S!8RE@X5JL[P>R.B%+2"EKI/%"BBB@
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M48I\9S&I]J 'TT(H8L!R>IIU% "%0PP1D4 !1@#%+10 4444 %%%% !1110
M$9&#3514&% %.JLSD7.WM0!9IJHJ_=&*=10 FU<YQS2T44 (0",$4*H4848%
M+10 $9&#2*H4848%+10 T(H.<<TZBB@!"JMC(SBEHI#T- "TW8N[=@9]:A@<
MM(P-6* "BBB@ HHHH ",C!I H7H,4M% !1110 4A (P:6B@!%55^Z,4M(?NG
MZ56LW9U.?4T 6J1E5AAAFEHH 0  8%#*&&&&12T4  &!@4444 -5%7H,9IU%
M% ",H88(R*  !@4M% !114-RQ6$D>M $A12<D#/K3J1?NCZ4M "%0PP1F@
M8%+10 4444 %(RAAAAD4M% "  # H(!&#2T4 -5%0848IU%% %*X_P"/V+Z5
M='2J5Q_Q^Q?2KHZ4 %%%% !1110 4444 %%%% !1110 56MO];-_O59JM;?Z
MV;_>H LT444 %%%% !1110 4444 %%%% !45Q_Q[R?2I:BN/^/>3Z4 ,LO\
MCV3Z58JO9?\ 'LGTJQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\>HKV'_A2Y_YZO\ F*/^%+G_ )ZO^8H_M##_ ,P?5:O8\>HKV'_A2Y_YZO\
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M 4444 %5'_X^JMU4?_CZH MT444 %%%% !1110 4444 %%%% !2'H:6D/0T
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M^E6*KV7_ ![)]*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%% !1110 4444 %%%% !51_^/JK=5'_ ./J@"W1110 4444 %%%% !1110
M4444 %(>AI:0]#0!6MO]:U6JJVW^M:K5 !1110 4444 %%%% !1110 4444
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MHH *K6W^MF_WJLU6MO\ 6S?[U %FBBB@ HHHH **** "BBB@ HHHH *BN/\
MCWD^E2U%<?\ 'O)]* &67_'LGTJQ5>R_X]D^E6* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:/'4R@5WG@NT.C>&;>RNY8EF0G($@-?.*ZIJ3#(NIO\ OLTUM7U%3@W4V?\
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M->[5YN)H>PGR7N==&K[2/,%%%%<YJ%%%% !1110 4444 %51_P ?0JU54?\
M'T* +5%%% !1110 4444 %%%% !1110 4R7_ %3?2GTR7_5-]* (K7[IJQ5>
MU^Z:L4 %%%% !1110 4444 %%%% !1110!!<_<%21?ZI?I4=U]P5)%_JE^E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ JM;?ZV;_ 'JLU6MO];-_O4 6:*** "BBB@ HHHH
M**** "BBB@ J*X_X]Y/I4M17'_'O)]* &67_ ![)]*L57LO^/9/I5B@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !1110 4AZ&EI#T- %:V_UK5:JK;?ZUJM4 %%%% !1110
M4444 %%%% !1110 C?=/TJI8_=;ZFK;?=/TJI8_=;ZF@"Y1110 4444 %%%%
M !1110 4444 %07?^H/UJ>H+O_4'ZT 3+]Q?I2TB_<7Z4M !1110 4444 %%
M%% !1110 4444 4KC_C]B^E71TJE<?\ '[%]*NCI0 4444 %%%% !1110 44
M44 %%%% !5:V_P!;-_O59JM;?ZV;_>H LT444 %%%% !1110 4444 %%%% !
M45Q_Q[R?2I:BN/\ CWD^E #++_CV3Z58JO9?\>R?2K% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% "-]QOI5:P_X]O^!&K+?<;Z56L/\ CV_X$: +5%%%
M !1110 4444 %%%% !1110 53O\ _5#ZBKE4[_\ U0^HH MK]Q?I0>E"_<7Z
M4M '@WCQ]2&OMY#W(7'\#'%>G?#PS'P=:FX+F3)SO)S6Y/I%C<R;Y8%9O6K-
MO;Q6L(BB4*@Z"N6GAW"HYWW/<QN;0Q.#AAE"SCU)12T@I:ZCPPHHHH ****
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M%% !1110 4444 %%%% "-]T_2JEC]UOJ:MM]T_2JEC]UOJ: +E%%% !1110
M4444 %%%% !1110 5!=_Z@_6IZ@N_P#4'ZT 3+]Q?I2TB_<7Z4M !1110 44
M44 %%%% !1110 4444 4KC_C]B^E71TJE<?\?L7TJZ.E !1110 4444 %%%%
M !1110 4444 %5K;_6S?[U6:K6W^MF_WJ +-%%% !1110 4444 %%%% !111
M0 5%<?\ 'O)]*EJ*X_X]Y/I0 RR_X]D^E6*KV7_'LGTJQ0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC_OX:]#^R)?S'+]?78^M/M$7]\?G1]HB_OC\Z^2_[;U3_G_N/^_AH_MO5/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDWYJ6B@ HHHH **** "BBB@ HHHH **** "CM110!%'%L8G/6I:** "BBB@
MHHHH **** "BBB@ HHHH 0C((J.&'R@1GO4M% !1110 4444 %%%% !1110
M4444 %,E3S$VT^B@! , #TI:** "BBB@ HHHH **** "BBB@ HHHH AD@WS*
M^?NBIJ** "BBB@ HHHH **** "BBB@ HHHH *K6W^MF_WJLU6MO];-_O4 6:
M*** "BBB@ HHHH **** "BBB@ J*X_X]Y/I4M17'_'O)]* &67_'LGTJQ5>R
M_P"/9/I5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$>Y\D_\ "/:Q_P! VY_[]FC_ (1[6/\ H&W/_?LU];44?VQ+^4/J$>Y\D_\
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M7K;7;;S(B ZCYE!Z5R<$XT+QEY;<1S G'N:;E:S1I5Q7+R5(N\7H>BU6MO\
M6S?[U6%.5!]1FJ]M_K9O]ZK.XLT444 %%%% !1110 4444 %%%% !45Q_P >
M\GTJ6HKC_CWD^E #++_CV3Z58JO9?\>R?2K% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% "-]QOI5:P_X]O\ @1JRWW&^E5K#_CV_X$: +5%%% !1110
M4444 %%%% !1110 53O_ /5#ZBKE4[__ %0^HH MK]Q?I0>E"_<7Z4'I0!YY
MXB^(K:+J)M1&IP.XKJ_#6L'7=$AOR -Y/ KCO$OPVNM<U,W4=W$BD=&!KK_"
MVBOH.@PZ?)(LC1D_,O2N6E[;VCYMCW<<LN^I0]@_WFES:%+2"EKJ/""BBB@
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M_4Q_[HJ&V_ULW^]4Z#:BKZ#%06W^MF_WJW/=6Q9HHHH&%%%% !1110 4444
M%%%% !45Q_Q[R?2I:BN/^/>3Z4 ,LO\ CV3Z58JO9?\ 'LGTJQ0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWQ2T@I:ZCP@HHHH **** "BBB@"M)_Q^Q_2K-5I/^/V/Z59H **** "BBB@
MHHHH **** "BBB@ JJ/^/H5:S54?\?0H M4444 %%%% !1110 4444 %%%%
M!3)?]4WTI],E_P!4WTH BM?NFK%5[7[IJQ0 4444 %%%% !1110 4444 %%%
M% $%U]P5)%_JE^E1W7W!4D7^J7Z4 /HHHH **** "BBB@ I,4M% "8HQ2T4
M)BDR,XSS3JJN3]JH LXHQ2T4 )BEHHH 3%&*6B@ HHHH **** "DZ4M(>AH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P CI<?[B_UKLP-"->KRR['/B:KIPYD>N_\ "T]%_P">B?\ ?5'_  M/1?\
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M!G_D,WG^XO\ .O;Q_P ?0KQ\91C1J\D=CT,/4=2',RU1117*;A1110 4444
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M;?\ [[/^%'.@^N0[/[F=;17)?VMXH_Z!MO\ ]]G_  H_M;Q1_P! VW_[[/\
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M$Y&/[-M_^^S_ (5%#?\ B>$$#3K<Y/\ ?/\ A1SH/KD.S^YG945R7]K>*/\
MH&V__?9_PH_M;Q1_T#;?_OL_X4<Z#ZY#L_N9UM%<E_:WBC_H&V__ 'V?\*/[
M6\4?] VW_P"^S_A1SH/KD.S^YG6T5R7]K>*/^@;;_P#?9_PH_M;Q1_T#;?\
M[[/^%'.@^N0[/[F=;17)?VMXH_Z!MO\ ]]G_  H_M;Q1_P! VW_[[/\ A1SH
M/KD.S^YG6T5R7]K>*/\ H&V__?9_PH_M;Q1_T#;?_OL_X4<Z#ZY#L_N9UM07
M?^H/UKF?[6\4?] VW_[[/^%,EU+Q/(FTZ;;_ /?9_P *.=!]<AV?W,Z]?N+]
M*6N2&J^)P /[-M^/]L_X4?VMXH_Z!MO_ -]G_"CG0?7(=G]S.MHKDO[6\4?]
M VW_ .^S_A1_:WBC_H&V_P#WV?\ "CG0?7(=G]S.MHKDO[6\4?\ 0-M_^^S_
M (4?VMXH_P"@;;_]]G_"CG0?7(=G]S.MHKDO[6\4?] VW_[[/^%']K>*/^@;
M;_\ ?9_PHYT'UR'9_<SK:*Y+^UO%'_0-M_\ OL_X4?VMXH_Z!MO_ -]G_"CG
M0?7(=G]S.MHKDO[6\4?] VW_ .^S_A1_:WBC_H&V_P#WV?\ "CG0?7(=G]S.
M@N?^/V+Z5='2N-DO_$SRK(=.M\K_ +9_PJ7^UO%'_0-M_P#OL_X4<Z#ZY#L_
MN9UM%<E_:WBC_H&V_P#WV?\ "C^UO%'_ $#;?_OL_P"%'.@^N0[/[F=;17)?
MVMXH_P"@;;_]]G_"C^UO%'_0-M_^^S_A1SH/KD.S^YG6T5R7]K>*/^@;;_\
M?9_PH_M;Q1_T#;?_ +[/^%'.@^N0[/[F=;17)?VMXH_Z!MO_ -]G_"C^UO%'
M_0-M_P#OL_X4<Z#ZY#L_N9UM%<E_:WBC_H&V_P#WV?\ "C^UO%'_ $#;?_OL
M_P"%'.@^N0[/[F=;5:V_ULW^]7-_VMXH_P"@;;_]]G_"F1ZCXGC9C_9UO\QS
M]\_X4<Z#ZY#L_N9V%%<D=6\3@9_LVW_[[/\ A5_0-:N=2FN(+N)(YH1\P4YI
MJ294,5"4E&S3?=&]1115'2%%%% !1110 4444 %17'_'O)]*EJ*X_P"/>3Z4
M ,LO^/9/I5BJ]E_Q[)]*L4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR^GBJ=7FE*UUIH14445ZY\R%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444"/4/@Q_P AF\_W%_G7MX_X^A7A_P &?^0S>?[B_P Z]P7_ (^A
M7S69_P"\,]G!_P )%JBBBO/.H**** "BBB@ HHHH **** "F2_ZIOI3Z9+_J
MF^E $5K]TU8JO:_=:K% !1110 4444 %%%% !1110 4444 077W!4D7^J7Z5
M'<_<%21?ZI?I0 ^BBB@ HHHH Y?6Q_Q5NC?4UT^T>@KF=;_Y&W1OJ:Z:ICNS
MEH?'4]?T0;1Z"C:/04M4-4UFPT:'SKZ=84]35'47MH]!1M'H*K:?J-KJEL+B
MSE$L1. PI][>0:?:275S((X8QEF/84 3;1Z"C:/051TK6;#6H&FT^X6:-3M)
M'8U?H 3:/04;1Z"EHH 3:/04;1Z"J-[K-AIUS;V]U.L<MPVR)3_$:)]9L+:_
MAL99U6XF4LB>HH O;1Z"C:/04H.1FB@!-H]!1M'H*6B@!-H]!1M'H*6B@!-H
M]!1M'H*R]6\1:7HB;M0NEA!]:S;/XA>&+^<0VVIQO(>@% '3;1Z"C:/04*RN
MH93D$9!I: $VCT%&T>@I:* $VCT%&T>@I:* $VCT%&T>@I:* $VCT%&T>@IL
MTJ00M+(VU%&2?2J-KKFGWD,LL%PKI$<.1VH T-H]!1M'H*JZ?J=IJD+2V<PE
M16*DCU%6^@H 3:/04;1Z"N=U'QWX<TF<PWNHQQ2#J#5K2/%6C:X2-.O$F(YX
MH V-H]!1M'H*6B@!-H]!1M'H*6B@!-H]!1M'H*6B@!-H]!1M'H*HVNLV%Y=/
M;03J\J'#*.QJ_0 FT>@HVCT%+10 FT>@HVCT%+5&XUBQM=1AT^:=5N9E+(AZ
MD"@"[M'H*-H]!2]1FB@!-H]!1M'H*6B@!-H]!1M'H*"0H)/05S]QXW\/VMS]
MGFU"-9<XVT =!M'H*-H]!45M=0WD"S0.'C;H14U ";1Z"C:/05G:KKVFZ+&)
M+^Y6%2< FF:5XBTO6P3I]TLV.N* -3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04
M;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EJ*2XBB=$=@&<X4>M $FT>@HVCT%4;
MK6K"SOXK&>=4N)5W(A[BKP((!'0T &T>@HVCT%+10 FT>@HVCT%+10 QU&QN
M!TKF?#__ ",NK?A73O\ <;Z5S'A__D9=6_"HENCEK_Q:?K^C.IHHHJSJ"BBB
M@ HHHH **** "HKC_CWD^E2U%<?\>\GTH 99?\>R?2K%5[+_ (]D^E6* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>-_\*7'_ #U;_OJC_A2X_P">K?\ ?5>R44?VAB/Y@^JTNQXW_P *7'_/5O\
MOJC_ (4N/^>K?]]5[)11_:&(_F#ZK2['C?\ PI<?\]6_[ZH_X4N/^>K?]]5[
M)11_:&(_F#ZK2['C?_"EQ_SU;_OJC_A2X_YZM_WU7LE%']H8C^8/JM+L>-_\
M*7'_ #U;_OJC_A2X_P">C?\ ?5>R44?VAB/Y@^JTNQP7@SP"/"]Y-.')\P =
M<UV2_P#'T*MU5'_'T*YJM6567-/<VA",%:):HHHK,H**** "BBB@ HHHH **
M** "F2_ZIOI3Z9+_ *IOI0!%:_=-6*KVOW35B@ HHHH **** "BBB@ HHHH
M**** (+G[@J2+_5+]*CNON"I(O\ 5+]* 'T444 %%%% ',:W_P C;HWU-=-7
M,ZW_ ,C;HWU-=-4QW9RT/CJ>OZ(6O)OCH[KX8.QB"0.GUKUFO*/C?SH"#_:7
M^=4=1%\%;Z:WTO\ L>Z=C, 9@'ZX/2K_ ,7-7FCM+71821_:.8V(ZBLB=_\
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MT-2U6'3--:]FSY:KN.!S7F/C*]34/&/A"Z0861F('YUV7C-@/!LQ)_Y9G^5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3))4B0O(X51U)-$4L<T:R1.'1N0RG(- #Z*** "BBB@ HHHH **** "BBB@
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MT#6K'5( GVFX+QC.<C!P:Q=,7QOX*A?2M.T>.^M%=F2620@\GVKV+I2%5/4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"]_J&J:7JNFM&#8*1Y;)G.3Z5A:QX=\3>++&*WN)(H;>%U?9Y6TEE^E>OT4
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M_"W?$/\ SVC_ .^*\\HKW/J=#^5'F?6*G<]#_P"%N^(?^>T?_?%'_"W?$/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\2O%\.KKI;IB[9MH3S#U_*OJ&:&(Q.3&A.T_PBOES657_A?5LNT;?M"\8^M
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MD_%?B_PMX6U1+&;1VFD8$CRXU[?A6Y\/?%?A_P 1W$@TRQ-M<*N6#* <?@*
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MW&O]E6V".FVI_P#A$?#_ /T";;_OFM*3_C]C^E6:7M9_S,.2'8Q/^$1\/_\
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MYX)^56**+!R1[%?[%;?\\$_*C[%;?\\$_*K%%%@Y(]BO]BMO^>"?E1]BMO\
MG@GY58HHL')'L5_L5M_SP3\J/L5M_P \$_*K%%%@Y(]BO]BMO^>"?E4-U96P
M@.(4Z^E7J@N_]0?K18.2/8:ME;;1^Y3IZ4OV*V_YX)^53K]Q?I2T6#DCV*_V
M*V_YX)^5'V*V_P">"?E5BBBP<D>Q7^Q6W_/!/RH^Q6W_ #P3\JL446#DCV*_
MV*V_YX)^5'V*V_YX)^56**+!R1[%?[%;?\\$_*C[%;?\\$_*K%%%@Y(]BO\
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M=2T*PU61'N[=)&3[I9<XH XG0_A3X92WL[T6$/G!5<-COBO188EAB6-!A5&
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MV3Z58H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD)"C). * %HK(O?$^DZ>^RXNT4].M6[/5+._0/;3J
MX/3F@"Y1110 4444 %%%% !114<\\=O$9)6"J.YH DHJ"VO(+M=T$@<>U3T
M%%07-W!9Q^9.X1<XR:?!/'<Q"6)@R'H10!)1110 4444 %%%(SJ@RS #W- "
MT4UI%1"['Y0,YJ"UO[:\+""4.5ZX- %FBBB@ HHHH **** "BBB@ HHHH **
M0G R:JP:C:W,YABE5I!U - %NBD9U099@/J:9)-''%YCL GK0!)15:VO[:[8
MB&4.1UP:LT %%%% !13))$B4L[!0.Y-8\WBW1H)_)DO%#YQB@#;HJ"WNX+I
M\,BN#Z&DN;V"T7,\@0>] %BBHH+B*YB$D+!D/<5+0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5',8EC+2[=@ZEAQ4E<O\0I9(/!
M.J2Q3-"ZPDAEZCD4 ="D-LZATBB(/((05,  , 8%>(^"/B_I-CHRVVKWKF5
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M+_JF^E/IDO\ JF^E $5K]UJL57M?NFK% !1110 4444 %%%% !1110 4444
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MB)\2WT%;DK:K*40]0!0![I:>/]!O+GR$O(E;.,LXQ7312QS1AXG5T/0J<BO
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M** "F2_ZIOI3Z9+_ *IOI0!%:_=:K%5[7[K58H **** "BBB@ HHHH ****
M"BBB@""Y^X*DB_U2_2H[G[@J2+_5+]* 'T444 %%%% !1110 4444 %%%% !
M51_^/JK=5'_X^J +=%%% !1110 4444 %%%% !1110 4AZ&EI#T- %:V_P!:
MU6JJVW^M:K5 !1110 4444 %%%% !1110 4444 (WW3]*J6/W6^IJVWW3]*J
M6/W6^IH N4444 %%%% !1110 4444 %%%% !4%W_ *@_6IZ@N_\ 4'ZT 3+]
MQ?I2TB_<7Z4M !1110 4444 %%%% !1110 4444 4KC_ (_8OI5T=*I7'_'[
M%]*NCI0 4444 %%%% !1110 4444 %%%% !5:V_ULW^]5FJUM_K9O]Z@"S11
M10 4444 %%%% !1110 4444 %17'_'O)]*EJ*X_X]Y/I0 RR_P"/9/I5BJ]E
M_P >R?2K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5\_?&[PK=0:Q;^([2-G2(H" .X(-?0-075I!>V[P
M7$:O&X((89H \F\(_&G1/[$CCU>1X;J-?F54R*X7Q9\1-5\5>+;5/#MQ.D"'
M;M3*AN1R:]7N/@MX/N96D>VG#,<G;+C^E:N@?#?PYX;N1<6%JPD'0R-NH Y7
MXC>'+[5_AQ;QR;I)X1YK<Y/W17-?"7XD6&CZ.-)U?= 8%"I\O)^M>]21)+&8
MW4%2,$$5Q&I_"3PIJM[)=SVTRRR')\N3:* /%OB+X@C\=>-;&/24>6)"JL=I
M[,*Z7XU:?_9G@'0[49.V4G_QT5ZGX?\ AUX=\-7/VC3[9O,QUD;=5[Q-X1TG
MQ;:PV^JQ.\<3;E"-C!H S?A\,?#?2^/^73_&O%OA,/\ B[&J9'>7_P!"-?1>
MFZ7;:5I<.G6JE;>)-B@G)Q6%H_P^T'0M8EU2QAD6ZESN+/D<G)H \Q_:/!^Q
M:/@?QM_(UL>(?^2%VW_7./\ D:[_ ,3^"]'\7)"FK1.ZPDE-K8J:Y\*Z9=^'
MUT26-S9*  H;GCIS0!X)\'/&EMH$LUMJ0>.W.=CA<Y.:J?%_Q':^,]=L;;2=
M\S0$J?EKVP_"OPN=,73_ +-((58L"'PV3[T:-\*_"^A:@E]:6TAF0Y!D?<*
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MZ'!KG8/@QX0MYTF2WN"RG(#2Y% '"?!3P]=6NDZAJ-S&468!H\]ZY[X5@_\
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MX1?7?^@7<_\ ?%'M(=T')+L5H)%5.35>X(:4D=*DFL;NVDV3V\D;>C#%68-
MU:[A$T&GSR1GHRKD&O+PV!H4,3*NIW;/HLPSC%8K 4\).G:,;6=F9E%:_P#P
MB^N?] NY_P"^*/\ A%]=_P"@7<_]\5ZGM(=SYWDEV,BBM?\ X1?7?^@7<_\
M?%'_  B^N_\ 0+N?^^*/:0[H.278R**U_P#A%]=_Z!=S_P!\4?\ "+Z[_P!
MNY_[XH]I#N@Y)=C(HK7_ .$7UW_H%W/_ 'Q1_P (OKO_ $"[G_OBCVD.Z#DE
MV,BBM;_A&=;#8_LRYR>VRE_X1?7?^@7<_P#?%'M(=T')+L9%%:__  B^N_\
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MR2[&12UK?\(OKO\ T"[G_OBC_A%]<_Z!=S_WQ1[2'=!R2['TCX&_Y$G2?^N
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M4M]KMM9:%_:S!S!MW<#)H U:*X_PG\0=-\6W<EO9),K1YSYD97I784 %%%%
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MJ8)!]Z /4**** "BBB@ HHHH :_W&^E5[#_CV_X$:LM]QOI5:P_X]O\ @1H
MM4444 %%%% !1110 4444 %%%% !5.__ -4/J*N53O\ _5#ZB@"VGW%^E!Z4
M+]Q?I0>E 'A'CS3KZ;7RT43%<=17IOP\AE@\'6L<P*N"<@UNS_V;O_?FVW?[
M97-6(/)\H?9]GE]MF,5RTJ"A4<[[GN8W-I8G!PPSA;EZDHI:04M=1X84444
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MCJ  /PH ]9HHHH **** "BBB@!&^XWTJM8?\>W_ C5EON-]*K6'_ ![?\"-
M%JBBB@ HHHH **** "BBB@ HHHH *IW_ /JA]15RJ=__ *H?44 6U^XOTH/2
MA?N+]*4]* /!/'KWHU]A$7VX[&O3_AV93X-M3+G?DYS6U<:7I4\N^XMX'?U;
MK5NU@@MX!%;(B1#H%Z5RTZ#A4<[[GNX[-88G!0PRA9QZDPI:**ZCP@HHHH *
M*** "BBB@"M)_P ?L?TJS5:3_C]C^E6: "BBB@ HHHH **** "BBB@ HHHH
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MG@+58KBWDBD8MA77!/RFN;^">F7UGX[UF6YM)HD9#M9U(!^8U] 1PQQ*510
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MFP;_ %H \)^.VFWM[XCTE[:UEF54&2BDX^85H?$/P[J6K_#?3X[1'\R$AW0
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M;-6'R>20VX5[%\';6>T\#V<=Q$\3A.5<8-=Y]D@\KR_+&P'.*DCC2)=J# %
M#Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ;(@DC9#T88.*Y/_ (5WI&[4CYEUG4$V2_OCP,YX]*ZZH&O($;:T@!%
M'G)^!WA<#/GZC_X$M4G@_P -^&?#GBNXM-,ENVO1$"XFF+#;]#7?O?6VQOWH
MZ5Y1X<=9/C=J;(<C[&O\S0![#1110 45#-=0P8\UPN?6HO[3L_\ GLM %NBH
MX9XYUW1L&'J*DH 1ON-]*K6'_'M_P(U8<_(WTKBK[Q]IN@W;V-RZ"1>3D^M7
M"G*H[15R9245>1V]%<!_PM?1?^>L?_?5'_"U]%_YZQ_]]5K]4K?RLCV]/N=_
M17 ?\+7T7_GK'_WU1_PM?1?^>L?_ 'U1]4K?RL/;T^YW]%<!_P +7T7_ )ZQ
M_P#?5'_"U]%_YZQ_]]4?5*W\K#V]/N=_17 ?\+7T7_GK'_WU1_PM?1?^>L?_
M 'U1]4K?RL/;T^YW]%<!_P +7T7_ )ZQ_P#?5'_"U]%_YZQ_]]4?5*W\K#V]
M/N=_5.__ -4/J*XS_A:^B_\ /6/_ +ZJO=?%+1I4 $L?7^]1]4K?RL/;T^YZ
M,OW%^E!Z5Y^OQ6T4*!YL?3^]2_\ "U]%_P">L?\ WU1]4K?RL/;T^YQ'CO4;
M^'7BL,LH7'16->F?#V>6?P?:R3,S2$G)8\UR5YXN\&W\WG7,$$C^I-7[+XD>
M'=.M5MK4Q1Q+T4&N6EEV(C4<VM&>[CL[PF(P4,/!6E'J>D"EKS__ (6MHO\
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MBB@ HHHH **** $;[I^E5+'[K?4U;;[I^E5+'[K?4T 7**** "BBB@ HHHH
M**** "BBB@ J"[_U!^M3U!=_Z@_6@"9?N+]*6D7[B_2EH **** "BBB@ HHH
MH **** "BBB@"E<?\?L7TJZ.E4KC_C]B^E71TH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110!2N/^/V+Z5='2J5Q_Q^Q?2KHZ4 %%%% !1110 4444
M%%%% !1110 56MO];-_O59JM;?ZV;_>H LT444 %%%% !1110 4444 %%%%
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MTD<Y#/OW9_&@"U\9+?6UUE9+R20V[$; 3QUXKL_A/#XEM/"]Y=74TOV#R?\
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M7$DMWNDB5R-_&2*[+PS\/=$\*NSV41=ST:09(^E &)\1]8U[2](BLM&A9IG
MS.K8*FO.;NP^)=IHSZE)JUV BEV3>.!^5=?\7O'EUX:O;/3+.&%Y;E<@R(#C
MG']:YG6?"7BB^\/SZEJ^IPQ0>3YBI%/M!XSC&: .N^#OC>\\4Z3<PWKEYK4
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MJ]CQ:BO:?^%+Q?\ /0_]]T?\*7B_YZ'_ +[H_M'#]P^J5>QXM17M/_"EXO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.E !1110 4444 %%%% !1110 4444 %5K;_6S?[U6:K6W^MF_P!Z@"S1110
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M@RC CVH9U099@!0 ZBL;7]6&G:-+=Q."5( /UK&EU75H?#\%VTG[UI<L=O\
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M*/,@:.W8\3LPVF@#NJ*AM;J&\MUF@<.C $$5-0 C_<;Z56L/^/;_ ($:L/\
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M='2@ HHHH **** "BBB@ HHHH **** "JUM_K9O]ZK-5K;_6S?[U %FBBB@
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M&R?_ *X&O-:]*^"O_(V3_P#7 URXW_=Y^AOA_P"+$]^[TM)WI:^4/<"BBB@
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MH?\ T"[7_OBC_A%]#_Z!=K_WQ7I_VO#^5G']0EW/DVBOK+_A%]#_ .@7:_\
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MOE+:M!:,P0S ]CQ75AVY/DBE?S,:J2U9T/A35Y-7TA)IN9<D$_2MUW"1EF/
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MBBB@ HHHH **** *TG_'[']*LU6D_P"/V/Z59H **** "BBB@ HHHH ****
M"BBB@ JJ/^/H5:JJ/^/H4 6J*** "BBB@ HHHH **** "BBB@ IDO^J;Z4^F
M2_ZIOI0!%:_=:K%5[7[IJQ0 4444 %%%% !1110 4444 %%%% $%S]P5)%_J
ME^E1W/W!4D7^J7Z4 /HHHH **** "BBB@ HHHH **** "JC_ /'U5NJC_P#'
MU0!;HHHH **** "BBB@ HHHH **** "D/0TM(>AH K6W^M:K55;;_6M5J@ H
MHHH **** "BBB@ HHHH **** $;[I^E5+'[K?4U;;[I^E5+'[K?4T 7****
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M^$CU^>Q31X+)4BW[DR"?SKD@BOX4M]372G6;2PL$J-$,N3R3C'/2MGP'JO\
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M_?0KY)^WWG_/W/\ ]_#1]OO/^?N?_OX:/[(_O?@'U_\ NGUM_:5G_P _$?\
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MU ^?'_WT*^4OM]Y_S]S_ /?PT?;KS_G[G_[^&C^R/[WX!]?_ +I];?VE9_\
M/Q'_ -]"C^TK/_GXC_[Z%?)/V^\_Y^Y_^_AH^WWG_/W/_P!_#1_9'][\ ^O_
M -T^MO[2L_\ GXC_ .^A1_:5G_S\1_\ ?0KY)^WWG_/W/_W\-'V^\_Y^Y_\
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MU2_2H[K[@J2+_5+]* 'T444 %%%% !1110 4444 %%%% !51_P#CZJW51_\
MCZH MT444 %%%% !1110 4444 %%%% !2'H:6D/0T 5K;_6M5JJMM_K6JU0
M4444 %%%% !1110 4444 %%%% "-]T_2JEC]UOJ:MM]T_2JEC]UOJ: +E%%%
M !1110 4444 %%%% !1110 5!=_Z@_6IZ@N_]0?K0!,OW%^E+2+]Q?I2T %%
M%% !1110 4444 %%%% !1110!2N/^/V+Z5='2J5Q_P ?L7TJZ.E !1110 44
M44 %%%% !1110 4444 %5K;_ %LW^]5FJUM_K9O]Z@"S1110 4444 %%%% !
M1110 4444 %17'_'O)]*EJ*X_P"/>3Z4 ,LO^/9/I5BJ]E_Q[)]*L4 %%%%
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ME7-B6^51>YM16K9)1117&= 4444 %%%% !1110 4444 %%%% !1110 4444
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MEQ_N+_6OIA_N-]*^9_B;_P CI<?[B_UKTLJ_COT./'?PSCZ***^C/("BBB@
MHHHH **** "BBB@ HHHH ****8R19748!Q36)8Y)R:MPPJR9-5YU"RD"O(PN
M,P]7%2I4X6DMV?29AE>-P^ IXBM4O"5K*[T(J***]8^;"BBB@04444 %%%%
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MHH *@N_]0?K4]07?^H/UH F7[B_2EI%^XOTI: "BBB@ HHHH **** "BBB@
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M_P!\T?\ "(>(?^@3<_\ ?-?5]%']KS_E0?4(]SY0_P"$0\0_] FY_P"^:/\
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M1_PB'B'_ *!-S_WS7U?11_:\_P"5!]0CW/E#_A$/$/\ T";G_OFC_A$/$/\
MT";G_OFOJ^BC^UY_RH/J$>Y\G_\ "):^&V_V5<Y/;;2_\(AXA_Z!-S_WS7U-
M)_Q^Q_2K-']KS_E0?4(]SY0_X1#Q#_T";G_OFC_A$/$/_0)N?^^:^KZ*/[7G
M_*@^H1[GRA_PB'B'_H$W/_?-'_"(>(?^@3<_]\U]7T4?VO/^5!]0CW/E#_A$
M/$/_ $";G_OFC_A$/$/_ $";G_OFOJ^BC^UY_P J#ZA'N?*'_"(>(?\ H$W/
M_?-'_"(>(?\ H$W/_?-?5]%']KS_ )4'U"/<^4/^$0\0_P#0)N?^^:/^$0\0
M_P#0)N?^^:^KZ*/[7G_*@^H1[GRA_P (AXA_Z!-S_P!\TG_")Z_G']E7.?\
M=KZPJJ/^/H4?VO/^5!]0CW/EK_A$/$/_ $";G_OFC_A$/$/_ $";G_OFOJ^B
MC^UY_P J#ZA'N?*'_"(>(?\ H$W/_?-'_"(>(?\ H$W/_?-?5]%']KS_ )4'
MU"/<^4/^$0\0_P#0)N?^^:/^$0\0_P#0)N?^^:^KZ*/[7G_*@^H1[GRA_P (
MAXA_Z!-S_P!\T?\ "(>(?^@3<_\ ?-?5]%']KS_E0?4(]SY0_P"$0\0_] FY
M_P"^:/\ A$/$/_0)N?\ OFOJ^BC^UY_RH/J$>Y\H?\(AXA_Z!-S_ -\T'PCX
M@ R=)N?^^:^KZ9+_ *IOI1_:\_Y4'U"/<^4AX2U]NFE7)_X#3O\ A$/$./\
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M 4444 %%%% %:3_C]C^E6:K2?\?L?TJS0 4444 %%%% !1110 4444 %%%%
M!54?\?0JU54?\?0H M4444 %%%% !1110 4444 %%%% !3)?]4WTI],E_P!4
MWTH BM?NFK%5[7[IJQ0 4444 %%%% !1110 4444 %%%% $%S]P5)%_JE^E1
MW/W!4D7^J7Z4 /HHHH **** "BBB@ HHHH **** "JC_ /'U5NJC_P#'U0!;
MHHHH **** "BBB@ HHHH **** "D/0TM(>AH K6W^M:K55;;_6M5J@ HHHH
M**** "BBB@ HHHH **** $;[I^E5+'[K?4U;;[I^E5+'[K?4T 7**** "BBB
M@ HHHH **** "BBB@ J"[_U!^M3U!=_Z@_6@"9?N+]*6D7[B_2EH **** "B
MBB@ HHHH **** "BBB@"E<?\?L7TJZ.E4KC_ (_8OI5T=* "BBB@ HHHH **
M** "BBB@ HHHH *K6W^MF_WJLU6MO];-_O4 6:*** "BBB@ HHHH **** "B
MBB@ J*X_X]Y/I4M17'_'O)]* &67_'LGTJQ5>R_X]D^E6* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** $;[C?2JUA_P >W_ C5E_N-]*K6'_'M_P(T 6J
M*** "BBB@ HHHH **** "BBB@ JG?_ZH?45<JG?_ .J'U% %M?N+]*4]*1?N
M+]*#TH \\\0_#I=:U$W1F=<CH*ZOPSHXT+1(; ,6\LGDU@ZW\1[#1+TVLUO*
MS =5-=%H&LQ:]I,5_"C(DA. W6N:FJ/M'R[GLXR>8O"05=?N^AJ"EI!2UTGC
M!1110 4444 %%%% %:3_ (_8_I5FJTG_ !^Q_2K- !1110 4444 %%%% !11
M10 4444 %51_Q]"K551_Q]"@"U1110 4444 %%%% !1110 4444 %,E_U3?2
MGTR7_5-]* (K7[IJQ5>U^ZU6* "BBB@ HHHH **** "BBB@ HHHH @NON"I(
MO]4OTJ.Y^X*DB_U2_2@!]%%% !1110 4444 %%%% !1110 54?\ X^JMU4?_
M (^J +=%%% !1110 4444 %%%% !1110 4AZ&EI#T- %:V_UK5:JK;?ZUJM4
M %%%% !1110 4444 %%%% !1110 C?=/TJI8_=;ZFK;?=/TJI8_=;ZF@"Y11
M10 4444 %%%% !1110 4444 %07?^H/UJ>H+O_4'ZT 3+]Q?I2TB_<7Z4M !
M1110 4444 %%%% !1110 4444 4KC_C]B^E71TJE<?\ '[%]*NCI0 4444 %
M%%% !1110 4444 %%%% !5:V_P!;-_O59JM;?ZV;_>H LT444 %%%% !1110
M 4444 %%%% !45Q_Q[R?2I:BN/\ CWD^E #++_CV3Z58JO9?\>R?2K% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM+L>1?\ "F+?_GH?^^Z/^%,6_P#ST/\ WW7KM%'U^O\ S!]5I=CR+_A3%O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?I45S]P5)%_JE^E $E%)10 M%)10 M%)10 M%)10 M%)10 M5'_X^JM55?\
MX^J +=%)10 M%)10 M%)10 M%)10 M%)10 M(>AHI">#]* *]M_K6JU56V_U
MK5:H **** "BBB@ HHHH **** "BBB@!&^Z?I52Q^ZWU-6V^Z?I52Q^ZWU-
M%RBBB@ HHHH **** "BBB@ HHHH *@N_]0?K4]07?^H/UH F7[B_2EI%^XOT
MI: "BBB@ HHHH **** "BBB@ HHHH I7'_'[%]*NCI5*X_X_8OI5T=* "BBB
M@ HHHH **** "BBB@ HHHH *K6W^MF_WJLU6MO\ 6S?[U %FBBB@ HHHH **
M** "BBB@ HHHH *BN/\ CWD^E2U%<?\ 'O)]* &67_'LGTJQ5>R_X]D^E6*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "L[4-;L-,=([JY2.1R JL>3FF^(+N^LM$N;C38%G
MNT7,<;G 8UX/K5MK[^(K.\UTF&5I$VP*^Y<%A0!]%*0RAAT(R*S[S6["QOX;
M*>X1)YAE$)Y-5]6N=0M=#WZ; DUSY0V(QP"<5XK-INMV_P 1M'O-:E?SKI6<
M0[LK'ST% 'T$"&4$=",TM1P?ZB/_ '1_*I* $?[C?2O$?&7CW6-!\136-G.4
MA500 /6O;G^XWTKYG^)O_(Z7'^XO]:]#+:<9UFI*^AR8R3C3NBW_ ,+6\1?\
M_3?E1_PM;Q%_S]-^5<)17N_5:/\ *CS?;U.YW?\ PM;Q%_S]-^5'_"UO$7_/
MTWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_ "H/
M;U.YW?\ PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]
M-^5'_"UO$7_/TWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5,D^*/B"48:Z8_
MA7#T4?5:/\J#V]3N=V/BMXB Q]J;\J/^%K>(O^?IORKA**?U6C_*@]O4[G6S
M^+=5U"3SI;EMU6;?XCZ]IT(MHKI@B].*XP.X& 33223SR:\K"Y1[+$RJS::?
M0^DS'/J>)P%/#0IN,HVN^YW7_"UO$7_/TWY4?\+6\1?\_3?E7"45ZGU6C_*C
MYOV]3N=W_P +6\1?\_3?E1_PM;Q%_P _3?E7"44?5:/\J#V]3N=W_P +6\1?
M\_3?E1_PM;Q%_P _3?E7"44?5:/\J#V]3N=W_P +6\1?\_3?E1_PM;Q%_P _
M3?E7"44?5:/\J#V]3N=R?BGXA,@?[4V1[4[_ (6MXB_Y^F_*N$HH^JT?Y4'M
MZG<[O_A:WB+_ )^F_*C_ (6MXB_Y^F_*N$HH^JT?Y4'MZG<[O_A:WB+_ )^F
M_*C_ (6MXB_Y^F_*N$HH^JT?Y4'MZG<[O_A:WB+_ )^F_*C_ (6MXB_Y^F_*
MN$HH^JT?Y4'MZG<[O_A:WB+_ )^F_*C_ (6MXB_Y^F_*N$HH^JT?Y4'MZG<[
MO_A:WB+_ )^F_*C_ (6MXB_Y^F_*N$HH^JT?Y4'MZG<[O_A:WB+_ )^F_*F?
M\+2\0[]WVIL_2N'HH^JT?Y4'MZG<[O\ X6MXB_Y^F_*C_A:WB+_GZ;\JX2BC
MZK1_E0>WJ=SN_P#A:WB+_GZ;\J/^%K>(O^?IORKA**/JM'^5![>IW.[_ .%K
M>(O^?IORH_X6MXB_Y^F_*N$HH^JT?Y4'MZG<[O\ X6MXB_Y^F_*C_A:WB+_G
MZ;\JX2BCZK1_E0>WJ=SN_P#A:WB+_GZ;\J/^%K>(O^?IORKA**/JM'^5![>I
MW.[_ .%K>(O^?IORI#\5?$1&#=-S[5PM%'U6C_*@]O4[G<I\4_$*#BZ;\J=_
MPM;Q%_S]-^5<)11]5H_RH/;U.YW?_"UO$7_/TWY4?\+6\1?\_3?E7"44?5:/
M\J#V]3N=W_PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_*@]O4[G=_\+6\1?\_3
M?E1_PM;Q%_S]-^5<)11]5H_RH/;U.YW?_"UO$7_/TWY4?\+6\1?\_3?E7"44
M?5:/\J#V]3N=W_PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_*@]O4[G<O\4_$+
MC!NF_*E'Q5\1* !=-Q[5PM%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5'_"UO$7_/
MTWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_ "H/
M;U.YW?\ PM;Q%_S]-^5'_"UO$7_/TWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]
M-^5'_"UO$7_/TWY5PE%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5'_"UO$7_/TWY5
MPE%'U6C_ "H/;U.YW?\ PM;Q%_S]-^5,/Q2\0E]WVIL_2N'HH^JT?Y4'MZG<
M[O\ X6MXB_Y^F_*C_A:WB+_GZ;\JX2BCZK1_E0>WJ=SN_P#A:WB+_GZ;\J/^
M%K>(O^?IORKA**/JM'^5![>IW.[_ .%K>(O^?IORH_X6MXB_Y^F_*N$HH^JT
M?Y4'MZG<[O\ X6MXB_Y^F_*C_A:WB+_GZ;\JX2BCZK1_E0>WJ=SN_P#A:WB+
M_GZ;\J/^%K>(O^?IORKA**/JM'^5![>IW.\_X6MXB_Y^F_*O4_AEXBOO$FC7
M=Q?2%WCEVJ3Z8KYPKW?X(_\ (N7_ /UW'\C7%F&'I0H.48V9TX2K.52S9Z1;
M?ZUJM55MO]:U6J^?/4"BBB@ HHHH **** "BBB@ HHHH 1ONGZ54L?NM]35M
MONGZ54L?NM]30!<HHHH **** "BBB@ HHHH **** "H+O_4'ZU/4%W_J#]:
M)E^XOTI:1?N+]*6@ HHHH **** "BBB@ HHHH **** *5Q_Q^Q?2KHZ52N/^
M/V+Z5='2@ HHHH **** "BBB@ HHHH **** "JUM_K9O]ZK-5K;_ %LW^]0!
M9HHHH **** "BBB@ HHHH **** "HKC_ (]Y/I4M17'_ ![R?2@!EE_Q[)]*
ML57LO^/9/I5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW;X(_P#(N7__ %W'\C7GYG_N[^1UX/\ BGI%M_K6JU56V_UK5:KYH]@****
M"BBB@ HHHH **** "BBB@!&^Z?I52Q^ZWU-6V^Z?I52Q^ZWU- %RBBB@ HHH
MH **** "BBB@ HHHH *@N_\ 4'ZU/4%W_J#]: )E^XOTI:1?N+]*6@ HHHH
M**** "BBB@ HHHH **** *5Q_P ?L7TJZ.E4KC_C]B^E71TH **** "BBB@
MHHHH **** "BBB@ JM;?ZV;_ 'JLU6MO];-_O4 6:*** "BBB@ HHHH ****
M "BBB@ J*X_X]Y/I4M17'_'O)]* &67_ ![)]*L57LO^/9/I5B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[]BFR>']'$;'^S;;I_SS%:M,E_U3?2CGEW#ECV,BV\/Z05.=-MC_ -LQ4_\
MPCVC_P#0-MO^_8JW:_=-6*.>7<.6/8S/^$>T?_H&VW_?L4?\(]H__0-MO^_8
MK3HHYY=PY8]C,_X1[1_^@;;?]^Q1_P (]H__ $#;;_OV*TZ*.>7<.6/8S/\
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MK3HHYY=PY8]C,_X1[1_^@;;?]^Q1_P (]H__ $#;;_OV*TZ*.>7<.6/8S/\
MA'M'_P"@;;?]^Q1_PCVC_P#0-MO^_8K3HHYY=PY8]C,_X1[1_P#H&VW_ '[%
M'_"/:/\ ] VV_P"_8K3HHYY=PY8]C,_X1[1_^@;;?]^Q5JVL;6QC9+6".%3R
M0BXS5FD/0T.4GNQJ*6Q6MO\ 6M5JJMM_K6JU4C"BBB@ HHHH **** "BBB@
MHHHH 1ONGZ54L?NM]35MONGZ54L?NM]30!<HHHH **** "BBB@ HHHH ****
M "H+O_4'ZU/4%W_J#]: )E^XOTI:1?N+]*6@ HHHH **** "BBB@ HHHH **
M** *5Q_Q^Q?2KHZ52N/^/V+Z5='2@ HHHH **** "BBB@ HHHH **** "JUM
M_K9O]ZK-5K;_ %LW^]0!9HHHH **** "BBB@ HHHH **** "HKC_ (]Y/I4M
M17'_ ![R?2@!EE_Q[)]*L57LO^/9/I5B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4444 %(>AI:0]#0!6MO]:U6JJVW^M:K5 !1110
M4444 %%%% !1110 4444 (WW3]*J6/W6^IJVWW3]*J6/W6^IH N4444 %%%%
M !1110 4444 %%%% !4%W_J#]:GJ"[_U!^M $R_<7Z4M(OW%^E+0 4444 %%
M%% !1110 4444 %%%% %*X_X_8OI5T=*I7'_ !^Q?2KHZ4 %%%% !1110 44
M44 %%%% !1110 56MO\ 6S?[U6:K6W^MF_WJ +-%%% !1110 4444 %%%% !
M1110 5%<?\>\GTJ6HKC_ (]Y/I0 RR_X]D^E6*KV7_'LGTJQ0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<:G9&\B/VF+@?WQ5P:I98_X^HO\ OL4<K[!=%RBJ?]J67_/U%_WV*/[4LO\
MGZB_[[%'*^P71<HJG_:EE_S]1?\ ?8H_M2R_Y^HO^^Q1ROL%T7**I_VI9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;+G_ )^9O^_AJ"BBR"[)_MES_P _,W_?PT?;+G_GYF_[^&H**+(+LG^V7/\
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M&C[9<_\ /S-_W\-0446079/]LN?^?F;_ +^&C[9<_P#/S-_W\-0446079/\
M;+G_ )^9O^_AH^V7/_/S-_W\-0446079/]LN?^?F;_OX:/MES_S\S?\ ?PU!
M119!=D_VRY_Y^9O^_AH^V7/_ #\3?]]FH**+(+LG^V7/_/S-_P!_#1]LN?\
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M9/\ ;+G_ )^9O^_AH^V7/_/S-_W\-0446079/]LN?^?F;_OX:/MES_S\S?\
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MZ4 ,LO\ CV3Z58JO9?\ 'LGTJQ0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y#X*_Y*1=_6
M2O7JY;2/!\>EZ_+JBR*6?=P/>@"SXM\46OAC2FN9F'F$$1KZFO/M T:;Q=J*
M:[K]Y"MN3N@@$HP5/]Y<]:ZOQMX#/BYX"URL8A?<H(-8*?"F^C0(NJQA1T !
MH ]-M!;K;JEL4,:C:-A!''TJ>L/PMH<V@:5]DFG$S;RVX5N4 (_W&^E?,_Q-
M_P"1TN/]Q?ZU]+O]QOI7B'C/P/J>M^(YKVVC8QLH (7TKT,MG&%:\G;0Y,9%
MRIV1Y/17<?\ "L-:_P">3_\ ?-'_  K#6O\ GD__ 'S7O?6J/\R/,]C4['#T
M5W'_  K#6O\ GD__ 'S1_P *PUK_ )Y/_P!\T?6J/\R#V-3L</17<?\ "L-:
M_P">3_\ ?-'_  K#6O\ GD__ 'S1]:H_S(/8U.QP]%=Q_P *PUK_ )Y/_P!\
MT?\ "L-:_P">3_\ ?-'UJC_,@]C4['#T5W'_  K#6O\ GD__ 'S1_P *PUK_
M )Y/_P!\T?6J/\R#V-3L</17<?\ "L-:_P">3_\ ?-1R?#768AEHG_[YH^M4
M?YD'L:G8XNBNX'PQUHC/E/\ ]\T?\*PUK_GD_P#WS1]:H_S(/8U.QQJP.XR*
MC=2C;3UKN5^'^N0C;]DE;W"TUOAOK4QW^0ZY[%:\?!YI4J8J5.I906Q]1F64
M8.AEU.O0E>H[75_7H<-17<?\*QUK_GD__?-'_"L-:_YY/_WS7L?6J/\ ,CY?
MV-3L</17<?\ "L-:_P">3_\ ?-'_  K#6O\ GD__ 'S1]:H_S(/8U.QP]%=Q
M_P *PUK_ )Y/_P!\T?\ "L-:_P">3_\ ?-'UJC_,@]C4['#T5W'_  K#6O\
MGD__ 'S1_P *PUK_ )Y/_P!\T?6J/\R#V-3L</17:GX::R) GE/D_P"S3_\
MA6&M?\\G_P"^:/K5'^9![&IV.'HKN/\ A6&M?\\G_P"^:/\ A6&M?\\G_P"^
M:/K5'^9![&IV.'HKN/\ A6&M?\\G_P"^:/\ A6&M?\\G_P"^:/K5'^9![&IV
M.'HKN/\ A6&M?\\G_P"^:/\ A6&M?\\G_P"^:/K5'^9![&IV.'HKN/\ A6&M
M?\\G_P"^:/\ A6&M?\\G_P"^:/K5'^9![&IV.'HKN/\ A6&M?\\G_P"^:/\
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M['#T5W'_  K#6O\ GD__ 'S1_P *PUK_ )Y/_P!\T?6J/\R#V-3L</17<?\
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M6O\ GD__ 'S1_P *PUK_ )Y/_P!\T?6J/\R#V-3L</17<?\ "L-:_P">3_\
M?-,/PTUD/M\I\_[M'UJC_,@]C4['%45W'_"L-:_YY/\ ]\T?\*PUK_GD_P#W
MS1]:H_S(/8U.QP]%=Q_PK#6O^>3_ /?-'_"L-:_YY/\ ]\T?6J/\R#V-3L</
M17<?\*PUK_GD_P#WS1_PK#6O^>3_ /?-'UJC_,@]C4['#T5W'_"L-:_YY/\
M]\T?\*PUK_GD_P#WS1]:H_S(/8U.QP]%=Q_PK#6O^>3_ /?-'_"L-:_YY/\
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M3_\ ?-'_  K#6O\ GD__ 'S1]:H_S(/8U.QP]%=Q_P *PUK_ )Y/_P!\T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6B@!**6B@!**6B@!**6B@!**6B@""Y^X*DB_U2_2H[K[@J2+_5+]* '44M%
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M444 %%%% !37&Y"/6G44 101F,$&I:** "BBB@ HHHH **** "BBB@ HHHH
MBF0NH IZ#:@'I3J* "BBB@ HHHH **** "BBB@ HHHH *@:(F??4]% !1110
M 4444 %%%% !1110 4444 %!Z444 00QE')/>IZ** "BBB@ HHHH **** "B
MBB@ HHHH 0\@U!;1&($'N:L44 %%%% !1110 4444 %%%% !1110 5'.ADBV
MCUJ2B@!!PH'M2T44 %%%% !1110 4444 %%%% !1110!7EA+W$;CHHJQVHHH
M **** "BBB@ HHHH **** "BBB@ J&&,H\A/\1S4U% !1110 4444 %%%% !
M1110 4444 %,E4O$RCN*?10!%;QF.%5/85+110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'E>L#[)\;-*N9OE@^QR R-PH.1WJQXEFCU/Q=8
MPVK"1HI5=BASQ7::YX<L==C N8@7'1O2JVA^$=/T6X:ZCC!N7&TO[=J%NK]
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MKK"2XB!F'1Z-!\+6&@M++;Q 7$H_>/\ WJ:=FGV%)73-VBBB@84444 %%%%
M!2$!AA@"#V-+10!YKXD 7XF:>%  ^SGI]178:[K]IX?TT7%RX&5^49Y)I;SP
M];7NM0ZG(H\V)-@/M53Q-X1M?$L=NMQC]P^],]C2Z6#J<OI5O+XHU1-<U2>)
M8H@3:1!\':?[P]<U+\.)H-(TO4;:ZF2*0W<L@5F .W)K5M? J6TJNLZX7M@U
M8U/P-IFHW*W)C"W&T(S^J^E#78#+\(,+KQMKU['S!*J[&'0\UWU9NCZ'9:':
M+;V<01 ,5I4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ***,T %%%% !1110 4444 %%%&: "BBB@ HHHH **** "BBB@ HHI
M,T +1110 444F: %HHHH **** "BBB@ HHHH **** "BBB@ HI,TM !1110
M4444 %%%% !1110 44F:6@ HHHH ***0]* ,>[\.:5>S>;<6T3OZD5?L;."Q
MM5@MD5(UZ!1Q7F'BSQ!XFL]7,5C$S18ZB/-=QX.N[V]\-V\^H*5N&)W C%<\
M*D'-Q2U/7Q>"Q%+"QJSJ)Q?2_P"AT I:04M=!Y 444F: %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)BEHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $Q2T44 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 !JM=7L%E%YEQ($7U-6
M:XGXER-'X==E8J01R/K45)\D7(ZL%AUB,1&DW:[L=A#<131>9&X9#WJ"/4[2
M6X>!)@9$^\OI7(^'_%&GPZ L<LW[S;W/M6)X7O1=^+]1D61FB+#'-9.NO=MU
M.^.4R2JN=TH;>>IZ5;ZG:74S10S!G4X(':KE>?>%9]/&MW[02S,Z2,6#]!BI
M;OXAP_:9$LXW=8_O?(33C77+>1G4RNJZKIT4W9+?S.\IJNK=#FN.N/%\=[X8
MNKR".=9(E^8&,@_A6!\./$,UQ-<6\YE?+M)O8' 'IFAXB/,H]Q1RFNZ%2M+3
MD=K'J5%<1K'Q MK.[:UM(Y)I4^]L0L/TK0T'QA9:T&1=Z3H/F1UV\U2K0;Y4
MS&>6XJ%+VLH.QT]5+F^MK65(YI KR'Y0>]<;<?$>T@NI;<1RO(N0 L9-1ZKJ
M5KJ$FA75T9HI)22JA2/SJ77C;W6;4\JKJ2]M%I._Y7/0%(901T-+7-ZQXILM
M M(Q*69V4;549)K,TKQ['=7ZVMS!,C.<(?*(%4ZT$^5O4QAEV)G3=6,?=.WI
M"0!FN5UWQA'IDZVT4,KS-TQ&2*AT'QM;ZQ/)9NKI<!2<%<<4>VAS<M]0678E
MTO;<ONG30ZA;3W#P1RAI$^\OI5JO/_"[LWC?6E+$J-N 3[UVFJ"Y-@_V3'G#
MD9-%.IS1N+%814:RII[I/[U<NT5YS%XXU'2KQH=;M2L8Z-$A/ZUT\>M+KVDS
M/H[!IL?*'XQ1&M&6VY5;+:]&SFO=?7I]Y>GUJPMYA#+<*KGM5HW,0@,Y<>6!
MDM7F+>"Y8=.N[[6[Z1+G<S($DX]J=X=O+Z7P%J0F9C&D+>6Y/)Y%9JO).TD=
MT\JHN'/1J7LTGVU[=STRUNX;M-T,@=?45/7$_#:1Y-&<NQ8Y'4UVU;4Y\\5(
M\O&8=8>O*DG>PQF"*23@"LE_%&D13^0]X@DSC%4O'+W">%KPVY<.(^"G6O-M
M(M/#]]9^7/>7:7K#DOQ\WU-8U:SC+E1Z.7Y93KT'7J-VO;17^;/:H)X[B,21
ML&4]#4M<)X4M;_0M/N9;NY2:WC0LA63>:V/#7BF'Q"+OR@1]G;!R,=JTA532
M4M&SDQ&!E!SE3?-&/7U.CHKD=*\:V^IZQ<Z>@;?"K,?E]*S[CXD6D4TT"Q3/
M*@X"QDTG7II7N..5XN4^10UT?WG?45QNF>-X[K4;>SGC>-YD+#<A%7M8\66V
MF:A!9G+2RL!@#/6FJT+7N1++\3&I[/EUM?Y&O_:5H;O[*)1YV<;:NUY]'-9'
MQV0))OM/F_=_AS6UI'B^VU/5Y=-PZS(6^\N!@4HUDW9FE?+YQBI4TVK)LZ>B
MN8E\6P+X@.E1AF=<;B%R!GWK/U7QXEM>26]K;S.8CMD)B.,^U-UH+J1#+L3-
MJ*CNK_([2218T9W.%49)JO9ZA:WP)MI0X'7%<U:>*[77]#O?)+"58GR",8P*
MR_A;(\EK<;V+<#J:GVR<TELS9Y;*&'J5*NDH-*WJ=W=WD%E"9KB0)&#@DUGC
MQ1I!.!>)6/\ $IF7PI)M8KF5!D&N5TWPGHD^D+=3ZK*LN,E1*/\ &IJ59J?+
M%&V$R_#U,,J]:35W;17/5+:[ANDWPN&7U%3UY7X!EN(=>O;>&626S63"LY)X
MQ6WJ?CY8+MX;6WF81YW$Q'''6G#$1<.:6A%?*:L<0Z-'WM$_O[G<TU75B<'.
M.M<0OCBWU/0;J6W$GG1QY8!>E8OP^\3337UU;S^<_FOO#,I(4 >O:G]8CS)+
MJ2LHQ'L:E22LX=#U.BN&U'X@P0W;06D4LI3[Y$9(]ZW/#WB2UU^%F@WJZ#YU
M9<$5<:L)/E3.>KE^)I4_:SC9&[5+^T[0WS68E'GJ 2GI4E]-]GLII>ZH2/RK
MA?!*SWDUYKDQW/("@&<C@T2G:2B@P^%52C.M)V4;)>;9W5W>P6,)FN) D8ZD
MT^*>.:(21L"I&0:\D\;OK]\DMS+MBLX&P IP6'TKO+*.ZN/"B1VI'G/" "3C
MM41K<TFDMCIKY;&C0A4<U>3L^RV-276]/AN/)>X429QMJ^CK(@9#D'I7E5UX
M).G>')[[4K^47Z(6P).,^U=)\.KBYGT63[0S-M8!"W<4H5I.?+)6*Q.7T(8=
MUJ%3F2=GIOZ'9TAZ5@:YXB719[=9E.R9P@('>J7B'QQ9Z$;?S,L)>F!FM)58
M1O=['%2P&(J\O)&_-M\CIFMH7.60$U(B+&H51@>E<UJ?B^VL(;5OF+7&TJ ,
M]:BUKQI;:44@"L]R_157-)U8+J5' XJ=DHO7;Y'6"EKD]!\9VVJW/V217CN/
M1E*U%KGCBVTZ\^QVRO-.HRP1=PQ^%'MH<O-<:R[$^U]CRZ[G8U4M]0MKJ1TA
MD#,APP'8UC^'_%5KKJ/&NY)XQ\ZNNVN3\,ZQ%IEYJT]U*=JW+ #/-)UHW5MF
M:T\MJ2C44DU*-M.]ST^D-<WI7B=+^QGOV1UMHE)R5P>*Q'^(T;.TD$,CVX/4
M1DFFZ\$KW,X99BIRE&,=MSMKR_M["-9+F01HS!03ZU-'(LJ!T.5/0USEW+;^
M)O#<LT8D0(I<;EVG(&:J?#_5)+S2?LTQS)".2?K1[3WTNX/!-8>53[479H[*
MBBBM3@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK>-HZVZV<,A=F9]K94$T ?2E%>5_"/Q]=^*S=6%ZJ^=:KEB/KBO5* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;
MXF\^')!ZD?SKN:S-8T:'6;0V\YPI]JSJQ<H.*.O 5XT,3"K+9,XW0/!.B7F@
MK<36[F0KG._VK(\*VD-CXMU*W@4K&C  $UZA9:?'960MHS\H&*S[7PU;6NHS
M7J']Y*<MQ6/L+<MEL>I'-G)5HU)-J6WWG"># #X@U4-PID<$_A6?/I3V4MQ<
MZ1J]L0"2T>TDCFO2].\,VFG74\\9R9B2PQZUFW?@*SGN6EMYFM@_WE1>#6?U
M>7*D=,<VH/$2GS632Z73MW.;\-:U+JFA:A!.H:2+ 9@.#2>!)X%T?5( Z"X+
M2X7OWKN],\.6.EVK011*=X^=L?>K/T[P5::;JDE[%(?GSE,<<U2HS3BWK8RG
MF.%G&M"*<4VFOD<9\/[K3[&]O5U)TBF(_P"6O?FH[%H+CXAF6P^:+:^YE/&:
M[75_ NG:I-YR_N'/4HO6KVC>%[#1HB(8U,A&#)CFE&A/2+V1I5S3"OGKQ;YI
MJUNB//O!5M%<^.[X2J& 0D _4UM^.E5/$&A*H 4.>!73:9X9M=,U.6^B/[R0
M8/%3ZGH4&J7=M<2G#6YRO%5&A)4W'K<PJYG2GC56^RHV^=K'FOBG$/BW3I;O
M_CW$0Y/3.17776L>'S=VB QRSL0%V'!!Q6OK'ANRUBV6*=!N4 !\<BLS2? >
MGZ;="X<^?(.5+KTH]E4C)VV8WC<)6H0]HVI035EU.6O]>EU'Q4=.L66TEC8J
M9)!D5FZ+OC\;R![J.X;RB"\8P,UZ!J/@FRO=06]B;[/-U9D'+4^#P986UZ+J
M'Y)-N"0.M0Z-1RN^YT1S3!PH\D-+QMMU]3!\*_\ (\:U_P !KMM3O&L;%YUC
M:0C@*.IJM8Z#;V.I7%[&?WD^-W%:;QK(NUP"/>NBG!QBT>-C<33K5XS2NDDO
MN2/+[O\ X2+Q3.UN+9K.W)ZRH#D5TWAGP[%X/L;AY[A2'P7?M75A0!@<"JNI
M:>FI6$EJ[$+(,$BE&BHOF>K-:N92JP5!)0I]4CR75_$B^*-;-B]XEK9(WS%S
MPV#793MI<7@6_M=,GCE2. D[#GTJ(_#+2V.2_)_V:UM/\(6>GV%Q:1GY)TV-
MQVK&%.K=N2W/1Q6,P+A3C1DTHM.UM/-G,?#[7M*L-)>.ZOH8GR.&-=U9:UIV
MHR%+.\BF8#)"&N5/PQTLG.__ ,=K8T'PC9Z!<-+;MEF&.E:4E5BE%I6.7,9X
M"O*=:G.7,^EM!_BK51I.DRW#V[2QA<L!7%SV?@_5]--X)XX+DKNP7Z&O2[NS
M@OK=X+B-9(W&"IZ&N.G^&6FRSETD,:$YV*O%%:$V]$FA9;BL/2A:<I0DGNNO
MDSE?!D]PUOJ]FLIEMT@)0CZU:^&U_:Z<VKQW<R1,T@P&/7BO0]+\.V&DVQA@
MA0;AAF ZBL>?P#82ZD;M7*;CED"\&LU0G'E:U:.RIFF%KNM3G>,9VU]/\S@/
M!$JR^-=4=.5,4N#^=;7@&SAN?$VK-*@8HH(S]:Z_2_!MAI5])=0 !G0H0!ZU
M;TGP[;:1>7%Q"<M.,-Q13P\H\M^C88W-Z%55?9W]Z,4OD<C\1+"2T>WUBW7'
MV<;>!ZFL[PJB^*/%3:C<(3''"H4G^\*],U/3HM4LFM9QF-NN:JZ+H%KHEMY5
MNHY).[%7*@W5OT.6EFL(8)TFOWBND_)G"1?\E2;_ *[U'XM#^'/% U2&)A"T
M)5F'3<:[I?#=LNMG4\_O2V[I4^M:);ZY9_9K@#;N#9QZ4G0ERM=;W1I'-*2K
MTY-7CRJ,CA? T)F%YK]PA?S$X_ U5AU2ZU>]U VMY#91QOAA*N=W%>D:=I-M
MIVG+91(/*';%8;>!;(W\EPDI19#EHP.#2=&:BDOF..98>=:I4GI>W+I?1>1P
M'@G(FU92X?\ <RY(Z'K72?"O_CUN/H*Z6P\(6.G23-!\OFH48 >M6]$T"WT-
M&6 YW=>**5"47%OI<K'YK0KTZL8?:Y;?(Q/B6-WA)U/>9!^M<?-X%2;PRE]9
MEA*H+,-QYXKU+6-)AUBQ-K,<(6#=/2I;2PCM+,6R\Q@8JYT%.;<MK'-A<VEA
M<-&%)ZJ3;\UH>?\ P_UBSBT^:V:W:*ZAP'#'ES6:FJ76L3WPM+J&TC3>&61<
MEL9S7<Q>#[.'5GOHVVEVW% .#58^ [+[:UQ'*8PV=R*.#FL_95.51['6L?@G
M6G5UO*SUUL^J."^'HR->4L'Q".>W6M[P#/ D.L0F1%G:0[01STKK-,\)V6ES
MW$EN JS+M90.*@L?!=K8:PU_%*1N))CQQS1"C.'+Y#Q>:8;$.MJUS<MO56/-
M_#B7C75ZL>J6]J=[[A*N3C)KL? VG+;W]].NIP7;2$%O*!&*TM1\!V%[<F>)
MOL[-][8O6M;1?#]EH<'EVT:AB/F<#EJ*5"49*_0C'YI1KT9>S>LK:67XL7Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>gtl21rgcbjm5000013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <T!G(# 2(  A$! Q$!_\0
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M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
M]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@N
MA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"
MB@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A
M!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:
M'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\
MXFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03
MP?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH
M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G
M_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!_
M_0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+
MH?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
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MBN+\._$[0/%OBHZ+H,DEVB63W<MT4:-5(=$"!6 )/S$D\ 8'7)QVE !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17E>B?$W7M3^,M]X/
MGT*.+3X'F02!7\V-4&5E<G@H_&.!_K$^8_Q>J4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45Q?B+X@PZ9XLT[PII%G'JNO7C_/;FY$*6T>TL
M6D?:V#M&[: 3@9[J&XOQ3\1_B)\/KRSF\2:'H=[ID^1YNFF9 7P<)O<G:W ;
ME3D9P>#@ ]HHK+\.:_8^*?#]GK6FM(;2Z0LGF)M92"592/4,".,CC@D<UJ4
M%%1SSPVMO+<7$L<,$2%Y))&"JB@9))/  '>O(_\ AH[P?_T#=<_[\0__ !V@
M#V"BO/\ P=\7=$\<:Y_9.DZ=JJS+$TTDD\<2I&@P,G$A)Y*C@'KZ9(] H **
M*CGD:&WEE2&2=T0LL494,Y ^Z-Q R>G) ]2* )**\OUGXY:)X>U%[#5_#WB.
MRNER=DUK$-P!(W*?-PRY!PPR#C@UN>%_B+'XO1)]*\,>(/L;.J_;)XH8HL%B
MI8%I<N 5.=@8C'3.!0!VE%%</XL^)EKX*VR:SX>UR.UDE:**ZB2"2.0CW$N5
MR.0& ) /'!P =Q17%^%_B+'XO1)]*\,>(/L;.J_;)XH8HL%BI8%I<N 5.=@8
MC'3.!7:4 %%%% !1110 4444 %%%% !1110 445YO??&+2Y]6DT;PII=]XFU
M-<8%FNV ?O C;I3T49!WA2G*_-SD 'I%%>?_ /"9>.X/WMY\,ITM4^:9K?6(
M)I @Y8I& "[8SA0>3Q67=?'SPI;:7?RM;ZE#JEJ[1+I=U;F.5W&!@L-RH 20
M<G(VGY3P" >J4444 %%%% !1110 4444 %%%% !1110 445XWX[^.%SX=18-
M,\+ZE%/*[K%<ZQ:O;Q.%9?F1.&<$$]2A7*Y!SB@#V2BLOPUJ4VL^%=(U2X6-
M9[VRAN)%C!"AG0,0,DG&3ZFM2@ HHHH **** "BN?\<:]>>&/!>J:S867VVZ
MM(MZ0D$CD@%FQSM4$L>G"GD=1E_"[Q?J7C?P<-7U33X[2?[0\2F)6$<RKCYT
M#9.,DJ>3RAY[  [2BBB@ HHHH **** "BBB@ HHK'\4^)+/PCX<N]<OXYY+6
MUV;T@4%SN=4& 2!U8=Z -BBO,]-^-.FZS;M<:7X2\77T"OL:2UTY95#8!P2K
MD9P1Q[BJ^I?'C0=&N%M]4\.^)[&=DWK'=621,5R1D!I <9!Y]C0!ZI17G_\
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M/L< 'I%%1P3PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'>I* "BBB@ HHHH ****
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M_P!HU[_7@'[37_,K?]O?_M&@#U_P)_R3SPS_ -@JU_\ 12US_P 7/!^E^(?
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M6\MW9R00WL]E(V,3P*A=,$'@.K+STY!Z^O->":EXZ\:Z'\:;;PF_B62\T_\
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MN9[1]ES'#,KM"V2,. <J<J>#Z'THU75;'1-+N-3U.YCMK.W3?+*YX4?S))P
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M_12UEZKI7@/P3JEQXWU&VM-/O)7V/=D.Q9WX.R,9&\@$DJN2-Y/!8UJ>!/\
MDGGAG_L%6O\ Z*6O!/A^8?BS\8[S4O$L<ES!!;O=6]G(X:-%611'$1@!D4.3
MC W$9.<L" >A^+/&>N^(_!NN?\(_X6G&B2:?.'U?4I! K1B-F9HX?ONK1XV-
MP-S#(PIKF/V9?^9I_P"W3_VM7K?Q!GAMOASXD>>6.)#IEP@9V"@LT951SW+$
M #N2!7DG[,O_ #-/_;I_[6H /VFO^96_[>__ &C7K_@3_DGGAG_L%6O_ **6
MO(/VFO\ F5O^WO\ ]HUZ_P"!/^2>>&?^P5:_^BEH \__ &CO^2>:?_V%8_\
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MTOG+ [P0<8 ZB@ HHHH *^8/VCO^2AZ?_P!@J/\ ]&RU]/U\P?M'?\E#T_\
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MH;;_ +"NF_\ H,-?3]?+GBR>&Y_:=MW@ECE0:Q8(61@P#*(58<=PP(([$$4
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M 1R8!RV3\VY8P.@Y/?%?1]5[^QM]3TZYL+R/S+6ZB:&9-Q&Y&!##(Y&03TH
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M705S_@3_ ))YX9_[!5K_ .BEKH* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN
M?\1^./#7A+RQKFKP6DDF"L6&DD(.<-L0%MORD;L8R,9S0!T%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5[Z_L]
M,LY+R_NX+2UCQOFGD$:+D@#+'@9) _&@"Q16/X<\4Z-XMTZ2_P!#O/M=K'*8
M6?RGCPX )&' /1A^=6-9US2_#VG/?ZO?P65JN1OF?&X@$[5'5FP#A1DG' H
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M?O5PXX '!Z<=*Z"B@#Y(EOKCX*_%R_BTF3[;;VVV*1)U"F:"14DV$CHPROS
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M_:-=O8^-K?PQ\//"]K;Z=?:QJ\NB6\T6G:?$9)-@B4>8^,[(]V%W8/)X!P<
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M]R:\D_::_P"96_[>_P#VC7H<$$UU\ HK>WBDFGE\+A(XXU+,[&UP  .22>U
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M.A  ///BYJ%SX_T;3XM-\"^+HM0L[@LLMUICJHB93O4;2<DL(SR/X3R._?\
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M]VTXV/%N0$$\)+R.@)&1GGM/!/Q/\.>-K>!+6[CMM4= 9-.F;$BMAB0A.!(
M%)RO08)"YQ72:M8Z7K-G+HFJ1P7$-Y$Q:UD;F1%*Y8#K\I9/F'W25.0<5XAX
MR_9V_P!=>^$+SU;^S[MO]XXCD_[Y4!_<EZ /6]%\*0Z)XQ\0ZS:B-(-82W=X
MUP-LR>8'.  ,,&1LY)+%R>U>6?&+7]4\'?%7POXE2#[38V]HZPP22X1GRRS
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M[ XR< @$?B?PQI?B[0YM(U>#S;>3E67AXG'1T/9AG]2"""0?G#P1XGU3X/\
MQ N?#NOS[=*,NV^CC_>HA*@I.F.1D%">,E>"I8 #ZGKPSXE>'YOBJEQK'AVW
MC-IHEO*D=]L+-JL@8%HH=H)9$VN _(9V*J,9:@#K_#FE+X\UFS\?:S;2);Q(
M1H>G3!OW*;C_ *3(IX,K\$;> H0Y8@,/1*\0^ WQ&_M&SC\&ZE_Q]6D3-93O
M+DS1@Y\LACG<H/ 7C8O0;<GV^@ HHHH ***CGGAM;>6XN)8X8(D+R22,%5%
MR22>  .] 'D_PL^$>I> O%6I:I>ZE:7,$ENUK;+"K;G4NK;WSPIP@^4%OO'G
MCF3XZZYX?/P_U+2)[^QDU<2P&"UWJ\T;[E8MM&2G[O=\QQPV,_, <#3/%'BG
MXS^*);/2+Z?P]X9TZ42SS6DICNY%8$(I8'[S;7.!\J\YWE5SM_$WP=X<\+?!
MW6UT71[2T<)"GG*FZ5E-S&Q#2-EV&<<$GH/04 1_LX_\D\U#_L*R?^BHJX#]
MH[_DH>G_ /8*C_\ 1LM=_P#LX_\ )/-0_P"PK)_Z*BK@/VCO^2AZ?_V"H_\
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M **6@#R#]IK_ )E;_M[_ /:->K_#JQM[+X>: ;>/:T^GV\TK%BS.YB3DD\G
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M0!P_Q ^!VE^*[RYU?2;G^S-6F^>12N8)WP>6 Y5F.W+#/0G:22:\4M=2\?\
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M.*\@_:.\,)!>:9XGMH-OVC-I=N-H!<#,9(^\6*AP3SPBCCC/H_\ PI+X>?\
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MR3SPS_V"K7_T4M=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3!7.3CYMK%3DC*XVE2HSZA10!YG-X[\5^(=+%AX<\&:SIFM3(H>ZU>W$-K:
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M5 ;)<?Q#&,\]*]3G^*LRV\K6_P /_&LDX0F-)-***S8X!8,2!GO@X]#7HE%
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M?\N1\K8P.@^B_#'BD>(K.$S:1JNEWS1>9-;7MC-&(R#@@2,@1N3D8.2.<#!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!7AL+.WO+F\AM(([JZV_:)DC >7:,+N8<M
M@<#/2K%%% !1110 4444 %%%% !1110 4444 %%%% !5>UL+.Q\_[':06_GR
MM/-Y,83S)&^\[8ZL<#)/)JQ10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!7L;"STRSCL["T@M+6/.R&"
M,1HN22<*.!DDG\:L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5GZGH6CZWY7]K:58W_DY\
MO[7;I+LSC.-P.,X'3T%:%% &7HGA_3_#UO\ 9].^UK!L1%CFO9IUC51A0@D=
M@@ /1<=!Z"M2BB@ HHHH **** .?\"?\D\\,_P#8*M?_ $4M=!7/^!/^2>>&
M?^P5:_\ HI:Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=$/&TEBC(/EP5 7&ZO1_!VOV7Q4^'7F:A!M\_=:ZA;P2R1@.,$J&!#;64J<
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M'J/AV_6/%U-%/#(^X_,B%"HQTX,C_G["@#WO5M2AT;1K[5+A9&@LK>2XD6,
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MWX*3P_\ \(EI]QX8LX+73+F)942(+G.T ^803F0;=K$DG*G).*S_ (F^$?\
MA-/ U[IL2[KZ+_2;+G'[Y <+]X#Y@63).!NSVKS3]G+Q7-,FH>%+@R.D*&]M
M6.2$7<%D3D\#<RL !U+DGD4 ='\9_#MGXGG\,Z);Q0)K>I:@$2Y\D&1;6-':
M4[CC*KO#;-PR>G->D:-H>E^'M.2PTBP@LK5<'9"F-Q  W,>K-@#+')..37'^
M'_\ BI_BAK^N2_O;'0L:3II_@6;&ZY;:W(D!*IO&T%>/FZUZ!0 4444 %?,'
M@W_DZ&Y_["NI?^@S5]/U\P>#?^3H;G_L*ZE_Z#-0!]%Z_HS:]I;6"ZKJ6F!G
M#-/ITJQ2D#^'<5) SC.,'C&<$@_,'A.QOK?X^7&G:9?2&\2]O[>*]NV\QU.R
M9?.;@AW RV" &(P2H.1]9U\P>#?^3H;G_L*ZE_Z#-0!ZGXD^"V@:WI>I2LUW
M<^(KA'=-4N[IM[2]4W*HV!!PF%3A1@<@&N$_9N\0W U'5O#3+NM7B^WQG('E
MN"D;=LG<&3OQLZ<FOH>OF#]G'_DH>H?]@J3_ -&Q4 >S_%/QTG@;PE)<1'.I
MWFZ"R4,N5<J?WI#9RJ<$\'DJ#C=D8_P_^&6G#0[;6O%UC_:WB*^B\RYDU0M.
M8U.-B%9!PRJJ@Y!8'< <8%><?M(WUQ)XRTFP:3-K#I_G1IM'RN\CACGKR(T_
M+W-?2] 'S9\=? ECX7M[+4]!M9+/3[ZX9;V".;]QYX#-$PC)X.UIAQ\J@8 7
M//J?P2_Y)#H7_;Q_Z/DKG_VCO^2>:?\ ]A6/_P!%2UT'P2_Y)#H7_;Q_Z/DH
M P[^>;XJ_$'4?"QEDB\):"Z_V@(6*M?7 /$3DX8(&5_N@C]V3G)0KT'B[X4^
M&?$'AJ[L;#1=-T^_V%[6XMH%@*R@';N*+DH3P1@\'(Y (\8^"WA[PWXXUG78
M/%,$FH:@42ZA,D\RLPW,)7+*PR=S1_>.>>.]>Q_\*2^'G_0O?^3MQ_\ '* /
M./@#X]O&UB3PIJM[/<0SQ;M/\YR_E-&O,:\'"E!D D*/+P!EJU/C%\(K%M&D
M\0^&+"TLI;-'FOK>(>6LL04?,@SL4H%)( &[)/) !]#T3X6^#?#FL0:MI.C?
M9[Z#=Y<OVJ9]NY2IX9R#P2.1784 >)_L]>)-%N-$E\/PV$=MK5NC333K&,W<
M6\X9F SE#(%PW8@CJ0K)OA_I?Q-^)5QKT-K!;^%;3$33VHV?VM.&9I&4@#Y=
MS%6D!.[9\I.24\S^+'AJ'PAX\OSH5Q(+25 \H@ 1;-IQ)FW)3@!D#$*0,HV,
M$ D_2_@+6](U[P5I=SHOEQVD=O'!]F60N;9D4 Q,6Y)7@9/48/0@T ;EC86>
MF6<=G86D%I:QYV0P1B-%R23A1P,DD_C5BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH Y_P)_R3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5
MK_Z*6N@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#5H[LFPBZ9[A<9!X61F /'7&>OJ:["""&UMXK>WBCA@B0)''&H544#   X
M[4 8?CO_ ))YXF_[!5U_Z*:O(/V9?^9I_P"W3_VM7L>O^$='\4(T6L1W<\#(
M$:!;Z>*)P&W#=&CA2<\Y(SP/05CZ;\*/!VC7#7&EZ==V,[)L:2UU.ZB8KD'!
M*R XR!Q["@#B_P!H3P?<:OH=EXAL+;S9M-WI=B.(%S W.\MG)5"#Q@X\QFX
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MR6JQ2DQW-H7R82S \A<*<@D'#<_*Q]CT;X]^"=0TY)M1NI]+NN ]O-;R28.
M25:-2"N20"<$XZ"N\U_PYI'BG2VTW6K&.[M"X?8Q*E6'0JRD%3U&01P2.A->
M;P?LZ^#8;B*5[O69T1PS127$85P#]T[8P<'IP0?0B@"YX9\0R?$OX@?VO8K/
M#X:\.^8EK(2R_;;J12A<J1C:J%L#AEWJ3]\J.@\;^)[BP^S>'= G@/BK5?EL
M8Y,%84&2\[YZ*JJY'!RPP%;!%=)I6E6.B:7;Z9IEM';6=NFR*)!PH_F23DDG
MDDDGDUS=]\+O"&HZY)K=UIL\FIO*)C="_N%<.,;2I$@VXP,8QC  QB@"P_@#
M0I/!=UX6DCG>SN\O<SM*3/-,2&,SO_%)N ;)XX QMXKY\\#Z_??!WXD7FBZ\
MT:6,CK#J'E)YN!M+12H1@X&\$CKM8_+N  ^H_L<7]G?8=T_D^5Y.[SW\S;C&
M?,SOW8_BSNSSG/-<7/\ !GP%=7$MQ<:))-/*Y>222_N&9V)R229,DD]Z .X@
MGANK>*XMY8YH)4#QR1L&5U(R""."".]25C^'O"^D^%K-K/1X9X+4](7NY943
MDGY5=B%R6).W&>^:V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#G_ G_)//#/_ &"K7_T4M=!7/^!/^2>>&?\ L%6O_HI:Z"@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M YOQQX,L?'7AJ31[Z22$AQ-;SIR890" V.C##$$'J"<8."/*-+\,?&'X>W"Z
M;X=>TUK18W>2*.1XQ&=Q(P0[*Z'H^U&VY/4Y;/O=% 'E^F7?QFU?S8;ZP\.:
M'&<(;A@TLBAL@O&JR.I9>N'P"<=1G':>&O#4/AZWG=[B2^U2]<2W^HS "2YD
MQ@<#A44<*@X4<#N3N44 > 6OA7XYV?BB<Q:]N6;=NO9KQ9;09&\[8G!*\C:-
ML8QT&%YKUOPAX4;PS;WTMYJ4FJZMJ%P;B\U"6)8VE.,*H SM15& N2!DXP#@
M=)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_@3_DGGAG_
M +!5K_Z*6N@KG_ G_)//#/\ V"K7_P!%+704 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\
MV-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V-
M '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3
M'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\
MV- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y
M,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3
M'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5
M_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y
M,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^
MH5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5
M_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_
M .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^
MH5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\
M"Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_
M .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?
M\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\
M"Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17
M"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?
M\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W
M17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8
MT?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T
M=W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?
M_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8
MT =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ
M_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?
M_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\ ZA7_
M ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA7_DQ
M_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +'_ZA
M7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\ ZA7_
M ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_PL?\
MZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +'_ZA
M7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)_P +
M'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_PL?\
MZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%<)_P
ML?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1_P +
M'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W=%<)
M_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]C1_P
ML?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0!W=%
M<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_ -C1
M_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]C0!W
M=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\ DQ_]
MC1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_ -C0
M!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?^3'_
M -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\ DQ_]
MC0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J%?\
MDQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?^3'_
M -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?_J%?
M^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J%?\
MDQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q_P#J
M%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?_J%?
M^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_  L?
M_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q_P#J
M%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5PG_"Q
M_P#J%?\ DQ_]C1_PL?\ ZA7_ ),?_8T =W17"?\ "Q_^H5_Y,?\ V-'_  L?
M_J%?^3'_ -C0!W=%<)_PL?\ ZA7_ ),?_8T?\+'_ .H5_P"3'_V- '=T5PG_
M  L?_J%?^3'_ -C1_P +'_ZA7_DQ_P#8T =W17"?\+'_ .H5_P"3'_V-'_"Q
M_P#J%?\ DQ_]C0!W=%<)_P +'_ZA7_DQ_P#8T?\ "Q_^H5_Y,?\ V- '=T5!
M8W/VRPMKK9L\Z)9-N<XR <9_&IZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#G_  )_R3SPS_V"K7_T4M=!7/\ @3_DGGAG_L%6O_HI:Z"@ HHHH IZ
MKI5CK>EW&F:G;1W-G<)LEB<<,/Y@@X((Y! (Y%?-GQ ^&=YX*\7Z;)X+N[XW
M&H_:I;2VMV*S6ZQ1AG5) VY\JSX'WL#'S$\^]GQ7##\1CX4N#&CS:8E[:L<
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M'0LV6/)Y)Y-:E !1110 5S_B'_D.>$_^PJ__ *175=!7/^(?^0YX3_["K_\
MI%=4 =!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .?\"?\D\\,_P#8*M?_ $4M=!7/^!/^2>>&?^P5:_\
MHI:Z"@ HHHH ***KS7]G;WEM9S7<$=U=;OL\+R /+M&6VJ>6P.3CI0!8HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Y_Q#_R'/"?_85?_P!(KJN@KG_$
M/_(<\)_]A5__ $BNJ .@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\ /D4
M=W17"?\ %??Y\BC_ (K[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\B
MC_BOO\^10!W=%<)_Q7W^?(H_XK[_ #Y% '=T5PG_ !7W^?(H_P"*^_SY% '=
MT5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^
M_P ^10!W=%<)_P 5]_GR*/\ BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?
M\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\ /D4 =W17"?\ %??Y\BC_ (K[
M_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^
M?(H_XK[_ #Y% '=T5PG_ !7W^?(H_P"*^_SY% '=T5PG_%??Y\BC_BOO\^10
M!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_P ^10!W=%<)_P 5]_GR
M*/\ BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5
MPG_%??Y\BC_BOO\ /D4 =W17"?\ %??Y\BC_ (K[_/D4 =W17"?\5]_GR*/^
M*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_ #Y% '=T5PG_
M !7W^?(H_P"*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_/
MD4 =W17"?\5]_GR*/^*^_P ^10!W=%<)_P 5]_GR*/\ BOO\^10!W=%<)_Q7
MW^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\ /D4
M=W17"?\ %??Y\BC_ (K[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\B
MC_BOO\^10!W=%<)_Q7W^?(H_XK[_ #Y% '=T5PG_ !7W^?(H_P"*^_SY% '=
MT5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^
M_P ^10!W=%<)_P 5]_GR*/\ BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?
M\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\ /D4 =W17"?\ %??Y\BC_ (K[
M_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^
M?(H_XK[_ #Y% '=T5PG_ !7W^?(H_P"*^_SY% '=T5PG_%??Y\BC_BOO\^10
M!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_P ^10!W=%<)_P 5]_GR
M*/\ BOO\^10!W=%<)_Q7W^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5
MPG_%??Y\BC_BOO\ /D4 =W17"?\ %??Y\BC_ (K[_/D4 =W17"?\5]_GR*/^
M*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_ #Y% '=T5PG_
M !7W^?(H_P"*^_SY% '=T5PG_%??Y\BC_BOO\^10!W=%<)_Q7W^?(H_XK[_/
MD4 =W17"?\5]_GR*/^*^_P ^10!W=%<)_P 5]_GR*/\ BOO\^10!W=%<)_Q7
MW^?(H_XK[_/D4 =W17"?\5]_GR*/^*^_SY% '=T5PG_%??Y\BC_BOO\ /D4
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M "BBB@ HHHH *Y_Q#_R'/"?_ &%7_P#2*ZKH*Y_Q#_R'/"?_ &%7_P#2*ZH
MZ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HJ.>>&UMY;BXECA@B0O))(P544#)))X  [UA_\ "=^#_P#H:]#_ /!C#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#CT55'OCGFNXH **** "N?\ $/\ R'/"?_85?_TBNJ/^$-TO_GZUS_P?7O\
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M=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94 =W17"?\ "N/^HK_Y+_\
MV5'_  KC_J*_^2__ -E0!W=%<)_PKC_J*_\ DO\ _94?\*X_ZBO_ )+_ /V5
M '=T5PG_  KC_J*_^2__ -E1_P *X_ZBO_DO_P#94 =W17"?\*X_ZBO_ )+_
M /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *X_ZBO_DO_P#94?\ "N/^HK_Y+_\
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MHK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94 =W17"?\
M"N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_PKC_J*_\ DO\ _94?\*X_
MZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *X_ZBO_DO_P#94 =W17"?
M\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *X_ZBO_DO_P#94?\
M"N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94 =W17
M"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_PKC_J*_\ DO\ _94?
M\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *X_ZBO_DO_P#94 =W
M17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *X_ZBO_DO_P#9
M4?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94
M=W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_PKC_J*_\ DO\
M_94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *X_ZBO_DO_P#9
M4 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *X_ZBO_DO
M_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\
M_94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_PKC_J*_\
MDO\ _94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *X_ZBO_DO
M_P#94 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *X_ZB
MO_DO_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J*_\
MDO\ _94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_PKC_J
M*_\ DO\ _94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *X_ZB
MO_DO_P#94 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)_P *
MX_ZBO_DO_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_PKC_J
M*_\ DO\ _94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%<)_P
MKC_J*_\ DO\ _94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1_P *
MX_ZBO_DO_P#94 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W=%<)
M_P *X_ZBO_DO_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]E1_P
MKC_J*_\ DO\ _94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0!W=%
M<)_PKC_J*_\ DO\ _94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__ -E1
M_P *X_ZBO_DO_P#94 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E0!W
M=%<)_P *X_ZBO_DO_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2_P#]
ME1_PKC_J*_\ DO\ _94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__ -E0
M!W=%<)_PKC_J*_\ DO\ _94?\*X_ZBO_ )+_ /V5 '=T5PG_  KC_J*_^2__
M -E1_P *X_ZBO_DO_P#94 =W17"?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]
ME0!W=%<)_P *X_ZBO_DO_P#94?\ "N/^HK_Y+_\ V5 '=T5PG_"N/^HK_P"2
M_P#]E1_PKC_J*_\ DO\ _94 =W17"?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__
M -E0!W=%<)_PKC_J*_\ DO\ _94?\*X_ZBO_ )+_ /V5 '=T5YAK_AK2/"VE
MMJ6M>(X[2T#A-[6I8LQZ!55B6/4X / )Z UX-XH\?2W\KVVB//;V/RD3.OES
ML>I^ZQ"C/H23CKR10!]&>./BSX<\#O)9SO)>ZLJ!A96XY7*DKO<\(#@>K88'
M:0:C\"_%[P_XYO!IT*3V.I^4)/L]SMQ(<9<1L#\VWW"DCG'!Q\@5V7PR\)ZQ
MXI\86BZ8K1PVDB2W=T<A(H\\@D=2P! 7OSV!( /LVODSXL:/X0T+XFI8V$%W
M#:;XY=4BMF&(M^"4A5E 4[/F'S%<N  H7%>\?\*X_P"HK_Y+_P#V5'_"N/\
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M:Z"N?\"?\D\\,_\ 8*M?_12UT% !1110!&)X6N'MUEC,\:*[QAAN56)"DCJ
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M4<,$2!(XXU"JB@8  '  ':H[^QM]3TZYL+R/S+6ZB:&9-Q&Y&!##(Y&03TH
MY_X<7UOJ'PU\.36LGF1KI\,).TC#QJ(W'/HRL/?''%<_\=;ZWM/A1J4,\FR2
M[E@A@&TG>XD60CCI\J,>?3UQ6/X4UI_A%9W'A?QDTZ:3!*7TO68[9G@E1R6\
MH[%)63(=L'/\7. I:/5'F^->LZ5:6%E=P>#-/N#=7=Y=Q&-=096*!(>C8P'&
MX$8WG< 54, =A\)=-FTKX5^'[>=HV=[<W *$D;97:51R!R%<9]\]>M=I110
M4444 %<_XA_Y#GA/_L*O_P"D5U705S_B'_D.>$_^PJ__ *175 '04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?-\P^Z,9 .2O&?F3Q1XNUKQAJCW^L7LDQ+LT4 8B* ''RQKG"C"K[G&22>:
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M?^P5:_\ HI:Z"N?\"?\ )//#/_8*M?\ T4M=!0 4444 %%9^LZYI?A[3GO\
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M?P+\&?#_ (-E%[<'^UM3&"MQ<Q*$B(;<&C3G:W"_,23\O!&2*](HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .?\  G_)//#/_8*M?_12UT%<_P"!/^2>>&?^P5:_^BEKH* "BBB@#Y\^
M.NHM9?$OPG+JEM)<:#:I'<-$8%993YW[Y1G 8E%C!4G'(Z;N>_\ $T\-U\5O
MAK<6\L<T$J:B\<D;!E=3;J001P01WK<\=>!=+\>:&;"_'E7$>6M+M%R]NY[C
MU4X&5[X[$ CYPU32O%/P5\7Z?>,8+JWAEN'TUY6+0S;HU21O+#!D;:R ].5'
M+ 9H ^@]8\$PS?$KP[XOL;>-+BW>:+4&4 &2-H'5';GDJV%X!)#C)PE=A/!#
M=6\MO<11S02H4DCD4,KJ1@@@\$$=JYOP+XZTOQYH8O[ ^5<1X6[M';+V[GL?
M53@X;OCL00.HH ^>/VD;"SL_^$5^RVD$&V*X@'E1A<1IY6Q./X5W-@=!DXZU
M]#UX!^TU_P RM_V]_P#M&O?Z *>JZK8Z)I=QJ>IW,=M9VZ;Y97/"C^9).  .
M22 .37C_ (,TW4OB[JC^+O%;2+X?@N,:=HF6\AV3.'<$ 2 ;B"?XFW X5=AD
M_:.UG[)X2TS2$>=)+^[,K;#A'CB7E6YY^9XR!@CY<\$"N@TKX8ZBGA[3M.U#
MQ?JME]CB5(X- =;*%/D4-D[2TK%PS%V(R6)"KDB@#TBN?\<>)/\ A$?!>J:X
M(_,DM8OW2%<@R,0B;AD?+N9<X.<9QS7D%[XB\8_!?Q196VO:Q/XC\.WVYEDF
M;,W 4.5W$LK+QA2Q1@W8DE=O]H>>&Z^&FEW%O+'-!+J<3QR1L&5U,,I!!'!!
M'>@#8^!FFPP_#R/66:2;4-8N)KB\N)2&=V61D +8R1\I;DGEV/>L_P".FFW=
MCI>F>-=&:2WU;1KA5:YB**1"_'S9&7 <J O(Q(^0037>>!/^2>>&?^P5:_\
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M /\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)H_X0W0/^?#_P C2?\
MQ5'_  AN@?\ /A_Y&D_^*H /^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\
MB:/^$-T#_GP_\C2?_%4?\(;H'_/A_P"1I/\ XJ@ _P"$RT#_ )__ /R#)_\
M$T?\)EH'_/\ _P#D&3_XFC_A#= _Y\/_ "-)_P#%4?\ "&Z!_P ^'_D:3_XJ
M@ _X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")H_X0W0/^?#_R-)_\51_P
MAN@?\^'_ )&D_P#BJ #_ (3+0/\ G_\ _(,G_P 31_PF6@?\_P#_ .09/_B:
M/^$-T#_GP_\ (TG_ ,51_P (;H'_ #X?^1I/_BJ #_A,M _Y_P#_ ,@R?_$T
M?\)EH'_/_P#^09/_ (FC_A#= _Y\/_(TG_Q5'_"&Z!_SX?\ D:3_ .*H /\
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MH'_/_P#^09/_ (FC_A#= _Y\/_(TG_Q5'_"&Z!_SX?\ D:3_ .*H /\ A,M
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M_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)H_X0W0/^?#_P C2?\ Q5'_  AN@?\
M/A_Y&D_^*H /^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:/^$-T#_GP_
M\C2?_%4?\(;H'_/A_P"1I/\ XJ@ _P"$RT#_ )__ /R#)_\ $T?\)EH'_/\
M_P#D&3_XFC_A#= _Y\/_ "-)_P#%4?\ "&Z!_P ^'_D:3_XJ@ _X3+0/^?\
M_P#(,G_Q-'_"9:!_S_\ _D&3_P")H_X0W0/^?#_R-)_\51_PAN@?\^'_ )&D
M_P#BJ #_ (3+0/\ G_\ _(,G_P 31_PF6@?\_P#_ .09/_B:/^$-T#_GP_\
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MS_\ _D&3_P")H_X0W0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ #_ (3+0/\
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M "-)_P#%4?\ "&Z!_P ^'_D:3_XJ@ _X3+0/^?\ _P#(,G_Q-'_"9:!_S_\
M_D&3_P")H_X0W0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ #_ (3+0/\ G_\
M_(,G_P 31_PF6@?\_P#_ .09/_B:/^$-T#_GP_\ (TG_ ,51_P (;H'_ #X?
M^1I/_BJ #_A,M _Y_P#_ ,@R?_$T?\)EH'_/_P#^09/_ (FC_A#= _Y\/_(T
MG_Q5'_"&Z!_SX?\ D:3_ .*H /\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\
MY!D_^)H_X0W0/^?#_P C2?\ Q5'_  AN@?\ /A_Y&D_^*H /^$RT#_G_ /\
MR#)_\31_PF6@?\__ /Y!D_\ B:/^$-T#_GP_\C2?_%4?\(;H'_/A_P"1I/\
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M\31_PF6@?\__ /Y!D_\ B:/^$-T#_GP_\C2?_%4?\(;H'_/A_P"1I/\ XJ@
M_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFC_A#= _Y\/_ "-)_P#%
M4?\ "&Z!_P ^'_D:3_XJ@ _X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")
MH_X0W0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ #_ (3+0/\ G_\ _(,G_P 3
M1_PF6@?\_P#_ .09/_B:/^$-T#_GP_\ (TG_ ,51_P (;H'_ #X?^1I/_BJ
M#_A,M _Y_P#_ ,@R?_$T?\)EH'_/_P#^09/_ (FC_A#= _Y\/_(TG_Q5'_"&
MZ!_SX?\ D:3_ .*H /\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)H_
MX0W0/^?#_P C2?\ Q5'_  AN@?\ /A_Y&D_^*H /^$RT#_G_ /\ R#)_\31_
MPF6@?\__ /Y!D_\ B:/^$-T#_GP_\C2?_%4?\(;H'_/A_P"1I/\ XJ@ _P"$
MRT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFC_A#= _Y\/_ "-)_P#%4?\
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M?_%4 '_"9:!_S_\ _D&3_P")H_X3+0/^?_\ \@R?_$T?\(;H'_/A_P"1I/\
MXJC_ (0W0/\ GP_\C2?_ !5 !_PF6@?\_P#_ .09/_B:/^$RT#_G_P#_ "#)
M_P#$T?\ "&Z!_P ^'_D:3_XJC_A#= _Y\/\ R-)_\50 ?\)EH'_/_P#^09/_
M (FC_A,M _Y__P#R#)_\31_PAN@?\^'_ )&D_P#BJ/\ A#= _P"?#_R-)_\
M%4 '_"9:!_S_ /\ Y!D_^)H_X3+0/^?_ /\ (,G_ ,31_P (;H'_ #X?^1I/
M_BJ/^$-T#_GP_P#(TG_Q5 &S!-'<V\<\3;HY%#HV,9!&14E1P0QVUO'!$NV.
M-0B+G. !@5)0 4444 %%%% !1110 4444 %%%% !1110 4444 <_X$_Y)YX9
M_P"P5:_^BEKH*Y_P)_R3SPS_ -@JU_\ 12UT% !1110!GIK-F_B&;0]^V^BM
M([S8Q WQN[IE1G)P4YXP-R\\UQ?C2"&Z^*WP^M[B*.:"5-422.10RNIMP""#
MP01VH\9>"O$U[XUT_P 7>%-9M+6_MK=;22UNU8131!G=@S+DD$L!MVCIN# @
M5R&M>(/'$GC[P-/J/@>./5+=+T06T>J1;;QC"HD(/(B"CYL,3G.,]Z ,/7M,
M_P"$ _:'T5/#TWV*UU:6V9[>%=J+'++Y<D>"2"I*%@, +D8 V@U]'UYGX,\!
M:T_BQ_&_C:[CGUQDVV=I;N?*LD92"OH2 S+@$C[S9=FR/3* / /VFO\ F5O^
MWO\ ]HU[_7AGQ?\ #?C'X@W&DKI?A*[@@L4E+/=7EJ&=G*\!5E(P @YSSD\#
M'/K^B:EJ&HV^[4="N])G5$+)--#*K,1\P1HW8D CJP7.1QUP >0?M+:;-+HV
M@:HK1^1;W$MNZDG<6D564CC&,1-GGN/P]GTG4H=9T:QU2W618+VWCN(UD #!
M74, <$C.#ZFH]<T:S\0Z'>Z1?IOM;N)HGP 2N>C+D$!@<$''! ->7^&=/^)7
MPY@_L"UT.Q\3:)#YCVLT-VEK(FYR<-O/^\Q&&Y?AR!B@"/\ :0@A;P+IEPT4
M9GCU-420J-RJT4A8 ]0"57([[1Z58^(/A*[N_@!8V4T,BZAHEE;7#0K(F T4
M824,>A"H9#P>2HQGH="P\)>(_%_BK3O$GCB&TL8-*=I-,TBTDWM')OR'FD'#
M$!(SA3@X'"_,K>F4 <?\*]3_ +7^%_AZY\GRMEH+;;NW9\DF+=G Z[,X[9QS
MUKG_ (_:G]@^%\]MY/F?VA=PVV[=CR\$R[L8Y_U6,<?>SVP33_#/B7X:7E_'
MX1TR#7/#U[*)H]-DNUMY[24C#$2."'CPJCD[ON^C,TEAX2\1^+_%6G>)/'$-
MI8P:4[2:9I%I)O:.3?D/-(.&("1G"G!P.%^96 .H\ : WA?P'HVCRK(L\%N&
MG1V5BDKDO(N5X(#,P&,\ <GK72444 %%%% !7/\ B'_D.>$_^PJ__I%=5T%<
M_P"(?^0YX3_["K_^D5U0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<\\-K;R
MW%Q+'#!$A>221@JHH&223P !WKC_ !M\3_#G@FWG2ZNX[G5$0F/3H6S(S84@
M.1D1@A@<MU&2 V,5\T>-OB?XC\;7$Z75W);:6[DQZ="V(U7*D!R,&0@J#ENA
MR0%SB@#V/QU\?M.T>4V/A6*#5;H9$EW(6\B-@V, #!DR W((7E2"W($?PY^.
MLWB7Q!;Z'X@L+2VGNW9;>ZMG*1[L#:C*Y)R2& (;DE1MYS7S97J'P;^'^J:_
MXMTW6YK6>#1K"5;K[4PV"9T8[%C)!W_.OS8Z $9!(R ?5]<GK_PT\'^*-4;4
M]8T6.>\9 C2K-)$7 Z;MC $XXR>< #H!7644 9^C:'I?A[3DL-(L(+*U7!V0
MIC<0 -S'JS8 RQR3CDUH444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/^!/\ DGGA
MG_L%6O\ Z*6N@KG_  )_R3SPS_V"K7_T4M=!0 4444 %5YK"SN+RVO)K2"2Z
MM=WV>9XP7BW##;6/*Y'!QUJQ10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<_XA_Y#GA/_ +"K_P#I%=5T%<_XA_Y#GA/_ +"K_P#I%=4 =!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N7\8_$#P_X'L_-U:ZW7#;3'90%6GD!)&X(2,+PWS$@<8SG /#
M_&CXI:CX.EMM#T-?)U*XB6Y>\=%<1Q[B JJ<@L2AR2, =,DY7YDGGFNKB6XN
M)9)IY7+R22,69V)R22>22>] 'H'CCXQ>(_&+R6\$LFE:2Z!396\N2_RD-OD
M!8'<?EX7&."1D^=U8L;"\U.\CL["TGN[J3.R&",R.V 2<*.3@ G\*]\\#_L]
M+$\=_P",IHY@4)_LRW=@ 2HQOD4@Y!+?*O&0#N(R" 6/V;-*OK;2]=U.>VDC
ML[UX$MI6&!*8_,W[>Y + 9Z9R.H./<ZC@@AM;>*WMXHX8(D"1QQJ%5% P  .
M  .U24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBHSCC.3Q7AGPT^-.BZ#836.O6-VEW>7KW=UJ,.)%FEE<[Y'3C8%78,(&S@G
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M_P )9JW_ $*U[^;_ /Q%'_"6:M_T*U[^;_\ Q%=910!R?_"6:M_T*U[^;_\
MQ%'_  EFK?\ 0K7OYO\ _$5UE% ')_\ "6:M_P!"M>_F_P#\11_PEFK?]"M>
M_F__ ,17644 <G_PEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q%=910!R?_
M  EFK?\ 0K7OYO\ _$4?\)9JW_0K7OYO_P#$5UE% ')_\)9JW_0K7OYO_P#$
M4?\ "6:M_P!"M>_F_P#\17644 <G_P )9JW_ $*U[^;_ /Q%'_"6:M_T*U[^
M;_\ Q%=910!R?_"6:M_T*U[^;_\ Q%'_  EFK?\ 0K7OYO\ _$5UE% ')_\
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MK?\ 0K7OYO\ _$4?\)9JW_0K7OYO_P#$5UE% ')_\)9JW_0K7OYO_P#$4?\
M"6:M_P!"M>_F_P#\17644 <G_P )9JW_ $*U[^;_ /Q%'_"6:M_T*U[^;_\
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M644 <G_PEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q%=910!R?_  EFK?\
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M[^;_ /Q%'_"6:M_T*U[^;_\ Q%=910!R?_"6:M_T*U[^;_\ Q%'_  EFK?\
M0K7OYO\ _$5UE% ')_\ "6:M_P!"M>_F_P#\11_PEFK?]"M>_F__ ,17644
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MEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q%=910!R?_  EFK?\ 0K7OYO\
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M?S?_ .(KK** .3_X2S5O^A6O?S?_ .(H_P"$LU;_ *%:]_-__B*ZRB@#D_\
MA+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\ XBNLHH Y/_A+-6_Z%:]_-_\ XBC_
M (2S5O\ H5KW\W_^(KK** .3_P"$LU;_ *%:]_-__B*/^$LU;_H5KW\W_P#B
M*ZRB@#D_^$LU;_H5KW\W_P#B*/\ A+-6_P"A6O?S?_XBNLHH Y/_ (2S5O\
MH5KW\W_^(H_X2S5O^A6O?S?_ .(KK** .3_X2S5O^A6O?S?_ .(H_P"$LU;_
M *%:]_-__B*ZRB@#D_\ A+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\ XBNLHH B
MM97N+.&:2)H7DC5VC;JA(R0?I4M%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!S_@3_DGGAG_L%6O_ **6N@KG_ G_ "3SPS_V"K7_ -%+704 %%%%
M '-GQ7##\1CX4N#&CS:8E[:L< NWF2+(G)Y.U58 #H')/ K#\6_\E>^'7_<2
M_P#1"UH>+OAMH7C'4;74[R2^L]3M=@AO;&X,<BJI9E R"HPS$Y W9 YK@]5\
M$>/(/&?@^,>,KN^,"721:F='1A8#R@/WAR0YD'RY<YR,\F@#(\=:7#=_M+^'
M4TI(Y;MWM+F]5902&C<LQ;)^4B&-#MXR,$ D\_0=<?X(^'>E^"OM-U'-/J&K
MWG-WJ-V=TDA."P']U2V6QDDG&2V!CL* / /VFO\ F5O^WO\ ]HU[_7E?CCX4
M:UX_N+.75O%EI$EFC+#%:Z254%B-S'=,22<*.N/E& .<^@:):ZU:6_E:SJMI
MJ+JB*DL-D;=B0/F9_P!XP)/!^4*!SQSP :E%<WXX\&6/CKPU)H]]))"0XFMY
MTY,,H! ;'1AAB"#U!.,'!'+Z!\-?%&BV2Z6WQ(U)])V%#!#9HLJKLV@1RNSF
M,# P%'&#C!.: (_%MBGBSXP^$].MXYY(_#^_4-0GA9=D!;:T*,><,S1#*XR5
M;(XR1TGQ)\+MXO\  >I:5!'&UYL$UIN12?-0[@%)("E@"F[(P'/;(K<T?1-.
MT&S>UTVW\F.25YY2SM(\LC'+.[L2SL?5B3P!T K0H \_^"VM_P!M_"_2]]QY
MUQ8[K*7Y-NS8?D7H <1F/D9]SG-8_P >KZXD\+Z7X:T^3-_K>H1PI;[1^^13
MG&X\+^\,/<?EFN@U/X>RKKEWKGA37I_#NI7VT7OEVZ3P7&,G<8FX$A)'S _W
MN,LQ,GACX>0Z-K+^(-8U6[U[Q Z,@O;L + I9B1#'R(P0V, G'.-H8B@#H/#
M>B0^'/#6FZ-!Y92SMTB+I&(Q(P'S/M'0LV6/)Y)Y-:E%% !1110 5S_B'_D.
M>$_^PJ__ *175=!7/^(?^0YX3_["K_\ I%=4 =!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYX3_ .PJ_P#Z175 '04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .?\"?\D\\,_P#8*M?_ $4M=!7/^!/^2>>&
M?^P5:_\ HI:Z"@ HHHH *KS7]G;WEM9S7<$=U=;OL\+R /+M&6VJ>6P.3CI7
MG?Q-^(&I:!K.C>%O#OV0:UJ[A//NE8K;*[>7&P &"2V3_%C8<J=PKF-<\"7T
M/Q#\&6>I^,_$%Y>:B^H/+>17'D& K'N_<+R(@00K $@@<8'  /<Z*\KTZ_\
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M)Y(PI."I!P: /1*X_P"*>LWF@?#/6]1L'\NZ6)8DD!(*>8ZQEE(((8!R0>Q
MJYX,\<:+XZTM[[1Y9 8GV36\X"RPGG&X D8(&002#R.H('03P0W5O+;W$4<T
M$J%)(Y%#*ZD8((/!!':@#X$K8\/>%==\5WC6NAZ9/>R+]\H $CR"1N<X5<[3
MC)&<8'-?0<_[.7AF;69;A-3U*#3W0E;2,J61RV>)&!^0+QM()[ECTKU31M#T
MOP]IR6&D6$%E:K@[(4QN( &YCU9L 98Y)QR: /._A]\$M(\)O#J6KM'JFL1N
MLL3[2(K9@O\  N?G(8DAF'92 I'/JE%% !1110 4444 %%%% !1110 4444
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M\KL.?7UQ5BO"/AUXZU3P7XH_X5MXP/F-%*EM8W4;>9Y98#RT)ZF-@R[2>5R
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MX'_QNC[!XU_Z"]E_WP/_ (W7644 <G]@\:_]!>R_[X'_ ,;H^P>-?^@O9?\
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M?V#QK_T%[+_O@?\ QNC[!XU_Z"]E_P!\#_XW7644 <G]@\:_]!>R_P"^!_\
M&Z/L'C7_ *"]E_WP/_C==910!R?V#QK_ -!>R_[X'_QNC[!XU_Z"]E_WP/\
MXW7644 <G]@\:_\ 07LO^^!_\;H^P>-?^@O9?]\#_P"-UUE% ')_8/&O_07L
MO^^!_P#&Z/L'C7_H+V7_ 'P/_C==910!R?V#QK_T%[+_ +X'_P ;H^P>-?\
MH+V7_? _^-UUE% ')_8/&O\ T%[+_O@?_&Z/L'C7_H+V7_? _P#C==910!R?
MV#QK_P!!>R_[X'_QNC[!XU_Z"]E_WP/_ (W7644 <G]@\:_]!>R_[X'_ ,;H
M^P>-?^@O9?\ ? _^-UUE% ')_8/&O_07LO\ O@?_ !NC[!XU_P"@O9?]\#_X
MW7644 <G]@\:_P#07LO^^!_\;H^P>-?^@O9?]\#_ .-UUE% ')_8/&O_ $%[
M+_O@?_&Z/L'C7_H+V7_? _\ C==910!R?V#QK_T%[+_O@?\ QNC[!XU_Z"]E
M_P!\#_XW7644 <G]@\:_]!>R_P"^!_\ &Z/L'C7_ *"]E_WP/_C==910!R?V
M#QK_ -!>R_[X'_QNL/Q1K^M^#]+>_P!8\2:=" C-%  IEG(Q\L:[,L<LOL,Y
M) YJQ\6/B))\/]#M9+*&"?4[V4I!'.&*!%P7<[<9QE1C</OYYP17RAK.N:IX
MAU%[_5[^>]NFR-\SYV@DG:HZ*N2<*, 9X% '9^*_C'XJ\1VUUIJ7S6^ES@QO
M&D:+)*AQPS 9&<'(&."0<BO/*D@@FNKB*WMXI)IY7"1QQJ69V)P  .22>U>Z
M>!?V?+B647OC-O(A&"FGVTP+L0W(D<9 4@=$.3NZJ1@@&%\"-$\17&O:AJND
M 6]M':M;/=2J-A<LC;!D')PN3@<<9QD9]X^P>-?^@O9?]\#_ .-UTEC86>F6
M<=G86D%I:QYV0P1B-%R23A1P,DD_C5B@#D_L'C7_ *"]E_WP/_C='V#QK_T%
M[+_O@?\ QNNLHH Y/[!XU_Z"]E_WP/\ XW1]@\:_]!>R_P"^!_\ &ZZRB@#D
M_L'C7_H+V7_? _\ C='V#QK_ -!>R_[X'_QNNLHH Y/[!XU_Z"]E_P!\#_XW
M1]@\:_\ 07LO^^!_\;KK** .3^P>-?\ H+V7_? _^-T?8/&O_07LO^^!_P#&
MZZRB@#D_L'C7_H+V7_? _P#C='V#QK_T%[+_ +X'_P ;KK** .3^P>-?^@O9
M?]\#_P"-T?8/&O\ T%[+_O@?_&ZZRB@#D_L'C7_H+V7_ 'P/_C='V#QK_P!!
M>R_[X'_QNNLHH Y/[!XU_P"@O9?]\#_XW1]@\:_]!>R_[X'_ ,;KK** .3^P
M>-?^@O9?]\#_ .-T?8/&O_07LO\ O@?_ !NNLHH Y/[!XU_Z"]E_WP/_ (W1
M]@\:_P#07LO^^!_\;KK** .3^P>-?^@O9?\ ? _^-T?8/&O_ $%[+_O@?_&Z
MZRB@#D_L'C7_ *"]E_WP/_C='V#QK_T%[+_O@?\ QNNLHH Y/[!XU_Z"]E_W
MP/\ XW1]@\:_]!>R_P"^!_\ &ZZRB@#D_L'C7_H+V7_? _\ C='V#QK_ -!>
MR_[X'_QNNLHH Y/[!XU_Z"]E_P!\#_XW1]@\:_\ 07LO^^!_\;KK** .3^P>
M-?\ H+V7_? _^-T?8/&O_07LO^^!_P#&ZZRB@#D_L'C7_H+V7_? _P#C='V#
MQK_T%[+_ +X'_P ;KK** .3^P>-?^@O9?]\#_P"-T?8/&O\ T%[+_O@?_&ZZ
MRB@#D_L'C7_H+V7_ 'P/_C='V#QK_P!!>R_[X'_QNNLHH BM5G2SA6Y=7N!&
MHE9>C-CDCIWJ6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_P)_R
M3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5K_Z*6N@H **** /-]=^(%OX4^+]O
MI.KW7D:3J.E0E9')V03B:4!CSA58<,V.R9( )J3Q-/#=?%;X:W%O+'-!*FHO
M')&P974VZD$$<$$=Z[C4M)TW6;=;?5-/M+Z!7WK'=0K*H;!&0&!&<$\^YKS/
M4?@5X8D\1Z+/8:7!%I$7G_VE ]W/OFR@$6T[CC#9)Y7\>E '.:@(?B9\?]+O
M- DDGTS04A-Y?(@:+=%(\@"G(W!F(0$=<,P!49/O=9^C:'I?A[3DL-(L(+*U
M7!V0IC<0 -S'JS8 RQR3CDUH4 > ?M-?\RM_V]_^T:]_KB]2^%'@[6;A;C5-
M.N[Z=4V+)=:G=2L%R3@%I"<9)X]S70:)X?T_P];_ &?3OM:P;$18YKV:=8U4
M84()'8( #T7'0>@H -2\-:#K-PMQJFB:;?3JFQ9+JU25@N2< L"<9)X]S5/_
M (03P?\ ]"IH?_@NA_\ B:Z"B@#YP^&VA:/??'7Q=IUYI5C<6,'VSR;::W1X
MX]MRBKM4C P"0,=!7N?B/PO8^(/!UYX;:..WM)K<0Q"-,+ 5P8R%4CA653MR
M <8Z5'I7@GP[HGB&]U_3M/\ )U.^\S[1/YTC;][AV^5F*C+ '@"N@H \O^"N
MI_9/#DO@S4H?L6NZ)+(LUI(WSO&[EQ(.,%<OC*DC[ISAUK+^+,\/CW5-%\!:
M%+'=W9O?M.H3V["06$:9C8N.!D;V^4L""H&,NM>B>(_!'AKQ=Y9US2(+N2/
M67+1R #.%WH0VWYB=N<9.<9JQX>\*Z%X4LVM=#TR"RC;[Y0$O)@DC<YRS8W'
M&2<9P.* -"PL;?3-.MK"SC\NUM8EAA3<3M10 HR>3@ =:L444 %%%% !7/\
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MMR<<9Y%?;=>(?M$^$?MFCVGBNV7]]8XMKOGK"S?(W+?PNV, $GS,GA: ./\
M#G[0WB73/,37+6#6HVR5;Y;:13Q@91=I48/&W.3UP,5Z_P"'/C/X*\1^8O\
M:7]ES)D^7J96#<HQR&W%#R>F[=P3C S7R!10!]_T5\6>!_B#K7@75(Y[&>2:
MP+DW&GO(1%,#@$XZ*^%&' R,#.1D'[3H **** "BBB@ HHHH **** "BBB@
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M4F5&\LG!V,6)P1UY&"6S[7KFLV?A[0[W5[]]EK:1-*^" 6QT5<D L3@ 9Y)
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MQDM)\-/A2OA&XFUS7;B/4O$EP[DW&YG6$,3DJ6 +.V3N<C/.!W+>F4 %%%%
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MFC_A7ND_\_%[_P!]I_\ $UUE% ')_P#"O=)_Y^+W_OM/_B:/^%>Z3_S\7O\
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MVG_Q-=910!R?_"O=)_Y^+W_OM/\ XFC_ (5[I/\ S\7O_?:?_$UUE% ')_\
M"O=)_P"?B]_[[3_XFC_A7ND_\_%[_P!]I_\ $UUE% ')_P#"O=)_Y^+W_OM/
M_B:/^%>Z3_S\7O\ WVG_ ,37644 <G_PKW2?^?B]_P"^T_\ B:/^%>Z3_P _
M%[_WVG_Q-=)?WUOIFG7-_>2>7:VL333/M)VHH)8X')P >E?)GBOXT>+_ !+<
M$6]])H]FK[HX+"0QMU;&Z0?,QPV#R%. =H- 'M_B.U\">$O+&N:_-:228*Q;
MQ)(0<X;8B%MORD;L8R,9S7D>O_%'0PC1^'-+U%G* B?49D4*V[D>6@.X;>AW
MCD]..?*** .@G\;>()[M;C^T&C*%BD<:*$&>Q&/F [;LXKW_ .%UGI_COP<-
M4NVNH;R*X>WN%B*K&6&&!3.XXVNN<GKGMBO$/#OPN\8^)_+DL=%GBM7\LBZN
MQY,>Q^C@M@NN.?D#<8XY&?J/X<^#%\"^#K?2&DCENV=I[N6/=M>5L9QGL%"K
MT&=N< DT 5K_ .&&AZE83V5Q/>F*9"C?.F1[C*=1U'N*\9G_ &;_ !4MQ*MO
MJNC20!R(WDDE1F7/!*A" <=LG'J:^FZ* /&-&_9Q\/VB[M7U:^U"4.2!"JV\
M97' (^9L@Y.0P[<>O967PN\/:;;+;V7VF"(?PHR#)P!D_+R>!R>:[6B@#D_^
M%>Z3_P _%[_WVG_Q-'_"O=)_Y^+W_OM/_B:ZRB@#D_\ A7ND_P#/Q>_]]I_\
M31_PKW2?^?B]_P"^T_\ B:ZRB@#D_P#A7ND_\_%[_P!]I_\ $T?\*]TG_GXO
M?^^T_P#B:ZRB@#D_^%>Z3_S\7O\ WVG_ ,31_P *]TG_ )^+W_OM/_B:ZRB@
M#D_^%>Z3_P _%[_WVG_Q-'_"O=)_Y^+W_OM/_B:ZRB@#D_\ A7ND_P#/Q>_]
M]I_\31_PKW2?^?B]_P"^T_\ B:ZRB@#D_P#A7ND_\_%[_P!]I_\ $T?\*]TG
M_GXO?^^T_P#B:ZRB@#D_^%>Z3_S\7O\ WVG_ ,339/ASHTL;1R2W;QN"K*S(
M0P/4$;>E==10!Y1K/[/_ (3U-9)+6:]L+DH0K0E/+W8PI9-O(&.BE<\\]Z\O
M\0_L_P#B[3+Q5T?R-9M6Z2)(D#K@#[RNV!DDXVLW3)QG%?4]% 'R]\-_@QX@
MU+6;+5==M)=,TN"3S"LK>7<2%=V-J%20 ZKG>%RIR,U[K_PKW2?^?B]_[[3_
M .)KK** /GOXI>(=)\$:BNBZ3%->:F8EEDDFG0QV^3PK*HW%BH)P2N R'G.*
MY/0/BCIX=8_$>EW3(7),^G3*I5=O \MP=QW=3O'!Z<<[OQU^'VM+XGNO%EG!
M)>Z?=HIG\F,EK4QQA27 S\A5,[^@Y!QP6\3H ^K] 3X?>*'6+1_$K3SLY18&
ME6*5R%W';&Z!B,<Y QP?0UTG_"O=)_Y^+W_OM/\ XFOBRN\T#XQ>-_#[KMUB
M34(-Y=H=1S.&)7'WR=X X( 8#(]SD ^E_P#A7ND_\_%[_P!]I_\ $T?\*]TG
M_GXO?^^T_P#B:R_AW\6-+^($LME'9SV.IPQ&:2W<^8A3=MRK@#.,IG(7[W&<
M$UZ!0!R?_"O=)_Y^+W_OM/\ XFC_ (5[I/\ S\7O_?:?_$UUE% ')_\ "O=)
M_P"?B]_[[3_XFC_A7ND_\_%[_P!]I_\ $UUE% ')_P#"O=)_Y^+W_OM/_B:/
M^%>Z3_S\7O\ WVG_ ,37644 <G_PKW2?^?B]_P"^T_\ B:/^%>Z3_P _%[_W
MVG_Q-=910!R?_"O=)_Y^+W_OM/\ XFC_ (5[I/\ S\7O_?:?_$UUE% ')_\
M"O=)_P"?B]_[[3_XFC_A7ND_\_%[_P!]I_\ $UUE% ')_P#"O=)_Y^+W_OM/
M_B:/^%>Z3_S\7O\ WVG_ ,37644 <G_PKW2?^?B]_P"^T_\ B:/^%>Z3_P _
M%[_WVG_Q-=910!R?_"O=)_Y^+W_OM/\ XFC_ (5[I/\ S\7O_?:?_$UUE% '
M)_\ "O=)_P"?B]_[[3_XFC_A7ND_\_%[_P!]I_\ $UUE% ')_P#"O=)_Y^+W
M_OM/_B:/^%>Z3_S\7O\ WVG_ ,37644 <G_PKW2?^?B]_P"^T_\ B:/^%>Z3
M_P _%[_WVG_Q-=910!R?_"O=)_Y^+W_OM/\ XFC_ (5[I/\ S\7O_?:?_$UU
ME8?B7QAH'@^W@GU[4H[-+ARD0*,[.0,G"J"<#C)Q@9'J* ,__A7ND_\ /Q>_
M]]I_\31_PKW2?^?B]_[[3_XFK'AKQ]X7\7W$]OH6K1W4\"!Y(S&\;;2<9 =0
M2,XR1G&1GJ*Z2@#X-U75;O6;][R\DW2-P /NHO95'8#_ #S5:"":ZN(K>WBD
MFGE<)''&I9G8G   Y))[5]$:K^S98W.J7$^F>(9+&SD?=%;/:><8A_=W^8"1
MG.,C.,9)/)[OP+\+/#_@:(2V\7VW4S@M?W**74[=I$?'[M3EN 2?FP2<# !Y
M%X!^ >H:KY>H^*S+IUIE62R7'G3*5S\QS^[&2!@@MPP(7@U[%:?#+0;"TCM;
M5[N*"(;4177C_P =Z^_>NSHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\
MOM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y
M/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_
M]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GX
MO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNL
MHH Y/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\
M/Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]T
MG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\
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MU]&\,:IJ^Q[2#RH%E$1F?Y%C*XS@#8WR^6@PH4JR1J!$R(+  R/]5_TS\O\
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M#O#'ER6.BP2W2>61=78\Z3>G1P6R$;//R!><<<#'844 %%%% !1110 4444
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M/^(?^0YX3_["K_\ I%=4 =!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445P_P 2?B);
M_#^STN22'SYKV[5#& 21 I!F=>@+ $  L.7!Y (H [BBHX)X;JWBN+>6.:"5
M \<D;!E=2,@@C@@CO4E !1110 445X_\2/CC;^%=1ET;0;:#4-2BXGFE8^3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!GZSH>E^(=.>PU>P@O;5LG9,F=I((W*>JM
M@G##!&>#7D_B?]G;0KV*:?P[>3Z;='F."9C+!PN-N3\ZY;!+$MCG"G@#VBB@
M#XX\3_"3QCX5BFN;K3/M5C#RUW9-YJ ;=Q8CAU4 '+,H QUY&>'K[_KF]?\
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MG;R]G9*50D-P#*?F*E1R JGG@\9/K7_"9:!_S_\ _D&3_P")H_X3+0/^?_\
M\@R?_$T +H'@[PYX615T71[2T<(4\Y4W2LI;<0TC9=AG'!)Z#T%;E87_  F6
M@?\ /_\ ^09/_B:/^$RT#_G_ /\ R#)_\30!NT5A?\)EH'_/_P#^09/_ (FC
M_A,M _Y__P#R#)_\30!NT5A?\)EH'_/_ /\ D&3_ .)H_P"$RT#_ )__ /R#
M)_\ $T ;M%87_"9:!_S_ /\ Y!D_^)H_X3+0/^?_ /\ (,G_ ,30!NT5A?\
M"9:!_P __P#Y!D_^)H_X3+0/^?\ _P#(,G_Q- &[16%_PF6@?\__ /Y!D_\
MB:/^$RT#_G__ /(,G_Q- &[16%_PF6@?\_\ _P"09/\ XFC_ (3+0/\ G_\
M_(,G_P 30!NT5A?\)EH'_/\ _P#D&3_XFC_A,M _Y_\ _P @R?\ Q- &[16%
M_P )EH'_ #__ /D&3_XFC_A,M _Y_P#_ ,@R?_$T ;M%87_"9:!_S_\ _D&3
M_P")H_X3+0/^?_\ \@R?_$T ;M%87_"9:!_S_P#_ )!D_P#B:/\ A,M _P"?
M_P#\@R?_ !- &[16%_PF6@?\_P#_ .09/_B:/^$RT#_G_P#_ "#)_P#$T ;M
M%87_  F6@?\ /_\ ^09/_B:/^$RT#_G_ /\ R#)_\30!NT5A?\)EH'_/_P#^
M09/_ (FC_A,M _Y__P#R#)_\30!NT5A?\)EH'_/_ /\ D&3_ .)H_P"$RT#_
M )__ /R#)_\ $T ;M%87_"9:!_S_ /\ Y!D_^)H_X3+0/^?_ /\ (,G_ ,30
M!NT5A?\ "9:!_P __P#Y!D_^)H_X3+0/^?\ _P#(,G_Q- &[16%_PF6@?\__
M /Y!D_\ B:/^$RT#_G__ /(,G_Q- &[16%_PF6@?\_\ _P"09/\ XFC_ (3+
M0/\ G_\ _(,G_P 30!NT5A?\)EH'_/\ _P#D&3_XFC_A,M _Y_\ _P @R?\
MQ- &[16%_P )EH'_ #__ /D&3_XFC_A,M _Y_P#_ ,@R?_$T ;M%87_"9:!_
MS_\ _D&3_P")H_X3+0/^?_\ \@R?_$T ;M%87_"9:!_S_P#_ )!D_P#B:/\
MA,M _P"?_P#\@R?_ !- &[16%_PF6@?\_P#_ .09/_B:/^$RT#_G_P#_ "#)
M_P#$T ;M%87_  F6@?\ /_\ ^09/_B:/^$RT#_G_ /\ R#)_\30!@>*_A!X0
M\6W!N[BSDL;QGW27-@PB:7EB=P(*DDMDMC<<#G'%>*>)_@#XIT6*:YTN6#6;
M6/D+"#'.5"Y8^6>#@@@!69CD8'.!]%?\)EH'_/\ _P#D&3_XFC_A,M _Y_\
M_P @R?\ Q- 'Q+?6%YIEY)9W]I/:74>-\,\9C=<@$94\C((/XU7K[2UG5O!G
MB'3GL-7\B]M6R=DULYVD@C<IVY5L$X88(SP:\WOOA9\*[N\DGAU35;*-L8@@
M<E$P ."\;-SUY)Z^G% &S^SQ?WUW\/KBWN#&UI9WKPVK!OF (5V4C:. SY!R
M2=Q' 49]<KDM$U?P?X<T>#2=)G^SV,&[RXMDS[=S%CRP)/))Y-)KWC[2M/\
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M3_XFC_A,M _Y_P#_ ,@R?_$T ;M%87_"9:!_S_\ _D&3_P")H_X3+0/^?_\
M\@R?_$T ;M%87_"9:!_S_P#_ )!D_P#B:/\ A,M _P"?_P#\@R?_ !- &[16
M%_PF6@?\_P#_ .09/_B:/^$RT#_G_P#_ "#)_P#$T ;M%87_  F6@?\ /_\
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M?\)EH'_/_P#^09/_ (F@#=HJ.":.YMXYXFW1R*'1L8R",BI* "BBB@ HHHH
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M  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)I/\ T"[+_P !T_PH_L32?^@79?\
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M?X4?V)I/_0+LO_ =/\*OT4 4/[$TG_H%V7_@.G^%']B:3_T"[+_P'3_"K]%
M%#^Q-)_Z!=E_X#I_A1_8FD_] NR_\!T_PJ_10!0_L32?^@79?^ Z?X4?V)I/
M_0+LO_ =/\*OT4 4/[$TG_H%V7_@.G^%-DT#1I8VCDTBP>-P596MD(8'J",=
M*T:* / /$_[.,DMY-<^&-6@BADEREG>JP$*$<@2C<6P>@*]#R21D^-Z_X.\1
M^%G9=:T>[M$#A/.9-T3,5W +(N48XSP">A]#7W'4<\\-K;RW%Q+'#!$A>221
M@JHH&223P !WH ^#+"QN-3U&VL+./S+JZE6&%-P&YV("C)X&21UK[?\ "OAZ
MW\*>%]/T.U;?':1!"^"/,<G+O@DXW,6.,\9P.*\@^$&BV?B?X@:WX\M]-@L-
M,MY6MM,MH(A$JL5"EBJM@,(R-PP5+2DCI7N] ''_ !-\(_\ ":>!KW38EW7T
M7^DV7./WR X7[P'S LF2<#=GM7)?#4>&OB9\-HK'6M+L[F\L2MO=C&R1BO,<
MNY6W@LO5LC<PD'2O7:\0U.3_ (5;\<HM2,GE>'O%.1<;GPD<Q8;F.Y_X797+
M$8"RN%'% 'H&C?"WP3H%_P#;=/T"!;C84#3223  ]<"1F /N!G!([FN@_L32
M?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A5^B@"A
M_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)I/\ T"[+_P !T_PH
M_L32?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A5^
MB@"A_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)I/\ T"[+_P !
MT_PH_L32?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I
M_A5^B@"A_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)I/\ T"[+
M_P !T_PH_L32?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$TG_H%V7_
M (#I_A5^B@"A_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)I/\
MT"[+_P !T_PH_L32?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$TG_H
M%V7_ (#I_A5^B@"A_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH H?V)
MI/\ T"[+_P !T_PH_L32?^@79?\ @.G^%7Z* *']B:3_ - NR_\  =/\*/[$
MTG_H%V7_ (#I_A5^B@"A_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X5?HH
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M% !1110 4444 %%%% '/^!/^2>>&?^P5:_\ HI:Z"N?\"?\ )//#/_8*M?\
MT4M=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_B'
M_D.>$_\ L*O_ .D5U705S_B'_D.>$_\ L*O_ .D5U0!T%%%% !1110 4444
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MBMBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$@2..-0JHH&  !P !VJ2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8%:E<G_PEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q% '645R?_  EFK?\
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M[^;_ /Q%'_"6:M_T*U[^;_\ Q% '645R?_"6:M_T*U[^;_\ Q%'_  EFK?\
M0K7OYO\ _$4 =917)_\ "6:M_P!"M>_F_P#\11_PEFK?]"M>_F__ ,10!UE%
M<G_PEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q% '645R?_  EFK?\ 0K7O
MYO\ _$4?\)9JW_0K7OYO_P#$4 =917)_\)9JW_0K7OYO_P#$4?\ "6:M_P!"
MM>_F_P#\10!UE%<G_P )9JW_ $*U[^;_ /Q%'_"6:M_T*U[^;_\ Q% '645R
M?_"6:M_T*U[^;_\ Q%'_  EFK?\ 0K7OYO\ _$4 =917)_\ "6:M_P!"M>_F
M_P#\11_PEFK?]"M>_F__ ,10!UE%<G_PEFK?]"M>_F__ ,11_P )9JW_ $*U
M[^;_ /Q% '645R?_  EFK?\ 0K7OYO\ _$4?\)9JW_0K7OYO_P#$4 =917)_
M\)9JW_0K7OYO_P#$4?\ "6:M_P!"M>_F_P#\10!UE%<G_P )9JW_ $*U[^;_
M /Q%'_"6:M_T*U[^;_\ Q% '645R?_"6:M_T*U[^;_\ Q%'_  EFK?\ 0K7O
MYO\ _$4 =917)_\ "6:M_P!"M>_F_P#\11_PEFK?]"M>_F__ ,10!UE%<G_P
MEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_ /Q% '645R?_  EFK?\ 0K7OYO\
M_$4?\)9JW_0K7OYO_P#$4 =917)_\)9JW_0K7OYO_P#$4?\ "6:M_P!"M>_F
M_P#\10!UE%<G_P )9JW_ $*U[^;_ /Q%'_"6:M_T*U[^;_\ Q% '645R?_"6
M:M_T*U[^;_\ Q%'_  EFK?\ 0K7OYO\ _$4 =917)_\ "6:M_P!"M>_F_P#\
M11_PEFK?]"M>_F__ ,10!UE%<G_PEFK?]"M>_F__ ,11_P )9JW_ $*U[^;_
M /Q% '645R?_  EFK?\ 0K7OYO\ _$4?\)9JW_0K7OYO_P#$4 =917)_\)9J
MW_0K7OYO_P#$4?\ "6:M_P!"M>_F_P#\10!UE%<G_P )9JW_ $*U[^;_ /Q%
M'_"6:M_T*U[^;_\ Q% '645R?_"6:M_T*U[^;_\ Q%'_  EFK?\ 0K7OYO\
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M:M_T*U[^;_\ Q% '645R?_"6:M_T*U[^;_\ Q%'_  EFK?\ 0K7OYO\ _$4
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MR?\ PEFK?]"M>_F__P 11_PEFK?]"M>_F_\ \10!UE%<G_PEFK?]"M>_F_\
M\11_PEFK?]"M>_F__P 10!UE%<G_ ,)9JW_0K7OYO_\ $4?\)9JW_0K7OYO_
M /$4 =917)_\)9JW_0K7OYO_ /$4?\)9JW_0K7OYO_\ $4 =917)_P#"6:M_
MT*U[^;__ !%'_"6:M_T*U[^;_P#Q% '645R?_"6:M_T*U[^;_P#Q%'_"6:M_
MT*U[^;__ !% '645R?\ PEFK?]"M>_F__P 11_PEFK?]"M>_F_\ \10!UE%<
MG_PEFK?]"M>_F_\ \11_PEFK?]"M>_F__P 10!UE%<G_ ,)9JW_0K7OYO_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/^!/\ DGGAG_L%6O\ Z*6N
M@KG_  )_R3SPS_V"K7_T4M=!0 4444 <?XN^&VA>,=1M=3O)+ZSU.UV"&]L;
M@QR*JEF4#(*C#,3D#=D#FN#U7P1X\@\9^#XQXRN[XP)=)%J9T=&%@/* _>')
M#F0?+ESG(SR:]LHH X_P1\.]+\%?:;J.:?4-7O.;O4;L[I)"<%@/[JELMC))
M.,EL#'8444 >5^./A1K7C^XLY=6\66D26:,L,5KI)506(W,=TQ))PHZX^48
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV/JIP<-WQV(('45\\?\ "O\ QCX;U'_A-/"%K]GFBB\V:P88^U(3\RK$ IY
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M 4457FO[.WO+:SFNX([JZW?9X7D >7:,MM4\M@<G'2@"Q1110 4444 %%%%
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M 4444 %%%% '/^!/^2>>&?\ L%6O_HI:Z"N?\"?\D\\,_P#8*M?_ $4M=!0
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M'V#QK_T%[+_O@?\ QN@#K**Y/[!XU_Z"]E_WP/\ XW1]@\:_]!>R_P"^!_\
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M#QK_ -!>R_[X'_QN@#K**Y/[!XU_Z"]E_P!\#_XW1]@\:_\ 07LO^^!_\;H
MZRBN3^P>-?\ H+V7_? _^-T?8/&O_07LO^^!_P#&Z .LHKD_L'C7_H+V7_?
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M' 380R1@%5&!&&4)MMUMNXTW2K'2+=K?3[:.WB9]Y5!WP /P"A5 Z*JJHP%
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M_C= '645R?V#QK_T%[+_ +X'_P ;H^P>-?\ H+V7_? _^-T =917)_8/&O\
MT%[+_O@?_&Z/L'C7_H+V7_? _P#C= '645R?V#QK_P!!>R_[X'_QNC[!XU_Z
M"]E_WP/_ (W0!UE%<G]@\:_]!>R_[X'_ ,;H^P>-?^@O9?\ ? _^-T =917)
M_8/&O_07LO\ O@?_ !NC[!XU_P"@O9?]\#_XW0!UE%<G]@\:_P#07LO^^!_\
M;H^P>-?^@O9?]\#_ .-T =917)_8/&O_ $%[+_O@?_&Z/L'C7_H+V7_? _\
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M3SV*D$'N"#7>57L+&WTS3K:PLX_+M;6)884W$[44 *,GDX '6K% '/\ CO\
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M$"<YYROR_NV+/E=_EL T:1R20=)H%[I7Q'\2KXM\?:]HUKIULY73-!FOXP%
M/WI%)!QD#.0"Y R @53V_C#4?!NI:7J%[I7B+P^-<V++ W]I1@2NF"$.)5 +
MA$7?D$%(F!W11E0#E+&^N-(O([JUD^SS09 )4 * "&5E.P;<1$%2$ $1!$0A
M_P")?U^E?$2XMLQZQ#YL<<1!EC 20NN_E]VQ>=C DB/:8W8A0LZ6OG'@W4+C
MQA9W<VFZ=.KV,L<;Q1$,5#G]T5V[/^>2@[=@0HF#&BQ/9:'^J_Z9^7_P#9M_
M[][=OD_],]OD_P#+'R?^)< >YV&JV.IINL[F.4[ [1YPZ LR_.A^93N1U(8
M@HP/((%RO!(9YK%R\$LELZ(R%D8Q%5VE6''E[1MB((_=X$1'[GR?^)=V>E?$
M2XMLQZQ#YL<<1!EC 20NN_E]VQ>=C DB/:8W8A0LZ6H!Z115.PU6QU--UG<Q
MRG8':/.'0%F7YT/S*=R.I# $%&!Y! N4 %%%% !1110 4444 %%%% !1110
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MK_Z*6N@H **** *>I:3INLVZV^J:?:7T"OO6.ZA650V",@,",X)Y]S7F>H_
MKPQ)XCT6>PTN"+2(O/\ [2@>[GWS90"+:=QQALD\K^/2O6** ,_1M#TOP]IR
M6&D6$%E:K@[(4QN( &YCU9L 98Y)QR:T*** .+U+X4>#M9N%N-4TZ[OIU38L
MEUJ=U*P7). 6D)QDGCW-=!HGA_3_  ];_9].^UK!L1%CFO9IUC51A0@D=@@
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M58<>7M&V(@C]W@1$?N?)_P")=V>E?$2XMLQZQ#YL<<1!EC 20NN_E]VQ>=C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9M_[][=OD_\ 3/;Y/_+'R?\ B7;>F>$=:OWC$=E):QAT7S9E,0C&U6#!<(V
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MAMP' PRJ,%-H7E8\?ZOA8R/*"*;#(_U7_3/R_P#@&S;_ -^]NWR?^F>WR?\
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M+5;'2+=;C4+F.WB9]@9SWP2?P"AF)Z*JLQP%)'G>O^/;R[^U6MB/LEH?E$K
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MLV$;0%"K\T:-P!C9&HPD<:IT%%% !1110 4444 %%%% !1110 4444 %%%%
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M\_%[_P!]I_\ $T#X?:1YD+/<7["(DJOG!>NTGE0".51@000R(P(95( /+/\
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M]TG_ )^+W_OM/_B: .LHKD_^%>Z3_P _%[_WVG_Q-'_"O=)_Y^+W_OM/_B:
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M_P#A7ND_\_%[_P!]I_\ $T?\*]TG_GXO?^^T_P#B: .LHKD_^%>Z3_S\7O\
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M_P#A7ND_\_%[_P!]I_\ $T?\*]TG_GXO?^^T_P#B: .LHKD_^%>Z3_S\7O\
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MPJA<!-FW#1H?E(P H788K=H<>[^'>J6WG/9S031Q<PJI\N1@NS: !M56^48
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M3_XFC_A7ND_\_%[_ -]I_P#$T =917)_\*]TG_GXO?\ OM/_ (FC_A7ND_\
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MG_Q- '645R?_  KW2?\ GXO?^^T_^)H_X5[I/_/Q>_\ ?:?_ !- '645R?\
MPKW2?^?B]_[[3_XFC_A7ND_\_%[_ -]I_P#$T =917)_\*]TG_GXO?\ OM/_
M (FC_A7ND_\ /Q>_]]I_\30!UE%<G_PKW2?^?B]_[[3_ .)H_P"%>Z3_ ,_%
M[_WVG_Q- '645R?_  KW2?\ GXO?^^T_^)H_X5[I/_/Q>_\ ?:?_ !- '645
MR?\ PKW2?^?B]_[[3_XFC_A7ND_\_%[_ -]I_P#$T =917)_\*]TG_GXO?\
MOM/_ (FC_A7ND_\ /Q>_]]I_\30!UE%<G_PKW2?^?B]_[[3_ .)H_P"%>Z3_
M ,_%[_WVG_Q- '645R?_  KW2?\ GXO?^^T_^)H_X5[I/_/Q>_\ ?:?_ !-
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M_P"%>Z3_ ,_%[_WVG_Q- '645R?_  KW2?\ GXO?^^T_^)H_X5[I/_/Q>_\
M?:?_ !- '645%:VZ6EG#;1EBD,:QJ6ZD 8&:EH **** "BBB@ HHHH ****
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M_P#3/;Y/_+'R?^)=[_4<T$-R@2>*.5 ZN%=0P#*P93SW# $'L0#0!X)_JO\
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M+6-2VAYOL21;]RV[/%UW@[B65OE577DIC9(Q\IUD:QP/]5_TS\O_ (!LV_\
M?O;M\G_IGM\G_ECY/_$NK^&KK_A*+-;C1K>>9H]HDAB3+P-E0H.S:%Y6/:04
M7Y$*F,1J=/\ 1](^'&S<VJW.W;L\I+*3;MQL)^;:N,;%4;0N-BLNS9 EN <)
M!!-+<16]O%(9RX2..-2&W X  &P@@Q=/W>WR?^6/D_\ $N[/1OAW</LEU.;[
M*L<H @@(+,BXY#KM"<I'M*@85%($96!+7T"TL+/3XC%96D%M&=N4AC" [5"+
MP/1551Z!0.@JQ0!3TW2K'2+=K?3[:.WB9]Y5!WP /P"A5 Z*JJHP% %RBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .?\"?\D\\,_P#8*M?_ $4M=!7/^!/^2>>&?^P5
M:_\ HI:Z"@ HHHH **** "BBB@#'U_PY9^(_[+^V23I_9NH1:A#Y+ ;I(\[0
MV0<KR<@8/O6Q110 4444 %%%% !1110 4444 %%%% !7/^(?^0YX3_["K_\
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M2[WNJ=_I5CJ:;;RVCE.PHLF,.@+*WR./F4[D1@5((**1R 0 >&?ZK_IGY?\
MP#9M_P"_>W;Y/_3/;Y/_ "Q\G_B7=/I7CK5-+S'=G[7")3)*;AL2*/GW@,VT
M+RKGYE4*8W!$2B5;+0U7X=W%MB31YO-CCB!$4A"2%UV<)MV+SL4@ Q[3&B@J
M%@>UXR:":Q<)/%);.B*X5U,15=H93SY>T;8@0?W>!$#^Y\G_ (EP!['I7B?2
M]7RL,_E3>:8A!<?NY&(WXPIYY$<AQU!1U8*R.J[%> ?ZK_IGY?\ P#9M_P"_
M>W;Y/_3/;Y/_ "Q\G_B7=/I7CK5-+S'=G[7")3)*;AL2*/GW@,VT+RKGYE4*
M8W!$2B5;( ]8HK'TKQ/I>KY6&?RIO-,0@N/W<C$;\84\\B.0XZ@HZL%9'5=B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P]3\7:+I:2&2]CED1'
M;RH6#$E692I;.U3E)/O%0!%*Q(6-RH!N5'//#:V\MQ<2QPP1(7DDD8*J*!DD
MD\  =Z\[UGXB7#[XM,A^RK'*29YP"S(N>"C;0G*2;@Q&%1@3&5G>UY"[O[RZ
ME$M[=SRR1;L/-(<Q_,7;D[-N&C9C_J\&(G]R8?\ B7@'I^L^.M+TO?'"?MD\
M<ICE1&V*@7.\EV^7C;(.N-T<FXJL4KQ\7J?CG6KU)(S+'91E'21804(&YB<L
MQ5E(",N<QD!)2?*82M9<Y_JO^F?E_P# -FW_ +][=OD_],]OD_\ +'R?^)=8
MM+"\NI3%96D\LD6W*0QG,?S!%X&S;AHU4?ZO!B _<F'_ (EX!'//-+<2W%Q+
M(9RY>221B&W Y)).P@@Q=?W>WR?^6/D_\2Z/_5?],_+_ . ;-O\ W[V[?)_Z
M9[?)_P"6/D_\2[L]'^'E\]Q"^HO';6Z.0T<,G[S"E0NTJ %!V+AAM*B-"%0B
M!+3L-,\(Z+I:1B.RCED1$7S9E#$E65@P7&U3E(_NA0!%$H 6- H!Y?H_A_4M
M6N(8[2VDCC+E?M#(R1Q;"H/("$%2L8VJ$8%$4")HU&G]AIGPVAC2-]0O)-X1
M#Y5KA!&P920' &0%2, JJ8*AE">7;K!WE% &?I^AZ7I6#8V$$#+N"LJ?,H;;
ME0>H7"1@+T"QHH "J!H444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@"GJNE6.MZ7<:9J=M'<V=PFR6)QPP_F"#@@CD$
MCD5X)_Q/?@#XH_Y;ZGX+U&7VW(V/P"S #V611V(^3Z'JGJNE6.MZ7<:9J=M'
M<V=PFR6)QPP_F"#@@CD$ CD4 >$:!H&M?&_Q*OB?Q.LEKX7MG*V=DCD"4 \H
MAX.,CYY."2-JXQ\GO\$$-K;Q6]O%'#!$@2..-0JHH&  !P !VH@@AM;>*WMX
MHX8(D"1QQJ%5% P  .  .U24 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"4DEH1MX  Y7@<<#.TF@#J/@/\1;72H+CPOK-S(D3.9[!RCN%."9(^"=HXW
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M )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\
MR#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^%
M%'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_
M  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_
M^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-
M'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?
M^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG
M_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I
M/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:
M!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#
M_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@
M79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+L
MO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\
M^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\
M@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P"
MZ?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'
M3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\
MB:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_
M  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\
MA,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^
MQ-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V
M)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@
M?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\
M_P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79
M?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0
M+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_
M )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\
MR#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^%
M%'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_
M  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_
M^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-
M'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?
M^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG
M_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I
M/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:
M!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#
M_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@
M79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+L
MO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\
M^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\
M@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P"
MZ?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'
M3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\
MB:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_
M  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\
MA,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^
MQ-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V
M)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@
M?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\
M_P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79
M?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0
M+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_
M )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\
MR#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^%
M%'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_
M  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_
M^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-
M'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?
M^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG
M_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I
M/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:
M!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#
M_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@
M79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\ B:O?V)I/_0+L
MO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\
M^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\ A,M _P"?_P#\
M@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^Q-)_Z!=E_P"
MZ?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V)I/_ $"[+_P'
M3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@?\__ /Y!D_\
MB:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\ _P @R?\ Q-'_
M  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79?^ Z?X4 4?\
MA,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0+LO_  '3_"C^
MQ-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D_P#B:O?V
M)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\ R#)_\31_PF6@
M?\__ /Y!D_\ B:O?V)I/_0+LO_ =/\*/[$TG_H%V7_@.G^% %'_A,M _Y_\
M_P @R?\ Q-'_  F6@?\ /_\ ^09/_B:O?V)I/_0+LO\ P'3_  H_L32?^@79
M?^ Z?X4 4?\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)J]_8FD_P#0
M+LO_  '3_"C^Q-)_Z!=E_P" Z?X4 4?^$RT#_G__ /(,G_Q-'_"9:!_S_P#_
M )!D_P#B:O?V)I/_ $"[+_P'3_"C^Q-)_P"@79?^ Z?X4 4?^$RT#_G_ /\
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M-H\JR+/!;AIT=E8I*Y+R+E>" S,!C/ ')ZUTE%% !1110 5S_B'_ )#GA/\
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M%]@HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\7_^2A_#'_L*G_T;;U[!7C_Q?_Y*'\,?^PJ?_1MO7L% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***\_P#BG\2+/P-H<EO#-NUV[B86<*8)BSD><V00%!Z CYB,
M=-Q !R?QS^)C:-;S>$-*$;7=Y;XOIR5;R8G!'E@=G9>23T5@1DL"OS94D\\U
MU<2W%Q+)-/*Y>221BS.Q.223R23WKO/A9\-[SQSKD=Q-#LT*TE4WDSY EQ@F
M%<$$L1U(/R@YZ[00#J/@I\++?Q'CQ/KL7F:;#*4M;1T.VY=<9=LC#1@\8&=S
M @\*0WN__"">#_\ H5-#_P#!=#_\36Y!!#:V\5O;Q1PP1($CCC4*J*!@  <
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M_P"A6O?S?_XBNLHH Y/_ (2S5O\ H5KW\W_^(H_X2S5O^A6O?S?_ .(KK**
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M_P"$LU;_ *%:]_-__B*ZRB@#D_\ A+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\
MXBNLHH Y/_A+-6_Z%:]_-_\ XBC_ (2S5O\ H5KW\W_^(KK** .3_P"$LU;_
M *%:]_-__B*/^$LU;_H5KW\W_P#B*ZRB@#D_^$LU;_H5KW\W_P#B*/\ A+-6
M_P"A6O?S?_XBNLHH Y/_ (2S5O\ H5KW\W_^(H_X2S5O^A6O?S?_ .(KK**
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M_P"$LU;_ *%:]_-__B*ZRB@#D_\ A+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\
MXBNLHH Y/_A+-6_Z%:]_-_\ XBC_ (2S5O\ H5KW\W_^(KK** .3_P"$LU;_
M *%:]_-__B*/^$LU;_H5KW\W_P#B*ZRB@#D_^$LU;_H5KW\W_P#B*/\ A+-6
M_P"A6O?S?_XBNLHH Y/_ (2S5O\ H5KW\W_^(H_X2S5O^A6O?S?_ .(KK**
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M_P"$LU;_ *%:]_-__B*ZRB@#D_\ A+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\
MXBNLHH Y/_A+-6_Z%:]_-_\ XBC_ (2S5O\ H5KW\W_^(KK** .3_P"$LU;_
M *%:]_-__B*/^$LU;_H5KW\W_P#B*ZRB@#D_^$LU;_H5KW\W_P#B*/\ A+-6
M_P"A6O?S?_XBNLHH Y/_ (2S5O\ H5KW\W_^(H_X2S5O^A6O?S?_ .(KK**
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M_P"$LU;_ *%:]_-__B*ZRB@#D_\ A+-6_P"A6O?S?_XBC_A+-6_Z%:]_-_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<((LC=(W(& #TR,G ')%?9?ACPQI?A'0X=(TB#RK>/EF;EY7/5W/=CC]
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M=;58&1INPW,!@;ERI7&5W&34->U3X2ZY80ZUJE]K/A&_S$EW=KYES82CD[Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'_QNNLHH Y/[!XU_Z"]E_P!\#_XW1]@\:_\ 07LO^^!_\;KK** .3^P>-?\
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MLHH Y/[!XU_Z"]E_WP/_ (W1]@\:_P#07LO^^!_\;KK** .3^P>-?^@O9?\
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M#D_L'C7_ *"]E_WP/_C='V#QK_T%[+_O@?\ QNNLHH Y/[!XU_Z"]E_WP/\
MXW1]@\:_]!>R_P"^!_\ &ZZRB@#D_L'C7_H+V7_? _\ C='V#QK_ -!>R_[X
M'_QNNLHH Y/[!XU_Z"]E_P!\#_XW1]@\:_\ 07LO^^!_\;KK** .3^P>-?\
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M\#_XW1]@\:_]!>R_[X'_ ,;KK** .3^P>-?^@O9?]\#_ .-T?8/&O_07LO\
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M_P!!>R_[X'_QNNLHH Y/[!XU_P"@O9?]\#_XW1]@\:_]!>R_[X'_ ,;KK**
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M!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ KG_$/_(<\)_\ 85?_ -(KJN@KG_$/_(<\)_\
M85?_ -(KJ@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N'^*?@5/'/A*2WB&-3L]T]DP5<LX4_NB6QA7X!Y'(4G.W![BB@#X$G
M@FM;B6WN(I(9XG*21R*59&!P00>00>U>H?!+X@KX3\0-I&I3QQZ/J3C?+-(P
M6VE .U_0!N%8D#^$D@+SN?'[P%]@U&/Q7I5EMM+GY=0\E/ECFSQ(W/&_."0
M-RY))?GP^@#[_HKS/X-?$%?&'AI=/OYX_P"VM.01R*9&9YX@ %F.[DDGAN3S
MR<;@*],H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M< _2@#K/AQ8V^G_#7PY#:Q^7&VGPS$;B<O(HD<\^K,Q]L\<5C_&W_DD.N_\
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M +[3_P")KK** .3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)KK**
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MFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\
MS\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'
M_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?B]_[
M[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[
MI/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_
M !-'_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?
MB]_[[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_
M (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\
M?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I_P#$T?\ "O=)
M_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH
M Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q
M>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I_P#$T?\
M"O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[3_XF
MNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\ X5[I
M/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I_P#$
MT?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B]_[[
M3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH Y/\
MX5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y/_A7ND_\_%[_ -]I
M_P#$T?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_]]I_\31_PKW2?^?B
M]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\ OM/_ (FNLHH
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M\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GXO?\
MOM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNLHH Y
M/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\ /Q>_
M]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]TG_GX
MO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\ XFNL
MHH Y/_A7ND_\_%[_ -]I_P#$T?\ "O=)_P"?B]_[[3_XFNLHH Y/_A7ND_\
M/Q>_]]I_\31_PKW2?^?B]_[[3_XFNLHH Y/_ (5[I/\ S\7O_?:?_$T?\*]T
MG_GXO?\ OM/_ (FNLHH Y/\ X5[I/_/Q>_\ ?:?_ !-'_"O=)_Y^+W_OM/\
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M%% !1110 4444 %%%% !1110!S_@3_DGGAG_ +!5K_Z*6N@KG_ G_)//#/\
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M@ HHHH **** "O,_C+\/E\8>&FU"P@C_ +:TY#)&PC9GGB ):$;>22>5X//
MQN)KTRB@#X KVSX"_$%M-U0>$M3GD:SO7_T%GD4);R\DISSASC !^]C RY-4
M_COX _L#7/\ A);"/&FZG*?/!EW%+IMS-@'G:P!8<G!#=!M%>/T ??\ 17G_
M ,)/'_\ PG/A?_3)-VLV&V.^Q%L5LEMCC''S!3G&/F#< 8SZ!0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M Y_P)_R3SPS_ -@JU_\ 12UT%<_X$_Y)YX9_[!5K_P"BEKH* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N?\0_\ASPG_P!A5_\ TBNJ
MZ"N?\0_\ASPG_P!A5_\ TBNJ .@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH S]<T:S\0Z'>Z1?IOM;N)HGP
M2N>C+D$!@<$''! -?%GB[PO?>#_$MWH]_'(#$Y,,K)M$\63MD7DC! Z9.#D'
MD&ON.O,_C+\/E\8>&FU"P@C_ +:TY#)&PC9GGB ):$;>22>5X// QN)H ^;/
M!?BR\\%>*+76K-/-\K*30&0JLT;##*2/P(SD!@IP<8K[3TK5;'6]+M]3TRYC
MN;.X3?%*AX8?S!!R"#R""#R*^#*]P^ /CW[!J,GA35;W;:7/S:?YS_+'-GF-
M>.-^<@$@;EP 2_(!]'T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%1SSPVMO+<7$L<,$2%Y))&"JB@9))/
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MBL+_ (3+0/\ G_\ _(,G_P 31_PF6@?\_P#_ .09/_B: -VBL+_A,M _Y_\
M_P @R?\ Q-'_  F6@?\ /_\ ^09/_B: -VBL+_A,M _Y_P#_ ,@R?_$T?\)E
MH'_/_P#^09/_ (F@#=HK"_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_ .)H
M W:*PO\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)H W:*PO^$RT#_G
M_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^)H W:*PO^$RT#_G_ /\ R#)_\31_
MPF6@?\__ /Y!D_\ B: -VBL+_A,M _Y__P#R#)_\31_PF6@?\_\ _P"09/\
MXF@#=HK"_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XF@#=HK"_X3+0
M/^?_ /\ (,G_ ,31_P )EH'_ #__ /D&3_XF@#=HK"_X3+0/^?\ _P#(,G_Q
M-'_"9:!_S_\ _D&3_P")H W:*PO^$RT#_G__ /(,G_Q-'_"9:!_S_P#_ )!D
M_P#B: -VBL+_ (3+0/\ G_\ _(,G_P 31_PF6@?\_P#_ .09/_B: -VBL+_A
M,M _Y_\ _P @R?\ Q-'_  F6@?\ /_\ ^09/_B: -VBL+_A,M _Y_P#_ ,@R
M?_$T?\)EH'_/_P#^09/_ (F@#=HK"_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\
MD&3_ .)H W:*PO\ A,M _P"?_P#\@R?_ !-'_"9:!_S_ /\ Y!D_^)H W:*P
MO^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^)H W:*PO^$RT#_G_ /\
MR#)_\31_PF6@?\__ /Y!D_\ B: -VBL+_A,M _Y__P#R#)_\31_PF6@?\_\
M_P"09/\ XF@#=HK"_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XF@#=
MHK"_X3+0/^?_ /\ (,G_ ,31_P )EH'_ #__ /D&3_XF@#=HK"_X3+0/^?\
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MD_\ B:/^$RT#_G__ /(,G_Q- &[16%_PF6@?\_\ _P"09/\ XFC_ (3+0/\
MG_\ _(,G_P 30!NT5A?\)EH'_/\ _P#D&3_XFC_A,M _Y_\ _P @R?\ Q- &
M[14<$T=S;QSQ-NCD4.C8QD$9%24 %%%% !1110 4444 %%%% !1110 4444
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M)_Z!=E_X#I_A1_8FD_\ 0+LO_ =/\*OT4 4/[$TG_H%V7_@.G^%']B:3_P!
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M  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!0_L32?\
MH%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#I_A1_8FD_P#0
M+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!0_L3
M2?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#I_A1_8FD
M_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!
M0_L32?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#I_A1
M_8FD_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ
M_10!0_L32?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#
MI_A1_8FD_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !
MT_PJ_10!0_L32?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=
ME_X#I_A1_8FD_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+
M_P !T_PJ_10!0_L32?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_
M *!=E_X#I_A1_8FD_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\
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M Z?X4?V)I/\ T"[+_P !T_PJ_10!0_L32?\ H%V7_@.G^%']B:3_ - NR_\
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M  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!0_L32?\
MH%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#I_A1_8FD_P#0
M+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!0_L3
M2?\ H%V7_@.G^%']B:3_ - NR_\  =/\*OT4 4/[$TG_ *!=E_X#I_A1_8FD
M_P#0+LO_  '3_"K]% %#^Q-)_P"@79?^ Z?X4?V)I/\ T"[+_P !T_PJ_10!
M0_L32?\ H%V7_@.G^%</\3?%.@_#[0XY1HME<:G>;DLH6MEV$KC<[D#[J[EX
M!R<@#')'7^)_$^E^$=#FU?5Y_*MX^%5>7E<]$0=V./T)) !(^,/$_B?5/%VN
M3:OJ\_FW$G"JO"1(.B(.RC/ZDDDDD@&3)(\LC22.SR.2S,QR6)ZDGUKMOAE\
M.[CX@ZY)$9OL^F6>U[V92-X#9VH@/\3;6Y(P,$G/ //^&/#&J>+M<ATC2(/-
MN).69N$B0=7<]E&?U  )(!^S_#'AC2_".APZ1I$'E6\?+,W+RN>KN>[''Z
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MM-2AGBMVN&:ZC15*AE7 VNQSEQV]:[RO'_#W_)T/BS_L%)_Z#:U[!0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 5S_B'_D.>$_\ L*O_ .D5U705S_B'_D.>$_\
ML*O_ .D5U0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>/_ +./_)/-0_["LG_HJ*O8*\?_
M &<?^2>:A_V%9/\ T5%0!Y9\9?A\W@_Q*VH6$$G]BZBYDC81JJ02DDM"-O
M'*\#C@9VDUYO!/-:W$5Q;RR0SQ.'CDC8JR,#D$$<@@]Z^W_%WA>Q\8>&KO1[
M^.,B5"8963<8)<';(O(.03TR,C(/!-?%FN:->>'M<O=(OTV75I*T3X! ;'1E
MR 2I&"#CD$&@#Z3\+_'_ ,+ZCI:'Q!))I6H(BB4"!Y(I&YR8R@8@< X8#&[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBC_A+-6_Z%:]_-__ (B@#K**Y/\ X2S5O^A6O?S?_P"(H_X2S5O^A6O?S?\
M^(H ZRBN3_X2S5O^A6O?S?\ ^(H_X2S5O^A6O?S?_P"(H ZRBN3_ .$LU;_H
M5KW\W_\ B*/^$LU;_H5KW\W_ /B* .LHKD_^$LU;_H5KW\W_ /B*/^$LU;_H
M5KW\W_\ B* .LHKD_P#A+-6_Z%:]_-__ (BC_A+-6_Z%:]_-_P#XB@#K**Y/
M_A+-6_Z%:]_-_P#XBC_A+-6_Z%:]_-__ (B@#K**Y/\ X2S5O^A6O?S?_P"(
MH_X2S5O^A6O?S?\ ^(H ZRBN3_X2S5O^A6O?S?\ ^(H_X2S5O^A6O?S?_P"(
MH ZRBN3_ .$LU;_H5KW\W_\ B*/^$LU;_H5KW\W_ /B* .LHKD_^$LU;_H5K
MW\W_ /B*/^$LU;_H5KW\W_\ B* .LHKD_P#A+-6_Z%:]_-__ (BC_A+-6_Z%
M:]_-_P#XB@#K**Y/_A+-6_Z%:]_-_P#XBC_A+-6_Z%:]_-__ (B@#K**Y/\
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M]C26LRRJ&P#@E21G!''N*N5\ 5N0>-/%5K;Q6]OXEUF&") D<<=_*JHH&
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MBC_A+-6_Z%:]_-__ (B@#K**Y/\ X2S5O^A6O?S?_P"(H_X2S5O^A6O?S?\
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M:]_-_P#XB@#K**Y/_A+-6_Z%:]_-_P#XBC_A+-6_Z%:]_-__ (B@#K**Y/\
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M).69N$B0=7<]E&?U  )(!^S_  QX8TOPCH<.D:1!Y5O'RS-R\KGJ[GNQQ^@
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M2S5O^A6O?S?_ .(H ZRBN3_X2S5O^A6O?S?_ .(H_P"$LU;_ *%:]_-__B*
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MB@ HHHH **** "BBB@ HHHH **** "N?_P"$$\'_ /0J:'_X+H?_ (FN@HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,GQM^)
M\/B2X7P[H-W(^EV[DW<T;#R[N0$8 [E%(/.<,3G'RJQ[?XV_$^;PW;KX=T&[
MC35+A";N:-CYEI&0, =@[ GG.5 SCYE8?,E !7TW\$OAA-X;MV\1:]:1IJEP
M@%I#(I\RTC(.2>P=@1QC*@8S\S*.(^"7PPA\27#>(M>M)'TNW<"TAD4>7=R
MG)/<HI XQAB<9^5E/TW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 <_X$_Y)YX9_P"P5:_^BEKH*Y_P)_R3SPS_ -@JU_\
M12UT% !1110 4444 %<OXT\ :%X\LX8-8CG$EON^SSP2E'BW%2V <J<[ /F!
M]L'FNHHH \3\7> _&EHGA^WM?&&I:M:1Z[ UN)M.6>6RRSD3R2Y)D"9YW87D
M=!@5VGA3X:V>@:Y<>(]3U"?6_$5SGS+^Y0*$SD?NT&=GRX7J< 87:"17<44
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MY)W YSSG-?/'P9\ :%X\L_$4&L1SB2W^S?9YX)2CQ;C(6P#E3G8!\P/M@\T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '/\ @3_DGGAG_L%6O_HI:Z"N?\"?\D\\,_\ 8*M?_12U
MT% !1110 4444 %%%% !15>ZO[.Q\C[9=P6_GRK!#YT@3S)&^ZBYZL<' ')J
MQ0 4444 %%%% !1110 4444 %%%% !7/^(?^0YX3_P"PJ_\ Z175=!7/^(?^
M0YX3_P"PJ_\ Z175 '04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M856).>G!QW% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7C_ (>_Y.A\6?\ 8*3_ -!M
M:]@KQ?2[^STS]I7QA>7]W!:6L>E1[YIY!&BY%J!ECP,D@?C0![14<\\-K;RW
M%Q+'#!$A>221@JHH&223P !WKS/Q%\>?!VB^9%8RSZO=+YBA;1,1AUX ,C8!
M4G^) _ )],^*?$#XOZUX[M_[/$$>FZ3O#FVB<LTI &/,?C< P)   Y&<D @
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MC7_H+V7_ 'P/_C= '645R?V#QK_T%[+_ +X'_P ;H^P>-?\ H+V7_? _^-T
M=917)_8/&O\ T%[+_O@?_&Z/L'C7_H+V7_? _P#C= '645R?V#QK_P!!>R_[
MX'_QNC[!XU_Z"]E_WP/_ (W0!UE%<G]@\:_]!>R_[X'_ ,;H^P>-?^@O9?\
M? _^-T =917)_8/&O_07LO\ O@?_ !NC[!XU_P"@O9?]\#_XW0!UE%<G]@\:
M_P#07LO^^!_\;H^P>-?^@O9?]\#_ .-T =917)_8/&O_ $%[+_O@?_&Z/L'C
M7_H+V7_? _\ C= '645R?V#QK_T%[+_O@?\ QNC[!XU_Z"]E_P!\#_XW0!UE
M%<G]@\:_]!>R_P"^!_\ &Z/L'C7_ *"]E_WP/_C= '645R?V#QK_ -!>R_[X
M'_QNC[!XU_Z"]E_WP/\ XW0!UE%<G]@\:_\ 07LO^^!_\;H^P>-?^@O9?]\#
M_P"-T =917)_8/&O_07LO^^!_P#&Z/L'C7_H+V7_ 'P/_C= '645R?V#QK_T
M%[+_ +X'_P ;H^P>-?\ H+V7_? _^-T =917)_8/&O\ T%[+_O@?_&Z/L'C7
M_H+V7_? _P#C= '645R?V#QK_P!!>R_[X'_QNC[!XU_Z"]E_WP/_ (W0!UE%
M<G]@\:_]!>R_[X'_ ,;H^P>-?^@O9?\ ? _^-T =917)_8/&O_07LO\ O@?_
M !NC[!XU_P"@O9?]\#_XW0!UE%<G]@\:_P#07LO^^!_\;H^P>-?^@O9?]\#_
M .-T =917)_8/&O_ $%[+_O@?_&Z/L'C7_H+V7_? _\ C= '65Q_B[X9>%O&
MFZ74K'RKYL?Z=:$1S?P]3@A^%"_,&P,XQ4GV#QK_ -!>R_[X'_QNC[!XU_Z"
M]E_WP/\ XW0!X9XR^ .NZ-YUYX>E_M>Q7+>3@+<QK\QQMZ28 497#,3PE>3W
MUA>:9>26=_:3VEU'C?#/&8W7(!&5/(R"#^-?9?V#QK_T%[+_ +X'_P ;K'\0
M^!M8\5V:VNN2:7>QK]PO'AX\D$[7"!ESM&<$9Q@\4 ?(E=QX8^+?C'PK%#;6
MNI_:K&'A;2]7S4 V[0H/#JH &%5@!CIR<]WJ_P"SCJKR>9I&I6$:L>8;B1\+
MUZ,$)QT&"/QKR3Q#X5UWPI>+:ZYID]E(WW"X!23 !.UQE6QN&<$XS@\T ?1_
MACX_>%M:EAMM4BGT:ZDX+3$20!BV%'F#D9!R2RJHP<GC)]4@GANK>*XMY8YH
M)4#QR1L&5U(R""."".]? E;F@>,?$?A9U;1=8N[1 Y?R5?=$S%=I+1ME&.,<
MD'H/04 ?<=%?-&C_ !]UF::&#5IEMPQVO<Q1*R+ENI3:6  Y."QXX'->MZ->
M^(?$.G)?Z1XFTN]M6P-\.#M) .UAY>5;!&5.",\B@#O**Y/[!XU_Z"]E_P!\
M#_XW1]@\:_\ 07LO^^!_\;H ZRBN3^P>-?\ H+V7_? _^-T?8/&O_07LO^^!
M_P#&Z .LHKD_L'C7_H+V7_? _P#C='V#QK_T%[+_ +X'_P ;H ZRBN3^P>-?
M^@O9?]\#_P"-T?8/&O\ T%[+_O@?_&Z .LHKD_L'C7_H+V7_ 'P/_C='V#QK
M_P!!>R_[X'_QN@#K**Y/[!XU_P"@O9?]\#_XW1]@\:_]!>R_[X'_ ,;H ZRB
MN3^P>-?^@O9?]\#_ .-T?8/&O_07LO\ O@?_ !N@#K**Y/[!XU_Z"]E_WP/_
M (W1]@\:_P#07LO^^!_\;H ZRBN3^P>-?^@O9?\ ? _^-T?8/&O_ $%[+_O@
M?_&Z .LHKD_L'C7_ *"]E_WP/_C='V#QK_T%[+_O@?\ QN@#K**Y/[!XU_Z"
M]E_WP/\ XW1]@\:_]!>R_P"^!_\ &Z .LHKD_L'C7_H+V7_? _\ C='V#QK_
M -!>R_[X'_QN@#K**Y/[!XU_Z"]E_P!\#_XW1]@\:_\ 07LO^^!_\;H ZRBN
M3^P>-?\ H+V7_? _^-T?8/&O_07LO^^!_P#&Z .LHKD_L'C7_H+V7_? _P#C
M='V#QK_T%[+_ +X'_P ;H ZRBN3^P>-?^@O9?]\#_P"-T?8/&O\ T%[+_O@?
M_&Z .LHKD_L'C7_H+V7_ 'P/_C='V#QK_P!!>R_[X'_QN@#K**Y/[!XU_P"@
MO9?]\#_XW1]@\:_]!>R_[X'_ ,;H ZRBN3^P>-?^@O9?]\#_ .-T?8/&O_07
MLO\ O@?_ !N@#K**Y/[!XU_Z"]E_WP/_ (W1]@\:_P#07LO^^!_\;H ZRBN3
M^P>-?^@O9?\ ? _^-T?8/&O_ $%[+_O@?_&Z .LHKD_L'C7_ *"]E_WP/_C=
M'V#QK_T%[+_O@?\ QN@#K**Y/[!XU_Z"]E_WP/\ XW1]@\:_]!>R_P"^!_\
M&Z .LHKQ?7_BFOA]&W>+].U"?8'6'3D6<L"V/OA-@(Y)!8' ]QGSW5?CYXOG
M=X],N8[6+HLCP1O)UZ_=VC(QQ@]^: /J:>>&UMY;BXECA@B0O))(P544#)))
MX  [UY_K_P ;?!&@NT2ZA)J<ZN%:/3D$H *YW;R0A'0'#$Y.,<''RQK?B36O
M$=QY^LZI=WSAW=!-*66,L<ML7H@.!PH X'I670![)K_[17B/4$:+1=/M-)1D
M \QC]HE5@V25+ )@C P4/?GICR.^O[S4[R2\O[N>[NI,;YIY#([8  RQY.
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M$ES,YPD:#J23R< G ) .,5)XG\3Z7X1T.;5]7G\JWCX55Y>5ST1!W8X_0DD
M$CRO0/B;X*NM47Q/XGU^,ZP4*V=DEK</%I<3=40^7AI6'WY._P!U<*.0#O/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?\
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M&:L>'O"NA>%+-K70],@LHV^^4!+R8)(W.<LV-QQDG&<#BMBB@ HHHH ****
M"N?\0_\ (<\)_P#85?\ ](KJN@KG_$/_ "'/"?\ V%7_ /2*ZH Z"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH Y_P 1^"/#7B[RSKFD07<D> LN6CD
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MT!8#'.2,<CU%?+GB?XM^,?%44UM=:G]EL9N&M+)?*0C;M*D\NRD$Y5F(.>G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"1&P2#AAP<$$?A0!8HHHH **** "N?\ $/\ R'/"?_85?_TBNJZ"N?\ $/\
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M,YZ@<^M^%_A5X0\*(C6FEQW5VCJXO+X":4,K$J5)&$(SU0+T&<D9H ^6- \
M>*_%"++I&AW<\#(76=E$43@-M.V1R%)SQ@'/!]#7K&@?LV3%UD\1ZY&J!R#!
MIR%BR[>#YC@;3NZC8>!UYX^@Z* ./\._"[P=X8\N2QT6"6Z3RR+J['G2;TZ.
M"V0C9Y^0+SCC@8["BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^+W_ +[3_P")H_X5[I/_ #\7O_?:?_$T =917)_\*]TG_GXO?^^T_P#B:/\
MA7ND_P#/Q>_]]I_\30!UE%<G_P *]TG_ )^+W_OM/_B:/^%>Z3_S\7O_ 'VG
M_P 30!UE%<G_ ,*]TG_GXO?^^T_^)H_X5[I/_/Q>_P#?:?\ Q- '645R?_"O
M=)_Y^+W_ +[3_P")H_X5[I/_ #\7O_?:?_$T =917)_\*]TG_GXO?^^T_P#B
M:/\ A7ND_P#/Q>_]]I_\30!UE%<G_P *]TG_ )^+W_OM/_B:/^%>Z3_S\7O_
M 'VG_P 30!UE%<G_ ,*]TG_GXO?^^T_^)H_X5[I/_/Q>_P#?:?\ Q- '645R
M?_"O=)_Y^+W_ +[3_P")H_X5[I/_ #\7O_?:?_$T =917)_\*]TG_GXO?^^T
M_P#B:/\ A7ND_P#/Q>_]]I_\30!UE%<G_P *]TG_ )^+W_OM/_B:/^%>Z3_S
M\7O_ 'VG_P 30!UE%<G_ ,*]TG_GXO?^^T_^)H_X5[I/_/Q>_P#?:?\ Q- '
M645R?_"O=)_Y^+W_ +[3_P")H_X5[I/_ #\7O_?:?_$T =917)_\*]TG_GXO
M?^^T_P#B:/\ A7ND_P#/Q>_]]I_\30!UE%<G_P *]TG_ )^+W_OM/_B:/^%>
MZ3_S\7O_ 'VG_P 30!UE%<G_ ,*]TG_GXO?^^T_^)H_X5[I/_/Q>_P#?:?\
MQ- '645R?_"O=)_Y^+W_ +[3_P")H_X5[I/_ #\7O_?:?_$T =917)_\*]TG
M_GXO?^^T_P#B:/\ A7ND_P#/Q>_]]I_\30!UE9>M^&]%\1V_D:SI=I?($=$,
MT09HPPPVQNJ$X'*D'@>E8_\ PKW2?^?B]_[[3_XFC_A7ND_\_%[_ -]I_P#$
MT >8>*_V<EFN#<>%-3C@1WRUI?EBJ EC\LB@G ^4!6!/4ECTKQ/Q#X5UWPI>
M+:ZYID]E(WW"X!23 !.UQE6QN&<$XS@\U]=_\*]TG_GXO?\ OM/_ (FFR?#G
M1I8VCDENWC<%65F0A@>H(V]* /BZMCP]XJUWPI>-=:'J<]E(WWPA!23 (&Y#
ME6QN.,@XSD<U]":_^SMX?U$^;I&I76F3E\ON19HB.<X3Y2IR1T. !C'>O%_%
M'PJ\7^%'=KO2Y+JT1&<WEB#-$%506+$#* 9ZN%Z'&0,T >J>&/VCK>>6&V\3
MZ3]FW</>63%D!+<$Q'Y@H4\D,QXX'.!['HGB31?$=OY^C:I:7R!$=Q#*&:,,
M,KO7JA.#PP!X/I7PI4D%Q-:S+-;S20RK]UXV*L.W!% 'WW17Q_X?^)<EM=11
M^(+5[RSZ/):LL4PRP^;D%6P,_+A<\?,.<Z_P_P#"'A/XC>*O$0U#4KRSWW7F
M:; L\4<TR,96;*E6W%552=O3)H ^J:*\?_X9Q\'_ /02US_O_#_\:H_X9Q\'
M_P#02US_ +_P_P#QJ@#V"BO'_P#AG'P?_P!!+7/^_P##_P#&J/\ AG'P?_T$
MM<_[_P /_P :H ]@HKYHO/!'ASP-\;-!TIM3G@TJ:R>XFN;ZXC4HQ690-VT*
M 2BCD=36WXB\;_#C1?,BL;W5-7NE\Q0MIM$8=> #(R@%2?XD#\ GTR >^57O
MK^STRSDO+^[@M+6/&^:>01HN2 ,L>!DD#\:^/=7^).I7<[?V7"NGV^04#$32
M#CD%BH4@G)X4=A]>0N;RZO9!)=W,T\@&T-*Y8@>F3VY- 'U#XG^/WA;199K;
M2XI]9NH^ T)$<!8-AAYAY. ,@JK*<C!YR/*/$7QY\8ZUYD5C+!I%JWF*%M$S
M(4;@ R-DA@/XD"<DGTQY?5S3=)U+6;AK?2]/N[Z=4WM':PM*P7(&2%!.,D<^
MXH COK^\U.\DO+^[GN[J3&^:>0R.V  ,L>3@ #\*KU[!X<_9Y\2ZGYCZY=0:
M+&N0J_+<R,>,'"-M"G)YW9R.F#FO3M.^ ?@O3V#D7]U("2&N94;J,8VA I'U
M']* /F71/#>M>([CR-&TN[OG#HCF&(LL98X7>W1 <'EB!P?2O4- _9U\1Z@B
MRZUJ%II*,A/EJ/M$JL&P P4A,$9.0Y[<=<>VQ_#G1HHUCCENTC0!5560!0.@
M V]*=_PKW2?^?B]_[[3_ .)H S] ^#O@CP^B[='CU"?84:;4<3E@6S]PC8".
M "%!P/<Y[RN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y^+W_ +[3_P")H ZRBN3_
M .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H ZRBN3_X5[I/_/Q>_P#?
M:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_ #\7O_?:?_$T?\*]TG_G
MXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y^+W_ +[3_P")H ZR
MBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H ZRBN3_X5[I/_/Q>
M_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_ #\7O_?:?_$T?\*]
MTG_GXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y^+W_ +[3_P")
MH ZRBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H ZRBN3_X5[I/
M_/Q>_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_ #\7O_?:?_$T
M?\*]TG_GXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y^+W_ +[3
M_P")H ZRBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H ZRBN3_X
M5[I/_/Q>_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_ #\7O_?:
M?_$T?\*]TG_GXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y^+W_
M +[3_P")H ZRBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H ZRB
MN3_X5[I/_/Q>_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_ #\7
MO_?:?_$T?\*]TG_GXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O=)_Y
M^+W_ +[3_P")H ZRBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_ .)H
M ZRBN3_X5[I/_/Q>_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5[I/_
M #\7O_?:?_$T?\*]TG_GXO?^^T_^)H ZRBN3_P"%>Z3_ ,_%[_WVG_Q-'_"O
M=)_Y^+W_ +[3_P")H ZRBN3_ .%>Z3_S\7O_ 'VG_P 31_PKW2?^?B]_[[3_
M .)H ZRBN3_X5[I/_/Q>_P#?:?\ Q-'_  KW2?\ GXO?^^T_^)H ZRBN3_X5
M[I/_ #\7O_?:?_$T?\*]TG_GXO?^^T_^)H ZRBHK6W2TLX;:,L4AC6-2W4@#
M S4M !1110 4444 %%%% !1110 4444 %%%% !1110!S_@3_ ))YX9_[!5K_
M .BEKH*Y_P "?\D\\,_]@JU_]%+704 %%%% !1110 5&9X5N$MVEC$\B,Z1E
MAN95(#$#J0"RY/;</6I*\W^)K>*=+USPUXD\-Z3/J<>F_:$O;:%SF2.7REV[
M5.YNA(P&"E0Q&!0 ?&*QM]3T[PG87D?F6MUXELX9DW$;D82!AD<C()Z5YAKU
MKJ/P"\<V=WH=Q/>:)J,7[R"Z=?WVPX=&*_Q+N#*^T8WX^8;@>D\<?%/POK:>
M&%6>[L[O3O$=O<WUG=VKI+;1Q,X<L ",CCY02>>F<@&HVMS\;_&NFS0Z=)!X
M,TAV87UPCH;\%@'5.0<,8]O'*@$L02$H ]SKQ_\ :._Y)YI__85C_P#14M>P
M5X9^T+XDT6]\*V>D6FJ6EQJ$>I[Y;>&4.T01)%;?C.TAF P<'KZ' !ZGX$_Y
M)YX9_P"P5:_^BEKB_P!H+39K[X9&XB:,)87L5Q*&)R5.Z+"\==TB]<< _2N@
M^&?B31=6\%:#8V&J6D]Y;Z9"DULLH\V,HJHVY/O !N,XP<@C@BNLO[&WU/3K
MFPO(_,M;J)H9DW$;D8$,,CD9!/2@#G_AQ?6^H?#7PY-:R>9&NGPPD[2,/&HC
M<<^C*P]\<<5S_P =;ZWM/A1J4,\FR2[E@A@&TG>XD60CCI\J,>?3UQ6/X4UI
M_A%9W'A?QDTZ:3!*7TO68[9G@E1R6\H[%)63(=L'/\7. I:/5'F^->LZ5:6%
ME=P>#-/N#=7=Y=Q&-=096*!(>C8P'&X$8WG< 54, =A\)=-FTKX5^'[>=HV=
M[<W *$D;97:51R!R%<9]\]>M=I110 4444 %<_XA_P"0YX3_ .PJ_P#Z175=
M!7/^(?\ D.>$_P#L*O\ ^D5U0!T%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <_X$_Y)YX9_[!5K_P"BEKH*Y_P)_P D\\,_]@JU_P#12UT% !1110 4
M444 %%%% !1110 445'//#:V\MQ<2QPP1(7DDD8*J*!DDD\  =Z )**\G\7_
M !MTZPTS4_\ A%;>?5KJRV"2]6U9[&%C)MQ(X93R VTC*DD8)YKH+'XK^&I;
MR.RU;[=X>OI,F.WUNU:V+( 3OW'*!20P&6&2I&.F0#N**** "BBB@ HHHH *
MY_Q#_P ASPG_ -A5_P#TBNJZ"N?\0_\ (<\)_P#85?\ ](KJ@#H**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\
M_P#D&3_XFKW]B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\
M\@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#
MI_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_
MPH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^
M)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\
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M%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\
M0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\
M_D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)
M_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_
MA0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]B:3_ - NR_\
M =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_
M .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q
M-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$R
MT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q
M-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]
MB:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH
M'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/
M^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?
M^ Z?X4 4?^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR
M_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\
M_P#D&3_XFKW]B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\
M\@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#
MI_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_
MPH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^
M)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\
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M%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\
M0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\
M_D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)
M_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_
MA0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]B:3_ - NR_\
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M_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\
M_P#D&3_XFKW]B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\
M\@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#
MI_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_
MPH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^
M)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\
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M%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\
M0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\
M_D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)
M_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_
MA0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]B:3_ - NR_\
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M_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\
M_P#D&3_XFKW]B:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\
M\@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#
MI_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_
MPH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^
M)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\
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M%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_ .)J]_8FD_\
M0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q-'_"9:!_S_\
M_D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$RT#_G_P#_ "#)
M_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q-)_Z!=E_X#I_
MA0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]B:3_ - NR_\
M =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH'_/_ /\ D&3_
M .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/^?\ _P#(,G_Q
M-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?^ Z?X4 4?^$R
MT#_G_P#_ "#)_P#$T?\ "9:!_P __P#Y!D_^)J]_8FD_] NR_P# =/\ "C^Q
M-)_Z!=E_X#I_A0!1_P"$RT#_ )__ /R#)_\ $T?\)EH'_/\ _P#D&3_XFKW]
MB:3_ - NR_\  =/\*/[$TG_H%V7_ (#I_A0!1_X3+0/^?_\ \@R?_$T?\)EH
M'_/_ /\ D&3_ .)J]_8FD_\ 0+LO_ =/\*/[$TG_ *!=E_X#I_A0!1_X3+0/
M^?\ _P#(,G_Q-'_"9:!_S_\ _D&3_P")J]_8FD_] NR_\!T_PH_L32?^@79?
M^ Z?X4 6X)H[FWCGB;='(H=&QC((R*DIJ(D4:QQJJ(H"JJC  '0 4Z@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Y_P)_R3SPS_ -@JU_\ 12UT%<_X
M$_Y)YX9_[!5K_P"BEKH* "BBB@ HHHH **** "BBB@ K/U/6;/2)]-BO'\O^
MT+L6<+D@*)"CNH))'785&,DLRC'-:%<?\1_!UYXT\/6]GIVI_P!G7UG=K>V\
MVT_ZQ$<*-RD%.6!W#)&.AH S_C;_ ,DAUW_MW_\ 1\=<)\?_  O8Z1;Z7XMT
MF./3]0%[Y4SVJ>6TKL&D64LI&'5D;YL9.X9/RBI/B-J/Q"@^&>K:3XGT&QN;
M=?(#ZW97BJA >(@F$C<6+C!("CG@8&3MWG@WQ7\2O$%K<^-+>/1O#=D^Z/18
M;L2R3N /F=TXP<L,Y! !  W%R :FMZ;XL\;?"SPW)H>M_8-7GBM;NYNO/>W\
MP- =XS$.[,#C ''L*XC_ (59\7_^A]_\K%W_ /$5[_10!S_@G2M8T3PA8Z=K
MU_\ ;]3A\SSKGSGEWYD9E^9P&.%('/I70444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!S_@3_DGGAG_L%6O_ **6N@KG_ G_ "3SPS_V"K7_ -%+704 %%%% !11
M10 4444 %%%% !1110!7OK"SU.SDL[^T@N[63&^&>,2(V"",J>#@@'\*L444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM*X990"<^6_&XA0"00#R<9 ) !Z)117%^)_B'#HVLIX?T?2KO7O$#HKFRM"
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M7!P #D@4 >J445R?C'Q[8^$WM[%+2[U76KM':UTRQ3?*X"D[F Y5,KC.">I
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MZH^[J<\#L1N!!JY\/_B_HOCNX_L\P2:;JVPN+:5PRR@$Y\M^-Q"@$@@'DXR
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M^LM%<;#!:I@!2,$,S%P5'."J$C!##TR""&UMXK>WBCA@B0)''&H544#   X
M [4 <G\4?$7_  C'PZU>^CE\NZDB^S6Q6;RG\R3Y0R'KN4$O@<_(>G46-#\'
M6^G?#JR\*3_)"+18;P0.2)2W,P#,,A7)<<8(#?+M(&.?\8>;XA^*OA'PU'YX
MM=/W:[>%-@'R$K 03R<."I '1_;*^D4 1P00VMO%;V\4<,$2!(XXU"JB@8
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M^1QCD8&%Z+6?XP\WQ#\5?"/AJ/SQ:Z?NUV\*; /D)6 @GDX<%2 .C^V5](H
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M0_["LG_HJ*@#T3QCH"^*?!VJZ*RQE[JW98O,9E591\T;$KS@.%/?IT/2N+^
MWB+^VOAU'8RR[[K2I6MF#S;W,9^:-B.JK@E .G[OCT'J%> ?LR_\S3_VZ?\
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M^9NC#*L,#G81['TB@#D_ _@>Q\(Z7&[Q1W&N3H7U#47/F2SROAI/WA ;9N'
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M>1D5EV)LP3\[D8(QS&1SDUV'PM\'7'A'PNQU7]YKNHRM=:A*SB1RY/"E\9;
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M=TGF2-]YVPG+' R3R: /;_#'AC2_".APZ1I$'E6\?+,W+RN>KN>[''Z
M2?\ "1Z1]BU:\6^C>WTEY$OI$!80M&@=QP.2JD9 SSD=017B$_PD^+-U;RV]
MQXWCF@E0I)')JUTRNI&"""F"".U=GJO@G7=-^"]EX)T%?/OI_+M[JX^U"-(%
M=S),^< M'DE-H&XJW0X((!<^#FGS#PG=>(KZ".+4/$-[-J,P$!C*JS'8H))+
M)U=<]I./4^B57L+&WTS3K:PLX_+M;6)884W$[44 *,GDX '6L/QQH>M>(?#4
MEAH.NR:/>%P_GH"#( #B/<I#("VW++DX!&""10!TE> >--'M]0_::\/1::\
MNF^S7=[F4G#Q%G((YVL8HDP,#.5/?-=GX?TOXO:5;P65[K'AB^@5U5KFZ6>6
M=(\ <;0@<@ GYCDDG+>G2>%O!%GX;O+S59KJ?4]=U#!O-2N@-[\#Y4 &(X\C
M(4=, 9(5< '45S_CO_DGGB;_ +!5U_Z*:N@KE_&MEXDU?0]0T?1+;2O+OK1K
M=[F]NI%,>_*MB-8SGY3P=PY/0@<@'#_LX_\ )/-0_P"PK)_Z*BKUB_OK?3-.
MN;^\D\NUM8FFF?:3M102QP.3@ ]*\W^%_@[QAX TZ;2;J/0[RQGNQ<&6*\F2
M2+(57X,1#\*I RO.<GGCH/B9INNZYX+GT;P_#NNM0ECMY9C<"$00DY=V[LN!
MM*CDASP>A ,OX.:?,/"=UXBOH(XM0\0WLVHS 0&,JK,=B@DDLG5USVDX]3Z)
M5>PL;?3-.MK"SC\NUM8EAA3<3M10 HR>3@ =:Y_QU9>+-3T,V'A.ZL;*XGRL
M]W<RNCQ)Z1[4;YCS\W&WMR05 ,_7+ZX\:7E[X4T23R].3=;ZWJ@4,(P1AK:'
M.0TQ!PS<B,'NQ '6:5I5CHFEV^F:9;1VUG;ILBB0<*/YDDY))Y)))Y->"6/P
M=^*>F6<=G8>,H+2UCSLA@U.ZC1<DDX4)@9))_&B^^#OQ3U.SDL[_ ,907=K)
MC?#/J=U(C8((RI3!P0#^% 'K^NVNG?$/X?ZG9Z=<07=O>Q2Q6\V]A&9HV(5M
MR\E1(@.1D$#N#SR?P#U*:;P'/HUVL<-WH][+;M;D%945COS(I.0=[2+T'W,=
M0:](TG38=&T:QTNW:1H+*WCMXVD(+%44*"< #.!Z"N/U7P/J6G^);CQ/X)OK
M2PU"[3%]87<;&TO6SP[;3E'&6.5!R?3<Y8 D^+VL_P!B?"_6I5> 37,0LXTF
M/W_-(1@HR,L$+L/]W." :/A)X8D\*_#K3[6Y@\F^N<W=TIW9#OT#!L;6"!%(
MP,%3UZG/A\!^(/$^L6]_\0=4L;RSM)3+;:+I\;"TW[5 =RV&?^+Y6SUZ[25/
MI% !7@'[,O\ S-/_ &Z?^UJ]KUN37DM]N@VFFS3LCC??W+Q+&V/E.U(V+C.<
MC*].O/'E_P -/AYXV^'5QJ+*OA_4(+Y(PZ&]FB960MM(;R6&,.V1CTY&.0#V
M2BBO*]5\&?$:R\:W&L>%_%\<FGSOYIL=7GD=$RVYHP@5@$XP"NU@#MSQD@'I
M&K36-MHU]/J@C.GQV\CW0DCWJ8@I+Y7!W#;GC!S7G_P(T2;1_AE;S3^8'U&X
MDO!&\90HIPB]>H*QAP>,AA]3L1>%-:\0I WC?4K2X@C=)#I&FQ%+21T9B#*S
MY>4<H=ORKE!E6ZUVE !1110 4444 %%%% '/^._^2>>)O^P5=?\ HIJ\_P#V
M<?\ DGFH?]A63_T5%7<>-;+Q)J^AZAH^B6VE>7?6C6[W-[=2*8]^5;$:QG/R
MG@[AR>A YY?X7^#O&'@#3IM)NH]#O+&>[%P98KR9)(LA5?@Q$/PJD#*\YR>>
M #U"N;\2^)9M/N(-%T6WCOO$5ZA:WMG)$<$><&><CE8E/XL?E7G)&QJIU)=+
MN#H\=H^H;,0"[=EBW>K%03@=< <XQD9R/"&^$?Q6.J7NIIXQM(;R^</<RP:A
M<1&4C.W.V,# !P!T X&!0!['X4\)V?A:SN/+?[3J5]*;C4+]XPKW4S$DL0.%
M7).%' SW)).I!JMC<ZI>:9!<QR7EDD;W,2G)B$F[9N[ D*3CKC!Z$9\,_P"%
M6?%__H??_*Q=_P#Q%=?H'@G7? WP>U31],7[;XAN_-<"VNA&JR28C#1NP7&U
M K\\[@0#R, $GPO5=?\ $'BSQRR1LFI7OV2QD^S,FZVA 575FY(?Y=PP!NC]
ML+Z96'X.T!?"W@[2M%58P]K;JLOELS*TI^:1@6YP7+'MUZ#I5CQ'IU]J_A^\
MT_3=5DTJ[N$")>QQ[VB&1NP,CDKD9!!&<CD4 :E> ?'_ $>WU?QEX2LK-X%U
M?4,VCEY3\J&1!$649PNYY>0.<'KCCI_#VA?&30+-K5]<\.:I'_ =2DN)'3DD
M_.$5FSG^(G& !@5UFC>!X;/Q+-XGU>^DU;7I$,:3R1A(K6/+82"/)V#:<$EF
M)^8Y^9L@'6445EZW)KR6^W0;339IV1QOO[EXEC;'RG:D;%QG.1E>G7G@ \4_
M9E_YFG_MT_\ :U>_UXW\-/AYXV^'5QJ+*OA_4(+Y(PZ&]FB960MM(;R6&,.V
M1CTY&.?2/&(U=O!VJQZ#;27&J2V[16RQW A96?Y=X<X *@ENHSMQD9H X_X7
MJNO^(/%GCEDC9-2O?LEC)]F9-UM" JNK-R0_R[A@#='[87TRL/P=H"^%O!VE
M:*JQA[6W59?+9F5I3\TC MS@N6/;KT'2I/$Z>()=#FB\,/8Q:G)\B37K,$A!
MZN %;<P[ C'.3G&" 9>OZ_?76J-X8\,-&=8*!KR]=-\6EQ-T=QT:5A]R/O\
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M<9/4DD@'24444 %%%% !1110!S_CO_DGGB;_ +!5U_Z*:O/_ -G'_DGFH?\
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M$191G"[GEY YP>N..G\/:%\9- LVM7USPYJD?\!U*2XD=.23\X16;.?XB<8
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M;Q1PP1($CCC4*J*!@  <  =J )**** "BBB@ HHHH *\ ^%G_)POC7_M^_\
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M7+8V_P )4<8P.TG,RV\K6\<<DX0F-)'**S8X!8 D#/?!QZ&@#'\2^)8?#UO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!S_@3_ ))YX9_[!5K_ .BEKH*Y_P "
M?\D\\,_]@JU_]%+704 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% '/\ @3_DGGAG_L%6O_HI:Z"N?\"?\D\\
M,_\ 8*M?_12UT% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!S_@3_DGGAG_ +!5K_Z*6N@KG_ G_)//#/\
MV"K7_P!%+704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '/^!/^2>>&?^P5:_\ HI:Z"N?\"?\ )//#/_8*
MM?\ T4M=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_@AO?_C-'_"9:7_SZZY_X(;W_P",T =!17/_ /"9:7_SZZY_X(;W_P",T?\
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M #ZZY_X(;W_XS1_PF6E_\^NN?^"&]_\ C- '045S_P#PF6E_\^NN?^"&]_\
MC-'_  F6E_\ /KKG_@AO?_C- '045S__  F6E_\ /KKG_@AO?_C-'_"9:7_S
MZZY_X(;W_P",T =!17/_ /"9:7_SZZY_X(;W_P",T?\ "9:7_P ^NN?^"&]_
M^,T =!17/_\ "9:7_P ^NN?^"&]_^,T?\)EI?_/KKG_@AO?_ (S0!T%%<_\
M\)EI?_/KKG_@AO?_ (S1_P )EI?_ #ZZY_X(;W_XS0!T%%<__P )EI?_ #ZZ
MY_X(;W_XS1_PF6E_\^NN?^"&]_\ C- '045S_P#PF6E_\^NN?^"&]_\ C-'_
M  F6E_\ /KKG_@AO?_C- '045S__  F6E_\ /KKG_@AO?_C-'_"9:7_SZZY_
MX(;W_P",T =!17/_ /"9:7_SZZY_X(;W_P",T?\ "9:7_P ^NN?^"&]_^,T
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MS1_PF6E_\^NN?^"&]_\ C- '045S_P#PF6E_\^NN?^"&]_\ C-'_  F6E_\
M/KKG_@AO?_C- '045S__  F6E_\ /KKG_@AO?_C-'_"9:7_SZZY_X(;W_P",
MT =!17/_ /"9:7_SZZY_X(;W_P",T?\ "9:7_P ^NN?^"&]_^,T =!17/_\
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M #ZZY_X(;W_XS0!T%%<__P )EI?_ #ZZY_X(;W_XS1_PF6E_\^NN?^"&]_\
MC- '045S_P#PF6E_\^NN?^"&]_\ C-'_  F6E_\ /KKG_@AO?_C- '045S__
M  F6E_\ /KKG_@AO?_C-'_"9:7_SZZY_X(;W_P",T =!17/_ /"9:7_SZZY_
MX(;W_P",T?\ "9:7_P ^NN?^"&]_^,T =!17/_\ "9:7_P ^NN?^"&]_^,T?
M\)EI?_/KKG_@AO?_ (S0!T%%<_\ \)EI?_/KKG_@AO?_ (S1_P )EI?_ #ZZ
MY_X(;W_XS0!T%%<__P )EI?_ #ZZY_X(;W_XS1_PF6E_\^NN?^"&]_\ C- '
M045S_P#PF6E_\^NN?^"&]_\ C-'_  F6E_\ /KKG_@AO?_C- '045S__  F6
ME_\ /KKG_@AO?_C-'_"9:7_SZZY_X(;W_P",T =!17/_ /"9:7_SZZY_X(;W
M_P",T?\ "9:7_P ^NN?^"&]_^,T =!17/_\ "9:7_P ^NN?^"&]_^,T?\)EI
M?_/KKG_@AO?_ (S0!T%%<_\ \)EI?_/KKG_@AO?_ (S1_P )EI?_ #ZZY_X(
M;W_XS0!T%%<__P )EI?_ #ZZY_X(;W_XS1_PF6E_\^NN?^"&]_\ C- '045S
M_P#PF6E_\^NN?^"&]_\ C-'_  F6E_\ /KKG_@AO?_C- '045S__  F6E_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\%]#*8;%[KC;C"_9FR 58$';GUV\84'M_C;_ ,DAUW_MW_\ 1\=<1\:_AO\
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M4L1\I)VY( (-6/ 7Q1TWQWI=T]M:20ZM:HSR:8)59W4?=,;-M# \#)VX)P<
M@G8^'T$-M\.?#:011Q(=,MW*HH4%FC#,>.Y8DD]R2:\@^$D$-K\??&%O;Q1P
MP1)>I''&H54472   <  =J *_P 2?%WBB\^)?A;3KCP])9"SO8;NST]KY&:\
M8S;49V4E$)V;0.=NYN2#7M?AG5O$6J?:O[>\+_V'Y>SR?]/CN?.SG=]P#;C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\&_\ (#N?
M^PKJ7_I;-705S_@W_D!W/_85U+_TMFH Z"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#G_ G_ "3SPS_V"K7_ -%+705S_@3_ ))YX9_[!5K_ .BEKH*
M"BBB@ HHHH **** "BBB@ HHHH *Y_P]_P ASQ9_V%4_](K6N@KG_#W_ "'/
M%G_853_TBM: .@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2\O_  _I5W=28WS3V4<CM@ #+$9.  /PH I_#Z>&Y^'/AMX)8Y4&F6Z%D8,
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M /"">#_^A4T/_P %T/\ \30!YA^T9X8N+W1].\16L$!CT_=%>2<"38[((_\
M>4-N&,\%\@8+$:_ACX]^%=0T.&7Q!=?V7J:_)/"MO+(C$?QH55OE/H3D<CG
M)]0L;"STRSCL["T@M+6/.R&",1HN22<*.!DDG\:Y.;X2^ Y]4&HOX:M!.'5]
MB,Z197&/W2L$QQR-N#SG.30!'X.\0W'C3Q#J.O6RWT/AVWB%GIWF$)'>OO)F
MGV8W<;4523P-_0E@O<5'!!#:V\5O;Q1PP1($CCC4*J*!@  <  =JDH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_!O_
M " [G_L*ZE_Z6S5T%<_X-_Y =S_V%=2_]+9J .@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Y_P)_P D\\,_]@JU_P#12UT%<_X$_P"2>>&?^P5:_P#H
MI:Z"@ HHHH **** "BBB@ HHHH **** "N?\/?\ (<\6?]A5/_2*UKH*Y_P]
M_P ASQ9_V%4_](K6@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BL_7-9L_#VAWNKW[[+6TB:5\$ M
MCHJY(!8G  SR2!67X#\5P^,_!UAK*&,3R)LNHTQ^[F7AQC)(&?F )SM92>M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Y_P;_P @.Y_["NI?^ELU=!7/^#?^
M0'<_]A74O_2V:@#H**** "BBB@ HHHH **** "BBB@ HHHH **** .?\"?\
M)//#/_8*M?\ T4M=!7/^!/\ DGGAG_L%6O\ Z*6N@H **** "BBB@ HHHH *
M*** "BBB@ KG_#W_ "'/%G_853_TBM:Z"N?\/?\ (<\6?]A5/_2*UH Z"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]]?V>F6<EY
M?W<%I:QXWS3R"-%R0!ECP,D@?C5BODCXX:SJ.I?$S4+*[>=;73]D5K;R%<1J
M45BP"DCYR=V3\V"H.,8 !]+_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0_
M_!C#_P#%5\044 ?;_P#PG?@__H:]#_\ !C#_ /%5L6-_9ZG9QWEA=P7=K)G9
M-!()$;!(.&'!P01^%?!%>@?!OQ#JFB?$73;:P6>>WU&5;>[M8SPZ'/SD8/\
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M26=_X@TJTNH\;X9[V.-UR 1E2<C((/XU7_X3OP?_ -#7H?\ X,8?_BJ^(**
M/O/3=6TW6;=KC2]0M+Z!7V-):S+*H; ."5)&<$<>XJY7Q1\.]9U'1/'VC7&F
MO/YDMW%;RPPE<SQNZAH_F(4Y[;B #@Y! (^UZ "OF#P;_P G0W/_ &%=2_\
M09J^GZ^4-(U7^Q/VB=0U#[!?7_DZKJ'^C6$/FS/GS5^5<C.,Y/L#0!]%^-_"
M-CXP\-7MA<65I->&WD6RGG7!@E(^5@P&Y1N5<XZ@8((XKQC]F_7[X:SJ?APM
M&=/:W:^"E/F64-&AP?0J1D'/W1C'.=#Q7\7+OQG<'P/X:TV33KG4G^PW%QJ[
M)"T>XLLD>SD XP,Y+<E0N[::[?X7?"Z'X?6]S<7%W'>ZI>(BR2+$%6%0,E$)
M^8@MU/&[:ORC% 'HE%>;_&BWGM/ E]K]AJNJV%_9>2$:SOY8D=6E"D,@;:?O
MDYP&X7G Q5SX3W%SK?PDTN74[R[N9[A+A)9WN'\UAYTB_P"LSN! P 0<C QT
MH [RBO!-+O=5TK]I9?#B:]K-QI*.[+;7=_),N&M#)M(8\A6/&<G@9)/-=/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M WCH<&O-S\-/%\'QGN/%.F3V@MH7CV7>JRF9KC? (Y6"1D'();"YC7[H7"C
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M?Z\7\)?#OQYX8\?:AXJD;PY=R:CYWVFW6ZGC'[QQ(=A\IMN& ZAN,CKR/:*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7/^#?\ D!W/_85U+_TMFKH*
MY_P;_P @.Y_["NI?^ELU '04444 %%%% !1110 4444 %%%% !1110 4444
M<_X$_P"2>>&?^P5:_P#HI:Z"N?\  G_)//#/_8*M?_12UT% !1110 4444 %
M%%% !1110 4444 %<_X>_P"0YXL_["J?^D5K705S_A[_ )#GBS_L*I_Z16M
M'04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^
M#?\ D!W/_85U+_TMFKH*Y_P;_P @.Y_["NI?^ELU '04444 %%%% !1110 4
M444 %%%% !1110 4444 <_X$_P"2>>&?^P5:_P#HI:Z"N?\  G_)//#/_8*M
M?_12UT% !1110 4444 %%%% !1110 4444 %<_X>_P"0YXL_["J?^D5K705S
M_A[_ )#GBS_L*I_Z16M '04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*#'G!4L0!M,;&,'?%V\GQ'UA=^;:QCQNSNC?Y,>9UW,OW=ISNV?ZE]WE_O\
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MY !Z]" ?6=1SQM-;RQ)-) [H566,*60D?>&X$9'7D$>H-244 ?/'Q5\;>-_
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/\ @W_D!W/_ &%=2_\
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M8?,F^SPLLDGEC/\ K/NXR",!LXXKTR>>&UMY;BXECA@B0O))(P544#)))X
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M-V".,@J?4]9^,6C:EISZ;X)GGU;Q%>Y@LH8;9T\MR#^]8R(%VIC<<YZ<X&2
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M$$'D4 7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N?\&_\ (#N?^PKJ7_I;-705S_@W_D!W/_85U+_TMFH Z"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#G_ G_ "3SPS_V"K7_ -%+705S_@3_ ))Y
MX9_[!5K_ .BEKH* "BBB@ HHHH **** "BBB@ HHHH *Y_P]_P ASQ9_V%4_
M](K6N@K'OO"?AO4[R2\O_#^E7=U)C?-/91R.V  ,L1DX  _"@#8HKG_^$$\'
M_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H Z"BN?_X03P?_ -"IH?\
MX+H?_B:/^$$\'_\ 0J:'_P""Z'_XF@#H**Y__A!/!_\ T*FA_P#@NA_^)H_X
M03P?_P!"IH?_ (+H?_B: .@HKG_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*F
MA_\ @NA_^)H Z"BN?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\ 0J:'_P""Z'_X
MF@#H**Y__A!/!_\ T*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H?_B: .@HKG_^
M$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H Z"BN?_X03P?_ -"I
MH?\ X+H?_B:/^$$\'_\ 0J:'_P""Z'_XF@#H**Y__A!/!_\ T*FA_P#@NA_^
M)H_X03P?_P!"IH?_ (+H?_B: .@HKG_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__
M $*FA_\ @NA_^)H Z"BN?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\ 0J:'_P""
MZ'_XF@#H**Y__A!/!_\ T*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H?_B: .@H
MKG_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H Z"BN?_X03P?_
M -"IH?\ X+H?_B:/^$$\'_\ 0J:'_P""Z'_XF@#H**Y__A!/!_\ T*FA_P#@
MNA_^)H_X03P?_P!"IH?_ (+H?_B: .@HKG_^$$\'_P#0J:'_ ."Z'_XFC_A!
M/!__ $*FA_\ @NA_^)H Z"BN?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\ 0J:'
M_P""Z'_XF@#H**Y__A!/!_\ T*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H?_B:
M .@HKG_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H Z"BN?_X0
M3P?_ -"IH?\ X+H?_B:/^$$\'_\ 0J:'_P""Z'_XF@#H**Y__A!/!_\ T*FA
M_P#@NA_^)H_X03P?_P!"IH?_ (+H?_B: .@HKG_^$$\'_P#0J:'_ ."Z'_XF
MC_A!/!__ $*FA_\ @NA_^)H Z"BN?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\
M0J:'_P""Z'_XF@#H**Y__A!/!_\ T*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H
M?_B: .@HKG_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H W)X(
M;JWEM[B*.:"5"DD<BAE=2,$$'@@CM5?2M*L=$TNWTS3+:.VL[=-D42#A1_,D
MG))/)))/)K+_ .$$\'_]"IH?_@NA_P#B:/\ A!/!_P#T*FA_^"Z'_P")H Z"
MBN?_ .$$\'_]"IH?_@NA_P#B:/\ A!/!_P#T*FA_^"Z'_P")H Z"BN?_ .$$
M\'_]"IH?_@NA_P#B:/\ A!/!_P#T*FA_^"Z'_P")H Z"BN?_ .$$\'_]"IH?
M_@NA_P#B:/\ A!/!_P#T*FA_^"Z'_P")H Z"BN?_ .$$\'_]"IH?_@NA_P#B
M:/\ A!/!_P#T*FA_^"Z'_P")H U-2TG3=9MUM]4T^TOH%?>L=U"LJAL$9 8$
M9P3S[FL^#P9X5M;B*XM_#.C0SQ.'CDCL(E9&!R""%R"#WJ/_ (03P?\ ]"IH
M?_@NA_\ B:/^$$\'_P#0J:'_ ."Z'_XF@#H*IZKI5CK>EW&F:G;1W-G<)LEB
M<<,/Y@@X((Y! (Y%9?\ P@G@_P#Z%30__!=#_P#$T?\ "">#_P#H5-#_ /!=
M#_\ $T :FI:3INLVZV^J:?:7T"OO6.ZA650V",@,",X)Y]S6?!X,\*VMQ%<6
M_AG1H9XG#QR1V$2LC Y!!"Y!![U'_P ()X/_ .A4T/\ \%T/_P 31_P@G@__
M *%30_\ P70__$T =!6'/X,\*W5Q+<7'AG1IIY7+R226$3,[$Y))*Y))[U'_
M ,()X/\ ^A4T/_P70_\ Q-'_  @G@_\ Z%30_P#P70__ !- %S3?#6@Z-<-<
M:7HFFV,[)L:2UM4B8KD'!*@'&0./85E_\*X\%?V=]A_X1?2O)\KR=WV9?,VX
MQGS,;]V/XL[L\YSS5C_A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
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M!S["C4M)TW6;=;?5-/M+Z!7WK'=0K*H;!&0&!&<$\^YK+_X03P?_ -"IH?\
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M_P"A4T/_ ,%T/_Q-'_"">#_^A4T/_P %T/\ \30 ?\()X/\ ^A4T/_P70_\
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M.F*X_P#X4_X!_M'[=_PCD'G>;YVWS9/+W9SCR]VS;G^'&W'&,<5L?\()X/\
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M_H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\
M!=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T
M =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\
M_"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\
MH5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!
M=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P
M@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-
M#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_
M /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!1
M7/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">
M#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#
M_P#!=#_\31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\
M31_P@G@__H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@_
M_H5-#_\ !=#_ /$T =!17/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W!X&
MT6UMXK>WEUF&") D<<>MWJJB@8  $N  .U2?\(;I?_/UKG_@^O?_ (]110 ?
M\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^
M#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_
M #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]1
M10 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _
M6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (
M;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_
M (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7
M_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1
M_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@
M^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\
M"&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_
M (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/U
MKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110
M ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@
M^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I
M?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X
M]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/U
MKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?
M\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/
MKW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I
M?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_
M^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:
MY_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?
M\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^
M#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_
M #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]1
M10 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _
M6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (
M;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_
M (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7
M_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1
M_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@
M^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\
M"&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_
M (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/U
MKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110
M ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@
M^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I
M?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X
M]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/U
MKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?
M\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/
MKW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I
M?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_
M^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:
MY_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?
M\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^
M#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_
M #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]1
M10 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _
M6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (
M;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_
M (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7
M_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1
M_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@
M^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\
M"&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_
M (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/U
MKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110
M ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@
M^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I
M?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X
M]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/U
MKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?
M\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/
MKW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I
M?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_
M^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:
MY_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?
M\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^
M#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_
M #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]1
M10 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _
M6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1_P (
M;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_
M (]110 ?\(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7
M_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1
M_P (;I?_ #]:Y_X/KW_X]110 ?\ "&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@
=^O?_ (]110 ?\(;I?_/UKG_@^O?_ (]1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>gtl21rgcbjm5000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2D",H# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI)LFI:**\XZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME]*YSX>>$8[V26ZU"+_5L-JMWK/#T:4:7MJNOD.K.;GR0,V7QYXAFY%M(O\
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MO3K>>.Y@2:)MR.,@UY%XO\!72ZMYFCV;M"P!(3L>]=YX*M]0M-'2WOXV1HP
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MI]/ZUQX/^/$WK_PV8_PAS_:-\/\ ID/YUZK??\@^Y_ZY-_(UY5\(?^0E??\
M7(?SKU6^_P"0?<_]<F_D:TQW^\OY$X?^$?.NF?\ (R0_]=37T59?\>,/^X*^
M==,_Y&2'_KJ:^B;+_CQA_P!P5OF>\3/"=3G_ (@_\B;??[E>"01RRRB.(,6;
MC KWOX@_\B;??[E>3^ XDE\0H'7.,$5K@)\F'E+L1B5>JD=MX(\!);QK?:B@
M9V'RH>1^(KFO'WA1M'O?M=JI^SN>,=CWKV\# P*H:QI<6K:=);2J#N4A2>QK
MCIXV:K<\MC>6'CR<J/._AKXK!;^RKN0[CS&6/  KU,$$9%?.6KZ;=^&M;*D%
M-K9C;U KV'P/XF37=.$;M_I$2_.,\UICL.OXT-F1AZC^"6YUM>:?%?2Y)[2"
M[C7Y8LES7I=8GBNQ?4?#MW;1C+NF *Y,-4]G54C>K'F@T<C\*=0W:<]FS98,
M6YJ+XL7KQPVMJK?+*IW#/O7-> ;\Z3XFDAD. <ICWS3/&MY/JWC"2SY989=J
M#VKT_8?[7S]-SD]I^YY?D;-EX<27X=-+(O[R-G?-0?"O4!#J+V6<>:=V/H*]
M*BTM3X8^PJ,>9"!^)%>,Z23X?\;F,G'E.4_E4TI^WIU(OU'./LY19Z1\2M6;
M3]"6%?\ EX)0U@?"G3"6EU C[I*#/N*ROB5J[WVJ1V"\K& X^I%>D>"M.%AX
M>@PN#*H<UG+]S@TNLBU[]:_8Y_XK3O'IEN@. ^017GGA/Q$/#M\USMR2I7IF
MO0?BQ$SZ;;,!D*237*_#W2-,UF[>WOK=96"EAFM\.X+"7DM#.IS.MH;G_"V/
M^F0_[YH_X6Q_TR'_ 'S75_\ "OO#O_0/CH_X5]X<_P"@?'7+[3!_RLUY*_<\
MD\7>)5\27,$H3:8U(/&,UZ-\+9MV@"+^ZS&M)O 7AI6"FQB!-;6DZ+8:1$8[
M&%8U/]VC$8JE*C[.":"G2FI\TF<9\1_"LVIJFH6P)>)=NT=Z\ZTGQ!JWAN;Y
M X4'[DF<5]#NR!2&(Q6+J'A;1M4!:>T1F/1J6'QJC#V=170ZE!N7-!V9P>F_
M%B8R 7\2A._EK79:5XXT?59%2*0H3_STXKG;[X4VTVYK:X$7< +7G^O^&+_P
MW.IE#;"?D?UK=4<)7=H.S,W.M3^+5'T.CJZ[E8,#W!K \;?\BM=?05SWPT\0
M3ZA9FTN9"[ID@GTKH?&O_(K77T%<*I.E74'W.CG4Z;:/(/ __(SI_OC^=?0%
M?/\ X(_Y&=/]\?SKZ KIS/\ B+T,L)\+"BBBO-.H0UYO\6/^05'_ +XKT@UY
MO\6/^05'_OBNK!?QXF-?^&SS?0_#E[K[2"SV?(<'<<5M_P#"LM=_Z8_]]5M_
M"3_6WG^\*]:Q7?BL=4I57".QST:$9QNSPK_A66NYQ^Y_[ZK3TWX4W[R@W[H(
M_P#8?FO8L4M<KS&LU8V6%IF)X?\ #%CX?@*6Z[G/\;#FMJEHKBE)S?-+<W22
M5D>$?$+_ )&A?I_6O6?!O_(K67^Y7D_Q"_Y&A?I_6O6/!W_(K67^Y7IXO_=H
M'+1_BR-B>.!E)G5"H[M7.7OB_0M$D,>1[^4 :YWXE^)[BP8:;;,49E#,P/4&
MN2\+>"[GQ(6GED,<>?O$9S65'"1]G[6J[(J=9\W+!:G;W?Q6TA5(MUF+?[2<
M5SMY\3M2NDDCMK9&C8$?=.<5TMI\+]-A(\\K+CU%:LWA70]+T^:2&RC1A&>?
MPJE/"0=HQ;$XUI+5V/'/";%_&%@QZM/D_K7T4/NBOG?PO@>-++'3[1_C7T0O
MW13S/XX^@L)\+/*_B_\ \N'U:M[X7?\ (KM_UU-8/Q?_ .7#ZM6]\+O^17;_
M *ZFG/\ W*/J$?\ >&=Q7A7Q/_Y&]_\ KDM>ZUX5\3_^1O?_ *Y+6>6_QOD5
MB_X9Z?X%_P"18M/^N8K+^)]R\&A1*AP)&*G\JU/ O_(L6G_7,5E?%&W>;0X6
M1<A&)/Y5%.WUO7N.7\'Y')?"N -KOG8Z(P_2O:*\8^%4X&N&+U5C^E>ST\QO
M[;4,+_#"O/\ XHVB2Z0LY W1@X->@5Y_\4;I8M'6$GF13BLL)?VT;%UOX;N<
M_P#":[<ZG-:Y.P1EL5TWQ._Y%Y_PKF/A+;,-5GN<?*8RM=/\3_\ D7G_  KL
MK6^NJWD80O[!W.8^$EN&U:[D89_=#'YU[#7DOPC_ ./RZ_ZYC^=>M5SY@_W[
M-<-_#0R7_5M]*^=IT\SQFZG_ )^Q_P"A5]$R_P"K;Z5\]-_R.LG_ %]?^S5O
MEOV_0SQ7V3Z$A0)"JJ,  4]ON'Z4B?<7Z4K?</TKRSK/GGQ?_P CG??]=Z]U
MT*,1Z/;!1@;%/Z"O"O%__(YWO_7>O>-&_P"03;?]<U_D*]7'_P &F<>'^.1>
M[5X'\2/^1RN?]Q:]\->"?$C_ )'*Y_W%K/+/XS]"\7\!ZSX*_P"1=M_]P5S_
M ,1_"\NI6ZWEJF9(\EQW-=!X*_Y%VW_W170.\:J=[#'O7.ZLJ5=SCW+Y%.FD
MSYWTK7=6\-7!*!P!P4DR!78:;\6)O- U")0G?RUYKO\ 4/"VCZJ"T]HCLW1J
MY.^^%%K,6-O<"+T 6N[ZSA:W\2-F8>RJP^%G0:7XZT?5) D<A1C_ ,].*Z5'
M610R,&4]"#7SYKWA/4O#;":16\G=A9/4UZ%\,O$$VH6DEI<R%FC(5,^F*PQ&
M#@H>UI.Z+I5Y.7)-:GHE%%%>>=04444 %%%(Q 4D]J *MVEDJE[I8@.N7Q7-
MW7C_ $+37,66(7_GF,BN"\?^*;F]U:73824BA;8<'[U3>'/AO+JEHMU=S&+=
MT4C->E#"4X4U.N]SEE6DY<M-&_>_%?3PI^R)(6[;TKF-7^(>JZMIUQ:_9D\B
M1=K,%/ KMK/X::1 1Y\:3?44>*-#TC2/#%Y]FM4B9HR%Q54ZF%C-*$;LF<:S
MBW)G$_"K_D:A_P!<F_E7MU>(_"K_ )&L#_ID_P#*O;JRS+^-\B\+_#/GCQ-_
MR-#_ /73^M>W^%_^1<L_]RO$/$W_ "-#_P#73^M>X>%_^1<L_P#<K;'?P8&>
M&^.12\8^'H=<TEP5_?1@LI'4FO%]'U&[\+Z\K8(9&VLIZ5]%D9KRKXE>%@@.
MK6Z8'_+3 ZDU&!KK^#/9EXBF_CCNCOEU&'4_#SW,+ JT?./6O KC_D9O^WE?
MYBND\&>*386\VFW$G[IUQ&">A-<W,0WB7(Y!N5_F*[,+0=&<X]#"K44U%GTA
M;_\ 'M%_N#^5>7_%GK%]!7J%O_Q[1?[@_E7E_P 6>L?T%>=@O]X1U8C^&SSO
M2=+N]7NTM;922QQGL*]FTKP'8V>B-;21AYI$Y8C)!-<_\(X8V2\<J"PQ@UZE
MBM\?BI^T]G'1(SP]&/+S,^<]:TNX\-:TR*70(_R-ZBO8?!/BB/6]-2.1@+A!
M@CVI/''AA-<TQI(XPUU&/D/>O'='U2Y\.:R'&5VMAU]0#6WNXVC_ 'D9ZT)^
M3/H^BL_1M4BU?38KJ,CYU!(':K^:\9IQ=F=R::NA:*,T4AA1110 54U/_D'3
M_P"X?Y5;JIJ?_(.G_P!P_P JJ/Q(3V/GO1%#^+K=3T-R?YFOHJ! L"*.@%?.
M^@_\CC:_]?)_F:^BHO\ 5K]*]+,_BCZ'+A-F/KQ+XK?\C+%_UR%>VUXE\5O^
M1EB_ZY"LLM_C_(O%? =W\./^18M_]RNMFCA=#YRJ5'7=7)?#C_D6;?\ W:S_
M (C^)Y=,A^PVSE)6&6(/8UG.E*KB7&/<<9J%)-FY?>*M#T)RF5R>OE8-8UU\
M5='12(5F+>Z5P'ACPG=>*+AY7D9(P?F?&:[ZT^%VG0D&=EE^HKIG1PM)VFVV
M9QG6GK%:'/7GQ1U"?S([2V1D8$<KS7(:-,\_BBUD<89I<D5[4O@_0["TE>*R
MC5A&W/X5XS8%?^$M@*?=$W'ZUTX:=*49>RC;0RJQFFN=GT-:?\>L7^Z*\M^+
MWW['ZFO4;/FTB/\ LBO+OB]]^Q^IKS\#_O".FO\ PF;'PG_Y%M_^NS5VFHV$
M6HV4EM,N5<5Q?PG_ .1;?_KLU>@5GBVU7DUW*HJ]-'SKKVEW/AK7B "-K;T;
MM7L'@OQ''KFDJ&;]_$ K@]S3?''AI-;TMG3B:(%AQ][VKR/P[J]QX:UL;\JJ
MMM=*[],90_O(YM:%3R9;^(W_ ".-Q_N+7K7@K_D7+?\ W!7C?C:]AU#Q)+<P
M.&1HUY'K7LG@K_D7+?\ W!4XQ6PT$QT-:LAOCS_D4-0_ZY&O +=)99ECA#%F
MXXKW_P >?\BAJ'_7(UY/\/H(Y_$BK(H8!<CZU> GR8>4NPL2N:HD=GX)\!I;
MQ+>Z@@9R,JAY%<QX\\)MHUZ;NU4_9W/;J#7N &!P*S]9TN'5M.DMID#94[<]
MC7)3QTU5YY;&TL/'DY4>>?#?Q8"1IEY)@GB,D\8KU,$$9'2OG'6-,NO#FLLA
M!78_R-ZBO8O _BB/7=.6)V N8Q\RYYQT%:X[#K^-3V9&'JOX);G6T445YAUA
M110>E %2[2R5#)=+%M'=\5SEUX^T+36,&6(3@>6,BN#\?^*KB^U!K&WD*PKP
M5![T[PS\.9=7LDO+J4Q(XRH(SD5Z4,)"%-3KNQRRK2<N6FCH;WXKZ<%/V1)"
MW;>E<KK?Q U/6=/DM6MD$#'.X+7<V?PTTB CSXTFQZBHO&&@Z3I'A6=[6U2(
MA@ 15TYX6,TH1NR9QK.+<F<;\,>==D/L/YU[5=?\>DW^XW\J\4^&AQK[^^/Y
MU[7<_P#'I-_N-_*LLP_CEX;^&?/%Z@E\4LAZ%Z^@=,7;IELH[1K_ "KP&?\
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M\A5ZO.G\3.I;!1114C/*OBY_J[/_ *Z'^5;'PJ_Y%Z?_ *Z_TK'^+G^KL_\
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MULM$A4:,>2[ZGS=;3W7AS7-V'C:-\$'C(!KWOP]KD.N:;'<1L-Y'SCT-<?\
M$;PH;V$ZE;)F1!\X ["N'\%^)I=!U-4=R+:0_.I]:Z*L8XNC[2/Q(S@W1GRO
M9GO]%16UPES;I+&058 \5+7C;'<%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@'CC_D:[C_ *Z_
MX5[_ %Y)XH\#ZQJ6OS75O!NC:3<#FN_+ZD85&Y.VAS8F+E%6.\\&?\BU;_4U
MOUD^&[*;3]%BMYUVR*>16M7)5:<VT;PTBB*XA2X@:&10R,,$&O!?&WAR31-6
M9T0^3(=P8=![5[_6)XGT"+7]+>W;AQ\RG'<5OA,1[&>NS,Z]+GCYGSO 2URI
M)).>]?3&F?\ (*M/^N*_RKQ=/AOKL=P"+?*@]=U>UV,30V%O$XPR1JI^H%=.
M8U834>1W,<+"4;W1X1X\M)K7Q7=32 [)9-RY]*]+\":]8W&AQP^8D<BD_*3B
MK_BKPE;>([<;CLF4?*X&37EY\"^)=.NV-I$0 >'#=:M3I8FBH2=FA<LZ51R2
MNF>V2W]I"A:2>-0.Y:O-/'OC2.>W;3;!@^_*R,.01[5C#POXROF$5RTAB/7+
M"NPT'X;V-@C27G^D2,. Z_=-91IT,.^>4N9]D6Y5*BLE8\S\'MY?B&'/';]:
M^AU^XOTKQX^ ]:M?$#75K!^Y$VY<-_#FO7K<N8$\U=KXY%+,)QJ2C*+N&&BX
MIIGS_P"*?^1H;_?_ *U[;X6_Y%NR_P"N=><:[X&UF]UQKF&#,9;.<^]>FZ%:
MRV6C6UO,,2(N"*>,J0E2@HNX4(24VVC2KSKXJ_\ (-3Z?UKT6N-\>:#>ZY9+
M'9Q[V ]:Y<+)1K)LUK)N#2.4^$/_ "$K[_KD/YUZM> M87 '4Q,/TKA/AYX7
MU'0+RZDOHMBR1A5YSSFO0" RD'D$8-7C9QE7<HNZ%0BU3LSYMC/]G^(5:48V
M2$FO=],\0Z9-9VZK=Q;RH&W<,YKB_&7P\GO;U[[3!N9^L?0"N;TWP%XCM]1M
MY3: *DBECN[ UWU70Q,%)RLT<T/:4I-6/3/B#_R)M]_N5Y7\/O\ D8E^@KUW
MQ5IMSJOAFXLX%W3.N ,UPWA'P3K&E:P+BY@VQ@=<UCA:D(X:<6]32K"3JII'
MK-(:!2UY9UG&>/?#"ZSIC3P+_I48^4]L=Z\AT?5+KP[JZ2@LNQOG7UKZ08!E
M((X/!KR_QG\/[B^U#[5I<0.\_,@X KT\%B8V=*IL<E>D[\\-ST#1=6AU?3X[
MF)U8D#=@]#5]AD8(KSGP1H?B'0+DQSP?Z,V21N[UZ..G-<5>$83:B[HWIR<H
MZH^?O$<$N@^*7D P2_F#\ZL^&"^N^.4N77(D<LW'%=KX^\(7FN7BW-E'O<*%
M/-.^'_A*\T2:>6_A"N2-ASFO5>*@\/S7]ZUCC]E+VENESOT&U%7T&*\*\?V,
MFF^)6N.GG,9 :]XK@_B!X7O-?,$EG'O>-=O7WK@P-54ZOO;,Z<1!RAH>9Z4\
MVO>*[-YEW;F56P.P%?0=M$(+:.)1@(,"O.O 7@R]T?4)I]1@ ^4;#G.#FO2J
MO'U8SFHPV0L/!Q3;W9A^*](&KZ'<0 9D*83ZUXGHNIW7A/Q 7V[2&V,&';/-
M?1%<=XG\!V>N;IH_W,V.JCK1A,3&"=.I\+"M2<FI1W1L:7XET[5+998[A%+#
M[K-R*GOM;L+&!I9;F/Y1G&[DUXXW@7Q-IUPWV2,A<\,&ZTDG@[Q9J#JMS&SK
MGJ6Z5?U.@W=3T(]M4M9QU(/$WB:[US6_]$FE2,-M0(Q'!^E>L^#+"ZL= B2\
ME:28DL2S$\&L/PQ\.+?3'CNKQO-EZE&' -=\JA5"J, # %1BZ]-Q5*GLBJ-.
M2?/+<\8^(::AIFMI+%/.(G^?AS@<UUW@GQ?:WNF1V]W.J7"CDN<9KI->T"UU
MZQ:WG #'H^.17E.J?#;5[&ZW::#,@.0Q.*UISHUZ2IS=FB)1G3GS1U1['_:%
MH$W&XCV^NZO,OB7XBM+F%+.V9)3R&8<XK#_X1KQFR>60^WTW5IZ)\,+NY;S=
M4D:$]=HP<TZ5&C0E[24[V"<YU%RJ)>^%.FRQ^9>LI"D%1FNT\81M+X:ND49)
M%:>G:?!IMHEM;H%51V[^]37$"7$#12*"K#!!KCJU^>M[0WA3Y8<I\]^%[R.P
M\21O,0J^9@D]N:]YM=:T^]E6*WNHI'(R%5LFO*?$/PTU".\>335,T;MGGC&:
ML>"O"&NZ1XBBN[FVV0JI!.ZN_%*C7C[12UL<]'VE-\K1Z]12#H*6O'.T0UYO
M\6/^05'_ +XKTFN+\?>'[[7;%(K./>P8'K71A)*-9.1E63<&D<Q\)/\ 6WG^
M\*];KS[X?>%]1T&2X-[%L#D8YKT&KQLXRK-Q=Q4$U!)A1117(;!1110!X3\0
MO^1H7Z?UKUCP=_R*UE_N5Q/B[P9JVJZXMS;0[HP.N:[_ ,.64NGZ%;6LZ[9$
M7!%>EBJD)4(13U.6E%JI)M'E/Q6A<>)%FP=AB49KJOASKMD^CK:/(D<D0"X)
M +5T7B;PQ;>(;3RY %D'(<#FO*KCP!XATZ^9K*,LJGY)-V":TA.E7H*E)V:)
ME&=.HYI71[6][:QKN>>-5]2:\_\ '7C2V%D]A8OYDK_Q*<BN:'AKQI=XBF:0
MQG@Y85U6A?#.VM,7%\YGD93F-QP#6<:-"@^><K^2*<ZE16BK'FOA9MOBW3V?
MC]]DY_&OHM"&0$="*\?U#P!K$&N&YTZ#]VARA!Q7J^F+.FFP)<C$RH W/>EF
M%2%3EE%AAHRC>+1YM\7QQ8'W-6/AMK]A::(UM<SI$_F%OF;%=1XN\+Q^([-5
M+E9(P=N!7E$_PY\0QS,L=KN4'@[NM:T)4JN'5*<K6(J*<*O/%7/=K>XBNH5E
MA=71AD%3D5XA\3_^1O?_ *Y+7I_@K3[[3=#BM;Z/8Z* !G-<CXX\&:MK7B%K
MNTAW1&-5SGTK+!N%+$--Z=RZZE.FM-3KO O_ "+%I_US%:FO6 U+1KFVP"SH
M0M5O"VGSZ9H=O;7"[9$0 BMNN2I*U5RCW-XKW$F?.MI<7?A/Q%O"E61MIR.H
M[U[;H_BC3M5M$D2=$8CE6;FJ7B?P59:_&7 $4X'#J.37FLO@+Q)IURWV.,[<
M\.&QFO0E*CBXIR?+)'*E4HO171['=ZWI]E"TDMS&,#.-W6O$_&7B%O$FJA(
MQA1L1CO4[^#?%=^ZI<1LZYYRW2NW\,_#BVTQDN;QO.EZ[&'2BFJ&%]]RNPDZ
ME;W;61?^'VARZ1H:_: /-<ELCT-5?B?_ ,B\_P"%=PJA%"J,*!@"N8\<:-=Z
MUH[6]HFZ0]LUQTJO-B%.7<WG"U)Q1QWPC_X_+K_KF/YUZU7G_P /O#&HZ#<S
MO>Q; Z8'/O7H%/&RC*LW%W"@FH),9+_JV^E?/3?\CK)_U]#_ -"KZ%D&48#J
M17D)\":R?$S7GD?N3/OSN[9K7 5(PYN9VT(Q$92M9'K\?W%^@I6^X?I2(,*
M>PI6Y4BO/.D^>?%__(YWO_7>O>-&_P"03;?]<U_D*\N\0^!-:O\ Q)<WD,&Z
M*27<#GM7JNFPO;Z?#%(,,J '\J]'&U(2I047>QRT(M3DVBT:\$^)'_(Y7/\
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M='2TFK,^:-6TVXT74I;9]RE6(!'>MGP#_P C)#_O"O1_'7@XZY +BSC'VI>
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M>ML=&DY>TIO<C#RG;EDC6HHHK@.D**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "DV@]12T4 (% Z"EHHH ,4444 %%%% !1110 4444 %&!110 F*6BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH 0@'J*-H':EHH **** "DP*6B@!
M-J^@I<444 %%%% !BDP*6B@ HHHH **** "BBB@ HHHH **** "BBB@ I"H/
M44M% "!0.@%+110 8HHHH *3 I:* $Q2T44 %%%% !2$ ]12T4 )M Z"EHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** $P*-J^@I:* $Q2T44 %%%%
M !1110 4444 %)M'I2T4 )@#M1BEHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** #%%%% '*^--:ETW36BA@=WF^0%>G/%4?AWX=FTBPDNKA2LMP,E#U
M%=C/:070 FB5P""-PZ&I@,# K=5K4O9Q6^YGR7GS,6BBBL#0**** "BBB@ H
MHHH **** $P#U%&T#L*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*3%+10 4444 %%%% "8HV@]12T4 )@#H*6BB@ HHHH **** "BBB@ HHHH *
M3:/04M% "8%+110 4444 %%%% !28%+10 4444 %%%% !28I:* "BBB@ HHH
MH *3:OH*6B@!, 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%,>18QN=@H'<T /HJ@^LZ;&</?0+]7%-_M[2?^@A;_\ ?8JN
M2787,NYHT5G?V]I/_00M_P#OL4?V]I/_ $$+?_OL4<DNP<R[FC16=_;VD_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **:[;$9L9P,UBOXDC4D>0W'O
M2O8:5S<HKGSXHB'_ "[O^=-/BN(?\NS_ )BCF0<K.BHKG/\ A+(O^?9_S%#>
M+(@,_9G/XBCF0<K.CHKF_P#A+HO^?9_S%.'BN(_\NS_F*.9!RLZ*BN?_ .$I
MB_Y]W_,4A\4QC_EW?\Q1S(.5G0T5SO\ PE<7_/L_YBD_X2N+_GV?\Q1S(.5G
M1T5SG_"61?\ /L_YBD_X2V+_ )]G_,4<R#E9TE%<W_PEL7_/L_YBIU\21LN[
M[._YT<R#E9NT5A?\))'_ ,^[_G1_PDD?_/N_YT7069NT5A_\))'_ ,^[_G1_
MPD<?_/!OSHN@LS<HK#_X2./_ )]W_.C_ (2./_GW?\Z+H+,W**P_^$CC_P"?
M=OSH_P"$CC_Y]V_.BZ"S-RBL/_A(X_\ GW;\Z/\ A(X_^?=_SHN@LS<HK#_X
M2./_ )X-^=+_ ,)''_SP;\Z+H+,VZ*Q/^$CC_P">#?G1_P )%'_SP;\Z+H+,
MVZ*Q/^$BC_YX-^='_"1Q_P#/!OSHN@LS;HK#_P"$CC_YX-^='_"1Q_\ /!OS
MHN@LS<HK"_X22/\ Y]W_ #J-_%MK&</&0?<T7069T-%8">*;>092(D>QH_X2
MB#./*;\Z.9!9F_16)_PD<?\ SP;\Z/\ A(H_^>#?G1S(+,VZ*Q/^$BC_ .>#
M?G2?\))#G'E-^=',@LS<HK%_X2&/_G@WYT?\)!'_ ,\&_.BZ"S-JBL;_ (2!
M/^>#?G1_PD"?\\&_.BZ"S-FBL;^WT_YX-^=+_;\?_/%OSHN@LS8HK'_M]/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLZC2A\Q2I*";E\CGZ***Z3G"BBB@ HHHH *]4^#_ /KY_P#>_I7E=>J?!_\
MU\_^]_2N3'?P)'5@_P",CV.BBBOF3Z **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'^+"R^/+8K]X.N/SKW ]*\2\3_\ )0;/_KHO\Z[\O^-^AS8GX5ZGIWV_5/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR"?S$E=<G) K21=B!<YQWJ)M-W1=--*S'4445)84444 !Z5XEXG_ .2@V?\
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M!84Z=3GCS"G#EE8B>-XVPZD'&>:: 2<"NM^(=O#;>(84AC5%-I$<*.^VN8M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'I7B?B?_ )*#9_\
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M:7>MR3VK*V]LDK7+U?UC4CJNHRW1C2/><[4& *H5W4H\L$CCJ2YI-A1116A
M4444 %%%% !1110 5ZI\'_\ 7S_[W]*\KKUCX/1,QN9,<*^/TKCQW\!G5@_X
MR/7Z***^:/H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>UAW#V<^QAT5N?\ "(ZS_P ^,W_?!H_X1'6?^?&;_O@T>UAW#V<^QAT5N?\
M"(ZS_P ^,W_?!H_X1'6?^?&;_O@T>UAW#V<^QAT5N?\ "(ZS_P ^,W_?!H_X
M1'6?^?&;_O@T>UAW#V<^QAT5N?\ "(ZS_P ^,W_?!H_X1'6?^?&;_O@T>UAW
M#V<^QAT5N?\ "(ZS_P ^,W_?!JW9>!-9O)E3R&CSW=32=:FE=L%2F]$CG;>W
MENITAA4M(YPH'>OH7P#X>_L+0U#IMFF =QZ&LWPC\.K?176YN\27&/7(%=\
M ,#BO&QV,57W(;'K8/"NG[\]Q:***\P] **** "BBB@ HHHH **** "BBB@
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M<D>Q@_\ "&>'?^@5;_D:/^$,\._] JW_ "-;U%'MJG\S^\.2/8P?^$,\._\
M0*M_R-'_  AGAW_H%6_Y&MZBCVU3^9_>')'L8/\ PAGAW_H%6_Y&C_A#/#O_
M $"K?\C6]11[:I_,_O#DCV,'_A#/#O\ T"K?\C1_PAGAW_H%6_Y&MZBCVU3^
M9_>')'L8/_"&>'?^@5;_ )&C_A#/#O\ T"K?\C6]11[:I_,_O#DCV,'_ (0S
MP[_T"K?\C1_PAGAW_H%6_P"1K>HH]M4_F?WAR1[&#_PAGAW_ *!5O^1H_P"$
M,\._] JW_(UO44>VJ?S/[PY(]C!_X0SP[_T"K?\ (T?\(9X=_P"@5;_D:WJ*
M/;5/YG]X<D>Q@_\ "&>'?^@5;_D:/^$,\._] JW_ "-;U%'MJG\S^\.2/8P?
M^$,\._\ 0*M_R-'_  AGAW_H%6_Y&MZBCVU3^9_>')'L8/\ PAGAW_H%6_Y&
MG+X/T!&!72X 1[&MRBCVM3^9_>')'L106\5M$L4*!(UZ*.U28I:*S*"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%)BEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)3 *2EI* "BBB@!:6DI: '5M67_'JE8E;=E_QZ)51)98HHHJB0HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!YB?RK1I",C!Z&FT!4L+L7, SPPZBK=8LZMIU\)4_P!5(>1Z5KHXD0,.A%"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@""ZM8[R!H91\K#!KD]5\ VMQ;D6?RR$]6-=G5>ZO(
M;2/=(V/2KA*2?NDR2>Y\\^.?"LGAZ>,D@B4X!%5_"WAD:FCW<[#R8\Y&><BO
M1_';VVIP@3 $IDQY[&N2\$":6>XM@N+;YLGWKT(M\FIR.*YM#,UB"V=2EO"J
MLO?;7)RI'YWRH,]#Q7I>N:,EK:M<;L+C)KRV4SR7,@A!VY.:UI\J=V*;E;EZ
M&S$L4<*9B1N.RTZ[N8XH&:.%?E&1\M5;;S([?YC@]JFBCEOBMG$,M(<9%<,*
M-5U7=Z=STZE;#?5XV5VNATEEH-S<Z)!>K+ 1*H)V'[F?6HF\/R/:W D02_9%
M\R1T&0X/93ZU&FCZWHUF]E'<2)&_+(.AQ6?%J>KVMK]FCOI8X8B691T-3.,X
MRU9E%0G"T?N':?9FZF6%K5TB=@%WK@UTM^\NAE-/MX@J6_WR1][/I7"R>(]0
M.6%Y(Q5LK[5T'AS5;G7;\+JMRS[B!EJUC0J:29A*K&_*MC9NM0EN[;,J)M"]
MA7)RF&5B54<>U=;J?DV=K*58,#E17%]$SC#'K6DXMM6V'3E&,)-WN9>H6[^8
MI5 8\] .:Z3P[KUKI%NRSV^<_=(7FLS=VS4%Q%TQRQ[5K)WW.:-^AUR>('UB
MZCMX3(#(VU1FNYTOX=W+A);F1=K#) /-<W\+_#PN]3^TW$8VP8="?6O<^.U<
MM:JXOEB;TH<RNS/TK1[;2K1((8Q\O\1'-:-%%<C;;NSH2L%%%%( HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** &3?ZE_]TUR)/SFNNF_U+_[
MIKD&^^:F140/2H)*F-0R5)1#WIZU'3TI#+"U(*C7I4@H$4=3^X*Q>];.I?ZL
M5C=Z4BD2)4HJ)*E6I&2#I4BU$*D!XIB)13J8M.IB&O7-^(^%6NC:N:\2Y_=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH)'JM4]&2M4+;WS7OFNP(PY S3V 4EO6J6F<1R_]=#5ME*[F)R#TI%%) O\
M:C +@[!S6AO5,!F )JI;INNVE]L4^YB5I4D9B-O&!WI 7!@T[D<AC^=,4\#Z
M4_M0!*E]<1\!^![58BU@CB12WTK-[&FJ*=P-#4KQ+NQ>->"16M:,IMHPK X4
M"N8;H:V-)D'E8+#/H333U$PUJ7RU0^@S7*7?BJ*[*#RF22)N#GTKH]><[HU]
M5->:"WD>Y=TVD!CP3[UI"*DG<B3L=Q-XP>WMHF$;2 CYF'8U/'J?]KPE9(R#
MCY3Z5R4)9D*3A%C)_A/?M6@LE]IMKYJ1HX[X.>*$E:SW!/J=):3NC?9Y3],^
ME3W5_;629DD4'L#WKEXM1O+O;,T6W'L:9JEO<Z@4>/&!V)K.]B['3NILY([J
M+F*3&0/>M6#4893@' JB2C:3'$Q&X1@?I63IMVD+/;2=1P#WHOJ(ZI;E'.!4
MF:Y2"_2WOU5O-8.V!\I(KJ0V1FKLUN)-/8=44\0FB9&'4<4_-&:0S+L)FMYF
MM)6SC[I]:U*S]2MRR">(8D3GZU/9W(N( <_,.#278"S6;J=L3BXBX=>OTK1I
M" P(/0T/4""RN1<P*W\0'(JS6*^=.O\ =SY4AR?:MA6#*&'(-"8"T4E+3 *X
MK6_^0K-]:[6N*UK_ )"LWUKMP/\ $?H<>,^!&?0.#FBBO5/-/0O!FL>? ;25
MOG3D$UU]>-:;>M8WT<RL0 PW8[BO6["\2^M(YT/#C->7BJ7++F6S/1PU3FC9
M]"U1117*=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %074C
M1P,54LV. *GI" >M ''W%K<31237GR6Y^^'%>9:QH,FN:C(+*/<Z#C:.H%>Z
MWMFE[:M;N2$88.*IZ9H%II9+1#<Q_B(YKIC7LC%TKL^9+_3;C3;@PW4+PR X
M^:J39['D="*^G]>\):9K\#)<1*KM_P M%7YJ\NU7X/ZA'<;M,=7CS_RT<"MH
M8B,M]#*5&2V/.X]4O(H#")3M/457,K/G=GFNKU'X<Z[8M\T*-GGY#FJ$?@S6
M6!S;MD>QK52CT9GRLYV.$QN63J:D+RCH>:ZNV^'NOW+A$A4,1GYCBJ.H^%-3
MTB;RKM%#>H/%/F3=KARLYWRY"^6-=+X?\+7VO3*L$+A#UDQD"K,/AJ5+-;N5
M'\LG'2O9_ ,"1:#$JPJ@"CY@.6K.I4Y(W1<(<SLSRF3PX^D3&.>,B0=R*]$\
M!:M(0;%U)'\)]!7:7.F6=WDS0([$8R1S4&G:):::[O"@W.<YQTKGE64HV:-H
MTW%W1I4445S&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 1S?ZB3_=-<<?OFNRF_U$G^Z:XP_?-3(J('I4,E2GI4+U)9%WIZ
MTPT]:0$Z5(*B2I!0(I:E_JQ6*>M;.IG]V*Q3UJ64B5.E2BH5J5:0R4'BG*>:
M8*<O6@"8&G9XI@IW:F(1JY_Q(A,49 R.]= >E5+B)9D*N,UI2GR33)G'FC8X
M&15+_(N!BDV^HS707.A2*Y:/!4]JABT2:60+C ]Z]Y5Z;C?F/,=.7-:Q=\,Q
M@RR2(FU"N*Z?HM06-@EC:+&HY[FIB>U>)6FIS;1Z-./+&P2GY*S+@_O!6C-]
MT5F3_P"L%8LLG'2.HU8>;@R!<G%2C[L=0(Q$^!LYX^:D,6]0QR*/,W"J1JW?
M!Q(H<J?3%5#0P,^]X4UR^JM\N*ZB]^Z:Y74^6(I+<'L85N?],'UKV'03_P 2
M51ZK7CL/%X/K7KOAU\Z9$/45<MR8[$&F/E9O:0UIGF,5C::>;@?]-36O&?EQ
M4(HRGU 6ETT.S<P&[%207L=_*JJ?F'4>E9%]OM/$WG2@F&5%0?6FF9;+Q!&4
M^X^>E58FYUR\5(.E1(00#ZBI,C'6I+&'[IIBU)Q@C--'2F(3&<U4CFD2XR"0
M15Y.5-9GS>8Q;'7M0!IS7!O#&'^\HP?>LRYT."(>8BXR<L:MVO,ZUKE RX(R
M*<6TM!-)G)'3K91N.,$YJTU\MG&L+0DYX7GK6X]M&>-@Q]*K7U@MQ 0H <?=
M/O0[L$DBBEXSC'E;?:H?-DAN"6.%?]*MZ=$.8VY93@YK0:PCGC,9'7O4V;&.
M@M?,@#B3(IDND(Z^<@Q(.0:BTZX:UN#:S<<_+FME23+M0?*.M5N(J:8Z2C8R
M@2*:UA6/>P-;SK=0\=F';%:5O.L\2N#U%-")Z*3-%, .",&L=]VG7N\#]RYY
M^IK8JO=VZW,#(>O4?6DP)U8,,@\&EK,TV=DS;2GYTX^M:>: (+NW6Y@:-A]*
MHZ;=,CM:S<,O3/I6K65J5L58747WE.6^E)]P-6BJUG<BX@5AU Y%6*8"UQ>M
M?\A6;ZUV5<;K7_(5F^M=V!_B/T./&? C/HHHKU3S0KL_!FL;)39ROPWW<]JX
MRI;:=K>X25#@J:SJP4XM,NG-PE<]K'2EK-T345U+3HY01NQ@BM*O&:<79GK)
MIJZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI*6B@!"H/4 _A2;$_N+^5.HH 3:HZ ?E7/\ B7PQ'XACB!<1M'G!Q70T4XR<
M7=":35F9BZ'9G38[*:(/&@&?<U<M+.&QMDM[=-D:# %3T4-MA9!1112&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'
M/_J)/]TUQC??-=G/_J)/]TUQ#R?.:B141Q-1/09*:6S4EC345S=)9P&:3A0<
M5/N^E138:/#*"#V(H RV\56:8VG)^E/3Q5:'KQ^%6Q;08QY,?_?(H%M #_JH
M_P#OD4"*5UKMI<( K?I5595<94_I6R(8ATBC_P"^13@J <(G_?-)H=S)61>]
M3(ZYK2^7^XGY4<9^ZOY4K#N4Z<M7%5&/S#\J=Y$'H?SHL%RL#3^U,<;7P.E
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ME+33:"R8PC''H*04YNM-[4ABT]?NTRI(]O\ %TIB%3[IK)W9#'_:-;9\O'R
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M4UK_ )"LWUKI%0P6[C=D^U<E=L7N79CDDUW8#^(_0X\9\"(:***]8\P****
M.D\):N;*_P#(<Y27"CVKTQ2&4$=#7B"L48,IP1T(KU+POJBW^G*A;YXP%YZF
MO/Q=+[:.["U/L,WJ***X3L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (Y_P#CWD_W37"/]\UW
M<_\ Q[R?[IK@Y/OFHF5$2BDHJ"PIDOW/QI],E^Y^- "=J***8!24M)0 @ZTZ
MF@<TZD OK5(O)DC>:N]ZI3_(YXH ?&Q(Y.:DSQ5>W;<C'WJQVI#0QC4#]*F:
MJ[&D D3A6Y-7HKN->I/Y5GJ1NJ_;QHPR15(1:2=902M1D_/3B @.T57+'=3
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M;_GF: (:.]3?99O^>9H^RS?\\S0!'WJE=?ZTUI?9IO\ GF:JW=I/D$1F@"G
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M *LU%:6<Z:@3Y38K#J:!;G=KTWLU;,@!K,LK2?\ MJX<QMC?P:VC;RG^ U2
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M)LI3[@FN/%TN:/,NAU8:I9\K.ZHHHKS3T HHHH **** "BBB@ HHHH ****
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M-*?Q'%4445N0%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KN#_R(#?[@KAZ[@_\ (@-_N"N>O]GU-:?7T.'HHHKH,@HHHH ****
M"BE52S *,DUHCP_JK*&%E(01D'%)R2W8[-F;14T]I/:R".:-D8]C5Q-!U21
MR6<A4]#BCFBMV%FS-HJQ=6-S9,%N(FC)Z U7IWOL 45/!9W%RK-#$SA>I':H
M2"#@]:+@)11UJQ-97-O#'++$RQR#*,>XHN@*]%%% @HHHH **** %7[X^M=K
MXG_Y%JS_ -X?R%<4OWQ]:[7Q/_R+5G_O#^0KGJ_' UA\,CB:***Z#(**** "
MBBB@ HHJ[9:3?:@";2V>7'7;2;2W':Y2HJ>ZL[BRE\JXB:-QV-68M#U*>)9(
MK21D89! ZT<RM>X69GT59NK"ZLL?:86CSTS5:A-/8 HHJS)874-N)Y(66(G
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ME1Y4?]P?E3Z* &>5'_<'Y4>5'_<'Y4^B@"+[/#NW>4N?7%.\F/\ N+^5/HH
MC-O"W6-3CVI1#&!@(OY4^B@!GDQ_W%_*D$$2](U'X5)10 SRH_[B_E1Y4?\
M<7\J?10 SRH_[B_E1Y,?]Q?RI]% $8@B7I&H_"E\J/\ N+^5/HH 9Y,?]Q?R
MKRKQ4 OB*Z &!FO6*\H\6?\ (QW7UKLP7QLY<7\",6BBBO2//"BBB@ HHHH
M*FM;AK:YCE5B-K G%0T4-7&>PZ1J*:E81SJ>2,D>E:%>;^$-7^RW?V:1ODD.
M/I7HX(*@CH17CUZ?LYV/4HU.>-Q:***Q-0HHHH **** "BBB@ HHHH ****
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M^MKM%+1R;6S]*AUOPXEEXNT^_MPK6L\VT!><8!S6GHIVZSX@(.,3-C_OFH?
MVM0:F[Z;?*"]NY:)V/4DUS2E/FE5797^:-4HN*BRGXGBC7QIIJA%"F,<8]Q5
MRX\'MJ_C6XGDCVVJ%2>,9'M4'BT!?'6G@=D'\Q5SQ%XYFTSQ-;V:?)! P\TY
M^^,4DZCC%4][,'RW?-W.6\9>(4D?^S+*(10Q?*3MP217%5Z#X\T**2*+6K/'
ME2J-RCU->?5Z.%<737*<U:_-J%%%%=!D%%%% !1110 5VOA;_D WO_7-JXJN
MU\+?\@&]_P"N;5AB?@-*?Q'%4445N0%%%% @HHHH ***MV>FW6H%OLT1?;UQ
M2;2U8TKE2BE92CLK##*<$4E,0445?MM%O[RV:X@@9XTZL.U)M+<:390HJ>VL
MY[NX$$$9:0G 45/'I%[+=M:I 3,HR5H<HK=@DV4:*FEM9HK@P.A$H."M6;O1
MK^Q@6:X@*1MT)HYEW"S*%%%%,04444 %%%% !7<'_D0&_P!P5P]=P?\ D0&_
MW!7/7^SZFM/KZ'#T445T&04444 %%%% %FP&;V('UKU;Q)K&HZ2]I'I^G+,A
MA0D^63V%>4Z?_P ?T7^]7K/B?QC<: +6WACW P(<Y]5%<&*3E4BDK[G31=H-
MMV*_B6*.]\'P:A<6T<-V=I("X/6K?B/5G\/^%]/N+6")GD.T[A["O/-5\6:C
MKDT<<\S>5N'R'ZUWOC'3KK4O"6FQVD1D96R0/]T5SRI.FX1J;-LT4^92<>Q%
MHM_:^--&NH;VVB2X0$JR+@\ FO++J P74D>/NL17IO@S2)M TR\OM3'D<%5#
M=\@USVFZMH"O,VHV,<SDG!8^];TI<DY\BNB)QYDN;1FM\.X(Y-*OS)&K$1OC
M(_V37GESQ<R?6O5O!LEM=0ZA]AB$:,CA5!]C7!W'A366G=A9MC-51J)5I\SM
ML3.+Y(V)/"UEITT_GZA(0D?(4'J171?$1K:72]*FM(PD3Q$J,8[UP(ADM[M8
MY 58-@BNU\9_\BUH?_7 _P S55(_OH2O_5A0?[MHX*BBBNPP"BBB@ HHHH 5
M?OCZUVOB?_D6K/\ WA_(5Q2_?'UKM?$__(M6?^\/Y"L*OQP-8?#(XFBBBMS(
M**** "BBB@#1T.Q_M#5K> _=9P&^E>A>)/$$?A-X=.TNVA)08D9EY)K@_#5X
MEEK=O(_"[P"?2NR\=>'+O4K^._T]#/%/EB1VKAK\KK14]CHIW4&X[F;K/BG2
M]<T9%N+?9?@GYD3@^G-=3<ZFVB> ;*[@AB:3RU^\/K7'7W@LZ9H2WU[<^3,Q
M($1'6NKU2PN=0^'5G%;1F1_+7@?C6-14O=47I<N+GJWO8/#6HQ^-[2]LKRU@
M65(\JRKR,FO,=3LS9:G<6PR1&Y45Z1\/]*NO#PU"_P!1B,,0B&"WUK!MM7T(
MZC?2ZC9QSEYBR,Q[5=*7)4G[-7CH*4>:,>;1F/X:L;"YGDEU&0I%%@D \FNT
M\>BT/A.W-H@6,.H!QC->?:W/9SZI+)81"*W)^5%Z"NW\5G_BA;/_ 'E_E5U4
M_:0F^O0F%N22)=.=-$\$07]M;1RSR(&8LN<4SQ/"FK^$;?4S;)#/O(;"XX J
M#PS-J<?A]EEL3?61 VQDX %:OBJ\D@\%PK/!Y#O(0(\]!VK#6-5=[[FNCA\C
MR>BBBO5.(**** "BBB@"UIO_ "$K?_KH*Z3QS_KK3_</\ZYO3O\ D)6__705
MTGCG_76G^X?YUSS_ (T?F:+X&<C111709A1110 4444 36G_ !]1_P"\*]1\
M=Z/-=Z58_9(,G8A.U?\ 9%>7VG_'W'_O"O6/&^NZAI&E6)L;AHB40''^Z*X<
M2Y>UAR[ZG12MR2N4_#.ER67A'41=0[7+#&Y?:M/PSOA\!23V\"23JTA4%<\Y
MJIX>UB]U?PCJ,E].971@%)[<5<\./=I\/96L21<!I-F.N<UQ5>;WN;^9'1"V
MENQSL^O>(S!('TV(*5()\L]*G^'1/V75)?*5Y50$ C/.:SI;OQR\+K(\Q0J=
MW3I6E\/I)K2QU9\[9EC!S[YK>I%*E*UNFQE%MS6Y9L-=UJ?5OL\VEQ?9R^"6
MB/3-9OB"31])\9B>2-6A5R61%R/RK<\,^,IM3N+K2[R3$QW;)3V]!7&:CX8U
M"X\6M92NTC2/CS".M*FDJC4_=TZ=1R;Y5RZZG5:#XA/B#4IX#8Q"R$?!V=*\
M[\0Q10^(+V.#'E+)A<>E>G:CI]UX>TH6.C66Z1T^>13ZCFO);Q)X[R5+D$3A
MOG!]:VPG+*3E#1?UJ16NDD]R"BBBN\Y@HHHH **** -WPA_R,=O^-)XL_P"0
MY)_NBE\(?\C';_C2>+/^0Y)_NBN?_E_\C7_EV8=%%%=!D%%%% !1110!W'PR
M4-K=SE Q$.0"*V]2UKQ!#J,\<&G1&)6PI\L]*Q?A@6&MW17[WD\5HZK>>-5U
M2X%L\ODA_DQCI7F54GB'>VRW.N#M31D6]M=>(O%L<>H0K$P*EU48XK:UWQ8=
M$O1IFD6D16+Y7^3DD5E:-J5_9>,$GUHGSI=JLS>E:&NZ!?6OB0:K8VYN89B7
MR/>G)1]HE/:VG8%?E;CW*FMZ]!J^A'[5ILD5X%/SK"0/SK3\'236W@FXGMH%
MEF$V "N:V-2:>?P-?RWMF+>3R?E!/TK"\-7]QIW@"YGMI#'()^HK*ZE2:BOM
M%6:G=]C.U7Q!KKZ?*ESI\<<1'S-Y9&*WO"$LL/@:6X@MUEF\YL KFN$O_%VM
M:C:O;75X\D3\,I[UVWA:^GT_X>R3V[E'$K<BM:]-QI)62U1-.=YWOT+/A[5M
M3U2\^SZGID*6Y!W,T>,?G7G/B.*"'6IDM\>7GM]:]-T+Q)-XJ\/S61F\B]1<
M>9U+5Y/J5K/9W\T5P#Y@8YSWYJL*K5)75GV_4FL_<74J4445Z!S!1110 444
M4 =Y\*_^1AG_ .N5>VUXE\*_^1AG_P"N5>VU\_F7\<]/"_PPHHHK@.@****
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M5P'0%%%% !1110 4444 %%%% !T&347VB+_GHM/D_P!4WTK _B-)C-WSXO\
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MK_Y&&?\ ZY5[;7B7PK_Y&&?_ *Y5[;7S^9?QST\+_#"BBBN Z HHHH ****
M"BBB@ HHHH ;)_JF^AK _BK?D_U3?2L _>I,:%I:2BD,*8:?332 8:::<:::
M ,Z\VA\MTK'CO'N2Q(P%.T5KZA&74X('N:Y_3K5K:.17?<2Y(YS7@9A.4ZKC
MV.JDO=N6]PSC=S2X.>M,$.V3?US4H!) '>N"2CHH[FVO4?#"TK8'2KT=LD1S
MCFI((1%&..3UJ0U[^#P<:<$Y+4XZE1MV0HDQVI?-'I45)7>9$V]32$J:BI*
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M1PE%3_8KK_GVF_[X-'V*Z_Y]IO\ O@UT71E9D%%3_8KK_GVF_P"^#1]BNO\
MGVF_[X-%T%F045/]BNO^?:;_ +X-'V*Z_P"?:;_O@T7069)!J=W;0M#%*P1A
M@C-5"<G)J?[%=?\ /M-_WP:/L5U_S[3?]\&EH/4%NYT@,*R$1GMFDCNIHHFC
M1R%8Y(S2_8KK_GVF_P"^#1]BNO\ GVF_[X-%HAJ26VI7=HK+#*RJPP1FFM?W
M+(4:5BI.2":;]BNO^?:;_O@T?8KK_GVF_P"^#2M$-1)+F::-4=R57H*6*\GA
MC,<<C!3U&:/L5U_S[3?]\&C[%=?\^TW_ 'P:>@:B1W<T4;(CD*W49IB2/')O
M5B&!SD&I/L5U_P ^TW_?!H^Q77_/M-_WP:-!:B3W4UR097+$>M0U/]BNO^?:
M;_O@T?8KK_GVF_[X-"L@U9!14_V*Z_Y]IO\ O@T?8KK_ )]IO^^#3N@LR"BI
M_L5U_P ^TW_?!H^Q77_/M-_WP:+H+,?IO_(2M_\ KH*Z3QS_ *ZT_P!P_P Z
MP=.L[H:C;DV\H&\?P&NC\;VT[RVFR&1L(>BD]ZYYM>VB:)/D9QE%3_8KK_GV
MF_[X-'V*Z_Y]IO\ O@UT71G9D%%3_8KK_GVF_P"^#1]BNO\ GVF_[X-%T%F0
M45/]BNO^?:;_ +X-'V*Z_P"?:;_O@T7069+_ &I=FT^RF8^5C&W-4ZG^Q77_
M #[3?]\&C[%=?\^TW_?!I*RV'JQ'NIGB6)G)11@#-'VJ;R!#O/ECH,TOV*Z_
MY]IO^^#1]BNO^?:;_O@T:!J2QZI>16Y@29A&>V:C:]N&55:5B%Z9/2D^Q77_
M #[3?]\&C[%=?\^TW_?!I6B%Y#)IY)V#2,6(&!FG_;)_(\CS&\O^[FC[%=?\
M^TW_ 'P:/L5U_P ^TW_?!IZ!J)]JF\GR=Y\O.<9IL-Q+;ONB<J?8T_[%=?\
M/M-_WP:/L5U_S[3?]\&C0-1DT\D[[Y#EO6HZG^Q77_/M-_WP:/L5U_S[3?\
M?!HT%9D%%3_8KK_GVF_[X-'V*Z_Y]IO^^#3N@LR"BI_L5U_S[3?]\&C[%=?\
M^TW_ 'P:+H+,UO"'_(QV_P"-)XL_Y#DG^Z*F\)6EPOB*W+02@<\E#1XJM+EM
M;D*P2D;1R$-<UU[?Y&MG[,YVBI_L5U_S[3?]\&C[%=?\^TW_ 'P:Z;HRLR"B
MI_L5U_S[3?\ ?!H^Q77_ #[3?]\&BZ"S(*4$J<@X(J;[%=?\^TW_ 'P:/L5U
M_P ^TW_?!HN@LR6XU.[NH5BFE+(O0&J8)!R.U3_8KK_GVF_[X-'V*Z_Y]IO^
M^#25EL/5B2W4TQ!D<MCIDT274TH4.Y.T8'/2E^Q77_/M-_WP:/L5U_S[3?\
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MNNQK_P!EV'_/%?RH_LNP_P">*_E61YLG]]OSH\V3^^WYT<DNX778U_[+L/\
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MU3?2N?/WC28T+2YIM+4C"D-%)0 AIM*:2@#/U#[IK+'6M34/NFLL=:^;Q_\
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MT_X^5HN_]>:G[0^A!1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!-4A/<743^X:L6#_ %0K6OFS"WTK)@_U*UW8#^(_0Y,9\")****]<\P****
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MQ+)F&/D\]:P;>-+CQ&S6 (A1,$@Y&15SK3C)=F5*<DSH9O$VFP3O"\C[T.&
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M5D:!5#5/^/7\15^J&J?\>OXBJAN)[&+5>^N!:6,]R>D2%_R%6*S]=_Y %_\
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M9II]7<RE231QVI:?)<7&G*T6Y R[@1[5/XCT4H(;RP0(\.!A>,C-=5@>@I2
M>HIO"Q:=^H>S6IRFHV-SK6E6]R@V7$!+ =.>E9\VHWLUK]EN-/224+L!*DUW
M0  QBC:O]T?E1+#-NZEON#I^9Q6BV%]HFD7<YC'FNN44<UE:?+?V]ZUS-:^=
M(QXWJ3BO2L#&,"C8O]T?E4?4]$HRV%[+:SV.+\0M=W#:;>+#EU4EE /%1W5S
MJFMPQV8MQ&F<,>1Q7<;0>P_*C:HZ ?E5/"MR?O:/<;IW;UW*NF68L-.AMO\
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M8=K6;)90,C-=I@#H!05!Z@&A86*22>J=P]DK:'':A97NFZL=2LT#1R8W+_\
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MFSN8K*>Y2"$(C( A'8TU))BM<N:C?03ZK'92OLA1=N5..:ZFQACM[...)]Z
M<'.:\UE075\K2)\V[KZUZ1IBHMA$(QA0.*Z,%K4;.?%_ BW1117IGG!1110
M4444 %%%% !1110 4444 %%%% !1110!+;S-;SI*IP5.:]8T+4EU'3HY,@R
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MU9O>J?2JT?\ K%^M6;WJGTJ>H+8J44450@HHHH&%%%% !1110 4444 %%%%
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MA[M=LI)R,8K3JLCOCY4&/K4F^3^X*+@2U/!"93STJGOD_N#\ZNQRLL8 &*:
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MCR)?^>;?E6MYS4><U'.PL9/D2_\ /-ORH\B7_GFWY5K><U'G-1SL+&3Y$O\
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MO.:CSFHYV%C)\B7_ )YM^5'D2_\ /-ORK6\YJ/.:CG86,GR)?^>;?E1Y$O\
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M "PH8$-%%%, HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1110 4444 %3?\L*AJ;_ )84,"&BBBF 4444@"BBB@ HHIDTJP0O*_W5&30
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MF,5./NV,S1R/^$XOSGCRE_F:I>.-LVOV*1<RC!X]-PK5U'P<]UJDEY%.T9<
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M^8NFFEJ%%%%;&@4444 %%%% "K]X5)/U6HU^\*DGZK0!%1110 4444 %%%%
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MA^E#&0T444Q!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *F_Y85#4W_+"A@0T444P"BBBD 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5-)_JQ4-32?ZL4 0T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% "K]X5)/U6HU^\*DGZK0!%1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 /B_U@HE_
MUE$7^L%$O^LI=1C****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHI@36W^L/TJ[5*V_UA^E7:B6XT%%%%2,**** "BBB@ HHHH *
M*** (;O_ (\YO]P_RKR:5AYK<]Z]8O?^/&?_ *YM_*O%YI'\YOK6<RXDUQIT
M5U(LC#YA[4R.Z@TN\52.).6;'(J2UU*&*58IN&/1B:Q-7#7.H2M$XRK<5GN,
MV[F\4ZTX#$#RU(%9T&M&;6C:C[HSDU5"74EV)W?YMH7IZ5E6N]/$3-L(Y/-"
M Z_43F)/K6'/(T<@*G!Q6O.3);)GUK"OODG7-*0T#W$Q_C:I+&9VO8LL?O"D
MDN(OLY0+@D5%8L/MD7^\*RG\+*CN=S>]JR=1'^B-]*U;HYQ65J'_ !Z/]*^5
M3OB$_,['\!S"-V[TD#-#=%20(S]WGO3,X8&B=%?RY"<>6=U?6HX&=5;R3K&I
M!XQZU.+Z5?X0:@LSNM8V]5JQMS6Q!)'?%W"E0.:UE:L58\.#CO6LAI%1+&?E
MJ-NE.SQ4<A.QL=<<4#(=XR>:,UP4NJ:TFOM"J,4!RPQT%=I:2-)$&88-,5RW
M13:6@8OTK7C4)$ /2LVV7?.H/3-:C< "G$0Y/NTTMS0I[4A'-4!&965OF'%*
MS@BB09%0 E3C- $C<C(ZT@)Q29/6ESS0!*A%.(P#48//%2$@KQ2 BZ-6'J\'
MES;U'#\FMYER*IW\/G6^.XH Y^SG,<VUNAZ5M*V<&L4Q!6SGH:T;:4/'C/2@
M#11JL1G R3Q6>&(H$[ T 72V]LFD+]ATJLLA)]JD9U XH LQOQ3,^E11.<TV
M3@?C0!.S_(0QJB;A<_>'%8OB/Q';:19.HF7[05.U,\UY/%XVU@[F-P.2<?+4
MN#EL%['N ND+X# _C4ZR9&<UYEI&JW,D0F:3+MR:Z2#71&G[_P#/-8M-,M'5
MB2B694 RN?PK*MM4MKA?DG4$BIS]H5<JX?Z"I8T.EOH2I/DYQ_LFN:N]5,VH
M*([94V\9&:M7VL7UJ^&@**3PQ YK*\^2YN?-<#.?2G;0#<21G4$TX]:@BSL&
M:ESQ1!6!B@UG:L?]#;ZU?4]:SM7_ ./0_6M&(P[7F+Z5+OP>E,LX^*DEVQO@
MTV)#C*2 ".E*C!LCN*7>C*H]:F-I\NY6I 4@/F;ZT21EAQ2[3'O9F"J&ZFKL
M%LT\>Y/G![BG?4"DN1CY:V;;_4+4#64L0"M$<GH*M1HT<85E*D=C7?@&W4?H
M<>-7N(?1117K'F!1110 4444 %%%% !1110 4444 %%%% !1110 5M^&M*;4
M=04E<PH?F-8\<;2R*BC+,<"O4_#6E+IVG(2N)7&7SZUSXBKR0\V;T*?/(V(T
M$<:HHP ,4^BBO)/3"H+K_5?C4]0W&WR_F8*/4TUN!2HI^(O^>RT8B_Y[+5DC
M**?B+_GLM&(O^>RT ,HI^(O^>RT8B_Y[+0 RBGXB_P">RT8B_P">RT ,HI^(
MO^>RT8B_Y[+0 RBGXB_Y[+1B+_GLM #**?B+_GLM&(O^>RT ,HI^(O\ GLM&
M(O\ GLM #**?B+_GLM&(O^>RT ,HI^(O^>RT8B_Y[+0 RBGXB_Y[+1B+_GLM
M #**?B+_ )[+1B+_ )[+0 RBGXB_Y[+1B+_GLM #**?B+_GLM&(O^>RT ,HI
M^(O^>RT8B_Y[+0 RBGXB_P">RT8B_P">RT ,HI^(O^>RT8B_Y[+0 RBGXB_Y
M[+1B+_GLM #**?B+_GLM&(O^>RT ,HI^(O\ GLM&(O\ GLM #*EA^]3<1?\
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MT8B_Y[+0 RBGXB_Y[+1B+_GLM #**?B+_GLM&(O^>RT ,HI^(O\ GLM&(O\
MGLM #**?B+_GLM&(O^>RT ,HI^(O^>RT8B_Y[+0 RBGXB_Y[+1B+_GLM !%_
MK!1+_K*?&(_,&)5)]*201[^95%+J,BHI^(O^>RT8B_Y[+3$,HI^(O^>RT8B_
MY[+0 RBGXB_Y[+1B+_GLM #**?B+_GLM&(O^>RT ,HI^(O\ GLM&(O\ GLM
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M!#;AZUV9>_WC]#DQOP(DHHHKUSS HHHH **** "BBB@ HHHH **** "BBB@
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M3GM56/\ UB_6K-[U3Z5/4%L5=Q]:-Q]:2BF NX^M&X^M)13 7<?6C<?6DHH
M7<?6C<?6DHH 7<?6C<?6DHH 7<?6C<?6DHH 7<?6C<?6DHH 7<?6C<?6DHH
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MD@**** "BD+*O5@/J:-RYQD9],T +1131(A. ZD^F: '4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %6['_6U4JW8_P"MJ9; BL_^L;ZFFTY_]8WU--J@"BBB@ HHHH *
M*** "BBB@ HI"0HR>E(DB.,JP/T-(+#J*8LJ,VU6!(]*?0%@HHHI@%%%% !1
M110 4444 %7;7_CW?Z&J57;7_CW?Z&IEL"*5%%%4(****!A1110 4444 %%%
M% !103@9IJNK E2#CK0(=12 @]"#02 ,DXI#%HIJR(QPK GZTZB]Q!1113&%
M%%% !1110 5>_P"7#\*HU>_Y</PJ9= 11HHHJA!1110,**** "BBB@ HHHH
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M4 %%%% !1110!/:?\?*T7?\ KS1:?\?*T7?^O-3]H?0@HHHJA!1110 4444
M%%%% !1110 44W>H;;N&?2EW#. 1GZTKH0M%%,\V,-MWKGZT /HHZ]**8PHH
MHH **** "BBB@"]I?_'P?I6W6)I?_'P?I6W7/4^(J.P4445!04444 %%%% !
M1110 4444 0W?_'G-_N'^5>22D>:PSSFO6;\[=/N&](V/Z5X(-0N)M:6/:5B
M+<M6<RHG0&E[TR>0(F?05634[<G:S8-067J:::DJ.,JP_.E)R:0%6[/!K#U!
M^%^HK<O/]6Q]JQ9HO-P#28$$DCYP*6V9_M</'\8J3R#GDFI[:+%S'S_$*SFO
M=8UN=9=?<%9EYG[,^/2M*Y8%0/2J,P"H<\C%?(W_ 'R?F=_V3F$,B$G::K6D
M,;ZA-*0ZMM'.>#6\TMNV43&[T%9S)L<Y&*^PBW8\YE=KRV=S'(K\<9!J6/3[
M>?F&< GL[9JE<6#M)O3D'DU+8P-'<Q[E[U:$=AX<\./]H$MWY;1C[NT8KLWT
MF"3G!!^M9FG7\<<4890H"CI6Y%?6\F-KU:L!F2:&X&4851ET^=#C:3]!76;E
M(X8'\:B:G85SCGB=.&4BH2*ZV2WB<_,@/UJG<:;"XX&WZ"E8JYS9%:^EIM@)
M(ZFHIM,"_=8FK\:B.)5Z8'-"6H-BL:C/O4A*]C3&8'@50A.]2#IFF4M,"1>>
M32/R.*!TI",4 1=Z4=:0]:"P5>*0"-\U,W$5(,&HG!!Q0!(27'L!5<@@U/&1
MLYIQ3(H J<TH-2L@IA''% "^8=N*HR<L:M.0L9]:IMFDQH;5;5+9KK3I84(#
M,I S5A>N#6!XLU*YL;'%N,,?X@>E(&>2:YI=_I]\(3,#_N9XJK#?SH?)E=OQ
M-:5Q-=7$XEF9G)ZDU7N+*.2,R,=L@&0 .M;IZ:F16BVSW#)N[$\46K.L07<V
M"2,9XJG9$Q7K,V0,'I6C8V[S(#M. 2:'H".J2Q%Q91NAQ(% Z]JB:U98B# S
M?05=TS<L(![4_4-8%@%6-5=CU!/2L%)WLC2RL8<\=T1C[.P7M\M1P:1+-)O.
M%/N*M7'B"YN4")$JDGJ#65+KMQ:W!CDZ@U?O"T.IT[1HK=?4DY-=1IT"QKQ7
M,Z+J*WD ;/-=1:9. *R;=]2EY&DHJ3'%1*'7[U2Y^6@8P?=:J=[_ *D?[PJT
M/NFJUV/W _WJEC+%H/W-,N#_  [@#[U):_ZL4D]KYT@(X)XI@5-\@&%P?PII
M$AX923[58GTZ2WC+K*V[L*I^9<*22S46U"YJVL#&+)5MO<U,%7IG'UI+*X?[
M)M8G!Y-0M-%YA+&J)+<RB) R$5FS,7E8G'/I5Y+F!UVL>/2J5QM\]MGW>U=V
M _B/T.3&? B*BBBO6/,"BBB@ HHHH **** "BBB@ HHHH *.M%;'AW2VU'44
M!7,:G+?2E*2BKLJ,7)V1UO@[1_LUM]IE7]XWW?I765'%$(85C7HHP*DKQ:DW
M.3DSU804(V"BBBH+"BBB@ JAJG_'K^(J_5#5/^/7\150W$]C%IDTJ00O+(0%
M09)-/K/UR%[C1+R*,9=X6 'OBND@Y>7XEV273JMC<O;(<&Y7&SZYJSK7Q!T[
M1Y(HS!+.TJJ4\L]<C.*\>MM.,.DR:;=ZK?PSC :U2+*$_6N@U#1Y;;7M%B;S
M9E5XFW%>V!6?,QV-/QEXEN;V33I88;BS# 91S@GYJU=*O[A_B7=6S2L8A9PL
M%R<9-5_BC [:AIGE1,P &=JY_BK.?6+;P_\ $FYNK]9EA>SA4,D9;D"EU#H>
MHZT+YM,D73V59VX!89&*\FU&UU3PS<Z?.;\RW\LIW1[R0?PKLKKXF:(;"62U
M^TO( 0H,##G%<%X>\0Z?>Z[_ &GKINGN-V8HFA)5#[&G)JX(]KT^62;3[>64
M8D9 6'O5FHK:5)[:.6,$(Z@KD8XJ6M!!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5NQ_UM5*
MMV/^MJ9; BL_^L;ZFFTY_P#6-]33:H HHHH **** "BBB@ HHHH CN(A/ \9
M)&X$<&O+KF_N_"%]?6Q\V19TQ"Q).&SGO7I]W<+:VSS/G"CL*\MFT^_\8W5[
M>%Y(TA7,"=BV<=ZX\5?3E^(]K*+>\ZO\/2_K?0Z_P;IDT%F;RYD=I9SO +'
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M]J#D1+^5!TZU8Y,2D_2K5%3R1[!9$<4$<"[8U"CT%24455DM@"BBBF,****
M"BBB@">T_P"/E:+O_7FBT_X^5HN_]>:G[0^A!1115""BBB@ HHHH *9)&DJ;
M74,#ZBGT4A%>&RM[=BT<8!/?%/6WB20R*@#'J<5+119+9!9$9@C:42%1N'?%
M1O8VTC;FB4D^U6**7*NJ"R*HT^U'2)?RH_LVT_YXK^0JU12Y(]@LAJ(L:!$&
M%'04ZBBJ ****8PHHHH **** +VE_P#'P?I6W6)I?_'P?I6W7/4^(J.P4445
M!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7E'BO\ Y&.Z^M>KUY1XL_Y&.Z^M=F"^-G+B_@1BT445Z1YX4444
M %%%% !1110 4444 %2V\#7-PD*#+.<"HJ[+P9H_FN;V5?D_A^HK.K-0CS,N
MG!SE8ZS1-.33M/CC"X<@%_K6G117C2;D[L]:*25D%%%%(84444 %%%% !5#5
M/^/7\15^J&J?\>OXBJAN)[&+111720%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !5NQ_UM5*MV/^MJ9; BL_^L;ZFFTY_P#6-]33:8!1113 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *NVO_'N_T-4JNVO_
M ![O]#4RV!%*BBBJ$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% !1110 4444 %%%% !1110 J_>%23]5J-?O"I)^JT#(J***!!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ^+_6"B7_641?ZP42_
MZREU&,HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBBF!-;?ZP_2KM4K;_6'Z5=J);C04445(PHHHH **** "BBB@ HHHH CG_U$
MG^Z:XIQ^\/UKMIO]1)_NFN+?[YJ9%1&@4X4@IPJ2A<4[% I: $Q2$4ZBF!&1
M3"M2FF&D! RU"RU:85$PH J,E,2/]Z,>M62*8HQ*/K2&(B8G_&M%@-[8]*I
M?O<^]71SN/M0A#XA\M.(I(ONTXTP(\4H%+BC%  WW#]*QIU^9C[ULG[IK.N5
MX)J6!:TK+Q*6YKH41V4#) K!TD8B6NHC7]VOTJ%J#(UMP>O-17<(6V8^U715
M>^_X]7^E78DY_37Q>(F?O5TX3BN3TSG58178A#BB(Y#-O%86H<7;5T!%<_J/
M_'VU,2*M#.$4LQP!UHID\'VB!HCT88H*&&ZBDCS&ZMSC@U)"1L&*QX-".G(Q
M@))9LGG-:-G%<*N&4TM0)KF$2Q8QR.15:SN#EH9.&' K0$;_ -TU1O+"7S5F
MA4[AUQ0^X%29O]-0>]3SCYQ1]@G>XCD*$8/-6Y;.1F!%" 2+@5+3EMF IWD-
M3 B[5DW2&";<O0]:VC ?6H+BS,L96DT",JV96O593G-:<OW:I6VFS0W(;!(K
M0DAD(^Z:%L-E1>M3K3%AD!Y0U)M8=13$%!HYI* &/C:<^E85Q:QQ2^:IY8YQ
M6S<?ZIL#/%<\K22SLC X4\"LYO6Q26ESJK2/S%7V JZV!P*CM4\JW7UQ22S)
M&,NP%:$C)H7FVHG3/S'VJ1M,B^SX=%<>]4'UNWB)5) S>@J%M;NYALCMG4?W
MNU.X%Y;>*/&V-5QTJ9DS"Q\Q ,?WA601J5S]^4!3VQ2-I<FS+EC^-%P'0R('
MV[ 1'T;UJKXAO%?3VBMS\^.U.*?9HVVN!ZL:R)IH+6%LSKR23GO0(S-+^T1K
M&[;BZC@>E;F^^N!\HV#V-6-)-K<0B419';FMI?+4?*F*2&<V-.N7/SLQ^IJ5
M-#=N6-;Y:F%C189DC1$7J:QKZ(07;QKT%=82:Y?5/^0A+]:[L!_$?H<>-^!%
M.BBBO5/,"BBB@ HHHH ***DAB,TR1KU8@4 ;OA723?WXD=?W<9YS7IZJ$15'
M0# K*T#3!ING1QD?O,?,:UJ\C$5.>?D>I0I\D0HHHK V"BBB@ HHHH ****
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MX*LEMPQ*(CL!Z 4W2I\L-=PY(V0Z#XA64EP \<BPL?E<QGFNQBD66)9$.58
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MB3_=-<6_WS7:3?ZB3_=-<6_WS4R*B IPIHI14E#Z6FTZ@ HHHH 0TPTXTTT
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MX:YIQ_Y>5IW]L:<?^7I:+H"_N/K2YJA_:UAVN%-"ZI:,>)11= 7Z,#TJJ+Z
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MG_V@1BO3U&U0/08JI!I=G;7+W$4(65SEF]:N4""BBB@ HHHH **** "BBB@
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MIT%*4)-ZQ"BBBLCH"BBB@ HHHH *FD_U8J&II/\ 5B@"&BBB@ HHHH ****
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M@ HHHH *@NO]5^-3U!=?ZK\::W IT4459(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %2P_>J*I8?O4/8"-OO'ZTE*WWC]:2@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *FC^X?I4-31_</TH8R&BB
MBF(****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4W_
M "PJ&IO^6%# AHHHI@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J:3_ %8J&II/]6* (:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!5^\*DGZK4:_>%23]5H&14444""BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!\7^L%$O\ K*(O
M]8*)?]92ZC&4444Q!1110 4444 %%%%, HHHI %%%% !1110 4444 %%%% !
M1110 4444P)K;_6'Z5=JE;?ZP_2KM1+<:"BBBI&%%%% !1110 4444 %%%%
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MD871J^4U'E-65]IF_P">C4?:9O\ GHU'(PNC5\IJ/*:LK[3-_P ]&H^TS?\
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MBBB@ HHHH **** "J&J?\>OXBK]4-4_X]?Q%5#<3V,6BBBND@**** "BBB@
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M_)CF <G W$#/TK5H ****8!WJ[=?\>R52[U=NO\ CV2I>Z#H4J***H HHHH
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M6 IW0&E165I_B'3]3G:"WG1I!_#N&:U: "BBBF 4444 %%%% !1110 4444
M%%%% !1110 5;L?];52K=C_K:F6P(K/_ *QOJ:;3G_UC?4TVJ **** "O.?
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M&]3;4I+_ %2X_>-'L"1O\O'M4MIX5>W@U2,L/],E$@Y]L4DF%RSX)_Y%R/\
MZZ-715FZ%IITK3%M6.2&)_.M*K6P@HHHI@%7;7_CW?Z&J57;7_CW?Z&IEL"*
M5%%%4(Q_$_.@S@>E>>:+X>\03>%C<Z?JQ7#,4A"<GFO4[VSCOK5K>7.UNN*B
MTO3(=)L5M("QC4DC=[U+6HSS[0I;9- U Q)MU) RS<\DX.35+1[0W7@;=+:,
M8I%.Z;/O7?KX7L4U5[]=X=T9&0?=.>IQZUG2^ ;!V8+=W21-_P LED(4?A4\
MK'<YC1XDN?$\-KJ,GFV20@QYZ!ATK0U6SL+3X@Z8UH LKAS* >]7/$ME:VB0
M0/;W!A4 ![=?GS]167HFEI>>*+:XMX[L16N5=KD')SZ9H\@&Z)%'<^#9X9;H
M0,]],J,>YW=*A^TOHUS:1ZGI$DD,8V+>%L \UW$'A>QM]*ET]"_ER2-)N)Y!
M8Y.*H6W@6R@N$EDNKF<1_=25]P_*GRL+G.Z9;P-\2-894^46<3+[9J;P?H]A
M+_;EY<Q;WCN&.2>@QFNDN/!MC/K8U4331SX (1L @= :T-.T.UTR*ZCA+%;E
MBS[CZC%"B%S@[:[BU!;I['17%FPP;G=D&N>C7S?!DBODXU10,^F:]$'@.P25
MVCNKI$;K&KX7\JGM_!.FV^DRZ<K2F*23S22>0U+E87,.\C6'Q%X76,8&&XI?
M#%K%JFK7LVIKNNPS( Q_@!.*Z"T\(V5K-82B::1[+/EEVSGZTFJ>$;34KPW0
MGGMY",'R6VYIV87."U".."V\16UKGRA=(' /W>!Q6O?:)8VW@-I8XL2(A<-G
MO@5TL7@_3X],FL=TC+,P9W)^9B/>M"XT2VN-).G.6\DKMR#S1RA<\^DU"#;X
M?MAI;W^H26>Y-K8(7/-/MF>+QK;DQ&WED<"2(GH,5U-YX(L+I;/$T\;VD?E1
MNC8.VEM?!%A;7\-[Y]P\T3;@7?.?K19A<J^ ONZQ_P!?K5V%9^E:/;Z0+C[.
M6/GR&1MQ[FM"J6P@J]_RX?A5&KW_ "X?A2ET!%&BBBJ$%5[_ /Y!MU_UQ?\
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MRSAN)(6D&8TWL0> *SSXSTH!&#DQM_RT'W1]32N@.BHK!D\7:9'*B^9N1O\
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MAN""22:$1$*SK@GGTKO#X&T0WOVHQ2^9NW8\SY<_2M6YT>RNI(7DB&8?N!>
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M45(PHHHH **** "BBB@ HHHH AN_^/.;_</\J\GE7]ZWUKUB[_X\YO\ </\
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M3Z "BD9E12S$*!U)-"LK#*D$>HH 6BBB@ HHHH **** "BBB@ HHHH ****
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M(QMQQ7/ZOXPM+"[.GVX>:^)PJ!25S[D=*K67C:-;U++586@N)#\FU25.>G-
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M31_</TJ&IH_N'Z4,9#1113$%%%%( HHHH A6VA6?SA&HD(QNQS4U8W]OP_\
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M_9]U_P \)/\ OFC^S[K_ )X2?]\T"*N*7%6?[/NO^>$G_?-+_9]U_P \)/\
MOF@95XHJU_9]SC_42?\ ?- L+H'_ %#_ /?- 7*M)C%6S877_/"3_OFD^P77
M_/"3_OF@+E0]*A<5H?8+K_GA)_WS49TZZ_YX2?\ ?- &:13"M:)TV[_Y]Y/^
M^:8=,O.UO)_WS2 H;?:FE*O_ -F7G_/O)_WS1_9EY_S[R?\ ?- &:4'I0(ZT
M?[+O/^?>3_OFC^S+P?\ +M)_WS0.YG%*9LQ6H=+O/^?>3_OFHSI=Y_S[2_\
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M?[IKQB;0M3(XL9_^^#7MG@2"6V\'V,4T;)(J\JPP15PW(GL='1116AF%%%%
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M 6+_ %@HE_UE.B5A(.#22JQ?H:749'13MC?W31L;^Z:8AM%.V-_=-&QO[IH
M;13MC?W31L;^Z: &;5]!^5  '0"G[&_NFC8W]TT ,P!T I:=L;^Z:-C?W30
MS:/0?E2X Z"G;&_NFC8W]TT ,P,YP*7 /44[8W]TT;&_NF@!FT>@_*EIVQO[
MIHV-_=- #:*=L;^Z:-C?W30 VBG;&_NFC8W]TT -HIVQO[IHV-_=- $EM_K#
M]*NU4ME(D.0>E6ZF6XT%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 3%&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,48HHH ,48HHH ,48HHH ,
M48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HH
MH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,4
M444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444
M&*,444 &*,444 &*,444 &**** #%&*** #%&*** #%&*** #%&*** #%&**
M* #%&*** #%&*** #%&*** #%&*** #%&*** #%&*** #%%%% !BC%%% !BC
M%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%%
M!BC%%% !BBBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BB
MB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1110 8HQ110 8HQ110 8HQ110 8H
MQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 4444 &
M*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,444 &*,44
M4 &*,444 &*,444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,DC25"DBAE/4
M&N;\:VL,7@S5O*B52;=A\HKIZANK6&]MI+>==T4@VL/44 >0:=X0OY/AUIE_
M9:K>>9Y"L;<MA=N3D5'K5Q+>>%=$72(F2%;EQ<1$;<\<Y'IFO8;6R@L[*.S@
M0+!&NU5]!55=!TY$F1;<!9AAQZT >1SV]P)@8EC27[*X!MCN.,=.*(O[*3X0
MS"XM_P#3A&W+I\X.:]0M/"FFZ4D[Z;"(9Y%;#DYP2*Y*7P=?WMK)9WBE[B7(
MEN\8##MQ0!CV(4^,H X<1/HFTD#_ &:CT<OHUU8^1;V]Q:C[LA.95'T'2O4+
M/P]96XAD>(-<) ("_JN,5%8^$=&TZ^-Y;6NV<G).<T <A?I:KJ.KJL2H\FG[
ML8P>152>"ST?X5V-S'81R3NB;LIU.3R:]#N?#^G75X]W-!NF=/+9L]5]*DFT
M:QGTL:;)"#:@8"4 >.ZIY\E_H;26]NIDG (MSN&,=\55O$B3PSK4:IME_MF'
M QSC->O6?@_1;#R_L]IM\MMZ9.<&EE\(Z+-*\CV@+.XD;GJWK0!R6G?9%\7W
MAU= T'DQ^091\H..<9K%E6&:RO18Q,MH;HAAMP"?;U%>G:IX<TS68$AO;?>B
M= #BI(M#T^&Q6S2 "!2"%^E '%1:5:6NG:1-%;JLR D.%Y%9^K:A-?:M(L5I
M:E1!AGG.US],]:]+_LZU,<<?EC;']T>E9^H>$]'U.\2[NK7=,@ 5@<=* /+M
M :1H+^,@A4E4*OI7L]M_QZ0_[B_RK.@\-Z7;/,T5L%,S;GYZFM50%4*.@&!0
M!YWJBD^*9.#CR9.WM6?H^DVB_"N\N?LJ?:4,C+)M^8'=7I+Z7:23F=H@9"",
M_6DCTFSBTY[!(@+9\[D]<T >8&.--?TZ1D =M&DPQ'\6WC\:YVPMKUO"4IOH
MX?-(.]F;]Z>?3K7M-QX<TRZ,)EMP3" $YZ 57N/"&BW6HK?2VN9U.0<\?E0!
MYUX6TZ*[^($*W<)FC%@,"5?:C7K2-++Q=!'!B..9!&@7A1QTKU6+2;.&^%Y'
M"!.$V!O:FR:+8R_:=\(/VDYE_P!J@!N@M =$L_L^W:(4!V^NT9K1JIIVFVNE
M6WV>TCV1[BV,]S5N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>gtl21rgcbjm5000012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1Z",H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BD+!>M('!Z&@!U%%% !12$X&32!P>AH =1110 4444 %%%% !1110 4444
M%%%% !129XI ZDX!H =1110 44A( R:;YB^M #Z*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIK.JC+'%,^TP_WQ0!+12!@
MPR#D4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%,:14^\<4 /HJ(7,1Z.*
MD!!&10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444$XH **:'4G@TM "T444
M %%)FC- "T5&9XU.&<"A9HV.%8&BP$E%)FEH **:7 ZFG Y% !132X!Y-*#D
M9H 6BBB@ HHHH ***;O7.,T .HHHH **** "BBB@ HHHH **** "BF[USC-.
MH **** "BD+ =:3S%]: '44W>OK2[@>AH 6BBB@ HIN]<XSS3J "BBB@ HHH
MH **** "BBB@ HHI"0.IH 6BD# ]*"P'6@!:*0,#T-+0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!R'Q(GFMO"=Q)#(T;@C#*<&O)_"OB^]TO6(GN;F66!F
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MD9;,T***Q=7\3Z9H=Q%!>RNDDHRH"YJ(QE)VBKE-I:LVJ*RIO$&G6]A]MEG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#B_B?_P B=<?5?YURGPCA2X_M&*10
MR-$ 0?K75_$__D3KCZK_ #KF/@Y_KK__ *YC^=>I3_W*7K_D<D_XZ.;\7Z'<
M>%O$(NH ?*+;U8<<^E>L^#/$<>OZ.CE@9HP%DY[U9\4Z#!KVD202)F1060CK
MFO%_#^IW?@[Q-Y,VX(&V.O8YQS35L71M]J)+_<5+]&>P^._^1.U#_<KSKX0_
M\AZ]_P"N7]:[[QA=Q7O@2\G@<.CQY!%<#\(O^0]>_P#7+^M30TPE0=3^/$]6
MU[4ETK29KDG!"D+]<<5XGI&G:EXZUN22XF<)N^=CT%>]311S(4E174]0PR*Y
M^;4O#_AUY6$L$<K'+(, UAAJSIQ:A&\F:U:?,TY/0Q8_A9I*Q . SX^]7#^,
M_!3^&$6]MI282P QQ@UW<_Q4T>%B!%(^.ZL*XWQGX^@\1Z<+6VM9$0-DE\&N
MO#?6_:+FV,*JH\NFYV/PPUV;5M&DAG))MB$4GOQFHOBL?^)(G/8UF?!O_CTO
M_P#KJ/Y5I?%?_D")]#63BHXVR[EW;P]V>>>&++5/$,*Z/;R,ELCF1B.V>M=^
MGPHL!;;7E#2X^_CO4'PC@0:9)-@;BS#/XUZ;VIXO%5(57&#L@H48R@G+4^=]
M>T:\\&ZRGES-MW?(XXR*]L\.:DNN^'(I\YW#8?PQ7G_QE4";32.X:NH^%G_(
ME0_]=7JL2_:8:-66XJ2Y:K@MCC/B)X2M='LFOX3\\LO/XT[P/X*L]:T\7<S
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MX[N^82W"'*[3QGZ5Z"  , 8 J,97A)*E3V15"G)-SENSP#6B?^%C3<_\O/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&CR3XS?ZW3?HU=/\+/\ D28?^NKUS'QF_P!;IOT:NG^%G_(DP_\ 75ZZJO\
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MXF^)9=,LUL[5RLS_ 'B/0U+\-_"\FD6+7ETFV>8<J>U9/Q8T6681ZC&I;HI
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M>IZ;-;. =ZD#V->$B/4? GB7S?+8HI(4]F%&$FZE&5.+M+<*RY:BF]CUO_A
M-$_YX+_WS3)/ N@Q1M))"BJHR25%4;'XH:)+;!KJ;RI,<K@FN9\8?$5=3M6L
M-+R5?AG7N/2LH4L5*?*[HN4Z*C='<:+H>@6UZ)K!X6F"G 0@G%9OQ1_Y%N3Z
M5E?##PQ<6CG5;G<K$$(I[@BM7XH_\BW)]*$K8I1YKA>]%NUC/^$G_(-D^A_G
M4GQ=_P"1>C_ZZBH_A)_R#9/Q_G4GQ<_Y%^/_ *ZBK_YCOF3_ ,PY)\*/^0'-
M]1_*J'QC_P"/+3_]]OY5H?"C_D!S?4?RK/\ C'_QYZ?_ +[?RIP_W[^NP/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH :0&&",BFI%&ARJ@5)10 4444 %%%% !1110 4444 %%%%
M !1110 50NM%TV]F$MS9QRR#^)AS5^BFFUL#2>XR**.&,1QJ%4< "GT44@"B
MBB@ HHHH **** "BBB@ IK*&&",BG44 1I$B'*J!FI*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"+R8PVX(,^M2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P ^D7ZT?\+<N/\ GTB_6CZA7[!]8I]SUJBO)?\ A;EQ_P ^D7ZT?\+<N/\
MGTB_6CZA7[!]8I]SUJBO)?\ A;EQ_P ^D7ZT?\+<N/\ GTB_6CZA7[!]8I]S
MUJBO)?\ A;EQ_P ^D7ZT?\+<N/\ GTB_6CZA7[!]8I]SUJBO)?\ A;EQ_P ^
MD7ZT?\+<N/\ GTB_6CZA7[!]8I]SUJBO/O#GQ#FUN]E@:W1=D+R9&>PS63+\
M6;B.5D^RQ<'WJ5@JSDXVU'[>%KW/5Z*\E_X6Y<?\^D7ZT?\ "W+C_GTB_6J^
MH5^POK%/N>M45Y+_ ,+<N/\ GTB_6C_A;EQ_SZ1?K1]0K]@^L4^YZU17DO\
MPMRX_P"?2+]:/^%N7'_/I%^M'U"OV#ZQ3[GK5%>2_P#"W+C_ )](OUH_X6Y<
M?\^D7ZT?4*_8/K%/N>M45Y+_ ,+<N/\ GTB_6C_A;EQ_SZ1?K1]0K]@^L4^Y
MZU17DO\ PMRX_P"?2+]:/^%N7'_/I%^M'U"OV#ZQ3[GK5%>2_P#"W+C_ )](
MOUH_X6Y<?\^D7ZT?4*_8/K%/N>M45Y+_ ,+<N/\ GTB_6C_A;EQ_SZ1?K1]0
MK]@^L4^YZU17DO\ PMRX_P"?2+]:/^%N7'_/I%^M'U"OV#ZQ3[GK5%<%>^/Y
MK70(M1$"$NX7'-87_"W+C_GTB_6HC@JTE=(;KP6[/6J*\E_X6Y<?\^D7ZT?\
M+<N/^?2+]:OZA7["^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@
M^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MR
MX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_
M #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^
MYZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y]
M(OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17E^G?%*>]O8X#:Q@,<9&:GUSXE3Z
M3JTMFMM&P3')S4_4JW-RVU'[>%KW/2:*\E_X6Y<?\^D7ZT?\+<N/^?2+]:KZ
MA7["^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_
M  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%
MN7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@
M^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MR
MX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_
M #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^
MYZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y]
M(OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1
M?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU1
M7DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH
M_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]
M0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_
M  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%
MN7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@
M^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MR
MX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_
M #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^
MYZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y]
M(OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1
M?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU1
M7DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH
M_P"%N7'_ #Z1?K1]0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]
M0K]@^L4^YZU17DO_  MRX_Y](OUH_P"%N7'_ #Z1?K1]0K]@^L4^YZU17E5M
M\5[B>X2(VL0W''>O48)/-MXY,??4-^8K"K0G2MSK<TA4C/X22BBBL2PHHHH
M**** "BBB@ HHHH **** "BBB@#Q#XJ_\C9_VQ2N%KNOBK_R-G_;%*X6OI\)
M_ CZ'DUOXC"BBBN@R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)RC')%8EKI]W>W'D6T#R2YQM4<U<:D9*XG%IV*U%:-MH6I7=R]O!:2/*GWE
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M.2S?A6;8^"]7O[5+F*.,1N,KO<*33C7CR\TM!.F[V1SM%:UQX=U&UU5-.DB
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MUN[UGQ@M]$1!,Y&(PW!Q[FE/#RC&ZT]T%43?S-WPYJNJ77C&XCN(V>)6*JK
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MC;H7<+FK=6"5VQ*$GLCG**T-5T>[T:=8;M5#,,C:V:AT_3[C4[M+:V4&1S@
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M ./R+Z5RUG_Q_6__ %T7^==3X[_X_(?I6$_XL?F:1^!G(5+!;RW+;84+L!G
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MT'B+PO/H)C=I4EAD&Y73IBN?K2$XS7-$F47%V844451(4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@":S_X_K?_ *Z+_.NI\=_\?D/TKEK/_C^M_P#KHO\ .NI\
M=_\ 'Y%]*PG_ !8_,TC\#.0KLOAM>0VGB,^<P57B903ZFN-IT<CQ.'0D,#D$
M5=6'M(./<F$N629Z/JG@O4[GQ?+=Q"(VTDN]6W]JOZW>PR>.M'M4<,T,B[B#
MD?=KAD\9Z\EOY"WS"/&,8K)2_N4O5O%E(G4[@WO7*L-4E\;6BLC9U8_9._\
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M^?E/UH_X5*/^?E/UKM_[5F_NK1_:LW]U:/K6)[A[&EV.(_X5*/\ GY3]:/\
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MV.(_X5*/^?E/UH_X5*/^?E/UKM_[5F_NK1_:LW]U:/K6)[A[&EV.(_X5*/\
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M/UH_X5*/^?E/UKM_[5F_NK1_:LW]U:/K6)[A[&EV.(_X5*/^?E/UH_X5*/\
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MI^M=O_:LW]U:/[5F_NK1]:Q/</8TNQQ'_"I1_P _*?K1_P *E'_/RGZUV_\
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M%2C_ )^4_6C_ (5*/^?E/UKM_P"U9O[JT?VK-_=6K^M8GN+V-+L<1_PJ4?\
M/RGZT?\ "I1_S\I^M=O_ &K-_=6C^U9O[JT?6L3W#V-+L<1_PJ4?\_*?K1_P
MJ4?\_*?K7;_VK-_=6C^U9O[JT?6L3W#V-+L<1_PJ4?\ /RGZT?\ "I1_S\I^
MM=O_ &K-_=6C^U9O[JT?6L3W#V-+L<1_PJ4?\_*?K1_PJ4?\_*?K7;_VK-_=
M6C^U9O[JT?6L3W#V-+L<1_PJ4?\ /RGZT?\ "I1_S\I^M=O_ &K-_=6C^U9O
M[JT?6L3W#V-+L<1_PJ4?\_*?K1_PJ4?\_*?K7;_VK-_=6C^U9O[JT?6L3W#V
M-+L<1_PJ4?\ /RGZT?\ "I1_S\I^M=O_ &K-_=6C^U9O[JT?6L3W#V-+L<A8
M_"\6=XD_VA3M.<<U/K/PV&JZI+>>>J[\<'-=7'J<KR!2J\TZXU&6*9D &!4?
M6:_->^H_94[6L<'_ ,*E'_/RGZT?\*E'_/RGZUV_]JS?W5H_M6;^ZM7]:Q/<
M7L:78XC_ (5*/^?E/UH_X5*/^?E/UKM_[5F_NK1_:LW]U:/K6)[A[&EV.(_X
M5*/^?E/UH_X5*/\ GY3]:[?^U9O[JT?VK-_=6CZUB>X>QI=CB/\ A4H_Y^4_
M6C_A4H_Y^4_6NW_M6;^ZM']JS?W5H^M8GN'L:78XC_A4H_Y^4_6C_A4H_P"?
ME/UKM_[5F_NK1_:LW]U:/K6)[A[&EV.(_P"%2C_GY3]:/^%2C_GY3]:[?^U9
MO[JT?VK-_=6CZUB>X>QI=CB/^%2C_GY3]:/^%2C_ )^4_6NW_M6;^ZM']JS?
MW5H^M8GN'L:78XC_ (5*/^?E/UH_X5*/^?E/UKM_[5F_NK1_:LW]U:/K6)[A
M[&EV.(_X5*/^?E/UH_X5*/\ GY3]:[?^U9O[JT?VK-_=6CZUB>X>QI=CB/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH_X2W6/^?@?]\T?4)]P^LQ/8]P]11N'J*\<_X2W6/^?@?]\T?\);K'_/P/\
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M?\_ _P"^:?U"?</K,3V/</44N0>E>-_\);K'_/P/^^:V_#OC6=+L1:BX:-^
MW3;4SP52*N..(BW8])HID4J31K(C!E89!%/KC-PHHHH&%%%% !1110 4444
M%%%% !1110!=F_X\5^M4JNS?\>*_6J53'8&%%%%4 4444 %%%% !1110 444
M4 %%%% !1110 4444 20?ZY:DO?^/IJC@_URU)>_\?35/V@Z%>BBBJ ****
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M@<'GFO6=$M9;+2+>WG;=(BX8YJ_M .0.:6FE85PHHHJ@"BBB@ HHHH ****
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MZ7I*P7LJRSQY=@>3S1J=MK.E:SINGKKUY*NI.(V=B,Q\9R*.8+'JM%<!I?\
M:.B>,6TR;4[B^B:WW@SD#!/TK/U&6Y6]U&2ZUZ^@VN3#%:J' &._I1S"L=SX
MBUR+P_I4M],K,L8R0M:-M,+FTAG48$B*X_$9KR#4-5N=5^&EVD\KRNB\22?>
M//>MB33]5\/Z/I^I+K5W.@16>"0@+MVCBES#L>F455TVZ^W:;;W6,>:@;%6J
ML04444 %%%% !1110 5=M?\ CVF_W:I5=M?^/:;_ ':F6P(\ UG_ )#-Y_UU
M:J<<;RN$12S'H!5S6?\ D,WG_75JDT(XU:$^G-?1IVA?R/*:O(HS02V\ACE1
MD<=F'-$T$L#!949"1D CJ*[;Q5:Q:NCWEJBK/ H,ZCT[8]:Q_&'%_:@_\^L?
M\JSIUN>R*E#EN<[16YIVF:;<V^^XGNU?TCAW"JFJV=I:.HM9)G!Z^:FVK51.
M7*2XM*YG@%B !DFI9+6>)T22)U9_N@CK6SX>TW<WV^:-FBCY10,AB.QK8\5W
M9M]5LKI;13FW^52#A34NM[_(D4H>[S,Y.XTN^M(P]Q:RQJ>[+BJE=Q-<7>H^
M%+J:ZN6GD8J40G.T5P_?FG2FY7OT%.*6Q)#!+<2".&-G<] HJU=:1J%E'YEQ
M:2QI_>9<"M3P?>VEEJ$[7192\16-U7)5NQK<NGUIK24S3KJ-H>TL@)'O@5$Z
MLHSMT*C!.-SA7MY8XDE=&5'^Z2.#4==?#H:WUKI:W%Y*(IF;Y<#"?2JZ>';.
M]29=/N99)HB<JZ@# .*KV\>HO9LYBI/)D\OS-AV>N*Z2+0M*^TQ6LUY,LS+E
ML(.&]*N3:*0)=,@<OM( 8\&DZ\;A[-G%T5UDWA>T7S8H[F4S*@* J "WH36#
M-I-W ?GC.,XS5QJQEL)P:*Z6EQ);O.D3M$APS <"H:]$T_3_ +):V-H=Y@O+
M=I)EQP'' KG[+0+:26_.H3201VHW'8N3@FLXXA.Y3IM6.;HKJUT'1VTL:A]N
MG\HR%!\@[4MYX>TBR:T\R]G_ -*CWI\@JO;QO87LV<G15K4;3[#?26^2=AZF
MJM:IW5T0] HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.
ME%% '8^%?%;64BVMVQ:%C@,>U>F12I-&LD;!E89!%>!5V_@SQ#<I.MC*&DB/
MW3R=OM7GXO"IKGB=5&M;W6>DT4=J*\L[0HHHH **** "BBB@ HHHH **** +
MLW_'BOUJE5V;_CQ7ZU2J8[ PHHHJ@"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"2#_7+4E[_ ,?35'!_KEJ2]_X^FJ?M!T*]9>M:Y:Z):^;.2S$X5%ZD
MUJ5P'B)5N?B'86UQS;B#?@]-P/%-NP(E7X@2JP>71K]82>IBZ5V&GW\&I6B7
M-LX:-NX/3VJ2ZC22SE1P"I0\'Z5Y'::E=Z7X8U1;*5D6+>T94]]U*]A[GL5%
M>6W-IK&EZ9IFK?V]>3&=T+POC;@U?M9]2\9:M=?9]1GL(;)C$XA(^8D9!YHN
M%CT.BO+[76=3\.77B!+R\EO([*-6C,IYY^E7/[%US^Q7U=]=NQ)M,R0 C:0>
M0,T<PK';7E^UK/'&L$CANZC(%7J\Z;Q'>W%M9LLS(^P"3!ZFH+&VUCQ!J>I9
MUJ[M(K8_((B#GCWHY@L>F45Y9!XAU2'PU:63W+O=7=U);BX)^90.AI/$-KK7
MAV+3+I=>O)A-<1QNCD8Y/-',.QZI138R3&":=5",;1_$$.K7,\,:,#$Q4Y'H
M:V:\ILKN:QL=<N('*R)YI4CUS2"TUI/"MCKW]OWK23%&,)(VX)YJ%(=CT:ZU
MFWM=4M;!PQEN"0I'08K1KRJ[M+F]\7Z1>G49U\_<0@QA,#M44WB"35M7N$EU
M74+**)=BBVCW9(.,T^8+'K54=5OFTZQ:X2%YB& V(,GFO.+/Q+J4GAZ\037'
MF13[(YI 59E]Z2X36M/\%KK3ZU=O-,Z'RR1A<G&!2Y@L>I02&6%7*E2PS@]J
MDKS)I]7U;Q(MA%J4]O"8T+,A&1D=:2SL=<GUN;0WUR[$:(91<@C>?;'I3Y@L
M>G5E>(M:CT#19]1E1G2(9(4<FL/P)=WDKZQ9W=U)<FSN1$LDAY(QFG_$G_D2
M;_\ W1_.B^EQ%"/XARF-96T6_,9 ;(B[5UFCZQ;:U9_:+?(QPRGJI]#4FFJK
MZ+9JPRIMTR/^ BN'T R6NL:Q;VC!(F,C$@X ;'%&J&>BUFZEK5MI=S9P3@[K
MN3RX\>N,UYC>WES9Z:)W\1:D;L$;HXT#1]?[U+XEAN=9NO#-V=0GB-Q<^6 N
M/D(7[P]S2Y@L>O Y /K2UP&MBZCOH89M9N;:WCA W089V/J14/@?6+B;6[VR
M>^N;N$2?(]PNU@,>E/FUL*QZ&[K&A=V"J.I-8>G>*[#5-?GTNU;S&AC#LZG(
M^E:U[:K>VDENS%5<8)%<-HFF6FD_%.^M[.)8XS8HQ"CJ3U-#; ZI]<B3Q+#H
MVUO-EA:4-VP*D\0:Q'H.CRZA*I9(R 0O7FN)\1W.JVWQ+L7TFUAN)_L<@V2O
MM&.]4/&NI^+)_#%Q'J.DV<-J67>\<Q8CGTQ2YAV/4K6<7-K%.HP)%##\17/:
MUXPBTN]%I#:3W4N-Q\E=V*VM(_Y!%I_UQ3^0JG?RZ9H2R7SHBS$'&!\Q-4]A
M$6B>*+;5[>X?RI('M^)$E&#G&:QV^(< F+?V?=_95.#/L^4?C6&4OO[)U;6V
M0PK>7"/$!UVG@Y':NBEM(#\/;B J/*:,Y':INQFIJ_B:VTJPAN/+DF:8#9'&
M,MR.*I:-XRBU+45L9[.XM9G4LOG+M! INA):2:-'=WZIF#A&;L!TQ6=;2R^)
M?&D5]!&18VL;1-(1@ECR,>HHNP.@\0^*-/\ #UJ9;F4%^T8/S&MB"43VT4R]
M)$##\1FN$^)&A6;>'+[494$EPNTQLP^YSVKM=,_Y!-G_ -<$_P#0135[B+5%
M%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 .C_
M -8*Z5/]6OTKFH_]8*Z5/]6OTK&J5$=1116104444 %%%% !5:__ ./";_=J
MS5:__P"/";_=IK<3V/._AM_R&=5_Z[M_*O3:\R^&W_(9U7_KNW\J]-K;$_Q#
M*A\ 4445@;!1110!B:K_ ,??X"J-7M5_X^_P%4:Z8_"9O<XOX@^*;GPS912V
MREF?L#7+-XX\7:9:K?ZAHTOV0C=N+#&*M?&?/]F6NWKV_.L]M'\:^)=(M]/N
M;BU2S9 ,^3@XP.]2V[C5CJ]=\:-:^&].U.U'-S+&K*#TW5TMAK-K=+%&9E\]
MADKFO.OB%HR:9X)TO3@QRMQ$C,#W]JP_%F@QZ!I^DWUG<7*SG;N)F)!RU%VF
M%CW-CA<UY=I7Q!O;Q]:#(?\ 0ED*\_W37I%FQ?3H68Y)C7/Y5X+X=_UWBK_<
MF_\ 0C3DP1ZYX2\2?VMH$=]=G86P.3ZUTZL&4,IR#7F/@O1(=<\"V]O-)(BJ
M\;Y1RIR.>U>E6T(M[=(E)(48R3FG&]A,XKXD>+KKPI8VLULI9I9"IP?:IK3Q
MFLO@QM6<XD"XQG^+%8WQ7M5O;C0;9_NR7>T_E7GWVZ2%&\--NPVHHP_W<U+D
MTQVT/2/AWXWO/$\URETA7RF Y/M7=-JMDMT+8SJ)2<!<UY#9G_A'];\5+9K@
M0SA5'H-M85G!)J'AZ:Z73]6EOV9MERDQ\L'/I0I-(+'T#+=P0;?,D"[C@9KG
MO%7B=-+T.:ZLW$DD4JQL >F:\W\3MJ-SH^C6UR\T,KS)&<,5.*V?%7ABW\.?
M#VX,,D\DTDT;R&20MEN>F:?,PL=UHNNQW6BVUW=2!'E'0UJ3WUM;0B::550]
MS7@?A*ZO-1U_2[?5A-%:[SY #%0?7ZUL>,[Z6Y\>IISPW<UI%%&RQ6[E6/%)
M2T"QZ_)?Q/IL]U;N'"1LP(]AFN<\#>)I_$<=TTZD>4P YKB?"BZI::KJ40M;
MN+37MY6VW!+$':<<UL_"+_4:C_OK33NPMH=5XP\50^%M-6=T\R60E8TSC<?2
MN&/C#QI;H-3GTB;[ PW ;ATJ3XK!DU?1)9_^/87!SGI]VO0!?:?:^'X)KEHA
M;>4,;^F,4.[8#M UR+6]$@U #R_,3<RD_=JW;ZG9W<C1PSJ[+U -><_$#7H6
M\)0G2OE@F9.8/EXST&*YB.UO+:\TZXTG3=4AD5LN9Y"ROQZ4<W0+'HLGBFX7
MQV^B[3Y2PJ^<^M-\,>*KC5_$NI:?(I"6TK(OX"N<C+M\5@9!AS91%A[T[P!_
MR/>N_P#7R_\ *DF[A8]&UO5H=$TJ:_N"!'&.<UYF/&?C#5E;4=,TF4V"L1D,
M,-BN@^*Z3-X0G*9V#&['UK3\%7%D/!T$JL@A4'<>W;--ZNP=!?!OBL^([&0S
MP&WN(7*.C'TK9.LV NOLQN4\W.-N:Q9M9T2[TF^-K)$B*&5VBPISCGD5Y#JZ
M6Z:$EY86FJ)AUQ=23$HW-#E9!8^@9+N")D5Y%4O]W)ZTR#4+6Y#&*56"D@X[
M5XOXA-UJUKX9@^T2H\\I4LKD=O:M7Q?IP\'>$K6+3IIPUU)ME>20L>1SS1S!
M8]/AU6RN+@P13JT@ZKFL"76-57QC'8BW8V);!DSQBN7M/!NG1:5I>I_VI+!,
MRJ6:2=L,<U4N+B7_ (6W;()V:/)X#'!XHNPL>IMJEFBNS3J GWN>E36]U#=1
M>;#('3U%>)^%-%7Q%XHU>&]N;GR8@654E(YW&JVGZU>Z%IVM6MK,[1K</&I=
MBQ QZTN<+'MQU>Q%U]F-PGF_W<U/-=0P!3)(%W\+GO7C5OX2M9OA]%KK7]P+
MZ1!(9#.VW/TK,UC5[[5/!FAO-.ZR&XD0NC$9 '%/F86/<H]5LI9S"DZF0#)&
M>U.@U*TN9FAAF5I%."!7A_B30X]+U#1_LMS=*;L1K(3,W.>M:5Q8CPO\0M*B
MLYYRLT#EQ)(6R<@4<S"QZ]>:E:6 !N9ECSTS4MO<PW40DA<.I[BO)_$YT^\\
M2W""WU"\G &Y;>8A4X]*C^#U]<R:GJ%G(\ABCW%5D8DCYCQ1S:V"VAW7C/Q2
M_ANP1X+8W%Q*ZHB XY)Q7-6/CK7+'5[>SUW2WMUN<E&9A7<:]J&G:5I[WFHB
M(I'ROF ')[8SWKSC1TOO'OB2+6KF,PZ;;D^0K#!8'WH=[@CI+7QC-/XWDT;R
MSY:HC!L^M=O7D5D GQAN5[".,#]:]<W ]Z<6)BT4450!1110 4444 %%%% !
M1110 Y/]8OUJS???%5D_UB_6K-]]\5+W0="I7%_$70[[6]+M8;&$RNERCL!V
M /-=I13:N@/._&'AK4M4\-V5I:V[/+'MW*.W-8M_X3URQ\36^JV]E)>H516C
M!QLP*]>HI.*87/)M"\)ZW9ZGJLL]HVRZMF">S'^&M'P)X.NK/0-6L=7M2GVF
M4,@;_=QFO2**%%#N>1^#_ >I>'O%L\S0L;3=E9.QK4\#^%;_ $OQ+J=U?6I6
M&?=L9AU^8FO2**.5"N>67GA35M"\<IJNB6KRV\V?.VG@9//Z5ZC&S-&I9=K$
M<BG44TK %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JVW_(,C_WS52K;?\@R/_?-2^@(J51U:"2YTV6*-=SL.!5ZBJ YOPYHC1^%
MVTW48>'=]R'N":Y_PUX1OM*\97-Q."]B\+(C'H!V%>B45/*@N9C:%8B.01PA
M79"H/ID5Q]I'XC\.0'2;/2WN[?)VW ( &?:O0Z*;07."'@F:W\/QI')NNHKE
MKM1C^(\XIJ6FO>)KF&WUBQ>UM(6#G<<[V4Y!KOZ*7*@N<;JG_"0:/J<USI]L
M^H0SGB)3CRZ;H^F7UK<W_B.^C*7D\(3R#U !X_G7:4C*'4JPR#UHL%S+T+49
M]2M'EGB,;*^ #WK"N-!NM6\9)>7T)^R6P9(\]&!KL$18UVHH4>PIU.P')>*?
M"4%[HLWV"#;>(N82.H-5M;\/WVN^$[:)D:&^M &C'=F KMJ*5D%SC;#PI)+X
M1^R7@VWDNV63(YWBLN.+Q/Y TG^S&7!Q]OP,?E7HU%'*%SCKC0;U]6M793(B
MA=[@8[<UDI:^(]*;4=/M]-DG@NW9EG!P%SQ7H]%'*%SSJT\+ZG;VVCQ/&SM;
M1[9&]\UJ:]HM[>>)-!NH82T5K/NE;^Z-N*[&BCE"YR5_HUY<>,6O40B VPCW
M^AKG[73=:TK4]1ACT62Y2Z<D7.[@<8Z5Z;11RA<\K?PGK)\+:A8&!FFD4;#Z
M\U?%MXBUJWM-*O--DM+>%5#RDY#@#&*]%HHY0N065LMG90VR?=C4**GHHJ@"
MBBB@ HHHH **** "KMK_ ,>TW^[5*KMK_P >TW^[4RV!'@&L_P#(9O/^NK4W
M3)TMKY)7.%%.UG_D,WG_ %U:J-?215X)'E-VD=!'KRVVNFZ"^;;-CS(\_>'I
M4?BG4[?5M32XMP%3RU7;Z5AT5*I14E+J-S;5C4L_$.I6$/E6\P5/3:*KW^J7
M>I,K74F\KTXQ5.BFH13NEJ+F=K7-;3_$&H:?"EM#/M@5BVW'K6QJGB6&_N[8
MS@31"'8XZ8;UKD:*ET8-\UM1JHTK'3M>:?IMK(+2<3/,> /X*Q+V&*.-'1P7
M8Y(]*ITI)/4DTXPY>HG*YI:)>6MI<2?:X?,25-@.?ND]ZVH+_3M#5I;:Y%T[
MJ1M'\.>*Y*BB5-2>K&IM'60Z];+:Z>A(W0LQ;VS5;1=92P>^8']Y*&V?4FN<
MHJ?8QLUW#VC.[L[9+F]@NYH=LOE[BN>O^U5>]\00VNJSS0D,=W&*YI=7NUA\
MH/P!C/?%4B23DG)J%0N[R*=330[*XUNU:-[G[4KLRX\C'(_&LJ'Q#<SW4:W,
MP%LKAMI';TK!HK2-&*5B74;.FO?%M\-3<VD^VU#_ "+CHM6;_7+.YL]0=6 G
MNHPI'TKD**7L(*UA^T9N+J4(\+1V.?WHF9R/8U)J^JP7;:28R#]FB"O]<US]
M%5[.-[_UJ+G=K%[5[E+O4YIXSE6/%4:**M))61+=W<****8@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBK-E937]PL,"%F8XX%)M)78TK[!9
M64U]<+#"I9F..*]7\-^'(=(MU=E!G8<G'2CPYX<ATBV5F4-.PY)[5T%>3BL4
MY^['8[J-'EU>X4445Q'0%%%% !1110 4444 %%%% !1110!=F_X\5^M4JNS?
M\>*_6J53'8&%%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 20?ZY:
MDO?^/IJC@_URU)>_\?35/V@Z%>N:\4>''U7R[NSE\J]A(*N!G('./QKI:*;5
MP.!?4?&%\K:>=)EM@WRF[)!&/I3[_P (36W@V;3K1?.N9 Q8@=2>:[NBERA<
MY'6-&O+KPSI=I%$3+"4WKZ8%8]O;WFB:E+)I(\]I&S=0#C#^OX"O1JP=5\):
M=J]R)YWN(W Q^YE*9^N*&NP7.,T;2Y]<\0>)+6^;/G1H&R.E7V/BE;231#IT
MDD#CRUN\C"KVX]J[#2-#L]%B*6H<YZM(VYC]36E2Y0N<)-X5NK>"TBA0RLB
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M'UFK_,'L:?8XS_A7.G?\_,_Z4?\ "N=._P"?F?\ 2NSHH^LU?Y@]C3['&?\
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M !]-3(/]<M/O?^/IJG[0="O1115 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #H_]8*Z5/\ 5K]*YN/_ %@KI$^XOT%8U2HCJ***R*"BBB@
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M9_.CR[?_ )YG\Z2B@!?+M_\ GF?SH\NW_P">9_.DHH 7R[?_ )YG\Z/+M_\
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MF?SH\NW_ .>9_.DHH 7R[?\ YYG\Z/+M_P#GF?SI** %\NW_ .>9_.CR[?\
MYYG\Z2B@ \NW_P">9_.IHDB$;A4(&.>:AJ:+_5O]*3&1>7;_ //,_G1Y=O\
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MEU&+Y=O_ ,\S^='EV_\ SS/YTE%,0OEV_P#SS/YT>7;_ //,_G244 +Y=O\
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MS/YT>7;_ //,_G244 +Y=O\ \\S^='EV_P#SS/YTE% "^7;_ //,_G1Y=O\
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MG/:O._!5M)>S^*=2@):S=)PI'0D@XKI/@Y>0Q^$KJ)Y KQJ P/;BA,"]X?\
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M@_TN%6P@S@D''6N"CT?_ (33Q%XCODNOL0BER4/\7RYJ2T\3I;_"B_TTVI;
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M44R25(EW2,%'O0(?14"W=NYPLJD_6I))HX@"[  ^M #Z*A6[@=L+*I/UJ:@
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M>WF#2(H9AZ U?KS3PY:6UA\5M;AM21$+:([<YP237I0(/0YH$+1110 4444
M%31?ZM_I4-31?ZM_I0P/*=1^(]]9ZE<6ZVL96.0J#N-5?^%H7_\ SYQ?]]&N
M3UW_ )#M]_UV;^=9]?0PPM%Q3Y3S'6G?<[S_ (6A?_\ /G%_WV:/^%H7_P#S
MYQ?]]FN#HJOJE'^47MJG<[S_ (6A?_\ /G%_WV:/^%H7_P#SYQ?]]FN#HH^J
M4?Y0]M4[G>?\+0O_ /GSB_[[-'_"T+__ )\XO^^S7!T4?5*/\H>VJ=SO/^%H
M7_\ SYQ?]]FC_A:%_P#\^<7_ 'V:X.C!H^J4?Y0]M4[G>?\ "T+_ /Y\XO\
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M:***D84444 %%%% !5:__P"/";_=JS5:_P#^/";_ '::W$]CSOX;?\AG5?\
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M5CVOBC2+NZ-O%>PF0''+CG]:M2ZM9PWJ6CS*)G^ZN1DT 7J* <C-% !1110
M4444 %%%% !1110 4444 */O#ZU)-U%1C[P^M23=11U&15YA\:YI8O#%OY<\
MD.ZY0%D<J<9]J]/KRWXW1&;PQ;H ?FNHQP/>A[ <9J>@:79>#8=6L]>NO[1
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MTVML3_$,J'P!1116!L%%%% %.Z_UOX5!4]U_K?PJ"K6PCR/XY$#2K7=]WO\
M3-<7KX\"MX:B31H!_:IC'*JV=V!_7-=_\9-,O-2TZU2TMGF(/S!![UU.@>$=
M)M;"TF:R03"-2=R@\X%%M0/.?&37UO\ #+0VN%9I5GA*J3U]JM_\)[X@\/\
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M56NO&.O:,D%I+#%83+<22/R#D8(^M:$?B'4K*_O+/6; SPAF:!P@"[>PY[T
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MY9_9)X5>#IL-9EEX-T'3IXI[6P2.2(Y1AVK>HH .E13V\5U$8ID#(>H-2T4
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MK1DBCE&)$# >HJ?R_P#:'YT>7_M#\Z *@L[8'(@3(]J<]O#(<O$K?459\O\
MVA^='E_[0_.@"JMI;JP984!'0@5-4GE_[0_.CR_]H?G0!'14GE_[0_.CR_\
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M_P#:'YT>7_M#\Z *TEM!,VZ2)6(Z$BG&*,H%* J.@Q4_E_[0_.CR_P#:'YT
M0/$DB[74$>]5K+38;%W:/)9^I-:'E_[0_.CR_P#:'YT 1D C!&0:155%"J
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M=W-ZG\Z-S>I_.N*M_B;H4]Y]GWE!G =F&*W+WQ'8V2V\CONAG&5E4_+UQ1=
M;.YO4_G1N;U/YTU6#H&'0C(I:8"[F]3^=&YO4_G244 +N;U/YT;F]3^=)10
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M!41Y[UGW>AZ[X1\4W&I:-:-=V\Z_.H..^32\QG43^ -&778-1M'%C)&N/+B
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MOBK6SX>T*745B\THP&W..M,\*^(%\0Z!!J+JL+2D_(6Z8HNKV W:*:751DL
M/4FFM,FQF5E; )P#3 DHK@].^(T%SXNFT.XB$3*VU&+?>JSK'C9M,\76.BK;
M;UN75?,W=,C-3S(+'9T5QUKXT,_C!]$:WVJL9?S-WI5;5?'Y3Q'%HVCVOVZ;
M)$NTXV$?_6IW06.ZHID)9HE+C#$9(]*?3 **** "BBB@ HHHH **** "K;?\
M@R/_ 'S52K;?\@R/_?-2^@(J4UT5UVL 0>QIU%4!YOXQMH5\:>&U6-0&O.1Z
M_*:Z+Q3?OHMO8-:H%\ZZ2-L<<$UG^*-(O;WQ7H-U!"7AM[G?(W]T;36AXUTZ
MZU#3;9K2,R26\ZR[!WQ4=QDWB[5)]*TM9X/O&15Z^IKG;?5-;UCQ#J.G6Y"0
M0QH3('P1GTJ/7I]>U^TMK==)9%W*TIW?=(-:_AO2[NS\2ZK<SQ%8IHT"-ZD4
M;L##TG6O$&N6MT@"1"U=E#J_+E3CFKY\:7%KX9DN9(E:XBN$M2,G!9N,U+X2
MT>]L+745N(2C2S2,ON"W%94WA?4KGP_?P>01+]O2XC7^\%YHU NZAJ.N>'M/
M&KW)62/(,D9?(7/I4.H:_K-[XE_L[3@H22"-R2V-NX9XI-=EUWQ'H:Z2=*:)
MI<>8V[[F#5[3M$O+;QD]RT1\@6L2!_<#F@#J"9[31':4[IHXB2<]P*Y/P+:P
MW]S?:K<1B2YDD#!FZKD=*[F6-98GC895A@UP5M%K/A76;Q;73VNK&Y?>IW8$
M8 Z4V".FO/#MC/J]KJ0(AN(GW$J/]9[&L)-3U7Q'>S)8$16D#%?,#89G'!'T
MI8)M?US7K:26U:QLK9]S<Y$H]*@L$U7PM?75K#8&XM)&:99,XRQ.<4K@)'XL
MO8["^MIT47=K+L3!^^,=2:IR:MK\7AY?$+$8')AW_+UHMM!U2\BU"_N;4Q32
MSAHXL_PD5M:GI5Y-\/Y+".$FX*@!/QHU K2Z_J&MZNNDZ<!&T<"33/NP0&':
MLFW;4(/&T_VY%WQ6$FPAL[@!U-6XM.U/P]KZZK;V1N$N+>."1<X\O:.31;V^
MLZIXGNK^YL&AB^QR11G.=V1Q2 S=3:XU'PUI%PC>5N0$JIXZUL7.L'1M0@^U
M ,D:J6?J<8J&;1]3@\&V$4=H9+F%5#1Y]Z=?Z%>Z]=QB>W,,4BJKG.<<4 3Q
M7FOZI:S:K&%C6,DQQ*_#J.F:AU'QE>'0(I[:-?MH=(YDR<*Q/8TMI>Z[INEW
M&G?V2SL"R1-NZCL:@'AB_31XY#"3<W$J2S)_<(-&H%O[?K6DZUIR73"2"\)W
M@OG9QVK/;Q)=6UA=SV\2"17?;SUP:Z3Q!IUU=:CI,D,198<[SZ<5S)\/:F=/
MN(_LQW,[$#/J:'<":ZUC7=+TFQUJ0JXG=$:(O\H#'K6@VM:EK^K36&G 1QVY
MQ+(&P0>U+XBT>]N_!>FV<,):>*6(NOH >:HV\&K>'-;N+BTL?M*7AW2C=C:0
M.*>P%[P[K&K2>,-0TG450""%&7:V<Y-=O7F'A>^U&\\?ZU=7=B8)Q;1XBW9[
M\<UV_A_69-9M[B22W\EHI3'MSG..].+$S8HHHJ@"BBB@ J[:_P#'M-_NU2J[
M:_\ 'M-_NU,M@1X!K/\ R&;S_KJU4:O:S_R&;S_KJU4:^DA\*/*ENPHK<MO#
MDMUH<VI1OD1KN*XJK9:4;NUFFW[?+!.,>E+VD===@Y69M% !)P 33O+?^XWY
M59(VBGQ1F658QU8XKHYO#=A;6JO/J>R4IN";/TJ)34=RE%O8YFBMRPT&*>W$
MUW=?9UD_U61G?6?J6G3Z7>-;7"[7 R/<'I0IQ;L@<6E<IT4H!)P*Z:S\-6+6
MD<M_J7V6249C0KG=3G.,%J"BWL<Q16K<:0EK?26\T^%7HV.M9K1L&(4$@' .
M.M"DGJA--;C**7:V<;3GZ5<TW3VO[Y+;)3<#SBFVDKL-RE15B[M6MKEX1EMO
M<"H"".H(^M":8"44Y%+R*@ZL0*V-7\/R:3:PS,^XR=5Q]VDY)-)]02;5S%HI
M0K$9"DCV%+L?^XWY50#:*<48#)4_E3:!!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 '2NS\*>*WM9%M+MBT9.%8]JXRBLZE
M.-2/+(N$W%W1[[%*DT8=&!4C((I]>9^%/%C6CK:7;9C/"L3TKTF*5)HP\; J
M>AKQ:U&5*5F>A3J*:NA]%%%8F@4444 %%%% !1110!=F_P"/%?K5*KLW_'BO
MUJE4QV!A1115 %%%% !1110 4444 %%%% !1110 4444 %%%% $D'^N6I+W_
M (^FJ.#_ %RU)>_\?35/V@Z%>BBL3Q#XBBT.W'R^9<.0$CS]XGI3 VZ*\_/B
MOQ9 !//X998?XCYG05V&D:O;:QIR7ENX*'@^Q'44)H+&A13?-C)P'7\Z"ZKU
M8#ZFF ZBFAU;[K _0T>9'G&]?SH =16=?7=U!<1I!;^8C?>;=C%7O,0=74?C
M2 ?12;EV[MPQZYIOFQ_WU_.F ^BBB@ HK!T3Q =5NKB)HO+$3,N<]<&MOS8_
M[Z_G2N ^BLB\UQ+36K/3M@8W!(W9^[BM4N@ZLH^IH =12;EQG<,>N:H:K>SV
MMBTMG$MQ,& "!L4P-"BH89MT*M+A'(R5)Z5)YB8SO7'UH =12!E;[I!^AK(\
M3ZRV@Z%<:@D7FM$,A,XS2 V**X!/%?BLP+.?#3>4RAP?,[&NIT#7(M<LFE4!
M)8SME3/W6]*$T%C6HIOFQ_WU_.LG6=>BTB\T^W90QO)?+!STXS1<#8HIGF)M
M!+*,CN:<&5ONL#]#3 6B@\"N.MO'$<WB$V#0[;<G8DV?O/GD4F[ =C12$A1D
MD >]()$)P'7/UI@.HIID0=74?C2AE(R&!'L: %HIOF(?XU_.EW#.,C- "T4F
MY0<%AGZTGF1_WU_.@!U%(64#)8 >N:0.K=&!^AH =13?,0'!=?SI2R@9)&/7
M- "T5@:[XB&DZCI=JD8E^V3&,D-]WC-;RG<@/J*5P%HHKE_$WC.RT!&CSYES
MVCH;L!U%%5DNU_LY+N3Y5,0D/MD9K/CUQ(;">]O!Y4*M\C==PHN!LT5S7ACQ
M7%XCEOC$F(;=@%;^\*HW_BW5&OIHM(TEKR&(9,@;%%T%CLZ*QM%\00ZOIDET
MH"M"2LJ_W6'45DW'C">*WN'ALC-*' @3/WU]:+H#KZ*XW3_%>IC4[>TU?2C9
MBX;$;%\YK3\1^*K+P_:L\KYFVY1/6BZ"QOT52TB^.I:3:WI7;YT8?;Z5=H *
M***8!1110 4444 .C_U@KI4_U:_2N:C_ -8*Z5/]6OTK&J5$=1116104444
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M6M:4.30B<N8****U("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7 ()N(ISY9Y]*DUVTCU67PS<7#2[Y[DQOAR, +V]#6S#X9U]M&_LB5+2&V&
M'B;YN*GN_"FIOI>EB$Q&[L)FE4,WRG(P,TK,"+5X+)]6BMY[F698X0%MX)2K
M_4FH/!5Q)'X@OK14N(X?,.$G?<PX]:MR^'-<M]8CU.TCM99FC"R"5N >^*NZ
M+X<O[+79-2N70F<EI%#9"GVIJ]P-;Q-J9TCP_=7B??C3(%>:N\=OX>AN1;2>
M=!.UWNSUSS7H'B/1+G6+FS5''V5&/GJ3]X5I/I%G)9&V:!-A38>*&FV!QOBK
M5IM0\!:?=PR&.2XGA#%3@C<V#TINJZ"- BM]2MKF<S(/F#RE@<^U32^#=0?2
MY; 2(8A>QSQ M]U%.<5TFOZ3+JFG?9XB V!U-%FP.,T_33XA\5WD5[<3^2EO
M&ZK'(5Y/6J<-_=Z-IUW9PS,RO=F)2Y+$ \=:[71- GTW6;B\D*E)(4C&#W%4
MO^$/:9;H3,/WDID0@]#VI687,G4O#RZ5X>BU*WNI_MJLNYFE8J<GGBIK/4)[
MGQ39EI&VL5!&>#Q4\F@>(K^SCTJ]:!=/0@^8C_O#@YJSJGAF]BNK6]T<QFX@
M.=LIPIXHU R]?NIT\9:A&LKA!IX8 $X!J#2/#J:EX>FO[NYN3-&ADC*3, ,
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MSY?(C"HW&6'6NA_MKQ$;'47U31H;>WB@9E992VX^E:6B^$=/T+5+J]LTVFX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .>*T9C_ .>*T<X<ID8/I1@^E:^8_P#GBM&8_P#GBM'.'*9&#Z48/I6OF/\
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M ,\5HYPY3(P?2C!]*U\Q_P#/%:,Q_P#/%:.<.4R,'THP?2M?,?\ SQ6C,?\
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M #Q6C,?_ #Q6CG#E,C!]*,'TK7S'_P \5HS'_P \5HYPY3(P?2C!]*U\Q_\
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M )XK1SARF1@^E&#Z5KYC_P">*T9C_P">*T<X<ID8/I1@^E:^8_\ GBM&8_\
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MT445 PHHHH **** "JU__P >$W^[5FJU_P#\>$W^[36XGL>=_#;_ )#.J_\
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MO[W^T(+*SMY/]'25#EU_#K7;?#W6;W7?"<%Y?@>>6920, @47$=52 @]"#7
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M]8::GWQ3IO\ 6&CJ!'1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC##;1UJK%X*T:&RN+1+6,13LS.N.I/6BP'/_  VUO3+;P;91S7UO&XC4%6D
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MS&D2JC<%0.#4)TZR:V^SFUB,(_@VC'Y46 SX?$6FJ+.$7*%I@JISU.*UY?\
M5/\ 0UF3:!93WD$YC">0P9 HQ@UK4"/._#.F1ZAJOBFWN8\QR7 QG_=KCEL]
M4TSXC:'I-PCO:6]WOBFQP<@\5[C';PPN[QQ*C.<L0,9IKVEM),LSP1M*ARKE
M>1189RLG@^Z.I?;%O^ ^_9DUS6ASV&BZ]XA/B/9"\]R6MC/SO3;CY?QKU6JE
MSIEC>.'N;2&5AT+H#18#R*XT:\U/0?$7]G6\C6DRK]E0<YYYQ6]J?B*SU#PI
M#HMK*LM\\0@>%3\RD #G\17HT5O#!%Y<42H@_A48%5TTG3HYO.2R@63.=X09
MHL!R=MKC^&DTO3=2MFBL5M<27+XV*W]T^]9EJ8-4^(5I?:(N^R3=Y\D7W">U
M>BW%G;7:;+B".5?1UR*;;6-K9@BVMXX@>H1<46 L4444""BBB@ HHHH *FB_
MU;_2H:FB_P!6_P!*&,^<]=_Y#M]_UV;^=4X"!<1DG@."?SJYKO\ R';[_KLW
M\ZSZ^HA\"/'EN===:Y!;^)F<GS[*1$655/W@!TI/'=[97NH0/92*T?DIP#]W
MCI7)$D]32DD]3FLU02DI+H4ZC::+]CJ9LXV0*3DYIE_?F]V94C;5*BM>17N3
MS.UCI/"MCI\\TDU]<QQ[%R@;N:LZS!%)<QSR:E#+'N"*B C:,]?PKE [+T8B
M@NQZL3^-9NDW/FN4II*UCM;,6NC7<]VVIQW,2Y"QY/SY'O7-WVG&/3X=2$JE
M;F5@$ Y7%9Q=B,%CBGM/(\"0LQ*(<@9X%.--Q=[@Y)JQI>'_ + UY(E^2JNF
MU'#8VMZUU&G)#I1G:;6K:>#8RA2I)8XXQFN IQ=R,%B1]:52ESO<49V/0+'5
M+)+300UR@,3N7_V<UF>']0@@EUXS3JOFPN(]Q^\=W:N1W-QR>*,D9P3S4_5U
M9J^_^=RO:.Z.ZCL;749M+G_M.*%HU4&-LY)S5K4]0M[/4-?6210[3)M4]ZY:
M#Q/<V\"1+;VYV+@,4YK*NKJ6\N))Y6)=SEJA4).7O;?\&Y3J)+0[V?4Y6O%N
M[?5[1$5%QNCSSBN7EUFYN[\PS2PF-Y,-($QQZUB[VVXW''I3:TA0C$B51LZG
M5/$<L-Q;6=JR-#9_('"_>&<U?N]0LYI!J23HLTP 91U&*X<DDY-+N.,9.*/J
M\;*P_:,Z6UOHET:Y1IP)&9L#/)J"^O$>;2-LV5C5=_/3YJP<GUHR?7I5*DD[
MD\YL>*;B*Y\174T+AXV(PP[UC4$DG)HJXQY8I$MW=PHHHJA!1110 4444 %%
M%% !1110 4444 %%%% !5S3M.N-3NE@MXR[,>U&FZ;<:G>);VZ%F8\X'05[3
MX9\,0:':+E0UP1\S?X5RXG$QHQ\S:E2<WY!X6\,PZ!9C/S7#CYV'\JZ&BBO!
MG-SES2W/2C%15D%%%%0,**** "BBB@ HHHH **** "BBB@ HHHH ****8$S_
M .I'UJ&IG_U(^M0TD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGX(O],\/SQW4T<!)CBY+=*[-]$TN1R[V%NS'J3&,FI;?3;*T+&WM8HBPP=B
M9HL!Y39Q>$X?#MI:W!EEU!45)+59R&#?RJ>6W71/$GAO47M);33(('5S*<^3
MD\ FO2_['TWSO.^PV_F9SNV#-6)[2WNH_+GA21/[KKD4K!<\SGU:UUCXAZ=+
M8E98%E!\Y.AX->A:?K%IJ4DJ6\BLT;%6 /0BI8=+L+9E:&SAC*G(*H!BH--T
MF+3Y)9%4!I&+''O3$6-3YTF\ _YX/_Z":\?TFW<^&O#BM'G$DF0?K7M) 92I
M&01@@U MA:*B(MM$%3[H"CBAC.)\=1%I?"FU<[;U<X[?+5'3'6.]U_3G;;=7
M E:*,]6&T]*]'EMH9MGFQ(_EG*;AG:?:F?8;3[1]H^SQ^=C&_;SCZT >0>';
M;PWI_AB&SUEI8M2C3;);F8J6/TJQ?V4,=OX1CM=/FM(!J,C>5*VXX*]<^]>I
M2:1ITTOFR6,#R$YW,@)J=[2WD\O?"C>6<IE?NGVI6"YP'CR)C=Z,$7@7,?3Z
MT_PC"5U;QPQ7[UT<'U_=UWLMK!,5,L*.5.5W#.*([:")I&CB13*<N0/O'WI@
M<%X>M]GPZF_=@,=V>.O-;?@1670"&&#YS?SKHEMH$A\I(D6/^Z!Q3HH8X5VQ
M(J+G.%&* //?B+-';:A83S.$B5T)8]!\PK3U7QUIATUTTB=-0NF7:L4)YY^M
M=5<V-I>KMN;>.8#LZYJ&'1M-MW#PV-NC#NL8% 'F[V^I^&/!]A;IMB^TW4DE
MQ*Z9$*MSDUD^)ETRX@TF2RN3?7*W<1DEB<[0,\\&O9YK:&YB\J:))(S_  L,
MBJZ:1IT8 2Q@4 Y ""BP'!ZI>Q6/CZSGF<(KP2%"W0GM6;INI0ZC+<KK]_'%
M(3\EJN4?&?:O4I=.LYW1Y;6)V084LH)%1MI&G/+YK64!D_O%!FE8#AOA#%Y.
MA7R!2J_;92H)[9XJUXPL[O3?$=CXHLX'N#;QF!XDZ[6/+?0"NV@M;>U4K!"D
M:DY(08J1T612KJ&4]013MH!Y]K7Q2TZTBBCL8S>SR*0\<3#*'WS5#P-J36?A
M&YU..)KFZ,\KO&G4+G(%>A#0M)5]XTZV#>OEC-26VEV=HKK! B(_557 - 'G
MOBC6](\0:59QV:+/J1F1FAB.'C.>I^E>@Z9'-;Z7"ET^Z5$^=L=:(](TZ&7S
M8[*!)/[P0 U=QD8- CRO7_%-KK7B&31[G48[#3H,&9I"?WX/\*D=#6U=G1K_
M ,*S6V@3QW30(658CDD@5U<FAZ7,Y>33[9V/4F,$U+;Z=96@(M[6*('KL4#-
M%AGG,WB.WN/ UGI:,&U;")): _.O/.?I3=8UU_#.DV'A^*X2VFGR'N7&5A[Y
M(ZUZ,-)T]9_/6R@$O]\(,TMQI=A=MNN+.&5O5T!HL!ROA*Y\+60$%CJD%Q>2
M<NP8DLQZ]1ZT[XEHS^'[8*,G[9%_Z%72PZ-IMM()(;&WC<=&5 #5J:"*X0+-
M&LB@Y 89YH ATX8L(A_LU:I  HP!@4M @HHHH **** "BBB@ HHHH **** "
MBBB@!5^\*T5Z#Z5G+]X5HKT'TJ9#0M%%%2,**** "BBB@ HHJGJKW,6EW+V:
M%[E4)C4=2: +E%>71?$S4]'D5/$NBR6-OG:;F1QC/TKN-$\5:-XB5FTN]2X"
M_>V]J -FBBB@ HHHH IW7^M_"H*FN?\ 6_A4-6MA'FOQ<T.^UJPM4LHO,*GY
MAGWKL-"T2SLM.M2+2-)EC7<0.<X%;)4'J ?J*6G81P?Q0TF[U;2;&.SCWLEY
M&[#V!K(^(.@ZAJ6AZ7#;1;GC*[AGI\V:]2(!Z@'ZT%0>H!_"BP%:RC:/388V
M'S+&H/Y5XEH'A/5[>7Q,9+< 7"3"/GKDG%>[TW8O]T<^U%@/-/#!UKPMX(MU
MAL(Y[G?&C1NQ  /4UZ/:2236R22H$<CE1VJ7:N,;1CZ4M '!_$32;S4KWP^U
MK'O$%[OD]ABN8^*/@&ZO[:'4M(CQ=!1&ZCC(/6O8B >H!H(!&" 1[T6&>-S>
M!]2O/AKHZ1)C4+*)0(R< \YZU7U=_%?C.SMM"ETZ.UB'[N:17/W<8[CVKVS
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MGT4_KU?N'U>GV/,/^%7-_P _3_I1_P *N;_GZ?\ 2O3Z*/KU?N'U>GV/,/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%4M4U.#2K":[G/RQ+N(SUH NT55L+^'4+2*XA8%9%#
M 9Z5:H **** ')_K%^M6;[[XJLG^L7ZU9OOOBI>Z#H5****H HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "K;?\@R/_ 'S52K;?\@R/_?-2^@(J55U"Y>SLWFCC\QEZ+ZU:I" 1@@$>
M]4!PUS\0)+2ZAMIK ++,VR,;NIKI-'U6;48RT]MY!!X&:X_QE&@\:^&@$4 W
MG/'^R:WO&-[-IMOIQM2J&2[1&P.H)J+C.HR!U-(64=6 _&N;\:7]QI^D++;M
MM?S4&?8FN<M#J^O>)M3LA>+':PQH=N#DY]#3N*QZ/N4#.X8^M+GC->5Z&VNZ
MY:7B37\82VD=8\*0?E.*N/XLO[/PI*Y8-<17<=H'QP=W&:.8+'HX92<!@3]:
M"RCJ0/QKSK5X]9\,Z3_;)O$D92#(NT\Y/:H;V^U?6/%?V&TNEAA>WB=\KG[P
MYHY@L>F9&,YKG=0\5P0WK6%DGVF]4X,?3]:T7CEL="D4OODCA/S>I KE_A_$
MDPO[R50UQ+(&8D9(.*&WL!KZ;XJAN;X:?>1_9[TG'E=?UKH2RCJ0/J:S[S2M
M/N+ZVNID"SPMNC93C)]_6N2M'U3Q9>7$D5RL-C"[1JN#G<IQG(HNT!WV1C.>
M*3>N<;AGTS7G">(=2MK34-/FE5[BWEVPN!V JM/_ &Y!X6'B%[U!<+R5VGU]
M*.8+'J!('4@?6LB77HH]9.G!09!"THY]*Y7^TM0\2Z\-)@G$"06T<\C$?>W#
MD#%4;>WO].\:SK=3+(R6$AC('0 4<W8=CNEUZVCL8;FZ(B\T<"ICJ?\ IT<"
MIE7QALUYQJ0N=5\,Z1<O*%<H-V!C/-:>H:Q-H%Y$9&#Q1(K-QR1BE<+'H990
M<%@#Z9I<@=Z\^MK36]6L)M5>]19 2T*[2,#M]:J:AXGU.?0$6"0"^BE2&9]O
M!)//%/F%8]*WKV8'\:I6.HF\>12@3:2.M<9)'JNAZ[I;/>++'<D^:H!YXK/F
MU[45TV[EAD59 [[3M]Z.8+'J&]<XW#/UI2P7J0/J:\NU!M9TG0M/UH7J---)
M&KC:<88\\5I)=ZEXIUJYM(+A8;>S;;(".23TY%',%COP0>A%+7!>&[G58/&^
MI:7?7*31PP(R%5QU-=[33N 4444P"BBB@ J[:_\ 'M-_NU2J[:_\>TW^[4RV
M!'+3>+=(@F>*2YPZ'!&*C_X3+1?^?K]*\MUG_D,WG_75JHUZ\<#3:3N<+Q,K
MGL'_  F>B_\ /U^E'_"9Z+_S]?I7C]%5]0I]V'UF9[!_PF>B_P#/U^E'_"9Z
M+_S]?I7C]%'U"GW8?69GL'_"9Z+_ ,_7Z4?\)GHO_/U^E>/T4?4*?=A]9F>P
M?\)GHO\ S]?I1_PF>B_\_7Z5X_11]0I]V'UF9[!_PF>B_P#/U^E'_"9Z+_S]
M?I7C]%'U"GW8?69GL'_"9Z+_ ,_7Z4?\)GHO_/U^E>/T4?4*?=A]9F>P?\)G
MHO\ S]?I1_PF>B_\_7Z5X_11]0I]V'UF9[!_PF>B_P#/U^E36WBG2;N8117(
M+'H,5XS3XY'B<.C$,#D$&D\!"VC!8F1[\N"RD>M6[[^&O/O"'BM;D1V=XX$@
MP%8]Z]!O3D(17EU:<J<^61V0FI1NBG1114E!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 7-/_US?[AJHWWC5O3_ /7-_N&JC?>-0MV'02BBBK *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"[-_P >*_6J579O^/%?
MK5*ICL#"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** )(/]<M27O_
M !]-4<'^N6I+W_CZ:I^T'0KT4450!1110 4444 %%%% !1110 4444 %%%%
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MLN<K@=JEMWT&MCJM=\;SV/AC3=4M5C+7,L:.&' W=:Z6PUVPNH(MUY!YS#E
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MH(D>7Y)7&-V!^5%WL%CV.+?Y2^9C?CG'K3Z <@$=Z*U)"BBB@ HHHH ****
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MCD&BJFFPS6]C''.Y>0*,DU;KPFK.QZ2>@4444AA1110 4444 %%%% !1110
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M ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHIWEO_=-'EO_ '30 VBG>6_]TT>6_P#=- #:*=Y;_P!TT>6_]TT -HIWEO\
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M@!M%.\M_[IH\M_[IH ;13O+?^Z:/+?\ NF@!M%.\M_[IH\M_[IH ;13O+?\
MNFCRW_NF@!M%.\M_[IH\M_[IH ;13O+?^Z:/+?\ NF@!M7;7_CVG_P!VJGEO
M_=-7+9&%O-Q_#2D]!HRVM+=F),2DGKQ2?8K;_GBGY59\M_[IH\M_[IJN9]R;
M%;[%;?\ /%/RH^Q6W_/%/RJSY;_W31Y;_P!TT<S[A8K?8K;_ )XI^5'V*V_Y
MXI^56?+?^Z:/+?\ NFCF?<+%;[%;?\\4_*C[%;?\\4_*K/EO_=-'EO\ W31S
M/N%BM]BMO^>*?E1]BMO^>*?E5GRW_NFCRW_NFCF?<+%;[%;?\\4_*C[%;?\
M/%/RJSY;_P!TT>6_]TT<S[A8K?8K;_GBGY4?8K;_ )XI^56?+?\ NFCRW_NF
MCF?<+%;[%;?\\4_*C[%;?\\4_*K/EO\ W31Y;_W31S/N%BM]BMO^>*?E2I:P
M(V5B4'U JQY;_P!TT>6_]TT<S[A81?O#ZU;OOX:KK&^X?*>M6KU&(7 J6]45
MT*-%.\M_[IH\M_[IIB&T4[RW_NFCRW_NF@!M%.\M_P"Z:/+?^Z: &T4[RW_N
MFCRW_NF@!M%.\M_[IH\M_P"Z: &T4[RW_NFCRW_NF@!M%.\M_P"Z:/+?^Z:
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M8"3S6]%_*CS6]%_*HZ*+ 2>:WHOY4>:WHOY5'118"3S6]%_*CS6]%_*HZ*+
M2>:WHOY4>:WHOY5'118"3S6]%_*CS6]%_*HZ*+ 2>:WHOY4>:WHOY5'118"3
MS6]%_*CS6]%_*HZ*+ 2>:WHOY4>:WHOY5'118"PTA\H' Z^E1^:WHOY4Y_\
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M_P"5"YY]S>_X377O^@C-^='_  FNO?\ 01F_.N?IZQ2/&SJI*K]X^E'L:?\
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M;M^T!>-PS7E?AC0UU_QM!J-GI"V%A!&0P"%<MU'!KV?4XFFTR>-1EBAQ^5"
M\J^$6J:HNFW4FH2QK8H[L9'Z@[N>:ZWQ=KFF:AX8OXK._@FD$+';&^3TKC?
M,#:CH>J>%KR&>W\UI TGEG@,W8GBKEQ\++3PSI=_=65Y<7,KV[($9!W'M1T
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MR,,.*Q9?%.L7DVM:+J21#RK%I,HN,FIK>9_"_C*[U*ZC9[:]@B3]V"[+M'/
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M@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 H^\/K4DW45&/O#ZU)-U%'49%1110(9Y,6<^6F?]T4[:",$#'IBEHH
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M** "BBB@ HHHH **** "BBB@ HHHH <GWQ3IO]8::GWQ3IO]8:.H$=(5!.2
M?PI:* $  )( !/7B@JI()4$CID4M% #6C1CED4_44"-%^ZBCZ"G44 %(% Z
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M^>GZ4>?;?\]/TH **//MO^>GZ4>?;?\ /3]* "BCS[;_ )Z?I1Y]M_ST_2@
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M^>GZ4>?;?\]/TH **//MO^>GZ4>?;?\ /3]* "BCS[;_ )Z?I1Y]M_ST_2@
M'45--VJ$3VV1^\_2I9I8%QO?'X4NHR*BCS[;_GI^E'GVW_/3]*8@HH\^V_YZ
M?I1Y]M_ST_2@ HH\^V_YZ?I1Y]M_ST_2@ HH\^V_YZ?I1Y]M_P ]/TH **//
MMO\ GI^E'GVW_/3]* "BCS[;_GI^E'GVW_/3]* "BCS[;_GI^E'GVW_/3]*
M"BCS[;_GI^E'GVW_ #T_2@ HH\^V_P">GZ4>?:_\]#^5 $T'WC]#4)ZU+!+
MSD(^3@]JB,]MG_6?I2ZC"BCS[;_GI^E'GVW_ #T_2F(**//MO^>GZ4>?;?\
M/3]* "BCS[;_ )Z?I1Y]M_ST_2@ HH\^V_YZ?I1Y]M_ST_2@ HH\^V_YZ?I1
MY]M_ST_2@ HH\^V_YZ?I1Y]M_P ]/TH **//MO\ GI^E'GVW_/3]* "BCS[;
M_GI^E'GVW_/3]* "BCS[;_GI^E'GVO\ ST_2@"9_]2/K4-3/+ ( 2_RYZXJ'
MS[;_ )Z?I20V%%'GVW_/3]*//MO^>GZ4Q!11Y]M_ST_2CS[;_GI^E !11Y]M
M_P ]/TH\^V_YZ?I0 44>?;?\]/TH\^V_YZ?I0 44>?;?\]/TH\^V_P">GZ4
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MMO\ GI^E'GVW_/3]* "BCS[;_GI^E'GVW_/3]* "BCS[;_GI^E'GVW_/3]*
M"BCS[;_GI^E'GVW_ #T_2@ HH\^V_P">GZ4>?;?\]/TH **//MO^>GZ4>?;?
M\]/TH **//MO^>GZ4>?;?\]/TH **//MO^>GZ4>?;?\ /3]* "BCS[;_ )Z?
MI1Y]M_ST_2@ HH\^V_YZ?I1Y]M_ST_2@ HH\^V_YZ?I1Y]M_ST_2@ HH\^V_
MYZ?I1Y]M_P ]/TH **//MO\ GI^E'GVW_/3]* "BCS[;_GI^E'GVW_/3]* "
MBCS[;_GI^E'GVW_/3]* "BCS[;_GI^E'GVW_ #T_2@ HH\^V_P">GZ4>?;?\
M]/TH **//MO^>GZ4>?;?\]/TH **//MO^>GZ4>?;?\]/TH **//MO^>GZ4>?
M;?\ /3]* "BCS[;_ )Z?I1Y]M_ST_2@ HH\^V_YZ?I1Y]M_ST_2@ HH\^V_Y
MZ?I1Y]M_ST_2@!5^\*T1T'TK.6:VW#$GZ5H@\#'I42&A:***D84444 %%%%
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M/JU7^4/:P[G845Q__"Q-*_YY3_E1_P +$TK_ )Y3_E1]6J_RA[6'<["BN/\
M^%B:5_SRG_*C_A8FE_\ /&?\J/JU;^4/:P[G845BZ/XGL-98I"2C#L_4UM5E
M*$HNTBDTU="K]X?6K=]_!51?O#ZU;OOX:A[HKH4Z***H04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% RWI_^N;_<-56^\:MZ?_KF_P!PU4;[QJ5N
MP$HHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 79O^/%?K5*
MKLW_ !XK]:I5,=AL****H04444 %%%% !1110 4444 %%%% !1110 4444 2
M0?ZY:DO?^/IJC@_URU)>_P#'TU3]H?0KT4450@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ='_K!72I_JU^@KFH_]8*Z5/\ 5K]*QJEQ'444
M5D4%%%% !1110 56O_\ CPF_W:LU6O\ _CPF_P!VFMQ/8\[^&W_(9U7_ *[M
M_*O3:\R^&W_(9U7_ *[M_*O3:VQ/\0RH? %%%%8&P4444 8FJ_\ 'W^ JC5[
M5?\ C[_ 51KIC\)F]PHK@OB9XBU'P_8POI\WEN_4X]ZYS4-5\;:1I,>JS7YE
M@V[V78!QC-#E8+'L%%><>(/&5Y!X0TO4K27RY)I8UE..QZUT6F>--%NC#:MJ
M$9O".4[YHYD%CI:*:6^3</3BO-/!'C'4-3U[58M2N<VUL7QD?= )IMV ]-HJ
MGI^IV>J1-+9S+*BG!(K$\<^()O#V@2W,"GS<?*1VHNK7 Z>BO(8M0\:RZ:NI
M6VI&Y7[Q@5 #BO1](U.271([K4%\APF9-Q_.DI7"QKT5@6WC7P_=W7V:#48W
MF)QM%8_BKQ!?:=XDT.UM9=L-U/LD&.HQFG=!8[>BN0L=6NI?%K6C:@&B$6[R
M-O3WK1U+Q=HVGRR6TU\B7(4X4]<T7"QO45PO@/Q)>Z[J6IQW,WF10X\OCI6O
MXHM]>F1#HUV8"#\WRYR*+Z7"QT=%>)Z)K_C36-<N=-CU(AX&*L=GI7J&GZHE
ME#9Z?JEXK:E(O0C!8BDI7"QN45G3ZYIUM?QV4URJW$IPB'J35*7QEH$"2-)J
M$8$;E&]B*=T!O45S[^-?#\=LEPVHQB)_NMZUJVNIV=[9B[MYE> C(<=*+@6Z
M*Y\>-_#QO/L@U&/SL[=OO5Z_U_3-+B26\NDB1_ND]Z+H"U>7MO8P&:XE5$'J
M:ATS5K+5[?SK.977)!&>>/:N.\4:SX8U_2YD-\LC1#& 2,4SX7V^DQ6,SV4F
MZX)(<9/W<\4KZA8]"HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>/="Z/VE8S(K^9\QDQTS6!JLMQ?^%=&CNF?!DA0'/)!;UKT0?"S31-DWUR8
MV[R"!LK8U'P9IVH06L)+1);%2@0?W3D4<K"X[3?!VD6-C)!' 668#<7Y-:>E
M:/9Z-;>19Q!5R23CDY]ZO*-J@>@I:M)(5PHHHI@%%%% !1110 4444 %%%%
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MG1RK" 8(.#UJ739K?5=*O+\,B7"VIC9.A('>N ^VW.V1?.?;(,.,]138;F>
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M* "BBB@"[-_QXK]:I5=F_P"/%?K5*ICL#"BBBJ **** "BBB@ HHHH ****
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MUQ-W$B?$S4FCACWK8(R_*.OK7HZJ%4 # '2L"_\ "MO>Z\FK"YEBF "LJ=&
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MB8XE"@FKE-; %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** '1_ZP5TJ?ZM?I7-1_P"L%=*G^K7Z
M5C5*B.HHHK(H**** "BBB@ JM?\ _'A-_NU9JM?_ /'A-_NTUN)['G?PV_Y#
M.J_]=V_E7IM>9?#;_D,ZK_UW;^5>FUMB?XAE0^ ****P-@HHHH Q-5_X^_P%
M4:O:K_Q]_@*HUTQ^$S>X44450!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 .3_6+]:LWWWQ59/O
MK]:LWWWQ4O=!T*E%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !5MO\ D&1_[YJI5MO^09'_ +YJ
M7T!%2BBBJ **** "BBB@ HHHH **** "BBB@!"JGJ :  .@Q2T4 %%%% !11
M10 4THI.2H_*G44 '3I1110 4444 %%%% !1110 4444 %%%% !5VU_X]I_]
MVJ57;7_CVG_W:F6P(\<U/PAK-QJ=S-':Y1Y"5.[M57_A"]=_Y]/_ !ZO8**[
MUCJB5K(YGAXL\?\ ^$+UW_GT_P#'J/\ A"]=_P"?3_QZO8**/K]3L@^K0/'_
M /A"]=_Y]/\ QZC_ (0O7?\ GT_\>KV"BCZ_4[(/JT#Q_P#X0O7?^?3_ ,>H
M_P"$+UW_ )]/_'J]@HH^OU.R#ZM \?\ ^$+UW_GT_P#'J/\ A"]=_P"?3_QZ
MO8**/K]3L@^K0/'_ /A"]=_Y]/\ QZC_ (0O7?\ GT_\>KV"BCZ_4[(/JT#Q
M_P#X0O7?^?3_ ,>H_P"$+UW_ )]/_'J]@HH^OU.R#ZM \?\ ^$+UW_GT_P#'
MJ/\ A"]=_P"?3_QZO8**/K]3L@^K0//O#G@J6.X$^I1[=O(0\UWZ(L:*BC"J
M, 4ZBN:K6E5=Y&T(*"LA5^\/K5N^_AJHOWA]:MWW1:QZHOH4Z***H HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** +FG_ .N;_<-5&^\:MZ?_ *YO
M]PU4;[QJ5NPZ"44450!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 79O^/%?K5*KLW_'BOUJE4QV!A1115 %%%% !1110 4444 %%%% !1110 44
M44 %%%% $D'^N6I+W_CZ:HX/]<M27O\ Q]-4_:#H5Z***H HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSI/[QH\Z3^\:.=A9&5]FE_N-^5'V:7^XWY5J^=)_>-'G2?WC1SL+(ROLTO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)IWQ&OKG^S=+TK2IFG4B.8W$+HJ@#&0<>HKU7:N,;1CTQ3%@B1BRHH)[XHL
M0-(T"-*H60CY@.@-2444""BBB@!1]X?6I)NHJ,?>'UJ2;J*.HR*N=\7>*H?"
MMA%=3*2KRK'P,]:Z*O+/C@6'A>W*#+"ZCP/7FAB.[_MV+_A'5U;!\MDW8Q6/
M:^.[:Y\'77B (?*MPQ(VGL<5YZ=;\7_\(2D/]AM]C\K E\SM1HA)^!&K%AAB
MDF1_P(4KC-A/C,DJ[H]+O'7U6V<C^5=!:_$..;PQ=:S+:30K!(J;9(F4G(]#
M7%^$M7\80Z%"EEH'GP@##[QS72^-I[Z?X9RR7]I]GN"Z%H\]^:+@4(?C/!(-
MXTV\:+^^ELY'YXKL]#\<:1KND2ZA;R.L<()D#KM(QUXKR'3/'FK^&_!MK%-H
M(>T8$).6^]78?#+PH&T2[NM20&._+[H<\;6.?ZT)@7'^,&C+>%!#=&W#[#+Y
M#8S]>E=]87T&HV4=W;MNAD&5->1^-Y-*BM(_"?AZT4S22JSA/X0#@UZ5X6TF
M31O"UGIKL?,BCVDTT ^7Q/IL6M+I+2G[4<< <<UL5X)=Z'J!^+SV_P#:KB3Y
M&\S;V.>*]-;QYH6G746F7%Z6NAA#\AY/2A,"2P\:6U[XJNM$ Q) Y4DC'09K
MJ596&58$>QKP&VL[[6?BMJL6G7[6F^5SYJC/85T?AG5=<T_6]:T.\U%[AK9%
M\N1N-N:5P/6?-CW;?,7/IFN6\7^-[7PD\ N02LK 9"YQDXKQ_6/$][I\<EU'
MXHEENTF;,/E]@>F:O?$"6;Q#X>T"29CYUU%'N;W+8HN![!>^*;.W\,-KD+;[
M?:".*Q;_ .(EK8^%H=:9#Y<KL@&T]J\KDU>;PYH.J>$-1F9O+VK;[AU'4U9\
M2?\ )(-/_P"N\G\A1<#UZ\\9:?8>&X=7N'PLT89$'4DCCBI/"GB*3Q)8?;#
M8HFP4W*02/QKY[COM3O'TB?6H&&E1&.-=QX^M?3.E&S;3(&L OV4K^[V^E"=
MP+E%%%,04444 %%%% !1110 4444 %2G_CV7ZU%4I_X]E^M R*H+RY%I:23M
MT09J>L[7/^0/<?[AH$<?:_$.XO8VEMK%WC#E0=C=C6O'XL=-(-]=6[1_/LVE
M37"^#M;\4VNAF*P\._:K<3R8E\S&>:ZKQ3/=W'A..2]M?LTQD&4SG%(9J?\
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MB@ HHHI@3/\ ZD?6H:F?_4CZU#20!1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<KX7\)16RWEQJ4$<L]S,9/G0':#VYKLJ*!'"ZSX9DM_$]AJ&F1B*!(G6=47
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M444 %%%% !1110 4444 30?>/T-0GK4T'WC]#4)ZT=1A1110(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"9_\ 4CZU#4S_ .I'UJ&A %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 Y/OBG3?ZPTU/OBG3?ZPT=0(Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!5^\*T5Z#Z5
MG+]X5HCH/I4R&A:***D84444 %%%% !5:_\ ^/";_=JS5:__ ./";_=IK<3V
M/._AM_R&=5_Z[M_*O3:\R^&W_(9U7_KNW\J]-K;$_P 0RH? %%%%8&P4444
M9E]>203[5"D8[BJW]I2_W4_*EU7_ (^_P%4:Z(Q5B&R[_:4O]U/RH_M*7^ZG
MY5G23Q0C,LJ1CU9@*8E[:R$!+F%B>@$@-/EB*[-3^TI?[J?E1_:4O]U/RK/>
M6.( R2(@)P"S 4\$$9!R/:CE079=_M*7^ZGY4?VE+_=3\JI5&EQ#*Q6.:-V'
M4*P)%'+$+LT?[2E_NI^5']I2_P!U/RJE02 ,DX%'*@NR[_:4O]U/RH_M*7^Z
MGY5EB^M&?8MU"7_NB09J>CEB%V7?[2E_NI^5']I2_P!U/RJE11RH+LN_VE+_
M '4_*C^TI?[J?E5*BCE079=_M*7^ZGY4?VE+_=3\JI44<J"[+O\ :4O]U/RH
M_M*7^ZGY52HHY4%V7?[2E_NI^5']I2_W4_*J5%'*@NR[_:4O]U/RH_M*7^ZG
MY52HHY4%V7?[2E_NI^5']I2_W4_*J5(6"C)( '<T<J"[+W]I2_W4_*C^TI?[
MJ?E66E[:R/LCN87;T60$U/1RH+LN_P!I2_W4_*C^TI?[J?E5*HQ/"69!*A9?
MO ,,BCE079H_VE+_ '4_*C^TI?[J?E6?'-%+GRY$?'7:P-/) &2<"CEB%V7?
M[2E_NI^5']I2_P!U/RK+%[:%]@NH=_\ =\P9J>CE079=_M*7^ZGY4?VE+_=3
M\JI44<J"[+O]I2_W4_*C^TI?[J?E5*BCE079=_M*7^ZGY4?VE+_=3\JSDGAE
M8K'+&[#J%8$BI*.5!=EW^TI?[J?E1_:4O]U/RJE11RH+LN_VE+_=3\J/[2E_
MNI^54J*.5!=EW^TI?[J?E1_:4O\ =3\JI44<J"[+O]I2_P!U/RH_M*7^ZGY5
M2HHY4%V7?[2E_NI^5']I2_W4_*J5%'*@NR[_ &E+_=3\J/[2E_NI^54J*.5!
M=EW^TI?[J?E1_:4O]U/RJE11RH+LN_VE+_=3\J/[2E_NI^54J*.5!=EY=1E+
M ;4Y/I4UU>R1, %7\16:G^L7ZU9OOOBDXJX[Z#O[2E_NI^5']I2_W4_*J5%/
ME0KLN_VE+_=3\J/[2E_NI^54J*.5!=EW^TI?[J?E1_:4O]U/RJE11RH+LN_V
ME+_=3\J/[2E_NI^54J*.5!=EW^TI?[J?E1_:4O\ =3\JI44<J"[+O]I2_P!U
M/RH_M*7^ZGY52HHY4%V7?[2E_NI^5']I2_W4_*J5%'*@NR[_ &E+_=3\J/[2
ME_NI^54J*.5!=EW^TI?[J?E1_:4O]U/RJE11RH+LN_VE+_=3\J/[2E_NI^54
MJ*.5!=EW^TI?[J?E1_:4O]U/RJE11RH+LN_VE+_=3\J/[2E_NI^54J*.5!=E
MW^TI?[J?E1_:4O\ =3\JI44<J"[+O]I2_P!U/RH_M*7^ZGY52HHY4%V7?[2E
M_NI^5']I2_W4_*J5%'*@NR[_ &E+_=3\JL->R"R67"Y+$=*RJMM_R#(_]\TG
M%#38[^TI?[J?E1_:4O\ =3\JI44^5"NR[_:4O]U/RH_M*7^ZGY52HHY4%V7?
M[2E_NI^5']I2_P!U/RJE11RH+LN_VE+_ '4_*C^TI?[J?E5*BCE079=_M*7^
MZGY4?VE+_=3\JI44<J"[+O\ :4O]U/RH_M*7^ZGY52HHY4%V7?[2E_NI^5']
MI2_W4_*J5%'*@NR[_:4O]U/RH_M*7^ZGY52HHY4%V7?[2E_NI^5']I2_W4_*
MJ5%'*@NR[_:4O]U/RH_M*7^ZGY52HHY4%V7?[2E_NI^5']I2_P!U/RJE11RH
M+LN_VE+_ '4_*C^TI?[J?E5*BCE079=_M*7^ZGY4?VE+_=3\JI44<J"[+O\
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MVCQ@>;$I8\^E>?\ B&[L=7\;Z*-!\MWCF#2/". -IZXJ#0+F/0?B==2ZG*L
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MANX&AGC62-NJL,@TES<);6TLI(_=H6QGT&:Q?"_BB+Q+!)+$@4(>U+38"$>
M]!$_F_8HCSG;L&*W'TZTDLOLC0)Y&,!,<"J^N:U;:%ILEY<MA5!('K7,Z3\1
MK6^OH[>YB$"S#,;#)W9Z4M$&I1\7^!+4Z$\6E6D8F+J0=N,8-=';^'+2_P!"
MM;74;=)&C7C<,X.*Z.N9\4>,K7PO/:+= ;+ARI;TXS19+4"U#X2T>W>-X[.(
M,A!!"TD_A'1[F\>ZDLXC(YRV5ZFEU7Q);Z=H:ZFN'B9=P_*KNCZDFK:1;7Z@
M*LZ;P*- U*T?AC2HK6>VCM8UBF&'4+P:GN-$L;FR2TE@1H4^ZI' K0#*>A!^
MAH+ =2!]33L@,ZYT.QNK2&VF@1HH2"BD=,=*=?:)I^I6P@NK:.1%&!N7.*36
M-532=-DO& 94%,\/ZS'KNB6^I( BS+N S1H!'IGAC2M)D,MM:QK(?XMO-)J/
MAC2]3NUN;FVC:5?XBM8GC#6M:T^\LTL(!Y3OC<'QOXZ5TVE3W5Q8I)=Q"*0C
MH#FEIL!6MO#6E6DKR0VD2EL@X6JG_"%:'Y_F_8HNN=NSBNBHIV0#8XTBC6-%
M"JHP .U07NGVNHVY@NX$EC/\+C-6:*8'/6G@K0[.X$T=C%N!X^3I6K?Z59:G
M;""[MTD0?=##.*N44K(#&TWPOI6E3&:VM8UDZ;MO-68M%L8KN>Y2%1+.27;'
M7M6A119 4--T>STH.+2%8PYR=HQ5JXMH;N%HIXUDC88*L.*EHH YR/P-H,=S
MYPL(<YR!L&!6K>Z197]E]DG@1H<8"D<"KU%%D!@1^#M%C6/%G%NC;<K;>15Y
M-%LH[U+Q85\Y$V!L<XK1HHL@*6I:59ZK!Y-Y DJ_[0S533/#&E:3(9;:UC60
M_P 07FMBBBR RK?P[IUJ]PT5NBF?/F87KGK4]II%G8VKVT$*I$_WE ZU>HHL
M!FQZ%IT=@;(6T9MSU0KQ5*S\':+977VB.RBW@Y4[.AK?HHL@,^71;&:_2]>!
M#.B[5;'(%-&AV"ZHVHB!/M).2^.:TJ* *,&DV=O>S7<<*B690KMCJ!6<W@W1
M'GDE:RB)DSN&RM^BBR I:;I5II,+16D:QH3T48J[113 **** "BBB@ HHHH
M**** ')_K%^M6;[[XJLG^L7ZU9OOOBI>Z#H5*\S^-! \,PEAE?M"9'KS7IE>
M=_%RUN+GP["+>(R,MPC$#V-$M@6YQVCZGX973K9)M!NGEP 7%H2"?K6S\0==
M.E>#;*UTN,V\5ZS)@KM*\9IVD>-[BPTNWM6T8,8UP3S6IXJT23QWX-CN8X/+
MNX=S11^_3O4+8KJ0Q>%?#>F^%K>XU-4WW$8)E8#.2/6GZ!:Z=8^'-5AT^^DN
M(V!(#,#M^4\"L"X\123Z+#H^M^'TN6MP%17)(R!BK/@G0;VVTO6;A[$6L-P2
MT42G@#:>*.N@')>#]0\/6UM*NIZ9<7,FX_-' 7'6NP\6+II\ )+IUJUO TC?
M(R;3T]*TOA;H_DZ5*+RWPV3]X>]:/Q*L'F\-+#:Q9^8\#Z4)/E"^IYY%K7@N
M+P[#;S:?,+YH=H;R.K8XY^M=S\)[*^M=$D:Z#K&^#&K\$#Z56OO EMJ?@FQF
M@@6'4H(5=90/FR.<5L?#S6-1O=+-IJJ,+FW 4NW5J<5KJ)G-_%V^U>W-E';[
M%MVD.T@\L<=#78>&-6EB\/VYUN6UMY-H"#S ,KCCK6)\6+.YN=,L9;>(R>1*
MS,!Z8IL/ANT\<Z%:R7B>4T*K'@KZ"C7F8=# ^+-XDNLZ--:21S?+\I5LC.[B
MMB#QEX@TK7+"QUFUMTM[G"HT1)/2L3QAX2.EZAHMM8QF2*-0"0.GS5N^/+&Y
MN-7\-M#&6$;G=@=/EHUW 76_&>NKJ,T6G0VL<$48DW73;-WT]:KKXKE\4^!=
M1DG1%F@?RVV="<'I7-2#4KK5KJW\06[W*F+%M&X)&>WZ59\+Z9<VWA+6K5K4
MQ.\^4C Z#::5W<9F?#G6[OP[+'%>DBRO@3&3T %:?A)@]WXG=3D-;Y'_ 'W6
MK#X0?6/A?9PM%MOH8SY9(Y7FL?X?:7J-M;:\MU&^\V^Q21UPU)75@.<TSQ?<
M:/HVH:;91N;B6X8LP4_*IZG->K?#70+"WT.#50_GWETH>21^2#6#\/\ PC#<
MZ9JK7EJ%N)9'19".0#3_  *^I>&/$=UH%PKR60?$4A'0 4XW6X,]8HH'(S16
MI(4444 %%%% !1110 4444 %6V_Y!D?^^:J5;;_D&1_[YJ7T!%2J&M?\@FX_
MW35^J.KJSZ9,JC)*FJ \K\+:SX>MM(,5YH=Q<3":3,BVI8'GUKJ->^PMX722
MQM/LT;2 ["FT_E6GX"@DMO#*QRJ5;SY#@_6G^-())]'5(U+-OZ"HMH/J<+JN
MI1Z3K?A:[EBED1;)P5B4LWWO2I_&WCJRU/P??V<5CJ$;R1X#26[*H^IJ_P#8
M;C_A)?#$GEG;%9NKGT.ZM_X@V\MSX&U*&%2TC18 %*SLP-+PS_R+UE_UQ3^0
MK7KF;/4AHN@Z6LR?-*$CQZ' KHPWF0Y7C<.*M"/--5(T7Q;?7FJZ?)>VMP^8
M=D1D*#^E:>A)H5_K7V_3R]G*0 UNPV$X]J<WB#4=!UR[CU4/)8NW[F3K@?05
MFQ1QZ_XOM=0TRS\I(G#2SX(+CT.:@9;;Q3/I^F7US;6D"NEX8L ?>]_K4=QX
MI\26-A!JUU;6HL)64<'YADXZ53FT^Y.F7B^4<G4=PX[9K8\86DTW@.&")"7$
ML? _WJ>H$MYXCU6\UAM,T6&%YH45YC*< !AQBLF3Q-J]Y)J^CZC!#'Y5D9,Q
M^M2PRS>'/%MUJ$\6;>[AC3(Y(P/2L2&\FU?Q5K<GD[2VGE4'J.U*[ T],\2M
MHWAC3[:W\O[5+&I7S3A<=*U;'Q9?6^KVMCJK6;?:CB,VTF['U]*Y:70'^P:3
MJ%U:">&"$1R1M[GK6OI]IH5QKMF=)T>.0*?WDS*5,?THNP/2 <@$=Z\Z\8>5
MX@U]=#:9%B$)E)+  ,*] GE%K:-*1Q&N<"N%\.>&$U*ZOM1U&++O,?*W#^$U
M3["1:\":K&EC=:-OW-I7[LMG.[C-)%K_ (@UBXEETBWMFLXS@-*<$D<&J-SH
M[>'/%<)T^,BUO4<W 4<9Q@4[0=6E\,VLVES0;F5F>(CG<6.<>U3?N,DTSQY<
MR:%<W>H111SQW#0*%^Z2*C_X3+5K*&&^OFL#9R,JE8I-S@DX'%<UI6G3Z]X8
MO)/(#>7J#RM'ZC/2M'[-X>FM;>.UT2.;4-R[X64@+SR<^U%V!OW_ (LU1];7
M3=,@A=I,;&?IT[U3N?$.ND:GH][#;I>16WFYC/RX/3FKEC8/#XOWB#9&", =
M!Q5?5;&XF\;:LZ1DK)8(JGU-/4#5\"/J+Z-F_6('(V[#GBNKKE_!=T'L)+9D
M*R0MM((KJ*I;"84444P"BBB@ HHHH *KZU_R*VJ?]<#_ #JQ5?6O^16U3_K@
M?YTX_$O5$RV9X0>M;/A>-)-:574,OEOP?I6,>M:GAZZBL]5$T[;4\MAGZBOH
M*E^1V/,C\1UEK;65UX:MK)TC6XN9'2.1N,'/<U0AT\6N@E)8QO6X9=Q'45F:
MCJ,+Z'8PP2'SHI78^V:VKCQ)8WWAN")P([I'P0.X ZUR.,UMLV;WBR+7=3.F
MQ::D,$>UH<MD=>:SO$,<,NF:?J$<2QO<@EE4<#%:>HKHFJP6+R:D\;11;64)
MGO6+KVH6L\%M8V9WP6V0KXQG-526L;+7J3)[W+O@V(2#5"%0NMOE2_0'-;6E
M6\WE7$NI);-:^2V&W9^;'%<OH%[!:6NJ),^TS6^Q/<YJQH>KP_9Y=/U-]UHR
MEE4\@/C@T582DY->01DDDA+/P\+BU-Y(DIA8C9Y:Y-.D\,F"[E64LL2*&Q_$
M<^@]:UM,UY8=-6RAU.2U,("J4'WQZTX:O97%Y<BYU%YY @\B=EY5N]+VE6['
MRQL9D_A7-A#>VXE6%Y1&?-&"/?Z5HZ-I>GPW%U&C&22)65@W3..U6KWQ-;'0
MH;&34'N9//R[,O*K5.SDT;3[BXN4OF8R*VQ=GJ*CFJ2BU(=H)Z&'/H$OV>TG
MC(873,% /3%4-3LUL;KR5;=\H).>]=/X;NS]ANKFX8F.R^:('ISZ5R%S*9KF
M60G.YB1^==-.4G)I]#*222:(J***W,PI0Q5@0<$=#25/:VLMY.L42EF8XH;2
MW&=SX*\32R3)I\^Y_P"Z>M>F7O1*X[PMX7ATA$GF4-<MW(^[[5V-[T2O Q,H
M2JW@>E14E#WBG11161H%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!<T_P#US?[AJHWWC5O3_P#7-_N&JC?>-0MV'02BBBK **** "BBB@ HHHH
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M HHHH **** "BBB@!T?^L%=*G^K7Z5S4?^L%=*G^K7Z5C5*B.HHHK(H****
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M1D;"=IQR:[#1+2\L].2*]G6:4#[RC%2:0\[Z9#]I&)0H5OP%7JT2ZDA1113
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MOOX:X/M(Z>A3HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MN:?_ *YO]PU4;[QJWI_^N;_<-5&^\:A;L.@E%%%6 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% %V;_CQ7ZU2J[-_P >*_6J53'8&%%%%4 4444
M%%%% !1110 4444 %%%% !1110 4444 20?ZY:DO?^/IJC@_URU)>_\ 'TU3
M]H.A7II16.2H)]2*=15 -"*I)"@$]2!UH*(Q!95)'0D=*=10 QX8I#EXD8^I
M4&A88D.4C13[*!3Z* "F-%&S!FC4L.A(YI]% $;00N<O$C'U*@T\*%&%  ]
M*6B@!KQI(,.BM]1FD2&*,Y2-%/\ LJ!3Z* &/#%(<O$C'W4&G*JH,*H ] *6
MB@!K(K8W*#CD9'2G444 -*(3DJ"?I1Y:%=I1=OICBG44 1I#%&<I$BGV4"AX
M8I#EXD8^K*#4E% #51$^ZJK]!BG444 1&V@9MS0QD^I04"VA5PZQ(K#N!BI:
M* (S;PEMQAC+>NT9J0# P.*** (V@A<Y>)&/J5!H6")#E(D4^H4"I** (V@A
M9MS1(3ZE12M%&XPT:,!V*T^B@"(6T .1#&#_ +@J0J"NT@$>F*6B@! H484
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.;F]3^=&YO4_G1[)!S'1_:(_[U'VB/\ O5SFYO4_G1N;U/YT>R0<QT?VB/\
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M]ZI<Y%<P&.1R?SKI(O\ 5+]!43CRC3N/HHHJ!A1110 4444 %5K_ /X\)O\
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MCZYI&J2:A80SRBX*J[CE>*L^![AM$\>:IH$))MEEVH.R@"A-]0L>IWM];:?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5BS_P"/J/ZU
M7JQ9_P#'U']:4M@15NKNW6YD#3("&/!-1?;;7_GO'_WU7E/BJ]N4\072K,P
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M[O1_9_\ >#ZUY'N'VVU_Y[Q_]]4?;;7_ )[Q_P#?5>'_ &^[_P">[T?;[O\
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M110 5;LNK54JW8]6J9; BJWWV^M)2O\ ?;ZTE,04444QA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%%  .HKIHO]4OT%<R.HKIHO]4OT%952HCZ***Q*
M"BBB@ HHHH *BNHS+;21CJRXJ6B@#C?"/AJYT74+V:8_+-*6'%=E3=Z[MN>?
M2G54YN;NR8Q459!1114E!1110!B:K_Q]_@*HU>U7_C[_  %4:Z8_"9O<\Z^*
M>AZCK5M:+86KSE#\P7MS79Z;IMO!86P:VC618E!^4<'%:1 /44@(/0T[:W"Y
MYQXKT'4;WQY87MM:,]M&BAG'0<U?O-(OY/B9IVHK;L;2..0/)V!/2NYP/2C
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M"C.NUBH)'H:=M7T%+0E8&[A1115 %%%% !1110 4444 %%%% !1110 4444
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M+G\3)K[3;O39!'=0M&Q&0#27FG7-AL^T1%-ZAESW!KO->\K6Y9K!E_TJ")3
M%ZLQ'ZUD^.HGAGM(W&&6W0$'Z5C3KN3C%[LN5-)-G'T5NZ*E@UO)]JL[F9MW
M!B/ IFMK8JL?V2TN(#W\T]:V]I[W+8CDTN8P!)P.M6KC3+NUDACFA96F :,'
M^(&M3P[I4MRTEYY#2+"-R@#[Q]*V?%:7 U/2KR2V=(D1<\8QSTJ)5K5.1#4/
M=YCGY/"^LQ1EWL9 HZDUD$%6(/4'!KO[Q]-\1WD\5C)=Q7KY;YI3LXZ\5P,J
ME)70G)5B#11J.:][<)Q2V+-AIUSJ4QBM8C(X&2!5\^%=8"L19N=HR:N>"P3>
MW8#;28#SZ5HZ?82Q337KWYN40$&&.0[CQU^E34JN,FD5&":N<4R,C%6&".HI
MM=';^1J$]Y.]K(6XV%1\J_6MYO#>EK9K>RAV3'SA6JI5U!VDA*FWJCSZIK6U
MFO)Q#"A=ST KJ(]-TS4K.3[*DB.)PB%C_#5[3H=.TSQ.FG^7(98@P=L\$XI2
MQ"2=EJ"IZ[G#2Q/#(8W4AAU%,KK]1L[.SLSJ,Z.[3R,D8!Z$>M68-!TN:<3A
M)! +?S'7=SNH^L)*[#V;;T.'J6&WDN&VQJ6-==;V.C7.BWNIK%*$MY5C0;NQ
MI&TBR<VMQ )$68X(W4_;K8/9LXYE*L5(Y!P:2NFTJRAN;B7S8R((F)9SW /K
M5FRT>PNY+N^&?L<3F-1GDDCBFZRCN)4VSD*L6ME/>"3R8R_EKN;'85UJ>'+'
M4&M5AE"RD$R MU^E2Z/+IX.JPPQ2*4AV@D]P:F6(5GRK4:IZZG(65[/IMV)8
MF*LIY%>K^'?$4&L6R@L!.!\RYKR&X_X^)/\ >JSIEU<VM[&]J6WYZ#O2Q%!5
M8WZCI5'!GN=%5-,FFGL(Y)U*R$<@BK=>*U9V/03N%%%%(84444 %%%% !111
M0 4444"+>G_Z]O\ <-5I/OFK.G_Z]O\ <-5I/OFI7Q,?0;1115 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!=NO^/=*I5=NO\ 4)5*ICL#"BBB
MJ **** "BBB@ HHHH **** "BBB@ HHHH **** "K=EU:JE6[+JU3+8$57^^
MWUI*5OOM]:8^=C8ZXIB.6UKQ/.FH_P!EZ3;-<W(.)&0_ZL^]46\1:UH3))J]
MH[VK'YYC@",>IJ/P>57QEXD6?'FFX&S=UZ=JU_B 8AX'U7S,9\@[?7J*G6UR
MC=AO[>:VCG60;)%#@^QI\-W!<$B*0-CKBO++JUDOO[&MFGECC:"/(1RO&*GO
M=/7PWX^L(+*XN#'+932,LDA8$CI3Y@L>EO>V\<OE-*H<]J<EQ%)&9$<%1U->
M<>'_  _#XBT"35;VZN1<3%@=DI &#VKG](NKE/"=K9"XE*W&JRV[.7.[;GUI
M<P6/98KRWG<I'*K,.PK/BO+K^UKB*12+=6PK5P_BO18_"FFV6HZ?<W!G%Q%"
M=\I8$,P!XID]W/)K&K'S7'S# W'CBBX6/2C?6RRB,RKN/05)+<10IOD<*OJ:
M\L_X1V-O!%YJTMU=&\B#LI$IQP>*EL3)XDUS3])O)I5MELEE_=N58L/>CF"Q
MZ9'=02E0D@.X9&.]35YU'I*:)\1]-BM[F=XIHI&9'D+ 8KT6J3N(@O+N*QLY
M;F=@L<2EF)["N.3Q!KFM[I]+LY$M5/R2<$2#U%;'C7=_PB>H8S_J6SBF^!=G
M_"%Z7LQ_J!FD[MV#H5--\17^HP7MF;5X=0ML @GDDU@:GXD\3:9>VEM+ ^ZY
ME\M.!UKT"&YL&OI8HFA^T@_O H&[\:X_QM_R,GAW_K\'\J3O8:-_0I-8=F_M
M*-E';(K<9@JECT R:S=<U?\ L6P^U?9)KGY@NR(<U@7/C96\-7NH/I]S;"+"
M;91RV[TJKV$5T\<.WC"+3A&3:3.$CDSP3WK=\3:S)H]M:R1C/FS!#7E#:A-'
MX8"QZ+??;HW:2.8KP,GBNNUW48]2\+:-,KAF6=%DYZ-CD5"8['0:5X@EO=8:
MT=2% /Z5O?;;;SO)\U?,]*\MN-0FTV[FFA'SLWE_0-Q6H/!]M_PC1O/MMU]H
MQNW^<<4TPL>C5YWXB\>S:'XLM=.:(M#-A2<]"3BNF\(:E+J>A++,/FC<Q ^H
M7BN(U_3H=1\>$3*3Y%I),N/[R\BFWIH)'HFLZFFEZ1+>L?E05SVB^+I9_!]U
MK=W$?W&\[<]0#@5AR:I+XCT#3=.D.)+J)FD]B*N>%;:QE\$W%AJ$HCMY&>-R
M6QQFE=WT'8E&M^))+;^TTM)/LNW>(^.5Z]:W[/Q-#/X>75)T\GY<M&QZ'TKE
MVTCQ7H]N3I-Y:2Z>JY5)$+L5]*K:WK#ZQX"D"0>3<P7,*SJJ[1G// ]J+M :
ML6M^(=7C^V6-G)%;Y^4<'=6WX<\0MK"/%/ T%S$2&1CSQQFM+26@;3(#;[?+
MV#[O3I26MSI\EU)';-"9P,L$ S35Q%7Q-JCZ/I7VJ,9;S%7\ZY+6OB"^C2Z.
M\J$Q78._GI6YX^_Y%S_MLG\ZXB\M(K[7?"EO,H9'20$$4I-W&CT36-;%KX3N
MM7MCN\N'S%Q^%8^N>)[RR\*:;J%NA,]V\:8'^U7)ZO=S^&_#^M:!>L3"T):"
M0_Q%CG&?85IZ]_R(WAG_ *^(/YBAL+&I)K/B?34\^?39;B-?O 8&!ZUU&BZO
M!K>G)>6Y&UN"/0CK5J]V_8+C?C'EMU^E<;\- W]DRL,^47;;Z=:>SL([*\N%
MM+.6X?[L:EC7(>&O&<FJZ[)I]Q$4\S+P$G[R"I_B%JS:=H:PQJ9&N6\HHO4@
M^E<#<:U)IXTFZM=(O+>YM56W,LJ_+M+<YI-ZC2/:FE175&8!FZ#UI))HX1\[
M!<^M<;K%Z9_%OAF2*4^7(6W8/!XJ3Q?F75-)M_,=5DN,,%;'&*=Q6+EMXLBO
M]/U26%=KV9=<9^]@=:E\+^(H]7\.V%[<.%FN(]Q4UQGAW3((-*\3W"M)O225
M "W&-IJGH/A:U?X<66I"XNEG:-7^64@#GL*5V.QZY)-'%'OD8*N,Y-)#<PSI
MNB<,H[BO+M,DF\6ZC#87L\L<-F008W*E^V/>KM];?\(IKRK93S/',@0I(Y;&
M>]/FZBL=_/>PQJRB0>9M)454T[46.GQR7S>7(Q/!KA]#T!=1GUJ_N[FX,D+L
M(@LI  VYZ5;T:ULKKP5;W6IW,RI#N^82$=^]*X['<I?VLCA4F4L>@ITUW! P
M660*3T!KSGPQH#W.H3:T[W26L?$,32')(/7W!K AO_MFH:J]UI^JW+K.RQM;
MN0JBCF%8]JWJ4WY&WUK UWQ"EA C6SAV+$$"O/X-3U*7PO=Z?+'<VT2,JQ/*
M2' SSDUH>(O"=K86&GW4%Q<%\[F#RD@\47'8]+LY3/9PRGJZ U-533/^07;?
M]<Q_*K=6(**** "BBB@ HHHH **** "BBB@ '45TT7^J7Z"N9'45TT7^J7Z"
MLJI41]%%%8E!1110 4444 %97B6[FL?#>H75N"9HH2R >M:M9^N745CHEY=3
MH'BBC+,I[B@#PJVUJ_75HW;7YR\MJUP8FD'RN!PE>R>!]1O-5\'Z?>WZ%+F6
M/+J0<@_C7C6H2>'/[:MI['PM%<7$J?:V;S"-J@Y)_"O</#6K6^M^'[34+50L
M,R;E4=J -:BBB@ HHHH Q-5_X^_P%4:O:K_Q]_@*HUTQ^$S>YP7Q/UO4=(T=
M!8[D$GWY5SE.:YJPLM7;['>:/XC-W*Q!D@NKA5'3ICZUU_Q!UA--T](KK2Q>
MV4O^N)/W:\S\0P>&88;2\\-R&&^W;@B*>N.E3+<:/7-5\5VOAVP@;4MS7+*-
MT<"[SGV [5%8>.]+U"PGN8A.K0'#QO&0_P"76O-?%!O!K^CW4UT]L39INEVY
M^:M+PEIR7GBZYNO[5>ZE(=7!CP"2*%)W"VAZ!:^+],NO#LFMH["UC!+;EPW!
MQTJJWC[2(]'&I/YPC9RBKY9W$^PKRF^AU"QU:Y\'(K-%<G:I[<G-:?C_ $F\
MT^YT9HV:&UC$:[U&=K <FCF86/1]$\;Z9K9D2$3QR1J6*31E"0!DX!K/'Q-T
M9[DP1I=2.#@[(2<?7%<;HMO]J\5FZ&LO=3K:2@#R\<8YJY\++)'U/77DCRV1
MM)%"DV%CK-5^(NCZ7="V=;F60(LC"&(OM!]<5T.D:O:ZU9+=6CED/8\$?45X
M1%#>6/BO5TNM0>R9H^6V9W+N.!7I'PPLEM=+NFBO&N4DF+$E<<T1DVP:T*_B
MK5+ZU\?:1;0W4B02(Y>-3PW-;%U\0=)LKNXLI!</<01AF5(BV<^F*YSQDI/Q
M&T4@'&Q^WO3_  O8Q7'Q+UB6:+<8H(V0D=#FB[N!LGX@Z=J&@7EW9"?S(U8;
M6C(8$>U<7\.O$,VJ:S=7VHZE?#;N*Q%?W6,=SZU)HT6S5/$8"$ PR]O<U2\+
MVL\WP\UI($(D^T(>G.-IS2NV,[^#XE:-/?K;!;I58X$K0D)_WUTK5UWQ;IN@
MV\4MPSN9?N+$N]CQGH*\6MA]I\*QV5QKDD49)'D>7G'-=!K*?V7XJTBZNV9[
M-4B"N1QD+34F*QVMO\0M,O\ 3KF6!+A9HE;]W)$5;@>G6N?\&>/)-;>^BN1<
M*[<H0APO'KVJ_'JGA_5=9NSIMJLEQ]EDS. 1CCI6%\/KVV@MM5LI#MN''RKC
MVHN[@=7X/UNW7P[/>SW\T\4<CY>;@\-TI+?XFZ+/>B QW:*S;%D> A2?KTK@
M+>VN9?AK=^4K%5FF+@=QNJ_KVL:1?>!]/T^R.^[4HNP*<AL4<SL%CT/5_&FE
M:-?6UK<NY>XC,D91<@@>]5-)\?Z9K5^UA;K/'<]%66(IG\Z\]U73I)-7\(6U
MZA9TM&WY]0];-_ L7Q7TED3&9 "0/:CF86(X-4\4+XW,[PL;25O)"<X&#UZ5
MZS'N\M=_WL<T;%_NC\J=5I6$%%%%, HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "KK_ /(/3Z52JZ__
M "#T^E3+H"*59/B6:6WT"\EA<HZQ,0PZCBM:L7Q4,^'+W'_/)OY&FP/+?AGX
MEU47'E:M>2S"Z0R0F1NP%5++Q)K5[\1=/D%].-/GN?+$>[Y3C.:SM06XL?"?
MAG4+9&$B6Q0D#U-:NFV+V5WX15D(=KUG;CU&:RN]BCT[7?&NF>'Y5@G\Z68@
M'9#&7./PJ?3_ !;IFHZ7+?QNRQQ??5UVL#C.,5Y3K,=Y9?$":2>^>SW0_+)M
MSD>E7=!L+1]/UJ:?4GN8I)LRL4Q\VW@U7,[BL=C:?$S2+N[CACAO=KG"N;=M
MOYUK:[XNTW0(8GN3([2XVI$FYN1GH*\=;4;S2+"$VFJO>6R,=L&S'>M'Q:UV
MWBZPO3,]I&]O#M<+G#;:7,[!8]/T7QEIFMVEQ/;F1# "7CE3:W R>#S6-)\5
M=#6(2*EVZ]RD!('U]*Y'PS8QR:]J5\FJO=2BUF5@4QG*FK/@>SC;PCJN^+)<
M G(]J?,PL>AIXLTM]!.L"4_90">1\QQUXK+TSXC:1J5^MHJ7,3-]UI82BG\3
M7F7V>=OAW:NJ,88KJ8R#'\.:[(:_X:N[;2;8P+<W2B,!<$;#ZT<S"QFGQC/I
M'Q!OUO+BZELXY&"PQJ7QP.PKL;3X@Z1>:3=7\?GA;5=TB&,A@/IUKCM%@5_B
MMJ#-'T:0#(]A4WA[3H[KQGXBLV3$,B(,8XH38'=)XMTQ] ;6!(PME!ZCGCMB
MLD_$O15DMXV%QNGA,J#RCR*\P,MR);;PE)&<_;VD;W1CQ71WFDQ0_$?2+(Q_
MNH;1@!CC@BCF86.GA^*6B31SXCNQ+#]Z,P'=^76MKP_XNTWQ%;236C.OEYW+
M(NTC\*X33[*-_BOJDK1\H_R\>U5_"LHT[6?$L_D&1([?=Y?][YC0I,+(ZJX^
M)^CV]XT#0WA"/L9Q;MMS]>E4O$>O3R^)M >PNI%M+F%G*@X#<]ZX*^U":^T2
MZE34'MHFE/\ HH3/ZUKPJQ_X0O@\6;9X_P!JES-CL>E^+K^ZT[PA>7=HK-<1
MP[E ZYKR_2UU#6+#[;:^)ITOMQS!-,J+GTYKU;Q'J+:5X;N+P6OVGRHMQBS]
MZO(]67P7?Z+->VB"UU$@L$4'._T_.G+<2.J\5>,+_P ->&+"&=6?4'V%I(LL
MA&>?F'&:W;3QQI\/A>/5+PS(NW.UD.]OH.IK@;V34)OA';OJ"L=EU 8R1SMS
MS4'CF3^T=,T.YM96%M$#O<+]VB[W"QZ7H?CO2M<N&MXA/%*J[MLT93(/3&:J
M3_$O18?M("W+O;R&-U2$L>._TK@],MA>^*;*9]:>XEC5#M\O&1C@5>\'6,;:
MCXEN6C_>!IE!([8-',PL=0_Q4T);6&X5;MUD&25@)V_7TKKM+U.VU>PCO+5M
MT3]":\C\+648\&ZSF+EF4\CVKL/A2"O@J$$$8EDZ_6G%M[@T9GBS5]8U;Q2G
MAW29/(4()))5;# =Z(?#7BW1=5MY+/49+Z _ZU;B4#'/;\*IZY=OX7^(ZZI<
MQ$V<T(B,GH:VKSXE6KZI;6>D0_;3+]X\C;S2TZ@:^N>-=.T"2."Y$TL[=4@C
M+D'WQ5>[\46NL>"]2OM,F>.2.)L!AM=2/:O/M=-S!\1[R;[<]D)"I1PN<\4_
M0;")-&\17<6H/=&2V=2"F.<T<SN%BYJNMZG'\.+*[2]F6X:ZA5I W)!/(KL)
M/&5GH.BV+:@TTL\Z94(A<G\JX'6%;_A5U@-IS]K@XQ[U?\2PP-;Z'-]O:RNH
MXF\MPF>]*[0['?\ AWQ=8^(Y)8K:.XCDB7<PFB*<?C705Y'X$UG4#XNN;2=F
MO 8T!G(Q@9KURKB[HEA1115 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !5BR_X^X_K5>K%G_P ?4?UJ9; C
MQ/Q;_P C%=_]=#_.L6-MDJ/_ '6!K:\6 _\ "17?!_UA_G6)M/H:^BI? CRY
M_$S6N]<EDUM=2MR4D4#&..@J;Q)KYUZXBF90&6-5/N16'M/H:-I]#35.":?8
M.9VL30WEQ;J5AF= >H!I)KNXN !-*SXZ9-1;3Z&C:?0U5E>Y-V6[;5+ZSCV6
MUU)$OHIK2U+Q+<Z@UIYDC/'"H#(W1B*PMI]#1M/H:ETXMWL-2:5CISX@L[=W
MN[. +=2#D;<!<^E9EZ;1]&MI$_X^FD8R<=JR]K>AHPWH:2I).Z&Y-[FEHVIC
M3)9V*Y\R,I2:;JTNG7YN$Y5@0R]B#6=M/H:-I]#5.$7>_42DSI[?7[-&NH]I
MBAE ^XM37'BV.72VLTB '(!Q7);3Z&C:?0UG["%[E>TD:UAK)LK9XU7YBX<&
MM6W\1V2W*W\T6Z\P=WR\$_6N4VGT-&T^AJI482$IR6QT::];W41MKZ/]P&+)
M@9()I[^*5\Z01Q*L/D&)0!U]ZYG:?0T;3Z&E[& <\C7M-9%MX=N]-VY,\JOG
MZ58C\0A+>VBV#]R2>E8&T^AHVGT--THL.=G5Q^(; :>;4QE-SEF*KUS56VUV
M"TD:&,'[(_++COZXKGMI]#1M/H:2HP#GD='-XABMY838QC]W_&1@FID\06%O
M%<M!#^^N$VME>GO7+;3Z&G1Q22R*B*2S' %#HP'SR';7N+C"*2SG@ 5Z/X3\
M*+:QK=WB R'E5/:CPIX32U1;N[7,AY52.E=I7!BL5?W('31HV]Z0#@8%%%%>
M>=04444 %%%% !1110 4444 %%%% BWI_P#KV_W#5:3[YJSI_P#KV_W#5:3[
MYJ5\3'T&T4450!1110 4444 %%%% !1110 4444 %%%% !1110 4444 7;K_
M %"?052J[=?\>Z52J8[ PHHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JW9=6JI5NRZM4RV!%5OOM]:2E?[[?6DIB.7UOPJ;N^&I:?.]O=KDD(<"
M0^YK.7PGJNJS)_;-VPMT.3$CAE<>AKN:*5D.YSMWX;$FI6L\1VQP*JA1Z"H]
M9\/&\\36FL%CY=M;21LH[Y]JZ:BG8#RJ&.-+:=+'49K>U;/[MR$9?HIJ7P;X
M6>^\'/!<&2.:.\EEB8C!R3P:[6Z\):)>WWVRXLD><'.[-;,:+%&J( %48 %2
MHCN<.WA'4]5:&WU>X/V6!U==K[BQ4Y&:NS>$F?4+VX5L+.00,UUM%/E0KG/G
M0'_X12YTC=\TJL <^M<UJ.FP6-_:6\=Q);7\4 'G?=4J.V[I7HM4=3T>PUB#
MR;Z!98\YP:&@N>>Z7;33>.[2Z%S)<^7$XD;.50GL"*['0S?G5+TW)8V^!Y63
M6AI>BV&C0>386ZQ(>PJ_0E8+D-U;1WEK);S*&CD7:P/I7%_\(OK.EN\>DW1:
MV<\([A1&/05W5%-JX'.>'/#']D2S7EQ.\UY<8+EN<?0T[7?#[ZKJ>FW2M@6D
M_FGGKQ70T466P#617&& (]ZP/$&@-K/DVP(6TSF0 ]2#QQ70T4,"L+&#[,L!
MC7:%"]*XN#P-<0V1M?-RGVPW ^8<9/2N]HHM<#E8O"2FZE>?#(X. >QQP:S3
MX4UG[.=,%XWV$G'F;QOQ]*[RBERH+F')H\UM:6-OI[^6D4FZ7!QNXYJNOAMO
M^$H&J.V4,#1%<]<UTE%.P'):9X/%AK=W>;R8V)\A.R CM4MKX2C_ + N-,N'
M/[UF(<<E<G/%=1119!<X%?#?B2"/['#>L;7[H<R#<!]*W]/\+VUIH\EE*QE:
M89ED8<LWK6_119!<X-/#.O::K6NG79>U)X9Y "*W?#GAJ/0T>1I6FN9"2\C]
M>>U;]%%D%S)\1:2VLZ9]E4X.]6_*L7_A$)/[6T:[W\6 8$9ZYKL**+(#F?&'
MA.#Q1IGD-A95R4;WJKK?A2XU#PMI^F02;9;1D8-G'*UV%%#2"YPO_",:]>CR
M;S498HB>3'("3[5UFDZ7!I%@EI;C"+[=35ZBBP7.<U#P\^H^(H[V=]UM&H*Q
MD\!AWK5U'3+?4+&6WDB4[E.,CH<<&KU%%D!PS>#+P:38HMPQO++/E.6'.?>I
M8O"FH7&H6>H7]TQFAD!,08%0!W^M=I12Y4%SC;7PI=VESJ<:2YM;T.Q!;HS#
MTJ]IOAQ[+P;;:*6RT487.:Z2BG9!<XI_!D\%K;R64QCO(7+G! $GH":FT_PM
M=S7SW^K2[YMFQ8]VY1[_ %KKZ*+(+F)I>BM86^H1EL_:22.>G&*YF_\ !&H3
M:/:6$$Y\J)F,B%@ ^?6O0:*+(+G(:9I&N6LL,<KH+=, J).U02>%M3TV[N7T
MFX+173EY [[=I/I7;44607.5;P@;G0)+&ZNY7FDP3(2"0165-X2UG4?(BO;H
MK#;G*;7!W=N:[^BBR"Y#:P_9[2*$_P "A:FHHI@%%%% !1110 4444 %%%%
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M>+?]]5O;&_NFC8W]TT>VGW#V<>Q@_P#"):3_ ,\6_P"^J/\ A$M)_P">+?\
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M;10 [<G_ #S%&Y/^>8IM% #MR?\ /,4;D_YYBFT4 .W)_P \Q1N3_GF*;10
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MYIB"BBB@ I\7^M7ZTRI(?]:OUH>P'C.L^,]6MM:O(4==J2L!Q5'_ (3G6/\
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MMYT?U 89'X4 6Z*** "BBB@ HJE_:MIMD;S1B,$MSTQ5FWGCN8$FB.4<94T
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MM-?$4]OXAN)TG=K>5RI5F)&T]:JM"4I^[V%"24=2Q>:;8ZGKMY/%,(;%'YD
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MELX2J/(\+;6.Y:HQV=QX=^),@FN9+EHK$NK2-DD"NL\2^ [MM2M-5T6=H[J
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M**!!1110 4444 %%%% !1110 4444 %%%% !4S?ZA:AJ9O\ 4+0P(:Q?%O\
MR+&H?]<'_D:VJS]:LFU'2+FT0X:6-E'XB@#C/@Y_R)%I_P!<Q6=\8+NXMKOP
MZ()GCWW+!MIQGY:HZ+X+\9Z%8I9V6ISQPH,!5(K5UKP7K.O:?HHO[EY+JSG:
M21VQD@C I=!G&?$+5Y=(\5:?>1H9)A9QE1C.3BM_PIJ=\-"U+Q->7TDD['(M
M@^5CRIXQVZ5NZQX"DU3Q)8WTGS0PPI&RGVING> I]/U;5(E8MIM^S.T?93C
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M:11)#&L<:A548 ':N?$XY./+3-:6'L[S%CC2*-8XU"HHP .@J=_]2E15*_\
MJ4KR6=I%1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"6W^^
M?H:C;K4EO]\_0U&W6CJ E%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 32?ZL5#4TG^K%0T( HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "I8>]15+#WH8$9ZFDI3U-)0!&+>%9&D$:AF^\<=:6*&.!-D2!%SG
M%/HH B-M"9O.,2^9C&['.*KOH^G22%WLX68G))7K5VB@".&WBMTV0QJBCLHJ
M0@$8(XHHI@1Q010[O*C5-QR<#J:DHHI 4Y]*L+J833VD4D@Z,RY-3/:P21HC
MQ(RH<J".E344 1R013 "2-6 Z9%0W.G6=YM^TVT<NW[NY<XJU10!76QM4C,:
MP($(P0!VIR6EO&R,D*!D7:I Z#TJ:B@"M=64=TAR-LF/E<=17 7'A3Q)+Y]@
M5M'LIB0URS_O0">U>D44 4='TY=*TR"T4EO+0*6/4U>HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #O6BOW1]*SN]:*_=
M'TJ9#0ZBBBI&%%%% !1110 54U+[1_9MQ]D<)<;#Y;$9P:MUC^*_/_X174OL
MN[S_ "#LV]<T >4WFI>)[Z[;2KCQ18AI#L:,P'.#P:]6\+:,?#_AVSTPS><8
M$VE^>?SKP]4\-_\ "/[YY[S^V@1E1)\WF?X9KV3P$U\_@O36U$,+HQ_O-W7-
M '24444 %%%% %.Z_P!;^%05<EA\QLYIGV4^M6FK"L5J*L_93ZT?93ZT706*
MU9^IZ)8:O'LO( X['H?SK9^RGUH^RGUHN@L8>E^'].T<$6< 7/<\G\ZTZL_9
M3ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6B
MZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?L
MI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1
M=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V
M4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUH
MN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[
M*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT
M706*U3-_J%I_V4^M/,&8POI0V@L4Z*L_93ZT?93ZT706*U%6?LI]:/LI]:.9
M!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4
M^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN
M@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*
M?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT7
M06*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E
M/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+
MH+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^R
MGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%
MT%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K5)#_K5^M2_93ZTY+<JP.>E
M#: K2?ZQOK3:M-;$L3GK2?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M
M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_
M93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM4K_ZE*D^RGUI
M[0915STHN@*=%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ
M"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI
M]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q';_ 'S]#4;=:MQP
M%&S[4TVQ)ZT75P*M%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*
M?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%
M6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"PR3_ %8J&KC0
M;E S3/LI]:$T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RG
MUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15
MG[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K5+#WJ3[*?6GI 5[T-H+%0]3259-J
M<]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1
M=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V
M4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUH
MN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[
M*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT
M706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]
ME/K1]E/K1=!8K459^RGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:
M+H+%:BK/V4^M'V4^M%T%BM15G[*?6C[*?6BZ"Q6HJS]E/K1]E/K1=!8K459^
MRGUH^RGUHN@L5J*L_93ZT?93ZT706*U%6?LI]:/LI]:+H+%:BK/V4^M'V4^M
M%T%BMWK17[H^E5_LI]:L@8&*4G<$+1114C"BBB@ HHHH *YC6[GQ'%>70LK*
MUDL5A!1Y9MI+]P?05T]<C\0]-U;4O#<T6EWYM?E/F@+G>OI0!Y^^A>*WNSJ(
M\&: SYWB?[6<_7->M>'I[RYT*UFOXX8[IE_>+"^] ?8]Z\=M[+Q%;>&XUN?&
M(@L25MV4Q9P6XVYKUOPCI2Z+X7L=/2X^T+"F!+_>H VZ*** "BBB@ HJG<WX
MMY=A7/&:@_M=?^>?ZU2@V*Z-.BLS^UU_YY_K1_:Z_P#//]:.2071IT5F?VNO
M_//]:/[77_GG^M')(+HTZ*S/[77_ )Y_K1_:Z_\ //\ 6CDD%T:=%9G]KK_S
MS_6C^UU_YY_K1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_P#//]:/
M[77_ )Y_K1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^U
MU_YY_K1R2"Z-.BLS^UU_YY_K1_:Z_P#//]:.2071IT5F?VNO_//]:/[77_GG
M^M')(+HTZ*S/[77_ )Y_K1_:Z_\ //\ 6CDD%T:=%9G]KK_SS_6C^UU_YY_K
M1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_P#//]:/[77_ )Y_K1R2
M"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R2"Z-
M.BLS^UU_YY_K1_:Z_P#//]:.2071IT5F?VNO_//]:/[77_GG^M')(+HTZ*S/
M[77_ )Y_K1_:Z_\ //\ 6CDD%T:=%9G]KK_SS_6C^UU_YY_K1R2"Z-.BLS^U
MU_YY_K1_:Z_\\_UHY)!=&G169_:Z_P#//]:/[77_ )Y_K1R2"Z-.BLS^UU_Y
MY_K1_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R2"Z-.BLS^UU_YY_K
M1_:Z_P#//]:.2071IT5F?VNO_//]:/[77_GG^M')(+HTZ*S/[77_ )Y_K1_:
MZ_\ //\ 6CDD%T:=%9G]KK_SS_6IC?@0"79U[4<C"Z+M%9G]KK_SS_6C^UU_
MYY_K1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_P#//]:/[77_ )Y_
MK1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R
M2"Z-.BLS^UU_YY_K1_:Z_P#//]:.2071IT5F?VNO_//]:/[77_GG^M')(+HT
MZ*S/[77_ )Y_K1_:Z_\ //\ 6CDD%T:=%9G]KK_SS_6C^UU_YY_K1R2"Z-.B
MLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_P#//]:/[77_ )Y_K1R2"Z-.BLS^
MUU_YY_K1_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R2"Z-.BLS^UU_
MYY_K1_:Z_P#//]:.2071IT5F?VNO_//]:/[77_GG^M')(+HTZ*S/[77_ )Y_
MK1_:Z_\ //\ 6CDD%T:=%9G]KK_SS_6C^UU_YY_K1R2"Z-.BLS^UU_YY_K1_
M:Z_\\_UHY)!=&G169_:Z_P#//]:/[77_ )Y_K1R2"Z-.BLS^UU_YY_K1_:Z_
M\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R2"Z-.BLS^UU_YY_K1_:Z_P#/
M/]:.2071IT5F?VNO_//]:/[77_GG^M')(+HTZ*S/[77_ )Y_K1_:Z_\ //\
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M_P#//]:/[77_ )Y_K1R2"Z-.BLS^UU_YY_K1_:Z_\\_UHY)!=&G169_:Z_\
M//\ 6C^UU_YY_K1R2"Z-.BLS^UU_YY_K1_:Z_P#//]:.2071IT5F?VNO_//]
M:/[77_GG^M')(+HTZ*S/[77_ )Y_K1_:Z_\ //\ 6CDD%T:=%9G]K+_SS_6I
MGU )"DFS[W;-'(PNB[169_:Z_P#//]:/[77_ )Y_K1R2"Z-.BLS^UU_YY_K1
M_:Z_\\_UHY)!=&G169_:Z_\ //\ 6C^UU_YY_K1R2"Z-.BLS^UU_YY_K1_:Z
M_P#//]:.2071IT5F?VNO_//]:/[77_GG^M')(+HTZ*S/[77_ )Y_K1_:Z_\
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M77_GG^M')(+HTZ*S/[77_GG^M']KK_SS_6CDD%T:=%9G]KK_ ,\_UH_M=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEW^UK[_GX:C^UK[_ )^&JFJEF"J,D]!4DUO+;D"5"A(R,]Z.6([LL?VM??\
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M<_\ 'LE4JNW/_'LE4JF.P,****H HHHH **** "BBB@ HHHH **** "BBB@
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M=2,J<]:YS4? 6MZDK6=VJW"&0$7CN-X'TI68:&?X]MI[Z^T>X6[WB?)#1O\
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MY))+7<%F7(Q7;>')_$,NIJNI65I'!@Y:-,&LK7?!FLMXD74]'E,.V+RQM8#
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M444 %%%% !1110 4444 7;G_ (]DJE5VY_X]DJE4QV!A1115 %%%% !1110
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MM_PEND_*#*X++N *<D470&NMM"L?EK$@0_P@<4V&RM;9BT,$<;'J57&:R/\
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M["EI#'-+,J /+]\XZU7.CV1M3;^0GE[BP&T<$]31RA<X[4-1MKOQ3,D$H?\
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M<]*ZZV^*6ER >>C1'O\ *:ZJ]&<I<T5='/1J1C'E;._HKB_^%F>'^]P1_P
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M_NT<R"S*=%7/[-N/[M']FW']VCF0693JQ9?\?4?UJ3^SKC^[4EO8S1W",R\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>gtl21rgcbjm5000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gtl21rgcbjm5000005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .-"#0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^,KPZA+'8:;%-;*V$DD<@M[XK(^(WCQM9G;2=-D*V$;8D=3_ *YO\!4/P_\
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MU\'/^16N?^OD_P A7HM95HJ-1I%P;<4V%%%%9%A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)?$JX>#P)J&S@R;$
MSZ#</\*ZVN6^(EHUYX&U%4SN15D '?##/Z9K2E_$5^Y,_A9XMX!@6X\;Z6K
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MN5/T/!JTU7C*F]T2U[-J2-SXH_\ )0-0_P!V+_T6M>Q> _\ D1]*_P"N1_\
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MHE^&$@<D0'KG-7!-P<:LDQ2LI)P1[1\0/$;^'?#;RV[8NISY<1]/4UXYX/\
M#-QXSUR5)KAEB0>9/,?F//0?4\_E7:?&=F^S:2I)QECCWQ7&^#M1\4:>+L^'
M+1Y]^WSBL'F8QG'TZFIH1<:-X[L=1WJ6>QU7C#X66VE:)+J.DSS.;==\L<I!
MRHZD$#MUJG\*?$UQ:ZPNC3REK6X!\M3_  /[?6IKK7/B9>6DUM-I4YBF1HW
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M2:]H[')2<TO=16^(GCZT\1VD.FZ:DAMU?S))9!C<0"  /3DTWX1:7-<>*&U
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M_P#GX?'TXKQ;7_\ D9]0_P"OE_\ T*JPT5&K-(55WA%GTIHG_(!T[_KUC_\
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M&D\NWBSPHS@?C7L.CDCX29!P1ILV/^^6KPC2Y+N/5K62QC\V[653$FW=N;/
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M5TQ[#[>UW&7WINCV;<]>YK?$585(*SU(IPE&3['S>?\ C\/_ %T_K7U+I?\
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M4*CTNAM3E'LS"TWXC^&=5TM/[3GBAEVCS(ITW GVXKROQW?Z'J&NB70;=8H
MF)"B;5=O4#M7=2_!6T9R8M9F1?0P!OUW5IZ/\)=%TZX6>ZFEO64Y"L-J_B.:
MUA4H4WS1;]")1J25FB?X3Z?<6'@W-PA3[1<-,@(P=N% _P#037<TB(L:*B*%
M51@ #@"EKCG/GDY&\5RJP5\S>,_^1RU7_KX:OIFO-M8^$D.KZQ=:@=8>(W$A
M<H+<';^.ZM\+4C3DW(RK1<EH=+X!_P"1$TC_ *X?U-=)6=H.E#0]#M-,68S"
MW38)"NW=SGI6C7/-IR;1K%621\P^+/\ D;=6_P"OJ3^9KW[P[&\W@6SBC.'>
MT*J?0D'%<IJOPAAU/5KJ^.LO&;B5I"@MP=N3G&=U=_I-@-+TJVL1(9! @3>1
MC/X5U8BM"<(J+V,:<)*3;/E\[[+5/WT9W0R_,C#T->[M\4/#2:6+I;@F79D6
MP7Y@?3TIWB;X;:5XBNC=K(]I=-]]XU!#?4>M8]A\&M,MYU>\U&:Z0'.P1A,_
MJ:N=6C52<]T3&$X/0\AUC47U;5[J_D7:T\A?'IZ5]'^$'5_"&DLIR#;)_*N6
MUWX3:?JU^MQ:WIL(UC">2D(8<=\Y%=9X:T5_#VBPZ:UV;I8L[7*;3CTQDU.(
MJPJ02CT*IPE&3N8'Q0T3^UO"C3QKF:S;S5^G?^E>""XE%JUMYA\EG#E.VX @
M']37U=-$D\$D,@RDBE6'L:\OD^"UJ]PSC69%0L2$%N.!GIG=3PV(C"/+,56F
MY.Z-/X3:)_9_AMKZ1<2WC;@2/X!TKJ?$^D_VWX<O; ??DC.P^C#I6C:6L=E9
MPVL*[8XD"*/85-7+.HY3YS:,4H\I\R:%J5QX4\4P74D3![:0I+&>I'0BO9[G
MXH>&X]*:ZANC)-M.VWVG=GW[5:\2> -&\22&>5&M[H]9HN_U'>N5'P4M?,R=
M:E*9^[]G&?SW5URJ4*MI3T9BHU(:1,30OB-XNU36(+*)H+AIGQM:$# _#'2O
M;EW;%WXW8YQTS7/^&_!FD^&$S9Q%YR,--)RQ_P *Z&N:O.$I>XK(TIQDE[S"
ML/QE_P B=JO_ %P-;E4M8TX:MI%UIYE,0GC*;PN=OX5G!VDFRWL?,FBW<5AK
M=E=S;O*AF5VVC)P#7M?_  M[PSZ7W_?D?XUB_P#"DX/^@[)_X##_ .*H_P"%
M)P?]!V3_ ,!A_P#%5Z%6IAZCO)G-"-2.R)=>^+NGR:;-#I-O.T\B%0\RA0N>
M^.<UY;H6F3ZSKEK9P*6>20;CZ#/)KU&/X*VBG]YK,KCV@ _]FKM/#G@[2?#$
M;?8HBTS##S2'+'_ 5*K4:46J>X_9SF_>*?CCP^^L>#)K. %KBW021#^\5[?B
M.*\9\%^(O^$5\1+<SQL86!CF7'('K]17TC7&^(?AKHNO7#7(WVERQRSQ#AC[
MBLJ%>,8N$]F74IMOFCN5M;^)^AVVC23:==B>\="(HPO*GU.:YCP?X\\6:[KU
MM89@GC9LS.T(&U.Y^7%7X_@K:+)F369G3^Z( #^>ZNZ\/^&-+\-6QBT^'#-]
M^1CEF^IIN5"$&HZL$JDG=Z'/_%+0I=7\,B>W0O-9MYFT#DKWKS3X>>+(O"VK
MS"[#?8[E0LA49*D9P?U-?09 8$$ @]0:X77/A7HFK7+7%N\EC*YRWEC*D_2E
M1K14'3J;!.#YN:)6\4_$_3+;1W&AW@FOI  C!,B/U)R*S_ 7C3Q/XCUI;:X\
MB6U09FD,6T@>V,<T^W^"UDDH,^KS2IW580I_/)KO]%T+3] LQ:Z? (TZL>K,
M?4FB<J$8<L%=@E4<KRT.2^+_ /R)2?\ 7W'_ ":N'^$/_(XM_P!>S_TKUGQ;
MX:7Q7HRZ<]T;8"59=X3=T!&,9'K6)X2^'$?A75SJ":F]R3&8]AA"]>^<FG3J
MP5!P;U%*$G44CM9_^/>7_</\J^68/^0U'_U\#_T*OJAUWQLF<;@1FO,$^#4*
M7BW']MR';('V_9AZYQ]ZEA:L*=^9CJP<K6/3;?\ X]HO]P?RJ2FQKY<:IG.T
M 9IU<AL17$$=U;26\J[HY%*L/8U\W>+/#5UX7UF2%D86[,6@E'0CZ^HKZ6JE
MJ>DV.L6C6M_;I-$W9AR/<'M6]"NZ3\C.I3YT>7^&OB[%;V,=KK<$KO&-OGQ
M$L/<>M0^+?BLFH:=)8Z+#+$)1M>>3@[?0#M6O??!G3)Y6:TU&>V4G[K1A\?J
M*++X,Z9#*&N]2GN5'\*QB//ZFNCFPU^8SM5M8\]\#>&)_$>O0@QG['"P>=R.
M,#^'ZFO=_$JA/">IJHP!:.!_WS5K2])LM&LUM+"W6&)>PZGW-.U.R&I:7=61
M?RQ/$T>\#.W(QG%85:_M)I]$7"GRQL?-/AK_ )&73O\ KNO\Z^H:\RT[X/PZ
M?J-O>#6I',+A]IMP,X_X%7IM5BJL:C3B*C!Q3N>9?%_0I;S3K;5H$+&URDH
MZ*>_YUR_PU\:VOAQ[BQU%F6TG;>K@9VMTY]J]SDC2:-HY$#HPPRL,@BO/]7^
M$6C7]PTUG<2V)8Y**N]1]!D55*M!T_9U-@G"7-S1*GC'XHVMO9)#X=NQ+=,P
M+3! 55?3D=34_P .O%?B+Q+>3?;EA:RB7YI1'M);L!CBJ]G\&-.BF#76J3SH
M#DHL03/XY->A:9I=GI%DEI8P+%"G0#O[FIJ2HQARP5WW"*FY7D>*_%VVFC\7
M+.X/E2PKY9[<#!_6MOX;>-M%TGP^^G:C.+:2.1G#,.'! ]._%>B>(/#FG^)+
M'[+?QDXY21>&0^QK@_\ A2MGYV[^V9O+S]SR!G\]U:1K4ITE">EB7"<9\T3E
M?B/XPM_$U[!#8JWV6VSAV_C)[X]*Z+X*L/\ B:)GYOE./:NAN?A9HSZ"=-M7
M:"4N&-TR[W..W;BI?"'P_P#^$2U*2ZBU5[A)$V/$8=N?0YW&B5:DZ+A$%"?/
MS,P_C3&QTS2Y /E660$_4+C^1KG?A;XDTS09]074K@0+*@*,0<$CM7L.N:'9
M>(=,>POD+1L<@KU4^HKSX_!6T,NX:S,(\_=\@9_/=2I5:;I>SGH.<)<_-$T/
MB%9)XK\%P:IIN91 ?.3"\LIZUY]\//%D7A;5YA>!OL=RH60J,E2,X/ZFO<]%
MT>'1=&@TV)VEBB7:"XY-<KKGPKT75KEKBW>2QE<Y;RQN4GZ4J=:"BZ<M@E"5
MU);E;Q3\3],MM'<:'>":^DP$8)D1^I.16?X"\:>)_$>M+;7'D2VB#,TABVD#
MVQCFGV_P6LDD!GU>:5.ZK"%/YY-=_HNA:?H%F+73X!&G5CU9CZDTIRH1ARP5
MV-*HY7EH<=\6M"EU+0H+^W3=)9,2X Y*-C/Y8_6N"^'7C"'POJ,T5Z&^Q7(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^*KP.BCZG2#ZQ,]\_P"%V^'?^?/4/^^$_P#BJ/\ A=OAW_GSU#_OA/\ XJO
MZ*/J=(/K$SWS_A=OAW_GSU#_ +X3_P"*H_X7;X=_Y\]0_P"^$_\ BJ\#HH^I
MT@^L3/?/^%V^'?\ GSU#_OA/_BJ/^%V^'?\ GSU#_OA/_BJ\#HH^IT@^L3/?
M/^%V^'?^?/4/^^$_^*H_X7;X=_Y\]0_[X3_XJO Z*/J=(/K$SWS_ (7;X=_Y
M\]0_[X3_ .*H_P"%V^'?^?/4/^^$_P#BJ\#HH^IT@^L3/?/^%V^'?^?/4/\
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MAW_GSU#_ +X3_P"*H_X7;X=_Y\]0_P"^$_\ BJ\#HH^IT@^L3/?/^%V^'?\
MGSU#_OA/_BJ/^%V^'?\ GSU#_OA/_BJ\#HH^IT@^L3/?/^%V^'?^?/4/^^$_
M^*H_X7;X=_Y\]0_[X3_XJO Z*/J=(/K$SZ(TGXMZ'K&JV^GP6M\LL[[%+HN
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M2#ZQ,]\_X7;X=_Y\]0_[X3_XJC_A=OAW_GSU#_OA/_BJ\#HH^IT@^L3/?/\
MA=OAW_GSU#_OA/\ XJC_ (7;X=_Y\]0_[X3_ .*KP.BCZG2#ZQ,]\_X7;X=_
MY\]0_P"^$_\ BJ/^%V^'?^?/4/\ OA/_ (JO Z*/J=(/K$SWS_A=OAW_ )\]
M0_[X3_XJC_A=OAW_ )\]0_[X3_XJO Z*/J=(/K$SWS_A=OAW_GSU#_OA/_BJ
M/^%V^'?^?/4/^^$_^*KP.BCZG2#ZQ,]\_P"%V^'?^?/4/^^$_P#BJ/\ A=OA
MW_GSU#_OA/\ XJO Z*/J=(/K$SWS_A=OAW_GSU#_ +X3_P"*H_X7;X=_Y\]0
M_P"^$_\ BJ\#HH^IT@^L3/?/^%V^'?\ GSU#_OA/_BJ/^%V^'?\ GSU#_OA/
M_BJ\#HH^IT@^L3/?/^%V^'?^?/4/^^$_^*H_X7;X=_Y\]0_[X3_XJO Z*/J=
M(/K$SWS_ (7;X=_Y\]0_[X3_ .*H_P"%V^'?^?/4/^^$_P#BJ\#HH^IT@^L3
M/?/^%V^'?^?/4/\ OA/_ (JC_A=OAW_GSU#_ +X3_P"*KP.BCZG2#ZQ,]\_X
M7;X=_P"?/4/^^$_^*H_X7;X=_P"?/4/^^$_^*KP.BCZG2#ZQ,]\_X7;X=_Y\
M]0_[X3_XJC_A=OAW_GSU#_OA/_BJ\#HH^IT@^L3/?/\ A=OAW_GSU#_OA/\
MXJC_ (7;X=_Y\]0_[X3_ .*KP.BCZG2#ZQ,]\_X7;X=_Y\]0_P"^$_\ BJ/^
M%V^'?^?/4/\ OA/_ (JO Z*/J=(/K$SWS_A=OAW_ )\]0_[X3_XJC_A=OAW_
M )\]0_[X3_XJO Z*/J=(/K$SWS_A=OAW_GSU#_OA/_BJ/^%V^'?^?/4/^^$_
M^*KP.BCZG2#ZQ,]\_P"%V^'?^?/4/^^$_P#BJ/\ A=OAW_GSU#_OA/\ XJO
MZ*/J=(/K$SWS_A=OAW_GSU#_ +X3_P"*H_X7;X=_Y\]0_P"^$_\ BJ\#HH^I
MT@^L3/?/^%V^'?\ GSU#_OA/_BJ/^%V^'?\ GSU#_OA/_BJ\#HH^IT@^L3/?
M/^%V^'?^?/4/^^$_^*H_X7;X=_Y\]0_[X3_XJO Z*/J=(/K$SWS_ (7;X=_Y
M\]0_[X3_ .*H_P"%V^'?^?/4/^^$_P#BJ\#HH^IT@^L3/?/^%V^'?^?/4/\
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MAW_GSU#_ +X3_P"*H_X7;X=_Y\]0_P"^$_\ BJ\#HH^IT@^L3/?/^%V^'?\
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M#O\ SYZA_P!\)_\ %5X'11]3I!]8F>^?\+M\._\ /GJ'_?"?_%4?\+M\._\
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M_P#%4?\ "[?#O_/GJ'_?"?\ Q5>!T4?4Z0?6)GOG_"[?#O\ SYZA_P!\)_\
M%4?\+M\._P#/GJ'_ 'PG_P 57@=%'U.D'UB9[Y_PNWP[_P ^>H?]\)_\51_P
MNWP[_P ^>H?]\)_\57@=%'U.D'UB9[Y_PNWP[_SYZA_WPG_Q5'_"[?#O_/GJ
M'_?"?_%5X'11]3I!]8F>^?\ "[?#O_/GJ'_?"?\ Q5'_  NWP[_SYZA_WPG_
M ,57@=%'U.D'UB9[Y_PNWP[_ ,^>H?\ ?"?_ !5'_"[?#O\ SYZA_P!\)_\
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M?_%4?\+M\._\^>H?]\)_\57@=%'U.D'UB9[Y_P +M\._\^>H?]\)_P#%4?\
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M1110 45VGA7X;:GXLTIM0L[RTAC$ACVS%LY'T!]:W/\ A1VN_P#03T[\W_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KTKXC_\ (I>%
M?^O>O-:]*^(__(I>%?\ KWK&I\<?ZZ&D/AD>:T445L9A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%;OA3PM=^+=5?
M3[.>&&1(C*6FSC ('8'UJIKVBS^']9GTRXDCDEA.&:/.T_G4\ZYN7J/E=KF;
M13X8S-/'$I +L%!/O75>*O &H>$]-MKV\NK6:.X<(JPEL@XSSD"ASBFD^H*+
M:NCDJ*Z"?P;K%KX9;7[J$06>5V!S\S[C@$#_ !KGZ:DGL#36X4444Q!1110
M445T%IX-UBZ\.W&O>2(M/A0N))#@OC^Z.M)R4=QI-['/T444Q!1110 4444
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5[?8?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Z1\%/^1TG_ .O)_P#T)*Q?B9_R/VI?[];7P4_Y'2?_ *\G_P#0DJ?Q
MWX%\2ZKXPOKRQTJ2:WD;*.'0 _F:Y.91Q#N^AT6;HJW<\VM466\@C;[K2*I^
MA->I^/?!_AWPYI^C7<4$ZQ2W2+<YF9\QXRV 3UQZ5Q-SX0U_09K2YU/3I+:%
MIT4.SJ><^Q->F_&C_D4])_Z[C_T TZD[U(*+T8H1M"5T=+XA;PP/ $)U))SH
MNV/8J;M_4;>ASUKS7PEX#TC5K>_\0:E,\.A12OY"[B"R GDGK[5UOBJVGU#X
M-V<=G$]P[)"0L2[B1N'I5CP!+Y?PM-NNGI?W-J\R2V,A W-O)VG(/8]Q7+%N
M%-N+ZV-Y)2FKKH<]'X)\%^+=,O#X5GFBO+89VR.QW'G&0W8^M8WPS\'Z7XBO
MM2M]8MWD-L,*%D9,'.#TKLM-\8:A"D\^G?#9[<(=LC1R+$3_ .0P35/X3WO]
MH^)?$-YY'D><=QBSG9ST[5HYU%"6OXZD*,'*)S?BK2O FBVUQI5I]HEUJ-A'
MYF]MB-GG/..*U%\+?#[0=)L7UJZDO;BZ_BMY&//&>%/09KA=9M5O_B'?VKOL
M6;49$+>@+FO5?$>F'P;!IMKX6\+VMY-,2K7,\)E*L,?D3SSTJYWBHQYG=DQL
MVW9:'*?$7P%I>@Z1:ZOH[2"WE<*T;L3P1P1GFO28F\,_\*T+!)_[ \@Y7YM^
MW//?-8GQ9$__  KRU-PH$PEC,@4< U'8127GP(:*V1II&MF4(@R2<],5BVYT
MXN3ZFB2C-I+H<]X$\)^%O%>MZ_BVFDT^W,)M 9&5@&#9SSD\CO7*^$=#L-6^
M($>DWD;/9M+*I0.0<*&QR.>PKNO@A#):7NOVUQ&T4X6#,;C!'W^WXBL[P)X8
MUB#XG/=W%C+#;VTLK/(ZX!W!@,'OU%;.;C*:OLM/N,U&ZB[=3/\ $_A/2-,^
M(^GZ-:P.ME,8]Z&1B3GKSUKJ?$7@KX?^%94N=4%RD,Z[(K=)78EAG<W7/=1^
M%4/&_P#R632?K%1\=/\ C[T?_<D_F*E.4G"-WJBFHQ4G;9F?X5\":/J\%]XA
MU%I+;0XF8PQ%R"5'<GKBM"/P5X+\6Z9=-X5GFBO(%SMD9CGZ@GH:Z7P%>QS?
M"U1;V2:C);JRO:.0/,(YQR"/TJIIWB_4($FN-/\ ALUN%^61HY$C)Q_VS!-1
M*=1R=GMYH:C"ROU/"IHG@FDAD7;)&Q5@>Q'!IE7-5N3>:Q?731&$S7$DAB)R
M4RQ./PSBJ=>BMCC84444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KZN\(_P#(G:-_UYQ?^@BOE&OJ[PC_ ,B=HW_7G%_Z
M"*X<=\*.K"_$S9HHHKS#M"OGCXQ_\CT?^O5/YM7T/7SQ\8_^1Z/_ %ZI_-JZ
M\%_$.?$_ >?T445ZQP!1110 4444 %%%% !1110 4444 %=%=^--7O?"\7AZ
M8P?8(@@4"/#?+TYKG:*EQ3W&FUL7-+U6\T;4([ZPF,4\?1A_*NKN_BOXJO(E
MC:ZAB"L&S%'M+8/0\]*XBBE*G&3NT-3DE9,Z+6O&NK:_?V=[?"W-Q:?ZMDCQ
MWSSSS2>)O&>K>+!;C4S ?L^[9Y4>WKC.?RKGJ*%3BK66P.<GU/3OA=HVH75K
M=7VB:XEKJ$;;7M9$W(ZXX+=^M=]X=M_'4WB%+KQ));PV-NK@)"RXD)& < GI
M[U\]6E[=6$XGL[B6"4<!XG*G\Q6A<^*?$%Y T%SK5_-$PPR27#$'\,UA4H2G
M)NZU\C6%512-+Q[JL=[X_P!1O[&<E5E54E0]T4+D'ZBM&W^+GBNWMUA%Q;R;
M1C?)%EOSS7"T5M[*#BHM7L9^TE=M/<U-;\0ZGXAO/M6I7+2R#[HZ!?H*Z"V^
M*7B>UTM=/6X@>)8_+#/%EMN,=<UQ=%-TX-6:$IR3NF.=S([.W5CDTVBBK)"B
MBB@ HHHH **** "BBB@ HHHH Z'P-_R.^D_]=_Z&KGQ+_P"1_P!3_P!\?RJG
MX&_Y'?2?^N_]#5SXE_\ (_ZG_OC^58?\OOE^II_R[^9R5%%%;F84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\UKTKXC_ /(I>%?^O>L:GQQ_KH:0^&1YK1116QF%%%% !1110 4444 %%%%
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MC_A%]"_Z!5K_ -^Q1]>CV#ZJ^Y\GT5]8?\(OH7_0*M?^_8H_X1?0O^@5:_\
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MH_X1?0O^@5:_]^Q1]>CV#ZJ^Y\GT5]8?\(OH7_0*M?\ OV*/^$7T+_H%6O\
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MBC_A%]"_Z!5K_P!^Q1]>CV#ZJ^Y\GT5]8?\ "+Z%_P! JU_[]BC_ (1?0O\
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MKZP_X1?0O^@5:_\ ?L4?\(OH7_0*M?\ OV*/KT>P?57W/D^BOK#_ (1?0O\
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M1_PB^A?] JU_[]BCZ]'L'U5]SY/HKZP_X1?0O^@5:_\ ?L4?\(OH7_0*M?\
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M_?L4?\(OH7_0*M?^_8H^O1[!]5?<^3Z*^L/^$7T+_H%6O_?L4?\ "+Z%_P!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/3CK714 %%%% !116=/KFGV^M6NCR3@7UT&:*(#DA023^0H T:*** "BBB@
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MK2A)I%;'D@_Q$=Q6Q'(DT22QL'C=0RL.A!Z&F(?1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %;UO_Q[Q_[HK!K>M_\ CWC_
M -T5G4*@24445D:!61J/_'U_P$5KUD:C_P ?7_ 15PW)EL5****V,PHHHH *
M*** "BBB@ HHHH **** *>J_\@>^_P"O>3_T$UY'\,/'GAGP]X3^PZKJBVUR
M)Y&*&*1N"QQRJD5ZYJO_ "![[_KWD_\ 037F_P (=%TR^\%^==V,$TGVB0;G
M0$_>-2[WT&MBUXG^)O@[4/#&HVEKK223RP,J)Y$HR?Q6F^%O^2#7'_8,N?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG4*@24445D:!61J/_'U_P$5KUD:C_P ?7_ 15PW)EL5****V,PHHHH ****
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MX'Q!\.)KSQ#)KV@:U-I&H3+MF*+N1_J,CV_*N^HI-7"YQGA'P GAW49]6O\
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M&V'A&SE2W>2XN[AM]Q=3'+RM[GTKI***>P'F^N?#?6+[QE<>(M)\1KITLRA
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M=%%@.5\7^"+;Q2UK=QW4MCJEH<V]W"<,OL?4?Y]:Q[/X<7MWK%KJ'BGQ!+K
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MQ=C%YJ,K7DV>V[H/R /XUT.MZ!9Z_%;PWQE,,,HE\I&PLA'0-QR*TP H
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M/L-Q_<_6KGF/_>/YT>8_]X_G1S,+(I_8;C^Y^M'V&X_N?K5SS'_O'\Z/,?\
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M;C^Y^M'V&X_N?K5SS'_O'\Z/,?\ O'\Z.9A9%/[#<?W/UH^PW']S]:N>8_\
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M\0]$\5W,EE;&>UOXAE[2ZCV2#\._X4W7/B+HOAWQ"^D:EYT3K:?:O.V@H1G
M4#.2Q],47 ZZBO.K;XR:$^I06E]8:IIJ7#!8;B\M]D;YZ8[X]\5Z("&4$'((
MR#0 .ZHC.QPJC)/H*HZ3K6G:[:O=:9=)<PI(T3.H( <=1S]:L7O_ !X7'_7)
MOY&O%/AUX]TOPQX8N[&2&[O=0DU*XD6TLHC))M^7YB.PHN![E17)>$_B'H_B
MZXFM+5+FUOH1F2UNH]D@'\JF\5^/-%\(&**_DDENYAF*UMUWR-^';\:+@=/1
M7!:/\6=#U+58=-O+74-(NISB%-0A\O?]#R/SKJM=U_3?#>E2:EJERL-M'WZE
MCV  ZFBX&A+*D$+RR-MC12S,>P'6JFDZQI^NZ>E_IERMS:N2%D4$ D=>M<!)
M\7=$U&PN89K'4["&X@=8+J[M]L4I*G&&]_>K'P7=8OAA:R.P5%>1F8G  '>B
MX6/1:*\YN/C+H27DL5GI^JZA!"V);JUMMT2>I)ZXK8\/?$71?%&OSZ5I?G2^
M5"DWVC $;!@#@<YR,X((ZT7"QMV'B#2M4U"\L+*]2:ZLR!<1J#F,GIG(]JTZ
M\F^&Q ^)GCDDX EBR?\ OJNMTOQ_I^M^*)]$TJTN[P6_^NO8POD(?3<3D_@#
M1<#:L?$&E:EJEYIMG>)+>61Q<1 ',?..<CVK2KBO#&J>';OQQXCM-,TJ2VU2
MW8"]N6 Q,=QZ<GOGL*KS_%K0+:2\@>&\-W;7+6R6T<8>29AU*A2>/<XHN%CO
M:*XKPU\3M&\1ZQ_9!M[W3M1()6VOHMC,!SQUKM: ,W5?$&E:'):1ZE>);M=R
M>5 &!.]N.!@>XK2KR?XS_P#(2\&?]A,?^A1UZQ0 45@>+?%=MX/TE=2O+6XG
MMS(L;& *2F>A.2.*VK:YBN[2&ZA;=%-&LB-ZJ1D?I0!+17'VGQ$TV]T_7K^"
MTNVM=&W>;)A<2D DA.>>G?%94OQDT/[)#/9Z?JE^SQ+++':0;S ",X<YP".^
M#1=!8]%HK@_^%M^&9-%@O[1[F[FG8JEE!$6GW#&05[=1STJ]X3^(FD>+;R>Q
MMXKJSOX%W/:W<>Q\>OI1<+'745P^K_%/0=#UR_TF^2Y2>T16R%#>:6Z*@!R3
M^%1Z-\6-$U35X]+NK34-*NI?]2M_#Y?F?0\_K1=!8ZO4-=TS2KRSM+Z\2&XO
M7\NW1@<R-Z# ]ZT:\H^+%W!8^+O!=W=2K%!#>,\CL>%4;235Z7XTZ##*KR:;
MJZZ>[;5OVM2(3[@]?THN%CTFBJL>I6<NEIJ27,9LGB$PFSA=A&<_E7 S?&?0
MQ-*+'3-7U"UA)$EW:VVZ)<=222.*+@>D45C^'?$^E>*=,%_I5R)H@<,I&&0^
MA!Y%<L?B_H(%W&MK?R7EO=R6HM(H@\LI3&64*3\O/4XHN!Z#17 Z9\7O#-];
M7KW+7.G3V@!DM;N+;*<D 849R<D<#UI-+^+>B7^M0:7<V6I:;+<-M@>]@V+(
M3TQSW]Z+H+'?T5B^)?%.D^$]/%YJMQY:.=L:*I9I&] !7'-\:M'@=&OM$URR
MM7.%NI[7$9_7/Z47"QZ714%G>6]_9PW=K*LL$RAXW4Y# U/0(**** "BBB@
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M#^E>R> ?%L7B_P -0WF0MW%^[NHNZ./;WI)A8UK;Q!I5WK%QI$%XCW]L-TT
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M/XLN;)K[56,@EOY54!2> -QI7"QZCI>L:=K=H+K3+R*Z@/&^,YQ]?2KU>?\
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M!'!'%4;!G^%'Q":PE8CPWJ[[H6/2%SVKHO!'A_5=+\?^*M0O;-X;2\<&WD+
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MI1@^E !11@^E&#Z4 %%&#Z48/I0 448/I1@^E !11@^E&#Z4 %%&#Z48/I0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 36O_'S']:=>_P#'V_UIMK_Q\Q_6G7O_ !]O]:G[
M0^A7HHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5V\_X]X/I5*KMY_P >
M\'TJ7NAK8I44450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<TU^D321'!*E'X_,"HKGXL^#+HQ"[M+U]K@QF:RR%;L1D\&J7QNF\WP?HL\
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MIK#:E>S730WA2,R'.U<#@5Z37D_P/_X\M>_Z_C_(5ZQ3CL)[A1115""BBB@
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M22)AAD<9!H:"YQ?B+XD>&[7P[/-:ZC#=W$T16""$DL[$< CM^-<A%HEUH7P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[_RI]!'FGPE\;:/:>#8-+U.\2SGMBY0S_*LB%B<J>AQDC\*DTJ9?&OQA37+
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M450@HHHH **** "BBB@ HHHH **** "BBB@ K>M_^/>/_=%8-;UO_P >\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J:;_5I]*AJ:;_5I]*'N,AHHHH$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZTLW^M:CJ/H1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **S?$&L0Z!X?OM5GQLM86DP3]X@<
M#\3@5R7PZ^(=QXQEO+74;&.RO(565(T).Z-AP>:!G?T444""BBB@ HHK$@\4
M6%SXJN/#T6]KRWB$LORX4 ].>] S;HHHH$%%%<YXY\23>%/"MSJ]O!'/)"0!
M'(2 <_2@9T=%<3\-?';^.M(NKBXMH[:[MI0CQ1DD;2,J>?7!_*NIU;4H='TB
M[U&X($5M$TK9] ,T 7:*\W^&'Q)OO'EWJ,%YI\%H+2.-U,3,=VXGKGZ5Z10
M4444""BBN2U7Q=<:?\0='\-I:Q/#?QN[S$G<NT=ATH&=;1110(**YOQIK.MZ
M'I,=SH.CMJMTTH5H0&.%]>*Z-22H)&#B@8M%5-5NVT_2+V]10[6\#RA3T)52
M<?I61X'\1S>*_"MKJ\\$<$DV<QQDD#'UH Z*BHYY#%;R2 9**6Q]!7*?#OQA
M<>--$O+^YM8K=X+U[8+&Q((55.>>_P U '7T444""BBB@ HHK(\4:O)H/AF_
MU6*)99+:+>J.<!N1UH&:]%8G@_7)?$GA+3M8FA2&2ZCWM&A)"\D<9^E;= !1
M110(**** "BBN<\4:SK>DSZ:FD:.VH)<3A+A@&/DI_>XH&='1110(**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *FF_P!6GTJ&IIO]6GTH>XR&BBB@04444 %%%% !1110 444
M4 %%%% !117&>&_&ESKGC;7]!EM(HXM,*A)58EGSGK^5 SLZ**X[P1XRN?%5
M]K5O/:10#3[GR4,;$[QZG- '8T444""BBB@ HHHH **** "BBB@ HK$O/%.G
MV?BBQ\//O-]>(TB +P% /)/X5MT#"BBN<\<^(YO"?A*[UBW@CGD@*XCD) .2
M!V^M '1T54TR[:_TNUNW4*TT2N5'09%6Z!!1110 445S5AK6N7'C?4=*N-&:
M'2((U:WO\-B9B%)'IU)'X4#.EHHHH$%%%% !1110 45G:[K=EX=T6YU6_DV6
M]NNYO4GH /<G KSZ'X@^-=1L_P"U=-\&A]+(W(9)")77U [T7&>I45SG@[QA
M8^,M':]M%>*2)S'/!)]Z-QV-<U>_$75]1UR[TSP?H2ZG]C.VXN)G*1AO0'UH
MN%CTBBN-\'>._P#A(;VZTG4K!]-UFUYEMG/!'JM=5?7]KIMI)=7EQ'!!&,L[
MM@ 4 6**X7P7\18O&GB/5K*SMU%C9J#%/D[I.<$X]*W?%OBFR\(:%+JEZ&<*
M0L<2?>D8] *+@;M%>5R_$7QC86*ZQJ'@[R](P&9DD)E1#W([5Z+HNKVFO:/;
M:G8OOM[A-RGT]1^!HN%B_1110(**X[Q?\0K+PS=PZ;!;2ZCJ\_\ J[. 9;'J
M?2L1_&7Q!MHC=W'@J-K0<E892TH'^[1<=CTRBN<\(^--+\96#7%@S)+$=LUO
M)P\9]#71T %%%8DGBBPC\6P^&OG-]+ T_"_*JCWH VZ**1F55+,0 .I)H$+1
M7GL_Q2L9O'UAX9TI8KM99-EQ<!N$/HN.IKO;JYAL[26YN'"0Q(7=CV ZT#):
M*\NC^(_BC6Q->^&O"HN]*B8CSIG*M)CKL ZUUO@WQA9^,=*:Z@C:"XA;R[BW
M?[T;>AHN%CI**\ZU/XC:C=>(;K1/".BC5;BS.VYFD<K$C>F?7K^57/"_C^;4
M]??P]KNF-I>L!"Z1DY24#KM/Y_E1<+'<T5G:YK-KH&C7.IWC8A@0L1W)[ >]
M1>&]0OM5T"UU#4;9+6:X3S!"I)VJ>5SGOC&: -:BO/OB%\4K#P9;B"U\J]U1
MR,6^[A!W+8Z5WL,GF6\<A&-R!C[9% $E%><7_P 1M5O]=N]*\'Z(NJ-9-LN)
MY7*QANX!'>M3P=X[_P"$AU"ZT?4K%M-UJT&Z2V<\,OJOMT_.BX6.SHKF=2\4
M2Z/XPL=*OH(TL+]=MO<@G/F_W&[<]JZ:@ HHHH$%%%% !1110 44R66.")I9
M75(U&69C@ 5P6D_$^TU_XA#P[I<<<]FL;E[K)Y91G"^HH&>@45A^*=0UO3=*
M$V@Z9'J%V7 ,4C%1M[GBN)D\9?$J&)Y9/!MDD: LS-.P  [T7"QZE17!?#;Q
MQJWC6&]N+_2X;.W@;8DD3$AV[]?2J,WQ)UC6-5N[/P=H U**T<I+=3.4C)'H
M11<+'I=%<+X5^(+ZKKLOA[6],?2]:C3>(B<I(/\ 9-3^,?'?_"/7]KI&FV#Z
MEK-W_JK9.BCU;VHN%CLZ*\XLOB+J^G:Y:Z9XPT)=,^V';!<1.6C+>A)KT>@
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M];'@_P (QB?5Y%_TB?/RVRGW]<&MWP3X'M/"-G([2&[U2Y.ZZO''S.?0>@H
MUKGP[I5[J-EJ5Y:)->V0'D2L3\GT&<5Y5\2OB#;:S:7'A2RLYX6GG-M+>WB&
M.)=K8)4]QQUKT?5O&FFZ+XFT_0[U)HYK_P#U4Q $?I@DGUJO\0;72&\$ZFVI
MQP+"(B59@ 0_;'OFA@:_ARQ33?#>G64<RS+# JB13D-QU'M6I7#?"$W3?#73
M#=[\_-Y>_KLSQ_6NYIH HHHH$%%%% !1110 4444 %%%% #XO]8OUI9O]:U)
M%_K%^M+-_K6HZCZ$=%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***0D $DX ZF@#RSXP74NJS:)X-M&
M/FZI=*9]O\,2D9/\C^%4_%L">!/B'X>\06Z^787"+976.F , _EBLFRTO5OB
M+\1]8UW2]8?3$TUOL]O<+'O)X((&>/[U:7BWX:>+-1\/W'VSQA-J0@4S1V[V
MX&YAR.1TI%'JFM:O;:)HEUJMRW[BWC,AP>OH/Q.*\VTJZ^)?C.S_ +:L=4L]
M%L9,FVM_LRR&1>VXL"15%]:E\7_L]731YDO+2(07"CKE"/\ V7::]!^'UW;W
MO@/2);:1700!3CL1U%&XMC"T#Q5XCN/#^N0:W9_9=5TQ'"W"1_NY<=&&>*UO
MAGK-_P"(/A]I>IZG/Y]Y/YOF2;%7=B1E'"@#H!5:]\8:?KT'B71K*.9YM/MW
M667:/+)Z8!SS5;X+3QR_"W2D1PS1-,C@'[I\UCC\B*!BZ;XAU>Z^+NLZ"]WG
M3X--\Z&+RU^23>HSG&3U/!->?Z7I'C%_BWJUO!XEBCU)($::Z-HA$B9X7;C
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M :/&Y0<=:3&C5_X79X;_ .@?K?\ X!?_ &59'P3O([V[\4WD:N(Y;S>H<88
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ME:@EK6-L+*<]ZY;7637/COH=M;GS/[+@:2=EY"'[P!KU>@#R#X965MIWQ/\
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M!%MEQ@>HS_6N%\*XL/C?XHL81B&YB69E'3<>2:[/P'JEOJW@C2[J"1640*C
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M5KPKC4/CKXHN9>6LX/)CSVY7^A-=_P"&O#6G>%='CT[3H@J+R\A'S2-W8FN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"IIO]6GTJ&IIO]6GTH>XR&BBB@04444 %%%% !1110 4444 %%%% !7,Z)X+
MM=$\4ZOKL5U-)-J94R1N!M3&>GYUTU% PKF?#'@NT\,7.JS0W,L_]HS&619
M %SV&*Z:B@#SB7X/Z?%J$]SI&M:GI,<[EY(+63"DFIX/A'HEGJNE:E9W%S#=
M6$IE>0D.UP3C.\GZ?J:] HHL@N<WXK\$Z1XOAC%_&R7$/^IN(CM=/H:YR+X0
M6$MU#+K&MZIJT,+92"ZD^0?E7H]%%@N<YXJ\'V?BG0[?2I)I+6""9)4\E1QM
M! '/;FMBZL4NM*EL&=E22(Q%AU QC-6Z* ,3PEX;@\(^&[;1;:>2>*W+D22
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2*5MZOCT; HYD.S.WHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU+5DA1110 4444 %%%% !1110 4444 %%%% $UK_ ,?,?UIU[_Q]O]:;:_\
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MX372?$=[J$5].DG^DC.Q8T]$'TJ=1Z'J=%%%:$A1110 4444 %%%% !1110
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M!P#G/%2^ H$/Q,\93E1YBR(@..QY/\A6KX1\':G8ZY=^(O$-^+K5+E=@2/\
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M6U(5<< #I5#X6P1P?#G1S&H!DB+M@=3D_P"%:?B;R=2\.:G807,/G/"5^9N
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M7_O'\Z9118!_FO\ WC^='FO_ 'C^=,HHL _S7_O'\Z/-?^\?SIE%%@'^:_\
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M%%@'^:_]X_G1YK_WC^=,HHL _P U_P"\?SH\U_[Q_.F446 ?YK_WC^='FO\
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M#%?J!TJ>@ HJM!J%E=2&.WO+>60=5CE5B/P!JS0 457:_LTN1;-=P+.>D1D
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MP!^- #Z*@M[VUNP3;7,,V.OER!L?E4] !14;SPQ2)')+&CR'"*S %C[#O4E
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MDB_UB_6EF_UK4=1]".BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D/QOMH
M[R?PK:S#,4VHK&X]5)P:V_\ A2W@MHN+*9&(X99CD5A_'*&2XD\+PPRM#+)J
M"HDJ]4)X!'TZU<?X<^,9("O_  L#43N7&&8XI=2BO\,7N]&\<>(_"BWLM[IM
MD5>%Y&W&//;/Z?4&NZO_ !SX:TR>^@O=5B@EL0IN%=&^7=TQQ\Q]AFO/?AO+
M/X,\8WG@S5[:%KRX!N([].MQGGG_ #V-&F:'::Q\?M=>^A6:*TMA*B.,C?\
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M+!6";!C.T<T >K1R++$DB'*.H93Z@U7U'4['2;-[O4+J*VMTZR2L%%60 H
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MKBVN+1=S(6Z@CZ ?E[U[)118+GF>G>*O%?B_Q59?V183Z5H,)W74MW"-\P]
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M):*B_M)_^>:4?VD__/-*+,+HEHJ+^TG_ .>:4?VD_P#SS2BS"Z):*B_M)_\
MGFE']I/_ ,\THLPNB6BHO[2?_GFE']I/_P \THLPNB6BHO[2?_GFE']I/_SS
M2BS"Z):*B_M)_P#GFE']I/\ \\THLPNB6BHO[2?_ )YI1_:3_P#/-*+,+HEH
MJ+^TG_YYI1_:3_\ /-*+,+HEHJ+^TG_YYI1_:3_\\THLPNB6BHO[2?\ YYI1
M_:3_ //-*+,+HEHJ+^TG_P">:4?VD_\ SS2BS"Z):*B_M)_^>:4?VD__ #S2
MBS"Z+$?^L7ZTLW^M:HH;]Y)E0QH,GJ*6XOFBF9 BG'<TK.X[JP45%_:3_P#/
M-*/[2?\ YYI3LQ71+147]I/_ ,\TH_M)_P#GFE%F%T2T5%_:3_\ /-*/[2?_
M )YI19A=$M%1?VD__/-*/[2?_GFE%F%T2T5%_:3_ //-*/[2?_GFE%F%T2T5
M%_:3_P#/-*/[2?\ YYI19A=$M%1?VD__ #S2C^TG_P">:46871+147]I/_SS
M2C^TG_YYI19A=$M%1?VD_P#SS2C^TG_YYI19A=$M%1?VD_\ SS2C^TG_ .>:
M46871+147]I/_P \TH_M)_\ GFE%F%T2T5%_:3_\\TH_M)_^>:46871+147]
MI/\ \\TH_M)_^>:46871+147]I/_ ,\TH_M)_P#GFE%F%T2T5%_:3_\ /-*/
M[2?_ )YI19A=$M%1?VD__/-*/[2?_GFE%F%T2T5%_:3_ //-*/[2?_GFE%F%
MT2T5%_:3_P#/-*/[2?\ YYI19A=$M%1?VD__ #S2C^TG_P">:46871+147]I
M/_SS2C^TG_YYI19A=$M%1?VD_P#SS2C^TG_YYI19A=$M%1?VD_\ SS2C^TG_
M .>:46871+147]I/_P \TH_M)_\ GFE%F%T2T5%_:3_\\TH_M)_^>:46871+
M147]I/\ \\TH_M)_^>:46871+147]I/_ ,\TH_M)_P#GFE%F%T2T5%_:3_\
M/-*/[2?_ )YI19A=$M%1?VD__/-*/[2?_GFE%F%T2T5%_:3_ //-*/[2?_GF
ME%F%T2T5%_:3_P#/-*/[2?\ YYI19A=$M%1?VD__ #S2C^TG_P">:46871+1
M47]I/_SS2C^TG_YYI19A=$M%1?VD_P#SS2C^TG_YYI19A=$M%1?VD_\ SS2C
M^TG_ .>:46871+147]I/_P \TH_M)_\ GFE%F%T2T5%_:3_\\TH_M)_^>:46
M871+147]I/\ \\TH_M)_^>:46871+147]I/_ ,\TH_M)_P#GFE%F%T2T5%_:
M3_\ /-*/[2?_ )YI19A=$M%1?VD__/-*/[2?_GFE%F%T2T5%_:3_ //-*/[2
M?_GFE%F%T2T5%_:3_P#/-*/[2?\ YYI19A=$M%1?VD__ #S2C^TG_P">:468
M71+147]I/_SS2C^TG_YYI19A=$M%1?VD_P#SS2C^TG_YYI19A=$M%1?VD_\
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MYI1_:3_\\THLPNB6BHO[2?\ YYI1_:3_ //-*+,+HEHJ+^TG_P">:4?VD_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 36O_'S']:=>_P#'V_UIMK_Q\Q_6G7O_ !]O]:G[
M0^A7HHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5V\_X]X/I5*KMY_P >
M\'TJ7NAK8I44450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW=R$GC7I(,]#2;L".\HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %7;S_ (]X/I5*KMY_Q[P?2I>Z&MBE1115""BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BO$_BI
MXJ\2:-XYAMM'U">*W2R2X>!",-AVR?R KUW1-2CU?1+/4(F#)<1*X(^E).[L
M.Q?HKRKXO^+-5T<V>GZ)=R6]SY;7,[QXR(QQ_.NZ\(7=Q?\ A'2[JZE:6>6
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M=0J!)11161H%9&H_\?7_  $5KUD:C_Q]?\!%7#<F6Q4HHHK8S"BBB@ HHHH
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MK%(/FZ&8CYC^=1Y#\QWA6SA@^-OB2R51Y$=E'$%_V1'&,?E5SX=N^@>,-?\
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MSCSIE'S/CIFK]% ",JNA1U#*1@@C(-8,7@GPS#??;8]%M%N,Y\P)SFM^B@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@!\7^L7ZTLW^M:DB_UB_6EF_P!:U'4?0CHHHH$%%%% !1110 4444 %%%%
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M3PGXPB@-W.F^TO(%VK,.>".G8]*+A8T/&/CR\T/7;'0=&TK^TM5NU+K&S[5
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M5ZG!/=.7E:-%!8DD_P!:O6GPINK6]@N#XSUB412*YC;&&P<X/L:-1F1\5_\
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M_P!4R<-&?53VHU8'$ZCX#\06VFW$U_\ $NZ2S6,^:SV*;=N.?XJS7TNPTGX
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M-&C\0:!>Z3+*T4=U$T32*,E01U%4;+PA96O@E/"TTCW%H(/(9V&&8?A3$,\
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M:IJ87:MS=')4>P[5=TGP9;Z5XSU3Q(EW+)-J$>QX64!4Y!X/X4:B.6\$D?\
M"XO&XSR1%_,TSXFP/H/BWPWXR@!"Q3BSNR.Z-T)]AEOTK:U3X:P7GBM_$-AK
M%[IMU*5,ZP8*RX]<U7^*VLZ+_P (3J6G3W$4MY+MCAME8&0R9!&!1T&4/!!'
MBGXC:YXJ8;K6V L[)LY!'<C\,C\:]0KF/A]X?'AKP7I]@5Q,4\R;W=N373TT
M)A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/Q*\,>&.MNA^U7 'IGO^0_.O6  JA0, #  KF3X+MSX_'BUKN4SB#R!;E1L
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MJGYT>4O_ #U3\Z+A8BHJ7RE_YZI^='E+_P ]4_.BX6(J*E\I?^>J?G1Y2_\
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MT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44
M&31DT44 &31DT44 36I_TF/ZTZ]_X^W^M-M?^/F/ZTZ]_P"/M_K4_:'T*^31
MDT450@R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB
M@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:
M,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB
M@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:
M,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB
M@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:
M,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@ R:NWG_
M ![P?2J57;S_ (]X/I4O=#6Q2R:,FBBJ$&31DT44 &31DT44 &31DT44 &31
MDT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44
M &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31
MDT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44
M &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31
MDT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44
M &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31
MDT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44 &31DT44
M &36];_\>\?^Z*P:WK?_ (]X_P#=%9U"H$E%%%9&@5D:C_Q]?\!%:]9&H_\
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M[5IZ7J=KK&F6^H63[[>X0.C$8.#[4K@6Z*S]:UFR\/Z5-J6H2%+:$98JN3^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M SRQE'2('!D(4D+GMGI6%X'\1ZNOC_7G'ARX=KV[ N%\\?Z)D]^/FQ[8KI/
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M3&E_&/PSJD_RVLT?DESP P)_Q'YUZO26[!['!7?@.>T\=V/B#P\]O8P]+V
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MZ7P;XG7Q?X>CU9;0VH=V3RC)OQCWP*O:_:V]WX?OH+E5,#0-N!''2N/^"_\
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MJ12?$7Q'=Z)&4T)\!2@(C9^^T?7TIW@SP!I/B/P_#K_B -J%_J"^:S.<!!V
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M]'HI6'<Y#P1X'3PLES=W5RU[JUXVZXN6[^PJ/PIX;U'2/%_B34KM(Q;W\B-
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M'[-M\O\ M#?^\V?3UQWKU&BG8+F!X;\*VGASPLFB0'>A1A+(>KLWWC^M<O\
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M3IZXKU&BAH+F!X/\+V_A'P_%IL+^9)DR32D<R.>I_I^%;]%%,04444 %%%%
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MLG]XT>;)_>-',PLBC]CG_P">9H^QS_\ /,U>\V3^\:/-D_O&CF8611^QS_\
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M\:.9A9%'['/_ ,\S1]CG_P">9J]YLG]XT>;)_>-',PLBC]CG_P">9H^QS_\
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M-2RNP1"#U%)MW&DC,^QS_P#/,T?8Y_\ GF:O>;)_>-'FR?WC3YF*R*/V.?\
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MG]XT<S"R*/V.?_GF:/L<_P#SS-7O-D_O&CS9/[QHYF%D4?L<_P#SS-'V.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %33?ZM/I4-33?ZM/I0]QD-%%
M% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M< ?C20SPW";X)8Y4Z;D8,/TKS;XS7TTVB6/ANS;_ $G5I\,.XB0;V/X86F_
MI?+\!.F?NW4@S^-%]0MH>GT5R^J?$;PCHURUM?:Y;QS*<,JAI,'T.T&M;1O$
M&D^(;8W&DW\-W$OWC&>5^H/(H TJ*YZ]\<^&=.DO8[S5HH7LF"SJRME2>W3G
M\,TC^.O#,>AQ:TVJQ_V=*_EI.(W(+>F,9_2@#H6944LQ"J!DDG  JI_:VF_]
M!"T_[_+_ (US?Q'UB.R^&>JWT,F5FMPL1'&X.0/Y$UP_A[X:^ &T+3EU:Z@&
MIR0JTJ&]56+'_9SFBX'L4=W;31-+%<1/&O5U<$#\:A_M;3?^@A:?]_E_QK*T
M?P7HNB:#<Z/80NME<DF12^2<C!YKEKOX.> [*TFNKBUF2&%"[L9SP ,FC4#T
M&+4;*>01Q7EO(YZ*DJDG\,U89E12SL%4<DDX KP[X3>#K*^\47/BRTMY+73+
M=VCL(F;)?C!8GZ5U_P 0]1GU+5]*\&6,A2747WW;J>4@!Y_.E<+'H*NCH'1U
M9",A@<@BH5OK-Y?*2[@:3^X) 3^5<EXZTO7G\+VFB^%(_)5Y$AFD1@IBA'!Q
MDC_(KG->^%&@:-X2O-0M;F[MM4M+9IA??:#N9U&>?8D4P/5V954LQ 4<DD\"
MD21)4#QNKHW(93D&N0^'&JW7B?X>6-UJJ^9-*C12%A_K "5W'Z@9K)\#WLGA
M_P 6ZMX'NI"88#]JTUF/6%NJ?12<#\:+@>CT5DW'B;1[77[?0IKU4U.X7=%!
ML;+#!/7&.Q[U9U;5+71=+N-0O9!';P(69C_*@"RT\*3+"TJ+(PRJ%AD_05)7
M@&C7NL:S\8]"US55,46H1/)96Y/,4 W!<^YP3^->W:[JR:%HEWJ<D,DRV\9?
MRXQ\S>PH3"Q>DFBAV^;(B;C@;F R:?7SEXBUSQ7X@\1^'M2UBR.G:7->*+2T
M).[KG<P]?R^E?1M"8-",RHI9B H&22> *2.1)4#QNKHW(93D&O$/'_C'Q3XC
ML-8L=$TV6RT>R5A=WLIP90."J^Q]L_A7H?PP_P"2;Z'_ ->RT7"QUU%%<#\4
MKC7I-.T[1]"2X1M1NEAN+J%"?)C)P3D=.HY] : .U&H632^4MW;F3.-HD&?R
MS5FO,KOX,^'HM%D-M-=PZI'&66_\\[]X'4^U+\./$NN:_P#"R:X0?:=6M]\$
M3.<>81]TD^N#^E%P/19;ZT@D\N:Z@C<]%>0 _E4P(905((/0BO+/#_PEM=1T
MK[=XQ-U<ZW<%FD8SG]SSP%QQ[T[X5:A>0ZUXA\-R7DE[8Z;.5MKB1MQQG&,T
M7 ]2HHHH$%%%% !1110 4444 %7H_P#5K]*HU>C_ -6OTJ9%1'4445)054N/
M];^%6ZJ7'^M_"JCN)[$5%%%40%%%% !1110 4444 %%%% !1110 5Y#\%P8]
M7\5PS'_25O3N!Z_YS7KU>4^(-#USP;XVF\6^&[,WUG>C_3[)."3W8?SH8T>K
M56BU&RGNY;2&ZADN(?\ 61*X+)]1VKSF?XO&:W:'3?#.JRZDPPL,D)"AO=N]
M7/AKX0U#2[G4?$FO8.LZH<NH_P"629SM_0?E1<+&'\'_ /D:?%W_ %]'^=>O
MU\^^$O%A\%>*/$;7FCZC.MU<L4,,+$<'Z5U&H?%+5M<M)+#PSX8U WDR[!-.
MA58\\9Z4DQM#/A#M?Q?XUEA!\@W2@'.1G+__ %Z[[Q7XNTOPAI;7FH2C>1B*
M%>7E;T K&\$>&SX!\%W4MWF>^97N[HIR68 G:/7O^=>2:1XIBNO%UQXD\6:+
MJE]=(_\ H4*P-Y<"]L#'6C8-ST3P1X=U;7?$;>.O$J>5<2IML;0_\L8^Q_+^
M?O5?PB"OQY\7A^";=2N?3]W6OHGQ5L];UJUTV/1=3@>X?8))82%7C/)Q6;XO
MT_5O"OCZ#QMI-C)?6LL'V:_@B^\%SG</R'Y"@#6^,9 ^&6IYQR4 ^NX5T'@Q
M63P-H"N"'&G6X8'KGRUKS7Q#K.H_%0VOA_2-)O+336F62\NKE"FT*<X ->PV
M\$=K;16\0Q'$@11Z # IB):***!!1110 4444 %%%% !1110 4444 /B_P!8
MOUI9O]:U)%_K%^M+-_K6HZCZ$=%%% @HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\K^-G_'IX;_ .PFG\Q7
MJE>5_&]9O[+T.:*WFG\B_$C+$A8X&#VH>PT>HP_ZB/\ W1_*L?Q?HD?B+PKJ
M&F..9HCL/HPZ&N)C^-%BL:J?#VL< #_4'_"NR\*>*8?%>GRW<-E<VJQOL*7"
M%2?>BX''^ O& A^$]Q<7K;;K1%DMI@QY#+]W]"H_"JGA72)+/X.>(M4NE(O-
M6L[JZD)ZX,;;1_.N6\7:%?6?Q(N_#%D,6'B2:&Z=1T 4MO\ S()_*O9/$MHM
MO\/]8L[="0FESQQJHR3B)@!20SBOA#X2TI_ =M?7EG%<7-V"6>4!B$Z #T&*
MP_AKX3TV?QWXIBG@66STZ[*VMN_*(6)R<?0**[[X5Q20?#G28Y8WC<1\JZD$
M?A6)\-K>>'QKXW>6&1$DOLHS*0&&6Z>M'8#/O--M=%^/^@?V=$MNE[;3"=(Q
MA6Q&QZ?7'Y56U'PW:>)/V@+N*_3S+6"SBE>(]'^7@'VS6SK]O.WQV\*SK#(8
M4MYPT@4[5_=OU-<]KVIZGHWQWO;_ $ZQ:^6*RB-Q A^9H]O)'N* -SXL^%],
MM/";:YI]M':7^G.LD4L*[21GH<5@_$N1O$GA_P "&4E6OKJ)'(.#E@ 35WQ)
MXBU+XF6L7AW0]&O;>VEE!O+FY0H$4=0,U<^(VDO:3> [.TADDBM-3@4E$)P
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M\+O^1S\<_P#7^/YM7J->9?#.WGA\8>-GEAD19+X%"RD!AENGK7IM-"9X\O\
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MXE^"9(X)'CCEEWLJ$A?N]3VHZ!U.6\9>(=(G^,!B\3-+)I.FQ_N[=(RX:3W
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MG<=R0*[&S^+^E6T,-I;>&M5AA0!$1;<A5'0=J5QV(_B NSXJ^".,1!G ]/\
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M'_"2_$S7]1/S6FA:>UM#Z>:ZDDC\,BD^#L)N/AO?0B=K?S+B9?-7JF2>:UO
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M*BBBJ)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ?%_K%^M+-_K6I(_]8OUI9O]
M:U'4.A'1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !6?KDVI6^CW$VD6R7-\BYBA=@H<^F3TK0H
MH \Z\(>'?$-_XJG\6^+H(;:\$/V>TLXV#"%,Y))!(R3[^M>BT44 %%%% !7!
M6WA_5(_C-?:ZUH1ILMDD23[UP6"X(QG/Z5WM% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !4TW^K3Z5#4TW^K3Z4,"&BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K*\0:+_;^F'3WN7@@D<&;8N2Z@YV^V?6
MM6B@!D4:PQ)$@PB*%4>@%/HHH **** "N1\>^&;C7+&UOM,P-8TZ43VISC=Z
MKGWKKJ* *]C+//8P2W-NUO.\8,D3$$HV.1D$BK%%% $<[O';R/'&9752512,
ML?3GBN1\"^&[S3GU+7-90+K&JS&25,AO)C'"1Y'!P/2NRHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J]'_JU^E4:O1_
MZM?I4R'$=1114E!28!["EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]
M!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EH
MH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'
MH/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT
M'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B
M@!-H]!^5&T>@_*EHH 3 ]!1@>@I:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*E
MHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M
M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VC
MT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6
MB@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T
M>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/
M0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:
M* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1
MZ#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]
M!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EH
MH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'
MH/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT
M'Y4;1Z#\J6B@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B
M@!-H]!^5&T>@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&T>
M@_*EHH 3:/0?E1M'H/RI:* $VCT'Y4;1Z#\J6B@!-H]!^5&!Z4M% ";1Z#\J
M-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 F
MT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E
M2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RH
MVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";
M1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5
M+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C
M:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M
M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4
MM% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-
MH]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT
M>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2
MT4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHV
MCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1
MZ#\J-H]!^5+10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+
M10 FT>@_*C:/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J-H]!^5+10 FT>@_*C:
A/0?E2T4 )M'H/RHVCT'Y4M% ";1Z#\J6BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>22
<FILENAME>nk-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3476423+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nk="http://www.nantkwest.com/20201231" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nantkwest.com/20201231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.nantkwest.com/20201231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nk-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nk-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nk-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nk-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="Role_StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100040 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100060 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness" id="Role_DisclosureDescriptionOfBusiness">
        <link:definition>100080 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100090 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails" id="Role_DisclosureFinancialStatementDetails">
        <link:definition>100100 - Disclosure - Financial Statement Details</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio" id="Role_DisclosureAgreementAndPlanOfMergerWithImmunitybio">
        <link:definition>100110 - Disclosure - Agreement and Plan of Merger with ImmunityBio</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment" id="Role_DisclosureViractaInvestment">
        <link:definition>100120 - Disclosure - Viracta Investment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities">
        <link:definition>100130 - Disclosure - Financial Instruments Investments in Marketable Debt Securities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100140 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements" id="Role_DisclosureCollaborationAndLicenseAgreements">
        <link:definition>100150 - Disclosure - Collaboration and License Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100160 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements" id="Role_DisclosureRelatedPartyAgreements">
        <link:definition>100170 - Disclosure - Related Party Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100180 - Disclosure - Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100190 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100200 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited" id="Role_DisclosureSummarizedQuarterlyDataUnaudited">
        <link:definition>100210 - Disclosure - Summarized Quarterly Data (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits" id="Role_DisclosureEmployeeBenefits">
        <link:definition>100220 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent" id="Role_DisclosureSubsequentEvent">
        <link:definition>100230 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables" id="Role_DisclosureFinancialStatementDetailsTables">
        <link:definition>100260 - Disclosure - Financial Statement Details (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables">
        <link:definition>100270 - Disclosure - Financial Instruments Investments in Marketable Debt Securities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100280 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables" id="Role_DisclosureCommitmentAndContingenciesTables">
        <link:definition>100290 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>100300 - Disclosure - Stockholders&apos; Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100310 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100320 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables" id="Role_DisclosureSummarizedQuarterlyDataUnauditedTables">
        <link:definition>100330 - Disclosure - Summarized Quarterly Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" id="Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail">
        <link:definition>100340 - Disclosure - Description of Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
        <link:definition>100360 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail">
        <link:definition>100370 - Disclosure - Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail" id="Role_DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>100380 - Disclosure - Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" id="Role_DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail">
        <link:definition>100390 - Disclosure - Financial Statement Details - Property, Plant and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail" id="Role_DisclosureFinancialStatementDetailsAdditionalInformationDetail">
        <link:definition>100400 - Disclosure - Financial Statement Details - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail" id="Role_DisclosureFinancialStatementDetailsOtherAssetsDetail">
        <link:definition>100410 - Disclosure - Financial Statement Details - Other Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail" id="Role_DisclosureFinancialStatementDetailsAccruedExpensesDetail">
        <link:definition>100420 - Disclosure - Financial Statement Details - Accrued Expenses (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail" id="Role_DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail">
        <link:definition>100430 - Disclosure - Financial Statement Details - Other Current Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail" id="Role_DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail">
        <link:definition>100440 - Disclosure - Financial Statement Details - Investment Income, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail" id="Role_DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail">
        <link:definition>100450 - Disclosure - Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail" id="Role_DisclosureViractaInvestmentAdditionalInformationDetail">
        <link:definition>100460 - Disclosure - Viracta Investment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail">
        <link:definition>100470 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail">
        <link:definition>100480 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail">
        <link:definition>100490 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail" id="Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail">
        <link:definition>100500 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
        <link:definition>100510 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail" id="Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail">
        <link:definition>100520 - Disclosure - Collaboration and License Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetail">
        <link:definition>100530 - Disclosure - Commitment and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail" id="Role_DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail">
        <link:definition>100540 - Disclosure - Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail" id="Role_DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail">
        <link:definition>100550 - Disclosure - Commitment and Contingencies - Components of Lease Expense (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail" id="Role_DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail">
        <link:definition>100560 - Disclosure - Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail" id="Role_DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail">
        <link:definition>100570 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail" id="Role_DisclosureRelatedPartyAgreementsAdditionalInformationDetail">
        <link:definition>100580 - Disclosure - Related Party Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
        <link:definition>100590 - Disclosure - Stockholders&apos; Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail" id="Role_DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail">
        <link:definition>100600 - Disclosure - Stockholders&apos; Equity - Summary of Common Shares Reserved for Issuance (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetail">
        <link:definition>100610 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail" id="Role_DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail">
        <link:definition>100620 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail" id="Role_DisclosureStockBasedCompensationStockOptionActivityDetail">
        <link:definition>100630 - Disclosure - Stock-Based Compensation - Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail" id="Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail">
        <link:definition>100640 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption" id="Role_DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption">
        <link:definition>100650 - Disclosure - Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail" id="Role_DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail">
        <link:definition>100660 - Disclosure - Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail" id="Role_DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail">
        <link:definition>100670 - Disclosure - Stock-Based Compensation - Summary of Warrant Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>100680 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail" id="Role_DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail">
        <link:definition>100690 - Disclosure - Income Taxes - Summary of Loss Before Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail" id="Role_DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail">
        <link:definition>100700 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail" id="Role_DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>100710 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail" id="Role_DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail">
        <link:definition>100720 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail">
        <link:definition>100730 - Disclosure - Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail" id="Role_DisclosureSummaryOfQuarterlyDataUnauditedDetail">
        <link:definition>100740 - Disclosure - Summary of Quarterly Data (Unaudited) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail" id="Role_DisclosureEmployeeBenefitsAdditionalInformationDetail">
        <link:definition>100750 - Disclosure - Employee Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" id="Role_DisclosureSubsequentEventsAdditionalInformationDetail">
        <link:definition>100760 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="nk_StockIssuedDuringPeriodSharesWarrantsExercised" name="StockIssuedDuringPeriodSharesWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_StockOfferingCosts" name="StockOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" name="OperatingLeaseRightOfUseAssetNonCashLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_NonCashInterestIncomeExpenseFromOperatingActivities" name="NonCashInterestIncomeExpenseFromOperatingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_IncreaseDecreaseInAccountsPayableCurrent" name="IncreaseDecreaseInAccountsPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_IncreaseDecreaseInOperatingLeaseLiability" name="IncreaseDecreaseInOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_IncreaseDecreaseInDeferredRent" name="IncreaseDecreaseInDeferredRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PaymentsToAcquireInvestmentsInEquitySecurities" name="PaymentsToAcquireInvestmentsInEquitySecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_DescriptionOfBusinessDisclosureTextBlock" name="DescriptionOfBusinessDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_FinancialStatementDetailsAbstract" name="FinancialStatementDetailsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ProposedMergerWithImmunityBioMember" name="ProposedMergerWithImmunityBioMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CashEquivalentsAndMarketableSecuritiesAbstract" name="CashEquivalentsAndMarketableSecuritiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CollaborationAndLicenseAgreementsTextBlock" name="CollaborationAndLicenseAgreementsTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_LiquidityPolicyTextBlock" name="LiquidityPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" name="PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_RelatedPartyTransactionsPolicyPolicyTextBlock" name="RelatedPartyTransactionsPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_StockRepurchasesPolicyTextBlock" name="StockRepurchasesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_LitigationCostsPolicyTextBlock" name="LitigationCostsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" name="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" name="ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" name="ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" name="UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_AccountingPoliciesLineItems" name="AccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_AccountingPoliciesTable" name="AccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_PrecigenLicenseAgreementMember" name="PrecigenLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CashAndCashEquivalentsOriginalMaturities" name="CashAndCashEquivalentsOriginalMaturities" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" name="MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" name="MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ITEquipmentMember" name="ITEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" name="FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_NonrefundableUpfrontPayment" name="NonrefundableUpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_VariableConsiderationRelatedToMilestonePayment" name="VariableConsiderationRelatedToMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_NumberOfProductsApprovedForCommercialSale" name="NumberOfProductsApprovedForCommercialSale" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" name="PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_InsurancePremiumFinancingAsset" name="InsurancePremiumFinancingAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidServices" name="PrepaidServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidSuppliesWithRelatedParty" name="PrepaidSuppliesWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidEquipmentMaintenance" name="PrepaidEquipmentMaintenance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidLicenseFees" name="PrepaidLicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_LaboratoryEquipmentDeposit" name="LaboratoryEquipmentDeposit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidSoftwareLicenseFeesInOtherAssets" name="PrepaidSoftwareLicenseFeesInOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" name="PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_AccruedLaboratoryEquipmentAndSupplies" name="AccruedLaboratoryEquipmentAndSupplies" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_AccruedPreclinicalAndClinicalTrialCosts" name="AccruedPreclinicalAndClinicalTrialCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_AccruedCapitalExpenditures" name="AccruedCapitalExpenditures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_AccruedFranchiseSalesUseAndPropertyTaxes" name="AccruedFranchiseSalesUseAndPropertyTaxes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_FinancingObligationCurrent" name="FinancingObligationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_ImmunityBioMember" name="ImmunityBioMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NantKwestMember" name="NantKwestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" name="ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_MergerExchangeRatio" name="MergerExchangeRatio" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" name="OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_OwnershipPercentageByKeyExecutives" name="OwnershipPercentageByKeyExecutives" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" name="TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_OtherIncomeAndExpenseNetMember" name="OtherIncomeAndExpenseNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_PurchaseOfConvertibleNoteUponConversion" name="PurchaseOfConvertibleNoteUponConversion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_CurrentAssetsMember" name="CurrentAssetsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NoncurrentAssetsMember" name="NoncurrentAssetsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" name="AvailableForSaleSecuritiesDebtSecuritiesPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" name="AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" name="AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" name="AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_TermOfAgreement" name="TermOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" name="AdditionalTermOfAgreementRenewableUponMutualAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_LicensingAgreementAbstract" name="LicensingAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_LicensingAgreementLineItems" name="LicensingAgreementLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_LicensingAgreementTable" name="LicensingAgreementTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_JointCOVID19CollaborationDevelopmentAgreementMember" name="JointCOVID19CollaborationDevelopmentAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ProgramEquipmentRelatedCostsMember" name="ProgramEquipmentRelatedCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NetProgramRelatedCostsMember" name="NetProgramRelatedCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ClinicalTrialCostAllocationAgreementMember" name="ClinicalTrialCostAllocationAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ViractaTherapeuticsIncMember" name="ViractaTherapeuticsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_RushUniversityMedicalCenterLicenseAgreementMember" name="RushUniversityMedicalCenterLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_INDFilingMember" name="INDFilingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_PhaseTwoMember" name="PhaseTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_PhaseThreeMember" name="PhaseThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CommercialSaleRelatedToLicensedProductsMember" name="CommercialSaleRelatedToLicensedProductsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_RelatedPartyAgreementRenewalTerm" name="RelatedPartyAgreementRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_MilestonePaymentAmount" name="MilestonePaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_LicenseAgreementTerminationNoticePeriod" name="LicenseAgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PeriodOfLicenseAgreement" name="PeriodOfLicenseAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_MinimumAnnualRoyaltyPayment" name="MinimumAnnualRoyaltyPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_MinimumSalesMilestoneOfLicenseForFirstYear" name="MinimumSalesMilestoneOfLicenseForFirstYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_AgreementOneTimeFee" name="AgreementOneTimeFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_LicenseAgreementTerm" name="LicenseAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_DirectorsAndOfficersInsurancePolicyMember" name="DirectorsAndOfficersInsurancePolicyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" name="DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ElSegundoCaliforniaMember" name="ElSegundoCaliforniaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_AltorBioscienceManufacturingCompanyLLCMember" name="AltorBioscienceManufacturingCompanyLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NantBioScienceMember" name="NantBioScienceMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_DougStLLCMember" name="DougStLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CommitmentWoburnMassachusettsMember" name="CommitmentWoburnMassachusettsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NantWorksLimitedLiabilityCompanyMember" name="NantWorksLimitedLiabilityCompanyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_AmendmentToExtendLeaseTermMember" name="AmendmentToExtendLeaseTermMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_CommitmentSanDiegoMember" name="CommitmentSanDiegoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NumberOfSquareFootOfFacilityLeased" name="NumberOfSquareFootOfFacilityLeased" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_BaseMonthlyRent" name="BaseMonthlyRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_LeaseCommencementDate" name="LeaseCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AdditionToNumberOfSquareFootOfFacilityLeased" name="AdditionToNumberOfSquareFootOfFacilityLeased" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_AnnualBaseRentIncreasePerSquareFoot" name="AnnualBaseRentIncreasePerSquareFoot" type="srt-types:perUnitItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_LeaseAgreementExtendedPeriod" name="LeaseAgreementExtendedPeriod" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PeriodOfLicenseAgreementDescription" name="PeriodOfLicenseAgreementDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AnnualPercentageIncreasesToBaseRent" name="AnnualPercentageIncreasesToBaseRent" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" name="AnnualPercentageIncreasesToBaseRentCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_RightOfUseAssetsAbstract" name="RightOfUseAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ShortTermLeaseLiabilitiesAbstract" name="ShortTermLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_LongTermLeaseLiabilitiesAbstract" name="LongTermLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" name="OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_PeriodOfExtendedLeaseTerm" name="PeriodOfExtendedLeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_MonthlyFixedCharge" name="MonthlyFixedCharge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" name="AnnualPercentageIncreasesToMonthlyFixedCharge" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" name="AnnualPercentageIncreasesToFixedChargeCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" name="RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_RelatedPartyTransactionAmountPaidToRelatedParty" name="RelatedPartyTransactionAmountPaidToRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_RelatedPartyTransactionInitialTermOfAgreement" name="RelatedPartyTransactionInitialTermOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_RelatedPartyAgreementExpirationMonthAndYear" name="RelatedPartyAgreementExpirationMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" name="NumberOfDaysPriorToWrittenNoticeToTerminateLease" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_SharedServicesAgreementMember" name="SharedServicesAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ReimbursementsMember" name="ReimbursementsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ImmunoOncologyClinicIncMember" name="ImmunoOncologyClinicIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NantHealthLabsIncMember" name="NantHealthLabsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NumberOfOfficers" name="NumberOfOfficers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_InitialTermOfAgreement" name="InitialTermOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_RelatedPartyInstallmentPayment" name="RelatedPartyInstallmentPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_RelatedPartyTransactionConditionalPayment" name="RelatedPartyTransactionConditionalPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_RelatedPartyTransactionAgreementExtensionDescription" name="RelatedPartyTransactionAgreementExtensionDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_NewAgreementTerminationNoticePeriod" name="NewAgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" name="PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_FixedAndVariableLeaseCosts" name="FixedAndVariableLeaseCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" name="PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" name="RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_RelatedPartyTransactionAmountPaidToThirdParty" name="RelatedPartyTransactionAmountPaidToThirdParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" name="ResearchAndDevelopmentExpenseRatablePaymentPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PrepaymentOfFundingAmount" name="PrepaymentOfFundingAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" name="UnderwritingDiscountsCommissionsAndOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" name="SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PublicMember" name="PublicMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" name="SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExecutiveChairmanAndPrincipalStockholderMember" name="ExecutiveChairmanAndPrincipalStockholderMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" name="StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_TwoThousandFourteenEquityIncentivePlanMember" name="TwoThousandFourteenEquityIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_TwoThousandFifteenEquityIncentivePlanMember" name="TwoThousandFifteenEquityIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NonEmployeeRestrictedStockUnitMember" name="NonEmployeeRestrictedStockUnitMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_EmployeeRestrictedStockUnitMember" name="EmployeeRestrictedStockUnitMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ExercisePriceRangeSixMember" name="ExercisePriceRangeSixMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nk_StockIssuedDuringPeriodSharesWarrantsExpired" name="StockIssuedDuringPeriodSharesWarrantsExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ClassOfWarrantOrRightsIssued" name="ClassOfWarrantOrRightsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_IncomeTaxLineItems" name="IncomeTaxLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_IncomeTaxTable" name="IncomeTaxTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_TaxYear2021AndThereafterMember" name="TaxYear2021AndThereafterMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_DeferredIncomeTaxExpenseBenefitNet" name="DeferredIncomeTaxExpenseBenefitNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_DeferredTaxAssetsOperatingLeaseLiabilities" name="DeferredTaxAssetsOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" name="DeferredTaxAssetsDeferredDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" name="DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" name="EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" name="ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_PeriodOfCumulativeOwnershipChange" name="PeriodOfCumulativeOwnershipChange" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_DerecognizedDeferredTaxAssets" name="DerecognizedDeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_NetOperatingLossCarryforwardsExpirationDate" name="NetOperatingLossCarryforwardsExpirationDate" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_TaxCreditCarryforwardExpirationPeriod" name="TaxCreditCarryforwardExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" name="NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_NetOperatingLossCarrybacksPeriod" name="NetOperatingLossCarrybacksPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" name="UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" name="TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nk_FourHundredOneKPlanMember" name="FourHundredOneKPlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nk_NashLLCMember" name="NashLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>23
<FILENAME>nk-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3476423+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="nk-20201231.xsd#TemplateLink" roleURI="http://www.nantkwest.com/20201231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10230.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeNet" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10110.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" order="10040.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInDeferredRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInAccountsPayableCurrent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonCashInterestIncomeExpenseFromOperatingActivities" xlink:type="locator" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" xlink:type="locator" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PaymentsToAcquireInvestmentsInEquitySecurities" xlink:type="locator" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" order="10070.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="nk_PaymentsToAcquireInvestmentsInEquitySecurities" order="10130.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="10140.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10220.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_MarketableSecuritiesGainLoss" order="10230.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="10240.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nk_NonCashInterestIncomeExpenseFromOperatingActivities" order="10250.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetImpairmentCharges" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10270.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10280.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="10290.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nk_IncreaseDecreaseInAccountsPayableCurrent" order="10300.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="10310.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="10320.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nk_IncreaseDecreaseInOperatingLeaseLiability" order="10330.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nk_IncreaseDecreaseInDeferredRent" order="10340.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentDeposit" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentDeposit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidLicenseFees" xlink:type="locator" xlink:label="nk_PrepaidLicenseFees" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidEquipmentMaintenance" xlink:type="locator" xlink:label="nk_PrepaidEquipmentMaintenance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSuppliesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidSuppliesWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent" xlink:type="locator" xlink:label="us-gaap_PrepaidRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidServices" xlink:type="locator" xlink:label="nk_PrepaidServices" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_InsurancePremiumFinancingAsset" xlink:type="locator" xlink:label="nk_InsurancePremiumFinancingAsset" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_InsurancePremiumFinancingAsset" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_PrepaidServices" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidRent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_InterestReceivableCurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_PrepaidSuppliesWithRelatedParty" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_PrepaidEquipmentMaintenance" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_PrepaidLicenseFees" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="nk_LaboratoryEquipmentDeposit" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_InsuranceSettlementsReceivableCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsOtherAssetsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesNoncurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSoftwareLicenseFeesInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_SecurityDeposit" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="nk_PrepaidSoftwareLicenseFeesInOtherAssets" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DueFromRelatedPartiesNoncurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsAccruedExpensesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedFranchiseSalesUseAndPropertyTaxes" xlink:type="locator" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedCapitalExpenditures" xlink:type="locator" xlink:label="nk_AccruedCapitalExpenditures" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedPreclinicalAndClinicalTrialCosts" xlink:type="locator" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedLaboratoryEquipmentAndSupplies" xlink:type="locator" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedSalariesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedBonusesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nk_AccruedLaboratoryEquipmentAndSupplies" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nk_AccruedPreclinicalAndClinicalTrialCosts" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nk_AccruedCapitalExpenditures" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nk_AccruedFranchiseSalesUseAndPropertyTaxes" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancingObligationCurrent" xlink:type="locator" xlink:label="nk_FinancingObligationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="nk_FinancingObligationCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeInterest" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:type="locator" xlink:label="us-gaap_VariableLeaseCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredIncomeTaxExpenseBenefitNet" xlink:type="locator" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="nk_DeferredIncomeTaxExpenseBenefitNet" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nk_DeferredIncomeTaxExpenseBenefitNet" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nk_DeferredIncomeTaxExpenseBenefitNet" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nk_DeferredIncomeTaxExpenseBenefitNet" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="nk_DeferredTaxAssetsOperatingLeaseLiabilities" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10130.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" xlink:type="locator" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>24
<FILENAME>nk-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3476423+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="nk-20201231.xsd#TemplateLink" roleURI="http://www.nantkwest.com/20201231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExercised" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="11540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11680.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio" xlink:href="nk-20201231.xsd#Role_DisclosureAgreementAndPlanOfMergerWithImmunitybio" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProposedMergerWithImmunityBioMember" xlink:type="locator" xlink:label="nk_ProposedMergerWithImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nk_ProposedMergerWithImmunityBioMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="nk_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="nk_UnderwrittenPublicOfferingMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10230.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfProductsApprovedForCommercialSale" xlink:type="locator" xlink:label="nk_NumberOfProductsApprovedForCommercialSale" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="nk-20201231.xsd#nk_VariableConsiderationRelatedToMilestonePayment" xlink:type="locator" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonrefundableUpfrontPayment" xlink:type="locator" xlink:label="nk_NonrefundableUpfrontPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasePracticalExpedientsPackage" xlink:type="locator" xlink:label="us-gaap_LeasePracticalExpedientsPackage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" xlink:type="locator" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashAndCashEquivalentsOriginalMaturities" xlink:type="locator" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrecigenLicenseAgreementMember" xlink:type="locator" xlink:label="nk_PrecigenLicenseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesTable" xlink:type="locator" xlink:label="nk_AccountingPoliciesTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesLineItems" xlink:type="locator" xlink:label="nk_AccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_AccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_AccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_AccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_PrecigenLicenseAgreementMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_CashAndCashEquivalentsOriginalMaturities" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_LeasePracticalExpedientsPackage" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="11240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_OpenTaxYear" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_NonrefundableUpfrontPayment" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_VariableConsiderationRelatedToMilestonePayment" order="11520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="11540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_NumberOfProductsApprovedForCommercialSale" order="11590.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ITEquipmentMember" xlink:type="locator" xlink:label="nk_ITEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nk_LaboratoryEquipmentMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nk_ITEquipmentMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10290.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageByKeyExecutives" xlink:type="locator" xlink:label="nk_OwnershipPercentageByKeyExecutives" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" xlink:type="locator" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MergerExchangeRatio" xlink:type="locator" xlink:label="nk_MergerExchangeRatio" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProposedMergerWithImmunityBioMember" xlink:type="locator" xlink:label="nk_ProposedMergerWithImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantKwestMember" xlink:type="locator" xlink:label="nk_NantKwestMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_OwnershipAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="nk_NantKwestMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_TitleOfIndividualAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_StatementScenarioAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nk_ProposedMergerWithImmunityBioMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_MergerExchangeRatio" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_OwnershipPercentageByKeyExecutives" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" order="10510.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureViractaInvestmentAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PurchaseOfConvertibleNoteUponConversion" xlink:type="locator" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OtherIncomeAndExpenseNetMember" xlink:type="locator" xlink:label="nk_OtherIncomeAndExpenseNetMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" xlink:type="locator" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="nk_OtherIncomeAndExpenseNetMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="nk_PurchaseOfConvertibleNoteUponConversion" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockValue" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" order="10680.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NoncurrentAssetsMember" xlink:type="locator" xlink:label="nk_NoncurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CurrentAssetsMember" xlink:type="locator" xlink:label="nk_CurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_2" order="10080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_CurrentAssetsMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_NoncurrentAssetsMember" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtMember" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain_2" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" order="11240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" order="11480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" order="11600.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_DebtSecuritiesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="srt_RangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" order="10410.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="10660.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NoncurrentAssetsMember" xlink:type="locator" xlink:label="nk_NoncurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CurrentAssetsMember" xlink:type="locator" xlink:label="nk_CurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_CurrentAssetsMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_NoncurrentAssetsMember" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="11040.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AgreementOneTimeFee" xlink:type="locator" xlink:label="nk_AgreementOneTimeFee" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerm" xlink:type="locator" xlink:label="nk_LicenseAgreementTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumSalesMilestoneOfLicenseForFirstYear" xlink:type="locator" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumAnnualRoyaltyPayment" xlink:type="locator" xlink:label="nk_MinimumAnnualRoyaltyPayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreement" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_LicenseAgreementTerminationNoticePeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MilestonePaymentAmount" xlink:type="locator" xlink:label="nk_MilestonePaymentAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementRenewalTerm" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementRenewalTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" xlink:type="locator" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TermOfAgreement" xlink:type="locator" xlink:label="nk_TermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrecigenLicenseAgreementMember" xlink:type="locator" xlink:label="nk_PrecigenLicenseAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommercialSaleRelatedToLicensedProductsMember" xlink:type="locator" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseThreeMember" xlink:type="locator" xlink:label="nk_PhaseThreeMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseTwoMember" xlink:type="locator" xlink:label="nk_PhaseTwoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_INDFilingMember" xlink:type="locator" xlink:label="nk_INDFilingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RushUniversityMedicalCenterLicenseAgreementMember" xlink:type="locator" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ViractaTherapeuticsIncMember" xlink:type="locator" xlink:label="nk_ViractaTherapeuticsIncMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain_2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClinicalTrialCostAllocationAgreementMember" xlink:type="locator" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetProgramRelatedCostsMember" xlink:type="locator" xlink:label="nk_NetProgramRelatedCostsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProgramEquipmentRelatedCostsMember" xlink:type="locator" xlink:label="nk_ProgramEquipmentRelatedCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:type="locator" xlink:label="us-gaap_SalesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:type="locator" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementTable" xlink:type="locator" xlink:label="nk_LicensingAgreementTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementLineItems" xlink:type="locator" xlink:label="nk_LicensingAgreementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicensingAgreementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_JointCOVID19CollaborationDevelopmentAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SalesMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_NonrecurringAdjustmentAxis" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentDomain_2" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentDomain" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_ProgramEquipmentRelatedCostsMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_NetProgramRelatedCostsMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_ClinicalTrialCostAllocationAgreementMember" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="dei_LegalEntityAxis" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="nk_ViractaTherapeuticsIncMember" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="srt_RangeAxis" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain_2" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="nk_RushUniversityMedicalCenterLicenseAgreementMember" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_INDFilingMember" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_PhaseTwoMember" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_PhaseThreeMember" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_CommercialSaleRelatedToLicensedProductsMember" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_PrecigenLicenseAgreementMember" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_TermOfAgreement" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" order="11540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="11610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="11670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_RelatedPartyAgreementRenewalTerm" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MilestonePaymentAmount" order="11880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicenseAgreementTerminationNoticePeriod" order="11920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_PeriodOfLicenseAgreement" order="11970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MinimumAnnualRoyaltyPayment" order="11990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="12010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MinimumSalesMilestoneOfLicenseForFirstYear" order="12030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicenseAgreementTerm" order="12080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_AgreementOneTimeFee" order="12160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="12320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" xlink:type="locator" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MonthlyFixedCharge" xlink:type="locator" xlink:label="nk_MonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfExtendedLeaseTerm" xlink:type="locator" xlink:label="nk_PeriodOfExtendedLeaseTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" xlink:type="locator" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreementDescription" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreementDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualBaseRentIncreasePerSquareFoot" xlink:type="locator" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionToNumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseCommencementDate" xlink:type="locator" xlink:label="nk_LeaseCommencementDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNet" xlink:type="locator" xlink:label="us-gaap_AssetsNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivable" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:type="locator" xlink:label="us-gaap_LegalFees" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentSanDiegoMember" xlink:type="locator" xlink:label="nk_CommitmentSanDiegoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AmendmentToExtendLeaseTermMember" xlink:type="locator" xlink:label="nk_AmendmentToExtendLeaseTermMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantWorksLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:type="locator" xlink:label="srt_ScenarioForecastMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentWoburnMassachusettsMember" xlink:type="locator" xlink:label="nk_CommitmentWoburnMassachusettsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DougStLLCMember" xlink:type="locator" xlink:label="nk_DougStLLCMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantBioScienceMember" xlink:type="locator" xlink:label="nk_NantBioScienceMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:type="locator" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" xlink:type="locator" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DirectorsAndOfficersInsurancePolicyMember" xlink:type="locator" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_CommitmentsAndContingenciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_ReinsurancePolicyTypeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ReinsurancePolicyTypeAxis" xlink:to="us-gaap_ReinsurancePolicyDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ReinsurancePolicyTypeAxis" xlink:to="us-gaap_ReinsurancePolicyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReinsurancePolicyDomain" xlink:to="nk_DirectorsAndOfficersInsurancePolicyMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_2" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_2" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_2" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_AltorBioscienceManufacturingCompanyLLCMember" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantBioScienceMember" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_DougStLLCMember" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_2" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_CommitmentWoburnMassachusettsMember" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_StatementScenarioAxis" order="11700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="11730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="11750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantWorksLimitedLiabilityCompanyMember" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_AmendmentToExtendLeaseTermMember" order="12010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_CommitmentSanDiegoMember" order="12150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="12240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LegalFees" order="12330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_InsuranceSettlementsReceivable" order="12380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="12450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="12470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="12490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_Liabilities" order="12510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_AssetsNet" order="12530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="12600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_BaseMonthlyRent" order="12620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="12640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_LeaseCommencementDate" order="12660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AdditionToNumberOfSquareFootOfFacilityLeased" order="12680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualBaseRentIncreasePerSquareFoot" order="12700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="12720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="12740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_PeriodOfLicenseAgreementDescription" order="12760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="12780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" order="12800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="13090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="13140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="13180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" order="13250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="13320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_PeriodOfExtendedLeaseTerm" order="13340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_MonthlyFixedCharge" order="13360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" order="13380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" order="13420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" order="13470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionAmountPaidToRelatedParty" order="13490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="13510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionInitialTermOfAgreement" order="13530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyAgreementExpirationMonthAndYear" order="13550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" order="14220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" order="14420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" order="14440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" order="14460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" order="14480.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureRelatedPartyAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaymentOfFundingAmount" xlink:type="locator" xlink:label="nk_PrepaymentOfFundingAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementRenewalTerm" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FixedAndVariableLeaseCosts" xlink:type="locator" xlink:label="nk_FixedAndVariableLeaseCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MonthlyFixedCharge" xlink:type="locator" xlink:label="nk_MonthlyFixedCharge" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NewAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_NewAgreementTerminationNoticePeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAgreementExtensionDescription" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionConditionalPayment" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionConditionalPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyInstallmentPayment" xlink:type="locator" xlink:label="nk_RelatedPartyInstallmentPayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_InitialTermOfAgreement" xlink:type="locator" xlink:label="nk_InitialTermOfAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfOfficers" xlink:type="locator" xlink:label="nk_NumberOfOfficers" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantHealthLabsIncMember" xlink:type="locator" xlink:label="nk_NantHealthLabsIncMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantBioScienceMember" xlink:type="locator" xlink:label="nk_NantBioScienceMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DougStLLCMember" xlink:type="locator" xlink:label="nk_DougStLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClinicalTrialCostAllocationAgreementMember" xlink:type="locator" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetProgramRelatedCostsMember" xlink:type="locator" xlink:label="nk_NetProgramRelatedCostsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProgramEquipmentRelatedCostsMember" xlink:type="locator" xlink:label="nk_ProgramEquipmentRelatedCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:type="locator" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:type="locator" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunoOncologyClinicIncMember" xlink:type="locator" xlink:label="nk_ImmunoOncologyClinicIncMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ReimbursementsMember" xlink:type="locator" xlink:label="nk_ReimbursementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:type="locator" xlink:label="us-gaap_TransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:type="locator" xlink:label="us-gaap_TransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:type="locator" xlink:label="us-gaap_TransactionTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharedServicesAgreementMember" xlink:type="locator" xlink:label="nk_SharedServicesAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantWorksLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantWorksLimitedLiabilityCompanyMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_SharedServicesAgreementMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TransactionTypeAxis" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain_2" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransactionDomain" xlink:to="nk_ReimbursementsMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunoOncologyClinicIncMember" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_StatementGeographicalAxis" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="11750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_AltorBioscienceManufacturingCompanyLLCMember" order="11910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_JointCOVID19CollaborationDevelopmentAgreementMember" order="12230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_NonrecurringAdjustmentAxis" order="12300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentDomain" order="12330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_ProgramEquipmentRelatedCostsMember" order="12350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_NetProgramRelatedCostsMember" order="12370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_ClinicalTrialCostAllocationAgreementMember" order="12510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" order="12530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="12570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="12590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_DougStLLCMember" order="12950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantBioScienceMember" order="13250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantHealthLabsIncMember" order="13590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="13680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="13740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="13980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="14050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="14110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="14170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NumberOfOfficers" order="14260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_InitialTermOfAgreement" order="14310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyInstallmentPayment" order="14360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="14380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionConditionalPayment" order="14440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionAgreementExtensionDescription" order="14490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NewAgreementTerminationNoticePeriod" order="14510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" order="14680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" order="14770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_MonthlyFixedCharge" order="14850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" order="14890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_FixedAndVariableLeaseCosts" order="14970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="15190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="15260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="15280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionInitialTermOfAgreement" order="15330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyAgreementRenewalTerm" order="15350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" order="15400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" order="15550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" order="15700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_BaseMonthlyRent" order="15760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="15820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" order="15880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="16000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" order="16090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionAmountPaidToThirdParty" order="16110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyAgreementExpirationMonthAndYear" order="16170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" order="16280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaymentOfFundingAmount" order="16400.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" xlink:type="locator" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PublicMember" xlink:type="locator" xlink:label="nk_PublicMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="nk_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="nk_UnderwrittenPublicOfferingMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_2" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_PublicMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="11290.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10140.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClassOfWarrantOrRightsIssued" xlink:type="locator" xlink:label="nk_ClassOfWarrantOrRightsIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_EmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonEmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_NonEmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFifteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nk_TwoThousandFourteenEquityIncentivePlanMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nk_TwoThousandFifteenEquityIncentivePlanMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_NonEmployeeRestrictedStockUnitMember" order="11070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_EmployeeRestrictedStockUnitMember" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="11670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="12090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="12150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ClassOfWarrantOrRightsIssued" order="12600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12660.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:type="locator" xlink:label="srt_OfficerMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonEmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_NonEmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_EmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_EmployeeRestrictedStockUnitMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_NonEmployeeRestrictedStockUnitMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_TitleOfIndividualAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_OfficerMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="11730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="12030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="12730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="13060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="13660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="13790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="13990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="14390.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeSixMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFiveMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFourMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeThreeMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeTwoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeOneMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeTwoMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeThreeMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeFourMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeFiveMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeSixMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="10920.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption">
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" order="10600.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11170.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExpired" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExercised" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExpired" order="10300.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" xlink:type="locator" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" xlink:type="locator" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarrybacksPeriod" xlink:type="locator" xlink:label="nk_NetOperatingLossCarrybacksPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCreditCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarryforwardsExpirationDate" xlink:type="locator" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" xlink:type="locator" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DerecognizedDeferredTaxAssets" xlink:type="locator" xlink:label="nk_DerecognizedDeferredTaxAssets" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfCumulativeOwnershipChange" xlink:type="locator" xlink:label="nk_PeriodOfCumulativeOwnershipChange" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="locator" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxYear2021AndThereafterMember" xlink:type="locator" xlink:label="nk_TaxYear2021AndThereafterMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2020Member" xlink:type="locator" xlink:label="us-gaap_TaxYear2020Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_KR" xlink:type="locator" xlink:label="country_KR" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxTable" xlink:type="locator" xlink:label="nk_IncomeTaxTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxLineItems" xlink:type="locator" xlink:label="nk_IncomeTaxLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_IncomeTaxTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_IncomeTaxTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_KR" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_2" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_TaxPeriodAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain_2" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxYear2020Member" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="nk_TaxYear2021AndThereafterMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nk_IncomeTaxTable" xlink:to="srt_RangeAxis" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_PeriodOfCumulativeOwnershipChange" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_DerecognizedDeferredTaxAssets" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarryforwardsExpirationDate" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_TaxCreditCarryforwardExpirationPeriod" order="11690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarrybacksPeriod" order="11920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" order="11970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_OpenTaxYear" order="11990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" order="12160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FourHundredOneKPlanMember" xlink:type="locator" xlink:label="nk_FourHundredOneKPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_RetirementPlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="nk_FourHundredOneKPlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NashLLCMember" xlink:type="locator" xlink:label="nk_NashLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NashLLCMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementGeographicalAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_BaseMonthlyRent" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10620.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>25
<FILENAME>nk-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3486398+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable debt securities, available-for-sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable debt securities, noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, net (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets, net (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities Without Readily Determinable Fair Value Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Due To Related Parties Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, less current portion (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 9)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 500,000,000 shares authorized; 108,726,551 and 98,460,404 issued and outstanding as of December 31, 2020 and December 31, 2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Revenues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Revenues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Selling, general and administrative (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other (expense) income, net (including amounts with related parties)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other (expense) income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax (expense) benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel">Basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares during the period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Income And Comprehensive Income [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income, net of income taxes:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized (losses) gains on available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Reclassification of net realized losses on available-for-sale securities included in net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive (loss) income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares warrants exercised.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments For New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Adoption [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2014-09</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201409Member" xlink:to="us-gaap_AccountingStandardsUpdate201409Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201409 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2016-02</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201602 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock And Warrants Issued During Period Value Preferred Stock And Warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of warrants, Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Warrants Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted stock units (RSUs)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Restricted Stock Award Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted stock units (RSUs), Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Award Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net share settlement for restricted stock unit vesting and option/warrant exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments Related To Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net share settlement for restricted stock unit vesting and option/warrant exercises, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Paid For Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased And Retired During Period Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of common stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased And Retired During Period Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative effect of the adoption of the new standard</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustment" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prior Period Reclassification Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_StockOfferingCosts" xlink:type="locator" xlink:label="nk_StockOfferingCosts" />
    <link:label xml:lang="en-US" xlink:label="nk_StockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock offering costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_StockOfferingCosts" xlink:to="nk_StockOfferingCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_StockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockOfferingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Offering Costs</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" xlink:type="locator" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease right of use asset non cash lease expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" xlink:to="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonCashInterestIncomeExpenseFromOperatingActivities" xlink:type="locator" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash interest (income) expense from operating activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NonCashInterestIncomeExpenseFromOperatingActivities" xlink:to="nk_NonCashInterestIncomeExpenseFromOperatingActivities_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInAccountsPayableCurrent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in accounts payable current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_IncreaseDecreaseInAccountsPayableCurrent" xlink:to="nk_IncreaseDecreaseInAccountsPayableCurrent_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in operating lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="nk_IncreaseDecreaseInOperatingLeaseLiability_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInDeferredRent" />
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in deferred rent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_IncreaseDecreaseInDeferredRent" xlink:to="nk_IncreaseDecreaseInDeferredRent_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PaymentsToAcquireInvestmentsInEquitySecurities" xlink:type="locator" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities" />
    <link:label xml:lang="en-US" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to acquire investments in equity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PaymentsToAcquireInvestmentsInEquitySecurities" xlink:to="nk_PaymentsToAcquireInvestmentsInEquitySecurities_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation Depletion And Amortization</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease expense related to operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset Non Cash Lease Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on equity investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of net premiums and discounts on marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Losses (gains) on sales of marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Gain Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Disposition Of Assets1</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Non-cash interest items, net</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Interest Income Expense From Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on impairment of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred income tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Accounts Payable And Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Due To Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncreaseDecreaseInDeferredRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Deferred Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales of property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Property Plant And Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of debt securities, held-to-maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Held To Maturity Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of investments in equity securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Investments In Equity Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable debt securities, available-for-sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Available For Sale Securities Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales of marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Available For Sale Securities Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from equity offering, net of issuance cost paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercises of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercises of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Warrant Exercises</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal payments of financing obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Long Term Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchases of common stock with commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Repurchase Of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net share settlement for restricted stock unit vesting and warrant and option exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Related To Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of cash, cash equivalents, and restricted cash at end of period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted cash included in other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Asset Obtained In Exchange For Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cashless exercise of stock options and warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment purchases included in accounts payable, accrued expenses, and other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred But Not Yet Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Viracta convertible notes and accrued interest into investment in equity securities of Viracta (Note 5)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Amount1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized (losses) gains on marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain Loss On Investments</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DescriptionOfBusinessDisclosureTextBlock" xlink:type="locator" xlink:label="nk_DescriptionOfBusinessDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_DescriptionOfBusinessDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business disclosure.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DescriptionOfBusinessDisclosureTextBlock" xlink:to="nk_DescriptionOfBusinessDisclosureTextBlock_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_DescriptionOfBusinessDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DescriptionOfBusinessDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_FinancialStatementDetailsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Financial statement details.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_FinancialStatementDetailsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_FinancialStatementDetailsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Statement Details [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Statement Details</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Unspecified [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ProposedMergerWithImmunityBioMember" xlink:type="locator" xlink:label="nk_ProposedMergerWithImmunityBioMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ProposedMergerWithImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proposed Merger with ImmunityBio.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ProposedMergerWithImmunityBioMember" xlink:to="nk_ProposedMergerWithImmunityBioMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ProposedMergerWithImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proposed Merger With ImmunityBio</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ProposedMergerWithImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proposed Merger With Immunity Bio [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement and Plan of Merger with ImmunityBio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments All Other Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Viracta Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost And Equity Method Investments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:type="locator" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash equivalents and marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="nk_CashEquivalentsAndMarketableSecuritiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents And Marketable Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments Investments in Marketable Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Marketable Securities [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs Disclosure [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CollaborationAndLicenseAgreementsTextBlock" xlink:type="locator" xlink:label="nk_CollaborationAndLicenseAgreementsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_CollaborationAndLicenseAgreementsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CollaborationAndLicenseAgreementsTextBlock" xlink:to="nk_CollaborationAndLicenseAgreementsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CollaborationAndLicenseAgreementsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration and License Agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CollaborationAndLicenseAgreementsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreements [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&apos; Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summarized Quarterly Data (Unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Retirement Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pension And Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_LiquidityPolicyTextBlock" xlink:type="locator" xlink:label="nk_LiquidityPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_LiquidityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Liquidity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LiquidityPolicyTextBlock" xlink:to="nk_LiquidityPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LiquidityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LiquidityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:type="locator" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Uncertainties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:to="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unusual Risks And Uncertainties [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Intangible Assets Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LegalCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LegalCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalCostsPolicyTextBlock" xlink:to="us-gaap_LegalCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LegalCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Including Intangible Assets Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="us-gaap_CollaborativeArrangementAccountingPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Accounting Policy</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" xlink:type="locator" xlink:label="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preclinical and clinical trial accruals policy text block.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" xlink:to="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preclinical and Clinical Trial Accruals</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preclinical And Clinical Trial Accruals Policy [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transactions policy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:to="nk_RelatedPartyTransactionsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transactions with Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Leases Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_StockRepurchasesPolicyTextBlock" xlink:type="locator" xlink:label="nk_StockRepurchasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock repurchases policy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_StockRepurchasesPolicyTextBlock" xlink:to="nk_StockRepurchasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Repurchases</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchases Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_LitigationCostsPolicyTextBlock" xlink:type="locator" xlink:label="nk_LitigationCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_LitigationCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Litigation costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LitigationCostsPolicyTextBlock" xlink:to="nk_LitigationCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LitigationCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Litigation Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LitigationCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and Diluted Net Loss Per Share of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment and Geographic Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in Viracta</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Policy [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:type="locator" xlink:label="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Property plant and equipment useful life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Estimated Useful Lives of Property, Plant and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Excluded from the Computation of Potentially Dilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="locator" xlink:label="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses and other current assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Other Assets Noncurrent [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Current Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Income, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeTextBlock" xlink:to="us-gaap_InvestmentIncomeTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Investments in available-for-sale Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Continuous Unrealized Loss Position Fair Value Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRealizedGainLossTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRealizedGainLossTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:to="us-gaap_ScheduleOfRealizedGainLossTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRealizedGainLossTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Realized Gain Loss Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of operating right-of-use assets and lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:to="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Operating Right-of-use Assets and Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Operating Right Of Use Assets And Lease Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost Table [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of cash paid for amounts included in measurement of lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" xlink:to="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Cash Paid For Amounts Included In Measurement Of Lease Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Future Minimum Lease Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of common stock reserved for issuance .</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:to="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Common Stock Reserved For Issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Reserved For Issuance Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Based Compensation Expenses Included on Operations Statement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summarizes Stock Option Activity and Related Information Under Equity Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Options Outstanding and Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average of Fair Value of Options Under Black-Scholes Option-Pricing Model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs) Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonvested Restricted Stock Shares Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Warrant Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Loss Before Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Income Tax (Expense) Benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Net Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Federal Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summarizes of Changes in Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Quarterly Data (Unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Quarterly Financial Information Table [Text Block]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" />
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts, commissions and other offering expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" xlink:to="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization consolidation and presentation of financial statements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization consolidation and presentation of financial statements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="nk_UnderwrittenPublicOfferingMember" />
    <link:label xml:lang="en-US" xlink:label="nk_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwritten public offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_UnderwrittenPublicOfferingMember" xlink:to="nk_UnderwrittenPublicOfferingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from equity offering, net of issuance costs paid</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts, commissions and other offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts Commissions And Other Offering Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net cash used in operating activities</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesLineItems" xlink:type="locator" xlink:label="nk_AccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_AccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesTable" xlink:type="locator" xlink:label="nk_AccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccountingPoliciesTable" xlink:to="nk_AccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VIE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity Primary Beneficiary [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Country [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">State And Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrecigenLicenseAgreementMember" xlink:type="locator" xlink:label="nk_PrecigenLicenseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_PrecigenLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Precigen license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrecigenLicenseAgreementMember" xlink:to="nk_PrecigenLicenseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PrecigenLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Precigen License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrecigenLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Precigen License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage of ownership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment Ownership Percentage</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CashAndCashEquivalentsOriginalMaturities" xlink:type="locator" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities" />
    <link:label xml:lang="en-US" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents original maturities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CashAndCashEquivalentsOriginalMaturities" xlink:to="nk_CashAndCashEquivalentsOriginalMaturities_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" />
    <link:label xml:lang="en-US" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum original maturity period of long term marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" xlink:to="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" />
    <link:label xml:lang="en-US" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum original maturity period of short term marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" xlink:to="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents original maturities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Original Maturities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum original maturity period of short-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Original Maturity Period Of Short Term Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum original maturity period of long-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Original Maturity Period Of Long Term Marketable Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other than temporary impairments for marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Buildings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Building [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Software And Software Development Costs [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LaboratoryEquipmentMember" xlink:to="nk_LaboratoryEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture And Fixtures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ITEquipmentMember" xlink:type="locator" xlink:label="nk_ITEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ITEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">IT equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ITEquipmentMember" xlink:to="nk_ITEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ITEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IT Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ITEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">I T Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment estimated useful lives, term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Estimated Useful Lives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful lives of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Asset Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charge/losses of long-lived assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Long Lived Assets Held For Use</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" xlink:type="locator" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" />
    <link:label xml:lang="en-US" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value inputs, transfers into level 1, 2 or 3 categories.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" xlink:to="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value inputs, transfers into or out of Level 1, 2 or 3 categories</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasePracticalExpedientsPackage" xlink:type="locator" xlink:label="us-gaap_LeasePracticalExpedientsPackage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeasePracticalExpedientsPackage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease practical expedients package</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasePracticalExpedientsPackage" xlink:to="us-gaap_LeasePracticalExpedientsPackage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeasePracticalExpedientsPackage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Practical Expedients Package</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Description</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest or penalties associated with uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax year open for examination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Open Tax Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total amount authorized for repurchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchase Program Authorized Amount1</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NonrefundableUpfrontPayment" xlink:type="locator" xlink:label="nk_NonrefundableUpfrontPayment" />
    <link:label xml:lang="en-US" xlink:label="nk_NonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nonrefundable upfront payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NonrefundableUpfrontPayment" xlink:to="nk_NonrefundableUpfrontPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrefundable upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonrefundable Upfront Payment</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_VariableConsiderationRelatedToMilestonePayment" xlink:type="locator" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment" />
    <link:label xml:lang="en-US" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Variable consideration related to milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_VariableConsiderationRelatedToMilestonePayment" xlink:to="nk_VariableConsiderationRelatedToMilestonePayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable consideration related to milestone payment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Consideration Related To Milestone Payment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized for milestone payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Milestone Method Revenue Recognized</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfProductsApprovedForCommercialSale" xlink:type="locator" xlink:label="nk_NumberOfProductsApprovedForCommercialSale" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfProductsApprovedForCommercialSale_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of products approved for commercial sale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NumberOfProductsApprovedForCommercialSale" xlink:to="nk_NumberOfProductsApprovedForCommercialSale_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfProductsApprovedForCommercialSale_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of products approved for commercial sale</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfProductsApprovedForCommercialSale_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Products Approved For Commercial Sale</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding RSUs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities excluded from computation of earnings per share, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid preclinical and clinical trial services with related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_InsurancePremiumFinancingAsset" xlink:type="locator" xlink:label="nk_InsurancePremiumFinancingAsset" />
    <link:label xml:lang="en-US" xlink:label="nk_InsurancePremiumFinancingAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Insurance premium financing asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_InsurancePremiumFinancingAsset" xlink:to="nk_InsurancePremiumFinancingAsset_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidServices" xlink:type="locator" xlink:label="nk_PrepaidServices" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidServices" xlink:to="nk_PrepaidServices_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSuppliesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidSuppliesWithRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSuppliesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid supplies with related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidSuppliesWithRelatedParty" xlink:to="nk_PrepaidSuppliesWithRelatedParty_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidEquipmentMaintenance" xlink:type="locator" xlink:label="nk_PrepaidEquipmentMaintenance" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidEquipmentMaintenance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid equipment maintenance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidEquipmentMaintenance" xlink:to="nk_PrepaidEquipmentMaintenance_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidLicenseFees" xlink:type="locator" xlink:label="nk_PrepaidLicenseFees" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidLicenseFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid license fees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidLicenseFees" xlink:to="nk_PrepaidLicenseFees_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentDeposit" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentDeposit" />
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment deposit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LaboratoryEquipmentDeposit" xlink:to="nk_LaboratoryEquipmentDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid preclinical and clinical trial services - with related party (Note 10)</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Preclinical And Clinical Trial Services With Related Party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_InsurancePremiumFinancingAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insurance premium financing asset</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_InsurancePremiumFinancingAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Insurance Premium Financing Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid services</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Services</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent" xlink:type="locator" xlink:label="us-gaap_PrepaidRent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidRent" xlink:to="us-gaap_PrepaidRent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest receivable - marketable debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivableCurrent" xlink:to="us-gaap_InterestReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable Current</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSuppliesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid supplies - with related party (Note 10)</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSuppliesWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Supplies With Related Party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidEquipmentMaintenance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid equipment maintenance</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidEquipmentMaintenance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Equipment Maintenance</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidLicenseFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid license fees</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidLicenseFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid License Fees</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory equipment deposit</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LaboratoryEquipmentDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment Deposit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Due From Related Parties Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InsuranceSettlementsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insurance claim receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InsuranceSettlementsReceivableCurrent" xlink:to="us-gaap_InsuranceSettlementsReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InsuranceSettlementsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Insurance Settlements Receivable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, plant and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense related to property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Intangible Assets</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSoftwareLicenseFeesInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid software license fees in other assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidSoftwareLicenseFeesInOtherAssets" xlink:to="nk_PrepaidSoftwareLicenseFeesInOtherAssets_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid preclinical and clinical trial services with related party in other assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid software license fees</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Software License Fees In Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid preclinical and clinical trial services - with related party (Note 10)</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Preclinical And Clinical Trial Services With Related Party In Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueFromRelatedPartiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesNoncurrent" xlink:to="us-gaap_DueFromRelatedPartiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DueFromRelatedPartiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Due From Related Parties Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedLaboratoryEquipmentAndSupplies" xlink:type="locator" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies" />
    <link:label xml:lang="en-US" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued laboratory equipment and supplies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccruedLaboratoryEquipmentAndSupplies" xlink:to="nk_AccruedLaboratoryEquipmentAndSupplies_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedPreclinicalAndClinicalTrialCosts" xlink:type="locator" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts" />
    <link:label xml:lang="en-US" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued preclinical and clinical trial costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccruedPreclinicalAndClinicalTrialCosts" xlink:to="nk_AccruedPreclinicalAndClinicalTrialCosts_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedCapitalExpenditures" xlink:type="locator" xlink:label="nk_AccruedCapitalExpenditures" />
    <link:label xml:lang="en-US" xlink:label="nk_AccruedCapitalExpenditures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued capital expenditures.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccruedCapitalExpenditures" xlink:to="nk_AccruedCapitalExpenditures_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedFranchiseSalesUseAndPropertyTaxes" xlink:type="locator" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes" />
    <link:label xml:lang="en-US" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued franchise, sales/use and property taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AccruedFranchiseSalesUseAndPropertyTaxes" xlink:to="nk_AccruedFranchiseSalesUseAndPropertyTaxes_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional and service fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedBonusesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Bonuses Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedSalariesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Salaries Current</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued laboratory equipment and supplies</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Laboratory Equipment And Supplies</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued preclinical and clinical trial costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Preclinical And Clinical Trial Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedCapitalExpenditures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued capital expenditures</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedCapitalExpenditures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Capital Expenditures</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued franchise, sales/use and property taxes</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Franchise Sales Use And Property Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued Liabilities Current</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancingObligationCurrent" xlink:type="locator" xlink:label="nk_FinancingObligationCurrent" />
    <link:label xml:lang="en-US" xlink:label="nk_FinancingObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing obligation current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_FinancingObligationCurrent" xlink:to="nk_FinancingObligationCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_FinancingObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing obligation - current portion</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_FinancingObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financing Obligation Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Sundry Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other current liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment (amortization expense) accretion income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Net Amortization Of Discount And Premium</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net realized (losses) gains on investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Realized Investment Gains Losses</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investment income, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment loss on recognized investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Immunity Bio.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ImmunityBioMember" xlink:to="nk_ImmunityBioMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ImmunityBio</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ImmunityBioMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Immunity Bio [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_OwnershipDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NantKwestMember" xlink:type="locator" xlink:label="nk_NantKwestMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NantKwestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NantKwest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NantKwestMember" xlink:to="nk_NantKwestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NantKwestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nant Kwest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Executive Chairman and principal stockholder, and affiliates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Executive Chairman and principal stockholder, and affiliates</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Executive Chairman And Principal Stockholder And Affiliates [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of agreement and plan of merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Date Of Acquisition Agreement1</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_MergerExchangeRatio" xlink:type="locator" xlink:label="nk_MergerExchangeRatio" />
    <link:label xml:lang="en-US" xlink:label="nk_MergerExchangeRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Merger exchange ratio.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MergerExchangeRatio" xlink:to="nk_MergerExchangeRatio_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-for-stock transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MergerExchangeRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger exchange ratio</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MergerExchangeRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Merger Exchange Ratio</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" xlink:type="locator" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" />
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership percentage acquired on fully diluted bases upon consummation of merger.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" xlink:to="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageByKeyExecutives" xlink:type="locator" xlink:label="nk_OwnershipPercentageByKeyExecutives" />
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageByKeyExecutives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership percentage by key executives.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OwnershipPercentageByKeyExecutives" xlink:to="nk_OwnershipPercentageByKeyExecutives_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership percentage acquired on fully diluted bases upon consummation of merger</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Percentage Acquired On Fully Diluted Bases Upon Consummation Of Merger</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageByKeyExecutives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership percentage by key executives</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OwnershipPercentageByKeyExecutives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Percentage By Key Executives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForMergerRelatedCosts" xlink:to="us-gaap_PaymentsForMergerRelatedCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Merger Related Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Investments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_ScheduleOfInvestmentsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Investments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" xlink:type="locator" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">2018 Note and Warrant Purchase Agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" xlink:to="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Note and Warrant Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Eighteen Note And Warrant Purchase Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_OtherIncomeAndExpenseNetMember" xlink:type="locator" xlink:label="nk_OtherIncomeAndExpenseNetMember" />
    <link:label xml:lang="en-US" xlink:label="nk_OtherIncomeAndExpenseNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Income and Expense, Net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OtherIncomeAndExpenseNetMember" xlink:to="nk_OtherIncomeAndExpenseNetMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_OtherIncomeAndExpenseNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Income and Expense, Net</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OtherIncomeAndExpenseNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Income And Expense Net [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Investments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity securities</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PurchaseOfConvertibleNoteUponConversion" xlink:type="locator" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion" />
    <link:label xml:lang="en-US" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of convertible note upon conversion.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PurchaseOfConvertibleNoteUponConversion" xlink:to="nk_PurchaseOfConvertibleNoteUponConversion_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of convertible note</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Convertible Note Upon Conversion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible note accrued interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Effective Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercised to acquire shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction in carrying value on cumulative basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CurrentAssetsMember" xlink:type="locator" xlink:label="nk_CurrentAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_CurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Current assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CurrentAssetsMember" xlink:to="nk_CurrentAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NoncurrentAssetsMember" xlink:type="locator" xlink:label="nk_NoncurrentAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NoncurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncurrent assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NoncurrentAssetsMember" xlink:to="nk_NoncurrentAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NoncurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NoncurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncurrent Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignGovernmentDebtMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Government Bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignGovernmentDebtMember" xlink:to="us-gaap_ForeignGovernmentDebtMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignGovernmentDebtMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Government Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnderlyingAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underlying Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnderlyingAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underlying Asset Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnderlyingAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underlying Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_UnderlyingAssetClassDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnderlyingAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underlying Asset Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government Sponsored Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AgencySecuritiesMember" xlink:to="us-gaap_AgencySecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agency Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale, Unrealized Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Available-for-sale, Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt securities period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" xlink:to="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" />
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities and held to maturity gross unrealized gain.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" />
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities and held to maturity gross unrealized losses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale, Weighted- Average Remaining Contractual Life</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale and held-to-maturity, Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities And Held To Maturity Gross Unrealized Gain</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale and held-to-maturity, Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities And Held To Maturity Gross Unrealized Losses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale and held-to-maturity, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities And Held To Maturity Securities</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" />
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities period of unrealized loss positions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" xlink:to="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesMember" xlink:to="us-gaap_DebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale securities, period of unrealized loss positions</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Period Of Unrealized Loss Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-Sale Investments, Less than 12 months, Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Available-for-Sale Investments, Less than 12 months, Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-Sale Investments, More than 12 months, Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Available-for-Sale Investments, More than 12 months, Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of available-for-sale securities in unrealized loss positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" xlink:to="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesRealizedGainLossAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesRealizedGainLossAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Realized Gain Loss [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:to="us-gaap_DebtSecuritiesRealizedGainLossAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale Securities, Gross Realized Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Gross Realized Gains</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Available-for-sale Securities, Gross Realized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Gross Realized Losses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available for Sale Securities, Net Realized Gains (Losses)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Gross Realized Gain Loss Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurements, Recurring</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets measured at fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TermOfAgreement" xlink:type="locator" xlink:label="nk_TermOfAgreement" />
    <link:label xml:lang="en-US" xlink:label="nk_TermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TermOfAgreement" xlink:to="nk_TermOfAgreement_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" xlink:type="locator" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" />
    <link:label xml:lang="en-US" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional term of agreement renewable upon mutual agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" xlink:to="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementAbstract" xlink:type="locator" xlink:label="nk_LicensingAgreementAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LicensingAgreementAbstract" xlink:to="nk_LicensingAgreementAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Licensing Agreement [Abstract]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementLineItems" xlink:type="locator" xlink:label="nk_LicensingAgreementLineItems" />
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicensingAgreementLineItems_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementTable" xlink:type="locator" xlink:label="nk_LicensingAgreementTable" />
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LicensingAgreementTable" xlink:to="nk_LicensingAgreementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Licensing Agreement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Licensing Agreement [Table]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:type="locator" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Joint COVID 19 Collaboration Development Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:to="nk_JointCOVID19CollaborationDevelopmentAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Joint C O V I D19 Collaboration Development Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:type="locator" xlink:label="us-gaap_SalesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="us-gaap_SalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrecurring Adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrecurring Adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="us-gaap_NonrecurringAdjustmentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ProgramEquipmentRelatedCostsMember" xlink:type="locator" xlink:label="nk_ProgramEquipmentRelatedCostsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ProgramEquipmentRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Program Equipment Related Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ProgramEquipmentRelatedCostsMember" xlink:to="nk_ProgramEquipmentRelatedCostsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ProgramEquipmentRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Program Equipment Related Costs [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NetProgramRelatedCostsMember" xlink:type="locator" xlink:label="nk_NetProgramRelatedCostsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NetProgramRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net program related costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NetProgramRelatedCostsMember" xlink:to="nk_NetProgramRelatedCostsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NetProgramRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Program Related Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetProgramRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Program Related Costs [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ClinicalTrialCostAllocationAgreementMember" xlink:type="locator" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical Trial Cost Allocation Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ClinicalTrialCostAllocationAgreementMember" xlink:to="nk_ClinicalTrialCostAllocationAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Trial Cost Allocation Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ViractaTherapeuticsIncMember" xlink:type="locator" xlink:label="nk_ViractaTherapeuticsIncMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ViractaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Viracta Therapeutics, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ViractaTherapeuticsIncMember" xlink:to="nk_ViractaTherapeuticsIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ViractaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Viracta Therapeutics, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ViractaTherapeuticsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Viracta Therapeutics Inc [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="us-gaap_OtherCommitmentsDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RushUniversityMedicalCenterLicenseAgreementMember" xlink:type="locator" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Rush university medical center license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RushUniversityMedicalCenterLicenseAgreementMember" xlink:to="nk_RushUniversityMedicalCenterLicenseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rush University Medical Center License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Rush University Medical Center License Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others Type [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_INDFilingMember" xlink:type="locator" xlink:label="nk_INDFilingMember" />
    <link:label xml:lang="en-US" xlink:label="nk_INDFilingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">IND filing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_INDFilingMember" xlink:to="nk_INDFilingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_INDFilingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First IND Filing</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_INDFilingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">I N D Filing [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseTwoMember" xlink:type="locator" xlink:label="nk_PhaseTwoMember" />
    <link:label xml:lang="en-US" xlink:label="nk_PhaseTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PhaseTwoMember" xlink:to="nk_PhaseTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PhaseTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Phase II Clinical Trial</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PhaseTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Phase Two [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseThreeMember" xlink:type="locator" xlink:label="nk_PhaseThreeMember" />
    <link:label xml:lang="en-US" xlink:label="nk_PhaseThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PhaseThreeMember" xlink:to="nk_PhaseThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PhaseThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Phase III Clinical Trial</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PhaseThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Phase Three [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CommercialSaleRelatedToLicensedProductsMember" xlink:type="locator" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial sale related to licensed products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CommercialSaleRelatedToLicensedProductsMember" xlink:to="nk_CommercialSaleRelatedToLicensedProductsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Sale Related to Licensed Products</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Sale Related To Licensed Products [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrecigenLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Precigen License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Licensing Agreement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicensingAgreementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Licensing Agreement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Profit sharing percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Percentage1</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Of Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional term of agreement renewable upon mutual agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Term Of Agreement Renewable Upon Mutual Agreement</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementRenewalTerm" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party agreement renewal term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyAgreementRenewalTerm" xlink:to="nk_RelatedPartyAgreementRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party, agreement renewal term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Agreement Renewal Term</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_MilestonePaymentAmount" xlink:type="locator" xlink:label="nk_MilestonePaymentAmount" />
    <link:label xml:lang="en-US" xlink:label="nk_MilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payment amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MilestonePaymentAmount" xlink:to="nk_MilestonePaymentAmount_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_LicenseAgreementTerminationNoticePeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement termination notice period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LicenseAgreementTerminationNoticePeriod" xlink:to="nk_LicenseAgreementTerminationNoticePeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_MilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Milestone Payment Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement termination notice period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Termination Notice Period</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreement" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreement" />
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PeriodOfLicenseAgreement" xlink:to="nk_PeriodOfLicenseAgreement_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumAnnualRoyaltyPayment" xlink:type="locator" xlink:label="nk_MinimumAnnualRoyaltyPayment" />
    <link:label xml:lang="en-US" xlink:label="nk_MinimumAnnualRoyaltyPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum annual royalty payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MinimumAnnualRoyaltyPayment" xlink:to="nk_MinimumAnnualRoyaltyPayment_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumSalesMilestoneOfLicenseForFirstYear" xlink:type="locator" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear" />
    <link:label xml:lang="en-US" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum sales milestone of license for first year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MinimumSalesMilestoneOfLicenseForFirstYear" xlink:to="nk_MinimumSalesMilestoneOfLicenseForFirstYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of license agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period Of License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumAnnualRoyaltyPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum annual royalty payment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumAnnualRoyaltyPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Annual Royalty Payment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments in license agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum sales milestone of license for first year</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Sales Milestone Of License For First Year</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AgreementOneTimeFee" xlink:type="locator" xlink:label="nk_AgreementOneTimeFee" />
    <link:label xml:lang="en-US" xlink:label="nk_AgreementOneTimeFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement one time fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AgreementOneTimeFee" xlink:to="nk_AgreementOneTimeFee_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerm" xlink:type="locator" xlink:label="nk_LicenseAgreementTerm" />
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LicenseAgreementTerm" xlink:to="nk_LicenseAgreementTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement term (years)</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LicenseAgreementTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AgreementOneTimeFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement one time fee</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AgreementOneTimeFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement One Time Fee</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Milestone payments</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_CommitmentsAndContingenciesLineItems_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesTable" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and Contingencies Table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="nk_CommitmentsAndContingenciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, General and Administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReinsurancePolicyTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reinsurance Policy, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReinsurancePolicyTypeAxis" xlink:to="us-gaap_ReinsurancePolicyTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReinsurancePolicyTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reinsurance Policy Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReinsurancePolicyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reinsurance Policy</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReinsurancePolicyDomain" xlink:to="us-gaap_ReinsurancePolicyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReinsurancePolicyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reinsurance Policy [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DirectorsAndOfficersInsurancePolicyMember" xlink:type="locator" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember" />
    <link:label xml:lang="en-US" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Directors and officers insurance policy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DirectorsAndOfficersInsurancePolicyMember" xlink:to="nk_DirectorsAndOfficersInsurancePolicyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Directors and Officers Insurance Policy</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Directors And Officers Insurance Policy [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative Effect, Period of Adoption</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect Period Of Adoption [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative Effect, Period of Adoption</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect Period Of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect Period Of Adoption Adjustment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Application Period Cumulative Effect Transition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Application Period Cumulative Effect Transition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" xlink:type="locator" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" />
    <link:label xml:lang="en-US" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Difference between lease guidance in effect before and after Topic 842.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" xlink:to="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Difference between Lease Guidance in Effect before and after Topic 842</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Difference Between Lease Guidance In Effect Before And After Topic842 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ElSegundoCaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">El Segundo, California.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ElSegundoCaliforniaMember" xlink:to="nk_ElSegundoCaliforniaMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ElSegundoCaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">El Segundo California</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ElSegundoCaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">El Segundo California [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:type="locator" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember" />
    <link:label xml:lang="en-US" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Altor Bioscience Manufacturing Company, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:to="nk_AltorBioscienceManufacturingCompanyLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Altor Bioscience Manufacturing Company, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Altor Bioscience Manufacturing Company L L C [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NantBioScienceMember" xlink:type="locator" xlink:label="nk_NantBioScienceMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NantBioScienceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">NantBioScience.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NantBioScienceMember" xlink:to="nk_NantBioScienceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NantBioScienceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NantBioScience</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NantBioScienceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nant Bio Science [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DougStLLCMember" xlink:type="locator" xlink:label="nk_DougStLLCMember" />
    <link:label xml:lang="en-US" xlink:label="nk_DougStLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Doug St LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DougStLLCMember" xlink:to="nk_DougStLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_DougStLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Doug St, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DougStLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Doug St L L C [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentWoburnMassachusettsMember" xlink:type="locator" xlink:label="nk_CommitmentWoburnMassachusettsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentWoburnMassachusettsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment Woburn Massachusetts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CommitmentWoburnMassachusettsMember" xlink:to="nk_CommitmentWoburnMassachusettsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentWoburnMassachusettsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Woburn, Massachusetts</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentWoburnMassachusettsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment Woburn Massachusetts [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:type="locator" xlink:label="srt_ScenarioForecastMember" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioForecastMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forecast</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioForecastMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Forecast [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NantWorksLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nant Works LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NantWorksLimitedLiabilityCompanyMember" xlink:to="nk_NantWorksLimitedLiabilityCompanyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NantWorks</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nant Works Limited Liability Company [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_AmendmentToExtendLeaseTermMember" xlink:type="locator" xlink:label="nk_AmendmentToExtendLeaseTermMember" />
    <link:label xml:lang="en-US" xlink:label="nk_AmendmentToExtendLeaseTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amendment to extend lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AmendmentToExtendLeaseTermMember" xlink:to="nk_AmendmentToExtendLeaseTermMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_AmendmentToExtendLeaseTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment to Extend Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AmendmentToExtendLeaseTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment To Extend Lease Term [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentSanDiegoMember" xlink:type="locator" xlink:label="nk_CommitmentSanDiegoMember" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentSanDiegoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment; San Diego.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_CommitmentSanDiegoMember" xlink:to="nk_CommitmentSanDiegoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentSanDiegoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment; San Diego</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentSanDiegoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment San Diego [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Litigation settlement amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Amount Awarded To Other Party</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:type="locator" xlink:label="us-gaap_LegalFees" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LegalFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Attorney&apos;s fee to plaintiffs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LegalFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Fees</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivable" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InsuranceSettlementsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InsuranceSettlementsReceivable" xlink:to="us-gaap_InsuranceSettlementsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InsuranceSettlementsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Insurance Settlements Receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Operating lease right-of-use assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNet" xlink:type="locator" xlink:label="us-gaap_AssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Build-to-suit related liabilities and assets adjust as accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Net</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of square foot of facility leased.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NumberOfSquareFootOfFacilityLeased" xlink:to="nk_NumberOfSquareFootOfFacilityLeased_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:label xml:lang="en-US" xlink:label="nk_BaseMonthlyRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Base monthly rent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_BaseMonthlyRent" xlink:to="nk_BaseMonthlyRent_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseCommencementDate" xlink:type="locator" xlink:label="nk_LeaseCommencementDate" />
    <link:label xml:lang="en-US" xlink:label="nk_LeaseCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LeaseCommencementDate" xlink:to="nk_LeaseCommencementDate_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionToNumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased" />
    <link:label xml:lang="en-US" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Addition to number of square foot of facility leased.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AdditionToNumberOfSquareFootOfFacilityLeased" xlink:to="nk_AdditionToNumberOfSquareFootOfFacilityLeased_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualBaseRentIncreasePerSquareFoot" xlink:type="locator" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot" />
    <link:label xml:lang="en-US" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual base rent increase per square foot.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AnnualBaseRentIncreasePerSquareFoot" xlink:to="nk_AnnualBaseRentIncreasePerSquareFoot_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_LeaseAgreementExtendedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease agreement extended period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LeaseAgreementExtendedPeriod" xlink:to="nk_LeaseAgreementExtendedPeriod_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreementDescription" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreementDescription" />
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreementDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of license agreement description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PeriodOfLicenseAgreementDescription" xlink:to="nk_PeriodOfLicenseAgreementDescription_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual percentage increases to base rent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AnnualPercentageIncreasesToBaseRent" xlink:to="nk_AnnualPercentageIncreasesToBaseRent_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" />
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual percentage increases to base rent commencement date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:to="nk_AnnualPercentageIncreasesToBaseRentCommencementDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of square foot of facility leased</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Square Foot Of Facility Leased</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_BaseMonthlyRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Base rent - monthly</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_BaseMonthlyRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Base Monthly Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial term of lease arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Term Of Contract</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LeaseCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commencement date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LeaseCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Addition to number of square foot of facility leased</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Addition To Number Of Square Foot Of Facility Leased</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual increase of base rent</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Base Rent Increase Per Square Foot</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Optional extended lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LeaseAgreementExtendedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement extended lease period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LeaseAgreementExtendedPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Agreement Extended Period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreementDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfLicenseAgreementDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period Of License Agreement Description</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of annual increase of base rent</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Percentage Increases To Base Rent</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual percentage increases to base rent commencement date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Percentage Increases To Base Rent Commencement Date</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RightOfUseAssetsAbstract" xlink:type="locator" xlink:label="nk_RightOfUseAssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_RightOfUseAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RightOfUseAssetsAbstract" xlink:to="nk_RightOfUseAssetsAbstract_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShortTermLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nk_ShortTermLeaseLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_ShortTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ShortTermLeaseLiabilitiesAbstract" xlink:to="nk_ShortTermLeaseLiabilitiesAbstract_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LongTermLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nk_LongTermLeaseLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_LongTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Long-term lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_LongTermLeaseLiabilitiesAbstract" xlink:to="nk_LongTermLeaseLiabilitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RightOfUseAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets:</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RightOfUseAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShortTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term lease liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShortTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Lease Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LongTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term lease liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_LongTermLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total lease liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel">Operating lease liabilities (including amounts with related parties)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:type="locator" xlink:label="us-gaap_VariableLeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rental expenses for operating leases including common-area maintenance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Rent Expense Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow Operating Activities Lessee [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Operating cash flows for operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Discount Rate Percent</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" xlink:type="locator" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" />
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease payments related to options to extend lease terms.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" xlink:to="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease payments related to options to extend lease terms</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments Related To Options To Extend Lease Terms</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future minimum lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of operating lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future minimum lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfExtendedLeaseTerm" xlink:type="locator" xlink:label="nk_PeriodOfExtendedLeaseTerm" />
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfExtendedLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of extended lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PeriodOfExtendedLeaseTerm" xlink:to="nk_PeriodOfExtendedLeaseTerm_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MonthlyFixedCharge" xlink:type="locator" xlink:label="nk_MonthlyFixedCharge" />
    <link:label xml:lang="en-US" xlink:label="nk_MonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Monthly fixed charge.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_MonthlyFixedCharge" xlink:to="nk_MonthlyFixedCharge_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" />
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual percentage increases to monthly fixed charge.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:to="nk_AnnualPercentageIncreasesToMonthlyFixedCharge_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" />
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual percentage increases to fixed charge commencement date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" xlink:to="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Period of agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfExtendedLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Optional extended lease term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfExtendedLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period Of Extended Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Monthly fixed charge</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_MonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Monthly Fixed Charge</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual percentage increases to monthly fixed charge</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Percentage Increases To Monthly Fixed Charge</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual percentage increases to fixed charge commencement date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Percentage Increases To Fixed Charge Commencement Date</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction, Reimbursed upfront payment to third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction, amount paid to related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionAmountPaidToRelatedParty" xlink:to="nk_RelatedPartyTransactionAmountPaidToRelatedParty_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction initial term of agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:to="nk_RelatedPartyTransactionInitialTermOfAgreement_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party agreement expiration month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:to="nk_RelatedPartyAgreementExpirationMonthAndYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reimbursed upfront payment to third-party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Reimbursed Upfront Payment To Third Party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction, amount paid to third-party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Amount Paid To Related Party</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction, aggregate value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Amounts Of Transaction</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial term of agreement entered into with the related party by the entity</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Initial Term Of Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party agreement expiration date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Agreement Expiration Month And Year</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfExtendedLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Optional extended lease term</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" xlink:type="locator" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of days prior to written notice to terminate lease,</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" xlink:to="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of days prior to written notice to terminate lease</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Days Prior To Written Notice To Terminate Lease</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unconditional purchase obligations, Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecorded Unconditional Purchase Obligation Balance Sheet Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unconditional purchase obligations, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecorded Unconditional Purchase Obligation Balance On First Anniversary</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unconditional purchase obligations, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unconditional purchase obligations, 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_SharedServicesAgreementMember" xlink:type="locator" xlink:label="nk_SharedServicesAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nk_SharedServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Shared services agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_SharedServicesAgreementMember" xlink:to="nk_SharedServicesAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_SharedServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shared Services Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_SharedServicesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shared Services Agreement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:type="locator" xlink:label="us-gaap_TransactionTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransactionTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransactionTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:type="locator" xlink:label="us-gaap_TransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionDomain" xlink:to="us-gaap_TransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transaction [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ReimbursementsMember" xlink:type="locator" xlink:label="nk_ReimbursementsMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ReimbursementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reimbursements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ReimbursementsMember" xlink:to="nk_ReimbursementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ReimbursementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reimbursements</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ReimbursementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reimbursements [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunoOncologyClinicIncMember" xlink:type="locator" xlink:label="nk_ImmunoOncologyClinicIncMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ImmunoOncologyClinicIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Immuno Oncology Clinic Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ImmunoOncologyClinicIncMember" xlink:to="nk_ImmunoOncologyClinicIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ImmunoOncologyClinicIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Immuno-Oncology Clinic, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ImmunoOncologyClinicIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Immuno Oncology Clinic Inc [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <link:label xml:lang="en-US" xlink:label="stpr_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl" />
    <link:label xml:lang="en-US" xlink:label="stpr_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Joint COVID 19 Collaboration Development Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ProgramEquipmentRelatedCostsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Program equipment related costs.</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical trial cost allocation agreement.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementMember" xlink:to="us-gaap_CollaborativeArrangementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NantHealthLabsIncMember" xlink:type="locator" xlink:label="nk_NantHealthLabsIncMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NantHealthLabsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nant Health Labs, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NantHealthLabsIncMember" xlink:to="nk_NantHealthLabsIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NantHealthLabsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NantHealth Labs, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NantHealthLabsIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nant Health Labs Inc [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative expense</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Expense</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfOfficers" xlink:type="locator" xlink:label="nk_NumberOfOfficers" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfOfficers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of officers.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NumberOfOfficers" xlink:to="nk_NumberOfOfficers_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfOfficers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of officers</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NumberOfOfficers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Officers</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_InitialTermOfAgreement" xlink:type="locator" xlink:label="nk_InitialTermOfAgreement" />
    <link:label xml:lang="en-US" xlink:label="nk_InitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial term of agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_InitialTermOfAgreement" xlink:to="nk_InitialTermOfAgreement_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_InitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial term of agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_InitialTermOfAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Initial Term Of Agreement</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyInstallmentPayment" xlink:type="locator" xlink:label="nk_RelatedPartyInstallmentPayment" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyInstallmentPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party installment payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyInstallmentPayment" xlink:to="nk_RelatedPartyInstallmentPayment_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionConditionalPayment" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionConditionalPayment" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionConditionalPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction conditional payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionConditionalPayment" xlink:to="nk_RelatedPartyTransactionConditionalPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyInstallmentPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction installment payment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyInstallmentPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Installment Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Estimated cost for new agreement with clinic</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionConditionalPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction conditional payment</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionConditionalPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Conditional Payment</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAgreementExtensionDescription" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction agreement extension description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionAgreementExtensionDescription" xlink:to="nk_RelatedPartyTransactionAgreementExtensionDescription_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NewAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_NewAgreementTerminationNoticePeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_NewAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">New agreement termination notice period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NewAgreementTerminationNoticePeriod" xlink:to="nk_NewAgreementTerminationNoticePeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Prepayments remain unearned extension description</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Agreement Extension Description</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NewAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notice period to terminate new agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NewAgreementTerminationNoticePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Agreement Termination Notice Period</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid balance included in prepaid expenses and other current assets and other assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" xlink:to="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid balance included in prepaid expenses and other current assets and other assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Balance Included In Prepaid Expenses And Other Current Assets And Other Assets</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_FixedAndVariableLeaseCosts" xlink:type="locator" xlink:label="nk_FixedAndVariableLeaseCosts" />
    <link:label xml:lang="en-US" xlink:label="nk_FixedAndVariableLeaseCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fixed and variable lease costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_FixedAndVariableLeaseCosts" xlink:to="nk_FixedAndVariableLeaseCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Date of agreement and plan of merger</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_FixedAndVariableLeaseCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed and variable lease costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_FixedAndVariableLeaseCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fixed And Variable Lease Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on disposal of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Sale Of Property Plant Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related parties, capitalized equipment amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Purchases From Related Party</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses and other assets current with related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" xlink:to="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Assets Current With Related Party</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Description Of Transaction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due between parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Due From To Related Party</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction reimbursed upfront payment to related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction, amount paid to third-party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_RelatedPartyTransactionAmountPaidToThirdParty" xlink:to="nk_RelatedPartyTransactionAmountPaidToThirdParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction,reimbursement payment to a related-party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Reimbursed Upfront Payment To Related Party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction, amount paid to third-party</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Amount Paid To Third Party</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development expense ratable payment period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" xlink:to="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaymentOfFundingAmount" xlink:type="locator" xlink:label="nk_PrepaymentOfFundingAmount" />
    <link:label xml:lang="en-US" xlink:label="nk_PrepaymentOfFundingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment of funding amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PrepaymentOfFundingAmount" xlink:to="nk_PrepaymentOfFundingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expense, ratable payment period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Ratable Payment Period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaymentOfFundingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment for services amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PrepaymentOfFundingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Of Funding Amount</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" />
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts commissions and offering expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" xlink:to="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" />
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares sold to public upon full exercise of underwriters&#8217; option to purchase additional shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Financing Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Financing Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction Type [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_PublicMember" xlink:type="locator" xlink:label="nk_PublicMember" />
    <link:label xml:lang="en-US" xlink:label="nk_PublicMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Public.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PublicMember" xlink:to="nk_PublicMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_PublicMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PublicMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Public [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" />
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares sold to public upon full exercise of underwriters&#8217; option to purchase additional shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Sold to Public upon full Exercise of Underwriters Option to Purchase Additional Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Sold To Public Upon Full Exercise Of Underwriters Option To Purchase Additional Shares [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Executive chairman and principal stockholder.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExecutiveChairmanAndPrincipalStockholderMember" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dr. Patrick Soon-Shiong</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Executive Chairman And Principal Stockholder [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares sold to public upon full exercise of underwriters&#8217; option to purchase additional shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Sold To Public Upon Full Exercise Of Underwriters Option To Purchase Additional Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts, commissions and other offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts Commissions And Offering Expenses</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" xlink:type="locator" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" />
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock repurchased and retired excluding commission during period value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" xlink:to="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock excluding commissions, value</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased And Retired Excluding Commission During Period Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesCommissionsAndFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Broker commissions on repurchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesCommissionsAndFees_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Commissions And Fees</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining authorized repurchase amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchase Program Remaining Authorized Repurchase Amount1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding RSUs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total shares reserved for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fourteen equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TwoThousandFourteenEquityIncentivePlanMember" xlink:to="nk_TwoThousandFourteenEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFifteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fifteen equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TwoThousandFifteenEquityIncentivePlanMember" xlink:to="nk_TwoThousandFifteenEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2015 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fifteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NonEmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_NonEmployeeRestrictedStockUnitMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NonEmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non employee restricted stock unit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NonEmployeeRestrictedStockUnitMember" xlink:to="nk_NonEmployeeRestrictedStockUnitMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NonEmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Employee Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NonEmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Employee Restricted Stock Unit [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_EmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_EmployeeRestrictedStockUnitMember" />
    <link:label xml:lang="en-US" xlink:label="nk_EmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee restricted stock unit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_EmployeeRestrictedStockUnitMember" xlink:to="nk_EmployeeRestrictedStockUnitMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_EmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_EmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Restricted Stock Unit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation, expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation vested and exercisable options outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" />
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of additional shares that may be added to shares reserved for issuance under an established share-based compensation plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional common shares reserved for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for future grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Shares that may be added to shares reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Possible Increase In Number Of Shares Reserved For Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants For Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Compensation Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_EmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee RSUs</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NonEmployeeRestrictedStockUnitMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-employee RSUs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:type="locator" xlink:label="srt_OfficerMember" />
    <link:label xml:lang="en-US" xlink:label="srt_OfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Officer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OfficerMember" xlink:to="srt_OfficerMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_OfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Officer [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stock Options, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Stock Options, Options granted</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock Options, Options exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock Options, Options forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stock Options, Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options, Vested and Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Exercise Price, Outstanding Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Exercise Price, Outstanding Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Vested and Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share-based payment award, options, aggregate intrinsic value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate Intrinsic Value, Outstanding, Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate Intrinsic Value, Outstanding, Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Vested and Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life, Vested and Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost related to unvested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining weighted-average period for recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options, weighted-average exercises prices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of stock option exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options, vested and exercisable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeOneMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeOneMember" xlink:to="nk_ExercisePriceRangeOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$0.4213</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeTwoMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeTwoMember" xlink:to="nk_ExercisePriceRangeTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$1.7554</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeThreeMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeThreeMember" xlink:to="nk_ExercisePriceRangeThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$1.9984</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFourMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeFourMember" xlink:to="nk_ExercisePriceRangeFourMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$3.07</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFiveMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range five.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeFiveMember" xlink:to="nk_ExercisePriceRangeFiveMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$6.21</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeSixMember" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range six.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ExercisePriceRangeSixMember" xlink:to="nk_ExercisePriceRangeSixMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$25.00</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Prices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Number Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options Outstanding, Number Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" />
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award fair value assumptions price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Shares, Unvested, Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Number of Shares, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Shares, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Shares, Forfeited/Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Shares, Unvested, Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Grant Date Fair Value, Unvested, beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value, Forfeited/Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Grant Date Fair Value, Unvested, ending balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grants of restricted stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost related to non-vested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExpired" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired" />
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares warrants expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_StockIssuedDuringPeriodSharesWarrantsExpired" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExpired_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of shares Warrants, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares Warrants exercised</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares Warrants expired</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Warrants Expired</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of shares Warrants, Ending Balance</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ClassOfWarrantOrRightsIssued" xlink:type="locator" xlink:label="nk_ClassOfWarrantOrRightsIssued" />
    <link:label xml:lang="en-US" xlink:label="nk_ClassOfWarrantOrRightsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or rights issued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ClassOfWarrantOrRightsIssued" xlink:to="nk_ClassOfWarrantOrRightsIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ClassOfWarrantOrRightsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants issued</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ClassOfWarrantOrRightsIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Rights Issued</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants outstanding</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxLineItems" xlink:type="locator" xlink:label="nk_IncomeTaxLineItems" />
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_IncomeTaxLineItems_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxTable" xlink:type="locator" xlink:label="nk_IncomeTaxTable" />
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_IncomeTaxTable" xlink:to="nk_IncomeTaxTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_KR" xlink:type="locator" xlink:label="country_KR" />
    <link:label xml:lang="en-US" xlink:label="country_KR_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Korea</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_KR" xlink:to="country_KR_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_KR_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">KOREA, REPUBLIC OF</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Country [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research Tax Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxPeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxPeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxPeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxPeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2020Member" xlink:type="locator" xlink:label="us-gaap_TaxYear2020Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxYear2020Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Year 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxYear2020Member" xlink:to="us-gaap_TaxYear2020Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxYear2020Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Year2020 [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxYear2021AndThereafterMember" xlink:type="locator" xlink:label="nk_TaxYear2021AndThereafterMember" />
    <link:label xml:lang="en-US" xlink:label="nk_TaxYear2021AndThereafterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax year 2021 and thereafter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TaxYear2021AndThereafterMember" xlink:to="nk_TaxYear2021AndThereafterMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_TaxYear2021AndThereafterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Year 2021 and Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TaxYear2021AndThereafterMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Year2021 And Thereafter [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_IncomeTaxLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="locator" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Income Tax Expense Benefit Continuing Operations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. loss before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign income (loss) before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Foreign</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredIncomeTaxExpenseBenefitNet" xlink:type="locator" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet" />
    <link:label xml:lang="en-US" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred income tax expense benefit, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DeferredIncomeTaxExpenseBenefitNet" xlink:to="nk_DeferredIncomeTaxExpenseBenefitNet_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal State And Local Tax Expense Benefit [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current State And Local Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal State And Local Tax Expense Benefit [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State And Local Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense Benefit</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit Net</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Income tax (expense) benefit</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="nk_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets deferred depreciation and amortization.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" xlink:to="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets leases and other accrued liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" xlink:to="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Deferred Depreciation And Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases and other accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Leases And Other Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Leasing Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred tax liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" xlink:type="locator" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" />
    <link:label xml:lang="en-US" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation stock based compensation contribution.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" xlink:to="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tax computed at federal statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation State And Local Income Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax rate adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Tax Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Deductions Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Continuing Operations</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" />
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development cumulative change in ownership Percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" xlink:to="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfCumulativeOwnershipChange" xlink:type="locator" xlink:label="nk_PeriodOfCumulativeOwnershipChange" />
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfCumulativeOwnershipChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of cumulative ownership change.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_PeriodOfCumulativeOwnershipChange" xlink:to="nk_PeriodOfCumulativeOwnershipChange_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DerecognizedDeferredTaxAssets" xlink:type="locator" xlink:label="nk_DerecognizedDeferredTaxAssets" />
    <link:label xml:lang="en-US" xlink:label="nk_DerecognizedDeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognized deferred tax assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_DerecognizedDeferredTaxAssets" xlink:to="nk_DerecognizedDeferredTaxAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative change in ownership</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Cumulative Change In Ownership Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfCumulativeOwnershipChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of cumulative ownership change</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_PeriodOfCumulativeOwnershipChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period Of Cumulative Ownership Change</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DerecognizedDeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognized deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_DerecognizedDeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Derecognized Deferred Tax Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets valuation allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax benefits credited to contributed capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Effects Allocated Directly To Equity Equity Transactions</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarryforwardsExpirationDate" xlink:type="locator" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate" />
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NetOperatingLossCarryforwardsExpirationDate" xlink:to="nk_NetOperatingLossCarryforwardsExpirationDate_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCreditCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TaxCreditCarryforwardExpirationPeriod" xlink:to="nk_TaxCreditCarryforwardExpirationPeriod_lbl" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" xlink:type="locator" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" />
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carried forwards as percentage on taxable income.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" xlink:to="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards will not expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carried forwards as percentage on taxable income</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carried Forwards As Percentage On Taxable Income</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards expiration date</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration Date</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward expiration period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Period</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarrybacksPeriod" xlink:type="locator" xlink:label="nk_NetOperatingLossCarrybacksPeriod" />
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarrybacksPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carrybacks period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NetOperatingLossCarrybacksPeriod" xlink:to="nk_NetOperatingLossCarrybacksPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarrybacksPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carrybacks period</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NetOperatingLossCarrybacksPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carrybacks Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized tax benefits at beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Decrease for prior year tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase for current year tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized tax benefits at ending balance</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" xlink:type="locator" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" />
    <link:label xml:lang="en-US" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The total amount of unrecognized tax benefits that, if recognized, would not affect the effective tax rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" xlink:to="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits that would not impact effective tax rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" xlink:type="locator" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" />
    <link:label xml:lang="en-US" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax cuts and jobs act of 2017 incomplete accounting change in tax rate minimum amount for elimination of several business deductions and credits including deductions for certain executive compensation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" xlink:to="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate tax rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum Amount for elimination of several business deductions and credits, including deductions for certain executive compensation</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Minimum Amount For Elimination Of Several Business Deductions And Credits Including Deductions For Certain Executive Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialDataAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialDataAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Quarterly Financial Data [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_QuarterlyFinancialDataAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share - basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares used in calculating net loss per share - basic and diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetirementPlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetirementPlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetirementPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="us-gaap_RetirementPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetirementPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_FourHundredOneKPlanMember" xlink:type="locator" xlink:label="nk_FourHundredOneKPlanMember" />
    <link:label xml:lang="en-US" xlink:label="nk_FourHundredOneKPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Four hundred one K plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_FourHundredOneKPlanMember" xlink:to="nk_FourHundredOneKPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_FourHundredOneKPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">401(k) Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_FourHundredOneKPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Four Hundred One K Plan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee benefit plan, company contributions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="nk-20201231.xsd#nk_NashLLCMember" xlink:type="locator" xlink:label="nk_NashLLCMember" />
    <link:label xml:lang="en-US" xlink:label="nk_NashLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nash, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nk_NashLLCMember" xlink:to="nk_NashLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nk_NashLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nash, LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="nk_NashLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nash L L C [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>26
<FILENAME>nk-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-03T21:45:45.3486398+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : dd7869ea2c354e89b797e6b64ad699a8 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/role/TemplateLink" xlink:href="nk-20201231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="nk-20201231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="11690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeNet" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExercised" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued_li0l2" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:href="nk-20201231.xsd#nk_StockOfferingCosts" xlink:type="locator" xlink:label="nk_StockOfferingCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="nk_StockOfferingCosts" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="nk-20201231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PaymentsToAcquireInvestmentsInEquitySecurities" xlink:type="locator" xlink:label="nk_PaymentsToAcquireInvestmentsInEquitySecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInDeferredRent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInDeferredRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInOperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncreaseDecreaseInAccountsPayableCurrent" xlink:type="locator" xlink:label="nk_IncreaseDecreaseInAccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonCashInterestIncomeExpenseFromOperatingActivities" xlink:type="locator" xlink:label="nk_NonCashInterestIncomeExpenseFromOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" xlink:type="locator" xlink:label="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesGainLoss" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="nk_NonCashInterestIncomeExpenseFromOperatingActivities" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="nk_IncreaseDecreaseInAccountsPayableCurrent" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="nk_IncreaseDecreaseInOperatingLeaseLiability" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="nk_IncreaseDecreaseInDeferredRent" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="11790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="nk_PaymentsToAcquireInvestmentsInEquitySecurities" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="12270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" order="12330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="12390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="12450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="12810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="12870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="12930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="13170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="13290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="13350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="13410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="13470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="13710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="13770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="13830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="13950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" order="14010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="14070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="14130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="14190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness" xlink:href="nk-20201231.xsd#Role_DisclosureDescriptionOfBusiness" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness">
    <link:loc xlink:href="nk-20201231.xsd#nk_DescriptionOfBusinessDisclosureTextBlock" xlink:type="locator" xlink:label="nk_DescriptionOfBusinessDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="nk_DescriptionOfBusinessDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio" xlink:href="nk-20201231.xsd#Role_DisclosureAgreementAndPlanOfMergerWithImmunitybio" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProposedMergerWithImmunityBioMember" xlink:type="locator" xlink:label="nk_ProposedMergerWithImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nk_ProposedMergerWithImmunityBioMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment" xlink:href="nk-20201231.xsd#Role_DisclosureViractaInvestment" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:type="locator" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="nk-20201231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements" xlink:href="nk-20201231.xsd#Role_DisclosureCollaborationAndLicenseAgreements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements">
    <link:loc xlink:href="nk-20201231.xsd#nk_CollaborationAndLicenseAgreementsTextBlock" xlink:type="locator" xlink:label="nk_CollaborationAndLicenseAgreementsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="nk_CollaborationAndLicenseAgreementsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements" xlink:href="nk-20201231.xsd#Role_DisclosureRelatedPartyAgreements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited" xlink:href="nk-20201231.xsd#Role_DisclosureSummarizedQuarterlyDataUnaudited" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits" xlink:href="nk-20201231.xsd#Role_DisclosureEmployeeBenefits" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent" xlink:href="nk-20201231.xsd#Role_DisclosureSubsequentEvent" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LitigationCostsPolicyTextBlock" xlink:type="locator" xlink:label="nk_LitigationCostsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockRepurchasesPolicyTextBlock" xlink:type="locator" xlink:label="nk_StockRepurchasesPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionsPolicyPolicyTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" xlink:type="locator" xlink:label="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LegalCostsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:type="locator" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LiquidityPolicyTextBlock" xlink:type="locator" xlink:label="nk_LiquidityPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_LiquidityPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UnusualRisksAndUncertaintiesTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LegalCostsPolicyTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CollaborativeArrangementAccountingPolicy" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_RelatedPartyTransactionsPolicyPolicyTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_StockRepurchasesPolicyTextBlock" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_LitigationCostsPolicyTextBlock" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:type="locator" xlink:label="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="locator" xlink:label="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InvestmentIncomeTextBlock" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRealizedGainLossTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:type="locator" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfRealizedGainLossTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="nk-20201231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables">
    <link:loc xlink:href="nk-20201231.xsd#nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:type="locator" xlink:label="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables" xlink:href="nk-20201231.xsd#Role_DisclosureSummarizedQuarterlyDataUnauditedTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="nk_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="nk_UnderwrittenPublicOfferingMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfProductsApprovedForCommercialSale" xlink:type="locator" xlink:label="nk_NumberOfProductsApprovedForCommercialSale" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="nk-20201231.xsd#nk_VariableConsiderationRelatedToMilestonePayment" xlink:type="locator" xlink:label="nk_VariableConsiderationRelatedToMilestonePayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonrefundableUpfrontPayment" xlink:type="locator" xlink:label="nk_NonrefundableUpfrontPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasePracticalExpedientsPackage" xlink:type="locator" xlink:label="us-gaap_LeasePracticalExpedientsPackage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" xlink:type="locator" xlink:label="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" xlink:type="locator" xlink:label="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashAndCashEquivalentsOriginalMaturities" xlink:type="locator" xlink:label="nk_CashAndCashEquivalentsOriginalMaturities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesLineItems" xlink:type="locator" xlink:label="nk_AccountingPoliciesLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrecigenLicenseAgreementMember" xlink:type="locator" xlink:label="nk_PrecigenLicenseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccountingPoliciesTable" xlink:type="locator" xlink:label="nk_AccountingPoliciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nk_AccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_PrecigenLicenseAgreementMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesTable" xlink:to="nk_AccountingPoliciesLineItems" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_CashAndCashEquivalentsOriginalMaturities" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_LeasePracticalExpedientsPackage" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_OpenTaxYear" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_NonrefundableUpfrontPayment" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_VariableConsiderationRelatedToMilestonePayment" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_AccountingPoliciesLineItems" xlink:to="nk_NumberOfProductsApprovedForCommercialSale" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ITEquipmentMember" xlink:type="locator" xlink:label="nk_ITEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentMember" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nk_LaboratoryEquipmentMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nk_ITEquipmentMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LaboratoryEquipmentDeposit" xlink:type="locator" xlink:label="nk_LaboratoryEquipmentDeposit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidLicenseFees" xlink:type="locator" xlink:label="nk_PrepaidLicenseFees" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidEquipmentMaintenance" xlink:type="locator" xlink:label="nk_PrepaidEquipmentMaintenance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSuppliesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidSuppliesWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent" xlink:type="locator" xlink:label="us-gaap_PrepaidRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidServices" xlink:type="locator" xlink:label="nk_PrepaidServices" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance" xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_InsurancePremiumFinancingAsset" xlink:type="locator" xlink:label="nk_InsurancePremiumFinancingAsset" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_InsurancePremiumFinancingAsset" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_PrepaidInsurance" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidServices" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_PrepaidRent" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InterestReceivableCurrent" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidSuppliesWithRelatedParty" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidEquipmentMaintenance" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidLicenseFees" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_LaboratoryEquipmentDeposit" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InsuranceSettlementsReceivableCurrent" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_Depreciation" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_ImpairmentOfInvestments" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsOtherAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesNoncurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidSoftwareLicenseFeesInOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidSoftwareLicenseFeesInOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_SecurityDeposit" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidSoftwareLicenseFeesInOtherAssets" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_DueFromRelatedPartiesNoncurrent" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsAccruedExpensesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedFranchiseSalesUseAndPropertyTaxes" xlink:type="locator" xlink:label="nk_AccruedFranchiseSalesUseAndPropertyTaxes" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedCapitalExpenditures" xlink:type="locator" xlink:label="nk_AccruedCapitalExpenditures" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedPreclinicalAndClinicalTrialCosts" xlink:type="locator" xlink:label="nk_AccruedPreclinicalAndClinicalTrialCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AccruedLaboratoryEquipmentAndSupplies" xlink:type="locator" xlink:label="nk_AccruedLaboratoryEquipmentAndSupplies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedSalariesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedBonusesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_AccruedBonusesCurrent" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_AccruedSalariesCurrent" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_AccruedLaboratoryEquipmentAndSupplies" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_AccruedPreclinicalAndClinicalTrialCosts" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_AccruedCapitalExpenditures" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_AccruedFranchiseSalesUseAndPropertyTaxes" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancingObligationCurrent" xlink:type="locator" xlink:label="nk_FinancingObligationCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="nk_FinancingObligationCurrent" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FinancialStatementDetailsAbstract" xlink:type="locator" xlink:label="nk_FinancialStatementDetailsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_FinancialStatementDetailsAbstract" xlink:to="us-gaap_InvestmentIncomeNet" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageByKeyExecutives" xlink:type="locator" xlink:label="nk_OwnershipPercentageByKeyExecutives" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" xlink:type="locator" xlink:label="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MergerExchangeRatio" xlink:type="locator" xlink:label="nk_MergerExchangeRatio" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProposedMergerWithImmunityBioMember" xlink:type="locator" xlink:label="nk_ProposedMergerWithImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantKwestMember" xlink:type="locator" xlink:label="nk_NantKwestMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:type="locator" xlink:label="srt_OwnershipDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:type="locator" xlink:label="srt_OwnershipAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_OwnershipAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="nk_NantKwestMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_StatementScenarioAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nk_ProposedMergerWithImmunityBioMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_MergerExchangeRatio" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="nk_OwnershipPercentageByKeyExecutives" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureViractaInvestmentAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PurchaseOfConvertibleNoteUponConversion" xlink:type="locator" xlink:label="nk_PurchaseOfConvertibleNoteUponConversion" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OtherIncomeAndExpenseNetMember" xlink:type="locator" xlink:label="nk_OtherIncomeAndExpenseNetMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" xlink:type="locator" xlink:label="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="nk_OtherIncomeAndExpenseNetMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="nk_PurchaseOfConvertibleNoteUponConversion" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockValue" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NoncurrentAssetsMember" xlink:type="locator" xlink:label="nk_NoncurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CurrentAssetsMember" xlink:type="locator" xlink:label="nk_CurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_CurrentAssetsMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10060.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_NoncurrentAssetsMember" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtMember" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10060.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" xlink:type="locator" xlink:label="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:type="locator" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_DebtSecuritiesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:type="locator" xlink:label="nk_CashEquivalentsAndMarketableSecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CashEquivalentsAndMarketableSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesRealizedGainLossAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesRealizedGainLossAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="nk-20201231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NoncurrentAssetsMember" xlink:type="locator" xlink:label="nk_NoncurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CurrentAssetsMember" xlink:type="locator" xlink:label="nk_CurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_CurrentAssetsMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="nk_NoncurrentAssetsMember" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AgreementOneTimeFee" xlink:type="locator" xlink:label="nk_AgreementOneTimeFee" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerm" xlink:type="locator" xlink:label="nk_LicenseAgreementTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumSalesMilestoneOfLicenseForFirstYear" xlink:type="locator" xlink:label="nk_MinimumSalesMilestoneOfLicenseForFirstYear" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MinimumAnnualRoyaltyPayment" xlink:type="locator" xlink:label="nk_MinimumAnnualRoyaltyPayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreement" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicenseAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_LicenseAgreementTerminationNoticePeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MilestonePaymentAmount" xlink:type="locator" xlink:label="nk_MilestonePaymentAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementRenewalTerm" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementRenewalTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" xlink:type="locator" xlink:label="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TermOfAgreement" xlink:type="locator" xlink:label="nk_TermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementLineItems" xlink:type="locator" xlink:label="nk_LicensingAgreementLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrecigenLicenseAgreementMember" xlink:type="locator" xlink:label="nk_PrecigenLicenseAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommercialSaleRelatedToLicensedProductsMember" xlink:type="locator" xlink:label="nk_CommercialSaleRelatedToLicensedProductsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseThreeMember" xlink:type="locator" xlink:label="nk_PhaseThreeMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PhaseTwoMember" xlink:type="locator" xlink:label="nk_PhaseTwoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_INDFilingMember" xlink:type="locator" xlink:label="nk_INDFilingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RushUniversityMedicalCenterLicenseAgreementMember" xlink:type="locator" xlink:label="nk_RushUniversityMedicalCenterLicenseAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ViractaTherapeuticsIncMember" xlink:type="locator" xlink:label="nk_ViractaTherapeuticsIncMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClinicalTrialCostAllocationAgreementMember" xlink:type="locator" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetProgramRelatedCostsMember" xlink:type="locator" xlink:label="nk_NetProgramRelatedCostsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProgramEquipmentRelatedCostsMember" xlink:type="locator" xlink:label="nk_ProgramEquipmentRelatedCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:type="locator" xlink:label="us-gaap_SalesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:type="locator" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementTable" xlink:type="locator" xlink:label="nk_LicensingAgreementTable" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LicensingAgreementAbstract" xlink:type="locator" xlink:label="nk_LicensingAgreementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementAbstract" xlink:to="nk_LicensingAgreementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_JointCOVID19CollaborationDevelopmentAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SalesMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_NonrecurringAdjustmentAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentDomain" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_ProgramEquipmentRelatedCostsMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_NetProgramRelatedCostsMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_ClinicalTrialCostAllocationAgreementMember" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="dei_LegalEntityAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="nk_ViractaTherapeuticsIncMember" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="srt_RangeAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="nk_RushUniversityMedicalCenterLicenseAgreementMember" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_INDFilingMember" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_PhaseTwoMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_PhaseThreeMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="nk_CommercialSaleRelatedToLicensedProductsMember" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_PrecigenLicenseAgreementMember" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementTable" xlink:to="nk_LicensingAgreementLineItems" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_TermOfAgreement" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_AdditionalTermOfAgreementRenewableUponMutualAgreement" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_RelatedPartyAgreementRenewalTerm" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MilestonePaymentAmount" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicenseAgreementTerminationNoticePeriod" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_PeriodOfLicenseAgreement" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MinimumAnnualRoyaltyPayment" order="11980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_MinimumSalesMilestoneOfLicenseForFirstYear" order="12020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_LicenseAgreementTerm" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="nk_AgreementOneTimeFee" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LicensingAgreementLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" xlink:type="locator" xlink:label="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfExtendedLeaseTerm" xlink:type="locator" xlink:label="nk_PeriodOfExtendedLeaseTerm_li0l2" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MonthlyFixedCharge" xlink:type="locator" xlink:label="nk_MonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfExtendedLeaseTerm" xlink:type="locator" xlink:label="nk_PeriodOfExtendedLeaseTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" xlink:type="locator" xlink:label="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfLicenseAgreementDescription" xlink:type="locator" xlink:label="nk_PeriodOfLicenseAgreementDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualBaseRentIncreasePerSquareFoot" xlink:type="locator" xlink:label="nk_AnnualBaseRentIncreasePerSquareFoot" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AdditionToNumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_AdditionToNumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseCommencementDate" xlink:type="locator" xlink:label="nk_LeaseCommencementDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNet" xlink:type="locator" xlink:label="us-gaap_AssetsNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivable" xlink:type="locator" xlink:label="us-gaap_InsuranceSettlementsReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees" xlink:type="locator" xlink:label="us-gaap_LegalFees" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentSanDiegoMember" xlink:type="locator" xlink:label="nk_CommitmentSanDiegoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AmendmentToExtendLeaseTermMember" xlink:type="locator" xlink:label="nk_AmendmentToExtendLeaseTermMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantWorksLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:type="locator" xlink:label="srt_ScenarioForecastMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentWoburnMassachusettsMember" xlink:type="locator" xlink:label="nk_CommitmentWoburnMassachusettsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DougStLLCMember" xlink:type="locator" xlink:label="nk_DougStLLCMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantBioScienceMember" xlink:type="locator" xlink:label="nk_NantBioScienceMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:type="locator" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" xlink:type="locator" xlink:label="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="locator" xlink:label="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="locator" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DirectorsAndOfficersInsurancePolicyMember" xlink:type="locator" xlink:label="nk_DirectorsAndOfficersInsurancePolicyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis" xlink:type="locator" xlink:label="us-gaap_ReinsurancePolicyTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="nk_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_CommitmentsAndContingenciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_ReinsurancePolicyTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReinsurancePolicyTypeAxis" xlink:to="us-gaap_ReinsurancePolicyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReinsurancePolicyDomain" xlink:to="nk_DirectorsAndOfficersInsurancePolicyMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="10030.16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_AltorBioscienceManufacturingCompanyLLCMember" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantBioScienceMember" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_DougStLLCMember" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10030.20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_CommitmentWoburnMassachusettsMember" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="srt_StatementScenarioAxis" order="10030.22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="11740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantWorksLimitedLiabilityCompanyMember" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_AmendmentToExtendLeaseTermMember" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nk_CommitmentSanDiegoMember" order="12140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesTable" xlink:to="nk_CommitmentsAndContingenciesLineItems" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="12230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LegalFees" order="12320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_InsuranceSettlementsReceivable" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="12460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="12480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_Liabilities" order="12500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_AssetsNet" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="12590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_BaseMonthlyRent" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_LeaseCommencementDate" order="12650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AdditionToNumberOfSquareFootOfFacilityLeased" order="12670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualBaseRentIncreasePerSquareFoot" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="12730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_PeriodOfLicenseAgreementDescription" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="12770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" order="12790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="13080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="13130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="13170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms" order="13240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="13310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_PeriodOfExtendedLeaseTerm" order="13330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_MonthlyFixedCharge" order="13350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" order="13370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_AnnualPercentageIncreasesToFixedChargeCommencementDate" order="13410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty" order="13460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionAmountPaidToRelatedParty" order="13480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="13500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyTransactionInitialTermOfAgreement" order="13520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_RelatedPartyAgreementExpirationMonthAndYear" order="13540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_PeriodOfExtendedLeaseTerm_li0l2" order="13630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease" order="14210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" order="14410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" order="14430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" order="14450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" order="14470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LongTermLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nk_LongTermLeaseLiabilitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShortTermLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nk_ShortTermLeaseLiabilitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RightOfUseAssetsAbstract" xlink:type="locator" xlink:label="nk_RightOfUseAssetsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_RightOfUseAssetsAbstract" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_RightOfUseAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_ShortTermLeaseLiabilitiesAbstract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_ShortTermLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nk_LongTermLeaseLiabilitiesAbstract" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_LongTermLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:type="locator" xlink:label="us-gaap_VariableLeaseCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_VariableLeaseCost" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureRelatedPartyAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaymentOfFundingAmount" xlink:type="locator" xlink:label="nk_PrepaymentOfFundingAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementExpirationMonthAndYear" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementExpirationMonthAndYear" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_li0l2" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAmountPaidToThirdParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAmountPaidToThirdParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRentCommencementDate" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" xlink:type="locator" xlink:label="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyAgreementRenewalTerm" xlink:type="locator" xlink:label="nk_RelatedPartyAgreementRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionInitialTermOfAgreement" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionInitialTermOfAgreement" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FixedAndVariableLeaseCosts" xlink:type="locator" xlink:label="nk_FixedAndVariableLeaseCosts" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToMonthlyFixedCharge" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" />
    <link:loc xlink:href="nk-20201231.xsd#nk_MonthlyFixedCharge" xlink:type="locator" xlink:label="nk_MonthlyFixedCharge" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" xlink:type="locator" xlink:label="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NewAgreementTerminationNoticePeriod" xlink:type="locator" xlink:label="nk_NewAgreementTerminationNoticePeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionAgreementExtensionDescription" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionAgreementExtensionDescription" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyTransactionConditionalPayment" xlink:type="locator" xlink:label="nk_RelatedPartyTransactionConditionalPayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_RelatedPartyInstallmentPayment" xlink:type="locator" xlink:label="nk_RelatedPartyInstallmentPayment" />
    <link:loc xlink:href="nk-20201231.xsd#nk_InitialTermOfAgreement" xlink:type="locator" xlink:label="nk_InitialTermOfAgreement" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfOfficers" xlink:type="locator" xlink:label="nk_NumberOfOfficers" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantHealthLabsIncMember" xlink:type="locator" xlink:label="nk_NantHealthLabsIncMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantBioScienceMember" xlink:type="locator" xlink:label="nk_NantBioScienceMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DougStLLCMember" xlink:type="locator" xlink:label="nk_DougStLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="locator" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClinicalTrialCostAllocationAgreementMember" xlink:type="locator" xlink:label="nk_ClinicalTrialCostAllocationAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetProgramRelatedCostsMember" xlink:type="locator" xlink:label="nk_NetProgramRelatedCostsMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ProgramEquipmentRelatedCostsMember" xlink:type="locator" xlink:label="nk_ProgramEquipmentRelatedCostsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:type="locator" xlink:label="us-gaap_NonrecurringAdjustmentAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_JointCOVID19CollaborationDevelopmentAgreementMember" xlink:type="locator" xlink:label="nk_JointCOVID19CollaborationDevelopmentAgreementMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AltorBioscienceManufacturingCompanyLLCMember" xlink:type="locator" xlink:label="nk_AltorBioscienceManufacturingCompanyLLCMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunityBioMember" xlink:type="locator" xlink:label="nk_ImmunityBioMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ImmunoOncologyClinicIncMember" xlink:type="locator" xlink:label="nk_ImmunoOncologyClinicIncMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ReimbursementsMember" xlink:type="locator" xlink:label="nk_ReimbursementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:type="locator" xlink:label="us-gaap_TransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:type="locator" xlink:label="us-gaap_TransactionTypeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharedServicesAgreementMember" xlink:type="locator" xlink:label="nk_SharedServicesAgreementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NantWorksLimitedLiabilityCompanyMember" xlink:type="locator" xlink:label="nk_NantWorksLimitedLiabilityCompanyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantWorksLimitedLiabilityCompanyMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_SharedServicesAgreementMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TransactionTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransactionDomain" xlink:to="nk_ReimbursementsMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunoOncologyClinicIncMember" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_StatementGeographicalAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="11740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_ImmunityBioMember" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_AltorBioscienceManufacturingCompanyLLCMember" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_JointCOVID19CollaborationDevelopmentAgreementMember" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_NonrecurringAdjustmentAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentDomain" order="12320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_ProgramEquipmentRelatedCostsMember" order="12340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonrecurringAdjustmentDomain" xlink:to="nk_NetProgramRelatedCostsMember" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nk_ClinicalTrialCostAllocationAgreementMember" order="12500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="12560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="12580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_DougStLLCMember" order="12940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantBioScienceMember" order="13240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NantHealthLabsIncMember" order="13580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="13660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="13670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="13730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="13970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="14040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="14100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="14160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NumberOfOfficers" order="14250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_InitialTermOfAgreement" order="14300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyInstallmentPayment" order="14350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="14370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionConditionalPayment" order="14430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionAgreementExtensionDescription" order="14480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_NewAgreementTerminationNoticePeriod" order="14500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets" order="14670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" order="14760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_MonthlyFixedCharge" order="14840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToMonthlyFixedCharge" order="14880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_FixedAndVariableLeaseCosts" order="14960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="15180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="15250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="15270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionInitialTermOfAgreement" order="15320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyAgreementRenewalTerm" order="15340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" order="15390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty" order="15540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" order="15690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_BaseMonthlyRent" order="15750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="15810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRentCommencementDate" order="15870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="15990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty" order="16080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyTransactionAmountPaidToThirdParty" order="16100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_li0l2" order="16120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_RelatedPartyAgreementExpirationMonthAndYear" order="16160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod" order="16270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nk_PrepaymentOfFundingAmount" order="16390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" xlink:type="locator" xlink:label="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" xlink:type="locator" xlink:label="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExecutiveChairmanAndPrincipalStockholderMember" xlink:type="locator" xlink:label="nk_ExecutiveChairmanAndPrincipalStockholderMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" xlink:type="locator" xlink:label="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PublicMember" xlink:type="locator" xlink:label="nk_PublicMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="locator" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="nk_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="nk_UnderwrittenPublicOfferingMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_PublicMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="nk_ExecutiveChairmanAndPrincipalStockholderMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_UnderwritingDiscountsCommissionsAndOfferingExpenses" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ClassOfWarrantOrRightsIssued" xlink:type="locator" xlink:label="nk_ClassOfWarrantOrRightsIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_EmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonEmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_NonEmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFifteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFifteenEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nk_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="nk_TwoThousandFourteenEquityIncentivePlanMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="nk_TwoThousandFifteenEquityIncentivePlanMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_NonEmployeeRestrictedStockUnitMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_EmployeeRestrictedStockUnitMember" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="12140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="12530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ClassOfWarrantOrRightsIssued" order="12590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:type="locator" xlink:label="srt_OfficerMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NonEmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_NonEmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EmployeeRestrictedStockUnitMember" xlink:type="locator" xlink:label="nk_EmployeeRestrictedStockUnitMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_EmployeeRestrictedStockUnitMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nk_NonEmployeeRestrictedStockUnitMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_OfficerMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="12020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="12720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" order="13350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="13650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="13780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="13980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="14380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeSixMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFiveMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeFourMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeThreeMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeTwoMember" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="nk_ExercisePriceRangeOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeOneMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeTwoMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeThreeMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeFourMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeFiveMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nk_ExercisePriceRangeSixMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption">
    <link:loc xlink:href="nk-20201231.xsd#nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" xlink:type="locator" xlink:label="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail" xlink:href="nk-20201231.xsd#Role_DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_li0l2" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExpired" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExpired" />
    <link:loc xlink:href="nk-20201231.xsd#nk_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="locator" xlink:label="nk_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExercised" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="nk_StockIssuedDuringPeriodSharesWarrantsExpired" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_li0l2" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" xlink:type="locator" xlink:label="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" />
    <link:loc xlink:href="nk-20201231.xsd#nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" xlink:type="locator" xlink:label="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarrybacksPeriod" xlink:type="locator" xlink:label="nk_NetOperatingLossCarrybacksPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxCreditCarryforwardExpirationPeriod" xlink:type="locator" xlink:label="nk_TaxCreditCarryforwardExpirationPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarryforwardsExpirationDate" xlink:type="locator" xlink:label="nk_NetOperatingLossCarryforwardsExpirationDate" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" xlink:type="locator" xlink:label="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DerecognizedDeferredTaxAssets" xlink:type="locator" xlink:label="nk_DerecognizedDeferredTaxAssets" />
    <link:loc xlink:href="nk-20201231.xsd#nk_PeriodOfCumulativeOwnershipChange" xlink:type="locator" xlink:label="nk_PeriodOfCumulativeOwnershipChange" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" xlink:type="locator" xlink:label="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="locator" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxLineItems" xlink:type="locator" xlink:label="nk_IncomeTaxLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_TaxYear2021AndThereafterMember" xlink:type="locator" xlink:label="nk_TaxYear2021AndThereafterMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2020Member" xlink:type="locator" xlink:label="us-gaap_TaxYear2020Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_KR" xlink:type="locator" xlink:label="country_KR" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_IncomeTaxTable" xlink:type="locator" xlink:label="nk_IncomeTaxTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nk_IncomeTaxTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_KR" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="us-gaap_TaxPeriodAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxYear2020Member" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="nk_TaxYear2021AndThereafterMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="srt_RangeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxTable" xlink:to="nk_IncomeTaxLineItems" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_PeriodOfCumulativeOwnershipChange" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_DerecognizedDeferredTaxAssets" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarryforwardsExpirationDate" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_TaxCreditCarryforwardExpirationPeriod" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_NetOperatingLossCarrybacksPeriod" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_OpenTaxYear" order="11980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nk_IncomeTaxLineItems" xlink:to="nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredIncomeTaxExpenseBenefitNet" xlink:type="locator" xlink:label="nk_DeferredIncomeTaxExpenseBenefitNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="nk_DeferredIncomeTaxExpenseBenefitNet" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" />
    <link:loc xlink:href="nk-20201231.xsd#nk_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator" xlink:label="nk_DeferredTaxAssetsOperatingLeaseLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="nk_DeferredTaxAssetsOperatingLeaseLiabilities" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="nk_DeferredTaxAssetsDeferredDepreciationAndAmortization" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" />
    <link:loc xlink:href="nk-20201231.xsd#nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" xlink:type="locator" xlink:label="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail" xlink:href="nk-20201231.xsd#Role_DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_li0l2" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSummaryOfQuarterlyDataUnauditedDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialDataAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_Revenues" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_OperatingExpenses" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_FourHundredOneKPlanMember" xlink:type="locator" xlink:label="nk_FourHundredOneKPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis" xlink:type="locator" xlink:label="us-gaap_RetirementPlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_RetirementPlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanNameDomain" xlink:to="nk_FourHundredOneKPlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="nk-20201231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nk-20201231.xsd#nk_LeaseAgreementExtendedPeriod" xlink:type="locator" xlink:label="nk_LeaseAgreementExtendedPeriod" />
    <link:loc xlink:href="nk-20201231.xsd#nk_AnnualPercentageIncreasesToBaseRent" xlink:type="locator" xlink:label="nk_AnnualPercentageIncreasesToBaseRent" />
    <link:loc xlink:href="nk-20201231.xsd#nk_BaseMonthlyRent" xlink:type="locator" xlink:label="nk_BaseMonthlyRent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NumberOfSquareFootOfFacilityLeased" xlink:type="locator" xlink:label="nk_NumberOfSquareFootOfFacilityLeased" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:href="nk-20201231.xsd#nk_ElSegundoCaliforniaMember" xlink:type="locator" xlink:label="nk_ElSegundoCaliforniaMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nk-20201231.xsd#nk_NashLLCMember" xlink:type="locator" xlink:label="nk_NashLLCMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nk_NashLLCMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementGeographicalAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="nk_ElSegundoCaliforniaMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_NumberOfSquareFootOfFacilityLeased" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_BaseMonthlyRent" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_AnnualPercentageIncreasesToBaseRent" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nk_LeaseAgreementExtendedPeriod" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>nk-10k_20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nk="http://www.nantkwest.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nk-20201231.xsd" xlink:type="simple"/>
    <context id="C_0001326110_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20210303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2021-03-03</instant>
        </period>
    </context>
    <context id="C_0001326110_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001326110_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nk:ProposedMergerWithImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMinimumMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMaximumMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkLaboratoryEquipmentMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nk:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkITEquipmentMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nk:ITEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20151130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2015-11-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-02-01</startDate>
            <endDate>2010-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_20201221_20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-12-21</startDate>
            <endDate>2020-12-21</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="C_0001326110_srtOwnershipAxis_nkNantKwestMember_20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">nk:NantKwestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="C_0001326110_srtTitleOfIndividualAxis_nkExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_20201221_20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">nk:ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-21</startDate>
            <endDate>2020-12-21</endDate>
        </period>
    </context>
    <context id="C_0001326110_20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesBPreferredStockMember_20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nk:TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_nkOtherIncomeAndExpenseNetMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nk:OtherIncomeAndExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">nk:NoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">nk:ProgramEquipmentRelatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">nk:NetProgramRelatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:JointCOVID19CollaborationDevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20150601_20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-01</startDate>
            <endDate>2015-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:ClinicalTrialCostAllocationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMinimumMember_20170501_20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_20170501_20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_20170501_20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nk:ViractaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">nk:RushUniversityMedicalCenterLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-01-01</startDate>
            <endDate>2004-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkINDFilingMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:INDFilingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-02-01</startDate>
            <endDate>2010-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseTwoMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:PhaseTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-02-01</startDate>
            <endDate>2010-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseThreeMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:PhaseThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-02-01</startDate>
            <endDate>2010-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkCommercialSaleRelatedToLicensedProductsMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">nk:CommercialSaleRelatedToLicensedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:PrecigenLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-02-01</startDate>
            <endDate>2010-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapReinsurancePolicyTypeAxis_nkDirectorsAndOfficersInsurancePolicyMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">nk:DirectorsAndOfficersInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20190809_20190809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-08-09</startDate>
            <endDate>2019-08-09</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">nk:DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="C_0001326110_srtCumulativeEffectPeriodOfAdoptionAxis_srtCumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160301_20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190701_20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentWoburnMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-11-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-11-01</startDate>
            <endDate>2015-11-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:AmendmentToExtendLeaseTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentSanDiegoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-06-30</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nk:CommitmentSanDiegoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-01</startDate>
            <endDate>2015-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">nk:ReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nk:SharedServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantWorksLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191001_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunoOncologyClinicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221_20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-21</startDate>
            <endDate>2020-12-21</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:AltorBioscienceManufacturingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_us-gaapCollaborativeArrangementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-01</startDate>
            <endDate>2015-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:ImmunityBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:DougStLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160301_20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160401_20160430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20170401_20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-01</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190501_20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NantHealthLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:PublicMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:PublicMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:ExecutiveChairmanAndPrincipalStockholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">nk:ExecutiveChairmanAndPrincipalStockholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nk:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="C_0001326110_20151102_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2015-11-02</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140101_20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20190601_20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200601_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nk:TwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20170101_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nk:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:EmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nk:NonEmployeeRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTaxPeriodAxis_us-gaapTaxYear2020Member_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapTaxPeriodAxis_nkTaxYear2021AndThereafterMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">nk:TaxYear2021AndThereafterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20200101_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20200401_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_20200701_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_20201001_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20190101_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_20190401_20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_20190701_20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_0001326110_20191001_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">nk:FourHundredOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">nk:ElSegundoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-28</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nk:NashLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_nkProduct">
        <measure>nk:Product</measure>
    </unit>
    <unit id="U_nkSecurity">
        <measure>nk:Security</measure>
    </unit>
    <unit id="U_utrsqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_iso4217USD_utrsqft">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>utr:sqft</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_nkOfficer">
        <measure>nk:Officer</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001326110_20200101_20201231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="C_0001326110_20200101_20201231" id="F_000002">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001326110_20200101_20201231" id="F_000003">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001326110_20200101_20201231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001326110_20200101_20201231" id="F_000007">0001326110</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001326110_20200101_20201231" id="F_000008">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0001326110_20200101_20201231" id="F_000009">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityCurrentReportingStatus contextRef="C_0001326110_20200101_20201231" id="F_000010">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityVoluntaryFilers contextRef="C_0001326110_20200101_20201231" id="F_000011">No</dei:EntityVoluntaryFilers>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001326110_20200101_20201231" id="F_000023">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:LeasePracticalExpedientsPackage contextRef="C_0001326110_20200101_20201231" id="F_000547">true</us-gaap:LeasePracticalExpedientsPackage>
    <nk:CashAndCashEquivalentsOriginalMaturities contextRef="C_0001326110_20200101_20201231" id="F_000528">P3M</nk:CashAndCashEquivalentsOriginalMaturities>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630"
      id="F_000684">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930"
      id="F_000685">P1Y</us-gaap:DebtInstrumentTerm>
    <nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_000735">P12M</nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions>
    <nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_000734">P12M</nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions>
    <nk:TermOfAgreement
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      id="F_000806">P5Y</nk:TermOfAgreement>
    <nk:AdditionalTermOfAgreementRenewableUponMutualAgreement
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      id="F_000807">P5Y</nk:AdditionalTermOfAgreementRenewableUponMutualAgreement>
    <nk:RelatedPartyAgreementRenewalTerm
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20150601_20150630"
      id="F_000812">P1Y</nk:RelatedPartyAgreementRenewalTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20201231"
      id="F_000848">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20201231"
      id="F_000847">P2Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20201231"
      id="F_000850">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20201231"
      id="F_000849">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <nk:PeriodOfExtendedLeaseTerm
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930"
      id="F_000884">P1Y</nk:PeriodOfExtendedLeaseTerm>
    <nk:AnnualPercentageIncreasesToFixedChargeCommencementDate
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930"
      id="F_000888">2020-11-30</nk:AnnualPercentageIncreasesToFixedChargeCommencementDate>
    <nk:RelatedPartyTransactionInitialTermOfAgreement
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      id="F_000892">P10Y</nk:RelatedPartyTransactionInitialTermOfAgreement>
    <nk:PeriodOfExtendedLeaseTerm
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      id="F_000896">P3Y</nk:PeriodOfExtendedLeaseTerm>
    <nk:AnnualPercentageIncreasesToBaseRentCommencementDate
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      id="F_000899">2017-07-31</nk:AnnualPercentageIncreasesToBaseRentCommencementDate>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190831"
      id="F_000908">P2Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <nk:AnnualPercentageIncreasesToBaseRentCommencementDate
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130"
      id="F_000917">2017-01-31</nk:AnnualPercentageIncreasesToBaseRentCommencementDate>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630"
      id="F_000926">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <nk:InitialTermOfAgreement
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731"
      id="F_000953">P1Y</nk:InitialTermOfAgreement>
    <nk:RelatedPartyTransactionInitialTermOfAgreement
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630"
      id="F_000982">P5Y</nk:RelatedPartyTransactionInitialTermOfAgreement>
    <nk:RelatedPartyAgreementRenewalTerm
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20150601_20150630"
      id="F_000983">P1Y</nk:RelatedPartyAgreementRenewalTerm>
    <nk:AnnualPercentageIncreasesToBaseRentCommencementDate
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      id="F_000995">2017-07-31</nk:AnnualPercentageIncreasesToBaseRentCommencementDate>
    <nk:RelatedPartyTransactionInitialTermOfAgreement
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      id="F_001004">P10Y</nk:RelatedPartyTransactionInitialTermOfAgreement>
    <nk:RelatedPartyTransactionInitialTermOfAgreement
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160301_20160331"
      id="F_001006">P5Y</nk:RelatedPartyTransactionInitialTermOfAgreement>
    <nk:RelatedPartyTransactionInitialTermOfAgreement
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331"
      id="F_001018">P5Y</nk:RelatedPartyTransactionInitialTermOfAgreement>
    <nk:RelatedPartyAgreementRenewalTerm
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180301_20180331"
      id="F_001019">P1Y</nk:RelatedPartyAgreementRenewalTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140101_20140331"
      id="F_001052">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <nk:PeriodOfCumulativeOwnershipChange contextRef="C_0001326110_20200101_20201231" id="F_001314">P3Y</nk:PeriodOfCumulativeOwnershipChange>
    <nk:NetOperatingLossCarrybacksPeriod contextRef="C_0001326110_20200101_20201231" id="F_001337">P5Y</nk:NetOperatingLossCarrybacksPeriod>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228"
      id="F_001406">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <nk:LeaseAgreementExtendedPeriod
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228"
      id="F_001405">2030-12-31</nk:LeaseAgreementExtendedPeriod>
    <nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_20190101_20191231"
      id="F_000737">P12M</nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions>
    <nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_20190101_20191231"
      id="F_000736">P12M</nk:AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000069"
      unitRef="U_iso4217USD">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">0</us-gaap:CommitmentsAndContingencies>
    <nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20200101_20201231"
      id="F_000703">P3M18D</nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod>
    <nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20200101_20201231"
      id="F_000704">P3M18D</nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod>
    <nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod contextRef="C_0001326110_20200101_20201231" id="F_000705">P3M18D</nk:AvailableForSaleSecuritiesDebtSecuritiesPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20170101_20171231"
      id="F_001109">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      id="F_001110">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      id="F_001111">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001112">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001113">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231"
      id="F_001143">P3Y10M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20200101_20201231"
      id="F_001157">P3Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231"
      id="F_001144">P4Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20200101_20201231"
      id="F_001158">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231"
      id="F_001145">P4Y1M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20200101_20201231"
      id="F_001159">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231"
      id="F_001146">P7Y8M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20200101_20201231"
      id="F_001160">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231"
      id="F_001147">P9Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20200101_20201231"
      id="F_001161">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231"
      id="F_001148">P4Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20200101_20201231"
      id="F_001162">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001149">P5Y6M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001163">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001164">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      id="F_001165">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      id="F_001166">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <dei:DocumentType contextRef="C_0001326110_20200101_20201231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0001326110_20200101_20201231" id="F_000031">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport contextRef="C_0001326110_20200101_20201231" id="F_000032">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001326110_20200101_20201231" id="F_000020">001-37507</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001326110_20200101_20201231" id="F_000006">NANTKWEST, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001326110_20200101_20201231" id="F_000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001326110_20200101_20201231" id="F_000022">43-1979754</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001326110_20200101_20201231" id="F_000025">3530 John Hopkins Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001326110_20200101_20201231" id="F_000026">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001326110_20200101_20201231" id="F_000027">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001326110_20200101_20201231" id="F_000028">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001326110_20200101_20201231" id="F_000029">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001326110_20200101_20201231" id="F_000030">633-0300</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001326110_20200101_20201231" id="F_000019">Common Stock, par&#160;value&#160;$0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001326110_20200101_20201231" id="F_000005">NK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001326110_20200101_20201231" id="F_000024">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory contextRef="C_0001326110_20200101_20201231" id="F_000012">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001326110_20200101_20201231" id="F_000014">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001326110_20200101_20201231" id="F_000013">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0001326110_20200101_20201231" id="F_000016">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0001326110_20200101_20201231" id="F_000015">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0001326110_20200630"
      decimals="-5"
      id="F_000018"
      unitRef="U_iso4217USD">415400000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001326110_20210303"
      decimals="INF"
      id="F_000017"
      unitRef="U_xbrlishares">109344573</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000447">
&lt;p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:2.5%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/p&gt;
&lt;p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As noted herein, the information called for by Part&#160;III of this Annual Report on Form&#160;10&#x2011;K is incorporated by reference to specified portions of the Registrant&#x2019;s definitive proxy statement to be filed in conjunction with the Registrant&#x2019;s 2021 Annual Meeting of Stockholders, which is expected to be filed not later than 120&#160;days after the Registrant&#x2019;s fiscal year ended December&#160;31, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;"&gt;&#160;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000033"
      unitRef="U_iso4217USD">11441000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000034"
      unitRef="U_iso4217USD">15508000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000035"
      unitRef="U_iso4217USD">9285000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000036"
      unitRef="U_iso4217USD">4105000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000037"
      unitRef="U_iso4217USD">54772000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000038"
      unitRef="U_iso4217USD">36144000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">75498000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">55757000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">1497000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">53927000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">60501000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">13463000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">11729000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">7849000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">9253000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">1121000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">4386000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">151858000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">143123000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">4101000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">1749000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">8343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">5343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">5269000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">486000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">5500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">3206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">1438000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">775000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">24651000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">11559000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">9814000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">10885000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">34465000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000068"
      unitRef="U_iso4217USD">22444000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000083"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000084"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000085"
      unitRef="U_xbrlishares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000086"
      unitRef="U_xbrlishares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000087"
      unitRef="U_xbrlishares">108726551</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000089"
      unitRef="U_xbrlishares">108726551</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000088"
      unitRef="U_xbrlishares">98460404</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000090"
      unitRef="U_xbrlishares">98460404</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">11000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">10000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">872078000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">782965000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">-122000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000076"
      unitRef="U_iso4217USD">-105000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000077"
      unitRef="U_iso4217USD">-754574000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000078"
      unitRef="U_iso4217USD">-662191000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000079"
      unitRef="U_iso4217USD">117393000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">120679000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">151858000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000082"
      unitRef="U_iso4217USD">143123000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">111000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">43000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">47000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000094"
      unitRef="U_iso4217USD">64483000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000095"
      unitRef="U_iso4217USD">49785000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000096"
      unitRef="U_iso4217USD">55718000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000097"
      unitRef="U_iso4217USD">27254000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">18065000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">42718000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">91737000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">67850000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000102"
      unitRef="U_iso4217USD">98436000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000103"
      unitRef="U_iso4217USD">-91626000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000104"
      unitRef="U_iso4217USD">-67807000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000105"
      unitRef="U_iso4217USD">-98389000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000106"
      unitRef="U_iso4217USD">366000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000107"
      unitRef="U_iso4217USD">1642000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000108"
      unitRef="U_iso4217USD">1857000</us-gaap:InvestmentIncomeNet>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000109"
      unitRef="U_iso4217USD">41000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000110"
      unitRef="U_iso4217USD">19000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000111"
      unitRef="U_iso4217USD">433000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000112"
      unitRef="U_iso4217USD">-1077000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000113"
      unitRef="U_iso4217USD">298000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000114"
      unitRef="U_iso4217USD">236000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000115"
      unitRef="U_iso4217USD">-752000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000116"
      unitRef="U_iso4217USD">1921000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000117"
      unitRef="U_iso4217USD">1660000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000118"
      unitRef="U_iso4217USD">-92378000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000119"
      unitRef="U_iso4217USD">-65886000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000120"
      unitRef="U_iso4217USD">-96729000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000121"
      unitRef="U_iso4217USD">5000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000122"
      unitRef="U_iso4217USD">-97000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000123"
      unitRef="U_iso4217USD">-503000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">-92383000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">-65789000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">-96226000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20200101_20201231"
      decimals="2"
      id="F_000127"
      unitRef="U_iso4217USD_xbrlishares">-0.89</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20190101_20191231"
      decimals="2"
      id="F_000128"
      unitRef="U_iso4217USD_xbrlishares">-0.70</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20180101_20181231"
      decimals="2"
      id="F_000129"
      unitRef="U_iso4217USD_xbrlishares">-1.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20200101_20201231"
      decimals="0"
      id="F_000130"
      unitRef="U_xbrlishares">103550936</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20190101_20191231"
      decimals="0"
      id="F_000131"
      unitRef="U_xbrlishares">94210087</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20180101_20181231"
      decimals="0"
      id="F_000132"
      unitRef="U_xbrlishares">79132220</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">-92383000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">-65789000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">-96226000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">-26000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">158000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">-9000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">-4000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">-17000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">162000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">114000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">-92400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">-65627000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">-96112000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231"
      decimals="INF"
      id="F_000148"
      unitRef="U_xbrlishares">79021878</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">717930000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">-381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">-498713000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20171231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">218844000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">23382000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">23382000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <nk:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000159"
      unitRef="U_xbrlishares">93254</nk:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">57000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000162"
      unitRef="U_iso4217USD">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">57000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000165"
      unitRef="U_xbrlishares">172330</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000166"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000167"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000168"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000169"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000170"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000171"
      unitRef="U_xbrlishares">61379</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000173"
      unitRef="U_iso4217USD">123000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000174"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">123000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000177"
      unitRef="U_xbrlishares">138349</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000178"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000179"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000180"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">228000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">228000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000185"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">186000</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20180101_20181231"
      decimals="-3"
      id="F_000187"
      unitRef="U_iso4217USD">186000</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000188"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000190"
      unitRef="U_iso4217USD">114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000192"
      unitRef="U_iso4217USD">114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000193"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">-96226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">-96226000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="INF"
      id="F_000198"
      unitRef="U_xbrlishares">79087734</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">741246000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">-267000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">-594981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">146006000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000204"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">2627000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">2627000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <nk:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000209"
      unitRef="U_xbrlishares">17589250</nk:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000210"
      unitRef="U_iso4217USD">2000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">35149000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000212"
      unitRef="U_iso4217USD">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000213"
      unitRef="U_iso4217USD">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">35151000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000215"
      unitRef="U_xbrlishares">1986300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">4070000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">4070000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000221"
      unitRef="U_xbrlishares">395051</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000225"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000226"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000227"
      unitRef="U_xbrlishares">124345</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">127000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000230"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000231"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">127000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000233"
      unitRef="U_xbrlishares">473586</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000234"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000235"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000236"
      unitRef="U_iso4217USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000237"
      unitRef="U_iso4217USD">501000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000238"
      unitRef="U_iso4217USD">501000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000240"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000241"
      unitRef="U_iso4217USD">0</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000242"
      unitRef="U_iso4217USD">-920000</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101_20191231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">-920000</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000244"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000246"
      unitRef="U_iso4217USD">162000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">162000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000249"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000250"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000251"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000252"
      unitRef="U_iso4217USD">-65789000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000253"
      unitRef="U_iso4217USD">-65789000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000254"
      unitRef="U_xbrlishares">98460404</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000255"
      unitRef="U_iso4217USD">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000256"
      unitRef="U_iso4217USD">782965000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000257"
      unitRef="U_iso4217USD">-105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000258"
      unitRef="U_iso4217USD">-662191000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000259"
      unitRef="U_iso4217USD">120679000</us-gaap:StockholdersEquity>
    <nk:StockOfferingCosts
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">4373000</nk:StockOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000260"
      unitRef="U_xbrlishares">8521500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000261"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000262"
      unitRef="U_iso4217USD">86301000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000263"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000264"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000265"
      unitRef="U_iso4217USD">86302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000266"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000267"
      unitRef="U_iso4217USD">2139000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000268"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000269"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000270"
      unitRef="U_iso4217USD">2139000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000271"
      unitRef="U_xbrlishares">1272273</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">1176000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000275"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">1176000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000277"
      unitRef="U_xbrlishares">648336</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000279"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000283"
      unitRef="U_xbrlishares">175962</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">503000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000287"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">503000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000290"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">-17000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">-17000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000296"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000297"
      unitRef="U_iso4217USD">-92383000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000298"
      unitRef="U_iso4217USD">-92383000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000299"
      unitRef="U_xbrlishares">108726551</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000300"
      unitRef="U_iso4217USD">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000301"
      unitRef="U_iso4217USD">872078000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">-122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">-754574000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">117393000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000306"
      unitRef="U_iso4217USD">-92383000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">-65789000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">-96226000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">9147000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">9012000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000311"
      unitRef="U_iso4217USD">9555000</us-gaap:DepreciationDepletionAndAmortization>
    <nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">3430000</nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense>
    <nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">2604000</nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense>
    <nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000314"
      unitRef="U_iso4217USD">0</nk:OperatingLeaseRightOfUseAssetNonCashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000315"
      unitRef="U_iso4217USD">2139000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000316"
      unitRef="U_iso4217USD">2627000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000317"
      unitRef="U_iso4217USD">23382000</us-gaap:ShareBasedCompensation>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000318"
      unitRef="U_iso4217USD">1405000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000319"
      unitRef="U_iso4217USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000321"
      unitRef="U_iso4217USD">-794000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">-463000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">-8000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000325"
      unitRef="U_iso4217USD">-4000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">3000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">-4000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000329"
      unitRef="U_iso4217USD">-209000</us-gaap:GainLossOnDispositionOfAssets1>
    <nk:NonCashInterestIncomeExpenseFromOperatingActivities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">251000</nk:NonCashInterestIncomeExpenseFromOperatingActivities>
    <nk:NonCashInterestIncomeExpenseFromOperatingActivities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">-246000</nk:NonCashInterestIncomeExpenseFromOperatingActivities>
    <nk:NonCashInterestIncomeExpenseFromOperatingActivities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">-291000</nk:NonCashInterestIncomeExpenseFromOperatingActivities>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">869000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000335"
      unitRef="U_iso4217USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">-498000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">1328000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">-9276000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000341"
      unitRef="U_iso4217USD">9818000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">339000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000343"
      unitRef="U_iso4217USD">4063000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000344"
      unitRef="U_iso4217USD">1151000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <nk:IncreaseDecreaseInAccountsPayableCurrent
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000345"
      unitRef="U_iso4217USD">2142000</nk:IncreaseDecreaseInAccountsPayableCurrent>
    <nk:IncreaseDecreaseInAccountsPayableCurrent
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000346"
      unitRef="U_iso4217USD">41000</nk:IncreaseDecreaseInAccountsPayableCurrent>
    <nk:IncreaseDecreaseInAccountsPayableCurrent
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000347"
      unitRef="U_iso4217USD">-1100000</nk:IncreaseDecreaseInAccountsPayableCurrent>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000348"
      unitRef="U_iso4217USD">3686000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000349"
      unitRef="U_iso4217USD">-12020000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000350"
      unitRef="U_iso4217USD">12708000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000351"
      unitRef="U_iso4217USD">5034000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000352"
      unitRef="U_iso4217USD">-1093000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000353"
      unitRef="U_iso4217USD">-685000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <nk:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000354"
      unitRef="U_iso4217USD">-3941000</nk:IncreaseDecreaseInOperatingLeaseLiability>
    <nk:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000355"
      unitRef="U_iso4217USD">-3076000</nk:IncreaseDecreaseInOperatingLeaseLiability>
    <nk:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000356"
      unitRef="U_iso4217USD">0</nk:IncreaseDecreaseInOperatingLeaseLiability>
    <nk:IncreaseDecreaseInDeferredRent
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000357"
      unitRef="U_iso4217USD">0</nk:IncreaseDecreaseInDeferredRent>
    <nk:IncreaseDecreaseInDeferredRent
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000358"
      unitRef="U_iso4217USD">0</nk:IncreaseDecreaseInDeferredRent>
    <nk:IncreaseDecreaseInDeferredRent
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000359"
      unitRef="U_iso4217USD">-508000</nk:IncreaseDecreaseInDeferredRent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000360"
      unitRef="U_iso4217USD">-70453000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000361"
      unitRef="U_iso4217USD">-61362000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000362"
      unitRef="U_iso4217USD">-63381000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000363"
      unitRef="U_iso4217USD">2639000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000364"
      unitRef="U_iso4217USD">4182000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000365"
      unitRef="U_iso4217USD">13102000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000366"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000367"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000368"
      unitRef="U_iso4217USD">412000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000369"
      unitRef="U_iso4217USD">0</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000370"
      unitRef="U_iso4217USD">0</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000371"
      unitRef="U_iso4217USD">723000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <nk:PaymentsToAcquireInvestmentsInEquitySecurities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000372"
      unitRef="U_iso4217USD">0</nk:PaymentsToAcquireInvestmentsInEquitySecurities>
    <nk:PaymentsToAcquireInvestmentsInEquitySecurities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000373"
      unitRef="U_iso4217USD">3000</nk:PaymentsToAcquireInvestmentsInEquitySecurities>
    <nk:PaymentsToAcquireInvestmentsInEquitySecurities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000374"
      unitRef="U_iso4217USD">0</nk:PaymentsToAcquireInvestmentsInEquitySecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000375"
      unitRef="U_iso4217USD">91572000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000376"
      unitRef="U_iso4217USD">86618000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000377"
      unitRef="U_iso4217USD">94770000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000378"
      unitRef="U_iso4217USD">65350000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000379"
      unitRef="U_iso4217USD">109730000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000380"
      unitRef="U_iso4217USD">165284000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000381"
      unitRef="U_iso4217USD">8272000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000382"
      unitRef="U_iso4217USD">2529000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000383"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000384"
      unitRef="U_iso4217USD">-20589000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000385"
      unitRef="U_iso4217USD">21456000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000386"
      unitRef="U_iso4217USD">57101000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000387"
      unitRef="U_iso4217USD">86302000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000388"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000389"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000390"
      unitRef="U_iso4217USD">1176000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000391"
      unitRef="U_iso4217USD">4070000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000392"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000393"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000394"
      unitRef="U_iso4217USD">35151000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000395"
      unitRef="U_iso4217USD">57000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000396"
      unitRef="U_iso4217USD">0</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000397"
      unitRef="U_iso4217USD">0</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000398"
      unitRef="U_iso4217USD">477000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000399"
      unitRef="U_iso4217USD">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000400"
      unitRef="U_iso4217USD">501000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000401"
      unitRef="U_iso4217USD">228000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000402"
      unitRef="U_iso4217USD">503000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000403"
      unitRef="U_iso4217USD">127000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000404"
      unitRef="U_iso4217USD">123000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000405"
      unitRef="U_iso4217USD">86975000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000406"
      unitRef="U_iso4217USD">38593000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000407"
      unitRef="U_iso4217USD">-771000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000408"
      unitRef="U_iso4217USD">-4067000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000409"
      unitRef="U_iso4217USD">-1313000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000410"
      unitRef="U_iso4217USD">-7051000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000411"
      unitRef="U_iso4217USD">15687000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000412"
      unitRef="U_iso4217USD">17000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20171231"
      decimals="-3"
      id="F_000413"
      unitRef="U_iso4217USD">24051000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000414"
      unitRef="U_iso4217USD">11620000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000415"
      unitRef="U_iso4217USD">15687000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000416"
      unitRef="U_iso4217USD">17000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000417"
      unitRef="U_iso4217USD">11441000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000418"
      unitRef="U_iso4217USD">15508000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000419"
      unitRef="U_iso4217USD">16821000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000420"
      unitRef="U_iso4217USD">179000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000421"
      unitRef="U_iso4217USD">179000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000422"
      unitRef="U_iso4217USD">179000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000423"
      unitRef="U_iso4217USD">11620000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000424"
      unitRef="U_iso4217USD">15687000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_000425"
      unitRef="U_iso4217USD">17000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000426"
      unitRef="U_iso4217USD">40000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000427"
      unitRef="U_iso4217USD">19000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000428"
      unitRef="U_iso4217USD">475000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000429"
      unitRef="U_iso4217USD">8000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000430"
      unitRef="U_iso4217USD">3000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000431"
      unitRef="U_iso4217USD">4000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000432"
      unitRef="U_iso4217USD">5164000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000433"
      unitRef="U_iso4217USD">800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000434"
      unitRef="U_iso4217USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:StockIssued1
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000435"
      unitRef="U_iso4217USD">1233000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000436"
      unitRef="U_iso4217USD">29000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000437"
      unitRef="U_iso4217USD">94000</us-gaap:StockIssued1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000438"
      unitRef="U_iso4217USD">289000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000439"
      unitRef="U_iso4217USD">74000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000440"
      unitRef="U_iso4217USD">4664000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000441"
      unitRef="U_iso4217USD">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000442"
      unitRef="U_iso4217USD">751000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000443"
      unitRef="U_iso4217USD">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000444"
      unitRef="U_iso4217USD">-17000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000445"
      unitRef="U_iso4217USD">258000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000446"
      unitRef="U_iso4217USD">123000</us-gaap:UnrealizedGainLossOnInvestments>
    <nk:DescriptionOfBusinessDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000448">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1. &#160;&#160;&#160;&#160;Description of Business&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Organization&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;NantKwest, Inc., or NantKwest, was incorporated in Illinois on October&#160;7, 2002 under the name ZelleRx Corporation. On January&#160;22, 2010, the company changed its name to Conkwest, Inc., and on July&#160;10, 2015, the company changed its name to NantKwest, Inc. In March&#160;2014, the company redomesticated from the State of Illinois to the State of Delaware and the Illinois company ceased to exist. We are a pioneering clinical-stage immunotherapy biotechnology company headquartered in San Diego, California with certain operations in Culver City and El Segundo, California and Woburn, Massachusetts. In these notes, the terms &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;the company&#x201d; and &#x201c;us&#x201d; refer to NantKwest.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are focused on harnessing the power of the innate immune system by using our natural killer cells, or NK&#160;cells, to treat cancer and viral infectious diseases. A critical aspect of our strategy is to invest significantly in innovating new therapeutic candidates, based upon our proprietary activated NK, or aNK, cell platform, and conducting clinical testing and scale manufacturing of our most promising biologic product candidates.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We hold the exclusive right to commercialize aNK&#160;cells, a commercially viable NK&#160;cell line, and a wide range of genetically modified derivatives capable of killing cancer and virally infected cells. We own corresponding United States, or U.S., and foreign composition and methods-of-use patents and applications covering the cells, improvements, methods of expansion and manufacture and use of aNK&#160;cells and their improvements as therapeutics to treat a spectrum of clinical conditions.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Liquidity&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June&#160;29, 2020, the company closed an underwritten public offering of common stock as discussed further in Note&#160;11,&lt;span style="font-style:italic;"&gt;&#160;Stockholders Equity&lt;/span&gt;. Gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020, the company had an accumulated deficit of $754.6&#160;million. We also had negative cash flow from operations of $70.5&#160;million during the year ended December&#160;31, 2020. The company will likely need additional capital to further fund development of, and seek regulatory approvals for, our product candidates, and to begin to commercialize any approved products.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are currently focused primarily on the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer and viral killing cell lines, and we believe such activities will result in the company&#x2019;s continued incurrence of significant research and development and other expenses related to those programs. If the clinical trials for any of the company&#x2019;s product candidates fail or produce unsuccessful results and those product candidates do not gain regulatory approval, or if any of our product candidates, if approved, fail to achieve market acceptance, we may never become profitable. Even if the company achieves profitability in the future, it may not be able to sustain profitability in subsequent periods. We intend to cover our future operating expenses through cash and cash equivalents and marketable debt securities on hand and through a combination of equity offerings, debt financings, government or other third party funding, marketing and distribution arrangements and other collaborations, strategic alliances, and licensing arrangements. Additional financing may not be available to us when needed and, if available, financing may not be obtained on terms favorable to the company or its stockholders.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;While we expect our existing cash, and cash equivalents and marketable debt securities, together with the ability to borrow from affiliated entities, will enable us to fund operations and capital expenditure requirements for at least the next 12&#160;months, we may not have sufficient funds to reach commercialization. Failure to obtain adequate financing when needed may require us to delay, reduce, limit, or terminate some or all of our development programs or future commercialization efforts or grant rights to develop and market product candidates that we might otherwise prefer to develop and market ourselves, which could adversely affect our ability to operate as a going concern. If we raise additional funds from the issuance of equity securities, substantial dilution to existing stockholders may result. If we raise additional funds by incurring debt financing, the terms of the debt may involve significant cash payment obligations, as well as covenants and specific financial ratios that may restrict our ability to operate our business.&lt;/p&gt;

</nk:DescriptionOfBusinessDisclosureTextBlock>
    <nk:LiquidityPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000464">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Liquidity&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June&#160;29, 2020, the company closed an underwritten public offering of common stock as discussed further in Note&#160;11,&lt;span style="font-style:italic;"&gt;&#160;Stockholders Equity&lt;/span&gt;. Gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020, the company had an accumulated deficit of $754.6&#160;million. We also had negative cash flow from operations of $70.5&#160;million during the year ended December&#160;31, 2020. The company will likely need additional capital to further fund development of, and seek regulatory approvals for, our product candidates, and to begin to commercialize any approved products.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are currently focused primarily on the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer and viral killing cell lines, and we believe such activities will result in the company&#x2019;s continued incurrence of significant research and development and other expenses related to those programs. If the clinical trials for any of the company&#x2019;s product candidates fail or produce unsuccessful results and those product candidates do not gain regulatory approval, or if any of our product candidates, if approved, fail to achieve market acceptance, we may never become profitable. Even if the company achieves profitability in the future, it may not be able to sustain profitability in subsequent periods. We intend to cover our future operating expenses through cash and cash equivalents and marketable debt securities on hand and through a combination of equity offerings, debt financings, government or other third party funding, marketing and distribution arrangements and other collaborations, strategic alliances, and licensing arrangements. Additional financing may not be available to us when needed and, if available, financing may not be obtained on terms favorable to the company or its stockholders.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;While we expect our existing cash, and cash equivalents and marketable debt securities, together with the ability to borrow from affiliated entities, will enable us to fund operations and capital expenditure requirements for at least the next 12&#160;months, we may not have sufficient funds to reach commercialization. Failure to obtain adequate financing when needed may require us to delay, reduce, limit, or terminate some or all of our development programs or future commercialization efforts or grant rights to develop and market product candidates that we might otherwise prefer to develop and market ourselves, which could adversely affect our ability to operate as a going concern. If we raise additional funds from the issuance of equity securities, substantial dilution to existing stockholders may result. If we raise additional funds by incurring debt financing, the terms of the debt may involve significant cash payment obligations, as well as covenants and specific financial ratios that may restrict our ability to operate our business.&lt;/p&gt;

</nk:LiquidityPolicyTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="-5"
      id="F_000522"
      unitRef="U_iso4217USD">90700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nk:UnderwritingDiscountsCommissionsAndOtherOfferingExpenses
      contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="-5"
      id="F_000523"
      unitRef="U_iso4217USD">4400000</nk:UnderwritingDiscountsCommissionsAndOtherOfferingExpenses>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000524"
      unitRef="U_iso4217USD">-754600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001326110_20200101_20201231"
      decimals="-5"
      id="F_000525"
      unitRef="U_iso4217USD">-70500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000449">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S.&#160;GAAP.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared assuming the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of the uncertainty discussed in the Liquidity section of Note&#160;1. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#x2019;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We may also seek to sell additional equity, through one or more follow-on public offerings, or in separate financings, or obtain a credit facility. However, we may not be able to secure such financing in a timely manner or on favorable terms. Without additional funds, we may choose to delay or reduce our operating or investment expenditures. Further, because of the risk and uncertainties associated with the commercialization of the company&#x2019;s product candidates in development, we may need additional funds to meet our needs sooner than planned.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements include the accounts of NantKwest and its wholly owned subsidiaries. All intercompany amounts have been eliminated.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We apply the variable interest model under Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic&#160;810,&#160;&lt;span style="font-style:italic;"&gt;Consolidation&lt;/span&gt;, to any entity in which we hold an equity investment or to which we have the power to direct the entity's most significant economic activities and the ability to participate in the entity's economics. If the entity is within the scope of the variable interest model and meets the definition of a variable interest entity, or VIE, we consider whether we must consolidate the VIE or provide additional disclosures regarding our involvement with the VIE. If we determine that we are the primary beneficiary of the VIE, we will consolidate the VIE. This analysis is performed at the initial investment in the entity or upon any reconsideration event.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For entities we hold as an equity investment that are not consolidated under the VIE model, we consider whether our investment constitutes ownership of a majority of the voting interests in the entity and therefore should be considered for consolidation under the voting interest model.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unconsolidated equity investments in the common stock or in-substance common stock of an entity under which we are able to exercise significant influence, but not control, are accounted for using the equity method. Our ability to exercise significant influence is generally indicated by ownership of 20 to 50 percent interest in the voting securities of the entity.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;All other unconsolidated equity investments on which we are not able to exercise significant influence will be subsequently measured at fair value with unrealized holding gains and losses included in other income and expense, net, on the consolidated statements of operations. In the instance the equity investment does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, &lt;span style="font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;, or ASC&#160;820, we will apply the measurement alternative under ASC&#160;321, &lt;span style="font-style:italic;"&gt;Investments&#x2014;Equity Securities&lt;/span&gt;, or ASC&#160;321, pursuant to which we will measure the investment at its cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#x2019; earnings performance and clinical trial performance, change in the investees&#x2019; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include:&#160;the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#x2019;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates. Actual results could differ from those estimates.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#x2011;CoV&#x2011;2) outbreak a pandemic. To date, our operations have not been significantly impacted by the pandemic. However, we cannot at this time predict the specific extent, duration, or full impact that this pandemic may have on our financial condition and results of operations, including ongoing and planned clinical trials. More specifically, the pandemic may result in prolonged impacts that we cannot predict at this time and we expect that such uncertainties will continue to exist until such time a vaccine is broadly available and in use. The impact of the pandemic on the financial performance of the company will depend on future developments, including the duration and spread of the outbreak and related governmental advisories and restrictions. These developments and the impact of the ongoing pandemic on the financial markets and the overall economy are highly uncertain. If the financial markets and/or the overall economy are impacted for an extended period, our results may be adversely affected.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea. We minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe that we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents include highly liquid investments with an original maturity of &lt;span style="-sec-ix-hidden:F_000528"&gt;three&#160;months&lt;/span&gt; or less from the date of purchase.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of cash, cash equivalents, and restricted cash is included on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Marketable Debt Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of 12&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than 12&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#x2019; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were no other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property, Plant and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment is stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. All repairs and maintenance are charged to net loss during the financial period in which they are incurred. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 39 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The lesser of the lease term or the life of the asset&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon disposal or impairment of property, plant and equipment, the cost and related accumulated depreciation is removed from the consolidated financial statements and the net amount, less any proceeds, is included in the consolidated statements of operations.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Intangible Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets, which consisted of the cost of reacquiring a technology license during 2015, were amortized using the straight-line method over an estimated useful life of 4&#160;years. As of December&#160;31, 2019, our intangible assets were fully amortized.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Patents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Patent costs, including related legal costs, are expensed as incurred and recorded in selling, general and administrative expenses on the consolidated statements of operations.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Impairments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;year ended December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, we determined that certain bioreactor laboratory equipment could no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; longer&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; be utilized in the production process. As a result, we recorded an impairment charge &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;totaling&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;million, which is included in research and development expense on the consolidated statements of operations. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; impairment losses recognized during the&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;years ended December&#160;31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and 2018&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in absence of a principal, most advantageous market for the specific asset or liability.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The three tiers are defined as follows:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;1&#x2014; Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets at the measurement date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Our Level 1 assets consist of bank deposits and money market funds.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;2&#x2014; Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities. Our Level 2 assets consist of corporate debt securities including commercial paper, government sponsored securities and corporate bonds, as well as foreign municipal securities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;3&#x2014; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December&#160;31, 2020, 2019 and 2018, no transfers were made into or out of the Level&#160;1,&#160;2 or 3 categories. We will continue to review the fair value inputs on a quarterly basis.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We utilize a third-party pricing service to assist in obtaining fair value pricing for our investments in marketable debt securities. Inputs are documented in accordance with the fair value disclosure hierarchy.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Collaboration Arrangements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We analyze our collaboration arrangements to assess whether they are within the scope of FASB ASC&#160;Topic&#160;808, &lt;span style="font-style:italic;"&gt;Collaborative Arrangements,&lt;/span&gt; or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our collaboration arrangements are further discussed within Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Preclinical and Clinical Trial Accruals&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; behalf.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accruing clinical and research related fees, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Transactions with Related Parties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As outlined in Note&#160;10,&#160;&lt;span style="font-style:italic;"&gt;Related Party Agreements&lt;/span&gt;, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Lease Obligations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, &lt;span style="font-style:italic;"&gt;Leases&lt;/span&gt;, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, &lt;span style="font-style:italic;"&gt;Leases&lt;/span&gt;, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We also elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception. Such leases are expensed on a straight-line basis over the lease term.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, as well as for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances to reduce deferred tax assets to the amount we believe is more likely than not to be realized.&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize uncertain tax positions when the position will be more likely than not upheld on examination by the taxing authorities based solely upon the technical merits of the positions. We recognize interest and penalties, if any, related to unrecognized income tax uncertainties in income tax expense. We did not have any accrued interest or penalties associated with uncertain tax positions as of December&#160;31, 2020 and 2019.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to U.S. federal income tax, as well as income tax in Korea, California and other states. To date, we have not been required to pay U.S. federal and state income taxes because of current and accumulated net operating losses. The federal returns for tax years 2017 through 2020 remain open to examination and the state returns remain subject to examination for tax years 2016 through 2020. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination. No income tax returns are currently under examination by taxing authorities.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock Repurchases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2015, the board of directors approved the 2015 Share Repurchase Program (Note&#160;11) allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&#160;1, 2018, we adopted the provisions of FASB ASC&#160;Topic&#160;606, &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;, or ASC&#160;606. This guidance requires that entities recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted ASC&#160;606 on January&#160;1, 2018 by recording the cumulative effect of the adoption to accumulated deficit. We applied the new guidance to contracts that were not complete as of January&#160;1, 2018. Implementation of ASC&#160;606 did not have a material impact on our consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We derive substantially all of our revenue from non-exclusive license agreements with a limited number of pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of the licensee products developed or manufactured using our intellectual property and cell lines.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC&#160;606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the company&#x2019;s license agreements with customers, the company typically promises to provide a license to use certain cell lines and related patents, the related know-how, and future research and development data that affect the license. We have concluded that these promises represent one performance obligation due to the highly interrelated nature of the promises. We provide the cell lines and know-how immediately upon entering into the contracts. The research and development data is provided throughout the term of the contract when and if available.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our license agreement with Precigen&#160;(Note&#160;8) included a nonrefundable upfront payment of $0.4&#160;million, received when we entered into the contract in 2010. In this instance, we determined that under ASC&#160;606 it would be appropriate to recognize the initial milestone payment at a point in time, when we transferred the license. In this case, the intellectual property provided under the contract is functional intellectual property under ASC&#160;606 and was determined to be a distinct performance obligation in the context of the arrangement. Prior to adoption, the upfront payment had been initially recorded as deferred revenue and was being recognized into revenue on a straight-line basis. As a result, upon adoption of ASC&#160;606, we adjusted our accumulated deficit for the effects of recognizing revenue upfront for the initial milestone. The adjustment to accumulated deficit upon adoption was not material.&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The license agreements may include nonrefundable upfront payments, event-based milestone payments, sales-based royalty payments, or some combination of these. The event-based milestone payments represent variable consideration and we use the most likely amount method to estimate this variable consideration. Given the high degree of uncertainly around achievement of these milestones, we do not recognize revenue from these milestone payments until the uncertainty associated with these payments is resolved. We currently estimate variable consideration related to milestone payments to be zero and, as such, no revenue has been recognized for milestone payments. We recognize revenue from sales-based royalty payments when or as the sales occur. On a quarterly basis, we re-evaluate our estimate of milestone variable consideration to determine whether any amount should be included in the transaction price and recorded in revenue prospectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon adoption, we changed our accounting policy from accounting for milestones payments under the milestone method to accounting for variable consideration as discussed above. The change in accounting policy did not change any amounts in the financial statements because of the significant uncertainty surrounding the estimate of variable consideration for milestone payments.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have no products approved for commercial sale and we have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Research and Development Costs&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, &lt;span style="font-style:italic;"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Litigation Costs&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We expense legal fees as they are incurred.&lt;/p&gt;


&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Comprehensive Income (Loss)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income or loss is composed of net income (loss) and other comprehensive income (loss). Our other comprehensive income or loss consists of unrealized gains and losses on marketable debt securities classified as available-for-sale, net of income taxes.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basic and Diluted Net Loss per Share of Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For all periods presented, potentially dilutive securities are excluded from the computation of fully diluted loss per share as their effect is anti-dilutive. The following table details those securities that have been excluded from the computation of potentially dilutive securities:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,506,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,493,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,139,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;867,911&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding warrants&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,984,852&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,646,378&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,950,411&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts in the table above reflect the common stock equivalents of the noted instruments.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Segment and Geographic Information&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating segments are defined as components of an enterprise (business activity from which it earns revenue and incurs expenses) for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the company&#x2019;s CEO. We view our operations and manage our business as a single operating and reporting segment. As of December&#160;31, 2020 and 2019, the majority of our assets were held in the U.S. For the years ended December&#160;31, 2020, 2019 and 2018, all of our revenue was derived in the U.S.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Application of New or Revised Accounting Standards &#x2013; Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2018, the FASB issued Accounting Standards Update, or ASU, No.&#160;2018-18, &lt;span style="font-style:italic;"&gt;Collaborative Arrangements&#160;(Topic&#160;808):&#160;Clarifying the Interaction between Topic&#160;808 and Topic&#160;606&lt;/span&gt; (ASU&#160;2018-18). ASU&#160;2018-18 clarifies when certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic&#160;606. It also specifically addresses when the participant should be considered a customer in the context of a unit of account; adds unit of account guidance in ASC&#160;808 to align with guidance in ASC&#160;606; and precludes presenting revenue from a collaborative arrangement together with revenue recognized under ASC&#160;606 if the collaborative arrangement participant is not a customer. This standard is effective for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years with early adoption permitted. We adopted ASU&#160;2018-18, as required, in the quarter ended March&#160;31, 2020. We are a party to several collaboration arrangements as further described in Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;, however, adoption of ASU&#160;2018-18 did not have an impact on our consolidated financial statements because the counterparties to our collaboration agreements do not meet the definition of a customer.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December&#160;2019, the FASB issued ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12,&#160;&lt;/span&gt;&lt;span style="font-style:italic;"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, or ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12. The amendments in ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 include removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (e.g., discontinued operations or other comprehensive income), and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 also amends other aspects of accounting for income taxes to help simplify and promote consistent application of U.S.&#160;GAAP. The guidance is effective for interim and annual periods beginning after December&#160;15, 2020, with early adoption permitted. We early adopted ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 effective January&#160;1, 2020, and it did not have a material impact on our consolidated financial statements. Although our adoption of ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 did not have a material impact on our consolidated financial statements during the year ended December&#160;31, 2020, it may have a material impact on our consolidated financial statements in future periods due to the removal of the exceptions discussed above. The amendments related to intraperiod tax allocation and the amendment related to calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;applied prospectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Application of New or Revised Accounting Standards &#x2013; Not Yet Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2016, the FASB issued ASU&#160;2016&#x2011;13,&#160;&lt;span style="font-style:italic;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;. The FASB subsequently issued amendments to ASU&#160;2016&#x2011;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. For public business entities that meet the definition of a Securities and Exchange Commission, or SEC, filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December&#160;15, 2018. With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We continue to evaluate the impact that this new standard and its related amendments will have on our consolidated financial statements and we do not intend to early adopt this new standard.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000465">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S.&#160;GAAP.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared assuming the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of the uncertainty discussed in the Liquidity section of Note&#160;1. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#x2019;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We may also seek to sell additional equity, through one or more follow-on public offerings, or in separate financings, or obtain a credit facility. However, we may not be able to secure such financing in a timely manner or on favorable terms. Without additional funds, we may choose to delay or reduce our operating or investment expenditures. Further, because of the risk and uncertainties associated with the commercialization of the company&#x2019;s product candidates in development, we may need additional funds to meet our needs sooner than planned.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000466">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements include the accounts of NantKwest and its wholly owned subsidiaries. All intercompany amounts have been eliminated.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We apply the variable interest model under Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic&#160;810,&#160;&lt;span style="font-style:italic;"&gt;Consolidation&lt;/span&gt;, to any entity in which we hold an equity investment or to which we have the power to direct the entity's most significant economic activities and the ability to participate in the entity's economics. If the entity is within the scope of the variable interest model and meets the definition of a variable interest entity, or VIE, we consider whether we must consolidate the VIE or provide additional disclosures regarding our involvement with the VIE. If we determine that we are the primary beneficiary of the VIE, we will consolidate the VIE. This analysis is performed at the initial investment in the entity or upon any reconsideration event.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For entities we hold as an equity investment that are not consolidated under the VIE model, we consider whether our investment constitutes ownership of a majority of the voting interests in the entity and therefore should be considered for consolidation under the voting interest model.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unconsolidated equity investments in the common stock or in-substance common stock of an entity under which we are able to exercise significant influence, but not control, are accounted for using the equity method. Our ability to exercise significant influence is generally indicated by ownership of 20 to 50 percent interest in the voting securities of the entity.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;All other unconsolidated equity investments on which we are not able to exercise significant influence will be subsequently measured at fair value with unrealized holding gains and losses included in other income and expense, net, on the consolidated statements of operations. In the instance the equity investment does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, &lt;span style="font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;, or ASC&#160;820, we will apply the measurement alternative under ASC&#160;321, &lt;span style="font-style:italic;"&gt;Investments&#x2014;Equity Securities&lt;/span&gt;, or ASC&#160;321, pursuant to which we will measure the investment at its cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#x2019; earnings performance and clinical trial performance, change in the investees&#x2019; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include:&#160;the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMinimumMember_20201231"
      decimals="INF"
      id="F_000526"
      unitRef="U_xbrlipure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_0001326110_srtConsolidatedEntitiesAxis_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_srtRangeAxis_srtMaximumMember_20201231"
      decimals="INF"
      id="F_000527"
      unitRef="U_xbrlipure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UseOfEstimates contextRef="C_0001326110_20200101_20201231" id="F_000467">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#x2019;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:UnusualRisksAndUncertaintiesTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000468">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#x2011;CoV&#x2011;2) outbreak a pandemic. To date, our operations have not been significantly impacted by the pandemic. However, we cannot at this time predict the specific extent, duration, or full impact that this pandemic may have on our financial condition and results of operations, including ongoing and planned clinical trials. More specifically, the pandemic may result in prolonged impacts that we cannot predict at this time and we expect that such uncertainties will continue to exist until such time a vaccine is broadly available and in use. The impact of the pandemic on the financial performance of the company will depend on future developments, including the duration and spread of the outbreak and related governmental advisories and restrictions. These developments and the impact of the ongoing pandemic on the financial markets and the overall economy are highly uncertain. If the financial markets and/or the overall economy are impacted for an extended period, our results may be adversely affected.&lt;/p&gt;</us-gaap:UnusualRisksAndUncertaintiesTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000469">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001326110_20200101_20201231" id="F_000470">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea. We minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe that we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="C_0001326110_20200101_20201231" id="F_000471">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents include highly liquid investments with an original maturity of &lt;span style="-sec-ix-hidden:F_000528"&gt;three&#160;months&lt;/span&gt; or less from the date of purchase.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of cash, cash equivalents, and restricted cash is included on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:MarketableSecuritiesPolicy contextRef="C_0001326110_20200101_20201231" id="F_000472">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Marketable Debt Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of 12&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than 12&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#x2019; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were no other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <nk:MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities contextRef="C_0001326110_20200101_20201231" id="F_000529">P12M</nk:MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities>
    <nk:MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities contextRef="C_0001326110_20200101_20201231" id="F_000530">P12M</nk:MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_000531"
      unitRef="U_iso4217USD">0</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_000532"
      unitRef="U_iso4217USD">0</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_000533"
      unitRef="U_iso4217USD">0</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000473">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property, Plant and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment is stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. All repairs and maintenance are charged to net loss during the financial period in which they are incurred. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 39 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The lesser of the lease term or the life of the asset&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon disposal or impairment of property, plant and equipment, the cost and related accumulated depreciation is removed from the consolidated financial statements and the net amount, less any proceeds, is included in the consolidated statements of operations.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <nk:PropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000493">Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 39 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 5 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3 years&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The lesser of the lease term or the life of the asset&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</nk:PropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231"
      id="F_000534">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20200101_20201231"
      id="F_000535">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkLaboratoryEquipmentMember_20200101_20201231"
      id="F_000536">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20200101_20201231"
      id="F_000537">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_nkITEquipmentMember_20200101_20201231"
      id="F_000538">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20200101_20201231"
      id="F_000539">The lesser of the lease term or the life of the asset</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="C_0001326110_20200101_20201231" id="F_000474">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Intangible Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible assets, which consisted of the cost of reacquiring a technology license during 2015, were amortized using the straight-line method over an estimated useful life of 4&#160;years. As of December&#160;31, 2019, our intangible assets were fully amortized.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="C_0001326110_20200101_20201231" id="F_000540">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LegalCostsPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000475">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Patents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Patent costs, including related legal costs, are expensed as incurred and recorded in selling, general and administrative expenses on the consolidated statements of operations.&lt;/p&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000476">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Impairments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;year ended December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, we determined that certain bioreactor laboratory equipment could no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; longer&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; be utilized in the production process. As a result, we recorded an impairment charge &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;totaling&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;million, which is included in research and development expense on the consolidated statements of operations. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; impairment losses recognized during the&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;years ended December&#160;31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and 2018&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231"
      decimals="-5"
      id="F_000541"
      unitRef="U_iso4217USD">900000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="INF"
      id="F_000542"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231"
      decimals="INF"
      id="F_000543"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="C_0001326110_20200101_20201231" id="F_000477">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in absence of a principal, most advantageous market for the specific asset or liability.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The three tiers are defined as follows:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;1&#x2014; Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets at the measurement date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Our Level 1 assets consist of bank deposits and money market funds.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;2&#x2014; Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities. Our Level 2 assets consist of corporate debt securities including commercial paper, government sponsored securities and corporate bonds, as well as foreign municipal securities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:4.54%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;3&#x2014; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December&#160;31, 2020, 2019 and 2018, no transfers were made into or out of the Level&#160;1,&#160;2 or 3 categories. We will continue to review the fair value inputs on a quarterly basis.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We utilize a third-party pricing service to assist in obtaining fair value pricing for our investments in marketable debt securities. Inputs are documented in accordance with the fair value disclosure hierarchy.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000544"
      unitRef="U_iso4217USD">0</nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories>
    <nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000545"
      unitRef="U_iso4217USD">0</nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories>
    <nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
      contextRef="C_0001326110_20181231"
      decimals="INF"
      id="F_000546"
      unitRef="U_iso4217USD">0</nk:FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories>
    <us-gaap:CollaborativeArrangementAccountingPolicy contextRef="C_0001326110_20200101_20201231" id="F_000478">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Collaboration Arrangements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We analyze our collaboration arrangements to assess whether they are within the scope of FASB ASC&#160;Topic&#160;808, &lt;span style="font-style:italic;"&gt;Collaborative Arrangements,&lt;/span&gt; or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our collaboration arrangements are further discussed within Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;.&lt;/p&gt;</us-gaap:CollaborativeArrangementAccountingPolicy>
    <nk:PreclinicalAndClinicalTrialAccrualsPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000479">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Preclinical and Clinical Trial Accruals&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; behalf.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accruing clinical and research related fees, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;we&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.&lt;/span&gt;&lt;/p&gt;</nk:PreclinicalAndClinicalTrialAccrualsPolicyTextBlock>
    <nk:RelatedPartyTransactionsPolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000480">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Transactions with Related Parties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As outlined in Note&#160;10,&#160;&lt;span style="font-style:italic;"&gt;Related Party Agreements&lt;/span&gt;, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.&lt;/p&gt;</nk:RelatedPartyTransactionsPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000481">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Lease Obligations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, &lt;span style="font-style:italic;"&gt;Leases&lt;/span&gt;, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, &lt;span style="font-style:italic;"&gt;Leases&lt;/span&gt;, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We also elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception. Such leases are expensed on a straight-line basis over the lease term.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="C_0001326110_20200101_20201231" id="F_000548">elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000482">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, as well as for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances to reduce deferred tax assets to the amount we believe is more likely than not to be realized.&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognize uncertain tax positions when the position will be more likely than not upheld on examination by the taxing authorities based solely upon the technical merits of the positions. We recognize interest and penalties, if any, related to unrecognized income tax uncertainties in income tax expense. We did not have any accrued interest or penalties associated with uncertain tax positions as of December&#160;31, 2020 and 2019.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to U.S. federal income tax, as well as income tax in Korea, California and other states. To date, we have not been required to pay U.S. federal and state income taxes because of current and accumulated net operating losses. The federal returns for tax years 2017 through 2020 remain open to examination and the state returns remain subject to examination for tax years 2016 through 2020. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination. No income tax returns are currently under examination by taxing authorities.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000549"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_000550"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      id="F_000551">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      id="F_000552">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_000553">2016</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_000554">2020</us-gaap:OpenTaxYear>
    <nk:StockRepurchasesPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000483">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock Repurchases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2015, the board of directors approved the 2015 Share Repurchase Program (Note&#160;11) allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.&lt;/p&gt;</nk:StockRepurchasesPolicyTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="C_0001326110_20151130"
      decimals="INF"
      id="F_000555"
      unitRef="U_iso4217USD">50000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000484">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&#160;1, 2018, we adopted the provisions of FASB ASC&#160;Topic&#160;606, &lt;span style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;, or ASC&#160;606. This guidance requires that entities recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted ASC&#160;606 on January&#160;1, 2018 by recording the cumulative effect of the adoption to accumulated deficit. We applied the new guidance to contracts that were not complete as of January&#160;1, 2018. Implementation of ASC&#160;606 did not have a material impact on our consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We derive substantially all of our revenue from non-exclusive license agreements with a limited number of pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of the licensee products developed or manufactured using our intellectual property and cell lines.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC&#160;606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the company&#x2019;s license agreements with customers, the company typically promises to provide a license to use certain cell lines and related patents, the related know-how, and future research and development data that affect the license. We have concluded that these promises represent one performance obligation due to the highly interrelated nature of the promises. We provide the cell lines and know-how immediately upon entering into the contracts. The research and development data is provided throughout the term of the contract when and if available.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our license agreement with Precigen&#160;(Note&#160;8) included a nonrefundable upfront payment of $0.4&#160;million, received when we entered into the contract in 2010. In this instance, we determined that under ASC&#160;606 it would be appropriate to recognize the initial milestone payment at a point in time, when we transferred the license. In this case, the intellectual property provided under the contract is functional intellectual property under ASC&#160;606 and was determined to be a distinct performance obligation in the context of the arrangement. Prior to adoption, the upfront payment had been initially recorded as deferred revenue and was being recognized into revenue on a straight-line basis. As a result, upon adoption of ASC&#160;606, we adjusted our accumulated deficit for the effects of recognizing revenue upfront for the initial milestone. The adjustment to accumulated deficit upon adoption was not material.&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The license agreements may include nonrefundable upfront payments, event-based milestone payments, sales-based royalty payments, or some combination of these. The event-based milestone payments represent variable consideration and we use the most likely amount method to estimate this variable consideration. Given the high degree of uncertainly around achievement of these milestones, we do not recognize revenue from these milestone payments until the uncertainty associated with these payments is resolved. We currently estimate variable consideration related to milestone payments to be zero and, as such, no revenue has been recognized for milestone payments. We recognize revenue from sales-based royalty payments when or as the sales occur. On a quarterly basis, we re-evaluate our estimate of milestone variable consideration to determine whether any amount should be included in the transaction price and recorded in revenue prospectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon adoption, we changed our accounting policy from accounting for milestones payments under the milestone method to accounting for variable consideration as discussed above. The change in accounting policy did not change any amounts in the financial statements because of the significant uncertainty surrounding the estimate of variable consideration for milestone payments.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have no products approved for commercial sale and we have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <nk:NonrefundableUpfrontPayment
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000556"
      unitRef="U_iso4217USD">400000</nk:NonrefundableUpfrontPayment>
    <nk:VariableConsiderationRelatedToMilestonePayment
      contextRef="C_0001326110_20200101_20201231"
      decimals="-6"
      id="F_000557"
      unitRef="U_iso4217USD">0</nk:VariableConsiderationRelatedToMilestonePayment>
    <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized
      contextRef="C_0001326110_20200101_20201231"
      decimals="-6"
      id="F_000558"
      unitRef="U_iso4217USD">0</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
    <nk:NumberOfProductsApprovedForCommercialSale
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_000559"
      unitRef="U_nkProduct">0</nk:NumberOfProductsApprovedForCommercialSale>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_0001326110_20200101_20201231" id="F_000485">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Research and Development Costs&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000486">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, &lt;span style="font-style:italic;"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <nk:LitigationCostsPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000487">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Litigation Costs&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We expense legal fees as they are incurred.&lt;/p&gt;

</nk:LitigationCostsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000488">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Comprehensive Income (Loss)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income or loss is composed of net income (loss) and other comprehensive income (loss). Our other comprehensive income or loss consists of unrealized gains and losses on marketable debt securities classified as available-for-sale, net of income taxes.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000489">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basic and Diluted Net Loss per Share of Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For all periods presented, potentially dilutive securities are excluded from the computation of fully diluted loss per share as their effect is anti-dilutive. The following table details those securities that have been excluded from the computation of potentially dilutive securities:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,506,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,493,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,139,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;867,911&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding warrants&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,984,852&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,646,378&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,950,411&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts in the table above reflect the common stock equivalents of the noted instruments.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000494">The following table details those securities that have been excluded from the computation of potentially dilutive securities:
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,506,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,493,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,139,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;867,911&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding warrants&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,984,852&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,646,378&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,950,411&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts in the table above reflect the common stock equivalents of the noted instruments.&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000560"
      unitRef="U_xbrlishares">3518010</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_000561"
      unitRef="U_xbrlishares">4506950</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="INF"
      id="F_000562"
      unitRef="U_xbrlishares">6493250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_000563"
      unitRef="U_xbrlishares">466842</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_000564"
      unitRef="U_xbrlishares">1139428</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="INF"
      id="F_000565"
      unitRef="U_xbrlishares">867911</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231"
      decimals="INF"
      id="F_000566"
      unitRef="U_xbrlishares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231"
      decimals="INF"
      id="F_000567"
      unitRef="U_xbrlishares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20180101_20181231"
      decimals="INF"
      id="F_000568"
      unitRef="U_xbrlishares">17589250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_000569"
      unitRef="U_xbrlishares">3984852</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_000570"
      unitRef="U_xbrlishares">5646378</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_000571"
      unitRef="U_xbrlishares">24950411</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000490">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Segment and Geographic Information&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating segments are defined as components of an enterprise (business activity from which it earns revenue and incurs expenses) for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the company&#x2019;s CEO. We view our operations and manage our business as a single operating and reporting segment. As of December&#160;31, 2020 and 2019, the majority of our assets were held in the U.S. For the years ended December&#160;31, 2020, 2019 and 2018, all of our revenue was derived in the U.S.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000491">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Application of New or Revised Accounting Standards &#x2013; Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2018, the FASB issued Accounting Standards Update, or ASU, No.&#160;2018-18, &lt;span style="font-style:italic;"&gt;Collaborative Arrangements&#160;(Topic&#160;808):&#160;Clarifying the Interaction between Topic&#160;808 and Topic&#160;606&lt;/span&gt; (ASU&#160;2018-18). ASU&#160;2018-18 clarifies when certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic&#160;606. It also specifically addresses when the participant should be considered a customer in the context of a unit of account; adds unit of account guidance in ASC&#160;808 to align with guidance in ASC&#160;606; and precludes presenting revenue from a collaborative arrangement together with revenue recognized under ASC&#160;606 if the collaborative arrangement participant is not a customer. This standard is effective for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years with early adoption permitted. We adopted ASU&#160;2018-18, as required, in the quarter ended March&#160;31, 2020. We are a party to several collaboration arrangements as further described in Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;, however, adoption of ASU&#160;2018-18 did not have an impact on our consolidated financial statements because the counterparties to our collaboration agreements do not meet the definition of a customer.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December&#160;2019, the FASB issued ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12,&#160;&lt;/span&gt;&lt;span style="font-style:italic;"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, or ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12. The amendments in ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 include removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (e.g., discontinued operations or other comprehensive income), and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 also amends other aspects of accounting for income taxes to help simplify and promote consistent application of U.S.&#160;GAAP. The guidance is effective for interim and annual periods beginning after December&#160;15, 2020, with early adoption permitted. We early adopted ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 effective January&#160;1, 2020, and it did not have a material impact on our consolidated financial statements. Although our adoption of ASU&#160;2019&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;12 did not have a material impact on our consolidated financial statements during the year ended December&#160;31, 2020, it may have a material impact on our consolidated financial statements in future periods due to the removal of the exceptions discussed above. The amendments related to intraperiod tax allocation and the amendment related to calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;applied prospectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Application of New or Revised Accounting Standards &#x2013; Not Yet Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2016, the FASB issued ASU&#160;2016&#x2011;13,&#160;&lt;span style="font-style:italic;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;. The FASB subsequently issued amendments to ASU&#160;2016&#x2011;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. For public business entities that meet the definition of a Securities and Exchange Commission, or SEC, filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December&#160;15, 2018. With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We continue to evaluate the impact that this new standard and its related amendments will have on our consolidated financial statements and we do not intend to early adopt this new standard.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000450">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;3. &#160;&#160;&#160;&#160;Financial Statement Details&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Prepaid expenses and other current assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, prepaid expenses and other current assets consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid preclinical and clinical trial services - with&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Insurance premium financing asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid insurance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;657&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;372&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;440&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid rent&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;589&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;392&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest receivable - marketable debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;473&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;222&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid supplies - with related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;467&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid equipment maintenance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid license fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due from related parties&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Insurance claim receivables&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,285&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property, plant and equipment, net&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, property, plant and equipment, net, consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,406&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,069&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,434&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;415&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79,108&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;60,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation expense related to property, plant and equipment was $9.1&#160;million, $8.4&#160;million and $7.3&#160;million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Intangible assets, net&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our intangible assets were fully amortized as of March&#160;31, 2019. Amortization expense was $0.6&#160;million and $2.3&#160;million for the years ended December&#160;31, 2019 and 2018, respectively, and is included in research and development expense on the consolidated statements of operations.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Other assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, other assets consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Security deposits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid software license fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid preclinical and clinical trial services - with&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;92&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,075&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due from related party&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,121&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,386&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash is comprised of a certificate of deposit that serves as collateral for a letter of credit required by our landlord as a security deposit related to our facility in San Diego, California.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Accrued expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, accrued expenses consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and service fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,920&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;975&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,236&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,002&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,368&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued laboratory equipment and supplies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;640&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued preclinical and clinical trial costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;638&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued capital expenditures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;337&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued franchise, sales/use and property taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Other current liabilities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, other current liabilities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing obligation - current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,438&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Investment income, net&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net investment income included the following for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest income&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,643&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,317&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment (amortization expense) accretion income, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(858&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net realized (losses) gains on investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;366&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,857&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest income includes interest from marketable debt securities, notes receivable, other assets, and interest from bank deposits. We did not recognize an impairment loss on any investments during the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000495">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, prepaid expenses and other current assets consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid preclinical and clinical trial services - with&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Insurance premium financing asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid insurance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;657&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;372&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;440&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid rent&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;589&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;392&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest receivable - marketable debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;473&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;222&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid supplies - with related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;467&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid equipment maintenance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid license fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due from related parties&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Insurance claim receivables&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,285&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000572"
      unitRef="U_iso4217USD">4626000</nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty>
    <nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000573"
      unitRef="U_iso4217USD">1021000</nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty>
    <nk:InsurancePremiumFinancingAsset
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000574"
      unitRef="U_iso4217USD">1421000</nk:InsurancePremiumFinancingAsset>
    <nk:InsurancePremiumFinancingAsset
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000575"
      unitRef="U_iso4217USD">757000</nk:InsurancePremiumFinancingAsset>
    <us-gaap:PrepaidInsurance
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000576"
      unitRef="U_iso4217USD">657000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000577"
      unitRef="U_iso4217USD">372000</us-gaap:PrepaidInsurance>
    <nk:PrepaidServices
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000578"
      unitRef="U_iso4217USD">607000</nk:PrepaidServices>
    <nk:PrepaidServices
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000579"
      unitRef="U_iso4217USD">440000</nk:PrepaidServices>
    <us-gaap:PrepaidRent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000580"
      unitRef="U_iso4217USD">589000</us-gaap:PrepaidRent>
    <us-gaap:PrepaidRent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000581"
      unitRef="U_iso4217USD">392000</us-gaap:PrepaidRent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000582"
      unitRef="U_iso4217USD">473000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000583"
      unitRef="U_iso4217USD">222000</us-gaap:InterestReceivableCurrent>
    <nk:PrepaidSuppliesWithRelatedParty
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000584"
      unitRef="U_iso4217USD">281000</nk:PrepaidSuppliesWithRelatedParty>
    <nk:PrepaidSuppliesWithRelatedParty
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000585"
      unitRef="U_iso4217USD">467000</nk:PrepaidSuppliesWithRelatedParty>
    <nk:PrepaidEquipmentMaintenance
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000586"
      unitRef="U_iso4217USD">243000</nk:PrepaidEquipmentMaintenance>
    <nk:PrepaidEquipmentMaintenance
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">251000</nk:PrepaidEquipmentMaintenance>
    <nk:PrepaidLicenseFees
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">233000</nk:PrepaidLicenseFees>
    <nk:PrepaidLicenseFees
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">78000</nk:PrepaidLicenseFees>
    <nk:LaboratoryEquipmentDeposit
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">66000</nk:LaboratoryEquipmentDeposit>
    <nk:LaboratoryEquipmentDeposit
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">0</nk:LaboratoryEquipmentDeposit>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">45000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">47000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">0</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">34000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">44000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">24000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">9285000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">4105000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000496">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, property, plant and equipment, net, consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,406&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,069&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,434&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;415&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79,108&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;60,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">33680000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">33406000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">23069000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">21434000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20201231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">22690000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20191231"
      decimals="-3"
      id="F_000605"
      unitRef="U_iso4217USD">22690000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20201231"
      decimals="-3"
      id="F_000606"
      unitRef="U_iso4217USD">1190000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20191231"
      decimals="-3"
      id="F_000607"
      unitRef="U_iso4217USD">1195000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231"
      decimals="-3"
      id="F_000608"
      unitRef="U_iso4217USD">415000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20191231"
      decimals="-3"
      id="F_000609"
      unitRef="U_iso4217USD">383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000610"
      unitRef="U_iso4217USD">81044000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000611"
      unitRef="U_iso4217USD">79108000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000612"
      unitRef="U_iso4217USD">27117000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000613"
      unitRef="U_iso4217USD">18607000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000614"
      unitRef="U_iso4217USD">53927000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000615"
      unitRef="U_iso4217USD">60501000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_0001326110_20200101_20201231"
      decimals="-5"
      id="F_000616"
      unitRef="U_iso4217USD">9100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001326110_20190101_20191231"
      decimals="-5"
      id="F_000617"
      unitRef="U_iso4217USD">8400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001326110_20180101_20181231"
      decimals="-5"
      id="F_000618"
      unitRef="U_iso4217USD">7300000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001326110_20190101_20191231"
      decimals="-5"
      id="F_000619"
      unitRef="U_iso4217USD">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_0001326110_20180101_20181231"
      decimals="-5"
      id="F_000620"
      unitRef="U_iso4217USD">2300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000497">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, other assets consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Security deposits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid software license fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid preclinical and clinical trial services - with&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; related party (Note 10)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;92&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,075&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due from related party&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,121&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,386&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:SecurityDeposit
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000621"
      unitRef="U_iso4217USD">481000</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000622"
      unitRef="U_iso4217USD">113000</us-gaap:SecurityDeposit>
    <nk:PrepaidSoftwareLicenseFeesInOtherAssets
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000623"
      unitRef="U_iso4217USD">318000</nk:PrepaidSoftwareLicenseFeesInOtherAssets>
    <nk:PrepaidSoftwareLicenseFeesInOtherAssets
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000624"
      unitRef="U_iso4217USD">0</nk:PrepaidSoftwareLicenseFeesInOtherAssets>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000625"
      unitRef="U_iso4217USD">179000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000626"
      unitRef="U_iso4217USD">179000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000627"
      unitRef="U_iso4217USD">92000</nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets>
    <nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000628"
      unitRef="U_iso4217USD">4075000</nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets>
    <us-gaap:DueFromRelatedPartiesNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000629"
      unitRef="U_iso4217USD">51000</us-gaap:DueFromRelatedPartiesNoncurrent>
    <us-gaap:DueFromRelatedPartiesNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000630"
      unitRef="U_iso4217USD">19000</us-gaap:DueFromRelatedPartiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000631"
      unitRef="U_iso4217USD">1121000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000632"
      unitRef="U_iso4217USD">4386000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000498">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, accrued expenses consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and service fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,920&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;975&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,236&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,002&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,368&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued laboratory equipment and supplies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;640&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued preclinical and clinical trial costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;638&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued capital expenditures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;337&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued franchise, sales/use and property taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000633"
      unitRef="U_iso4217USD">2920000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000634"
      unitRef="U_iso4217USD">975000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000635"
      unitRef="U_iso4217USD">2236000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000636"
      unitRef="U_iso4217USD">2002000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000637"
      unitRef="U_iso4217USD">1368000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000638"
      unitRef="U_iso4217USD">1064000</us-gaap:AccruedSalariesCurrent>
    <nk:AccruedLaboratoryEquipmentAndSupplies
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000639"
      unitRef="U_iso4217USD">641000</nk:AccruedLaboratoryEquipmentAndSupplies>
    <nk:AccruedLaboratoryEquipmentAndSupplies
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000640"
      unitRef="U_iso4217USD">640000</nk:AccruedLaboratoryEquipmentAndSupplies>
    <nk:AccruedPreclinicalAndClinicalTrialCosts
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000641"
      unitRef="U_iso4217USD">638000</nk:AccruedPreclinicalAndClinicalTrialCosts>
    <nk:AccruedPreclinicalAndClinicalTrialCosts
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000642"
      unitRef="U_iso4217USD">281000</nk:AccruedPreclinicalAndClinicalTrialCosts>
    <nk:AccruedCapitalExpenditures
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000643"
      unitRef="U_iso4217USD">337000</nk:AccruedCapitalExpenditures>
    <nk:AccruedCapitalExpenditures
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000644"
      unitRef="U_iso4217USD">0</nk:AccruedCapitalExpenditures>
    <nk:AccruedFranchiseSalesUseAndPropertyTaxes
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000645"
      unitRef="U_iso4217USD">103000</nk:AccruedFranchiseSalesUseAndPropertyTaxes>
    <nk:AccruedFranchiseSalesUseAndPropertyTaxes
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000646"
      unitRef="U_iso4217USD">200000</nk:AccruedFranchiseSalesUseAndPropertyTaxes>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000647"
      unitRef="U_iso4217USD">100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000648"
      unitRef="U_iso4217USD">181000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000649"
      unitRef="U_iso4217USD">8343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000650"
      unitRef="U_iso4217USD">5343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000499">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020 and 2019, other current liabilities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing obligation - current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,438&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <nk:FinancingObligationCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000651"
      unitRef="U_iso4217USD">1421000</nk:FinancingObligationCurrent>
    <nk:FinancingObligationCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000652"
      unitRef="U_iso4217USD">757000</nk:FinancingObligationCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000653"
      unitRef="U_iso4217USD">17000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000654"
      unitRef="U_iso4217USD">18000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000655"
      unitRef="U_iso4217USD">1438000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000656"
      unitRef="U_iso4217USD">775000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:InvestmentIncomeTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000500">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net investment income included the following for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest income&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,643&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,317&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment (amortization expense) accretion income, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(858&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net realized (losses) gains on investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;366&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,857&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000657"
      unitRef="U_iso4217USD">1233000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000658"
      unitRef="U_iso4217USD">1643000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000659"
      unitRef="U_iso4217USD">2317000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000660"
      unitRef="U_iso4217USD">-858000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000661"
      unitRef="U_iso4217USD">3000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000662"
      unitRef="U_iso4217USD">-463000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000663"
      unitRef="U_iso4217USD">-9000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000664"
      unitRef="U_iso4217USD">-4000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000665"
      unitRef="U_iso4217USD">3000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000666"
      unitRef="U_iso4217USD">366000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000667"
      unitRef="U_iso4217USD">1642000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000668"
      unitRef="U_iso4217USD">1857000</us-gaap:InvestmentIncomeNet>
    <us-gaap:ImpairmentOfInvestments
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_000669"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_000670"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_000671"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231"
      id="F_000451">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;4. &#160;&#160;&#160;&#160;Agreement and Plan of Merger with ImmunityBio&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December&#160;21, 2020, NantKwest and ImmunityBio, Inc.&#160;(ImmunityBio) entered into an Agreement and Plan of Merger&#160;(the Merger Agreement), pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The Merger Agreement provides that a wholly owned subsidiary of NantKwest will merge with and into ImmunityBio&#160;(the Merger), with ImmunityBio continuing as the surviving company and being renamed NantCell,&#160;Inc., upon the terms and subject to the conditions therein. At the effective time of the Merger&#160;(the Effective Time), NantKwest&#x2019;s name, as the parent of NantCell,&#160;Inc., will be changed to &#x201c;ImmunityBio, Inc.&#x201d;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the Effective Time, each share of ImmunityBio common stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions as set forth in the Merger Agreement, will be converted automatically into a right to receive&#160;0.8190&#160;shares of NantKwest common stock. At the Effective Time, each share of NantKwest common stock issued and outstanding immediately prior to the Effective Time, will remain an issued and outstanding share of the combined company. At the Effective Time, each outstanding option, warrant or restricted stock unit to purchase ImmunityBio common stock will be converted (using the merger exchange ratio of 0.8190) into an option, warrant or restricted stock unit, respectively, on the same terms and conditions immediately prior to the Effective Time, to purchase shares of common stock of the combined company.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon consummation of the Merger, on a fully-diluted basis, ImmunityBio stockholders and NantKwest stockholders will own approximately 72% and 28%, respectively, of the outstanding shares of common stock of the combined company. It is estimated that, immediately following the closing date, Dr.&#160;Patrick Soon-Shiong, our Executive Chairman and principal stockholder, and his affiliates will beneficially own, in the aggregate, approximately 82% of the common stock of the combined company. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Following consummation of the Merger, shares of common stock of the combined company are expected to be listed on the Nasdaq Global Select Market under the symbol &#x201c;IBRX&#x201d;.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms and subject to the conditions set forth in the Merger Agreement, the closing of the Merger depends on a number of conditions being satisfied, including approval of the Merger by holders of a majority of the outstanding shares of NantKwest common stock as of the NantKwest record date (excluding all shares of NantKwest common stock beneficially owned by Dr.&#160;Patrick Soon&#x2011;Shiong and his affiliates Cambridge Equities,&#160;LP and Chan Soon&#x2011;Shiong Family Foundation or any of their respective controlled affiliates or any of the directors or executive officers of NantKwest or ImmunityBio).&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February&#160;1, 2021, our Registration Statement on Form&#160;S-4, which was filed with the Securities and Exchange Commission (SEC) in connection with the Merger, was declared effective by the SEC.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A special meeting of the stockholders of NantKwest will be held on March&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, 2021 &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to consider and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;vot&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;e&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; on a proposal to approve the issuance of shares of common stock of NantKwest to security holders of ImmunityBio&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to consider and vote &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;on a proposal to approve the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;M&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;erger.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Only holders of record of NantKwest common stock at the close of January&#160;29, 2021, will be entitled to notice of and to vote at the special meeting.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We expect the Merger to close in the first quarter of 2021, subject to receipt of the requisite stockholder approvals and satisfaction of other customary closing conditions.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Merger is expected to be accounted for as a transaction between entities under common control as Dr.&#160;Patrick Soon-Shiong is the controlling stockholder of each of NantKwest and ImmunityBio. Upon the closing of the Merger, the net assets of ImmunityBio will be combined with those of NantKwest at their historical carrying amounts and the companies will be presented on a combined basis for all historical periods presented.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the year ended December&#160;31, 2020, we incurred costs of $6.2&#160;million in connection with our proposed merger with ImmunityBio, consisting of financial advisory, legal and other professional fees.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="C_0001326110_20201221_20201221" id="F_000672">2020-12-21</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_0001326110_20201221_20201221"
      decimals="4"
      id="F_000673"
      unitRef="U_xbrlishares">0.8190</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <nk:MergerExchangeRatio
      contextRef="C_0001326110_20201221_20201221"
      decimals="6"
      id="F_000674"
      unitRef="U_xbrlipure">0.008190</nk:MergerExchangeRatio>
    <nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221"
      decimals="2"
      id="F_000675"
      unitRef="U_xbrlipure">0.72</nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger>
    <nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger
      contextRef="C_0001326110_srtOwnershipAxis_nkNantKwestMember_20201221"
      decimals="2"
      id="F_000676"
      unitRef="U_xbrlipure">0.28</nk:OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger>
    <nk:OwnershipPercentageByKeyExecutives
      contextRef="C_0001326110_srtTitleOfIndividualAxis_nkExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember_20201221_20201221"
      decimals="2"
      id="F_000677"
      unitRef="U_xbrlipure">0.82</nk:OwnershipPercentageByKeyExecutives>
    <us-gaap:PaymentsForMergerRelatedCosts
      contextRef="C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231"
      decimals="-5"
      id="F_000678"
      unitRef="U_iso4217USD">6200000</us-gaap:PaymentsForMergerRelatedCosts>
    <us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000452">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;5. &#160;&#160;&#160;&#160;Viracta Investment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2017, we participated in a Series&#160;B convertible preferred stock financing and invested $8.5&#160;million in Viracta Therapeutics, Inc., or Viracta, a clinical stage drug development company, which was initially recorded at cost. In May&#160;2017, we executed an exclusive worldwide license with Viracta to develop and commercialize Viracta&#x2019;s proprietary histone deacetylase inhibitor drug candidate for use in combination with natural killer cell therapy and possibly additional therapies. See Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements &#x2013; Royalties and In-licensing Agreements &#x2013; Viracta License Agreement&lt;/span&gt;, for further information.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2018, Viracta executed a 2018&#160;Note and Warrant Purchase Agreement with existing and new investors, including us. The initial closing under the Purchase Agreement occurred in June&#160;2018, at which point we purchased a convertible note for $0.4&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#x2019;s common shares. The convertible note accrued interest at 8% and had a &lt;span style="-sec-ix-hidden:F_000684"&gt;one-year&lt;/span&gt; maturity date. In September&#160;2018, a milestone closing under the Purchase Agreement occurred, at which point we purchased an additional convertible note for $0.4&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#x2019;s common shares. The convertible note accrued interest at 8% and had a &lt;span style="-sec-ix-hidden:F_000685"&gt;one-year&lt;/span&gt; maturity date. We classified the convertible notes as held-to-maturity notes receivable on the consolidated balance sheets. Effective January&#160;31, 2019, the notes, together with accrued interest then outstanding, were converted to Series&#160;B preferred stock resulting in an increase to our investment in Viracta&#x2019;s Series&#160;B convertible preferred stock of $0.8&#160;million. In May&#160;2019, we exercised warrants to acquire 253,120&#160;shares of Viracta common stock.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Based on the level of equity investment at risk, Viracta is not a VIE and therefore is not consolidated under the VIE model. In addition, we do not hold a controlling financial interest in Viracta, and therefore we do not consolidate Viracta under the voting interest model. As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, we have elected to apply the measurement alternative under ASC&#160;321, pursuant to which we measure our investment in Viracta at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020, our fair value assessment indicated that the recent offering of Viracta&#x2019;s Series&#160;E preferred shares, at a lower offering price per share than the per share carrying amount of our investment in Viracta, is a directional indicator representing an observable price change in an orderly transaction for a similar investment. On December&#160;31, 2020, we reduced the carrying value by $1.4&#160;million due to the observable price change, which has been included in other income and expense, net, on the consolidated statements of operations. On a cumulative basis, we have recognized a reduction in carrying value of $1.4&#160;million. At December&#160;31, 2020, the carrying value of our investment in Viracta, which is reflected in equity investment on the consolidated balance sheets, totaled $7.8&#160;million.&lt;/p&gt;

</us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="C_0001326110_20170331"
      decimals="-5"
      id="F_000679"
      unitRef="U_iso4217USD">8500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <nk:PurchaseOfConvertibleNoteUponConversion
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180601_20180630"
      decimals="-5"
      id="F_000680"
      unitRef="U_iso4217USD">400000</nk:PurchaseOfConvertibleNoteUponConversion>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180630"
      decimals="2"
      id="F_000682"
      unitRef="U_xbrlipure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <nk:PurchaseOfConvertibleNoteUponConversion
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180901_20180930"
      decimals="-5"
      id="F_000681"
      unitRef="U_iso4217USD">400000</nk:PurchaseOfConvertibleNoteUponConversion>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_20180930"
      decimals="2"
      id="F_000683"
      unitRef="U_xbrlipure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:PreferredStockValue
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesBPreferredStockMember_20190131"
      decimals="-5"
      id="F_000686"
      unitRef="U_iso4217USD">800000</us-gaap:PreferredStockValue>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001326110_us-gaapDebtInstrumentAxis_nkTwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190531"
      decimals="INF"
      id="F_000687"
      unitRef="U_xbrlishares">253120</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:InvestmentPolicyTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000492">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Based on the level of equity investment at risk, Viracta is not a VIE and therefore is not consolidated under the VIE model. In addition, we do not hold a controlling financial interest in Viracta, and therefore we do not consolidate Viracta under the voting interest model. As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, we have elected to apply the measurement alternative under ASC&#160;321, pursuant to which we measure our investment in Viracta at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_nkOtherIncomeAndExpenseNetMember_20200101_20201231"
      decimals="-5"
      id="F_000688"
      unitRef="U_iso4217USD">1400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000689"
      unitRef="U_iso4217USD">1400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000690"
      unitRef="U_iso4217USD">7800000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000453">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;6. &#160;&#160;&#160;&#160;Financial Instruments &#x2013; Investments in Marketable Debt Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020, our investments in available-for-sale debt securities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="18" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000703"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000704"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000705"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2019, our investments in available-for-sale debt securities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,752&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,144&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated unrealized losses on debt securities classified as available-for-sale that have been in a continuous loss position for less than &lt;span style="-sec-ix-hidden:F_000734"&gt;&lt;span style="-sec-ix-hidden:F_000736"&gt;12&#160;months and for more than 12&#160;months&lt;/span&gt;&lt;/span&gt; at December&#160;31, 2020 and 2019, were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;More than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;More than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020, 34 of the securities were in an unrealized loss position. We evaluated our securities for other-than-temporary impairment and concluded that the decline in value was primarily caused by current economic and market conditions. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases. Therefore, we did not recognize any other-than-temporary impairment loss during the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognized realized gains and losses on sales of available-for-sale debt securities as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains (Losses)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000501">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020, our investments in available-for-sale debt securities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="18" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000703"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000704"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000705"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2019, our investments in available-for-sale debt securities consist of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,752&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,144&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000691"
      unitRef="U_iso4217USD">54789000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000694"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000697"
      unitRef="U_iso4217USD">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000700"
      unitRef="U_iso4217USD">54772000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231"
      decimals="-3"
      id="F_000692"
      unitRef="U_iso4217USD">54789000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231"
      decimals="-3"
      id="F_000695"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231"
      decimals="-3"
      id="F_000698"
      unitRef="U_iso4217USD">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20201231"
      decimals="-3"
      id="F_000701"
      unitRef="U_iso4217USD">54772000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000693"
      unitRef="U_iso4217USD">54789000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000696"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000699"
      unitRef="U_iso4217USD">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000702"
      unitRef="U_iso4217USD">54772000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000706"
      unitRef="U_iso4217USD">32382000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000713"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000720"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000727"
      unitRef="U_iso4217USD">32389000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000707"
      unitRef="U_iso4217USD">1007000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000714"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000721"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000728"
      unitRef="U_iso4217USD">1007000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000708"
      unitRef="U_iso4217USD">2752000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000715"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000722"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000729"
      unitRef="U_iso4217USD">2748000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000709"
      unitRef="U_iso4217USD">36141000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000716"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000723"
      unitRef="U_iso4217USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000730"
      unitRef="U_iso4217USD">36144000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000710"
      unitRef="U_iso4217USD">1501000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000717"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000724"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000731"
      unitRef="U_iso4217USD">1497000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000711"
      unitRef="U_iso4217USD">1501000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000718"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000725"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_20191231"
      decimals="-3"
      id="F_000732"
      unitRef="U_iso4217USD">1497000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000712"
      unitRef="U_iso4217USD">37642000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000719"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000726"
      unitRef="U_iso4217USD">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000733"
      unitRef="U_iso4217USD">37641000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000502">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated unrealized losses on debt securities classified as available-for-sale that have been in a continuous loss position for less than &lt;span style="-sec-ix-hidden:F_000734"&gt;&lt;span style="-sec-ix-hidden:F_000736"&gt;12&#160;months and for more than 12&#160;months&lt;/span&gt;&lt;/span&gt; at December&#160;31, 2020 and 2019, were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;More than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;More than 12 months&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&#160;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&#160;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000738"
      unitRef="U_iso4217USD">42762000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000740"
      unitRef="U_iso4217USD">19000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000742"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000744"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000739"
      unitRef="U_iso4217USD">42762000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000741"
      unitRef="U_iso4217USD">19000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000743"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000745"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000746"
      unitRef="U_iso4217USD">11021000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000749"
      unitRef="U_iso4217USD">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000752"
      unitRef="U_iso4217USD">1497000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000755"
      unitRef="U_iso4217USD">4000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000747"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000750"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000753"
      unitRef="U_iso4217USD">2748000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0001326110_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000756"
      unitRef="U_iso4217USD">4000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000748"
      unitRef="U_iso4217USD">11021000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000751"
      unitRef="U_iso4217USD">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000754"
      unitRef="U_iso4217USD">4245000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000757"
      unitRef="U_iso4217USD">8000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
      contextRef="C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231"
      decimals="INF"
      id="F_000758"
      unitRef="U_nkSecurity">34</us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1>
    <us-gaap:ScheduleOfRealizedGainLossTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000503">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We recognized realized gains and losses on sales of available-for-sale debt securities as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains (Losses)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRealizedGainLossTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGains
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000759"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000762"
      unitRef="U_iso4217USD">13000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000765"
      unitRef="U_iso4217USD">-9000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGains
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000760"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000763"
      unitRef="U_iso4217USD">8000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000766"
      unitRef="U_iso4217USD">-4000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGains
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000761"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000764"
      unitRef="U_iso4217USD">0</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_000767"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000454">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;7. &#160;&#160;&#160;&#160;Fair Value Measurements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as an exit price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Authoritative guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Recurring Valuations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below at December&#160;31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements as of December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets measured at fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements as of December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets measured at fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,149&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Non-recurring Valuations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-financial assets and liabilities are recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. There were no material non-financial assets and liabilities deemed to be other-than-temporarily impaired and measured at fair value on a non-recurring basis for the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000504">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below at December&#160;31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements as of December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets measured at fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,441&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements as of December&#160;31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Government sponsored securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,748&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets measured at fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,149&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,508&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000768"
      unitRef="U_iso4217USD">11441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000769"
      unitRef="U_iso4217USD">11441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000770"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000771"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000772"
      unitRef="U_iso4217USD">54772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000773"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000774"
      unitRef="U_iso4217USD">54772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000775"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000776"
      unitRef="U_iso4217USD">66213000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000777"
      unitRef="U_iso4217USD">11441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000778"
      unitRef="U_iso4217USD">54772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000779"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000780"
      unitRef="U_iso4217USD">15508000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000781"
      unitRef="U_iso4217USD">15508000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000782"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCashAndCashEquivalentsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000783"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000784"
      unitRef="U_iso4217USD">32389000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000785"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000786"
      unitRef="U_iso4217USD">32389000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000787"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000788"
      unitRef="U_iso4217USD">1007000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000789"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000790"
      unitRef="U_iso4217USD">1007000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtMember_20191231"
      decimals="-3"
      id="F_000791"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000792"
      unitRef="U_iso4217USD">2748000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000793"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000794"
      unitRef="U_iso4217USD">2748000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkCurrentAssetsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapUnderlyingAssetClassAxis_us-gaapAgencySecuritiesMember_20191231"
      decimals="-3"
      id="F_000795"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000796"
      unitRef="U_iso4217USD">1497000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000797"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000798"
      unitRef="U_iso4217USD">1497000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_nkNoncurrentAssetsMember_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000799"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000800"
      unitRef="U_iso4217USD">53149000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000801"
      unitRef="U_iso4217USD">15508000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000802"
      unitRef="U_iso4217USD">37641000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001326110_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000803"
      unitRef="U_iso4217USD">0</us-gaap:AssetsFairValueDisclosure>
    <nk:CollaborationAndLicenseAgreementsTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000455">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;8. &#160;&#160;&#160;&#160;Collaboration and License Agreements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Collaborative Arrangements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are&#160;(i)&#160;active participants in the activity, and (ii)&#160;exposed to significant risks and rewards dependent on the commercial success of the activity.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have entered into the following collaborative arrangements with ImmunityBio&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inc., &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ImmunityBio&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, as described below. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ImmunityBio is a related party, as it is &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; (&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Note&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Joint COVID&#x2011;19 Collaboration Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On August&#160;21, 2020, we entered into a definitive agreement, which we refer to as the Collaboration Agreement, with ImmunityBio to pursue collaborative joint development, manufacturing and marketing of certain COVID&#x2011;19 therapeutics and vaccines. The terms of the Collaboration Agreement supersede and replace the terms of the binding term sheet executed on May&#160;22, 2020. Through their efforts, the parties agreed to jointly develop ceNK, haNK, mesenchymal stem cells&#160;(MSC), adenovirus constructs&#160;(hAd5), and N&#x2011;803, a novel IL&#x2011;15 superagonist fusion protein, for the prevention and treatment of SARS&#x2011;CoV&#x2011;2 viral infections and associated conditions in humans, including without limitation, COVID&#x2011;19. Pursuant to the Collaboration Agreement, we have contributed our ceNK, haNK, and MSC product candidates and certain of our manufacturing capabilities, and ImmunityBio has contributed their hAd5 and N&#x2011;803 product candidates. hAd5 has been developed as a vaccine, and ceNK, haNK, MSC and N&#x2011;803 have each been developed as therapeutics for treating COVID&#x2011;19 at various stages of infection.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From and after the effective date of the Collaboration Agreement, the parties will share equally in all costs relating to developing and manufacturing of the product candidates globally with the exception of certain laboratory equipment purchases that will be borne solely by us. With the exception of N&#x2011;803, we will be primarily responsible for the manufacture of each product. Each party will be responsible for the regulatory affairs and the commercialization relating to its contributed products. The global net profits from the collaboration products will be shared 60%/40% in favor of the party contributing the product on which the sales are based except if the parties mutually agree because of certain circumstances. All net profits from sales of combined collaboration products will be shared equally. This collaboration is supervised by a joint steering committee, which is comprised of an equal number of representatives from both parties. The term of the agreement will be &lt;span style="-sec-ix-hidden:F_000806"&gt;five&#160;years&lt;/span&gt; and it is renewable for an additional &lt;span style="-sec-ix-hidden:F_000807"&gt;five&#160;year&lt;/span&gt; period upon mutual agreement. Each party will also have a right to terminate in the event of material breach, bankruptcy, or insolvency.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the year ended December&#160;31, 2020, joint research activity under the Collaboration Agreement totaled $8.4&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $5.0&#160;million to be utilized in the manufacture of the hAd5 COVID&#x2011;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#x2011;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#x2011;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $3.3&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Cost Sharing Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio and its subsidiaries to co-sponsor and conduct certain combination clinical trials (each a Joint Study) pursuant to clinical trial protocols wherein at least one investigational agent is a proprietary therapeutic drug candidate owned or controlled by NantKwest and at least one other investigational agent is a proprietary therapeutic drug candidate owned or controlled by ImmunityBio. Prior to initiating any activities for a Joint Study the parties agreed to enter into written work orders describing, amongst other things, development and management responsibilities, allocation of Joint Study costs and expenses, regulatory responsibilities, and any other matters relating to the Joint Study.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the Cost Allocation Agreement, each of ImmunityBio and the company will receive exclusive rights to any new intellectual property developed that relates solely to its respective study drug, and the parties will have joint co-equal rights in any other intellectual property. The Cost Allocation Agreement expires on June&#160;22, 2022 with the option to renew for additional successive &lt;span style="-sec-ix-hidden:F_000812"&gt;one-year&lt;/span&gt; terms, but work orders for any joint studies still in process at the time of termination will continue until the applicable study is completed.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We and ImmunityBio are splitting certain costs related to these joint studies equally in accordance with the terms of the Cost Allocation Agreement and related work orders. Shared Joint Study costs include cost related to conducting the Joint Study development activities, such as personnel related costs, as well as all costs associated with regulatory matters. Costs and expenses incurred in connection with the development, manufacturing, supply, delivery, and pre-patient administration dosing mechanism of each party&#x2019;s study drug, are excluded from the shared Joint Study costs.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January&#160;2020, but effective on October&#160;1, 2019, we executed Work Order Number One with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number One, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the parties &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; conduct&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ing&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; a clinical trial pursuant to the protocol titled QUILT&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.063:&lt;/span&gt;&lt;span style="font-style:italic;"&gt;&#160;A phase&#160;2 study of combination therapy with an IL&lt;/span&gt;&lt;span style="font-style:italic;"&gt;&#x2011;&lt;/span&gt;&lt;span style="font-style:italic;"&gt;15 superagonist&#160;(N&lt;/span&gt;&lt;span style="font-style:italic;"&gt;&#x2011;803), off-the-shelf CD16&lt;/span&gt;&lt;span style="font-style:italic;"&gt;&#x2011;targeted natural killer cells&#160;(haNK), and avelumab without cytotoxic chemotherapy in subjects with Merkel Cell Carcinoma&#160;(MCC) that has progressed on or after treatment with a checkpoint inhibitor&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The ImmunityBio study drug included in th&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;is&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;J&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;oint &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;S&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tudy is ImmunityBio&#x2019;s proprietary IL&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15 superagonist known as N&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2011;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;803&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and our study drug is our proprietary &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x201c;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;off-the-shelf&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x201d;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; CD16-targeted natural kil&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ler cell therapy known as haNK. &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the sponsor of this &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;J&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;oint &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;S&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tudy for purposes of regulatory matters, including submissions, correspondence, and communications. Additionally, we are &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;designated as &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the contracting party to execute agreements with third and related part&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ies relating to the Joint Study&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July&#160;2020, but effective on June&#160;22, 2020, we executed Work Order Number Two with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number Two, the parties are conducting a clinical trial pursuant to the protocol titled QUILT&#160;88:&#160;&lt;span style="font-style:italic;"&gt;Open-label, randomized, comparative phase&#160;2 study of combination immunotherapy with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer&lt;/span&gt;. The ImmunityBio study drugs included in the joint study are ImmunityBio&#x2019;s proprietary IL&#x2011;15 superagonist&#160;(N&#x2011;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin), and our study drug is PD&#x2011;L1.t&#x2011;haNK. ImmunityBio is the sponsor of this Joint Study for purposes of regulatory matters, including submissions, correspondence, and communications with the FDA. Additionally, ImmunityBio is designated as the contracting party to execute agreements with third and related parties relating to this Joint Study.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $1.1&#160;million and $35,700, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, we owed ImmunityBio $0.3&#160;million related to the Cost Allocation Agreement. As of December&#160;31, 2019, no balances were due between the parties with respect to the Cost Allocation Agreement.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Royalties and In-licensing Agreements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Viracta License Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May&#160;2017, we entered into an agreement with Viracta under which we were granted exclusive worldwide rights to Viracta&#x2019;s phase&#160;II drug candidate, VRx&#x2011;3996, for use in combination with our platform of NK&#160;cell therapies. In consideration for the license, we are obligated to pay to Viracta&#160;(i)&#160;mid-single digit percentage royalties of net sales of licensed products for therapeutic use; and (ii)&#160;milestone payments ranging from $10.0&#160;million to $25.0&#160;million for various regulatory approvals and cumulative net sales levels. We may terminate the agreement, at our sole discretion, in whole or on a product by product and/or country by country basis, at any time upon 90&#160;days&#x2019;&#160;prior written notice. In addition, either party may terminate the agreement in the event of a material breach or for bankruptcy of the other party.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Fox Chase Cancer Center License Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2004 and amended in 2008, we entered into an exclusive license agreement with Fox Chase Cancer Center, or Fox Chase, for the exclusive, worldwide right to certain patents and know-how pertaining to CD16 receptor bearing NK&#x2011;92&#160;cell lines. In consideration for this exclusive license, we agreed to pay Fox Chase&#160;(i)&#160;low single-digit percentage royalties on net sales of licensed products for therapeutic and diagnostic use; and (ii)&#160;mid-twenties percentage royalties on any compensation we receive from sublicensees.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Rush University Medical Center License Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2004, we entered into a 12-year licensing agreement with Rush University Medical Center for the exclusive rights to license and grant sublicenses of certain intellectual property related to clinical use of NK&#x2011;92. We are required to pay low to mid-single digit percentage royalties on net sales depending upon the various fields of studies and other factors. We were required to pay a minimum annual royalty of $25,000. The Rush University Medical Center License Agreement also provides for payments in the aggregate amount of $2.5&#160;million upon the company achieving various milestones, including upon&#160;(i)&#160;the completion of phase&#160;II clinical trial associated with the licensed intellectual property; (ii)&#160;the approval by the FDA of a new drug application for a licensed product; and (iii)&#160;the first year that sales of the licensed product equals or exceeds $0.3&#160;million. The license had a term of 12&#160;years from 2006, the year in which royalty payments were first made, and included customary termination rights for both parties. Beginning in 2018, this license converted to a perpetual, irrevocable, fully paid, royalty-free, exclusive license. No milestones were met during the years ended December&#160;31, 2020, 2019 and 2018.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Out-Licensing Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Precigen (formerly known as Intrexon) License Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February&#160;2010, we entered into a 17-year license agreement with Precigen Corporation, Inc., or Precigen, pursuant to which we granted to Precigen a non-exclusive, worldwide, sublicensable license to research and sell products under certain patents relating to modified NK&#x2011;92&#160;cells that express Precigen&#x2019;s proprietary gene sequences for use as a therapeutic and prophylactic agent in humans in specified therapeutic areas. In consideration for the license agreement, Precigen paid us a one-time fee of $0.4&#160;million. Prior to our adoption of ASC&#160;606 at the beginning of 2018, this upfront payment had initially been recorded as deferred revenue and was being recognized into revenue on a straight-line basis. Upon our adoption of ASC&#160;606, we adjusted our accumulated deficit in an amount equal to the then remaining deferred revenue after concluding that under ASC&#160;606 the upfront payment would have been recognized when the license was transferred in 2010. Precigen will pay the following milestone payments:&#160;$0.1&#160;million upon the first IND filing; $0.1&#160;million upon the commencement of the first phase&#160;II clinical trial; $0.4&#160;million upon the commencement of the first phase&#160;III clinical trial; and $0.5&#160;million upon the first commercial sale relating to the licensed products. Precigen is obligated to pay us a low single digit percentage royalty based on net sales of the licensed products by Precigen and a mid-teen percentage royalty based on revenues received by Precigen in connection with sublicenses of the licensed products. No milestone payments were due or received in the years ended December&#160;31, 2020, 2019 and 2018, and, therefore, we did not record any milestone revenue for any of those years on the consolidated statements of operations.&lt;/p&gt;</nk:CollaborationAndLicenseAgreementsTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="2"
      id="F_000804"
      unitRef="U_xbrlipure">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSalesMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="2"
      id="F_000805"
      unitRef="U_xbrlipure">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000808"
      unitRef="U_iso4217USD">8400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000809"
      unitRef="U_iso4217USD">5000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000810"
      unitRef="U_iso4217USD">3400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231"
      decimals="-5"
      id="F_000811"
      unitRef="U_iso4217USD">3300000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000813"
      unitRef="U_iso4217USD">1100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231"
      decimals="0"
      id="F_000814"
      unitRef="U_iso4217USD">35700</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20201231"
      decimals="-5"
      id="F_000815"
      unitRef="U_iso4217USD">300000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20191231"
      decimals="-6"
      id="F_000816"
      unitRef="U_iso4217USD">0</us-gaap:DueToRelatedPartiesCurrent>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMinimumMember_20170501_20170531"
      decimals="INF"
      id="F_000817"
      unitRef="U_iso4217USD">10000000.0</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_srtRangeAxis_srtMaximumMember_20170501_20170531"
      decimals="INF"
      id="F_000818"
      unitRef="U_iso4217USD">25000000.0</nk:MilestonePaymentAmount>
    <nk:LicenseAgreementTerminationNoticePeriod
      contextRef="C_0001326110_deiLegalEntityAxis_nkViractaTherapeuticsIncMember_20170501_20170531"
      id="F_000819">P90D</nk:LicenseAgreementTerminationNoticePeriod>
    <nk:PeriodOfLicenseAgreement
      contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231"
      id="F_000820">P12Y</nk:PeriodOfLicenseAgreement>
    <nk:MinimumAnnualRoyaltyPayment
      contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231"
      decimals="INF"
      id="F_000821"
      unitRef="U_iso4217USD">25000</nk:MinimumAnnualRoyaltyPayment>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231"
      decimals="-5"
      id="F_000822"
      unitRef="U_iso4217USD">2500000</us-gaap:CostOfGoodsAndServicesSold>
    <nk:MinimumSalesMilestoneOfLicenseForFirstYear
      contextRef="C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231"
      decimals="INF"
      id="F_000823"
      unitRef="U_iso4217USD">300000</nk:MinimumSalesMilestoneOfLicenseForFirstYear>
    <nk:LicenseAgreementTerm
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      id="F_000824">P17Y</nk:LicenseAgreementTerm>
    <nk:AgreementOneTimeFee
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000825"
      unitRef="U_iso4217USD">400000</nk:AgreementOneTimeFee>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkINDFilingMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000832"
      unitRef="U_iso4217USD">100000</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseTwoMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000833"
      unitRef="U_iso4217USD">100000</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkPhaseThreeMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000834"
      unitRef="U_iso4217USD">400000</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_nkCommercialSaleRelatedToLicensedProductsMember_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20100201_20100228"
      decimals="-5"
      id="F_000835"
      unitRef="U_iso4217USD">500000</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231"
      decimals="INF"
      id="F_000826"
      unitRef="U_iso4217USD">0</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231"
      decimals="INF"
      id="F_000827"
      unitRef="U_iso4217USD">0</nk:MilestonePaymentAmount>
    <nk:MilestonePaymentAmount
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231"
      decimals="INF"
      id="F_000828"
      unitRef="U_iso4217USD">0</nk:MilestonePaymentAmount>
    <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20200101_20201231"
      decimals="INF"
      id="F_000829"
      unitRef="U_iso4217USD">0</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
    <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20190101_20191231"
      decimals="INF"
      id="F_000830"
      unitRef="U_iso4217USD">0</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
    <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized
      contextRef="C_0001326110_us-gaapTypeOfArrangementAxis_nkPrecigenLicenseAgreementMember_20180101_20181231"
      decimals="INF"
      id="F_000831"
      unitRef="U_iso4217USD">0</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000456">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;9. &#160;&#160;&#160;&#160;Commitments and Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Securities Litigation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2016, a putative securities class action complaint captioned &lt;span style="font-style:italic;"&gt;Sudunagunta v. NantKwest, Inc., et al.&lt;/span&gt;, No. 16&#x2011;cv&#x2011;01947 was filed in federal district court for the Central District of California related to the company&#x2019;s restatement of certain interim financial statements for the periods ended June&#160;30, 2015 and September&#160;30, 2015. A number of similar putative class actions were filed in federal and state court in California. The actions originally filed in state court were removed to federal court, and the various related actions were consolidated. Plaintiffs asserted causes of action for alleged violations of Sections&#160;11 and 15 of the Securities Act of 1933 and Sections&#160;10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule&#160;10b&#x2011;5 promulgated thereunder. Plaintiffs sought unspecified damages, costs and attorneys&#x2019; fees, and equitable/injunctive or other relief on behalf of putative classes of persons who purchased or acquired the company&#x2019;s securities during various time periods from July&#160;28, 2015 through March&#160;11, 2016. In September&#160;2017, the court denied defendants' motion to dismiss the third amended consolidated complaint. On August&#160;13, 2018, the district court granted plaintiffs&#x2019; motions for class certification and to strike plaintiffs&#x2019; claims under the Securities Exchange Act of 1934 and Rule&#160;10b&#x2011;5. On August&#160;24, 2018, at the district court&#x2019;s direction, plaintiffs filed a fourth amended consolidated complaint. On August&#160;27, 2018, defendants petitioned the U.S. Court of Appeals for the Ninth Circuit to authorize interlocutory appeal of the class certification order. On September&#160;7, 2018, defendants answered the fourth amended consolidated complaint. On September&#160;21, 2018, the parties informed the Ninth Circuit that they had reached a settlement in principle, and the parties moved to stay appellate proceedings. On September&#160;24, 2018, the parties notified the district court that they had reached a settlement in principle. On November&#160;9, 2018, the plaintiffs filed an unopposed motion for preliminary approval of the settlement and notice to class members. On January&#160;9, 2019, the district court granted the motion for preliminary approval. A final approval hearing was held on April&#160;29, 2019, and the district court granted final approval and entered judgment on May&#160;31, 2019.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the settlement, we paid $12.0&#160;million to the plaintiffs as full and complete settlement of the litigation. We were responsible for $1.2&#160;million of the settlement amount, which was recognized in selling, general and administrative expense during the year ended December&#160;31, 2018, while the remaining $10.8&#160;million was fully funded by our insurance carriers under our directors&#x2019; and officers&#x2019; insurance policy. We and the insurance carriers paid the settlement amount into a settlement fund during the year ended December&#160;31, 2019. Subsequent to receiving final approval of the settlement on May&#160;31, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stipulation of Settlement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In early April&#160;2019, following board approval, we entered into a settlement agreement, or the Stipulation of Settlement, with three&#160;stockholders of the company, each of whom had submitted a stockholder demand for the board to take action to remedy purported harm to the company resulting from certain alleged wrongful conduct concerning, among other things, disclosures about Dr.&#160;Soon-Shiong&#x2019;s compensation and a related-party lease agreement. The Stipulation of Settlement called for us to adopt certain governance changes, and for the three&#160;stockholders to file a stockholder derivative action in the Superior Court of the State of California, County of San Diego, followed by an application for court approval of the Stipulation of Settlement. On May&#160;31, 2019, the court entered an order preliminarily approving the Stipulation of Settlement and scheduling the final settlement hearing for August&#160;9, 2019. Pursuant to the Stipulation of Settlement, we have provided stockholders with notice of the settlement and the final settlement hearing.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the Stipulation of Settlement, which received final approval by the court on August&#160;9, 2019, we paid an attorney&#x2019;s fee of $0.5&#160;million to the plaintiffs as part of the settlement. Of that amount, we were responsible for half, which was recognized in selling, general and administrative expense on the consolidated statements of operations during the year ended December&#160;31, 2019, while the other half was funded by our insurance carrier. We and the insurance carrier paid the settlement amount into a settlement fund in June&#160;2019. Subsequent to receiving final approval of the settlement on August&#160;9, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Insurance Recoveries&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have reflected our right to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund. The amount of such receivable recorded at December&#160;31, 2019 was $34,000, which is included in prepaid expenses and other current assets on our consolidated balance sheets. There were no such receivables recorded as of December&#160;31, 2020.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Contractual Obligations - Leases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On January&#160;1, 2019, we adopted the new lease accounting guidance as discussed in further detail in Note&#160;2. The most significant change requires us to record the present value of operating lease payments as right-of-use assets and lease liabilities on our balance sheets. We adopted the new guidance using the simplified transition approach. As a result, reporting periods beginning on January&#160;1, 2019 are presented under the new guidance, while periods prior to January&#160;1, 2019 continue to be reported in accordance with our historical accounting.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The adoption of the new lease accounting guidance had a substantial impact on our balance sheet. The most significant impacts were&#160;(1)&#160;the recognition of $13.5&#160;million of operating lease right-of-use assets, net, and $16.4&#160;million of operating lease liabilities, and (2)&#160;the derecognition of assets and liabilities associated with build-to-suit leases under ASC&#160;840, resulting in the derecognition of property, plant and equipment, net, of $6.6&#160;million and net adjustments to related liabilities of $5.7&#160;million). The build-to-suit leases were recorded as normal operating leases under ASC&#160;842. The difference between the excess of build-to-suit related liabilities and assets of $0.9&#160;million was recorded as an increase to our accumulated deficit. The cumulative-effect adjustment had no tax impact due to the valuation allowance against the gross deferred tax asset less reversing deferred tax liabilities. Adoption of this standard had no material impact on our results of operations and cash flows.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Lease Arrangements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Substantially all of our operating lease right-of-use assets and operating lease liabilities relate to facilities leases. As of December&#160;31, 2020, we lease:&#160;(i)&#160;a&#160;research facility and office space in San Diego, California; (ii)&#160;a research and manufacturing space in Culver City, California, from a related party; (iii)&#160;research and manufacturing facilities in El Segundo, California, also from related parties; (iv)&#160;a research facility in Torrance, California, and (v)&#160;a research facility in Woburn, Massachusetts. See Note&#160;10,&#160;&lt;span style="font-style:italic;"&gt;Related Party Agreements&lt;/span&gt;, for further information.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our leases generally have initial terms ranging from &lt;span style="-sec-ix-hidden:F_000847"&gt;two to ten&#160;years&lt;/span&gt; and often include one or more options to renew. These renewal terms can extend the lease term from &lt;span style="-sec-ix-hidden:F_000849"&gt;one to three&#160;years&lt;/span&gt;, and are included in the lease term when it is reasonably certain that we will exercise the option. These operating leases are included in operating lease right-of-use assets, net, on the consolidated balance sheets, and represent the right to use the underlying asset for the lease term. Our obligations to make lease payments are included in current and non-current operating lease liabilities on the consolidated balance sheets.&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our operating right-of-use assets and lease liabilities as of December&#160;31, 2020 and 2019, are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right-of-use assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease right-of-use assets, net (including amounts&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,729&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,206&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,814&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,885&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,091&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of lease expense for the years ended December&#160;31, 2020 and 2019 consist of (in&#160;thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Variable lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,566&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;Total lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,113&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Rental expenses for operating leases during the year ended December&#160;31, 2018, excluding common-area maintenance, was $2.8&#160;million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid during the years ended December&#160;31, 2020 and 2019 for amounts included in the measurement of lease liabilities is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating cash flows for operating leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,345&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted-average remaining lease term as of December&#160;31, 2020 and 2019 was 3.2&#160;years and 4.5&#160;years, respectively. The weighted-average discount rate used in determining the present value of operating lease liabilities as of December&#160;31, 2020 and 2019 was &lt;span&gt;9%&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum lease payments as of December&#160;31, 2020, including $3.9&#160;million related to options to extend lease terms that are reasonably certain of being exercised, are presented in the following table (in thousands). Common area maintenance costs and taxes are not included in these payments.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ending December 31:&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases (a)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,545&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,083&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,527&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Present value of operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a related party&#160;(Note&#160;10), whereby we leased approximately 6,901&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional &lt;span style="-sec-ix-hidden:F_000884"&gt;one-year&lt;/span&gt; term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in &lt;span style="-sec-ix-hidden:F_000888"&gt;November&#160;2020&lt;/span&gt;. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. At inception of the lease we recognized an increase of $4.0&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August&#160;2018, NantBio, Inc., or NantBio, a&#160;related party (Note&#160;10), assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#x2019;s laboratory and vivarium premises. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $0.9&#160;million, and paid $0.5&#160;million directly to the third party for an aggregate value of $1.4&#160;million. The assigned agreement is for a term of &lt;span style="-sec-ix-hidden:F_000892"&gt;ten&#160;years&lt;/span&gt; and expires in June&#160;2027. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September&#160;2016, we entered into a lease agreement with 605&#160;Doug St,&#160;LLC, a related party&#160;(Note&#160;10), for approximately 24,250&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional &lt;span style="-sec-ix-hidden:F_000896"&gt;three&#160;year&lt;/span&gt; term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in &lt;span style="-sec-ix-hidden:F_000899"&gt;July&#160;2017&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2016, we entered into a lease agreement for an approximately 7,893&#160;square foot facility in Woburn, Massachusetts, for a research and development laboratory, related office and other related uses. The initial lease term ran for 48&#160;months from April&#160;29, 2016 through May&#160;31, 2020. In June&#160;2016, the lease was amended to add 260&#160;square feet, for a total of 8,153&#160;square feet. Base rent for the initial term of the lease was $19,000&#160;per&#160;month with a $1&#160;per&#160;square foot annual increase on each anniversary date. In August&#160;2019, we exercised our right pursuant to the lease agreement to extend the term of the lease for an additional &lt;span style="-sec-ix-hidden:F_000908"&gt;two&#160;years&lt;/span&gt; through May&#160;31, 2022. Consequently, in August&#160;2019 we recognized an increase of $0.6&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets. Base rent for the extended term of the lease is $25,800&#160;per&#160;month with an annual increase of 3% on June&#160;1,&#160;2021.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2015, we entered into a facility license agreement with NantWorks LLC, or NantWorks, a related party&#160;(Note&#160;10), for approximately 9,500&#160;square feet of office space in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. The initial license was effective from May&#160;2015 through December&#160;2020. Base monthly rent for the initial lease term was $47,000, with annual increases of 3% beginning in &lt;span style="-sec-ix-hidden:F_000917"&gt;January&#160;2017&lt;/span&gt;. In September&#160;2020, we entered into an amendment to extend the term of this lease through December&#160;31, 2021. Commencing on January&#160;1, 2021, the monthly rent will increase by 3% to $54,500. Subsequent to December&#160;31, 2021, the lease term will automatically renew on a month-to-month basis, terminable by either party with at least thirty days&#x2019; prior written notice to the other party. In addition, we will have a one-time option to extend the lease term through December&#160;31, 2022. If we exercise the option to extend the lease through December&#160;31, 2022, or continue on a month-to-month basis, the monthly rent will increase by 3% annually commencing on January&#160;1 of each year. On the date of amendment we recognized an increase of $1.2&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets, which reflects our belief that we will extend the term of this lease through December&#160;31, 2022.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2015, we entered into a lease agreement for an approximately 44,700&#160;square foot facility in San Diego, California, for a research and development laboratory, related office and other related uses. The term of the lease extends for &lt;span style="-sec-ix-hidden:F_000926"&gt;seven&#160;years&lt;/span&gt; commencing on August&#160;1, 2016. The base rent is $0.2&#160;million per month with 3% annual increases on each anniversary date.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_0001326110_20190101_20191231"
      decimals="-5"
      id="F_000836"
      unitRef="U_iso4217USD">12000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231"
      decimals="-5"
      id="F_000837"
      unitRef="U_iso4217USD">1200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_0001326110_us-gaapReinsurancePolicyTypeAxis_nkDirectorsAndOfficersInsurancePolicyMember_20190101_20191231"
      decimals="-5"
      id="F_000838"
      unitRef="U_iso4217USD">10800000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LegalFees
      contextRef="C_0001326110_20190809_20190809"
      decimals="-5"
      id="F_000839"
      unitRef="U_iso4217USD">500000</us-gaap:LegalFees>
    <us-gaap:InsuranceSettlementsReceivable
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20191231"
      decimals="0"
      id="F_000841"
      unitRef="U_iso4217USD">34000</us-gaap:InsuranceSettlementsReceivable>
    <us-gaap:InsuranceSettlementsReceivable
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_20201231"
      decimals="INF"
      id="F_000840"
      unitRef="U_iso4217USD">0</us-gaap:InsuranceSettlementsReceivable>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101"
      decimals="-5"
      id="F_000842"
      unitRef="U_iso4217USD">13500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101"
      decimals="-5"
      id="F_000843"
      unitRef="U_iso4217USD">16400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101"
      decimals="-5"
      id="F_000844"
      unitRef="U_iso4217USD">-6600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Liabilities
      contextRef="C_0001326110_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_nkDifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member_20190101"
      decimals="-5"
      id="F_000845"
      unitRef="U_iso4217USD">-5700000</us-gaap:Liabilities>
    <us-gaap:AssetsNet
      contextRef="C_0001326110_srtCumulativeEffectPeriodOfAdoptionAxis_srtCumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101"
      decimals="-5"
      id="F_000846"
      unitRef="U_iso4217USD">-900000</us-gaap:AssetsNet>
    <nk:ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000505">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our operating right-of-use assets and lease liabilities as of December&#160;31, 2020 and 2019, are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right-of-use assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease right-of-use assets, net (including amounts&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,729&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,206&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,814&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,885&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating lease liabilities (including amounts with related parties)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,091&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</nk:ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000851"
      unitRef="U_iso4217USD">13463000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000852"
      unitRef="U_iso4217USD">11729000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000853"
      unitRef="U_iso4217USD">5500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000854"
      unitRef="U_iso4217USD">3206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000855"
      unitRef="U_iso4217USD">9814000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000856"
      unitRef="U_iso4217USD">10885000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000857"
      unitRef="U_iso4217USD">15314000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_000858"
      unitRef="U_iso4217USD">14091000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000506">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of lease expense for the years ended December&#160;31, 2020 and 2019 consist of (in&#160;thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Variable lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,566&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;Total lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,113&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000859"
      unitRef="U_iso4217USD">4655000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000860"
      unitRef="U_iso4217USD">3898000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000861"
      unitRef="U_iso4217USD">1566000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000862"
      unitRef="U_iso4217USD">1215000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000863"
      unitRef="U_iso4217USD">6221000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000864"
      unitRef="U_iso4217USD">5113000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-5"
      id="F_000865"
      unitRef="U_iso4217USD">2800000</us-gaap:OperatingLeasesRentExpenseNet>
    <nk:ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000507">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid during the years ended December&#160;31, 2020 and 2019 for amounts included in the measurement of lease liabilities is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Operating cash flows for operating leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,345&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</nk:ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_000866"
      unitRef="U_iso4217USD">5345000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_000867"
      unitRef="U_iso4217USD">4371000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001326110_20201231" id="F_000868">P3Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001326110_20191231" id="F_000869">P4Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001326110_20201231"
      decimals="2"
      id="F_000870"
      unitRef="U_xbrlipure">0.09</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001326110_20191231"
      decimals="2"
      id="F_000871"
      unitRef="U_xbrlipure">0.09</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000508">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum lease payments as of December&#160;31, 2020, including $3.9&#160;million related to options to extend lease terms that are reasonably certain of being exercised, are presented in the following table (in thousands). Common area maintenance costs and taxes are not included in these payments.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ending December 31:&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases (a)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,545&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,083&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,115&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,527&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Present value of operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,314&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <nk:OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms
      contextRef="C_0001326110_20200101_20201231"
      decimals="-5"
      id="F_000872"
      unitRef="U_iso4217USD">3900000</nk:OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000873"
      unitRef="U_iso4217USD">6563000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000874"
      unitRef="U_iso4217USD">5607000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000875"
      unitRef="U_iso4217USD">2545000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000876"
      unitRef="U_iso4217USD">1083000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000877"
      unitRef="U_iso4217USD">1115000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000878"
      unitRef="U_iso4217USD">614000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000879"
      unitRef="U_iso4217USD">17527000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000880"
      unitRef="U_iso4217USD">2213000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_000881"
      unitRef="U_iso4217USD">15314000</us-gaap:OperatingLeaseLiability>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930"
      decimals="INF"
      id="F_000882"
      unitRef="U_utrsqft">6901</nk:NumberOfSquareFootOfFacilityLeased>
    <us-gaap:LesseeOperatingLeaseDescription
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231"
      id="F_000883">The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in November&#160;2020.</us-gaap:LesseeOperatingLeaseDescription>
    <nk:MonthlyFixedCharge
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930"
      decimals="-5"
      id="F_000885"
      unitRef="U_iso4217USD">200000</nk:MonthlyFixedCharge>
    <nk:AnnualPercentageIncreasesToMonthlyFixedCharge
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930"
      decimals="2"
      id="F_000886"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToMonthlyFixedCharge>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200901_20200930"
      decimals="-5"
      id="F_000887"
      unitRef="U_iso4217USD">4000000.0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <nk:RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_000889"
      unitRef="U_iso4217USD">900000</nk:RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty>
    <nk:RelatedPartyTransactionAmountPaidToRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_000890"
      unitRef="U_iso4217USD">500000</nk:RelatedPartyTransactionAmountPaidToRelatedParty>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_000891"
      unitRef="U_iso4217USD">1400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <nk:RelatedPartyAgreementExpirationMonthAndYear
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      id="F_000893">2027-06</nk:RelatedPartyAgreementExpirationMonthAndYear>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930"
      decimals="INF"
      id="F_000894"
      unitRef="U_utrsqft">24250</nk:NumberOfSquareFootOfFacilityLeased>
    <us-gaap:LesseeOperatingLeaseDescription
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231"
      id="F_000895">The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional three&#160;year term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in July&#160;2017.</us-gaap:LesseeOperatingLeaseDescription>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      decimals="-5"
      id="F_000897"
      unitRef="U_iso4217USD">100000</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      decimals="2"
      id="F_000898"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331"
      decimals="INF"
      id="F_000900"
      unitRef="U_utrsqft">7893</nk:NumberOfSquareFootOfFacilityLeased>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160331"
      id="F_000901">P48M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <nk:LeaseCommencementDate
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160301_20160331"
      id="F_000902">2016-04-29</nk:LeaseCommencementDate>
    <nk:PeriodOfLicenseAgreementDescription
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20200101_20201231"
      id="F_000907">In June&#160;2016, the lease was amended to add 260&#160;square feet, for a total of 8,153&#160;square feet. Base rent for the initial term of the lease was $19,000&#160;per&#160;month with a $1&#160;per&#160;square foot annual increase on each anniversary date.</nk:PeriodOfLicenseAgreementDescription>
    <nk:AdditionToNumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630"
      decimals="INF"
      id="F_000903"
      unitRef="U_utrsqft">260</nk:AdditionToNumberOfSquareFootOfFacilityLeased>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160630"
      decimals="INF"
      id="F_000904"
      unitRef="U_utrsqft">8153</nk:NumberOfSquareFootOfFacilityLeased>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630"
      decimals="0"
      id="F_000905"
      unitRef="U_iso4217USD">19000</nk:BaseMonthlyRent>
    <nk:AnnualBaseRentIncreasePerSquareFoot
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20160601_20160630"
      decimals="INF"
      id="F_000906"
      unitRef="U_iso4217USD_utrsqft">1</nk:AnnualBaseRentIncreasePerSquareFoot>
    <nk:LeaseAgreementExtendedPeriod
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190801_20190831"
      id="F_000909">2022-05-31</nk:LeaseAgreementExtendedPeriod>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20190701_20190930"
      decimals="-5"
      id="F_000910"
      unitRef="U_iso4217USD">600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601"
      decimals="0"
      id="F_000911"
      unitRef="U_iso4217USD">25800</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkCommitmentWoburnMassachusettsMember_20210601_20210601"
      decimals="2"
      id="F_000912"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130"
      decimals="INF"
      id="F_000913"
      unitRef="U_utrsqft">9500</nk:NumberOfSquareFootOfFacilityLeased>
    <nk:PeriodOfLicenseAgreementDescription
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231"
      id="F_000914">The initial license was effective from May&#160;2015 through December&#160;2020. Base monthly rent for the initial lease term was $47,000, with annual increases of 3% beginning in January&#160;2017</nk:PeriodOfLicenseAgreementDescription>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130"
      decimals="0"
      id="F_000915"
      unitRef="U_iso4217USD">47000</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151101_20151130"
      decimals="2"
      id="F_000916"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <nk:LeaseAgreementExtendedPeriod
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930"
      id="F_000918">2021-12-31</nk:LeaseAgreementExtendedPeriod>
    <nk:AnnualPercentageIncreasesToBaseRentCommencementDate
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930"
      id="F_000919">2021-01-01</nk:AnnualPercentageIncreasesToBaseRentCommencementDate>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101"
      decimals="2"
      id="F_000920"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20210101_20210101"
      decimals="0"
      id="F_000921"
      unitRef="U_iso4217USD">54500</nk:BaseMonthlyRent>
    <nk:NumberOfDaysPriorToWrittenNoticeToTerminateLease
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101"
      id="F_000922">P30D</nk:NumberOfDaysPriorToWrittenNoticeToTerminateLease>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_srtStatementScenarioAxis_srtScenarioForecastMember_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20220101_20220101"
      decimals="2"
      id="F_000923"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkAmendmentToExtendLeaseTermMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930"
      decimals="-5"
      id="F_000924"
      unitRef="U_iso4217USD">1200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150630"
      decimals="INF"
      id="F_000925"
      unitRef="U_utrsqft">44700</nk:NumberOfSquareFootOfFacilityLeased>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630"
      decimals="-5"
      id="F_000927"
      unitRef="U_iso4217USD">200000</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_us-gaapLeaseContractualTermAxis_nkCommitmentSanDiegoMember_20150601_20150630"
      decimals="2"
      id="F_000928"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000929"
      unitRef="U_iso4217USD">2700000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000930"
      unitRef="U_iso4217USD">1200000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000931"
      unitRef="U_iso4217USD">1200000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_000932"
      unitRef="U_iso4217USD">300000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000457">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;10. &#160;&#160;&#160;&#160;Related Party Agreements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Our Executive Chairman, and principal stockholder, founded and has a controlling interest in NantWorks, which is a collection of multiple companies in the healthcare and technology space. As described below, we have entered into arrangements with NantWorks, and certain affiliates of NantWorks, to facilitate the development of new genetically modified NK&#160;cells for our product pipeline. Affiliates of NantWorks are also affiliates of the company due to the common control by and/or common ownership interest of our Executive Chairman.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;NantWorks&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the NantWorks shared services agreement executed in November&#160;2015, but effective August&#160;2015, NantWorks provides corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy, and other support services. We are charged for the services at cost plus reasonable allocations for indirect costs that relate to the employees providing the services. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded $2.5&#160;million, $2.1&#160;million and $2.8&#160;million, respectively, in selling, general and administrative expense, and $1.5&#160;million, $1.5&#160;million and $3.3&#160;million, respectively, in research and development expense under this arrangement on the consolidated statements of operations. These amounts exclude certain general and administrative expenses provided by third party vendors directly for our benefit, which have been reimbursed to NantWorks based on those vendors&#x2019; invoiced amounts without markup by NantWorks.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2016, we amended the existing shared services agreement with NantWorks whereby we can provide support services to NantWorks and/or any of its affiliates. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded expense reimbursements of $1.4&#160;million, $1.2&#160;million and $0.6&#160;million, respectively, in selling, general and administrative expense and $1.6&#160;million, $2.3&#160;million and $2.6&#160;million, respectively, in research and development expense.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020 and 2019, we owed NantWorks a net amount of $1.2&#160;million and $0.4&#160;million, respectively, for all agreements between the two affiliates, which is included in due to related parties on the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2015, we entered into a facility license agreement with NantWorks, which became effective in May&#160;2015, for approximately 9,500&#160;square feet in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. In September&#160;2020, we amended this agreement to extend the term of this lease through December&#160;31, 2021, as further described in Note&#160;9,&#160;&lt;span style="font-style:italic;"&gt;Commitments and Contingencies&lt;/span&gt;. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.6&#160;million, $0.6&#160;million, and $0.2&#160;million, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Immuno-Oncology Clinic, Inc.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning in 2017, we entered into multiple agreements with Immuno-Oncology Clinic, Inc., or the Clinic (dba&#160;Chan Soon-Shiong Institutes for Medicine, in El Segundo, California), to conduct clinical trials related to certain of our product candidates. The Clinic is a related party as it is owned by one officer of NantKwest and NantWorks manages the administrative operations of the Clinic. Prior to June&#160;30, 2019, one of the company&#x2019;s officers was an investigator or sub-investigator for all of the company&#x2019;s trials conducted at the Clinic.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July&#160;2019, we entered into a new agreement with the Clinic (the Clinic Agreement), which became effective on July&#160;1, 2019. The Clinic Agreement, as amended on March&#160;31, 2020, covers clinical trial and research related activities on a non-exclusive basis relating to our existing clinical trials, commenced prior to July&#160;1, 2019, and prospective clinical trials and research projects. The Clinic Agreement also specifies certain services and related costs that are excluded from the Clinic Agreement. Prior to commencing any work under the Clinic Agreement, the parties have agreed to execute written work orders setting forth the terms and conditions related to specific services to be performed, including financial terms. For clinical trials that commenced prior to July&#160;1, 2019, fees incurred for services performed after July&#160;1, 2019 are covered under the Clinic Agreement and applied towards the below-mentioned prepayments. The Clinic Agreement allows for an automatic renewal and additional extensions beyond the initial &lt;span style="-sec-ix-hidden:F_000953"&gt;one&#160;year&lt;/span&gt; term.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In consideration of the services to be performed under the Clinic Agreement, as amended on March&#160;31, 2020, we agreed to make payments of up to $7.5&#160;million to the Clinic, of which $3.75&#160;million and $1.875&#160;million were paid in July&#160;2019 and October&#160;2019, respectively. As amended, a conditional payment of $1.875&#160;million shall be due and payable at such time, if any, that the payments made in July&#160;2019 and October&#160;2019 have been earned by the Clinic through performance of services. On a quarterly basis, our prepayment is increased by an interest credit computed in accordance with terms specified in the Clinic Agreement.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to&#160;(i)&#160;not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)&#160;extend the term of the Clinic Agreement for up to three additional one&#160;year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within 60&#160;days of expiration. The Clinic may terminate this agreement upon each anniversary date upon sixty&#160;(60)&#160;days prior written notice and reimbursement in full to us of any outstanding unearned balance of the prepayments, provided that any such termination by the Clinic will not apply with respect to any work orders still in effect at the time of such termination.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July&#160;2019, we executed a clinical trial work order under the Clinic Agreement for an open-label, phase&#160;I study of PD&#x2011;L1.t&#x2011;haNK for infusion in subjects with locally advanced or metastatic solid cancers. In July&#160;2020, but effective on June&#160;22, 2020, we and ImmunityBio executed a clinical trial work order under our existing master agreement with the Clinic for an open-label, randomized, comparative phase&#160;II study of ImmunityBio&#x2019;s proprietary IL&#x2011;15 superagonist (N&#x2011;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin) and our PD&#x2011;L1.t&#x2011;haNK with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December&#160;31, 2020, 2019 and 2018, $0.6&#160;million, $1.1&#160;million, and $2.7&#160;million, respectively, was recognized in research and development expense on the consolidated statements of operations related to clinical trial and research related activities conducted for us by the Clinic. As of December&#160;31, 2020 and 2019, we owed the Clinic $0.3&#160;million and $0.1&#160;million, respectively, for services excluded from the Clinic Agreement, which are included in due to related parties on the consolidated balance sheets. As of December&#160;31, 2020 and 2019, we had prepaid balances related to the Clinic Agreement of $4.7&#160;million and $5.1&#160;million, respectively, which are included in prepaid expenses and other currents assets, and other assets, on the consolidated balance sheets. We anticipate that the remaining prepayment amount as of December&#160;31, 2020 will be utilized in future periods as the Clinic provides additional services pursuant to the Clinic Agreement.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;ImmunityBio&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ImmunityBio, Inc., or ImmunityBio, is a related party, as it is controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December&#160;21, 2020, we entered into a merger agreement with ImmunityBio pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The proposed merger is discussed in additional detail in Note&#160;4, &lt;span style="font-style:italic;"&gt;Agreement and Plan of Merger with ImmunityBio&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a subsidiary of ImmunityBio, whereby we leased approximately 6,901&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in November&#160;2020. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. Lease expense for this facility is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million during the year ended December&#160;31, 2020. As of December&#160;31, 2020, we owed $0.1&#160;million under this agreement related to variable lease costs.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On August&#160;21, 2020, we entered into a Collaboration Agreement with ImmunityBio as further described in Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;. As of December&#160;31, 2020, the joint research activity under the Collaboration Agreement totaled $8.4&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $5.0&#160;million, to be utilized in the manufacture of the hAd5 COVID&#x2011;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#x2011;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#x2011;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $3.3&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio, which (together with related work orders) is described further in Note&#160;8,&#160;&lt;span style="font-style:italic;"&gt;Collaboration and License Agreements&lt;/span&gt;. During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $1.1&#160;million and $35,700, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, our balance owed to ImmunityBio related to the Cost Allocation Agreement was $0.3&#160;million. As of December&#160;31, 2019, no balances were due between the parties with respect to the Cost Allocation Agreement.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November&#160;2018, we entered into an agreement with Etubics Corporation, or Etubics, a subsidiary of ImmunityBio. Pursuant to this agreement we sold used laboratory equipment to Etubics for $0.3&#160;million. In conjunction with this sale, we recognized a loss on disposal of related laboratory equipment of $0.1&#160;million, which was included in other income, net on the consolidated statements of operations.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June&#160;2015, we entered into a supply agreement with ImmunityBio pursuant to which we have the right to purchase ImmunityBio&#x2019;s proprietary bioreactors, made according to specifications mutually agreed to with ImmunityBio. We also have the right to purchase reagents and consumables associated with such equipment from ImmunityBio. When an upfront payment is made, it is included in prepaid expenses on the consolidated balance sheets until the product is received. The agreement had an initial term of &lt;span style="-sec-ix-hidden:F_000982"&gt;five&#160;years&lt;/span&gt; and renews automatically for successive &lt;span style="-sec-ix-hidden:F_000983"&gt;one-year&lt;/span&gt; periods unless terminated earlier.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020 and 2019, we had $3.2&#160;million and $1.8&#160;million, respectively, in equipment purchased from ImmunityBio pursuant to our supply agreement, which has been included in property, plant and equipment, net, on the consolidated balance sheets. During the years ended December&#160;31, 2020, 2019 and 2018, we recorded research and development expense associated with reagents and consumables purchased from ImmunityBio pursuant to our supply agreement of $0.3&#160;million, $0.1&#160;million and $0.1&#160;million, respectively, on the consolidated statements of operations. At December&#160;31, 2020 and 2019, we had $0.1&#160;million and $0.5&#160;million, respectively, included in prepaid expenses and other current assets on the consolidated balance sheets related to consumables purchased from ImmunityBio.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;605&#160;Doug&#160;St,&#160;LLC&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September&#160;2016, we entered into a lease agreement with 605&#160;Doug&#160;St,&#160;LLC, an entity owned by our Executive Chairman, and principal stockholder, for approximately 24,250&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP laboratory manufacturing facility. The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional three-year term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in &lt;span style="-sec-ix-hidden:F_000995"&gt;July&#160;2017&lt;/span&gt;. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million, $0.9&#160;million and $0.2&#160;million, respectively. At December&#160;31, 2020 and 2019, no balances were due between the parties.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;NantBio, Inc.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August&#160;2018, NantBio assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#x2019;s laboratory and vivarium premises. NantBio is a related party as it is an affiliate of NantWorks. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $0.9&#160;million and paid $0.5&#160;million directly to the third party for an aggregate value of $1.4&#160;million. The assigned agreement is for a term of &lt;span style="-sec-ix-hidden:F_001004"&gt;ten&#160;years&lt;/span&gt; and expires in June&#160;2027. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2016, NantBio and the National Cancer Institute entered into a cooperative research and development agreement. The initial &lt;span style="-sec-ix-hidden:F_001006"&gt;five-year&lt;/span&gt; agreement covers NantBio and its affiliates, including us. Under the agreement, the parties are collaborating on the preclinical and clinical development of proprietary recombinant natural killer cells and monoclonal antibodies in monotherapy and in combination immunotherapies. We benefited from the preclinical and clinical research conducted during the first four years under this agreement. In each of the contractual years under the agreement we paid $0.6&#160;million to the National Cancer Institute as a prepayment for services under the agreement. We recognize research and development expense related to this agreement ratably over a 12-month period for each funding year and recorded $0.6&#160;million of expense related to this agreement in each of the years ended December&#160;31, 2020, 2019 and 2018. At December&#160;31, 2020 and 2019, we had balances of $0.1&#160;million and $0.1&#160;million, respectively, included in prepaid expenses and other current assets related to this agreement on the consolidated balance sheets.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;NantHealth Labs, Inc.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March&#160;2018, we entered into an agreement with NantHealth Labs, Inc., or NantHealth Labs, to obtain blood-based tumor profiling services. NantHealth Labs is a related party, as it is a wholly owned subsidiary of NantHealth, Inc., a majority owned subsidiary of NantWorks. We are obligated to pay NantHealth Labs fixed, per-patient fees. The agreement has an initial term of &lt;span style="-sec-ix-hidden:F_001018"&gt;five&#160;years&lt;/span&gt; and renews automatically for successive &lt;span style="-sec-ix-hidden:F_001019"&gt;one-year&lt;/span&gt; periods, unless terminated earlier. During the years ended December&#160;31, 2019 and 2018, $10,000 and $0.3&#160;million, respectively, has been recognized in research and development expense on the consolidated statements of operations. There were no expenses associated with this agreement during the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, no balances were due between the parties.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000933"
      unitRef="U_iso4217USD">2500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231"
      decimals="-5"
      id="F_000934"
      unitRef="U_iso4217USD">2100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231"
      decimals="-5"
      id="F_000935"
      unitRef="U_iso4217USD">2800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000936"
      unitRef="U_iso4217USD">1500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231"
      decimals="-5"
      id="F_000937"
      unitRef="U_iso4217USD">1500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231"
      decimals="-5"
      id="F_000938"
      unitRef="U_iso4217USD">3300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000939"
      unitRef="U_iso4217USD">1400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231"
      decimals="-5"
      id="F_000940"
      unitRef="U_iso4217USD">1200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231"
      decimals="-5"
      id="F_000941"
      unitRef="U_iso4217USD">600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000942"
      unitRef="U_iso4217USD">1600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20190101_20191231"
      decimals="-5"
      id="F_000943"
      unitRef="U_iso4217USD">2300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20180101_20181231"
      decimals="-5"
      id="F_000944"
      unitRef="U_iso4217USD">2600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20201231"
      decimals="-5"
      id="F_000945"
      unitRef="U_iso4217USD">1200000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_us-gaapTransactionTypeAxis_nkReimbursementsMember_us-gaapTypeOfArrangementAxis_nkSharedServicesAgreementMember_20191231"
      decimals="-5"
      id="F_000946"
      unitRef="U_iso4217USD">400000</us-gaap:DueToRelatedPartiesCurrent>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20151130"
      decimals="INF"
      id="F_000947"
      unitRef="U_utrsqft">9500</nk:NumberOfSquareFootOfFacilityLeased>
    <nk:LeaseAgreementExtendedPeriod
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200901_20200930"
      id="F_000948">2021-12-31</nk:LeaseAgreementExtendedPeriod>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231"
      decimals="-5"
      id="F_000949"
      unitRef="U_iso4217USD">600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20190101_20191231"
      decimals="-5"
      id="F_000950"
      unitRef="U_iso4217USD">600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20180101_20181231"
      decimals="-5"
      id="F_000951"
      unitRef="U_iso4217USD">200000</us-gaap:OperatingLeaseExpense>
    <nk:NumberOfOfficers
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231"
      decimals="INF"
      id="F_000952"
      unitRef="U_nkOfficer">1</nk:NumberOfOfficers>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731"
      decimals="-5"
      id="F_000954"
      unitRef="U_iso4217USD">7500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <nk:RelatedPartyInstallmentPayment
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190701_20190731"
      decimals="-4"
      id="F_000955"
      unitRef="U_iso4217USD">3750000</nk:RelatedPartyInstallmentPayment>
    <nk:RelatedPartyInstallmentPayment
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191001_20191031"
      decimals="-3"
      id="F_000956"
      unitRef="U_iso4217USD">1875000</nk:RelatedPartyInstallmentPayment>
    <nk:RelatedPartyTransactionConditionalPayment
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190731"
      decimals="-3"
      id="F_000957"
      unitRef="U_iso4217USD">1875000</nk:RelatedPartyTransactionConditionalPayment>
    <nk:RelatedPartyTransactionAgreementExtensionDescription
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231"
      id="F_000958">To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to&#160;(i)&#160;not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)&#160;extend the term of the Clinic Agreement for up to three additional one&#160;year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within 60&#160;days of expiration.</nk:RelatedPartyTransactionAgreementExtensionDescription>
    <nk:NewAgreementTerminationNoticePeriod
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231"
      id="F_000959">P60D</nk:NewAgreementTerminationNoticePeriod>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20200101_20201231"
      decimals="-5"
      id="F_000960"
      unitRef="U_iso4217USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20190101_20191231"
      decimals="-5"
      id="F_000961"
      unitRef="U_iso4217USD">1100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20180101_20181231"
      decimals="-5"
      id="F_000962"
      unitRef="U_iso4217USD">2700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231"
      decimals="-5"
      id="F_000963"
      unitRef="U_iso4217USD">300000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231"
      decimals="-5"
      id="F_000964"
      unitRef="U_iso4217USD">100000</us-gaap:DueToRelatedPartiesCurrent>
    <nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20201231"
      decimals="-5"
      id="F_000965"
      unitRef="U_iso4217USD">4700000</nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets>
    <nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets
      contextRef="C_0001326110_srtStatementGeographicalAxis_stprCA_us-gaapRelatedPartyTransactionAxis_nkImmunoOncologyClinicIncMember_20191231"
      decimals="-5"
      id="F_000966"
      unitRef="U_iso4217USD">5100000</nk:PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201221_20201221"
      id="F_000967">2020-12-21</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200930"
      decimals="INF"
      id="F_000968"
      unitRef="U_utrsqft">6901</nk:NumberOfSquareFootOfFacilityLeased>
    <nk:MonthlyFixedCharge
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231"
      decimals="-5"
      id="F_000969"
      unitRef="U_iso4217USD">200000</nk:MonthlyFixedCharge>
    <nk:AnnualPercentageIncreasesToMonthlyFixedCharge
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231"
      decimals="2"
      id="F_000970"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToMonthlyFixedCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231"
      decimals="-5"
      id="F_000971"
      unitRef="U_iso4217USD">900000</us-gaap:OperatingLeaseExpense>
    <nk:FixedAndVariableLeaseCosts
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkAltorBioscienceManufacturingCompanyLLCMember_20200101_20201231"
      decimals="-5"
      id="F_000972"
      unitRef="U_iso4217USD">100000</nk:FixedAndVariableLeaseCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000973"
      unitRef="U_iso4217USD">8400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkProgramEquipmentRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000974"
      unitRef="U_iso4217USD">5000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapNonrecurringAdjustmentAxis_nkNetProgramRelatedCostsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000975"
      unitRef="U_iso4217USD">3400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkJointCOVID19CollaborationDevelopmentAgreementMember_20201231"
      decimals="-5"
      id="F_000976"
      unitRef="U_iso4217USD">3300000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_000977"
      unitRef="U_iso4217USD">1100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_nkClinicalTrialCostAllocationAgreementMember_20190101_20191231"
      decimals="0"
      id="F_000978"
      unitRef="U_iso4217USD">35700</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_us-gaapTypeOfArrangementAxis_us-gaapCollaborativeArrangementMember_20201231"
      decimals="-5"
      id="F_000979"
      unitRef="U_iso4217USD">300000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130"
      decimals="-5"
      id="F_000980"
      unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20181101_20181130"
      decimals="-5"
      id="F_000981"
      unitRef="U_iso4217USD">100000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231"
      decimals="-5"
      id="F_000984"
      unitRef="U_iso4217USD">3200000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231"
      decimals="-5"
      id="F_000985"
      unitRef="U_iso4217USD">1800000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20200101_20201231"
      decimals="-5"
      id="F_000986"
      unitRef="U_iso4217USD">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20190101_20191231"
      decimals="-5"
      id="F_000987"
      unitRef="U_iso4217USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20180101_20181231"
      decimals="-5"
      id="F_000988"
      unitRef="U_iso4217USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20201231"
      decimals="-5"
      id="F_000989"
      unitRef="U_iso4217USD">100000</nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty>
    <nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkImmunityBioMember_20191231"
      decimals="-5"
      id="F_000990"
      unitRef="U_iso4217USD">500000</nk:PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160930"
      decimals="INF"
      id="F_000991"
      unitRef="U_utrsqft">24250</nk:NumberOfSquareFootOfFacilityLeased>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231"
      id="F_000992">The lease runs from July&#160;2016 through July&#160;2023.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      decimals="-5"
      id="F_000993"
      unitRef="U_iso4217USD">100000</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20160901_20160930"
      decimals="2"
      id="F_000994"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20200101_20201231"
      decimals="-5"
      id="F_000996"
      unitRef="U_iso4217USD">900000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20190101_20191231"
      decimals="-5"
      id="F_000997"
      unitRef="U_iso4217USD">900000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20180101_20181231"
      decimals="-5"
      id="F_000998"
      unitRef="U_iso4217USD">200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20201231"
      decimals="INF"
      id="F_000999"
      unitRef="U_iso4217USD">0</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkDougStLLCMember_20191231"
      decimals="INF"
      id="F_001000"
      unitRef="U_iso4217USD">0</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <nk:RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_001001"
      unitRef="U_iso4217USD">900000</nk:RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty>
    <nk:RelatedPartyTransactionAmountPaidToThirdParty
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_001002"
      unitRef="U_iso4217USD">500000</nk:RelatedPartyTransactionAmountPaidToThirdParty>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_001003"
      unitRef="U_iso4217USD">1400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <nk:RelatedPartyAgreementExpirationMonthAndYear
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      id="F_001005">2027-06</nk:RelatedPartyAgreementExpirationMonthAndYear>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231"
      decimals="-5"
      id="F_001008"
      unitRef="U_iso4217USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231"
      decimals="-5"
      id="F_001009"
      unitRef="U_iso4217USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <nk:PrepaymentOfFundingAmount
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190501_20190531"
      decimals="-5"
      id="F_001014"
      unitRef="U_iso4217USD">600000</nk:PrepaymentOfFundingAmount>
    <nk:PrepaymentOfFundingAmount
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180801_20180831"
      decimals="-5"
      id="F_001013"
      unitRef="U_iso4217USD">600000</nk:PrepaymentOfFundingAmount>
    <nk:PrepaymentOfFundingAmount
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200401_20200430"
      decimals="-5"
      id="F_001015"
      unitRef="U_iso4217USD">600000</nk:PrepaymentOfFundingAmount>
    <nk:PrepaymentOfFundingAmount
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20160401_20160430"
      decimals="-5"
      id="F_001011"
      unitRef="U_iso4217USD">600000</nk:PrepaymentOfFundingAmount>
    <nk:PrepaymentOfFundingAmount
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20170401_20170430"
      decimals="-5"
      id="F_001012"
      unitRef="U_iso4217USD">600000</nk:PrepaymentOfFundingAmount>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20180101_20181231"
      decimals="-5"
      id="F_001010"
      unitRef="U_iso4217USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <nk:ResearchAndDevelopmentExpenseRatablePaymentPeriod
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231"
      id="F_001007">P12M</nk:ResearchAndDevelopmentExpenseRatablePaymentPeriod>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20200101_20201231"
      decimals="-5"
      id="F_001016"
      unitRef="U_iso4217USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapBalanceSheetLocationAxis_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_us-gaapRelatedPartyTransactionAxis_nkNantBioScienceMember_20190101_20191231"
      decimals="-5"
      id="F_001017"
      unitRef="U_iso4217USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20190101_20191231"
      decimals="0"
      id="F_001021"
      unitRef="U_iso4217USD">10000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20180101_20181231"
      decimals="-5"
      id="F_001022"
      unitRef="U_iso4217USD">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20200101_20201231"
      decimals="-6"
      id="F_001020"
      unitRef="U_iso4217USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20191231"
      decimals="INF"
      id="F_001024"
      unitRef="U_iso4217USD">0</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNantHealthLabsIncMember_20201231"
      decimals="INF"
      id="F_001023"
      unitRef="U_iso4217USD">0</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000458">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;11. &#160;&#160;&#160;&#160;Stockholders&#x2019; Equity&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Issuance of Common Stock &#x2013; &lt;span style="font-style:normal;"&gt;On June&#160;29, 2020, the company closed an underwritten public offering of an aggregate of 8,521,500&#160;shares of common stock, which included 4,811,500&#160;shares issued to the public at a price of $9.50&#160;per share (which includes 1,111,500&#160;shares sold to the public upon full exercise of the underwriters&#x2019; option to purchase additional shares at a public offering price of $9.50&#160;per share), less underwriting discounts and commissions, and 3,710,000&#160;shares issued to our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong, at a price of $12.12&#160;per share, less underwriting discounts and commissions. All of the shares were offered by the company. Including the underwriters&#x2019; option exercise, the aggregate gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stock Repurchase &#x2013; &lt;span style="font-style:normal;"&gt;In November&#160;2015, the board of directors approved a share repurchase program, or the 2015 Share Repurchase Program, allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015&#160;Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified, or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. The shares are formally retired through board approval upon repurchase.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To date, we have repurchased 6,403,489&#160;shares of our common stock under the 2015&#160;Share Repurchase Program at a total cost of $31.7&#160;million. In addition, we have paid $0.1&#160;million of broker commissions on repurchases. We did not repurchase any shares during the year ended December&#160;31, 2020. During the years ended December&#160;31, 2019 and 2018, we repurchased 473,586&#160;shares for $0.5&#160;million and 138,349&#160;shares for $0.2&#160;million, respectively. At December&#160;31, 2020, $18.3&#160;million remained authorized for repurchase under the 2015 Share Repurchase Program.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Common Stock Reserved for Future Issuance&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are authorized to issue up to 500,000,000&#160;shares of our common stock, par value $0.0001&#160;per share at December&#160;31, 2020. As of December&#160;31, 2020, there were 108,726,551&#160;shares of our common stock issued and outstanding.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the common shares reserved for issuance on exercise or vesting of various awards at December&#160;31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:78.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,984,852&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="INF"
      id="F_001025"
      unitRef="U_xbrlishares">8521500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="INF"
      id="F_001026"
      unitRef="U_xbrlishares">4811500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkPublicMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629"
      decimals="2"
      id="F_001027"
      unitRef="U_iso4217USD_xbrlishares">9.50</us-gaap:SharesIssuedPricePerShare>
    <nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="INF"
      id="F_001028"
      unitRef="U_xbrlishares">1111500</nk:SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkSharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629"
      decimals="2"
      id="F_001029"
      unitRef="U_iso4217USD_xbrlishares">9.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="INF"
      id="F_001030"
      unitRef="U_xbrlishares">3710000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001326110_us-gaapSecuritiesFinancingTransactionAxis_nkExecutiveChairmanAndPrincipalStockholderMember_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200629"
      decimals="2"
      id="F_001031"
      unitRef="U_iso4217USD_xbrlishares">12.12</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="-5"
      id="F_001032"
      unitRef="U_iso4217USD">90700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nk:UnderwritingDiscountsCommissionsAndOfferingExpenses
      contextRef="C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629"
      decimals="-5"
      id="F_001033"
      unitRef="U_iso4217USD">4400000</nk:UnderwritingDiscountsCommissionsAndOfferingExpenses>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="C_0001326110_20151130"
      decimals="INF"
      id="F_001034"
      unitRef="U_iso4217USD">50000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_20151102_20201231"
      decimals="INF"
      id="F_001035"
      unitRef="U_xbrlishares">6403489</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
      contextRef="C_0001326110_20151102_20201231"
      decimals="-5"
      id="F_001036"
      unitRef="U_iso4217USD">31700000</nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue>
    <us-gaap:SalesCommissionsAndFees
      contextRef="C_0001326110_20151102_20201231"
      decimals="-5"
      id="F_001037"
      unitRef="U_iso4217USD">100000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_001038"
      unitRef="U_xbrlishares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_001039"
      unitRef="U_xbrlishares">473586</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
      contextRef="C_0001326110_20190101_20191231"
      decimals="-5"
      id="F_001041"
      unitRef="U_iso4217USD">500000</nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_001040"
      unitRef="U_xbrlishares">138349</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
      contextRef="C_0001326110_20180101_20181231"
      decimals="-5"
      id="F_001042"
      unitRef="U_iso4217USD">200000</nk:StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001043"
      unitRef="U_iso4217USD">18300000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001044"
      unitRef="U_xbrlishares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001045"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001046"
      unitRef="U_xbrlishares">108726551</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001047"
      unitRef="U_xbrlishares">108726551</us-gaap:CommonStockSharesOutstanding>
    <nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000509">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the common shares reserved for issuance on exercise or vesting of various awards at December&#160;31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:78.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,984,852&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_001048"
      unitRef="U_xbrlishares">3518010</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="INF"
      id="F_001049"
      unitRef="U_xbrlishares">466842</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001050"
      unitRef="U_xbrlishares">3984852</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000459">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;12. &#160;&#160;&#160;&#160;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;2014 Equity Incentive Plan &#x2013; &lt;span style="font-style:normal;"&gt;In March&#160;2014, the company&#x2019;s board of directors and stockholders approved the 2014 Equity Incentive Plan, or 2014&#160;Plan, under which 11,109,000&#160;shares of common stock were reserved for the granting of incentive stock options, within the meaning of Section&#160;422 of the Internal Revenue Code, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and performance awards to employees, directors and consultants. The maximum term of awards granted under the 2014&#160;Plan is &lt;span style="-sec-ix-hidden:F_001052"&gt;ten&#160;years&lt;/span&gt;. Recipients of stock awards are eligible to purchase shares of our common stock at an exercise price equal to no less than the estimated fair market value of such stock on the date of grant. As of December&#160;31, 2020, there were approximately&#160;1.1&#160;million vested and exercisable options outstanding under the 2014&#160;Plan, and there were no additional shares available for future grant.&lt;/span&gt;&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;2015 Equity Incentive Plan &#x2013; &lt;span style="font-style:normal;"&gt;In July&#160;2015, the company&#x2019;s board of directors adopted and the company&#x2019;s stockholders approved the 2015 Equity Incentive Plan, or 2015&#160;Plan. The 2015&#160;Plan, as amended, permits the grant of incentive stock options to the company&#x2019;s employees, and for the grant of non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to the company&#x2019;s employees, directors and consultants. The 2015&#160;Plan is the only equity plan of the company available for future grant of equity awards to employees, directors and consultants of the company. In April&#160;2019, the company&#x2019;s board of directors adopted, and in June&#160;2019 the company&#x2019;s stockholders approved, a first amendment to the 2015&#160;Plan to reserve a further 3,000,000&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. In March&#160;2020, the company&#x2019;s board of directors adopted, and in June&#160;2020 the company&#x2019;s stockholders approved, a second amendment to the 2015&#160;Plan to reserve a further 3,000,000&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. As of December&#160;31, 2020, a total of approximately 10.2&#160;million shares of common stock were reserved for issuance pursuant to the 2015&#160;Plan and a total of approximately&#160;7.2&#160;million shares were available for future grant. In addition, the number of shares reserved for future grant under the 2015&#160;Plan include shares subject to stock options granted under the 2014&#160;Plan that expire or terminate without having been exercised in full and shares issued pursuant to awards granted under the 2014&#160;Plan that are forfeited to or repurchased by us (provided that the maximum number of shares that may be added to the 2015&#160;Plan pursuant to this provision is approximately 1.1&#160;million shares as of December&#160;31, 2020).&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents all stock-based compensation as included on the consolidated statements of operations (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants for common stock to an officer&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,817&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,388&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,309&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;629&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;938&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,193&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-employee RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;122&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,139&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense in operating expenses:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;499&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,139&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stock Options&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity and related information under all equity incentive plans for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&#160;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,693,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,920&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001109"&gt;5.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;800,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,493,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001110"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,986,300&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,506,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,710&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001111"&gt;5.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;400,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,272,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.89&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(116,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001112"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and Exercisable as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,868,008&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,509&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001113"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020, the unrecognized compensation cost related to outstanding stock options was $1.3&#160;million, which is expected to be recognized over a remaining weighted-average period of 0.9&#160;years.&lt;/p&gt;


&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the years ended December&#160;31, 2020, 2019 and 2018, there were 166,667, 343,810, and 462,875 stock options vested, respectively, with weighted-average exercises prices of $2.09, $3.51, and $8.45, respectively. The total intrinsic value of stock options exercised during the years ended December&#160;31, 2020, 2019 and 2018 was $12.7&#160;million, $0.2&#160;million and $0.6&#160;million, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash proceeds received from stock option exercises for the years ended December&#160;31, 2020, 2019 and 2018 was $1.2&#160;million, $4.1&#160;million and $0, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2019 and 2018, a total of 3,973,614 and 5,577,531 vested and exercisable shares were outstanding, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table provides a summary of options outstanding and vested as of December&#160;31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Prices&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$0.4213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001143"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001157"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.7554&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;288,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001144"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;288,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001158"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.9984&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;262,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001145"&gt;4.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;262,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001159"&gt;4.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;600,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001146"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;349,998&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001160"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$6.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;400,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001147"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001161"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$25.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,455,450&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001148"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,455,450&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001162"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001149"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,868,008&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001163"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We may grant stock options to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#x2019;s shared services agreement with NantWorks&#160;(Note&#160;10). The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001164"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.0 - 6.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.8%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96.8%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75.9%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average grant date fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$4.64&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$2.09&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The expected term was estimated using the average of the contractual term and the weighted-average vesting term of the options. The risk-free interest rate was based on the U.S.&#160;Treasury&#x2019;s rates for U.S.&#160;Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. For grants issued during 2020, the expected volatility was estimated based on the historical volatility of our common stock. For grants issued during 2018, the expected volatility was based on a weighted-average calculation of the company&#x2019;s common stock together with a peer group of comparable companies whose share prices are publicly available. The assumed dividend yield was based on the company&#x2019;s expectation of not paying dividends in the foreseeable future. There were no grants issued during 2019.&lt;/p&gt;


&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the restricted stock units, or RSUs, activity under the 2015&#160;Plan:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;RSUs&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;888,189&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;487,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.57&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(172,330&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(335,420&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;867,911&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;749,793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(395,051&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.83&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,139,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.43&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(648,336&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.04&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We may grant RSUs to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#x2019;s shared services agreement with NantWorks (Note&#160;10). During the year ended December&#160;31, 2018, we granted 90,906&#160;RSUs to employees of related companies under our shared services agreement with NantWorks&#160;(Note&#160;10). There were no grants made to non-employees during the years ended December&#160;31, 2020 and 2019.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2020, there was $0.6&#160;million of unrecognized stock-based compensation expense related to RSUs that is expected to be recognized over a weighted-average period of 1.8&#160;years. Of that amount, $0.6&#160;million of unrecognized expense is related to employee grants with a remaining weighted-average period of 1.9&#160;years and $6,400&#160;of unrecognized expense is related to non-employee grants with a remaining weighted-average period of 0.2&#160;years.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Warrants&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the company&#x2019;s warrant activity:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,721,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(93,254&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(38,584&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash proceeds recognized from exercises of warrants during the years ended December&#160;31, 2019 and 2018, were $35.2&#160;million and $0.1&#160;million, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;No warrants were issued during the years ended December&#160;31, 2020, 2019 and 2018, and as of December&#160;31, 2020 and 2019 there were no warrants outstanding. &lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20140331"
      decimals="INF"
      id="F_001051"
      unitRef="U_xbrlishares">11109000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20201231"
      decimals="-5"
      id="F_001053"
      unitRef="U_xbrlishares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFourteenEquityIncentivePlanMember_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_001054"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20190601_20190630"
      decimals="INF"
      id="F_001055"
      unitRef="U_xbrlishares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200601_20200630"
      decimals="INF"
      id="F_001056"
      unitRef="U_xbrlishares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231"
      decimals="INF"
      id="F_001057"
      unitRef="U_xbrlishares">10200000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20201231"
      decimals="INF"
      id="F_001058"
      unitRef="U_xbrlishares">7200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance
      contextRef="C_0001326110_us-gaapPlanNameAxis_nkTwoThousandFifteenEquityIncentivePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001059"
      unitRef="U_xbrlishares">1100000</nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000510">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents all stock-based compensation as included on the consolidated statements of operations (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants for common stock to an officer&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,817&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,388&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,309&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;629&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;938&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,193&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-employee RSUs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;122&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,139&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense in operating expenses:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;499&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;460&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,139&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,627&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,382&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="-3"
      id="F_001060"
      unitRef="U_iso4217USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="-3"
      id="F_001061"
      unitRef="U_iso4217USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_srtTitleOfIndividualAxis_srtOfficerMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="-3"
      id="F_001062"
      unitRef="U_iso4217USD">17817000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="-3"
      id="F_001063"
      unitRef="U_iso4217USD">1388000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="-3"
      id="F_001064"
      unitRef="U_iso4217USD">1309000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="-3"
      id="F_001065"
      unitRef="U_iso4217USD">4057000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231"
      decimals="-3"
      id="F_001066"
      unitRef="U_iso4217USD">629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20190101_20191231"
      decimals="-3"
      id="F_001067"
      unitRef="U_iso4217USD">938000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20180101_20181231"
      decimals="-3"
      id="F_001068"
      unitRef="U_iso4217USD">1193000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231"
      decimals="-3"
      id="F_001069"
      unitRef="U_iso4217USD">122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231"
      decimals="-3"
      id="F_001070"
      unitRef="U_iso4217USD">380000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231"
      decimals="-3"
      id="F_001071"
      unitRef="U_iso4217USD">315000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001072"
      unitRef="U_iso4217USD">2139000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001073"
      unitRef="U_iso4217USD">2627000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001074"
      unitRef="U_iso4217USD">23382000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_001075"
      unitRef="U_iso4217USD">220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_001076"
      unitRef="U_iso4217USD">499000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231"
      decimals="-3"
      id="F_001077"
      unitRef="U_iso4217USD">460000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231"
      decimals="-3"
      id="F_001078"
      unitRef="U_iso4217USD">1919000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231"
      decimals="-3"
      id="F_001079"
      unitRef="U_iso4217USD">2128000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231"
      decimals="-3"
      id="F_001080"
      unitRef="U_iso4217USD">22922000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001081"
      unitRef="U_iso4217USD">2139000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001082"
      unitRef="U_iso4217USD">2627000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001083"
      unitRef="U_iso4217USD">23382000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000511">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity and related information under all equity incentive plans for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&#160;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,693,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,920&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001109"&gt;5.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;800,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,493,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001110"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,986,300&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,506,950&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,710&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001111"&gt;5.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;400,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,272,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.89&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(116,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001112"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and Exercisable as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,868,008&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,509&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001113"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231"
      decimals="INF"
      id="F_001084"
      unitRef="U_xbrlishares">5693250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231"
      decimals="2"
      id="F_001094"
      unitRef="U_iso4217USD_xbrlishares">7.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20171231"
      decimals="-3"
      id="F_001104"
      unitRef="U_iso4217USD">11920000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="INF"
      id="F_001085"
      unitRef="U_xbrlishares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="2"
      id="F_001095"
      unitRef="U_iso4217USD_xbrlishares">3.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="INF"
      id="F_001086"
      unitRef="U_xbrlishares">6493250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="2"
      id="F_001096"
      unitRef="U_iso4217USD_xbrlishares">7.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="-3"
      id="F_001105"
      unitRef="U_iso4217USD">563000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001087"
      unitRef="U_xbrlishares">1986300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="2"
      id="F_001097"
      unitRef="U_iso4217USD_xbrlishares">2.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231"
      decimals="INF"
      id="F_001088"
      unitRef="U_xbrlishares">4506950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231"
      decimals="2"
      id="F_001098"
      unitRef="U_iso4217USD_xbrlishares">9.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231"
      decimals="-3"
      id="F_001106"
      unitRef="U_iso4217USD">5710000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_001089"
      unitRef="U_xbrlishares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="2"
      id="F_001099"
      unitRef="U_iso4217USD_xbrlishares">6.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_001090"
      unitRef="U_xbrlishares">1272273</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="2"
      id="F_001100"
      unitRef="U_iso4217USD_xbrlishares">1.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_001091"
      unitRef="U_xbrlishares">116667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="2"
      id="F_001101"
      unitRef="U_iso4217USD_xbrlishares">3.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_001092"
      unitRef="U_xbrlishares">3518010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="2"
      id="F_001102"
      unitRef="U_iso4217USD_xbrlishares">11.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="-3"
      id="F_001107"
      unitRef="U_iso4217USD">21922000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_001093"
      unitRef="U_xbrlishares">2868008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="2"
      id="F_001103"
      unitRef="U_iso4217USD_xbrlishares">13.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="-3"
      id="F_001108"
      unitRef="U_iso4217USD">16509000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="-5"
      id="F_001114"
      unitRef="U_iso4217USD">1300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      id="F_001115">P0Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_001116"
      unitRef="U_xbrlishares">166667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001117"
      unitRef="U_xbrlishares">343810</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="INF"
      id="F_001118"
      unitRef="U_xbrlishares">462875</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="2"
      id="F_001119"
      unitRef="U_iso4217USD_xbrlishares">2.09</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="2"
      id="F_001120"
      unitRef="U_iso4217USD_xbrlishares">3.51</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="2"
      id="F_001121"
      unitRef="U_iso4217USD_xbrlishares">8.45</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="-5"
      id="F_001122"
      unitRef="U_iso4217USD">12700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="-5"
      id="F_001123"
      unitRef="U_iso4217USD">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="-5"
      id="F_001124"
      unitRef="U_iso4217USD">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="-5"
      id="F_001125"
      unitRef="U_iso4217USD">1200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="-5"
      id="F_001126"
      unitRef="U_iso4217USD">4100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="-6"
      id="F_001127"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231"
      decimals="INF"
      id="F_001128"
      unitRef="U_xbrlishares">3973614</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="INF"
      id="F_001129"
      unitRef="U_xbrlishares">5577531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000512">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table provides a summary of options outstanding and vested as of December&#160;31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Prices&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$0.4213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001143"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001157"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.7554&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;288,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001144"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;288,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001158"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.9984&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;262,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001145"&gt;4.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;262,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001159"&gt;4.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$3.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;600,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001146"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;349,998&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001160"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$6.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;400,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001147"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001161"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$25.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,455,450&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001148"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,455,450&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001162"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,518,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001149"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,868,008&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001163"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231"
      decimals="4"
      id="F_001130"
      unitRef="U_iso4217USD_xbrlishares">0.4213</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231"
      decimals="INF"
      id="F_001136"
      unitRef="U_xbrlishares">512036</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeOneMember_20201231"
      decimals="INF"
      id="F_001150"
      unitRef="U_xbrlishares">512036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231"
      decimals="4"
      id="F_001131"
      unitRef="U_iso4217USD_xbrlishares">1.7554</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231"
      decimals="INF"
      id="F_001137"
      unitRef="U_xbrlishares">288404</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeTwoMember_20201231"
      decimals="INF"
      id="F_001151"
      unitRef="U_xbrlishares">288404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231"
      decimals="4"
      id="F_001132"
      unitRef="U_iso4217USD_xbrlishares">1.9984</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231"
      decimals="INF"
      id="F_001138"
      unitRef="U_xbrlishares">262120</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeThreeMember_20201231"
      decimals="INF"
      id="F_001152"
      unitRef="U_xbrlishares">262120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231"
      decimals="2"
      id="F_001133"
      unitRef="U_iso4217USD_xbrlishares">3.07</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231"
      decimals="INF"
      id="F_001139"
      unitRef="U_xbrlishares">600000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFourMember_20201231"
      decimals="INF"
      id="F_001153"
      unitRef="U_xbrlishares">349998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231"
      decimals="2"
      id="F_001134"
      unitRef="U_iso4217USD_xbrlishares">6.21</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231"
      decimals="INF"
      id="F_001140"
      unitRef="U_xbrlishares">400000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeFiveMember_20201231"
      decimals="INF"
      id="F_001154"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231"
      decimals="2"
      id="F_001135"
      unitRef="U_iso4217USD_xbrlishares">25.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231"
      decimals="INF"
      id="F_001141"
      unitRef="U_xbrlishares">1455450</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nkExercisePriceRangeSixMember_20201231"
      decimals="INF"
      id="F_001155"
      unitRef="U_xbrlishares">1455450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_001142"
      unitRef="U_xbrlishares">3518010</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_001156"
      unitRef="U_xbrlishares">2868008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000513">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We may grant stock options to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#x2019;s shared services agreement with NantWorks&#160;(Note&#160;10). The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001164"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.0 - 6.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.8%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96.8%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75.9%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average grant date fair value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$4.64&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$2.09&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="3"
      id="F_001167"
      unitRef="U_xbrlipure">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="3"
      id="F_001168"
      unitRef="U_xbrlipure">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="3"
      id="F_001169"
      unitRef="U_xbrlipure">0.968</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="3"
      id="F_001170"
      unitRef="U_xbrlipure">0.759</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="3"
      id="F_001171"
      unitRef="U_xbrlipure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20180101_20181231"
      decimals="3"
      id="F_001172"
      unitRef="U_xbrlipure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="2"
      id="F_001173"
      unitRef="U_iso4217USD_xbrlishares">4.64</nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice>
    <nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="2"
      id="F_001174"
      unitRef="U_iso4217USD_xbrlishares">2.09</nk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001175"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000514">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the restricted stock units, or RSUs, activity under the 2015&#160;Plan:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;RSUs&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;888,189&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;487,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.57&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(172,330&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(335,420&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;867,911&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;749,793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(395,051&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.83&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,139,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.43&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(648,336&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.04&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited/canceled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested balance as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;466,842&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231"
      decimals="INF"
      id="F_001176"
      unitRef="U_xbrlishares">888189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231"
      decimals="2"
      id="F_001189"
      unitRef="U_iso4217USD_xbrlishares">8.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="INF"
      id="F_001177"
      unitRef="U_xbrlishares">487472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="2"
      id="F_001190"
      unitRef="U_iso4217USD_xbrlishares">3.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="INF"
      id="F_001178"
      unitRef="U_xbrlishares">172330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="2"
      id="F_001191"
      unitRef="U_iso4217USD_xbrlishares">6.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="INF"
      id="F_001179"
      unitRef="U_xbrlishares">335420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20180101_20181231"
      decimals="2"
      id="F_001192"
      unitRef="U_iso4217USD_xbrlishares">6.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231"
      decimals="INF"
      id="F_001180"
      unitRef="U_xbrlishares">867911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231"
      decimals="2"
      id="F_001193"
      unitRef="U_iso4217USD_xbrlishares">6.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_001181"
      unitRef="U_xbrlishares">749793</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_001194"
      unitRef="U_iso4217USD_xbrlishares">1.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_001182"
      unitRef="U_xbrlishares">395051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_001195"
      unitRef="U_iso4217USD_xbrlishares">8.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_001183"
      unitRef="U_xbrlishares">83225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_001196"
      unitRef="U_iso4217USD_xbrlishares">7.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231"
      decimals="INF"
      id="F_001184"
      unitRef="U_xbrlishares">1139428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231"
      decimals="2"
      id="F_001197"
      unitRef="U_iso4217USD_xbrlishares">2.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_001185"
      unitRef="U_xbrlishares">33500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_001198"
      unitRef="U_iso4217USD_xbrlishares">6.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_001186"
      unitRef="U_xbrlishares">648336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_001199"
      unitRef="U_iso4217USD_xbrlishares">2.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_001187"
      unitRef="U_xbrlishares">57750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_001200"
      unitRef="U_iso4217USD_xbrlishares">4.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="INF"
      id="F_001188"
      unitRef="U_xbrlishares">466842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="2"
      id="F_001201"
      unitRef="U_iso4217USD_xbrlishares">2.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20180101_20181231"
      decimals="INF"
      id="F_001204"
      unitRef="U_xbrlishares">90906</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20190101_20191231"
      decimals="INF"
      id="F_001203"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231"
      decimals="INF"
      id="F_001202"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="-5"
      id="F_001205"
      unitRef="U_iso4217USD">600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      id="F_001206">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20201231"
      decimals="-5"
      id="F_001207"
      unitRef="U_iso4217USD">600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkEmployeeRestrictedStockUnitMember_20200101_20201231"
      id="F_001208">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20201231"
      decimals="0"
      id="F_001209"
      unitRef="U_iso4217USD">6400</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001326110_us-gaapAwardTypeAxis_nkNonEmployeeRestrictedStockUnitMember_20200101_20201231"
      id="F_001210">P0Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000515">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the company&#x2019;s warrant activity:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,721,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(93,254&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(38,584&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,589,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20171231"
      decimals="INF"
      id="F_001211"
      unitRef="U_xbrlishares">17721088</us-gaap:ClassOfWarrantOrRightOutstanding>
    <nk:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231"
      decimals="INF"
      id="F_001212"
      unitRef="U_xbrlishares">93254</nk:StockIssuedDuringPeriodSharesWarrantsExercised>
    <nk:StockIssuedDuringPeriodSharesWarrantsExpired
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20180101_20181231"
      decimals="INF"
      id="F_001213"
      unitRef="U_xbrlishares">38584</nk:StockIssuedDuringPeriodSharesWarrantsExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20181231"
      decimals="INF"
      id="F_001214"
      unitRef="U_xbrlishares">17589250</us-gaap:ClassOfWarrantOrRightOutstanding>
    <nk:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20190101_20191231"
      decimals="INF"
      id="F_001215"
      unitRef="U_xbrlishares">17589250</nk:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20191231"
      decimals="INF"
      id="F_001216"
      unitRef="U_xbrlishares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001326110_20190101_20191231"
      decimals="-5"
      id="F_001217"
      unitRef="U_iso4217USD">35200000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001326110_20180101_20181231"
      decimals="-5"
      id="F_001218"
      unitRef="U_iso4217USD">100000</us-gaap:ProceedsFromWarrantExercises>
    <nk:ClassOfWarrantOrRightsIssued
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_001219"
      unitRef="U_xbrlishares">0</nk:ClassOfWarrantOrRightsIssued>
    <nk:ClassOfWarrantOrRightsIssued
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_001220"
      unitRef="U_xbrlishares">0</nk:ClassOfWarrantOrRightsIssued>
    <nk:ClassOfWarrantOrRightsIssued
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_001221"
      unitRef="U_xbrlishares">0</nk:ClassOfWarrantOrRightsIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_20201231"
      decimals="INF"
      id="F_001222"
      unitRef="U_xbrlishares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_20191231"
      decimals="INF"
      id="F_001223"
      unitRef="U_xbrlishares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0001326110_20181231"
      decimals="INF"
      id="F_001224"
      unitRef="U_xbrlishares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000460">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;13. &#160;&#160;&#160;&#160;Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amount of loss before taxes is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. loss before taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(92,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(94,423&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign income (loss) before taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,306&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss before income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(92,378&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(96,729&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax (expense) benefit for the years ended December&#160;31, 2020, 2019 and 2018 consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;498&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax (expense) benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;503&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components that comprise the company&#x2019;s net deferred tax assets at December&#160;31, 2020 and 2019 consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,536&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,254&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases and other accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;451&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,419&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,148&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,965&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;121,409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91,732&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(121,409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(91,732&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the federal statutory income tax rate to the company&#x2019;s effective income tax rate for the years ended December&#160;31, 2020, 2019 and 2018 is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.08%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax computed at federal statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State income taxes, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax rate adjustment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(82.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective income tax rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to Internal Revenue Code&#160;Sections&#160;382 and 383, annual use of the company's net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a &lt;span style="-sec-ix-hidden:F_001314"&gt;three-year&lt;/span&gt; period. We completed an Internal Revenue Code&#160;Section&#160;382/383 analysis through March&#160;2019 regarding the limitation of net operating loss and research and development credit carryforwards. As a result, we derecognized a portion of the deferred tax assets for net operating losses and federal and state research and development credits of $0.8&#160;million from our deferred tax asset schedule as of December&#160;31, 2020. There is no impact to tax expense for the derecognition of the net operating losses and federal and state research and development credits due to the valuation allowance recorded against the deferred tax assets. Additionally, we have not recognized the deferred tax asset for research and development credit carryforwards as of December&#160;31, 2020 and 2019 because we are a part of a controlled group of affiliated companies with common ownership and cannot complete our calculation of the credit until the time that all members of the controlled group complete their analysis and calculation of qualified research expenditures.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, we have recorded a full valuation allowance of $121.4&#160;million at December&#160;31, 2020. The change in the valuation allowance for the year ended December&#160;31, 2020 was an increase of $29.7&#160;million which was mainly driven by losses for which the company cannot benefit. The portion of the valuation allowance for deferred tax assets for which subsequently recognized tax benefits will be credited directly to contributed capital is $0.2&#160;million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2020, the company has federal net operating losses, or NOLs, of $389.8&#160;million, state NOLs of $350.3&#160;million, and foreign NOLs of $0.2&#160;million. Of the $389.8&#160;million in federal NOLs, $226.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. Of the $350.3&#160;million in state NOLs, $4.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. The remaining federal NOL carryforwards begin to expire in 2024, the remaining state NOL carryforwards begin to expire in 2030 and the foreign NOL carryforwards begin to expire in 2022. At December&#160;31, 2020, the company also had federal research tax credit carryforwards of $11.1&#160;million and state research tax credits of $7.8&#160;million. The federal research tax credit carryforwards begin to expire in 2034 and certain state research tax credit carryforwards begin to expire in 2031. The California research tax credits can be carried forward indefinitely.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On March&#160;27, 2020, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, was signed into law in response to the economic challenges facing U.S. businesses. Under the CARES Act, the Internal Revenue Code was amended to allow for federal&#160;NOL carrybacks for &lt;span style="-sec-ix-hidden:F_001337"&gt;five&#160;years&lt;/span&gt; to offset previous years income, or the federal NOLs can be carried forward indefinitely to offset 100% of taxable income for tax year 2020 and 80% of taxable income for tax years 2021 and thereafter.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June&#160;29, 2020, the state of California enacted Assembly Bill No.&#160;85&#160;(AB&#160;85) suspending California net operating loss utilization and imposing a cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020, 2021 and 2022. There was no material impact from the provisions of AB&#160;85 in 2020.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the changes to the amount of unrecognized tax benefits (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease for prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase for current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease for prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase for current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,763&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,413&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Included in the balance of unrecognized tax benefits at December&#160;31, 2020, is $18.3&#160;million that, if recognized, would not impact our income tax benefit or effective tax rate as long as the deferred tax asset remains subject to a full valuation allowance. We do not expect that the unrecognized tax benefits will change within 12&#160;months of this reporting date. Due to the existence of the valuation allowance, future changes in our unrecognized tax benefits will not impact the company's effective tax rate.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We have not incurred any material interest or penalties as of the current reporting date with respect to income tax matters.&lt;/p&gt;

&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We are subject to U.S. federal income tax and various state income taxes. The federal returns for tax years &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; through &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; remain open to examination and the state returns remain subject to examination for tax years &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2016&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; through &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to the adoption of ASU&#160;2019&#x2011;12 in the first quarter of 2020, as described in Note&#160;2, intraperiod tax allocation rules required us to allocate the provision for income taxes between continuing operations and other categories of earnings, such as other comprehensive income. In periods in which we had a year-to-date pre-tax loss from continuing operations and pre-tax income in other categories of earnings, such as other comprehensive income, we had to allocate the tax provision to the other categories of earnings. We then recorded a related tax benefit in continuing operations. However, with the adoption of ASU&#160;2019&#x2011;12, we are no longer required to allocate the tax provision to the other categories of earnings and related benefit to continuing operations under these circumstances.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000516">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amount of loss before taxes is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. loss before taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(92,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(94,423&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign income (loss) before taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(600&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,306&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss before income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(92,378&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(96,729&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001225"
      unitRef="U_iso4217USD">-92412000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001226"
      unitRef="U_iso4217USD">-65286000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001227"
      unitRef="U_iso4217USD">-94423000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001228"
      unitRef="U_iso4217USD">34000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001229"
      unitRef="U_iso4217USD">-600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001230"
      unitRef="U_iso4217USD">-2306000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001231"
      unitRef="U_iso4217USD">-92378000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001232"
      unitRef="U_iso4217USD">-65886000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001233"
      unitRef="U_iso4217USD">-96729000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000517">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax (expense) benefit for the years ended December&#160;31, 2020, 2019 and 2018 consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;498&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax (expense) benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;503&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001234"
      unitRef="U_iso4217USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001235"
      unitRef="U_iso4217USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001236"
      unitRef="U_iso4217USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001237"
      unitRef="U_iso4217USD">5000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001238"
      unitRef="U_iso4217USD">3000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001239"
      unitRef="U_iso4217USD">3000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001240"
      unitRef="U_iso4217USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001241"
      unitRef="U_iso4217USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001242"
      unitRef="U_iso4217USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001243"
      unitRef="U_iso4217USD">5000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001244"
      unitRef="U_iso4217USD">3000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001245"
      unitRef="U_iso4217USD">3000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001246"
      unitRef="U_iso4217USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001247"
      unitRef="U_iso4217USD">-79000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001248"
      unitRef="U_iso4217USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001249"
      unitRef="U_iso4217USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001250"
      unitRef="U_iso4217USD">-21000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001251"
      unitRef="U_iso4217USD">-8000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001252"
      unitRef="U_iso4217USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001253"
      unitRef="U_iso4217USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001254"
      unitRef="U_iso4217USD">-498000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <nk:DeferredIncomeTaxExpenseBenefitNet
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001255"
      unitRef="U_iso4217USD">0</nk:DeferredIncomeTaxExpenseBenefitNet>
    <nk:DeferredIncomeTaxExpenseBenefitNet
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001256"
      unitRef="U_iso4217USD">-100000</nk:DeferredIncomeTaxExpenseBenefitNet>
    <nk:DeferredIncomeTaxExpenseBenefitNet
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001257"
      unitRef="U_iso4217USD">-506000</nk:DeferredIncomeTaxExpenseBenefitNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001258"
      unitRef="U_iso4217USD">5000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001259"
      unitRef="U_iso4217USD">-97000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001326110_20180101_20181231"
      decimals="-3"
      id="F_001260"
      unitRef="U_iso4217USD">-503000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000518">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components that comprise the company&#x2019;s net deferred tax assets at December&#160;31, 2020 and 2019 consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,536&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,254&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,128&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases and other accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;451&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,419&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,148&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,965&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;121,409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91,732&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(121,409&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(91,732&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001261"
      unitRef="U_iso4217USD">105537000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001262"
      unitRef="U_iso4217USD">78377000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001263"
      unitRef="U_iso4217USD">7699000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001264"
      unitRef="U_iso4217USD">8536000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <nk:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001265"
      unitRef="U_iso4217USD">4254000</nk:DeferredTaxAssetsOperatingLeaseLiabilities>
    <nk:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001266"
      unitRef="U_iso4217USD">3884000</nk:DeferredTaxAssetsOperatingLeaseLiabilities>
    <nk:DeferredTaxAssetsDeferredDepreciationAndAmortization
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001267"
      unitRef="U_iso4217USD">4128000</nk:DeferredTaxAssetsDeferredDepreciationAndAmortization>
    <nk:DeferredTaxAssetsDeferredDepreciationAndAmortization
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001268"
      unitRef="U_iso4217USD">2042000</nk:DeferredTaxAssetsDeferredDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001269"
      unitRef="U_iso4217USD">898000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001270"
      unitRef="U_iso4217USD">898000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001271"
      unitRef="U_iso4217USD">762000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001272"
      unitRef="U_iso4217USD">775000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001273"
      unitRef="U_iso4217USD">451000</nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities>
    <nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001274"
      unitRef="U_iso4217USD">453000</nk:DeferredTaxAssetsLeasesAndOtherAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001275"
      unitRef="U_iso4217USD">1419000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001276"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001277"
      unitRef="U_iso4217USD">125148000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001278"
      unitRef="U_iso4217USD">94965000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001279"
      unitRef="U_iso4217USD">3739000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001280"
      unitRef="U_iso4217USD">3233000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001281"
      unitRef="U_iso4217USD">3739000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001282"
      unitRef="U_iso4217USD">3233000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001283"
      unitRef="U_iso4217USD">121409000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001284"
      unitRef="U_iso4217USD">91732000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001285"
      unitRef="U_iso4217USD">121409000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001286"
      unitRef="U_iso4217USD">91732000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001287"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001288"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000519">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the federal statutory income tax rate to the company&#x2019;s effective income tax rate for the years ended December&#160;31, 2020, 2019 and 2018 is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.08%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax computed at federal statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State income taxes, net of federal tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax rate adjustment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(82.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;80.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective income tax rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001326110_20200101_20201231"
      decimals="INF"
      id="F_001289"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001326110_20190101_20191231"
      decimals="INF"
      id="F_001290"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001326110_20180101_20181231"
      decimals="INF"
      id="F_001291"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001292"
      unitRef="U_xbrlipure">0.077</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001293"
      unitRef="U_xbrlipure">-0.194</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001294"
      unitRef="U_xbrlipure">0.062</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001295"
      unitRef="U_xbrlipure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001296"
      unitRef="U_xbrlipure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001297"
      unitRef="U_xbrlipure">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001298"
      unitRef="U_xbrlipure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001299"
      unitRef="U_xbrlipure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001300"
      unitRef="U_xbrlipure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001301"
      unitRef="U_xbrlipure">0.032</nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution>
    <nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001302"
      unitRef="U_xbrlipure">-0.825</nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution>
    <nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001303"
      unitRef="U_xbrlipure">-0.001</nk:EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001304"
      unitRef="U_xbrlipure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001305"
      unitRef="U_xbrlipure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001306"
      unitRef="U_xbrlipure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20200101_20201231"
      decimals="3"
      id="F_001307"
      unitRef="U_xbrlipure">-0.321</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001308"
      unitRef="U_xbrlipure">0.805</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001309"
      unitRef="U_xbrlipure">-0.267</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001326110_20200101_20201231"
      decimals="2"
      id="F_001310"
      unitRef="U_xbrlipure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001326110_20190101_20191231"
      decimals="3"
      id="F_001311"
      unitRef="U_xbrlipure">-0.002</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001326110_20180101_20181231"
      decimals="3"
      id="F_001312"
      unitRef="U_xbrlipure">0.005</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <nk:ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage
      contextRef="C_0001326110_20200101_20201231"
      decimals="2"
      id="F_001313"
      unitRef="U_xbrlipure">0.50</nk:ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage>
    <nk:DerecognizedDeferredTaxAssets
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_001315"
      unitRef="U_iso4217USD">800000</nk:DerecognizedDeferredTaxAssets>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_001316"
      unitRef="U_iso4217USD">121400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001326110_20200101_20201231"
      decimals="-5"
      id="F_001317"
      unitRef="U_iso4217USD">29700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
      contextRef="C_0001326110_20200101_20201231"
      decimals="-5"
      id="F_001318"
      unitRef="U_iso4217USD">200000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231"
      decimals="-5"
      id="F_001319"
      unitRef="U_iso4217USD">389800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231"
      decimals="-5"
      id="F_001320"
      unitRef="U_iso4217USD">350300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20201231"
      decimals="-5"
      id="F_001321"
      unitRef="U_iso4217USD">200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231"
      decimals="-5"
      id="F_001322"
      unitRef="U_iso4217USD">389800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20201231"
      decimals="-5"
      id="F_001324"
      unitRef="U_iso4217USD">226400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      decimals="2"
      id="F_001326"
      unitRef="U_xbrlipure">0.80</nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231"
      decimals="-5"
      id="F_001323"
      unitRef="U_iso4217USD">350300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231"
      decimals="-5"
      id="F_001325"
      unitRef="U_iso4217USD">4400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      decimals="2"
      id="F_001327"
      unitRef="U_xbrlipure">0.80</nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome>
    <nk:NetOperatingLossCarryforwardsExpirationDate
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      id="F_001328">2024</nk:NetOperatingLossCarryforwardsExpirationDate>
    <nk:NetOperatingLossCarryforwardsExpirationDate
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_001329">2030</nk:NetOperatingLossCarryforwardsExpirationDate>
    <nk:NetOperatingLossCarryforwardsExpirationDate
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20200101_20201231"
      id="F_001330">2022</nk:NetOperatingLossCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231"
      decimals="-5"
      id="F_001331"
      unitRef="U_iso4217USD">11100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231"
      decimals="-5"
      id="F_001332"
      unitRef="U_iso4217USD">7800000</us-gaap:TaxCreditCarryforwardAmount>
    <nk:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231"
      id="F_001333">2034</nk:TaxCreditCarryforwardExpirationPeriod>
    <nk:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_0001326110_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231"
      id="F_001334">2031</nk:TaxCreditCarryforwardExpirationPeriod>
    <nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome
      contextRef="C_0001326110_us-gaapTaxPeriodAxis_us-gaapTaxYear2020Member_20200101_20201231"
      decimals="INF"
      id="F_001335"
      unitRef="U_xbrlipure">1</nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome>
    <nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome
      contextRef="C_0001326110_us-gaapTaxPeriodAxis_nkTaxYear2021AndThereafterMember_20200101_20201231"
      decimals="2"
      id="F_001336"
      unitRef="U_xbrlipure">0.80</nk:NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000520">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the changes to the amount of unrecognized tax benefits (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease for prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase for current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease for prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase for current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,763&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized tax benefits as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,413&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001326110_20181231"
      decimals="-3"
      id="F_001338"
      unitRef="U_iso4217USD">11983000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001339"
      unitRef="U_iso4217USD">7000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001326110_20190101_20191231"
      decimals="-3"
      id="F_001340"
      unitRef="U_iso4217USD">3680000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001326110_20191231"
      decimals="-3"
      id="F_001341"
      unitRef="U_iso4217USD">15656000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001342"
      unitRef="U_iso4217USD">6000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001326110_20200101_20201231"
      decimals="-3"
      id="F_001343"
      unitRef="U_iso4217USD">4763000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001326110_20201231"
      decimals="-3"
      id="F_001344"
      unitRef="U_iso4217USD">20413000</us-gaap:UnrecognizedTaxBenefits>
    <nk:UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
      contextRef="C_0001326110_20201231"
      decimals="-5"
      id="F_001345"
      unitRef="U_iso4217USD">18300000</nk:UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      id="F_001346">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20200101_20201231"
      id="F_001347">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMinimumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_001348">2016</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_0001326110_srtRangeAxis_srtMaximumMember_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_001349">2020</us-gaap:OpenTaxYear>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000461">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;14. &#160;&#160;&#160;&#160;Summarized Quarterly Data (Unaudited)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair statement of the results of the interim periods.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The table below presents unaudited quarterly data for years ended December&#160;31, 2020 and 2019 (in thousands, except for share and per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1st Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2nd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3rd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4th Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;68&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,228&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,995&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,907&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,586&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(30,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,092&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.30&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used in calculating net loss per share - basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,472,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,769,687&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;108,246,579&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;108,607,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1st Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2nd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3rd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4th Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,313&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,335&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,065&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,885&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,682&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used in calculating net loss per share - basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,261,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,594,355&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,331,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,419,166&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000521">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The table below presents unaudited quarterly data for years ended December&#160;31, 2020 and 2019 (in thousands, except for share and per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1st Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2nd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3rd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4th Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;68&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,228&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,995&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,907&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,586&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(30,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,092&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(32,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.30&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used in calculating net loss per share - basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,472,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,769,687&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;108,246,579&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;108,607,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1st Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2nd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3rd Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4th Quarter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,313&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,120&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(18,335&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,065&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,885&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,682&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,581&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used in calculating net loss per share - basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,261,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,594,355&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,331,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,419,166&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_0001326110_20200101_20200331"
      decimals="-3"
      id="F_001350"
      unitRef="U_iso4217USD">21000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20200401_20200630"
      decimals="-3"
      id="F_001351"
      unitRef="U_iso4217USD">1000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20200701_20200930"
      decimals="-3"
      id="F_001352"
      unitRef="U_iso4217USD">68000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20201001_20201231"
      decimals="-3"
      id="F_001353"
      unitRef="U_iso4217USD">21000</us-gaap:Revenues>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20200101_20200331"
      decimals="-3"
      id="F_001354"
      unitRef="U_iso4217USD">18607000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20200401_20200630"
      decimals="-3"
      id="F_001355"
      unitRef="U_iso4217USD">20228000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20200701_20200930"
      decimals="-3"
      id="F_001356"
      unitRef="U_iso4217USD">21995000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20201001_20201231"
      decimals="-3"
      id="F_001357"
      unitRef="U_iso4217USD">30907000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20200101_20200331"
      decimals="-3"
      id="F_001358"
      unitRef="U_iso4217USD">-18586000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20200401_20200630"
      decimals="-3"
      id="F_001359"
      unitRef="U_iso4217USD">-20227000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20200701_20200930"
      decimals="-3"
      id="F_001360"
      unitRef="U_iso4217USD">-21927000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20201001_20201231"
      decimals="-3"
      id="F_001361"
      unitRef="U_iso4217USD">-30886000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200101_20200331"
      decimals="-3"
      id="F_001362"
      unitRef="U_iso4217USD">-18383000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200401_20200630"
      decimals="-3"
      id="F_001363"
      unitRef="U_iso4217USD">-20092000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20200701_20200930"
      decimals="-3"
      id="F_001364"
      unitRef="U_iso4217USD">-21776000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20201001_20201231"
      decimals="-3"
      id="F_001365"
      unitRef="U_iso4217USD">-32132000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20200101_20200331"
      decimals="2"
      id="F_001366"
      unitRef="U_iso4217USD_xbrlishares">-0.19</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20200401_20200630"
      decimals="2"
      id="F_001367"
      unitRef="U_iso4217USD_xbrlishares">-0.20</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20200701_20200930"
      decimals="2"
      id="F_001368"
      unitRef="U_iso4217USD_xbrlishares">-0.20</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20201001_20201231"
      decimals="2"
      id="F_001369"
      unitRef="U_iso4217USD_xbrlishares">-0.30</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20200101_20200331"
      decimals="0"
      id="F_001370"
      unitRef="U_xbrlishares">98472641</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20200401_20200630"
      decimals="0"
      id="F_001371"
      unitRef="U_xbrlishares">98769687</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20200701_20200930"
      decimals="0"
      id="F_001372"
      unitRef="U_xbrlishares">108246579</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20201001_20201231"
      decimals="0"
      id="F_001373"
      unitRef="U_xbrlishares">108607715</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:Revenues
      contextRef="C_0001326110_20190101_20190331"
      decimals="-3"
      id="F_001374"
      unitRef="U_iso4217USD">5000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20190401_20190630"
      decimals="-3"
      id="F_001375"
      unitRef="U_iso4217USD">17000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20190701_20190930"
      decimals="-3"
      id="F_001376"
      unitRef="U_iso4217USD">12000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0001326110_20191001_20191231"
      decimals="-3"
      id="F_001377"
      unitRef="U_iso4217USD">9000</us-gaap:Revenues>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20190101_20190331"
      decimals="-3"
      id="F_001378"
      unitRef="U_iso4217USD">18340000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20190401_20190630"
      decimals="-3"
      id="F_001379"
      unitRef="U_iso4217USD">17313000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20190701_20190930"
      decimals="-3"
      id="F_001380"
      unitRef="U_iso4217USD">16077000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001326110_20191001_20191231"
      decimals="-3"
      id="F_001381"
      unitRef="U_iso4217USD">16120000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20190101_20190331"
      decimals="-3"
      id="F_001382"
      unitRef="U_iso4217USD">-18335000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20190401_20190630"
      decimals="-3"
      id="F_001383"
      unitRef="U_iso4217USD">-17296000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20190701_20190930"
      decimals="-3"
      id="F_001384"
      unitRef="U_iso4217USD">-16065000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001326110_20191001_20191231"
      decimals="-3"
      id="F_001385"
      unitRef="U_iso4217USD">-16111000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190101_20190331"
      decimals="-3"
      id="F_001386"
      unitRef="U_iso4217USD">-17885000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190401_20190630"
      decimals="-3"
      id="F_001387"
      unitRef="U_iso4217USD">-16682000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20190701_20190930"
      decimals="-3"
      id="F_001388"
      unitRef="U_iso4217USD">-15581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001326110_20191001_20191231"
      decimals="-3"
      id="F_001389"
      unitRef="U_iso4217USD">-15641000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20190101_20190331"
      decimals="2"
      id="F_001390"
      unitRef="U_iso4217USD_xbrlishares">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20190401_20190630"
      decimals="2"
      id="F_001391"
      unitRef="U_iso4217USD_xbrlishares">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20190701_20190930"
      decimals="2"
      id="F_001392"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001326110_20191001_20191231"
      decimals="2"
      id="F_001393"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20190101_20190331"
      decimals="0"
      id="F_001394"
      unitRef="U_xbrlishares">81261302</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20190401_20190630"
      decimals="0"
      id="F_001395"
      unitRef="U_xbrlishares">98594355</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20190701_20190930"
      decimals="0"
      id="F_001396"
      unitRef="U_xbrlishares">98331695</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001326110_20191001_20191231"
      decimals="0"
      id="F_001397"
      unitRef="U_xbrlishares">98419166</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000462">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;15. &#160;&#160;&#160;&#160;Employee Benefits&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Defined Contribution Benefit Plan &#x2013; &lt;span style="font-style:normal;"&gt;In December&#160;2015, the company adopted a 401(k) retirement and savings plan, or the 401(k) Plan, covering all employees. The 401(k)&#160;Plan allows employees to make pre- and post-tax contributions up to the maximum allowable amount set by the Internal Revenue Service. The company, at its discretion, may make certain contributions to the 401(k)&#160;Plan. We made contributions of $0.5&#160;million, $0.6&#160;million and $0.5&#160;million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Compensated Absences &#x2013; &lt;span style="font-style:normal;"&gt;Under our vacation policy, salaried employees are provided unlimited vacation leave. Therefore, we do not record an accrual for paid leave related to these employees since we are unable to reasonably estimate the compensated absences that these employees will take.&lt;/span&gt;&lt;/p&gt;

</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231"
      decimals="-5"
      id="F_001398"
      unitRef="U_iso4217USD">500000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20190101_20191231"
      decimals="-5"
      id="F_001399"
      unitRef="U_iso4217USD">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20180101_20181231"
      decimals="-5"
      id="F_001400"
      unitRef="U_iso4217USD">500000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SubsequentEventsTextBlock contextRef="C_0001326110_20200101_20201231" id="F_000463">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;16. &#160;&#160;&#160;&#160;Subsequent Event&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Related Party Lease Agreement&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February&#160;2021, but effective on January&#160;1, 2021, we entered into a lease agreement with 605&#160;Nash, LLC, whereby we leased approximately 6,883&#160;square feet in El&#160;Segundo, California. 605&#160;Nash, LLC is a related party, as it is owned by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon&#x2011;Shiong. This facility will be used primarily for pharmaceutical development and manufacturing purposes. The lease runs from January&#160;2021 through December&#160;2027, and includes an option to extend the lease for an additional &lt;span style="-sec-ix-hidden:F_001406"&gt;three&#160;year&lt;/span&gt;&#160;term through &lt;span style="-sec-ix-hidden:F_001405"&gt;December&#160;2030&lt;/span&gt;. Base rent for the term of the lease is approximately $20,300&#160;per month with an annual increase of 3% on January&#160;1 of each year during the initial term and, if applicable, during the option term. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <nk:NumberOfSquareFootOfFacilityLeased
      contextRef="C_0001326110_srtStatementGeographicalAxis_nkElSegundoCaliforniaMember_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228"
      decimals="INF"
      id="F_001401"
      unitRef="U_utrsqft">6883</nk:NumberOfSquareFootOfFacilityLeased>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231"
      id="F_001402">The lease runs from January&#160;2021 through December&#160;2027</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <nk:BaseMonthlyRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228"
      decimals="0"
      id="F_001403"
      unitRef="U_iso4217USD">20300</nk:BaseMonthlyRent>
    <nk:AnnualPercentageIncreasesToBaseRent
      contextRef="C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228_20210228"
      decimals="2"
      id="F_001404"
      unitRef="U_xbrlipure">0.03</nk:AnnualPercentageIncreasesToBaseRent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663897976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 03, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NANTKWEST, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,344,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 415.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par&#160;value&#160;$0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">43-1979754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3530 John Hopkins Court<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">633-0300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:2.5%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As noted herein, the information called for by Part&#160;III of this Annual Report on Form&#160;10&#8209;K is incorporated by reference to specified portions of the Registrant&#8217;s definitive proxy statement to be filed in conjunction with the Registrant&#8217;s 2021 Annual Meeting of Stockholders, which is expected to be filed not later than 120&#160;days after the Registrant&#8217;s fiscal year ended December&#160;31, 2020.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583227368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,441<span></span>
</td>
<td class="nump">$ 15,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets (including amounts with related parties)</a></td>
<td class="nump">9,285<span></span>
</td>
<td class="nump">4,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable debt securities, available-for-sale</a></td>
<td class="nump">54,772<span></span>
</td>
<td class="nump">36,144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">75,498<span></span>
</td>
<td class="nump">55,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable debt securities, noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (including amounts with related parties)</a></td>
<td class="nump">53,927<span></span>
</td>
<td class="nump">60,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net (including amounts with related parties)</a></td>
<td class="nump">13,463<span></span>
</td>
<td class="nump">11,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investment</a></td>
<td class="nump">7,849<span></span>
</td>
<td class="nump">9,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets (including amounts with related parties)</a></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,386<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">151,858<span></span>
</td>
<td class="nump">143,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,101<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">8,343<span></span>
</td>
<td class="nump">5,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">5,269<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (including amounts with related parties)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities (including amounts with related parties)</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,651<span></span>
</td>
<td class="nump">11,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, less current portion (including amounts with related parties)</a></td>
<td class="nump">9,814<span></span>
</td>
<td class="nump">10,885<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,465<span></span>
</td>
<td class="nump">22,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 500,000,000 shares authorized; 108,726,551 and 98,460,404 issued and outstanding as of December 31, 2020 and December 31, 2019</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">872,078<span></span>
</td>
<td class="nump">782,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(754,574)<span></span>
</td>
<td class="num">(662,191)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">117,393<span></span>
</td>
<td class="nump">120,679<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 151,858<span></span>
</td>
<td class="nump">$ 143,123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395577798984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">108,726,551<span></span>
</td>
<td class="nump">98,460,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">108,726,551<span></span>
</td>
<td class="nump">98,460,404<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395666700712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="nump">64,483<span></span>
</td>
<td class="nump">49,785<span></span>
</td>
<td class="nump">55,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative (including amounts with related parties)</a></td>
<td class="nump">27,254<span></span>
</td>
<td class="nump">18,065<span></span>
</td>
<td class="nump">42,718<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">91,737<span></span>
</td>
<td class="nump">67,850<span></span>
</td>
<td class="nump">98,436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(91,626)<span></span>
</td>
<td class="num">(67,807)<span></span>
</td>
<td class="num">(98,389)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense (including amounts with related parties)</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net (including amounts with related parties)</a></td>
<td class="num">(1,077)<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="num">(752)<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(92,378)<span></span>
</td>
<td class="num">(65,886)<span></span>
</td>
<td class="num">(96,729)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (92,383)<span></span>
</td>
<td class="num">$ (65,789)<span></span>
</td>
<td class="num">$ (96,226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (0.70)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of shares during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">103,550,936<span></span>
</td>
<td class="nump">94,210,087<span></span>
</td>
<td class="nump">79,132,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584321960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement Of Income And Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (92,383)<span></span>
</td>
<td class="num">$ (65,789)<span></span>
</td>
<td class="num">$ (96,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Net unrealized (losses) gains on available-for-sale securities</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassification of net realized losses on available-for-sale securities included in net loss</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (92,400)<span></span>
</td>
<td class="num">$ (65,627)<span></span>
</td>
<td class="num">$ (96,112)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395582286904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2017</a></td>
<td class="nump">$ 218,844<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 717,930<span></span>
</td>
<td class="num">$ (381)<span></span>
</td>
<td class="num">$ (498,713)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning Balance, Shares at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,021,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">23,382<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">23,382<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Exercise of warrants</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs), Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises</a></td>
<td class="num">(123)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (228)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, Shares</a></td>
<td class="num">(138,349)<span></span>
</td>
<td class="num">(138,349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Cumulative effect of the adoption of the new standard | Accounting Standards Update 2014-09</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(96,226)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(96,226)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2018</a></td>
<td class="nump">146,006<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">741,246<span></span>
</td>
<td class="num">(267)<span></span>
</td>
<td class="num">(594,981)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending Balance, Shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,087,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,627<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,627<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Exercise of warrants</a></td>
<td class="nump">35,151<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">35,149<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,589,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">4,070<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,070<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,986,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs), Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises</a></td>
<td class="num">(127)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124,345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (501)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, Shares</a></td>
<td class="num">(473,586)<span></span>
</td>
<td class="num">(473,586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Cumulative effect of the adoption of the new standard | Accounting Standards Update 2016-02</a></td>
<td class="num">$ (920)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(920)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(65,789)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(65,789)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 120,679<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">782,965<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(662,191)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending Balance, Shares at Dec. 31, 2019</a></td>
<td class="nump">98,460,404<span></span>
</td>
<td class="nump">98,460,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">$ 86,302<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">86,301<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,521,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,272,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units (RSUs), Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises</a></td>
<td class="num">$ (503)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(503)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and option/warrant exercises, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,962)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, Shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (17)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(92,383)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(92,383)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 117,393<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 872,078<span></span>
</td>
<td class="num">$ (122)<span></span>
</td>
<td class="num">$ (754,574)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending Balance, Shares at Dec. 31, 2020</a></td>
<td class="nump">108,726,551<span></span>
</td>
<td class="nump">108,726,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a reclassification adjustment made to prior period financial statement amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395668321896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement Of Stockholders Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockOfferingCosts', window );">Offering costs</a></td>
<td class="nump">$ 4,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664102424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (92,383)<span></span>
</td>
<td class="num">$ (65,789)<span></span>
</td>
<td class="num">$ (96,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">9,147<span></span>
</td>
<td class="nump">9,012<span></span>
</td>
<td class="nump">9,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense', window );">Non-cash lease expense related to operating lease right-of-use assets</a></td>
<td class="nump">3,430<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">2,627<span></span>
</td>
<td class="nump">23,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Unrealized loss on equity investment</a></td>
<td class="nump">1,405<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of net premiums and discounts on marketable debt securities</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Losses (gains) on sales of marketable debt securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NonCashInterestIncomeExpenseFromOperatingActivities', window );">Non-cash interest items, net</a></td>
<td class="num">(251)<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Loss on impairment of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">869<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(498)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,328)<span></span>
</td>
<td class="nump">9,276<span></span>
</td>
<td class="num">(9,818)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(4,063)<span></span>
</td>
<td class="num">(1,151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncreaseDecreaseInAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(1,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">3,686<span></span>
</td>
<td class="num">(12,020)<span></span>
</td>
<td class="nump">12,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">5,034<span></span>
</td>
<td class="num">(1,093)<span></span>
</td>
<td class="num">(685)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(3,941)<span></span>
</td>
<td class="num">(3,076)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(70,453)<span></span>
</td>
<td class="num">(61,362)<span></span>
</td>
<td class="num">(63,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(2,639)<span></span>
</td>
<td class="num">(4,182)<span></span>
</td>
<td class="num">(13,102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchases of debt securities, held-to-maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PaymentsToAcquireInvestmentsInEquitySecurities', window );">Purchases of investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable debt securities, available-for-sale</a></td>
<td class="num">(91,572)<span></span>
</td>
<td class="num">(86,618)<span></span>
</td>
<td class="num">(94,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of marketable debt securities</a></td>
<td class="nump">65,350<span></span>
</td>
<td class="nump">109,730<span></span>
</td>
<td class="nump">165,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales of marketable debt securities</a></td>
<td class="nump">8,272<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(20,589)<span></span>
</td>
<td class="nump">21,456<span></span>
</td>
<td class="nump">57,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering, net of issuance cost paid</a></td>
<td class="nump">86,302<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">4,070<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercises of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,151<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Principal payments of financing obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock with commissions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(501)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net share settlement for restricted stock unit vesting and warrant and option exercises</a></td>
<td class="num">(503)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">86,975<span></span>
</td>
<td class="nump">38,593<span></span>
</td>
<td class="num">(771)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(4,067)<span></span>
</td>
<td class="num">(1,313)<span></span>
</td>
<td class="num">(7,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">15,687<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">24,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">11,620<span></span>
</td>
<td class="nump">15,687<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash at end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">11,441<span></span>
</td>
<td class="nump">15,508<span></span>
</td>
<td class="nump">16,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">11,620<span></span>
</td>
<td class="nump">15,687<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">5,164<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Cashless exercise of stock options and warrants</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases included in accounts payable, accrued expenses, and other liabilities</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">4,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of Viracta convertible notes and accrued interest into investment in equity securities of Viracta (Note 5)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized (losses) gains on marketable debt securities</a></td>
<td class="num">$ (17)<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_IncreaseDecreaseInAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in accounts payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_IncreaseDecreaseInAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NonCashInterestIncomeExpenseFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash interest (income) expense from operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NonCashInterestIncomeExpenseFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease right of use asset non cash lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PaymentsToAcquireInvestmentsInEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire investments in equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PaymentsToAcquireInvestmentsInEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395666785736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DescriptionOfBusinessDisclosureTextBlock', window );">Description of Business</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. &#160;&#160;&#160;&#160;Description of Business</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Organization</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NantKwest, Inc., or NantKwest, was incorporated in Illinois on October&#160;7, 2002 under the name ZelleRx Corporation. On January&#160;22, 2010, the company changed its name to Conkwest, Inc., and on July&#160;10, 2015, the company changed its name to NantKwest, Inc. In March&#160;2014, the company redomesticated from the State of Illinois to the State of Delaware and the Illinois company ceased to exist. We are a pioneering clinical-stage immunotherapy biotechnology company headquartered in San Diego, California with certain operations in Culver City and El Segundo, California and Woburn, Massachusetts. In these notes, the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;the company&#8221; and &#8220;us&#8221; refer to NantKwest.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are focused on harnessing the power of the innate immune system by using our natural killer cells, or NK&#160;cells, to treat cancer and viral infectious diseases. A critical aspect of our strategy is to invest significantly in innovating new therapeutic candidates, based upon our proprietary activated NK, or aNK, cell platform, and conducting clinical testing and scale manufacturing of our most promising biologic product candidates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We hold the exclusive right to commercialize aNK&#160;cells, a commercially viable NK&#160;cell line, and a wide range of genetically modified derivatives capable of killing cancer and virally infected cells. We own corresponding United States, or U.S., and foreign composition and methods-of-use patents and applications covering the cells, improvements, methods of expansion and manufacture and use of aNK&#160;cells and their improvements as therapeutics to treat a spectrum of clinical conditions.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the company closed an underwritten public offering of common stock as discussed further in Note&#160;11,<span style="font-style:italic;">&#160;Stockholders Equity</span>. Gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, the company had an accumulated deficit of $754.6&#160;million. We also had negative cash flow from operations of $70.5&#160;million during the year ended December&#160;31, 2020. The company will likely need additional capital to further fund development of, and seek regulatory approvals for, our product candidates, and to begin to commercialize any approved products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently focused primarily on the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer and viral killing cell lines, and we believe such activities will result in the company&#8217;s continued incurrence of significant research and development and other expenses related to those programs. If the clinical trials for any of the company&#8217;s product candidates fail or produce unsuccessful results and those product candidates do not gain regulatory approval, or if any of our product candidates, if approved, fail to achieve market acceptance, we may never become profitable. Even if the company achieves profitability in the future, it may not be able to sustain profitability in subsequent periods. We intend to cover our future operating expenses through cash and cash equivalents and marketable debt securities on hand and through a combination of equity offerings, debt financings, government or other third party funding, marketing and distribution arrangements and other collaborations, strategic alliances, and licensing arrangements. Additional financing may not be available to us when needed and, if available, financing may not be obtained on terms favorable to the company or its stockholders.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we expect our existing cash, and cash equivalents and marketable debt securities, together with the ability to borrow from affiliated entities, will enable us to fund operations and capital expenditure requirements for at least the next 12&#160;months, we may not have sufficient funds to reach commercialization. Failure to obtain adequate financing when needed may require us to delay, reduce, limit, or terminate some or all of our development programs or future commercialization efforts or grant rights to develop and market product candidates that we might otherwise prefer to develop and market ourselves, which could adversely affect our ability to operate as a going concern. If we raise additional funds from the issuance of equity securities, substantial dilution to existing stockholders may result. If we raise additional funds by incurring debt financing, the terms of the debt may involve significant cash payment obligations, as well as covenants and specific financial ratios that may restrict our ability to operate our business.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DescriptionOfBusinessDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of business disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DescriptionOfBusinessDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395671548648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S.&#160;GAAP.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared assuming the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of the uncertainty discussed in the Liquidity section of Note&#160;1. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#8217;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We may also seek to sell additional equity, through one or more follow-on public offerings, or in separate financings, or obtain a credit facility. However, we may not be able to secure such financing in a timely manner or on favorable terms. Without additional funds, we may choose to delay or reduce our operating or investment expenditures. Further, because of the risk and uncertainties associated with the commercialization of the company&#8217;s product candidates in development, we may need additional funds to meet our needs sooner than planned.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of NantKwest and its wholly owned subsidiaries. All intercompany amounts have been eliminated.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We apply the variable interest model under Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic&#160;810,&#160;<span style="font-style:italic;">Consolidation</span>, to any entity in which we hold an equity investment or to which we have the power to direct the entity's most significant economic activities and the ability to participate in the entity's economics. If the entity is within the scope of the variable interest model and meets the definition of a variable interest entity, or VIE, we consider whether we must consolidate the VIE or provide additional disclosures regarding our involvement with the VIE. If we determine that we are the primary beneficiary of the VIE, we will consolidate the VIE. This analysis is performed at the initial investment in the entity or upon any reconsideration event.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For entities we hold as an equity investment that are not consolidated under the VIE model, we consider whether our investment constitutes ownership of a majority of the voting interests in the entity and therefore should be considered for consolidation under the voting interest model.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unconsolidated equity investments in the common stock or in-substance common stock of an entity under which we are able to exercise significant influence, but not control, are accounted for using the equity method. Our ability to exercise significant influence is generally indicated by ownership of 20 to 50 percent interest in the voting securities of the entity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other unconsolidated equity investments on which we are not able to exercise significant influence will be subsequently measured at fair value with unrealized holding gains and losses included in other income and expense, net, on the consolidated statements of operations. In the instance the equity investment does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, <span style="font-style:italic;">Fair Value Measurement</span>, or ASC&#160;820, we will apply the measurement alternative under ASC&#160;321, <span style="font-style:italic;">Investments&#8212;Equity Securities</span>, or ASC&#160;321, pursuant to which we will measure the investment at its cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#8217; earnings performance and clinical trial performance, change in the investees&#8217; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include:&#160;the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#8217;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates. Actual results could differ from those estimates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#8209;CoV&#8209;2) outbreak a pandemic. To date, our operations have not been significantly impacted by the pandemic. However, we cannot at this time predict the specific extent, duration, or full impact that this pandemic may have on our financial condition and results of operations, including ongoing and planned clinical trials. More specifically, the pandemic may result in prolonged impacts that we cannot predict at this time and we expect that such uncertainties will continue to exist until such time a vaccine is broadly available and in use. The impact of the pandemic on the financial performance of the company will depend on future developments, including the duration and spread of the outbreak and related governmental advisories and restrictions. These developments and the impact of the ongoing pandemic on the financial markets and the overall economy are highly uncertain. If the financial markets and/or the overall economy are impacted for an extended period, our results may be adversely affected.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea. We minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe that we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents include highly liquid investments with an original maturity of <span style="-sec-ix-hidden:F_000528">three&#160;months</span> or less from the date of purchase.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of cash, cash equivalents, and restricted cash is included on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Marketable Debt Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of 12&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than 12&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#8217; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were no other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property, Plant and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment is stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. All repairs and maintenance are charged to net loss during the financial period in which they are incurred. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 39 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &amp; fixtures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IT equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The lesser of the lease term or the life of the asset</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon disposal or impairment of property, plant and equipment, the cost and related accumulated depreciation is removed from the consolidated financial statements and the net amount, less any proceeds, is included in the consolidated statements of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, which consisted of the cost of reacquiring a technology license during 2015, were amortized using the straight-line method over an estimated useful life of 4&#160;years. As of December&#160;31, 2019, our intangible assets were fully amortized.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Patents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patent costs, including related legal costs, are expensed as incurred and recorded in selling, general and administrative expenses on the consolidated statements of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year ended December&#160;31, 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we determined that certain bioreactor laboratory equipment could no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> longer</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be utilized in the production process. As a result, we recorded an impairment charge </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">totaling</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">million, which is included in research and development expense on the consolidated statements of operations. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment losses recognized during the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years ended December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 2018</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in absence of a principal, most advantageous market for the specific asset or liability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The three tiers are defined as follows:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;1&#8212; Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets at the measurement date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Our Level 1 assets consist of bank deposits and money market funds.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;2&#8212; Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities. Our Level 2 assets consist of corporate debt securities including commercial paper, government sponsored securities and corporate bonds, as well as foreign municipal securities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;3&#8212; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, no transfers were made into or out of the Level&#160;1,&#160;2 or 3 categories. We will continue to review the fair value inputs on a quarterly basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We utilize a third-party pricing service to assist in obtaining fair value pricing for our investments in marketable debt securities. Inputs are documented in accordance with the fair value disclosure hierarchy.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaboration Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We analyze our collaboration arrangements to assess whether they are within the scope of FASB ASC&#160;Topic&#160;808, <span style="font-style:italic;">Collaborative Arrangements,</span> or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements are further discussed within Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Preclinical and Clinical Trial Accruals</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> behalf.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accruing clinical and research related fees, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Transactions with Related Parties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As outlined in Note&#160;10,&#160;<span style="font-style:italic;">Related Party Agreements</span>, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, <span style="font-style:italic;">Leases</span>, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, <span style="font-style:italic;">Leases</span>, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception. Such leases are expensed on a straight-line basis over the lease term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, as well as for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances to reduce deferred tax assets to the amount we believe is more likely than not to be realized.</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize uncertain tax positions when the position will be more likely than not upheld on examination by the taxing authorities based solely upon the technical merits of the positions. We recognize interest and penalties, if any, related to unrecognized income tax uncertainties in income tax expense. We did not have any accrued interest or penalties associated with uncertain tax positions as of December&#160;31, 2020 and 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to U.S. federal income tax, as well as income tax in Korea, California and other states. To date, we have not been required to pay U.S. federal and state income taxes because of current and accumulated net operating losses. The federal returns for tax years 2017 through 2020 remain open to examination and the state returns remain subject to examination for tax years 2016 through 2020. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination. No income tax returns are currently under examination by taxing authorities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Repurchases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, the board of directors approved the 2015 Share Repurchase Program (Note&#160;11) allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2018, we adopted the provisions of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. This guidance requires that entities recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted ASC&#160;606 on January&#160;1, 2018 by recording the cumulative effect of the adoption to accumulated deficit. We applied the new guidance to contracts that were not complete as of January&#160;1, 2018. Implementation of ASC&#160;606 did not have a material impact on our consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive substantially all of our revenue from non-exclusive license agreements with a limited number of pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of the licensee products developed or manufactured using our intellectual property and cell lines.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC&#160;606. A contract&#8217;s transaction price is allocated to each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the company&#8217;s license agreements with customers, the company typically promises to provide a license to use certain cell lines and related patents, the related know-how, and future research and development data that affect the license. We have concluded that these promises represent one performance obligation due to the highly interrelated nature of the promises. We provide the cell lines and know-how immediately upon entering into the contracts. The research and development data is provided throughout the term of the contract when and if available.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our license agreement with Precigen&#160;(Note&#160;8) included a nonrefundable upfront payment of $0.4&#160;million, received when we entered into the contract in 2010. In this instance, we determined that under ASC&#160;606 it would be appropriate to recognize the initial milestone payment at a point in time, when we transferred the license. In this case, the intellectual property provided under the contract is functional intellectual property under ASC&#160;606 and was determined to be a distinct performance obligation in the context of the arrangement. Prior to adoption, the upfront payment had been initially recorded as deferred revenue and was being recognized into revenue on a straight-line basis. As a result, upon adoption of ASC&#160;606, we adjusted our accumulated deficit for the effects of recognizing revenue upfront for the initial milestone. The adjustment to accumulated deficit upon adoption was not material.</p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The license agreements may include nonrefundable upfront payments, event-based milestone payments, sales-based royalty payments, or some combination of these. The event-based milestone payments represent variable consideration and we use the most likely amount method to estimate this variable consideration. Given the high degree of uncertainly around achievement of these milestones, we do not recognize revenue from these milestone payments until the uncertainty associated with these payments is resolved. We currently estimate variable consideration related to milestone payments to be zero and, as such, no revenue has been recognized for milestone payments. We recognize revenue from sales-based royalty payments when or as the sales occur. On a quarterly basis, we re-evaluate our estimate of milestone variable consideration to determine whether any amount should be included in the transaction price and recorded in revenue prospectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption, we changed our accounting policy from accounting for milestones payments under the milestone method to accounting for variable consideration as discussed above. The change in accounting policy did not change any amounts in the financial statements because of the significant uncertainty surrounding the estimate of variable consideration for milestone payments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have no products approved for commercial sale and we have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Costs</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation</span>, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expense legal fees as they are incurred.</p>


<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income or loss is composed of net income (loss) and other comprehensive income (loss). Our other comprehensive income or loss consists of unrealized gains and losses on marketable debt securities classified as available-for-sale, net of income taxes.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and Diluted Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all periods presented, potentially dilutive securities are excluded from the computation of fully diluted loss per share as their effect is anti-dilutive. The following table details those securities that have been excluded from the computation of potentially dilutive securities:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,506,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,493,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,139,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">867,911</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding warrants</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,589,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,984,852</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,646,378</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,950,411</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts in the table above reflect the common stock equivalents of the noted instruments.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment and Geographic Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating segments are defined as components of an enterprise (business activity from which it earns revenue and incurs expenses) for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the company&#8217;s CEO. We view our operations and manage our business as a single operating and reporting segment. As of December&#160;31, 2020 and 2019, the majority of our assets were held in the U.S. For the years ended December&#160;31, 2020, 2019 and 2018, all of our revenue was derived in the U.S.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, the FASB issued Accounting Standards Update, or ASU, No.&#160;2018-18, <span style="font-style:italic;">Collaborative Arrangements&#160;(Topic&#160;808):&#160;Clarifying the Interaction between Topic&#160;808 and Topic&#160;606</span> (ASU&#160;2018-18). ASU&#160;2018-18 clarifies when certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic&#160;606. It also specifically addresses when the participant should be considered a customer in the context of a unit of account; adds unit of account guidance in ASC&#160;808 to align with guidance in ASC&#160;606; and precludes presenting revenue from a collaborative arrangement together with revenue recognized under ASC&#160;606 if the collaborative arrangement participant is not a customer. This standard is effective for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years with early adoption permitted. We adopted ASU&#160;2018-18, as required, in the quarter ended March&#160;31, 2020. We are a party to several collaboration arrangements as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, however, adoption of ASU&#160;2018-18 did not have an impact on our consolidated financial statements because the counterparties to our collaboration agreements do not meet the definition of a customer.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December&#160;2019, the FASB issued ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12,&#160;</span><span style="font-style:italic;">Simplifying the Accounting for Income Taxes</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12. The amendments in ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 include removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (e.g., discontinued operations or other comprehensive income), and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 also amends other aspects of accounting for income taxes to help simplify and promote consistent application of U.S.&#160;GAAP. The guidance is effective for interim and annual periods beginning after December&#160;15, 2020, with early adoption permitted. We early adopted ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 effective January&#160;1, 2020, and it did not have a material impact on our consolidated financial statements. Although our adoption of ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 did not have a material impact on our consolidated financial statements during the year ended December&#160;31, 2020, it may have a material impact on our consolidated financial statements in future periods due to the removal of the exceptions discussed above. The amendments related to intraperiod tax allocation and the amendment related to calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applied prospectively.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Not Yet Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, the FASB issued ASU&#160;2016&#8209;13,&#160;<span style="font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments</span>. The FASB subsequently issued amendments to ASU&#160;2016&#8209;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. For public business entities that meet the definition of a Securities and Exchange Commission, or SEC, filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December&#160;15, 2018. With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We continue to evaluate the impact that this new standard and its related amendments will have on our consolidated financial statements and we do not intend to early adopt this new standard.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583411288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Financial Statement Details</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3. &#160;&#160;&#160;&#160;Financial Statement Details</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, prepaid expenses and other current assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,626</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance premium financing asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">757</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">657</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">372</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">440</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid rent</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">589</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest receivable - marketable debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">473</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid supplies - with related party (Note 10)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">467</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid equipment maintenance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid license fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related parties</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance claim receivables</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,285</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,105</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property, plant and equipment, net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, property, plant and equipment, net, consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,406</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,069</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,434</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,690</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,690</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &amp; fixtures</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">415</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">383</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,044</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,108</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,117</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,607</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,927</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense related to property, plant and equipment was $9.1&#160;million, $8.4&#160;million and $7.3&#160;million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Intangible assets, net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our intangible assets were fully amortized as of March&#160;31, 2019. Amortization expense was $0.6&#160;million and $2.3&#160;million for the years ended December&#160;31, 2019 and 2018, respectively, and is included in research and development expense on the consolidated statements of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Security deposits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid software license fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,075</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related party</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,121</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,386</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash is comprised of a certificate of deposit that serves as collateral for a letter of credit required by our landlord as a security deposit related to our facility in San Diego, California.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, accrued expenses consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and service fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,920</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">975</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued bonus</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,236</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,002</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,368</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,064</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued laboratory equipment and supplies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">640</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued preclinical and clinical trial costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">638</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued capital expenditures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">337</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued franchise, sales/use and property taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other current liabilities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other current liabilities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing obligation - current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">757</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,438</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investment income, net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net investment income included the following for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,643</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,317</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment (amortization expense) accretion income, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(858</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net realized (losses) gains on investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,642</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,857</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income includes interest from marketable debt securities, notes receivable, other assets, and interest from bank deposits. We did not recognize an impairment loss on any investments during the years ended December&#160;31, 2020, 2019 and 2018.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583403832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement and Plan of Merger with ImmunityBio<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember', window );">Proposed Merger With ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Agreement and Plan of Merger with ImmunityBio</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4. &#160;&#160;&#160;&#160;Agreement and Plan of Merger with ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;21, 2020, NantKwest and ImmunityBio, Inc.&#160;(ImmunityBio) entered into an Agreement and Plan of Merger&#160;(the Merger Agreement), pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The Merger Agreement provides that a wholly owned subsidiary of NantKwest will merge with and into ImmunityBio&#160;(the Merger), with ImmunityBio continuing as the surviving company and being renamed NantCell,&#160;Inc., upon the terms and subject to the conditions therein. At the effective time of the Merger&#160;(the Effective Time), NantKwest&#8217;s name, as the parent of NantCell,&#160;Inc., will be changed to &#8220;ImmunityBio, Inc.&#8221;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Effective Time, each share of ImmunityBio common stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions as set forth in the Merger Agreement, will be converted automatically into a right to receive&#160;0.8190&#160;shares of NantKwest common stock. At the Effective Time, each share of NantKwest common stock issued and outstanding immediately prior to the Effective Time, will remain an issued and outstanding share of the combined company. At the Effective Time, each outstanding option, warrant or restricted stock unit to purchase ImmunityBio common stock will be converted (using the merger exchange ratio of 0.8190) into an option, warrant or restricted stock unit, respectively, on the same terms and conditions immediately prior to the Effective Time, to purchase shares of common stock of the combined company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon consummation of the Merger, on a fully-diluted basis, ImmunityBio stockholders and NantKwest stockholders will own approximately 72% and 28%, respectively, of the outstanding shares of common stock of the combined company. It is estimated that, immediately following the closing date, Dr.&#160;Patrick Soon-Shiong, our Executive Chairman and principal stockholder, and his affiliates will beneficially own, in the aggregate, approximately 82% of the common stock of the combined company. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following consummation of the Merger, shares of common stock of the combined company are expected to be listed on the Nasdaq Global Select Market under the symbol &#8220;IBRX&#8221;.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms and subject to the conditions set forth in the Merger Agreement, the closing of the Merger depends on a number of conditions being satisfied, including approval of the Merger by holders of a majority of the outstanding shares of NantKwest common stock as of the NantKwest record date (excluding all shares of NantKwest common stock beneficially owned by Dr.&#160;Patrick Soon&#8209;Shiong and his affiliates Cambridge Equities,&#160;LP and Chan Soon&#8209;Shiong Family Foundation or any of their respective controlled affiliates or any of the directors or executive officers of NantKwest or ImmunityBio).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February&#160;1, 2021, our Registration Statement on Form&#160;S-4, which was filed with the Securities and Exchange Commission (SEC) in connection with the Merger, was declared effective by the SEC.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A special meeting of the stockholders of NantKwest will be held on March&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to consider and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">vot</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on a proposal to approve the issuance of shares of common stock of NantKwest to security holders of ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to consider and vote </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on a proposal to approve the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">M</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erger.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Only holders of record of NantKwest common stock at the close of January&#160;29, 2021, will be entitled to notice of and to vote at the special meeting.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect the Merger to close in the first quarter of 2021, subject to receipt of the requisite stockholder approvals and satisfaction of other customary closing conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger is expected to be accounted for as a transaction between entities under common control as Dr.&#160;Patrick Soon-Shiong is the controlling stockholder of each of NantKwest and ImmunityBio. Upon the closing of the Merger, the net assets of ImmunityBio will be combined with those of NantKwest at their historical carrying amounts and the companies will be presented on a combined basis for all historical periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, we incurred costs of $6.2&#160;million in connection with our proposed merger with ImmunityBio, consisting of financial advisory, legal and other professional fees.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663852104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Viracta Investment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock', window );">Viracta Investment</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5. &#160;&#160;&#160;&#160;Viracta Investment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2017, we participated in a Series&#160;B convertible preferred stock financing and invested $8.5&#160;million in Viracta Therapeutics, Inc., or Viracta, a clinical stage drug development company, which was initially recorded at cost. In May&#160;2017, we executed an exclusive worldwide license with Viracta to develop and commercialize Viracta&#8217;s proprietary histone deacetylase inhibitor drug candidate for use in combination with natural killer cell therapy and possibly additional therapies. See Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements &#8211; Royalties and In-licensing Agreements &#8211; Viracta License Agreement</span>, for further information.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2018, Viracta executed a 2018&#160;Note and Warrant Purchase Agreement with existing and new investors, including us. The initial closing under the Purchase Agreement occurred in June&#160;2018, at which point we purchased a convertible note for $0.4&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#8217;s common shares. The convertible note accrued interest at 8% and had a <span style="-sec-ix-hidden:F_000684">one-year</span> maturity date. In September&#160;2018, a milestone closing under the Purchase Agreement occurred, at which point we purchased an additional convertible note for $0.4&#160;million, which under certain circumstances was convertible into preferred stock of Viracta, and a warrant to purchase Viracta&#8217;s common shares. The convertible note accrued interest at 8% and had a <span style="-sec-ix-hidden:F_000685">one-year</span> maturity date. We classified the convertible notes as held-to-maturity notes receivable on the consolidated balance sheets. Effective January&#160;31, 2019, the notes, together with accrued interest then outstanding, were converted to Series&#160;B preferred stock resulting in an increase to our investment in Viracta&#8217;s Series&#160;B convertible preferred stock of $0.8&#160;million. In May&#160;2019, we exercised warrants to acquire 253,120&#160;shares of Viracta common stock.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the level of equity investment at risk, Viracta is not a VIE and therefore is not consolidated under the VIE model. In addition, we do not hold a controlling financial interest in Viracta, and therefore we do not consolidate Viracta under the voting interest model. As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, we have elected to apply the measurement alternative under ASC&#160;321, pursuant to which we measure our investment in Viracta at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, our fair value assessment indicated that the recent offering of Viracta&#8217;s Series&#160;E preferred shares, at a lower offering price per share than the per share carrying amount of our investment in Viracta, is a directional indicator representing an observable price change in an orderly transaction for a similar investment. On December&#160;31, 2020, we reduced the carrying value by $1.4&#160;million due to the observable price change, which has been included in other income and expense, net, on the consolidated statements of operations. On a cumulative basis, we have recognized a reduction in carrying value of $1.4&#160;million. At December&#160;31, 2020, the carrying value of our investment in Viracta, which is reflected in equity investment on the consolidated balance sheets, totaled $7.8&#160;million.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395740853496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CashEquivalentsAndMarketableSecuritiesAbstract', window );"><strong>Cash Equivalents And Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Financial Instruments Investments in Marketable Debt Securities</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6. &#160;&#160;&#160;&#160;Financial Instruments &#8211; Investments in Marketable Debt Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000703">0.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000704">0.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">0.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2019, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,752</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,144</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,501</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,642</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated unrealized losses on debt securities classified as available-for-sale that have been in a continuous loss position for less than <span style="-sec-ix-hidden:F_000734"><span style="-sec-ix-hidden:F_000736">12&#160;months and for more than 12&#160;months</span></span> at December&#160;31, 2020 and 2019, were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,762</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,245</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, 34 of the securities were in an unrealized loss position. We evaluated our securities for other-than-temporary impairment and concluded that the decline in value was primarily caused by current economic and market conditions. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases. Therefore, we did not recognize any other-than-temporary impairment loss during the years ended December&#160;31, 2020, 2019 and 2018.</p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized realized gains and losses on sales of available-for-sale debt securities as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains (Losses)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_CashEquivalentsAndMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_CashEquivalentsAndMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583424600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7. &#160;&#160;&#160;&#160;Fair Value Measurements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as an exit price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Authoritative guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recurring Valuations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities measured at fair value on a recurring basis are summarized below at December&#160;31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,149</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Non-recurring Valuations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-financial assets and liabilities are recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. There were no material non-financial assets and liabilities deemed to be other-than-temporarily impaired and measured at fair value on a non-recurring basis for the years ended December&#160;31, 2020, 2019 and 2018.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583386456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CollaborationAndLicenseAgreementsTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8. &#160;&#160;&#160;&#160;Collaboration and License Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaborative Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are&#160;(i)&#160;active participants in the activity, and (ii)&#160;exposed to significant risks and rewards dependent on the commercial success of the activity.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into the following collaborative arrangements with ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inc., </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as described below. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio is a related party, as it is </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Joint COVID&#8209;19 Collaboration Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a definitive agreement, which we refer to as the Collaboration Agreement, with ImmunityBio to pursue collaborative joint development, manufacturing and marketing of certain COVID&#8209;19 therapeutics and vaccines. The terms of the Collaboration Agreement supersede and replace the terms of the binding term sheet executed on May&#160;22, 2020. Through their efforts, the parties agreed to jointly develop ceNK, haNK, mesenchymal stem cells&#160;(MSC), adenovirus constructs&#160;(hAd5), and N&#8209;803, a novel IL&#8209;15 superagonist fusion protein, for the prevention and treatment of SARS&#8209;CoV&#8209;2 viral infections and associated conditions in humans, including without limitation, COVID&#8209;19. Pursuant to the Collaboration Agreement, we have contributed our ceNK, haNK, and MSC product candidates and certain of our manufacturing capabilities, and ImmunityBio has contributed their hAd5 and N&#8209;803 product candidates. hAd5 has been developed as a vaccine, and ceNK, haNK, MSC and N&#8209;803 have each been developed as therapeutics for treating COVID&#8209;19 at various stages of infection.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From and after the effective date of the Collaboration Agreement, the parties will share equally in all costs relating to developing and manufacturing of the product candidates globally with the exception of certain laboratory equipment purchases that will be borne solely by us. With the exception of N&#8209;803, we will be primarily responsible for the manufacture of each product. Each party will be responsible for the regulatory affairs and the commercialization relating to its contributed products. The global net profits from the collaboration products will be shared 60%/40% in favor of the party contributing the product on which the sales are based except if the parties mutually agree because of certain circumstances. All net profits from sales of combined collaboration products will be shared equally. This collaboration is supervised by a joint steering committee, which is comprised of an equal number of representatives from both parties. The term of the agreement will be <span style="-sec-ix-hidden:F_000806">five&#160;years</span> and it is renewable for an additional <span style="-sec-ix-hidden:F_000807">five&#160;year</span> period upon mutual agreement. Each party will also have a right to terminate in the event of material breach, bankruptcy, or insolvency.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December&#160;31, 2020, joint research activity under the Collaboration Agreement totaled $8.4&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $5.0&#160;million to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#8209;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#8209;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $3.3&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cost Sharing Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio and its subsidiaries to co-sponsor and conduct certain combination clinical trials (each a Joint Study) pursuant to clinical trial protocols wherein at least one investigational agent is a proprietary therapeutic drug candidate owned or controlled by NantKwest and at least one other investigational agent is a proprietary therapeutic drug candidate owned or controlled by ImmunityBio. Prior to initiating any activities for a Joint Study the parties agreed to enter into written work orders describing, amongst other things, development and management responsibilities, allocation of Joint Study costs and expenses, regulatory responsibilities, and any other matters relating to the Joint Study.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Cost Allocation Agreement, each of ImmunityBio and the company will receive exclusive rights to any new intellectual property developed that relates solely to its respective study drug, and the parties will have joint co-equal rights in any other intellectual property. The Cost Allocation Agreement expires on June&#160;22, 2022 with the option to renew for additional successive <span style="-sec-ix-hidden:F_000812">one-year</span> terms, but work orders for any joint studies still in process at the time of termination will continue until the applicable study is completed.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and ImmunityBio are splitting certain costs related to these joint studies equally in accordance with the terms of the Cost Allocation Agreement and related work orders. Shared Joint Study costs include cost related to conducting the Joint Study development activities, such as personnel related costs, as well as all costs associated with regulatory matters. Costs and expenses incurred in connection with the development, manufacturing, supply, delivery, and pre-patient administration dosing mechanism of each party&#8217;s study drug, are excluded from the shared Joint Study costs.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we executed Work Order Number One with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number One, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the parties </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> conduct</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ing</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a clinical trial pursuant to the protocol titled QUILT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.063:</span><span style="font-style:italic;">&#160;A phase&#160;2 study of combination therapy with an IL</span><span style="font-style:italic;">&#8209;</span><span style="font-style:italic;">15 superagonist&#160;(N</span><span style="font-style:italic;">&#8209;803), off-the-shelf CD16</span><span style="font-style:italic;">&#8209;targeted natural killer cells&#160;(haNK), and avelumab without cytotoxic chemotherapy in subjects with Merkel Cell Carcinoma&#160;(MCC) that has progressed on or after treatment with a checkpoint inhibitor</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The ImmunityBio study drug included in th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">J</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oint </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tudy is ImmunityBio&#8217;s proprietary IL</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15 superagonist known as N</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">803</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and our study drug is our proprietary </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">off-the-shelf</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> CD16-targeted natural kil</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ler cell therapy known as haNK. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the sponsor of this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">J</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oint </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tudy for purposes of regulatory matters, including submissions, correspondence, and communications. Additionally, we are </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designated as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the contracting party to execute agreements with third and related part</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ies relating to the Joint Study</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2020, but effective on June&#160;22, 2020, we executed Work Order Number Two with ImmunityBio, pursuant to the Cost Allocation Agreement. Under Work Order Number Two, the parties are conducting a clinical trial pursuant to the protocol titled QUILT&#160;88:&#160;<span style="font-style:italic;">Open-label, randomized, comparative phase&#160;2 study of combination immunotherapy with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer</span>. The ImmunityBio study drugs included in the joint study are ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist&#160;(N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin), and our study drug is PD&#8209;L1.t&#8209;haNK. ImmunityBio is the sponsor of this Joint Study for purposes of regulatory matters, including submissions, correspondence, and communications with the FDA. Additionally, ImmunityBio is designated as the contracting party to execute agreements with third and related parties relating to this Joint Study.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $1.1&#160;million and $35,700, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, we owed ImmunityBio $0.3&#160;million related to the Cost Allocation Agreement. As of December&#160;31, 2019, no balances were due between the parties with respect to the Cost Allocation Agreement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Royalties and In-licensing Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Viracta License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May&#160;2017, we entered into an agreement with Viracta under which we were granted exclusive worldwide rights to Viracta&#8217;s phase&#160;II drug candidate, VRx&#8209;3996, for use in combination with our platform of NK&#160;cell therapies. In consideration for the license, we are obligated to pay to Viracta&#160;(i)&#160;mid-single digit percentage royalties of net sales of licensed products for therapeutic use; and (ii)&#160;milestone payments ranging from $10.0&#160;million to $25.0&#160;million for various regulatory approvals and cumulative net sales levels. We may terminate the agreement, at our sole discretion, in whole or on a product by product and/or country by country basis, at any time upon 90&#160;days&#8217;&#160;prior written notice. In addition, either party may terminate the agreement in the event of a material breach or for bankruptcy of the other party.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fox Chase Cancer Center License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2004 and amended in 2008, we entered into an exclusive license agreement with Fox Chase Cancer Center, or Fox Chase, for the exclusive, worldwide right to certain patents and know-how pertaining to CD16 receptor bearing NK&#8209;92&#160;cell lines. In consideration for this exclusive license, we agreed to pay Fox Chase&#160;(i)&#160;low single-digit percentage royalties on net sales of licensed products for therapeutic and diagnostic use; and (ii)&#160;mid-twenties percentage royalties on any compensation we receive from sublicensees.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Rush University Medical Center License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2004, we entered into a 12-year licensing agreement with Rush University Medical Center for the exclusive rights to license and grant sublicenses of certain intellectual property related to clinical use of NK&#8209;92. We are required to pay low to mid-single digit percentage royalties on net sales depending upon the various fields of studies and other factors. We were required to pay a minimum annual royalty of $25,000. The Rush University Medical Center License Agreement also provides for payments in the aggregate amount of $2.5&#160;million upon the company achieving various milestones, including upon&#160;(i)&#160;the completion of phase&#160;II clinical trial associated with the licensed intellectual property; (ii)&#160;the approval by the FDA of a new drug application for a licensed product; and (iii)&#160;the first year that sales of the licensed product equals or exceeds $0.3&#160;million. The license had a term of 12&#160;years from 2006, the year in which royalty payments were first made, and included customary termination rights for both parties. Beginning in 2018, this license converted to a perpetual, irrevocable, fully paid, royalty-free, exclusive license. No milestones were met during the years ended December&#160;31, 2020, 2019 and 2018.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Out-Licensing Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Precigen (formerly known as Intrexon) License Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February&#160;2010, we entered into a 17-year license agreement with Precigen Corporation, Inc., or Precigen, pursuant to which we granted to Precigen a non-exclusive, worldwide, sublicensable license to research and sell products under certain patents relating to modified NK&#8209;92&#160;cells that express Precigen&#8217;s proprietary gene sequences for use as a therapeutic and prophylactic agent in humans in specified therapeutic areas. In consideration for the license agreement, Precigen paid us a one-time fee of $0.4&#160;million. Prior to our adoption of ASC&#160;606 at the beginning of 2018, this upfront payment had initially been recorded as deferred revenue and was being recognized into revenue on a straight-line basis. Upon our adoption of ASC&#160;606, we adjusted our accumulated deficit in an amount equal to the then remaining deferred revenue after concluding that under ASC&#160;606 the upfront payment would have been recognized when the license was transferred in 2010. Precigen will pay the following milestone payments:&#160;$0.1&#160;million upon the first IND filing; $0.1&#160;million upon the commencement of the first phase&#160;II clinical trial; $0.4&#160;million upon the commencement of the first phase&#160;III clinical trial; and $0.5&#160;million upon the first commercial sale relating to the licensed products. Precigen is obligated to pay us a low single digit percentage royalty based on net sales of the licensed products by Precigen and a mid-teen percentage royalty based on revenues received by Precigen in connection with sublicenses of the licensed products. No milestone payments were due or received in the years ended December&#160;31, 2020, 2019 and 2018, and, therefore, we did not record any milestone revenue for any of those years on the consolidated statements of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_CollaborationAndLicenseAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_CollaborationAndLicenseAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583413480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9. &#160;&#160;&#160;&#160;Commitments and Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Securities Litigation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, a putative securities class action complaint captioned <span style="font-style:italic;">Sudunagunta v. NantKwest, Inc., et al.</span>, No. 16&#8209;cv&#8209;01947 was filed in federal district court for the Central District of California related to the company&#8217;s restatement of certain interim financial statements for the periods ended June&#160;30, 2015 and September&#160;30, 2015. A number of similar putative class actions were filed in federal and state court in California. The actions originally filed in state court were removed to federal court, and the various related actions were consolidated. Plaintiffs asserted causes of action for alleged violations of Sections&#160;11 and 15 of the Securities Act of 1933 and Sections&#160;10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule&#160;10b&#8209;5 promulgated thereunder. Plaintiffs sought unspecified damages, costs and attorneys&#8217; fees, and equitable/injunctive or other relief on behalf of putative classes of persons who purchased or acquired the company&#8217;s securities during various time periods from July&#160;28, 2015 through March&#160;11, 2016. In September&#160;2017, the court denied defendants' motion to dismiss the third amended consolidated complaint. On August&#160;13, 2018, the district court granted plaintiffs&#8217; motions for class certification and to strike plaintiffs&#8217; claims under the Securities Exchange Act of 1934 and Rule&#160;10b&#8209;5. On August&#160;24, 2018, at the district court&#8217;s direction, plaintiffs filed a fourth amended consolidated complaint. On August&#160;27, 2018, defendants petitioned the U.S. Court of Appeals for the Ninth Circuit to authorize interlocutory appeal of the class certification order. On September&#160;7, 2018, defendants answered the fourth amended consolidated complaint. On September&#160;21, 2018, the parties informed the Ninth Circuit that they had reached a settlement in principle, and the parties moved to stay appellate proceedings. On September&#160;24, 2018, the parties notified the district court that they had reached a settlement in principle. On November&#160;9, 2018, the plaintiffs filed an unopposed motion for preliminary approval of the settlement and notice to class members. On January&#160;9, 2019, the district court granted the motion for preliminary approval. A final approval hearing was held on April&#160;29, 2019, and the district court granted final approval and entered judgment on May&#160;31, 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the settlement, we paid $12.0&#160;million to the plaintiffs as full and complete settlement of the litigation. We were responsible for $1.2&#160;million of the settlement amount, which was recognized in selling, general and administrative expense during the year ended December&#160;31, 2018, while the remaining $10.8&#160;million was fully funded by our insurance carriers under our directors&#8217; and officers&#8217; insurance policy. We and the insurance carriers paid the settlement amount into a settlement fund during the year ended December&#160;31, 2019. Subsequent to receiving final approval of the settlement on May&#160;31, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stipulation of Settlement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In early April&#160;2019, following board approval, we entered into a settlement agreement, or the Stipulation of Settlement, with three&#160;stockholders of the company, each of whom had submitted a stockholder demand for the board to take action to remedy purported harm to the company resulting from certain alleged wrongful conduct concerning, among other things, disclosures about Dr.&#160;Soon-Shiong&#8217;s compensation and a related-party lease agreement. The Stipulation of Settlement called for us to adopt certain governance changes, and for the three&#160;stockholders to file a stockholder derivative action in the Superior Court of the State of California, County of San Diego, followed by an application for court approval of the Stipulation of Settlement. On May&#160;31, 2019, the court entered an order preliminarily approving the Stipulation of Settlement and scheduling the final settlement hearing for August&#160;9, 2019. Pursuant to the Stipulation of Settlement, we have provided stockholders with notice of the settlement and the final settlement hearing.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the Stipulation of Settlement, which received final approval by the court on August&#160;9, 2019, we paid an attorney&#8217;s fee of $0.5&#160;million to the plaintiffs as part of the settlement. Of that amount, we were responsible for half, which was recognized in selling, general and administrative expense on the consolidated statements of operations during the year ended December&#160;31, 2019, while the other half was funded by our insurance carrier. We and the insurance carrier paid the settlement amount into a settlement fund in June&#160;2019. Subsequent to receiving final approval of the settlement on August&#160;9, 2019, the aforementioned settlement accrual, associated insurance claim receivable and restricted cash were released and are no longer reflected on the consolidated balance sheets.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Insurance Recoveries</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have reflected our right to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and receipt is deemed probable. This includes instances where our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund. The amount of such receivable recorded at December&#160;31, 2019 was $34,000, which is included in prepaid expenses and other current assets on our consolidated balance sheets. There were no such receivables recorded as of December&#160;31, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contractual Obligations - Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted the new lease accounting guidance as discussed in further detail in Note&#160;2. The most significant change requires us to record the present value of operating lease payments as right-of-use assets and lease liabilities on our balance sheets. We adopted the new guidance using the simplified transition approach. As a result, reporting periods beginning on January&#160;1, 2019 are presented under the new guidance, while periods prior to January&#160;1, 2019 continue to be reported in accordance with our historical accounting.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adoption of the new lease accounting guidance had a substantial impact on our balance sheet. The most significant impacts were&#160;(1)&#160;the recognition of $13.5&#160;million of operating lease right-of-use assets, net, and $16.4&#160;million of operating lease liabilities, and (2)&#160;the derecognition of assets and liabilities associated with build-to-suit leases under ASC&#160;840, resulting in the derecognition of property, plant and equipment, net, of $6.6&#160;million and net adjustments to related liabilities of $5.7&#160;million). The build-to-suit leases were recorded as normal operating leases under ASC&#160;842. The difference between the excess of build-to-suit related liabilities and assets of $0.9&#160;million was recorded as an increase to our accumulated deficit. The cumulative-effect adjustment had no tax impact due to the valuation allowance against the gross deferred tax asset less reversing deferred tax liabilities. Adoption of this standard had no material impact on our results of operations and cash flows.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Substantially all of our operating lease right-of-use assets and operating lease liabilities relate to facilities leases. As of December&#160;31, 2020, we lease:&#160;(i)&#160;a&#160;research facility and office space in San Diego, California; (ii)&#160;a research and manufacturing space in Culver City, California, from a related party; (iii)&#160;research and manufacturing facilities in El Segundo, California, also from related parties; (iv)&#160;a research facility in Torrance, California, and (v)&#160;a research facility in Woburn, Massachusetts. See Note&#160;10,&#160;<span style="font-style:italic;">Related Party Agreements</span>, for further information.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our leases generally have initial terms ranging from <span style="-sec-ix-hidden:F_000847">two to ten&#160;years</span> and often include one or more options to renew. These renewal terms can extend the lease term from <span style="-sec-ix-hidden:F_000849">one to three&#160;years</span>, and are included in the lease term when it is reasonably certain that we will exercise the option. These operating leases are included in operating lease right-of-use assets, net, on the consolidated balance sheets, and represent the right to use the underlying asset for the lease term. Our obligations to make lease payments are included in current and non-current operating lease liabilities on the consolidated balance sheets.</p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operating right-of-use assets and lease liabilities as of December&#160;31, 2020 and 2019, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease right-of-use assets, net (including amounts</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;with related parties)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,729</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Short-term lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,206</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,814</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,885</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,091</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of lease expense for the years ended December&#160;31, 2020 and 2019 consist of (in&#160;thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,898</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,566</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Total lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,221</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,113</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rental expenses for operating leases during the year ended December&#160;31, 2018, excluding common-area maintenance, was $2.8&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid during the years ended December&#160;31, 2020 and 2019 for amounts included in the measurement of lease liabilities is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating cash flows for operating leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,345</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average remaining lease term as of December&#160;31, 2020 and 2019 was 3.2&#160;years and 4.5&#160;years, respectively. The weighted-average discount rate used in determining the present value of operating lease liabilities as of December&#160;31, 2020 and 2019 was <span>9%</span>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum lease payments as of December&#160;31, 2020, including $3.9&#160;million related to options to extend lease terms that are reasonably certain of being exercised, are presented in the following table (in thousands). Common area maintenance costs and taxes are not included in these payments.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years ending December 31:</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases (a)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,545</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,083</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,115</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,527</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,213</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a related party&#160;(Note&#160;10), whereby we leased approximately 6,901&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional <span style="-sec-ix-hidden:F_000884">one-year</span> term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in <span style="-sec-ix-hidden:F_000888">November&#160;2020</span>. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. At inception of the lease we recognized an increase of $4.0&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August&#160;2018, NantBio, Inc., or NantBio, a&#160;related party (Note&#160;10), assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#8217;s laboratory and vivarium premises. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $0.9&#160;million, and paid $0.5&#160;million directly to the third party for an aggregate value of $1.4&#160;million. The assigned agreement is for a term of <span style="-sec-ix-hidden:F_000892">ten&#160;years</span> and expires in June&#160;2027. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2016, we entered into a lease agreement with 605&#160;Doug St,&#160;LLC, a related party&#160;(Note&#160;10), for approximately 24,250&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional <span style="-sec-ix-hidden:F_000896">three&#160;year</span> term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in <span style="-sec-ix-hidden:F_000899">July&#160;2017</span>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, we entered into a lease agreement for an approximately 7,893&#160;square foot facility in Woburn, Massachusetts, for a research and development laboratory, related office and other related uses. The initial lease term ran for 48&#160;months from April&#160;29, 2016 through May&#160;31, 2020. In June&#160;2016, the lease was amended to add 260&#160;square feet, for a total of 8,153&#160;square feet. Base rent for the initial term of the lease was $19,000&#160;per&#160;month with a $1&#160;per&#160;square foot annual increase on each anniversary date. In August&#160;2019, we exercised our right pursuant to the lease agreement to extend the term of the lease for an additional <span style="-sec-ix-hidden:F_000908">two&#160;years</span> through May&#160;31, 2022. Consequently, in August&#160;2019 we recognized an increase of $0.6&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets. Base rent for the extended term of the lease is $25,800&#160;per&#160;month with an annual increase of 3% on June&#160;1,&#160;2021.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, we entered into a facility license agreement with NantWorks LLC, or NantWorks, a related party&#160;(Note&#160;10), for approximately 9,500&#160;square feet of office space in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. The initial license was effective from May&#160;2015 through December&#160;2020. Base monthly rent for the initial lease term was $47,000, with annual increases of 3% beginning in <span style="-sec-ix-hidden:F_000917">January&#160;2017</span>. In September&#160;2020, we entered into an amendment to extend the term of this lease through December&#160;31, 2021. Commencing on January&#160;1, 2021, the monthly rent will increase by 3% to $54,500. Subsequent to December&#160;31, 2021, the lease term will automatically renew on a month-to-month basis, terminable by either party with at least thirty days&#8217; prior written notice to the other party. In addition, we will have a one-time option to extend the lease term through December&#160;31, 2022. If we exercise the option to extend the lease through December&#160;31, 2022, or continue on a month-to-month basis, the monthly rent will increase by 3% annually commencing on January&#160;1 of each year. On the date of amendment we recognized an increase of $1.2&#160;million in both operating lease right-of-use assets and operating lease liabilities on the consolidated balance sheets, which reflects our belief that we will extend the term of this lease through December&#160;31, 2022.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2015, we entered into a lease agreement for an approximately 44,700&#160;square foot facility in San Diego, California, for a research and development laboratory, related office and other related uses. The term of the lease extends for <span style="-sec-ix-hidden:F_000926">seven&#160;years</span> commencing on August&#160;1, 2016. The base rent is $0.2&#160;million per month with 3% annual increases on each anniversary date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664086232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Agreements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. &#160;&#160;&#160;&#160;Related Party Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Executive Chairman, and principal stockholder, founded and has a controlling interest in NantWorks, which is a collection of multiple companies in the healthcare and technology space. As described below, we have entered into arrangements with NantWorks, and certain affiliates of NantWorks, to facilitate the development of new genetically modified NK&#160;cells for our product pipeline. Affiliates of NantWorks are also affiliates of the company due to the common control by and/or common ownership interest of our Executive Chairman.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantWorks</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the NantWorks shared services agreement executed in November&#160;2015, but effective August&#160;2015, NantWorks provides corporate, general and administrative, manufacturing strategy, research and development, regulatory and clinical trial strategy, and other support services. We are charged for the services at cost plus reasonable allocations for indirect costs that relate to the employees providing the services. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded $2.5&#160;million, $2.1&#160;million and $2.8&#160;million, respectively, in selling, general and administrative expense, and $1.5&#160;million, $1.5&#160;million and $3.3&#160;million, respectively, in research and development expense under this arrangement on the consolidated statements of operations. These amounts exclude certain general and administrative expenses provided by third party vendors directly for our benefit, which have been reimbursed to NantWorks based on those vendors&#8217; invoiced amounts without markup by NantWorks.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, we amended the existing shared services agreement with NantWorks whereby we can provide support services to NantWorks and/or any of its affiliates. For the years ended December&#160;31, 2020, 2019 and 2018, we recorded expense reimbursements of $1.4&#160;million, $1.2&#160;million and $0.6&#160;million, respectively, in selling, general and administrative expense and $1.6&#160;million, $2.3&#160;million and $2.6&#160;million, respectively, in research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020 and 2019, we owed NantWorks a net amount of $1.2&#160;million and $0.4&#160;million, respectively, for all agreements between the two affiliates, which is included in due to related parties on the consolidated balance sheets.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, we entered into a facility license agreement with NantWorks, which became effective in May&#160;2015, for approximately 9,500&#160;square feet in Culver City, California, which has been converted to a research and development laboratory and a cGMP manufacturing facility. In September&#160;2020, we amended this agreement to extend the term of this lease through December&#160;31, 2021, as further described in Note&#160;9,&#160;<span style="font-style:italic;">Commitments and Contingencies</span>. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.6&#160;million, $0.6&#160;million, and $0.2&#160;million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Immuno-Oncology Clinic, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning in 2017, we entered into multiple agreements with Immuno-Oncology Clinic, Inc., or the Clinic (dba&#160;Chan Soon-Shiong Institutes for Medicine, in El Segundo, California), to conduct clinical trials related to certain of our product candidates. The Clinic is a related party as it is owned by one officer of NantKwest and NantWorks manages the administrative operations of the Clinic. Prior to June&#160;30, 2019, one of the company&#8217;s officers was an investigator or sub-investigator for all of the company&#8217;s trials conducted at the Clinic.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we entered into a new agreement with the Clinic (the Clinic Agreement), which became effective on July&#160;1, 2019. The Clinic Agreement, as amended on March&#160;31, 2020, covers clinical trial and research related activities on a non-exclusive basis relating to our existing clinical trials, commenced prior to July&#160;1, 2019, and prospective clinical trials and research projects. The Clinic Agreement also specifies certain services and related costs that are excluded from the Clinic Agreement. Prior to commencing any work under the Clinic Agreement, the parties have agreed to execute written work orders setting forth the terms and conditions related to specific services to be performed, including financial terms. For clinical trials that commenced prior to July&#160;1, 2019, fees incurred for services performed after July&#160;1, 2019 are covered under the Clinic Agreement and applied towards the below-mentioned prepayments. The Clinic Agreement allows for an automatic renewal and additional extensions beyond the initial <span style="-sec-ix-hidden:F_000953">one&#160;year</span> term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In consideration of the services to be performed under the Clinic Agreement, as amended on March&#160;31, 2020, we agreed to make payments of up to $7.5&#160;million to the Clinic, of which $3.75&#160;million and $1.875&#160;million were paid in July&#160;2019 and October&#160;2019, respectively. As amended, a conditional payment of $1.875&#160;million shall be due and payable at such time, if any, that the payments made in July&#160;2019 and October&#160;2019 have been earned by the Clinic through performance of services. On a quarterly basis, our prepayment is increased by an interest credit computed in accordance with terms specified in the Clinic Agreement.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to&#160;(i)&#160;not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)&#160;extend the term of the Clinic Agreement for up to three additional one&#160;year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within 60&#160;days of expiration. The Clinic may terminate this agreement upon each anniversary date upon sixty&#160;(60)&#160;days prior written notice and reimbursement in full to us of any outstanding unearned balance of the prepayments, provided that any such termination by the Clinic will not apply with respect to any work orders still in effect at the time of such termination.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2019, we executed a clinical trial work order under the Clinic Agreement for an open-label, phase&#160;I study of PD&#8209;L1.t&#8209;haNK for infusion in subjects with locally advanced or metastatic solid cancers. In July&#160;2020, but effective on June&#160;22, 2020, we and ImmunityBio executed a clinical trial work order under our existing master agreement with the Clinic for an open-label, randomized, comparative phase&#160;II study of ImmunityBio&#8217;s proprietary IL&#8209;15 superagonist (N&#8209;803) and Aldoxorubicin Hydrochloride&#160;(Aldoxorubicin) and our PD&#8209;L1.t&#8209;haNK with standard-of-care chemotherapy versus standard-of-care chemotherapy for first and second line treatment of locally or advanced metastatic pancreatic cancer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, $0.6&#160;million, $1.1&#160;million, and $2.7&#160;million, respectively, was recognized in research and development expense on the consolidated statements of operations related to clinical trial and research related activities conducted for us by the Clinic. As of December&#160;31, 2020 and 2019, we owed the Clinic $0.3&#160;million and $0.1&#160;million, respectively, for services excluded from the Clinic Agreement, which are included in due to related parties on the consolidated balance sheets. As of December&#160;31, 2020 and 2019, we had prepaid balances related to the Clinic Agreement of $4.7&#160;million and $5.1&#160;million, respectively, which are included in prepaid expenses and other currents assets, and other assets, on the consolidated balance sheets. We anticipate that the remaining prepayment amount as of December&#160;31, 2020 will be utilized in future periods as the Clinic provides additional services pursuant to the Clinic Agreement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">ImmunityBio</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ImmunityBio, Inc., or ImmunityBio, is a related party, as it is controlled by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;21, 2020, we entered into a merger agreement with ImmunityBio pursuant to which NantKwest and ImmunityBio agreed to combine their businesses. The proposed merger is discussed in additional detail in Note&#160;4, <span style="font-style:italic;">Agreement and Plan of Merger with ImmunityBio</span>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2020, we entered into a sublease agreement with Altor Bioscience Manufacturing Company, LLC, a subsidiary of ImmunityBio, whereby we leased approximately 6,901&#160;square feet in El Segundo, California, including laboratory space and related furniture, fixtures and equipment. The agreement also includes certain non-lease components related primarily to the right to use certain common areas within the building and the related furniture and fixtures. This facility will be used to manufacture and produce clinical products for our oncology product candidate trials. The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in November&#160;2020. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses. Lease expense for this facility is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million during the year ended December&#160;31, 2020. As of December&#160;31, 2020, we owed $0.1&#160;million under this agreement related to variable lease costs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August&#160;21, 2020, we entered into a Collaboration Agreement with ImmunityBio as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>. As of December&#160;31, 2020, the joint research activity under the Collaboration Agreement totaled $8.4&#160;million, which has been included in research and development expense on the consolidated statements of operations. Expenses incurred during the year ended December&#160;31, 2020 were primarily related to purchases of equipment of $5.0&#160;million, to be utilized in the manufacture of the hAd5 COVID&#8209;19 vaccine candidate, and net program related costs of $3.4&#160;million, after applying the eligible cost sharing under the Collaboration Agreement. Certain equipment purchases made by us during the year ended December&#160;31, 2020, which are necessary for us to fulfil our manufacturing obligations related to the COVID&#8209;19 program, were borne solely by us. The equipment purchases do not have an alternative use and were therefore expensed as incurred within research and development expenses. Prior to the effective date of the Collaboration Agreement, COVID&#8209;19 related program costs incurred by us and ImmunityBio, including expenditures related to property, plant and equipment, were the responsibility of each party and not subject to the equal cost sharing. As of December&#160;31, 2020, we owed ImmunityBio $3.3&#160;million for net costs incurred under the Collaboration Agreement, which has been included in due to related parties on the consolidated balance sheets.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January&#160;2020, but effective on October&#160;1, 2019, we entered into a Cost Allocation Agreement with ImmunityBio, which (together with related work orders) is described further in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>. During the years ended December&#160;31, 2020 and 2019, we incurred net costs of $1.1&#160;million and $35,700, respectively, after applying the eligible costs sharing under the Cost Allocation Agreement, which have been recognized in research and development expense on the consolidated statements of operations. As of December&#160;31, 2020, our balance owed to ImmunityBio related to the Cost Allocation Agreement was $0.3&#160;million. As of December&#160;31, 2019, no balances were due between the parties with respect to the Cost Allocation Agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, we entered into an agreement with Etubics Corporation, or Etubics, a subsidiary of ImmunityBio. Pursuant to this agreement we sold used laboratory equipment to Etubics for $0.3&#160;million. In conjunction with this sale, we recognized a loss on disposal of related laboratory equipment of $0.1&#160;million, which was included in other income, net on the consolidated statements of operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2015, we entered into a supply agreement with ImmunityBio pursuant to which we have the right to purchase ImmunityBio&#8217;s proprietary bioreactors, made according to specifications mutually agreed to with ImmunityBio. We also have the right to purchase reagents and consumables associated with such equipment from ImmunityBio. When an upfront payment is made, it is included in prepaid expenses on the consolidated balance sheets until the product is received. The agreement had an initial term of <span style="-sec-ix-hidden:F_000982">five&#160;years</span> and renews automatically for successive <span style="-sec-ix-hidden:F_000983">one-year</span> periods unless terminated earlier.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020 and 2019, we had $3.2&#160;million and $1.8&#160;million, respectively, in equipment purchased from ImmunityBio pursuant to our supply agreement, which has been included in property, plant and equipment, net, on the consolidated balance sheets. During the years ended December&#160;31, 2020, 2019 and 2018, we recorded research and development expense associated with reagents and consumables purchased from ImmunityBio pursuant to our supply agreement of $0.3&#160;million, $0.1&#160;million and $0.1&#160;million, respectively, on the consolidated statements of operations. At December&#160;31, 2020 and 2019, we had $0.1&#160;million and $0.5&#160;million, respectively, included in prepaid expenses and other current assets on the consolidated balance sheets related to consumables purchased from ImmunityBio.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">605&#160;Doug&#160;St,&#160;LLC</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September&#160;2016, we entered into a lease agreement with 605&#160;Doug&#160;St,&#160;LLC, an entity owned by our Executive Chairman, and principal stockholder, for approximately 24,250&#160;square feet in El Segundo, California, which has been converted to a research and development laboratory and a cGMP laboratory manufacturing facility. The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional three-year term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in <span style="-sec-ix-hidden:F_000995">July&#160;2017</span>. Lease expense for this facility for the years ended December&#160;31, 2020, 2019 and 2018, is recorded in research and development expense on the consolidated statements of operations and was $0.9&#160;million, $0.9&#160;million and $0.2&#160;million, respectively. At December&#160;31, 2020 and 2019, no balances were due between the parties.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantBio, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August&#160;2018, NantBio assigned an agreement to us for the use of a third-party research facility, which provides us with the exclusive right to use and access to a portion of the third party&#8217;s laboratory and vivarium premises. NantBio is a related party as it is an affiliate of NantWorks. In conjunction with the assignment, we reimbursed NantBio for upfront payments which it had made to the third party of $0.9&#160;million and paid $0.5&#160;million directly to the third party for an aggregate value of $1.4&#160;million. The assigned agreement is for a term of <span style="-sec-ix-hidden:F_001004">ten&#160;years</span> and expires in June&#160;2027. The agreement may be terminated by us at any time, with or without cause. In case of termination of the agreement, the third party will reimburse us for a pro-rata amount based upon the passage of time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2016, NantBio and the National Cancer Institute entered into a cooperative research and development agreement. The initial <span style="-sec-ix-hidden:F_001006">five-year</span> agreement covers NantBio and its affiliates, including us. Under the agreement, the parties are collaborating on the preclinical and clinical development of proprietary recombinant natural killer cells and monoclonal antibodies in monotherapy and in combination immunotherapies. We benefited from the preclinical and clinical research conducted during the first four years under this agreement. In each of the contractual years under the agreement we paid $0.6&#160;million to the National Cancer Institute as a prepayment for services under the agreement. We recognize research and development expense related to this agreement ratably over a 12-month period for each funding year and recorded $0.6&#160;million of expense related to this agreement in each of the years ended December&#160;31, 2020, 2019 and 2018. At December&#160;31, 2020 and 2019, we had balances of $0.1&#160;million and $0.1&#160;million, respectively, included in prepaid expenses and other current assets related to this agreement on the consolidated balance sheets.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">NantHealth Labs, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2018, we entered into an agreement with NantHealth Labs, Inc., or NantHealth Labs, to obtain blood-based tumor profiling services. NantHealth Labs is a related party, as it is a wholly owned subsidiary of NantHealth, Inc., a majority owned subsidiary of NantWorks. We are obligated to pay NantHealth Labs fixed, per-patient fees. The agreement has an initial term of <span style="-sec-ix-hidden:F_001018">five&#160;years</span> and renews automatically for successive <span style="-sec-ix-hidden:F_001019">one-year</span> periods, unless terminated earlier. During the years ended December&#160;31, 2019 and 2018, $10,000 and $0.3&#160;million, respectively, has been recognized in research and development expense on the consolidated statements of operations. There were no expenses associated with this agreement during the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, no balances were due between the parties.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664050536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. &#160;&#160;&#160;&#160;Stockholders&#8217; Equity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Issuance of Common Stock &#8211; <span style="font-style:normal;">On June&#160;29, 2020, the company closed an underwritten public offering of an aggregate of 8,521,500&#160;shares of common stock, which included 4,811,500&#160;shares issued to the public at a price of $9.50&#160;per share (which includes 1,111,500&#160;shares sold to the public upon full exercise of the underwriters&#8217; option to purchase additional shares at a public offering price of $9.50&#160;per share), less underwriting discounts and commissions, and 3,710,000&#160;shares issued to our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon-Shiong, at a price of $12.12&#160;per share, less underwriting discounts and commissions. All of the shares were offered by the company. Including the underwriters&#8217; option exercise, the aggregate gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock Repurchase &#8211; <span style="font-style:normal;">In November&#160;2015, the board of directors approved a share repurchase program, or the 2015 Share Repurchase Program, allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015&#160;Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified, or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. The shares are formally retired through board approval upon repurchase.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have repurchased 6,403,489&#160;shares of our common stock under the 2015&#160;Share Repurchase Program at a total cost of $31.7&#160;million. In addition, we have paid $0.1&#160;million of broker commissions on repurchases. We did not repurchase any shares during the year ended December&#160;31, 2020. During the years ended December&#160;31, 2019 and 2018, we repurchased 473,586&#160;shares for $0.5&#160;million and 138,349&#160;shares for $0.2&#160;million, respectively. At December&#160;31, 2020, $18.3&#160;million remained authorized for repurchase under the 2015 Share Repurchase Program.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Common Stock Reserved for Future Issuance</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are authorized to issue up to 500,000,000&#160;shares of our common stock, par value $0.0001&#160;per share at December&#160;31, 2020. As of December&#160;31, 2020, there were 108,726,551&#160;shares of our common stock issued and outstanding.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the common shares reserved for issuance on exercise or vesting of various awards at December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:78.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares reserved for future issuance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,984,852</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583214680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12. &#160;&#160;&#160;&#160;Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2014 Equity Incentive Plan &#8211; <span style="font-style:normal;">In March&#160;2014, the company&#8217;s board of directors and stockholders approved the 2014 Equity Incentive Plan, or 2014&#160;Plan, under which 11,109,000&#160;shares of common stock were reserved for the granting of incentive stock options, within the meaning of Section&#160;422 of the Internal Revenue Code, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and performance awards to employees, directors and consultants. The maximum term of awards granted under the 2014&#160;Plan is <span style="-sec-ix-hidden:F_001052">ten&#160;years</span>. Recipients of stock awards are eligible to purchase shares of our common stock at an exercise price equal to no less than the estimated fair market value of such stock on the date of grant. As of December&#160;31, 2020, there were approximately&#160;1.1&#160;million vested and exercisable options outstanding under the 2014&#160;Plan, and there were no additional shares available for future grant.</span></p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2015 Equity Incentive Plan &#8211; <span style="font-style:normal;">In July&#160;2015, the company&#8217;s board of directors adopted and the company&#8217;s stockholders approved the 2015 Equity Incentive Plan, or 2015&#160;Plan. The 2015&#160;Plan, as amended, permits the grant of incentive stock options to the company&#8217;s employees, and for the grant of non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to the company&#8217;s employees, directors and consultants. The 2015&#160;Plan is the only equity plan of the company available for future grant of equity awards to employees, directors and consultants of the company. In April&#160;2019, the company&#8217;s board of directors adopted, and in June&#160;2019 the company&#8217;s stockholders approved, a first amendment to the 2015&#160;Plan to reserve a further 3,000,000&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. In March&#160;2020, the company&#8217;s board of directors adopted, and in June&#160;2020 the company&#8217;s stockholders approved, a second amendment to the 2015&#160;Plan to reserve a further 3,000,000&#160;shares of common stock for issuance pursuant to the 2015&#160;Plan. As of December&#160;31, 2020, a total of approximately 10.2&#160;million shares of common stock were reserved for issuance pursuant to the 2015&#160;Plan and a total of approximately&#160;7.2&#160;million shares were available for future grant. In addition, the number of shares reserved for future grant under the 2015&#160;Plan include shares subject to stock options granted under the 2014&#160;Plan that expire or terminate without having been exercised in full and shares issued pursuant to awards granted under the 2014&#160;Plan that are forfeited to or repurchased by us (provided that the maximum number of shares that may be added to the 2015&#160;Plan pursuant to this provision is approximately 1.1&#160;million shares as of December&#160;31, 2020).</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents all stock-based compensation as included on the consolidated statements of operations (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants for common stock to an officer</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,817</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,388</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,309</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">629</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">938</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,193</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employee RSUs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">380</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,139</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,627</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense in operating expenses:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">499</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,919</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,128</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,922</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,139</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,627</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock Options</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity and related information under all equity incentive plans for the years ended December&#160;31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,693,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.71</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,920</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001109">5.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">800,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,493,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001110">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,986,300</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,506,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,710</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001111">5.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,272,273</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.89</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116,667</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.93</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,922</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001112">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and Exercisable as of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,868,008</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,509</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001113">4.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, the unrecognized compensation cost related to outstanding stock options was $1.3&#160;million, which is expected to be recognized over a remaining weighted-average period of 0.9&#160;years.</p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the years ended December&#160;31, 2020, 2019 and 2018, there were 166,667, 343,810, and 462,875 stock options vested, respectively, with weighted-average exercises prices of $2.09, $3.51, and $8.45, respectively. The total intrinsic value of stock options exercised during the years ended December&#160;31, 2020, 2019 and 2018 was $12.7&#160;million, $0.2&#160;million and $0.6&#160;million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash proceeds received from stock option exercises for the years ended December&#160;31, 2020, 2019 and 2018 was $1.2&#160;million, $4.1&#160;million and $0, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2019 and 2018, a total of 3,973,614 and 5,577,531 vested and exercisable shares were outstanding, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of options outstanding and vested as of December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Prices</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$0.4213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001143">3.9</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001157">3.9</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$1.7554</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001144">4.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001158">4.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$1.9984</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">262,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001145">4.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">262,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001159">4.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001146">7.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">349,998</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001160">7.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001147">9.4</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001161">&#8212;</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$25.00</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,455,450</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001148">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,455,450</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001162">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001149">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,868,008</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001163">4.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may grant stock options to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#8217;s shared services agreement with NantWorks&#160;(Note&#160;10). The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001164">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 - 6.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96.8%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.9%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average grant date fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$4.64</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.09</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected term was estimated using the average of the contractual term and the weighted-average vesting term of the options. The risk-free interest rate was based on the U.S.&#160;Treasury&#8217;s rates for U.S.&#160;Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. For grants issued during 2020, the expected volatility was estimated based on the historical volatility of our common stock. For grants issued during 2018, the expected volatility was based on a weighted-average calculation of the company&#8217;s common stock together with a peer group of comparable companies whose share prices are publicly available. The assumed dividend yield was based on the company&#8217;s expectation of not paying dividends in the foreseeable future. There were no grants issued during 2019.</p>


<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the restricted stock units, or RSUs, activity under the 2015&#160;Plan:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RSUs</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">888,189</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">487,472</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.57</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(172,330</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.16</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(335,420</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">867,911</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">749,793</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(395,051</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.83</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.29</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,139,428</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.43</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(648,336</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.04</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.47</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.52</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may grant RSUs to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#8217;s shared services agreement with NantWorks (Note&#160;10). During the year ended December&#160;31, 2018, we granted 90,906&#160;RSUs to employees of related companies under our shared services agreement with NantWorks&#160;(Note&#160;10). There were no grants made to non-employees during the years ended December&#160;31, 2020 and 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, there was $0.6&#160;million of unrecognized stock-based compensation expense related to RSUs that is expected to be recognized over a weighted-average period of 1.8&#160;years. Of that amount, $0.6&#160;million of unrecognized expense is related to employee grants with a remaining weighted-average period of 1.9&#160;years and $6,400&#160;of unrecognized expense is related to non-employee grants with a remaining weighted-average period of 0.2&#160;years.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warrants</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the company&#8217;s warrant activity:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,721,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(93,254</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,584</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,589,250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,589,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash proceeds recognized from exercises of warrants during the years ended December&#160;31, 2019 and 2018, were $35.2&#160;million and $0.1&#160;million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No warrants were issued during the years ended December&#160;31, 2020, 2019 and 2018, and as of December&#160;31, 2020 and 2019 there were no warrants outstanding. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395673092312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13. &#160;&#160;&#160;&#160;Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of loss before taxes is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. loss before taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,286</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(94,423</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income (loss) before taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(600</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,306</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,378</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,886</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,729</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit for the years ended December&#160;31, 2020, 2019 and 2018 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.92%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">498</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">506</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components that comprise the company&#8217;s net deferred tax assets at December&#160;31, 2020 and 2019 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,537</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,377</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,536</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,254</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,128</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leases and other accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">451</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,419</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,148</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,965</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,233</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,739</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,409</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,732</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(121,409</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,732</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the federal statutory income tax rate to the company&#8217;s effective income tax rate for the years ended December&#160;31, 2020, 2019 and 2018 is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.08%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax computed at federal statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income taxes, net of federal tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax rate adjustment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(82.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Internal Revenue Code&#160;Sections&#160;382 and 383, annual use of the company's net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a <span style="-sec-ix-hidden:F_001314">three-year</span> period. We completed an Internal Revenue Code&#160;Section&#160;382/383 analysis through March&#160;2019 regarding the limitation of net operating loss and research and development credit carryforwards. As a result, we derecognized a portion of the deferred tax assets for net operating losses and federal and state research and development credits of $0.8&#160;million from our deferred tax asset schedule as of December&#160;31, 2020. There is no impact to tax expense for the derecognition of the net operating losses and federal and state research and development credits due to the valuation allowance recorded against the deferred tax assets. Additionally, we have not recognized the deferred tax asset for research and development credit carryforwards as of December&#160;31, 2020 and 2019 because we are a part of a controlled group of affiliated companies with common ownership and cannot complete our calculation of the credit until the time that all members of the controlled group complete their analysis and calculation of qualified research expenditures.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, we have recorded a full valuation allowance of $121.4&#160;million at December&#160;31, 2020. The change in the valuation allowance for the year ended December&#160;31, 2020 was an increase of $29.7&#160;million which was mainly driven by losses for which the company cannot benefit. The portion of the valuation allowance for deferred tax assets for which subsequently recognized tax benefits will be credited directly to contributed capital is $0.2&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, the company has federal net operating losses, or NOLs, of $389.8&#160;million, state NOLs of $350.3&#160;million, and foreign NOLs of $0.2&#160;million. Of the $389.8&#160;million in federal NOLs, $226.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. Of the $350.3&#160;million in state NOLs, $4.4&#160;million will not expire and will be able to offset 80% of taxable income in future years. The remaining federal NOL carryforwards begin to expire in 2024, the remaining state NOL carryforwards begin to expire in 2030 and the foreign NOL carryforwards begin to expire in 2022. At December&#160;31, 2020, the company also had federal research tax credit carryforwards of $11.1&#160;million and state research tax credits of $7.8&#160;million. The federal research tax credit carryforwards begin to expire in 2034 and certain state research tax credit carryforwards begin to expire in 2031. The California research tax credits can be carried forward indefinitely.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;27, 2020, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, was signed into law in response to the economic challenges facing U.S. businesses. Under the CARES Act, the Internal Revenue Code was amended to allow for federal&#160;NOL carrybacks for <span style="-sec-ix-hidden:F_001337">five&#160;years</span> to offset previous years income, or the federal NOLs can be carried forward indefinitely to offset 100% of taxable income for tax year 2020 and 80% of taxable income for tax years 2021 and thereafter.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the state of California enacted Assembly Bill No.&#160;85&#160;(AB&#160;85) suspending California net operating loss utilization and imposing a cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020, 2021 and 2022. There was no material impact from the provisions of AB&#160;85 in 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes to the amount of unrecognized tax benefits (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,983</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,763</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,413</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in the balance of unrecognized tax benefits at December&#160;31, 2020, is $18.3&#160;million that, if recognized, would not impact our income tax benefit or effective tax rate as long as the deferred tax asset remains subject to a full valuation allowance. We do not expect that the unrecognized tax benefits will change within 12&#160;months of this reporting date. Due to the existence of the valuation allowance, future changes in our unrecognized tax benefits will not impact the company's effective tax rate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not incurred any material interest or penalties as of the current reporting date with respect to income tax matters.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to U.S. federal income tax and various state income taxes. The federal returns for tax years </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> remain open to examination and the state returns remain subject to examination for tax years </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the adoption of ASU&#160;2019&#8209;12 in the first quarter of 2020, as described in Note&#160;2, intraperiod tax allocation rules required us to allocate the provision for income taxes between continuing operations and other categories of earnings, such as other comprehensive income. In periods in which we had a year-to-date pre-tax loss from continuing operations and pre-tax income in other categories of earnings, such as other comprehensive income, we had to allocate the tax provision to the other categories of earnings. We then recorded a related tax benefit in continuing operations. However, with the adoption of ASU&#160;2019&#8209;12, we are no longer required to allocate the tax provision to the other categories of earnings and related benefit to continuing operations under these circumstances.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584740888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summarized Quarterly Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Summarized Quarterly Data (Unaudited)</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">14. &#160;&#160;&#160;&#160;Summarized Quarterly Data (Unaudited)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair statement of the results of the interim periods.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below presents unaudited quarterly data for years ended December&#160;31, 2020 and 2019 (in thousands, except for share and per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,607</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,228</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,995</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,907</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,586</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,927</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,886</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,383</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,092</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,776</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,132</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.30</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,472,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,769,687</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,246,579</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,607,715</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,313</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,077</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,335</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,065</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,885</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,682</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,581</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,261,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,594,355</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,331,695</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,419,166</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395666698840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation And Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">15. &#160;&#160;&#160;&#160;Employee Benefits</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Defined Contribution Benefit Plan &#8211; <span style="font-style:normal;">In December&#160;2015, the company adopted a 401(k) retirement and savings plan, or the 401(k) Plan, covering all employees. The 401(k)&#160;Plan allows employees to make pre- and post-tax contributions up to the maximum allowable amount set by the Internal Revenue Service. The company, at its discretion, may make certain contributions to the 401(k)&#160;Plan. We made contributions of $0.5&#160;million, $0.6&#160;million and $0.5&#160;million during the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Compensated Absences &#8211; <span style="font-style:normal;">Under our vacation policy, salaried employees are provided unlimited vacation leave. Therefore, we do not record an accrual for paid leave related to these employees since we are unable to reasonably estimate the compensated absences that these employees will take.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395574924824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">16. &#160;&#160;&#160;&#160;Subsequent Event</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Related Party Lease Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February&#160;2021, but effective on January&#160;1, 2021, we entered into a lease agreement with 605&#160;Nash, LLC, whereby we leased approximately 6,883&#160;square feet in El&#160;Segundo, California. 605&#160;Nash, LLC is a related party, as it is owned by our Executive Chairman and principal stockholder, Dr.&#160;Patrick Soon&#8209;Shiong. This facility will be used primarily for pharmaceutical development and manufacturing purposes. The lease runs from January&#160;2021 through December&#160;2027, and includes an option to extend the lease for an additional <span style="-sec-ix-hidden:F_001406">three&#160;year</span>&#160;term through <span style="-sec-ix-hidden:F_001405">December&#160;2030</span>. Base rent for the term of the lease is approximately $20,300&#160;per month with an annual increase of 3% on January&#160;1 of each year during the initial term and, if applicable, during the option term. In addition, under the agreement, we are required to pay our share of estimated property taxes and operating expenses, both of which are variable lease expenses.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584046728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LiquidityPolicyTextBlock', window );">Liquidity</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;29, 2020, the company closed an underwritten public offering of common stock as discussed further in Note&#160;11,<span style="font-style:italic;">&#160;Stockholders Equity</span>. Gross proceeds from the offering were $90.7&#160;million, before deducting underwriting discounts, commissions and other offering expenses of $4.4&#160;million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020, the company had an accumulated deficit of $754.6&#160;million. We also had negative cash flow from operations of $70.5&#160;million during the year ended December&#160;31, 2020. The company will likely need additional capital to further fund development of, and seek regulatory approvals for, our product candidates, and to begin to commercialize any approved products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently focused primarily on the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer and viral killing cell lines, and we believe such activities will result in the company&#8217;s continued incurrence of significant research and development and other expenses related to those programs. If the clinical trials for any of the company&#8217;s product candidates fail or produce unsuccessful results and those product candidates do not gain regulatory approval, or if any of our product candidates, if approved, fail to achieve market acceptance, we may never become profitable. Even if the company achieves profitability in the future, it may not be able to sustain profitability in subsequent periods. We intend to cover our future operating expenses through cash and cash equivalents and marketable debt securities on hand and through a combination of equity offerings, debt financings, government or other third party funding, marketing and distribution arrangements and other collaborations, strategic alliances, and licensing arrangements. Additional financing may not be available to us when needed and, if available, financing may not be obtained on terms favorable to the company or its stockholders.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we expect our existing cash, and cash equivalents and marketable debt securities, together with the ability to borrow from affiliated entities, will enable us to fund operations and capital expenditure requirements for at least the next 12&#160;months, we may not have sufficient funds to reach commercialization. Failure to obtain adequate financing when needed may require us to delay, reduce, limit, or terminate some or all of our development programs or future commercialization efforts or grant rights to develop and market product candidates that we might otherwise prefer to develop and market ourselves, which could adversely affect our ability to operate as a going concern. If we raise additional funds from the issuance of equity securities, substantial dilution to existing stockholders may result. If we raise additional funds by incurring debt financing, the terms of the debt may involve significant cash payment obligations, as well as covenants and specific financial ratios that may restrict our ability to operate our business.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S.&#160;GAAP.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared assuming the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of the uncertainty discussed in the Liquidity section of Note&#160;1. As a result of continuing anticipated operating cash outflows, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash, cash equivalents, and investments in marketable debt securities, and our ability to borrow from affiliated entities, will be sufficient to fund operations through at least the next 12&#160;months following the issuance date of the financial statements based primarily upon our Executive Chairman&#8217;s intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt. We may also seek to sell additional equity, through one or more follow-on public offerings, or in separate financings, or obtain a credit facility. However, we may not be able to secure such financing in a timely manner or on favorable terms. Without additional funds, we may choose to delay or reduce our operating or investment expenditures. Further, because of the risk and uncertainties associated with the commercialization of the company&#8217;s product candidates in development, we may need additional funds to meet our needs sooner than planned.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of NantKwest and its wholly owned subsidiaries. All intercompany amounts have been eliminated.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We apply the variable interest model under Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic&#160;810,&#160;<span style="font-style:italic;">Consolidation</span>, to any entity in which we hold an equity investment or to which we have the power to direct the entity's most significant economic activities and the ability to participate in the entity's economics. If the entity is within the scope of the variable interest model and meets the definition of a variable interest entity, or VIE, we consider whether we must consolidate the VIE or provide additional disclosures regarding our involvement with the VIE. If we determine that we are the primary beneficiary of the VIE, we will consolidate the VIE. This analysis is performed at the initial investment in the entity or upon any reconsideration event.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For entities we hold as an equity investment that are not consolidated under the VIE model, we consider whether our investment constitutes ownership of a majority of the voting interests in the entity and therefore should be considered for consolidation under the voting interest model.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unconsolidated equity investments in the common stock or in-substance common stock of an entity under which we are able to exercise significant influence, but not control, are accounted for using the equity method. Our ability to exercise significant influence is generally indicated by ownership of 20 to 50 percent interest in the voting securities of the entity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other unconsolidated equity investments on which we are not able to exercise significant influence will be subsequently measured at fair value with unrealized holding gains and losses included in other income and expense, net, on the consolidated statements of operations. In the instance the equity investment does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, <span style="font-style:italic;">Fair Value Measurement</span>, or ASC&#160;820, we will apply the measurement alternative under ASC&#160;321, <span style="font-style:italic;">Investments&#8212;Equity Securities</span>, or ASC&#160;321, pursuant to which we will measure the investment at its cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We own non-marketable equity securities that are accounted for using the measurement alternative under ASC&#160;321 because the preferred stock held by us is not considered in-substance common stock and such preferred stock does not have a readily determinable fair value. All investments are reviewed for possible impairment on a regular basis. If an investment's fair value is determined to be less than its net carrying value, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an impairment indicator is present include:&#160;the investees&#8217; earnings performance and clinical trial performance, change in the investees&#8217; industry and geographic area in which it operates, offers to purchase or sell the security for a price less than the cost of the investment, issues that raise concerns about the investee's ability to continue as a going concern, and any other information that we may be aware of related to the investment. Factors considered in determining whether an observable price change has occurred include:&#160;the price at which the investee issues equity instruments similar to those of our investment and the rights and preferences of those equity instruments compared to ours.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to valuation of equity-based awards, deferred income taxes and related valuation allowances, preclinical and clinical trial accruals, impairment assessments, the measurement of right-of-use assets and lease liabilities, useful lives of long-lived assets, loss contingencies, fair value measurements, and the assessment of the company&#8217;s ability to fund its operations for at least the next twelve months from the date of issuance of these financial statements. We base our estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the ongoing coronavirus pandemic could have on our significant accounting estimates. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2020, the World Health Organization declared the novel strain of coronavirus disease (SARS&#8209;CoV&#8209;2) outbreak a pandemic. To date, our operations have not been significantly impacted by the pandemic. However, we cannot at this time predict the specific extent, duration, or full impact that this pandemic may have on our financial condition and results of operations, including ongoing and planned clinical trials. More specifically, the pandemic may result in prolonged impacts that we cannot predict at this time and we expect that such uncertainties will continue to exist until such time a vaccine is broadly available and in use. The impact of the pandemic on the financial performance of the company will depend on future developments, including the duration and spread of the outbreak and related governmental advisories and restrictions. These developments and the impact of the ongoing pandemic on the financial markets and the overall economy are highly uncertain. If the financial markets and/or the overall economy are impacted for an extended period, our results may be adversely affected.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accruals for loss contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause a change in the potential amount of the liability recorded or of the range of potential losses disclosed. Moreover, we record gain contingencies only when they are realizable, and the amount is known. Additionally, we record our rights to insurance recoveries, limited to the extent of incurred or probable losses, as a receivable when such recoveries have been agreed to with our third-party insurers and when receipt is deemed probable. This includes instances when our third-party insurers have agreed to pay, on our behalf, certain legal defense costs and settlement amounts directly to applicable law firms and a settlement fund.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are held by one major financial institution in the U.S. and one in Korea. We minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe that we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product candidates developed by us will require approvals or clearances from the U.S. Food and Drug Administration, or FDA, or international regulatory agencies prior to commercial sales. There can be no assurance that any of our product candidates will receive any of the required approvals or clearances. If we were to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on us.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents include highly liquid investments with an original maturity of <span style="-sec-ix-hidden:F_000528">three&#160;months</span> or less from the date of purchase.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash includes a certificate of deposit held as a substitute letter of credit for one of our leased properties. This certificate of deposit is included in other assets on the consolidated balance sheets as the landlord is the beneficiary of the account and we are not able to access the funds during the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of cash, cash equivalents, and restricted cash is included on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Debt Securities</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Marketable Debt Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We invest our excess funds in investment grade short- to intermediate-term corporate debt securities, government sponsored securities, and foreign government bonds and classify these investments as available-for-sale. Marketable debt securities with remaining maturities of 12&#160;months or less are classified as short-term and marketable debt securities with remaining maturities greater than 12&#160;months are classified as long-term. All marketable debt securities are reported at fair value and any unrealized gains and losses are reported as a component of accumulated other comprehensive loss on the consolidated statements of stockholders&#8217; equity, with the exception of unrealized losses believed to be other-than-temporary, which are recorded in investment income, net, on the consolidated statements of operations. Realized gains and losses are included in investment income, net, on the consolidated statements of operations. Realized gains and losses from sales of securities and the amounts, net of tax, reclassified out of accumulated other comprehensive loss, if any, are determined on a specific identification basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically evaluate whether declines in fair values of our investments below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Additionally, we assess whether or not we have plans to sell the security or whether or not it is more likely than not we will be required to sell any investment before recovery of its amortized cost basis. Factors considered include quoted market prices, recent financial results and operating trends, implied values from any recent transactions or offers of investee securities, credit quality of debt instrument issuers, other publicly available information that may affect the value of our investments, duration and severity of the decline in value, and our strategy and intentions for holding the investment. There were no other-than-temporary impairments recorded in the years ended December&#160;31, 2020, 2019 and 2018.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property, Plant and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment is stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. All repairs and maintenance are charged to net loss during the financial period in which they are incurred. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 39 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &amp; fixtures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IT equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The lesser of the lease term or the life of the asset</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon disposal or impairment of property, plant and equipment, the cost and related accumulated depreciation is removed from the consolidated financial statements and the net amount, less any proceeds, is included in the consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Intangible Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, which consisted of the cost of reacquiring a technology license during 2015, were amortized using the straight-line method over an estimated useful life of 4&#160;years. As of December&#160;31, 2019, our intangible assets were fully amortized.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Patents</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Patents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patent costs, including related legal costs, are expensed as incurred and recorded in selling, general and administrative expenses on the consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairments</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets include property, plant and equipment and intangible assets. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected undiscounted future cash flows arising from the assets using a discount rate determined by management to be commensurate with the risk inherent to our current business model.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year ended December&#160;31, 2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we determined that certain bioreactor laboratory equipment could no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> longer</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be utilized in the production process. As a result, we recorded an impairment charge </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">totaling</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">million, which is included in research and development expense on the consolidated statements of operations. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment losses recognized during the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years ended December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 2018</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in absence of a principal, most advantageous market for the specific asset or liability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The three tiers are defined as follows:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;1&#8212; Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets at the measurement date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Our Level 1 assets consist of bank deposits and money market funds.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;2&#8212; Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities. Our Level 2 assets consist of corporate debt securities including commercial paper, government sponsored securities and corporate bonds, as well as foreign municipal securities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:4.54%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;3&#8212; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December&#160;31, 2020, 2019 and 2018, no transfers were made into or out of the Level&#160;1,&#160;2 or 3 categories. We will continue to review the fair value inputs on a quarterly basis.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We utilize a third-party pricing service to assist in obtaining fair value pricing for our investments in marketable debt securities. Inputs are documented in accordance with the fair value disclosure hierarchy.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Arrangements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Collaboration Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We analyze our collaboration arrangements to assess whether they are within the scope of FASB ASC&#160;Topic&#160;808, <span style="font-style:italic;">Collaborative Arrangements,</span> or ASC&#160;808. A collaborative arrangement is a contractual arrangement that involves a joint operating activity. These arrangements involve two or more parties who are active participants in the activity, and exposed to significant risks and rewards dependent on the commercial success of the activity. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. To the extent the collaboration agreement is within the scope of ASC&#160;808, we also assess whether the arrangement contains multiple elements that are within the scope of other accounting literature. If we conclude that some or all aspects of the agreement are distinct and represent a transaction with a customer, we account for those aspects of the arrangement within the scope of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. Amounts that are owed to collaboration partners that are within the scope of ASC&#160;808 are recognized as an offset to research and development expenses as such amounts are incurred by the collaboration partner. Where amounts owed to a collaboration partner exceed our collaboration expenses in each quarterly period, such amounts are classified as research and development expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements require us to acquire certain equipment for exclusive use in the joint operating activities. These equipment purchases do not have an alternative use and are therefore expensed as incurred within research and development expenses.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our collaboration arrangements are further discussed within Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock', window );">Preclinical and Clinical Trial Accruals</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Preclinical and Clinical Trial Accruals</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the process of preparing the financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations and consultants. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate clinical trial and research agreement related expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> behalf.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accruing clinical and research related fees, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> estimate the time period over which services will be performed and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will adjust the accrual accordingly. Payments made under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionsPolicyPolicyTextBlock', window );">Transactions with Related Parties</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Transactions with Related Parties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As outlined in Note&#160;10,&#160;<span style="font-style:italic;">Related Party Agreements</span>, we have various agreements with related parties. Some are billed and settled in cash monthly. Others are billed quarterly and settled in cash the following month. Monthly accruals are made for all quarterly billing arrangements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lease Obligations</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lease Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2019, we adopted FASB ASC Topic&#160;842, <span style="font-style:italic;">Leases</span>, or ASC&#160;842. For contracts entered into on or after the effective date, we determine if an arrangement is, or contains, a lease at lease inception. Our assessment is based on:&#160;(1)&#160;whether the contract involves the use of a distinct identified asset; (2)&#160;whether we obtain the right to substantially all of the economic benefit from the use of the asset throughout the period; and (3)&#160;whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Leases entered into prior to January&#160;1, 2019, which were accounted for under ASC&#160;840, <span style="font-style:italic;">Leases</span>, were not reassessed as we elected the package of practical expedients permitted under the transition guidance within ASC&#160;842, which among other things, allowed us to carry forward the historical lease classification. We determine the lease term by assuming the exercise of renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. Several of our leases have renewal options, however, exercise of renewal is only assured for two of our current Good Manufacturing Practices, or cGMP, facilities, where we have made significant improvements or extended the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. At lease commencement, leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met:&#160;(1)&#160;the lease transfers ownership of the underlying asset by the end of the lease term; (2)&#160;the lease contains an option to purchase the underlying asset that is reasonably certain to be exercised; (3)&#160;the lease term is for a major part of the remaining economic life of the underlying asset; (4)&#160;the present value of the sum of the lease payments and any guaranteed residual value that is not already included in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or (5)&#160;the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. A lease is classified as an operating lease if it does not meet any one of these criteria.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently have any leases classified as finance leases. Our operating lease assets and liabilities are included in operating lease right-of-use assets, net, and current and long-term operating lease liabilities, respectively, on the consolidated balance sheets. At the commencement date, operating lease right-of-use assets and operating lease liabilities are determined based on the present value of lease payments to be made over the lease term. Operating lease right-of-use assets also include any rent paid prior to the commencement date, less any lease incentives received, and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have elected to combine our lease components (e.g., fixed payments including rent, real estate taxes and insurance costs) with non-lease components (e.g., common-area maintenance costs and equipment maintenance costs) and as such, we account for lease and non-lease components as a single component. Lease expense also includes amounts relating to variable lease payments. Variable lease payments include amounts relating to common area maintenance and real estate taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception. Such leases are expensed on a straight-line basis over the lease term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The depreciable life of operating right-of-use-assets and leasehold improvements is limited by the expected lease term.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, as well as for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances to reduce deferred tax assets to the amount we believe is more likely than not to be realized.</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize uncertain tax positions when the position will be more likely than not upheld on examination by the taxing authorities based solely upon the technical merits of the positions. We recognize interest and penalties, if any, related to unrecognized income tax uncertainties in income tax expense. We did not have any accrued interest or penalties associated with uncertain tax positions as of December&#160;31, 2020 and 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to U.S. federal income tax, as well as income tax in Korea, California and other states. To date, we have not been required to pay U.S. federal and state income taxes because of current and accumulated net operating losses. The federal returns for tax years 2017 through 2020 remain open to examination and the state returns remain subject to examination for tax years 2016 through 2020. Carryforward attributes that were generated in years where the statute of limitations is closed may still be adjusted upon examination by the Internal Revenue Service or other respective tax authority. All other state jurisdictions remain open to examination. No income tax returns are currently under examination by taxing authorities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockRepurchasesPolicyTextBlock', window );">Stock Repurchases</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Repurchases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2015, the board of directors approved the 2015 Share Repurchase Program (Note&#160;11) allowing the CEO or CFO, on behalf of the company, to repurchase from time to time, in the open market or in privately negotiated transactions, up to $50.0&#160;million of our outstanding shares of common stock, exclusive of any commissions, markups or expenses. The timing and amounts of any purchases were and will continue to be based on market conditions and other factors, including price, regulatory requirements and other corporate considerations. The 2015 Share Repurchase Program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. We have financed, and expect to continue to finance, the purchases with existing cash balances. As it is the intent for the repurchased shares to be retired, we have elected to account for the shares repurchased under the constructive retirement method. For shares repurchased in excess of par, we allocate the purchase price in excess of par value to accumulated deficit.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;1, 2018, we adopted the provisions of FASB ASC&#160;Topic&#160;606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, or ASC&#160;606. This guidance requires that entities recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted ASC&#160;606 on January&#160;1, 2018 by recording the cumulative effect of the adoption to accumulated deficit. We applied the new guidance to contracts that were not complete as of January&#160;1, 2018. Implementation of ASC&#160;606 did not have a material impact on our consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We derive substantially all of our revenue from non-exclusive license agreements with a limited number of pharmaceutical and biotechnology companies granting them the right to use our cell lines and intellectual property for non-clinical use. These agreements generally include upfront fees and annual research license fees for such use, as well as commercial license fees for sales of the licensee products developed or manufactured using our intellectual property and cell lines.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC&#160;606. A contract&#8217;s transaction price is allocated to each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the company&#8217;s license agreements with customers, the company typically promises to provide a license to use certain cell lines and related patents, the related know-how, and future research and development data that affect the license. We have concluded that these promises represent one performance obligation due to the highly interrelated nature of the promises. We provide the cell lines and know-how immediately upon entering into the contracts. The research and development data is provided throughout the term of the contract when and if available.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our license agreement with Precigen&#160;(Note&#160;8) included a nonrefundable upfront payment of $0.4&#160;million, received when we entered into the contract in 2010. In this instance, we determined that under ASC&#160;606 it would be appropriate to recognize the initial milestone payment at a point in time, when we transferred the license. In this case, the intellectual property provided under the contract is functional intellectual property under ASC&#160;606 and was determined to be a distinct performance obligation in the context of the arrangement. Prior to adoption, the upfront payment had been initially recorded as deferred revenue and was being recognized into revenue on a straight-line basis. As a result, upon adoption of ASC&#160;606, we adjusted our accumulated deficit for the effects of recognizing revenue upfront for the initial milestone. The adjustment to accumulated deficit upon adoption was not material.</p>


<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The license agreements may include nonrefundable upfront payments, event-based milestone payments, sales-based royalty payments, or some combination of these. The event-based milestone payments represent variable consideration and we use the most likely amount method to estimate this variable consideration. Given the high degree of uncertainly around achievement of these milestones, we do not recognize revenue from these milestone payments until the uncertainty associated with these payments is resolved. We currently estimate variable consideration related to milestone payments to be zero and, as such, no revenue has been recognized for milestone payments. We recognize revenue from sales-based royalty payments when or as the sales occur. On a quarterly basis, we re-evaluate our estimate of milestone variable consideration to determine whether any amount should be included in the transaction price and recorded in revenue prospectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption, we changed our accounting policy from accounting for milestones payments under the milestone method to accounting for variable consideration as discussed above. The change in accounting policy did not change any amounts in the financial statements because of the significant uncertainty surrounding the estimate of variable consideration for milestone payments.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have generated minimal revenue related to the non-clinical use of our cell lines and intellectual property. We have no products approved for commercial sale and we have not generated any revenue from product sales. If we fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval for them, we may never be able to generate substantial future revenue.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Costs</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major components of research and development costs include cash compensation and other personnel-related expenses, stock-based compensation, depreciation and amortization expense on research and development property and equipment and intangible assets, costs of preclinical studies, clinical trials and related clinical manufacturing, costs of drug development, costs of materials and supplies, facilities cost, overhead costs, regulatory and compliance costs, and fees paid to consultants and other entities that conduct certain research and development activities on our behalf. Costs incurred in research and development are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Included in research and development costs are clinical trial and research expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations and other vendors that conduct clinical trials and research on our behalf. We record accruals for estimated costs under these contracts. When evaluating the adequacy of the accrued liabilities, we analyze the progress of the studies or clinical trials, including the phase or completion of events, invoices received, contracted costs and purchase orders. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period based on the facts and circumstances known at that time. Although we do not expect the estimates to be materially different from the amounts actually incurred, if the estimates of the status and timing of services performed differs from the actual status and timing of services performed, we may report amounts that are too high or too low in any particular period. Actual results could differ from our estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We account for stock-based compensation under the provisions of FASB ASC Topic&#160;718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation</span>, or ASC&#160;718, which applies to share-based payments issued to employees and nonemployees in exchange for goods or services. Under ASC&#160;718, the fair value of an equity-classified award is estimated on the grant date without regard to service or performance conditions. The grant date fair values for options and warrants are estimated using the Black-Scholes-Merton option pricing model, and the grant date fair values for restricted stock units, or RSUs, are based upon the closing market price of our common stock on the date of grant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use the straight-line method to recognize stock-based compensation expense for our outstanding share awards that do not contain a performance condition. For awards subject to performance-based vesting conditions, we assess the probability of the individual milestones under the award being achieved and stock-based compensation expense is recognized over the service period commencing once management believes the performance criteria is probable of being met. For awards with service or performance conditions, we recognize the effect of forfeitures in compensation cost in the period that the award was forfeited.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LitigationCostsPolicyTextBlock', window );">Litigation Costs</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Litigation Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expense legal fees as they are incurred.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income or loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income or loss is composed of net income (loss) and other comprehensive income (loss). Our other comprehensive income or loss consists of unrealized gains and losses on marketable debt securities classified as available-for-sale, net of income taxes.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share of Common Stock</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and Diluted Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted loss per share is computed similarly to basic loss per share except that the denominator is increased to include the number of additional shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For all periods presented, potentially dilutive securities are excluded from the computation of fully diluted loss per share as their effect is anti-dilutive. The following table details those securities that have been excluded from the computation of potentially dilutive securities:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,506,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,493,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,139,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">867,911</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding warrants</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,589,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,984,852</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,646,378</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,950,411</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts in the table above reflect the common stock equivalents of the noted instruments.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment and Geographic Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating segments are defined as components of an enterprise (business activity from which it earns revenue and incurs expenses) for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the company&#8217;s CEO. We view our operations and manage our business as a single operating and reporting segment. As of December&#160;31, 2020 and 2019, the majority of our assets were held in the U.S. For the years ended December&#160;31, 2020, 2019 and 2018, all of our revenue was derived in the U.S.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November&#160;2018, the FASB issued Accounting Standards Update, or ASU, No.&#160;2018-18, <span style="font-style:italic;">Collaborative Arrangements&#160;(Topic&#160;808):&#160;Clarifying the Interaction between Topic&#160;808 and Topic&#160;606</span> (ASU&#160;2018-18). ASU&#160;2018-18 clarifies when certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic&#160;606. It also specifically addresses when the participant should be considered a customer in the context of a unit of account; adds unit of account guidance in ASC&#160;808 to align with guidance in ASC&#160;606; and precludes presenting revenue from a collaborative arrangement together with revenue recognized under ASC&#160;606 if the collaborative arrangement participant is not a customer. This standard is effective for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years with early adoption permitted. We adopted ASU&#160;2018-18, as required, in the quarter ended March&#160;31, 2020. We are a party to several collaboration arrangements as further described in Note&#160;8,&#160;<span style="font-style:italic;">Collaboration and License Agreements</span>, however, adoption of ASU&#160;2018-18 did not have an impact on our consolidated financial statements because the counterparties to our collaboration agreements do not meet the definition of a customer.</p>

<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December&#160;2019, the FASB issued ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12,&#160;</span><span style="font-style:italic;">Simplifying the Accounting for Income Taxes</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12. The amendments in ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 include removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (e.g., discontinued operations or other comprehensive income), and the exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 also amends other aspects of accounting for income taxes to help simplify and promote consistent application of U.S.&#160;GAAP. The guidance is effective for interim and annual periods beginning after December&#160;15, 2020, with early adoption permitted. We early adopted ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 effective January&#160;1, 2020, and it did not have a material impact on our consolidated financial statements. Although our adoption of ASU&#160;2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;12 did not have a material impact on our consolidated financial statements during the year ended December&#160;31, 2020, it may have a material impact on our consolidated financial statements in future periods due to the removal of the exceptions discussed above. The amendments related to intraperiod tax allocation and the amendment related to calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applied prospectively.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Application of New or Revised Accounting Standards &#8211; Not Yet Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June&#160;2016, the FASB issued ASU&#160;2016&#8209;13,&#160;<span style="font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326):&#160;Measurement of Credit Losses on Financial Instruments</span>. The FASB subsequently issued amendments to ASU&#160;2016&#8209;13, which have the same effective date and transition dates as described below. The new guidance supersedes existing U.S. GAAP for measuring and recording of credit losses on financial assets measured at amortized cost by replacing the incurred-loss model with an expected-loss model. Accordingly, these financial assets will be presented at the net amount expected to be collected. This new standard also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. For public business entities that meet the definition of a Securities and Exchange Commission, or SEC, filer, except entities that are eligible to be a smaller reporting company as defined by the SEC, the standard is effective for annual periods beginning after December&#160;15, 2019, and interim periods therein. For all other entities, the standard is effective for annual periods beginning after December&#160;15, 2022, and interim periods therein. Early adoption is permitted for all entities for annual periods beginning after December&#160;15, 2018. With certain exceptions, adjustments are to be applied using a modified-retrospective approach by reflecting adjustments through a cumulative-effect impact on retained earnings as of the beginning of the fiscal year of adoption. We continue to evaluate the impact that this new standard and its related amendments will have on our consolidated financial statements and we do not intend to early adopt this new standard.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other recent authoritative guidance issued by the FASB (including technical corrections to the ASC), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission during the three&#160;months ended December&#160;31, 2020 did not, or are not expected to, have a material effect on our consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in Viracta</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the level of equity investment at risk, Viracta is not a VIE and therefore is not consolidated under the VIE model. In addition, we do not hold a controlling financial interest in Viracta, and therefore we do not consolidate Viracta under the voting interest model. As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC&#160;820, we have elected to apply the measurement alternative under ASC&#160;321, pursuant to which we measure our investment in Viracta at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer, with such changes recognized in the consolidated statements of operations. Some factors we may consider in the impairment analysis include the extent to which the security has been in an unrealized loss position, the change in the financial condition and near-term prospects of the issuer, as well as security and industry specific economic conditions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LitigationCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LitigationCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preclinical and clinical trial accruals policy text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transactions policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockRepurchasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock repurchases policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockRepurchasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRisksAndUncertaintiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583411288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of Estimated Useful Lives of Property, Plant and Equipment</a></td>
<td class="text">Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets, as follows:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 39 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &amp; fixtures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 5 years</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IT equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3 years</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The lesser of the lease term or the life of the asset</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Securities Excluded from the Computation of Potentially Dilutive Securities</a></td>
<td class="text">The following table details those securities that have been excluded from the computation of potentially dilutive securities:
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,506,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,493,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,139,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">867,911</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding warrants</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,589,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,984,852</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,646,378</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,950,411</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts in the table above reflect the common stock equivalents of the noted instruments.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576312952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, prepaid expenses and other current assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,626</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance premium financing asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">757</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid insurance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">657</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">372</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">440</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid rent</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">589</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest receivable - marketable debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">473</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid supplies - with related party (Note 10)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">467</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid equipment maintenance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid license fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related parties</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insurance claim receivables</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,285</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,105</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, property, plant and equipment, net, consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,406</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,069</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,434</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,690</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,690</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture &amp; fixtures</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">415</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">383</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,044</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,108</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,117</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,607</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,927</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Other Assets</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other assets consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Security deposits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid software license fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid preclinical and clinical trial services - with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; related party (Note 10)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,075</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due from related party</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,121</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,386</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, accrued expenses consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and service fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,920</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">975</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued bonus</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,236</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,002</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,368</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,064</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued laboratory equipment and supplies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">640</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued preclinical and clinical trial costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">638</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued capital expenditures</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">337</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued franchise, sales/use and property taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2020 and 2019, other current liabilities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing obligation - current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,421</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">757</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,438</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Investment Income, Net</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net investment income included the following for the years ended December&#160;31, 2020, 2019 and 2018 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,643</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,317</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment (amortization expense) accretion income, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(858</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net realized (losses) gains on investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,642</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,857</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583413480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CashEquivalentsAndMarketableSecuritiesAbstract', window );"><strong>Cash Equivalents And Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Investments in available-for-sale Debt Securities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2020, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000703">0.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000704">0.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000705">0.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2019, our investments in available-for-sale debt securities consist of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,752</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,144</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,501</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,642</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock', window );">Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated unrealized losses on debt securities classified as available-for-sale that have been in a continuous loss position for less than <span style="-sec-ix-hidden:F_000734"><span style="-sec-ix-hidden:F_000736">12&#160;months and for more than 12&#160;months</span></span> at December&#160;31, 2020 and 2019, were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,762</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More than 12 months</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross&#160;Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,245</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock', window );">Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognized realized gains and losses on sales of available-for-sale debt securities as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Realized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains (Losses)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_CashEquivalentsAndMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_CashEquivalentsAndMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investments in debt and equity securities in an unrealized loss position categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRealizedGainLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576238760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities measured at fair value on a recurring basis are summarized below at December&#160;31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,441</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,772</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements as of December&#160;31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government sponsored securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,748</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Noncurrent:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,149</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,508</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576425944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock', window );">Schedule of Operating Right-of-use Assets and Lease Liabilities</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operating right-of-use assets and lease liabilities as of December&#160;31, 2020 and 2019, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease right-of-use assets, net (including amounts</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;with related parties)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,463</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,729</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Short-term lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,206</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,814</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,885</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating lease liabilities (including amounts with related parties)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,091</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of lease expense for the years ended December&#160;31, 2020 and 2019 consist of (in&#160;thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,898</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,566</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Total lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,221</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,113</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock', window );">Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid during the years ended December&#160;31, 2020 and 2019 for amounts included in the measurement of lease liabilities is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Operating cash flows for operating leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,345</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Summary of Future Minimum Lease Payments</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum lease payments as of December&#160;31, 2020, including $3.9&#160;million related to options to extend lease terms that are reasonably certain of being exercised, are presented in the following table (in thousands). Common area maintenance costs and taxes are not included in these payments.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years ending December 31:</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases (a)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,545</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,083</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,115</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,527</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,213</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,314</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash paid for amounts included in measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of operating right-of-use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663810744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock', window );">Summary Of Common Stock Reserved For Issuance</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the common shares reserved for issuance on exercise or vesting of various awards at December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:78.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:78.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares reserved for future issuance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,984,852</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock reserved for issuance .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576102392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock Based Compensation Expenses Included on Operations Statement</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents all stock-based compensation as included on the consolidated statements of operations (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants for common stock to an officer</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,817</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,388</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,309</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee RSUs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">629</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">938</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,193</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employee RSUs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">380</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,139</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,627</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense in operating expenses:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">499</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,919</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,128</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,922</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,139</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,627</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,382</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summarizes Stock Option Activity and Related Information Under Equity Incentive Plans</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity and related information under all equity incentive plans for the years ended December&#160;31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,693,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.71</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,920</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001109">5.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">800,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,493,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001110">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,986,300</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,506,950</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,710</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001111">5.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,272,273</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.89</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116,667</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.93</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,922</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001112">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and Exercisable as of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,868,008</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,509</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001113">4.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options Outstanding and Vested</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of options outstanding and vested as of December&#160;31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Prices</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$0.4213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001143">3.9</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001157">3.9</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$1.7554</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001144">4.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001158">4.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$1.9984</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">262,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001145">4.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">262,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001159">4.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3.07</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001146">7.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">349,998</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001160">7.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001147">9.4</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001161">&#8212;</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$25.00</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,455,450</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001148">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,455,450</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001162">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001149">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,868,008</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.22%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001163">4.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted Average of Fair Value of Options Under Black-Scholes Option-Pricing Model</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may grant stock options to both employees and directors of the company and to employees of related parties that provide shared services to the company under the company&#8217;s shared services agreement with NantWorks&#160;(Note&#160;10). The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001164">5.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 - 6.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96.8%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.9%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average grant date fair value</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$4.64</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.09</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Restricted Stock Units (RSUs) Activity</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the restricted stock units, or RSUs, activity under the 2015&#160;Plan:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RSUs</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">888,189</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">487,472</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.57</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(172,330</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.16</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(335,420</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">867,911</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">749,793</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(395,051</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.83</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.29</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,139,428</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.43</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(648,336</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.04</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited/canceled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,750</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.47</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested balance as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,842</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.52</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Warrant Activity</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the company&#8217;s warrant activity:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,721,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(93,254</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,584</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,589,250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,589,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576373208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Loss Before Taxes</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of loss before taxes is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. loss before taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,286</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(94,423</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income (loss) before taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(600</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,306</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,378</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65,886</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(96,729</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Income Tax (Expense) Benefit</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit for the years ended December&#160;31, 2020, 2019 and 2018 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.92%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">498</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">506</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Net Deferred Tax Assets and Liabilities</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components that comprise the company&#8217;s net deferred tax assets at December&#160;31, 2020 and 2019 consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,537</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,377</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,536</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,254</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,128</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leases and other accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">451</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,419</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,148</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,965</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,233</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,739</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,409</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,732</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(121,409</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,732</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.44%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Federal Statutory Income Tax Rate</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the federal statutory income tax rate to the company&#8217;s effective income tax rate for the years ended December&#160;31, 2020, 2019 and 2018 is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.08%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December&#160;31,</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax computed at federal statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income taxes, net of federal tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax rate adjustment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(82.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.54%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summarizes of Changes in Unrecognized Tax Benefits</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes to the amount of unrecognized tax benefits (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,983</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decrease for prior year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase for current year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,763</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,413</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663849592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summarized Quarterly Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Quarterly Data (Unaudited)</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below presents unaudited quarterly data for years ended December&#160;31, 2020 and 2019 (in thousands, except for share and per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,607</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,228</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,995</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,907</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,586</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,927</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,886</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,383</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,092</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,776</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,132</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.19</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.30</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,472,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,769,687</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,246,579</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,607,715</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1st Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2nd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3rd Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4th Quarter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,313</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,077</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,120</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,335</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,065</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,885</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,682</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,581</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,641</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in calculating net loss per share - basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,261,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,594,355</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,331,695</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,419,166</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584148088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering, net of issuance costs paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,302<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(754,574)<span></span>
</td>
<td class="num">(662,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (70,453)<span></span>
</td>
<td class="num">$ (61,362)<span></span>
</td>
<td class="num">$ (63,381)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering, net of issuance costs paid</a></td>
<td class="nump">$ 90,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses', window );">Underwriting discounts, commissions and other offering expenses</a></td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts, commissions and other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395582292968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Product</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CashAndCashEquivalentsOriginalMaturities', window );">Cash and cash equivalents original maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities', window );">Maximum original maturity period of short-term marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities', window );">Minimum original maturity period of long-term marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet', window );">Other than temporary impairments for marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories', window );">Fair value inputs, transfers into or out of Level 1, 2 or 3 categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasePracticalExpedientsPackage', window );">Lease practical expedients package</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest or penalties associated with uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Total amount authorized for repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_VariableConsiderationRelatedToMilestonePayment', window );">Variable consideration related to milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Revenue recognized for milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfProductsApprovedForCommercialSale', window );">Number of products approved for commercial sale | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NonrefundableUpfrontPayment', window );">Nonrefundable upfront payment</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Revenue recognized for milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment charge/losses of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_CashAndCashEquivalentsOriginalMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents original maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_CashAndCashEquivalentsOriginalMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value inputs, transfers into level 1, 2 or 3 categories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum original maturity period of short term marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum original maturity period of long term marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NonrefundableUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrefundable upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NonrefundableUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfProductsApprovedForCommercialSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of products approved for commercial sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfProductsApprovedForCommercialSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_VariableConsiderationRelatedToMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable consideration related to milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_VariableConsiderationRelatedToMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasePracticalExpedientsPackage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether practical expedients are elected for not reassessing whether any expired or existing contract is or contains lease, lease classification for expired or existing lease, and initial direct cost for any existing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL77916155-209984<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL77916155-209984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasePracticalExpedientsPackage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period for the milestone or milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395577518072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">39 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture And Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_ITEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives, term</a></td>
<td class="text">The lesser of the lease term or the life of the asset<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_ITEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nk_ITEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584073800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">3,984,852<span></span>
</td>
<td class="nump">5,646,378<span></span>
</td>
<td class="nump">24,950,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">3,518,010<span></span>
</td>
<td class="nump">4,506,950<span></span>
</td>
<td class="nump">6,493,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Outstanding RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">466,842<span></span>
</td>
<td class="nump">1,139,428<span></span>
</td>
<td class="nump">867,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Outstanding Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,589,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584185720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty', window );">Prepaid preclinical and clinical trial services - with related party (Note 10)</a></td>
<td class="nump">$ 4,626<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_InsurancePremiumFinancingAsset', window );">Insurance premium financing asset</a></td>
<td class="nump">1,421<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidServices', window );">Prepaid services</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Prepaid rent</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable - marketable debt securities</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidSuppliesWithRelatedParty', window );">Prepaid supplies - with related party (Note 10)</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidEquipmentMaintenance', window );">Prepaid equipment maintenance</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidLicenseFees', window );">Prepaid license fees</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LaboratoryEquipmentDeposit', window );">Laboratory equipment deposit</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance claim receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 9,285<span></span>
</td>
<td class="nump">$ 4,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_InsurancePremiumFinancingAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance premium financing asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_InsurancePremiumFinancingAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LaboratoryEquipmentDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Laboratory equipment deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LaboratoryEquipmentDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidEquipmentMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid equipment maintenance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidEquipmentMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid license fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid preclinical and clinical trial services with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidSuppliesWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid supplies with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidSuppliesWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584300680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Details - Property, Plant and Equipment, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 81,044<span></span>
</td>
<td class="nump">$ 79,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(27,117)<span></span>
</td>
<td class="num">(18,607)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">53,927<span></span>
</td>
<td class="nump">60,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">33,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">22,690<span></span>
</td>
<td class="nump">22,690<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">23,069<span></span>
</td>
<td class="nump">21,434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture And Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 415<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583344616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Details - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense related to property, plant and equipment</a></td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment loss on recognized investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584925528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Details - Other Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposits</a></td>
<td class="nump">$ 481<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidSoftwareLicenseFeesInOtherAssets', window );">Prepaid software license fees</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets', window );">Prepaid preclinical and clinical trial services - with related party (Note 10)</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">4,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesNoncurrent', window );">Due from related party</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets Noncurrent</a></td>
<td class="nump">$ 1,121<span></span>
</td>
<td class="nump">$ 4,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid preclinical and clinical trial services with related party in other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidSoftwareLicenseFeesInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid software license fees in other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidSoftwareLicenseFeesInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583324136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Details - Accrued Expenses (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and service fees</a></td>
<td class="nump">$ 2,920<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus</a></td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">2,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccruedLaboratoryEquipmentAndSupplies', window );">Accrued laboratory equipment and supplies</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccruedPreclinicalAndClinicalTrialCosts', window );">Accrued preclinical and clinical trial costs</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccruedCapitalExpenditures', window );">Accrued capital expenditures</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AccruedFranchiseSalesUseAndPropertyTaxes', window );">Accrued franchise, sales/use and property taxes</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities Current</a></td>
<td class="nump">$ 8,343<span></span>
</td>
<td class="nump">$ 5,343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AccruedCapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued capital expenditures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AccruedCapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AccruedFranchiseSalesUseAndPropertyTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued franchise, sales/use and property taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AccruedFranchiseSalesUseAndPropertyTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AccruedLaboratoryEquipmentAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued laboratory equipment and supplies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AccruedLaboratoryEquipmentAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AccruedPreclinicalAndClinicalTrialCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued preclinical and clinical trial costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AccruedPreclinicalAndClinicalTrialCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576398632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Details - Other Current Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancingObligationCurrent', window );">Financing obligation - current portion</a></td>
<td class="nump">$ 1,421<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 1,438<span></span>
</td>
<td class="nump">$ 775<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancingObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing obligation current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancingObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583236520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Details - Investment Income, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FinancialStatementDetailsAbstract', window );"><strong>Financial Statement Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">$ 1,233<span></span>
</td>
<td class="nump">$ 1,643<span></span>
</td>
<td class="nump">$ 2,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Investment (amortization expense) accretion income, net</a></td>
<td class="num">(858)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized (losses) gains on investments</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 1,642<span></span>
</td>
<td class="nump">$ 1,857<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FinancialStatementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial statement details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FinancialStatementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663921880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 21, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Date of agreement and plan of merger</a></td>
<td class="text">Dec. 21,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Stock-for-stock transaction</a></td>
<td class="nump">0.8190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MergerExchangeRatio', window );">Merger exchange ratio</a></td>
<td class="nump">0.819%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember', window );">Proposed Merger With ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForMergerRelatedCosts', window );">Merger related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember', window );">Executive Chairman and principal stockholder, and affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OwnershipPercentageByKeyExecutives', window );">Ownership percentage by key executives</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=nk_NantKwestMember', window );">NantKwest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger', window );">Ownership percentage acquired on fully diluted bases upon consummation of merger</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Date of agreement and plan of merger</a></td>
<td class="text">Dec. 21,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger', window );">Ownership percentage acquired on fully diluted bases upon consummation of merger</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MergerExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MergerExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership percentage acquired on fully diluted bases upon consummation of merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_OwnershipPercentageByKeyExecutives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership percentage by key executives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_OwnershipPercentageByKeyExecutives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the reporting period for charges associated with the mergers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=nk_ProposedMergerWithImmunityBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=nk_NantKwestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=nk_NantKwestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395574953032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Viracta Investment - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,849<span></span>
</td>
<td class="nump">$ 9,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Unrealized loss on equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Reduction in carrying value on cumulative basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=nk_OtherIncomeAndExpenseNetMember', window );">Other Income and Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Unrealized loss on equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember', window );">2018 Note and Warrant Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PurchaseOfConvertibleNoteUponConversion', window );">Purchase of convertible note</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Convertible note accrued interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument maturity date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember', window );">2018 Note and Warrant Purchase Agreement | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised to acquire shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember', window );">2018 Note and Warrant Purchase Agreement | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PurchaseOfConvertibleNoteUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of convertible note upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PurchaseOfConvertibleNoteUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=nk_OtherIncomeAndExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=nk_OtherIncomeAndExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395582928776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 54,789<span></span>
</td>
<td class="nump">$ 37,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="nump">$ 54,772<span></span>
</td>
<td class="nump">37,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod', window );">Available-for-sale, Weighted- Average Remaining Contractual Life</a></td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember', window );">Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 54,789<span></span>
</td>
<td class="nump">36,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="nump">$ 54,772<span></span>
</td>
<td class="nump">36,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod', window );">Available-for-sale, Weighted- Average Remaining Contractual Life</a></td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember', window );">Current Assets | Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember', window );">Current Assets | Foreign Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember', window );">Current Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 54,789<span></span>
</td>
<td class="nump">32,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="nump">$ 54,772<span></span>
</td>
<td class="nump">32,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod', window );">Available-for-sale, Weighted- Average Remaining Contractual Life</a></td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember', window );">Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember', window );">Noncurrent Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,497<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt securities period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395663810552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail) - Security<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions', window );">Available-for-sale securities, period of unrealized loss positions</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions', window );">Available-for-sale securities, period of unrealized loss positions</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1', window );">Number of available-for-sale securities in unrealized loss positions</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities period of unrealized loss positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investment positions in available-for-sale investments in a continuous unrealized loss position for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584755080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-Sale Investments, Less than 12 months, Estimated Fair Value</a></td>
<td class="nump">$ 42,762<span></span>
</td>
<td class="nump">$ 11,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-Sale Investments, Less than 12 months, Gross Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-Sale Investments, More than 12 months, Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-Sale Investments, More than 12 months, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-Sale Investments, Less than 12 months, Estimated Fair Value</a></td>
<td class="nump">42,762<span></span>
</td>
<td class="nump">11,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-Sale Investments, Less than 12 months, Gross Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-Sale Investments, More than 12 months, Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-Sale Investments, More than 12 months, Gross Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember', window );">Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-Sale Investments, Less than 12 months, Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-Sale Investments, Less than 12 months, Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-Sale Investments, More than 12 months, Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-Sale Investments, More than 12 months, Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395587931768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLossAbstract', window );"><strong>Debt Securities Realized Gain Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains', window );">Available-for-sale Securities, Gross Realized Gains</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses', window );">Available-for-sale Securities, Gross Realized Losses</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet', window );">Available for Sale Securities, Net Realized Gains (Losses)</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the gross profit realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesRealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesRealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395580510424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 66,213<span></span>
</td>
<td class="nump">$ 53,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Current Assets | Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Current Assets | Foreign Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Current Assets | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">11,441<span></span>
</td>
<td class="nump">15,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Current Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">54,772<span></span>
</td>
<td class="nump">32,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Noncurrent Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">11,441<span></span>
</td>
<td class="nump">15,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Current Assets | Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Current Assets | Foreign Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Current Assets | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">11,441<span></span>
</td>
<td class="nump">15,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Current Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Noncurrent Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">54,772<span></span>
</td>
<td class="nump">37,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Current Assets | Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Current Assets | Foreign Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Current Assets | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Current Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">54,772<span></span>
</td>
<td class="nump">32,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Noncurrent Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Current Assets | Government Sponsored Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Current Assets | Foreign Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Current Assets | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Current Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Noncurrent Assets | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=nk_CurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=nk_NoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395582456648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Feb. 28, 2010</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2004</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,483,000<span></span>
</td>
<td class="nump">$ 49,785,000<span></span>
</td>
<td class="nump">$ 55,718,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,269,000<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=nk_RushUniversityMedicalCenterLicenseAgreementMember', window );">Rush University Medical Center License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfLicenseAgreement', window );">Period of license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MinimumAnnualRoyaltyPayment', window );">Minimum annual royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Payments in license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MinimumSalesMilestoneOfLicenseForFirstYear', window );">Minimum sales milestone of license for first year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nk_ViractaTherapeuticsIncMember', window );">Viracta Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicenseAgreementTerminationNoticePeriod', window );">License agreement termination notice period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nk_ViractaTherapeuticsIncMember', window );">Viracta Therapeutics, Inc. | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nk_ViractaTherapeuticsIncMember', window );">Viracta Therapeutics, Inc. | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementRenewalTerm', window );">Related party, agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_TermOfAgreement', window );">Term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AdditionalTermOfAgreementRenewableUponMutualAgreement', window );">Additional term of agreement renewable upon mutual agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement | Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Profit sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement | ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement | ImmunityBio | Program Equipment Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement | ImmunityBio | Net Program Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember', window );">Joint COVID 19 Collaboration Development Agreement | ImmunityBio | Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Profit sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_ClinicalTrialCostAllocationAgreementMember', window );">Clinical Trial Cost Allocation Agreement | ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">35,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementRenewalTerm', window );">Related party, agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicenseAgreementTerm', window );">License agreement term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AgreementOneTimeFee', window );">Agreement one time fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement | First IND Filing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement | First Phase II Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement | First Phase III Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember', window );">Precigen License Agreement | Commercial Sale Related to Licensed Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LicensingAgreementLineItems', window );"><strong>Licensing Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MilestonePaymentAmount', window );">Milestone Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AdditionalTermOfAgreementRenewableUponMutualAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional term of agreement renewable upon mutual agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AdditionalTermOfAgreementRenewableUponMutualAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AgreementOneTimeFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement one time fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AgreementOneTimeFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LicenseAgreementTerminationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement termination notice period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LicenseAgreementTerminationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LicensingAgreementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LicensingAgreementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MilestonePaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone payment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MilestonePaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MinimumAnnualRoyaltyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MinimumAnnualRoyaltyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MinimumSalesMilestoneOfLicenseForFirstYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum sales milestone of license for first year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MinimumSalesMilestoneOfLicenseForFirstYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PeriodOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PeriodOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party agreement renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period for the milestone or milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=nk_RushUniversityMedicalCenterLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=nk_RushUniversityMedicalCenterLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nk_ViractaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nk_ViractaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=nk_ProgramEquipmentRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=nk_ProgramEquipmentRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=nk_NetProgramRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=nk_NetProgramRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_ClinicalTrialCostAllocationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_ClinicalTrialCostAllocationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_PrecigenLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_INDFilingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_INDFilingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_PhaseTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_PhaseTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_PhaseThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_PhaseThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_CommercialSaleRelatedToLicensedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nk_CommercialSaleRelatedToLicensedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395566937048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 09, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>$ / ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Nov. 30, 2015 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorney's fee to plaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,463,000<span></span>
</td>
<td class="nump">11,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,314,000<span></span>
</td>
<td class="nump">14,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,927,000<span></span>
</td>
<td class="nump">60,501,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,465,000<span></span>
</td>
<td class="nump">22,444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,164,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rental expenses for operating leases including common-area maintenance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms', window );">Operating lease payments related to options to extend lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">elected not to recognize right-of-use assets and lease liabilities for qualifying short-term leases with an initial lease term of 12&#160;months or less at lease inception<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Unconditional purchase obligations, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Unconditional purchase obligations, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary', window );">Unconditional purchase obligations, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary', window );">Unconditional purchase obligations, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nk_CommitmentWoburnMassachusettsMember', window );">Woburn, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,153<span></span>
</td>
<td class="nump">7,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Initial term of lease arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 29,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AdditionToNumberOfSquareFootOfFacilityLeased', window );">Addition to number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualBaseRentIncreasePerSquareFoot', window );">Annual increase of base rent | $ / ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LeaseAgreementExtendedPeriod', window );">Lease agreement extended lease period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfLicenseAgreementDescription', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In June&#160;2016, the lease was amended to add 260&#160;square feet, for a total of 8,153&#160;square feet. Base rent for the initial term of the lease was $19,000&#160;per&#160;month with a $1&#160;per&#160;square foot annual increase on each anniversary date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nk_CommitmentWoburnMassachusettsMember', window );">Woburn, Massachusetts | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nk_CommitmentSanDiegoMember', window );">Commitment; San Diego</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Initial term of lease arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember', window );">NantBioScience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty', window );">Reimbursed upfront payment to third-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionAmountPaidToRelatedParty', window );">Related party transaction, amount paid to third-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionInitialTermOfAgreement', window );">Initial term of agreement entered into with the related party by the entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementExpirationMonthAndYear', window );">Related party agreement expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2027-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember', window );">Doug St, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate', window );">Annual percentage increases to base rent commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease runs from July&#160;2016 through July&#160;2023. We have the option to extend the lease for an additional three&#160;year term through July&#160;2026. The monthly rent is $0.1&#160;million with annual increases of 3% beginning in July&#160;2017.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfExtendedLeaseTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfExtendedLeaseTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LeaseAgreementExtendedPeriod', window );">Lease agreement extended lease period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfLicenseAgreementDescription', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The initial license was effective from May&#160;2015 through December&#160;2020. Base monthly rent for the initial lease term was $47,000, with annual increases of 3% beginning in January&#160;2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate', window );">Annual percentage increases to base rent commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks | Amendment to Extend Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks | Amendment to Extend Lease Term | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease', window );">Number of days prior to written notice to terminate lease</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember', window );">El Segundo California | Altor Bioscience Manufacturing Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease runs from August&#160;2020 through July&#160;2022, and includes an option to extend the lease for an additional one-year term through July&#160;2023. The monthly fixed charge related to the agreement is $0.2&#160;million, a portion of which is subject to annual increases of 3% which began in November&#160;2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfExtendedLeaseTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MonthlyFixedCharge', window );">Monthly fixed charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToMonthlyFixedCharge', window );">Annual percentage increases to monthly fixed charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToFixedChargeCommencementDate', window );">Annual percentage increases to fixed charge commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfExtendedLeaseTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember', window );">El Segundo California | Doug St, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Initial term of lease arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Initial term of lease arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Optional extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 | Difference between Lease Guidance in Effect before and after Topic 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (including amounts with related parties)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,700,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-02 | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Build-to-suit related liabilities and assets adjust as accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (900,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivable', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsurancePolicyTypeAxis=nk_DirectorsAndOfficersInsurancePolicyMember', window );">Directors and Officers Insurance Policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AdditionToNumberOfSquareFootOfFacilityLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Addition to number of square foot of facility leased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AdditionToNumberOfSquareFootOfFacilityLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualBaseRentIncreasePerSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual base rent increase per square foot.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualBaseRentIncreasePerSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to base rent commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToBaseRentCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToFixedChargeCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to fixed charge commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToFixedChargeCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToMonthlyFixedCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to monthly fixed charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToMonthlyFixedCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_BaseMonthlyRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Base monthly rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_BaseMonthlyRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LeaseAgreementExtendedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease agreement extended period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LeaseAgreementExtendedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LeaseCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LeaseCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MonthlyFixedCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly fixed charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MonthlyFixedCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of days prior to written notice to terminate lease,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfSquareFootOfFacilityLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of square foot of facility leased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfSquareFootOfFacilityLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease payments related to options to extend lease terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PeriodOfExtendedLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of extended lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PeriodOfExtendedLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PeriodOfLicenseAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of license agreement description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PeriodOfLicenseAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyAgreementExpirationMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party agreement expiration month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyAgreementExpirationMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionAmountPaidToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction, amount paid to related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionAmountPaidToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionInitialTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction initial term of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionInitialTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction, Reimbursed upfront payment to third party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nk_CommitmentWoburnMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nk_CommitmentWoburnMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nk_CommitmentSanDiegoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nk_CommitmentSanDiegoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nk_AmendmentToExtendLeaseTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nk_AmendmentToExtendLeaseTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePolicyTypeAxis=nk_DirectorsAndOfficersInsurancePolicyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePolicyTypeAxis=nk_DirectorsAndOfficersInsurancePolicyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576187368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RightOfUseAssetsAbstract', window );"><strong>Right-of-use assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net (including amounts with related parties)</a></td>
<td class="nump">$ 13,463<span></span>
</td>
<td class="nump">$ 11,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ShortTermLeaseLiabilitiesAbstract', window );"><strong>Short-term lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (including amounts with related parties)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LongTermLeaseLiabilitiesAbstract', window );"><strong>Long-term lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, less current portion (including amounts with related parties)</a></td>
<td class="nump">9,814<span></span>
</td>
<td class="nump">10,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Total lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities (including amounts with related parties)</a></td>
<td class="nump">$ 15,314<span></span>
</td>
<td class="nump">$ 14,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LongTermLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LongTermLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RightOfUseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RightOfUseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ShortTermLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ShortTermLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576395016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Components of Lease Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 4,655<span></span>
</td>
<td class="nump">$ 3,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 6,221<span></span>
</td>
<td class="nump">$ 5,113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583435144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 5,345<span></span>
</td>
<td class="nump">$ 4,371<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395671280920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 6,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">5,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">2,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">17,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">2,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="nump">$ 15,314<span></span>
</td>
<td class="nump">$ 14,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395569134744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="14">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 21, 2020</div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th">
<div>Apr. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th">
<div>Nov. 30, 2015 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Officer</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,254,000<span></span>
</td>
<td class="nump">$ 18,065,000<span></span>
</td>
<td class="nump">$ 42,718,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,483,000<span></span>
</td>
<td class="nump">49,785,000<span></span>
</td>
<td class="nump">55,718,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,269,000<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Date of agreement and plan of merger</a></td>
<td class="text">Dec. 21,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">412,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LeaseAgreementExtendedPeriod', window );">Lease agreement extended lease period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate', window );">Annual percentage increases to base rent commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks | Shared Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember', window );">NantWorks | Shared Services Agreement | Reimbursements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunoOncologyClinicIncMember', window );">Immuno-Oncology Clinic, Inc. | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfOfficers', window );">Number of officers | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_InitialTermOfAgreement', window );">Initial term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyInstallmentPayment', window );">Related party transaction installment payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,875,000<span></span>
</td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionConditionalPayment', window );">Related party transaction conditional payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionAgreementExtensionDescription', window );">Prepayments remain unearned extension description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">To the extent any portion of the prepayments remain unearned by the Clinic on the third anniversary of the Clinic Agreement, we may elect at our sole discretion either to&#160;(i)&#160;not extend the term of the Clinic Agreement and have the Clinic reimburse us for the total amount of any remaining unused portion of the prepayments, or (ii)&#160;extend the term of the Clinic Agreement for up to three additional one&#160;year periods, at which time the Clinic will reimburse us for the total amount of any remaining unused portion of the prepayments plus interest if reimbursement is not made within 60&#160;days of expiration.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NewAgreementTerminationNoticePeriod', window );">Notice period to terminate new agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets', window );">Prepaid balance included in prepaid expenses and other current assets and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunoOncologyClinicIncMember', window );">Immuno-Oncology Clinic, Inc. | California | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Estimated cost for new agreement with clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Date of agreement and plan of merger</a></td>
<td class="text">Dec. 21,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionInitialTermOfAgreement', window );">Initial term of agreement entered into with the related party by the entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementRenewalTerm', window );">Related party, agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related parties, capitalized equipment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio | Joint COVID 19 Collaboration Development Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio | Joint COVID 19 Collaboration Development Agreement | Program Equipment Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio | Joint COVID 19 Collaboration Development Agreement | Net Program Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio | Clinical Trial Cost Allocation Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">35,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementRenewalTerm', window );">Related party, agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember', window );">ImmunityBio | Collaborative Arrangement | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember', window );">Altor Bioscience Manufacturing Company, LLC | El Segundo California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_MonthlyFixedCharge', window );">Monthly fixed charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToMonthlyFixedCharge', window );">Annual percentage increases to monthly fixed charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_FixedAndVariableLeaseCosts', window );">Fixed and variable lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember', window );">Altor Bioscience Manufacturing Company, LLC | Research and Development | El Segundo California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember', window );">Doug St, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease runs from July&#160;2016 through July&#160;2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate', window );">Annual percentage increases to base rent commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty', window );">Due between parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember', window );">Doug St, LLC | El Segundo California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember', window );">Doug St, LLC | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember', window );">NantBioScience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Estimated cost for new agreement with clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionInitialTermOfAgreement', window );">Initial term of agreement entered into with the related party by the entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty', window );">Related party transaction,reimbursement payment to a related-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionAmountPaidToThirdParty', window );">Related party transaction, amount paid to third-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementExpirationMonthAndYear', window );">Related party agreement expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2027-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod', window );">Research and development expense, ratable payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PrepaymentOfFundingAmount', window );">Prepayment for services amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember', window );">NantBioScience | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nk_NantHealthLabsIncMember', window );">NantHealth Labs, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyTransactionInitialTermOfAgreement', window );">Initial term of agreement entered into with the related party by the entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_RelatedPartyAgreementRenewalTerm', window );">Related party, agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToBaseRentCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to base rent commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToBaseRentCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToMonthlyFixedCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to monthly fixed charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToMonthlyFixedCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_BaseMonthlyRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Base monthly rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_BaseMonthlyRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_FixedAndVariableLeaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed and variable lease costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_FixedAndVariableLeaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_InitialTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial term of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_InitialTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LeaseAgreementExtendedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease agreement extended period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LeaseAgreementExtendedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_MonthlyFixedCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly fixed charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_MonthlyFixedCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NewAgreementTerminationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New agreement termination notice period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NewAgreementTerminationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of officers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfSquareFootOfFacilityLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of square foot of facility leased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfSquareFootOfFacilityLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid balance included in prepaid expenses and other current assets and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other assets current with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PrepaymentOfFundingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepayment of funding amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PrepaymentOfFundingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyAgreementExpirationMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party agreement expiration month and year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyAgreementExpirationMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party agreement renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyInstallmentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party installment payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyInstallmentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionAgreementExtensionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction agreement extension description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionAgreementExtensionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionAmountPaidToThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction, amount paid to third-party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionAmountPaidToThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionConditionalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction conditional payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionConditionalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionInitialTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction initial term of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionInitialTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction reimbursed upfront payment to related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense ratable payment period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919370-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121603689&amp;loc=d3e36975-112693<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918703-209980<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919784-209982<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NantWorksLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_SharedServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_SharedServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=nk_ReimbursementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=nk_ReimbursementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunoOncologyClinicIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_ImmunoOncologyClinicIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_ImmunityBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_JointCOVID19CollaborationDevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=nk_ProgramEquipmentRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=nk_ProgramEquipmentRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=nk_NetProgramRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=nk_NetProgramRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nk_ClinicalTrialCostAllocationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nk_ClinicalTrialCostAllocationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_AltorBioscienceManufacturingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_DougStLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NantBioScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NantHealthLabsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NantHealthLabsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395681668840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">62 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering, net of issuance costs paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,302,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Total amount authorized for repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">473,586<span></span>
</td>
<td class="nump">138,349<span></span>
</td>
<td class="nump">6,403,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue', window );">Repurchase of common stock excluding commissions, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 31,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Broker commissions on repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,726,551<span></span>
</td>
<td class="nump">98,460,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,726,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,726,551<span></span>
</td>
<td class="nump">98,460,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,726,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="nump">8,521,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering, net of issuance costs paid</a></td>
<td class="nump">$ 90,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_UnderwritingDiscountsCommissionsAndOfferingExpenses', window );">Underwriting discounts, commissions and other offering expenses</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | Public</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="nump">4,811,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | Shares Sold to Public upon full Exercise of Underwriters Option to Purchase Additional Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares', window );">Shares sold to public upon full exercise of underwriters&#8217; option to purchase additional shares</a></td>
<td class="nump">1,111,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | Dr. Patrick Soon-Shiong</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="nump">3,710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="nump">$ 12.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares sold to public upon full exercise of underwriters&#8217; option to purchase additional shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock repurchased and retired excluding commission during period value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_UnderwritingDiscountsCommissionsAndOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts commissions and offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_UnderwritingDiscountsCommissionsAndOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=nk_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=nk_PublicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=nk_PublicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=nk_ExecutiveChairmanAndPrincipalStockholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=nk_ExecutiveChairmanAndPrincipalStockholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395576360568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Common Shares Reserved for Issuance (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="nump">3,984,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="nump">3,518,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Outstanding RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="nump">466,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664702040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,984,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176,000<span></span>
</td>
<td class="nump">$ 4,070,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercises of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 35,151,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ClassOfWarrantOrRightsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nk_TwoThousandFifteenEquityIncentivePlanMember', window );">2015 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock reserved for future grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance', window );">Additional Shares that may be added to shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based compensation vested and exercisable options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,868,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to unvested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="nump">343,810<span></span>
</td>
<td class="nump">462,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Stock options, weighted-average exercises prices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 3.51<span></span>
</td>
<td class="nump">$ 8.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock option exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,700,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Stock options, vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,868,008<span></span>
</td>
<td class="nump">3,973,614<span></span>
</td>
<td class="nump">5,577,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | 2014 Equity Incentive Plan | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based compensation vested and exercisable options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | 2014 Equity Incentive Plan | Common Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based compensation, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | 2015 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional common shares reserved for future issuance</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember', window );">Non Employee Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">90,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost related to non-vested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Outstanding RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,500<span></span>
</td>
<td class="nump">749,793<span></span>
</td>
<td class="nump">487,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost related to non-vested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember', window );">Employee Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost related to non-vested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ClassOfWarrantOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ClassOfWarrantOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares that may be added to shares reserved for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nk_TwoThousandFifteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nk_TwoThousandFifteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nk_TwoThousandFourteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nk_TwoThousandFourteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664011112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,139<span></span>
</td>
<td class="nump">$ 2,627<span></span>
</td>
<td class="nump">$ 23,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Warrants For Common Stock | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,388<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">4,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember', window );">Employee RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="nump">1,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember', window );">Non-employee RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,919<span></span>
</td>
<td class="nump">$ 2,128<span></span>
</td>
<td class="nump">$ 22,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nk_EmployeeRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nk_NonEmployeeRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583491112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Option Activity (Detail) - Employee Stock Option - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options, Beginning Balance</a></td>
<td class="nump">4,506,950<span></span>
</td>
<td class="nump">6,493,250<span></span>
</td>
<td class="nump">5,693,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock Options, Options granted</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock Options, Options exercised</a></td>
<td class="num">(1,272,273)<span></span>
</td>
<td class="num">(1,986,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Stock Options, Options forfeited</a></td>
<td class="num">(116,667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options, Ending Balance</a></td>
<td class="nump">3,518,010<span></span>
</td>
<td class="nump">4,506,950<span></span>
</td>
<td class="nump">6,493,250<span></span>
</td>
<td class="nump">5,693,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Stock Options, Vested and Exercisable</a></td>
<td class="nump">2,868,008<span></span>
</td>
<td class="nump">3,973,614<span></span>
</td>
<td class="nump">5,577,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning balance</a></td>
<td class="nump">$ 9.37<span></span>
</td>
<td class="nump">$ 7.14<span></span>
</td>
<td class="nump">$ 7.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options granted</a></td>
<td class="nump">6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options forfeited</a></td>
<td class="nump">3.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options exercised</a></td>
<td class="nump">1.89<span></span>
</td>
<td class="nump">2.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending balance</a></td>
<td class="nump">11.93<span></span>
</td>
<td class="nump">$ 9.37<span></span>
</td>
<td class="nump">$ 7.14<span></span>
</td>
<td class="nump">$ 7.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested and Exercisable</a></td>
<td class="nump">$ 13.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Beginning balance</a></td>
<td class="nump">$ 5,710<span></span>
</td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 11,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Ending balance</a></td>
<td class="nump">21,922<span></span>
</td>
<td class="nump">$ 5,710<span></span>
</td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 11,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Vested and Exercisable</a></td>
<td class="nump">$ 16,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Outstanding</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Vested and Exercisable</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share-based payment award, options, aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664035560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail) - Employee Stock Option<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">3,518,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">2,868,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$0.4213</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 0.4213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">512,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">512,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$1.7554</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 1.7554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">288,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">288,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$1.9984</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 1.9984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">262,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">262,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$3.07</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 3.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">349,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$6.21</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 6.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$25.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise Prices | $ / shares</a></td>
<td class="nump">$ 25.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding</a></td>
<td class="nump">1,455,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, Number Exercisable</a></td>
<td class="nump">1,455,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Outstanding, Weighted- Average Remaining Contractual Life (in years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nk_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395574824776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option - Employee Stock Option - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">96.80%<span></span>
</td>
<td class="nump">75.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583852376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail) - Outstanding RSUs - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares, Unvested, Beginning balance</a></td>
<td class="nump">1,139,428<span></span>
</td>
<td class="nump">867,911<span></span>
</td>
<td class="nump">888,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Shares, Granted</a></td>
<td class="nump">33,500<span></span>
</td>
<td class="nump">749,793<span></span>
</td>
<td class="nump">487,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Shares, Vested</a></td>
<td class="num">(648,336)<span></span>
</td>
<td class="num">(395,051)<span></span>
</td>
<td class="num">(172,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Shares, Forfeited/Canceled</a></td>
<td class="num">(57,750)<span></span>
</td>
<td class="num">(83,225)<span></span>
</td>
<td class="num">(335,420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares, Unvested, Ending balance</a></td>
<td class="nump">466,842<span></span>
</td>
<td class="nump">1,139,428<span></span>
</td>
<td class="nump">867,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Unvested, beginning balance</a></td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="nump">$ 8.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Granted</a></td>
<td class="nump">6.43<span></span>
</td>
<td class="nump">1.12<span></span>
</td>
<td class="nump">3.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Vested</a></td>
<td class="nump">2.04<span></span>
</td>
<td class="nump">8.83<span></span>
</td>
<td class="nump">6.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Forfeited/Canceled</a></td>
<td class="nump">4.47<span></span>
</td>
<td class="nump">7.29<span></span>
</td>
<td class="nump">6.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Unvested, ending balance</a></td>
<td class="nump">$ 2.52<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395664330552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Warrant Activity (Detail) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of shares Warrants, Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of shares Warrants, Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Outstanding Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of shares Warrants, Beginning Balance</a></td>
<td class="nump">17,589,250<span></span>
</td>
<td class="nump">17,721,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Number of shares Warrants exercised</a></td>
<td class="num">(17,589,250)<span></span>
</td>
<td class="num">(93,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_StockIssuedDuringPeriodSharesWarrantsExpired', window );">Number of shares Warrants expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of shares Warrants, Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,589,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_StockIssuedDuringPeriodSharesWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_StockIssuedDuringPeriodSharesWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395569066952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage', window );">Cumulative change in ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_PeriodOfCumulativeOwnershipChange', window );">Period of cumulative ownership change</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DerecognizedDeferredTaxAssets', window );">Derecognized deferred tax assets</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets valuation allowance</a></td>
<td class="nump">121,409<span></span>
</td>
<td class="nump">$ 91,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets change in valuation allowance</a></td>
<td class="nump">29,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions', window );">Tax benefits credited to contributed capital</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarrybacksPeriod', window );">Net operating loss carrybacks period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would not impact effective tax rate</a></td>
<td class="nump">$ 18,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member', window );">Tax Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome', window );">Net operating loss carried forwards as percentage on taxable income</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=nk_TaxYear2021AndThereafterMember', window );">Tax Year 2021 and Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome', window );">Net operating loss carried forwards as percentage on taxable income</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 389,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards will not expire</a></td>
<td class="nump">$ 226,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome', window );">Net operating loss carried forwards as percentage on taxable income</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarryforwardsExpirationDate', window );">Net operating loss carryforwards expiration date</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Research Tax Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_TaxCreditCarryforwardExpirationPeriod', window );">Tax credit carryforward expiration period</a></td>
<td class="text">2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 350,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards will not expire</a></td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome', window );">Net operating loss carried forwards as percentage on taxable income</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarryforwardsExpirationDate', window );">Net operating loss carryforwards expiration date</a></td>
<td class="text">2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax year open for examination</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Research Tax Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_TaxCreditCarryforwardExpirationPeriod', window );">Tax credit carryforward expiration period</a></td>
<td class="text">2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NetOperatingLossCarryforwardsExpirationDate', window );">Net operating loss carryforwards expiration date</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DerecognizedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DerecognizedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carried forwards as percentage on taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NetOperatingLossCarrybacksPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carrybacks period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NetOperatingLossCarrybacksPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NetOperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NetOperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_PeriodOfCumulativeOwnershipChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of cumulative ownership change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_PeriodOfCumulativeOwnershipChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development cumulative change in ownership Percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_TaxCreditCarryforwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_TaxCreditCarryforwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would not affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effect of an increase or decrease in contributed capital (for example, deductible expenditures reported as a reduction of the proceeds from issuing capital stock) during the period charged or credited directly to shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=nk_TaxYear2021AndThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=nk_TaxYear2021AndThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395577766216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Loss Before Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. loss before taxes</a></td>
<td class="num">$ (92,412)<span></span>
</td>
<td class="num">$ (65,286)<span></span>
</td>
<td class="num">$ (94,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign income (loss) before taxes</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(600)<span></span>
</td>
<td class="num">(2,306)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (92,378)<span></span>
</td>
<td class="num">$ (65,886)<span></span>
</td>
<td class="num">$ (96,729)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395588624312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax (Expense) Benefit (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DeferredIncomeTaxExpenseBenefitNet', window );">Total deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DeferredIncomeTaxExpenseBenefitNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred income tax expense benefit, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DeferredIncomeTaxExpenseBenefitNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395740848888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 105,537<span></span>
</td>
<td class="nump">$ 78,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">7,699<span></span>
</td>
<td class="nump">8,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">4,254<span></span>
</td>
<td class="nump">3,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DeferredTaxAssetsDeferredDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,128<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">898<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued compensation</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities', window );">Leases and other accrued liabilities</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">125,148<span></span>
</td>
<td class="nump">94,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(3,739)<span></span>
</td>
<td class="num">(3,233)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(3,739)<span></span>
</td>
<td class="num">(3,233)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">121,409<span></span>
</td>
<td class="nump">91,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(121,409)<span></span>
</td>
<td class="num">(91,732)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DeferredTaxAssetsDeferredDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets deferred depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DeferredTaxAssetsDeferredDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets leases and other accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583275608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax computed at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="num">(19.40%)<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements', window );">Tax rate adjustment</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Research and development credits</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution', window );">Stock-based compensation</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="num">(82.50%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther', window );">Other</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(32.10%)<span></span>
</td>
<td class="nump">80.50%<span></span>
</td>
<td class="num">(26.70%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation stock based compensation contribution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583668616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning balance</a></td>
<td class="nump">$ 15,656<span></span>
</td>
<td class="nump">$ 11,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease for prior year tax positions</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase for current year tax positions</a></td>
<td class="nump">4,763<span></span>
</td>
<td class="nump">3,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at ending balance</a></td>
<td class="nump">$ 20,413<span></span>
</td>
<td class="nump">$ 15,656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583161176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">30,907<span></span>
</td>
<td class="nump">21,995<span></span>
</td>
<td class="nump">20,228<span></span>
</td>
<td class="nump">18,607<span></span>
</td>
<td class="nump">16,120<span></span>
</td>
<td class="nump">16,077<span></span>
</td>
<td class="nump">17,313<span></span>
</td>
<td class="nump">18,340<span></span>
</td>
<td class="nump">91,737<span></span>
</td>
<td class="nump">67,850<span></span>
</td>
<td class="nump">98,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(30,886)<span></span>
</td>
<td class="num">(21,927)<span></span>
</td>
<td class="num">(20,227)<span></span>
</td>
<td class="num">(18,586)<span></span>
</td>
<td class="num">(16,111)<span></span>
</td>
<td class="num">(16,065)<span></span>
</td>
<td class="num">(17,296)<span></span>
</td>
<td class="num">(18,335)<span></span>
</td>
<td class="num">(91,626)<span></span>
</td>
<td class="num">(67,807)<span></span>
</td>
<td class="num">(98,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,132)<span></span>
</td>
<td class="num">$ (21,776)<span></span>
</td>
<td class="num">$ (20,092)<span></span>
</td>
<td class="num">$ (18,383)<span></span>
</td>
<td class="num">$ (15,641)<span></span>
</td>
<td class="num">$ (15,581)<span></span>
</td>
<td class="num">$ (16,682)<span></span>
</td>
<td class="num">$ (17,885)<span></span>
</td>
<td class="num">$ (92,383)<span></span>
</td>
<td class="num">$ (65,789)<span></span>
</td>
<td class="num">$ (96,226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (0.70)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in calculating net loss per share - basic and diluted</a></td>
<td class="nump">108,607,715<span></span>
</td>
<td class="nump">108,246,579<span></span>
</td>
<td class="nump">98,769,687<span></span>
</td>
<td class="nump">98,472,641<span></span>
</td>
<td class="nump">98,419,166<span></span>
</td>
<td class="nump">98,331,695<span></span>
</td>
<td class="nump">98,594,355<span></span>
</td>
<td class="nump">81,261,302<span></span>
</td>
<td class="nump">103,550,936<span></span>
</td>
<td class="nump">94,210,087<span></span>
</td>
<td class="nump">79,132,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395583624360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=nk_FourHundredOneKPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employee benefit plan, company contributions</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=nk_FourHundredOneKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=nk_FourHundredOneKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140395584599320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail) - Nash, LLC<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease runs from January&#160;2021 through December&#160;2027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_BaseMonthlyRent', window );">Base rent - monthly | $</a></td>
<td class="nump">$ 20,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_AnnualPercentageIncreasesToBaseRent', window );">Percentage of annual increase of base rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_LeaseAgreementExtendedPeriod', window );">Lease agreement extended lease period</a></td>
<td class="text">Dec. 31,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Optional extended lease term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | El Segundo California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nk_NumberOfSquareFootOfFacilityLeased', window );">Number of square foot of facility leased | ft&#178;</a></td>
<td class="nump">6,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_AnnualPercentageIncreasesToBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual percentage increases to base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_AnnualPercentageIncreasesToBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_BaseMonthlyRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Base monthly rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_BaseMonthlyRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_LeaseAgreementExtendedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease agreement extended period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_LeaseAgreementExtendedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nk_NumberOfSquareFootOfFacilityLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of square foot of facility leased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nk_NumberOfSquareFootOfFacilityLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919370-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121603689&amp;loc=d3e36975-112693<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918703-209980<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919784-209982<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nk_NashLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nk_NashLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=nk_ElSegundoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MU<>A!A"@U?;[/:>/4:I$WSM)]"<BD HB4;8 SK)8!*X&U940"Y2=BF%M3&]
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M?Z]O+O(6NPFT/X%CC0!/+; 3SN -.KS!#](=]*Y4CVM40&=3=;;KXBQ B!1
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M(JLO$T8!O#: ]T<!;;R]T=\^NV_=^W\!4$L#!!0    ( '6!9%+?,8EW;0(
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MTMB^Y(>5_7* <@%V?R6E>9ZXYC1\B_*_4$L#!!0    ( '6!9%(UF_N-VP0
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M(E,E^%,"1(-)HP@%OB' $ 5C-S0%&*)\-"I W D03PKPC0K)F@Z6E(U,/)A
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M*8#\?T.I.#VH ;H/18O_ 5!+ P04    " !U@612@U;,MT@#  #/"0  &
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MJ/D,K;]4<NV^9%_;!AY)2VUD48-Q!043U9\^U#H< ,+D#""J 5$;$)\!#&K
MX+F N ;$3IF*BM-A20V=3Y7<$V6MT9MM.#$=&NDS8=-^;Q3.,L29^4(*+3G+
MJ(&,W!O\84Z-)G)-%K+ G93;%.^ ?)!:DPOR]7Y)7KYX15X0)LB77)::BDQ/
M?8-KL1[]M(Y[4\6-SL0-(_)1"I-K\D9DD!T[\)%$PR1Z9'(3]7I<0GI)!N%K
M$@51T+&@Q;/AX:0#OGP^?-S#9M#D9>#\#<[X:U)!/J_)>Y'* LBUR%I)J2=^
M7*^T47B$?O9$CIO(L8L<GXG\"6L-QV1WY;1"CAS2%I3=_&(2#<:#J;\[5+K#
M+!F.QI-CLV67MR2*DL;L:/W#9OW#7N4^FQP428]T>FD)O<(M:^5Z3012Q U>
M=8FA#Z"O>I1+FLC)D\J5 HLO9W_Q-+F@@&$W6'WQ1&&1VU'&Z8K#!=;K"TTY
M$ UIJ9AAT*EW%6]XJ-"!/)78IS;A<-Q2NL,FC+ME'C5D1[UD[R#E5&NV9BEU
M%1P%M;HV]"OV3]*V6> EE@!;4$3/WAN=<&CMI\6I1=S2X=0BZ%9AW*@P[E7A
MBS24$_G4ENOB,S[-;3AJ,3JU"9.HQ:G#YEQN)PVK22^KXR)S+B&3KF(0!T&+
M0X=9,DRB%M5EE[<D#*,6$__@JBM ;=R30:/VI3#57=&,-J^2:W<9M\9O\+52
M/2[^NZF>.A^IVM@#RV&-+H/+$6JKJN=#U3%RZR[4E31X/;MFCB\N4-8 Y]=2
MFL>.#="\X>;_ %!+ P04    " !U@612\M!;ZT8(   4,   &    'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;+V;:V_;-A2&_PIA#%@+S+5XT6U( C2.A!78
MI6C6[;-JT[%06?(D.6F!_?B1LF*9/!2II%V^-';R\NCP)44]AU0O'JKZ<[/E
MO$5?=D797,ZV;;O_>;%H5EN^RYHWU9Z7XB^;JMYEK?A:WRV:?<VS===H5RR(
MYP6+79:7LZN+[G?OZZN+ZM 6><G?UZ@Y['99_?6:%]7#Y0S/'G_Q(;_;MO(7
MBZN+?7;';WG[<?^^%M\6IRCK?,?+)J]*5//-Y>PM_CEEH6S0*?[*^4-S]AG)
MKGRJJL_RR[OUY<R3&?&"KUH9(A,_[OF2%X6,)/+XIP\Z.UU3-CS__!@][3HO
M.O,I:_BR*O[.U^WV<A;-T)IOLD/1?J@>?N%]AWP9;U453?<O>NBUW@RM#DU;
M[?K&(H-=7AY_9E]Z(\X:8#K2@/0-R-0&M&] M08D'&G ^@9,:\""D09^W\#7
MKS#6Z:!O$'3>'\WJG+[)VNSJHJX>4"W5(IK\T U7UUH8G)=R9MVVM?AK+MJU
M5\NJ;*HB7V<M7Z/;5OP0TZ9M4+41WZK5YVU5K'G=_(B2?PYY^Q7-T<?;&_3J
MA]?H!Y27Z,]M=6BR<MU<+%J1C8RY6/57OCY>F8Q<^<^JS0I#LZ6]V;+:[<2,
M[)(SM+ZQMWZ[7N=R1F<%>I_EZ[GHPC+;Y^9,$D>LU>JP.Q2=<W^T6UXCD9NX
MO;?ROKOGZ%VYJG8<O?JU:IK7AO#I]/ W?).O\E8-LA!#?1IO<AIOTD5E(U&O
M^5U>EGEYAZZS(BM7'&6M"+]Z@RC^"1$/AZ:1/,8,NYARK;J_(CB*&+M8W)^/
M')1%JN(&*D(<QM1390F4S6F$55%J$+$X"C$]Z12'Z,DA^C2'?D*WVZSFS12G
MEL?8_GD'8T^8%4;FK-@I*V;-JIOO<[F&KI&85N+!TF3=TLR_R,_<-&H,Y$(H
MC8@V: S8J(W&S:0X"51I<5*;0C'%/YGB6TU)OO!ZE3=<KE8/65UG8N4R&>&#
M"_NAYH+O=,$=)($2W0*;0K$@.%D0/-F"QPEKFI\!2""FQ&?F),)3$J$UB;]X
MT\H;1N0@+MO6^4HN6HV<LNA0YN)Q\NK#[4?C(G@=NCQ;ALZA<<9(G(K4IE!,
MB4ZF1-_%%-MH12 I'(I[;R2S^)19;,WL=P&LC;PF:GC;%MT3'PE(->>)[ON.
MB,<\JO9RT5GT,TTL/L?99[SK8I#\'!.J#6[L'-PI81(HTL?7IE!<Q-Z 3MY+
M^VB;#'TVBA,!IF$\TH\S!,36?GS@^T.]VF;'561U!*QF!+"N^V#*<Y<0[4&_
M-*CT@>TEMMO6+4D-$B4=U9,!D["=D\8]L0S1=1]4G:PTHBS6[7$+U<0'>L%V
M?%D>H5$"*-]L1/TF\Q=TBK+U<=(]?B]%U=>T8C)F]1K]BP1N5H>RFZ"W_6\;
M]'$O"P,).VSNQ<8>4S#.. KTWD(1F P0G,!D<$I2@^0\&]72 ;VPG;V.<+]2
MX#[OX;X8@?MK#&D'8QV8#2)@C%.23+E4:HVC&C/@%[;SEUP I0'&_D/4F<<!
M(6!N.*'IQBU)W)+4G9#JPD!@V(%@Y=I23T5&<R"&819X'C G<%94AE APX0%
MND-0-R=!J)MD4/FQ**OPB$L#(F([(ZHNC=54)K>6&+*9**JB,*0CW(H'1L-V
M2'M.684AE9& Z 5%K[*N>5,")085F-HVB>K,P(C8#HE3:RL,P8KZV,>Z'1#T
MB&Z',9+^Z$P,,N#'9-@C ^P1.^P]M= BD-9PZ$<Q\<=2&7B-V'GM/)4C7QZ?
M[,;Q(9"/F!?J-19QX]JD0(E!I8^.5:):<K:K9<>U44NL0P0A#,=10+VQ= 8(
M(W8(^Y:"F#@Q9TG</.6.DK@EJ56B>C/0%+'3U/>HBPF$&1K[GC_RE"(#T1 W
MT;Q :4P,+(+!(X2X-Z4F!4H,*C#2DW>FR !&Q Y&+UP?$P.["!"BS!_IR, N
MQ,XN3RN0"=RPFON>_D TJ,#@NO>UW)+4(%'243T9R(G8R>EY!3*!I#)G(?5!
MR3A!J"8^@ VQ@\W_5" '<X\8>PS!9QX3L**[]\&(DWL2MR0U2)1TU".3@8ZH
MG8Z>52)3 R(%^O&$0:0[XY8D4RZ56N.HQ@RL1NVL9BN1J6'K*O##2-\L,NB
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M'[1Y.S$/60.02&J/AYNQ$TG83MRPP[GH5GR_5X5F/1$?:['33^2R\Y*;=Q,
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M!34VA(9MR.?Q4!B*&P5N#]A! S#8GB)0/[FGQ$^-9:!AR_#Y=&(*>P$Z?[D
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M\$'P@[["?L>%X'O]ZXZ5&]8I@/S[ELM9,7Y07W#Z;Q/7_P-02P,$%     @
M=8%D4H9RW0:""0  .18  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6RE
M6.]OVS@2_5<(W^$^>6W'3;?=;1H@35M<M]L?:*Y7X [W@9)&$A&)5$G*CO>O
MOS=#29'=I@O<?6ECB1R^F7GS9JB+O?.WH2:*ZJYM;'B^J&/L?EVO0UY3J\/*
M=63QIG2^U1$_?;4.G2==R*:V66\WFY_7K39V<7DASS[ZRPO7Q\98^NA5Z-M6
M^\,+:MS^^>)L,3[X9*HZ\H/UY46G*[JA^+G[Z/%K/5DI3$LV&&>5I_+YXNKL
MUQ?GO%X6_-/0/LS^5NQ)YMPM_WA3/%]L&! UE$>VH/'?CJZI:=@08'P=;"ZF
M(WGC_._1^FOQ';YD.M"U:[Z8(M;/%T\7JJ!2]TW\Y/9_I\&?QVPO=TV0?]4^
MK7WRRT+E?8BN'38#06ML^E_?#7&8;7BZ>6##=MBP%=SI($'Y4D=]>>'=7GE>
M#6O\A[@JNP'.6$[*3?1X:[ O7KZDD'O3281<J5[T 0M"N%A'&.<EZWPP]"(9
MVCY@Z&RKWCD;ZZ!>V8**8P-KH)J@;4=H+[8_M/B2\I5Z=+94V\UV\P-[CR97
M'XF]1P_8^^ K;<T?6GR]=C:XQA3IUY4MU$=/@6Q,#SZ4ZK6QVN9&-^H&#PE$
MC$']^RH+T8-*__D!H/,)T+D .O__8_]C0V<K]8 M=>3T>VWCVSV%N%1O;+Y:
M*N?GS_8Z*&-SYSOGX7&!'^I-@\.<"8J#DD>7D5=/."6;K>J1:*]B3<KJEM2_
M4%KTZ0ZA309PXDI]L.HW;7O4N]IN>=_99BE;<M=VVAY47FM;\5F(KIB)CI-S
M.X>ID1Z<_UO?'!3OAY7'?V[EQ%O\H]YIG]>\_?QXNZ?"M5AI<O&[]*Z5]Y)Y
MCN<4!M@]>O&2&KW7G@0COYE63M (HE'P1KHS(:[4%RSF#:I#A(B\L97*L0F'
M-S^%""E4IFU[ZV#.Z^Z@,N,BY;5UC:L.D]T:$OP5@8WD4ZINM%4O#55NJ:YU
M8R#8UFC(2:R!P4<(M(*6I\1PHM5UW^R0P&L3#P+_%:A.%;)Z;(%??7%9[^T2
M 0Q!YW4?**(7<$@!,H  0!A23(&G#>IO?WFZW6Z>[6DI?YT]&Y^XWI\^FF5B
M?,-G#F_[,#Z$7C/?9IF=@EDZ:"4)2VKMF?D<53;<N3TV(5/\PUC+>9/PD@J'
M@+I6V4'ULAS00)[8>]3\K0&9/0+7-"'5R=OQ!U, _2^J'/J -8QU9WB3L:4T
MFSZHP@3..V)TI5"8S*Q&Z=#A/8/AHUA((B&CB5;&[N"1"J:RIL1R&\%V9 F8
MW0Y) T"+)I=(03TL,H"")8Q#GPG+^H[K'\8[[SIO*'+A2><38K]_*[YH_I^]
M45VC(W?V5&.YLT6?QSDAD<X@#_A]P -"][%]"9N],'=PIG7 CD-;(Z$$94%6
M0,0C-CF#*CFK79/*A>[R!M'?D?+</SD0H$)+GI77_$&,=0R\GKU";'9&9X S
MO%<LBLD-)GT!@RP)C*\B2Y( ;&I=@>@B%) N#@I.1JGJ3DQA+>==_#_)K>2"
MLXNM D?<<'L+3!Z= W$O>-]G:WB)Z$,BSN?5S2!A"#2&!"M<=\&DJ03/6XJU
M*\)/KOP))%8=MG*O$5>ZKF%1DI+-W2ZIA11,BHEI$>%=ZD[+T1([0G>HIS =
M,>4L*16?@T53<$?Y,O[((A@[)URXY[Y6PF7?MVQG8@LS2!Q#?'XW7WM3L+AP
M$^""V_Z2FOF)=C>.J0OUDH:R1[4@ *KK,[@.ZR6-1./TPR$,1?DM0T.1H>QY
M<]E[QLGU\AY2I,XP-MSP,B8:>0PEP (D5R&)=DXM=[)QNC@&5&M!H_.\;_M&
M"@=SGLF-E.Y?GSP^7_V,60Q$X0['"M0$)[LL54(IT"?4JL3$FWK)3'?%PF;U
M>#2@BG[*Z8&T5\3CT[<05^H?,XA[(XR_)? 2/01XBQ1WSH'N3.3*=5-82D06
M/NPP@W><6*!(E Q$M]#5BMUT+!4=)Q_^,%F7HY*<5'#:"O,950CXMR5K1T,
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M(0&2 U[#\RAZ@>L BYT?UL#>?=&X,C#YM>YK7X!\W[!\7_D&L*^L5@/?D5A
M=E6"F&1:U*<52@LX6@TB8M@B+< Q?OH*9T-]75S=E#7P3?L?_^?%Q?EW/R B
M>H04#VP.*PBGEPWP+)CRRX*3,Y,AO(TOX;'C."J14.!>0)ZH9# W"7+-W=8D
M(L( 'Q&!S8O?';%(V00 S+DO!" 8'A827+3?SR)Z?>N0A#8>F)G1>0JXV X+
MD-^ PQ6(QG8=2#8"*004<8A=0:M^Y!?(<T"V2P"X!O8LEX2BG! 1.)0U</=$
M303>$L4(G2*N25*^Z,$(@[N!.P!)3INTL.ZM[_A=UVT"''F:,4+<;WGC?:"M
M*M? S[ .@#@LG;TR9J-$]L F8'W"B@ ;;/)NZ("4X P+MRR'$&FKJ\,7(H@D
M=5!6@1SS2[Y0H@-1 Z!ED Z-+#?Z(9+9MO, 70^<"?M7=,6 C0IPV/@MPI8P
MZ5#7C,Z-!]V@48VGPR> 0KQ'!()4@GMM$)O5'+1QU)0 R%54<]^NG%5AX"%$
M!=-:_P2A]U\[0"2+$OCE[L:C'O8[V)GD(LA@X#O$["40)S)6IVI2-4)2JT#R
MH$P1#B+P<KN%M7#36UB#2($6P TW'NX8+J."X[Z+,!NK!'1^6X'T!;/$PU]$
MNN\NK]_,IA^Z\E542/3LY?75K/CLM\ :+\[/9B.\@;D>.1@O"8Y=D3!OA>LL
MA9&2 '.!&"+#-L./)_SM_4]\)KIS?*C&CW8W#LF1KMBLB)_#Y@-9-8#K+MS4
M6]*W0"Y_^ X!$**[]3VS&2,NF@H$_5Z-"]#[*!4",!@<9)$@0)* LRZSTR>P
M1ZOS$>9@=V7'/$!)A )Y!18$'V3YA?GR5+3I<OSABI#+4#, 458B;E7*N*_(
M>\"XP5BK=;MJ!@=K E^#!)%[Z#L/Z*:7F23DL&@SL9H1P#=P"1YH\D.N_>[>
M"G24L4QK8/$E(6.QSZ_LX@S7>G96@'Q:.EI!D"DX$APG5:Q7R\A@SO)$)L.]
M> =\9FA#5'P;ZHPN7P18&99#D0WZ>B!+&#5!W0&KPN,L#(>6#5KX%/D##[$&
MP<DV8 /6I8NBA>PV/@/\!HT\?(9$<X!+:QW(0J\D8TYHA!0@)6GE>?&>GX;M
MF)C,=1I&JCS @#@@(81&85FAE5 Y5#H@5\C^3>=B*UK>^7. TZWV1#-D,*-+
M!UAK"/!*K1W8"XR//EMGPK<!@5.\N !)\PX?^XT>^X6Q2Z"^3[=(&N3BAY_X
M.->),$!H FT!<.VIL>3DV(: HD0Z1O@;LW'9 "Y *J.IQ(R'H#ZY.(\ZD@_O
MP(#HZ$Z07V]<0[0^!&0$E7PB4HZS.2*8+(3Q>G_QIE3?),K'XW9@2KF=G#;Z
M-S7H(S  \:P8Q$&S?6A*"L742$DD>=)2_QFRFPP1!%@7;6('1FP(K(11)P+Q
M@HKONCTBEUZ:"6E&,H1%=G U8'7".>$"81E\TQ[G&I&"$A!_9C$,;_TQ5&M<
M 6B.2-.A+2,'"5NW1"Y&"TT=K[I;#AO&.QH[\('O0GXS\3@(KNH?/$K"D@@S
ME-=HQ9"SKYS\O3F;<T&,G<*5'2X84,I1G ]OGGU!V EYIN]0@YN/P64!%*Z=
MRL&#-0$,\%T[5F)KY]==N079AC==XDLLZ,!$9;F MC99N60Y;8<.E@]D$9/A
M3"XVLPBS=(E>P]+>)HN?T*L 3C<X(X]$.:LK48J*0P>87Z#9:H_PG^$;O4'V
MNM!:4N'(0=*:A"%L)08BFMD[I'" K',-R498.0?R+UZX!S'?W1)?,2+D.@!K
MA5\"HOAU<^O\&$)%F+<G5OQ$$0P7-S!C!C#ZD-T(7L\F]\C>T1!(AP%0)F66
M#ZB81!_BFQ.KD[79,3HP+ +&"6_QDXCE0$8P1W2BN?XM-C$^A+>!.Y($CP$E
M]><">C3EFL4H6NOE%\ BNP]1+?!Q*)"T57<8I3-%6R32@GXGZMA--+U-;,C&
M3D@(U&$)VG5@:F#B6A,6C[S#NUA/^O[CQQN9@ VDK&L'@49T.$C)H5/MPB]1
M% ]\3K*L6J*XEHF?!"\9PB+M)*"A&+/>-5^\H?DD'P$4)HA3#@(@AZ"[6*EF
M$5.C+[\*L+I,6J-$-YG$Y0QI)$JK"=$%NK0#BP"A2Z(2<1["A@,N8\V*N$**
M/O6K4]2C]H(<RB9S33/0I&XU-/"[6R;Y!M!UBC]5\N*,C*ITXTMZS>@JL[?$
M<\BCBR ><U2-K*+0#>HF$P$A87D0NNEWK@%-K>$;#>(IF<4(#N\9IL,WY <N
M2$Q; D#U=E.#8=!%<PN<3%4I\"$ZC!Y,#Y::; N=1H4H5PW$Q3>4<YX-[Y$Z
M!W42/!L8R?,9J=(D3<BL(I2B!5ZB*4-$SM&#;:5TJJ%6$J1L:*MHG[$)5')4
MV,&%^@V K5);T#Z6\W!G2W$V*5K:JB;I /C;N@-TP*U6CI="/X],*0F'69O?
MA-DCRL&@6O9 WA(W#;($>,W 3'J])(/3&Y_J\(7)^=<L:@*V^2\EJ%_*L3!;
M_.X[6.T?X"^ (/W0K<M6@R<5,!T+< IPWSJDCPXE*$FW=#B0>\0T#Z\O/UTC
M[9Z]_.'*_R;_NGB$$=P%W.47U.R"B#FX^$22LW%8CW##$2RPR@QVT)DC5+,O
M1WHOKF9#8/ P>5=X'6 G88P+10B83GQ!D1R!6\B$  F9X@_ ZLWH3FMS@:CT
M[?4EY@$JX3B1D#G?5N8=6?FI9$(ZE4-&(\$&%_D+!0<$7O1G9]FY;;2^QNR(
M1]F$ I;@3WPE*%$L9*A! %#B R_KD8D+\H!;GELAIQ7D0('4VO#SO!A(@.42
M3'*T4!>=+RO,#MV68&@@&W/D&R4JYWX$SR+^XK'$XTRXM<9K+BL9,+:_*7K)
M.1,3S!MI+1>OFWT>RG?KHHE2C5):8[JE56N_NJV#[^JHN( GZJ7XOI])GMJ]
MH[#/3ZJ7?_S$+#K3^Y3R@9.R4-J3M+L!'8:1=;TH<IF.+O-8O.6IE2)CD4II
MF3,P.L BE)E425KMW@H6"A@^9I,)@X=75@6B"L%D55=%%4WK'RI+%:7,D(EJ
MO<0_ZYX='K_@D G9:5%)[\DR)G$!%\WF<=2Q9!W%8++<*$, Y[1*9A\E*$=!
MU02:L7/ZYU""O=7!8V(E9=<,1-VX-5)JYY?.5>1RD4X410@^9B?\R *</?AR
MY&MM/6* K)H,\G16QBBFR;IX+%H!?DAO2Y1'3%(\$8H2KR)2K@6C0J.;\"V<
M$)P1 F<OSCM%U 'SLS%>X5:^M. X@Y**07(44FD+(ASV'M"Y;L$.(BZ6+"99
M2AA]-@I5J !M%;U.C!KH[?/19NRTP3*N9E^)@"9)E-8V,>YRW3G>@WP&A MD
M8%>=@OO!K@O(C8XOC9:BI;<]!QK *JHB",CH=0RAA1CK"OSBT:4Y@A+AV);[
MF:J1A;LIF]4L.BE,3&@PMX%]7X8,S,V^D?"0&/X5.#Q+U(ZP)$;N05$0FLH=
MR(%N(VZ.?1-M2>)5#'LFW^N*\TJ?-./R@4CWF"V1@O_6ZR,"CV0(0(5A\0?J
ME2&(QYWV9)\%=R,#*_1:6T OHI&!F5,R^$<I5/KE\90I!XSO>!MEIX3),#='
MH7LC-&L)\E.L1PH:T,5D&Y=X];^ FTK.!H+*WM3_<IJ6XX35*#WE[X0'P& Y
MRSH^AIJTO($7IJ@GYQ=P.<ZL[J?!1OO]ID:FP-/!C1&CX[Z@*7VH66*]>_O^
M2JBS.K(./N:^+C$2 _NN7!7#ZOP6L2Z[C%+DD&7H)=@-M@4*(4I&&G/78JQB
MJV*D]A%4D\@3X'VW/P!2(Q\^N'1&O6BZJ&A8)J^%(SPB*[U(#TVT80+O($\H
M0M]IB)6L#XDZ(/=U_A;5'&9NP"WK6"I$'XRHZ)T7G^1M-ZQ!;B(!A=Y8H._>
M7DHN6.*_E'KDX"B=O51A#33@.^8K37T6 8B*39'.J8YK/7E;G03D47NVAI .
M3BFG0M'J]%'6GYPN/W92,D!V2'6=^G"5:VOS0O8\E:>T>T'[Y!.[,L2%FG*/
MF7J@F%WRHC#Q!FBJV31#@R2:6FAG@IBC(@S\L_AI)$$^B?$&\-'G5V/&U/RK
M&%H-U;9DP6TN0@ "!1U7MV1P]4-* X*H5T?<;$:,&+5'24*?DZ"DQ85\6421
MEJ.8/:4=03&@)4'24<H *&L?@W<4OR!5M<55F11 61W9HY[*!&GQT$3>9U$V
M="]4E1C44X;?50UJ^YI_7KC68=F)U*^9]+5Z&^,4&!:0!7Z9<^PF:H5!TF@'
MX?' VB =WRZIJ$-#AW=4VW1CY)MCWY_>HE>H!@D/#+]X"ZRQ60"FM%X1_SQ_
M25O!/U[,T<U6Y?06E5.>*V(*DF(A.C@?NK;ICF+=E16EAKO^E(TGQ 1<.L!V
M2D@!"VOKJ5;DH&@H.2W@XN#1**,SJBK"W#/(8_OPPB,@IEAL+U&B+*43DD]W
M"HN<HM#)#CV"A_FD<ZB+\%J%2R2GFHJ-T#M ="!Y:+$:A=D$#73JNY7_'5N!
MY86R@G,*:=/#S2C"AWMQ-NN.S=@^UE!L/TY9HG0SV=B#+&S^.LD"<&N!G=G^
M!:X8-@/[+,R:^''G;K!R^I9-X6^@7TKD8288Q&/,"TF-4JR>04+<*B\9F 52
M4>N::2-H3A&1IUA*"438[;6(B@\E7DI.TASX_;?RRI_N1*(58O_;^Y$Z)S5+
MR#7$D#E'@;8EP55^G2%&$HUA7NH;[Q<4'N9!]UPP85*>Y)7&6%:-V<=4VBDI
M5) U4Y:EB^FFBB+K7 "5:#<<IH*( OP.SP=/82F^DGDW30VB=TS:5*Q\P1I%
M(<2HY1PWH@]^QN(*_L5*LF:IG)-SA>C;20E-C.7$VM2,<,E+W%%Y7LAJ*#D0
MU4M^B*J(1JEACFR5)"-! > 5B5^YYRQ<F'!Z.?Z<JH<Z4G([,3XQS!=BP6"6
M]_3=^"56SE0SV-1?'!5DE:VNIS4AT2*+98AM5F>QX/JB!/F*D@A H6 .()8H
MK2K4,IFE9 OHS\$C!E@2<KXQ$$V3/QD-=@T1E:TMX^T[QZ69&_!.)<NC?(3P
MRC)@ [>!RZP#1S<H9TQQ $EF6@5VZ!:1<$[>**<^.\P^$V*YX#*+1QZD=:FV
M,V4 F<0/F6$V"B(J248_A;@*F4KJ#K2&EPQ]M[8$&%,Y6JLS3AZS*4\V-1CR
M4[QF$E\A$[VXU!YL:>!#"N?=;[A\9,,1R/EC4XJ]AG8SQ;G,I]OXJ8N? KV2
M/"5-:-)$1&.LUXW  Q,40&7[;5[\8_1X-(]MF6BJGXE!C[('PVXQ]&I(LJT)
M(.6>8PVXDEI(3#C7G<80Z ZX***C3'NW9FY"V4WZU5BB64 :4TO&\91@F8:L
MYH#K=#X*SMV'.SC[4G"3"H(HY8*I2B(H+HBC$"XK;8U8'B0I-<'8LPSDLN/P
M_<F;H28J"R=/7C)IG%S[58\U#"=/Y!<_EPNT*M'5C ">/),/WPU=2[=1_$>Y
MV?X ./E*=Q,?>/_9O!671+N=Q"R0*OAYK'-//M]PF8?K,@-?3/Y.0I\KEYVH
M^!5+R:L:[-K _J(M)+H'T;-43&)C_,<($^\%;$F/ED]TX[\]2X]$Q-; 3!@
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MRQ<3JKO/"-W$JIU_=5\I:U7MAUO.*J[= >RO%8S:3YR \5O.Q3]02P,$%
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MN8<,,J<&9<N@$TE9%LM#..H-I,BA[LB"V>3T^,TL.NF'J=?W<?(TB'9O_ML
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M;8@KTPZV?87R$&DH:N]1'P^)56A#[12*S^LP"'I'2PUQ,G/)I&5^2R>!YOZ
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MF[Q^.8H'K_8AV(HOPI8VH"SX9ZXDTHT6X'MF4=S- RGH;D8O_@]02P,$%
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MPW*"YE$ 7AQ5;W VIAUX"Q&XS Y^1X,N(>_!0&XYT;*BBHB-#M-,3&P O_-
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M#"P=: &^KSU.->T/<M#__\3YOU!+ P04    " !U@612E+?*VSP%  "B#@
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MY<17J4N(SDOGT*&CZ-RZA74R;#@1]?<&T5:TGW:'HT,\)/BW'1]&.S5QF*Q
MQ((,L88E:OZDYJTY/]L@]2L0-Y,0'_[Z)* -OSJ86]$@Z0Y&Y'+<)[\'[#83
M#R.<SE@$1LPL5H A)\7$HJE1W.WWAQ$7<_*F^:VHUVMFOT!?$2-OJTRZP_VD
MD=E.42&2TM%&V@8'W3B-R:[M(3+Q8QI]L";[N5]Q=[\?/U02=]/#84N\T?,L
M;U4=&(UA]R!=ARB.JQ@1-8[&6586I48C<E&NLZ$Y&P*WXT;^M?1>314R2?]4
MP82Y#&(N[T!,  Q7%15-4*;$4F%DM-TKWKTH)30@!:6,P!505"L *XK?8?W
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MSO$2"8X8\/W4VK!Z( 7-M?3T'U!+ P04    " !U@612&Q'@[70$  !5"P
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MKF7G0[IL<_CZ@]5E\?BA!.;[H*N+R3DN*#RM2W7]-FKPL4B?+6UMX"2+EN'
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M!)B%/ZXT((VC!W!_86T3O] &Z6=F+_\74$L#!!0    ( '6!9%( K\3WM!
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MLT!=8S V2=PYB<L']XT$1XLE5BC4B_'GI4L3,G]0/@6ASH!P1B-,<'&S="M
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MM1NZ#^JCIWXZ%,I"I?)L;$-%$E4-AJJ+3",TMF&3"FD>5CDG6O2A29E6#PO
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MIQ*VU9?"K?FW"S-7%&[%'Y<&Q4-.#^ ^J;'Z0AO4/V9Y^2]02P,$%     @
M=8%D4EL" K6C$0  W3<  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
MM5MM<]LXDOXK*-_<55(ER[;\$F<W297CS-[D)LFD)K,W'Z[N T1"$B8DH05
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MHI0WC./(R=-KQVRY=2Y6 KUA2L16775-S8O)B!Q_KB33OX]AI ?B[^[%CK2
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M&4S]3:&#0W#U3=V=WDR<(H>3K10Y@&C7N(<GL@8QK682V?#!$N3QJ@)1#R5
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M<']A4#+&+S1!]XN^-_\"4$L#!!0    ( '6!9%++!OZ&@@8  +D/   9
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M$L<A#9&^_VZ>Q,=O6SSZH'7#JI237-*5+$MDLI,F)Q>_I9N*?FTJ3LF)=U9
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M</*T]8HNEP)@L,$%\'Y> V2:&V0P_"[OY;\!4$L#!!0    ( '6!9%((O#\
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M#9:.A4NK^F'B]M!">8^$8.L&L )4:-"Z?R!RMZ'#::7;P\!X0KMD4U\O_<[
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M ,\7!M76W)" [O\F7OP/4$L#!!0    ( '6!9%)TAR%:\0,  $0)   9
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MX[B7Q6G+/P^DH,#RVACWL@@.IM_1]F]02P,$%     @ =8%D4@HM=/.W-
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MJ5GM&)YT%L;1\'PFU.;YXPI_>_L3KXE8$!\J\4_@(Y&KB!SG1L2_P\=[,K*
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MACE8C -MU+Q HZ4($F8@<SRNBXUZ>>>/'E:WO"6>(?L=,S@4PL6)%VI\P;?
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MI I(.Y8(L,?%DKYA.*S)VAD2T8'<:,KWGF(-5J*-5Q)JQ^T$ _3BJHT)&9-
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M7"N3M E,>PGR!OALB<4KD30B \ UV;*==W[YBLJ.I2/#\1EV9+#10=[X>4S
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MP4)]P"UW95>XZ&W<:./@,!A]Q4P*8L:6?!E;DZN?B(![EB*$ I"R&K:W<K8
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MAW:Z[+O(Z_:^%__@>HMPJ/H23:.+2Q2.[OM;/[&J=3UEHRQV*#>L\)< -&W
M]5(AY<.$ (:?C,7_4$L#!!0    ( '6!9%(CNSQM"@8  $ 0   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;*U86V_;-A1^YZ\@O*!P *V6*%F2VR1
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M<%W2[7NU75BU\V_$I;)X<?KI%D]\H=T![*\56DNW< ##/PU._@502P,$%
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MHE;OEV%Q;5^S%X\?O%5.C=,I3%#4/^_BQ)3%@Z+8:#&WE_BQT/@DL,L9OL%
M&@;\/A%"KS;&0/6J&_P+4$L#!!0    ( '6!9%+/6!IP, ,  !H(   9
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;*U6WV_;-A!^UU]!J,70 D(D47)L
MI[:!.%FZ 4T1)%WW,.R!DLX648IT22KN]M?W2,FRTB99"^S%O*/NON^[XR\O
M]DI_,C6 )5\:(<TRK*W=G<6Q*6MHF#E1.Y#X9:-TPRRZ>AN;G096^:1&Q#1)
M3N.&<1FN%G[N1J\6JK6"2[C1Q+1-P_0_:Q!JOPS3\#!QR[>U=1/Q:K%C6[@#
M^\?N1J,7#R@5;T :KB31L%F&Y^G9.G?Q/N CA[T9V<154BCUR3F_5\LP<8)
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M"=T/2E:[?"MS33*34I''?B%6I.6.O>) 2X+(CS4]S0"AVPK:S\=Z;\#_4>>
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MA]@Z5#6I5QLCUW8Z7DB#L[9=IOAQ XH.X/NEE&:W(0'-Y]+T.U!+ P04
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MH7$*?)]K37O!.>C>T=D_4$L#!!0    ( '6!9%(A9AOG P@  )L5   9
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M@@E;5E?L:J/%REQKIT+#)=DLEYQ!34 "^#X70C<;!&C_SW'V#U!+ P04
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M"' 6EOHW*[;6HV5 X32*@HVO>%<-W5B'^&>1RB)(<A9D";5FGI5!5N0>C8J
M)5F0YJ6SL6]!3M/_H!(6<50IM2+E]L'P4;XA4IQ$Z!7$-/9H%D1Y;E\4*W]%
MI#A.;7_1G96NTQ:1I9-%*7TI4HZZ'1:SPHE$4U2:3I9MP[\3B;&#(#2?K>R%
M]?]%*FC ,AK$$;,BI642Q&EJS1@_P*QT9D++@&;9:\=.>'+X]Z"V[HK3I++?
MWG@/S+/S+7HS7AY']_$*_LC5MA6:=+!!:'29ISY1X[4V#HS<N:MD+0U>3,YL
M\)\ *.N ZQLIS6%@ \S_+59_ 5!+ P04    " !U@612^0Y)0#P#  "6"0
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M+H 1B?6'G8)F=BI*AOE7*>TD4A:5D+KP.8/BM[G?S5PC/Y>K]+/CZ+ _FQ>
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M],!JEX7^1 !A#/1]SKG:;TP ]]$Q_@=02P,$%     @ =8%D4J('95!8 P
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M">VSN<L4= R\QQ%"T9[/'AF*0QCU&PT:H\'_L,VI[K,<''@)O G>=WRH"F$
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M@SPW'!]Q-/<.=WT3?Z-BPPI),E@CS!H%J% TMUO34+RLS_L55WA[U)\I_A"
MT $XON8X\6U#7R'=+\;\'U!+ P04    " !U@612U3[K:"4#  #="0  &0
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M,F'U+MW.@XE6;GLL6M=H,AJV-F^ !RWPH!?PFA65%:QV'QZ#!6%T F8Q\KS
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M[&,<D<5$^^>FF*\/5"Y-[3)8H,O.583'*HN956RT6-DN/A<:9X)=ICCF01H
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M$WD#_7[.N7J]R3NHCEW'_P%02P,$%     @ =8%D4I8$J$_5 @  -0D  !D
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M9P-3X-PQ81X_&](HQ'3 _?:._;T7CV(6U,!4\6^LL.MA=!:1 I:TXO9&;3]
M(ZCG^'+%C?\EVV9M$I&\,E:)!HP9"";K+[UK-F(/D/8/ +(&D#T%= \ .@V@
MXX76F7E9,VKI:*#5EFBW&ME<P^^-1Z,:)IV-<ZMQEB'.CMXS267.*">7TEA=
MH4/68'L#QM9M)LD5U;=@Z8(#F<'"DCGDE6:6@2''9%P4S#GB*>ISY?QY,T,$
MXV]Q1;/\?A!;S-C%C?,FNTF=778@NS0C5TK:M2'O9 '%8X(8I0:]V4[O)&ME
MG$%^0CKI$<F2+'DFH>E?P]/SEG0Z8?L[GJ][@.^*WC%1B1:F;F#J>J;. :8Y
M_L&+"AWZO"3C#>Z\MPN/.IE3;.Q9]OTC0LFE!6%^M 3NA<"]5@DAV#&:?VQ<
M,!."'9$2-%,%44M22;QG./L%!>'*&%(JXP^.>>Y<M,?$<R'\N7C.P1=!'TGO
M!^G]=O>8_(-[IX'I]'7=.PN!S_Z#>^TQ6]U[$?21]/,@_;R5Z\E5UL*8)@^W
M:?*Z/J9[%WG:*N=3)1:@G56TS5-WG_^3ETW8G@_K7@6;4:<[B#?[R<9[!4B
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M,%)3907@^TI*\[BQ0ULUI,^^ U!+ P04    " !U@612I_X0H-T"   +"
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M$U0DC')R+[11!6;4:!PO09MRS 1YH.H%#)UR(#%,#9E 4BAF&&C2(A.LQ+3
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M.,POEXSZ3&0-U._S.)9O-UD'V^\N+_\%4$L#!!0    ( '6!9%+9[CY*>0X
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M1'6#-'Q#R]^X*>PM_9.J)1,:,UZ@+CCK(VZUOOG6'2,K=WG,I<&KR#4+_%@
M90-P?B&E>>[8^ZC]_!C_ U!+ P04    " !U@6129*1PHHH"  !G!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6R-5=MNVS ,_17!V$,+;/4M=B]P
M##1.APU8L:*W/0Q[4&PF%BI+GJ0TW=^/DATO39-T+Y8H\1P>4A*=K:1ZTC6
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MH6A\ JUOM';[P&_0-^7L+U!+ P04    " !U@612.YP2Z>$"  !>"   &0
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M#_#(R7P4SR^T6-OA]$EH''7M<@4\ FD N+\00K]>F >4?XB,_P=02P,$%
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MRQ KSOV*"T$/^<'6F@I!DWRX)WA#6 :0S[>4BO-%-D%U^CK_%U!+ P04
M" !U@612<15)O$<%  ! (0  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6S-6EV/VC@4_2L6XJ&5.B3^"(2*09JOU59JMVA&;1]6^^ ! ]$D,1N;86:U
M/W[M),29)7$@I8)Y&(@3GWM]<G-.;#/:\.1)+!F3X"4*8W'964JY^N@X8KID
M$14]OF*Q.C/G242E.DP6CE@EC,[23E'H(-?M.Q$-XLYXE+9-DO&(KV48Q&R2
M +&.(IJ\7K.0;RX[L+-MN \62ZD;G/%H11?L@<EOJTFBCIP"919$+!8!CT'"
MYI>=*_CQF@QUA_2*[P';B-)WH(?RR/F3/O@TN^RX.B,6LJG4$%1]/+,;%H8:
M2>7Q=P[:*6+JCN7O6_3?TL&KP3Q2P6YX^".8R>5EQ^^ &9O3=2CO^>9WE@_(
MTWA3'HKT/]CDU[H=,%T+R:.\L\H@"N+LD[[D1)0ZX+H.*.^ TKRS0&F6MU32
M\2CA&Y#HJQ6:_I(.->VMD@MB?5<>9*+.!JJ?'#](/GVZN%;CFH$;'JF;+6A*
MUP5XR&X4X'/P=:7;!/BZED+2>!;$"Z ^P'<FI.HX28*I;E)7WKVP9!H(EK8Q
M =[=,DF#\+W"NXM6(7]E#*0Q<\R1(]4H="[.-,_X.LL8U60,$?C"8[D4X"Z>
ML=E; $<-O^  ;3FX1E;$6S;M 0P_ .0BMPL<()8T82+[;\''!<<XQ<=U'&L@
M4,%Q>D* J[5<\B3X1YW^IH:4O"$(3$*JF'_+*[BG\8*!/S^K2."39)'XRY(G
M*?(D:9ZD)L^*N_P!_+&.'E5*I;:J6Y8!>RFP%H+G,?:@[T)WY#Q79.05&7F'
M9_0C?=+8[ )</;-$20>X9UI_= 7>J,I(U).^IB'X',P9>!?$X)711+RO2ML>
MW<MZ@CZ(TH*S4-PO!M1O37%^B^ECR*IR[>]0C/R^[[I^-<6#(J/!22FV1R<Y
MQ7Y.,5!/]XR^VJCVBX'Y5NBNVR,(8@O2L$ :GO7S"UTCYJYUS/]7WW^!D;-*
MI<W@_%)1;5FKJBE8<A7XJZ0D1RX7N@>1B_LU.2&3$SIII3>$QWFI0W=;ZX@T
MU3HT%@/QKQ*6''EOPHV=P!9^<DS"[>%;$6Z<"=K-H0M[ \\C-BQC"K!_W@)C
MS +:]?I@@1GL",R6M\K:,N(.[>K^,P+C5SBI3]RZG(Q-P.%IZ]T>/O=2VPNQ
M,1)D-Y*?D),<>5]ZD?$4U,)3CDAO0_@]Z#56A.Q>H,1C./1MXH&,\J/SGET@
MXP?(+LB'BD<.]U8\,MXJ*\EH-VHQK=A//'+D-]7=1\HN:W(R'H!:S R.6=WV
M\-L7<9AYI9KS-#@E,IZ!6LPP]M22P6%L&_M +>SCF&S;PQ_.MC$A9'>!+NZY
M ]NBA?$ [)ZUL&#C#-@NS8<*2PXW+"]7I*Q5%14VJHY;3##VDY4<N5SH?5?_
MU>146GIJ,2\X8J$WA!\</K_'QD]P^_6J!F'!%0M69*B\I89O8RWXM"M6#>';
M\&TL"ML]HMOO(6A#,I: !^<M+<8HL%VI#Y86?T=:,M8JR\JH.FXQM=A36H8[
MI4XLTD*,/Y 6<X0CEGI#^&%>ZF3_V3TQCD+:KU\U2 O97;^JH]HX"SGMTE5#
M>+=QZD.,(1&[(W21U].U5P]5VJX@9ZTBQ+@"L<ORH2J2PPW*[[U>31$9^2;M
M]QZ:MG=V-Q\@\3SBU56V<0)RVNV'AO#;%_'!5D0:W\2)L0[2?HFJ24-VEZCL
M?!LC(:==HVH(?P#?3FE3.V+)(MVZ%V#*U[',]K>+UN+G 5?9IKBY//MMP1>:
M+ (UZ)#-55>W-U#$)MEV?78@^2K=(G_D4O(H_;ID5$F&OD"=GW,NMP<Z0/&C
MB?%_4$L#!!0    ( '6!9%*F7YWH@0,  ,P+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;,U6VV[;.!#]E8'0!5J@MBZ^%[8!VTFW!398(T';A\4^
M,-+8)D*)7I*VX[_OD%)D)Y69+M"'OM@BQ7-XS@PUG/%!J@>]033PF(M"3X*-
M,=L/8:C3#>9,M^46"WJSDBIGAH9J'>JM0I8Y4"[")(KZ8<YX$4S';FZIIF.Y
M,X(7N%2@=WG.U'&.0AXF01P\3=SR]<;8B7 ZWK(UWJ'YLETJ&H4U2\9S+#27
M!2A<38)9_&$1=RW K?C*\:#/GL%:N9?RP0X^9Y,@LHI08&HL!:._/2Y0",M$
M.OZK2(-Z3PL\?WYB_^C,DYE[IG$AQ3>>F<TD& :0X8KMA+F5AT]8&>I9OE0*
M[7[A4*V- DAWVLB\ I."G!?E/WNL G$&B <7 $D%2%X DLX%0*<"=)S14IFS
M=<4,FXZ5/("RJXG-/KC8.#2YX85-XYU1])83SDSOC$P?6G,*1 8+F=/IT,S%
MMP5SP>C57;J1 C7\O;73K:7B*2_6<",S%& D7*%!1<(0/C*NX"L3.P2Y@IFF
MD^$P&KY8=CIR<)UOA3PB@MNVXM3PIV*%H25OB8QQ\8XV;USIF7\#(>@-4ZC'
MH:&X6'=A6L5@7L8@N1"#."$[A=EHN"XRS)X3A!30.JK)4U3GB9?Q"M,V=.+W
MD$1)U"!H\=/P>.B1TZF3W'%\G4M)MH&!AB3/%$5^C?19&I@?X7S=DAW=].S
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M-9KCWEF"<,_5>\AYY'E[G@9 ./"B84M19RDZ:NFV5YO6UD$CT5")@LETS\P
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MG+:;RP-\$%&A#>#YCG/U,M!'[OX3:_4?4$L#!!0    ( '6!9%+(8SFW?0,
M "4-   9    >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;)U7RV[;.!3]%4)
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M!YL,:LJ[D;SVY[ #" \!HAX0?0;$!P#C'C#^*B#N ;$[F4Z*.X>,:)(F4FQ
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M."4UN^YF/9@'X6;U]@]S>_ZB+=C_KXC_ E!+ P04    " !U@612EXJ[',
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M\!4^G"]D55PXT?WID[NB).T2O.9M51V'<^?FLY7EZD<@JQ^P?/@74$L#!!0
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MZ\%UXTL^F_]K?/T;4$L! A0#%     @ =8%D4@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !U@612
M"Y_Q:NX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !U@612F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '6!9%)8X(/W\ 8
M +,:   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " !U@612M<U6HL<%  #W%@  &               @($S
M#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ =8%D4M\Q
MB7=M @  EP8  !@              ("!,!4  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( '6!9%(UF_N-VP0  #02   8
M  " @=,7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !U
M@612@U;,MT@#  #/"0  &               @('D'   >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ =8%D4O+06^M&"   %#   !@
M         ("!8B   'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( '6!9%**GO*(* (  (,$   8              " @=XH  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !U@612$6'@@'L*  !",0
M&               @($\*P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ =8%D4H9RW0:""0  .18  !@              ("![34  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( '6!9%(&# 'CXRH
M .^$   9              " @:4_  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ =8%D4O7+1-_K!@  UQ$  !D              ("!
MOVH  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !U@612
M<*W3/[('   E%0  &0              @('A<0  >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( '6!9%*N_]K<ZP8  *L0   9
M      " @<IY  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ =8%D4I2WRML\!0  H@X  !D              ("![(   'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !U@612&Q'@[70$  !5"P
M&0              @(%?A@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( '6!9%+][OR7L1(  '(V   9              " @0J+  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ =8%D4@"OQ/>T
M$   V#(  !D              ("!\IT  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " !U@6126P("M:,1  #=-P  &0
M@('=K@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( '6!
M9%++!OZ&@@8  +D/   9              " @;?   !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ =8%D4JA(/0W,#   HR<  !D
M         ("!<,<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " !U@612"+P_  L,  !#(0  &0              @(%SU   >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '6!9%)TAR%:\0,  $0)
M   9              " @;7@  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ =8%D4@'&*=.# P  HP<  !D              ("!W>0
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !U@612^VO;
M\2\#  ":!@  &0              @(&7Z   >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( '6!9%(*+73SMS0  -FP   9
M  " @?WK  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
M=8%D4A4OQE;Q P  < @  !D              ("!ZR ! 'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " !U@612([L\;0H&  ! $   &0
M            @($3)0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( '6!9%(AYD:HG@0  .$-   9              " @50K 0!X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ =8%D4L]8&G P P
M&@@  !D              ("!*3 ! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " !U@6121R 1$;L$   Z#0  &0              @(&0
M,P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( '6!9%+?
M<\+^@P(  %,%   9              " @8(X 0!X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ =8%D4B%F&^<#"   FQ4  !D
M     ("!/#L! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '6!9%+PY"'X(@,  ( ,   9              "
M@;Q7 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ =8%D
M4J('95!8 P  50P  !D              ("!%5L! 'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " !U@612GA"VF]T#  !?#0  &0
M        @(&D7@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( '6!9%*^FO'$50,  %$-   9              " @;AB 0!X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ =8%D4I ?&VNT @  8@<
M !D              ("!1&8! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " !U@612."K <N("  !N"   &0              @($O:0$
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( '6!9%+5/NMH
M)0,  -T)   9              " @4AL 0!X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @ =8%D4C AX=5+ @  U 4  !D
M ("!I&\! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !U
M@612?4D0-]\"  !$"   &0              @($F<@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( '6!9%)=$",$>P,  #,,   9
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M970U,"YX;6Q02P$"% ,4    " !U@612I_X0H-T"   +"   &0
M    @($ B@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M '6!9%*BR3I>K@4  /4K   9              " @12- 0!X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @ =8%D4M@V&G%;!P  @RD  !D
M             ("!^9(! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    " !U@612V>X^2GD.  !<3P  &0              @(&+F@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( '6!9%)Y##@:T@(
M (H(   9              " @3NI 0!X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @ =8%D4F2D<*** @  9P8  !D              ("!
M1*P! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !U@612
M)@PR3WL"  "@!0  &0              @($%KP$ >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    ( '6!9%([G!+IX0(  %X(   9
M      " @;>Q 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @ =8%D4F\OZA+)#0  @5   !D              ("!S[0! 'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " !U@612F\VDTS<%   T%@
M&0              @('/P@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+
M 0(4 Q0    ( '6!9%(,U_DH70(  )4&   9              " @3W( 0!X
M;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ =8%D4JN$:NPP
M!P  :"8  !D              ("!T<H! 'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6Q02P$"% ,4    " !U@612U5UX9.X#   <$0  &0
M@($XT@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( '6!
M9%)K:;VJX00  (D5   9              " @5W6 0!X;"]W;W)K<VAE971S
M+W-H965T-C0N>&UL4$L! A0#%     @ =8%D4G$52;Q'!0  0"$  !D
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M=#8Y+GAM;%!+ 0(4 Q0    ( '6!9%+@!8DYKP(  &,'   9
M  " @1GR 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @
M=8%D4O 60_\A P  I@L  !D              ("!__0! 'AL+W=O<FMS:&5E
M=',O<VAE970W,2YX;6Q02P$"% ,4    " !U@612ED-:%[D#  !N#0  &0
M            @(%7^ $ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4
M Q0    ( '6!9%+(8SFW?0,  "4-   9              " @4?\ 0!X;"]W
M;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ =8%D4K^YCLS) @
M<0<  !D              ("!^_\! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX
M;6Q02P$"% ,4    " !U@612&;JIL/($  #I%   &0              @('[
M @( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( '6!9%(C
M2' ==@(  "H&   9              " @20( @!X;"]W;W)K<VAE971S+W-H
M965T-S8N>&UL4$L! A0#%     @ =8%D4FX?H[$G P  *0D  !D
M     ("!T0H" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4
M" !U@612M[N__5("  !D#   #0              @ $O#@( >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( '6!9%*7BKL<P    !,"   +              "
M :P0 @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( '6!9%+=179/I@4  $0S   /
M              "  941 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !U
M@612>NU.;58"  ".+0  &@              @ %H%P( >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !U@6125:BY9Q("  !S+   $P
M            @ 'V&0( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     50!5
+ $H7   Y' (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>349</ContextCount>
  <ElementCount>537</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Financial Statement Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails</Role>
      <ShortName>Financial Statement Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Agreement and Plan of Merger with ImmunityBio</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio</Role>
      <ShortName>Agreement and Plan of Merger with ImmunityBio</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Viracta Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment</Role>
      <ShortName>Viracta Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Financial Instruments Investments in Marketable Debt Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements</Role>
      <ShortName>Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Related Party Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements</Role>
      <ShortName>Related Party Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Summarized Quarterly Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited</Role>
      <ShortName>Summarized Quarterly Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Financial Statement Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables</Role>
      <ShortName>Financial Statement Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Financial Instruments Investments in Marketable Debt Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Summarized Quarterly Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables</Role>
      <ShortName>Summarized Quarterly Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Description of Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Financial Statement Details - Property, Plant and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail</Role>
      <ShortName>Financial Statement Details - Property, Plant and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Financial Statement Details - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail</Role>
      <ShortName>Financial Statement Details - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Financial Statement Details - Other Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail</Role>
      <ShortName>Financial Statement Details - Other Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Financial Statement Details - Accrued Expenses (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail</Role>
      <ShortName>Financial Statement Details - Accrued Expenses (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Financial Statement Details - Other Current Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail</Role>
      <ShortName>Financial Statement Details - Other Current Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Financial Statement Details - Investment Income, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail</Role>
      <ShortName>Financial Statement Details - Investment Income, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail</Role>
      <ShortName>Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Viracta Investment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail</Role>
      <ShortName>Viracta Investment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail</Role>
      <ShortName>Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Collaboration and License Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail</Role>
      <ShortName>Collaboration and License Agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Commitment and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitment and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail</Role>
      <ShortName>Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Commitment and Contingencies - Components of Lease Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail</Role>
      <ShortName>Commitment and Contingencies - Components of Lease Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail</Role>
      <ShortName>Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail</Role>
      <ShortName>Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Related Party Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail</Role>
      <ShortName>Related Party Agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Stockholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Stockholders' Equity - Summary of Common Shares Reserved for Issuance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Common Shares Reserved for Issuance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Stock-Based Compensation - Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption</Role>
      <ShortName>Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Stock-Based Compensation - Summary of Warrant Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Warrant Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Income Taxes - Summary of Loss Before Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Loss Before Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail</Role>
      <ShortName>Income Taxes - Summary of Income Tax (Expense) Benefit (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>100740 - Disclosure - Summary of Quarterly Data (Unaudited) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>100750 - Disclosure - Employee Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail</Role>
      <ShortName>Employee Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="nk-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>100760 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="nk-10k_20201231.htm">nk-10k_20201231.htm</File>
    <File>nk-20201231.xsd</File>
    <File>nk-20201231_cal.xml</File>
    <File>nk-20201231_def.xml</File>
    <File>nk-20201231_lab.xml</File>
    <File>nk-20201231_pre.xml</File>
    <File>nk-ex1035_433.htm</File>
    <File>nk-ex211_10.htm</File>
    <File>nk-ex231_7.htm</File>
    <File>nk-ex311_8.htm</File>
    <File>nk-ex312_6.htm</File>
    <File>nk-ex321_9.htm</File>
    <File>nk-ex322_11.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>gtl21rgcbjm5000001.jpg</File>
    <File>gtl21rgcbjm5000002.jpg</File>
    <File>gtl21rgcbjm5000003.jpg</File>
    <File>gtl21rgcbjm5000004.jpg</File>
    <File>gtl21rgcbjm5000005.jpg</File>
    <File>gtl21rgcbjm5000006.jpg</File>
    <File>gtl21rgcbjm5000007.jpg</File>
    <File>gtl21rgcbjm5000008.jpg</File>
    <File>gtl21rgcbjm5000009.jpg</File>
    <File>gtl21rgcbjm5000010.jpg</File>
    <File>gtl21rgcbjm5000011.jpg</File>
    <File>gtl21rgcbjm5000012.jpg</File>
    <File>gtl21rgcbjm5000013.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>111
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nk-10k_20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 41,
   "contextCount": 349,
   "dts": {
    "calculationLink": {
     "local": [
      "nk-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nk-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "nk-10k_20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nk-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nk-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "nk-20201231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 756,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 35,
    "http://www.nantkwest.com/20201231": 28,
    "http://xbrl.sec.gov/dei/2020-01-31": 10,
    "total": 73
   },
   "keyCustom": 110,
   "keyStandard": 427,
   "memberCustom": 52,
   "memberStandard": 43,
   "nsprefix": "nk",
   "nsuri": "http://www.nantkwest.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Financial Statement Details",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails",
     "shortName": "Financial Statement Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Agreement and Plan of Merger with ImmunityBio",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio",
     "shortName": "Agreement and Plan of Merger with ImmunityBio",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_srtStatementScenarioAxis_nkProposedMergerWithImmunityBioMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Viracta Investment",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment",
     "shortName": "Viracta Investment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Financial Instruments Investments in Marketable Debt Securities",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Fair Value Measurements",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:CollaborationAndLicenseAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Collaboration and License Agreements",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements",
     "shortName": "Collaboration and License Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:CollaborationAndLicenseAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Commitments and Contingencies",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Related Party Agreements",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements",
     "shortName": "Related Party Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Stockholders' Equity",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Stock-Based Compensation",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Income Taxes",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Summarized Quarterly Data (Unaudited)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited",
     "shortName": "Summarized Quarterly Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Employee Benefits",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Subsequent Event",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "nk:DescriptionOfBusinessDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:LiquidityPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "nk:DescriptionOfBusinessDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:LiquidityPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Financial Statement Details (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables",
     "shortName": "Financial Statement Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Financial Instruments Investments in Marketable Debt Securities (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Summarized Quarterly Data (Unaudited) (Tables)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables",
     "shortName": "Summarized Quarterly Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Description of Business - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
     "shortName": "Description of Business - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "nk:LiquidityPolicyTextBlock",
       "nk:DescriptionOfBusinessDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapSubsidiarySaleOfStockAxis_nkUnderwrittenPublicOfferingMember_20200628_20200629",
      "decimals": "-5",
      "lang": null,
      "name": "nk:UnderwritingDiscountsCommissionsAndOtherOfferingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:MarketableSecuritiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:MarketableSecuritiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail",
     "shortName": "Summary of Significant Accounting Policies - Securities Excluded from the Computation of Potentially Dilutive Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail",
     "shortName": "Financial Statement Details - Prepaid Expenses and Other Current Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:PrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Statements of Operations",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FinanceLeaseInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Financial Statement Details - Property, Plant and Equipment, Net (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
     "shortName": "Financial Statement Details - Property, Plant and Equipment, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Financial Statement Details - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail",
     "shortName": "Financial Statement Details - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SecurityDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Financial Statement Details - Other Assets (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail",
     "shortName": "Financial Statement Details - Other Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SecurityDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Financial Statement Details - Accrued Expenses (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail",
     "shortName": "Financial Statement Details - Accrued Expenses (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:FinancingObligationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Financial Statement Details - Other Current Liabilities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail",
     "shortName": "Financial Statement Details - Other Current Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:FinancingObligationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Financial Statement Details - Investment Income, Net (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail",
     "shortName": "Financial Statement Details - Investment Income, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201221_20201221",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
     "shortName": "Agreement and Plan of Merger with Immunity Bio - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201221_20201221",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Viracta Investment - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
     "shortName": "Viracta Investment - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20170331",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities - Schedule of Investments in available-for-sale Debt Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_nkSecurity",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapFinancialInstrumentAxis_us-gaapDebtSecuritiesMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_nkSecurity",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities - Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesGrossRealizedGains",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail",
     "shortName": "Financial Instruments Investments in Marketable Debt Securities - Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesGrossRealizedGains",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Collaboration and License Agreements - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
     "shortName": "Collaboration and License Agreements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapOtherCommitmentsAxis_nkRushUniversityMedicalCenterLicenseAgreementMember_20040101_20041231",
      "decimals": null,
      "lang": "en-US",
      "name": "nk:PeriodOfLicenseAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20190101_20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Commitment and Contingencies - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
     "shortName": "Commitment and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20190101_20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail",
     "shortName": "Commitment and Contingencies - Schedule of Operating Right-of-use Assets and Lease Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Commitment and Contingencies - Components of Lease Expense (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail",
     "shortName": "Commitment and Contingencies - Components of Lease Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail",
     "shortName": "Commitment and Contingencies - Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail",
     "shortName": "Commitment and Contingencies - Summary of Future Minimum Lease Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Related Party Agreements - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
     "shortName": "Related Party Agreements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapRelatedPartyTransactionAxis_nkNantWorksLimitedLiabilityCompanyMember_20200101_20201231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Stockholders' Equity - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
     "shortName": "Stockholders' Equity - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20151102_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Stockholders' Equity - Summary of Common Shares Reserved for Issuance (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail",
     "shortName": "Stockholders' Equity - Summary of Common Shares Reserved for Issuance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nk:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "nk:ClassOfWarrantOrRightsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock Based Compensation Expenses Related to Statement of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Stock-Based Compensation - Stock Option Activity (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
     "shortName": "Stock-Based Compensation - Stock Option Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail",
     "shortName": "Stock-Based Compensation - Summary of Options Outstanding and Vested Pricing of Exercise Prices (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
     "shortName": "Stock-Based Compensation - Black-Scholes Option-Pricing Model to Determine Fair Value of Assumptions Used for Employee Stock Options Granted (Detail) - Employee Stock Option",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
     "shortName": "Stock-Based Compensation - Restricted Stock Units (RSUs) Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20171231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ClassOfWarrantOrRightOutstanding",
       "us-gaap:ClassOfWarrantOrRightOutstanding",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20181231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Stock-Based Compensation - Summary of Warrant Activity (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail",
     "shortName": "Stock-Based Compensation - Summary of Warrant Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20171231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nk:ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nk:ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:StockOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nk:StockOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Income Taxes - Summary of Loss Before Taxes (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail",
     "shortName": "Income Taxes - Summary of Loss Before Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail",
     "shortName": "Income Taxes - Summary of Income Tax (Expense) Benefit (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail",
     "shortName": "Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail",
     "shortName": "Income Taxes - Reconciliation of Federal Statutory Income Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Taxes - Summarizes of Changes in Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20181231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201001_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100740 - Disclosure - Summary of Quarterly Data (Unaudited) (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
     "shortName": "Summary of Quarterly Data (Unaudited) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20201001_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100750 - Disclosure - Employee Benefits - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail",
     "shortName": "Employee Benefits - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapRetirementPlanNameAxis_nkFourHundredOneKPlanMember_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100760 - Disclosure - Subsequent Events - Additional Information (Detail)",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
     "shortName": "Subsequent Events - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_us-gaapRelatedPartyTransactionAxis_nkNashLLCMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:DescriptionOfBusinessDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Description of Business",
     "role": "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nk-10k_20201231.htm",
      "contextRef": "C_0001326110_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nk:DescriptionOfBusinessDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "country_KR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KOREA, REPUBLIC OF",
        "terseLabel": "Korea"
       }
      }
     },
     "localname": "KR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r680",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r680",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "nk_AccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting policies.",
        "label": "Accounting Policies [Line Items]",
        "terseLabel": "Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "AccountingPoliciesLineItems",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_AccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting policies.",
        "label": "Accounting Policies [Table]",
        "terseLabel": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "AccountingPoliciesTable",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_AccruedCapitalExpenditures": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued capital expenditures.",
        "label": "Accrued Capital Expenditures",
        "terseLabel": "Accrued capital expenditures"
       }
      }
     },
     "localname": "AccruedCapitalExpenditures",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AccruedFranchiseSalesUseAndPropertyTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued franchise, sales/use and property taxes.",
        "label": "Accrued Franchise Sales Use And Property Taxes",
        "terseLabel": "Accrued franchise, sales/use and property taxes"
       }
      }
     },
     "localname": "AccruedFranchiseSalesUseAndPropertyTaxes",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AccruedLaboratoryEquipmentAndSupplies": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued laboratory equipment and supplies.",
        "label": "Accrued Laboratory Equipment And Supplies",
        "terseLabel": "Accrued laboratory equipment and supplies"
       }
      }
     },
     "localname": "AccruedLaboratoryEquipmentAndSupplies",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AccruedPreclinicalAndClinicalTrialCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued preclinical and clinical trial costs.",
        "label": "Accrued Preclinical And Clinical Trial Costs",
        "terseLabel": "Accrued preclinical and clinical trial costs"
       }
      }
     },
     "localname": "AccruedPreclinicalAndClinicalTrialCosts",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AdditionToNumberOfSquareFootOfFacilityLeased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition to number of square foot of facility leased.",
        "label": "Addition To Number Of Square Foot Of Facility Leased",
        "terseLabel": "Addition to number of square foot of facility leased"
       }
      }
     },
     "localname": "AdditionToNumberOfSquareFootOfFacilityLeased",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "areaItemType"
    },
    "nk_AdditionalTermOfAgreementRenewableUponMutualAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional term of agreement renewable upon mutual agreement.",
        "label": "Additional Term Of Agreement Renewable Upon Mutual Agreement",
        "terseLabel": "Additional term of agreement renewable upon mutual agreement"
       }
      }
     },
     "localname": "AdditionalTermOfAgreementRenewableUponMutualAgreement",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_AgreementOneTimeFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement one time fee.",
        "label": "Agreement One Time Fee",
        "terseLabel": "Agreement one time fee"
       }
      }
     },
     "localname": "AgreementOneTimeFee",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AltorBioscienceManufacturingCompanyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altor Bioscience Manufacturing Company, LLC.",
        "label": "Altor Bioscience Manufacturing Company L L C [Member]",
        "terseLabel": "Altor Bioscience Manufacturing Company, LLC"
       }
      }
     },
     "localname": "AltorBioscienceManufacturingCompanyLLCMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_AmendmentToExtendLeaseTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to extend lease term.",
        "label": "Amendment To Extend Lease Term [Member]",
        "terseLabel": "Amendment to Extend Lease Term"
       }
      }
     },
     "localname": "AmendmentToExtendLeaseTermMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_AnnualBaseRentIncreasePerSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual base rent increase per square foot.",
        "label": "Annual Base Rent Increase Per Square Foot",
        "terseLabel": "Annual increase of base rent"
       }
      }
     },
     "localname": "AnnualBaseRentIncreasePerSquareFoot",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "perUnitItemType"
    },
    "nk_AnnualPercentageIncreasesToBaseRent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual percentage increases to base rent.",
        "label": "Annual Percentage Increases To Base Rent",
        "terseLabel": "Percentage of annual increase of base rent"
       }
      }
     },
     "localname": "AnnualPercentageIncreasesToBaseRent",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_AnnualPercentageIncreasesToBaseRentCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual percentage increases to base rent commencement date.",
        "label": "Annual Percentage Increases To Base Rent Commencement Date",
        "terseLabel": "Annual percentage increases to base rent commencement date"
       }
      }
     },
     "localname": "AnnualPercentageIncreasesToBaseRentCommencementDate",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "nk_AnnualPercentageIncreasesToFixedChargeCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual percentage increases to fixed charge commencement date.",
        "label": "Annual Percentage Increases To Fixed Charge Commencement Date",
        "terseLabel": "Annual percentage increases to fixed charge commencement date"
       }
      }
     },
     "localname": "AnnualPercentageIncreasesToFixedChargeCommencementDate",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "nk_AnnualPercentageIncreasesToMonthlyFixedCharge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual percentage increases to monthly fixed charge.",
        "label": "Annual Percentage Increases To Monthly Fixed Charge",
        "terseLabel": "Annual percentage increases to monthly fixed charge"
       }
      }
     },
     "localname": "AnnualPercentageIncreasesToMonthlyFixedCharge",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities and held to maturity gross unrealized gain.",
        "label": "Available For Sale Securities And Held To Maturity Gross Unrealized Gain",
        "terseLabel": "Available-for-sale and held-to-maturity, Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities and held to maturity gross unrealized losses.",
        "label": "Available For Sale Securities And Held To Maturity Gross Unrealized Losses",
        "terseLabel": "Available-for-sale and held-to-maturity, Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_AvailableForSaleSecuritiesDebtSecuritiesPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt securities period",
        "label": "Available For Sale Securities Debt Securities Period",
        "terseLabel": "Available-for-sale, Weighted- Average Remaining Contractual Life"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesPeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities period of unrealized loss positions.",
        "label": "Available For Sale Securities Period Of Unrealized Loss Positions",
        "terseLabel": "Available-for-sale securities, period of unrealized loss positions"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesPeriodOfUnrealizedLossPositions",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_BaseMonthlyRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base monthly rent.",
        "label": "Base Monthly Rent",
        "terseLabel": "Base rent - monthly"
       }
      }
     },
     "localname": "BaseMonthlyRent",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_CashAndCashEquivalentsOriginalMaturities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents original maturities.",
        "label": "Cash And Cash Equivalents Original Maturities",
        "terseLabel": "Cash and cash equivalents original maturities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsOriginalMaturities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_CashEquivalentsAndMarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and marketable securities.",
        "label": "Cash Equivalents And Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "CashEquivalentsAndMarketableSecuritiesAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "xbrltype": "stringItemType"
    },
    "nk_ClassOfWarrantOrRightsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or rights issued.",
        "label": "Class Of Warrant Or Rights Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsIssued",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nk_ClinicalTrialCostAllocationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical trial cost allocation agreement.",
        "label": "Clinical Trial Cost Allocation Agreement [Member]",
        "terseLabel": "Clinical Trial Cost Allocation Agreement"
       }
      }
     },
     "localname": "ClinicalTrialCostAllocationAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_CollaborationAndLicenseAgreementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreements.",
        "label": "Collaboration And License Agreements [Text Block]",
        "terseLabel": "Collaboration and License Agreements"
       }
      }
     },
     "localname": "CollaborationAndLicenseAgreementsTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_CommercialSaleRelatedToLicensedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial sale related to licensed products.",
        "label": "Commercial Sale Related To Licensed Products [Member]",
        "terseLabel": "Commercial Sale Related to Licensed Products"
       }
      }
     },
     "localname": "CommercialSaleRelatedToLicensedProductsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_CommitmentSanDiegoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment; San Diego.",
        "label": "Commitment San Diego [Member]",
        "terseLabel": "Commitment; San Diego"
       }
      }
     },
     "localname": "CommitmentSanDiegoMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_CommitmentWoburnMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment Woburn Massachusetts.",
        "label": "Commitment Woburn Massachusetts [Member]",
        "terseLabel": "Woburn, Massachusetts"
       }
      }
     },
     "localname": "CommitmentWoburnMassachusettsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies Table.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_CurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current assets.",
        "label": "Current Assets [Member]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "CurrentAssetsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_DeferredIncomeTaxExpenseBenefitNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred income tax expense benefit, net.",
        "label": "Deferred Income Tax Expense Benefit Net",
        "negatedTotalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitNet",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_DeferredTaxAssetsDeferredDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets deferred depreciation and amortization.",
        "label": "Deferred Tax Assets Deferred Depreciation And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredDepreciationAndAmortization",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_DeferredTaxAssetsLeasesAndOtherAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10120.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets leases and other accrued liabilities.",
        "label": "Deferred Tax Assets Leases And Other Accrued Liabilities",
        "terseLabel": "Leases and other accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasesAndOtherAccruedLiabilities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_DerecognizedDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognized deferred tax assets.",
        "label": "Derecognized Deferred Tax Assets",
        "terseLabel": "Derecognized deferred tax assets"
       }
      }
     },
     "localname": "DerecognizedDeferredTaxAssets",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_DescriptionOfBusinessDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business disclosure.",
        "label": "Description Of Business Disclosure [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessDisclosureTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between lease guidance in effect before and after Topic 842.",
        "label": "Difference Between Lease Guidance In Effect Before And After Topic842 [Member]",
        "terseLabel": "Difference between Lease Guidance in Effect before and after Topic 842"
       }
      }
     },
     "localname": "DifferenceBetweenLeaseGuidanceInEffectBeforeAndAfterTopic842Member",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_DirectorsAndOfficersInsurancePolicyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and officers insurance policy.",
        "label": "Directors And Officers Insurance Policy [Member]",
        "terseLabel": "Directors and Officers Insurance Policy"
       }
      }
     },
     "localname": "DirectorsAndOfficersInsurancePolicyMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_DougStLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Doug St LLC.",
        "label": "Doug St L L C [Member]",
        "terseLabel": "Doug St, LLC"
       }
      }
     },
     "localname": "DougStLLCMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation stock based compensation contribution.",
        "label": "Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_ElSegundoCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "El Segundo, California.",
        "label": "El Segundo California [Member]",
        "terseLabel": "El Segundo California"
       }
      }
     },
     "localname": "ElSegundoCaliforniaMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_EmployeeRestrictedStockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee restricted stock unit.",
        "label": "Employee Restricted Stock Unit [Member]",
        "terseLabel": "Employee Restricted Stock Units",
        "verboseLabel": "Employee RSUs"
       }
      }
     },
     "localname": "EmployeeRestrictedStockUnitMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Chairman and principal stockholder, and affiliates.",
        "label": "Executive Chairman And Principal Stockholder And Affiliates [Member]",
        "terseLabel": "Executive Chairman and principal stockholder, and affiliates"
       }
      }
     },
     "localname": "ExecutiveChairmanAndPrincipalStockholderAndAffiliatesMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExecutiveChairmanAndPrincipalStockholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive chairman and principal stockholder.",
        "label": "Executive Chairman And Principal Stockholder [Member]",
        "terseLabel": "Dr. Patrick Soon-Shiong"
       }
      }
     },
     "localname": "ExecutiveChairmanAndPrincipalStockholderMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range five.",
        "label": "Exercise Price Range Five [Member]",
        "terseLabel": "$6.21"
       }
      }
     },
     "localname": "ExercisePriceRangeFiveMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range four.",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "$3.07"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range one.",
        "label": "Exercise Price Range One [Member]",
        "terseLabel": "$0.4213"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range six.",
        "label": "Exercise Price Range Six [Member]",
        "terseLabel": "$25.00"
       }
      }
     },
     "localname": "ExercisePriceRangeSixMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range three.",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "$1.9984"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range two.",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "$1.7554"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value inputs, transfers into level 1, 2 or 3 categories.",
        "label": "Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories",
        "terseLabel": "Fair value inputs, transfers into or out of Level 1, 2 or 3 categories"
       }
      }
     },
     "localname": "FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_FinancialStatementDetailsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial statement details.",
        "label": "Financial Statement Details [Abstract]"
       }
      }
     },
     "localname": "FinancialStatementDetailsAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "xbrltype": "stringItemType"
    },
    "nk_FinancingObligationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing obligation current.",
        "label": "Financing Obligation Current",
        "terseLabel": "Financing obligation - current portion"
       }
      }
     },
     "localname": "FinancingObligationCurrent",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_FixedAndVariableLeaseCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed and variable lease costs.",
        "label": "Fixed And Variable Lease Costs",
        "terseLabel": "Fixed and variable lease costs"
       }
      }
     },
     "localname": "FixedAndVariableLeaseCosts",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_FourHundredOneKPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four hundred one K plan.",
        "label": "Four Hundred One K Plan [Member]",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "localname": "FourHundredOneKPlanMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_INDFilingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IND filing.",
        "label": "I N D Filing [Member]",
        "terseLabel": "First IND Filing"
       }
      }
     },
     "localname": "INDFilingMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ITEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IT equipment.",
        "label": "I T Equipment [Member]",
        "terseLabel": "IT Equipment"
       }
      }
     },
     "localname": "ITEquipmentMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ImmunityBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immunity Bio.",
        "label": "Immunity Bio [Member]",
        "terseLabel": "ImmunityBio"
       }
      }
     },
     "localname": "ImmunityBioMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ImmunoOncologyClinicIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immuno Oncology Clinic Inc.",
        "label": "Immuno Oncology Clinic Inc [Member]",
        "terseLabel": "Immuno-Oncology Clinic, Inc."
       }
      }
     },
     "localname": "ImmunoOncologyClinicIncMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax.",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax.",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_IncreaseDecreaseInAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10300.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in accounts payable current.",
        "label": "Increase Decrease In Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableCurrent",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10340.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in deferred rent.",
        "label": "Increase Decrease In Deferred Rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10330.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in operating lease liability.",
        "label": "Increase Decrease In Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_InitialTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial term of agreement.",
        "label": "Initial Term Of Agreement",
        "terseLabel": "Initial term of agreement"
       }
      }
     },
     "localname": "InitialTermOfAgreement",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_InsurancePremiumFinancingAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance premium financing asset.",
        "label": "Insurance Premium Financing Asset",
        "terseLabel": "Insurance premium financing asset"
       }
      }
     },
     "localname": "InsurancePremiumFinancingAsset",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_JointCOVID19CollaborationDevelopmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint COVID 19 Collaboration Development Agreement.",
        "label": "Joint C O V I D19 Collaboration Development Agreement [Member]",
        "terseLabel": "Joint COVID 19 Collaboration Development Agreement"
       }
      }
     },
     "localname": "JointCOVID19CollaborationDevelopmentAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_LaboratoryEquipmentDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment deposit.",
        "label": "Laboratory Equipment Deposit",
        "terseLabel": "Laboratory equipment deposit"
       }
      }
     },
     "localname": "LaboratoryEquipmentDeposit",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_LeaseAgreementExtendedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease agreement extended period.",
        "label": "Lease Agreement Extended Period",
        "terseLabel": "Lease agreement extended lease period"
       }
      }
     },
     "localname": "LeaseAgreementExtendedPeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "nk_LeaseCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease commencement date.",
        "label": "Lease Commencement Date",
        "terseLabel": "Lease commencement date"
       }
      }
     },
     "localname": "LeaseCommencementDate",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "nk_LicenseAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement term.",
        "label": "License Agreement Term",
        "terseLabel": "License agreement term (years)"
       }
      }
     },
     "localname": "LicenseAgreementTerm",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_LicenseAgreementTerminationNoticePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement termination notice period.",
        "label": "License Agreement Termination Notice Period",
        "terseLabel": "License agreement termination notice period"
       }
      }
     },
     "localname": "LicenseAgreementTerminationNoticePeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_LicensingAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing agreement.",
        "label": "Licensing Agreement [Abstract]"
       }
      }
     },
     "localname": "LicensingAgreementAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "xbrltype": "stringItemType"
    },
    "nk_LicensingAgreementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing agreement.",
        "label": "Licensing Agreement [Line Items]",
        "terseLabel": "Licensing Agreement [Line Items]"
       }
      }
     },
     "localname": "LicensingAgreementLineItems",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_LicensingAgreementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing agreement.",
        "label": "Licensing Agreement [Table]",
        "terseLabel": "Licensing Agreement [Table]"
       }
      }
     },
     "localname": "LicensingAgreementTable",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_LiquidityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity.",
        "label": "Liquidity Policy [Text Block]",
        "terseLabel": "Liquidity"
       }
      }
     },
     "localname": "LiquidityPolicyTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_LitigationCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation costs.",
        "label": "Litigation Costs Policy [Text Block]",
        "terseLabel": "Litigation Costs"
       }
      }
     },
     "localname": "LitigationCostsPolicyTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_LongTermLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term lease liabilities.",
        "label": "Long Term Lease Liabilities [Abstract]",
        "terseLabel": "Long-term lease liabilities:"
       }
      }
     },
     "localname": "LongTermLeaseLiabilitiesAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum original maturity period of short term marketable securities.",
        "label": "Maximum Original Maturity Period Of Short Term Marketable Securities",
        "terseLabel": "Maximum original maturity period of short-term marketable securities"
       }
      }
     },
     "localname": "MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_MergerExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger exchange ratio.",
        "label": "Merger Exchange Ratio",
        "terseLabel": "Merger exchange ratio"
       }
      }
     },
     "localname": "MergerExchangeRatio",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_MilestonePaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payment amount.",
        "label": "Milestone Payment Amount",
        "verboseLabel": "Milestone Payment Amount"
       }
      }
     },
     "localname": "MilestonePaymentAmount",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_MinimumAnnualRoyaltyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum annual royalty payment.",
        "label": "Minimum Annual Royalty Payment",
        "terseLabel": "Minimum annual royalty payment"
       }
      }
     },
     "localname": "MinimumAnnualRoyaltyPayment",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum original maturity period of long term marketable securities.",
        "label": "Minimum Original Maturity Period Of Long Term Marketable Securities",
        "terseLabel": "Minimum original maturity period of long-term marketable securities"
       }
      }
     },
     "localname": "MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_MinimumSalesMilestoneOfLicenseForFirstYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum sales milestone of license for first year.",
        "label": "Minimum Sales Milestone Of License For First Year",
        "terseLabel": "Minimum sales milestone of license for first year"
       }
      }
     },
     "localname": "MinimumSalesMilestoneOfLicenseForFirstYear",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_MonthlyFixedCharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly fixed charge.",
        "label": "Monthly Fixed Charge",
        "terseLabel": "Monthly fixed charge"
       }
      }
     },
     "localname": "MonthlyFixedCharge",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_NantBioScienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NantBioScience.",
        "label": "Nant Bio Science [Member]",
        "terseLabel": "NantBioScience"
       }
      }
     },
     "localname": "NantBioScienceMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NantHealthLabsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nant Health Labs, Inc.",
        "label": "Nant Health Labs Inc [Member]",
        "terseLabel": "NantHealth Labs, Inc."
       }
      }
     },
     "localname": "NantHealthLabsIncMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NantKwestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nant Kwest [Member]",
        "terseLabel": "NantKwest"
       }
      }
     },
     "localname": "NantKwestMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NantWorksLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nant Works LLC.",
        "label": "Nant Works Limited Liability Company [Member]",
        "terseLabel": "NantWorks"
       }
      }
     },
     "localname": "NantWorksLimitedLiabilityCompanyMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NashLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nash, LLC.",
        "label": "Nash L L C [Member]",
        "terseLabel": "Nash, LLC"
       }
      }
     },
     "localname": "NashLLCMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carried forwards as percentage on taxable income.",
        "label": "Net Operating Loss Carried Forwards As Percentage On Taxable Income",
        "terseLabel": "Net operating loss carried forwards as percentage on taxable income"
       }
      }
     },
     "localname": "NetOperatingLossCarriedForwardsAsPercentageOnTaxableIncome",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_NetOperatingLossCarrybacksPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carrybacks period.",
        "label": "Net Operating Loss Carrybacks Period",
        "terseLabel": "Net operating loss carrybacks period"
       }
      }
     },
     "localname": "NetOperatingLossCarrybacksPeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_NetOperatingLossCarryforwardsExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration date.",
        "label": "Net Operating Loss Carryforwards Expiration Date",
        "terseLabel": "Net operating loss carryforwards expiration date"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsExpirationDate",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "nk_NetProgramRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net program related costs.",
        "label": "Net Program Related Costs [Member]",
        "terseLabel": "Net Program Related Costs"
       }
      }
     },
     "localname": "NetProgramRelatedCostsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NewAgreementTerminationNoticePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New agreement termination notice period.",
        "label": "New Agreement Termination Notice Period",
        "terseLabel": "Notice period to terminate new agreement"
       }
      }
     },
     "localname": "NewAgreementTerminationNoticePeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_NonCashInterestIncomeExpenseFromOperatingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10250.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash interest (income) expense from operating activities.",
        "label": "Non Cash Interest Income Expense From Operating Activities",
        "negatedLabel": "Non-cash interest items, net"
       }
      }
     },
     "localname": "NonCashInterestIncomeExpenseFromOperatingActivities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_NonEmployeeRestrictedStockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non employee restricted stock unit.",
        "label": "Non Employee Restricted Stock Unit [Member]",
        "terseLabel": "Non Employee Restricted Stock Units",
        "verboseLabel": "Non-employee RSUs"
       }
      }
     },
     "localname": "NonEmployeeRestrictedStockUnitMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent assets.",
        "label": "Noncurrent Assets [Member]",
        "terseLabel": "Noncurrent Assets"
       }
      }
     },
     "localname": "NoncurrentAssetsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_NonrefundableUpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrefundable upfront payment.",
        "label": "Nonrefundable Upfront Payment",
        "terseLabel": "Nonrefundable upfront payment"
       }
      }
     },
     "localname": "NonrefundableUpfrontPayment",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_NumberOfDaysPriorToWrittenNoticeToTerminateLease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of days prior to written notice to terminate lease,",
        "label": "Number Of Days Prior To Written Notice To Terminate Lease",
        "terseLabel": "Number of days prior to written notice to terminate lease"
       }
      }
     },
     "localname": "NumberOfDaysPriorToWrittenNoticeToTerminateLease",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_NumberOfOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of officers.",
        "label": "Number Of Officers",
        "terseLabel": "Number of officers"
       }
      }
     },
     "localname": "NumberOfOfficers",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nk_NumberOfProductsApprovedForCommercialSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products approved for commercial sale.",
        "label": "Number Of Products Approved For Commercial Sale",
        "terseLabel": "Number of products approved for commercial sale"
       }
      }
     },
     "localname": "NumberOfProductsApprovedForCommercialSale",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nk_NumberOfSquareFootOfFacilityLeased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of square foot of facility leased.",
        "label": "Number Of Square Foot Of Facility Leased",
        "terseLabel": "Number of square foot of facility leased"
       }
      }
     },
     "localname": "NumberOfSquareFootOfFacilityLeased",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "areaItemType"
    },
    "nk_OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease payments related to options to extend lease terms.",
        "label": "Operating Lease Payments Related To Options To Extend Lease Terms",
        "terseLabel": "Operating lease payments related to options to extend lease terms"
       }
      }
     },
     "localname": "OperatingLeasePaymentsRelatedToOptionsToExtendLeaseTerms",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_OperatingLeaseRightOfUseAssetNonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right of use asset non cash lease expense.",
        "label": "Operating Lease Right Of Use Asset Non Cash Lease Expense",
        "terseLabel": "Non-cash lease expense related to operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetNonCashLeaseExpense",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_OtherIncomeAndExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income and Expense, Net.",
        "label": "Other Income And Expense Net [Member]",
        "terseLabel": "Other Income and Expense, Net"
       }
      }
     },
     "localname": "OtherIncomeAndExpenseNetMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership percentage acquired on fully diluted bases upon consummation of merger.",
        "label": "Ownership Percentage Acquired On Fully Diluted Bases Upon Consummation Of Merger",
        "terseLabel": "Ownership percentage acquired on fully diluted bases upon consummation of merger"
       }
      }
     },
     "localname": "OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_OwnershipPercentageByKeyExecutives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership percentage by key executives.",
        "label": "Ownership Percentage By Key Executives",
        "terseLabel": "Ownership percentage by key executives"
       }
      }
     },
     "localname": "OwnershipPercentageByKeyExecutives",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_PaymentsToAcquireInvestmentsInEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to acquire investments in equity securities.",
        "label": "Payments To Acquire Investments In Equity Securities",
        "negatedLabel": "Purchases of investments in equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestmentsInEquitySecurities",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PeriodOfCumulativeOwnershipChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of cumulative ownership change.",
        "label": "Period Of Cumulative Ownership Change",
        "terseLabel": "Period of cumulative ownership change"
       }
      }
     },
     "localname": "PeriodOfCumulativeOwnershipChange",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_PeriodOfExtendedLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of extended lease term.",
        "label": "Period Of Extended Lease Term",
        "terseLabel": "Optional extended lease term",
        "verboseLabel": "Optional extended lease term"
       }
      }
     },
     "localname": "PeriodOfExtendedLeaseTerm",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_PeriodOfLicenseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of license agreement.",
        "label": "Period Of License Agreement",
        "terseLabel": "Period of license agreement"
       }
      }
     },
     "localname": "PeriodOfLicenseAgreement",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_PeriodOfLicenseAgreementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of license agreement description.",
        "label": "Period Of License Agreement Description",
        "terseLabel": "Period of agreement"
       }
      }
     },
     "localname": "PeriodOfLicenseAgreementDescription",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_PhaseThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase three.",
        "label": "Phase Three [Member]",
        "terseLabel": "First Phase III Clinical Trial"
       }
      }
     },
     "localname": "PhaseThreeMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PhaseTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase two.",
        "label": "Phase Two [Member]",
        "terseLabel": "First Phase II Clinical Trial"
       }
      }
     },
     "localname": "PhaseTwoMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PrecigenLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precigen license agreement.",
        "label": "Precigen License Agreement [Member]",
        "terseLabel": "Precigen License Agreement",
        "verboseLabel": "Precigen License Agreement"
       }
      }
     },
     "localname": "PrecigenLicenseAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PreclinicalAndClinicalTrialAccrualsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preclinical and clinical trial accruals policy text block.",
        "label": "Preclinical And Clinical Trial Accruals Policy [Text Block]",
        "terseLabel": "Preclinical and Clinical Trial Accruals"
       }
      }
     },
     "localname": "PreclinicalAndClinicalTrialAccrualsPolicyTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid balance included in prepaid expenses and other current assets and other assets.",
        "label": "Prepaid Balance Included In Prepaid Expenses And Other Current Assets And Other Assets",
        "terseLabel": "Prepaid balance included in prepaid expenses and other current assets and other assets"
       }
      }
     },
     "localname": "PrepaidBalanceIncludedInPrepaidExpensesAndOtherCurrentAssetsAndOtherAssets",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidEquipmentMaintenance": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid equipment maintenance.",
        "label": "Prepaid Equipment Maintenance",
        "terseLabel": "Prepaid equipment maintenance"
       }
      }
     },
     "localname": "PrepaidEquipmentMaintenance",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses and other assets current with related party.",
        "label": "Prepaid Expenses And Other Assets Current With Related Party",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherAssetsCurrentWithRelatedParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets Table [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_PrepaidLicenseFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid license fees.",
        "label": "Prepaid License Fees",
        "terseLabel": "Prepaid license fees"
       }
      }
     },
     "localname": "PrepaidLicenseFees",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid preclinical and clinical trial services with related party.",
        "label": "Prepaid Preclinical And Clinical Trial Services With Related Party",
        "terseLabel": "Prepaid preclinical and clinical trial services - with related party (Note 10)"
       }
      }
     },
     "localname": "PrepaidPreclinicalAndClinicalTrialServicesWithRelatedParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid preclinical and clinical trial services with related party in other assets.",
        "label": "Prepaid Preclinical And Clinical Trial Services With Related Party In Other Assets",
        "terseLabel": "Prepaid preclinical and clinical trial services - with related party (Note 10)"
       }
      }
     },
     "localname": "PrepaidPreclinicalAndClinicalTrialServicesWithRelatedPartyInOtherAssets",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid services.",
        "label": "Prepaid Services",
        "terseLabel": "Prepaid services"
       }
      }
     },
     "localname": "PrepaidServices",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidSoftwareLicenseFeesInOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid software license fees in other assets.",
        "label": "Prepaid Software License Fees In Other Assets",
        "terseLabel": "Prepaid software license fees"
       }
      }
     },
     "localname": "PrepaidSoftwareLicenseFeesInOtherAssets",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaidSuppliesWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid supplies with related party.",
        "label": "Prepaid Supplies With Related Party",
        "terseLabel": "Prepaid supplies - with related party (Note 10)"
       }
      }
     },
     "localname": "PrepaidSuppliesWithRelatedParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_PrepaymentOfFundingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment of funding amount.",
        "label": "Prepayment Of Funding Amount",
        "terseLabel": "Prepayment for services amount"
       }
      }
     },
     "localname": "PrepaymentOfFundingAmount",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_ProgramEquipmentRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Program equipment related costs.",
        "label": "Program Equipment Related Costs [Member]",
        "terseLabel": "Program Equipment Related Costs"
       }
      }
     },
     "localname": "ProgramEquipmentRelatedCostsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment useful life.",
        "label": "Property Plant And Equipment Useful Life Table [Text Block]",
        "terseLabel": "Schedule of Estimated Useful Lives of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_ProposedMergerWithImmunityBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proposed Merger with ImmunityBio.",
        "label": "Proposed Merger With Immunity Bio [Member]",
        "terseLabel": "Proposed Merger With ImmunityBio"
       }
      }
     },
     "localname": "ProposedMergerWithImmunityBioMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PublicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public.",
        "label": "Public [Member]",
        "terseLabel": "Public"
       }
      }
     },
     "localname": "PublicMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_PurchaseOfConvertibleNoteUponConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of convertible note upon conversion.",
        "label": "Purchase Of Convertible Note Upon Conversion",
        "terseLabel": "Purchase of convertible note"
       }
      }
     },
     "localname": "PurchaseOfConvertibleNoteUponConversion",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_ReimbursementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursements.",
        "label": "Reimbursements [Member]",
        "terseLabel": "Reimbursements"
       }
      }
     },
     "localname": "ReimbursementsMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_RelatedPartyAgreementExpirationMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party agreement expiration month and year.",
        "label": "Related Party Agreement Expiration Month And Year",
        "terseLabel": "Related party agreement expiration date"
       }
      }
     },
     "localname": "RelatedPartyAgreementExpirationMonthAndYear",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "nk_RelatedPartyAgreementRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party agreement renewal term.",
        "label": "Related Party Agreement Renewal Term",
        "terseLabel": "Related party, agreement renewal term"
       }
      }
     },
     "localname": "RelatedPartyAgreementRenewalTerm",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_RelatedPartyInstallmentPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party installment payment.",
        "label": "Related Party Installment Payment",
        "terseLabel": "Related party transaction installment payment"
       }
      }
     },
     "localname": "RelatedPartyInstallmentPayment",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionAgreementExtensionDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction agreement extension description.",
        "label": "Related Party Transaction Agreement Extension Description",
        "verboseLabel": "Prepayments remain unearned extension description"
       }
      }
     },
     "localname": "RelatedPartyTransactionAgreementExtensionDescription",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_RelatedPartyTransactionAmountPaidToRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction, amount paid to related party.",
        "label": "Related Party Transaction Amount Paid To Related Party",
        "terseLabel": "Related party transaction, amount paid to third-party"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountPaidToRelatedParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionAmountPaidToThirdParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction, amount paid to third-party.",
        "label": "Related Party Transaction Amount Paid To Third Party",
        "terseLabel": "Related party transaction, amount paid to third-party"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountPaidToThirdParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionConditionalPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction conditional payment.",
        "label": "Related Party Transaction Conditional Payment",
        "terseLabel": "Related party transaction conditional payment"
       }
      }
     },
     "localname": "RelatedPartyTransactionConditionalPayment",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionInitialTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction initial term of agreement.",
        "label": "Related Party Transaction Initial Term Of Agreement",
        "terseLabel": "Initial term of agreement entered into with the related party by the entity"
       }
      }
     },
     "localname": "RelatedPartyTransactionInitialTermOfAgreement",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction reimbursed upfront payment to related party.",
        "label": "Related Party Transaction Reimbursed Upfront Payment To Related Party",
        "terseLabel": "Related party transaction,reimbursement payment to a related-party"
       }
      }
     },
     "localname": "RelatedPartyTransactionReimbursedUpfrontPaymentToRelatedParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction, Reimbursed upfront payment to third party.",
        "label": "Related Party Transaction Reimbursed Upfront Payment To Third Party",
        "terseLabel": "Reimbursed upfront payment to third-party"
       }
      }
     },
     "localname": "RelatedPartyTransactionReimbursedUpfrontPaymentToThirdParty",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_RelatedPartyTransactionsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transactions policy.",
        "label": "Related Party Transactions Policy Policy [Text Block]",
        "terseLabel": "Transactions with Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsPolicyPolicyTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development cumulative change in ownership Percentage.",
        "label": "Research And Development Cumulative Change In Ownership Percentage",
        "terseLabel": "Cumulative change in ownership"
       }
      }
     },
     "localname": "ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nk_ResearchAndDevelopmentExpenseRatablePaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expense ratable payment period.",
        "label": "Research And Development Expense Ratable Payment Period",
        "terseLabel": "Research and development expense, ratable payment period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseRatablePaymentPeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_RightOfUseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets.",
        "label": "Right Of Use Assets [Abstract]",
        "terseLabel": "Right-of-use assets:"
       }
      }
     },
     "localname": "RightOfUseAssetsAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_RushUniversityMedicalCenterLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rush university medical center license agreement.",
        "label": "Rush University Medical Center License Agreement [Member]",
        "terseLabel": "Rush University Medical Center License Agreement"
       }
      }
     },
     "localname": "RushUniversityMedicalCenterLicenseAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash paid for amounts included in measurement of lease liabilities.",
        "label": "Schedule Of Cash Paid For Amounts Included In Measurement Of Lease Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Cash Paid for Amounts Included in Measurement of Lease Liabilities"
       }
      }
     },
     "localname": "ScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_ScheduleOfCommonStockReservedForIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock reserved for issuance .",
        "label": "Schedule Of Common Stock Reserved For Issuance Table [Text Block]",
        "terseLabel": "Summary Of Common Stock Reserved For Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of operating right-of-use assets and lease liabilities.",
        "label": "Schedule Of Operating Right Of Use Assets And Lease Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Operating Right-of-use Assets and Lease Liabilities"
       }
      }
     },
     "localname": "ScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Price",
        "terseLabel": "Weighted-average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPrice",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption"
     ],
     "xbrltype": "perShareItemType"
    },
    "nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share-based payment award, options, aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares that may be added to shares reserved for issuance under an established share-based compensation plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Possible Increase In Number Of Shares Reserved For Issuance",
        "terseLabel": "Additional Shares that may be added to shares reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPossibleIncreaseInNumberOfSharesReservedForIssuance",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nk_SharedServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shared services agreement.",
        "label": "Shared Services Agreement [Member]",
        "terseLabel": "Shared Services Agreement"
       }
      }
     },
     "localname": "SharedServicesAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares sold to public upon full exercise of underwriters\u2019 option to purchase additional shares.",
        "label": "Shares Sold To Public Upon Full Exercise Of Underwriters Option To Purchase Additional Shares",
        "terseLabel": "Shares sold to public upon full exercise of underwriters\u2019 option to purchase additional shares"
       }
      }
     },
     "localname": "SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalShares",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nk_SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares sold to public upon full exercise of underwriters\u2019 option to purchase additional shares.",
        "label": "Shares Sold To Public Upon Full Exercise Of Underwriters Option To Purchase Additional Shares [Member]",
        "terseLabel": "Shares Sold to Public upon full Exercise of Underwriters Option to Purchase Additional Shares"
       }
      }
     },
     "localname": "SharesSoldToPublicUponFullExerciseOfUnderwritersOptionToPurchaseAdditionalSharesMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_ShortTermLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term lease liabilities.",
        "label": "Short Term Lease Liabilities [Abstract]",
        "terseLabel": "Short-term lease liabilities:"
       }
      }
     },
     "localname": "ShortTermLeaseLiabilitiesAbstract",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nk_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares warrants exercised.",
        "label": "Stock Issued During Period Shares Warrants Exercised",
        "negatedLabel": "Number of shares Warrants exercised",
        "terseLabel": "Exercise of warrants, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "nk_StockIssuedDuringPeriodSharesWarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares warrants expired.",
        "label": "Stock Issued During Period Shares Warrants Expired",
        "negatedLabel": "Number of shares Warrants expired"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExpired",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nk_StockOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock offering costs.",
        "label": "Stock Offering Costs",
        "terseLabel": "Offering costs"
       }
      }
     },
     "localname": "StockOfferingCosts",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock repurchased and retired excluding commission during period value.",
        "label": "Stock Repurchased And Retired Excluding Commission During Period Value",
        "terseLabel": "Repurchase of common stock excluding commissions, value"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_StockRepurchasesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock repurchases policy.",
        "label": "Stock Repurchases Policy [Text Block]",
        "terseLabel": "Stock Repurchases"
       }
      }
     },
     "localname": "StockRepurchasesPolicyTextBlock",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nk_TaxCreditCarryforwardExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration period.",
        "label": "Tax Credit Carryforward Expiration Period",
        "terseLabel": "Tax credit carryforward expiration period"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationPeriod",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "nk_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax cuts and jobs act of 2017 incomplete accounting change in tax rate minimum amount for elimination of several business deductions and credits including deductions for certain executive compensation.",
        "label": "Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Minimum Amount For Elimination Of Several Business Deductions And Credits Including Deductions For Certain Executive Compensation",
        "terseLabel": "Minimum Amount for elimination of several business deductions and credits, including deductions for certain executive compensation"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_TaxYear2021AndThereafterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year 2021 and thereafter.",
        "label": "Tax Year2021 And Thereafter [Member]",
        "terseLabel": "Tax Year 2021 and Thereafter"
       }
      }
     },
     "localname": "TaxYear2021AndThereafterMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of agreement.",
        "label": "Term Of Agreement",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nk_TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Note and Warrant Purchase Agreement.",
        "label": "Two Thousand And Eighteen Note And Warrant Purchase Agreement [Member]",
        "terseLabel": "2018 Note and Warrant Purchase Agreement"
       }
      }
     },
     "localname": "TwoThousandAndEighteenNoteAndWarrantPurchaseAgreementMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_TwoThousandFifteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fifteen equity incentive plan.",
        "label": "Two Thousand Fifteen Equity Incentive Plan [Member]",
        "terseLabel": "2015 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFifteenEquityIncentivePlanMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_TwoThousandFourteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen equity incentive plan.",
        "label": "Two Thousand Fourteen Equity Incentive Plan [Member]",
        "terseLabel": "2014 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFourteenEquityIncentivePlanMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_UnderwritingDiscountsCommissionsAndOfferingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discounts commissions and offering expenses.",
        "label": "Underwriting Discounts Commissions And Offering Expenses",
        "terseLabel": "Underwriting discounts, commissions and other offering expenses"
       }
      }
     },
     "localname": "UnderwritingDiscountsCommissionsAndOfferingExpenses",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_UnderwritingDiscountsCommissionsAndOtherOfferingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discounts, commissions and other offering expenses.",
        "label": "Underwriting Discounts Commissions And Other Offering Expenses",
        "terseLabel": "Underwriting discounts, commissions and other offering expenses"
       }
      }
     },
     "localname": "UnderwritingDiscountsCommissionsAndOtherOfferingExpenses",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten public offering.",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten Public Offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nk_UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would not affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would not impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_VariableConsiderationRelatedToMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable consideration related to milestone payment.",
        "label": "Variable Consideration Related To Milestone Payment",
        "terseLabel": "Variable consideration related to milestone payment"
       }
      }
     },
     "localname": "VariableConsiderationRelatedToMilestonePayment",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nk_ViractaTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viracta Therapeutics, Inc.",
        "label": "Viracta Therapeutics Inc [Member]",
        "terseLabel": "Viracta Therapeutics, Inc."
       }
      }
     },
     "localname": "ViractaTherapeuticsIncMember",
     "nsuri": "http://www.nantkwest.com/20201231",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r470",
      "r471",
      "r476",
      "r477",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r470",
      "r471",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r131",
      "r138",
      "r225",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect Period Of Adoption Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r131",
      "r138",
      "r225",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect Period Of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r131",
      "r138",
      "r225",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect Period Of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r355",
      "r361",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r355",
      "r361",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officer"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r302",
      "r355",
      "r361",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r302",
      "r355",
      "r361",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Unspecified [Domain]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r277",
      "r278",
      "r624",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r277",
      "r278",
      "r624",
      "r659",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r258",
      "r360",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Scenario [Axis]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r194",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update201409 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update201602 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Amortization of net premiums and discounts on marketable debt securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses Current",
        "terseLabel": "Accrued bonus"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Accrued Liabilities Current"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Accrued professional and service fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r41",
      "r249"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r61",
      "r62",
      "r63",
      "r610",
      "r633",
      "r637"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r63",
      "r66",
      "r128",
      "r129",
      "r130",
      "r475",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r403",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r135",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r444",
      "r445",
      "r446",
      "r447",
      "r586",
      "r587",
      "r588",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments For New Accounting Pronouncements [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Adjustments Related To Tax Withholding For Share Based Compensation",
        "negatedLabel": "Net share settlement for restricted stock unit vesting and option/warrant exercises"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r363",
      "r365",
      "r409",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Government Sponsored Securities"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r365",
      "r395",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r103",
      "r242",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization Of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r103",
      "r246"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10260.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Loss on impairment of assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r118",
      "r173",
      "r182",
      "r188",
      "r221",
      "r470",
      "r476",
      "r499",
      "r591",
      "r609"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r55",
      "r118",
      "r221",
      "r470",
      "r476",
      "r499"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r1",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Assets Net",
        "terseLabel": "Build-to-suit related liabilities and assets adjust as accumulated deficit"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Available-for-sale, Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax",
        "negatedLabel": "Available-for-sale, Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r201",
      "r233"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Amortized Cost Basis",
        "totalLabel": "Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available For Sale Securities [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAndHeldToMaturitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and equity financial instruments classified as either held-to-maturity or available-for-sale.",
        "label": "Available For Sale Securities And Held To Maturity Securities",
        "terseLabel": "Available-for-sale and held-to-maturity, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAndHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investments in debt and equity securities in an unrealized loss position categorized neither as held-to-maturity nor trading securities.",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Fair Value Table [Text Block]",
        "terseLabel": "Accumulated Unrealized Losses on Debt Securities Classified as Available-for-Sale in Continuous Loss Position"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r196",
      "r202",
      "r233",
      "r596"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Available-for-sale, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r198",
      "r233"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10230.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Available For Sale Securities Debt Securities Current",
        "terseLabel": "Marketable debt securities, available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r198",
      "r233"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Available For Sale Securities Debt Securities Noncurrent",
        "terseLabel": "Marketable debt securities, noncurrent"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.",
        "label": "Available For Sale Securities Gross Realized Gain Loss Net",
        "totalLabel": "Available for Sale Securities, Net Realized Gains (Losses)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the gross profit realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.",
        "label": "Available For Sale Securities Gross Realized Gains",
        "terseLabel": "Available-for-sale Securities, Gross Realized Gains"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedGains",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.",
        "label": "Available For Sale Securities Gross Realized Losses",
        "negatedLabel": "Available-for-sale Securities, Gross Realized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfRealizedGainsAndLossesOnSalesOfAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investment positions in available-for-sale investments in a continuous unrealized loss position for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement.",
        "label": "Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1",
        "terseLabel": "Number of available-for-sale securities in unrealized loss positions"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the business acquisition agreement was executed, in CCYY-MM-DD format.",
        "label": "Business Acquisition Date Of Acquisition Agreement1",
        "terseLabel": "Date of agreement and plan of merger",
        "verboseLabel": "Date of agreement and plan of merger"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued",
        "terseLabel": "Stock-for-stock transaction"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Agreement and Plan of Merger with ImmunityBio"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r108",
      "r109",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred But Not Yet Paid",
        "terseLabel": "Property and equipment purchases included in accounts payable, accrued expenses, and other liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r37",
      "r105"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r14",
      "r106",
      "r113",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash Cash Equivalents And Marketable Securities [Text Block]",
        "terseLabel": "Financial Instruments Investments in Marketable Debt Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash at end of period:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r98",
      "r105",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r98",
      "r500"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Operating Activities Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r116",
      "r118",
      "r143",
      "r144",
      "r145",
      "r147",
      "r149",
      "r155",
      "r156",
      "r157",
      "r221",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Warrant Or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Warrants exercised to acquire shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Outstanding",
        "periodEndLabel": "Number of shares Warrants, Ending Balance",
        "periodStartLabel": "Number of shares Warrants, Beginning Balance",
        "terseLabel": "Number of warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r275",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class Of Warrant Or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement Accounting Policy",
        "terseLabel": "Collaboration Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r257",
      "r597",
      "r614"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 9)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r253",
      "r255",
      "r256",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r261",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments And Contingencies Policy [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Total shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.0001 par value; 500,000,000 shares authorized; 108,726,551 and 98,460,404 issued and outstanding as of December 31, 2020 and December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation And Retirement Disclosure [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs Policy [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r69",
      "r71",
      "r72",
      "r79",
      "r601",
      "r617"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income Policy Policy [Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r160",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r163",
      "r164",
      "r193",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage1",
        "terseLabel": "Profit sharing percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation Policy [Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r303",
      "r348",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).",
        "label": "Cost And Equity Method Investments Disclosure [Text Block]",
        "terseLabel": "Viracta Investment"
       }
      }
     },
     "localname": "CostAndEquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r80",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Payments in license agreement"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal State And Local Tax Expense Benefit [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r440",
      "r450"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense Benefit",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r440"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense Benefit",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r440",
      "r450",
      "r452"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense Benefit",
        "negatedTotalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r440",
      "r450"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State And Local Tax Expense Benefit",
        "negatedLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r108",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion Converted Instrument Amount1",
        "terseLabel": "Conversion of Viracta convertible notes and accrued interest into investment in equity securities of Viracta (Note 5)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r592",
      "r594",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r47",
      "r263",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument Interest Rate Effective Percentage",
        "terseLabel": "Convertible note accrued interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument Term",
        "terseLabel": "Debt instrument maturity date"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r211",
      "r235",
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer",
        "terseLabel": "Available-for-Sale Investments, More than 12 months, Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r211",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss",
        "negatedLabel": "Available-for-Sale Investments, More than 12 months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r211",
      "r235",
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months",
        "terseLabel": "Available-for-Sale Investments, Less than 12 months, Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r211",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss",
        "negatedLabel": "Available-for-Sale Investments, Less than 12 months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesRealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities Realized Gain Loss [Abstract]"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r441",
      "r450"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10030.0,
       "parentTag": "nk_DeferredIncomeTaxExpenseBenefitNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense Benefit",
        "negatedLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal State And Local Tax Expense Benefit [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r441",
      "r450"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10050.0,
       "parentTag": "nk_DeferredIncomeTaxExpenseBenefitNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense Benefit",
        "negatedLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r119",
      "r441",
      "r450",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10270.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense Benefit",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r23",
      "r24",
      "r430",
      "r593",
      "r607"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Income Tax Liabilities",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r441",
      "r450"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": 10040.0,
       "parentTag": "nk_DeferredIncomeTaxExpenseBenefitNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State And Local Income Tax Expense Benefit",
        "negatedLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r433"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets Liabilities Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration",
        "terseLabel": "Net operating loss carryforwards will not expire"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10130.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r436",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10110.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Deferred tax assets valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r418",
      "r433"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities Leasing Arrangements",
        "negatedLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan Employer Discretionary Contribution Amount",
        "terseLabel": "Employee benefit plan, company contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanTable": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan [Table]",
        "terseLabel": "Defined Contribution Plan [Table]"
       }
      }
     },
     "localname": "DefinedContributionPlanTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r103",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense related to property, plant and equipment"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r103",
      "r171"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation Depletion And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Country [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r3",
      "r15",
      "r28",
      "r120",
      "r543"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10110.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due From Related Parties Current",
        "terseLabel": "Due from related parties"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r38",
      "r125",
      "r543"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due after one year (or one business cycle).",
        "label": "Due From Related Parties Noncurrent",
        "terseLabel": "Due from related party"
       }
      }
     },
     "localname": "DueFromRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r43",
      "r125",
      "r543"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due To Related Parties Current",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "positiveVerboseLabel": "Basic and diluted",
        "verboseLabel": "Net loss per share - basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Basic and Diluted Net Loss Per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Continuing Operations",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate",
        "terseLabel": "Corporate tax rate",
        "verboseLabel": "Tax computed at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.",
        "label": "Effective Income Tax Rate Reconciliation Deductions Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation State And Local Income Taxes",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements": {
     "auth_ref": [
      "r420",
      "r454"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation Tax Settlements",
        "terseLabel": "Tax rate adjustment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Remaining weighted-average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
        "terseLabel": "Unrecognized compensation cost related to non-vested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized compensation cost related to unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Outstanding Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r140",
      "r142",
      "r154",
      "r225",
      "r267",
      "r274",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r628",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment Ownership Percentage",
        "verboseLabel": "Percentage of ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities Without Readily Determinable Fair Value Amount",
        "terseLabel": "Equity investment",
        "verboseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount",
        "terseLabel": "Unrealized loss on equity investment"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount",
        "terseLabel": "Reduction in carrying value on cumulative basis"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r485",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Fair Value By Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r348",
      "r486",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r485",
      "r486",
      "r488",
      "r489",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r303",
      "r305",
      "r310",
      "r348",
      "r486",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r303",
      "r305",
      "r310",
      "r348",
      "r486",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r348",
      "r486",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Inputs Level3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement Inputs Disclosure [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r348",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r491",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r113",
      "r494",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value Of Financial Instruments Policy",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r520",
      "r527",
      "r537"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10060.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease Interest Expense",
        "negatedLabel": "Interest expense (including amounts with related parties)"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r207",
      "r208",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r236",
      "r237",
      "r238",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite Lived Intangible Asset Useful Life",
        "terseLabel": "Estimated useful lives of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Country [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities (such as bonds) issued by a national, local, or municipal government not within the country of domicile of the entity.",
        "label": "Foreign Government Debt [Member]",
        "terseLabel": "Foreign Government Bonds"
       }
      }
     },
     "localname": "ForeignGovernmentDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Foreign Income Tax Expense Benefit Continuing Operations",
        "terseLabel": "Tax benefit"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture And Fixtures [Member]",
        "terseLabel": "Furniture And Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10240.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain Loss On Disposition Of Assets1",
        "negatedLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain Loss On Sale Of Property Plant Equipment",
        "terseLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r113",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill And Intangible Assets Intangible Assets Policy",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Impairment Of Investments",
        "terseLabel": "Impairment loss on recognized investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r103",
      "r246",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment Of Long Lived Assets Held For Use",
        "terseLabel": "Impairment charge/losses of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Including Intangible Assets Policy Policy [Text Block]",
        "terseLabel": "Impairments"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r122",
      "r453"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Domestic",
        "terseLabel": "U.S. loss before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r173",
      "r181",
      "r184",
      "r187",
      "r189",
      "r589",
      "r598",
      "r602",
      "r619"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10010.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r122",
      "r453"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Foreign",
        "terseLabel": "Foreign income (loss) before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossBeforeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r421",
      "r428",
      "r435",
      "r448",
      "r455",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions": {
     "auth_ref": [
      "r456",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tax effect of an increase or decrease in contributed capital (for example, deductible expenditures reported as a reduction of the proceeds from issuing capital stock) during the period charged or credited directly to shareholders' equity.",
        "label": "Income Tax Effects Allocated Directly To Equity Equity Transactions",
        "terseLabel": "Tax benefits credited to contributed capital"
       }
      }
     },
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r141",
      "r142",
      "r172",
      "r419",
      "r449",
      "r457",
      "r620"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10020.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "negatedLabel": "Income tax (expense) benefit",
        "negatedTotalLabel": "Income tax (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r73",
      "r113",
      "r416",
      "r417",
      "r428",
      "r429",
      "r434",
      "r442",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10320.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase Decrease In Due To Related Parties Current",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10310.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase Decrease In Other Accounts Payable And Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10290.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase Decrease In Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10280.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceSettlementsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.",
        "label": "Insurance Settlements Receivable",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceSettlementsReceivableCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10120.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Insurance Settlements Receivable Current",
        "terseLabel": "Insurance claim receivables"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r96",
      "r99",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable Current",
        "terseLabel": "Interest receivable - marketable debt securities"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r84",
      "r170"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r83",
      "r86"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10050.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income Net",
        "terseLabel": "Investment income, net",
        "totalLabel": "Investment income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.",
        "label": "Investment Income Net Amortization Of Discount And Premium",
        "terseLabel": "Investment (amortization expense) accretion income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r83",
      "r86",
      "r87",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Text Block]",
        "terseLabel": "Investment Income, Net"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r220",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment Policy [Text Block]",
        "terseLabel": "Investment in Viracta"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r534",
      "r537"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease Cost Table [Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasePracticalExpedientsPackage": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether practical expedients are elected for not reassessing whether any expired or existing contract is or contains lease, lease classification for expired or existing lease, and initial direct cost for any existing lease.",
        "label": "Lease Practical Expedients Package",
        "terseLabel": "Lease practical expedients package"
       }
      }
     },
     "localname": "LeasePracticalExpedientsPackage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r113",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs Policy [Text Block]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Attorney's fee to plaintiffs"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee Leases Policy [Text Block]",
        "terseLabel": "Lease Obligations"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Lessee Operating Lease Description",
        "terseLabel": "Operating lease, description",
        "verboseLabel": "Period of agreement"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Lease Liability Payments Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee Operating Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Optional extended lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Term Of Contract",
        "terseLabel": "Initial term of lease arrangement"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r118",
      "r183",
      "r221",
      "r471",
      "r476",
      "r477",
      "r499"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r118",
      "r221",
      "r499",
      "r595",
      "r612"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r46",
      "r118",
      "r221",
      "r471",
      "r476",
      "r477",
      "r499"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement Amount Awarded To Other Party",
        "terseLabel": "Litigation settlement amount"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10230.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).",
        "label": "Marketable Securities Gain Loss",
        "negatedLabel": "Losses (gains) on sales of marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities Policy",
        "terseLabel": "Marketable Debt Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r98",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "terseLabel": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r67",
      "r70",
      "r77",
      "r104",
      "r118",
      "r132",
      "r136",
      "r137",
      "r138",
      "r139",
      "r141",
      "r142",
      "r146",
      "r173",
      "r181",
      "r184",
      "r187",
      "r189",
      "r221",
      "r499",
      "r599",
      "r615"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10040.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income Expense",
        "totalLabel": "Total other (expense) income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income Expense [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]",
        "terseLabel": "Nonrecurring Adjustment"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]",
        "terseLabel": "Nonrecurring Adjustment"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity Table [Text Block]",
        "terseLabel": "Restricted Stock Units (RSUs) Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in CCYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Tax year open for examination"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10090.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "verboseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r173",
      "r181",
      "r184",
      "r187",
      "r189"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10030.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations",
        "verboseLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r528",
      "r537"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Liability",
        "positiveVerboseLabel": "Operating lease liabilities (including amounts with related parties)",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Present value of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Liability [Abstract]",
        "terseLabel": "Total lease liabilities:"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "terseLabel": "Operating lease liabilities (including amounts with related parties)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Operating lease liabilities, less current portion (including amounts with related parties)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r522",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease Payments",
        "positiveTerseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfCashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "positiveTerseLabel": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease right-of-use assets, net (including amounts with related parties)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfOperatingRightOfUseAssetsAndLeaseLiabilitiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r533",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease Weighted Average Discount Rate Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r532",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r511",
      "r513"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases Future Minimum Payments Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases Rent Expense Net",
        "terseLabel": "Rental expenses for operating leases including common-area maintenance"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10130.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets (including amounts with related parties)",
        "totalLabel": "Other Assets Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r58",
      "r59"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10030.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax",
        "terseLabel": "Net unrealized (losses) gains on available-for-sale securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r58",
      "r59",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r68",
      "r71",
      "r74",
      "r78",
      "r267",
      "r501",
      "r506",
      "r507",
      "r600",
      "r616"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income Loss Net Of Tax",
        "totalLabel": "Total other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r65",
      "r215"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10040.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Net Of Tax",
        "negatedLabel": "Reclassification of net realized losses on available-for-sale securities included in net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities Table [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r45"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Current",
        "terseLabel": "Other current liabilities (including amounts with related parties)",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10070.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other (expense) income, net (including amounts with related parties)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r262"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.",
        "label": "Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net",
        "terseLabel": "Other than temporary impairments for marketable securities"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForMergerRelatedCosts": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the reporting period for charges associated with the mergers.",
        "label": "Payments For Merger Related Costs",
        "terseLabel": "Merger related costs"
       }
      }
     },
     "localname": "PaymentsForMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments For Repurchase Of Common Stock",
        "negatedLabel": "Repurchases of common stock with commissions"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payments Related To Tax Withholding For Share Based Compensation",
        "negatedLabel": "Net share settlement for restricted stock unit vesting and warrant and option exercises"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r88",
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments To Acquire Available For Sale Securities Debt",
        "negatedLabel": "Purchases of marketable debt securities, available-for-sale"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments To Acquire Held To Maturity Securities",
        "negatedLabel": "Purchases of debt securities, held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r302",
      "r304",
      "r310",
      "r328",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r348",
      "r349",
      "r350",
      "r351",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r35",
      "r36"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10220.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets (including amounts with related parties)",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r4",
      "r7",
      "r239",
      "r241"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidRent": {
     "auth_ref": [
      "r5",
      "r7",
      "r240",
      "r241"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Rent",
        "terseLabel": "Prepaid rent"
       }
      }
     },
     "localname": "PrepaidRent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.",
        "label": "Prior Period Reclassification Adjustment",
        "terseLabel": "Cumulative effect of the adoption of the new standard"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "terseLabel": "Proceeds from equity offering, net of issuance cost paid",
        "verboseLabel": "Proceeds from equity offering, net of issuance costs paid"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r88",
      "r89",
      "r197"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities",
        "terseLabel": "Maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r88",
      "r89",
      "r197"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10160.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds From Sale Of Available For Sale Securities Debt",
        "terseLabel": "Sales of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds From Sale Of Property Plant And Equipment",
        "terseLabel": "Proceeds from sales of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r93",
      "r398"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "terseLabel": "Proceeds from exercises of stock options",
        "verboseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds From Warrant Exercises",
        "terseLabel": "Proceeds from exercises of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r67",
      "r70",
      "r97",
      "r118",
      "r132",
      "r141",
      "r142",
      "r173",
      "r181",
      "r184",
      "r187",
      "r189",
      "r221",
      "r469",
      "r473",
      "r474",
      "r479",
      "r480",
      "r499",
      "r602"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r41",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r113",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property Plant And Equipment Estimated Useful Lives",
        "terseLabel": "Property and equipment estimated useful lives, term"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r40",
      "r248"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r250",
      "r613"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property, plant and equipment, net (including amounts with related parties)",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r113",
      "r250",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r16",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Property and equipment estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Summarized Quarterly Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains Losses",
        "terseLabel": "Net realized (losses) gains on investments"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsInvestmentIncomeNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsurancePolicyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coverage retained or reinsured.",
        "label": "Reinsurance Policy [Domain]",
        "terseLabel": "Reinsurance Policy"
       }
      }
     },
     "localname": "ReinsurancePolicyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsurancePolicyTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type, risk category or other classification of reinsurance coverage.",
        "label": "Reinsurance Policy Type [Axis]",
        "terseLabel": "Reinsurance Policy, Type"
       }
      }
     },
     "localname": "ReinsurancePolicyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r542",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction Amounts Of Transaction",
        "terseLabel": "Related party transaction, aggregate value",
        "verboseLabel": "Estimated cost for new agreement with clinic"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r329",
      "r542",
      "r543",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "auth_ref": [
      "r22",
      "r510",
      "r536",
      "r538",
      "r539",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.",
        "label": "Related Party Transaction Description Of Transaction",
        "terseLabel": "Period of agreement"
       }
      }
     },
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": {
     "auth_ref": [
      "r125",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction Due From To Related Party",
        "terseLabel": "Due between parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction Purchases From Related Party",
        "terseLabel": "Related parties, capitalized equipment amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r540",
      "r541",
      "r543",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Agreements"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments Of Long Term Capital Lease Obligations",
        "negatedLabel": "Principal payments of financing obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research And Development Arrangement Contract To Perform For Others By Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research And Development Arrangement Contract To Perform For Others Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r412",
      "r676"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10100.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development (including amounts with related parties)",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r113",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research And Development Expense Policy",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research [Member]",
        "terseLabel": "Research Tax Credits"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r9",
      "r18",
      "r105",
      "r111",
      "r660"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash And Cash Equivalents Noncurrent",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "Outstanding RSUs",
        "verboseLabel": "Outstanding RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r274",
      "r406",
      "r611",
      "r632",
      "r637"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r140",
      "r142",
      "r225",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447",
      "r628",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r332",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r332",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consideration recognized during the period for the milestone or milestones.",
        "label": "Revenue Recognition Milestone Method Revenue Recognized",
        "terseLabel": "Revenue recognized for milestone payment",
        "verboseLabel": "Milestone payments"
       }
      }
     },
     "localname": "RevenueRecognitionMilestoneMethodRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r75",
      "r118",
      "r168",
      "r169",
      "r180",
      "r185",
      "r186",
      "r190",
      "r191",
      "r193",
      "r221",
      "r499",
      "r602"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10080.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r531",
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesCommissionsAndFees": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Sales Commissions And Fees",
        "terseLabel": "Broker commissions on repurchases"
       }
      }
     },
     "localname": "SalesCommissionsAndFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule Of Accrued Liabilities Table [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Securities Excluded from the Computation of Potentially Dilutive Securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Available For Sale Securities [Line Items]",
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule Of Available For Sale Securities Reconciliation Table [Text Block]",
        "terseLabel": "Schedule of Investments in available-for-sale Debt Securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r205",
      "r206",
      "r210",
      "r211",
      "r212",
      "r214",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule Of Available For Sale Securities [Table]",
        "terseLabel": "Schedule Of Available For Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule Of Business Acquisitions By Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunityBioAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]",
        "terseLabel": "Summary of Income Tax (Expense) Benefit"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Components of Net Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Reconciliation of Federal Statutory Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r365",
      "r394",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r365",
      "r394",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Stock Based Compensation Expenses Included on Operations Statement"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]",
        "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]",
        "terseLabel": "Summary of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]",
        "terseLabel": "Summary of Loss Before Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Investments [Line Items]",
        "terseLabel": "Schedule Of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule Of Investments [Table]",
        "terseLabel": "Schedule Of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule Of Other Assets Noncurrent [Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r41",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Schedule Of Quarterly Financial Information Table [Text Block]",
        "terseLabel": "Summary of Quarterly Data (Unaudited)"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummarizedQuarterlyDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRealizedGainLossTableTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.",
        "label": "Schedule Of Realized Gain Loss Table [Text Block]",
        "terseLabel": "Schedule of Realized Gains and Losses on Sales of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "ScheduleOfRealizedGainLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r121",
      "r544",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule Of Related Party Transactions By Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]",
        "terseLabel": "Summary of Options Outstanding and Vested"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r372",
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summarizes Stock Option Activity and Related Information Under Equity Incentive Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Weighted Average of Fair Value of Options Under Black-Scholes Option-Pricing Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r50",
      "r116",
      "r155",
      "r156",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r275",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]",
        "terseLabel": "Summary of Warrant Activity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r427",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]",
        "terseLabel": "Summarizes of Changes in Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r56",
      "r126",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction Type [Domain]",
        "terseLabel": "Securities Financing Transaction"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposits"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10110.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling General And Administrative Expense",
        "terseLabel": "Selling, general and administrative expense",
        "verboseLabel": "Selling, general and administrative (including amounts with related parties)"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling General And Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period",
        "negatedLabel": "Number of Shares, Forfeited/Canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Forfeited/Canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "positiveLabel": "Number of Shares, Granted",
        "terseLabel": "Grants of restricted stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
        "periodEndLabel": "Number of Shares, Unvested, Ending balance",
        "periodStartLabel": "Number of Shares, Unvested, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-Average Grant Date Fair Value, Unvested, ending balance",
        "periodStartLabel": "Weighted-Average Grant Date Fair Value, Unvested, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Number of Shares, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized",
        "terseLabel": "Additional common shares reserved for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
        "terseLabel": "Common stock reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "terseLabel": "Common stock reserved for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock option exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Stock Options, Options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "positiveLabel": "Stock Options, Options granted",
        "terseLabel": "Share-based compensation grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding, Ending balance",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r374",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Stock Options, Ending Balance",
        "periodStartLabel": "Stock Options, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending balance",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Vested and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number",
        "terseLabel": "Stock options, vested and exercisable",
        "verboseLabel": "Stock Options, Vested and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number",
        "terseLabel": "Share-based compensation vested and exercisable options outstanding",
        "verboseLabel": "Options Outstanding, Number Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Vested and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedStockUnitsRsusActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonSharesReservedForIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]",
        "terseLabel": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options",
        "terseLabel": "Options Outstanding, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Share-based compensation, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r389",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationBlackScholesOptionPricingModelToDetermineFairValueOfAssumptionsUsedForEmployeeStockOptionsGrantedDetailEmployeeStockOption"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Weighted Average Remaining Contractual Life, Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Weighted Average Remaining Contractual Life, Vested and Exercisable",
        "verboseLabel": "Options Outstanding, Weighted- Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares",
        "terseLabel": "Stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value",
        "terseLabel": "Stock options, weighted-average exercises prices"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1",
        "terseLabel": "Exercise Prices"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2",
        "terseLabel": "Options Outstanding, Weighted- Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedPricingOfExercisePricesDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued Price Per Share",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Shares Paid For Tax Withholding For Share Based Compensation",
        "negatedLabel": "Net share settlement for restricted stock unit vesting and option/warrant exercises, Shares"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software And Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetailsPropertyPlantAndEquipmentNetDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State And Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r116",
      "r118",
      "r143",
      "r144",
      "r145",
      "r147",
      "r149",
      "r155",
      "r156",
      "r157",
      "r221",
      "r267",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Statement Class Of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r52",
      "r128",
      "r129",
      "r130",
      "r133",
      "r140",
      "r142",
      "r154",
      "r225",
      "r267",
      "r274",
      "r403",
      "r404",
      "r405",
      "r446",
      "r447",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r628",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureViractaInvestmentAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Income And Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r154",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureAgreementAndPlanOfMergerWithImmunitybio",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of preferred stock and warrants for common stock issued.",
        "label": "Stock And Warrants Issued During Period Value Preferred Stock And Warrants",
        "terseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Stock Compensation Plan [Member]",
        "terseLabel": "Warrants For Common Stock"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpensesRelatedToStatementOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r108",
      "r109",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued1",
        "terseLabel": "Cashless exercise of stock options and warrants"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of common stock, net, Shares",
        "verboseLabel": "Shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r267",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period Shares Restricted Stock Award Gross",
        "terseLabel": "Vesting of restricted stock units (RSUs), Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Stock Options, Options exercised",
        "terseLabel": "Exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period Value Restricted Stock Award Gross",
        "terseLabel": "Vesting of restricted stock units (RSUs)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r267",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program Authorized Amount1",
        "terseLabel": "Total amount authorized for repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program Remaining Authorized Repurchase Amount1",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased And Retired During Period Shares",
        "negatedLabel": "Repurchase of common stock, Shares",
        "terseLabel": "Repurchase of common stock, shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r26",
      "r27",
      "r267",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased And Retired During Period Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r32",
      "r33",
      "r118",
      "r195",
      "r221",
      "r499"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r274",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r508",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r508",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r508",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r508",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r549",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Financial Statement Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialStatementDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2020Member": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2020.",
        "label": "Tax Year2020 [Member]",
        "terseLabel": "Tax Year 2020"
       }
      }
     },
     "localname": "TaxYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r207",
      "r208",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r135",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r444",
      "r445",
      "r446",
      "r447",
      "r586",
      "r587",
      "r588",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type Of Adoption [Member]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureRelatedPartyAgreementsAdditionalInformationDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnderlyingAssetClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by underlying asset class.",
        "label": "Underlying Asset Class [Axis]",
        "terseLabel": "Underlying Asset Class"
       }
      }
     },
     "localname": "UnderlyingAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnderlyingAssetClassDomain": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance).",
        "label": "Underlying Asset Class [Domain]",
        "terseLabel": "Underlying Asset Class"
       }
      }
     },
     "localname": "UnderlyingAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesAccumulatedUnrealizedLossesOnDebtSecuritiesClassifiedAsAvailableForSaleInContinuousLossPositionDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsInvestmentsInMarketableDebtSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain Loss On Investments",
        "terseLabel": "Unrealized (losses) gains on marketable debt securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r415",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at ending balance",
        "periodStartLabel": "Unrecognized tax benefits at beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions",
        "negatedLabel": "Decrease for prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued",
        "terseLabel": "Accrued interest or penalties associated with uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions",
        "terseLabel": "Increase for current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummarizesOfChangesInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation Balance On First Anniversary",
        "terseLabel": "Unconditional purchase obligations, 2021"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary",
        "terseLabel": "Unconditional purchase obligations, 2022"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary",
        "terseLabel": "Unconditional purchase obligations, 2023"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation Balance Sheet Amount",
        "terseLabel": "Unconditional purchase obligations, Total"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualRisksAndUncertaintiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risks And Uncertainties [Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "UnusualRisksAndUncertaintiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r158",
      "r159",
      "r161",
      "r162",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "terseLabel": "Deferred tax assets change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r470",
      "r471",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity Primary Beneficiary [Member]",
        "terseLabel": "VIE"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r529",
      "r537"
     ],
     "calculation": {
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureCommitmentAndContingenciesComponentsOfLeaseExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Outstanding Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWarrantActivityDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Basic and diluted",
        "verboseLabel": "Shares used in calculating net loss per share - basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/DisclosureSummaryOfQuarterlyDataUnauditedDetail",
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract]",
        "terseLabel": "Weighted-average number of shares during the period:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.nantkwest.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(m))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6283291-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.11)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121603689&loc=d3e36975-112693"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918703-209980"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919370-209981"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919784-209982"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=49176635&loc=d3e9760-107771"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r677": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r680": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r681": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r682": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r683": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r684": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r685": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001564590-21-010945-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-010945-xbrl.zip
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MZR20Z]>OX^/A4Q(04/+=IKG-]S_^7'T"2'"P:W!Z,2",P#42" 8)Y*H=H <
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MG6?9=3?9LZ7?DJ]+D5P!K89%\&'N\X7J"_%28WO7[II;/"7Q52Y:DO-XB>C
M<?1IF</-APYWY*U?*]9:!". HO)-+U^'H2[LOERBQKK2PD;=(K'"@M[/3XEZ
M-+Q;T)(I:Y));KOPKG;X3MRJ%%UA 3M1(9AOTZ9Y(O^IY\)-<,.&8<='SL\F
MI<Z_I';3<8Y\X%^V:.G1_.N,[I#U>JO]N8G<3S'M_I\\2Y(^>[MI"GF%L$HV
M!$I2[_@.0(R,=R*/<+B6(L6:BMOQRSR35D0R+\*LKP#O*T $6#\4]SU0:]K/
MGZB9<#$6=\X@OP)>OD9N_^>ST3\BZ&<L#O?^T6(%34W1C'\WS,7\,$*+F?I
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M/8]D*JY7'J?*@*K5PJ";%PV?89C. \Z&//=/2]=$J/=?3^<BV@H%UU.M!AI
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M=, 0K-XD:PR*,_;K6PQUE,F"3F6JLH U+<83BT3[*@$1V6B">E$/35W;+$P
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MVW[LVOQ_V'O+H#BCK5VP$Q((%B0T+DEP&@G2N";! P1MG 2'1H([)"1(.DB
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MU<,,6J?9\/V!_SV@ED9H&;1R8[D\#Q7R>+36][/2XT/FGJ +RENW%/U#KO&
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MD-BHO5/R7JN/A'4W8X9XY=*+IK#]^5S/?Q3SE^]I$.&HWO2+J]I94 ]H/24
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MIZ_<?M&E<2G7-N\S>S&*G@B*Z1IM2SF"7 )1$N,MGC830MNJ59J\[V')]C%
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M>CL_<ZG (^*3W]_F@-& ME=J9HYQ:@])^:Q[[%POU,7"#J$QYY]"[)__(I-
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M3$V($\[U.*$HL$W'9#J-HOKKHU=R5>+!K.O7 C,'ND$ -F-'R/5V0QT\Y]K
M_?W>V,H *F$-0K"+GP&?=2_]@@'J!>N:N,5_T[[-E%OA!='^2XGA#)BV'A(W
MSB;B!BIA/I07N.82TXYSDT/BCZ%T=8<IO:3=LOB^ ?6LK1,3GSS7H THWT$Z
M?Q-L2JWWY.?V00YAM*-0,2Z;5XFQ$G^)#_4\D\0K,23ZB-QM9NB>>:"5T2HA
MB.4OP8$Q4OY'W]O(P UP5WQ+$_YR U N45+HS$1@3#.5M!?,/.<4)5L\3=,<
M1E5<0>106UP'_(: >G^H5WD^X#N ZUL#,QQR$664&,V-5]!^++1/#W'[R/I+
M1,O-E8#(9,Y*S+R&:)-/HPQ,K.H&#IM"LA\6ZZ<<%!AU-I)&CVL(]'LI2A/9
M%L86%IX"7$JLEL\AYP2X^BGO^@*DC92=X"R"8Y9C*]9!1.JZY-2T1P'+:Y/L
MM';VT:\>Q$"MD91A2D9*,=\H?1,8.Y1%(;LZ/1 V6_50JNX2G>6-L)5#5&D$
M!''Q]5W**6.#IXW@,O1)0IW6V!5^>!Y^D9FC_7GHOAFWF>"\X=/HQF?Z!KI*
M9KE]U,L=#YBO*YIQ-5**8X=_/S0< 7*VZ2Q.7Q&/+2U]?N;[;#( X80&&(Y5
M6-O;EZS3+S*RJ9[![(](4ME0A.!I'"O="T*?$+[BS6O![.G'!7W)\I?M^WB3
MP1[':\F<V\!Q7D@$N4I2KL%T;H+S=3:NXL\38Z/W1*H%L^U.]X-RU!D%5D0F
MJV>1/(=1_;6JE"^)'+^\7J]SY  K*)-J:%PS0MP/.E\9LY55A,]TZ-(%2_4=
M/W+BCG34!V%;)O 9=(U^=35:F)N87_S<2#VU<!,'5R#TMG)( 18=#H;PLI,(
M?BAW-2W#>_ER?TM7!<JG%,<,EB5T7K<[68P4"OGN!;3."VV>8T((OC-OK&F:
M<6O_UNMIKO/RB/!ZKY&CEL57YAGGFG'J85KO[@*9C6.,: *JWK3$=YWLA=F!
M5HTJ_#QCS?K'#'.K<+"X(ESLZ13%(#&=O\*U&)W8W$1(^RP:(&X4/$_02^G^
M_@ \B1"TJ/@ X[X([D/Q<CH_W"98*/3L_XOO^%<_R?J_ I\MY$7;V8DP6G;
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MNC0:3*FWK4I"L32Z5*1FZ<E+T8J$GRT&SWC9H(A?N[ ,K'718H-W*AE_2P"
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M%4XQ3@1'Q[&!091:\3"WC@G;H0S@T]NWKZK4C?5E7#$_!+_%C]J^WU4BK8&
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M4%=!5"%2#8L +T"$.>?._1<C(H&H35@<ZH7^7%/T_K3]&NVMVI[!?DK@ @
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M0D)&Q:U;+Z+\=MC2Q_M2V$P3W(9_\L8\OJ HF'Z?Z=6.W]MQJ;C@]FNE(H(
M2RDLV]97.HS$B?EN)^!8:>9+!3Y[PXAD]=Y(+H&2/(DC\QGOPK@:[DF\GX\G
M<O1Z'6=^IO+16QJR"#00@$;.9I45^;B[^*FGH<85)_W1%6+?/\*(/K\[A:D=
M7D2E-\A$N\TLY%;;+L^YRKD*;>N_K,RVQ.5188X=I"P]D+WK P1/NOZ,\WA4
M-1:^45H6I[B>N@^C%-02Y/LV4QZMH',#3/.*NU%E ,?V]">8A0_+4&I"&4Z?
MZ![9WQ3R8(E\(AX@H+1EN;_@49(&?)W*S1,\"+5J"K++\5E:F27:#?V:QU@S
MA& U3E:7-0APW@;^Y%?'GM$UGX3,LFQ]@<_9=SIJ-.<KT#5/A[W(Z5C_ >NI
MT=M\MFH9GI,[=Y,YK>+1;E0\4+X?<.O'W_^K'R/_B?\VY#TU1JB_8J3Z?@RN
MMC>*7B]91WH'5QOI>O=+D-4J5]=/V&=8S$4O\8_4PHAWGMAD"C_@,7TNJ^>^
M9[@8LJ[+MV/IB^$XF&./@/?(IG(^5HCTPZ&J3L>]4HVDKZQ,9!TY(>3*/KF<
M" ED>-+KPY+96?.3V!.?%3R"%/]4V'8L$Z1%=C>Z8AC!0L8.OF)^6Y31C+TE
M0:K?&<KW0%1_X^G/0KH4CGU6TVTXS5/W>_N66A[O-8C0@'+6?F\C+[JT%PU!
MGCCRF!,-V)(5]IC+T)7!X_)\"[7Y8U85 ];O)_-35<LW)"LJAW)3Y1VS'H)T
MBJ#/*>1]XS3M8/R (Q.VIT.5GP3IOVF7;3_I/USW2A6)YV@-:)"$%R)8MC?4
M#UV[FMR^ I!=3L[*)FY*E5T&9&NC*'+VB92:U& %XP9ER24CJ8LV8[(QT['I
M7*U+K<4X7_W.P[2&HBVAMTTVPR4<I\65G5&RW(-05Q3UY.Z9,O7^?J_*-=97
M:Z4/@ \K,&(-9<8,;IN*@F7/; 6K0D.#SI:.-1D%*V%N3,%\/J_0?=>BFJQW
MP_79!53M"E9C[W1\Z#S&C3=\,FR SJ0>@O>@V_JD?F3OQ9GVE ^K$^Q_W@AK
M[UA:6 \ZZI_PT8*[LX(M!3MS1,2),T 9<U(=,I?^HH!"[JEY;C1 8\Y+NSNW
MQ,HR-7B?:,G)EC]J1+GX/NU$!6^_P%SJQGZX<G:X?)55;CM]Y:78T99>U8^;
M1%._2:G"YA;_X_"N,7NKZH9?TH&+Q#@[^8S.S[IL_A_VWO(IKJ]KT.X0 H$$
M2(#&W6E<&F@LN+MTXTEP&J=QB!""->ZA<=>&X$X@N%OC$MQ= T3F]SQ34_/.
M/S#WU'O?'ZXO^]0^=3Z<6K6N?=99*^30Q)E*(=(-\@8"C&;;\BCPX%*T^VKV
M3)^R$YW))Y.M>S<^2%^*#EI_YKTYRO+;D7.C5-\[4;3X,UH7H4CS)E'JB>IS
M/8UY0_ ,$8[@$%YRX+>^!L;)JT,C;X!Q:\8LHE\7.:VOYN?EUQY#9RY\9QH<
MV%UO^%+\O&[N_2)/VV1C@HKK333"YT9P<;BZ;]5_1K=7J2B\_V5(J?RFDDS#
MEZCPI8M2AL8/=6Q7#-9>0+MCK>"M-S)%O64;LDV<75?HI40(9B-M3^<X9DA@
M&CG>W'?<]15N#KJ04NOA>.CT+$MM2,!SP^L-O%9:%REXUV ^J(=79%37%&_F
M\K8AL2><93IX$V6J+F?LQP[4[VDL^<I3D]'HWR;D45+Q%@6"/]^BH#F787E.
M16B/;[31WKW#S<AU.,K?UQ^OE4!)'@?"<0"LQ3E4,;W^(O1DLUV)7<=M$XE#
M89.^4T*S=556+8JW*%T"!]P=RO,)3W'.\_)N[8)-7K<'Z0UD\\KCEXQTE7"\
M=KFF=AD7)M:&[*",LHHBL:S"2$DT>/I)RWJFJE7<'K4:E(6+"4].(]T&CW6&
M-)1TI$^%T^C5WO/[3W\ZV24-!9",JI7A2G&F?[S)>44AC*+MFC1OF0DOY%_+
M?]$]519"W?C/F_+C6&]23=FTV'?H8FBY9\S(<U!XO>)W[J\^IQ3P0.TQS50W
MX\KM5ZX4-/:UL@*\/6WOI4I-#S78@Q*)O\533Q >[.6"7O/%\.F;I;#NEU;6
MW$7/)H[]WNDMFWP1[\*.^CRZE2U4Z9#H;=*<;"EG-BN#45/QGF3I.S"#=)9-
MRS$FO1#D(#O9=5V7,BR*^SZS.$>T+L'F@+TN@O8!)C5*@6#;F'_$.U$F[_^!
MO]?_O1F>NPZ_TF1R[.^R_D<93ZGTX* CS8+*434NZNX_3'5S1ST3_$2_5+,4
MG28I.;ER_N=H0(&0_^-XVX!XZ(57#IYZD&Y:DD]%>:8"FU]%<_U'HM4<PNSC
M9X?*B^2SS8\K_@+J57_7_ID!>-/;OS;1KN-#>] OO3K6_>\U3Q^/<L:=IF-C
M04V3=Z_='F92?;Q9<%& GE2..^Q/XB_-V3(WH9^6!CL:R$$XY$&_'=.;G!(<
MI54%1@'><W^DH[DSN=%/:E]&95@VQQ+]O!96CTS)6E3/!M?&S1^?FF7^ODO0
MYM$&6HC=7J%S"< "F>I21&H?D.(2$)^S/5O)%$:\/X;#OE5]M](LSURQ;5='
M(2^C[%[I+C;?\=Q$H:*MQ 9HH.<%*26[R= K.]5U/IKQ]9X TW""F73$]OG<
M-Q/,W'MVGA/4K+]+]@W#7X#O^?BV&9><,CQJ2<@3:#$HZFUW7)"<*$&$_TLA
M4:;647WX=;WI!_SGS]][\86_9Z=5UG#D 74:]6T2?;]XA;\>Q>)=TJ,L!9JA
M: P@.=Y*KE2DHIE377^PXEE\_MPN SD02N@/T\Q1IRUX**"!:;PY\AA3VW5U
MR:.H[@1XE]^XD@ZIB;' ^#Y4RMYX-!RG@-.*#TE,5;14]6=+]9PI$05C-S[6
M:Q^5F\KZ9/R^!UU5PC=[/&J.HS9*1<H1'%W^0':,%LP&;:'@F/@U^*H<Q59,
M6W)10$,R^_5Y2(PV6RK/H8G8BI%#YD-(O$(\/^@=1PAENACN6844\<XK/BO5
MRP#4LNK,^WW@V+0)D?JR:9)*GA]UC,0</:G<)13PO!0^.><E+^2GV_@8;;MW
MZ2<>Y;0B!$W4<:K+VXK?HXA9'+72(7]<KQM005 R#X;?L*-6+'AE@>/CI!NZ
M&<&HNUNN1L2)FP%G$X_61[,[M[=+/,BQ@-\QJA3EJO"^)XC!7L1B*JJV0;97
M[IUQ!UTT9# _KZ%=:8L*O<%A\N[5F&P"EY#&I2F%/G(9<T*VI.2\F4+1ZQQ6
M^C!_D?7>/;087U Y<UAD1@I5*N;0'/4+<ZQDZ4'J!<Y\-OH\/6)M;KK7_OV[
MYF\%K\T7-),2L;W!\XL_L_"8>S< W3_+/T9@,A]N=M$2QQQFN8$[S8?KI;,_
MXZ?#^J YO_O\27XF+/?\L*$712-$$>">(J5!MIJ<M/5$^RVJN<^5RQU"1OU$
M^*_P%J[+OH3YU7RE7P5R!QAL8?0&=]2#IN*_\ &+UH8)$'3>UV6I$C(#I M8
MC^+\2B#>=^G(DKZ>P0:8#[3DU_=VP*L0T^0WNOUL97$2T(CET=ZX6I(Q$)-J
MZ9@B?Z6BH!/86&X]%"X8M[6MO:O-3-JW6\AX .7(O:?M2-HEV_;%ID>K# F,
M*DUB":%P*I6W<NFY8@N%J+5 9KQ3^)>'.LD,UP4ZY]?%NQ,8R"Z:@P7\6.'
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M0YFP%459R/S[4C?$RWE(Y>TRG:/N9_@/?J PO[RH'.="A*H0^VC+7T#6Q5_
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M5K74TW*N_U*D[_]JL_QWH^WF+Z S532+-U$_065U4=7G"(1 GNZPOHT/TRE
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M)UXUYJ&/2'*J1 J<V30*'4BXPXYE:U=;*513%K3\L)H4 _G!,_N-0<<?5P:
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MF7$6ZWZTM5V79&FB$W7 @U;(269>&TS-Q6<SEU&H$) &527YA8+2I(A6AK6
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MAHXOYRUDID\*^HEAUDFFYYY)"(D8M()2/N:S<+C()[=02IL5Z-5T*'F7MVU
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MJG>=ZMZKSUF]#O,[(KC(=N6-3!<L/@:!.KPH2?6U$<S*ND3L36<7%%+C6XB
MV3EDVK\=P[:\<^),30JW0".09\HH[VP<?-_?HSZ/Y!XY+VUQL,1HT4VMTW2C
M7@LT%5;.:[X-L&V!C#J+YSL(@&-)VKHIF\9]0W3_](=I,T[*#W4TR2P72+MN
MV/BU2ZGOP-/6E";8XIED3<D*4^/\<6&*$U1]ZJ?M9U&QQ;M@(0WCZ+-$2?#0
MC$5DSP+A@O-MLE2&%3*8@Z,7#(\[_HKG,\O&\(6/9$;CV4'2WGE[^W1Y^M$
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M0ET5W/#_[6Z6(A>5<2F+1\WS6[;=];\F3U*P $\8P/@JC[ ](+@UDE=/#^F
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MC<\W/ZPW72DXU0GIP*[/_VB'F<"G;[(6B7!GVL?"BN)01A$7PY;P_K+2+$#
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MI-;%-(X)5_U@[-$3'ZB[(%L^OMGJ/*X\DZO@'X^Q%$AQ6XE&V.B/6YWXV5@
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MIH!2AD\,SE_5B:?QC(LD"8NJG+.PG3#'8].P,>RM2"<WZD&G%==#-* U)4%
MRW<#H2XA9-G_2\5@J#P;P%?D)D-V."#TLR&8(+T(D">[</IZMX7+DRS[HUC
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M4O-I17NDJ[4UB44P99(O^$)6FUJ&#35OH099W-Z(GO7^!%@*,H93!M7!_&B
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MS3F2"$M?0]3Q7\<3'1+%UIF^WZ>E)L+#F_=^  3^-A^QJS3Z9%<S4%/24P+
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MYR#&4C,3]K2XS<W6]L1E-]# 0E0 5%TV#'W03Y^$:T",R0?LK:KO>HT7$K3
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M5E/@[7$@<)7ER7:LJ8:F0ZF<4S;7WQ$Z2*\B>7D_1U&]8KC:^CCIOF=(S_*
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M>K[XOY-N1^ITYP:5RR.1COI-E3X AM2W[ULHSTZ.Z[Q11^$J['GM F/,C0^
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MO?#XEZ@.?P$-H6S;M_I4:XO>E]4Y7)MT7V#)1HH#I)UIBR:*6/GD<5).>)6
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M:881V$9-S#.0Y_M2K15UX/5^&W*P'X>I&_+SI[#7'W##FXC!2H"7KD'<S@.
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M62HA@9.1**CR6N!+E$9ODI(@P:=$Y1%.=>KL7N#IY2V[.6V@Y\@#X%%E7,]
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M39A)EV5@GB N.GE4"NN/M;<3^0@=-;)DG=&YOHSM?]X5QEXW#Z\Z'\<Q<FA
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M><)59IWWW*+!NV(J>!14;F%XV]W1Q7 @I:^N<-NI[F]9\F><)+JZI38 8?Q
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MCUZ1JT%/TQ7B]+0K$"=1A]D17+NW+:$-3JE?L&HWLPOO^S!6[*DNO-H]$VA
M>#T?JS+^XGLH7D[YOK#"B+:(Y::AC(;*YX"MA?AC%B\"<+(NL/9))7%([_OM
M;A**-2N'SP$WY%X6N/F>E<!^!$X%M%2OK39R&VY4D1A$E;!4(;M4J6Y-'Q,
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M9->I_(+H258G:V#YJR_!SJ,5W+6O,MT<?PP'7<<:6#0QIK^L)-O+BA 36"$
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M 2:]'DGGSVSQ"L2ZYQ9B)3[<=-W?YVG)Y8AMX7(&:\-H&1[K;,VC*47KMI/
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M#6'9*F?7N*[W-N_:$[SAB&,VUWY>P3T)#MD=2>DGE+3MANYS9![:?MKXRH7
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M*HBN^(J6UC>3PU[+_ERTU9X6"NRN(=AQ0- ') )S:H$?54(XV@9^%0?T9^&
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MGD"294PWN@2C9LG$^;X=/T/6/ZAFSL F,AY\,;E=.S[_WJKTOM;Y78GU.T5
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M+1)'5G7+=:,_9A[RBS^N>7>9O@WP&42=/:P8QBB38ZCXF3[2;,^] 66<)^"
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MFR3* MN?PE3WI=8][FYCTG8(A#;K*X8*60\7[>%G6LB^I?GN%)(U*$_50F:
M+-!.4QEY]L2%,*51-(;C5CB5.G[V9D/J*3P<6N.TG+0G>U>%D+P];'H)7],Q
M),B?T9*QMESU33\G!RP/$'KX2:MI324J!5-M/#_<+;)W:R\NT.'?!EPVS?J#
M?&1) @\D2VL\4PPS.(/?B#J;T$P2B$BRJ"5I7[H9=UW!4GRXNH"=8D&+OLU'
M?Y'!OHR-R4[4MN6.AMQM(F316;N7<*MMV6:/MV29;0%+O?;[S[<+,3)HD3R-
M_*8<:)1$[?7O,+YV^N]+VB0('WXD>D"&ZF5X(E>E N<[ELV*;^D"-E0T_ '^
M)':N?^RX=*R70KL^6VRK,)GNVL9$!2P#SC^]1[6(,*!A'W(8UZ_DP]ZMC2<A
M\D2I6>ZEV@1&K%S([=10<>D(H>/;]^-LWHCJS1C4X6?FVME]&] MUS'A)A*.
MJ[60]-0K'3R!X._6#94)LC6/=R-6JOEYB;H.M/Q/A8+S%7(>YIFK<@K0@_CG
MYE;J[ND5:V@]KBR.BK_APFOD%3Y:S4O4N55/8!,K56L<:E=1R.GD&:!6= 4!
MV;NYE6K=-;V\U5\NHCLHSRJ+ \@.O\)L?$O.C,]@B2N+=HOW^[QZZ<*(0Z?R
M;^0E.GF-AN+K.H3Y2W$C\LWL;FQ4Y'*U!D[J0X"$0W*0%EQUR-X%G9PB;1,K
M\7)#GM8I%-AKN(XA&ZQ5+%3/[<_]K<R9K$_[!M2 7 FD##I0$:_Q-#=<^,G0
MP7T1.!W6[D==CLH.SAPL6HTE35'\6/O4FM_Y=R6^41BJ08Q(04>NB1W$J3.9
M=M31_*LB8.D1W5IN?O.[R32*/3#QM8XSO-#3+3?#YSXZT(4K\E"@Z-NBDSU9
M!PJAAQ(*<%C0H%C4J&(3R'ERSU6N;%^I FG=QDA[$J>A7*7_JGV T)!BA&!C
M"MS8?\UF**QKYT5=A-\KS7R\)74=C7"U!\.%TXOW^@H>"?@9=:Y#$M70!:@3
M\LOEEF"A*Y)MKSW4YV(K<C>B?D$]W_XR%,M_RP W!@X;WMU5&IY??O?]Z<MP
M.=+3\:_Z]G+MY'>;F4 OKI"!RFC<:%_^U7WWM[N^4DF57,Y-L/4W3R!?9__Y
M%6#ZPUIHZA/F?:RXG'6:.NDSH_V)H'[:'XHB'QE7I"@T-Q]39-)VRN9_&JUE
M@#I796CQX8!)V@U=DW=3.?W/*>TJGWQF6>A*XI"PY6AR92.?-13A%MW<J!VS
M+Q65&+KUL.;-(NWN3:FG3Q5,0UM]+_^^?R^K&N056+2V0AD[I,S\73T!]9*K
ME(Q=D>,C/\8ML,;@O1N)N]IHV??U-L^^7\D]#TD-V=0LMO;7S>S6%UDNWKVY
M+L\,._(\R#B3.84\.T^I_PRS1F0!>+ PN3H$OZ ,/O(ZU;G((.C  =:I:N"2
M_BPW-GQ!97R&-@G;>8HO+[9?+F;BHB#;GQ7^)U7H.-R?99"H\5QNV]T"_T"G
M/"$;;4/4]UH\EA-3EBH4VDO*%V7^[?1!ZGP.FZ(>1IQ@L2*%)E);[5O[$>W/
M60^OG?X57B-?>81/]$,]C$2J8QJ(CYB I!SDY;I,*<8P& X']E0DVUAU$#IC
MM60_@CY-NH&S[>9?'ZP7?!/18C!@3:]CU O4_]ID<./;H:A,AO)G.QP0LZT<
MLVUR)B;DM!)<H)[=F\LN>$4&KG801LTR ^)\S*"5Y6F!)_C-,K8T]%K?-#8
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M[<\Q+%#/"Z4JBEO=>#--5?&B,<]RK\B[XS<-#GBO#*DH]JR=_$W V7&?H";
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MR&:)3L8!8!$<,-N&T$V'%S0L6[SYD^I/JC^I_J3Z[Z<">5.&?%+J'*>*>:K
M^OQ 8@ CC<2;&<&OA*FU]8UX/DI>G=PV2Z;)_O Y??%%W=4(8@9GL^\7H=,F
M_CMM5[ZK*WA=GR_ 'JRV*K%]F5QW<#[FLLJ)IA3C)FD.UX<[ZQKW;KIP1QM8
M]U6/1<G!?9!JV:_]# YI$\TW%QK(V@J,1+<)K1B4CA$WZDIBV]>W5W0+LIG'
MJX):^8O'G3M:M5V6O[5Y.4ES!.F]I5#X-FC&<W\#>PW%-FUO<"7U>##<^7?=
MU;&Y.\SC/XWM,=6N6^Y4Q?0RBY4(NP$)EX;2R!?/.I>\(&'A7[>6>\NM"P,+
M^UDAU=(2KT)]]2KBWC"/?G<"A6_2_8MV2=@ISI!FY@^/UBPB6@"'-OS8TDQ]
MA:[\[*2PK&BKF9C+1:.HFJ,<GP1I!=/>+<YEDG8'6[U??'<,+WQSD/E)55:#
MR_M@+K=-D95S957H)8V.\930%P>>&Y+G0X?'Z9DC'+W-UYWC^(77I#0='45Q
M0#6YZW>%3W?X8I$ K?R<P79$BLI"+>.HF9&SV%26AAZ<G\W2*LG1C#;KB[9D
M9DGI% EM/O/3JYT#'!]X<_W3KAK_MV(4$-@T(FL D:$0:T-/L-EFHZ,A+1V2
MG\_*,0^CW4BA'E[ZSBA0LO*@+?0[-J8&;V^KZ^. KTY:70W-=0^)!G0"UD!Y
MAJ%./D-!]=DR-IK\W;  /"\C2\LL3F]R8A(QO#@@,"L/!PQ4\2S-SIM_#5CC
M;3R@E9N*V_/C.-*'I2)E&K!TL?DXX,%2:C0LD.UO)4$C=V2)Z5G?PNW53\#7
M_Z3]D_9/VC]I_Z3]@];*<':#E1L-_[;AM/[#1.#5UP ]_\N>7;1;E:QOPRG5
MH%2DL[%T)R$#B17BB#V\'BS2R_P_Z0C[_U/B(\U*]P=I7']F#D41-<_:!2"V
MHX]SY)Z2Z)AG*BGJ5E<865I97:+JE,CBCTSZ'$7+E]L1DRIR7>'6(3.CVF:M
M\WQ+IAVW1]SQC22XW1)T-EM",I>C-8F9J[NYNO\R]&4WTKASML9Y[QP:G<U1
M^II%DY[YG5JAA"Z% %]?LYK**7_SFF@DU(ZG$R&!C*P4+OA(=[[P1M&]/'I'
MI\\',S?/0^?]\=-GSZAL11%-1;G,M/107L*4W!S%;[;#9KT3*N,2^Y$U>3T%
M=L-FW9,",[Z@!G36@H6H3N9TP[7>]ZQ5""&$)9%RK,RNFZ=A=^W0LLDM?)>[
M&HL6PU.&)G=VZ#A9M'B&:C:O290'/%<81HR5B).+FS1R.9YUL&6YWHU=_K!0
M^\H*9BND_T/VE2"KRK[LY,OV<4=FB):E#<"L;R8WG$T[H'!=6[*(H\!')Y!6
MDH9 _3_-#_%G^A^>1.)NIRH"SN;<@QRC!U5/71DX^*&-#@7+WVL_3>GSK[U1
M0&1;:3379BQ8!+OEC-YZ_'3A,45FPF[CV'(<QV228;?,X*I)1B]^D1[V"TPC
MV[^Y;.N(3D0^((*4V%8\&U21H4HXP=R@4+8[9".!LD%+GKCAEPZTMV,0!\1]
M.+BC[]<BJW3E'H$!\8M)K2IEB9R(*/-G:_""7][Z&DS*E75.8HPW,D;&8CPI
MV[2N>XY3K6LW=*>*??1:<BG\?E"7I4C-?RB;Q"2S@=U1WUPOXGQN-)'B*Z:?
MDUX? ++QB)@!:3TJON<>JG)"G="G+S2OK.MH]COLN:#]=<O5U\95CJYU2>*_
MDNF-S8>\MB),;+P 2=K!]:.JIC9K0Y,=CM"- L'O)+3S*4U.0^1ICL97*VDZ
MAPF__8/#^,_T9[K$(1&7;Z@,>R9^@_?IAGQ_$<@@P[7S6W+R@(0O97Q9A)0&
MZ$G*D#S,;8)D+ >2YZ,UH/!H9,$<LOQ4>K7.T\S[@/],A8^5Q<[OYVMV$S^&
M$8W(G/A72JODAI_SVDSO;%! 59LTA00^J+:KJ1QOWUUURNTW7IN+Y@?U84!Y
MOD7-W(+[ 4%%.]WVW:!5ZYL,DB6_PC]_LBG)FQ5*SIHQ*R;J>=!<_VIDEQ$'
MZ*8L?TD5Z6(X0!BALPI]4Q]'-M]K_<3\'0>\K'U=9THL_3#Y4&;&7KTG[KN.
M(G]$+[#C:+9*59AF>)ZWW_MLCV>_Z'1,L%>RP/Y&I_%D6CM+E=V&"UJT)119
MK.^;I3S)^I,QM20XOC#;Q&6A6MVF/"?O[IUGRK0(QCF(R( ,!9_-W_9[7P6M
M(L*Q@BC6B 4/>Y=D@XU)M@!FC?"$18@ANK2;X;7$$.4#&CP*!7P=%'U6D<<Z
MZ(A[H=O11G&0NR\B%EREO<Y!OW?+MGD>?WGHFV,RW3D3&-7([2]N4Y#80&-C
M0$WZ^A"J\H*?'M1-T+1F=YZU7'9>/6.L&?U@UG5@B1%("<V%Y1FNOSD9/W8T
M44YZ'5,>FD\94BH=YI["8C XKU6[>>N6]N5"VBCN7-M\FW'1=>-PRL!;&LS^
M@6#C.2P3X@.DU3A^M%;+(<]D\?A-QQOFCGW6C H:@@T7 R@Z6#GR;$LKUT1P
M'+,G2CX;H\ 3)@.F[8CB+GY98LU$EG$_C3R!+V?S-HD26?9'9:^?(S(/,];U
M/KB2JTU-Z=Z[%"N?&0H,I^<9VL4R%G";7*M\;4E"G&[?7-!U6Y'!DYX_IXL3
MR4LP8G +!0^:TJ$?VU*/G;KYDZ$_RYZ.0/T&84#2 .&@$1@9O:9D])RQ+#O^
M.K?BOM(32N,XS?&#"'-(F-:(?5&F0E4L']%U7B*ET.YZE%#(-]-$Z+;NV.\W
M!")=MTA(LFF=.G1*1M*H)TW;'*G64.47P=#C!8J;J-5![R.4C+[,$1CJHBL>
M5E4D2,L^'U(]NI'/G)8T0**@Z"'<XD"[.97:VJ?;?J9?E3(FZO9H.\8BH6X#
M/^,_Y;A\=,J0KGDFD[40QO<-O!J3DSN.0V58-H^$65/D:&I\3INC7_?CL%HZ
MYN,TBN;0[!R[*;\8^D_8/:87LHR0J_PLX%8IN4*QA]D;!N.BO#.Z?_1!+90?
M](W/6HROA73BW7H;H*[HXU4O@7Z78Q=W]]2M.$^S!P1$,<\1^N;UH*,74I+H
M-C96C0PMGYKTZ=*<L?(2;2: ^NII,6JLXJ50D[)'([<9^+-WA0NU40L>X>B-
MD?5ZOO+A+4S9+UNN1B7+GYJ\1&.\!5UEWN2WFT?+-!Z0DGT /$V![4C'31W5
MA0;*UNX?4#H[DYUWO"O^=WGS]BR,VVR/<H4X3'RL>P7WL*[)#@O]E+]^?I_>
MI'/J[K@:PLLY<+F/QL#M*V)=ZLE;V8<ZY>7. ^JW].09Q?7)I4V'#IT6-1LJ
MJD7.<0!?B_WI."5*>L$5\>Y@4K#@1:BO?B55[)G_(0\+.> E2]OL 6K[OND'
ME$0=\F:-1L1[:DL*%8B-0%(P]U!!%3 4QY.RD4//Y>) ^O<Q6/VF-$K?])(M
MB3Z\<%(1<+WF'6+)X!+20GLZ&C9]IB'U*[NV,I(4DM\Y0>@OH*/_RA4DJ,DF
MU;X!^M#0P/1"/^__."3X,_U_@$WD@C0$446VFSFVT=,_WIJ1LAF?]&N70IE.
M"I.N6SXO.S@K4O1 M/ZZN>65\+N],M*<\FQT[2G_E"D\MRTBVV-?*)A(D092
MX&FM,_?KT?1LHAL8M'\"*30T(X8[,P.BT*97V5#OSDR]\#L(G<K1,7)"=?\9
MJ>O9&Z"N]J'S!6CN^CP_=CM[8$'&.J\\=^'*1%+!H_1S4'*VRK9 ^(Y3KY/&
MW3H5125^WOTL'KZ[S:7BWA9E%NE1>Y$:UN-F\XFRL2O/[_O%1')GEWR;+&)-
ME7T4&3LF\!&4/6Q_ZF@X=GTYF';,%CFO3#N7,IAESTJCWRB9LVAZ-=;_[T\6
MR3U'[XJ9>(R-N;2O37OTY]P:M6FP$:9MN]%>?B2I$W!6 O&[5VJ[N$D21R@1
MH[[Z353,/!ZZJ!48!F6L&XNH%+Y?P8;1 )YBA- E"(^>5D3VAHAQ 8CJC>5C
MYI4JBREJ=PR7P;1838^IY1ITW 7&@)&)TXDDYSY^?-,I^0-[&/2NMPN"&WV"
M S@B4L_",!& S88%2>&.#X5KS=E9;MFSUP41G/':E?1L_OG@$FR)VX!=@FOK
M\EP91X^NE^M/T+ $_(0;!QPMLV'?@CKE"/E\]4P51D.(#M/(9NE^V<&HZOFZ
MYB=VU-91ZA_]DVCH>5";Q@W7_>@>SLV2=;FF_?Y%;[A@D^GS5CK)0"[$G3)(
M3M:,1;$56O?U$BKV*8#00_<7&4Z@[YIX<NN)=USUW^_W I;ER&%=@J,X8!:V
M;@0FN+@F%D5YUG!VO]#AG<6>NBOL>/;40*L1=L(J\Q"[B_UI0Y2(*OM?[+UG
M5%31MB:Z 9$DH$0E%5&0*#E3*))%1)* @)*A!"2G@D*1G 0$%) <)8E$B9*3
MY%"2J2*#2!6Q@**JL<?H'N>^U[?'O6_<?N>,'O[X?JV]YUY[K;7G^N;<<\WY
M:3$''64&N6-Z)Y^?J*2=J,431*M$_]37LB,+]<[,XEF_]U<UEH'3?MYRHTGP
MZC+C-CC9W[[7\I3'&'2T"-I0OM4*H .[P&0N(A6%8MH0ABX[6=E9C2&_^##$
MJ()7B?EVD!2:>B:26RU6F/0LP%AW&4)62_WFK/E5S-=WJP%7)$-02>T6M&CW
M^5E($.SX[8,O#[+L^P^S21S2)MF(,4F0(@>YAM8Q6UN1VA,16>Y ?V-S='T/
MW&C0-O_GO 3AJVN_BJX( $[S2H08W0),XF*WZX;YP[O["&E!37"RNR6K1(XS
M,IJBQ##V?0[7$[EE0&Z4&+)W%4-(37E1,=&M)_7U,S?1\(J/Q8<=\[WVRIL6
M$!S#I& M69ICN5I70IPV9?Z!X6XK'50LJ7,,0JOCF5(67!/V:YGMHC0?Q1:^
MG,XJ_J0!%3@WWT- *_J^@;)^GFJ2 "$7%"H=T7IGR7%L&-7)O?KH\?+[$<Z6
MS)U..>D.$?+MM,)WMI"BMY\ERC/>>40=X(&P95 L4Z$Z6OJ ?AL/W/0\K6PF
M@+ZXM6]M_YS$"4"+D&]E,J(C&Z>:'9&ZM[?OW^<:"KNI$'2S'$3L&PKE0K,X
M--H5'>_2Q]$GGX@HO6\C:R997KJY)5Y1YD)5X**9_"0P6/B53+=WH_$;)7I'
M'%_4^ #.^G./^Y?T%-[3Q\2@N$R!UJA L/)$D4/K3[#OP"N/IIMG'H:_E$CF
M9C$/G#0#/!@JV$4^+%%D:0UB=IR.V23&7"TOU%1^]RJS&']50;(JZ0(51<<?
M?@B]-'NEZ)M-38'AH4-!U5JCUJ)_1(9;S_^N+-I9=PU)%5V$/IZLL)*->VRB
M6^5T9O<GL/(<$2 D8OQEBMWQVLDOH\>]K^,^5&P@8"$U6908<P4=NB3F\->K
MKX;V4916N+$JQA 5*"I1":;UNQE$LP"]'06X#SFR VP>(<IL\H6] >CHWE11
M\X6':8\%MU\W/!;M?HK>>+V.,72#5/@Z[7N]_:).A4V"D\PF+0=B_:EC*FH^
M*4?8/I]O8UEV,W?=)2Z?H:8VW8+PU\YI<>^W;[C(C9+D8W@M\,#;^([CU-4W
M:_=;P<W D+,%K#>V]\+#=>V9:X>YG+/T=^^$X;O#T/9>JZL"7YOQ0#QS_-GZ
MTD"PDBL&]">=T=Z%9](9?*PQ-H/QF-9LON?K@^U[1K=V+46P=] ,28@EIL5Y
M)WC5;(<M[.-!7&%+D1&F<WG.6<Q/R"L]X&,':P*'+"\;,E@AZ7NPPQ*S)(6V
MZ%>>A%P YL-9AK7% XG=13 X*1XH5T6ES>YT@VE%O"9HU8D8WE>QN*Q$I:Z(
M8%.$Y'$-ZA<.1);'KT>PG!8,O>9+YP_UE=BPG!-83<2.HKU)8Z-CM(NJ\?+S
MR:S++J\:HBK_5!9@K]3%O 10DL%$H#O9U*R8:J1/ ]JP+32[A<&(X0=G T==
MC(T7EM+&-ZN3C6Q,0K(5U1ME>/1TGH6L.F&)Q:L8Q^. 4D4'.4IZPKXL/;IK
ML"NS[%5Y?U*)#BHX7M,U6>GB\J+:G7  ;D\"#@4@6##Z5V-X)T6L*;I>NXC#
MR&Y[3EW?PAY!3:6)]N@Z2UZL]9*MCEZ/AWC/JY$@+-*=$6U4JJAZLVH4=$2Q
M]L<C(O'405"Y6QL@*0"A5'DR[F)S8Y[O^[Q;P^^ML\=$A[IA."Y45M>;M"M)
MZ@7!!06I/-PK.;W/C(Q[VRA,MF8S_,<5PGX?VCW6'4SHI=])B^]FI=!&.VTR
MBGQ5B1EJ6KNUU?T*5G/?+\TB2^P+/V,\- UH0S5]][?XN#QH2=O)O7[\N_U'
MU-!^S"H+=4?#2.@KGI%N'2<R-;T5KQ>[:4=MX3^*EA<3<\+4,GU'IIOS$"!L
M\I#9Q33.$UBBDF@EQLQ/4T$;O,B^]&:3:G(VPN)G<4-2O1JOJX]3N[)48@Q!
M\:8*LT$%19C,(3>Q+_>_OVI2-UVK:3K!I**UM;U#<?TL;OE1O1Q:%618C6QJ
M7XQS#H@:<[MG:()F=[Z7)>/ W%F,^\:#A+BH''6$[C_=\OZ+_Z"'0E'@'?HX
M^2(/L17QK(:]H:*CU%RY^CM:9N!+._WCI)CW">+Q$L]T4Y_26Q45RT@DER(5
M%6L6W->OWAQ, =V'\+?&"6F:LUU+_O2F]K>77;IJV"#O6@^$,^K)FR2=0Q:;
ME0"O2ZI5G(#*232\-YEVZ"PWKW+%[?5W^NY-AL6@[#(U0UG)36^WM5 _DU#M
M?N5#U-V:9['E4M<2NKV,$A"JUHY?4#(58?0=\ P?VF)DRK]-C$TTJ,2.Y8 Q
M;^] &S_/.9.LB:XWX &,W3?8Y@O=\WW(IAP?45>S-(I*A\BR>G*X[FNT']&O
M_:H,8W4T$<(,,V<2=N'%4[<_21FFL$&_9?#XJLYZC M6\B)I?5?I?O>Z]2A!
MV@J.#2OF2KBX.%^7*QS:Z?+]H7.E6FZP B_2O.TU5+M2J!3"I3N=J'<+=B?^
MAP8>V/%XVLJ'\2GT->Y@E/:/:[HH\AZJ8SC0G.M]: //\UU:7D]:H50_OR\?
M]J71^B-WK/NS,[BLZ[F"*<^DKA>2HO2#7J?$HXR[ASO*#$JD#@<ZJ,7]6]2I
MQY%/[W!5]4HV+8-"*Y?+??0FTY^89=5=>TD6VR8*GFYJ$="L'GO)];7JK>HU
M:P)5\VSJNPV8AP?8>VQ\N,G'!*"&_4OE[8E30"7YCG2X.T1["D7WQ:_3CRPH
M)4_J*;/X!#=?4V#.'BH8]*R'"!":N<CT",2B0=\_U+*ZZ*BH364]I(GIBZ#F
MW1;XN9E-+8;2;3\7N>9$4;RT4)<'#1<=F#F%R>U 31"L\MVS^B:6:F(D?1>3
M\'NJ@.]]W(A/3C)S-PWS\YF[B*J8PQV+:@0>(-M:9!J=>SB1MS\&O[;@[A8S
M?41'L&[!A'F, Z%KX1&/"K]&]BL9I\;8+[;<]N7Z]GKY(U'/RK6BAA*^;&KZ
MZ2""\IYJQ?78\O["=NG;/ L9)ZM,6U *5&YOAS38Y5N#]&SPEKS]*=.A*1]1
M)AH6<GA)5D1L86R/P-X7D\<7D,'#O1F<F0^9'_*.?2T1F]9O/>S.O$,VM3!*
MO8,891_).\4Y^>!+GU2^_%T#>T7(I$-NL*P(R)=IKI=)Y.=J:G_#(ZOT6S,[
MW1XX &/FM]RB,:]=(;E*K+&O]4Z6;;U%*@HX$&'"LDU@=7SA9X']$Y6?ZA5*
M,P-]Z5,1;:^-SH*^U,^N%Y]][@%[QR;4MOCA#'])/";B")/W?<+WGI^]X_5/
M/8F@ES3J&:Y/OIU%!=(1+$N#JM]6SP]*8[E)%7J%XKG126D:8+OQI)[QG0%T
M&/'[!VKJ;I<D0A6P\K7O2+,,E< #55M?7CYQ[\I(#*KM]9U :&.J>XQF49/3
M\_>C,O7B97M;_&WI"+Y#[V%<%J7'/=-Y)HGK?S+S1-G#!D@.*_(Z3451N%#7
MPH_-$]=[4*)I\,L1H&:%@B>:G6U*P+\K\O" \5T<V]&&%!ZH7AN996=<Y$E9
M'V-A# [KI'[4;-PXIDPG\8FI5W4B[TO56Y[&:\0*\(^^I<N!==6E=3GY3CJ%
M"N$B];R\;5I' WQ$_5 .E-K$_:GAO%++3X]LVR.^<#F>C)CN8#V6HRV9'+*>
M)V,_,K(]^^2],MO8R$<TT$R+BCOI,'V;I%G9,M5DULQ)F$\\+W>T:]3,@2K!
MBB#/6SRW(3(-5_SN*UCS3K<(7\Z':\R)G+7OU3/9]9CYEZX\*H0^QJ!S!0QL
ML*YIFB?^PF'N%E<.2=H\FOK[(.PZ1-^)!I)ZHRSF:0<MURF\T,%?*"O\\(/G
M^<T.E9N[\R?@2U-M[-^INO07_WK0?^KV*%^1CZBG56 KEU6->;GAX-7',_*#
MM!-PI+_/G(+4@?7M)9$+@4Z!N7;=M,1]!>@S/R?PW=PH@;+U/XX"N24*L]W7
MA;U+R*9 )<$OR&]#5$O]7V-%]T[AUH6J?959E4K^L9EK-_<G-#8%.3NBX/=>
M&Y33DO.?'9;IJ/[#?D485UUJYN"O.%WDT_3KN+_E^%I& /E!R+DRYBX-]1P&
M#Q2"+ORW<3RP?EDX>.?GGZ1>TKY$';@;\,2M9O6RB]?OL"$_*#(#-XEFN2ZO
M7N[G-KB*86"W:>\]J%2?\)+7L1B0;[J3\C3#AEZV,AVKLPP.-_4.5QQ.1;K6
MF%?.QP^12,X&C=S8)NI,"YG_2-R6T:H<%.I]?)Q-]0/Z&'6*UO?U#"S:'>1]
M#_/:W]@Q+_>5\ZT31P>9BY]3Z,P+UP46#5X@-BH"(1[(^&XAXW:F>:D4H^/]
M!YNW8H(WTH"C 8'V6EA,D,@^K*8FBZK^6*NKH"B3J]-Z?=5[R&>)4HF]*$XB
MU3'!NC7\PKWRD;]5L'SC#WCM')AJR]V)<0[[?J?*'3+<RH7]8PY98!SE%.YX
M?'8E'^CDI_(/]*M@[@;3**@'( *BP;2;3TP^-D1.BQ&L+ 8K=G98B(]C'8M:
M?B=O^&FL4:>E/U+UE%R!5?=B(^&@(]32> M$+\U7XK2@+O['1V/^AFT'PL)R
M)*NTVL]Z'_*OL@365US H4X"5Q]WYMRB1V]$*F@CS?9 Z>ESQHRC;;_+-638
M/K ='8:_;=;YK(-0G\3JV FR<???;W('3LX>DSBJ^JK">^)I=IC>1B-821=-
M<]I%;@F"^9=0H&YT^;9.[LXQ<M"(YB7Y54;PPMDH29F1="14YP7"_+:.MMZ!
M0L39*:1A>LBOLN=/UB$X[$\"V0I46U3-'L-6-*SPM%5S:UUXPBSY@#&XE1WB
MKQN:^@BU&,]S-&FYHZDS .;_W4R)3MQX K<=4]!U2#&>.\[6JZ&VSCR5(/CE
M:40=K6#\ L'*4;GW<W>87OT)I&>D1X3-0E41EXZ83-4QDK<5I0T]D2 XI+>%
M9').0!5=$K<9*4 ?VO7$I$5Y6<C7H13HVX,]1N[<3E9MH6)HZ5NNKCVM/I@0
M))C&"2>D-BUD<<NYZ*+KRG49A><!:&60B=/94$5T@5*>5UO?O:0O-M/&;Q4\
M\GUGIR&QO",S%+]<):4.8N!7SDXB:I?"3,LR.2:4.KG-C'A^&KOO*L SH,+H
MP@+$!<-QYX/QM;;)@M0?A@;S.<KM0T"@H:IO:@A.W.DD2%"'L>L,ZATK2G93
ME3U\!'I<^?+*W2LL(>/!#-_P #VF5POEDBGBI?9.30-0:_JP,=M(?EJ_8E<B
M'0%UM47L./?VP82F8+-<28?9U/:H\"XAZIY%GV-]G4:N,!-]QZU,@=+*E&:Z
M Z@LIE8XU7VC7]BY'>S5_WTH4(/TQ3MW2D"('N&#!YB/= 1Z]@KF?ZH*16D]
MCGC_D;1_:\] 4B0&)STN3&.NHAPW/6"LI*]]BSBU?B4*.+OV[JKN/9.[F'B=
M;]-M7[,SM-WIJJ_(4L3UCL+ID98L3M)MU(PFJ(6\1Q.]83?['W6A+5A1&UV9
MMZO0 O-;WD+%SQYA/GQ-86<CPQ83;>[10U5'L1S%<S^W80X'1>;]:[T-UC*E
MIB>QAUE4FU)G0WN?CDUZ]*UL&^T+_%*[\ !#:VKIYI9/SM:)O@ZIG;1H8I_'
MJ&%6C'A@'L([]6ZL]2+1RWL=V!9BP#\^K%G3&MER2U)'_L>Y?-6]R\67 (^"
M5W[$TJ*IN^3L0YP/VZXY)%KJ7JOD_C66\KBH4-3\)%A)1+O2J4@=7IXRCLW@
MTWNMS%:KZF$AB2[,6FZY44OQHXF&029I3U21>KPY'L?(&'\[M);"E8K+$>:K
ML\;R\NAR?HE4W3(),*%%F!7=A:O633%!Q[=WCMBFPM&\R*Z@ZQ\<SSPA;B77
MJ:;7U/SM@N4O($_K1CU+:IF'< ^XA"[7F7280F">[]>.XQ.= VRIZ$=HWW'F
M6_2I<1P$#] JZ/H@S"Y-: <Q4U7WD+YD+G90!41_63!'00!YQSN,O*FN7F4_
MDQ+P!X?B>!R4A"=7OTP$36RHD2G9!*C3_X1'0+G0!O[PJ-_.J0\FRJ)*06*S
MBF6^Y2,@K'$@B5Z\VJAST-SGZN<5TB(3.\IL1:J^=NGHU"Y_NU(6B[MC2IW.
M=\C+N/@],/#/D$S!B4/=:TK?!/:"U5CO9YJ!<8W 4FYK8/@*21>EUAWAPS8J
M[F/EQ*^DD3?I%Z#BF(Q6":/JELCGDRL@"<AW&19DL"+GOX#1^!?_$0A(F\ %
M#^7=%%=^W7]%)3^A66]S>]S86N$>G?YFJMZC=FN;3EI+J6= O=CGC&)WD@V+
M]G*LZEBEYTZTZB 9H\N];M_#?(D*X]\IW,:5KXOX>'^4^7WH[W%VC[DD)@U(
M\K0IA<'BT1-)2HY^%AKJX@*!FE\RLV>9644B?2&CY+\D^C#TJVFP*,I$SILF
MQS%>E;JHGD(O9HF,[U8DV;>;F1K\WQ\E*G[VRE'D]+XK3&>85DY$6?O<Z&K'
M/S!;@@&L%AY(]*B P:MP5JWV*' G!1Y@$YI,20MM^?)VG^>)QTAMH#B:PZ25
M%1*5G>@<![ A6TU1([%0_>4]10FO_6G] ]?ZA<5@>4K]8RC<<T@.,C4E)*R0
M+&P=)]5/E#3=Y!J\>#?]R7C^Z&^K6)V2.2*UG*#'8C[^&?"/%MAG:%R)T[&^
MW(=U9@TS\_R-N-JM)2*%&X&YICJEVS<^9 99J2QHK ?+?, #JZU#>,"R;;H\
M:)24&^V5*ZW"%'+*%"9S&P^$'HF?ZE;OM@4X]II^0Z^3V:!#/VI\"NM>,\CL
M"5:$/*FJ#T' 9L9Y]F/3:!J6$W.;BY998NEQS;1$B3!!^!<(>2]B>)1JKTJ]
M!SQ#OYH%E*^:VYO0=&V784[?QQQE7[.\UDM5B=[>W";_2FB.>Y'U@2#JJ"W&
MFP%N0?RI(%9;S>=.[T/R_3W0IAS\=1![6[0$YEJ*^P#9[+?9_&!C=+=(;"OG
MCI(B:O6=8R/]4'F-\T>38?_'));G"K"^3VZ7+T5Y(?!S1,4"?*[8RVUQO8&&
MB^-<Y54G6_(O"8+]D^C+5V_*^@SC/QR)D_:YM,8H!SJZZ3.%?C2SU6YD,0BY
M>HI$15=*OD^<[6,<_*ET3"*Y):( 8VQEF3>CT!2<=[;5I-*TO?):^1J&OFC.
MS)?'A<OPP&YV^.>&3*4"IMZ5(0'MH9W9SW"'U<B(7S1EQ-3U+192CN6CW9QM
MC79[5? U*OSF]U[35.4Q+SP0B5.,[ZJ?'KKZT55*WQ\/D((]=O:402I;[A*S
MAOEQ[B,TB8'H9R3_D^@(C"%C7T1RW@N]%ZQ8.MPJQ=6/PNWJF<3)\8VX*=^"
M$0@*(5&1WS0FM>^<SK&D(8)$9CN+L'KC+D+OU+G'2=Q)])L-P>&M4G %DMR:
M>CG%[NE/TF<MS3>>;$G)+77#(E1,4J:6)W8+KTE7SK>3N+:Z*3.VRBR:FX_D
MF6FMF@V2-_F[# 7XO)68TX9==9P>ZPICK+^_$\?,U>*VQ-A,X(8,9+KCV34T
MU;9P;YYJJL,1=*O6E1(36*-=3H/4/G^QQOW]5<-*PF*P./;VHR0T4D!>-Y'L
M-[/_V<6*'M;Z\J,I<,4#YKDXJ\:EMXO$4S;H:ZW\TTA1^?IT\GH+37#?M$BO
M$/_Q7+>W?^-L\SM7XX&X)C=EMF]H:ISFT<B%!^B,K%+V(J-L62XHQ_>QWX[P
M]Y\;-\LCH2X*7J@YHT1%*8A:K< M]=4Z@RG0S/0=SM%:#FZ7M_/4S0TX)F 5
MQ_FK'C-6),=G^?'I[@KO[=;$*N=IAMT=IJSQUE>8CU=&T"&ZMI$S01;W,[PD
M#[VS>M(A_ST;\.,K_N6'_MZI;EX"SD]',\Z1K9KCS:[VCF@V5QJGZ23S$KO3
M&\&RF]1@K1-0G-QJH\_;MNIE*ML6&?/@S.0!J!1&/F<GDS'Z"=RYR+'H]+U@
M@:@R6P":I#?-)PJK:EOFF$([JPT,GI91K0][= =*+@NY>>V1/C6_NL#[/E?W
MI/0U6OW['H69K__O%>VZ!K/B/.&F0J$,:JU^#$'9,[/ :N5&S>MO;)DGT7-T
M!/T_9U7\T+\7[\#= VM6V<*3+)+1ZS?Q ((B?M5R89675<Z8(*_]+N;<99UW
MYGBDI6:EI%(5L\?<OSS/*<Z226<_'LR/%7-?NKJJ/_8\"910(7X,Q0,):0>;
M>&"@:>FMT3BXHR>XYT'\M2CZ,%EV9'/J]\:CI4X8X_S<DJ,TK8:-Z!<+J8TH
M8*M5"=:WE@^#<^"!'*.-[OA3[D;P>0@>N%<1L/+PJU,F^Z@KYQN=K]_+@_-7
MUBN2D#5/P!V!K$92=J1B0/]Y#4$MZG;'(G5XPJ.$UX+5&JQ5_;>V+!S13!+C
M2F*J'C:YTG[7KY.PEK0"Z.-Z%![H=!+QA$272_F\>&G\!B3[<BJ>W)&IMPL6
M$=Z56E=)G_W<S'?9NH@.P .Q!R,>R 7R:3LE%6?F@.M/C1NWY,PS+*Z_:>=4
M<5UUGHLCK01CAI8I%H(&X,;CUP<#K( ;5/GVW+B;%?='5J1*BWP=',0V4X6*
M>QD3>7\QP^D(=!'-L858Z\E=YR"-AX6*>872AF:N(B:8<V>V; 95:7G"+\NO
MFZ)V6ZDPC 9UDRX*NA7J:R.>8A'JO+SRI41(^S O5W+,.HC1\=TM]MB0-6.9
MERQ_*JP=B43-!M:.=#9A5B,U8J]VQAEO602@^*P[V'B(:NSQ@+)D,K(M,FTD
MKIG'K<CQC/['C5R161OKC L!RV4;L>YE/$ CF-!8%8,:4 M24;X)NO*L%SFD
M"=\3%+OQIWZ7)/U)1'S7A=;._:^,LV^&?]Q("EKT#X:48QB=V=$%FRF\AC9N
M!W=80WEC#LVM$2/QETN(MZK.KTSX]OS:58^D3S4$VMW32_10B"-E:RG"4:IK
M+CFWGGRF1VZ]A=SRZH[_4@?QN(N5KR3=M2ON<6X]X&2/:NP+M'V4R^XOJ$"^
MIN,KLXV#=S(O,/!"3 RF@YI$\.S!F%(5RXM,\>ORPU>56:N& .B%/3*+%2I4
MB_N1V>Z\_/Y=J1?#[G>O7LDM/$#1RK6IQ#[)426GP&#Z+3(FJ9?I<UN%Z)"'
M&]:FM:X6(D*+>;:T?>--H>Z=5]1?VHMQ#+Z6>M-8#Y$HT]&9GW6[GXU9E7MU
M"X! QO]MW?:_^)>!2>-Z,E55P9 C'TCN7='H=#*79V'ZHTV=VV4C'XYBQ9QY
MGZ1-V[*7LK:NU-I''5M&*C$S'JOKO0;#K@\NNW=^J61B+[WNR[X,;PDO^]RQ
M$6V15"1/H4IGM,ZA2I=-\XJ/</TCY+BTQN@\^\"B.G>X2BTB@^]FI=PX^_[W
ME4L^UL+!O%9)36\Y.Z*3\.M%\;D,I$F^2;:>KYQ'P4CUS?7<VG=NSXHT>?XA
M3)RTKZ+ 7.7.-FF?I.6YTB .NHL']L8O>9=);K  S'X&-O*I[>+,$E5*GF/
M'PQL @6YP9SG0FT?U_UN^'T<W@T!?Z(QNR?NDD(Z'_<K>++F,2'=DR:M-RVB
M<?PRN]EOD^A$>W2?%%]U,N4C2%2A&ZQ[.JYZ:'O% &+O]-G0.8?<__7-]:+<
MX%MTHO>;K"*YV"*R]3<O'Y"R2(;>4&'YL-5RKUM.QBK4NYN)_="0,$L54.$I
MJ!EJ-//]U&)"((%!1-'/T3E$;WX&BL:4B<4T\I*]^Z)V-CO_1+XKO]S5>BDU
MNLO*.'BSJ-OU&A#Q(D[AZ&>V77YN,'G%2\&9:,G\*YGY/?S==$#4Y\_TRH G
MH,_SYE8/3R0W4>'1U<O+.,S,/-4>U$<:-A8K$Q2I7KE+R!')15*L2GC9QAE@
MY@<*:*>5V>PFD.1;?JZG"J@+-8NO#(?)BD[XA\0/9T0D%!L8&K(2QI![T0%O
M"4G9K_N'Z/5"7&GWXD@3XI\4$Y0X9).&EC<D_;C^@'NGZ?G(QJ-$OD+SKSUQ
MK3'9$YO95]7IW(1_KAA8JMZD9S8Q;4J%.)C$\\0\3\N, B)WG5=[,)S.S91]
M5'<L2&V4XVG$XJ(&2.EYZ @(JFMM2)US^&7)K6_28;*C;D3D:O3F\ETV 6QJ
ME,92#+;US!KB.VM15:H .X$R.4"433?#&6<[)^CT/X:NSKN8U,S!@"U;[:HC
M>JZ3/#GJYJCTX\]7G;3X"/EVRQ'.8_=H1'\7$Q1I7].OF+'2I//VNJ*_F4UJ
M75T76:_N3"[].?MJ86X44#$M]7(N;9I0U^-FB764C/%+O<\BN15_,N/\LR/H
M_N(_&&E(K67*1U@P*2#X,$8L_WD4RI49XU?CK)<?JYMP9R KZ.B0XEK4.M0P
M1[W,T;UC0'J%/U @C])L1K>O\X;VK,J/TU^>!245NS95_^/423%DX='V1LS4
MIS?E)ITM)S<,QRCJB)V?MB=FDR-[X*OQG N??+44QM<#N.RUZ^8'NWW25 L)
MT4^9A%*TT.;KGU[2J].O9);D0!BF6 Q'90K5&NAY_M?973P\B#.H%;M*Z33$
MAC< \FX\\':I P\<LGW! VT=WV#1II*XJKQ\Q_(Y1V\ =[K.[7*\4NOK&EWC
M"FPV*KAMF;Z=#<L?"[8)>VQ-&?_0,YNZ/"]--L?$VLOAI\LUZBM&GA;<8W8M
M4FY.WI7N!+<YV.=%X5$'EJ_36G[G+6_E-'TLN![V<]A=>41K7T.BM-P5N9K"
MX$-SC[OB>[-S2'W;EC+H464,5&JB3*#<Y)9)W5N:F*0ML^0#ZF[=L#38&\%=
M+QU^I#OB_;?D?1_[-P)3S8K(T@C<=?729SKKYNJ.[WZY:S\_RJ8:Q@-=C;=3
MW58MMU/J]E?DN=\11:'Q0 Q.;+(,I).J/&T316;3#O%!-%3H?\^D2$5F5OJ5
M[L#U)5LUF)^NLARR3<6CM3MH?55,ZFJBMAUKD,;])D\_E<<Y$&V#*4>$1L)_
MK7\<[$.7V+GD+QM8"$ F46MSCNOW/*__VL<=O_)_@M''J::#SE;;^HPNF5"X
M1SG6H/IUT;>F:62DG_!R,%BKO,BW$OFHK&PVJ*AT_C/JH;JWP)9K)&R?:PD/
MP,6QL7XCOW;P /O@R,D0X 4BK<"JS5[;Q^1JMTF:?(%#KXN;!_C".\G7F,VK
MKE&1BE-1VF*U)FJ%U#O&>U]\OE?8DYT>N<X-9.GM61!5^,(0N.CLLJPYZL].
M%8_VONKLAVS?HR,XTOES3.#KO.G#I/MXX,\Y@3R1R!H-5YNOJ0:UVA]P6+5[
MWX)RFUV/_:=%A+DF!6T^+LY*L9E6#8_M6L!6M&5KJ6//RO/%).P@HS$#KUYY
MARB#GICZICYH:Y2:3BLHFX@_M4LD=#)7-Q^O>9/W>%)H-]KSX)DP).(/WU>D
M_JZV8AZFN=:H074@L!94N]HHG.R%AB I?_DG3Q9V+$1?+PM:=^MM 0+IH'HY
M%#S-<K5%,Q^23:#M-0F3=C6">\ZU%+;?:C[QAK;NY/1)'HATQU]:!QW413.%
M'[W<A#^*)ZQIG=>QV&3U-)Z+T&DBXH.GX0Q#=5LG@O;;KQR(IEVP)HASBA*A
MBJ, &?L8Q(J?,G_@CM;T\?39C(NS?9S#4UMSJGOT^R>A-=3$ON$/T_71]I%=
M_AEXX"ZEZ#7J\V>! I:(\,@L=?04/)RC33I-[>$KF9<AHX2*Q41?,3EH)T6R
MMJ^>CKDINS@36R,\8* 8L6<1B8CU[C4=%S*=/6/^^);4]N<I^[(].!8Z@8[O
MF):CCJV;K<DWCY?3V<WZ<-0=,-(93^081#MNU?C%+TU[T--1H:=OE:@;\*%_
MO:+HI2"+@ S=6WIAR%>>&7.O=\?L"+%40U6?'D!-W;&6MO7Z.340M@+^!/C5
MA^-X,'5+7=XT2]LG[J8Z_+\U06O\NMS&TRFI>HNSJAYD/]PKUI2F#MIB@D"L
M8(140B"+^OG]A1NV[.ZRW/!\+#/Z)AQ*?^WE:2+\^CM=7J)RP#LMKB5_2["T
MV(GAN+N1[)FP$_.?0RB"I5ZEIO=_$/'Y 7V*E+ZN?VJ)@J;!>MC/DR"2W2,P
M847IYR7SP9*(>@Y')>6&9>LM9;8=2(F)I<E%Q?3VG7*4;EIL\O>=(=^E.)RH
MH!+/Q&$@%5(<<OSVW'#4Y<.+=]2% ES+DD==7YUFZ2:J3>NL#7A_QUQWV[*
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M26N1.JTDJ>$,/1Y/@;U6/^[U\TC(VB!0?^!6),N-VA8_< '@'Q:MD&K*$W,
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M/I(?'Z5-3;.9EO>K:G*W@GE<>@AZPMB^=,NW<.)<Z]S@Z:Q>LZJ,E=^NA6L
M0_7RD-NO'P=F\_<]]D6?Q?4$*RW9&ZAYL_/') ;\R4=X$KGKI;TKO*0UQ=50
M=T,ZXUVK\2L7\3V+>M2)158W'J >U^QC%'N %@<5$E2FX3A\"4^^^X?62*>^
MFF>N=:3K(ITEZ)7-IEI95FHJ<!A?9-7"43SN6AF"VD>=746>J$W6R*XW9"X&
MBKX[K>CE,UZ:;55'B72F[[$V#]H'$+<EPX>N;.Q79DN"J480\6\:>]+=Q'2X
MO9U3E)5WE1D/&Y1N"1<03#"JG=OM+?@]<!FI]5SD[L5RI7[86F,),D3C@<[*
M4SXF\(4/+JRU%4V"C6:T//J.!_@!3/U#/)!0.()KT\<#*O3'ZSGE6VE:(;!
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MW]K[[J@FNG?=@5"D@X!(C0@*@HA(46H I8D84"D*)"@H(%($@5!#;P(!%%!
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M-EQ4S+"ZQB8CO*HK;LF:^ILKE4A"K>(<'5F?)XJ^;.%-SYQ[D\AIS4; 132
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M"Y76%NP0+U?E?PX2:-%T+MH73,D8<8;_#CA#&BF^#V<W8'.#0K5WT2%B"8=
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M<Z6K4Z=[Z=EXXP)'WH2Q:O93):-%J!B?:KLA7-!T*OU/03L'T$N&2R\@,\&
M.#LN6)773"P:]+]'/'U\+)E_LT8#D!*YR<Z !MAV1; TNN':WUG4)<UO^MO_
MT.%J4=HCJ6D =YP&A<Q.KMRHZ+0D@7.^\UA(/;?FMO[XTX"[E]5:M_#A:*#Y
M?5?FA\1 E,+ W^DARO.2NO'"U3EG9Q%HF@I[V:4;+"J;W@;=YXI#6O<7+=$
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M'05._5R9,O^_V'O/J*;"MDTTB(!2%0F]J("4"$KO7;IT"! @()T$D"(=1$%
MD(Z A-Y+2$(+'93>>XE4 9'>>Q,.[_>>L]8WZYPS,]^L,_.NF3,_KC_/LY/L
MW,^^KONZGV3?VWEPBB)GP3!+SA78+Z^2QA_W$]>S4"$LQ_WC+VCLFLF[]56*
MHW->]Y:&.ZXUKR[+0;/2>50*$?'*8HV6,8@+/B0N_]^JE2F@<]>DH\()^-]?
M5@EV\UU4DPO>N^'OG\"H$<@6PKD2E65]<9IH;+JZ?O3#JN)-8]_53UCX ,0X
M2:"J_/J1"3/A7O[?)'3%K'((\\0Z5E7O4.Q1:MS6I,WT%&FF]T=$!B+X7NZP
M'K+/SNB_1DYU'WW0X%&6< Q2DOJ* !S*,)WU[JHT\)D %T[1+_W5)ODFN#$Q
M;Z7'T"IXW81U?28.+SB,+%GX1(&;H[D$!.]<-=U6AC>_+UIO7!?+WJY;<%H^
M.&9Q!<OV!F=+@96X!@[67'?]T1R7##HFN_>>&[9?)F'%NFX&#=L'DQ2#0;N)
M,:>&$0=_U=OHDY($)*T_SO)8'12R/@Y6R%:#OV(>=?7--(1 %?SN])&$ZJW!
M.GR(6F\ #]2V3XQ-8_$Z-7S/EFT;>ZOFQ-S2M9/Y:W44@7%O_I_Z$.@+.2E)
M\;>J+HNVQG/_]4EN;[*4M1P;CJO;"Z0?_2KVQ]*.U\#]6\KN%;Q4C+3//BI>
MCC5B\ZC67R"',WSO\ 59+?X 9*\Z'N'U*<\IUT^Q!R,V]NYH_,I04J_[TK\_
M8,O09GPGH4*)A2P3[%NV3Q26YCA%R[S!G5&X:,;0+EQZDO_JVT(V_CE8J6%!
M2ER*JR#"UI!D7JW][*V?.SGZI/F-=UM<SX!M5IWIP@E7SZ\DE3#-QG%).C0)
M/,G*6>MNO"_BQ(2D>Q=%:=_]),3UUT-!Z\;1YM&2NQ%RW2=%UPP;@?9CUX/]
MZD\$2R!Y8A?1TEMUFM<1G&@%BYS_4H>W_XU_0U8:Z8@V5'UYJH?C5,D>OZV9
M WH^G9F8\2EBL73I\.W3F,EJ27//MT+KJ5*,X\RTU9?@.F(K25R-AIN>*'OI
M4%8C!ZQZ6E"6U$8.M5%<T/JX+)SH5-$$0Z]YX+BCUGV;4.)";.'T$^@8BA0W
MI5F[!(C'<B!PMR;GA]9>7,1DE+3/S_"^)!'QF#,C7XZ<:\MZIA?@ZG%4_S O
ME6&?:RM[G#9Y07/TGD;\C+>//N]]\W4SVH@'A0RYX@;L'$4UUZ)C59?!I%VD
M,M-YY?OSR8$NCZ-"?U]/^,BT(X%?#.U(<,!!;YMV^BV-L>?<OT,^9?>K(]E!
M+#I((NVV[/P2A&.&4Z33!O<8?TZ250B3AHM0\:C>.%8]@!=?J V099=@.G46
ME7=':;'KTJ#E2GU?K*%6^&6S@5LA8>/*Y !Z1Y=VN))OVVR\+.ZK6)Z[9J5F
M]X6)RKY40<7/FKN7*^@-!*HY^>VJZ<.:V4FBCXUBS'$%N=]:NW_0K[X'S7_;
M;HS<<S7B=DV$&FW!EL=Y!W[]6PB.CX%-N9O"]550FXJHVB'@P98+LC>":!YV
M0;$X$3,EJ#+X4FWR9Z0D5^?:8+JJZH:G;G>YTN <E;LI%A=3A50/#?GIK!?3
M!&EFJ[L4_N(RU3)E+K#A%H#4S5"Z/E:B#RKV[$7J=%FM#0AT0MX7\W9K_:[/
MFY T*5C_K-X?^>,=F;F4@V\C0K=FZ@"MI6-(HSQY?"+P-\-8;H? <2].<WM-
MOG1Z^,@OYDM27*^!TS*KE!RJZ=$2;WJ):%0E \NND'=T=A:,'K*R,JW2A20>
MC  '62<)A.JE3<:0J*G/L<YH2&F5YB:RRZ[]*-[A.FZ_DIPTUQW5L69+A!Y/
MJVS2T[C?+H-/97!DG69M S+\>3$Q35Q0T0[\ZZ2_7\$Z[(=H7)@-;.DJ\'>Q
M9&=YA1M?(AO] <Z!UW;VW,O*[)U+6A_"]A'*SCZC]3L-ZG6#1F/MD"G./->[
M3W,BZ%.<P9#EQ*+P_,-)WNQ#UHJOQ4RR103-^8LSXW%+\=1W/8"E9>/Y>= \
M[DI(Y=J (;1JU))2LXUHO@RW)!S;7\(0[R(-.XAY<%:,;1(7S6,KVTPPK4YU
MK(0)KT=>';]LZ4HZX#9(/Y(N*/L>HUUCG'M9RL\]9WEF.6NR-LQ)>PZ'U;+%
M>RK+__P')3YK4B7\- R[TAN_>Q$>3B$/FN&EY:GZE/9&ZP"3)@EW786/+BP;
MVI*+I/?#&U[]J-;BWZ&Z/K1LCMFS^88=7F3P17D3A:&DIU"RM8,XX%%S,DU<
MH0++J2(\*BG\H9P'SS9S\$&);W3JVR)((W_G/=91] C4UXF)8Z"9?_@&4'YL
M2/PR4K540W@1A;UGK1>3%BA^]/;+9^H_*D? /PO;UM*?#+%*FN_&[.Y.Y&<?
M4X0YA]PNWTY/A[V9:7XIV?-,#R4-U^]D._1.U"^["F"K,5A\JQQIF2@5#%?;
M:5JA97*#FYCT4P<^E6XC&]^KB>*\LYP^,.EP&N>&*B:%O7U,\%/ ;S.SC/IZ
MI6BK*D>US4$*WZT,<BZ'ND_PA@W?^:;??V54V/$.:3W!I0,T2Q[5R/?5K??Q
MI'HPE&FS9FIC]94"C"M-^(N988BE/3.MAPMIUCJ24N(N#01@W:2P6Q\Z5YT,
MJQQTR2,__G@#(&%1N3Z]EC+MZO"KI *]S2"<!W6_"8%ZCS%!<J*I!<($N/,-
MZ8Q9=-?%^^D;I1U9WD4>H[B7_?$LGQ^)UG:"ZS=^%\4GJ$SS8#WM8-,#S7%$
MJ2XNM4.0U9CV@,>!#VX S<AO9\@2_'O5Q[J@KG:Y*7UR570OK=$@XRA?L4$G
M6'F"'EQ.B*)()9J[F(QR8Z'8:A[(?@(*<H&[FTP^&7T.=:"UQO^(6$X+N#9*
MY=B92S"')=7[VZPF&C*%HUD-SO+?V'&IQ.6U;!0TMK5?@QHG=ZW[4<NK'^#D
M@ZU+%V9)PU61@0UFXWMQ:H=B?XSG1Z12-<]05AXO52W?W3VV,IO,1$[#M,,?
M)QH]'*8_GWY+N,G7:@VGJ_Z8T&&\]RO\A;_,NS=Q*=HB(+4":DK#@B[Z"JUY
MJ4*=_>K4@EE:FS>U@5B-LOW.U*+9>V_$K*XGO%D^OTC6'R>]KD,'+Z)B4XT,
MIWX,">:'?'K3WP).2(S)FJCA?#.K[VZJ^);.QY0[>GG82.%M[1[0_<(P\NP&
MT%E#:2:56/KIL>0"CIU;,Z\TJE (Z-XT(1F8O[[XP9658@?K_F+?=USLSKQI
M +P'Y>B,5=VG<GH>-EI_=X^Z8N3MI6#6A1/Z!H#4"8VWD\&F_CPBD?D"=G]-
MK6*M[9=@EI&\%"!A@-^3@L\\@UR54I;_/B;S>V-J),!('P)&NN9#V29WE"@>
MZR914AI^X![5TMLHDZ.C,I1:E++>N-!5.9\%$ D-XU(Y:QL$BB60(50Z*F_T
M/:0TR?AG^\089(<@35"G?<B98N&]Q.8#9I":]BHB7""9NZ[D_1/[K%CYO0!%
MY[7IN8RRU.VO5D('.QULC!Y"N[_(JGY5K),\XTM ;&#"0D3G:,>*N228^J-9
MH]+K.7O0NJM=%P:H-ODMD1?FB!JANDDR7ENKR&R6?/\NY'8J.*7K,6*(3$Z_
MZ9^JW?2BDYJ^JE.40K-0B!>YA))0!Q_:RK>5P<Y_*T\^&_F"+>?>XHLS#*P4
M^OZP'T=XWX;4/0V\2P0$U6035]:DK)W*T/ \_58BQPKP#3:A9VEWDM&/53H/
MCSF=;M33WCO)SD=OICJPFH.!WZ*'NRN>M.%# L!?D^N5JQ&^F<8=_!JTWC_Y
M,Y8R36G:TITU%#2-\BW5]@>\L"OCP9_JC"?HW$&W0=/6UE%T>R^P;PH!!CNZ
MKC[LI!#2^9)0\<@!5*FGM\^;F1^\^CHUS&FBT]S?J")(M[QU2TH.\V3"PR\*
MNIZ?(3\EB0]VE!0H@3W<K:E*3!XG/K+Z],E@9= .HG%96,#1L6GK0M98>X'3
MRSW;?#TAC-Z+]!,P#/WE;6)0]J4_8]1 2Q?TC XZ^>:Y,IQK0"0DGWTG'OF/
MK*.K&*? >H?"51.-OSCT.6_\Z#C"DWW"#Q<(]5 154],U_FGBR8@T)YD?^A0
MR2=Z3G& /.[SWMA'"7+8B'(\+2$^4-'U5/ZPF7!^T3B0=F@BC5\A(KXDS8^/
M;]J.MDE<EE)%_UZ<^)N4Z3EJUA]W=-G9A$C6GXNFW62=?QRE"S3+_;BNZV2^
M$]-;-_;;B90QH)YE,(4C^IV^?.O!,]8RH64_L1,)G]S9FB4_$Y\JA\8):.*A
MV44)[!%WP'#7.2[/NV%)MCEDFP>8J+6/W^'SS=C9[ER_H<'S%*-,HJD=T^@V
M&9\PO"7-J,BZ"2A4NR 05;PP1%P)[[4G"2^MO.-N]P*N^Q#S^Q+_[M!0\V48
MB<HA;:&J9,0;QTF4G/6]'A,A2C0.LY@8\+[E:=OK*!2/^6D8MXK0TN'L0-'L
M;EQDO!B*\XT/3C"\V"1QBOF[Z[[;J)A:*>4#"FW[FK,Z![9LZ'W K4:+8/="
MRST>Q$MPJ66$ ?5TACW(7@;FFZC2'K\Q(Z%07+/9YG8.(,GSKM&<D'W8FQUC
M.=%XC_5IL_Z8Q_VCOBH$$2B4KB, N,ADL5'_VDVLSXI(J.=SVZ44N'-\X]!^
M,"(G8PEDW]>[J._U[$OXZ#1U8C=QKB0NPGNWZ]&<F51^WJ=7Y.04M*7%NAY,
M<>Z("(D!NR7FU((=?6FK6W&Q:-OW'%DAGCS V]#P/LA+UK.X<\"W;>)R)F&<
M\7C3BD]7=*GA&J4&FA?[6SK?U6P_SSEV_(F02Y_OFG)V[#CFX=1:FPBIV"DF
MPXEC7%*HN-AB+VZ<?G1?*URSX0Y1CP5 3"AS',=?W>%G]U8 9W46GM?S-"?#
M:,%_HMU[9Y$7V^>0O$.GZ'/RT9[7XYN>L\N/:^RF--_>&3TCC0['+JM$-!%6
MQHY8"%C_!:'W17SS&7@OP>D&D.&Q)/=V*-Q9IG+&,<.N #YRQ81FWPU]5AWW
M(^7I9=ZA:4VH5:*_'1^G[*'O:%Z:V([8Y:2 D(9Z>\FF0]$@F)I);<$P]^Q1
M6Q+8LW6=B2VNCEW#=!\3EF T8MP:_!0#[+R2F40+;LL=;6;U9D>+^!)K0D<3
M_@P[N WIC32"NQ&,#1<6-P#NA68:Y-]J6Q8OGJL!>W_%_3L!B8ZH//(=PQ!I
M;/'>I:HP1+=W?]N3[= 8X_;ENVY&Y?"V?4[$LO"_O'_Y_RSHV6<:A:S5L$?S
MIX&QKBR4=B_7/A%VZD^,Q0B./M,<D>3021X<1[,4\71X9))M*0Y65%A)0&J3
M').LYIO@BTIIW9#%,(9*:)-7GT;:NXEEWUDK1UAS4+HB<"F]19%*&]\LZ(G5
ML.&'*^7O-.(-3S/KVPT;-LA9RU/"?Y"8"YV5N$HW\!$]%D//4KT%?3/T-2K.
MD746^LR*_Q@W>B%XAXR?JE-:[@KYHQ'/D==CK8>N!9.395;V-+J7N[QBXHDV
MQ/3 /.+$2-HM1NU@YKY_ZIGYWW+H[CYSNU9N5>T:_$=7GWCF3M/;D&0A";I)
M<-S1:NBSPRH5!BFD0.?U8PT.]3B#L&\;LBLEW@RZ1&WR2I)**1B>_?GFZ0(D
MF_UYE,EDG</(2LG8FA/7--$+GW>G7KJ:R_%=DKB<6WDKKZLS61_[H]>IZ"K-
M/&H]<2RZ:,#N'FRN; ^Q]K5-I5+)8LH5&HM ]C#KVR@Q#FZ- !2IB12!B]^I
M//B\BGW4?"V;6A<G)7SHH@G'S(7/>EVEF[CTXDQ_BLY[":*W&>CHWRDY*=W5
MR4PS'&-FK*&^$ 1%,AH.S9/4T$@_47R3]@"^#O)NU^;&^P$L$(;D:3)YB+%\
MKLFT'3&R8_B*&XJ>BLL<7VER7ZK.\>1I#E#TH7SB5D2HBBJ+PTK$&<\KVRP$
M$C,Y[UNG!+XKC%4&[M)[IKXMF'FNK42%-UWW/>P"-FW??>G2CX?NK"T7,EUU
M#CW*RHF1/$LK3Q=,PA<#+MK%R^[ ?S9S_\H*ZR$[M#:,4;J?Q+=Q//<)7. ^
M>18#/]-SW'=HB)''CIT-Z5X/C>0_*3/6Y,9\<+J*(F>-I,0.^AO4O</JD\H^
MQ@'K-E.O!(=8FFKA7^ILW=.JX;5G/HOO)G@GEQ9%E JS@3\ZFZU*,I<P.9($
MA5WP7%:\/@"\YI&TBC&M;HP@5CP5;K]M892C74+X$I2POQ+\-C!?,N?)2K1[
MQ!:2H]TM3_Q5Z5_AN O#9$T-#4&/GF<QWVPBVR0Z;XV(-"56!+)E:DT(3"D6
M#5"SA7["V>P-X@8GU./&")L0\5CA05ID;U>]4>?3RBC &G?'8P8E AYOQZ-_
M;"J2QCP<G+QXA2XD<K@V.-3,E] JZMUR<X>>[^/K4OL*O'#O\#\&^43O;FCX
M>G->HM*P\]7BO\*2WKJBP_"Y[PD=2<*Q@",,\YF6,RJ%^+#*'=IE^K,.FA_%
MB7S%*<59Y%QHXN<5-P@ ]CIZXSK"P>I8;3<7T "5<QS-1,B[]X+C4=?59XY%
M;&#A5'S3C9>=N1S>UQ[;(Z95$X/W&[I/8\(\H][F=!I9B96^C4A>JU9_&]?
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M1J6B#]=9"\UIX'[OEB1HJ7*)]C3DL=6M*^'/%D56">GR3%%?F4G(9<\"125
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MB>#Z5[OF_SA4$0*R)(HB@BE91+:18^Y*]GA3N8*S(PB I_V B*#M!R:$@,8
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M!7O:)RNHWNJ8B9W%H<]-",:#?PE-;9C?6\B0=]KQSUY#&J_ON9ZZ%PG+S-T
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M"2>*UO1J]OPE61-/%1U!T>.[C+^B 94UX-EN;GV,?MJ9)O@^U*02A1@'IF=
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MH?)HWZS(Y$HX=Z7F[7P*%72KT03[=%$68O'C85[M=^7<WOLNK+GTWP5["C4
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MWB/.A^U34'6[6"SO65_M5RWV.=?S!2L4),DAN2J6E[X?IU*FHV,TA(S\/D]
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M _T NO'\"0]:ZYF>_!=T\C_CU'L+PRW/B$-2X_%X= (6,?CW6U&FGG5#.A>
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M:FRD___S9H:Y=\Q!D%E0562M.+B?ABRQH.!*Y%-T7,QEZ:*^##87JA_D[!%
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MX'/JU&,C1W3C<J<SG](';JNT2&K&\3%ONRMOU^U-"@7=W_+XZ5#RM61,4#_
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M(KVF1OZ([24WRY/:+ABK94ZTC(-[H+ZS7MR#T#U@2>5!0@"U\S:+A]]Y*CI
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M[?09&C\/;Q #>KR+0<">CRWQU6^@.^!,<)0YUZQZ!$,1[5:.DXT2E$'\MX)
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M>U3M=(!+.Q!@KMK->A[\8&[3FWQGW1"N]\Q5E*T_/Y06!TP^6AO(GZAAMWL
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MJO3N.P 7HS4M_UN7K_>Z^G!")&G77%K'OY'TB=4G4%3&TYS(,%\,&[OV'NK
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M(D,2>7 !<"+798FNB.+Y?%;($%?>3@JAV*T@9.?1\V[V^NK&#83$T2X+%'"
MZ>#PP;/]B1I3U0%CIA1H.DQ_PCSZ3-@V/E%9P."%7W)#4#?6#_8?[3,$C_(R
M)J 5+(4>?_/Y"SBMO"Q:8+D9=SSHNH.=]5UBQCT=),4&1ZJ*\<G0>-Y5: S[
MWM[+X/B[JVWF[ETMY"5B4N;K^]Y$77W4R9MZ0;:8,4]NO,Q1#>N9WIR;^-I4
M1,,;K2EB2T1O .3+GAY;P('EX_ 3B9'RD#M%$9_%1^#,8FVUD1"U^99=L5SF
M!2&_-9UG_$^S+YJ1@!]D(AB&M+UXOBM-+76.^CCUFUK^(P ;0=3=H:K1WV03
MOSW/GFQ#4_4]I;V^9A%/ 'Y5OC_3C>:<X?RI70^B\ 8O[*>7E@Z60>5T\K?L
MT19.LUS]IIN_*/%/L .".V\^@KP1G:0<[!W/(+/'OYY4,+ZOYY@(7BB\->P[
MV[\.Y-G5U_':CWP\G;6<=@F!Q)\_9>&K81)8'D1*\O"UO)&9.>O">HG?+.)Y
MDDD(,#5$@;"C.8N)CJ3U"G"Z)'6 O^P'F57SI4**'LP,07BXIBF*V&F_3;RK
M(LL9D("&Z3^G\3T2(9=@$0("0L@Z_R<.#L;R!KN'*-]99V(3]FH3P4W$)PX-
MEUZ;H6*R,O PF_J2Q?:K9_B?PZ^4."7IS[7R^'BPP>_<F<6]IN(6/HP^G'5S
MJU&P2%O5]O^16\YVBEPU;P+Q?D.48,66MX5+N5-:%XZ9BRXJH-5HYDP7Y\0/
M1;B.E>$Y_ Q%\8+(EA3=EWX7>(T09H--+OYSA'W$GEY9,0X=HBTA<\1BF6"*
MA=E^'O!"1OHQ[J1O6#TLJ^QU:GUR!]HH(W=QCS'2]<&\-J%Y>]N"^/T@RJ$*
MX7'#XAJP[V/9^E:$TAEP>S+V6)#39UO@([WX7B9I00UY76WR7\! L]<@Q\#+
M'"-\VQ&'<=L,MKFQ-0G%>KLZR%V!Y?S#W#>;TRQ/S>K'GL%Z*;ZKZ^.'%]3'
MOW562TU*<S5P^?'KAU/5<NAJ9 OG(V\$B]W1#NP(.*D\Q*163=B'.IHOC7FT
MSJ-@Y@AB4*\^QAZ9?GY0]9[$.QHX"L<]EGC-NR00]Q<00!R/@!HE!R<9N"\S
M#[KL:/K9!;&7#%W5R,WZM<?*FV%*>6RZZ<6=<.?[-_V/"#B"P#QT\I4\RJM8
M?:8UFC ;N_0ZL?^8X6J)!IXW<U*9/I^4%N"M#,F=F#DC&WVD1HD)DHSM, L5
M*L8U.80QLO!5_ &=J: =R_N9]CP$$\ZH+3SH*=S-09/4S.[F3.G8T^N>2]'N
MEV[?"AOE>#:^^ZK%>60[;(J/WPY"/S6K5;O=.Q]YZXDH.+5^;VY6?T?+ \3
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MYEN.HI5P;4\.6]]^56G\)F;R)(,./6'0T^@,A;&[!E1'C:K' ^X!O9>G6?4
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MY*\AD6ZV/AU?00S.;U_)"B3'5GZ<E-OZ!PQ+BX<ZYMJW4 35Z#<UQ>/80'
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MK"2K/..9+\-,5:K]V%#!8^GS(DVM6M0WRM2C*TS$QD]Q^G3%/"^3TB5;%R"
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M@9.)+;_-EU0=DRQ1+566MX8H!QV""C/L8M<OC'X:99XPTK%;"T0PVX</[C"
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M/9O/F$DJUN>A'$8>E/6 ^8K5(]7?WK4,G][&1994PRF23 ?M ZRQ\"=&^O7
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M]GE'ZH=-NX2N,<N?R2L>N/VYUJ($.2]AM4FP.V*?%UY5>)-AHSH]&16VC8.
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MU8%&7O=@<<SCOWNUV![L%_FEZ\<-9Y$R=R+5B-Q/<)!1F)U;7JJH4 VI"4P
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MEZV[<&XC:_C6>Y*26A^07\]^O[)W/NC$$LTHO"[H9E-L%F8G=7>4SM&XJ$
M3CZ?LN69I"(OMUQH(_E026$HVU<C/LCT'UPPB=2 T__NT%0K9TV9%NYGB:"5
MO,705%#.9T.6[&3 ;%FS&F0/M]CSLFHO^C<M(PW;J93[MZ)J.]B,"@ C9EM*
M^@*Q#2XEMX)Z.HD:ZTV]Y;(<<"T^BL)W_H!P$$GN:@K3.%?#C+8DQUP7=B77
M4%:\33CD!MR<2*5D2,=+,H4^R'^4S%^F/.V!!2XCZ2XE+6Z?T:TN-Q9N./XL
M?(71X<(L,LW'#SN48-K5N?].[\!I]/N@_:__X.X@1XN,04-2)Z1N&T[^#\4U
MELD]HXZY)1(31T.#0NWMH;$(_\_"5#6BMB.G/]B%M1;F5URUT58(6]U>/]$:
M:9R V3N3 2HTV?LZ*0$6UG:N)%6C&$55'N]9QQ)L!@'$U[;_$SRIQ\1);QW.
ME<AVZTM>0$!Q!8SQ33HG1<3S):ZKU( M"$X[!G-^B;[<4-Z77_Z-S_CB&# @
MW0;'A+R268.62:( >B_=O+KVO"3$4[JRD!E?\.\XU/3$"Y@4M03KMJ7?AL!.
MGZ24%XT]1  GPBK4]]/QLKJB0X&W0B]T\W=(-;%IDW9D2D'%E"JN9G(Y(W)&
M&>/#?\3ES!'(D YP7.&##N.IF7_]OU0P ),/2TCD3R7[: ;1/<KCJKQ2*]I"
M^TMED7=?=72Y=9R(!39 2F%'0?(O# NJRF>!A\S=[O*74OFE14W<OVG\<8I+
M'G37!S*\S%58#22N[TP&Z0CAYW(*CO[2ZKN" ZHYK".PVD,F$458UV\AP1 "
MA419?W%..W%6 %AN^?;IX$FP^-!J?;2.;,$7#C2%QA*E27ZC_'&96":@H?!Y
M\8!;ZPI=CQITGW?22#3('4(:W:5C4.-.W]UB;.T2AFE<IR)^XL_B401A"_V?
M.S<(S'>&Y=S6/*T*%1;@YGZ\L918Y@FL(!J!=59->VTLBP$N:N55%G*TL;!C
MXI3?X.:7>A$EHVXGP3^5T)+\%_IJ%1\HZ+9JNBUZUS2+[1AAP>%!B=E#[IJE
M:?'L>IT=$MKCLB/,60RM=N[C';G8 R=;;*3"-NQTU,#RC0";_A8KHIV6!II1
M^*9^5H234 !=CNPAPZENX+,'>*E+Z?)0L[,!W,WVV](!]70,J-X1(K-*3\Q\
MYE,=J<!4R%^&9,E3N?B<"N<*&HF6HE(BC11<*OK>19B,(KC_>RGR[G=CJ*\+
M#H..RA&;GA-':GRY!-KGL%35D)&E[O"!GP3-G5Q2XKD&];:F2;"&8-_M3BHJ
MK5:G"QS7S81;]K%.O%DGTYUW;:*G( \UZ%+[44Y4WQG8</6T"O]0("TAS8T5
MPT$0PQVJ10/^&$0J!\E;P.Z,IP,5)N-I86R9'KU$-27/RRFKSNC-Z6K1]PM:
M7"R+5BJOQU&N-[0EW@^A0=OPT]*J0,HJO749-3FV\U*_67.% 3:O;=V%&6$_
MYUE^TA?4.)XS_DPHZZ!A'AQ\L0*$.33$YPKB:9@\]3F!?T$.I)M!.UE-H(X?
M_(7:X RN>VW]N\KOWOFHT=%-WPT=A[Z\RZ\+.H:[)2/QDBW#.,)57EP7YX_F
M?K'C.VURZ1@]<YI)ZD#AJUS=?79T; >-7058"CY;S.N1CT >!E=JX.(."]M<
MG,.!2(=GI!-3 \G*","<=ZO<5V3&.0$%N]NW.'W F']*X!R=HK+GZKU3-A:2
M,C-F6-)Q&I\-^3X/C[M7;-:CH:Y$-?GS^3H6@FD.][M_SM,RY]>TUO=#8-F:
M#9.1UG=_P2,C=CUKP9=!^4IIA_/]<JL3^DY]A8$N;_ZAB&5H=X9KMESOOFL@
MKU$1[&S'XA.M^8.^(?7;2VNIL7]?(N6@8HH?GSZ/GOK;B0*_P,V?Z/:R<>]0
M;,$/\GIACFL%5U.?*DL+;RB[C<D_CLW#TD5"*6PT49-,=7G1$YW,ZNM+&B1\
M2O]DQ^OIYX65Q]O TL\$:@DQ\9KORI5QA,?95OJFV8WF/<8JW"N=,+31T(5!
M"!*-?&<(S_=S(#I[[2_5<5W[6<B[CAP3^1 P#.9Z35H=!/^5R[QXQ-Z=%K%<
M"R"9FV,_VV+K)K3X[+2!<WKVS$(TTN%'\0\E*,MWI]/K=6S'%X3I*96J[K[Z
M28#8;+0XB#I<6L -V7PX9\C,(/$7+.1(*[2&6CL-!.>HEI@@1E=/^)D<UX]W
MYKD]\X/R7'%K%!6DX5)*UB$U[C:X>SDP86^(3_&$5SE"[AN[AC;2*7YA;K6,
M2*5 '8%W"_4Y!A+K<0XP-P;A).4<5*I 69E]-+\[HF; PA[H&L\E#'W(KN5Z
MC_74@EA,>>&29='2#<Y 16"ZK&@Y]AI[(+VA!-W25Y=7PU] DW.;HPO)L@"[
M$GI.2NP,'.\% Y5:]82O<U%]2CKM>[,:I5-\0[\TS]4IIL0I"N1:=9'9H\@2
M\S1E=06]CC)V9214;*&S028&JBRQ,(YV[4A] ['HE@F?W-C0,U;QP/;6XY0%
M"M3C;BK=5:;\J+@((H@LY%UELQKFJ&].(W<Q1\06CT./9Q.^#QP;SEE1]XVH
MWK!4VWE[-7DV$2W ?'\\*6L[DY>K5?32IC:8O&(APEU2/X[KAHECBFH[.>=V
M;[A2A@566T91 +*68-:S"B2XK$5-OMV&7 Q:R0>*Z(XEFVFKVG$YJ3:=[Y9N
MU?! ]*TN!4%7YM[5P6SU.4W'RY@Y]YR87H\SB8*YUM?R3?@V&%\;M&YKFJ^P
M8P3:T>LSOW11 09TX:*2.G=&ZM\I/DJ=JTD-P97Z:-_-9GMAX1!0F2Z-A-7Y
M[B\6A^FQR?32#"X#M[]0ER'B3.[BQ[%] 4=.Y2#&'F<YRE;3*DB5C_7?(WYJ
M>SM#F(_G6^"%%OXO)G_?$4$F$J#3#>?_FPE1MM>]+'/IU5OM:D"KXX_HO+Z+
M*3I/?&B>6XU="KOH)>9QCDA_+^Q-BE.=!RN)\X_&%BGMD?;@2.#0B5$HUA9B
MGEPI;W)H['IC:4["OA7XQ;XC >G]]PIRAHIA2PVY_D["81Z03%"?D^;+"9SK
M,'[67 M6 5/S2)SVK:KZU#G0%L>?^TSW0PX$9DCBAJ!,D<@TD0'?*IV %8W*
M;-8"Z :UK5_-WU3(86PQ\@LA'B5>0YB]6R: ++(.8;+/M[5KQ8+N)G)N*AV?
M6/:XV<Z/VNZ%2B,&='*M&BMR(NR^K69((]?I.QYR.2[5,/'[F+;WZ\<I:^W;
M@ OE"^!,8Q:]7Z_],0BV#$'.N]AT:!M3;ULNF0_[-P1?(::F/EX:K74-&;?$
M;QN8,1AKZ%"D"ZM_"0#R$,25+'*6IIQYQ7P\]#QR#A!\./,)K"/EOZX-J+K7
MX!"L:%^<7H/</$B$2"Y63^'%GU4N0(X%"-XR-[V6,E'<WHZJ2&-3,$O0Y+'Q
M@H1=.X2A'47&G'$D=5RE/@87;(+4&]*'M4B*L;FB]M(/W16\,[98H_!()3]^
M,#:10#?B?99)5@LX-&&+5TK>K$JCZ/Z6@TR2K0HJ/9H_8VQ_EYN7EO4/Y;7@
M]_OWWR6L_%UG!$=/Q%Y*JX_)=.5KZ]%_0#Q*UA>8!* _'DR&CI&O]Q-THD8X
M1FNC7E[PI#;+LD)1@I8SGMG'VMNXEJ=$X3PQ*5J"9T(Z/8209&GV.9\,Q+X)
M(46/IO7/9Q9OTXVS9D16BLBH.N1,8**U$V',J&@H&3-D<W1:=@0R!7-"AP=M
M+P2%*I%J)I+2YX87C772'@L:;.(* -*E1@=9!4\03X+MDG"@H;<K^J^@>00/
M8,MIO^03VR1X&9)OP['R>4ZH?776]"4?:83 8[J8Q2$Y>7W0H#>\3"P0AQ?_
MJQX*5=%-P18I[BAJY^(??E,I<U+?,=W^1\N<@_)F>"TA=<>V,8?-!1WB'+]>
M+P9%S"@6M8U<!7^3Q6CL/V%R\09EY-&K?1(/3"6R/\)D454./MJRPVV3Q+,U
M?W#K?R;\X)VO6.OU-*)A)Z"3'4A3<H2)/9*$7M'6E"4<7R'P-^+IS9K\;/3.
M?21&CW7_?M.S!FPC7+FA5:;2G1:["K+W<[B5]+IXRDXX>9/ ^6A_N2!.G2S"
M(X@[L.18!4^#7\5U1ZN3B* (\HT]$8*]8ZI]U1S+U]RBQ\FY@AMDV%*.='2Y
M7;DHUF/)ZC60^'&L(HXMH=$9[7B^N6#[M1< +3T="_1EZ@QK9!L1F,(V;EMD
M^,G4#*VD=@/,;-H/#*F]DU!A=B[&0_YFFK!/?('8\AQ\K#OAUZK10*LX =K/
M;714,GXR.)E>J.."I_Q]9QOB!!_+;A01_T6YJ<0QN#2I??52V_4/Q;3]R>Q4
MO4J?=YK7O#KP2Z&9XA&A_VXB>-HWSNAEZ93\C_>0[YQ:X2ZRO5G77Q&M* E6
MAF-2JL#)QYFMI-I$)):8MBEGD]Y/3J"GRRBUZ/2V\;F_U*B[6G$ZAL6J7CZ$
M?>XBU@M3BOSA&$CT_MV0_:H?_^*>%ZARRU0Y%-EB*Q_Z%OQ&#^KWK2AY(3T*
MU$6<OY4$@__-P]JNFS ]LU;(\ NH+9HFYFH3/<C)!F7@^; @$,H9O+:?!3\+
MO?.&019QGLMJR4=*;5C\*V<!A6\:89&1&DSU3ZMEYZ8V M_&_[R[*]W::DY^
MC[U6WM@J3(S) +&6=4=7?PZ'?/^;[38@+F,%I&5$R!"G)"[JN.E/1 F6T/]6
MHG&N[#&4Y1D7>NLA9A" ]$]AI$' .9=JVACRX4)4U3Y4RG 2F GU-.'!8M:<
MS.AV^(.^UP2O970YPJ3+D.=@V$ML6W?0.N!Y9'C_W+"T=#35[2Q^=,=Q?S-_
M&MZH."B.IEQ!4Q(8Y_"*3>)Y'RT?;I!-+Q3KZ6M$\L?KO;2L:C*#)BU#Z"?*
ML8 T.D]1EKG<Z*?9%MZU)/L.;$2&7F%[,AO#JX$#P? *I[D_&O4>"BIX$UVA
MW\4#X11U\9=_P!3'2_6YPC2):R(1MY]HI>'R5QN-M.TU"6T2RV4_'0DWQV?>
MH:1LM7^:>3.=P3"^+QG)8N^G>/4C27$>=A1ECE+;(C*H3-Q6YI2.UK^"FK!Y
M8DCA,N>&C'>YP/!6#M+]KLF.-M*M 7G?+D)1$Y>G"38WY8,:Z]6QS#7'YD J
M?S<82O3P&RQ^=H$T1W-HQ)*L9-8"ND]KZZ$L7ST4P1FYPFS(TME?N&14-&VU
M00OKBU1Z:<T.[NYO7]CK:0CKV4MT"V6V+$6K?ZR7-%R@P_:/*_V<C@P[ZDT*
M897@,@6P%Z7!1D]:DSMZ+&\>:T\ UW@3]+:JG$U)N4&3-[U12;+VN.4X%IF0
M:@@"\ZT.O"2N>)K7PA3ROA="*?$>3DVGH@=4:"__M+W.0W8Z(LDX#&A':%SX
MO73+6B4N3OZAZ"XR&N1F7HC\,N^[/!P(FQYS2/OLQ7X2+-XL1X'J52ZX8K3&
ME=;8W]:_1!ZO;BIJZ6-U.:]WD&4/8:T3N0W[OW1>PJYM,)M&I2.(S2U\KX1,
M7!7.X]W[X$ZS:5H1XZ6.\P])P**N\Q?Z(4 T[,_/Q"SX#,Y#]I,?T1[A2%"E
MU8F"MX"Z)\G>'STQ"&M1O?#_]ASS>:.0NRSLVH(T8.LOS]K:4$/BRE30Y$0/
MF86!(#(H,8]3PNS C.4B,U%+$S$2GYJJ&SL5ZZ5BU%X0L*P'.1Q;D'OU,]0/
M6?.0WS^WQ>%\GVSW^3=6JX1LJ1,0QCZ#/MS(NH$?4IU<?]4P?]ON\V= Y=H5
MPZ<V$,217-UQ-&EG=['@H';Y#\4LV4#(^_MD)O5R,3#J@7/&$TD*8W*-WUYN
M'1E4ZYR''?=-C>>5/3@)XRG-:A Q4&-AY9HYR/S/)\1(P"_UCIYZM(66BR @
M6<&S>$>7;_+M<W??J?FHC*0".7H+!RS 43-XCC?MU;CIY/!<%V^YDW(1J^+.
MLK_@U$-3W])CSBE3%W1PMU:3_1\*Y-D./X%8B7!R91>[-#!XBV7)]U/1>VAF
M2B]:0YUA/+ ),5FM"3--EXP>  7.NZ1CY3(R/,%A6W5X3<N(39Q]RC-E!D8'
M^FY_N47D8HVNK:4*=?S22M!L\C[(:"[!:,RKV!#"6IOR'V.SHL+G&A'HUY1+
M;FD9G]OE9*B%*C1!V3N91*Y*7.L H6J*C<7<DLUL+@6C'#;Z4)Z':Z3V% ZO
M 38B$-'267V<++;:^4%2%F.Y"4S)*47?2B3'QY'G!::=Z2<5 W0M"U\/O1]6
M%(&_9XP_)+T7H</:V+ (:!2MC6+D21EFIXM-48;!,*'1$ZO56A_;6[Y0N86Z
MQBM[3KD'U.U,S<34[K9#7LB7W14!=7RZG7S[;F(4/U_?O3X,,V*RMUW;##P#
MPQ8%*R2$D7_*KW][#F,%3@5Q)Q2N/1 KIYO$99:D.-&QC>B84R!#9)Q!7:WH
M%\DRSR>%3BH]7SDJ2C[513[K2<<*@-LMT*09MVT ^V*ZC/EOR3^,$D'.>L@F
M*!_L3[U#@U.6NN[%[QJN)M1-]F]0F7, .<DDFW,NOZ<LU.<O7%W_H33;K;ZB
M1GD*J.497B.9=>RQS_CP22;WC9O@#^='X#,SC*FRL0<BI'_(7'VRI14E0<.4
MMCBNP2:#A6='9I_ 6)N$3I5NB/?[ZT&S:WZI3MI@JU?;T:1RM4<\L%C]YH0!
M)(3,,X7 B3WUW,Y-FDCB7CVE)XP(HN66E8P*Q)DEN'(8)O?[BO>HWYA-4N:F
M/:.D:Z\<,G<-]+#I.C&XI\74<BH2 1"KN6TN9JI4M#EXJ4J>/L]##IL!D*TM
M2ZC7ZR$/N+^XA^E"(.,>[+ \?3ZNTU_LY""MBH,62A]WA''U0?2$ ^U)(UEQ
M W7*P4GL;(G[;;)>&4<38H&+NYB(VN'4W(T%541M<Y%VRR*W0G%^DWJQ)85M
M>,=,*-^^!1J8-,S&W/.5BKV;@^])/]UVI?V-GA*JKOO6+ %=WK!'LW$NW"RD
M:*\J#QN0:<W)/J'4EJS%G(G?-]>3#M.&0(Z"#10/69CEZ,7*G:OS1*M+X^+M
M,UU3XY=BU[THVS$<)-F2BU-@]3:$H4'S(/4D57_F(5]M;$FG??PMMLFO44YQ
MG2+GFCM69)+'Y"EZ(4%Z$D.;"65QD9&*5%)6ZIP%5YI>Y(_SJDK'D+>\N'8]
M+G,%_^5L2;)2-HIM=(4A*_EP/P)5G8;\4"?XZQ%! 9T(BG659H,(],-><H#8
M5YC]DOVVIZYEP;'VJ@K.JK0JC.&:>L%9N);7L*#U#UB4#YD[%(N^2*-Y)!])
M<J-G80XOL0/^ @ISG@M$9BZ4^KD"K(!\JMBFL%L\VC4.20F54/+$NSY0FDDJ
MRP+05Z#&Y_;Z$9@-TQB&*=\W!O%6FT_" RN^PX#^ %63>VHVYJH-XLZ\YE%\
M.D;[ML;'VXJI\2*I#-$)#FM'5JO-SD1F%=N)< BXV:X!LII(R"D>,P*8_LFF
MEO3M=UW)@+65N7#LGR5Q=#U,O60KUI#M\,CJ@WO6<P]3XB30= ?/O42XZ>[8
M>T;27Z!QOQ_CN=QV7D-_^R=$.>:J+LI"5<HCT!I<SG5^F"]2E!/K]H&Y)B(3
M7L\4_ >F*^<A.!')GFIFC%+$[8Z_FS!G*JHRS&D[HQG1>H-PQJS96FTG?.S3
MUGB=A5@$!1HDU T6PG_I$)HPD*)F+^4>",,_W)8=9$8G:^EI#)&TE[WGA_Q/
M_Z\8+D%I65Y!,CCR%0959)<(#:C\9JO'B/*GK;(>;8Z5I#P/#X7]FX)RVY B
MUA:F:O77%#DR'?W#<) 8%V33HBCO:S7_.R],ORVT.8V[;3]J-#P;0].&=KC(
MC3A-=T]ZI34DO*#*U8%]K#F1HSM:(U&D?]M39Z)T^+"@CDM]*\!^6I>KY837
M$'.=&G44'ML,2"G#)'U\I_BG7D'*5K58QS&&JS#Y8PT?1\%7'$744WG#8Z)0
M3#7C5N_:M_LXK"7V!B<R)8Y<@19#$V,,+4:IW^#QRY5DVIVQ_S%-_K/*;#YP
MGA+L1?,-']/.3!C;YL?X/KEUT6&#TLYGJ*V+Q#7DFL@[#]RRU"5I5;DR1EW/
M^D?S%0HPXL%F&)@':/LP6;<?)@LZOWCA,Y;,9O1+CL79%:UA,R@KM ]JV_A.
MP:G57%X5HDEIPG+Y.]XF"JL_"Z57\%8H@T&M7/Y\ 7+I3F"R^5 WB+R6=^?\
M8*E<]P418;)>(O>@(,&W"8]O&GM^FS&87K*@H^";+_7_RB('J//_7:YV+LJ3
M%L+2TM%PP]U[9E5:LZ<[%[1Z2-[8"&C0EMHXGW(Y.GG\W'A5+VZ4 O+/HS3I
M-G9_1A+0<7.49RGZ\S9YUN__@'/6[.<RZ$G-='',^%3'+5\I]%&U7@!.AU"3
MK/8((=MW/]^8]U7DRJDY;)DPO=4M%JS*T,[Q<\SU,2EI:_N>.^W=B:%/2S)/
M;V;]J0#K'PJ_*%R2B,OZA()A(5EYX$L0PF>*Q&FN,U;83?185:_1J:%BL\R3
M5N0?"C1J_>_/$[8\/B^F!M/G3IN7M"6P.<#,_$6\6%0CG'Q(#FGQAD9W"$-3
MON%K&+:$07\)D(TO?&'R2D!;.(I+#35W@*[4:^L=9S"_-5UY)A@T/Q!T?AOK
M&CS/U>4*[2RLS0=>NH#2<]V=FP*MF:=E3O7+R06RB>/2-N/_,AE(H%['?SZH
MK_V^I]7Q#Z76=PMT],:]\(O]GY*$;'_KBHD=S!3EY)&9=V*[?NP,NFP_)\NQ
M;8C[G+]?QIM2!QE\?X7"4_8/)7AI*6D',=<\QCDX%/Y[2*WDB$$]=X\H?6/P
MMC)7N<>==YC+*-MT$:C:R)=GE(-J[H0\S973F;5I3\NUYO/ "Y*.\<D_!V/%
M4'_8(S1E>:8/6GS^.'R@HKMIXL'H:2 [Y#RDHW*D'W_Q\ 7KR]I+FKL*^LM;
M]R<[,T9S/'19#8%I&=/GE;MJTAXB$U?B)_$91I?U3H!FC>L-TT>+K[T_LY0B
M_Z'XY@0&(SLTA.DNPR9.F^U;&2YS5(K'K&<ZO;9Y:3A2XOH?]WBX(!/"J]1_
M+WKU#N,7ZQ9$3<W&_Z&\^;Y[?_K2*>@8\ ]ELG6QL/V5JAW6%_;5RXP(DX'I
MB[D,[O5$!3=PD(#85%:4.M8)%8"OFLYUZH<SP>K*P1T7+=XGF2<5N_&R+^]-
M?9O-%4-_D(Z'@MTTB =!UI*E31J>Z+8.]5..3N9X>1K\XQU^":.BH]6Z.J#N
MUTYC9RR1;ERW7]Y0U6#22_P%2QT"%R1DR\PZR)1)/F, C<DB=^,^AHCF?]9S
MM.: AO?#%O DX[U4TVL]VWR&U.VP-CH2*AFA/%%]&CA7*F.X_* >(O2QCD>$
M^>PSYQ)E<,L,K\W[,6L..=4?&1HJ)&J=@9)5++K<]^R\0;3^.W]T"4A-E<\
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MTT(SG5TRN0,X\Y.F([(+U?).[42KJBBAJ:12*HE=BXZ(@.[(M+6OO)G^!-Y
MD%ON9]?O.B-KZ^C\]UV!"5^:+(.PUJ&-YD] EH]/N"=T:_BNM/:$BX@8:9/
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M!6HZ0BQ^,V3'>[Z:\[Z0.!R3FLI1/15+' SB-L<JBJ7L S-/I[76Y9]UK#W
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M7<,;ZM@3K_;><4]7<S8#ZY@[^H)DUW_-1MA9D%T"#B;2D"PN;/W5&?00LK:
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M$XX%C[K3P(YR6PW]!0:-<I86T7OK H8E16Z2:OBYC\.D!>V6 E&6CV7+^E\
MU2+L>LD$LR%N/OL6M>XAN#;P,#1P#9+H%U(M+O#8S>?[.G;B554LXUMJD;2M
M6-<!IH.:^M.M92=OLSTX*M!E-K<<-=9F5M),V_DQIQP[T5I\/N)DUCZE:[$H
MD-J?G_RBB^[ (BDYU=UGD(RJJC:FS<> HX@;6=OG0 J%RY&#27;#Q[_@:C:
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M&29&P3W(^I_K49>K()#MQC::/0S.6:3V\;V@-IY^IG'5A_JV8;D[#V#?S5]
M+VF!G!LZ\^?8^=U5!7],E\2?;\3[I$*<+-)JF*"T6RL>HX6#=<$ZR-<Z-)])
M6P+T#%T8]">"8\$^;O"YF#%^JT=7^XNFT_CRB7Y:%?0%#N<D.,Y*?B8"T6^'
M5U]]/K.Z;_DHIKN>*^B]LO=0,D/\V[31I;+;@F9IN&<D$7-G2YNXZVA[5Q_4
M:#OC.C*5A$S^&?W9D?>ZE/I&H1DKF^(;XA/]OX#.FMGN/]"ACV,V7I9):S^B
MSIQ:'!L?%%V-&%RGN=&!:'O63AEGG'4RVI)F=FG0CH5=5%>+LFDN^@# O[T;
MTM(2OF1E%6[>_<N?//%_0K[\W_=2.6>R49$U'DV/3#\?5Y5KDEH93NA"=>RE
M>\EPGV&!JWI0[G1SM,7C=?3$-C-+Y)\#W?@_DN)J_6QRVQ@M_-(-L8WWO=?C
MI0.49'6[OD:_W&@RB1<.FK(+G/7V1+AP'J31LAH#L>@7Y[_TZP)>.!B->H(F
M2DHB5.E\@)SLY=YSS2 79J FQ%R#!6!GS&9?YM+,5+CX;MXQL<;:0I6V E*R
M2#N_B=$R=%DP126OA^IU!'!T_:18;ON]D7AL\EY5:B[WNO!?$5IZXDTMU05
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MS$(#]7VZ;XO[<K+BX;NNA)*7LP)>S5#]2*V#A8]V[B)1Z0V.*)GE"-SH6+C
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MX73@R7,[OWF'7V\R!Z<:I8(!?UMC.H(EO;88?S_&G@#1-!]75GCGJ,_>^37
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MWV7X&51["B0(P8C1\O)%E\</&#5!LC"1=TXY6_(4GSU^=E-ZX6':!3;\L/F
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MGG5?U4(Q+F=D,;]T+TH\+<"A6TD_$67'7"\\<(_-8MP=_F4^+FF]"1J_8O#
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M'"+E?SO3M_$R&-I1L$@PLDEG?GW)=QFV"T&R7UW V@R!!-@K-;HVQTY?CJX
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MZF):-."==O;V<\B0Z(^M4!C_X_FS<E>?7WS 3A[1)_Z(J+B]JUE7=:/'T[;
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M&V58=AWFH+1N9\,6T2"1^WAS4V*6E "V\I8T_BRN//P(](4C/% B^EAYZ&H
MH2XS0?>B@8&/SYG9;Z<_ZO,L&XU4:25D'S;U [VN2:BE!ZD5LNS(\\^*N,\/
MIMQV)=__@)/7Z8QEN3K7Q=<9[9<5OY+*5:FP<\=56PDTTKZ%X-'%=%;%>/2R
MCUU+7BM%]M_9RGB3(*;):QK]5R_K_-4$_F,E[X%\"_(R#;!@V\VI;*$!7((6
M9,'>?RWEE=3)TQ%7.'H<5&9L0KC=,GV)/GJ\H!FTL)I>9<J]THCB%?8J^>6J
MQ"B$LJ.D,+_\JF+K&7\#^_>)1V^9B4P9L9S%%%N.^28(XEZ:@C?L(W?@UX?7
ME2E*=ZA## SG6$EPJ1OD /@SYF%_GZ[\6=E"6QKP"-W:N'ZPCJY3SHRYX1KW
M1RG8NRWN3W6.[H[TH_>I:8RFAL?I'CU=9[\(EUT2$BUS5.M:WD\0+7I;M#6U
M%8XN\ZFHO/^N,F"GEZV:8DIW[)8T0&P.?NIK99</ >S[XO;5="ZX*>6:A^0C
MQ9"X2U2S51H0!IUUH9OAHHP@2".Q,MG%_M67+*.\[8!@F"II1*<\6+PZ]ERI
M;((';#J#'E:<Y-A"M#=<1+='0[^++:N+8)O:Q:V8U/AQ-\EI[CR^MRS.%ZWX
MM/K^:)K</GQV=V.%'L-I(4\I]AJQ=34(F+GS2MG%S]. E:%-F1 79G^'$_9&
M]V/519-)DZ%DDMX"U?\WGGD$?=SST.-BG4%J[C.Y.Z$TP'>$@VA(U8*3!8IF
M_L\KZ1QN?T($G3NVKR?(P3?MXO!P4^0-^B#<0N_,(^:Z#_M4DN0\2YHXU,7@
MOJK:%<6]Z1JA?NK7U->+P#,G@]T],N4[W[]J%@F&A4Q')5?WG1G?)WZ+!DC/
M0F0FV]VF1[3$/2Y*,2T8,MI^L">$;W++3J.MMC@B)XX_GFSATHJ^%,>)EB;B
MV+1&(*>BG/$_&.B1$%5F<4 14SAVK$DB]6(>4P?R4'9.&4&'S^=TP\UN5$"F
M\_!]H3OG-1D!?I$\7&*#(.Q,6H3=A/K83"$*??MXEQ-/?@=87525].3=?8-<
M^75CEGB+/-QQLMMKA6>$MXD>!Q+.<=0'5+5=U)HXPJB38C;1U=2-I %3U@H-
M).]+*G?QR^JBK:0"LW@Y)6.!T-M7MH-AUL06S2ASDM!VBV?^H9V13 JB-,YY
MF,P<E(^? H>2KP2 <.&;'4U.3&GT*-[8/=?ZDF/E,ON=-LA7W(L&^:]\F_Z8
MT6/JM4\3(W>L%"VBSZG9%R(W2#U4_I=V%BPAG%K.3!Q3& H&^BV=FKP\":I3
MJ&D/<W@NZ#S"6(?Y)V.]?B\#[H)C#I'NZ@^"0(F:E!1H5/R!%;-;=7N(Q4F>
M95W$U(\*,#9%S4%L$S%O*.)B^(J<EW0]TF$\K:T&R^4[:^.K<.;BB;$6P>;-
M],,G>_8C+Q&&/O?<%L3G()9_''")ROYZ3YW_8&;*]O)4>UC/JX+G\^+."[GU
M*$BZ=)#J;\E2&+I]%ZB:46G92*<";GG=#NHVU6?3*18]>Z-ZQZ+]P;D#,2C"
M12$;L9Z@T^2 %BM,Q-UHA:5V]FN$_2#1DHP)LKTI5\\^[Z,/6<%+[F$3O,7]
M<CHYD2>XE6;W-#UI@*":0-6FD]'#TQV'K[%E _K$D#;2DHK_C3'=W4'8?'U8
M@QBQI\)KNMOS5%)22TS+:$,#$1,^33J,/?1.P:;(.@68@\C29]O;WS0ZB*)*
MU^(>CBWL.BZ0W$77]!D:,'(!QD3\0=56@DY Z8-8/(2>M:8!E?#^!L@P/5B_
M0Z]/[LJC0NC@O:.*#N#_\[C &BZ$GK6ESR5TX2W* 1H09X^N 2-F#"E1.#KH
MQF^D<^PCN]$%O6P<I %Z.V5TVQ/OTKC\9!V71!5&=RRX;T#I6&D8/6OEOC.W
M)\4T$^-WA1R?M"X[LX'+@_ Y5]Y/%0YSB'A0Z:G#VF#WLQ-.T(TO-, 1]R90
M!-V1[T9%23$QS; FNYS%I-AS'F909JSCF<9W$0KN01?2<1F!9^C=*Z8!WU.V
MOTQ/4F+NTP>/;G?ZTCC/I@PTR[(HC8.0]1FC1?F$BC##IZJS5)_UA??Z6F^)
M^G$7P@OFW0^-G<%&929<";4XNK"L+G;3%Z%=,5#N?#Q6HOFGD< ID0>FNRS+
M,WV/&TW%JK?ZAX7Z@>83W26N"O@A!A9A7J0TJZJJWNY\C[K49^D<^\GWSQ.>
MMF=B%^#VG]'M&2CP3!K&"2(=O?.6KFCR3RC^DOU!IW^N-)N+14%G6<[<_;VT
MA<9PF4P[G2"V?]>G[J(OP!)A;O^L!WNAW%P$_>9-F0:'/R7[O\$?_J;+Y[K_
M^U3E]?Z.U_107QA&QKHX"JG"7V*T3& N!>1VDR'+X*?A>'L+?3;EI74-T];+
M0F<,34<:CGURZ?RP7V:FYL7(TV68XN"&N=W\M^AU@58OB<>W/GH:6NFMN]BY
M#*PYL5R].J\\ZR?L52*QD^+&:Z';\Q.I*!_)=.N\Y]H[Y)YT\UH3RL D(U'W
MNVJY+76DD0:D?MM.@5;\H $+M8&.^<;:TBLB^.H'NS :0 VHFG?^9YML39&"
M8B_(W.2W !JP_7WR6>8?;5R3>3V+FC_N/D'_(0;[1YO7IL:=M6P7OO^ZU:];
M_;6W,CPQ][$QT!P:D:>RH9P1>9_SC\VC%ZEL5NON3"["'JHXY:(KE_O3C.K@
M22MLJ>#/Y=8L5<%<6N? ^';STEGM^X=C)E45WPRP@S6U03#F)I!C7>+ 7WT0
M^&]!TPW'T 4A>P.VW7]L3A;2C?M[+3,JJ[>H$-W]:$"_1WY^X_['YN2@*?G9
M/;*1L2:(1<3B?8R'=QJ'?L1#U7S0*NIU5Z%OPE%=K]-/3S;T#->IVA=IB-=%
M2!A_#KWUB:)(W OMQ!^*/C8XRUG.X-[LK[+8(%H9C3MY/N5K73@=")SJ:RO1
MRLMD9P5RC=@X2)(MI*4)X:=O;G;4@^<.Z&;WJ:D+L^AU8UM\4.URI]0,1"(%
M#8T0<=5DE^GE@A"YQ^?X))7!ZB(YM6]:WR#E8\WN=3_DF 4WJ9W3IIS@F]P8
MM!@I\;VB'V6XRUF%_; PUPYZ[D8<:-FL JO=/X<QB;O<RZ;Y?P?>L"\']9GU
MA0"0/X.ERD*8]QZ*<:(I 3BGR YLSTRY4S#\>SM;AF(W/@1,^R6<T[=/WS&+
MX6]6T0I5?.Z$X'5[,:?I??U=HH:]S\&LFR'J8@<^2.Q ROMO%F1E42N^HSD:
M3N-?3VAFU]<6C1UJ+:@>IO)^3:G+,6;V4%:6.*,_/1FF<BWXGF2LG L;R2W]
M,,_,L^YRIZ&8>S2 F>ZU;]. X,@=?2MBP\NB/.LN[SB.'^RYF;[\6GTR:KOZ
M.IG(!6DI)F%".R6*YV<8 Y>ZA+@XD=?WY:'#F2;0%FM^UA?7X;8#>4.]T9SO
MJG>A&!66Y$_5L6V<,V^M .(X/R&U9&K9[G: BUR(B .A&BN O#RH9J?0?X1S
M9M\UQ&+,@^GAJ$(<'L&M)'"HLJ0<'S)Z(II@*1YK(Q)D'J0V.?4C6.9VO=#+
ML:OYL4SL6QQ\OBCY;G9]&,.^^R1K/G.^4>2!0^7Z0H>#7;L!I"6._,",F%K:
M<SR>V6VU 5S<2U5:$C)[^,7P8&*RP*&:AJ@ARH7L9>/DVO+8RP'%1:)K4Y51
M'C+D(7'18&>F!3R7;ZXY*><5_NET++-?M__".S%,HJ7LDF(?*+ 9X_IC'1XF
MQ!>W?+0B4OM(YXC+P?/- K'R[.DW&=1%TK!(V9K-(&+&O*9-[$469)J/2[ZO
MB?5I,X(#<F$D91<9I,5QQ::M<<I &';0J2+J([1-6XYA^C'\".[5@.:SBN2Y
M-J;O-&!YY #!L@+E]L6D7I?9?>W0T+IY&M%+HZQZ#:8T!\PR5@S:D"4UJ\NL
M'4LQ7<9!YW_N>'&*[WIC=YRAV2BMNC:V"J\4Q>!UU&&T0D^_U!?ESLBO$F\C
MN3 WI9B:J4ID;_MO)6?59=5Q3!$PZT?A:T\.8-L:GI%;"08J%X]]*\6*VPOB
MV(B.CWW0W.T"5XN(DW14<82(;5G,<>8R*#O8-))M'ACE4"GD<$[ZVSOLG-5O
MYI,>FB__(S0/VD>'Q$ET+7%?AKM-?+Z"OM-[[55\38A-+@5\E@.5B=]E%EY[
M\2W]$)P-W5'O3OU*-<O-_WQB[U'E]_2PZ]+6^CIOTF_8&>5E NRI01!5<O*T
MB]R1^]?S-.Z,B9C3@'=0$4AB7G;,^[<1'4;["0WAPW6GLI?;%2M+.KQ>%+]Q
MA@CX^D]X/U85 /UF&S D3^]J8NZ+1R#?"+8U'"O95YMR\AZZ#IV-<D%-+Q^Y
M8FBM&FY,,!ME$+E5>AIRQ%G%AS#6?)N]HWZ?%3! #]"M_@C0.^C=PE&_H.E8
MM[RRK\M]5O;ATS9PXO-I'&:A9O?*IW=PY9Y1(&UZ&Q]VYF<T'DIY "49*>YN
MK!>&/A)"E38S,FM^9;FU'+B_7WX9J[(Y?$KDQ5PHX-?>U+C-6K6;4=D@ET;.
MA5.KTY9MVZ*FZZ&7L;>3]@NT08Q-$$)'4JO<9R<T2D^>#^-E6+5HN06=OE"U
MD[8(-T? 5\\H[GE2DY_G4E1[R[]45%>5ACK 'IWQ7K-JEZ^*6V*WIX/M")_&
M;4'\'CV\_ERP+(816Y6V1J?I.4P>I$ OXE,WSSWI\:JLB8$:AAA46 =X[XOJ
M90<(@6=>^-K2@''YM:J64N@TF(Y(BAXVU YY/[>%?6KV$>K E+$W%9,?I"^.
MZ'NP)$DO>=*'[%/UP,S@.@/B*(OM^6YDY@R>;=)99;!,^RZ!NS6$H14%+UR"
M?[*2JW+A].!></.3F 115(L,3A25V-\)4ABKEMSY^>9> "&U.L-J+]XQN5V=
M8=',9X0D%G'338L&])S;'(?M9OMJ-UMEZ?NYN;EV^DTCA DOVV(RR>XKY@6\
M!JF,O6R1%!4!DH9]'V8-5[+2.-,'25[E:%%UJB99)0LR!.\A5H1OG[K[.H =
M>/SS&$PQA0YZCIY">!;76?^LN"Y2G"/3#JC158V_[-/B$VYKC7[(PC1::%8>
MSX50+*NQU3U^,G#&PH>X<(AY.DQK86:M8'0!L^)^)7 .A+T'[MTDYEJNB4=]
MZLD^T8GG5WN1 LX>4CMUL>S"I>K!  O5T[*76QULN&S7E]YEU%FVJ'B&;,5U
M2F64'_VKE]BD,F+)Z8Q%+CO(JK77QU_P?"A0@6$\\G0@UWF&Z\4T>F^5:C)<
M<K>Q."D.$G+M\GH=)F1V9.)]JD@?7R=H.]!^N#9 22&/\/JSU<W#X%M2[R))
MV9*2]_W[(B-+)8R##?^K$P7]=Z'_]*FM_]\$98DS$E9-%1;]<\F!U^Z+6!0.
M7AAM]JQUC!!!EU]0%Q- WR1GVKR0*#C]\1K$"[9 +)O.2A$JG*/<=A1_A3/#
MZA9'5)W(DD9=9G_[,T>-%, $<.A9_;\] WM-3+1_3/3C_KT1 ?DU:&P#C^OP
M:-(3%9_JA),GRN#&)J)2LP+>YJ*$(,B%L+/\+O8=L?KA3520_37X87+5>R_I
MCC+#1(H;' Z)R57NLGQGN/LP"W.U-.1I80:<KK^K^% :<$BBU]1V\IAE^%?$
M2,UU &@2^/U;\?^:YO^H_#[-E7Z$1=0H-TZ@YQ&XFK+Q5' 2V9Y:!-^:W$Y9
M5PB71T12P1=:Z&)%W'I2KWE6!.?Y!AY(5HX^M<%8+VJMWI+M9)@;TFM^/C&J
M1B')-/G9C!4VU/'1XT=\(+R!VYE:4+R._'=%H0?PQ\6X=2D97DSTP2W&VGS[
MK/+47-!57EAQ[ZHK^/5@W0D)C8H&G:TBSP#EPJ<1G-$!%IG7RJ7/^KP G;K&
M,:%!Q^ZNCKQF]2HL;VMO?'DE_T5S&F$183T_ZV\.*N',^B;N;WK"S%84I>DO
M23ENWO@MT+21&$%W7!7;YE!X#F)#&O/2&!9% _8EXW;AR6*_\XPW=NQ^L7ZQ
M_GNQF-[=3U^8I^3M[)W;2;[20T0=4K:+[P'IXO2B6NYW>/) C2T(?78"[\$T
M #FH]NXB%X))YLU:@"WKZBQV/*YB8#&56^-8]@?((PM[UJ?\ NI0]L&J@1H/
MF^3SR9(9O5]S'SV2]W]F+G1=@S'K)H>=+2@[SL;#_&;I@5%<UB5MO=F["V9O
M%*0>QB;?/&C$>LKY+_]VWM^%_GET;VQ$D3#.;7NK=Y_.X4PF^4*^I %'G\1[
M+GQU<DMRX8%V6]K^GR;2)N ]=9V3VB3;K$!3"V-F$8XG- !W?2^D36QMBW]O
M%=U6D<P[OAV?Y%I>V(G7^:U]S.+>'&6YF]H\P[&]&T7=ALYH?U*SHP%0#_2D
M),4E@(72@;M# Y)3X^NA=8TOA0=VN[9'GO]))+;8MX4:2* !#8;DOA7^M:.;
M^&W+Q=_:]?WV%[_&/PETWF6+ABY\/[L[2P-B1)O1LAR_A/\2_DOX+^&_A/_M
MA0^+18Y?PYS]"%69_9._,+9UG@#7!;7(?]3D,*ZB.YQKO-<3D!W/S-SD.S\T
M".Q]0$^ZSR/Z$?%$..9D[]3Q6P>X==OK?88$(DZ9NO%?EI'KO\5Y2*N/:30[
MHUA!2M^U<+3LNQS1J]4=E#=ZSIDI[NU #:4B I71JA)'PC99O-*](^#]9GN=
M&&!BD.M],K$O]5*^KV;8?-6>@1>_@B)?D;F&V@/&^K8%@^7@&UO^:B8/2[4X
MIFW+2P9B$P9G"T*B*V(Q3[Z":TVC[<D%GU?N*%IK>8Q6!XBQ:?*EE[4!P +S
M2.:-)FZ0C3=(H*;O]4#$#=?K.2GQ+^1Z5*[3 $<.O4FN@][9JYALSR/:T+VG
M%Z6H'T63>_VN]&.E_(W8?EWY'W>%==\ 6[:!Z LVU\^K[=DRS>J"I,]2W\P3
M@/K7J/*WZ:RO&0Q;_P;O>_S=*'A1BRW[5_D?EG\:*T:NJ\[-^5+I[)[6K$>D
MDRJ!U.228 ,I#E>@/;(#? ^L)[ 9F:1U:NI6$$/_X[\!*OE%O^@7_:+_A<1$
M^_QO4$L#!!0    ( '6!9%*.1$FI"R,# .W* P 6    9W1L,C%R9V-B:FTU
M,# P,# S+FIP9^Q\!U04W99N-4V2*$C.@@K2!$&:'!J5_).C1 4#T))!DM"-
M""B2)$J0'(5N!,E1R:A($&@D2I"<<VQ>H?_][YU9,W-GWIM9;[VU7KL.5M%%
MU]G[[/WM[SOG5)\.G?X SJLKJRD#$ @$N /^ TY'@)L *3$Q"3$1*0D)R;ES
MI&04=)04Y.04S+07J.G863@YV%G8V+@N"?%R<0OPL+'Q25P5N"8B)B;&R2LE
M)RDJ*W1=3/3L0R#GSIVC(*=@HJ1D$KW(=E'TO_PZ_0#0D!(GDGZ"0K@! AH(
ME 9RV@)P @"$"/+K!?SY@A! "8F(24C/D9&#%Y2?!P@@4"@!(92(B) 0?-</
M?!\@I"&BO2BB2'Q!]RX)MPN=:,"K#%*>&R4?Z?5ZUR]=MW9]>HZ,@9&)F>7R
M%5Z^J_QB<'$)22GIF[>4E%54U=3U#0R-C$UNF]K<N__@H:V=O9N[QV-/+V^?
MP&=!P2'/7X1&Q\3&Q2>\3DS*S,K.R<W++WA;^KZLO**RJKJFJ;FEM:V]H_-3
MW[?^@4'<T/?AR:GIF9^S<_,+BQN;6]L[NWO[!X=G=D$ *.1OKW_3+AK0+@)"
M0B@AR9E=$ +/LPMH"(DNBA#3*NJ2W'6YP"T:0$IWXU5&R<=S/-?UUNFM77O)
M&"Z)35[>.#/MEV7_.<.>_F]9]I=A?[=K&*" 0L#!@]( "L#>(5\FFNROEGV)
M*A?-$/KP==HXG?>+DTD$=6;B+.]>$(<URDL'.I][]CN5LS>!PZO00G>I]!2/
M=*+?ETA><PP&_Y0OG>#?;5<;K".V@<6KF4J\P+=\(#.4#\A,LE#\*.;]'/5<
M!YJ?&0KP_9?:Z[Y,OUD"-*<2PO$'^SVZG]4O(JDH 0TE=B4Z0/>_LVF*\DE>
M">".0=M"^G65 +I_VE15V6TAMK_\I47!FM$%"-+I(HC^1]LSM*A=P^]QRCZ[
MI>!_HIO_E:9J(JP?"IA>307OH7LVXH#\[T#)Z-\6 Q9_QX\ 8T$K:&NWB$+=
MU0^!??]!0-SXJ*S6>LOQ!PFQ(N*"KJY@B_:>.4O\/\3B?T/KV*#85+S'(LXU
M5XX<?%QLC=MM@G>3E /.C<-[:5L#C=(*Y6L*<X7^'IA3@#2V<=Q>89(V82 ?
MRGMDN87WJ9Q3V:V?.]YQ^II97R;NQO35"TZH-ONI)&(;XO:O+BCG62^*5BZ.
MGWGPYL]/ LHGD[]C'W"K"+;[C/?/V"Z_B?V!1LK<ZK72BGI_X5N]U< I,-VD
MG9%.15GN6Y<V7CEG(1&T.EM-ZXTU@]:[./3CS'[@HT_XH$6_TN3?;@12G29L
M$4U5K"=Z"T)C1D8 I^F:(VIZ6#O'NR+K%. L];,EL/5(SI\ULF-">S-CM[3J
M-#X;>DA)SM9]JCR6*CA@)&!4@+$ J_ER5^D#\^_V]*7&0EJ]0G2J*OL?J_!
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M## 3)Q Y#@CY6$CWN%?R\IZ>4L!FBGO>D%?,BB>,@03LU.+$YH6TD\6$&Z=
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MJ=HM^@3@^CQ0RS_;Z;\M2$_L/BMZS48V=;$L_L<#>)>[/TMITOC/+R_1*CF
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M=]XG0]@(O/N@3YHT0'*;KM&ZJNU)Q7$^M+A/]H;3%9-L0$3RAS%B4\"N.@+
M:C3M4I7610M=\^HH>*)94$K-+=?,DT(&5/I.V7)=MI&ZNW*;$N2,$_Q"L%36
M-R6=-F8,>):ZJC!),@@H*N\_N>V6JNMB.BA_)?CQN8O-G/:S:^ZP0KHQ+D)?
M(RM^UW.$H/NRBD*9M11SW,K/;9^!9#B\,;[]LI(["(EOG7( -T]+WB.YSZU@
M=3$,OV[%^/Z1)!3>L=BX29-\LAA,GE!)\I"PA\0IWRN47$^7RFS!)!SLSBCW
MU'M!]Q&,4J>.MYQI7LWZR<\BW^^*'*,]Q#\C0_5N,#PA\"-R=_X2D^XN15Q7
M]#2/[2DL?7WU[8;FC.IWR^_I5$V;#YX2OU)VOFX^XE54>![1L8O-5+J ^(QS
M+I8>%-0L/WX9<1W!_B"N6/ XB I"7(GL$GL9^7Z1)F52;;:>FY'V5I$T#8*Z
M2-/8PNS<8XH+H4.OFI1-=NGGI%N[AYU,=DGH(%4- @*+Z51:TL::2)@F02W%
M@[H]Y7()B4\B45+%RB\(E-_*D %^9_,.KN/"1R"AK[70_-L1@LW/TY_Q%(B\
ML(.EK8VD5']A??,:VYX8I*=/%$9 2@)GKGZ.^JQTO$@>KCY.^C*!)*(-+5E,
M<RMJT94?(+I'Q:ZZ4SA<_J.AP5OEIL%DV&=I[AV;4&#;@BXF]V;:ZJ!PF,+/
MA)[!W01RQ;MT#OUD'_\4QS/&:V3;X:QX6?UY6!?NKV,^J/)[X9UD7X%@IZ3L
M 4=\^X/NKS[&;T9'U5RNR\3/])#<=)GJ]/1?,(CT"<33?BY>%7QHLB#!>-Q6
MYSOP75;8EX7AP&LOG9+\E^@B!L?EL6?/N#*+>)=W2HF8*)W+4Y@^HCZ:?";2
M9;B].IUJ<7-Z>7"%-\=%NN'][@]]: 2LN-\P]]MKOD[N.OSB5Q/V1!P49"7&
M]4X+#5Q'E.]>0@--Z!_ SLUI=F1'Y@">XJ:-PT4LTU"TIMMPPG/Y[]2Q $:0
MN\^@=US<7$3??.QK@@L@M-0*Z&#"8;?Q7V]<DRKR*7?(ZW*_SO25#_J^SZ-[
MA9GLA[.+65RGEYM6ZN!C42$I;"A^Y=%*T@T?'2BV.*/L1I\X+*UVP[2 FX(S
M'^MZ"NC$;SX0:'?T9<%0UL54&>BYK2!8&]?C+1ZN"EJ]WS 5)]PG&0)!F\>S
M03LQJ'VP-/>I*EMA <D"*.B0OI3#Q.'OC< (6U$W8QX(I$V<NU)/W+0A+!BO
M)*=L2V"7O9GY<!MK;47O[5IZQ]G%@GWMV*?>.P=W[*>&WTBGFM#&12^*>W)!
M;E>.\]^/+0+.RR$3U694=Z]^D(\M1,J$?V3"TT&^+>#YHF_'2QE0I+B8UE04
MGZ31RI-\02;TN!^8G@)N&8!;!T:;D4+Q_"E@CZ:1O5VC9$ZEZ:!6V$R9V<5C
MX]Q-/T?V^-W=82SOL >)20(O&[4Z,%JS8;/60I;CMU"!%TCXPN&:;V7_]HFP
M#_?6M<8W-AH7;EY480*I_I5VO:>[<AT#QF=S)YNUI0/-IN-=MJ3AD?([\/JX
MP3PA8U[Y,D@^7J!J8O/M%/:V5[X,41I4_FG)ZK&<IQWCZP\TRTBNIW+A@$_V
MA787)J^OB@7(B/7Z ^-KM1?:B!Z+033TZH_HJV-ZC.6?F 7V&*4]/P6F/^ZO
MF$.A,9NI#;&0!1:CK),,2$S/5!GRS7K>L;<$X9.!WG][UO9O3=5'KX\C%C+7
MP 5FX>[AH%_"L7^[*<<_GB$XDI&G $?O*5##;Q^,P\ME@9S#H!\PI+3"RUXZ
M9&DT@*/VUV- L=REK6_6P%IV>U7CW==O24V.N37=I$)/OJT@V*WS#0$*HP>U
M9/+)/#0=] 6W#W''3W^F4TNXA-Q=LW!ZIKUJ@BI#QL2<V/@A"]<C#W-/ :\>
M$L4"<[^DKI%^&DL'V6"UQ$@WB[WGC3.L^[C4U+PE!.LX4V6$6:XWZ0=F9NRH
MVGDFJJR-8I&GOL]1_7/K!?@)%![W$\&>6TG(**[E*?1#<K8.KS2\G%52Z.#[
M9-&P\LZ1H3Y;]DP6&,+L"4%KLB-NS,LN%I==QFF-C1P^J72-U[+\)V9"A/<?
MXA4:688VA%YS",LQ1DD5H2A1[7O3%J,E KUT+E&VT$_/N::KL.^;I5-5OL\X
M^CXHV<'(%:V.0'\ZV@>5K3B)=H00ZA 7OS@%9GA/ <A?4R!Z]@G6FY/W.,<(
MLKZAIO$*^>G4?T2>F)[ 8C;N-P>;?)R&#ZK@,?YQ+?O9,=Z1N_E0"..3T+R,
MXIN]/YX.=Y'>[V3;LGPLR151[N'D%(>P&&*73*=6%;VE3%X\9Z[PPB$K>)UI
MXZFHBX'\+S_I= EV??P2VG+"!WETQ5:8)G;Z$MEV!ZL[O]N0<4([VU,#>3._
MR>%Z3@WK0;5:#&!2%?0PZ%6P*ZQ[YPV\")L,G>$-W39MVR S*T\4G7;F% 2<
M=3^MS]UMLROZLA+3*<91I[^R^S)H8L^WAT1ELHO']^4+QHQI^% ^&<#^-C?)
M6OS%SVFFPEB@DUY='"$+8N[2:\:5@-#MAT?AV\72( 4XR2<0Y,$KX.0SZSG$
M+ )_6GVJFU8!">G3$R6?/U#.?ZXNKBC105J\\A3LCV%O./W\,VNZ&10[HJC5
M9XX"002*S#SOOMUJ9\08G$=KPM?-76D+96UAI#4;7@W[,54UL?*R^V#!8A!C
MC>MYI$?"OO0&)+=:5FL8P.84>&2)ZE97J!!&-1J5LU,N<X]_H68OY$#+1%)8
M:+H],C7J'#,Z5I2YF1>=1YABY/D,-=W;. Z7"#UW=$5N'OK<6H/6!W=[TM?D
MEJ5OW&AS-5:]J-G#@]9:8&67#K+0\,AJPNIK]2E .](L6/!*?55WN!I5.7$*
ME!_HWZNICWM<90U6 >W+6GZPGK)S7P9Y>'.)O ]"_T 5.GVJ52!/8)BYQI.Z
M#?%LX=RDMM_Z-M!0/F\)IF^4KW%JI?Y..E5RT^Y5F/=7460I $'#$M?3CGV-
MM1%,_I<K;POLW;FOC'PJ!^N%KQV0=.)7O+^O(=CSGD4XS.S""S#:,W:EDDNW
MY6E ,/"6+W=J:3D%'E2E4]$J3_!(%&!CFG8W&+;NP28P;G!K\I>OC<_/<32A
MY<3.,K'QC;57*.GE\G&R58[@:H4_S;%<W54:/GI^J$-T?3,E(K-VC7*4^9&A
MVD\EYP=7%>:2_0UQ^]I>:M"K3#OIY'CN,QM.8&@%+QQJ2OB I+&O"KH7#CCN
MV[<Z.A)&B&:%KK2(K(R4N$2JSQYSI<U'M!\-].M :2^%.Z=##!S=D68)0HL:
M++U%7=K&H1^E?M9#TLG6]_V'S[6 7&EFL""5-)CBN<@(O,5\/VG36%Y_17\H
MM,M[32C-9;3E4(?$IFA1/-QV@Y;I51NE<W'X2D3B%.84>#A6RGC_$;6N(1/]
M)8Y,M'3DN9).CIW!FH*;4=0<<1W[VFMIF,>4>ZQ@N'E@;8X4W_'+L>)OD*?I
MZB'3-L_;1RK_CEG 1YI[A<0>;X#9HSRW1P0[:49PV!6B.K10>V\MR/$W=$_L
M!<WP-]Q.@7J]>:M-VL@E!,?SM,7VOJK("V-B":DF"D*P2LY%%-G6FSOOK<37
M3($\P@=V@R*CH=N:,.V(O@&$;DV5G #4/W&'?D'WUQPJ((E6)J7_LI^@H1S9
M'0:H"%K(/43R2+LWKO:0)*?"*M=;1S0<=2.UB%R$]X9KG,@NU(<\ZB'1+ #1
MZ"4N20-?C<^M%]8'(X&D6"SAQ.U$$T#N/^YU=!*=YB);>T5/!P"M('1"NWB'
M< \1='"D>U*37G.<GI+W^S 1^H7#D&,O3?Q"L4C"B8T.B<;D]:-.^?+OQLR3
M"CN1._3??Z\NFC1<!MWC?#@X\->J% G& T\+@@#VYF -**W]V@YUB/$YIP#7
M04/<;"7GTL2295P!JD/>*<<;TWZX=]A#M$(V9+ZH6TB!\;ED6Y)N"-PQOC!Y
M1WZ0NMY3+A_*V.)<%$_XJ@/^@>-<L1*N<89C8$YS+WD)P2X15!2M<OU:-_UW
M /@ NDD;+Q?25^,#3-?==BRI<R01-*_WP%\[>H>'=SQ.IU;OHW+?;QRCUP<S
M8I,4E5_HHW <. 6614/M"Z= QT5\)EJ2;%%6\$'1DT%FK&4MBIQZF\NO"W#G
M D1"IXX-TLWO4>T,XQBG&G>F02M[=[%;S?%V]$F=E;-WDR9U'AAR["RP(%J?
M6:WV$,T"!83&*4LZSXM?4\TD;;OUU>VU<&Z< @BZ[8E]O#;&QUQA,0'DL6(3
M^R?:^<4:(2=Z)T2 Z[C0T4O\CJO+*8#5QGBD_G6&T<8 /EH@^>::;XCSS[?C
MW*1ZN6 \#TW8<!JUVD-&L*L,UE(SI,61',';([+ N M)1[6C"Y-"CKT[\0MO
M?4B.O<BJ\U'M*6FK2<"6%&JP<K#,':;KXB-!$215M- (GM=0DX5];1]&RTA.
MF_3PHX&W264PH3=\7 _9#!>+_4 JX>K'!_URWR(:Y.+#Z[6O\OEWX3&>IP"G
MGA]2NYESDTZ[#2V#<RAY[P/&]X/EL8GK]WZX6 :!V<#1?19#(%9&OE 8%X,(
MI3URQ Z(M"DC>XM6N"N"#.E<5LR=@N),#]Z?#*\>Z4!OT[<Q0?>-F:<<X XS
MMVV8*#NQ@^^.U0.*3%+371!L3-9Y/&'&&?/&5G8EYJ< *4'=_#9\9-_@%,B4
M&$2+P<NMEO=D5'Y:NI\"?@VY]:QF8'BZX5(:)YP*TJG>-]F3N4*.885D69D!
MV_2?]K57C8T1S,-_7XN$SQ_^X\)DCY=EUX.4CF89S<>+&<I JVL#->>EO/&:
M&J!C@X+OT$V$+=#29\QLR3*\&-4A@B^?$QQHR$7+*)SCW!9N&6S N H6I8"T
MB.8VQQD@"[<,-(+*LAT-ROO)RZZ;#')+*!"0Z[HO/7/IZ'*K?]O"R'@^<G1N
M'2PQF:KH#Q['2[R6E4^G.D=@551M56N_(5E/[N<6=G!4<3>=[)%X-;0$.]',
MZ.^ ;?)AF0ISY7@L\=-"^UE<G-9/GIA!M'AY]_ZZ_5;,7N1@/:OYKPJ34FF4
M3EE,-?0R&;,J6MB!759DLJAEY%2?K;L4V#&V""M()[ZDQCD&&,(PW,,KE:K9
MY;9&CW,*;]Y)M(G?)D;SJTR.V.;10K[U#U8F$_+3=01R[+2,>26MJLAKK%BY
MW"XU'[=HT)KE[4/+:)KIEAU=YSG?SG8'1W21:"@BL?"F=NTK3_I'D%0E@[ME
M4;XZ)-J3%XX6%,:P-58[FB!B-"DL98.^KSE #4CTH65'#,$NATVL&1CI^.6N
M\.P4>%@=D';A=TS6UTF,7H+,?,QD.*>^E#^?A&W#B)V^OQ!P4Y<F,P5^R"I9
M"SJ=4]Q,Z@SXXDGS;KFI)HT!@O;=,$\ZV3GL(<E=^':P:XL'G?.V(^H]WUJ,
M&0OC<2!W0;D&JLRDHWYW \%A>\Z(0@:,,T_KJ59@,8NX#C_%0['&O$@%RU['
MS.*NI<ZBI2GMEY9K?"M]MA)9GX2-Y]84TX^S%9%Y\23]S+@I\ GM(089V-?K
M>+;5787%%M@]SASLTO%D+BS[M8'I;PO0Y?VXOY:BV_M+1C^?;Q*!+ND:C2>G
MBV>0O&96 =F(P/A798J0K?QA.\XU*85P]XGUD,Z3G3SA9TP<%K;0.*#D V'2
M_+%"ELPGH<OFD [BBA59*3MBYF\",K,5- SPX2P"-!T%!=G/)W=/ 8&&X)J:
MG[*_C]!2]$=-]3Q@A8ND.R3;\OB'$Z#<#<D^ZGN9F3Y..'C%+'-Z ^,]I\HC
M- <87\W?S]BCJ^C@ IE*=-\X.2GAG;?3_7U=^6;*S\I"54JPQ'ZFAVO!KA.*
MNI<Q,\=$_K8$?O93L)>#MB',^>[%!^>:=_)Y*Z/'=CND"K:+#\AN[J13JX%<
M1#ZNVRO'P&P=.(9EGB$B+'7#^-@7U(>MGIRF:W7B;]T'/@5VYSC+G0(L:\=P
M$ Y;#WN(.W2( >AZD1,-(. %W<2\;=M@/ 9U2%K2<AT_)*@4@A7#W9_4WA%$
ML%\#W %_^DXO[/*:B>*/T*7"@(V+-D^N+R"8WDI(ZH[B?-,72D:&"TO#VP>K
MD(Z.^HNP;RMHAH7(U5 @!LKTH4C3]P^-EP]>&1#KQIC%$?WHRDX'0Q4M6QU
M0EP323;.5O:'7Y!;Y1W!SP%+IOXLW2,A@V@9W^[]'9\MC>+]PYB3:<L$;Q /
M07HL5@LZN> ,#N7CD+N% WJBL%[!%>M0>IV7W_JJNLGR)3ZD^:RVJP/A=\-9
M^=,Y[YIWOSP%^MOQ.QZ&G_8;3_Y K>F0< [76I$/\X\<A-6]2IK"K0GZ7'D&
M?)MNSP'L?]@P%<MO$-X5UB*^GK3-\J-.#43J6$AHH%O^#G<]J]I[#3,Q@.)5
MTM9GW>380UP>J++;ZU"@G6:O!S4\]618MC1O7*1<2I^'?;M_"AA,J&\Y6.%O
MB.H0'D).@1?/#W&95'%SIB3'SU0&Z^G<TTGG*B,FQ55%*77Q3:7X28PT'P$Y
M4A6C_^@F0=X_V3%XE5K=]":8Z6?U$3]AVET*.F9HZ>8_GLU#OSF@IH<5]I0T
M=8;!CI:!'4U"D_UM<=]X,;@8]"JM'R7@7>@!']Q7R&Y4GTDNP%9^/+D,DL+;
MOW4KAJQ[L'&&41#P;DE;8EVRL'H&0LQ16[6:PJ#$8$TCZ=F$'TA5'9 Z8KL4
MA2-)6WD6V.;Q>B.E"5;A_%;OV?*\^C<C;.PA&>GDXRP1X]XL4@A)M@<U:<O)
MV@>SL*\K0JE]=[DOX)(6[VQ8DWYPGP.U+NV0"2(YVU!WS3#6CL*91>%K]9B-
MI<3G$N*!M2YKE5E&<F:9<,#G?C9#P1>F8_ZQ>[9&?3=M*9Y%@S>;_[67#):V
MOQNS8.F0#UJZG&:ZG?POSX'&R>)]_#&R@1T6L(X[1OG#)ZAB(0F8A:G=WG?R
M+CVX- U6)1@/Q7GD@&K'1ZQ$2XU5+/X)<G.O%7"#(S5!W^[C,]\.8/ZV=ZSC
M%!@H[JN:8%"^M3BTB"S])5UYK=XQ&N7$N7ZZCF"C,-F*\=3:F5C897#[WO81
M(CE;=8['=C2+@L:,1:MF5X'GZ6<0$MJ/KGS#>X=B!*3-!<MWH:M(>6V&6S8R
M^K.'.$'OQWMNB4QI]L!J5HA&5'C0N</!%)#RD4H6*_2LK HYXFS.!Z;@TM-'
MF$C>I1/&*X6*+CL#6'++_JZ?G[G3HCA@5BU)#1\<IF3W6EV.2_;$@)GPF:^M
MO!RQ83E:I!_I<?N>JKK4R?QSSMWPY"E*@>&O]Y4.6&,B^B$*(7 WNJ?C1C]2
MSV&[3$2?2K-L!KE&,&N18M<0 TK]!!(*UZ;0$IRK$GUU2^9G$RG%2HXZ)[!N
MC^VK_M_3R0X5P;C_4[@:QX]\N?/F'GL$,O=EJY1(^[N9%(]TJIK0X&$K:2*4
M[I]+]4;5=KO)#,.B374[/5FEKWIPA=<HLCFFJKI0MVQGKC=5Z_=#$'3N@G\,
MC:XX58WZP>J#IZ1Z1*]);1?#N H^_@AMM"L<_?X#5M$[C);CCWJGV]GJ FW5
M7_EIIF!:Z#(%JVZ#BO80XUZL3MH^*7<V8R=RZ3^X[&WF'AZCQN8$"U*ZE-J$
MEJ$&H[H]"U5G/_?"9BQOCFTV<;*6V4%0A(LK)A5IN3GFZ/"=Z6%@*+#Y;;QF
MC<IL>-24SYD\H /KIO/>5R->68](Z$V^VEWQ;5Z2?#H(R#WN#:.Z170U[^>9
MA7UZVVCZ19M!Z?UL9!KFKOUA\R)U0%16.>"AGJ210ARYA6&UO1..<B66*^P2
MC+=[8#+%Z[)=K/R-R\N!3NHS#8+^">A0KMUB.<>\)<N@*>H#DG+O)0\%4V#Y
M^"J8S$TU]K-/_CP /H.<GY/WJ'Q.I=Y'J/Y,1RB,%4N#9;%T/?+8MW,'PWF^
MZ7[?3+OIU]_GV-"IB[*"S&L(#I-F"I4,;%JSKMFH2JD24761@U&;ADPN19Z=
M5)>2C=_EL(\]::#Z)?D=L*%(=ODQ3]6W6>.E4QOWK$6JI0X'Q8LQY0?#U:34
M?_20:!5F2TUF'2_=&&3UZG\M$KA@:>=X.=I0M;-3<JJ>6K4RFER,EM:,K8<(
M18/JD,/'S<T5'.+2O5[B%=>VBQ7DM,%JX'0.U1Z#JK=@=TL%-4?DE5/ IT8:
MN(>IX'523-H*MYS$"J>4=/G(-KL+D7C 9VNR!2FW"BETH&7)(KZ/:1KF97'>
M#MG#(_GD3,4*W]98/LVH2C],6IK>D"46B+J^D 0TOCUPMNNS@89N)6HMF!\F
MC0S"IY\TF!+0K7L7\0.+LKQ[W8.UQ&?:3+C)Z6BE86=88E1!'=C"N.%O4.K.
M3VR>M\HO*-^&Y8LCY8=MG*0[ZD& BO;[J'X*..,N,X:J;7ZSZY1<LA"C/=C-
MU-9%<'C^,P'<N!C25R5,TV3=?SV"%'NHL&.S8"+/_8WRRQ4#SFOI5*)]5E<6
MV Y#MPMA0545QOJIL"_,ZB)ZUQ0Q#A+F2>VDKI]D=$@RC(2?.]&RBM_P?\!4
MU"EK(ON^7.H0)^>7K^%W98%I6A:*H&>:NU)+33;RZH(4^U+BN]+HW4E="(]L
MFOJV!KE2684!-,4-<>XO65RC75"LT7\*3+<N=8'JU8*W'Q3-D]1U*)9E9,1Z
MR+A"^..S'2?@ )UK'(//BIX"1?;;*S?QLN!XN>->?\:7Y$.SU],.VP]#EY?"
M_CR8_[TU\L_%=*1]R1,-,%0G03R$_DT&&U_\:V\F2@\DMD_ NFH6N;.V4ZS>
M#X8X"#V#TR>^)[90SZ:)C9U]G,MP%8H<U8Z;MFC_G05GRK?_!-GKL7:6+]_^
MGB_-"Q9P-WDZL,=WM[%):"DK)K\A%,N,C+'5-'4M];1YB#VPC>'$*VZ@:OCS
MSJ8MSY\"ND;;J .25OS\VU1>L#,W3Y0 9_I1+S.\K$H_CMJB/:AQNL5/$W"'
MM^X7GW@=XNS,K4)/ 5PD!G![A0+UJ8]6''AG$52MI0/CX<PA+GO!:F.:$62Q
M7MO%OW;LX3(XXG[/41\">6<SI(M^2O^N\#T%C!K7C"_528.\IT[3]D$9E0P;
MCGP%P1&>4>4G+\LQD&=.%8F%/UUVONUK5(07N,D\]-H) QAON&?DAAMLL^&$
MI",QIC6IOCB[U[3I>$,##TY38%ON']>Q]7L4IC\8=H'C. ..8P])HB:^O*&\
MSTO[!.D'2TX&?R+/1K4-Y P/#==0TWW:.29O]QHW%D M(SNXAI<'E8E/V;'(
M*7#QUC%2]%_]PA9:&^=YHWE TSLW ZKX>+$Y6JU8:\4\[459Q8.C&Q2[4V@1
M,61CZ02T1X)^OD2U5)E92[&8O].H^P:EX\(X=_P @;P)M0^PNI2PH;GXS"0N
MX-*=T*?3K?>SN,6X#F>K:Y,+A')$5=4N[:63JG;33WBYCC;?CY;?@W^R/41.
M6 @9+),D;3-QGV_*EZ'0(1)TPBMV6[K^EL"\QC=VJ8B\ZP)I)??.%(GJ<=R@
M<<J"=,&WY%QE6%[?3C/*M;,2H#8%ZC&H#FFK/>17:GW+R+\?(]@] T%JT+6#
M?5MM17(*%"8O61@"#Y 3FQ0HC/=G#Z>"8F4P.IE. =.M^,4)\/JT9ZCISQOP
MK.(/WX;>-#;'W![_+7]Q*F+^CX32QIG2J?GO\ZMB8YIU1T:=U QHI1^\A[\D
M*:V]HSBL35QXVU+MX;57Y]BV0%(B_(M@\4L5"7!I]O'G<Y3'4+_DH4$O=/LC
M828XEN-'BD%RWNE4X<:J-NA>O$>&'669S34;CH'95][A7":=H]KVV^P,PZJ"
M)*_5>%-M(1Z_]'#\XL#\\-RQ%QSLO3VP7 <F ,=$D/O.%R]MO%PCV<(\!#MB
MD*:^A;%? !'Y0E,TK/>>18<*QKNB&/(4_\<I<.$!FC77].7GUO"&%<_X)$U,
M';)"),4X[;L%/.?3I_K"=R$MZ]Y<[X" )02+\92D0!I 15HL^7K62'ZGML@+
M/2Z<P'31O[R[!]2_G#M]J%J+)XV+R0OF3L]2R L,#HWO"Q_F@F&8;/][I5E3
M:'H9M]'ARV)AC+]Q'55O\$%J&@/XO*G+-*'_N,AO.BDV0:-AVV">>$=N<:4[
M=._6+;NG?O,$U/3FA:,']FYHV)L7GG^$RB2Y;]6W!(W.)/7UE.W6UAKQ_+1T
M0[!C8VB"F^!R;Y<H/RFNJ8;2 ^P%_9 Y_,7WF\+D <TL>3D6)Q$[EU92D9@-
MP;0WR%G(G@J\:5LRG7SXS61MU40J/R[$0;[7'ZML8"3W&,_TGL;TX)DKB!O\
MXOG0=SE_TGQ8_ 9J-/)D>!'YYP$PO52[WGCLE89QCAO;M\++@N51XF^/&\%B
M?R_Z+B[%_K/57YY68PR+-YE+"LOTA]$?/DE+LK?MOSQ9EP3(9CXV0^=MH>6]
M[AJH]P*E? _@-14];?*&4/K/=AS<JEPF.>PR,4;"==I,X=$7HU5TSE86'E&E
M#RFT&I3]$J7Y0KR^+TQ5I"[UU]@0]6?PYMI"OUT$U5"C^ER=(1@PIT"0^_GS
M=V_(P1A;UN-+[.3XH,_6]G%^DS%O1/S+/Z265^<@\[0K-T.CI7M(?$W&N<$4
M8(E1Z8_(H-H4T=U_B9>UA79W/;8$85MOH V4JU?Q.?G0/"RLU9F^QA@:7CX\
M:%29=U+16Q'YVCV=6BZ\0A4SC^PM>]E:4Z9'S65=MVJ;Q'R;[4Z@L=B*J1G)
MC^BSY41X6J'%Y?*8F<UF@G>GP*0 A]7HW)*)3P0&?O2D)6B9CR ,:WFCO=Z=
M@Z'BP9OL=F"0LKYV]$M)V[G.CZT^#)%Y+UD-F0Z>SZ(%+5'MA2>P+J'&Z47M
MO7 ?BW^QKDO92(9JGYBS:'7&GQ6=QJ^UX*#%;: .7Y\"XV<HP7@*%$2>+ (S
MC&L8'Z$0L!+N@X1(8V^PGO'F6>5#J0/]6/*6M(T#BQ5GRTO@9WP"/KT'_\L^
MQ.6.H-IK4#6P+T5@B5Z0+U^HF-A830/%J?M9CE@Z@+JO0UE]._%LBJANQ/AL
MAB@6(AX HC#-3K$2.^QK&?4!:23&AV\! ;FHPDLW(:ZP%OH%EQO->L5VJ*#5
MA=>HOO/D2(<D)YBR9S;^71W<1; U2PQK,E?O^.\_,?/GNFLO@NU!2=;HZ/CU
M3!'" 1D+XE69;.OP (O=W@7EW@4$S4B!*HVV#K\I7SK!6WL1L<&(4"FN@1H^
MZ-?ND+5S"CS&2I/U\LB+O$G9]SRQ(?:'.@ [$2"H/W#1;OE2.+%:8:P.26IC
MR!IYR= 8,GU]-@T>>T\]VVV\ACVK#PW,\T'LW^#3Z+=EV"@.!SZ!T5:WWM6B
M]>3=ET;UKP[<RVS>5^H%T#ZA3C',> A(S1A"O*^VQS;5:/(V%SHVJ06;/.:N
MH6$15B)X@R!]2X^  GJ]OQ\D4Q&-#^KWX*[R':-:-<N[K_P1/J[GP!$+Z;#U
M4>K"C!_0!:3N#%'%OH:6"P+TEIO?'3'#XLQ=)IEH2?)(JK%SR=8BS%-O[F=8
MM#Z.Z!@B-/8NX^@'_QQX?@VM%\5T)RQ00PEP&ZX,T9M)O'A@A@6P]@[$F]RH
MQVWU+$FZ9F\#$1SV8B]+76:2&A].UB:F> ?$^<>->8-5U5D?#4UO!?2^;0\5
M721#/QS,:; CJB4--@DS3+H!60+UZ*'@\6991)%:P?8$5?=NCEU4D#[( )S*
M_?@ JJ=H5CHDW5VZ.U0#5KKOS3X;A46H3F%Z$1Q^$B&.+47T3&$;^D-VGKO&
M,.Y"FRKLG.UV%C@@T(L"UA;-*6XF2:NA3BJ)G./;](U*@'=1$GS&(?)JN)I3
MQKCL_+@9!<OV=5J.MU=OV=;3D0%/V\2#!VAJ HQL_WQP =E6>M68F?@-:'A2
M9+#UFR15K3Y?B,D%+Y]5;N<P9$\!6?#B=02'K7OR!]0 7#7I\G2*MX/ERYGV
MDX_J/(K@L+@8-3 D=J]I\!T:*]W-&+F-5B^L+* O5 *X  HR,+HHQK350O'7
MHZ"'.!ZWR<_Y)LM&]XL1V?RL^5V =T:?T,?V:'LO,?+JUU!6B&70K\^E,4XG
M0(NXOR&6$5 ]!:[OS+AC/ER[!O;V>GFR9_7[>XK1R#!YSKK. U:,#Z^I9N$"
M@LF?HR3^*V4I 76]8Q] HFX*9!0B]A@<GXNJ8OGV?;:.PBU?J(&^AE(WQXM^
M;UKBCU);,RM#0WKT>H@H-?YXJ?.\$& MP=Y8:_:\5LU7]'D;>QB%5N$1@\R&
MJ-:2G*@59/0X7;XC6T%03]T9>?0TEKM8B0!];3L<(O#!6_[A'CO,G>+,6.AU
MTPK?9/%;A-&PB%\=9*F_P+STZ\:,S15ZWX=+U4DO[6%J$,""!H+H[I(T]P24
MFT+A'09,D:]7>M:XK64KQ(:VS3JI9'/IYV?%'-]2<H63@+>2\I-H9E5>BFAX
M9N2Q%H(E^NRM^CBF#5:7/4RMBV#S?Y%K\=TB^)Y#^1!US?6S]-9 ,+'\BHKS
M!_6%<3'*=<KML6WU5UY;WQP 0^1G0XC7UL7-H3LX[_OD2O=>5>KP?PAGS S0
M2J=BU.U9S6V,5U(>-N/.[G,W*_2=>=6+)JZUR.H+!S.;AO@\F9%.,^$]%M#8
MM %9*?I.T9N;)<M$;F[[_JM7N'A8MM5OA(XA0,<%JM;Q<F@8+FE3CGZ9_D)1
MN(U=.W-="L!.S$<0_";GYETF,HCC;!DXK#"KMKYA46%]<[%4SCH[MF>.:L4W
MLH?!&M&U[Z29VAF9E.VQ9"'(!;C3E4&(II@%+RLM&A-4J8F1-\T\L]_FUP0[
M)I5&M1#SO9;9("QUYQL8 8I_/JAV?RF^S^(V81BMFVFLC1AD#K4>:8ER*<Q>
M7WDV:-MDR!.QT_AG"G(UA'U^R"VL)XEE<2#8R+&FJ8;/BR6KY "N#9Q]6$$A
M"=5LBCTL-@HXF[7/*/RPQW#__#T<W3C'[SB\?&5@.YU"@=KD\T/B[W2!$3NU
MJ@#[55MHVL;E9[A"QMCL:2PL^11XYK/%Z5+8TT&2?Y;"1)KB5X(_B=U]"N3#
M1^R$M@=#KVE<&"Z;;_/I(7ES"C3)>9^T88L1[^/[>BZA U-W2G[U-18H_^(5
M\D?JIHZ-GO>*A=Q%8(<.,M<Y>?21_TWX1^R$]HN,LG"F.P%&%9%@(L@8,Q?-
M[TE()/>>H__>=P:634/SGBX6L%)Q"'9*Y'D_1].;,A^]'D*W&^];.J:Y0J=W
M%"A52Z]_.&>%@)5E<W&406;S5.N^RN86QONS5K]IV[EO9;HFFW\*5%W]>&.;
M*9W*=>LFS4(NG[&0RB6R#Z")_EL\,X[E\U[=OU*3^5"N=F28T%FQ4.)5HN ;
MXP+B(O=,M.RN-O6X6-@-B2L5QW*YV@^6[^N)RN TRWQ^UYF;[D$K;U3T^.WY
MH.CJ'L?QR2&>.TF-Z0N,X@E+ET(1'.6X%8Y8!V@Y("BJ&FW OT@J7W;(!TWH
M/Q8M+8FFNG[,94110S_SD,.,9=O>3DG.@ 78NM^[QC3]R?Y;R7I+G^1U1\-#
M8^1/906T_H=V=:#P_EW*%$5=9=^D<B4ZH%-'C5E_U)CQK=?C^XFI])>U<QYO
M/R.XIFP+[4*5"E^/O%J(1/1A,:NR[<H SN(,L;3(&,_0O_^']_*;\_=>F>NN
MG\SZ3QMG]#E8J0,?UL>>#:IQQ:EVKED0_0YB%:. 50$6,68;<WTO__7XL_AA
MO])[!F-L)?&?1NZE!\8,5MH!T!Q!0+=?;*AXBO_#PQ*L\E:S,8W49K/H"9CX
M7!R@$WL6&.],=\(%I.EG,)&"03Z\,9Q[1'Q*EJ%$P!T[>0X-O4NQCDXW8.D
M)* ') 1T<%N.J2^9%$E3D;]K?*;>60>;UU?"*IP=HLZ[C/]Y4_KP(MN2B?9J
M93:J@?<@8'PYI!\50(0_S_^F7.<6>37(1S&<]6V@*O<9_KLF.063RJQ>[YA7
M,NB7E5,83NZ\^;X"5OT;FAZ\RK&\/4["]U%MMI99H;^R#XPU_=\3]<"6PV^-
MH&^KDWT8YE)%I+:F\^>&U?>3W0?D2COIE)3:S5IL=4 46)+F5&I)./2-<VQX
MDISB0#L!Y[-X3/P8)8IY;.J?1A]V\3Q(-MYE^%#H@>2()$ G.?\FO7!'.F'M
M<\U'\V.DQ?#Z,"5O?JJ PHJ!G7RNRGLJ1!U8VML4I>]3LV?1G _/I2Z<IY@K
M][&(Y6:]IR/R 2O3M/O +$/*_&V*L;,D4SK17P^54M,,:?@\Y]9SEC$Z^9U\
M:;]A!=/C<*FL["H7UUP]\LRST)R_/[KO-G[I7=+>Y\W8%*J!GK[SH',X?&05
MO*N>A%M4))(KVN9/$Y)5E_M=M26H'WMK\<'&F0H9UK ^UJ(G\ORZH*?[,P(I
MYG1J.+ZC;BSRZMN=A.#5*QZBP8;8I;] %1K7?RS+, ZO_./=(J+(HT?8,)#_
M&G<]*=JG%X0-@MR4TLN9 HFC)%(%P@Y!8X4WQBA-%L"Q/5D+6<UX%<HC.EN
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MA*FA5G%?NOV*Z:,2<>)9\/Q#]^H *K(C'*'W]\"8.ZKCKB$4-73"GB^APP&
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M,C=F?(AXNCO6&G3P(GA<;FQ,UFA1_CX-VL\;EL 9Y>WDDC@S/CU;D)CN]"P
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ME>4=\-89A1",,([QIQQ\\@GHB!UT-P'Y"%VFGRP-#"G^_'6:UE$.'NB[?@I
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MO<LDB,=R0U_,Y GM:=?[_ Q_V;:^TY?O4_XN'O.G'PM(<G.)#&MK47Z+V>Q
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M4@\'B)V[ =I.4SN?;U3A!2U\:MOG)C_?II1<UAY"!(W1IOIQ1VLF%8AUW+$
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M2/H<,6R1$$S.#R5)#K'Y'H>1%5'Q/6=RRC;$HFQ!SQO^M%QJ]08,N9E '2"
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MB7#R>LZ-GG>PW\%M5](&S<EN*K$.Q=/ATEJA#D9A04)/5X,W@T+= P&GS%M
MK1AI';!"U<9:'W609)M;]*)P5F;BV '?UJSC@+30Y$ &:1PSG?8_G'>/F6I#
M<(&8Y6XXUQWJ%YY">ZI;!P.!B%WU2,-8?;6@/NHK0C7J:\D0LD\:NC.9G4K4
M*25Q7LK%4")#/GXHPO(MD(;\_%H#,7]P-ST;FX<72PZQ)"!WIR#K;F@ D27-
M+%MGM?466N+P%*'QC6^GVB'Q\^I2D4W_II6(:5)KVL?J1EAQXB]EX5-:M5;]
MZ!^()>WM?L4K.8MUE?&#;3(:<K$BEC;==!W,^A4KS'PEL!^QKB]H'60*&-[D
MUBB:83TH"I TKGG,]INR),I^%P6A =KN_%VY! 4RM=KJ(:"1_J%3/'9*+J^P
ME_9&3 GL#OT3?J5>3!,FIUS*68J4NHSO&:D"N%8S!M(\* 9-(4AY<NB:"'I;
M 6K;Q:K@&?:O%22QT9G4.)@AT89S2*<)C9S++VZ]P :93.>!5=\D%7 +8!H+
M^RV$)K0&KIR:XCYF2,&2<Q_?I10VK55C_@7XIGW\O'<FS/B^<4G4>E\&Z,RB
M=B4R]3VN2 _\I7T:(RMHQ>"NR#]>KDEH22RNV;2F(8OR#&D\CC_W?:O'=H);
M+/.K5NSV8IE-2AR^GZX+9$%V6A6C<OP7'_[16,(W@058*;.FU++R&X : ?LW
M\R&&BL^("S[%2>-P0D@-@(\X%S#J&@#-;EW\84@T,N!^)5W,:="QD1[CT1SR
MJ,JEU]#"2^E\R-6I><I#E$G29&*>P+@*/@CEN#D(QIJC%MOD_0 <]^Y2:VGJ
MP)'^!=$G(SF"]?4_EG+'8+&88&1$6!Q"4)KXGF4QBHB++"UO*SO'^EX-J[+B
MTL+$*] =A%E^$U#MU9*Y&4IL"O&,$/CYSDK8%QZ31ZMP)5H$;Y%,-K4^*Q9-
M*2YDB9LU!R>;T\?9]M?$#_!'/$T3<'\*&XYBK#0]DG-^9Y2[I$:UB8,Z6[,;
M2O>KLYZ] 'LL4:MOO^94=PGD1OIZRBP,+;_2%OS&WE.RKB=9\[O[(/Z&_<;O
M] <5,1'.N3XOX>QHKF *Q6V6DZ5D6U!O>J+*^GBY#TK,Y]&]PDA:T$;BAF3C
ML#-_B9 ?X+^P]]91<7U/OFCC#H'0N 77$*1Q#<%=&I<$IQMW#9( 20?7T&AP
M:]P)%MP=@KL%">Z!RW=^,W/O6W=FWKWOK3N_67?]_JC3:U6?KJJSNVK7I\X^
MNXZ+AOCW2?\%[UQ>DV'.1M,$M( %XO2>E&?>QFR[T+?2J.\LY18?$B;L4Q1E
M(9K*BB]<=EYB72!PA,H.R[I.7F#B.[-O5E"FFH':=4V]2P]%3;RY'T;IV50V
MX'F4?&Q3JM3OO^H9MVK-_"+'5\8^+Q&2&'6,O<75PW-"[%T*-(^Q]\F_4YW\
M;CNYXF/\3(U]2%TF^UM=ZFBHV93.U/_Q3?\Z@@+C2W):4I@2TR!BI!'5-64?
M6KJ*>\AT<C@"H2_ *X^P'Y<BF[Q^/V\G^#8ZS[2RRDCHDHW1;[J)%?F?=BM*
MF6> W@;(.M]&_Q@6.-+:-7'UH]+[-F[X.O?;<96Q3KW8G?JU2?Y\'_E@G;A/
MV7RO6OWD&J$T12$*%2ZXB4TMM^#DE:;R.TS<5U(,RPU+7FN7Z24#$S'@U/AZ
MV,%N'OD _@DES"_#+\>?IVKB@K%9UW5P[+G1[<K'0P]$MNM/, IL=[?8(W]I
M@>BC5N70K@1>U5A9Q#%*0X2;"8A89T!-[<".J5)9>S)[ZM 0JW6/K$R-.ZS)
M6 _G)>66<-DVS*6(M829A?B*KJ8V:F3IQ6<I,!F5SKFFAJ:RUB37A;)NR)JT
M[F_8ZE'K\[TS8W)@+HHX4KEB=DVH0>>:Y0"V45I^RJHJGWH]S\=%!09./AVS
MM;JO5\AF7Y^Y=7OQ:QX6^"T*,_PL*9AC"LWNH/$L5YGQ;%XK$??DJL?IVY5"
M-+'KP+UDJFJC>9P^^OJD2=SP9*247<E/O)O@C%M^">,QY >KE6XCF%E_\/P<
MF3J'JNH^I^Z"N*U0S1+Z'>>H-214U03Y49S#6/\RY^T::6.'72:N^R ;BL1V
MK]B9"0*10.*"N1:I0R -JY1EFTIX8,9FL^=5F-&?HT+.??O!6*W^>$5MFMD.
M?=-:LO,O@[&>1MO"16OQ;)AOS3K=AK<YV9YF!U00N(HG<$['KL/:WE[V U9@
MF./5R)[F1^9+$';HSCK'U7$3I09UA7$(LK!X:BG:$VO*ODC@/N\K#V,<YNU4
M".L>E,^ *L$ [,)K!NL\#:M3"1KHSZ\ATU\S?!!&RN":+^;N)<0::'C:"G73
MB'G*CZ@TUV4D@1_G_9-IWOH 1ES@YW .!7":!(G*-W)'UUNG$/XED>EU_4Y2
MD]R*TO-KI_Q>]_BRU;XYX**F?&VF\V:T.8>M['<<LMWLRHM' ,X<M-+<O1.I
M [G>MDC+;@DO=SIEFV4-&)SL><.3:7A.+:H>]:.;*\:_^)M/2<W3>._D?LU!
MHXX2-3U&SRQ5L*0KH3TZ,?"DQ:Y9L)-I%GU[)5PNFPTOU^1@9E'C6NX%^:T.
MBVQW<[UY!U9S1<>3S?:F[Y5KLEOKM]@W 1.WE!Y"HQ--MQTK<WM+C'R(B(@C
MJ/0$[8YW5&N;E4,7#=2> @*F^9<+XK,U5\9TO?AL80KC4<^&A42H>G4*&&Y:
MJK4)B 0/NQ+>,T_.;/CX8(ZJS.9I&O;4K)>FO"3TK4Z1P)F4@]=!R>9%5ZV+
M]E8(#OCW.UP('=JWF]G9_ SF9_$5$D!<(! E<UU,>NDK%^.6\LY(@9DCT2?E
M^'+0^NP$B!)[_P>87VPG42=13POQ6YT$30V-ITEAWXTPLHD"#@-TFN$M< ;W
MN.)#S<D^:GZD1E.4!0"5'@&J8=<$K]S/2VHTT(FN(7/ZS_0)U:>_BZ,C++GR
MN>K)UNL*\U/5=E6--_@? >%PA\CYD=1Z;H1'W )G4C[^Z\2%6YUSL))K?//;
M[*1>W$< 7LULPYG:_=&2B4=HA"?)%U0S#U]P$VNBHK(G$W&=L"JT0\!W>E)5
MV*%KNWR7AK)V3#-I1?+5#JA1%C\7OM4:/%#N7&IBTZDK,F#NW6[O@5Q76*1:
MX"X0OWC&]D!D=ZK<(!9D,U-7$QWN:PT?V%*N>#@>]G37+6N1>P(7:7JO^4/I
MOPS*8C?T(C>*&[7K4B#.EI2;W3R>W'V$+\%D7(WMR-+6%Z\NW/Y%D#,Z+]04
MQB:PT(SZKRT&R7Q[0VO^&#_GE^(Y(FG8S_SH2=1G8"I]#MJKT:U "-GW.7]9
MHO$I\.><=- G??GS0KAL5GW"@?^GKA"]!F"_'MXBRS:==F6A ?O)+ISUM^WG
ME_2YV=6L:Q>!8;?6.0Q"N+F/ "_84-VU<D$GJ_63([B9)LO:ETPIS;Z8_+)K
MN2=!4SG!@.-$L>G% *\LMAO_Y1F&A84=P'X!S.1K&:BJC:*?7>M)=?"BVF]V
M%9#U-)4BV69:M0!R$6\)*WL^30LN>BOXYW=W12P)C3;"H$D[$6,1<'8'YHV.
M>?GXFV(EI>'/LBSN3Y<K+?WW:&@+=K0WSV!&0U<X+]'1P$B!/N! PWT$"C5'
MW(RY-MD*G#Z^C6TOMSO1?00<I A04>=_%]G&B+/8%E +@# .[Y;E6<E;+?N=
M%TK;ZE>[Z3INGM)A\DP$4XC7;?^2E6Y4_#FRF,'6C.I(  E,#'&92(\<7]5
M^8"E/L#FLG4*870A'1"9BNP;U'YFV=]7\">MCD\UVC5B _95!;#HI\$L_MQ\
MU3U?F;ZP!RH2H%'3:NA[JS-F-"Q!WD1A7K%O&Y3I1\.NW/!%8(N\)&3<$Q"8
MKE2WK]2I-M2>8KUP"K/Z[M;G RPOBB4J:Q>Y!0^+L$9(+SSA*L,$%7*'^_@F
MN=XZNVI"1G(I;YK$G,*?E"45.O=!MY/;^O1U)+N\U]T26CX+; 9[QXO2:?[7
M"#_Z&3+4M^!T%O735?PEA1(MP]+R^'GXFT8!]2+&>D/%&!(RE&^EZKCS./OK
MU7Q41,)E/[JZ+AUPVUR_U4X><N;S&5:,^* 5,M]2)-WB"NB%;&8F.[F!+P1#
MH)%]&#33XM-7J4XUSYLJ80T!/2E,Z<%)*<$4\9J@GNX"(^',WQI\E!HSD37-
MGO'7X&:.WB8IS]A,R'BR2GULO<AV1FPW.C(WK1**]%B/5'_1",\'%9OU[$5;
MI(F&2%<T&^7" _NW#^"L=TG&+R<_K!#?N#=\4^V.C<ZB&^/"KC#V*:8H[V3M
M80\F[/GN IZYT#S& SCZV$K;8X\D:[Y)'>P1/B]"E(MU?% &)?#>[R!04!OP
M7XE.*%)L,.).$JT,.A( [>4PMX,HD1V,86'KNPP.8N!I)#0;2 5Z4)](E"WR
MFV0.>.21$O*WIKL9U:1"Q'.V7]G%B'UC-:EA)'.Y^M3#=?"6XK#$Y1V47<#-
M\/)985=\;'6+0=,8UT5PZW#8UB, \@5#I+%OP5C!RMR'O+C/ZQ< MJ?7.3E/
M1(7R8;Z:F_^R/A DAWF1.ZC*:U04(2TG$JQC8_;B8TND,5\O/V!PR@7L1.DO
MR4*?UP\D$P"=N,/VIF@@'#,NCD%N4;6H@MR4#@P?#O70L3=/:Y@%*;$@&0X5
M&QC 3!_4V %:<N0Z!T-!7<(+X@B92GF4TWREL3SL/_G/1-?+C.JZ>7BC![Y!
M#=[&\ =ZEG;IRB$UC:&KY5!VE7:VZ$XZXM6H\D<,^;2+S<H7SG$L'!EN[= 3
M2>]-%'-_2U18<D/-H&^TMC0E/@&OODRFM77UW<Z",WN9L5H^WS-*,G1*?A:W
M$0JR1LN=0ORF)R1UGI[Q-E(PTKTS#N=(BTB;H<E<NS.Z.J-?ZA6C.#P79]:5
MM.D@+,?@QSVRMS)PF"I0 1>'3"P:O7[F"11'_GLWA_@W";;MXH2BY,NEK.,1
M>(.N>IY?:^[+$",A##?ZK(5C\%5N01$'[G7/K-=VMN7R"/"G2&WO*ZV?TP@,
M,(F.I[W"V#+A2Q123D[X09B6\][BTR/@X\#5@W^9Y.\/\O_#CP[OOSX"&B39
MQ?[V$6U'L,4Q-WH3Q?#PG&/EYK3A$="*1WN<8OH(&$WL_7,,K3^U>%B]+_S;
M\3+F0>/2[>%_5;AXKF2">-HCX.NZY!IORR,@DR/Z;G7\$8"5^/O^QCAP!;TY
MD%GRB& @^F_')U,(;"2WA:*O5<H#=P8V'J[Y W]8^3T")/1HKSK*5OJC[SZ<
MYOSM."]S(_,/L_]A]C_,_H?9_[[9.)FTPU:U95PL8$9\/>"BW>R7 -OX0KI7
M&/ -"<;L2,YG6?[[)I+ADIN$!'<?;L Z$28@_E)502;-[F;XN::L&_5_@?<K
M_+\2!MK&L*<RV??0W:ZHQ,U3=<8X)_'],0E&O+/( B$+8V A7LQ2B;"X6I,=
M:R*37,KI$AIC,M+SMR#7@&\&>@ASE2HG<8@R/_"^J[TP?4B2&R'K\/*'(+@
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M/HQMQU1HQDG=P@&&;"'Z_>VQ6)<0&OT-<B_-BZ?IEQWSZ'!+2%'CZ6SUV3P
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M\0AP#F3?2SXF+1JEW> SA;&6663]O;/8?YCA,@IBK5Z@,+*5)/3KB-ECKL(
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M_K\3P[.L^/D@DIPD2QCOB#.@C-+T.A@_U76FT61Z<'"=^O6?RYX=*-6?HRG
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M.O>@<]Q:Z5D732CQ8KHVNQG#%.2M8*H<\=(FYF82?REW;*^3U!<B&S?K.>A
M"OG JO.1CCG26H[C2)V3G*_!]JBAAI^Y>F$LSD@K./=7SB1MV^45*!JTI'[Y
MVE;2T6Z=BS<&TC=9H:K-W;JK!'3+.?,UW$JAX2*Y%8KM_C['H N(AG+:_;2$
M?3JT[<A3'SG#@X@5MIYK7)U>C/]I-WS<5MJ7-GZ,'* 9Z@+-AD<2PT(K60![
M=0<I=34*]M\-Q6$MAK<P:^\,+H1$)4ZU246SZ5^-0_.?-G'YOR:]R.3.K*4X
MB-FG0DJ'^?7M+'(:=\Z!N_3MT%7_!^!-44;;;9 &'NHAB&_[;W!GG DDA5!7
MK:^I7\N7T58<D>D^+-:\K@U*W6IYU=KHYJ/D'(U$&=_MKX'EVO^X2078]"Z<
M^N0%UR]?LS0\&>P^<@3?[_"D4-$2;C94I+!H)OWV)!EY^0^ _6AT-OH-LVRS
M_/@(''#A3Q\.WQD5/>U?*[H_#6(*K;M%BK'O:72!_'X,6)^O1=?6<5W^JX"T
M W-/B<7"1_0 OK%;UFM[<N0H'QWTH_VZ!C>[]=6-! &-_;F.#VV+7VX^6^AR
MR*!"G*]#Q^=V&*W<;R<KO4\M?!MH#+0CK3JENO"ZY8_Q0^]N1[Y&"^F<(36W
M46Y3L1,(R&Y+CCTK &DS^)'6<I)LV<\HQZLHR%3O5.C45"W1D\S=2!'AO48B
MI%#K&$1DZ=<6EU+E]IG56FQHQVDB'5*6YKX<IL#$N'LW>_\<E9^0'/H2PBQ*
M&\[<US^R,>03D9'1JKRD4&V?KOK"*N6\]36O9RE69BQ3 !)PVDLBIA6YU>[#
M*4GQ' ('/$[^T>\6-J0J[=L#>:]:4&VLD7J<^-7:^7,)Y'LN1K03=F@!$J9$
M:F:*J?W &K+.[7U1=?[PS0LW$B6<]NUORH^P+=T'.^".+5\(5'".R80'0'6(
MW6EO:;L9-3^UUTY)*REQLQ$> 9E:*1P9CN7&Q4;B\CN3;ST#!-.?VQTX86HO
M[W((OJ-XIS7)POOY',RZ6?B@R#/;61OTC+VA$G9]:^@'2VF'UB?<]>2,%BZY
MK-\M\B&GBA8N:R^12Q0JR6%EXYTC1/8KOC;_*#8\8&J4B,B1R\6JC>7$RS$.
MR?W6XEI3/[0-RY/2>E$^0Q D%G'OXB4HJ,8W5V-#O>V/SDD_E"+1:PX3R@D\
MN^A[A]+&LM=3TL=VLVNBO<S$128-RW),]8A7EOG8=>=7?0[91AD_H]U\_-:&
M8&%<'.KZWVGM\JQG#;V!+>^47$$5"GNP#CG%JE4,6_304]A80X_FPK[%A5C\
MREW  G8Q$E3E=\"2'[*&;!8KIFOV$,/^M2+N &JYGNG0G_'7-GAL;@G@N(.F
M0?/3J,E?^G%C[ML*#1X?=?P5D/9G-%$$%7S90NIWF$Q4CTO+GU'DM^H(3&;+
M*KAI6KZ^6 I?TRV=]6GQ3>;<WD$059I>QE@N>Z.]V321!&P5L[(N0,I6RR0I
M=C"=R[]IVV,IEP43TJ(XM#Z;;)0CID:6!]<P,T_CW%WKE# I:1.9:BV<V7G(
M;%CWAQC70\WJ$H]LMXR?"X78Q_* E#1SBZQ'^.>F@R+I(@4\S-A4?K,.KVNE
M[U?U24R:;N:8NWK[OE6Y^EO)?6JJ6W'E8O.$XQ E?]RFGY$K.0A\[EN9X/IZ
M!.<(]Q<:I7%O/K2_^K-E&Z [!6E8'$1%WU&@)Z*>Q\EJP=CD_!:H:)Q*WE1V
M=DFYR+#3*9KL;.X*H)IMA'4?\2\F!;ZT!+IP]<=8?Z\(Y.9Z_<LB!\:3%/OB
MW,JYG32,,WMYAV%D^DZ-+KW+6N?+8,J6N/5\D[ICS2K>%R?R,L>%+N,M/'<H
M_VMK-=CZ^FU$D.#:B>"RD=Z2/-Y*H,:5R> IIY"2.)TZU._206$]PA$Z<U4:
M7_]#'U2NS'ZQ4%S[0F5!C$>-C8U<[>I?L<Y[=A: %$DF3S1U(QX3)2Q5X[=L
M9<)>F[P\S&;=:7P!?(D"FB0QN7+W47W\\-!GKL*N[,40(*1:=\G[0:E?BVV?
M&JC<HFV"WAGRB(/4X?\'M7;_'7@ #^VX)DSQ!NKI?.S0KAGH*!J7$D6P?!I4
MRLCV8>]^*>1Q]-E&]'$@Z6_I/=EAE>.BUOPA>I]+@V@SET$R++AKB+*3IT6Q
M%R[!#+,\4U:;8 1\#!5&..B9L(FNUH).WKF^V/ 6>#1!KQJ_,5PG<B'I47^3
MKS %56BP@XW5.NX@@BQ='_-MHGR-N&ZXT5YY[U<4V\(X$LBP]O:/-'3K"ZJ>
M9M(^U;9GC2QIQ'BOODKVY>F"AR\&E+V8(H>DZ<X$?Z6UZ\/OS(SQW=4FZWV-
MTS]V;E]TJ50Y3*V%R.FV;P5.G"*!LOB;Q?WJ@^Y;U \X2O)>QF=79:N\I#_"
MLAUUNC#:W>[A_?+T5ZGAZ^83D+]NXKA;R, Y77.1Z/0E%L@YV+TQ[3PO<M+[
MH&I:N;5RW)P?^M;>**%F:.L]XW1$P%'[7[\ /$*^035:VZ37H4/Z_G,]4?%&
MD9_M61Z1"VA?_G7\@F')-/9GZ-'9BJ^(&+:R@_KM90QTLE?WRTHP2PXO4H&:
M=L4*;_X/(/:MM>D_@(=/IM#KSQV.Q%1G^;;D*^YE,AUI5MC)$:-\[1("%;9:
M1+F6-7W7WG; 3VH8X^N3M7-6E<Q5G0=DOHH6O#1_:[#Z)< 8-),QN0NS3/JJ
M%X2 T+-Y\LX/%OCBK/BV7K\U"P&R-9.7U]TK"JZ26.L,,CWA0 ?-5?AGH2C$
MQ*D4J@LD#40[S?5C!)?%GDSBI:>(F@UID?[C"I79]H/#YJ:Y?EW5#(9<,C=/
M\[6*LS_/9PRP$WS((FI'?<XUX5V> 8[>A[!E"\DZ]QNT,P,\-WV>G5<DR-!#
MH<:7I=(3)*O)IQ7!X3VZJR5($[YCKA6%-!+ "5/*>$NE?VC9QD&A[R45K9KM
M"6Y")1!VL7HH:TH&CH4JQAC(NI'[PB-3Y^U(AH4EF!\?J/?6CNF4+U@'/GO&
M?X72#2VN:-Y^M^\MC]%_HH!W]NC@@Q$V<*DH9=4GK#V\TU!.YC?")?"K]%W#
MYP\,8?<79?+5L#"N7#/UV@&N"XA"97C55*"@4>B..=^2.\J^6AM\^$<PB+2W
M,SMFA+ DZ;'.,5R[Z2@C%Y':_'8UT7P_5/%P3-W^1V*UKH64!,\R(6>G^T&*
M>WN&:\$8^'OJ$UO<^Q2FC, HC]8Z/9/UTSB=:5<]N'3&$#"C[/^+*;'8SXR'
M]HLU6[^C9;]49+(8D>E2#P5O8.XZSIWRSONAPB\^\.U_PR2(WFZY1WFYV?W1
M:.[.X8$KV#2/W.D^X&,<; %H14/'_K(MKQF*3'/?%\Q\HGC2V.M)EB>M?EL<
M^$6Q!?$DQ]<J<V_WC73L1B,/IJ)9QI@1#(6U:M2G5&:[CM:OI3VTL=NPM[MA
M4$Z7G4-'@. ULJ>N1N&K/Q17A4MZST.*<TORS 9O0M9YIB>AHN]X;;B%=3T5
M_;@ G_ZB(=F;HT8P!Z-%^$3ODJ]/VTYOUED3B5C$7M.7GV_=1?N33O83&6.F
M9^8L=JYT_&!VQ=#1C.TH]'ZUH6KOQQ%.$:^:-OUPO@_CS$T''^>Z?<6'[]FO
MR+2LX@&:TU_E\7:5CX&/A.#7BDCAY"?T]<_*7P[!FDJO2C_^P91'A\[*9-7F
M<IHX+..?UH"Z68L<AWK6<EIQ$<OLXBA/+_!W\*K!K/!=T>LB^&[(\\3[2ZPO
M9AM*@SJJ_WX:K_X)E2@9/[-DII4->,6ZM-PY[Z>#"-[)5%H=("B;>]8<47L_
M4IIZ EXK& SH*1DW#'_WKN4HLI:P-9V=2?KD-4H+64@(X=UJ4ZD0O&^SL%3.
M]&M@+L0K/J;#C:&6+B":U#TM$1DU#!:VK>)!UXT!.<<-#^#[^D$MM>]F[Q:T
M3AIN%NQU)8MSK#P?$=2/L-(9-G"[= SSW5K+.6]KF)F<90E/H=.TE[C(^3J3
M9 EO/I%3K)?M:%KM5-H]A/?2J:GBAM>AH=:*BR4M:WJM.E(%*L)E"Z!"7\Z1
M4\9 P!?U'8(>K:T-ZG%=C2;,=0N$T/HM'$OR^?[A'TPU*_;]LNKROEOX]*2W
M7E%E-VMFU(,ZBM&!!J6_]SGR2IIO$='U:\^*,786YRHE.9[ 2;0MKSR;L9Y?
M]CSN;8D*WKH-KA[/\FM.TY.$7R#F)7#<\/S^L, @QEUIY';WX(G>@8ROWYH=
MSO;T@HAE0!EN5B./::."^8W.K;[?>)@#()HQFS4Q^:_7/@28\ZILY5-W;T9J
M_Q[.JXP&>GJ?4F;XM<D+S APOYV3MC,/[ \BSV2;QT5NR'"_32<%1.PG_B'E
MP'=CT8#EO9:O+RBNP5K?AS_W7CJVFCBL8?&MSSZ^U<4@Q*;V\>9KT26[;^D2
MR#!-;"VXA? )(WWJ/8NO6?;%/0P[5IXN8<_01,H(B),L0HCA)20CHHQBKR![
MJQKW7P6V-.,48S+IHXJ"AVHT[V)O*M3GRNAEW@:<6I\9.>_/H==T.[@RS'WU
MW\7)7#Y;!L'J-S5ID6KW\!E6O</4KXT^[#6!U7>_12Z@^J 1[1W"MK/VHZU_
M^K<:JZ"!D68K;Q?8.(.EUXHD2-+ ^Q[S9_=/\-29TB6XB'H6[?%E#/*EN?!C
MV_Q3Q9O"']*W9T7PP^_'@ZU)G0\EI_5V0ZB=$&(\IWB;UG>7]\A.-1BMM4XW
MBT,P@L$ON$YH@[HGS>L?NNML%,H?(H^"'4S4^885S!V$P,M&SSH=-B) WD47
MJ06#/X4_SJT^6?4PDRZA]0W/779HS)4'SCC8VZVM!5@C\AO,+LWE&%S+\#0P
MHWWN7T$V^FE?0"A7>JU-Z;;%N*O.3(+.!CF(LT!$2F@H72FDWMU,,M335Y&Q
MCM/-7LU( A(X9*YPJ!MR-QWMRO5O9_7HD=FAP-Z82O+[Q04D';Q3Q'?G<,XC
MV6S $F?&S[5[*+DGGC&5(16C8?[/'!#7(J>?S<5"F#-"LQ:;1#.A$V];>4JJ
MVQK:!%<!)_U;E:7--2WZ6SQ>9@'/>9Z )[-T^KIZK#O\NX/>0'9X3MX+L\ZU
M]7@]GTR$XW@4/C[5FM;(O9YE^ > 1D@.!8/]X.D:3BE_:C9;?7&#N2JM".TO
MX&LDKM[TS'[_V"KHHAF4C/'E&_TPZ!X/S8W7V5D?6]]KZ?6NTXT(++?99CH%
MJ Z\1Q8>02K=8:LY]7E4$5L%J"<KTUF;N,8J&U?>'\",&K6Y3RQJ2M[W<5K;
MX[,#N2S3.$]M/_!S^6^*B[UIK-4/<<Z?UO7P+30QX8>&<.Y/CM4TIBD=1L(@
MT89 1^,>*^<DT0U'\SQ0E&D7=4UF93&.UGY.:G>6Y>%JLUW[#-V70_.*]<W.
M4"?,UR'WU561#A=K8*/B=!"W-F"U+-)27;4ZI"IKIFGBMCB)_X9P/@+R/,DU
M [,=9$&C%@R-]I2B+.+]\\^+K')Z S8.RIVWB](-[<#,0T?NX$T9^&[".#G*
MM84M^=I)U20(;*8+K,@/3=^@U8 Q/>X_$I9&>9GVY3Q-G"MF>-SKO.R>!F))
M=<^*P!+3!#ZK^5WQ)C$EXY0DQ0,SGB'G^'U1]W%ZVA='P2\\!R,97W4H4NQ<
ME<*!J6$B:?D5/B#O3QLB/$[.;RTXB9I&ZZ6/+8%!0IDM3:>RTV:4%]TM"-AB
M'[0_6=CNKH*:DXKPZ/<^%SMH1?U'KX9YP_,N7 C\7C0=J5?0^C4[E<%===M(
M/LQM):2A/YZG#S+#S>//R)[]?+R*BLD)(.CUGU;J_SWI<P0S^3LQP%*@PYG&
M#W28=3G17E-#B#V#G GY,__L,'1'(W"')D4=']B(8;\]\K^N^WL%6!C/"[A%
M6)F]-$>.Y :@FL$_\BB#W\N!]\27!_?GVLP4A$Q.E$Z+BI ^8513$?5U^Q32
M2-1UN]4H*$S!04G%<.6,O"!E0?<,\-4V\[F?PC2(3<^-PQNK>=+#J"^MY,0^
MT^ZSS5>9XLL#BA9C$I.VTZ)D?>Q2N9PIS_2II:4!@/4JIMBK3YQ-&%? ;E,7
MC*-2[I[L.>,?KDSVD09/>+_.M8^:F>&N<]&T?E2(#H)6]P1"GK50#T$%7 :)
MAN3MSB"-;L;MDLC^DNPF[QWVIJ%@:C]TGU2T=RHE7YQ!G@7*WVL#-O0<H5)1
M;2G,24H4OM<.;TXI'C339NK1K8Y5ZB;TD9K*\@A(&NH %.H4K\N0=SY(]A\:
MTG8C;<Z&Q-0.U48D:Z?U6 X+?YLWQ?JX5/:K0+2^U[:G1RYP$_LIFK,8A=<9
M\E%6<ZOTFNNQOO>OF0Z$L4K^LKS\,M%4V-ZQ:RK4G-SJD5&C ,F(9P1)=/P
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MA.;;_(7;WA4Y33)XE;.<)$Q(GBTU,.O=A5:DI=>9QQL3K7#0O*(0K'G$F%[
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MC:>9]MCVS;B+CJ1C ._(!TNUDR^\GUYH^:>^I7WCV+@1+1]JN!.7R%?3VMT
M#W@DG&C? D*PR6T!T6UA^<W\;WHOMI/=7CDZG%# J!,]W2-<'\7)4[KG*3&C
M'N$K".]5&MK+?.CG./^1]\3\L1PN>CE,+VOQQ%PE0RR ]&2S9K"7-,JR#K#5
MZ9>F"N^D. &,L#!]6SJP(Q'0.;PY$"AZ:FJ?+.S&I;TP8BEQV5T3J#F\RQ"X
M66(8G:9MH&Z6,7;F'WK_UYR"V=,W.>CF!3TGS[?@78H)%5%G2KA&^HM=+S_S
M2_VPFG)X&3,+/%*$!P6$?9Z%BH\K.9>18KJO:]!/A(FE[B QB5*RV4VNBAC-
M1_?]\F$&26LQH07AOIR5DZ\MN]HK;],94N]*LK;,5KT^7#!<HR6YE_T"H,(Q
M!8NGQQ[!EL4=TD>%D*HY>^??+"9DY9;,FLA4_TGHOL3E\J'$B*^D';965O@]
M%ILUV/X1]IX5Z9>^*M/"B'$0U21/^]HO$\'>L*,*+*<LMHA FN3L^.T?F92/
MY.L8ZN6-A%/,200E?;F/&ZA$Y5(]K[IAXJ?$QO#*LGIC-)>L$/BPD#01SYP:
M2)_FHU=J!FU'U>T1HL,7O3[W[:"[^.2BED?M%/D+U9D]VMC.E/C)(R4#_?@\
M'W_8JVP>=+\40O"3!#B-*UU5_.>%@@UE6):")YYI6F/TR0Q2TC#D+2CN$EV.
M]6[EQ7 CCQVZY8RDDJR8<0NH6;LZGAJ0XL"666#JX[?"5]4"@:,7F-?0VK8@
MO2"3U%LUZB877R-C>U\+GW+Q&$1F4EYK/0FO]-:17L>8"CX\46G=./R3!O*#
MC4?NP''*1%'P33Y3YJZO,)B3X<(UP[[Q0PYY8@54VMQSI#KA8XT1'&Q;5NH@
M7VD)X_#22$I'L<]2^2D/VCY68=F-H6R1KCSO%T9QE#30MB,D;9'V_4IC!$5V
M/S8+J0[?L\R<#FH06VF5&$K6H9*MIFUF1)B#*XFYMNCZ/1IQOY$SA!>S:EG#
M8NUI.CH6:5I)#8:>]S*4>63AD4.2-O W:NY30XF*_=IHJU-E=JG-=$@NN[2!
MLLXRH.I""/5RLPP]FE!7S(8")<2ZUK%NL!Z1/7&SF<]TIVK:TQ&D&NO21.RN
M?PG=[Q! =14'(Z,;F?;\"V3V] KT:3[PUD#PX="2LEQ'[*O\1)R!DS:3E7:8
MK'WS._WG#$!;.$3L\W^ID#@D6V2YG6I$6U/?LCB85=4 :6@1?QS"4XQ>Z6K\
MZ0M0:/)\R["ZK/J9)05ELG#%7&U6N+_EHO!QE>2ES(I=D,:-?:44[]1WNY./
M*["=6JHC240LFC'GY"ED;E:6V*UP1@[B509T>)43MO"2F!@RT3?W'K\CK\7-
MWR/TJ:)17]F/]7\V=_:^'U;-+,[U>PJ#]9IN=?UMJ3/(#GJ"Z-5H<R\3^I(,
M^1H0(6G<AF/$2W+Y_*5]3L=T<3KQ6*B@O!68Y)YAV=[JB?Q1J]0YS9VGO+3=
MDOL.7_53K/O2\INHE8K2Y9QMI-1#A]E38O5MW$9^!X3]"2I(@?WG:Q#^O8?'
M.S85UU/,NIK_"9"15K20"FR?Y#(Q,7;96*B^=4N7'Z9?%WD[EU)1L]>+IX#A
M* 5ZH@(7^#<3YM7Q4GJ1U"A!@U6C@L1*CRVN ,='\<_HMENSC%\7?K3HX?8K
MQ%:&,O$@L.*PG5TS$HWE)9H/]G[PL7?:V-LVHT_.1'4($Z',>A>.)!57)#+C
MJKQ=6OZ->6+K:G,N*'7EA('P$\KTDJQ;_K#JQ! &[*5@ JAG?HPSU/]38]-[
M!U8G)8S6>!>X#0?44?A:IEK$8(B:8F+GGTGBBBX#+<([8$'+!=S,?KAZWR 9
M#FUHH*NMIIGPM\!RMQ01D507T-M&LZA5UR@2U?5S<^55!G6SQ7R\TVZ%0TL
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M!^_TGR<#4\J(P6[/N(U+]7\HOSYZ)/PQII:9&6[LP7 <P:.<]9LI:?YG;N#
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M]$G$?#?91GJ#- >8S'0OW&I#Z#B$SN*EI>0/987EC>MM7-I*:8PGE<BX_S^
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M9]3Q-]?EX6/-./:IUF,)Y:9I60F9_#^;EHUZ[Q<KX3@FM\GEQ4(U\PA&R=_
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M0HELYP16#WRY'2HT[1WA%.6E:-)FNCF<;76AKN\!53!3">A!_;;UIC<AUO%
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MI&=SCW)TFA<QX!GK')#@L:>;.NWNV&DP=\@;22T+>G(']L%R$DR_PER'% 9
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MGO^"%%SD_*)9#"YK]@;< 4+C+P.M0SF$3DQF2G/C8^7)C7,$(3N\!:= L3V
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M]T;NX4T]R/S&[?OU?/+VAH1*<^,T2-;/R\JBD\/)ZXEUC\RP^T%_-OYPNK!
M$R4XGLLQ[W4;-F_; ]8=O*VK^P(KY>89Z68_9^-ASN@#Z1ZA?T%C)Z9*PA[[
MV?24/YQ5;0AM_4$'+!B#]] +/=\)I71]2)=>!$KI>,G'QN]XI&BNI#TO,ZG/
M#R(I#Y'G5^'QS\?0R+;)HAWW-(K3.4L%.X,1WY]'RKQ?J)/: H9]!W:4=P2_
MO']HV9YUF@*D#G>E>T_EOOFL*'X9%)A1IZ<2T&?RG\@$TH*&_>=D#9"CEUYL
MWY*C"1]!RQ4O:D:G#]_OG<J(2$E3WM7\&ME\/CS&5DNC'3AC&L2RT6\C8)4\
M=#D2S%^M\U9+A-!]G^XO8/ T\?N8IYR219#>ZQM]-^K]ZX1F=283UIURM3+$
M=<3[0IW0)?#EYMZL?O!OQXQ]_.,)$.' YLX_1!\H<LK M3(O9AD'8$6RF0[=
M9K\/?C]^MB1K]SYZ+L^0_CKU&EM/I@^^U$-F-^<Q,"YDDPC4(8R\D#5O5>B,
M,M?_?V]_:P;<XZ7^B3D(/8MNC->=D V-)]3G00QS@ X2 BUYU-X5ON%Z]?+<
M -8T"0.,L9V<7^63WSY;-I_><, B+:#[4@,T[2'XQ5/ZA6S/D8 Z#UF<:_!S
MG4^QSNUOKRO8V;R&OM+DG9@?_C VKGTT*?O./L>MV/)DE "T .V55IB*HPN7
MU_ZMITSP9S-5H5#]EI9)3>Q>8*ECI^+(=^#P5GTVZ&8ZW+1FV7PIDW#(4D]E
M)TC'T37B9 ^@K</+<CR&]19W30)=*<6 "0IF_,F.3%@G^9F51@9*,^(\,,S\
M8<H9[.WI8$83'G[L(>Y:^)0,-O;XTYV!G<KEFLK)TL'OU=LZX.65Q#BP[ZO$
M[6@VS$N:+5J]OJ=4Z,_V4*G"]%KEC4^M'71)XF:) CUE#V&8XLX/D*V9,>ZZ
MC 0E9==?B24O%SU&M*E5C$F)[(N5$TU%\SHVTG#B;<^?V'_NU2>V+C84"PO_
M"C U%[?RP=U7OB>;L%K8V<(EK$7#QRVF-:"0GZD7:V?]3/$2,ZN:/O#Y['5Z
MVN<H1AQ@%**QS?T!R^ KS5ZWE2E[)"\ C$GD8!J1 $;(-X%QL1ES2G;Z2;=9
M_'9- GEJ, CK#F;T)UM &;[?N DXE)@44-H^'0@VF?0V&X%J5?-SXHM.J0O-
M/K[(>H4U"*]+KW._2)I@TET.';_$ILZ=,ZG)$9NBBU$^^9 :.WF/V5Q\DRQ!
M=LJ\UOB5!DWQE>P7X9ABI3T-5_40K;<P2[G7\E3P(W$^GPK3KCXC@=;!WDV1
M1/>N)%G/D3Z-"O/HLWBX.OXAYT(GAP25UZAYM0O;]-LCGKQE-"(#^+3>F*5M
M+^R=6<^?(<K?_X+Q.>/G(;U9U=GIN(2'%M49KIM)0"2X9,1W+#?;%*)_(9,F
M>P=F>\>T;7]M@8FPN5H8.6/S!'TI7:?@@15SG)4UN5W09L!)62Q:!B4^SH%K
M0:=7G8HXN44L9P:<?H44W?^%,6B0][(,VM=,SUYE(%<M8FG 3&DZ#BSFS?M^
M0RZAB.H40ZY)X.$E;, *E!K?2K8*'$[KH<K66__-H]>F[CE=E#30@FI]WG<3
M9Y D6A4&K'FNG*0QW&>_B[-?32+4N=)2>BQB4/=H5K ^><F!J"-<;%:@T27>
MY*8,(Z5ZC;U>*CE*A-1KVE;G)TGA,O@H*CP,DT:6*$DU9B, L<("W,<.TC#!
MZ2DAHZW[S?8M2T+LBSL3VJ3;YN"2QT0/1] G0>#GOQA5G?$!/^> CM[;&D(K
M:-]?0?1G$634\F6#^;E=I73[P$'Y_^60<*GKU'!M.NG94XXB+16B ,E(C\*?
M@_NS>N%U-B\,+*O("%[F[5_7I:X>A :XCK!U2-_XCQC7U)_1:-8XI@W^O?Z+
MR"\PDC](5ST=WVHU\'KW?I./LU[_'R+[M&(XFX</"YMKUZ]S+CJG)&U$]<2M
MJ(?+QH.6WZA^5$V3-.XA_<_WO_TT_6D_2:RKXXQ,B@O&XU6G'%YL8F8/.A7@
MF9&*7J8<\Y9O/G)]A<!4+;ZVR ,+IX.$?/S65:9(-,ON'\#J8;1JZR=5FG..
M'$4:I04LO-.N5"WMW;? TF=_4\K+&!P&%:]Q^]NWO'DKCM5#K N+D^*4.086
M*E[3#>+5Y<]=7B+Y2OG^)]G?^5F.<XJ$V$J).VZ-O ("-D@:+ECMHHD]KG"(
MYY'HN"[NY,?5'UZ$M 1K=DKX!>:O2;($WLYC&[)YIT F]-+<5-6*-]J($1/'
M"VDC*=1]WWW6X!_=9F;RHH6Q_?9$9^BH#DL.&Y\G;1]]0PG;6'1"SW<BS@7(
MKPIX?/AF!G;$D:OGGJLBBP'=UX49E<'GRQ@L>X&+S?W2'G7L)2,6A/3,G9PK
M1-7+?OXWV77PY=?(J6&I."!)6]F!%/I)R!9:)V"MSECT0)5,ZN6(T8R/5%T+
M3V/*-R(/2Y5_,?%CN&0VCYA=.N/F!X_9YI/HVO[F_R 2WFF"/M/(0'^WPEXH
M#;#6%YP)_#5+_2V&4?2_0;SO6GL$N_:I;^]JDF($C-S^'[R]YU>3T=<M"M(4
M*2($Z2*]"-)"!^F]0P*$T&M")W00*8(2Z54BH'0")-3005JHAEZD2D?I55$L
MU]\9]]Q/Y\,YX[SO_;#^@&>/\<PYUUYSKJTXA0':=,2WL=:U,4PP?['_)(^"
M+L6B/W"U<9LUI.*Z7RJZ@Y[ GM%Z:=/$9&VS!"$*:6;_$C5)6>FSM5< IQ;0
M=P0UI4*TH*/_2 [$\#\FG0M?C4H=\41.^T)ZJ$V<[/CN9A?Y/ON^9^[LX[OT
M>** R>N$/97XI379Q<1Q*Y!@E!#<)N7 TTF[BO:T>JGYC6'C+US/RM*]0_&U
MYC*&[^+5?,VB]M?3WTWG&*^*XIG]HZMC\#[/^Y;F +=P71T.SED4/RWOS>-U
M-ZN;[.9F#F>^!-Q8BU; $&?.H-:8#2L'E7YFT- EEF7_>'-_HR(,JL#A-Y@%
MR0@0THR;!:>7YPR/@]A:7 DD R'=#SMN-$1M&_/EALL](3OC':$+]/GB<CU?
M0=1MEV@''"D;$F=LD[$/<\ 9OP'_KOI5W.B02L&$L2(G"QR4UF;;";8URA:K
M^C(G!N>!WB&A,R(=]C=UBUYF!;[55G,R)B&O,B-A14#L0GUP9'TUKYYYF'GZ
MP7>@VQ:/;\)G7P\Q&#()IAO]3"VJ*!X.^4=%"2/&J+I ]88#BNF64@>7(?B@
M_;TU?/!-I\7CCER^BFPM(R%R!3":62*^/ST;4NGHOCVW.ZC+C;'D)ZZ'X/-T
MJJ7O$0FUV6_AC2QNV;:5CSX/20?K:JDQGT=8^"R_O%6^I,,SS>,\NEM)&1,%
M+;QBU>[@!+5Q<RDK6 @EK2 I BI?%>%EM3/!UD2<YM9BJ@S];^)&2!&F34IX
M2"]?6BRY0!WB7M6OUO)7?^!UZ)0FP(1>,(UC*9W1[14ZHQ3%W_M^WJ5;. D;
MC@K.A /(&N-,0@FFGYF9M<[S09Z$9^6IU)@W5@V:8M=8'40^97&XFZDTWS<G
M(L*=R" Z-W2K+94IM-R07;$ZTI=;$7E0Y,^CUU\$P(=N]9WOUX?-?WZF)0?<
MG-H)4KI8PGQ$W[PLL O--.MR,BB+2O*LN0[]3K_/9VW[R9L[$WI4$1>DZTIW
M1%*H"]BW8SK]^:4YQH;#<=^SA<XLWW&,_B6M46D%@?N];VM4]M8?T5C=2'7E
MN6'EN4.*LK"_1(D5R 7SM'4?Y>).?.+/#UV>A4UB ?BQQ8&=2W9E*]SK8"'_
M[B[4DRO]RUK@-- BTS3^-C1G2.^R]<\ZVJKBU5RU57M;9)UQ]I6L+SM5Y_-C
MU 7!)+YE,*Q6[6S&2>=E?:WTW#M9CKDOIM=TN\;72<?*'-=IK3<,1^.AA'!W
MJI)HS<AEQS#>^$UCUGNJM:&G\_4<F/)29+\?$U?]@'GCKK:FH*WU6Q7B2:>Z
M2$LWT4-3XU7S3)NK[%J73V+L?IXY9OZ6V@9<9;R,88N%2SUA_E4%W<7MJ7=L
MAP+/ 2:W+P%[D,8WMMFI?.VU"><YL,%PI\Z?DEE5\(ER_#ILIK<-SY%GIW1&
M>6R.?APQOL(A:==OQW]&M65M7%3K3GOVCMMF0\ZV)\G2?MT[XD;ZAT/V7Z+@
MSQ\7&&_S8_A^/,JVE<SF/+,=I]0;HD>/'J>6._OSP/<#;A,0RA*GEY#N_(FZ
ML%=WW0&6/86/_LS,S#/K7EC.=_"9[%N<WZX%HLWS5AFKU/8^/LB)TNQ7YUPZ
M6&H4=739PX6'#'R@4JK9,VFQS_Z4F3*WBQ9,#_X0?OEU#"6C37IR)Z AAI\!
MZ8<P@P[5MYZ8EA/M-A&[>,U(J@? FNXD^W;I:0HR[R(=I&-42W>C5X(U6</*
M8Y!!XD\?>11G!94_TM8CJO C$X!23>HJOVF;$^GY<UU;$2FK 6$C>[7QS'.G
MM=Q#U#D[O-JM*[6_F[>M?;KX5:'T3TMR$1GGAA>SIFMV!U\9$F1_/-6K ;:E
M^N 267(4)H"N4)HNX72-@!I"3+4.A6S9:^O(;S6F$L/+L#S/X*N*T:0_]<(%
M7BQ(/;_PN2NY[4"LVORAW)"Z#?A[F1C3F<F6<WD!B-L.Z>7#KDYSN9_I\$\U
MD+ .<'"V3'I37>0+?"O_4LA?-[]!ZRLP421;Q2%YVA^:@"_1ZM]*\;?C]7?&
MALJ8KG0[@I2T=/ (BVI9?6]:3[+H(F2)J[#!3WL,8#>*[CJ/O*AA_D<S(<DE
MB?+RE7M*:/_ _FA$'&H)P T,#/N4SPM5;(-SZ0D4U^S^KQ+=_\=54@FKM]<
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M2IE*";=(]N' V(3YB\H2Y)2H<G;CNRH]U,6V+58"+\N'@F/\42G6,8I@O9.
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M-3FCA>4QYPKL;9$.9W1[P3H[48Q*^?+YA5[#/&O!>UT1L0T-L15<W=!<C85
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M26#,-MT(HHF*)1 <0::/+EJD]/5/XPN?^Y3+C^2*8Z^:UGB W,M*:=56!>D
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MDH>C'1J/T@!,I):O?LF=QB_.+IAT)*<5#7T47DX/YK17M95R%=0Z5X2.)[,
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M-+&A#U/7*165IA82 K\/_(JSJ7L8??+Z )CA=*$T@DS=>^^0AY"-N7UW;9]
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MI*14C0X(JYPWV /I"V(2I\WWV@*Q@-U4YZ($1?CGD0I::=1IK/$SO\Z=)J<
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M2T@D%%294=(H5A70D-(V&T>_:L0P%7$IZ)?$T+H:SX!62-Q*;:J,2\L:9?2
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MN T\C?-H;MF+EQEZN-]EAWV__?M9;G3M-XASYOF'?FEW&BV, DP&,/JT:2
MHA#\<C&FQ)F=@,//Z HGW38;DC;_!);'2/^XVGIO'-RV>OB&A+W^'*^=Y_9A
M;S%>&RXHDE>56)8X<?5-<K?UN"T*U;[UL#>X;'*[#NI)J5/<%8GDK9+1<1^F
M2=T(L-_F51)2'P(=+(-SX1J!@IT+@+1>7*@:]TRTI(A:T(7%FZWQHY7E/+F/
M+^R8:KJ\;/C&=,X5H[B'#$IS95?=[$.$YEPI3] =.7'9'/MA,C6:"_<\)0&I
MS#.\]@K$3RQ%:^ZHH&=7D<ZA,[R]OY? #O]R\B=-@G1TPB3U$3V##L1(DM0B
M.4]C&1N>ZVJF:UF9, JVC@&#@B3YBC#GQK,OX5?K@!\IPUFZ!CK.DU?/&(_:
M)Y&/8K)'O,1$9[HJ%58)3YN:Z&;#KO3W]Z%UZ3-EIL&%.Q&#U/H6/._^,T/T
MOP,#8E, "-_D[ A1TYJ_T/*U*GJ/*"!K#LV0LI<ZM5=]S^+JMEE_<([QF\;(
MEZK&D\;#,H &&!FYYA<B<P75*7M_.,^^-MLGD\O9M!EZ\P_O?I#^2NB\=/T+
MW%:;G+]E>KXT_6J S^V+?QAHKA]V4!;HEO08&.MS[#5LK^KZVM-3! J74>C%
MEKT\ ZW5!KXE[,"(OZA/W.#[1\5/=N$_TH#C;=HJ=TJNXM95!.-]L]N2T %A
M7W1:>,O%5#TW.&8L5[;6U<:<9X[EH+.I/]?3$SW-KYQ;)[Z=5JA*>PV<1[Q#
M<R[$P\XW5D_E41;>FJB9K0_60T';!?5IWZ+VY8/@=;Y</H%4!G#ET.3G'A4_
M#9_2"(Y@:+J1ZJ/Z.+NUHVQR8E3CJ<=8AM:1I(MI_'D:SKM%_?+E*YF*[[Z/
MF!LF5M# B=?'"TT:&&V^%0:@Z69)MMWAR\P]]3ZC%73YH_T:S@4?F@O1">DJ
M;?$*SAV_(:8Z<%.Q64)'QSP?FVK2WJ_YFF+L4AM:(4+G=/!"3*9(M"5J:FXP
MH'S-RKY.-4$]I,V_QALUT^2>X]!EKR8]06:::$ZA^C*-P?[>X^(A.&Z[*DL0
MHZX2O]!(R\(*-GS52'L3:-F4[I/:IHTUQ%FWI%[L$#_B7'Q==.=A5C\NMCOW
ME&5F!80;?,2B>;),7+[=A)&38X/H:&Y1$'>H/< HEX&)7QC;&95_9W1E712'
M\^]7DW8\5T!X%5R:]+9+J1A@%NG :5%?3<M3Y]I%B*A'[?2:-,VZ17(1#;KL
M%UY.E2XZ]0*Z7K4OC/%1%>Y>BP\_*[&8-A;)%/=7E MSQJXHU/W++&B#*?<Q
MWHI[^&Y^'L\8^C.7UY=3_@),/WF2MJ@1+^$T48'-+:RU JH^H!=#]RLY6Y!(
M0S89UI^STPD[%P_Q%YIL9EI&)@:\$+!:=7UDHK..CVI6@O0$^_/G56??(_%:
M4+%[RN34^QA(2*N*Z ^GED).0XN3ERE1)BTMEHCPQS+H3^T:=GWD!$9Q4I*7
M4]!!1UT#7&.L]-D\B;A$9]!LGO;)Q1G_"U_A>._GIP^X;0#'IGXWJN$P(G^$
M;SJCL?JZ'"PO/]0-E6,3XCJ)L35P%21S&O25$R9V8GG]]K/O;@[R&(&)3QYU
MB:4DWFDRK2&N7MM=5:CTU$](_I?$9A7\GS^_&8@3T/,\R*S:&)I9:2_LM]J.
M)G6Y=6RN5X]_!)TD;".3&RC=@0?LNI#>5C-VF>E/?^>.Z&]_DDA@/; (EXW(
MW)""\<QT5$S!_*41<'^80B^G"2V_4MD"42SLFTE2$U4'\Z#[(G5&;N)(1U4,
MM;YZP?^TCU?*1_Y4'4!ERA'LXK.-&D'$,"%*.VY4<#Q=7Y7M?RK<[O^5J+'D
M.^=P%'6C:" -W;(0=#A:4>VN<;'.Q2-:*"I*2^IH$]<>7I=_HW<74[G1(-@P
M2G>%]9_LG*]YX?W9OVY(.U@[/T(B6\_?;.A;\';K&X8 '6W^W5=+;$9$X<6E
MH'&,<GV2Q/H$<7JE&4IG%_6JWV,ZM.C(:*F8A[WM%<6JZ7!%MA87DR3AQO54
M_\[HA_XO=NEIH@8D5#B'.W'(!],%U;F>C(0HN]MR5!E(&;66Q:LY':E TF/Z
MX' %,7$<QPE8=-*'U*VLQFSIJWJ$<9_?!X5.Q:X>#),J'5KF;BD_$F\_1S/K
M*A75WBMLDX3:XRS,W7M&<&ZPNM34=@EML,^_M5AOXM50$'0#70IL26-4XO)<
M:'WSZ([8!/OB=C3&,)D.7I.2$J5<KA\N:G[9W^=]8"]63*^5];%]O83F#T-K
M-.^32EO@EL>@EZ_&TQ[*KVNN-?;G\W\!RSXRQ7\!>7&6WF>'\B<>F?0$/[#F
M!@95=!QY[0;E1?K=YX1=GJXW?)UK/BO.[CUAM&UI^F;''Y<!DZ2@6>ZIQOH_
M(<V'*6OS)/E QQ7X::;CD)Q]A77Z:YR!*K]\_7ZV+!5QH_7#35(H[31F17N5
M0'^V\Q7ZB-(E<5]AN-DYU%AD1(:P8P?,==I0MIZ'MJN-(7K([QM'6U V_;(D
ME9BW*"*!G\YJD7';G90D>;:GV.,*N&) 06=U51F]9C$M'IG:(,]]-+B57E4(
M(^H23=%TY0 ?F?X%Q!9WPE*Y\+IB O=NLL#I);+)>-@[J*%:OJP.Z;Z0ZV=#
M2B+"<G/55M1168M)T:X7B/!H/>4=</Z1^0&J#FF]FJ+_(UA']54JN\P@-.4Q
M8IGS\RGKC_:YE+:$>OY6+C/"4J:I*?-/9%\^L*8$S:^>Z.$>0N7SFN)2.Z_+
MAC:<\T0'M:OE_JGSOR[WPX,Q*CPJ?[?_GDRT\#F:XT&\04J*YF I6,<I-2DS
M]]8)Z]5IU&@:E,YEPU_*8/* =YPJG!_76ZQV8!K^9/CCIXFV4MPFUT)*L /Q
MN#SYN_5'0#7PR3/*K3AY+KN1<,K?;_ LN;_XU;_?AX-3&^K"AC6[YFY#4XG2
MW"V*L'\!?5R8OX#)^"^WN""6WO64981XHZ5U A[)\0C&[ N2RM1R_,&=ZQJ'
ME>3I)XQ*3HT=4A_6(6_YZV7G[#M:O4Z[OX  (S\_?_A,3%/<KON-JD^>Y+G#
M/:<8UN<2,28:Z5Q]YU[6C_XZ<_0AY7%&#V,7F11WL1\G]ELBOVI;DQ)PSI5J
MIQ@J8R]S;)$_$*/U]5GC"63>7(@@,' NCLZMJ'5/Y_3K*3HN0X&LY&/=L:ED
MI(F9W4.+26MS7,926V<BP+,K\F"FZR^@5Y%QNK%U*_5HFP]KM_E AC"US'6L
M IDSCPVD?%^EK1\SY\KHM@EV%NP7OZ[Z1&/B<J])ZMP8^+9LQ[@]Y-B;(4-^
M(</Z<WK\V7Q7SCKNM7>\/3IN20I,2M'FYJQ#HJS.@_9N-;_=2HJVK1)<ZN:P
MMQTB\Y2M*GXE8YF%S3:<LVEH$N5XL-_:QC2RE^1M&4L8%;,[F?VY3K-)&U_"
M$.*T!/[ZU+7'4--N]EP#]6"3FMB2CX^WUIN\*#4[4EN.>"=\OX3)T,A3%VWE
MHI+J")BYU.R<K<5*.99P)J;? /Q+#J$VC'2T1-SH5T&$HBCJW>T(DJ;WKW4(
M=$D=*M O.'VJ]/LO'*@_FB,V*0#[U8&JW;=! ?&N_PA+_,:,<A>FJS18;<Z&
M--D3M,\F4PD]^FX8R$_'M)_7QR;:<"8-Y/0,;_T.\]OSX'L")-<6LJJ=4R;D
M\PMW2EMG]P$KFQTRG:@^,WTKT2+XO-L2[-$1NV/Y?O,+*;I':S2<HWRD!M32
MG+)'*4>I!C[N)EC<H<#DQ./I 4:QFO/9L+AYR)/NLD(UAD$Z5;H'^>K5='9,
M45KF#E;_QQ.FZBV[VC/#LD5?X&2Q5%..:$:YJ)[:J]^-D 8M\"WX"%,,+:3B
MJ&)WW((6T^Y0M[!S^#ONAJ9+!NDO;K1-WHLH2,=61::?ALTP6YVY]X#<UT;%
MM,=I*AG>1HT;Y<>=MF?S)R;8JRD&\4M7)>-N^G-L\595G:N7^0 YL0]VM??9
M$_9/<2Y@=GR?M0/,JW.'_E5!-WQ_*R GQS/>8_W1-V$I[8.R[D>MU[[3N991
MV\[,?O.6?/! )FP@AF!6D.8$F\EV(-*+N,Q_&_:X:T:(P2QUA/"Y 6A.#1^X
MJ-T&N5"+2(B1!><XCOU',ENC=&3*1_9,A0KGC'.U]]6-%LT7[:>><WD98JG(
M#G"QIJ_#.(&?AZ7H751Y=]$"@XKL2!L+'U:[4W>'A) *Q_FU;4(=^[Z'9H&A
M)LY-J/3AM]=<WH>6#>4!WMISKJ1BJX7_>*)VXGF@WN8_33]62Q)J1I6%?;O\
M_N@>D@0;S*Q(-;9JR&NJJ;X7G[F..EAYN+T^X6GY:N?9XS=]PMCRB#\6O;%$
M7<'/PGWIP8_)^SE+,@]Q4)Z)==E<TKI:XP U8+2? >M93?B)O-QE<A(?G0"!
MGY&^A3X26:\8UA2443:IO_[OLVYD]]\5$ZSH$NK&_W$WU)2,437O7*^^IR?C
M#E'ERH9^<505=$).HMT<<SM-]:EBD'VZ8TO=UW2MYZ1>Y.A+,]F%*NX:WW>]
M/Y( L.\Q]WQUF4>;(</)#VM@HHE/D[HZY*5D;,Z?[H^<5!,*%+%\FT<A6%_\
M*_]\ X5AP>,OJ/7UM3V92-HAQ J'I <A6J0&0\NO/GJC+D%U6?34#D\S5N]:
M3-Y!QO$?J ^I!NZ:HGJJ[2P^!R^&T;1PQV\-&!@N!;GK9%%+L/LJ6MT?+K0X
M!:96Q1M-Q@,GR((0FJ;%$YZ>?O9<Z^T\XRL-3Q>=W30WVJ-K5W_.LQ&E>YT,
M(DIL-B'LE$J_>HU:*IG?'QNL6X;[\6BB,_PF/!"I$DBA07OTQ1*XRIVR<DO5
M7HD-/PTU%>DE:S2V!Z+%)X\MS/%,=EHF.G)*C84*+JZ4]K>9JUZD3<W=',2#
MC;YP8H;@U'OYMM9O=:Y66D]])+G45X8QEHDT,CJ5S@\>D<83*X*")FQ*W&2J
M>6A,4X5,5M3<Q/J!KF=&KOOI$E["TN7+TXR('!A#2X5K22.^%[M^!(YGY664
MGTSIMWCFSTJED?%?V+8QG+9\8OJ@UE'"RK=MJ2[_N+9554J1^H 1''O"\K-=
M<5VW_ \YAX(8ZD@%R.U<9H4X_614D%5<Y]'6JQ+5NUKI-H[JO41C,I7B+YAH
MD[WU?C>I?_F4I!GQ'3?N8DE@$/6B/2Z3%4J$5C02?*FF;DC_SZSEMR?Q-FDZ
M/VE*,.572?@8>*L5'G7LP1C$WKVOW@U,J>4)I9,<YJLB;_/!WP?G>_M\9\G,
MY>_"]7KG_ '2)5IT]++"E6'B:^^LJ%H-:90Q\?>-'PP26ID1C $EN3=N'.!@
M4+U9G9.]LD=LDTLU@T%-"^=-I>2*0-$)U&OM)[PBP+L_&\J9$<"TB3RHL938
M\2Z*H=7/$MP:SVI,..<S>7 ^Z'%[([60EB0OPE&J&OHPA=/Q"02 U1H,8_HS
MI2]@2Z!F;1G*9+'GY.)K4YN4AI(KINU39 O@,':C.SE!71GS:.R0QS\$;S<,
M<U5WPQZ"S&@VA/-UZT6M&OQDJ@:L W]_9;J3=W[;IG?U+S?=F/;78D^J*#/]
MHN37491B=FC)YUEUA"IFWM?.&L$Y'LHVG:)V!%850,_*M3Z$:J-12CH+4S>R
M(-2,O"'P\N$2@;NW!2M;K!*6;S:=N22(NDJYLI.N45]5J?Q_7[+)]2U:7A^Q
M-(X2+7?M5'!P?I;%9 7K II/++3)UW5]8P60$IL6!E:NFCC@4I2N))H9<J0V
M/WYD"C+8\VO]D?'-L@C)1_H_Z^%76#UR?IC6&+C>$@]//T2AUQ,KY"]I./Q4
M@S8*T-6O 789AY8:_NZ>W.53=%G0;.!7JSD[E$-6HE=\T?3"89B$%%S1D,,J
MKPT[0_]/'2AQNPU#U;=0^SRU$V$>?P"<A41*$!='F-^]U;F)F(V%&G1!%)&\
M6._R_[[UX'\-T#-3=9:7V9. \G^%=HSW'^&6UK;I7-?+Y$?2Y>4G-"_7BR9)
MNR)X%E[2;+K:]PP&PZ,:':\2F)\JQ8(N*4&3]T^VEKGG\O;/U=7_6&F[!4P.
MQ2$2K&WZG_FDK'2NR29(''W>*G;D,5#I=-]Y'6<YANL-BS>Z "&G0\"AVS(K
ML"^->:;U=HW=K9!.'X$N+8;K9X"[R#ZMUXUL'!^M/#>*A%?G?^_4<PNOS-U.
ML//YLA >%9J]R7RLLM'UIG^#M66A>G['LX..%2I,Z^C7GOF!$VTDS40!^BS/
M4:%;>O?^6_G <*IH?M"*D#$BIXN^TBW^1Y#X^M=2Y=5MB$*/Q,__$02"__[N
M;>G:%Z?LD[E:59E!JWN)Z149KCRE6 @3O%R#89Q>36\L* J*$6"K%[+6ZYC0
M(? >B_2%JM!JR.8<D.S\!0"S.7\!J^Z_R5@% @]00ME_ 8_("_?6UL4Z[.9/
M?!D.!DOYXE;,=YZ9'ET+$TK0B+YR2NS3*]@*P#ZJ6,C.//21X40;:%]!:!HV
MQS^1*[<T-ZCW4'@1@CK/A#I7L*@*OM_;!_*+^%5WW:<6PK]DMT4X#1.U?;Z0
M?D,C/Z^U]C4[:U(B,8A@6@VTP=32%9*_^ A6-[K76  V@</I#1[6:![F+C*K
M4AO^I_P]-C'-2R"X>D&-U^5IVFBH7>;S'[M@Z8B?3,WD888M"VT=[]T>#7E;
M[OC;DJV]MM-[0[QU_86,T6,&4H+Q,ZB9SO%U]%7[.(E0EV8&B:F/'2"/W4[&
M8GOV:[%L8E1##[%W.@?YTLL?,;'2'-01FO,M44Z[AGZ1HF947@16.F3JX1R[
M!M\($Z(97MK%9_^QULNXJ0!X2!\:5$;1*1P]Q\0CW35K884I.@$%3O&OZ<K-
MK: Y3-YZ8P#J+ 3$8E (^6;;U_TOP(+VQ\Q:1:F3EV!W!6FB1^5FVMTBY_0\
M8=!?P,"4;K1+[;.DG\3GE F-YZ]4A9'RPN5.(JL;GQ-:<H X^U>ZFVEE:X':
MM%D->S_D%B4XMS&V1?H=79_SHU(Q7;%EH/+7ZKVLM[O0]W\!<0R<M)<JW F(
MSPF1 WEO3#^?V;>5'B8?/^DLA!GA$<I>@"; ;;;9T-8,$6@^>SZ/1.[ P3C0
M5@W>_GY@Y<K)UJ7.79X?7K=QYYO?.VT\M$]K9Z"9N E/#B VDW.G4/4-^D4I
M>87YWXA[ZZXV_V];E!:I8(427%J<(,6"0PLM7AP2"!"*0X*[%RG28,4A2"D0
M/,%="L7=78IK*4[1]O:[[QUW[+//[XYSQCA[[_O'>@//&,_ZS+GF7'.-1+0*
M^"[L0%2;W3Z:M\\ZOUE;4'Y,KBPRA,"0*[F)V[.GH=LYMLK$QFYY[RK>L_(^
MC\4[ WAV9+%F24XPW TTRZNK9DP[?'V_L<?+E^FR\_ W"3<?.#-:-P'"AV@E
MDV'0JU>>2V44PVB$T]:<_\%!FE%1D>Q1FRKO&O%<1Q^,'V1M*3_(I=UI9=RC
MO#:)T/9-F0\*%_[Q@PHB\3WJZPG_^X77=XC0B4/66B=9L3-LP9I'E77IOHQ]
M7OJ,MSA6$+@<WVPW"'=T<[_X_;R-1O8S1O\]>4-4,2?3:Z-2=W,IR%N;B>5N
MP2+I2!TC9:?-Q02M$"UNGXDZHND^%@;EP@.E9J07!7[WJ+Q8E XG8="*KL6I
M-IG"/+X3 Y>B\ >=\/M!1DYKH0_<0??8"PC?\@E4C6H":B>_D2\&J0Q4:W(G
M>="?:ML-J90T9I:'($U=!,B8D\7*775R*L0 UGVS(2PHM8AG<HMFV!SB;*MX
M81D37 "UE0&_>.E"@TW\*P@:6+&PK^9B%$IQ\DVX6SP/]XGE:2W:C@1.O''?
M-H(U7=I61=E!.[JO=6QX:F-BFL:2YAE2%2%7:;$Q':$ PSDPJL+<HB7E:;ZU
M*?]"H<.^@=9Q0?84A[M@*&@EAIM]83%<A#<,%:I??J"]\&HZY9M2:A3]L?;"
M0(U*K$H:SCL-G^3HYT(39X3'KE;(H61<U%R9T-'03;MO3?HF+RSA:7BTOB<@
M$FS]11VNY$^AI53Q"(?<Y_%I+.WM:V/:"TE#I]+>E3KIDG%2%H)Z4H9+6E[X
MTD_[F:<Q3@^@_74O7S1Z;@Z'U\*^FWM^^\U=<TR,[*/C3*>Q>(!V8B+W4RO1
MAWF3=8^]K@]LN]L[O9/4FO1C*?GA/U#3:CD"^)$,D8#$NFE7XMTH#'MMT&[K
M,>B?+ ^>[[U;#<*6G)SJO _JO.6=MG]9@Y69[N=(:W][+LT]ZZ[&/&)0+3!"
M7F_:SMP:</PBU)V4$$ZP1KQ/+0X!+'H]71/L9ZF<I.<F31200G%.:MTM]@^6
MQV/L8#1+]"E14F3^JPOKGE;T'1F'N'3^)5\OS8OW/&L-^:;2*-9=:0_SZVJF
M>%_%42K-6L>I6A8LZ+,/>"41N)X@IRG$K8>HOK1'##'XB5:6T/6Y\P0^D%65
M!XQZM<L#H-<GDG3B?&QBND8H@@2'WG(E!L2PG^>* >C(P1YM%:?X\ %TL^:0
M$8[JSKY J6P0M &=41T:5%Z1KQH)?C21N]:@ZO? 'ZH1KW?*O:V 44E*REP>
M A,WD&^TV5:0CXEGYV7*$ZTOOO$"')A?K9@G3%>?S9;>>N<)+2[TT&>*!@UY
MCR #F$QLJH3+NT<(7!,,H&XSPB*25T?U<S<\*M5C,@WOO=<//$2K:ZY<L@^D
M@\K@1]CHN\C<+KN HXV9CY<ONODO U9>.R.H:=I=Q,O<QVH6I*WF+&L2/.01
MX9N.:2WJ1)MZ!0_'HNS5[.!:\H!9OY7_C/7EX.1/VJ/_^$3NB_4_D42NG)>1
M&!OOL;6;?9CQ5=)ES*G--1CW5)1A(:4]WHSKMY5YBISKC(^*&V%NS)./EBML
MH]@#PO62%+T!"A\X>Y(?_D4;@[,6994BCK)&['7^KI+\1'(AQI0-10^?"Q1=
M13M'%GZD[UYQ02CUE ADG%?R._X2NTI%?6L*- ^"A=Q]<L@Q*_J+$3.:)VBI
M+.*<D5.LINS3VP+V3G;H!TPO?):5S9LC!^6$#G2W)CH\UHKZQZ'/R;;JT'KM
M5S3J JC)L<;H9.DV-T#0>]:HO& O3*;@)9S3?N'.6E;'R%8&<MVU,I.K7FJ!
MC8%^<EY<7Z]&&34,XPM1^UG'&3,,PB,K!;HL1PJJ HX1>M+NXG?H)62%BEYY
M-Z;'-6R_2_?;.O%T?@P9\P;MA()-M'S]W?+FQL1:$AKV'CC\\;:J"F,8]7GU
M4'O43FFEJ)<!6/(SKB+*=ZKY@$G4Q[CXUBTOW*6:E*W)0@!40)EWUPV,J'+S
MOTTJ4.93$+DGG_#4;I:V@]6OQJ!N,M[FEY"K/EG@"JE/?;^>+O.Q]DJ$"XCR
MMCI=^0J^X5IXDU^9$R%(XEU$8":%,BH<ZDM'B"^T;X6U<,J8&]WLL0L%>N?G
M0>H$2][]D#E_JH5L#G^HFUZM1H>QAL<QL5>996U=&*.5,"7VSYUHPC3\IJ,H
M^;O7'S]8-:KL0N>1S1!1&52AZBN:PGBOS*2!'R32HI%D88 =$VOEV)1 !>[4
M8ZKPT)*['(% >/EE 9?+H "UF +]Z(XU7T[G!BH,<:7JC+(3L'S  %>L:5MO
M\90T6D5:"OGRE%57Y*@-RH7TE2B,F1M_[P+SKH33S;6:SB?$&]*B%X=J@[3?
M#GO]RFML-J*((O(%)QXK',Q0=$_@%9U@V-B:N/9SQ*WXK&E&V&O,HG,[[H48
M7GN&T:[)7PD-N<TP$KVO<-03QP5EOGWSM,K<R[M?%"D@)>E- ;&]""31\#EO
MHOF"6H+2V_? C_K6D_LW<HD H!W8DQES0V>*D6 "<:R4):/-:><,7Z?8P%SO
MSUWJ^_4.2>&%7EG# [^AN'H'?@:VOHDD]\K$M3++S*?==PL&_-5UN@\1CBZ4
MQ/ERXEW:8V<<D\')ZC6*FL&(D2>4+@:B]%8MJJ\J8PA9GRLX<4^X,]!R-ZP5
M"W2NF5A *HY:\D16H2".12W/55]EL^=DLA> T3&89UV1[^*%3(G*]*94OQKE
MH7K+(.?L XPG+6N5LIW4RNM[R]4HZL7-3T]5"@OYB_&-C32JHU&3W6&/M-(3
M89GA?WO"H.>_UR.H:;>0*152H<<Q/A!"VV+5/!-E6G$@!OFS6?V7JI5\.6N<
M44SZJF%)OM @'8\+HHF4L_"E;45'1%3&3!4T,^9CF7R18O KYVYNE^:;M^/8
MLR5;@H=1J,/UF\C/*ML8ZF[8S^XS-B[%[XON%%KZZ?\[JLK#5RQXSKJ6X_:6
MJ2KFQFW;8B5G.MH(,TL ;W?.AU>YV05:\LS!_Y61:*@=AL?EO2P$F?(X+K\Y
MJ[,6E)SS.[-7?K+$< ]4,Q$N[T.S]I/LOU1VHGYYRL>IE.,Q09&$8KQ] MTE
MGV61FR5A>NSIL]_<*#;2^<N$525?$ _<[RR F[.ZPIBAOO9F&I7D-":!Q+[;
M$9OZU9+Q/4R\7@7A*0>,O%J![9_KL786$"FS* $N5WGFS<-HD/?9'YSR/DH"
M@7IKT(O@:KJ2%EU8/UK3(AXQF=)!ZU<8<\SWX^^S%]XI XO.[K77TCWKI2Z^
MKD[8+CPT:PG10#E<4)YV-<)2:FFLKA+OM0W])4,E:I/I=D*NAUU>M='Y(VO&
M5DHP\ A'"D;-^IM/2MBBT4)3:ON/SG']8HQKX0X;+/=7_.@OG-=$(7&J,/^5
M]]3IEUV98W=KL2IGM#\+M$$L@S&%:FK&^/_L,WF/Q$BQL'7<M?8R"2B*K34T
M.=+L0]U4K7DK*X/OL3Z]XYXW>$W$C^=#9E"U(T)%VK+Z]H83JY)J/32D-KN=
M215@(TEOZ.4RTB4R]CU)0/"3H4V/>DW*VDL*OCB<\;-%4]\88L_Y96$,N495
M(>SABB\DVL:#%.OUX2.)TYRXS'FH;WMACX<E^!@NL)1@,'L9HOO:F:XOYJO7
M='?06J:BW&3RB-;PM'V#.>H\DEB&4%(/*3:#\P^&BIAGZTSH<;9_LOKQ2O[I
M%Z# =N0DFXKNC*!/5IJM6XK'KK UL(.Y .OZC63TTF/F@(<LV+5^K0[_H(K^
MT1K'W;'Q4=):NL0Z=U[?3AX>V2=9QLF:_]O&IRC,)65)?Y]861['"?4')^SA
M$@]+R)!3G83YFX,&)=!/.^1^& ZR;>I6'+!AT5T/WT,;]RBX3'44P6,!3=7/
M_.>'^9\L<3=-N1E@Z,,U$GW!^$.HPN5[97* ?S0@>Z$' ^V[VGGB4E,?F3FR
M@"#_\+AK<(I0^4.16DD=QL6P*Q_=?;Z+JW" *0W=)NYI49.\_M!)MY//! PW
M*@CJ:'78>Q]E%L]_[W[,NTW!Z";^%3UO7OIS3-L;\Y_G%X4&E7<2-UJ#VF#Q
MN8/>=4 Z;Q6NL?]0)?^(ST#6F*JS@;+1M&#%\.]?8N1?MU7P?GA<Q5Y-)R:_
M>]D/[*1D+3(#>JMN"RK'DP5V^DR^10]K0&?B"8C[C\_R_1/I,S2S7Q>:/]D)
MT(;L:K5NW71^QB!:ZD'Z"^92>K[\.I/]%@[9<9K-=C[Q".7U!>W96=#MPA.K
MR@SMQ9T0*\Z(K&"TOB5](<NN<;4,@[[B< $HUSY;_ME-3D-&_"S6S7LGS.-F
MSA$##1Y?';X_X^/&.7HWILH0+#<W^Q((SY5S!8N-6;J$L'$UI9%0TYXI8;)M
M/EHR)>DDR"%=!JG.,.;&F,&KA,4UJ3;;O39/S,)GXLV8-@1P6Z&QC@,WR%"A
MT;07-:HT2Z9!XNFK1V'U.B1CJO>S)W1.,DU%A'W8*Z\-W<O B8/*P6LK'#Y8
M?)Q.YS,1'%/=R<]GNRJDCBN,.8GABGA5+U;D5"P(QR-2>\O<M_&[.O#3P$D@
MOA#>1##^[I Z@:(*WJOLD"Z5HF2:(6@83J<3?.W5O2M%X8S21T:%S[M%D+5Q
MCD:TE<S/7=IT7]7>WNNRVG099]4/6WP<'<?2!Q)?#\J8K+!U7?Y4&'VE"UM(
M3KH0BA<<:I"'U8TYOO!&,B-JCO[@!,T%M_2V,9Y_G]L5J77&4YHY!H2^58&^
MV2D(=P1[B8T7U#0N2*P35(=E13-JNAI__5@]^WNLGI/F#!#X*8\%M>WJ,H74
MVO3@'ZJ/+K==]<A*PXCS-$\O9@+9JRR_T)^V#!Y\%J6(*C6,27*W-_&XGZ#M
M'R._5W!2+% %[.1O  6,$H )4/8+3&Z_]7B<JUF$*:HM//*5RI35NUNXY2:E
M+BE%;CJ0IUYU_@5.#/O%H_G<'B'352B)HRE0Q>*84@&0^+6[.T,I,7<6A56E
M-%ZZQYNS#_?Y%63+1&/70IN\ N>RGMUD)VV#=I)_D2U^JU1H3XSISA&*JA4M
M"RV16QZ#;I.MQ^+*8@RE.Q]2.B>T=2.Z2P_=7SS8IS-T^>&8:K'6^N4968B1
M:'0SJ2/64.HH^VDAJWD4ZEL-X<WHXGGEX)"L[^/KKM@Q]^@7W3Y*8?YAVO5V
M0>U8.MU+<T_*9HR%_JN-^+859.=1:Q+&-HO#T$NO39E_;IA[AUO/U9XFE92?
MQ%86./9KNK!93=ERZJ4S=[?Q0V%?D<H)TZ#4*F"@,B@ R5W$S<V(E[>QF*HE
MCQ<HJ,X5#VB_U6Q $3^U>Q.X]]JLIJ:,?I>6OIL[[9'SW3#B\7ZGA$:,\$TD
MM];S5+ZG+BM6%46<U6M9!>B0+^!,I>E$)N">\Q^<QYL3JU1UHDVJS_$H<>?3
M"SO]G-?0=76AX'D1H($"-W+*[4#Q53-JZ4.$4#!$#+1XR='=*!)NRC&OUSKJ
MY%H%ZGK$GLCVY:P>*1B%1N8>BM;%B7ZLV;T%7LR[(X'1V0([:C[)257@,5-$
MZM2O;J&XK*DU42&U]:\4W>1"&\%.<NOU9=[C=ETQF42XEYJDXXTVHERBH\=5
M2MU)0&<?#0_O[Y$!5/(^WVTF@DY5B<IDD;M^I*LIH\)=RFE1S1M/4?LV&#W.
M(E>6D:)42)'B[-#2/T]/QO/_PYBV?V,WCZ&RJO\3'J''-J&-EHP<HYQCH25H
M+\O.U9]4R!]'I)J<;0SX$*&:"$WEQ3!N_9Q7Q2$G6-&NZ5WZ](L5ZW+L5OT?
M'.KA'/X/)-6[7[U0)4M2UYOMU"HA/Y@M!G03GA@2+I=V6!PP*C]C\MFM\F&)
MV46P<*O5Q,P8(F4SBQ>GMQJ\&=IE&0D(2("@:E5+*YQDJ5,#M:TA]\U =34/
MT\*3F\'38_<E^3Z&L(=O,8' ED4^S";G6LL+E:,\%]LL<]PMLC@CAZ*"OOQE
M_C2O$8*::"\5H\)B?8-NJ7'Q/N'-A1$H_%MY5PAJ-HW2$H],A2=9J=P9M:31
MX,#!WR^ZS9ZG/.B>ZUP &,8'4]93,]>H"8EN28A_:$95DIE0LQ==4;_D@T_R
M/&#8%33P 73?VRJ]$A"["F0*U=&I2] @#_9!I9/_5*\]?N-) G<4?3^PB95)
M,E(/7$-3/?[NYGJ&-J,SC_+:>*KGP"[P90CVZN2%2I&OW1 A/I,(5WX</>:3
MK4AT$<SZ4A:[)_DFF,TX-VA7/^!)E06?D2MJ__, S*3&6ZRH0;?NC:^8#:?V
MA(<NV:>,QX%'\,%?8Q_F/_>7Y!U__FHTHS!M,?U3\WCZ<]%\GZ_E1 &(K9*%
MH0-MJW)_3OR@>B(2KORE'ZCE;)TN+*,;BK.KU==.?PKAB'5?*-]]BU!("WFA
M!5N+KYE;=:G+X>ZCB^@@&P9^GMOR)!+$=^A!<+4Y\0,W-+N;WSEK[['""QL<
MS&5->3KIW3 VS[@"VW0/7"EPX4&?3=4?6AC?<2=C?!G<=EAM;4_]49;SV<&*
MT)_,G>5$0;UE(E2\9(S=3=$D1XMS169",$O5.@\?80R"GBFZNC;F:##B?L)\
M@]?;_I<>2M>T/Z40A14--R)C4>MHJYUYL49+ZNL9C)Q)H[KUR-KZS2]:WRIF
M0L+T1<O,V 9TND;CQ$( -:1(WX8?&BKI#3"[4:QKCLA]MCL+?D$'X&;[,EK9
M'T/EN"PUW*WQ$K_U$K33R-#K^RYM T+CNWI5ZNA*+4D*0J.-^^S=*DA^U^B'
MTI8W*WU3UP7.V_RTR?^RB/27EV@.V?E7X1H$S;;/.CA?0@$  @H<Z:))6IR^
MR7-5Z9?;"73A-?H3YWBMD3YNUQ#\=6&;P[A?\9G="(VWQ\:AF7G.# OEDA"-
M"@=4XE]Z75,L-O"Z/J?$8(EW\;[>#GS(%63^1?)_32/TB+5__? H7<>*K668
M;?P(Y>(LJ?QM@U5\-?,31#C'DD"GJ+)?O*?CMMG?BP:#6(:>Y""YA5[]=UR.
M3#VNJ1GJC@0NG'B<E4E>OL_O77Y&WO]!6",D#C;93VT:)F\UMY.<#-'6(/(U
M7G#&PE,#X$C_* Y%%%S!HV4M0IAK/>;UIPXI;3AYUYH)J7BM>._(+LS]^)G1
M>SC[[8\NCZ\D42:S\H"@ 1<A@^Z23(C:CS=P<5TG7T9#<_>7X:"#P<>9EU(>
M0[[T==/77\,L4G$VNIT><(AA==8XPBB^? UZ)85K\)G$/<6P;@+-F@U+"F7?
MF71#5PF&[@Y-^ K1??LH#.,  E*V:/#,6L)UCP%9,6:J85<9ZR'C.2D=\^ZE
M)WO*)&RXG@3-X9TSGM##""AUQ\D?',ZSDN;R\MJ#),S#A1+I\?YKPDM*?2.
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M:AO'S9'?F9J,Z"$:QHF;0WC#$9)=_']9Q<#C O<"68\/$KBH!OE'L[0-7?
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M%ON5BP5M=AEV?/[YZ<KGQ'KJ,K.CI0R?@(^TA31Z6SDHO7UQZ3A^%8S"<N^
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M21+EII]<N#\<*Z'&?ZA@VYPU]2]1.DYQ57X9KJB=Z^8,BAQ7?S.@@Z T";+
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M]$;BQJ!>8)3B&+@)#>C3!??0B# <G&0^>IML,2097%-SV^7 Y<6'^5KDU1W
M:S!."X\UG,[G:+?4B!$C<$AL*KQ''7]KAO2TZOLS<ROS[(#:_ -RD?MZ$YX?
M3.9CV_3K$3]%:/4<GLYEY\0 5&$_/<G;<#B?.<GXJJG#[<+;VW"VF@:3)]<_
M$*>\6K$==#"V>;<MA5-!PLSZK/:+H>O$](.#C5Z%=A/;\?U=9C.3D$QS4HP<
MA'DG>3IV1 6JKUGSH,MZ#C02<&-<$]Y,HQIAA[!,248OR'[7Q?SG+S4IPD$
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M5-P SJ% P'\$()(U+OR U'YV<,R9ZDP[W"R6J4O4A0<C$GRWIL<L93,G8MP
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MI>HWU.V-EF3:0E%T.2P7H_;XI.D&R5;337JBQ-X7^A8\V:4RB3\RP@X)8#1
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M?*(F3=#M9LQTD)P:\:#K2S@FH,+MA7:R;:.KB88&1%?<SN2MIXG=];@9)QH
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M:$#+Y/PD7 K2]^&*_R80?.7P8L(=A[^9K;F1^5F6(I17/0I%'O.#VIN7D&C
M8('_4X;60?=D.7";UL6$W^B* W%_7O&K,*?BZ@AV\XV%6#F 79VEHL[S413
M4/!&2]O9H-\X#,D'.CAIR_)0-%P)MF=2'.<^R1BN-N"CN!C!GFP[:+CB0 ,D
MUM" 5OO<@[-H-]A])]1P0H9-?Q_LO4('C#@A7O0R_90H!$4ZX2=N+;38%4AH
M@SG],>\=TX3&K=$_"EW^WSY<?AO5)L@!R&BKNW&N5R/:]A^3:>NUHKZ-[L'
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M<*S_8Y0?SQ%/\9*K:>5NR$FWW^[*\.UMSP7&1!OBKR0N@?XVF)O71,95"(+
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MOTE60M_>DY=S7>!# ^+QV_9RUK155N1>(*EB#CI1<M_1@ 6[O>VWR!O!,^Z
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M7884-6 ]CWI$;D2A3Y C%JB I=0B^C@]A;-72^%\,H03SMLN/H12[8;PPY.
M'?DZ]*K,+=JP)4P;+KW8J,!A <;U09=^,ML*@T;%QY[UAJK'HUPLA>"9LO$H
M*X$$W+$;3W3/B)]B!M8@C%\F6Y9>43BW9R+E[XL*+F"<*)**%^1&<28\$!F/
M<98J)U"HG.&!(?KOL97N>+F?%5D-5(#-?(X#?.)C528[EQ QE8.^BHB>S%V(
M]7!W56J]KLN-<>KT'!D]AY,LKM0R31!OL>EP7O/GG^PO4*F*>7BJJZKRRL_9
MPYBWXI'%<#:=2*'^YQ?H.YF:8JR122#YK)??7!:CF>ZJ\'Y:72EMPW.ORD=X
MYD:R-!2*-L%L"7I^^O7P<%\+16D3Q?@&-UD)KN/*C@R=6)&[5"#XRA9:+WY5
M!@O!B>*S7NZZ#*M(D@T+>F5G>CS?WW _$_,U+!,9D/"5U'!M5-=C^W]"=X30
M$^C#;9.1-L(,6\[U:,'<.388#ON*"ARZ>4OS7BAR<CB"R7=U.1"]RDU3K9ZP
M[C)&ZTZF>K[XS/$PN7).7:CTN1!G$@('C>R!=Q\=]H&@CQP.\I%K(+L2]!/J
MC4NN'Y(1.^ #"ZK2AH1NS-H?Y8Z0_WI1%>3<3DG3ITDX3!16#-W2)SY &N@C
MG<6P%[S-^WJ=_S>/: M8*^@89,HY=F'7D6&,PD33?$]/['HZX[#*M+<.OK50
M3@31E)TT?*,K-Y2X12E'CZ>R^TW R1'R(#6KT15UBB9+#6G*I2'@ ,VUWGV=
M>VF<"S)E4+FW@UN@BAD!0X[<K%D>&*J DA]:[ZFQ?TEPHL@(&FSY-],(U3?L
M&R+M_1<I@H>M8EY4_<OSJ1P7B3M4 ,1 83"F !*4WM=;JS5-'U#^5"#Z(16@
MRU8!T"TZ:-(T199NG4:QR$@]RA+*886% N6G J0YN#T<W1P\_G.@"7VD9LJ]
MAM:N.+IUR&>"?C"> 9,@5:MR2NK<4X0\3;G#5<DTEV=6H*T#/@Y-&)8.V]S=
M\B,OIMH*FG6 #= C]JQZ5CH0$BUJ%8W\?#=+V@U<0C%>Q=0CGMQ'&E/:W2IQ
M]E].$:1J5N!-E:9%3:4]S^R>#3S/ZQ$)!'LTG8V>+&?FC*8Q-WM,E@HWNN6E
MZP:D&PLM*TOX871,]TV'F,^6W$9S'6;[F PVBV3 Y/'']URF9!K,GV8>V.VG
MQ,^JIV*4_Y&E6')3.MZ&@(KG9;@,+69P?_:GY[^*7=5R<DQE+FPLXZO#%K:
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MHA/. 2(:U4.6\_*N;8G(<4FO)HQ6AP9W6Y_X/!6^Z%JT:'W&^B98]TYA?;>
M-Z2U:BO\_0VGNU'3H<$B0S"<.Q5XPHJ^:141_X,FY=-I1XRTHZ!T[BA18D1_
M&*%S7B*M0&Z/I5V&/QYC2VP<1@SAO6_&!!A:P((H'-^)?A8[MFW"/#^E1F93
M#Z8M:<+5;B5+$OHP3SR;2\I4K[-W0]7-BPR8VA4QM=5:+$&;6C!>/'U1%81P
MG:1;EM$G%J>5%6_3Z'\XT+=+5>A 'IEI+;_4M!6''C);[Z!'WL;7^ZH/??TY
M!+Z7WQ0.K.CSHT3*5X0^(8Z: J("S#]5!)'7]0\[7FF"V@L_:>,P6YQ-I2_7
MYX(C?6?D>XJU\3!$W$%!-B\O'!7@JX)DMQZG-*/'3I<D!P5>0%"8S>83V2Z]
M]%[B5. W*2(K$"[P\[]57O\PGZ5DB<2(=H(1-&&U;=$N&YX5YWTY?V8-W_1>
M[I6F8(;?"]N32< :AF]$S6'2O-*11C(R5;G7]3\K>8?5G[UEZT$/,=ON[M'O
M15EB"J6E[=ZLNBQT,#E2@<'A ]7EEIB"!_Z.=,G2!/_H\+M)4L&&8I=1=@-A
M\S7TQ2P^IHMCIG1@:UAWG"UM-)\Q!SU,*NYY7^D4XY L-03F))":ZQ)J<\)>
M1%SD;/=.I>M."!2N*-7--3T9<T? .IR .$$^EKQV(_EG;3GL;HAA+0:=%JB"
M(LC7">I?71$L27<[I<;BP @K<U:4P^:^XU?*8,VPGC)) .9T54$0Y-.):\]'
MP9L7KJJ="C'.]SX7Y+O8[7/_<)!#-S8]HU;P . #>8@]8N9X-*]]?#E#D &C
ML^&IJ7$HG5GI9G8J.U,SFEV:;'SL:BH4(GX_2ALC\&KB7@%W?TMPYL6M KA!
MM[7#Y52.(P0J4$O,^S#M,F#_LIPN,?-.],,'AW-VWXK%G40%'L<&IP5*SGF_
M:],K+147DV7I^)@;9ZAZP ?:H!\:2RPT<'D\[<7X@UFJ;S:50YSH3OB&/C36
M+ON\Y7,MCXU5@28772)FMG,AR:C?0T)$+0*?B33>JC5_@KCS7#*3V5R4!:Y!
M>\S\"#MU?-&A=^V**\H2C&Z[UQ2[8Z6(<A[Y+AS>A3H,0G75W>' %!:$M-)G
M1OK(;@N^?'0L(=]O4KZ^O,I2PG'*J]YAFGNNUX IFJQ,A+GC]*[KOCS][!'=
M5L@#RKG.%'B7V">M,Y:7IF#JF@"*"J23CU3T;&0C6%=C(I,U_8KC"TIZ\(&O
MX_6*G<,!@C)Z(K,_*Z_=MU W+*:&8:P:4<=W;)9/T4SIN&A_!9\$PU?L*13X
M5>/J<A34*L73",T6(- QL?-%[#G4^DLIJU2O8^JA?-LUUXP(])%&I/X3+/.H
M"]]TXWR[Q-%+2.YE3P,F\0DXZQ?<&V$9._O;.4PBN<2<Y7K%*OUW\R<XG^BW
M7KB@Z1V_5M.DS^:<,( W_.0$KCI^.RL3N/1C J48T:X<\CV2$^QJ]ITP\%G)
M_W1F.=8[T5F^=6')2A^'?NS[(_1>P(/G=DSQSZ*D<OL"%.9+$V083;J"ZAG?
M*]">B$8#3<2D+=<9;I-K@$KQ!D<=%LS[BQ# NV3]H8UF).[(%T4/7Z1<&QC
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M2C;V4KHF!Y2<2-P0JUY4M4FYZ27MQOHU.#/[8_H]2R'A*LIQJ6@+)XH&PU$
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M+L]]-3I6'U=]]6_ROOTZM%PF!:%T$K0/HFII^_PI$\"TM*]VG_(3*0<W;*]
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M4]N@;MV 0X+ +.&DD8_)2-GINFOZQI5Q,UY%=0ILHP!/ [ \*BQ!#GM@.G=
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MUQ!;4_E?]_P7>N]2P8"1=MA]4LG(]K+#Y9EZM"NP2\14#@L1Q(K7HE6DRB2
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M#@P@]<YR6HFD[:U@K*R&7MH?;3<XFQU<B$R@QT\?#R7&J*C"4P9]I%F3.)+
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M0D)UR*K25N6P-1K*)G__85+#$-6110%,SP9Y[X6IO_1.. 3S] 0Q[5!NMT#
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M=H@27Y.8K_3JA$G2ATL+R7T1)F^J:?O1^^DZK-$CFE"[+K4%VB_E_&SIJ.Z
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M0)M[[QYSU-SR%SI)C!==&$? _&M!PK=5",,%&]N6HOSKH==P(=ZEP3/)62C
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MJ9T57_F+T8W\.T))>;V/\-?1[?W-Z";^GM']K8+_E2M6_DK&OOJ?NJ*VD'?
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M7#*8DF/V4J#+"ZE6P4[_[[W\_&_Z[Y!VK(<\&GX'PR[L;5>,PHUL]EB1#P5
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M+-"Y3';9D6]#BM5EL_FJ0(D@[#KB 35Y[;B:5;BA+)D.Z8L*JC5H*@K NW>
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ME=*JK'DST+Z]_)X9IVJL)L=;'#1R%!AE3& Y;\DD>$\QCB&Y#9U_%4PJ/B7
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M#FTL9I?1*]]_$F#(T%Z$\:AVF:&1@V^H!-]8M^*2;M R_S1O61U#1V4!S9K
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M%\N,21B'\HIS.A6L]IEU&6]8O!"/F-*%[S2>".#9G^PU3=BOUB\I9\JW[:Y
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MP?8O%ENO4H>BH5Q'NI!0%9-L#SLKS_S1?08ROF^F*$!WW_%,S4.^NRS0,38
M@X?0*,Z,W^RKGN9QW;Q5M6J6='_2\X:\,[-OVC)[A(UAX!C6Z.=5^5LA\"$G
MDTD(^T2TM%W@:M"I?F#HZ*,' 3BK&NKE!:*[B4TTDN:1U)-^(\=$Q<6!KU%
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M;.U)@B4&5K#OMK_X)C&9Q@[EZ2)@6B[,KEBC*,0PUTW1?>F^T9E05:"0+..
M[2A[PJ6/V;[\_&Z(I!<F\E67F'T?9V!VH1"O S+F _^V@"FLKRU_,QI)&>5L
M5VIOAW'-8_U 0I5#S<<V[7*1'WVJT>+BM-.N/'H"!'4LZ>">DC,ST<COFCHR
MU(?-]--5V+%^[-=K672Q3$(\I72 D$096MH5K#J:ZNP]9.A"+:)4-CF"'/ S
M[Q4:2:0/EG\$L^&Z^5:Q+CLQ)@XEUT@/Q4$<O9T_"_+*-4$_T@>BS*M]\I_%
MD>*%Z$$,2(2W:UB@HI^MF"T6X2G*\;P$EI=[!N!.0L=U((('4E?-%Y)#0H7<
M$S-0 BPCL8_%JS*7#=G0'/#'6 ,X<[?=_.()%ZNO%@SZ=Q83]N_6*UAN-*R[
M@MN"CKO"9,+I[4"_L?DR\)0CR)*^49; ',5.!D+OJW_*,X:T(KB*"HB[,DGX
MK)1EX;C-E'I QI-_=:J!_>O[Z&_X%8BO6:#R]&.43'^V]CC%[.%K'X,J')N>
M&[Q_BT^CP*$=-CFN)T+SDL+D:7\Z37OYW;8/55FD.T5_#J3$;@RHC@K4L:A>
MK4YF9$2_H?,:YQ3X_2,6X7_HNM+4G(*399#VXNEVNJ9UM2'I!ZC)@M4?4[]T
MVZ(0B6[=PJ+YE$4@=#F*M^/\F0R*W&<,C.<\N<"4*WF(4Z H!JO,HOXVW%80
MJ <WJP[_D!A8^R;<X!B/6BR9%G4PV.AGF1.A>HKS-"\6L$/96.&2,'YMX;JE
MIG0XVY>,BOP=CAH#R?1N_LZOFQQ2Z2"&U6/4>8X$$&_$2/^LR!T>DG=;!7ZQ
M'E/4-Q.KUT2MJK)B_JSCDJ=!"DY>HF(E=.PM7>==9A)O]$:W8 U/Q/Y$>4?0
M^:,O'+T?])$K]B*VKG94P+W"B3:9B=R[[!WA<!G)[AIW7_)""4[XA<J:AJP[
MB1@SL]1.5:45_@4]G^SH/C?#6@XJ\0/LA62'$$=AU21V]T!HD$_.4:7KRF"Z
M8\7S+X [/31!3=I 9]X>I$(_43ZO8]R:QI.4=*:7=K[\P%81/D5^5V5U%D.-
M2$QP%IM#_T:K>#L(\Y#@T?&JG>J[?QW B]P5O-"Y"R84B+J5#WM7O+^)PC6E
MJW)0F>F5]>DS* $EO+6*WE%KW,,Z0[0'RUAP*]9!;*A,A!U;ZM(LNKBQN67^
M3CG-TP=(BE7'=8K\=&):4.S@YM#TU=U%=7:.,N]9+P0$XR^B]I2!\-'0J?M^
MNN/[?>FH:>B@Z^\2:P6=!O ('I\':$\0H?&=_1S4V7'6!_D;"3(%?F?=:;U
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MM&_KN:K D,57+:_*7RE]*-W;\@[U>2<?2I(B;0[S">9JKCV%* ^_LVGK,JW
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M.920,!/ZO"H\6PN_S6G)TY2LHF^2*ON]3W7>^M3BR4IJR:DPV02LP0]]=PC
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MME(F8HM]TIC#B/P&4IF1O7_<.$71^M$+*T6WY%,T^2X?,Z@@S=UV>1CE*QT
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M>VU"D==2VC#'A[#1Z#J (/(";-F8[X:](L]2#>&NRL.@V_EI4M2RL2$CE=!
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MU=14]W3US+(X^/#,93QV[CXY86RM/NY9OL4 YMF[;<.A;C-1%T_%B&#;.,Y
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M+<)%O#EI*>.B1TF\1#B8&O&G5R8P6Y$_JKP=<M5T!ZXI[*CIPI08BJL#2RW
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M1V.I!]IIE?+2:X%FFII(XN J"@8:O#0621F@&[6@:JND8TMWFAM59,C6'@(
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M,D15[7X'/6U%!&(=ZCH/*JH+:!]Y4D#2TZ_Y/ZO-7K#T=JO/H8M*>V#G[1N
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M[I+<_YZZ@UNOZKWI.X,S^.9[LG;MO09KX9DK\W$HNZ/_Z6>$V<#8Y\W[,^H
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M(2ZYJ[>V A)$/VU@W%I$-.Y<3<8)EY;GE(7$GJ"QOZ5/AE'_"@-9>3!NA5.
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MM6[(S@>T=J?:V)UVJ>E!-SY<P8745@5E)KP'?Z[V;G2DOK2R_,H&R]$IZ^%
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MF.; 854>I ;0"V1K9N+8W>)C_URUK75+40RI">#NW8)MN(T7!=7::=++&>3
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MIPE^L]1RT'S-%+=E4AQ5<B(LN?QYCVOSERYA@" .'FO$"]5ZPG,4L7R"9@C
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M37H0Y>G>[-S[".-F&QU!.E$]]/UM/$6HVEAY[US<H"5)?$B5+&-'(ULCO00
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MB-3I2]%-E.CP,@3KYY(TIQU6\P);-GEBNEDT-A,$>56>U-IU68ZH9N1"#I*
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M29XI?UX715A]?H7$)^K-.5"NO6CQAF_N90+-$ W>#[(]@H#4]#C1FCN07<(
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MN]! 616!X51,.U)H;'+<J\%GMP(.QM.:S>!LY0AH-DFG/F]][.E(WVABPV^
MSDR3'_@YO-DCVYH@'A!SWL0_YAC2^&,YULPCC#LNJ4W^-O6 "%/AO7F4V=LZ
M<>ZAM\=CU/U4V]/E!6TCM<M29!&#1OQGU] X="_V1WVPBQ9M@_#9TA.H=B:
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M=^[!_."0*A(\@/ I+([_%M:[@.DQ0>N_(XZSHSXAF62N5E6G)B7[;^[4_X)
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MO .72[G :"1?A3;I)WJ=&$W(10$QOO+=Q75IZWG$80T6)+Q5[)2RW ;R!4W
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M5._OSG?KZ%7IH3PM,G-8NGKTYK/FPC-/JKL>5_[.?9UZ;X7C"!=FH^>[C?6
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M&K:>$$GCH[;2C(1?=*J/P:6?ZG-\<FVBB/:0EDGV>(X_]/DWC2BMM6GJ'#E
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M&ES00$G<3Y?:Z=G1@+!GL:\H?$@4L]>%IMP^=Y6XP6?[GKX.W<P51XMW[0E
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M 1$1(3$I-1DI"0DI ]5]"FH61B K"R,S\P,.(>X'; +LS,P\DKP"CT3$Q,2
MW%)R3T1EA1Z+B?XU"1X1$1$I"2D]&1F]Z$/FAZ+_CP_L=P EX>U80K';>&R
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MCW5/:-ZZ31+3<HBM<R+^<NU?GOW?<RSH_Y5G_\VQ_^[7 H#T-AYN\VY3 D"
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M*0P_1+<2C^H-/E14VV>P*:-2-KU&>!^2[&RS5TFJP\ZJW$<Q/SNB=H8'T^M
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M36_'W0#LJ158@ 69F0\P]LM;"17]KVC#Y&<3AV+=!94]RQ*^81O.1^[3]E5
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MF'G(H7H- HI1:-6^\4J^(H:>:%0W80&.H(LBDIMIU)'P58 ?7737IN9<U\&
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M(\[@[29_,7DNKG2%IN'JF/)ODSH58J'Z*Y2V4QG<Z(\>QZCS^+\Z :>T95C
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MZH^X8MQ4FH\-M:JD]>66TT5#2EB\1=I!"&#O-Z3-J)"0;.3AVNL%EO:D N9
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M4P=J)02^M>V$]!R>'*.O]H&7/1#$J[^-]-<\=,ZE%?Z!^ _$?R#^ _$?B/]
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MWKC2!]V&#!T78@$PR*[#3E_7%? <=#GXIQ*T=3ER+H8%I$$>)^5'\;OCD/
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MY%7O(5F]O&)MNWZ[V\W?;.=%JH?I?,JFZSS&V-8RQV81#AY+D8$ZH%D0A^'
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M70;'& W-K.(?-(B3X3P9T( +'XXXA78-\;3'@B[A^N'HU+2'3\+6F"1GO)%
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MD390N.:9[IYAX[YWC'#C4^7AKQECI8+?*/A<DYBBY]S9U;VO.PE$AZZ9[-^
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MDL?_Z"0O'C$B#*UG-$?.T)JE+%?55$(?3:_<_LT"YV)_L\ 75JWB0A8:7BJ
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MEQVD[=!.ST""AF3EU;^O=@)GK2#;_OZ36T;.Q5#>76<FA5$?-H&1SB^N;E+
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MT=2O<$_JB@-&N*3ZGEQ^2[;X#F]H_8%(AB,+EK/YIE#T^AQ@MQM0Z*(15 6
M]$AW\VOK8GO"FF^C67>NXU7F6$\UU;:;*F)KT\_Z,]^H$S0!?#T:=^DZ&$ZJ
M[D:?#&VP,">%,,N+GA!OS8<ECO=D.2@\J+/>'Q126WXC\UEJ>'$NNV4DP ;'
MI5<5 ?<+,!,*=KZ;LI6HN?NLLY(KTC@/@])L+<ZR=-3[^F"8_&/,ZQ=OY>:7
MA+[*&7LM6M.82*P?J&C\<A^ZTZT"C1''?'J<>(AK9X*[%RISO*6BV'4-#J1
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M1I[JK@1R',-TQYBUIF\.1B2I=F_:X_$/NK=0J3-EMG;;FJIQ\?H &U^8>[%
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M\JW]S<B'(3\ K/2U4ZWU]0#65R?-9@L(,+C[>"$Y8%I5#T21MN!#B$#5G7T
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MZ?4M&'1'7"961,',<)#R*,=$57QY[,LD(3Y4=8#'U.=(O-;>C5);$-&6U'!
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M %$ZGJ^>C5T!K$VDMD_\/Y@:_'HI[;1<%>[%[B-/.I&-34-*TTS9(2!\[Z:
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MWW(#:S>-3'4]^B<'R?\_LOP]X_1WB-ORI2SZ"N"DZWS;AX-*TX#AYM]MJ\R
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M.08#9<_#A&>T@L+<0,:U7SV'%JIOP5ZB]D-=]JFTE#QR26!<')QM6J$B#N2
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M_%,BV*3?B / (*!8VJD2\'I"H:;(0>.3@I+7D5:ZFC(*4_T917]+EJ!.1QQ
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M\1<YGH14/YE.^1$5,%DFG,H/DQ2XY5ZN5-C.,*VX,MBD_;I%#R#?CS&KXR>
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M5R[G;=:!A-> 'G:8B:/PLM2 >D(3EMVI?FK&0$"%HKQ&GD"#F>E-A#+NT&/
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ML<9_C*0;^[B:0NH'.L)W'DT3@!-7#\-:]?U3FNMJAH5YD@O,F?6SP%QJ4R+
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M ;NCHYEO_'K'B$\FB4=8]]EQPBP,;5M]$]K1\AY_NWV+U*O,F0:J,6B%!?I
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M9]6$S'N;V,3MQ/QVU=^<_DVWW&Y\RI_&4*%4J1C$6'=6(]#TF\_#7Q?X^K0
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M 82XH/@9%-=X%?YHW6TQ9:E)QGDANSPZRU[DM\>59SYGKB6:>5;,'!"F=F=
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ML8^GCBWH[N_-]S(\@\#?GVL:.ADT!KA,]V*V_2E6X7 0*-K556.Y"')UZ,J
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MC$\]N(V8Z(\#;2_\1ZZTZOS6JEIT5D=TM2A4UA*)S?OO%3Y4X=&]'@RBW4(
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MY<C-SOZ6#MR#$M3_,XV%SJ+66RZ.W.*@?WDL\G^^X""A99;E/"M[)BG_+>F
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MWZNJ!R=O, 7? )9/1QX)!C+OD>\"'TB]MCE68_,6,,LG?B1^/.RLYW$J4H*
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M9BI;K4\/);9F&J3Y>WR\@=7)31&&5PJN=6H/-N0]KDFX9VM[>;,MN4*,%AH
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MHE;T@W36UP]1J\:4Z:SB/,LA"4%FR,-DZD9D=7>:&*"V>6Y3#Y]A2A4#=)I
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MR$?G$Z,:W0,RJY#.YG5AG ''0<YK6&U*3MV7/BD_U\W6H<X_0+QM2??$_:M
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MB5[B<WN_*?:--/-Y/ !.:P@F0OLN&G>1O:24!YR4CH8L'PK+7GE*SZ+0+VS
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MCS8T8B\3LO*3W KY>=0;<8Y^C <@=7?-(+RH6J4'#L7S O(Z$^^$6+J6#Z5
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MG\&&VF]X +C^A+_&#ZD',;X=E2O+[*5?6,"128[FP*ESQ)TQMT#;+0]%S?"
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M_L)?^ O_-72&&9(D??XT.XB\F8N5OU62*'R*?F8K!YL?!F_^_!C0$U(H[43
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M. *9U9UM[MMXM.\, -="#8JV)FB'MZAGG;S[S ),C>_"S.]&),_%LRXP.7A
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MJ<3S <  #-+]N;.*8,D,-E[W*Y_C\^VGN!_T7[TD3-.H.4#^60!-TQ<(!N$
MQJGCD9O4B&Z%?0B@$S91C0B!=:5T5V2+2('BN""$0;26_CCB)O4C!QQ0L8_(
M'$RU:0;G<>7!E7I3)'0.UU4)#G!01)$\[VTZ.:!;^^T)A*F"9W\AVOQ!U+,\
M,C@K3"[!)&%]M,TT*93]\\K9[D;.U()&:/F]'@T]U,LC 5MHLVFHDCC>:>?
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MEGA)NEY!>17C7*#>V3_Z,8WT0WA0)]5P_E6GM1@C U>32&2L<_J*[:S#20D
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MDHW!+\TX;3JKL)<N5'$_:70-=F3(&L>Q@I,F:F)P=RJUP& !5^XY,CW[^!,
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MB2GW?,S]5+4^(>AQ:(=297DH,UF:GX]JQ/Z0GCW/"VC\[#$B-51OOL0!MSB
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M?H;Y@5?'R_,?KIR(NW79^UVR\B)W>9.(LS+H$2$%'CMR(["3XLD#X="4^BN
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M01]0P(IT\I.$K@!NHAH!3\9+@!^97[?R,6'VR<DK8)8A[2]?%GE;HU%LX"M
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M'7AVLT5=1 VV7_M3S^H*(!IY:1+V%Y2MO7FSC?X(Q':MN^=LL\Y/Y7_!Q/X
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M[UD5CK\R,[<)%YL"]K J??D$L9G@4U]6<]B42IT9_SD@7>%_/,Y0)@[ZSD$
M@.]W9..2JLF$531J9_[DE?TB/L#)B>9>?*LIZ=;*WV-54?(^GQ<BP-VYF$@B
M>E3-XJCD!5L-:DG@L"5#[FYC+_;G=T;D$CY>H+^(,O1P:NI, 1_9WVVS=<'_
M=OSHDV7KG :UJ3YEBQ]_;-*H;@FOIG2J9E;G5B'OY\60(&%V\RQ%L91LV9<R
MK2J>$0:DC=(E<?+]F<7!#,J$K-RA1S\"S4HK=1;OZ A@HT::H?OLEM"C'U<
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MMHP^+DGR-8HI.V&U]CPDK_GD,Y39!IQ5/\AC(.@N/J=D&)Z^5Y8\?B?VM0"
M#3XZ"/<XQX.R;\671K7]DA #U>\.730GS=Y/V$KG;GVRSL:&4(.P;0$MLMQ&
MNX>\)% U*:SZ:WLMA-2\'F8FI56T3PM^DNL%L@_K5BW_8(//<9X;("$"^;8N
M[ONOSGF2CR;<P:?>8G.;41/E,@]+Z=#YBLV16O(:BH+3;K4O>P+0MLH:56>B
M69DO8Q<I._L6J),\>@+G/_P/]MXZ+,YNR1?M0( $2R"X!_<$=P@A>'!H'!*\
M(;A[("% X^X2O('&&Y<$@J=Q"^[NT+A<\ME\9^_L>>;.O6?NW//,'TT_O+7>
MU56_5:M652TCMS2IZ4Q(G],YGL'X%N-6U':D3=P8,J+GGB:O&;,)K/PQ!\?_
M(OK&./5TM0@=JJH)]&Y1M1*S=V:^&YW7R?Y<[XSFOE]Z(T5\"]B*\[1V2VAM
M.2<ROQO*-79@1^<)!_U*&%?/L\ L[]?_/S]>ZN^?PXB[8+#3&5&J6<IX8'X5
MZFJHL_W5Z]U*^]6#G\?0#@G__:*J>X,-TM3UJ3@&10M-ZI8Z#@1O5Y_U2/NP
M]+#8M@E^'H;A]\_$K(B.]@?G]F/Q21TS.\AW(2R9HNJ[_$96E.2\W1GR_BM6
M#>+KW )NA'-O 2[%HU:W@+/#A.M)^VDEXU7/O?,'>K> <>"-6=%HR-_^&1^#
M1A#]%5PR[V;DZF_:J(Z)?'/N;M>JV=_-=;9EW?]:SQ^,[3A,;GD7!9LRUI0K
MMEYX"V[8L$WA/I.;C.FH+^HJ(>$QW2T*'6/+#6M'3$Y^2<FS 5N.>*!FLUUJ
MTPJD2<FM9EG&N,8%$G)7T85\J]F'VS-S?DJ-OM+ D-_8+B78)&2AKMZMJM@X
M?3X+2^GP0ECG2D-U1H3%"C;L:,?M[TM?-@Y?3PXK2,S.E=7X4#4UM80?FJ%J
M==PK3/[T633799SO/C%I"7/!\CP0GA\ LYIZ*\Q['GI,N_@)T@I??^8A3AE<
M.JS$^ZJH5>KY$G^Q9;J\P&+=I5#'JZ0.%LT;''+S[1O?'\VOS4NY#5*%6,*'
MH@(E#:L&]VR]]JA9$]4K_3WNJ<LPVWF,YJ54T'^78\Q*_"UUTV"(X=N%>GI3
M![/7^#=7%E/I"TAID;^0,:N&BO&/:[7PUPTQC7#[G7*08^8V##P-/NQW5\NZ
M.$;< C0<C<7\X197%HYGZ"S=[(TI$R:UF'T:AOS$)>:*^P=UHRL5Z8N,KQ5@
M(:F::OL;1XLSRI4N-BU[)"FO!Z$\S_"WGO17*S$;W;<>K"WQM1:T48GY06,@
MTTV?H":Z]L5.Y.,X 5^4W$#)ZKTC?;[W\*;23S8!0Q!@K)0L13;>SM,79:-R
M&W;:4D;,N:3QJQ50P]Y]8.;7LEZ''!_8QS7F*+N8S3!<9:_>,ITS+Q"%:#7'
M9]XA.=XG<-GL#N@!^H:+OW#^$CYTWML,RV$2K\'N%!AH9[:E[<'J)TH]W2R-
M4[<EVZ/0QS5#)6LQ!D_8N6(CSX.Z0V=:3="GLL.D?.6.(IY8C9/T9=Z\>4A"
M7@CF"/74M&4(RP_LJ-#5ZY&,O\+O!VB*+;4\8@N8:(8!IA2133S2K=[Q+*EX
MZD\.@*OM3T7-">\&B#R'__LN.G;8I !RJ8JF,YO!FKJ3E?]#272.=>8*707:
M9\R?&=,4F4E2Z/=&L7<LF*.+B9S1>(8DE[QU&(%4@W$J?G'%<"[Q$1ZWW/@^
M\BW".8$-[=U<\JAZR%=([%N5'UM&,;$:@]""LP25D:7#M82'ZXWHG5G@VG9)
M'<;XJ>G1(2]QSVQ4@N),BCK\NY[Z< QZ"WC=LI?\/:3M(G0,%4'U';G(K&@"
ME*"3UN4_)G+XY#V7MAR>J;L00>I8T"?/)'9VS+VP;VO@2L^B&4-=<5L.E*?Z
MD&,(6Q66U.&BUM- IR@D+?,\Y@K0.*=!BF1HDE_'9$/KS<?+.7<@>'"D2FB'
MEJDAE'XW=;6R,)N.SHD^>3#@C\0M4ND<I<Z.E](M@'HTX[+M''TQ82\"ZM+,
M<(>D9?_UPE6 X^C9O-6C3])/_CXL S(C'?BI:ZIN 426R4Y(1#/Z+[[,<FG-
MF23JGJ\\B.#O8R8)EN("6J[0+Y7G%EK5U#?LUD5&"C(* P-*0Q&Z\EH[V2:'
M V^06$2QT&^6%*W.%N#U:VP9<G#(<CY=KW4@G';7VI*"<03&V @QG4QKM4]N
MSXI%^@[85&1>0L$W*6:@/\6M*D$T-/3B5<;Y!7/X279\*-"9R%TNPT$._52P
M[>0Y(R5 6QWBT('!)P+(64';$_4#L6$(:@8_.W8RJ;%3:0DXQ\>&0 TL#_?J
M(C,DT?S.5'4L$L:K*Z:_$JQG77:*, N1L^^IU#[7?:7?J:)F":H#V<\J:.5+
MZHUP]Z9Q^M)O(+5D"A0Z9X&*LG2L[++ 3$$_8PK8/Z=/4X9]E^EL;P'Z*$[I
M G=?H)N%&^=^L27I58MF5 ?NGPKZYYXQ;"G&A4!E1QV=]";WPC8R35;T#H#>
M([E<MIR!;]%= 1H=ZND(%(6LF4Z7*NYMV%0O!I/UVS<TD2N%LQF+.TH*500#
MG.YO8OQ%+$,OV!"PCZX5[4&TQ,!^%6T$6>S:T(JC',/K6?Y1?6*E./_G/CI]
ML .4G<345SWWEQZUFZI'MIX^854);2"[IZ":%_^UG^'.=7:4<#X)FBY.J3$A
M^6%+9&GK3-[-<5Y^+&0EICQH6U66MXOKUR&>HT^".%YMT6H9'#&I!HF9L^G[
M.>:;O,N@V,(Z3>9"Z*S9[)HT-D2OZME&+B]"?8WF?,TQ;@$LUV1I#96S"0H#
M>PCECB'R!8^8=ASUSZZD3VL$++YO,EL5:;];LS #""( (SR%KA/O_\A<WVOX
MQ[SNLX]BR\8U5Z"?B:BGW3^CWUO LQNIEL/MGQ=;9_X1[\6I5Z*H1'LS(IW$
M%<U8G&*)0.Y-O%FM?A2.<'#P*KU<K=L* 5GKT79I!'6A#65IL'_5A/#CI^0J
MVB85Q>?299GN2 /K1G9]!CF0E#06JXJ]3 LGOE!+:ZH,N\'-+$DD5Y-J=E2V
MI^^1C9((,/7QP@8<9<6XC-4.V+,+\[I76ETU^%&+VHIGQ/.:_'&6*VUH9BLW
MX6$!'=EV5-4*AQ3V2M$X8=#,NIP?.E7SX\_8CCO*I"AD::/ 'Y2'=H\;/F!-
MZY*Y0$J<V%X.]0E!/D]A?D01V)*PBRMY*/M./-]24]!T:%I7 $A>V<Z>70"'
MS) &G^S14#*V"Q[)-);Y$Y?03,:P+PML,GN*86]JCH4YWB<.]BCGS_7P)=IY
M]K$G*XW6&B\T[#1V?MCJ)=(?$Q381PN&5Z%<=RX#\\GDP;._99_7CIXMI:<3
MGKV],PCW!O[1'2%'59 \"6I9RQI>O@6HS\E]N:&1#9TY6KP%I(=(9Q">MK\%
MZ[ 3\%Z=W149\LZB/%^'!;_F+B'@:QY^='5LV!=1=6?$132/2MR&%0@Q2'=\
M+3,\G"C#*&VK.KR.K[9"1R2I9= !/8+JBL5O#X2PI"[),T[",JZN&-;D># D
MAA;$!!=#Q--CYP1Q!GSB<+^IA1]*+,<(1=3\O+/%Z6I#<J><_PG#FIZ>PQ<I
M[:!.&,=>K%<YE2@B]N#8J,J5235&R*RQ1E''E#*,ZU*N_\;'^&HK:,K1SB/5
M<Z3(1'JV(#^X5&7V><41Z4>:!B$.7PL//88UQ4OGTJM3I;[:!8)9_["\!J,9
M&*?+NHN8=?6=T!OG@R=;AN>[&6GV$]QO%@L7!1<@/_CD$_N75*'3V)P5D"LK
M/UT5LH#85(K1\OQ; ,062D==[$SA97@T:/$[;%I.*O9:TW] .$G]VR/U6#U6
MF^N?\%7]#F) \NMD]CL4!^]0U!'][>_:D91%K=:ZZ/!OCWZ'MVX1Q"79VBEY
MDNB[EG7CY)WWZ'RS)<TQ*0=.B$'.,/GFKO*B\R'OPM\?N^>LA@2$)^PH^_9K
M7*U?JE,>C?H*KE;NR39)'SSJNR.E_*^DE60G ZARTS$_U9.,7+*OQL67WK\A
M$VD)-,]M]7%N)?YB1M.DB:W^6"AU:)62:=UWDM?WZ(!R3?HD[JX-I<_'TQ*,
M)V.P/0>_D^5GW0(L?MRUVG??-(:3M(2KJ\[S\=3X-_8QLC%;\JD"2M(W(S\S
M_HFW $$Q&*OOVJI87^,2=U)VJE=^CJ^EUN]O4D[&BQT=4:X9V"9S20MAJPWV
M%1D)SDB?#V/#\L)KHGSG-%:',N(KS&T3A];>]GB<GJPFW0+$RFX!<^HM4Q[F
M5S=MMP!OS= /<"'ZC+O7?Z#"\M(3HGR<EHHVEFX,%J^V.K.74D=NC'G1Z)-C
M")FV#"?'B/HG%SO'4I-S0U+91LPI/C6FY3&\DS\;FX&5^^._1%WJD\[E;>WT
M>;:C)#M\E/NG[L"(B/*XWY.9)^M][7&Y!=C"?M.=(>_F\1O/_#4]L>2F(T7,
M1QX"@3TN<W\0QQ/./H\I/=:K>,ZL=!^X*PUUF"R]^FAZ,6Z#,FL[L-S!(H[W
M,ZORB/OOIP$PB3.+_SS8Z]Z&Z./1]I6$'\NVZ<*,:$U.B*4+T:P+ZRO'9S3\
M5./0*<4:@@WFQQ+8HRM&( >Y+3,/+8_4P<IUA;M>S_%/O?Z_65 C@B%;==-W
MYNWM]9S"[:O:-'"N+?BS(7;/.!'SX7,C*Z'O\A$!GH^O!MJ/T#^T'K'ZH-:1
MCFIQS9LG'Q:R>SBT')%'N437&.V=H)WX1K#MO3'UU$WK2Y$&J">_H=PO6UNZ
MT2X]XC'^0G),$A<$:\()AB:\4^R,9BY)8S5>)&]S#ZXQ.DH73.Y3=(TUK9=D
MT>8935%Q [*P&=T"M&K%N0-Z7X5,&#4V?$N&KU9"*GH>H$^H=[ 4U1^$P?/#
M5F3-V"Q+C*=2_;&9*8DWXNMM<JV@D[%1M&]>OPAU@EHXO@2-C,+RSW%4AT)6
M-NHZ)[04:TYVN#%IC@AIPP7'(59JF\#)M(\>[YY"N:Z8.N66;;RL\!$5.F&"
ML]1:6%NIX(UB5IAOY:1W^@Y=#<.J:RQ25OK3[DDUX)Q=7G1]L'0'I=D0K%=?
MRH+K$L9:"%C-WS]I*+!JIN/#(%)XCBM7X82OV4YS@_L(9W)"DIHSZUEB>Z -
M;, RF0V>'IGL\W%L'K^M=S7 LKV'.=7X67!I':'9\N0/LM&2;+-F_G06.^&4
M@,-$Y#GA<8;%HGOY9Y]V\8E"95RNF6^2LF>TSSHF'X*K0J@;\-^%*S!$,,AZ
M*3@4^BQ%6E6G96LP-JR_97OK.KVR_E?F]V]+#-HUK19LSP&S=\K 6\PA=B]7
M+&BQ( L\_:?7 -"8PE+=4F"USK#9A<F!%>B+.])"Q@1ALQF.M">[!+*B!^VB
M<[K-L!;/KMQO?0ZSGRH+<A8(!]CA@0>B>8?=3Q.1EC !2X>%MX IOA;3Z+GO
M%'IA=9^$QKSQFE*%'B6=LDUL:NJ\F[6N2B')#=%I B-*AE[0OQ'G1Q1?,-7F
MU^/_X#[EG)[F/N0U,8ZV1(RU^+I;5@]WD? 0(>,G2(IJ3+"W@AGS_LQ^ DKF
M;P%=[^=VT1>V:L4.J?@N_>NVKC/4=+R]L2G C"4??BN8Z7S7FQ%-2&WR,5]P
MB:L!!Q$<E5U75M]I*^)EER^Y7Q\$/I6Y&/==J"55VV?;"<5.]Z0"<-W3TA$+
MUFPK$XD=(SBJ;S!-S- YVA"04EL9G3/. _&0;GP>\6+Q2U <-8YS23L3(!?5
MR?1ZFK-I9^ -=K;J"A%Z6R%X >ST<[8HS1RS06]'/>UZ82>Z\]9+)(Y0=RRD
MOH#1/F9\E2<T=61304BG(UBR@\-CUVC=@*RJKB'E4NJ$,=L/7,'QU7A'5[#E
M0]7J0-Y(50=S&<0,\P?<XLSW=55] K">"?/TH<!#LF( #?YGCD0W%@W=(&BF
M\4,,,E7SVD*(@=>%:&L8_^%F\!4Y794/CFG=5(74X3F"!C\JQX)!ZF"(N?1"
MJ&6W'ZKQ),B'PM1$A;HO!_-(_YD_(D7!LH.@SNE2HV E<8QKU3]UK&\C@52V
MG9@")^+[@6C!>P>-+U=PT-29.S=^\QA=1'\M@P-UN":X9S^N56+16U%A\WF)
ME.[TJ+Y8^W!IR*YU*=T<B"527 "CT]+QXXJ PXZI70A8[KJ/5'O4!J;_4G97
M=[4/*1R /%E95'S0_#'9YO-)BIE4=<K]-^'YZ7'=XT52*K%/PCO)AE5!=_Z_
MSN.?9H_Y^@!1,O[M%G#(=N?,-HI%EC#]X]2&B&$X:MF9B3WW7Y$MXV7;EJR<
M(!AP0J[:)B]Z/]"GG50"B;_7J#%CFY"53QJY@N(C^G'#E.;HU3UTG<9W@[PG
MF/-V*&^TW,;8A!3"NX][023<DWIK](W;W/E$S?KZ?87!O*5Y@=(+0EJK9]ZL
MCA4=#1GVEFTCPC1Y_9]Y3N($*R4"8E;[>:!Y!M)B;5/Y/31",B[(>]KIV%&$
M7^NS*@OH->8SC+7S^>L4A#S;>0@MFCM< QM%<J=U>&9SW2G09"3>UA89T.Z'
M5:>\Q8883=28JU2EIBM86WCH5[CIS4R)6SL[R)N:O>$] C:J?[]!#:;LEA4^
MZY:9)G-4&,^  3T,6M7'Z0LFJC[UG;82U#M_?3'.K,$U5M>"O>$ LBK4[:G]
MIHK?M0,''A!DCHE2#IK[BZ]V:(7RR6VQ(H3(-=N>S!9)588XA,7X*[*@P1_P
M#2D=U)5$)R1+\\T+237MGV0C&3M:=^+G\R8W8^Q?U3S_8EX?6\:>_=1S3-.O
MM+EM849.PQD7\\T3L.W'*YG)G--D((1]/6>F?.*8=G0D='KYIL=R/:@J&W_D
MJ*BWN[3$8-%E>M?!$GWR@#?B.J)('KVB2C*\%=NM6 >1.9*5ZB) F^QRYTMK
MX/[4 )WAEG^.%N$;<X>X-;> $O]Z);*[K[NPV^[.ZUG+.,@^XC9$%B#YN;*H
M]:?C7FJQ098,K>\]??U!+$VEB("5X )5!#ET*/Z[E>/(E>_;O)* =VV67<&7
MF?QP=RLM?>:$YZ*S=>T>2F&LRRT#3EM39F&+?J)>M?V&<M\R.CED\V 9)_IE
MQA3P)8&-L<8KUGP2D*2AOE=X<B&[SKI3Q<9)C<^#X;!E"!DU'5:,OWN)[K<;
M@LJ*X<\C3C^0=;MDMM(_)(\>W%^?11H>U7=<85>G=%1I>#6'_6X)A.=S<,C5
M;PFVL:N*F55ZF=]S7/.R)&2AZ?$/:;;K'CAM[3?[9O2UL;2B,Q4OL1(M!8P/
MMD(+:*K\)?XB@BPB!!VZ&+KRG]X$S$I_-;!4(I8IF63H)V9Y.@/SZ\2+<Z]/
M%B%O^Y%+'J;T6%O'*ED05"?N%'E>*)2*OB)9')_QZ-GG))>NH'OWU7UHQW3E
M#S0"OK&C)^(;HM5X; BKN9JZSWL6%9F)KU'QHV7T5(#C>% &JWJM9;L14C8!
M.:*5\Q;6 WZ7AUI1DVF+3(\^5#W8X3Y[Z*ZVFD&,5 BZ*$ZV;6L:D".0B@K$
MZH((BT#$%UL>*>59JAF9 &ABNI=F(1 F 7FM_+(8H*RM<6].U$I46C=K)^VP
MY6RVV1CAD&XY&HB?:@T,,:@'%64'[Q7\N<CI/[? :4,8'Z7JANJ]WA)I+6I=
M_?C^]Q""EG>[+Y1G%,PU^-",%@YHRL[B3-_4J CS7ZIHZ(,]C<-9 C[UK)(&
MI<OHJ_,O1WCL>KF#N$E&\RKNJ^K>?X%ZD_-(#C[B94P M:DNRM=MU1Y?>[WL
MJ%?KKJ *!M=?A14R'C6L.S?3##EMY5?$**<1\+ZZY_AAJ-80W\V&C>)B0K>6
M]Q39H=K1+Q6X%KZJ65N&05V&GH9M?SB2SGS(\.%5V#+I:SE2-/[S(A)LY>5Q
M:8=".I9U^J0%$53)3[.>?B+?&VW"]E%(S -3VM+YPF?2]"DXM\);ZQ^5AV!)
MP=]!6>'-4AO?$VUB9PRT^L.WY[Z_S)JZ_XFH^+IJ>;)I^'7SJ[B=$6''G*FM
M^!AYR\\E4%1M30C<[*P<TP=[."X!DTY9>IZY_.#Q4#/5#&MIBJP)Z;X#QYTW
MBF-6'2->:>7Z$LI9?8]\0UP1-Q^M>MVA*C8GH';_Q[C3#F8YTH-%H?XE;5'!
MD97!3 7JGB=X]Z1,.F>[$!!AZ=)I4#/AT)NJV&=)!%I%#L\M00;C':(X1[11
MP!. $L.>,=A.-21T;7\&#'0-=14NB%:4[<[*8%7 A)(N.:22J;%,\/_,/XO_
M/YAX(66XR+L@^7+#/!=SK>;- KC>?&VAHR/'A,GT*4.!^_W;O&3[O&1 7^,D
M)=M0^5*C9_2W4!0A2:M-G 0U?[2Z$E]%F)7%LJ;WMSJ:U'&_1$6UPJ6)S9RF
MJ?A3S"57[EJ!K=>/=V)\]48R<5^0;_G+"3+>#9$J^ZU#U6AR3>05KQS#+66>
MXDCQ+R,@6)YGPF2@KP)LBH)QI"XO@SDF$^ 4<?ATKDE/;-5DY)+!T>]I6X?(
MU#A!%O=2LR(M$8%WC(\RB>[HW\5[ZCY5CS[;@.6X7J#0L3_R88:-(F"9U]M=
M8O,OWS/DE)A==L3SKKW3G;YDEU2A$/R(""N_V<C$[HNN*_(E_-'OUP 2S<;W
MW2G7*S%.=)S@(20NT,+.R^;Z)MB%8IJ8:Q-]8_VBFO)PL'\>I,=J:#6AF?U!
MA5Q<B(E'=[N,(M1Q3^8D] .5/]IG..%;([,1KE-U<.AL[\2HG0@(ZYZ1='U<
M/>RE7GHQB.@]I\(KLQ=U.1SGHGDQ4*GA]XW(YZK2M-$RA83$W.]A^(W1&5&R
M1<$Y/=/QR/M0>;<AHE:_?JA22W*SBE[O3<>Y?:/-A8;L<7>6U-LN_'H3BFSN
M82JG-]Z,%<A1 GN2(/F\GF$._<PGG7<>FV-6/#__,0^!,>.@7$^/G3A>['NY
MU_:*.7LONLP66*@=CTC&ZL28BMT%C&50T=VX!Q7QOLE@"<NO' HN?NYC&LA6
MXLR\[^_>SOUE>"CSB*R?ZEP3 84Y(Q5$EA5.=?BHSV?HN%QA5WVIY!EJ)S9[
M ]A37S![U[7&ZANGD2S!_145T^JT4O7\/28ZH)86*>$[K7.A@6V3'&4N0$ZO
ME&H,_XB@P<$S>33Z-7IGK5"^L7[MS[W\,<3[U,Q_[>7_7Y?]-N(7A7WJD#AU
M5U72&\< LMJD]^T*1$95K586*4V^[(C-6V!)'Y94'=H#7G0(Q/K+74UL6^ZX
MP;FW^S6$BNX<*9G_K5M:-4IO 4L]AJ>6<&!+=V7LH]WA\$5/2JXYWZZ7:S?U
M-4<\!J6&VC/D+Y=#W'W':O8IU92]P5LWWGFW@&8L;TO+SC S<4FE$Y;2\Y.?
M%VW^&TTHLY(J*_\2?_SJ4N'GY:JB[<ZW -%AWSG4D,Q*P6>/K)Y+Y\QNN-K@
ML^,QUPFS.>XXTM++&,6>ZX8_=^.>*]?W[:^:._V:O:UI>+3#=[UOQ3\,MCYE
MZE&@Y21>\3O]MJ([,=R^O,41*^.:?OY7*8M_^[T6)YVH;IKNIU$3\0RT(W!O
MN_USA:<FQ_0IO^"58MU27//SZ-Z;FN?20O=IB.#BORB$);F+OD[3D,[T&D*#
M)G*D=@MX9^C;WW9CEODK(6-4/#_E2RR$&; (%34TU(DG=']S%UZMN]S*;VY.
M7KDY#JL=^K>J*8WJ;P$9H):]#VI$DK)=UM7%O\84Y*20A((O-E'2LC9I>SD_
M^%<1?90D%)=F@EM )-;>M:/ELL]??#2(84PIUN.O6YC<[YA 47!<U%GFSFM:
M"OAUT]34<_VK5DL;T(Y44;O^!<^2_P=2-.U\EU_8GJ+8S_WU6!]2DW'SF%>)
M7F%*FE31*KW!8 \"Y48<\PLR^Y;/_*.Z>F:S<*+?$?Y1CT$S*/^J"1.W%%ZN
M=L7<SW4<3_:;R7'8=OBVG)SP"]76,5@:H6I,_Z%M%%E@4\L=.:. S"6U(N_\
M=4O^%TI#$&0IB'&9 @HME^OI+.5>'2F9K@,E[A'1"*O[_B6<])\,#55)*/,Y
M)KZ6[&MU!,NPYU73MM&P>\P/_0HHI1<C-(WI#.:R#\PV'56(B7-FM7:%5W-_
MI3UA* 65!OUVX.@N;>G7R:6_Q/UEQ03/?TKY_G'";QG8MW4734BEE)YBN?C0
M5Z<U"E@0$#_$Y$?W1G$<M4I'+5.*EW[XRQ[FI$_\GU*8:''(S-3+@7:6^V_]
MN30>=G=#;OYB/N)/)<C-1* TI%$]+_XHY6D6+03)"LZ6?JJU'/I+<"6S2*)U
M+35=P+V8Q85M]\V2QT]9 TB S(HROS1A+*]X<.63\L)4IN,,_.-9NA=".\E"
M\1#$OS*-'JA9TJ[<*A4TD= 1L\1H80=;X%._/G&(Z#^SG"UN27NJIA=IZO#-
M8X3G%VK+0C7Z+U!17&?M8OP5#%GKK)T;+;\*_[X.%^]^RK91:,RTI?QBE7W0
M5+7'EM=E\N[I>LYIB3ML)\LB9MF<^%\UW(__5,/= BSU4Y0JDB+B0JWA:K_B
M-Z>XFJ)8NCYI42NI6Y((F=N[T)9*HO'<.!/^[)_QL"")[BPTD+1Y(YMXU\C9
M5E.?-(!Q009)(DR_0#?7(F"9$[2<]D&F/8B(./^ZPI>FZXBT]V;7XE>=(-VO
M(,,RI?O0->.90 >H;%K>YC++(7]B^!<L9[\8,1GN%MJ+7&FR%,SXA0IPX__:
M"NWZ?_<'_^H%=O_O8_N!5Z$NMX PAA"Q90&&RZR\_;C<UC/P=!6N7S\=%@5S
M59VUS<LR.:G!+@F]<8.Y92OS[3Z77]:V4<_Y[W@'5+GW(5W\U'G_@DQ7.[*[
M^UDK+[;BV0O+1%JR\-%?"!(7WS8:S#8R_-C$86(CYE6"FAR>4$S5&\>A7QE4
M;BQ978U&"X(G7.\,4H>QKKN='5D(5-X[*OR*@V@5<7><;I;>GYZ%B((\W<ZW
MP6);&L[2%PH,_\S&,994KR-K%X0F7H,(<)(O[BI2[05!7RN 4_ZSZ1W,M'RU
M.R3@(L  Y?TU-)__E2+_>WVM;_SOTYZV 2='[:7?33Z]HC $JK),6JT=42ZE
MQY/^B[E/7B6$]7$Q\LC85<9FRKI5AIC;D+%$04Y6SAM07BHH[SW)[U^<B->P
M1O C%:WJLNZ'DW//A5>K88^G4B[S*G6?$H5GVAN*@"',SC/AM9+\GU=SJXF3
M?& IIHZL)5N<2VCA+(HC/F= (HNC,3![=I5V<6L6#T=!UVISSCPQ6,Z;CHH(
MQ#2BC P"@:*[RI^:\2.])W9D;J?0W<_7%ADICP:_3$>\G!3@$4K;B4+/Z*M_
MH-OK' 8X_++J%\4&6THWI?)F?N/?CGG*%9;I"IG<H;Y?)@S$VH:[<IB+,<YC
MC_"BB,@;M#0;4Z2'EJ4+?QTJ7][?KO$5&9T]$<VJT7@9ROQ>)$ P<MNQ>T%2
M$>4+\C!>=R-M'W;O%[%YGJ'!%UI'E_V8L[JXQL#$\,6*L8M+Q10+%TW*KP8%
M+YC%][1)\B)LG1^B<H2O2,,EVXT)90]DTCYJ,AA?Q.ASZD5SDGXP<(:L#VNE
M=<=0N$V->%NNAI2*U.EZQO<<8TGH*].[FJFVQ2A]VLFTCXG=91&AQZ4R%4!-
MZX8P_JB5_!(ER /DH4O-TA7Y>/4EYO5;N'+0#'['@X*KQ+-S#_6/$2HJW'ZZ
M1 P;,L;[3,H!SJ*?LLR,1,7[FZCF:K!"+U61<VL2Y8DLG4KPS,K8;)?*L5;+
M)[VW5'+D$R4Z?J"E8^FX/NY,K#06'@EV0J=P1ZJ@-3_J-XQ/-]/L($+;"!U
M#:H-JT^V3PW%W+=B0=$B)@)X8PDKBFZ6T;]G[\?49)D0Y>>)HK5^$O?6GWEQ
M&E\ 0H_A?,_YLH>)F]LT1I)!("O3U"H]<$-;48"GR.XA:B6Y'>C>8[+A=GH.
M^72F("EAHQKN,ZRT\L0#EGVT\N)KSN_3>FB^"%"O-XO%U=Y-S[YH[  .<Z1
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M,O0>CIOG&OU>J*ZIN2VMDQ^1L\2^I$#P[TJ_<2A?6_(_*/[7ZEBA=#G,"?T
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MD4?2T5M3*B<(C9<L\4DAA<_Y9+%MQ_".G.=]'^IO%?.K65S+S@5T,3PDJ:E
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M-26BR7+3(UD;M.>(H\T;*:J6?"A?I)MFOBB.,^W^>DSY_V+OK:/B:K)%\29
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M*"+B$HU9ZO6]3,@+&,]-OJZ1$Y(MQ/GVZOUY!CKS-!9=_G&_5,W)H'#%*18
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MYV?5<R(@><VKKFVY/_?C\GU1))T1D0_.C=PCA:*9<*I*L?V\*ONG7IQ[!TC
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M%O, 12):]Z!W5/(+#U!_$MDJ<FBY\_I1S$\2K7?\9P@3QL17S\Y.;J#L@SM
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M: +<5#]%^D['/*QD!7_^T4@3"%=!7A1;@#N4(:) 1>QIL5J2/8@(],S!DD1
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MM!CH*VV(?/C&6_*%T21PS&893TH_JY U;KV?VH:)"Y?>28XH_;TJ4&=L3!I
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M?M48U2SUM++(N"W6A"@97+R)2Y#6)MQ,9Y>_CM*&29^>M.3+]5 (R=3J>2%
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M\E;IH/IX3CA2^S6,EEM7/XEH=W\2,,N),[R@DYV-JT026[HN6N_O&N_'!T@
MO=$3\9+)2&.>-KR3Y,?S:J0OJ_L%C@;R+"_-RFX!"=UW)X_42&VK?U30\'7A
MG>@9:0!Y<?&3 N'UPAN7X-U9UR1A/D R"'J=997JFRUP"VA4L)D!7HYD7EG6
M/AE2NB[Y>N--LRXY?6<7KE>\<H'AO&L03#_WFVUJ[EY\_R>C:L+6/_='FH;0
MKX[NLD?UMR(80_R5X:Q+M;LSPGQ"$_9W5?+N1Y6\^K6?L^-V"SB<NA>F(:<]
MXX!USM=F5&CJY\729_NR16?!FW&O<X^QIUZ?3?6&GV%$WNFI7,_%OV_AKAPP
M]O(5L3<G/)3X5!,E5B>.DU.Y&+1 ."IT[34?_)QS%M\2X/E,W(6&/L.7=N!:
M(OT4211!!J-GAO*=R;G")_9'FRJS#LGD?,)AX*Z+K;]'M1O1"5#MN2],BFCZ
MF1L/D Q]-^[?'=/"^!39GR_1'D";UT-SL_W_S]6[J_2:*H^_4HFH<?Y 8>CZ
MXC83941L^>.1K!\KQ<C_HX4?QL"?P8/[?8$:>KSMG1$ISOSSYRE6VZ\]$F#-
MU3Y6G,I_5DWD3:''1#/:'A70VY\;/<?'_3M951\W_=CQ5/]ZV*:B+(7PX^&<
MGT_&@@ &/UXM</]>.MK,_]U7$UZ\Z8"30#HJL+82'@,]$%_5\1O D/RMV)'^
MWQ7N7UUUZK2M-<903"*CL@LE^&VM/^G?E;H2[/E]>2O_R(^T.(#Y/^,J?(PD
MX*UM*-SVBYB9Q/-L^&'QGQAN?!'V?W_C?^372A<@6"%601P3Q+.M0?\+B2VU
MAN#.-'K;\@]>,M*N\/*\XJF\ SKIGLZVWM4M8'^/YC*OUL)@GB )&Q.#F+\7
M\GJD>C1.=/52>16E'*17":/1?9+WWK=P;5JL$B9]<)0)O<JJ0HV)&&!>*30&
M]UP[DEAD:!@_8=\$S,9A7BM.M4.3/&19R+/TP&S 1#KS.;GBLY7%YX]G449,
MS=.F.@BQM2C;)Y:U7];%#U0AP^'#^S$I5B=@GUNM )$B4+R.<]MI,Y&YC:2)
MBQ+&. E74@M9#TY-H"[KNZ1@(STR*T)*@=$N-%\YN24:=4K'G1<$Q"N%I11O
MWWP?&_IL^DZG@TJQWEG/A47\1'.PX!-LQ>I'XF].T^YOEDP-!'8-'/6(O,3C
M@W*PE!QXEHIW@H5"C@N>K<-.Q8MNJL>^F&V5-DNJ%O,O/RURW%3M/I1ED/Q&
M5R\GFI;!8^@!C69,SXN4F!+GF-&\.0@C' 6]7@2:D6/=N80EY,4?A\)?T^52
MP,A*RZJSX=LMA0?S",OXL(5$L @0O#Z9LPA!'$^QP9""=8--5'I6#-*QY.6(
M[5PKX3:9+RAL-Z%VZ/3LD(:BK9@2V$T,OI^?3MW-R6YWY;#B3R3\" IS.3L:
MG[(_@ CX,ZBX]PW[-<H*"?3'I::H-P5IZ:^FF%-C]\DYM,*K*5WW) 1@K7@R
MK<-'SSTY!T(_E4B"N;XC?B!#3WU$GU;<V4N[OH95'R$_4X4 H<'C5'^2)N)K
M?=5*X4]?.H_MQ!X#%#M45P492EG3$"8^R)"RA*,^8*:+GRCO8_K2HKEHKZR^
M1XDITCI=AOE2BGQ@=D%-$*\_27BL=#C92O5:^YK>8Z?7IV^X6-P!' 4H4IZJ
M9EN'S3TWT44#T*.&;T 7V=A-X2+@Y)![.D)@1$^+' KQ;IQUOY[D?NC)PR)'
M7L$8KV3*K8UQES[P]P:Y8?=.(!-<CPP7DA847YMOF0OIY40.?(6:AS0%?^GV
MD(T9S&PGXT,+'!Q6EX_*)PS50'0IBAF0&3KL-*,.B%6UKDP,;3RYMHJ$S)1J
M(.[G(KS3K8;< LB17U65/_L BQ[WY(@ST)VGKLY*I&-W;,[_AO+'A'SR;!##
MV-]/R(?*(\K;2BJ_@*//9SHJ;E?Y B!*/MI#L8)3+-.B,IAOYCWA#*8H_1"2
M5(7B<\"=&62[(/762,U0+4Y97W3KGURI'VO4(5NHI<<&D9RU6!O9H JQO[8*
M^O]@MO^/,-N["K)!\/]!B]$I,ZY?9.PF+Z6^^GYM4YWR\^#K7G(2-D:F:A!9
M/DIL4#L_%HHV0$X%0R'[/4:,'(-*LE$N/%H5*I.VD3)+)DI$7%OT:0Y)E2G(
M.$)&J#*8@IKFRD;<?W[RJ%#DU:G0L8MS[:72&R'R@Y'0W/#=D4@6RG9:K-H<
M+ #W715VI+TR%SJN>+59O!V_D)R  &5@QDQ8J\>2-(.C0OD\+$&AO45I,%<Z
MG&6-%FG[>;M/W!U)QUQHS 7HO7=V[ ?6"^.]YMSW",MHU.-18'@WPCMFA#WY
MAB>;\FU?@SI.5ON,AHBX\T7TE6\5*P44;1'K Q',.,CTNV_V@] C(Q *GEUV
MK$#'UNQRH(J8Q&=09Z 8GQ.K?ZQ6A6>?Y52[0U&PJJP2==T;61S6KA6@#7]@
M0K "G@.#B,0M8(Y3XJ#%@-,\2&%Q DMH02VI>43)>_0P.E7Y!'E^B1<%([!/
M)Z%?PE <"3X\0&4D8<H_W_.A'-)'=?EA/.K91G3M:192[==+7WKQM>5AV:!)
MVL=:"L[:3M?38-N\OH==+S$9Q*1,*7>3<5K-Q+=5H:Q&;TF41E,T7;':L AX
M<S,?"'&E7JACMQ<[RJY!5J,<=;A)MU+@!#0$H%0?*EAX5#\5KQV72ULY%U9&
M?P&>P)94(\+F5"G2S_DZ2C-VX_6686=14@>M38>-"+.>0 CEPK^=N6B0'(L>
M?_0(4WO+[H425/6Q+KAK)TWR]*-J+6["/.U^-:>N"R2)'964%=!Y&F2* =&]
M/A=1G<&*!'=_>*9YPZ&+^)P"<:8,@U3BN+")O$%C9)K!^7"YBB=_*L>V!+&(
MH"O9DLGH97]#K(+W("6[[.4+&\+JI2T>DOBZIHL%GQS#$TX3::Z:QV$OM(CK
MH."#41\(2,J"BV,[49B?]2(YGH/;3G/\W-K(1#S8-!(#%U)LL_$&UY[@"'L<
MTR9Q3'B%G'G\8QEIVZL0$NX%<3[:[$;5/^!X0,A#^]@D&C4#1 B;L(?EK\]B
M)DX=TYWUTPLQL"5%6!@81$8>I.1+XI,V='ZQT6Z($%?P/"<!H_C$W#U>QO5/
MLXY_+0+'-=AJ)K!QH!N4@J-:0&'@-XA9&F1>>1ZL211X!HQUKA]H:T27;([M
M^W+0B]]ZSHH+MX]=OCB ;=5$7<D^*=4&*ZI!J&DRW7"Y<!T)O<EP]W7"L4DJ
M,V4:X)RRFF8..4+=;A0;0.9J,86IA=L4Z?0(Z4SF#CY&]6:8TI05GD.IVXNR
M7ONX%"G<>F'J?AJQA/] K7#EJ,^#J\XUSR-%:VSOV3%M9NST\C4>KS#;LL K
MSJIBCZ#C@6!UE9YYTZ&>S8!9  #LP/_FK'5Q?%++7HP5P%K]TGE/KS^M0,<Z
M0=K=^G+I57 #NM+^BV$/XU:)NL'<#X<Q8KJUNMPO+TY+#;[CA%,'+<KJ\)H=
M:IKN7@R^)Q BVW^8&,*X5-=HKKD2;ZQ7E/$^%64XV"P=.UYH&PUT> N($#Y@
MFO2;%".]1E)'2R???]H9OCQX='E<$Y1BR9C4B:6+;IS;U<_&T'[T%>\LFR%2
M5C[!Q-41EK\H>QEO$WC$3& ]\G7Z^F/;8Y%O[(S/0JB&' 0[0/N-[IU\:5]!
MU"/%51[%9,%8CE3A;U>.VS$\UO5N 6_8U6HOI6R*;')!_/X-+(*?\AT$7RTM
M,6B2>+YGM&1K2X]/<5]B8-#CWCF/69S%79'OS ![!BUY%)XN[D(*MPA:!-AT
M4L4HR:(DO3AFTFPDSFR)9PRH/J9QP:;![,@L>(VG%(A#)B7=D8P(C^9KA>-U
MNP09NDH%M*#5D9G:6KJ,&E[A;/ANWY%.(!*-2XHH9Z_'1S2:=#:>N064<RU4
M\0=%:^9U4X@32GV#+>CF7'UB0T(W=F5?M*G.EZPSHR-;Y4[MP*I6.8"WE:A/
M/,'H*MVPN0@2J8")"H&-_W0L2*-3/3:_:1M&@3@IC8>XN:WM25*UEBQW>F'0
MXJUSS<85>Z 9'S44Z[4RP;]X"\"S/N4#%^I[!"/E>KHUH(4XH\NXPXU!?9Y;
M.!=5)^,'?>I&T<"'K=KNN9)T<HD.XP->R<?'SN:8U!D_L!E]NRMNKYP,S_=_
M3Z^.H2MC%+ "QR_AJ$F@&%%Y+:<'^!+YDEL*WS$@54/B$S;9$67ROB(1F]7%
MZK#5!_KS'AQ7_5[-\8+-$E,O3SN<='J%N)J- :4A <E'=1S9<SJ]D:!=!M!L
MB=_G\?$RCU>S,]A/W^)2CM>C#*>=JUJ0/!7CU#4LOF>DDOB+<#8%:TE,2U:F
M/, M:YFU*ROVSJRN0JFYT=%^W?*7\E.Z^<[+H6VYVI\.R'B8RL:;WBTQV*KC
MHWEB2@B941(7DJ).BR33 T S4=(4Q=211C9,?:-T84F:J:36/20CTEPR:[,M
M=RUSAT CDIQ1[:T;A!,"]B@<4:[#Z:OGE>I"JR6%.@L!Q'UME-$R]V?]JE0]
M^I%VCL-YC0@)Z7F6:XM-5/)I*E\&T6FOV_H5Z&R>E KTPQ;TL_>I#[EZ'(=K
MI MAZ]B:V1 0?)VI^G)@ABV*FASX>4$\\RO\ D,U@YVGMZQ@^,>U<G>U?;VJ
MR%Z=[(98\E8$%;]X2RN"-H*JYB2<!='/\,:U3-3>-:.E<H_Q34UZ37A*,EH2
M3TZ%7LKB)O*5SR*?%H#551*R(U(LE.\GL67^;B)]/6C)NL?Z04.R_#F>^@/
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MA:*G-6@R%/PP&PC<,AF,G+.\E*9\Z*'J*KJ _:ZR\G/=#L^2#CH<S807O.H
MT &3K%K5N\\G)T5(6LLB>*>JR4?,B -/.T,6K1Y)+<5[R;"NR;1 X..'&N\:
M-7GH7^!<FK MT!E4MTLL?I;#$5/0T2)NJ7@#OHG_M(F;Z%:32&I>[>G4E]:L
MO0&65\#<]=(48+09*K@HTMPNK7+]T B:C3+%+_2*#L/I./QVR4T$]ZF8H:@H
M!6H^56+H\?X1G/O:.W5/RGTV#N4D(H26J"OU_2S"W$OB(Z<M&655C5.=K\=<
MJNUH!_37:>=DOJT:KGJV+F.A\0-)@\8%G7Z02A"A[%M8"05$;(-V)ZS:"M^@
M4/N/9VJ%CLXR7\/B'$;S0R-X,14N^1-PVVU2&Y[A3AA!S<:9=!0O[997 ])3
M)SB=2Y-LQP<U.9Q8/M%@0\&6((XLA,$NHRX(1 &%V[IMR6&4[K."X^J$S?R&
ML4<)'"U:%"4-3#7!UV#@78__"!@L[E0_6[U+,0)]S [+IE'EXN7"9)O_&=5W
M19< 5 X"Q0ZNMP^!"913<1E\!3XFW'E%ZP*#ORU/VO^)<1'Z"S92MJ!#^2<?
MR ^OR-0C1$?O4=\S?.>ZZF7L?O10M%:*?C%T1T)@=&A;),EDP+MU!P8&A;&J
MRI$%S4K>7)$&%N!:(P&'X0:$TWW;I*]4V_K#:S?]1/Z'-#HZURSS,L%/\?L7
MH]<UN>>%0+S3_#PDAOEH;@3F-;X>/B2FZ5-0L%-/EP@\>@OTS U5GKT58PXI
M0<(5[1:@':2 H>"D,=Z-M:7V3BD":N:V<X'CHHBKO37BFQ8HZ7@]7%MP? O
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M3;C,G._YC&JII78)2 M+.3;'M4,$CT P)81J(Q8I'?L#JSCAQJ\=V]U=[FJ
MH[#>MFIT'(JM3'7!GZH1WB!,9WG\D/>%4_OI:P=Y%VWLV0DO4WL^[+<^N1A1
M\?F2,D[%JPB(@Y2B8CG)6_>%]/*7^\)"_0NP'?*345>9J>.N.4'P_G'8J-LS
MZ'Z8H;L!WSE0#]A-,:W"]X;S4Z2VFC$4Q_$K)QL]M7_TVDRZU9U_;OWE9ARF
M%>]3D551AU>$VFSVP-O1)EFUY\# NFNZ5F#-S>FF^"?WN/FX8*XC,$%:^8WP
M<#KSSL#^31P,LL011TODAO7$#-G--<?L)S]0>( 2Y*A@DE2FWOS-*=;P/JF,
MB'EW/&\G-OR9Y2%HC )G8:E@MH.2/Q%!T5Y&SLRUE?XU/W!#J5+ O;!"&J?]
M,R!@/"]0J2;JJ?HKR2KD@%=(>,R<U)_R'P*;JS(I5WBOZ%/KPWVS/!;2Q?E#
MQU'J]F17(<<%3.N8I"FK>-NR@I\C;G;<AQR8BJTE6!5EI4QYS(K=QLRCB^$.
M\SJ7N*(4TP$(N"+VX2[^D3EXD%>#+77=/JKUHJ$2TP9G4O%1.(\MZU&)D1O?
M>JFQZ0F$ LL#-;>+<.\4M @P='?9\=!1?% SEL<$M&BN?,@L(R^VDZN+\#0Z
M$WR8=7-^54CX\;TME,!W%D9,8PCFBX'GQ!-/I,\&PI$O/UOP5JFY7XFNU0GB
M;&SITR28\))K^C?%?S6"C4[A6$7$M4)YMOV<QRJGH?1^&<N$XAM7"^%(W:[<
M^9PS9YEVK-RRL'KVY6V@@53 QYIU[0[QFXV\1 -1<?\6WT=/1H331*8QW4K>
M5%R@6)F=7&W"]%6_X5<5+CLOR:#;$.9C27\=CM#ORL$AZ*S^1#3T>.Y\?.L;
M<9!,2<Z9. [J^Z$-%O>!=?4GXE7$D=;(&I>O$_L4S]=HRW0S.5*,)@=="OQ"
M*$K/PZ\_2^QOBOOW^E(KGILO[W/J'4%%?*=,.L=KV"J;F4\+RJ)\-FL\SE?L
MSY#SL.JJ\6'5.T<G) ]N 5[).L0/<>"2?.VVYD4JQ,XH2Z;K; LZ73L<YH,K
M\X/,2?D>7(PS7EB#!Y/1WP8.JHR:MT/.^W2?3>[H]H.7D#@8_+A>Y1K7A?F8
M%5E_N@68Z<0V1CFJ(>96+KXZ##@;1?>SSGBUQ'IL?;!X"T VF\D07 DEE>AC
MOJ+TBEL_O7B3F]Z&HB%J[D5T0S:2A<B-D9&C[C//.6R\3?TJN$[SZD&6\]/#
MYC%QQG34"O'5YZFG6'6O.S6LEIAHM*(4OV(AWXRS*T>JRM6\?4=.YK)6-V./
MKJT=G8"@Y+4 #'/IE3/I(8U7Y.PT3L]:GDFQV<RI#&$-/I>66ZM8.0N#2CE4
M-WA+ZIC(?NA$$J8'ED4*+:'P3F\0Y3-S@P1$7=!W>]:'I(JG[ 5$V?V@;RWN
M%(!M2@4(PO2A[7.2 [J,#+0U;AF>A-SQG5/K#;Q-V5""R_"B3L(<+2EKG\ !
MJSHY7BC*$=MFC?+7\LY(:57]W#AE<6_$A)]J0EO[61HUN$ 2$\W?R0]%Q8JA
M/'>F@J\989.0XO)EH9!]W8X>^+DMK(Y(N4064%)452-2W<[)2=#:02GROG/Z
M<[ZU?QBX&A+'-OU3)^6_FNY,T()"S5?'Z(:4]WB_<=![8_2OL(O_LB6$:U_%
M/_PQLH_79?F3'^3M7YL-< M@I"=(N=%4^A1\U^/ _&58^GO#A9[@WHCQ)_\K
M#_P6H-+X$0Q4+IW'IKI6#XBYT]=(?W6"N<\O#I3LGV/[*ENL<3^G+_R6';D[
MRR'W7TP+_XL<EABS?IT-&;O)"T]GUD@0W"=(]W=H+O,:+M2OEWVM3=4DBV&5
M/Y'&*R18X"T?%$_NQI0V]3^E_V0G%%^"+WE539HF*E(-?PMP/\CWLR"U[PE*
MI9$6/:$.JO=M.P=)7HX",J;.CG*Y0C-\0&7/.ITRTLP'G [F%GL836JM ?5,
MAH+25UOVW[9UT<KQ;P'6D.OLKSDR= _;T/R6EX]S^7$5DBRB&Z;N%8M+N I?
MW2T@0$VY#U%5R'I8]Q.?C# ?!X;N1L*=^*=3>5QA-H.5&>')314YUU/L1QP1
M65'N!(P/E >9'%N%#?;4AC9Q]@]$A2.U+9V$QUGR!#\^%GYUI8(W_J$&;E47
MJ/B!9@9K_R!=7)X*?=JBQ%VCJLD3N;HN1F=R<,Y_*R1!D Z\?%+*8V.K9<I
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MX#)(4&$U\4GX=. SFW/8^5H-?)K['A"N_/G-M ,7^9=,WG#NPV9;'1OGU0S
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MO0[4)(!]DV$:!-=MUV,%X!4")1$NUC?4AGCJO1YKN0.ON+0I8=F2%YC88Y#
MUK74<!]),8=9#"75,&;HTQA@1L?@8:GA 7<N%Q:61'Q?**(Q0<V ?RAO68_R
M9[^.82UL0+-#"M]]K2JB3=Y^7#873\X"_BXZ^U W[MB[733YG&LL5C<W,Y#9
MQ,3:_U VG*1N14MDR?1'Y";8]Q/TY;C0DM-E%L6H+W%\Y#[X2M[TPVF)Z61=
M29",R'>#_ +BN?:?D3G"13V[9.@][*(+FJAG54<_Z*B$WQM*:85IMJ5PL8ZS
MV2P))(0+MFM87Q(80_HJ7IB\7B/H:B=$=AC!,-2%V$UUT,2P]\Z_'V#$/]2K
MJ,^($%4R2,@!V, >1BNN;0U'L;JO@1\;1Q'U_EHQ_%*DJ\0T$0PXQB?%I,T7
ME]YP&XK ,FOOY<6B&N0;Z0T[(Z_'$G^D+OJ?.?4[.Y(]'YLF/BG5':X\'2DV
M\O=<8.U$U!D\V;@AG51_?Y ^;JMORE+*6:<E,=2J]FWMP^]\]]'_6[K=WU2Y
MKO[BK6?4IG8PXZOSJ,'AQ17-L^'RE.DE,<_R2YE"#0XIP][L182N=)HA>P0J
M/D<;'O80*\E-RF\M! >DSM$Y.JI5+N=Q"?XP&C(OY1ZY$2O8HJ",6%%Z;(=;
MQS)!#BE/:@-Y1FM;6QOI^%NV.V/:O2YX65XN:3].<MMTE\"Q><[F&MK9UQK"
MJ:<NMMBU5P7,ES=>'0O$($+.R/S&)"B;N\7Q(CV%QS>9D)Q18)# PHFCDGV&
M;I77BG4I-+V\1M+V[LTA*<@\_ASFD+^XBB;#1S!DKL6N;UY=@WM[B4<7ZILA
M^?$[S2'!6MI2+RE#R"5[5^'D"=>0TA*<<78E?"]KGA1J,L,A.42JKFGEMI?"
M'*K/W.<E%Q9;JX6W-$@63/++H3LZ++;#WRR?"2FCTJ\S6T4W)6?W^*+$'+2$
M;(VVQ#K/>@.46V\':13?O4M@VT-%1?_3%M 9V7;S()1W.F>[5&3/^[A6*+:4
MPKW%!WN=X"#;6$#]<!)&#]#_8#U\H-F^<#H^'/0,K76:FAC>C#G??>L_SA_0
MQJ0QSQ)^Y)L&TGI._H0@"#64\_.>8%Q#&-D"[C(*7'\[GA"SP/9C,#A7&\U9
MU$)%!^0=['"KZ.0WYV"!>K!'# ?]867]/R<<-JZW+.]XT8W"K:58:+ZNB+K%
ME4J5:+4)X_$''%EJLK^PP8:^L'HDM&7P45HLWV#*HEI53[^G_,>+7@X'@I8+
M/VW'>7S0Y%?DB1U9+?)G1:HN\CH(<BH$"]%.UCZ3TJAF2=4BP_[+&FXKH]1Y
MZ]9D,W(.V=FPMD.O2+/,IUP"CX]*7BV*"ME9!@2&6Y1ZB-63A)FJ$ZKPZI[0
MU1@=5!?D;['J0M@S(L@"9*8_G1(4Y5VX3+JD+JL_MHIY$HQ^I0(57T^V')E)
M(Z1-)N&L&0(%1O!&E[?KC434$'TN-JDZV.U(P?\64.=D%?C.H:15[Z!Q')0,
M2H4M">2/AN$%\)WF;@I3C X4G.V"EM=T\6625@>'XU):-DX)S(9+QKR.Q1<\
MG6#+=\0RT>:Y[1<-0<+F0E(*SF\?/17"L'5+^[1G.+8R>F+16+?*YV#Z\TY#
M\;PV(DEUS(JS,KPT5R9>^FE 0_D&L.?T5NKLN./X9[UN_1>G(QP2:J-']4G>
MJ :6)/[._"N+_F_9LZ$=THJ,>S6+.KFC(VHC9+3#,3)& 4;[LK.1$J$C(]J1
M;:9;;[!FM*4V<,ZYI8 2<@_]^@WN/6!\^!ZPP35DD4HZ.JWZ8%6JU]XN2Y?1
MV!P=[JI.N6CL+HQ1,XF,T.)B>I;+TA$Q7=#?278]>"E96I(Z]80P!S@;5'LE
M\,%79*PJ\_N]!*\%]5Z>O0LL^$MVY[>8C[J*I'*8-]YQ^@!JCNM:Z.(^ML*B
MD7W>5OO'/E7LY%3(Z+[5\O<JB*M]5?U2YO!)ET,20:5/>;@LM7.3/"CL>!<-
M;#S$A8P+'8UB[Q^D65@98Z88FG4A=:@.,XQ6W*S8U[NZT&_GTFK66YPE)D:=
MY=NRW=89OD#Y,>DW.TOS.T4@7AS?BT"PV)DOG(*F[E"0NSXL%1HCCNZZ\<(!
MCJ$Y\'-D"3,1X<-40M:#M*\E*&\",8\2/3M'(0"@UABDB:CHN-'%)Z0R5-?6
M1.Q(0N*<ZE#IA;]F=:%L1$O;+TPNQF^(#GJR9U&L.\L%[;[)TIV2+MC$E44W
M,IPC;!$<MT4-V(&>%#B<O%GMII:M314SB@W)@"Z &5AP=5A*S'!N1^/.L7K2
M@,^3][[:('O(((C55@EMV:]-<P^\(C^\.5M=[0//"03RT:=W0+)K#Z!A5Q-C
M;T>DA0&O2 &^0R1#(Y4">NS _$4FS=50X>4M-O%@W87=DJ51PLT=!RU"*U9K
M9V.2]2P#GA\QP)5E=66.3=B)V(+ X[@I@:)LJ6V2[T1'!;LW>+G3F^R;/<.)
MV;']-*D2JJL?[#&/N(+:](FT.U!(0PS00>V%EN,5EI#Z'8Z7Z-X^>"$;S(+4
M)A N_TR+;'>F2Y-IOJMARU2<RM%2C*%4=]>G/X[ UA:3 0//E2-XF1LEH9 T
M!KV7'[%F%VQ!YU.TX34^4]I+;<$!K6;?GSB4NX@H1;Z#=3J$5;":V7F94L]5
MLG#*0\)I-@? W<":E\?2#+K'FUQ/N2^\)BQLO/-ES>JXJY_J'BM5FX5V5*^T
M05>C6V*HW-"UU%P70I_G5+2-=)Q%7ZK4<V-.@0T>:X,-6MW79P1_<2_H':?!
M"3_8E?I\WWMPNPW@>@%FFR"A[U$LP@/:ET?$I+9[$/$"JY=%\T>+%QHD3?<
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MU1CF04)%/J:W5UX$5115MH:LZ5:[T6!Z0XQY[&3M_-WZVC41H"?$\!X (@F
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M?W[GMB#;_:3JG7CVHFC(14LSPF6VU%?CO<R,961DUK=QVD\R?J)3$4X%FO<
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MWEAE1$D2A9C*Q5ATWC8/LI#(@L8FI5&X&]6=>BONIQ;\$YQ>'0LMFHQ: +8
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M\/_YL2^LDC.!EGR#IK;$ZY&YB*]U;D6PC@$&W)@%-S%Z2(04L.?%E_X]?:O
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MFKA%E'&(H=5_5%Y0NVK/3BN$_<,U,U%5$D?F\PFV[ET4THL+*:]]17T5\L,
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M-$"AAK9:W(HM9)['[L"&I*A:$55'CV>L/Y$Z_.'VFS!8.T:\ 3=-T&FGM#A
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M.!O)81-^61>%_6KU\<-L"4H<Y^JZ !'2+*>54-7Z%)N5&*F2-)/A\D/O9G&
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M$2,@N=X&[RV'2$;CB?6>!U. $NN.FLO26!"T?5$Q]#9!82Y%.\M[S-6X>VG
MVSXBA\L/=GV^0,C0W%35V^SHC_;,70A"7U%C%>+-NN5ZHY50<)CC;,<6Z*5-
M>#MYC#<H*U89&M&]9\-5+.Z&+$6"#[@LMLD+DZ1CZFOFR@JQ:4FQM+Y:]D.Y
M WA:#&]HM5 <L9<%+[F7/.0L(N@E7B577P,HI\E4UB4,Q#Q@OS>[&RL02, 3
MR&KW1.)A+V:ZZLEO6Z$HR_=>&E/"C2F>3S&^[&UE@E)89@AS<(BGA:TJVVB1
MKR,2R7KL;OEEBUU\8[>7*DSQ@0;AR!Q#[XH6$=]W@!4S]XZTH:;^ \[\-N4L
MY!)UG-;E1FS4K,#W>P[/9]_J+:0R(1]O0ARC/O3B=;]+O_][-057I*O^FF!>
MH#I47"SM49!I0%]\>]9A0QJ_,RX<U^RS+"0B/X:6QUI1:\CS13<V]:LB6AC\
M2!= +V[(1T)20/"&28T8);U4?:&KIGT?PPYOF8B]YLGC8^^=PIXN3T44AH]\
MXR;Y) KO7ZJMC^UNF)H'N#&U46,M5QPTZ=@19C&D682S#^CV\'S%NIH(9^S4
M=BT!"58(%-3V?.%:>>#270*PE,S3%J/I)<<K*I/ ?*G\W08+HQ??JK C!K -
MBO$))I0I<7TB9ICF8<"V05"6?Y$E/WZR:4?GRLR'_*(H1GHK6I34QZAFXYQY
MF'&-@"Y*G$ETL_CQFB._!J_-"JN1-W;.MJ"RKA/AX\5()P04&FX[+#&>W50?
MIZ;D9BR8UN[+IKL%KWU+8B1A-%H3%N+2' [-IR%6<H(%D  -Q"?>PYWK[-*'
M$U@"=<,<M/&17I^ T*,:=21C83;$0-M'X)),O#<AP?>Z99%A^BW(!/R]XJO,
MS(W13S7$9UMN?"5QJ?9_RGS"L/TC68\Y5ACD#9HH;5T9^^V<Y4L:\%?R'JUE
M>]2]'_XF!)Q-G(<)8.IDQP>T__9KEL"=F)..["\K#GB)_TEEBPF9@4#>PH^A
M+%IM55O45,XV#ZH8T\X[I*J^(PGQR\!O6\\9-?R0S_*UA;CV@RCM)JCXA:>R
M.S$^4D=MP#,*U#?S!)$C&O8C&U#&Z2Y^)?N*#I]V5JH<0;"VR&N]LB@A9BR4
ML="(;LI4TD\^& 6TX^(!;>#)/.V=![1C&3$$7$M!VG(!P>P;TBM]J9)*6\IJ
MK(-<FLE#4&M>O?HVH#0P,."ZL6Y:9T(C)%37C=ML1VT0;9WD"WZTO/?6[/OL
MC,3E-.+U"&8U7^ZVM NKHC"HO,XCM91OW($/'-1,=E1>+JI*HD,L2$AVE%ZL
M9].IFOD1F%_E%N! /5;V)[!^O'L8"XSS[">="(;;[/.2RMX[U=1>I\+"VI$7
MV\H2J!:B)UOJ1@1Z4IC,_?;Y]GQV5N]Y]GQ["-PSA[6'QI62_(5L$B_3L:Z"
MVVIB;Q ;Q<:X=+X1UQIJX,3JA,BE4G6$2<!YE&M$';X6-)T,C@.'#Y%(8[Q,
MTX:/ 9-!"5.ZK'< 9TA7Q+9 N+#9NYOYY:+-GUY$O;1L77Q?CH98V&>S1E=6
M52#U-KC*]U[2%<^1_ZM7ZD-.>K(G.>4$N84*ZNN%D5*F&@0/R2<""1X2<X_@
M+:=^A%ANO\JE(6G0:/(2O@-$LWR_&=?'YA73/SH\OWU;A'LN]YOO+?[?];U_
MY?"]9<DK]#_%3[^?$/ 5D6UT-RRN\]M.\*M5 &U"XL3HOYXOHH7\3%2O)=!S
M[NTM63+].A^ XX]?K8@DAY&^RD05P!\B^DS1P_=#9GBA1_YU@44NLJ$')D\I
MI]^E\J@H!H&D.,IA>F%J(2Y,>50*)4_F?Y:/\%O*&?8X?G520OX;R3459:X@
M"961,%+ CU8 S>S.ST%8FV!Q6\KW5Z7#RJ/.-U+MDP[([^TW)<E#5O+&77P>
M@<[=?IIP#H+ T]&:Q^D>F-8ERP;X!C,,HR!SK(\2IO1:%3!O)A+9COD7$09X
M*4Q6(UN'.A7230,IW8?YW&F$N+7S6Z&%XC[61JBDG*.1\&K@ 18P*%@^C^ 3
M492\[/!ZZ3*N-6:L])AY8V-CHB5//+R+34*)IV9;U&G2YQ@SX;;%^-9EEV?A
M: OW*O2Z:+#4BS=?.(W."&V%GU>_;3)'-,=F605&C7Z<^\G]P%]DU09V!]BI
MFE1;(4NROF;V<7B(_#:2.EI7$ _40!1\P,&^%R.U%IWX-!8./>" EOA\;XA+
MZ:R4V*-\"O@A.J!38J[U1>NUY2N))$7.F:G3HC*&DB4[ LN:JH7BLW.C4$!=
M%PO(#G>!?B[V"W&X*N^2=BKC:"F0"G]S$B__17LQ^8TE4D?W"O'I]+ZMK==K
M.T/:Z"PI>G1[%H?&D-T/5."XTYZRQ9@E6^%NIG S_1@L<YKZ9 5<Z:6"4ANS
M,?;2Y6B$YIK)[$SB!CJB\3F:Y22AZSG7K)8.XG*(1!TO@G/>EQ_"E)GX>[#W
MEV<D]ENT/I"+]'=L-I(X0?=%GY 5N]B[UK&A]S6.XY)I3<(IFRB",<) /HKJ
M[:%)('L#]+#UB ":CWV52$Y>!M4:==X#:1R)#S6Z/1'5ALVDJ_BG=N7K;&FH
M.\WK+&R-S.MQ=CA*);=JB]&/-BGDZX&?K&_LT8""5Z/H"E]14[(\?'^$3TE0
M/3F4GPK:%> A]U6@R1NYYBM @,VVV\'&TGJK+JJ;*)2L&2UC'#D7/J"\PD@A
M9!-O;(#S3^?U]782G0-\DI_+E66QXH?+<H6ZUI\3TY*&YXVGO$$*L@&+XYGA
MW0.%2&4OCE!;6KV7AZOED/N-<=2,^%CF/T5J6Z,E'G!8>XDO&]#OK:3BK3W;
M\]_3^Q!MC@RF<<7([K<=ZJ;H@_%[+NQHNPPEN5N2/^:R04)CI2'Q$LNS/"<5
MT)$8I,4/#Y3" ._L2#V\)C!L:/672'O)&UN+ @EZ.U;B'!F:P //5^?,R^#C
M6V]8>&A1EK%)>!:S.% 41+U>E3EFJ[$<T)6OZIU4#'_AO8F"N;TE"%SA*SU]
M)5U3Y[@EX VCX%0M=O&IN9:+]WS54QO#- G>])@47U9K"5+[/-]'UDCXH,YE
M]O6>G^*%SIN&6+TTS<;:"(PY9,DG]F@"R[X"?;]_S%?Y?^6_$:P3V1I?U+XL
M^,X!6?V@UKI\<1KJN4-V\^(@@I&=V^10<JS"F8)*8^):@Z<Q_VVT!'P0 %C\
ML2<Z&(FZ[:9Q.)_\F1>?BMT>?LL -SML?)?PZNNV8WM)Y!*6:,G.6_BU0+X5
M8;D.;2=S!WOORGQE]0+&=@78EM@T_&VWDOL4RM37,>2AFEOJP_T W& R90U'
M#0]4P=7E6*VCI/HCW#.3G\4\CR7MR#M7R?F,>HA+0[L0[/-YB\X5M8IF6$'H
M4W#Z\T .[AMO%W?N*\\Z^IH((DF]3M<(*7PDQD_7!FD$DAFY&9196#UC;*/V
M3RDB0*,'UDLPMC5H'6IFG&LY.KD&T5(XESNPRN<FSA)DZUOX1:]D&.H"@9VK
M(X0&:IC*' L2)QJ>RB$-7B2HE(^<+.QZ,JGK%,2^;Z^;15IQ6X*L9E?6CW$(
MDF7-QD+G/A5*:MN&4K8:NP'WUB"ZLSUK_E(/IW"-]O34*_*L2.$)YD793$"!
M%]IT@AR6@+3'U.'<-_31;RKG<C&H9! 6W"DT?*=%4172C(.T]3V#CI,5._HL
MJ>UP34*F$A,MO0:3"*ADI])%D-+1"X-G\BG6G<J<7Z6$.@$O7>9V6YX=L;P9
M$85+,-5MJYZ6QG[CI+M%E5X5MV2H95N-R$-+D/+<4Q]:D6FJBIB?6)XYYF#E
MF(8.(B,VI *G*6E<=6H>7G)&^/ #X!>V,F!PF_!RWRI55R/_AA=1ED(FV$-
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M^A(,7%Q< GP"*D)"*D%F.F;!_^F&_@4@P<&ZQNG!Q& !/"#!P"3!0'<"& $
MC(<8_VB ?S:,!YA8#Q]AX^#BX=\/J'X,>("!B?D "_/A0RRL^ZO^]]<!6"0/
MGS +R#XBU7J#S>)")O@I)A.'5:Z\C5Q[[(A-R-(U$!>/@I**FH:=@Y.+FT=8
MY+FHF+B$_$L%1:57RBHZNGKZ8 -#(ROKMS:V=O8.;NX>GEY0;Y^@S\$AH6%?
MPF/COL4G)'Y/2L[*SLG-RR\H+*JHK*JNJ:VK;VCOZ.SJ[NGMZQ^?F)R:GOD]
M.[>RBEA;W]C<VMY!'I^<GIU?H"ZO_K(+ X")\:_M/[6+Y-ZN!UA8F%C8?]F%
M\<#KKP$D6 ^9!1X]D=7"?N-"RB+X"8=,+B:SO V754C[B-S2=0R/@DUXA1WY
MEVG_L.Q_S+# _R7+_LVP?[=K#D" B7&_>9@D !#@XHHKZR/>W_@;?^-O_(V_
M\3?^]P+X#;G1Z/W#KMC#NK^"^L%ZHA28<07^1?1"(N>]@U,(IUBOB66#_0J/
M;OX^:_FW8D7!==O2L=?A"@DB,>IZ(0HR]9%RX<4!0FUOI/HN8O#Q3IP)4 B#
MR1L]H@P7-IM'ECBX0<8ZF1(QKM'RXI-:]C+YA6.O)+2G.3XID&EB_ >0!\%1
M>0.R/'$WXS+//IX,Z3)S-RK@]BF8IDSJ\?)=7,MK1*T]P#P7 7>*GFS/O4Y\
M_)A>B9HZ4[;>]0R;'9)\"DY R??0=)>7]D \V&R>OWM,2KZCYU'0#ZNW5I,(
M=]CBRA'I1/7TD&S%7#Z/HD',E''KY/+$KH>MBY![>IZ"OT/!G>G F8/)Q"^.
M;>LP4\B$SGL% M??:]%&'@4-VNMQDYK)R0WT"F3Z"L%D6B\>_J?0M -DU1MG
MT!IR%#3X,34%U\3F?S)]5?R-G=:-MT];XXU=5GA@8'C@L6+(N"'E(4\LL$>$
M^ L#4Y!6,DY.A$,-X'@W*X3&XW!@=#C78&+AO$C(C!D-P*?L,C\=N;O5">TT
M)[O 10,^% ?L[32/94S_\'4D1U"@ :1GT+>,[_# 4A^_BVRUT"(=$\.8;^??
M?0_ 9%"S N/JQS8E!+=7<>Q%A<>)F%W9!';;ZQSRK(&3M]+%IOF;]-TO<V"_
M</]PBI 5J.>89(^Z%62-^VOH9"7G,S$Z>%C:D6DI ,BT9'\\"-\06:8VM)M(
ML3H9F7!(CQ\U&CJ/>)77+5K@4*NN%1YG)*@;Y_GR]/.GR=6LAKJH\=G-^, L
M6"RD1P0>)M&\?I,PC>7MT(E1RS;][=E$R>VX@QY,5#I5(AU&C%"'LQ[E%:]Z
MS91F-7Z97AP9- 1.)XI1YYI%9 -%W^?KI)EU%&2%=XYR984#_L;_'?CS 8@&
M]%:TGLU"NC-#;)22F3Q[!DCFFA-76V\B[B^9)M0[AUQ92U2G%T($ ^E?P)UQ
MM;3;3UHV']JY39=/WD@BY1R>LW1OF)]^VR*^4/"J/IGJ]/KP!,F)54"<4;31
MW",[S3Q=U5N6)56Q5N9-WA/Y(^LVY[G-*<_S^K<-3QU:CW$;T8 RM9OB+C\2
M-(#UK/6ZN[E8#PWXJK9\Z^J\;@;\$WW)6(H&+(E ^?],GG*T(EE\FYF97-4?
M,C,]T " $U$3/8DD9C)I>:F":64NJ<F(;$6]W %2GW@R\MGMD(W'WLD":, #
M,OSOQ,K9H",!,W[(BO,3A^U-9:FOAYL;(ZA)B=!@/X5L>'*EZC,SUQPT(-+#
M7R7MTC^K/KHV'M[O^]VB@T>6H3NA*:*-0:S1^&P"/N]3/I?J2N@S&7JAKG2A
MYCJ3R2.T'E,J$>[20/Q<>MZO:R1OA^&E1M-.JT[XT:VY><-/9%A,KA7!.UQ-
MG[-B4=$E%J1C!ZU>#.^G]J\2'_2FSK"S72L$K]JGC'5F92:P;RZB[Z[)>2I^
M]G]5*H?CM!RUAE7]'KRS'G^XML\9/5US0XQ0+3A[.'%&#?*$8IU+%VI@'HA/
MQ+>+1?N,ZTL[)NF^#<-<F(GTT_ ((#6,M^BP6&-T,4M<-?9-&:+1K;1DL[Y\
M!<>?V1/!!Z*R6BW'?UXJEPKN0#*2K\XYR3D'( R;*X96=[]JS 6$HE*"A;H9
MC_F'3D']3<L=R1Q-XW/#%:#9"ULJ:>#HC79)"Z7%,I0?%/]6._6-H>'27MU0
M?TJ#5./*S WL" UH-=N![IJ1'NW>*4(#ELLNNM-%0E5J?8W!A.\[L(+&:WNT
MXU5V!/84< MT&HEI4'.\'(^JJRQFL"R^^M#\\1-?:3PDWS%W:.!?.^BSNBEL
MH3PZ&XD0>9Z^W??%F#_UQ&PQWW[ZRK%(]L%#/:JL',3GT,K0K@6MB)++W)^+
M0JHUXZ5/EN:>%6538Y8:"W;G$[($;:G)-$6OOFR(RBCE'104_*7W8A<V0TBC
MWJRN?R;!HS';?2[][K&B;&]NF5=;0\RDG[C#P7P.CFB&S^14F<Q KLE0*ADL
MQK"?4.-K+AMBT.@D:UBJ<R1O11L\' >-O5/3[8_[J?_UL2!DN:K^;B*OC4F\
MGT]CQ90JE:V ;7YA./ZM5I4)&T:LBYJAE55PC/*Y2!!"6K9JF7#$A=;Q_0OR
M[AOAV ,T0+.^KCX^6;K>3,-D4IYH77G*^4U_;MX/GS3%B9=-P@6M^@_JS:FA
M+2#B^4LMM_<(8-34QI'\JCGYH.TB2W=/*.#3S<[6"AUBA-.:>UK+K] T?97/
M@O,+ @UHZ7J%\^:K+$-6D_INVQ+K!.L)HC[64KQ]\P:BT6XFU5#;K":JUT?@
M6;A==3TU\/"@7B=1Y(O>655\M%$.&Y'RK[P>ECZ:AJ^ZL" S>T0K]>*\64U\
M/I)I)4HH>>/>Y=X.D!I.:H)M<VB_8VS8]=S@:$>$&?Q1H[YZ!J>L/ H(JP[K
MZEB4D@QY\>[>P_1:QYN45N"GT<^57JZUBC&6>I20T:[KD0_Z-\4V?CDX[8DA
M/92 3Z[6!6! V\[J[OH\?RUP]>[_RNZ1,"L->(JMX:F)NPB; 4TM.%R+-]+X
MZJX,T6M(31@$M#MSLUGM8Z>B =5FY['=RQY3+2$M]H'3VV?ZGZAN?\C@7@SY
MU 8)1SKTHYI/87WI?V8RHW.2M3=FZ5#>57/E6^[:VC-1GO$>Q)?8"P%UD,W]
M",[P19,'>>JR\!__VOF+]$YQXSYFQ>^L+Q,,OP;++SA6T7.7ON'HIOM&C9C+
MO?LU'K#9SMA?-H<&].2 SH8"XE5\P,F;P(/A>/+?ZU+R?X;XT "UN+Z:*&K=
M)]38'$W1BLUQ'1^X,,6/E]]@+S5?W:U*0JAS8S[JF:3.C(!?[)@!XTN[;T]"
MJ$Y7FU^W:*>^I=YSM63)9D/4'U[ -[9<E6^W*J_ ,*C5G=+Y5>TIW#J-X /#
M6^F7K)?@2-0_.TN.S#L*M_0"PCD;X(OFN=Q,!+& B[Q BF?*OQXT97<M23:G
M:/J+ON[?=XSL=H5$1>+JQV<Y:V<%-DIK+OR2&*)" S[A/1S$SAG+0%'!J6N.
M KZ(")]8UT-5W4)&4%-J\AT?6,:PDRN&>.!L92XWN[D6A;7.=F76NWV0?M^*
MKXJR6+[:DD4$E0\9-LG7[S"0:5U3X]LS!]1?YAF=($7(ZLC;\Z^L/RTK#K&C
M53;3Z2>*]S;V-^QIBC0WE!)18_%-WN_E'XA&R<+MQ_/"MCU_O/I\J7HC/]X"
MG>+EYZWV"ES_4H<="VDX.@B%]PB[]K%>LHM1B6Q;%G3K9M77F'L/*#JJ;=?/
M0W=6=-II0OHHH>H )\B@#*VLL\>J/B6S2M@ X5*U6]>53#7C/%].3.2/-1A#
M_ #4I__JZC9KXG=)INNKTZ*.,55BMMQ6+=T4#QV[*QZQ_0M,*CFE"W47?4DP
MY1]I4=V)Z<-KY=E:DEKQ BD(PB4;T]Y.MHX5;@).W&/G:1DFVC2O4J$;']U/
MAH)#XK&G@IGJ/J9SP-" 7\%0_[R457-2T!SUVLNXKR@FQNG<IJ/:L%/KDW%O
M#OR^^720T?;5-])U#_+!YJ92#WKB]U@D7UVY(?U^](CMKG'[J\S#8*?O5S-%
MK-@*%JY4UF!V'])L/D/:B8*\LL^"W40$X<1Y]@QV<8>]$6<6P"X_PU+36521
M1>6S2&LIFV+S':/E\#)Y0P50;-$CRDFP[GO"7$X@AR62^WEIX8&RL#8=6UC/
M[*=\:BO].5/94XZF[%\^GO7VJSAW<W$E +K#(3WD=+F'%4+NB3X)E[8N373A
M$KP2!L_MV=\GLHFVM"=1-)PDUG8 5;5EG"'1@&7+)@=3B#GRA<'3)[).09!G
M]'?5*FA !P/SA(6HVM-ALK<_-1A+C7Z5Y@M_3V<^2 AM+ 82%&+YTD &:/PO
M]*Y2P5%0\"K!E8]T]9T)P#-#/HJ[DO$)JL9-^(.U_MX'^4!03.$5+)LC;Z\Q
M>A<7[F&:WGD? A_8C=S@Z/X(%"2"_!+A!9H?(4G[V+HPKB_%1C;-(HY.N@1W
M]<>-3=8&\&"UI3R_95[YOE+98C9/-BDU3%M4/.[.^*!@7MAE"YGK-.)+8I_,
M(2#@GZF&7IR'M"+P+[&(YC%VLG-MY0EV\CGV8CQX"B2=1MY?OV8\60)=[^F&
M;2'6WSIG#D$[6QX@"4B\!WR&7=)^U 2DZ8\W@4N@SCH4,_--/]_O="0O[Z@H
M7XLO)MV^R3\$,JRKV>I>#U+N.-!*QC=6A7M(23RZV8U%?6%?\#%XGE)K<3N'
MR%<;=J"E[3<IWY!DCV$\:*@=W<@P@QQ-.\HIYUS;W#B*+9K%JU?SOQ7%7]#=
M'*&]5T6&%/\B%?[&?Q7>@\C1@#5#\ZN]ZHBCH%N;3#0 HQ0>C@8</X7?>AIU
MHT!WE9IHP,>90N(+"I>!VQ5ZQN@FP8:6[S./%5OMHF,7CX"!1XQA:V,>LK;N
MG7+[01DK<&=WHF #:Y(@,R$D:0=_WG* W1S\8(T]Q?EH\L].=XXI7HITJ!D1
M_]S+LTA%A<27]3%$>IEL'_00##AH0,S5\BW"U/RSG[8'/Y&IH>DKPO:7O]$
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M?^P/"S4NZ%,93*<AU&8]A$O^E*SY;*;A<3$X$!#M ?F-IH115=?!R=!A*PN
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M2UN59(@VCD -SA68]:@V@OMD^UX-CR/A?D2F42H=@0%X)Y' KLC,K9/Y>30
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M_"#=&JY!V09QXS)^B3-(K.&SPRMEOF(LJ5<;?HQ! \/0H\$CFTPU22$M6.>
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M=(=$2YP@[P*O8*$ H@SB)4>26+GF/#BDZ^CFYA<M6U,?M;-H^^63(O6C^J&
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M.P]6+*(5&V1B;0PDT;N#-/.J5L&,#3)58:^)1[76['])1NMJ-D6X^>6&?HM
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M(VTR!=1 GTY][BG6,BRYO5RB)T]:XYRQ%BF1[>U ;DF^J$4N2P]FLM(HT$A
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MPM+]:%<&7=V@!?HVZF@]/Z%E&X'NJ3G%]B?,5[4Y!Z/:WLF#=L54B/YR**S
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MW#:I"LG_H/V&,*@^=]-LGHF+;]LU3?S$?WN2UC[73Z:Y.DW8O5<WS/L/^^]
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M!2S3->O'IPVPC-M]V]4QGX +$=-Z?Z&7BLGR*<+'G7O_U R=8<%T*I#7K=C
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MI%9PE<7O,@,.2YR.E =NKRE_:P'$F%'?D4MLFR,X_H.QK?_Q2J PUU29G-'
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M>IB(:U_AHJ"24^!YL<K..@^33;70D&(]?7;)$WXF8EN!E<^1ZNB+%W+K.@P
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MI/= (PM*U+<8++YW ^(PW].25CT<8CE-@WBFOF0_=$"X>'&P2E1[8KP2_E!
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MO6I35@2EZ:IO\*L8Y'B.KG>QFG KGIM_4*,W;$(%3D2/M/)2CI5VBY;-FP4
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M#1NJS]IE+9=B9K,LNIC?N8$#B&#=HLI-3<;.QF]()LF?:[VX>YW1^VSM77S
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M4<)O3=4L6:V!+%3C]$I4;>*5]Q+L8C;]L\^+,(%<RAQ+J>6V$U"1VC)'@>=
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MJ*C1[G.AE0%D\OGGNJ<SX"1HPH<*1#^C;^X)6P-Q'X%Q]&7=(G(:6NWE>P^
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MIXB.L9)6];LIK<TC.HMJ1 =8PP\F3W9L=94LNNXD\ZXMV*NV3HH3=X>K!IO
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M!67F^V@^@\ALSV] 7P_<QD$!$4*$DM73>7)>I9^1IB92;"HR5%7!%#=^F]"
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M\/&P29ORO(J,=]3^F2[<YS<RS\"\/'-@W7RS:=&[U*I$D?X*H Q3=DNZ[N"
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M0W/ ,3,I'=EOZ'D&I+ELM+[.Y&MUM!4M__<*SF;_&M\<0@1C:&]/RS16;/1
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M%5($OD[J%L4;JF^=0H2;A>EKB# PAM"'2K)*$.8S1872K.U)!LE5A.(#2]U
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M<8+,LY6OA:_I?BQ&]B9T.D3^1:7Q9]X%-Z](M-SB]PN@1OZ!BU\5IG[J4;E
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M3O(?)#(D?^%5\49UCL=>@K:P9V]3C3)G26"KI_RKAD&+?#)^LI*LR7D!:'6
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MD&^Y4<N&1<I,'S="_A7:L5"HM[YAJV0A1N9*A?/D,>LXW!2*]6LCW>:QD43
MU+_7+#D"?5<.%<MU.W.05Y!-T[I.A'RIYTSWS.'@6WJ:Y7"+&;RC"/%7@F+V
MA/%UT+WU_8#=&%>&N*Z<<IR^YVQZ.GXY+D\OP*,]D=+JS?E\]"I0L><7X3&S
MFMAB0 S7U:AX@:@SW ]"!>F=.J<K:@[*#D^>_+0DHM6 K>3:028;7)$)0([;
M3HPW\Y;<HM):ZF5Y']YQ=\VW-R&O/1D96YFM<+(6'RD8,[3-U[?J5_),*J6G
M[$I'%)'=@BMA-) ;,/:&)XIL^5 :/W_5Z8FAOU5#>,.7^Y=F9<.RL.PY.O8+
M8,#'(#-;!]:5=\X &D4EN^H!&:DI^"6\.1_IL4<.'+.@N9$3/,P*F_I4(T9=
M8@'^)J\17>3O+"^;7YRC-C3]QE('A_CWLA69($(NJGQR9U"H$PS4^'5 C#1/
MZG[V(.B/;\C5/>]J1G5%,5M@Y<;2;1$^V:0HGH[3C+KC-HF8'LYG[OTN&_,@
M9%S/UIDO)#2&2!0MC71:>3Y*JR]4._]]\':ZD /Z#NBG/BI90%WJKE/9YEV\
MA4LK9&;0%863Y;^]WS];UF_ZYBZD*"\!6>M&Z!T?TF#C]$Y<+"%>SA6V+J-U
MKCUMGP2#[D_ W3QZ7Q/W#)15K"-I=:7TSL8L]?$<$QW\G3/<1*9MK-D6<Q%4
M3P$763F*O"FU>-XG_ >Z&?T./&(5$2]P-/5;@C@M,F)$E249OU,PH0U9?"YS
MYN.8*'S5H;YPP>]^MFX2>=O?B_J6*#3U+HOI(L6JWC+Q5+\N4QJ%QMF'";\0
M78Q2?$(8+_NRO_!KNLQE@'7-JUN0P8&LXCW# $Y6$)0.SP\6&J[NOJ6^F'0&
M\\1 Z(CO4MC9RX\Y+/=A(<=9SAE'KZ?]"HNQ\8]$D(-W:$1V%%F_LGH";Z44
MYU:PK_AL*-RPD-9UX>]W!PZBO$>6HY9V6D:HN(#SO@6+[]#DK 2FK%]A-P7E
MTZ&.!"+LG O@7P]--#BQ0C6PE(4_@=K.9FF$J>:9A8YZ2-MFW2O=6,>.O=(W
MN'V"!TO>5C'-38(RH^K/$_-YHG>*>(6[KL015>6&J[,EN@=5GWAZ'4@75+[\
MH GT5QIW.O&+57=!)(:Y];,A,SDO=K2:?&\W,]K_D7'IIJ!J(UHR#CHR^FB6
M;:V@\4RA77L Y_ "6#05[O'E,VU0P3X -^Y+W]&+9)J&<*U?J'%T(2[5*0V3
ML[T)_XSS4P!+&EZ<0>P.I\Z*4A.6R&_Y0BMRCOQ;5,Y;-%1=O6\S8VW&=Y(4
M3)<X)=99,HZ8C4K<:,&53K;OO:$2$9OQ@H,5TE-FD!V<&&HXQ3QK?&K339,,
M$O1TY:#%\3;I#G0;78?ANSEGLQSR.O W]\Q;1V%7@X>#5"&BT:>K5RI4,FF1
MB0Y\ 00Y"YN_AB?Y$.M>._\-GWH-9_(%Z!8X/QZ4IJ,V1I8+\UW5/^17GZB9
M_H*/7;*(U6E'PKK$T2M+X^OSI;_T+(P+[#5>%N'=B"*J15 *IL!IKD;8D!R^
MWE??^>:A[.L4!0K"M+X#QS6IFC9>L%]=/9I1JD5=_%'Z-+2Y8[:[TG3H<L%5
M?[11;V+X-D.6;NA@:P:B**[\=2:1/^6B>!^<OU:N*)L&1 B XQD5)5Y #N@Y
MT]ES/. ZF%"/,KW0(.B%I=RZS-?5DZ",CI+"86RH<N>!)0I3S@0[3I%A<L%1
M@F%,I\^9M3) ."(X5%B20PKT*O%ZDF@2"L@$Q@0J)0/?@:Z6O=S#F1+$X<H#
MU;2CE@C%A$%=,T@[=$U-%UTTCGIF*>OADO?+7YB+"U::%K^,KKT /-H<I?DY
M]WY>%EG/Y]E8L2T  _>O?=3"$^YGP]ET[$:%JLS5K*W_@@2C?W=^45G7MZ0(
MS!!YY41&.R$A[OHQ>,P27EU, BR34>06*3>9\F5F6O8%L,S,H5 UYS2J0<UU
MPR8-&*8U=*M@.:W_;K2IB'V82+"$[$0>Y0Y^ 71#]]=N?;^L/SRTB7^.MLZR
M<@A>EB(%I80=.+6$,V]8SOXT1,?O2=?"'V]G4&EEZ2+YJ(CJVZ5=R&YKFFSW
M;5, :5&(\XPDD8@@/\OB!6#4: <P6U>[R!@*]3_DU(P[7,74.SE:KXG["=>%
MJQUW569-VN=:=>MP\*#<P!.D'2-IVQ$Q?0*?J:S/;7W&K1S67:1(",S=PL"W
M^4"#TU;F-J7:=(;BP1S]M4\]A-I58Q>%MI&X"WSM8/ 48J8J+,SL7C*S_HR5
M?F(;JM7VHY_>%IZF0O9Z%S8+L';_ZYN)P>VKYN>?Y[>$NJV5GT5KUCZ!AM5"
MO7/WR?[4^?>ZN51D<T5N,$GN:I[>3ALVQJ=1NSP$U M\]#0RRCZX@6+YVQ,1
MM@]E_!QE"+L&,XSFWT*$UU$_W]ZU:N<$?QK_F#1CB^EVJ#1)-F6=MPR;J%B7
M/[Z,-V:Y)%58 Z<R(@(PC546=48=.@E6B_96VVE=Z.[Q6"E8?Q)%L28O%OI]
M,6T-C#[=U6F?]"+T+5XND;%]BZN;CLZIZR((A9PUME,?L,K@/$[4@$;9^RB8
M.E'LH;_:STX*N$,7I::,+#$ED<((\S[ S-!6D%:>G71X"I[$7[OJE-B=NZ<T
M+;255-SZ;H0\2N6S-8E1__#J2=T)]9\;))<@Y*]45XZ1V=?"=)L3A]@RKHHI
M>'S'*[6%>(2/?@_>T+&4,]LPPHK>LTII.$T,<,I  BT=<E4FFT8R<:#)7&6O
M>?A>]T;.M\\WL-62KJ*PR>0?:O#5VES'YD(RW$I@(.>ZEG1KR"7>U(^ZB\E$
M82C6U^7FG<UGIS8A7M6G<XVL,9Y.>795?S16**:83TP;@G>X8X1;86 @%=QA
MG!8T;J:M/_B(WNO:ZW]<2Z&I/NO+)N6%+HZ]FIH0X=FL*<K39JL5LN?5^@C+
ML!= $_HEMBYZUA'PLZ ""_OD!J_4 R,JWX-2PU36A8VIFIQ_C+V^YFE UPGR
MX?"W!M;]<H003W/@I)=R4\!<M^=N U8%--!2Z/)/)G&/ V-52=90Y0#GP;F>
M5#]?>'"'58Z63@UC97\#ZHT#@V;7,_,,Y9D<E*0(V=98MH;$3]E.$!<2<*UM
M6).@97)!J3Z4[P$])U;M;SY)=)K[P+^IS-['=&,G*FC1&/FEU/,%@&7I\76#
M,"5I8F ,^8UF[6)'@Y:X?9BMDKT^QJ9!=49(I7?U3]OL<P/6JK7+G> ^3[WO
M(9QED@;T*^>X49=*F]1U);O+;YSZ;OT+4G1@)Z_E$"1V1];.].+[PYR7K=2;
M R7KG(,GDO4FFN./9=<\@G!VKH789H!I:(^B,!)%VM0[/TBT=FHN.WY TSN*
MN_/F%[E3DRX&;"3YIAJUKB!T'_@E/382_/_;Q*8I)1)#WJ0\12<7V6;TFY?+
M_9R\-M]U)$F9\8":>Z97^+XRD$&?VEFMR19U(G2C9+7^LW5!IU;B%[/%IRD]
MP2"HEG:_+=Z=DG&3,,K^A[.#<<="BO>A5<@>:/$+TY/R#5SF$KS<*I_MLB$,
MJIG_BLC\XQ<+%?W3^E4F(LT+0%M9K>8O 2K4^9=GM:IPN:0ZYV7[\88:8 Y!
M1Q*X![?#^X>_&F*H.3<I5%0L:E'+V?.8]\MA@%:H)]X56.WT=.S3W> Y%_M@
M3OYARH,>W&(PAC9D@'?!UN>"$;ST$?JC!RUI N_+6A$Q4>C#D&(@#)G_Y1&O
MQ*3WO:\&W_P_?N6H?LS,AM!+_MMS3X$;6K 3G6AN)CHSH1MO/]EMS@9S.JX:
MA]IR]@4C_.0?)[GBU?3A\%=N9:5]VD&5D3!WVR*4M(0)=>XJHGQ0I6ZN_[[]
M"7;&MDX@=\U^7R349E)XB9Z^99"(:.A.&/1CD S6-$9"_3-U\D@BBFQ$GQ\E
M-_NRT,#[H*M>O8:I&.%TE]U#:6;#FM M@''U"1#?)JD8$PY@L0Q&SJ!>0G>$
MZ$@OB%\0(8T'3 3\L8$OTWJPF=CN\\GWXY88DFQ1FR3T.X[(KA2:A(<KUJK#
M(W^8-(V8AG!11I"QDXM>*BL-2,5)_A)&R@4J\LDY$1=K-JN2H(,U8&+/^ 7L
M@\.<@0,ZM25T"2IL^WJ*/_ZLQSTEX^%CQ3#$)C(B%&YI$O_V'(^0$?^(?\+@
MT;,-YYZVO-V7X5)=Q,]Q@0X^:14NEO"U*0WC6%*?3TGC-#3.[=4,+[9SE!/7
MLM=.A V+XC@&A?^:0=E0E9-$'>D-0<8?O,*AI[0(=#+=\M HZZ$+/\BQ*R0W
MC</Y(X*O8KT:%/:L3I!CPH^PVUB6A39RHALME8'P49_,S@(?A*R9YH?/>UG>
M(%(9J1@[G@'W8Z/FV/;8"%#67*8O#\)D-=(@=H2*? 6#OMW &?NMO_)JXVZ,
M3RU)Z;SXY;8*S0]Z?>3?R&$6VYRO70[LY$QX#N60H\=*><3OU/QLCR1D" J%
MG9"B*HGW\!'#(N+V$"]8+5>,[R=[AB;M14+_X0(1V7.8]DIF*G1MFWWBMYZI
M2,^$$O=H$WYBI47[>+R=KJX8%RLSTZ[+LBL5/,P,FQ/,/NW1.">QS&(_,BNC
M4,<&5X;+26R#X^75I(KB"]_^ MMW%ZFNE 07?,^'3S[,E')G-&_B*=>G0N2,
M%J[ ^>U6_=MD6CQP$!\XJ"_Z,,[F.5T55[[JMC\%"?=UMXV4;;Q^V(0]@_K!
MA25-FT)$1*K.&K O"*V1 O('!-"RHRFM;]]%#3(9TG+S/.XG0F-TTJ(?Q[SI
MG(>3F6HO+<[Q(SATBYI9"U(^+G_<A\K'XSA*[MQ:7]#PFDQ(?/GL-H>ZU^;W
M2F% VI\'?G,BBNYKR]0[2=+A[F]D2HW*EAVJFGR.@0E4S;%7_XE?PK8) ;18
M<E $\&MJ&_F82DCU"1[&!1$2!IS2"Q\[PJYSFT!SD]DM22*)?+^0[V!R71GI
MF04? T/Y7<'GB[;O!> T)):Q[M/K]E:(I^'&4N+T EU%=22<>(N!314.&4V^
M><:2&?NF)G5.["A=J[(]HJ$7S\<J;*;<F CN](KK2J%!1EW0L;/@'.HT,\JP
MZYU&N+.T1>E,-ABAVF-[D@+2$0Y(O *\K&WPSH?[3ZI\;WL=Y*GS"G4629FP
M<;/U#UHP75T8&8?:PGE6N]\/$^QLSZ9D;IZ5AA[>+5=3\I3JZ?>E?E<LLGJ3
M>&-JK[L]6\ FAISNC:KZ\-G=W00ZEKY)&6/%33TL0VY;B\4RT@\_/9-1A]<'
M+]N_HF66"]F]!>6:A2XGJ*#G&;==(.)[,XC46Z%MP35[N6:O&RLVL)>0>B2M
M)(AJLY,($R1QX\CXNU-^;*_CD)X_UMZG>Y=_<:&P07U!R-ENLELGNA,HE0)U
M?3N>^CR]3N&IKLBZDUI- '#ZO]A[Z[BXGBU?M D$0K $"^XA0./0:)"$X.Y.
M"$YW<+< (8'0. 0('EP;;]P]N#0-P=W=G4M^9^Y],Y\Y9^;,_;P_[KQW/Y_>
M5;5KKZJ]JW9UU5J[UEK?S+5?>4MB#9UX' (@_.I]28 >VR 3SH"X_GKFZQ%[
M=E%7=*+FQ68"^1P#%IG.C%=1!E><P,IS(MVDWAB,7'#6#F.Q#U$VF,M(/VNX
ME.8:B5!'IYCX<B'?B9=CP,K-]\$TE&"T\?/H*3N-KNG'0NP _2YM[NBR^D26
MSP:10HB,K3S) I;JJ<=<Q5://,Q0''0KFIR4HKW/"QS[Q(F*GQ05AE*,;ZX4
M72;Q^@VF>$ZD0:8FK]6E@\B5N(R"[-L$$H8^&.D7MMFZA(9_;8:!",]9&,^#
MLJ\U6"<_^,_5@=['5;[F7]QVR))FHG?"56(A33]:-:-8&/LL_\Y<O3;6T5!_
M=4 B^-L0*)W!K%K.U-8( %/CLNTD6,==\V?(+ ;_XMC4,-S'HGCG<%JP2I\<
MM6XO/*Z%D"LU\N#-FGG@[C5EXWDX*+=<F8530$DOOG#M:R&B5'1>77'?LDSJ
M9<F3_\HUB;<>$"/\9<JE62Q-Y$:DM>J>_GFFO\)@-N*\TW, NM2) ??0_+RV
M?X<.1+*ALR*\-!H#=HG3KV/9)/%FQ/3BRKU2G._0'A89NK;_+565''F2.,:P
M.L[6W!$]?(^7:S%+U(\OH.<JHVJ"12743HRS_8#".:K1&]E"\ N]IA+VGCD"
MLK=9)6/0DRFFTJ$7Y1>^>48Z%]&S!]&&<K#GKW&9S\E\@[TE3&U^&KP-)JKW
MVZ\ Y"T';'=ZL1$6O7@=9'#0E)G;;FEQ-J*8*_Z5L"LAGEJOY*>W*")W[/15
MG ?QG+LN+51:4.N<: >A7DI%D.NNK:-JDYE=<TS35AG-J+*P5J=H^09Y8O>"
ML=&DK"=&@@([W5%J9, SEK ((_K"LOUJ].8MV< 5#=2PGR_T81(V*J/;#XL7
MZ,E557QR)']QH[XXJ[=#8M)87N>X0?JZK='OK- ([:!S%7:7"=M:(J&K#^6(
MR[0B$>GT#--$%,6HEB:.#Q)+3BD2DRZ0L8>QW0,Z^E)$&/ G7\/$>AQ_%C^,
MLN4!H%J-EY:\NWE9Z,VB:?^/;O#F:\&%7?[VT"/]=TV0Y'A4]#H6+=0>;\I%
M2CGAD.G2HVYK!FZI,KEN07,:!]G%(=RM@44;_;;SYU_82#5B2-1CMHV:)851
M%HD_$2.?+X[ASY#2)<AZ$#!74OF2;7Y\#?2"')*\_TYMB8\:"43D9;1X:$4M
M>EW[$H.KPW^$6[V4%-A[TPFYX1LNX;6R_3JZT,35Z890-1;<)W%W=H^7XDOH
M@+IU.44DP3UZ!Y9NZ94-<2'DD$R2WQ1AN*<WLB66&2$H*V1N?J<V8FUNSX96
M2=?=8CZ:^M<GFY3>R!Y<:S2--@CCU#UV-^F8<1OPFOWS6LOQ,.?T+T;VQL6<
M;E,(=;L/409T#UY]&4BM*![*UY.@&[(GHV<P/O3?-HI]:!<%IX1M$FTP_?MW
M!D^7[Q@VSO4F@IJ&P+6^7'C*$H;9A$^.7 ]@U^Y;@S<_CTRA-$K"_@/@J8T7
M43?RBC(E5P+:I-W%P.&-C'8>^+972./3H[GQJB$&,WK+]!*"^+;$3F04*#E*
MYASH&&IF+T-#90^9MTHO](]?W%@)DOPLJ%&8UXJFG7"1)(6T:? BKC"UC2YX
M]RM(L3WQ["E3*94P9''_F7M$IY[/[0K?V;!NWQI_7!(6MDE6A.PA1@!<?[^\
M*V9Z3IASJOX;6\N Y^G#J(O9K*."IV]<I1S3-67F27]]6JM)<TZ4E.W.H7?0
M5(T.A\#GEJD<HY)MMXW&)84!/6G>X$EZ^O3<$<E'_YK!1$'F),'?"B'&7-/]
M<?ZC'0N \W_(;O[7=Q-:*!__Q]\K4/]E$Z#H+Z=LR$JP&>_#K63^Z0FG]$:2
MNYWP99 :Q+&T0:I@I#5VQHU"I2O<>H_]E? '<NE\(BS=?H]H<>6RPD6&Z99)
MEJSC;HSY&#8UE8X*25)?9'KJ&M !SK=6..#RNON)C)Y?YXNYV&HR-.;:8UQ[
MI]1QBHE.=YH]2A'F+G&!0!HPUE?C^BP5ID<X\2^&8MJNGM;AI,9374[RX$)Q
MWGSD*(:]C)OE>^>WVGI2[,H0?>6AI\U6>:#LR8[><%4Y46[_MGL2ET4G6T74
M@NB[T1-<,@734J+:]*8H-R;='_SCUMAV22A;R\<Y)9/!+;C=DQ-&O#;X*M@.
MG3K*.1*Y[CES; 6'!NC&PD^U25-W;?!M@717^) 76LB5\-](!/[D<J,G;FZ&
MI$]F]7=_75GZ1PU'(NP:=58Z3LFJ]M+/<Y4=SX_[G)7.*._@WG+8/V #7NTP
M<^HI(@_Z5&#LUZ2AM>QZ,JG7_1&JU02?N721+_B%*+?Z2!E?'^&!&OIJMX1A
MKQ4Q6];RN5^2\U2-P@5<R,WC&"G"I2":0MI1UG5A70&>0I<,-^VE1%MDYC?:
M9X6\"D_HT\!F+_3R^*_:M1,*19J19"8,@^ O9]/4_1&"A0DM:Y'5I#GH;M-G
M,6L!49J*+1Z81)ZJMGO>PQB-&C7R,F/,-(1^GC,V%*6$%R6ILD@&>HQ0)$-,
MH1D]^EGA%3O9QJ.&<*O2(=5A-->X_)3:;L'B:.0N WG3KN/4^W@R^AF?4>$S
M&+.+HL@++ YJ.< <)*L;5TPH8G>K4<>DE$"](M:!E%1DH]_6<>R9"#/VQN-1
M^6$H'')7Z6302W@/B..)/G63KZM]L20HC4&Q]H/2U =YI?W](M*WX^R!C];Z
MPT>O?J*C/A2)V6!6_B#MA&M^F0_(SWW_0QV0Q\OKG,K0:9M>1,D?W/QT6ET1
MOT\.; XN@*GEY] M-2J4:(P72((!=27*.)JH8QW?6]:\S?'Z8\*3V9P<](I:
MXFDX/DZX%+53=D;-B>Z#V@WZ,V8_8^..LUJ9([\;H!+V8"#+<\96/]OT]PVP
MQA-<DFBSM*Q#\\YY>C!^K'8WTH831V/7N+1F:4S.C'6$!H?:6UE<ONF6 X3H
M1\KFQ(3ND!*MJQMR,21/9,QQ).7TB_T&K3>;S^Q@;H 9K!\ESB0G!ZA+OFSW
M+51JRBB2MB&C*$4;[^E1/<I3523N+=.?L3UF^'"AT<>EW4J:5V*'9  VKQ5H
M5<,8?FS+R>?%(#:4)OP-L/D]X2;%!@^<X9 LBF0KC!R/VSJ6S@#QFRPW7337
MB>4MX:Z*ES^T79:>(Z;/H@[O^50/D@N5JIU*/LK@Q'7D\G'L'1BF,"UUFW7=
MACY=JIUQ(;KSR]AA6-[?2!K;#>LCI6[X7D:C>JMJ=E.XGJ/&7D]/H7Z"O"D\
M0DUW;X\-()RY!8Y0%%^/B"N'%9/A*&UM>]"I<:4BXO6@[.;6G)Z:?'6DD]G+
M5E1;+:QR9BTK;!X!&^=T[[CT?YW7+C6"YXZ A2:F\><_KIO@42(K53'X(RSI
M)R)@@]T"LF"^V +%7*O#J1+<%QAT>0.. [4IY1T(?GYKAB:3 W*819\PQ7&G
M4Z^M?CQ)=IES+PD5N*C(S1)$R.,]R;NI0] ITR8K:J#EG<M8U"2ME]>]Q@O
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M!,9862M1V)+7G( 5PJ6MOU:@=-/& R6$D/<'$1MJ6X_E/QISBFP,@R;A/G3
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M3<(U45-&-0D/%8NJI>8V2"P'GP#]+Q/C>&U4%;2QT[^O4'U16\LR60L=LQH
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M- H%DD^L.#.(;=$@GJ2JK#U79BMF1/Y#F\E=)($LUU\\7X)-OY+?:#&::C&
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M%7EM]>"^PRU^PT-0=">M8BE(X$MU[JA'R?+J,H<I>O4YINFR^YL_ +5I6*"
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MV8I9K/9@]0:;A$0I3/X=C%OBC(!S8Z3L[X_C_-?E5?P8"T=JU>9,A;@)]/[
M'/8A;@(CP6GU\25T9.(IN*B^:?Z2<P'#:>D)*X""/ 6D:#50_@++XG6:G8Q!
MSE3TI1W7+P H?)S.Q9## C%0Y9473H8ETA"GI+Z5F?JG V5K\C,YB9G=%4(3
MXVS+N3U':R&SK--&&S&<Y&^"[F442,1DVO")%%M5-I9M)'.YAS@\,=M12I1M
M%*YP8.E]1I_1GE1>-.HO&!9@1PEG0M]0JNED6;\388^JIKBJ)O@MDCHY+*,)
MZ:;:3 8XA[6V,0Y]5R\-7J:[K&WCC-FZ3&C9&#P/BQ)3.@GF^\D"DMZS"CPT
MTS 0U5FEUIPF_I<_@"HV9JXQ<SY3NZ2YL<Y?;NPQXA.(&C07C!B<;ZSZH_<2
M'KR4D([->U*T*VV:K1W9'A9J^#MO93T^V5'/S9-ZF33-:E]9L/3YN50,+1*?
MTX?=!9S07]XMT<\41L[*&\G7#"4\EB 4,^Z3D=WRD#C)IT _JK4IQ\=P&K#K
M?V N6HF3*Q1@QZ=,$'=J;.SFY?DYJ']E]('+]=<M+0+7>H@KH[?/E *O!*F/
M@3[CE(%R&"[90M5U#+^X))WN.?X5>E-<=)0CU).N*(%\I(3:N?I6[RL6. ?Z
M!^#3+\/-5H!N;BNZ =1D\?@#6+1%O8M[8B2T<'G;C4/-4L!])+H4^NQ-_@?0
M15]5^KC<U6^7HY?T<FL4I+F>$3G87S6B3$2IT3R$1,*SY+H!^6M#8.+3R-;S
M.W$@#R1U,C?"G+K>/X()CX^.('>&0Q&YW9OT#HLR[M23\(+3A4JZ6VAN(+H<
MARX"/)A7\HDTVL5F8$/X4/;==TGA<DR.7WH2VT,^UO90H_$!188/C6?'$J&.
M1,-PZ>+/^\5@L)-L&=QU?,P( U\96ROH]WWQO=I;/^]TS@.(;:KS1ZS-W& 9
ML=QK()S6RE.!F8^!3,(KPYBKE]!.F*&ABU5Q*B]#S"XN.XW+[\1P^O(AK6.H
M0(5==^Q1G)7Z(S'"UV*M0T=M.1[1$2]<#189OWFY$;>+J!FZQE$;+D/]46H<
MCW(IQG'&XM/!2%OFMSRI-)Q1%[H#192C9@_>F!+&3H3:E"D($9.O)_?UZ6=S
M9[7YR>/8B#=<-UM51*Q<,IE2'I)VXV*@8WW=[C?V#C N.N 4?\EU :AO<2WN
M*\-';4 94"GM%T.,E1KB]KV:<94 QP(YO).>IH>V919?_T-QT$I7HXD:&"&[
MN"AD7%)(H^WS-TIZ8W]MR%Q)@"6S-;%1D\VQU" 0JY>\Z;I*UOLT*X_R"Y"/
M."*^-M\_E6J6!+P8FM:5[#GE]4I!2C/\BCL@OF,B2,4GH*;7F%4E]#Q_.'@\
M&[_JBY@T<":V)(0?N?5W_7@!@ZXW@T4U-[IX_ 7V=6OQ3,HWYS&"RVMB?S72
ME;QM]5'?UP-[ICUL=GH=:O.XXAQF'%C>="I>; Z_3("[N:D_"+N._#,*R#<R
M&CCC9SEL#Z[;2//<\_*:7%57-/(LM?4JX^[J/U8NGC!:\1F'.Q RQ(HQVE6=
M#Z;0C7UJ_;+,!V6%']HGW;0);8O7 ^6$<!VI$P1K#9Y!YNBAV2Z'LJYVA&PQ
M0R;V@V^")0!H/G3Y==S_U(P:L?6D)_NW>G<>'#B"KNK5R\6T?YNLI?YM;;CX
M!2.I_%O^A-[O!6__KPMO_3_)._V;T, =(N&3!J1$ .009M"TZ7(1O[X '>87
MI 9&*7K!:G\!Q;]4(8QQ0H3N[46'4,F35C?!8\6/(_1^?5+%UP>C;V7&T.W"
M]O"M\(F4RIEDJ! ,B372#KO;;\L)R;I&\3][.BE9-:UQ>=,[9PT4L;W17-CV
M/[3\3%]@U:88L7:D^X'KXF-\!8T66,!)REQ^2X^PSQ)7_X[J&"YT3.,1YP^
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M#5+D/QB-J_X!BQH+:H5[_L66_\_4Y6!,./OVU%_S,'BGH:-;$AUB^-*6^\O
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M)W3BT>(SD^?G67_\/)H!LX"04,]Z3;D-1*MIO,E-HLD.)Z:H#M$RZ^*=2HV
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M^4;- 3O!T#>JMPU%=3P)$>G9!*CYN8(R+HY!Z2SZQ':E=L(+=9+1"'PM^':
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MG'#L42%O"^V4O3BJC\A_J7<*NN/(UU59:=HNI=:*[WVC[<(W_O-*6+:B2;'
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MY*1?ET&W+^$L_D.#'[/]'7.3TN:P87\2"T9V7_:V>I!!:1O&/H%?J6'_ET<
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M\&_X-_P;_@W_"A!__/G_ %!+ P04    " !U@612H-)ZTI3. 0!XI ( %@
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M0W1QIY>0@ -PBYJ D)K@NAW #@ 0$!/\.P#_=1#<(B0BODURYRXIV<T)E52
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M-"&0R%:V+*S]%=8B LPLS&X\V28N(-3SE7D,74IX$)/CWX7"Q5]H=WQU2-=
M)>KO<*:#AE4ZAC_B/[K>3 0ZZW-+?RM+9"Y24."%?LZ?0<-^0=T1%+Q" N=4
ME7!()4FI8PCML4?:>"$]/=SQ$M> 6,CAU?2A=O"0DF2AZ^H#)XMB7XMHQ65(
MPS7 J\'V=[I ^?Y$UN-9Y6TRJ5F4-AFC!@68=4!V1*>8;M#_@AAYN:_=6VO!
MA@MLW6HSI%A6CB.W_+T,@5\*[M"S8W<45T'?L,[MAECNV-&*>J-OJLINXD:O
M6C' %]-EGE!=5ZC;:<M6[8M3.J7/T5+49Q/:7P#.X=2?Q,ASZ[5#%1A35$<#
M1SUJDI^YW=F&1F&;+[_Q7@.V\DMZW:+*W%VW+7DKG_&E=^5.3J>)_?U^7^'U
MCNY@]FM395V3UY/4?_6.!L]NF\#1HI"M+C<';;U&;JO?E]X9U4&7SYWA2'&.
M7@U+&%F_GU18)77^^L1A4'S9<W;_&[/N=&>^S5F<H)&DU\$BN)I".%A*1DY=
M!3QO=&$JX" _6M:GZ09Q-1%OSLR\>*%X. R7=>MC3@5]"HCVF;"UQ"" BLMV
MU=< '^CXI?A-O*T@KMQ1O#CD-8!3J?FBSQRUB#BC%[AAD>;+@#AUL.5F7U)%
MWQ2& =E!&>QIA*>9PBZKE&;5W&C^V1FF8:T]G6;,8Y9M_O6XM5==\GM'G@>$
M(TTA?JI<7U6QG"+KZD'F?M@HJS;(!\HS&/M(HQP;QVBT-,C"/89:'>L>+VMQ
M"]Z=9HE?\4CHQ]W'OYBA/ 5EES#-MR?ECVHO/&/**C0S,;(?&82)WXKY;@4.
MK)UGODDVI ]^1Q/<+Q$F95>EV,;4E%1H+%=G'!)MFM^ZE.PX'^51+^@HD9\#
M<MFI('=%%+LUDUP#EDENHL^"\K+?%4'],WFM*_ %.42-JS5V*\ALN.W9Z\]Z
MSB_<U2L2N"5\M3*PXL]_U<?]U>!LL*6HDHL:2]9N#Z TJ*?K$?^L_:0G(JS-
M_-;(ML?D<O*C.(S!GY !GTMH,"YRL<^9PF)F,Y$Q1HP@:A2I0:$;V"O5[*KE
MF<'F#64;]7U:'L^6L#!W^\:.X6+]7-TNK'2$-'WQ'P,>Y2S,F-3>,U<]T(0Y
M!666-"YM%4K:&!RR?AG]0E#8\I37(.JDM(S&Z97=L4\@R$YU#=JK[XK@G3@-
MN[3,@<5:;(O3O9-^TP8TDZ/(+$D[42R/"W'1A@\TQ*M7.=_S?WD!+A?[S?70
M4+ZF:%$YQ*Y'K\XN7[]0L\3QQ\[T2895[L9JP-/GS].7P/1A8$TI@]$)1_"S
M5A4&4PA[.V1V\4%7LV*. 4[G)E+:+78GV'H"+!#%_3+SE2O2]49QE!$HKBB@
MOJH:SX;9GWE:"6G33#E4]:<7[]")T'./<V2,^<1L1+VJV].=V.03,_H68_.T
MG)SFKRR_+CMJ9< S$?JZ404.V^[#GLQQ,6YF))W3*N&L617?SR)<#)* ]9X"
M+M,] @V=!1H!HN8\2XVT,"F3JK&*7\-GP>7D6'/$O4RP(HF:M(S5>^\ +[2@
M Y4ZF.]28"[-Z'&G228JU%_MYV;Y;,FWC^; /]]?>J,$<?DHX\VZJX*9Q&N
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M)E8[S=8#E"GTL/21'GL4$ASGRA82UBZU*$&<CMM)TZ.F"C6R9_2DXK%CX]>
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MSPVS#5,NK8@;I.P /%<//"[Y%JX!,>PZ;Q6#!^)_(PX>3<)KS;C= XF76B8
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MP^:H)VD<\X!T;?7%5GB#RM@&ZO+1>]AC[\L'2[86/.=,2X'4O^"MFOE\%]<
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MBQ<<_+<YWQ.Y?EV,\R$\"?OT[*MR++B>5$NFK8L_O*DW6T@[JF%%D:VP :S
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M(66<=521(!?YPY\-![Y\S\#/VOKNSO[+4SC^-Y>38S95$3JU&.'J;U(YQ;^
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M$'@C_"@FT::/Q1/DJN<^DSVYWO?:E&PG01-I1*,< =UZQU BK_.S'J]PLZK
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M!DO^-6"Q1TB)F=;)Y"&"Z8$ '4:^/%FQPD)YR2C(I/K% "7>3U-:C+D//%)
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MK+D[XDXF5Q!U3*\%&'EI8ME-1)K8\3H@^H-^A.5G7AWJR:<O+=X)XU,/1=P
M[!/<5P0&U&MC*?JTL31L:Q+G (53.5##5$,QZ,!^O^0#1LW3TQQ5B_"1QG>I
MHHL@2_7]@'?P+(EU^G$83+T99BKFD8;>>1@$4?!T9TFHAD"SS(&3);I(EHAM
M:?D%Y[S^H.U%XG?A$[1;<DS3*O0^1[HGG[0*0\\!3F.-(:)[*YFNBP.T&T>"
M;<D,3V%DB>8\;1;K<V(HV4 (R#%KSEA!LGLCZTUJ+B7>ABP-1ML;'LD]#&8/
M?A\JO5CQ$G(;'=_(OL<K2B<V%W\VM2K!M)'0,2D]3V)3<H8 K9O(O"#)7:B;
M%3:L)+ +I6T42J.8\P<&H[\CP .$:-NI[4[,CMA(__TB@>N;"9()+>$R>HX'
MNP^K]^;J%Q$K38X(EF #RR5^!F'_'S)(86.8?]-2E,TYX&!'CG&BI839UFNU
ME2%%: T+E^Z%3*X;PUI!+ 9H)34[R8I1_\^<#9!3N!_50[@ DZWDV[Q>/R\H
MS>A^GMV!(JHD^E:"R8>?\1J75JWQ4T?Q-LX!Q!7S5!YE6J?&W2)ZW/.",W[Q
M/%-RS6\F+N6M3;FF)N;(.YJ%WM)MCL-_K[\&*.1S;SN1#;D#Y5-UBUQN'Z21
M&* B")>V>K& ?A%_S!2O]6!+=(&%4MHO!YVK^36IBT,WM'BK8S!0CD7CH1#H
MAAI=]_W++.:@$N[!1J$U(27+Y[>2^RR?[J6BV[PB*'B1A05'3RTTKI)&NDJ4
MPTC570GF-9P&*CQ(WJ/PVY,P>TJY"BNT-8YS9&]@V=[1K;!C2GY@R+%^,(8&
M=2<1?@;2]GF4]HR"L(ZY'.^E7UCJ/>38DM^4&XQ+>KF+%E,P50ZBE4?(7@$5
M3*9JW1FPN\<X$0,Q0(V'%*VS//_RQL =GR3-R5B@.9DG'/2VJADA%O&>"R_X
M?AH).6GH'-^8J J?R_X>K1A@3L&H'C4?50_L$3V(UW!EZ,+&Z</)>= K<MVD
M.P2:IH\V#8Q3MF-=&2M1++."+*S[(G@]&$ETN/VBFC #'M.^N9"B))[Q,J0$
MB3@$D6"44L?9@U*:R;:J)T9![HX,]I[O0>DB>"0%4H8V-+&Y<U$T3@>7ZA/@
M2M&N A2;-.-'_E?":8_+YAJ4#&J"'4DWV"1THR>SUOPF11?\<&)]R6Q,EG15
MCD5YQ.11I)K4%<V9)-?G'G6JM>,B^N7E"3WOOS.416@0)$$TT&7,<5PC^V'N
M,_QZ#TCN^42Z-1%5%!2YMYC:UII9S$8] ;=*^R'G!*ZOW9PQ4MTSE23?J7\'
M6C2I0YIB'\VC:=-(E8K]VA/$QU-I:Y*?T-48V=.UN5!U8E2;DM61,ENCEZ]3
MT';V 330]GF;^B?>C5_2+4A^')>U@^O(;]TGR3H#=P(IP$>U)<$"5M66<ZDO
MQ2)<^EX->9RV=K13K(\+78U1FF;69Z4'G)CVA[O-"XI[.5">'">TZC-+(N.&
MP>)5W&NM%!5/AF)'BKP36LX!9$U0"*=C?M?1)#15<(02;_2?^:JL+X BP#Y*
MT3B.>BOG*1\[JJ]IE%.V2$Q/;$9\=96\SP7[3$,>?T/V!F!W_C)&KWQXOZ1T
MPTD54L\M&!JCX*4?!+RUGLK5%-/?J\Q$X31+9\(3BS(-Q_#![35Y7PY-V="2
M2U=/5,$-8:00?=R&03:C+-)#8?^J()XHC='WDK\,R9\4PJM-LX[99IPAY9$/
MQ6F\(!2J*E=F7X/M<:HF=T,(QMOO6Z0H)XU+Z[!WXCPR%.V'?2,V?]3'\F^W
M]D/Z6U:87J-W/W$V&CN.V\GE:;]YD3_=BU8I,(_[];;$,$6 T(\NTK'()3N>
MKD3_Z;YR+7-JX/CCZX>E.-WW6G3(.6"-POX< !GZFU_CLY3>S\X!PB3*;H*R
M<#*<(GQVR;YI)^G/]],9T6#9E1==).V<&#8@RSD@3;WJ;$_7$<*55OB\.,Y.
M@J7%F.\B"DP/^$=-+[12RRD-]K;8K&R=*H0=CO'KO#.-/2Z*^P65CNMWGO?5
ME>!NL=Y.*QWLAB5'[)K0L1%IPO0?3[/KXS6-OA[$*"Q-2"!,0YVM:Q,K%#KQ
M3RLFT(9/[9WE@\_:B=X>%AOH<ITJ=:&8Y\2B9)XO;-:-K.$W_]% I3\UUO!!
M?&U#X3D@,963PYL6]G=&'?3?/6 =DEB*P2LSX+,X^P!)^_QSP)\J#<=B9<U/
M=)-,_N$\YEXL!HE;/UIQ5HT2[C79OUYY#FBT_IM?8 >HS$7_0CBD_F[WE"I@
M>_>60LPIL&0LI.> P8L)R?S3?5'MW<,R[$O&?WK9%9!>7V.QZ3C4K92=+8[Y
M!4>EH0B$&P#FYJ?KE08NOL8IY:\XC?,$]=8RLBL/+&\_SX!R_3LTSE].;/G\
M<GXK[5K1!3I\R46JC;_&Y>3_ QD^ZG>T^#].^^$QONL0.&DECC:P^E'4M KU
MU96AO-XF,V3Z4V]^[[LL-[ --XW2%+L%E)HO7BN5_L6_GR]%FS5=/!O@J_OL
MYU;C6/1M6>ZA7Y&$GTJP__#[M4S'!SJ-]>!<UKN;\;V+N<VOU-!OX#(F[Y2J
M"H,$=1=J*@3&R$#/ 6:XZ4F]?JQYR.-XO "+>YH13L#A387]C5WF;^Q+%:A)
ME ]YSGXEJ?0;=S,H+^/[G_J_D0RTM \\_8#YW'9KS?H+KNDP1RL["\>9W&4]
MW]^HY4S[%=E6_+<SCOZU:Y_;*"^Z7_(;09;?&.A"[UZTYEEA425L)A>D6F!N
M9:=;=N- ID#E#[3DBR:% ?]5K/_!'!*/Q7WQ1U!NKNM__@6>^:(QP45QE4.G
M'];7U7XC^>0B7+7\?YO)_\EBH$N@=D/LWEHJ :E6\A:58M-EN:&_XT'_:^?L
M'PR<R5S_CQ[Q;>T=+[V@WZ&G+ZB97M"FQ'Q^"H\2.+"F 7XXN4L/-;S 7:+]
M\TNMH\^"VN$<SLXKEEV< V4#A'JP,K'K>MP-"1AOSN&_]M?^S65Z'^(>H890
M-I>AS2O)W.P&LF,D1C'Z10KN-F5F<9S.B]F YQY6"\4)G]&^_2<JVB[YU9$5
M:W.T:.=TCQ=OQ\??GV4YK;SIYP&W&+C4@D(*?[[L2+QA?U^BR!: +)F2Q<K3
M@\[<'9=-@I#+5+XL3V\*)COX&72CRQ:,'[:/BVG\^#E[.2C9V;S"%4@YE#L$
MX0/G@J+%[KHQ,N[)L0!M/D&>^1V= PYMMQK9(8IC19@'$*E,1^BJVW<V9F<]
M/B"-[: 'O")X%Q,P>8HYZ%-#$<*-#^MP0AJ\3FY?QU>][5,M@M>)GFY.90O\
MEJLW+GJ<2]3SD<D'; 5G=-/RN+HB=:1;Y>KZ>E90LPM9UC;5GGQH;(#<T@Q2
M2&9='*_UPX=(-PV52Q5Q:G'?BJ-[R&ZQ)\?LR-E2O<W/[PBA*#C+S[3[^,*T
MVH<[)WE1@-Y#N/6PUJ'J=OMM2TW"3Z^>"!OKS%^7!F7,]V*9:H%JE;Z>E2M9
MPXTDFY)1=229B&>[0S>[M=1G210 +R#.%%W>N;,2/(PEN[ G/&!%9$F$%7*L
MJ-7D;C5T"-ZI4<]]HI_E,?^MLI%G*&:L.H;J;)*Y8KD V=0QCDSF\9[?!P:>
ML;^[BP^"RP85E0]0S,X9@MEV];2^ JI7.46WJ;YCI)%DR,@Z%>GB(U#*L5T4
MN#[M4CW#X=MS@';..6#"&5,P!^X#<GF0:J BW,(MRXZT'*22F?+PLY&"T\A3
M%6!\#=9U>8Y0$<79YMVS&9UX2U&!<TRE1'=$I&Y+X+M>K84\\<P]3P_.B+VY
MFH'@QANC$)$)=_J,=OX[24H,#-*"''Z2@&G40(0=AB6CH7>[T9MKUYSS2N>6
M"07\C% 7G8X0SK>-J?V1^8F:[H8DHH$ X=@R?Q,]H*GM8'[*^_BQ9RQ5^Q2&
M#I4=8<GG^)C;ZRT,IQ#B+.&10I%(H!3#99THP2$?'[!J?14<%E"O!B\R6UDU
MJ/>$Q[#FT1O_$-W0 73YC3:=YC0:COLM-1KZ331??+B):U^;])&G6KS(H'4
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M7D8O?]A:WN\#^1N]\'NUG/]Q1GB;UU*A@;_Q_X=$-WX1Q:#?B.@&C;+8LC2
M^G&D1>[^9_QVTI6F%BX87L!!74RLMFY@L<X2<W"*\O\YQ+3I7T),_P%M+8OQ
MT:W%M1MU($?]5[*>B_3A+Q!W.#%9\7E,%R<D#<9L_U*8D?TAO_6F?Q?J(GBO
M_XIK6MTY0,.W0D;>'9MV9GW)\D**9_TBT/]RI\MVNM@/?;C7UG6*<5,MD&W,
M]-?1L?\>E4[N DSR/VXDOQYAU!K]U?_D3_?;"48JDU\=4/][:=U*6-'?49=6
M'TYGVA0"Q^XS+I8NGDR4, <W&J SM@3:I$B%R]]'8SPT")3@I&_=DP[C#L]>
M'OZ4SKR;X7:9I;^FYXRES8^DWMS!+G5E0TRVSJ@<2L.>5Y(K<J#[Y>W=;U.R
M<<J'7[J$>E$!&_>NI]VHE?F9X/58G.:&^6O_ZA<1C,[/IDHB1=1O'X(\R1S@
M1A9Z2FTLY%7!TMPCC]SJ6]NSW.Z7L*']D...]-_OE!;T5:N':+7L:! TK0,Y
MA@\^]&6//IZ?);F>[VIOVZ,(E1"X_72LG[*T';P2368C&=*\0_^L&.;R2"ON
M]H=7>.S0G[[W;=DUD$_"W!FL7'+?>6]1XFU,-(H,V=EGIAIV0CN%TN[W/2U'
M/7GO:>&0V1#2P_SU!JKD&H8OO-6$%'JD^4EYAWI-#7^75'6AGB9C=F..IP:)
M<;]MG_&^2L ,C\T?&/\5-1[BXWGXM'AQ_A-1]<K71M[^+B1VY2F'I=0$462T
M <H1FDH8\DV?WN<PD54QKO_2X;<2593]: +L\O,D[02+B-*#33DZ%H+ZAXXO
MX!/)F@UK ]C*)UZG$WGKS/>&#A*)W":<'/LO)=")[DTTS^.+AT.^>W*>D)/K
M7EN46$E#OX%/^M)[1/7OJ%;O8L;YF.?A::2OT;#<EGP/.P7114/.I%ROGK*F
M(A/D([<3V0#62TM]1'*Q/,"?6-$5G.)=<5V4]&VE.$EKYP"9^89'4?256)P]
M2-SON6MZ# 7L/$?Y1DHJ-^_>9+]O9J3K+<"TIC_Q<DJJ,W 5GU^BY),T'GQ=
M&H1XMG_,.6V[R[3A/1[="KLBO]!@,KX)>A76 -0].$@CS3.PCF'G4<X0[#+S
M*#;;0Y $6DH$;2^^)"  0_M&GM>AE%JNL9]:3:Y4AUPU$X;NKF%H%E*X>:H/
MHF\:&,TMAW*R!AYK$-2O^[*.N'I >M0^PO!O/PQ0\,AM:PIU=[)U6A<3O_%E
ME?S#_1<#><7Z\**=0\>H[+(O-7M\.;?$N18BDD(0\\&($6FSX@C2:<8R;[<T
MTC276;,>(V1 !W$GY\\ZX\!=DCG/8F^X7K1]CK$M\=6T"<-1"[JJK=5-Q;"%
M']+""U)AMUZU@Q6=HUWZG.;+TN_@U*\NSB66$RJ =VIZP=-U)SK^;?-0+V&\
MI)9R%#;0TWGI]I+M9/NS=IYF:27/?(]S $(G"=](J(WBZYN?UXIC<:/$-N)"
M/<KKH,M9"1(,)?AT W#D6AT&W],<BZ6;(5$P:UEDHO>NX0M:>J#\?3:!J:#7
MEQ3=N/ELT%'DM,-LO)OJN@RX%R*0WH40"$L8YY']0!1#S5D]@%N0'T(Z:HDF
MFBP-.P.MZ/@%C7E?<Y06OO]B\>+=MR7ZXQ#$A'\1A ;\PN?Y=P.;:[>\G^O7
M0B1JO&&7;2)OW:Y_@[/X[-SR.2LLE!#&DL:/UQ$N-("M'T^M9%4G6,D"YQI?
MHY*ZX+ (L9/*&P_YVG?,W\@Q'W\&5])+!M>GL ^H]UY1M\R?FO]Q]O6Z;OKJ
M"@'T>& 1F.Y9O"EI)R:5]8P/TAR^%04V_<;,"08%31SR+JE3OB:+[13!^YF/
M4!<[V5"CY=3[ ,D%D_#X(_FC;7(]IDY0HF(II;>L>T_]-Z=%NS$WOR2=5:@;
M;#WMI!6JV6FS@K!'S$#TQF^9O=J4Q'JF$;.$P<@%2$,S1^SYJ>S)'Y.'$- >
M4,W-;+[:\"-,4C,,&%:@+_A:Q;HP$8)11HX:6$4!NR-N=-TAW32IL(1[0$21
MGY=:OS>.4BMV# X2""/-C0P-3]=="1>7\R">7[UA!H=,XNTG=_)=#SWX%_>$
M_0FCP*N@8" 9D&=\>VLUP?XKM5F6Z])8=%@C&2A$LB\(FWA/4YA:P13>!O!1
MO?;\F@1!>MJ[JR#5'N18RZR'(RCU88('9>P.M":O5!WH9I)^/XWT$AJV6*1F
M,)'<(BGU%1[QFK+3[I3LH(B!)4!K(/TL8P.[-O_5P70_^-MBU$&'A])1$].G
MKB[A2N=]J@/N"%;F4;P]V4!.E&,@Q//L/;>1T73]FSMN1!L$I<4]BY%+Z^D*
M'%I=%/>T=TNUQQN"[%^H)+V@W6/(;_.8[]@YOE0LTY0"L,8(H5["LB'2E3Z*
M!X]S]#H]A68;P(/[./E:.^-=N&WN?#;X+0D)"X$1\T'4%F+S3>_QML51G@.N
M,VURPH^FI&50+M:#O9 WP''\]#32'($*!G5)"KY15&OFZ<\KSPT@<H,.VXW]
M"4[!_4)&9O4@Q%'8TEB][M6XPY([K51[0A[]BNIZ$]+B"W6F)&>9ZA-;?N6L
MZN< _M>K(]D '^'#C[X#JP4%2A';!-"VD'9)D3D'@5O,)LZXEZ0?2(U.731&
M\J<3]P8EC7J"8Z>OUM==>#6FVTQ$FD:RDNWN;O\D=:H>)!A.\HO<5U?=^3EH
MW+%BA9-FF5JHQK <HVLOZT-KL)M1/*L"84!&4\#F^-ZZUO&C&JXJM).Q_7P+
M#QB&3VR+T+S]L_/VWKW70L)RS'LO\J8V]#9E"KO8Q%WM1D2)#7K4WG:Y.S/*
MN;W$%X4WX54DQU6/VN5^3#:T[N%.G1DG#140)0V%D<_+&\94%G ]DI&CQ-N.
M3Y4=_%_LO6=45%NV-ER @&1%<E1 0;+D'$2R2%!R$E!2$21G"D%R$A"0C.14
ME" Y2@81R122J\BYBEA" 1]X3I\^W>W;]_:]_8;QC?MC,VI4;>9:>ZVYYYIS
MK6<^TY';]TU3N*%(OTB7Z[ JW7!H^/C0 ;LSQ^<F;82)).O#4X<LWEOMPA4:
M+I\'7!FQ))YZ@/5F;8ZU*(7">-6A9!A;_VWV'CF]3U4M(^5<NWI<C05T"3'L
M9\X@TA>I/!@;@WBWPTB8-]BP^MS$(:$T]@=)!2-'[@I3!G?J='T0<R3X:@+)
M#3?B[KV<ZKNS1)+OD@D8\25Q@W4EK6\O-;[$L<N4LT@%+U175J.J_2A#4PSZ
MMS:S.)'IZ4.X#<-7"2:HQ2X2V("@U%<L$R/2M_>I:5L2^ZHN #>8AJ!Z]X:^
M?19.KCW1\>B:?>AC#)+C;1_MHY]86S0I<])UPUI\+P #1Z[[Q@O32SNR2_++
MT$.##DO!+O*4PF^KGI:2/==U9&K 7_$E@K.AE;//P,Q[W^FZ-[/@=(P3#;8
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MZ D#+05/@Z B%X"X\@M YSG!,-KH;0'X5D.[LAHX(G6UO>'E?"CT49*PD H
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M(P$M3!< QPX\S^6WO4UT&.?RWGZ0[GG"#.J725[8GQ^3[UT:'L9%X_-/'_2
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M6T5I@,'+X/H:B@10-W%89WA;XA%HL;N2)4D= VV4K-$0'ER8J62?M^1D<@&
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M0,J\N@61WYR87C1,L) [:.?2V *L0'"-YQ]WB:=441#9' D0/BWP&C!'A73
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M3)'NU+.9V%ZX/9*4ZA6(O%N&AHITD2S6^#'?R4MA7DM!1Z!4Z\E0);I J9P
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M6?LX5LE8R%49_T=H+W,6 B*','V]@A@,V"7Z/.LCP%7'\V%)MZ#'S)Y@5RG
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M?BXR&#(D_V+:&4;E[7@AN>$08HZ$"T"P1Y[#6&R*6X:LD.KIXN=OG@?E#=G
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M'DL[_WUZ9L"U!=C]-@GF]5DZV/'\6X#=1/V:[HFN*.*,0CW* S;&2ZKBQ7"
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M:>PP?R@/">HD$(],L]FV![]#SQG:24J6QH\<C!;XJM36 +,D@XJMYAO3]P<
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M.9',QB!$M0I^Y4^-\C%;B"6=M>U[%6?0SS C?B J.*@.:PW7D.JM[N][!J+
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MQ=@B,L[\ZT9+'N=,XV^2=5R\;A!KZ_/'J0B\V/7C%!:(V12PK,\B .[9)HV
MOST:%K\_Z*LM/F"J/5:M;U=5P!L6R\>W1./?;O2-)]M''IB10=YMX[V3:P,N
M2"RI36$)J.S%P<'60U*TNF'/>/NGY\T\H&;.R#[.G51/>V<R;+"JG<IOQ')2
MWOA!C6SJ'=S'I1_;R+Q6$'*SI]#F@5%.4KS]AQL,7NMR'SCRJNO8([ZMG-L
M7R<==]:X9TT]?4(SJ[ 2:252GC.H'[,H%ZO!C)'@A%M]*Y>M=$=D3%U.5Z"Z
MK:W8,\B(;]!,^#M,@9T<*MIEZ^EH7-?8D*7>@KO-^YR?@?^)GI>\L-^;DGO?
M<B(BX' ./1I](_:B#6#8*%K?H\PSQU#5"-STG/1!ED&8UKM1X M1-?F\;WL)
M@M]06<;)C_? ]F_34GIZ%6T[ZUN1#(F$PAZZ3-;& 6S%@1@EP7C*K'Y=[.'B
M]#LVMN#@*5,#13&_"7*S&2;^6Y^I!1/4Q&E,B^KSRVU[=.K'W6RDOD[;#5F(
M]+*XE:2NAJ\:[F[-<E'O\%>G>$WZ;6HK/#'*NQIA?^N!5Y7R<-1M8:XBYB+:
M*',I)T,&!B3)4<'[$17\ 2KQMLU'157U"76)CV93ABV3ZF,)-HX-\H^*/K58
MA#ROB'*E*@\O9WH:\A9K75-$1#4QD?H^1_RPTG7FVTM/3:P73W<H-S4T3NZ7
M;"RR?XY03&2F=L?:E"')28UG"6+['&O[L]8,&6"#@]9T/"0C5]7C5N"S )*)
MBOQQ-VM?:>QIY=.)9$[WRT 22*,57T]L(TZ?2*ZJTD1YXBK,C.JVW;8<STA1
MGKV"7<C]U\KT_ -XR*7'(+\[%D:DL#=>,TAW-ZZ9". H^/5ZU+: ;<DKO8^?
M<VA+?6(/^;M83V-(]B#I@LU6AI'M0_IJWO>R=+Z+_'_L?7= 5$N6=R,H""BB
M9(1&0'*0+!E%LN309%2"0!.4G!M%@D3)2LZ9;I&<<P;)M#1)@N2<<W^ SZ<S
MR^SN[+YO9G;W_5%0<.M6G7.JSJU35:?.CPX#P1&TJ$-8GP&K8)LJM7'V@Q6(
M[[RE:W)@/O-T8CAK@R$B/1,QSVUI;<N01-=%4TIW0FN22[=)8;S\99W_'L(8
MM2PIL;#,:V/4Z%5],N !/A> ZE>K]R,28%L5/EG%NO<JQYC\3E13KWD>'=JU
MJL)"S)LP%O4/_=DDIAN"GWSWX2<$<)_JV2DD@"SY9Q;:M51V(B$,-XD74]3C
M0P+J$.N$1T>0J0+(SYPA? ,'VB?DFU1EBP1X%DZR[N^=3@O&O^9/VF'30)TT
M5WPQET4D  O<H+=YNMX/[/DU?QRIUR)4_OB X6_1DGS(4OW.U>[#ENJ9E:XB
ME%2!_O-AFLPZJ.&F/U?S";_$C@Z$XF"98Z[PS!^PTV5)B-GA#;9K<OHAYV]4
MXQS.!)WR)7I::) KR$?3*,#)'"K0.=7#H75  [M2FMH,,8]GWO3W!W5$!58*
MY5I96$3;>%>:F4!PN0)(:IER:88Q3X<R)A&3P>)]*0V6]&[],0T95,R"NTZ!
M<(G>I(C?)(&+!+ "]Y:!:T458DB \&G6'@DX%9>0\V)!5U(&+!8R8>[@=^(F
MO(X0_IG[M+B/_D<)'/7["H)K,W@O=Q*5 E* ';1C@@3\) @X9'OD\8^BY@_J
M?A7@^A9CS4\:GQ\Q6]ZP'-T)A(R>%SHYK8;[WZVFZC_7$/XF[(@9A@OI.AM5
M/W,_QE<6XZS>GI;NZ3(I/NC(+NB7[.G@>K"->-ZC OI<_8NL+Q![YO>KG"[K
MO\BB%^@G=(?"XR7\..J'^!^<V6SXFU$NH/5+UUE.>5X6(MV;4EVGJ6;.72J?
M4O=#\;=6!+%DRUVW&!2K)Y2S4I3(4922T4:7_#<F7M</$V_4]4\3[Q]OXD7-
MFMZ:HQ]05HENZ6,Q6,G+ X9S0I>POS+G$&JMBU?>LB(""&;+UY4%%Q=5]<V:
M25U]2B18@^=PJ2?N:J'$(?QAA@.4IGL[O#]9>9K3#(IN9[I%W3\S=^ Z]TUW
M09EXPIHZ66DP?C7, 'W.=/45<^_,QJ%".*KD"K'Z-CZK1X[.$3'[O?J.KH,!
M'"Q3Q3F^@%'/-;9O->(6*$GIE<MX]L>7^*R*G.@!F>B)BZKF2TS+:8X)GC<E
MB(QTMU_E[D''L)3)0AW[A-O0(-P<H",._#;C]<()&J//X("^L*<=6SPS<FIB
M..0C[P5X&1+K\^GP$R<">&U&">C<F]8K3@3@_%.MFN!R64%>]H O!R3+YH3F
M,9C.XLE;N;0KW;ZKF6R#R<]Q<Z5.)RY2DYT&BT#B%XN(L@#;WF'Q2'<\EFYA
MS!E6Z?DX+BV_0*HX.:(M?%9?+L6L'"=##T?_I1P-1P!JI^E$Q]>(P3O2;3KM
M)U<]#=:RFAE6U((W<%XJ[D5JE*TM)_F1HCD\_+HACM!:+*W@TG^*7^#X-OYF
M;&E-HVPV^$#?A.7;5-C'B2M7C[*8OBG'P64#YR4B=HP3OS)*(NK =<-Q&D0?
M!?,1Q5RT?+(%D03<QAO!+?-1,T?LK 6P:R-R/O:<G11*PF\VM30MW^; . >B
M5M2G0H'LO( 3%37_6(F[624/H"I%O%TX\JQO*\2Y2!LW# L[GMUIX87.R&C1
M&8&;WZ(EOC 0?,'HN];!+.RS IL2E[&U6W8?V[Y>#HW55^=[ILVDUC,1Z_<D
M7C&J-Y6'+R+P+6O)^U9Q'L, B_T*1;<H<]]5=[)\J6.$7\-.UU/(4^H%S<_4
MCX177^H0>-($&>4A-%H"9]WM+S6O9]AV*@W9<O;!](_KTY:_.: O2G.8FK)I
MLBY,O:S0LE3"N;7G6\>*W?'Z<4&>N6+@-H^'^='X-1$60BN^2WA;4'V-_+PX
M=9MCIH).#G,[VA<*D'!;$.CMA##6HYP'(7A8K\;>UC*8WAC]J%01$]=2GK'
M!_'.B396H5VAW#5M6&O,V=#568QL_>::C$WX,2?VIA;_8FBF:;%D[ZV--"0@
M[/H(R,3V-M_G .;*;/<0%A11?S=5=MU.J]W1 *'GUM']K#3K7",1@UV?FBA<
MAA[,OECVA7V--I;P866APLS2O]J<QW6MRT-/ZF.$6(FM,OPFN2SYE;6E<2.=
M!ZDO9((#FO-RA],R9<+G\Z*49D%BJT3:HC39QH.!!OT4+9)Y]<!<PP7-HG3(
MCC.9[HAZG8ZD#2^3=6^N21!^I+\M8;^0PJ8136C:/3ZCV,G%$EOG:"W&&W=M
MPV]_LKJ'L95$X.?/_&F$/+/\*'"F#L$O<W_";P6E\9D#7 ',?/4HG9&1_560
MJ X:IAH>>L:EDGB2FP<#_LPGN9'4=HO:-C?#5:V= KN[OWPJT@'6?2K#Y@DS
M["HESM'SWJDV!0?H6D;)Q-RC+;0M5ALWZ2$?A022)6] :>OX?-:.&PY4D8"5
M078";@N4([ Z#Y]UT;1T3YAEWIP_*CUZ(A&77];PT'P4\]).=XKYMQ#IW2R^
M<=^O7L/MGX1<5C=> 3O]!\53+,TKF+%Y CY B<.FNON5DIE)>Y<R.\'/R/CV
M"X!8G9ETH\R#9"J[RR!F%[8,780KU%QS@OQ!I8J^_Z9*X2(O\Q%76FO!^T0?
M= 7!Q50ARH\>XN)2P3&/ "+UO,VIECR,U@],AV*4*E,4UR*2;7<..RDG.M*Z
ML26;(W(X8PMEK1:P1I6<05*8S22!&-O943=U-8=-W>XX?-[OLZ+A_7J@$HH$
M/-M[79M6%FZ^HF*P_"0@RHF^=;A=SE^S)$6CCZ)_2Z8](L*^[*-D<0[4>5"U
MLK_J;G6<"1>Q.45 M5UFRU.9B7U6"P'A#$W#N#ND/E\VY*=4CS@,3^<X(Q_8
M<P<+2J(7!L.A*B%!',[[=W3*63S;25MMY&_D?JP*61E]E\?ZI1_.0QA'!T_K
M6UXQ*/3Z<H45N&X4*E&07U45FSOU/BF9SGZ6EKP0Z+GZI(^K?,]B5/\=W7[,
ME$!_&Z*5U?$.].V2H4.Z3&5O131KL:PU=@,'>C,1US!8,6,M@8R[AFU[6/O;
M]@%XC/-3D;\1OAK:E(>6+D?)H5"XI87W3'"# SZ[E46,[F& AC6GQAH'A\/#
MFF*E\!XU/6^S3B]O<S-Q3!9&I5*&@AG$BN5EXX0S,(G7?\24];%"!_P\P\'H
MI'<'0D-,R;#"R\!H5P&>A 9/9H9LR'+5:Y0=M90R!YD"NM9FZ_9G^Y,J2P<,
M2_-?80Y;-G'O0(-JXX!>S<V$]CS%G8+K;^@"UC<R:/'KC)U #9R]B5J.^I([
MV$SNTR"MK\ K#KXX>)VYX$B,X4D,?**=G02<)V>N+UU"3)JC72D(&1SNM1;-
M">M:;1#]Z>JZ=M<-/;!IC.YDZ".@' =]42L>#V84AP1(]NR:%967;*0*LJ<X
M#8S*3S1YXW@]5OSF4K!OP#R_*D*"!%S/9347N/?6.;:QG99W7UZ^MVQA$PEX
M4Y;;E#KQUK.6NM::F@$RI"1RHCJ'!PC:)9W7XSB210*">Z>.&T\*M\YP/$$=
M2, MR+3-J>WQ$I+KI %:'T]L#CPA;NX1P]]Z_NYOG91(?BS'?B5K2/?"::#D
MKFK0E>S/M:G4H* W3<],)U.E4\SQ\X7BV=O6[KM4Q5$&R/2'0V$+8F)7?'=P
M/IQ:2*_^6Y"G3J!:O7U26B0 >J5BL)+Q*^PHX%2CX*C:)>.[C@>D$TB WZWQ
M\MY>^U18F&#-7UM;6#_ 19)_X(W0H6Q==!1T?BR0.W#NO@ HOF@C6=*)1%.T
MN_LR^.PN6%;NF0&I<B'.1L#OX")%OR..)&"%7=3JN<V8N7!^,4SDUCF^".79
MZ<V%\2XO,P;M'?O-@R2D?Z)*7BRSWZZ"#1C]9D,"\B]BZ#>;,>*WJV%A@/;O
M1F/6SO>;8?\-J-JF",[#S]G;]U-!$L1JU[8X 0OT5P$&<70@-6(U]#EC%.,4
M)D KA:L)3Z9.K9>@M<CU#"CS5*EG4K@]%3:NTA4E=B+<[03VCVT?A45%\)=R
MGO0M*R&&+CV*MY4P-4I,TUQXX<CS\NHMBJ^'JI_:DIE$#OH$]JK/P5EC1U<8
M&=7-"W/4WOD\5<C@0U'A$KYN$E7.J*O%Y%]Y-1?(Q[H_%[_;G3YMEY9*5YZ>
MP1F5S\8D<#=YOL]Q<- WQ&EP[-X].FJ43LJ6@%UU8&*24ECL],K5NWER4Y+Y
M996^*\:BLC?JV)9!(C4 N]2D4/,5?N*#.#_][ 29+X_<;3K%TARL97N!MK%E
M36-)!1T^Z9?=A68B*;/CI 6*N[6S=N^4%GBM7/&RN4:*?0-\DQ5M3J'CK@PU
M-A_)G$S6\0SJ@C$VD<$-M[!D7C$-MOOI);68&!4Y+N^'@TSK2M;4O*WY99E#
M\HN5=5">7)%"792$YI[3R!'F1L =.@(S?VKYW'S'X0;U$WW4WD]WU^0\.'.I
MOB0:\=*4D= WI22MO(]YMBM.%OFFP)QOGL4\%_^N:/A3!-34B3D01ACIB!'L
MNOCPPPS%?9;2K4[R7O.Q V\FI4+_3I[Z**.0CD&[=M)[M91I_39@9LU[D>_>
MJMAQ)8K1\NI%'02%:S;S( $8M-[5L[6,S^H?%_91W$ T4?EC QB&#!4C*%R-
ML7/84W"73-I2IBMG7]*)F?FPY$Q4NM?SH3^T]I !FUP+NT1T2O8TBK+1.\DW
M7^_1?ND?130Z?BA+]]Y:?I)96:PAO=7)\WAMYD.*5-7G(7W])C'3F=".QU-6
MLWU<NKTN%<7=<>ICDW#:*6?YK<M58J-,9EEL*^"<3G9UJEANZ5?P[AXYEQ"E
MJ\T?U -;C]J)M(X]N[ZI%)X/C2L511H8<[(F65ETJD2H'Q/*,MKO 96E9-,=
MYKA#U8RXXR=DJ1['?RXL5'EGC^^V^;BP>N.DCPC"M**]PV5V[^F[!Z?J.DNS
M,I:0%/*)45;_<F/Z4*I(]Q0IF$08;4[Q\UTMZNO7'^Q"_3AK*6^YU\0_[O.?
M!7IZ^#HG)J'A.FJ)=^CC>PJ_MF%\&Z7!]*[\=JC.U2=\,4J.;X^WC^;%K0+S
M[&[Y.H?GV SK\/5K#3^Z>>>(\M-*!6F2[DAAPXYI+V\[4'/T^ODP2(Q5,7R/
MDYE._)EE?N$ZFVGG#8TO6E]$[A3Y4^M_S!E& C!-2&);2\H*0.^V:8H\+K%C
M4"$B0F)"RYR"PKGT::YA/>[[P'*G6,4X$M.5\3KI\_7K91;?3K\,]TO$!'FN
M;W_YY$5$19GL2Y2@E)>4-$N- B+)U=F^6RO\\(',XYMWOO*%+ID,Y?@1^#[N
M)<9UVT39/E-Z]FM4?.?B%+F>% 7-;7OGYA5)H7"I1_8FU0LB8&+Z?_U83]V-
M95#KP5KG3H)?::+/1_Q2[:Z&ZRZWLG"86M_CM%V15Q0A9S/,/E*"6SL;6$P5
MAJT$ ?3QQXX$Y&^SY/$<45O+[53IM5 3$</N];@Q.62+Y!/8E=&%X$W()-L<
M9?><D+I(P8]T<CN?9\Z;@&]*5-Q3(Q;V2<!1/YO8/ZQ[OTE:YTIQ>(K?CZU+
M+/FY:1O*(G]Y;VQA?(EC+Q8QGMCV0LQI  _%;R((1VL/+*7%^(*7?R1PR2D*
M<7;"'Q_\EW?^9*I'+%/U&Q/G[;.>E^6]UI"BR(?*VCY9Q\)1CLU^#TI9: X'
MTBGJ:4#J6!//(L##OT> QSEY95>]V^@$0:R=J+T\?JC3%6H,RZF>(.Q& N8(
MP3\BZWN?1977.YP,6G: ,.)DR)1NF.-O1QY1'@"/+RU_1Q/X^<(Q#.?;T^VK
M]D*R256?SB  1,\@ &#'ZQ*_O% X<90CE,@RVUH &M1;\YN#;&$5_H ,^+W\
M3H5PN'?_W9%];M^#]I_4JE:N#?KFO2XS_#AM(_U[36U;H$'&B0"<9TA  W0X
M?9=>WHM3 -)RSNFA+K"M?N'FBDL"E=5])3&J2[D>M3#I]4AO(QUC/\9[P?I)
MK/ASNE?6!N/&"(IX$#:L0G*3\YTO%;O2&3[?\O+NUM^S\P*B8HOQ18;EVKA,
MB;D:"+"=BW'X+\1HAP2 Z_<U3NTIA4CK:03C(NN>V);PP67$613^7R7_.SW1
M8JZ&?R'@7U\XK4O=]>_J$JV]YX\.#?0/V8?1;(:4SP A_K\W^4\;!2!RXAZA
MOJ"E=C-(Z<\R:G]1!OA+G2=P[XV/!V_*XVEZ_I8: ,^T /A/ZKM?!&D61]3=
M8(X$W"RWB!_YV6"\;O@:Z$2\%0E8? 5[6K3VV4=E5J9(> VSVB39!.&2IB5#
M]]3JG@8A.GX$%4> I@4F?Z3,E0DNQB7=U"3?]2Z1/[U>_KE>+^I5E/"D[J6*
M)J5>WB^^@O+2"!C_.E]1XI0S&%U_.HOI_2Y^$3FF]6Z1N"WU%-E5<TY7:UWY
M0E-"AN!B!G=\JNV,M-*!(RIG8,R)75SS#(*7/ :>D(!%DC%WV0H)N$&&[D6M
MY,A.@SZEI9PSRW6EP$#N=EZ94Q1)4]*M^MZ1AB^L!"HG^'JUEDQCI 4E'XJE
M* VB:M:Q5W&\. ]?R,V/*J]1@'0F%JG2Y^P&<P>Y&A]/)DH,!#*W0:@8FTG\
MR]Q\<U&?280K;W+A#W0<Z'D G6?L'JH<#EH&I7.,(N;GV&<>N3A?8H"0"K63
ML?3;AN_HK^72UUK5VMO3* T^CB/=7Q+ (D]DG 'YWP*YX,%O&B\SMUO8![]W
MO6;@D#G85;.N<>NP+@MP!,[J_KK!&6W;Q$$2WYN46AGM.J18+5A^ARN:-/K0
MDF%,D9@J!/Q90-0PRWA#[$8%]@:N.\>B;J&N:Q9*MLO#3\6TNU*W#)Q?TT_0
M](&3^E63<F<T/JT5I9%<C=N67FNPUDF1^M:4)?] 3@S3-_EC([-U?S;]"IB(
M;LEJC+)R0/.$_QJO] J@P-.*;41-/.$ Y@7-F>:A6^_8"W[YF;&TC.5=Q;OF
M*H7K/8NZ+VU?.F>"(X+!/F;!AL>]M][-]I89"QF"&9D/WP^H;0O2]%H6:$IP
MLU5:J]H&2'&V$WX(ZO2GV^:RPABDP[VUDE$#Y6@&73'),7MG/9MIF?I4&M.6
MN7O0ZEM DP8"[+0,&X[Z1C7&<3.< C984,&6T^4(ML5O'>7*#VLA>ZFU3JW&
M_>J^>C>(ZJLMN[:I-00'H8ZJ66I=)YM+T* 5(8FWZ+1]5"_\O%!Q@Q%ZW:W
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M#M^0O)JQO8'4OA 9=2.M-\0,Z\%1'?D1JTU.N7D50H_9L 4,EIE<O9VV>&W
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M)BF$9HSF&L9PP8GJB'R:YD@+=0B%NGTV_<VF<A4 >JH6#)^P)>=+9;3EF)&
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M81[:^N %"JC_2C_)J%)Q%\Q8B9&1Y+L=%/W?OFO':BJMVX^R)'P)"8";QJ_
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M"Q2KQP.T%CBD?3+N91#.L<DGN1/U4,5_P*]*YL3H$<<'D+LKSR5<P>C&1@,
M'TCCT=6YHW],5Q2YAI$P38<.QPL@$1X7L\SH%/(%/'OT=A<7=%;%Q4$F_ZL)
MG!#"+7Z8<P_L4[TG-<$LOB/3[B?EW^LZ^6F*:Z1'A/QTU8:I7*M5[.KK.E9E
MCP1H%E7PKQV*K!4NCLZ_D XI6[X[/=IHR_E]V4(&DLP?-$,,[@BNWZO=ANKB
M>.H2%'\PE'%LU7V51NVF.JPH@NV%]QK?EPO3%P!0GDMRQST+FC\+\Q$B']C&
M(9!_:9+>Q2DF<MTO>*S*\U<O,ATB,]'ZKEC&#VHI6<WA\<R0NCN3P .TTT7D
M..<O>:YM5_SQ8YCP-PG6?JJ1?=$37)Q3^ZB;9O9D/_F7/"Q[+OE0%]+FL8"[
MXI*(!&!X^T#F;ITN3EUZ?OT#/K"E>%;9@VV,72$%)."-:(/PUM73U765\:]_
M@!<.Z$[@\1L)!V^<X^G^-F5X$'#7OH+K0\&N,.&)&^LXQY<L(*M1XFMQ51[,
MJ=I!>]=<G_YV_GA*7/KWZE@@=523.+]7]WN>:]OJ>PQ5"+C_1 6H$&3]376M
M^2W>$Q.0\&XC6P7M)"$OG^QGR"A,;5TOR+(@0'WXT0<%X4J=:H]"#5O8]0>N
M]^I+>8FA?+R%7*H;RM(Z7=:D85.)'F\6^RVBA_2VA%Z<<BC1 +R0W0D9G7C$
MYHF* ^2L79R]1P*B2(!(=/SA3- O^2I84M#RZ?!AP,F0*-WP/J(DOX,$),AV
M'6]*_)+7 _5([%0@ >'H_^D.BS_MHX@J4LL=U<_RY@75:SX.WB>O>(1W.UUE
M?POM>J&@?\D>5/D*%\X>90@EDL^V 7]6\$O654\,>,8C\)_"XE^,R5Y('2UL
M%C@$.K53[*H^9B6?"'G^I WV3Z7MC]47(,:>.W;L]Q;GO\=P^LGHG0EFUS(3
M$.T)JMQY;?>1@'?G+"AK'O>I_5YCG,P:6*+?IM26RO4Y<XDMJ;V_4:6I+^-G
MF,9@QLS@K Z#:8RC@J(8_MN$/P,X_6N9!O\#$]JO<Y2:UL]HN-T7NV>D0TXR
M7,6TLTXGT@7O?H7+A>>!;Q-/NY).D [5;["*;!XQL%[Z(05;PJC1AH\@Z+IW
M2O-3%'V2Y\2\7(T.H9/\QE$?"@F@1[97RE:Q%FEUNQ/[,?$VK^Y+04TM(@M<
MRN,&V>.>WJ:^JW.RFI;6G9J"5]CKD/CKSN)OL-%9O_F;7&QEJP+7MQ@&SG[2
M71JXJ,"_"8 =]:?S\Y_*]?]5N?3^2\J5*DA/>-JA'KWN IL-PM<C-?ME>S[
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M'<#!LNB<Y8\6DW^O9W$VBNZD/0&HD^%Z[2RRJ!@2$)=W8GL9WJA#KE(3SG<
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MC^4 @/2?,4-@*7=)/.*BJ2NG$;EX TF[(>/IIE#J!5.]'J9E:]\:G5K6[/U
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MO+4S[;4Q\T=XHS"BP]QUO87RUNX:EL_M&MZ)PP5;)BPUOL.!FWO^_( C_+H
MI<-I4'BI36[.FS)!5G6!FKEZUP886J+HCA=IB6%5$(T<,KGX ?WE>F0##_3
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MY7QPZE!A#W;_:S4I=0D"=<49O__3/2F7@+9U1H%&3(A.V>)Z)HU\MJN'6N/
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MMN(-I5^O\D+H='X?Z9#701<C_=6WD2X'*WYM4H%G4+'"DJ#7'GXM#4A\FJ)
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M;8+KZP[MI'AM)D]]*(7OO72WS0BX&!ZT:6PI3;?M 9>4^.:\N9D6M>E:*LY
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M9",Y>W8\*-9L1([5!LM64&->3,76V+N81(839:@>3EU3$2$]#.<$??7+>P.
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M,HE+XE9AOQ+T17;S,-(SZE!2\OS\R@A5NI;)1S:$(UIV!P@17SAH6]$[K%B
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MKT-)QS&F7=*CH5&3\#=_4S5_X<"[(K19SG(%(59>GOKC\CTM^148OU4*)5S
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MX4*H\RB%>UD,6+O\\ 'LOC+\; 86KVK8)$]7E^_Z_HIZW4F:V88BL?(U%XE
M9>R7\#5_6KMW&3*-M34$*;[M"^ MT6P]?V_7^!"@2:A\!=?H1J-U#JRNY]R?
M2COJ&P+*AD?]+%-Y@Z''G]]T4RY+[>7N']D\A]U%^K^,4V"#"<?:QK5BQ3L
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M[TIW#_Z8VJI[L<19JY7/ON9H\TOU,"';%2?.MT@JY>64EYR4/@/$*<8/-$K
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M]5#CT9QFD=JTS4C2-]1(1[PPE?P\S18@CD\9]*22^DE<Q7*4,!5B[+/%\XB
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M*_%403.B^+*Y3M!' N[AH(GAG'$-3J$9H'#DZ.EA.(W$N*^UC>L?9J/8< ^
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MON=XREIEY_,0+99S*Y]GX^WF=9'F>A/%CV.B.?]J0:B[GT5DK'BG^[9TI=\
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M4DU#LU$9=*UE,T8DD_2$$ 8**9:R72O4D3/65XQ;Y.6I(33I6B3BN=4=\E:
M;J:'L:F!RP'60HVO*UJJ:V'UH7/F]]A23PG4)!?ZVS\N1W!R-,E\,:*H.NP$
M'9MLUL49JO>(:0,LOX$+7_5G=92[/"L4F#S?M]_1\Z,<$]A"['-R_HITOS_#
MMZCB$'#*Q:17ZPWG5Z>82^1DFDT' RF1:E8ZB0I-I2.<'!ZT2'">C:@:(M(T
MR>W;,] )5=]IV7:C8V%__N -X.Y2/CMT6C$)2XE3J2W'[=Q:RS.:%1?&^S<
M,VSEL<%Q2NLHE9WP"FL31X2QTF2JXVY8-B75G_/'KW(:(@/^4V#F_Z8 4G8R
ML%0>KOW,/#W+/BN),,K(85>6-T[3T7L8(@XIP*98"/+M'_4^X0U;S'F7P,B9
M^%U!167S50E-:ZE#KDV5B;'D[QSCSFF-$'%8@4?J-L2;VEU<A;I^3TTK/6<]
MZ9NZH]::@W9^3AC'X_^J>UEFY]^IY\?PA;79MV3C7EA15]^,6&@-N=O',1VB
M8L!X5';3^0NAC9GB34G6"LS=WH^+;AW2*^-9S&7SU3+KX(HZ>3(=LO^IT(ZV
M\J\^8?+!'4GQ,0&P=4'#(#+GU9#1"_8F>:,4%5[PQ^U7Y: 0]%ZX1BW,,DK\
M^HIFM]J!U,;KQ**,6R[-*["]M#BX5 VJR0IZ+T$J^"HOOTSM?QFDB'_MZ!&5
MHTL):;7J*AOC/U;%/#5#J'.LUY7-6ALZFQC7_DX,B(\V;+.2$%C\X+F":*+1
MT>5BTPH$3SQOJQ4)MI@K0$Q63U31N(.EY5\(4[.1#\"@DF,"-@SXW$)&KX:[
MJ(=TV/OMQ\!D^52E524YS>A9]'H:\ZS]"^O<$9YJE$T>[,*M@3CM_2=FHVM"
MX[<2*K9'<MUES'L4-F/RY*$_-.7) /]?Z-1(*-!S]^TC:$D*M75/N+PF3"HO
M==/VHU'D1G%KZ[5?CX&SQ:6WXYCP7V,H?=O)]AJ,;A#JV^K8L[?SSS^ &3)@
M7B7O$OQ>L+-_)-/4!1&JH-[6PL(;OCJ6:]DPSU;2CM;)\[%36"?)B>@! G=M
M3C[_5RVG-*9O:$_:G&*VPQ\/-8V8KG1'M?2BAU@2EI;5.'QT#S$?Q8=S4>\1
MT273.#V+O:USL1+@0R5,<#A"R:RBB6C)"N]#G:)*][L$X[PRZ[P\1-!MVBC<
MMN_@2F GR2BX_BXTW<E:N<Z<EJ*H0/%E[Y?1-:7>PM$[_RG92)8 J-:E!^O6
MCNTR[&^==;<5[[VSIFF"&3I!/24-I>;/2U9]FN?O#Y:;Z87)O,'+#&AX@2&6
MM[,1Z*I_8.D;&'6RK*[=QM$2Q-XM5H7(B=7G"W[X/"+,," @N[%.M=3F>8R%
MN58AAAQ$QF8J[("_Z94< DH;D,@^Z?'IZ&K=[,EW%S#5!&OE%G-;-;P."ZN\
M3?8?/[K(=)P'DPZ;*P4GI9,D SXSYS1?G*,1R?</8C\6?"(B '@@9M^V&*NJ
M!V,>4.C.W8>)@MCS5N%.3%I\;F]O,UU//H@\$*U!KN]A^<J\-=ZVOPL<AJJN
M5VVRWHA88WZ'W+1-9\[)FXY(9)Z/E2#3U'KW/^6! 4U/J$L+_CV3N6_'HW?B
MC8Y\M [_IL'>;F=\[X;ICQ:#/+IB.6+"JZP<Y;4F0! )Z!][SO5G"LCG84G[
M1[2O:+Q#\&ENU=":S4R7L>%:&# T&1T2DIOV87CWQ])/66.*:#2AF''(T,]T
MI=QR,T.52"5@O^BS$AGUOE373FRI[*2/+,)PEISQ3^SK6)Q#LW<$V(8YG(;2
M[7%NG)J3T.(S<2DKH!PWC3+9<D"VP"9'.JH T06.FXX7;8)8[W&9U86^B0+-
M_' C!SG-@*.KN0Q= VC+WOH')3,.-WYVXB.46Q864],OZN>#;E;?NCN/'L51
M<Q+HW%Y"%+D"3$H#&_UC\>W/ZQ]Y$9^R8R*F.,CI/!.,OVZWBPFZD6F3('^X
M/@_@X]5_ZE'"A!81\"[JY/LL7I75DOJM0ZLE">FDZIR3$T-C&!<0%G"T+094
MMK<05IJL8GQO=/9EI86V4TAA9GR%WS0FS^R+7G&_II.JG&JZ=I65ICQY,@*6
MU$@8;CQ?^QM5W/7VP^IN\(S*[F1.U8DQ=-%HPJRUQFY,1!B4+9>#WFT7F!J]
MG:A@,EW5>164AHX07XF#:0FQEIJ!WI/L$%GY# 0EO3QY&APF.,.0QK(W81<F
M64BV0LEF_J_>6B)Y.T^7W?U@N2C%2AHO'^U1 I^CQO+R))C_O[5E]=]K2Q$3
M'(GH-_MYN[;, W@A.14)%I0V0!IV=F"V=4Y8;-!_ZI[]OP&6\$1?BPX8&',;
M\(K1W0DKZM!V"R/+RVT8'5,J_/1P.BGO_7^MM-L@SRK;GKY@36,YG; +?81W
M;=/-K=ZKEH<8>@SDEYN&U\SB-5?;C4G)ADWD:#JZF:;:;MX"A.S_4@69]W_,
MU]OX\'^<#O]_B.:>E6<AXW:C)U::-X!H<$'JL4;XK;\DK+D!($)O -E@/0(L
MYG7G#0 _/1KY=R3D"IH4-6NWS^?D]0FX(-V+YUY.@E'/M',Q)C;X;,=+O/#Z
M'+23*IA/D9^#]"3I)]O)DH:8M5SJ0K,<,VGGFQF+.WPT&^HG67^.?EP\3]8B
M<Z7O!J9A>4@".R^JN<YSO[%?T9)7Y73Z:&*X-[07+TOI\Q4_1@0:+.*WK7JB
M;@!+)A?4B*Q 0@[C.(>I*IZP:JOYS"$!S&SGN$J[IH(R:& $PXA\_79,,"<M
M8;E>',R(8=)O;L&P9(68)O20Y:ORI;O"KZ661X*7?I*H1S*7M8E1BJ>N1#Y^
M%Y!A>3K3(ULLHMQ-3]2D.LWI&OY>(F*'TZJ^=+!=IXKN#I3)G2R+V,?"6N#O
MGS*$^GQ0Z&/\>RVNBZ0^2B[7-$!5 UZ)/[14#'_:\\59-LC5MKB^@,\A29LS
M;9CS$)>=@MKZ21(+[6 C!F X-JU,?T>2L;J^(L,BHJ*=/'M9*H3&/%4.[)6J
M#)K,Y59-7?%C\A#Q$6%^]KLYRSRQ;2J)S<YE>3E$=])T'H4VT],U%ERMMD+8
MH">QDKQ>CG:KT?Q;7W2;F1B#8UEOE;$ODK#'#U]\(Q5V ^@3C\>U]!R1#UP]
MOP%H>]\ C!G_%<WS4QU/+Z\27*]&PT=/C%7U*\;V!L]1!&1F#0AO'(5#4+C9
MI3+O3J#1>N[2GDGG K<GR 3DLKK\AD6:&IXAN]P33*EA/<B9!EZSN][4.<0H
MJ]4NFCJ7 H]*>?@1$Z=B:EK_P-G@P_L8>=W)*^5\&\IWLR;&97Q#YV3GY1Q8
MF",H)&J_VGJ#Q[JI%R]^U%$=VXN8.8N)3><O?N?+-P5[R%C&H;8YU><1LMNP
M5[PYDQSE0LCJ_W+_^IGTE.UZ)-J.#?K$Y;(ZS>$=,&X,1VG#VB$"TA!$;Z$X
M<>]Q-;U&-O?:LTAVD_KF[1BDO\[YLBL$/0[M)CSFJ:<WC*W.JY88#C/7:"7S
M/W@E<+$D&L6(5@Q=E!Y[Z]8C1$K_F>@'PVG04G3(V;E;[/9%]]9ZNL.[3DQJ
M+S89J($A5JTU^QXU6+X"[3%[AC1[8@W0-;H#C5C=?(_.SDTJ6PW3Y6BUBTT1
M^GIBL\PKD;/7+5S.@3$)X;XB*.DJW=S=L6K: !P&2@#G@)'87"J'>\:K+A8X
MUZ1GS5/R%/N90:A"R@?3F^,3/MIF0D$KTPA6DMF]OXOCU=5PRQ[#:DH]TK+1
MN#?OH:Z',_>GQ$DE(I NWNIW2MJ>.-@+M#VUI>%:XOV\V"B[WXTHH '..!U0
M8DEI1N9;!T^+"Y1>V)B;%N4R9TZEY6.C5:<MXX $^2DKS*_O%0!)T9)U%+'+
MJE_=.I,YS*+3G:<KFJEMQ7F78)%:%H-KAN]\I=<K@O VCUMF*P42]4J<RE-F
M;'%,XR?"R&U*Y:?B3Z8MLCIY"!>-.)]N/S(W^_S:LUSX,#.2,:J&%@[6RYCY
MK>2&;(Z@V:XY"/'"2_T8;V ?L$[&&4%W1KT'$25C;[,2_-N&9UDR&;<>IB=!
MHO^Z/T:QQKPM3.#;*;O+>;.T*^6B[$Q]6Q#T9>;1L!WWD<SX[--ORJL1EO4W
M )(_(\57.DT3RTZ9SD>*1A\2Q6G.*@N%*NM5G_XERZF3@/;T9#).NMZOJ&U3
MK#>KT2$JJ*GALNQ1JA6BO,UV4_-X(T3LX83B.,]>#8%K_!Z)SQ]N=74@J<ZA
M'QQM0ODW]7NBRZ\W'/COY#4JD?U^NZFJ;9M@"5UZO4+E&P"!4,=LQ77>]]-V
M1+S&%.<IY+U$^@"G539Y/]1'^+#G=X0&@>(7).66D0D2G[D:4YM=J,@/JGX?
M<+<SJD8]B"9A351M:TXE7ZE/P6VR!<.#4_0EO3[Y5^NR  N_];YRBZ=_@"G8
MY!L 4VTH[L)_4Z;1(6SQB%GM=@W'7TR7>C&BM!BF"&X 1&VK,N/^.]&GB)P&
M_Q"3HQ<V4J<]%RA-(^%H],!4AD#K_<T/'K5GQF)(H;IW-X"R2#[@L!\-UDQC
M>BD-/ D925DU93+K7SHMUV^K"G]7&3?]_OLJU<MF^XT./^"A7R'7=& KFD*L
MMF25R'D.!:50'D\$<1OP/^XK+JYQ\?(=^2J@6O2$SP QSMM#OM&H& +R)_!8
MM$OG WTM1 7A3<$<PAH7DKGG;3L4>M[]X')OI<%,QZ(M9PDXP50C"3U<.LO?
MLBD'RRF/*4$<D1"%R'F(0<48)PY5I/XBY)-QS^3DM-"HK: FU+"7.4!W+DHL
M;!GWVK_W=E3LQNN:']Z.$W?T#0"Z\C=UU27N1\FI?7=_KBN=>"0]&#I1+0>>
MY-8CM_]Z7@S6K?(5V]MY+?A[^.+X((+QB*CV!N#A+XJZ9;DX6ZF=#).?T'[^
M_5V-&I]]B4@]3.OG6B[/,^Q5(C/%A6L1*9HQ.'-Q!#>NP8-ZT)S["TIN0FYL
M+.O-Y!OU@*M"/_*/.,JSQ$=D@M.'Q_=!%JUG,'^5LU7J9G$(4CNKRFYNF-QV
M6+P/2+^7OTHYW>?H\#R.C5J/?HN'YWE%K7=X"I[C\P'>/:.'';Z:)LIIJJE&
M\]),%LJK=[KD,69:,;]GMP3'/Z#1\AU1>0S K.V1V4N>[>[,V7.C#4W)JN5K
M;]E4&VX]".#3+I^8#@W]>;! Y!V$2]^4P.DOGCC'+?VZ5,UQ22J6JA\&<K*#
M5 >!NJUT!CW^2\I[J\;MN4O>2^AJEQ_%@FF5;FR91EL@>-2ERG09J-1?2J/>
M(/>4W$E9CVI&45B7FK4Y>3E_QWKA9>LH-W]+UNK#6F Y-K3L!F".A:Z8?;"A
MQ#>81#I-ZZQ4_2[2:Y%T'T6-^VCD[2232A?.EXW+XG[>F4C7LL6QCPMP^EM#
MF>4;[QF5(X=8C<7:CZ"*=VB^KH7VKA['&A@R(F<C-?0:6C O!W?JOX]64*W#
MQW(*@0/S)MZ4U47HLAHK,'%GUA,UCL[&,/M_4(/(H5YI"+4(13(]"0 .71DO
M\1!#-NLHWP%E'9]8Q!SLL]\ 'O*P-1R>=@PQ2?;]%*+#A.F^TG9I@0N>[#\M
M!DDJIW@17R5=MIVSXF1:O)I#I&\38M$=M[K8"R[7O 5I'!F5;U;ITQBR^%%G
M*"/&N9/"'47A-NWN/<,F:5O,1+Z/9Z]%+,,+I<2XRU9,.'!NU$:4Q3<0*>^
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M.UQ!SEB<!W(5UM>"8YKNJKGR>4C)Q:K4I"ZA$K&R:.E1<3'"D#.=X]T/[J4
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MGHK1;:ONXS> G<*3<OVO) Y43#&Y?\&I'K,JK4V8X#1QBG'E9\I)%M"'Y,A
M&UWWW>%TF69BY=H;0+2^_YS)FK:.WA*\^DW$T\^,_?D(H8;1:$9L56%-9KE9
M>90>JVZ7EV)PC;5KY..9;5:\2L)?;I*)@C6YLS OEZ3D5]3Z=.8NDC6K/8H8
MDR\\D$LNP_VI*!D Y&[+(R?TJQ*[&<W?:XE;.DZU$6=EJ,PK_6FNI<.)K=F0
M&>Y'OQM.0-%2T>+O65I[743D\DSCB<D?A"Q%FG2FYGG5?3,J,]TGH0N0>NSR
M:3NB)5^O+$BKM*CA>9UH6["H4:I_T'N;A+(X(IVPM68'.YX0'^_WY<4$3^(
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MZ%]Q+2RL0[2U!<Y:5[[F4]O?[?1(:MF8[ 6GQ)J6H5OKNBYSR1]I6]BM=RG
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M:V( 6/K91'D6L@4#,$M.;X$5%S# "PQP1.ED>'QL>$K@(Y513@ZI'(P)F<4
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MLYWI)TA].6I,)\KO,%3)Q !NE)V_\.P#^E*ON<-5T7)O.QG&\?EN.G CRZQ
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M9X,0VZ M"&A6V2)Q%\OY&1S*N6  \SF)^#KU-%<V%$>^.MJ;\'0;&['\17+
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MZK<MVX496![V8W-?,KTV,&O1]&/%0]Z=&)SB<*G;,">$E?OS8Y*>U;Q<*PS
MP58HQ=4Z/%,S.2[KEFZQ;N6,7@BM?BW]%J=B>VQ'EX]A35P9WJ__F-O/,H:;
MD"',@\>MK2F?[M[VY.34!_R&#VJ?=[]\8A-9W@,TJ)C<^0YSW'_;*GW3+ D_
M!3M^T.%@_U<,W>];I#4#3C)7-/,PP +L>]JKR [85GI'SQH(% Y_0]!O6%*.
M!KWR?3U7,RP2YE2P/-1?XD+%S^V7]8*FP%-.1$W4IBW_K;'%,\Z*_D"IH=:
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M0MA7:*?T7%<XC<>PE^%&D'C!+7>5MFSL39)+V$;;JM@X\ 5$.@WVY>MA!8[
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M)SX)V=6F'XV^^&G,Z:?=T#VQT5K'-)K$W6]MF_+31[ U2H.:--#\[:&BAVV
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MAYT<A:0_;IXH)U4?)U!FD[SI6WM8/(&.A?V3&=[$'$!&UO$]'\*'SX]AJ&9
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MUD!I>#!F_Y(:)]#?(Z^0F5M6XC7B0XGXG(& )R(1N?> 0&\8Y=7OZW((7,$
M<E%CT+=V'2&<P7X/Z&B%8]TB!N\!7BKW +2;+O'3-?8[N.%'%9G?5&(YF%L/
M]X[+FR7O 6)<]X!E/-]_/*$UA:=R5ZI5B570V7!R#[AE/GKU.W2P[;*;\D]/
MX)\_Q?,%:^P'['(<>K7]J1.9/SW@_5:*<F[:\_7_?JX4#0%[1ZG:@[V&":V9
MO_,$#4:1P'M R]]['A;_'^[X0^LS.$D$.K$]<L.;RV?G6BO(K:W+8Q@2LA6T
MM&D6\>@ST<P;;EXE]+EV.0JH3+Q6*5#AI4;[O.,W<:SF=TH^G0]LR?UY'!1
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M0AR77 >HF61Q"*V86_&*VD9X[8]*JKDR#FX@A4@E=-]+QKKHUWS-<%[#XD;
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M[KUVEQZ3Q0/LH/_B)5ZF[39P#=L<7YV$8$JPQL1-_#@3)@6U<EAR"%&R&GS
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MEN!Q/EW],8D,PT(IR^>M/3V?1!:?YXAXQZ?]\T_[GLIM<\D5.4T5*;$[R?O
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MR1;Y6=5'TC93D(QYOC"AC_B9+A-6[D](KN"<:6+W-CT]<W9NDBZ^*U%B4<%
M_C!\NC'9BT12*-Z)2?'^L8IK</-TUD(HFQ-$\) V#K]@[^54SUH#16B3E5#.
MI&Z! ?=/U1;!\:8(/+TKD-SL'HK@6M9A3L"I#ZZ%<WD;5V?\.A7^ 'C$++M
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MBZ*6^Z_!>SZ$8I5EI+%B"^.%GB8EF17MSC\<$K;.DJ&%U9\M+T8%%+%3&!'
M"06HV3&C>GT%? )-7G@Z0?3- 1&LW9R1R2PSVY1MC42CPB_>LYYTRTD)E?91
MYD%" <Q_JS8V+B)A=Y[^JXPGXS];?_Y<T"#^SP4-+.[P(6I:O[W[UZB*"*[3
MW0]QK\/&3&O+NVGJ<]I]L(#D1J#X(Y9J9=W']W* @6YJX3[.18.JS!D!!>J%
MNC7J4:K^ZBGS K%[W3^"A\;BT,(9IEOGT07,EM7H/!ZK_2I<:AP36]7R7[K^
M&(8 Q*>[[<[WJ!X?QJX5C1O8-CCBV&S: SJ^VHO*DIO[/N83HCIQ\G)8DD!:
MYK<= #4NO19\/PI)#1&4O()F;S;>-$\C2U9K>FF-;G5[E&LFU 6_[N[<Q#7\
M;R]'4*@W*K\N16B(&+3!)F3<F:3HSI50BG$$LW\4>H)&3[GMF*>3FLKO:U#+
MOHE,9D+=<&=).<0(YUG KFUA<8-:<K$-E[2[CSIB$YO7GG1.84>[HGL/TIH<
M;HN3DW-F1]!I3?DZ$Z/":N8\.J>M@VVK<OCXK+K]>=N,:HJ8]]MAE^L=E%@W
M,2X*5;%N9U<7KU+"!4U]1?08(N:BM9X9U(L\/^TSP\Z\!;0J0&YB9".FRVXR
MA;.^V'5B6 2K(0)SM.9$*@M?^+#Z>+TS/+IQ$"?W(AA$N'1<VH2PK7C( N+9
MC3]6:0MT 6-?M.\2O7I>A;[FFFDV_V#2FFB9!V5&6<N;_% C&:Y%O$MW[S6_
M:TB/ZK[FJ9<$3P/SVN&E)"G_>7,_0%%D[%E?K3D!1@,=H:W>XS;FZC/@JBCY
MP5@3#NKVY6G'K/-(,BQ:@EORHVCUXK$\W "];_$;GM[!^/B,\&/AR9R$K,</
MUP.ZY "GO2S1H]=>V;.;EWI]U^F(IYG0EX*PO5((R*SV36W<J-]C</5Q)!.J
M5.CZ*27A9J)I M;J3S^0W;?W;,>RG;9BF%D9U^*C0*%A<R[@EWTDA,'PZTDG
M$RHDO<;+H2M1+/A4K$2_%]>!\%M:%9\')ING2Y9">F..[8))B!85+I0^2D*<
M7%*:;KB]62B0,1L<$@7W_LZN(E0@ #'\[%O>VV;.F&7B*5WG4&3&9B/T:8%Q
MY3W*FJ\(ZR!1M!$['Y_$MHKFMZW1GZ(,"&=.EH]&O4'\8B^RW)T K^Q<T/+7
MS-513M,?Y;)K<G07B12T\WB %4E<RY5]\+8<))B%)+$*52ND,=M1_;IH:C4.
M%-:#@%>D@UB#3O0517F"BBSR'_?<A)4P<I6U\1!!(POZ8=(.R%@Z_7?KE0SE
M<"$17#/:6G[S;\S'D3GX**62]M/G48Y1V/H0R(Z?\3NYB,D!9C8^.'IRKNY4
M\[!(G=YZWS&10RA@.U],4(RO=Y[O4L.YIGAJ@U?,HM8NX%R3G^VDD,F:!QQ%
M2HRJBR6Q%!'JUF4ZPG]AAEJ67L:CB*.]G>Y3EII(3,)+/$@%S[#!FV2OO92U
M6Z?3!Y.=@  SF::862'-Y."P)D1LCHXB#6A&WCV:3):.E:-)=QQZ2!_UJ9[:
MRRUGX,DDJ:O&ZI/1EK0GZ0*X6FT9Z*I#H4YVMX!'QC$&P21"W3M[[P5,!1AC
M09?[(2>#3RX,IOD>8B<E)T5RBY/R:)+>=11J$SMY&HR\*DIZ,[9;"::OJ_@L
MBT>&CN[+_N?M/@W-$+$5W:9;0)%4)9BE/?6(W> 6,$$KNV-B@% Y,8F@14H\
M2SWM\8G3RP=)7_NSB6W'W *8ZUY.YOO<._FU!_;O/A_]#P,<I$)O!9=#CU/Q
MKF5]'FT-3\WI<#]\@LJT3%PL7<QZN!>4N%>^8H4N&3&EF"T ,3NJF=9!G3S1
M8U0)4Q]]7_]QE8Z8(&+Y!:$.0E'AZDU:795S[A8X%"$+1P]]%/'LM+?'VC9T
M'",*?SO1.L][ =A0B\TH6M,"T2,@J2]^;\0"<1&RP7#-]R$P7[N@YFR5!7"L
MTY2>1GV*W:1@"'X=/Q5>SO&@Q74]2VAQ_?K3X9TJ-9%.W:Y72+G.:.2U3V^>
M:D#1DA407\?6*B7))1_\#)9J]@QIABJ$XP94;$L1+8/M4W1JS<-VGSRV7R39
MIKH%1#E>:@8BUJBSKM^.9I9?D)BBG9WW80Z$&ZEX1CS15%H3^="NSUPYY)G[
MG=C:A(I.]CR*OU^M\?!)5HXV9*4J_/"["8&W8>(BDM'\LMY]+:EP2OR8E<D%
M[?XMX)E/EBSXT)\MNJ5P<X2*'^/<4UTJ<#&+W$!9 %S4E;]Y&6I@GN=6T5G(
M';2K>X+D][>2F33_+.M"\YV[J[<8EN>::N#72*'HD\4[.>7]LB$_JF5;JVF)
M'-R:-LC">[[GEJ<VGL5;M4'63[_F" J"YFW&FV[I:,0#B5E(CEAT),<UM4IT
MLD+@/2V:VYHK$?3A&;DFAOY8=!S2]RQ#[KU((XB- ;\OE)5\A\A1:1IQ3+!A
MA?%RYIEB;["$#5]KPJ-P-KCGM=JL(<2#_=$IW&]Y9M-7AU&=1>1"CZ/N(<ZV
MM6IK1BNU8$)UGBM,)\1 -FB8$_93U]#MMZ,$]Y_M5B;7GF1O],LM<#JPZ)XP
MLPP4"IM[?8#? G:P%%19;2,KL<,\[0K-!/LK$U\]DA8RE"$[Z0=**6361EY=
M4'R5=-,,\52'-V%+VN0I8-5I=Z-0V\L0]=O,(6J/%#%N 5:3=!\L/;Z+C<1F
MT,4^VC:JRK3<$7)?#EV\%H-#5#4/ CL+\[ 3$RPIOG5:V 0C6>H/WQ"6Z=%0
M!^D%V(R$*,<T7#Z4U>;Z<=APB5CB(8QXF;S NR!W@C.D&7GWY^PQ"]AD/"E6
M:8K??6UN4X%.R<UGD1^M6PI5H[LYBV#NG/"4ST%XTX-K !_X7P^R>A6$*I):
M@&PBX,/6UPE4R26%P70:?!T93@S%F;BE1#^GWIP.S)]L#M7#L\K)LHROHT Q
M-YKR5Q:T7!>&K9'9)=?/X0L(F94:Q3)YPIA5%_[E4!D&&-7!2/?AS#,9"=0J
MS@XC3]'#1UME"S95_BCXX:2]1#WDF\SN\O*3;T&,LR>"+(/IAUY[=?"0DP@.
MJDBLF;D&20F,B/V*)L((/+774PR>4 -+[&V5W)[-"?OOD",1FCL#DKN.:A[T
MG]8K2SZ2%+C ]OQ D Q7)'+->!6TH.0*B2C\QD_<G4."&Z-8S6<$8RJ2NNI\
M;KZXL-N0(,0=[@(OVZF7R#/0;O&P<0!3._=)%<=&Y4#HY4 +V7X_"U,=AG)S
M(7.951&SA@D2M/-9A4'_(<&H_VLG+@3]/WD_\XQVEW8&T'\[8(FH0F2EZ8-3
MIYS+B%/!?-_",1>=<AO9*T<0%*H6NGR)=6=.,PLGQ0PCE=A84ULIS^)1[\M5
MX;*-VCY\[Q.V@(]R\BRJV/QRQ?J,[^'SJ&!U 9;3.Y"N&%26U=5.;J%'!SW3
MD:GN>ANWZ_BO2XC]DS0+?'_4]2U@^R,X+O?>^*\*P&]1@.N7$^U]5I1J,?V[
M*Z9O%S%/4+L[W)"5!R,+FF,K]>:SA#M8A@;3]LA]A['>QJQ=R@EO4O*Y0OC:
M"'%S<S2JWREQ7CZIEF1E)@=J-,G]ZR!FBRE+MS(H]_^.CK9FM&OH''LCV^90
M-U=ANQ$25;].-W#]HW'-84-V+9FE7YFFZ!A*J]:V)@7YP<*G:^$(9()9A#!J
M':$W('>/IR5K>QY?H=J\*.;.'&Y?&>JP/BQMC'G:@8LEV2?;7J12N#JA9K-(
MZQS$;KDCXW*EEE1ZU;UJ=M"94'_R)"4;*"%"\@:H0]W263_%,NPP"3]E43E_
M"TOM?$:X8V6YBJ8>IVJ].@@<1X0U3_"1;&V#R&X!)G73!%]XQVT@[(&+<V_
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M1,D+9G742EO'L);FTL4(*IV4HQ5UY?2MTO 4H>-_ '[T-,@F9%)9#+3*JL^
MBH'"9!I2CMOX&%P^,&$&6Q>*@#]'*8WC2=7Y6=)XF,:BOURG,BIZ+D+Z"E20
M\@.K7;4YIK,Y(SQO$%1T&9&_D)5!N<!!YTVP/JTX76QI%,FFK\-ON41-8"L\
MZY "%IV6;S "C;ZI#8\?>9#*Y<^UD,Q;B3MY2@IY"9MW???M>M2K-\:-"OJQ
MMR^NZR!\(EZ_86X DC,IF]?S3=ZJCL[X%B W8O5*J5PP*^KL(_31?>8>3MJ\
M2^5)4$H8Y1<E @ Z<<=SF9[_B[WW#(MR61:%7T22),DY"(C*$"2*" Q!DHB
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M&['&56?R)BAGG8PT+.%E2794E&?VYE.X AV7CWGR:H>8-0C^RIU.B+^\<)P
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MAF"I.P9@CCHHN 30;I%6F[F$R[K@LL0 8Z6#:MCY_V2S-*MH8[R>,^7FQ:+
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M;#K,1Y;EW NP+7VUE55>';;R/$ITCF+&1X(^.KI0:0W7IL/)),J%S+@G^4D
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MW$=>&>)%<T]*WR7*Z?)^M-Y\'RZ51C4BTY5EC>Q^@@,HEYR_:"$C;*)YE&Q
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M+>2;X^[[9(9AL7M.CK1$YM^MARR5M8W,,4?/:9<@DA0R[)-%8C5K^ZV. HO
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M'8;O/E31^&:Y<_,''80WO$^K&(8_]<:_E8_G%C*J-)HZ=\N+T9(X6L+@F_4
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M:N(EX'@&."$@&8<SMC!^&A]T8O9S<92RQ^-+@+3P)6"W2O*K)927$-9<?"A
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MD1R]/GL'Y9B),I:-Z7X1MZ9>\E3V(>9D]15%M^ZB;QE,;@X9K+N53#*VK J
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MIA:RS>V'\WM26%OCU4\YE]I2J@RL'4_"(5^FZ]269UTUXV/:S]E SH-H>AU
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M0 < 8&!C_#, _WU@/,#$PL;!?8B'_P@]H>$)X $&)N8#+$QL;"PL]-T@]'T
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MTK0X,JQ\,#U:Z;@B<[H'+- -0.?A.>G@;T;V-49R3_#4U(K\U4+N >LF3?<
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MG:690\,U)->C#"A2N#8S[J?)E_:N8&'B;2D3E\9' F]0+TJV/6?PE=_SSP4
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MA$ZK*KB<NE(+II32&56 XC[J<;][3R&?U?J-'M%QVYV<V,CER$G5 &=JK+(
M?L9DM&U]&/F.*; Z+P+N*(8CT"1\#6N%A?O&WREY2AW3;>FO_&#W)_LT2R/5
MP]G__!AJ%QH[<^<UB!3KZ96="&&.B>LM!W!6(].*%?U6K1)!_6\AHL7'*SMZ
M<^]"?/-/DZI6ASRUDDFI=(+>6A7NSCY.@K^IE>N;\^Q1^+6B1UC4[\4;%WNF
M6RM+G?@41S+EX'3'7P+*S?7Y-5!.[4'SHE2/(:CWT[):8ZVFSO>JFMPM+:4*
M;>O^IV72BQX*Q0BK+=DFUBH15'D>TM*>6I):#I^_5Z2"-[I9]*W$![23F:LP
M5+3Z+>Y):29$1U8>N0YYQJA[7'B%V6"#8FN,%7R]*@=7$[ZL5(N$G'"H(76(
MPB G&"BUTQ*SP_A))UYG1]\-(%3BI;PEJCP&J3#OZ-)>@RIO0/2BHB=NB4ZJ
M>%?)%^T#)13N=#P[%JW8.Y89<Q*E#M0B1PM[W;FB/T,H+WWS%<SUQU[ID /P
MC[/U_HP&,TI[\:>$]A5F!8'G]ZM7VAL4X0E*WT<,LYP6WDU/T]+V_]@DBZNP
M:#M>_.F%%;8";Z$+K>M($\=*+!N*'V[E_60XU9X6L1G_!T>>&@!^M I*+K7G
M'BS%F#F_G@B;!BYH3M?6[,H4,09-G!456I[D%OEM&:P:W@-0R0&0Z^V.Z?;$
MK;M7[N@*37HG!P6;22'<#OYI9=<N0OH>JUW#E_M@!9%(^RQ/GP1X,$:3(LIS
MX[V8U1KHZ''T>NU:C&?U8Z37/8 1NGP^WCZL=NYT5M(K=*#WU=?ZL*Z+B[L
M$@GCT'ZGL&"Y8[K^*?\)X,"4]=O?1E(KNB+%WG+.:]_M![&O94*#L,-UWQYG
MJ[Q&*7]TH8.:;9DFK1U=D3)=XY_&ZMTI:=.=CT&R_:70FEX_:5NJTDD/_LV6
M*-P6=!PRSN?D)CG6TK:VU%8-?.[R>,D*\^;;G4YO( -:V1MW;+5[![.AL=3_
M]*Y%Z*0J4.8>8 \J0C$.!C\UDIO+.M1^2A4G40[STM'ZIOIPS<E/OE,*>0]H
M_OL-3Z_"H>.$,/=VKL+ZKN;R$1%*H/>.#K&F_%V8PF7+*)=,:FV8KN3.*V*%
MZ(K&^:X2M1< A_--P%T?8U"@]O+-CC3XE2^Y]L2)[@$,4QWC!8@C5+0 ^I"4
M0+']"'Y0ON>*3I@'J<$E2[%H:1)Y^92;R'&:DXVZC?YL.W'("QU;WDDXWP.6
MZ 9J)5F>)_U6I]\V@*2  \GO ?'*'9<1)Q4CD>CKT+GYVXT[N;:)>P#8<=-_
M5+X2Z8T5\:911UW*F_,SLIHRFZ 1YU75!-KMSQ)-MQ[ WD!=]"7>M1XA[MUH
M;OJ$1O!V_$]W?E^,958.LVL]YI4 ZTEQ-R]TG9&<=K1!AREBC *%,Q9780SA
M6!/G<_<DHAFA@?4E"KS+V(VKJFP261IM.<P#Y&&8>B%LU:),'HN]SU.(4X7@
MGY$T1ZX1U+)C>>% >^&_FS"^1ZA]N/QC]EED)6JMDSW VC*_S3BF8T4Y(O-7
M4KC(/#$=<J>*\6=J/V_,NHVZ&[-/#GY=@!KV'Q,%;F+Q^ L5-PA1Q[I+YNWU
M04Q*6;W'P&78B&.Z_*R^96P#W%^G0A.E_ID_!,,C)HASW@:]1VCSAMK*W0,2
MO[).W0.*S$.1MMM@$Y/NB_=YLG_Y@FISOE3DDS#R0=[3:I\[HDXHIQEZ<A+1
MS2!J^R=*\XQ -9*&M8<J307_8<HG AR(Z#S2O+C':56?"5_HASN8%VZ3S3T2
M89$!8GU'T3M=@>*>SLOL&IMM^R!HT,=2Y8 T$4NBX73PQRJA9=$%A'!V->B'
MIR-(7T9L+&P]#Y(-L)Y:T+TX8NS[^FK$$$'!C*XWGRH!W)0B6W1*,<#;S8L:
M_?#LA*\(49_F24=N/#'RF#N=G26*^CC8FZ8WZI+2J/*A.W;]0:Q&G]W"3\.J
MN T^/XBFS"<%A2FL3 ;RB',=O,Z[?G<6>>DL)/TFY5O:)GNX^Y@,M 5Y&#[?
MUG"&EEN]Y5!$5>7CW#Q50]D%.<"0J]G#3*^I"8COUGE^5&*7T@VV<H"5'K(<
MG=N@7!3N%:P<";Z3W9.ZWC+505A32CV94Y*>>WF*A'U#ZIZP!XK9Z<KVJ?H5
M/+L[>H3-TEX?(Q6%II/]9R"R+J(KTGG415DNT$N83/8E7)9GEAP79+N*EL11
MUG5WOOE#YEZ'9.V6T5-2Z\6]:&)/&("-(O6PCVKZ<O*: %VBXG=S3[36T'@1
MWMH1.5?4$Q?F0LU4\MF)*8AC3WI8&][V3%6)0R6)CM+.\"$8S$SX<4RA8E$&
MS@7SKI7'#JVH$%VA]'D?R%ZT9!]RN,TTWL0:3.@E.I037VC_3($^3,'T!8Z]
M\DQG8*-3;("BW&6M>/5J12QKU(;[RU3'!&3&F5H4Y(2SZ=;3\#0WPKTBYT5Z
MVGNS^#^P@D -BN,VRSM_;K#9[2Z3YMTC*G0IE=VXUC7K&4%>_.7Z'>/UP60J
M=!</2KV&16WJ?O!0SQN@@=9L1[\'TE"+)N>EP D#E.A37BU2J1?@#*2*0^T(
M:/#]2-;Z+;BLMO;&IPM!!&%E/,9!HU'8Y6"Q@\"L\7?YQ0\Y' 65')$N;E)Q
M0A*YU-X]OB,] <('YV"Q+S]U5[(@[:;=MC$L!WOQQK HE/)DP13H1EG,LL.^
MRS('7O.S^$"%[^6Z&%7+W-9J82)?/Y^>R''XG%!+2WHRZ2#!VE)KD-SD+$HD
MD92<@2=E))!VQ^ON!B(Z*W7AGWIH SMB])AR)J'RPZ &@N"MFEQFSRC4W[D
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MLL&*^MR3J6L?SLMSGHX7CY\)-GYY F]E8'\%K_4J7-V_)MN'"?%M^MN&\AY
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M]YMJ6]*F_AM[;QW4]O?]#892H*5(*>YM<0*T2* XE.(%BKL738'B[@5*&J!
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MQ!'Q?0&-X<7=BEC#5+IY^T8W8W\T4+6)/ ZB0.I"_+]5K_0JP%$TAK:Z<;\
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M%H=R;!%$8AR<Q)O.B ;E-N%B]!P/^8>LP %O0N6G=?K5D6(W0,:.6Z+):O$
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MLT1: ]*Z.;DKW'<A /[?[S9D/(/9B?$^_Z#X>T7K?@6_/2N\)D#=4MAZT"1
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M=W,WP&(Q,B_3&&3I7203?,R?$R0?M]!L?3AF*.-ZUG'@:)A//K7LIQ)<G.2
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MJ=;Q.JP9]Y5QKRO$Z8Q1:9K%<IME*"1B=3.AH&4R.>JL<O7D;16=ZX'>,HE
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M!\S R'@<69MFSUOS6A+_I.T1^!E&7C.==L #OX=Z_LC _ >=%3NW#XEV4_Z
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M?),\G!H()-SQR-<!*K1+A-1L(S2+!(MG.5-U>E$UIA&-_@?C"[^O(K'Z9EK
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MR)FT_YH74^UW/@7E>LT%$I,!5\HT[&ZBQ4[J4B?%8S>1@)S+<>7-?E5I)CC
M:<:0&_[C0WZ[-GGWM?+H$:B$;_'3I$#L>T:\N:9!#5206&6/.MHA#:J#&N>2
MJS\R%!P'^]0F>>*</0J+?P)%N@;OR.'! 2ZWC.,VE6,\W!M4-L/ Y*KCFGT=
MD6JK +MU@K8$'W<J,JS>;9J'L9C7.S^Q"1!5F.0M+H>:.P!ARC>]%_HO/5@4
M^Q ^4:SWA+SA/\.<MLI;&YNP#X3P/@/.\DO$./P90V$55@QFR7)[,\A\,XV5
M#WA)(ZN^R.GJJR#8)YU5VCV#.9X(5S#*=Z".L2GV!%C;#B/#VD(NT=6G]+C:
M,P?"JA5R;OCU/-8^C)Y_ZY[X"%'X:,U5>AUJ4KU+K\ 4:N1P&?SE9XQXVFPM
M'UVY^G20L.0CT'E/-&OR?A%OX*KP@Y:(&M=&O+"2:AL[:6)1_ZT>UD;.?WM*
M_E_X_P"%R0F[=M-\BXJ7EM2@S8@UDSA6KPX%I0K-KWT[4@PELMZM:6A?N>9&
M/:I&BC>T\>0SNP;GM1F90X6)BP3@^M@A 'C,"!G6; I&>1DH?UI5I(.ZE<8+
M *HUK/_5.ORO)O1_\O\D^+T'BM;7H9I=",IT4?ELT(-P8'K?:$O6#&WQX#G:
MD&((E75AH$7?_D2QG:S&?\I8- \U]O"Z?Y2\ Y."$L^(>#54/-8["+BJB#?Z
M@UG.P9W3D/(7JY)BJ)'UGHY"Z_3HMD5/OX$3; %^]9:]U5V +,$$ '^!>%U+
M+*&=B9)V:7JE4G]T0:_"SS'-,G!Y_T=FT7Q\O%*T O^:JY%) 1JWYSV::FQ]
M)-70:;&T@^-=>4XH#&#[0.E?'<\(5G RVA1:W/S*D;G!,GX4*QFPDU_*U)'Q
MM.1:S<4BG%J7?HX/Q\/EGYN[Q,FL@YBSFWO4,0CXC+VF?F6#5XI=!ZDB7K<Q
M@Z(VG4)0.OQ1)K%:=F4):%YYD;LL\[N8?4HT,+@!,P*7]F1I[:/^OH+BL\6>
MW"X3J,0@8 NJ%7V;\O'02A+CVXP"PUV= ?&F"#GZ*(!1=CPH%!5(9H"QGF)K
M9 ;&X>( G,;T?1AJ<.LLZC[0P7P@DYD/$52%R,MCNXLRL</"0OZ^4J?.=-%R
M-$41=U0!"VSDS5DF42/D_01+T@MHTW<R%\7,Q^S%+9+&59-Y<4 [[$HZ.IK)
M^\7K1C.TX454GWI*>,1()\=TFC#7H>ECYDI.ZQ8L@H3^UQ9Q4!1*\NGOU0/A
MPZUA!/6*=9!@?JE,1X#$1+.&,7<&4<ZQ'.<6Y%H?O.H+JF\8'I=:L6D!N+GI
MBMJ@BL!M1+6E#2<)GFZ% 13HJ9^1AU;A\Z(PYGNE^F>"FWZ::^*BG11+5H.A
MGE9TR39AS>:4D=^;21HS#WME >X"ZD;6;6M[XD^THKNU7 YGJ-[:8E=E9X>K
M"Y#TBHB$,T8I_M.\C@7_MT?A_\+_?1"\H@KLK?*^W?"B[!BB59H" 5<+7KY^
M)B'$>!'E>P257-=OO@.XM%H?ZX;7<'MJ-%,(L7(I_?G-A(F! ]R6R:OIB>7U
M6,<OF'__Q JHF42X.CL?RYV7\C?U'IT7"K;A'I66,?W4:+;35GC#LSS=%$AK
M]WU'\DD-4$\7__M],A"Z>@>(-NUL_#1F.$\;Z<G;+G&^G4Z"J0>EZ5Y)7,SW
M_DCGFXHXEE>LKJ].U\^2MQB4L,)K,0-?H&?]C"+-U&D2+=Y"/<FP]DQ F%"G
M55MU#4D1SZM\PL]%Z-J_<UJ^0]RPL)@E;MUF3Y0QY_C)W,Q<2LHP!("7ZD.#
M$O/Z6[,5L9;NRWZ0.=(O]CTOKP3@^_.:=9KQ&));5^_M&%R187":A^DK,!(=
ML()7?^>X^KWC!X+5-AQGBSH)O)BI9[X!1U;'=-V2<1/X^"S,A018?:&+*<@D
M=C@VC6%"BWTJHTS@.]< \W<'DI4T2_I>T+Y!#(WV6N%1@88QI-V"/W-WE_?3
M94?EV#:P,SJ:#Y<V3TPC/<>Y<%'2O!WDBS,> EB[-,3=:I(:D FMZBNAY!D=
MZS+#NOKHS8?)@OUO>D&G@=\$AIP,&ZL#]^\ 5<T.WW6>-ZS-M<QWD"S(K.YY
M'4J?D@.$_W[ 670<-SS@ WOI%=6WOVQ>[@S$/RAF;6Z<EOK52_0D.A59U%1L
MJQ]-1A!OPHNF1&F%KV\;\)ZR_5SO/Y6BBRHFL;L#D&D0,M_N2;XV20/O:(TD
M\N^8:!]/M//9;5WI:@X8*Y[Z+5:=E^F288468F04IS;Y%^>!;05E:==J67IS
MU[)UE9#GY55!NK</@;L>5[FM]NC ZP1#T[_;DF<OI!B:;ZG&_"3-;V X<=ZQ
MI7+ ;X%1*US?$99)WQ/P:2<@9VVD@;UE0E<)*,E'9V!C&80/]"=O<;"+%)-D
MERUVT72S?7)$Z-!% ?S0N%^07U=MQ=@%T4Q"?DV!6@(D/2)R-KH#=!LJ.(@Q
M:SR:HO0YAI$S=NY=J4BN:O&;!!:2G/!+D;L30W_FGNCM"TPGONG#"?71E5^)
MB1SS2M\I8?TB(W)?8@N74@P89V@8YHP)9*W'M?<>%Q&UUD0>'ZM1=ME1? )N
MU.%0T><_N(P:N38A[[D^9^QO#2N_ WSW;[MQ-=TP%<,@;Y6N \]' SG_TJK]
M;^-2)/;)::T)EBQ3 U_>4?>5/6_#+'(TQ0KL88O9!YS4.%S;-Z83$R9\_5XL
MYZP=0&2;[-#SQ3)=SS+.!L_YW@8 ]EZ2J+2,KW"P_J2T&^S%XW5DO)\QFNMR
MZ?D5<#Y!P10[HV5(M*N"-1ZM,>9V!_@A4)1@6F)_;10L67VV0Z!4ND[Q)W N
MDVADE2>/(@M<;M>Q"%,_W2KQ<<?< :0R;CKU&9Y6UX5*U=IFRUK 6+3P9UKO
M #&/[P + EBG@M_R9NT9R<JR6[5MFS=76T.:&+\&D!XC,B)RTF=DZ?J_E(J#
MA[MCO8O]Y">?5_U"O/AU&K\M#FR\ X1)%YM6?IN_\+J*.K@5P)+L4"Y*:F8K
MD&>BB-*0RKD!)F.<LV;!)@*33"U?%;)-L/[J5MNE4]8>]WPY+,DT\4OLNP;V
M!SR] _2>%@0BG;;9L4O1=9W<]&X<AP[/]>!1R@^ P)7T)H&?E#3OAPW[N:%7
MNG#,\*:H$X&) !1P,F* S@C]_'[N%NY+$U<?;W<N@'4F(5_B3=D3>J_C-[G$
MU]5.&WK)RU'7EN"B(<+6#."[DK"7G 5HO ]MD[>,,T;VO-6N2:GDYM$=0>),
MJ[H2I*';D@F>T,\Y5[IXQWFWLF\D0O_H^DHQ4*XU-&N7V5\:^!<JTD,5J.JW
M_<%L*V[$X+4G^<S,C7@/,^"^I54/E7.61+JSH#9L=,AO?B_N '&A^7> %K:3
M3&*_4EJ41Y-$U.JLV"_E)"RCT G(85$2>I!W8/5;&R]Y!373RR QVM6\J".!
M&_.)_1*AC%=LDIYBNA.Q"@PLEMURSB;DQR;]2X9-%U[J21]%73+7("UKKR@Q
M12K(W+J)?:LXG#<:%>L?\%3007< !#/F\E9[,P ?$R$8O+I<-3N;$HG[^'<W
M4-E@NB;*LOU97Y$46H'ZF-K9<!G/[9NP&"]7I31M%5%QYH4 %GPE$.*,B;O:
M%WK]AW^+BK7,:QDE)D&5Y& >,=)@1C3J/-T\WD^UWRJ@3(!/\A 6C' S :$E
MDHB_OJP)Z5U8QC%ZBOT!QTM"<'%^L;LQ/-DB^BW 8JH)S:\9H7.,;=SN$D/-
M1+Z1\72X"%13?)D8.]^M=*#^5!,YUWBC%7_L\E(UT&,2:^,6?_I5,W\QP@_[
MB4V\)1UZNL42=5% 4;(RKUS_BX1UXO<=P+ZBF7M5[UKVN-4B7PR3ZZ&#G0X<
MJ3%V.>'FKJ8=3 R;TI7H#A)OZKP#G"BPW@%*Y?] 3N\ $0RL-<<+C0E#7<&&
M6W/$KB:AF8%]C"FW#8P[)ORKK_",,%7&#2%"P*<>;/%[4O1$"4Z!:%U$%/-)
M>;7\MC=#S9EU1-:<K0?OO*$<&?MOA-],I.]Q57<^7\#@L'P%/7#'F%2[;EJ@
MUW'E<_^N" U@0AS8+1:((N3I1+R6=LTM/J%L=YGI >WWP/V6T>!;^2+3OSLW
MMMA3S89K[L?IL7:?GR^5AF*_Z0$@F3S1N=:UBI^J3SD/!KXO<A)#0SW#JM%W
M@/<]MR' P-^-+%\QG@TE:]:V+HH?U!8S"26Q_&1#$:O9[$QIK_&W0,NZ(XSX
MH])HW!-VC!I_YE_=T4E M;HL@.S_-11\:  ARO->II_B"NNR! I\G5YT*.7<
M@-NOG25@@6@Y;M8G>='".4\Z2>;RD-623S&"2]P:P.E$D)F^,N\:6@#KR)NL
M!N'EVT/Q,_U9A';CYSRS5\/"A1_\],>LF_5H.)B(YF6J"#[@929B%\"'O):[
M&",)<^T%2?13NX:A79[4I2ABNIV\MS2I2=%BV.%BHWCZR<"@"DP)S,24I4J>
MV7#>OJK\=^DNM897HL(,N?EW68!R\GOD*]0KNIUT^I_]J4FLDNT1R1'WBO%4
M(..I$OK=>PWV/EU'6^S27G@IK18F"6Y7Y^#X,LY#YI2J%U4G)HGRE^SR6')/
MB7$;5L@D7!A35^:4H55DPM&F9D82YU]KCW&](FRE,<XCZ.U\$"3:(;7WP;]Q
M?O#D>FIQ)WD#](I63WG5NX96&#LJJ2,5U?RSW:=SSX3CE,?F5UVR1_"+'LVY
M((FH8;LXI5B>+3/8TM?N2?5M8!BFP%?\9[A5'!YGNSMND&A.++-Q[RS9WQ4Q
M#A2[VQ&NO'_^4+<:\WGNW+7>F*/3,]PH%-'GTOW7MMBC_,I&PW5K*OQO7_O#
M6_5;]W!1E<\Q!=E#^2Q9NF_7<:S-0Z7H#_@4-5@&RK&74@@*Q)1?TA41A !'
M_/S!9?9"B1?)=A_#?D68$:N5 'P(/#\,.M,%MX8G*G_-N@/HK0;D-N,=--:%
MBAF"K9'A5C]X-IA3;?8,:"[R"C PA.EL8ATNL]3L;Z:\\2#Q#F%8@@OTT47^
MTN&C>>*7H>=EU,?1;07;<QO38:X<R;( 5N_U&SL>,7&4N'89B'8^MTYA@(P:
MV+ZS%"1>PJR(JQW,,!DCIEY.L$(Z?B\W"6"+L<0%,&KB)NE_X>TMH]IJM[7A
M!"D.A4*1XE(<2G&*E18O7MQ:'-+@$AR*%-<";0H$BFN*!'=WE^+NI4W0X!_/
M/F>_^]GG.^,;WX]SWA]K9&6-M3+6O>YKSON:,VM>\V,)?P!WZG239;F#&4_5
M,4OJ_,_A("I+21K )=5#!7E>MW.:$YJG(=A;RRHIF&7FXPB(< GN']ZJK;J^
M_BPBFO=087!>^!^5LB*3?I U:T6/Z905@'O <D:XJ"D0PS29EI=>SI)N%_,G
MC;S\X$-LA33-/N<DC !$AY_<U.]#Z/+\4X%.]I7D29C13GYBM;^.A@CE'<!.
M\/DGM:U&FR"I:*&O%-@E5?,]OY^I;,X\1:P?2-%K</0<#][TC0H!Q\=->J(W
M5.DLULJN:VN_*G@J>1<B9.@,]LYMYAB3MF;_>+_VJP;.V"0S_^#UT\]?W!N&
M3. F*AB(;^J9F),*7?"%VLSKQM2,<[+8WR_WS*GU:JJ]/GI?);645*N+FD5J
MC?S38C_ Z;&>]3]YXYP="W"_(*\OS5 TJ9F4A+^0:6;D%U;40\6&?T[<%)JH
MZXLE&9:EH[=W,]F.7E^0LAZR$/VH=4U&[Y!?ME$FW;%6EB1:YRQM27U5#9PN
M+1S2-2"3F*SD'KDF+1,I*S=OJ!>X:.*4$BL?-&Z5<$P1[E-PC4['!TP0DKQ2
MD/>&W9L8C4@.V,=):]9JY%5FD&W>AV$460=W,LV""BHDA"NQ)NB%RIMI52*Y
M%:T:P\/%YZ+9Q9<]M:#O"]ZSO+\>>#\-$K*"BH6;!EU.!F-9T:#^4*.WG Z9
M5*U2YP;Y1._YD.<$I'Q6:9(WM'CR39_T:\G[L!S.'-N6;E/_A(1NSKPZ4;CI
MAPKY#T/<_E)^$LB,:BO%BN$@5HM!,KXO1S? QYJB;U]:ZD=%W;/<YR;/KGJ>
MBY5E,)A4SQPV+=CBT#[?2;##5%O2N@]BR%E*8HKZ2IT>]=-*T(YR4[R,27 Q
M% E@FSR)):-^ZLGQ6RYI"OASPJ;NP"G"R.\\&M-XD*RBHV_SW:Q)'*OL_DN<
M["P,Y9P(ZY\D9:2CY#D<JS?<<:C'*87[1A'#;5'#LNQ8(1>SHGG+:KF0:@,C
M4__BI>]>%E0U$R_<9.DK$@\T^[T(M;&\@/$O3<1G_TP\B:YA&8Q.$-"%@BX0
MT88V"1]<<X%_9.GCZX#I*#5E[9>?WSF$%Q[2QPMRMI/"-D%):"=?J:7F]J^#
M[U#)?V3I#B2R!FGQ*::#&#=INE%"B=WYOQ,'RGU"HD8"R?<NZ9-M;'DZE(X*
MO(P !W;E(J/KCS,\"N5MD/W SVMT?>UE4K;=>A(2Y=>#+(2AK^ZMZ9+[Z[B?
MM76IQN8'D'<CZZ=D4W:J+!QM*WW!$O1,IPJL#W>6+*Z(>O,M5#]&Z% /CXZX
M-_I/3^\V.7#<2BO1Q"_P8?7>*=6OU8_*U"N.6RP8#=Z_4Y^PUSM2:"( JKQ=
MFC%]:P'5?7_*MCZP%FO,-%6.F+[J;1B>4X9R<S 0?'S)>!75ZK]ZJ*HLL&1?
MJRW(U*_G.I=%HMJ7-^PZ2\_UZ?7D.[ 2*>?+!+'M-'547NQIS#GX43NM07_"
M:19QCI ^-4Z7FC0H+_(P+TH$_%V/!0QRR&2OF.1-M7%Z)C90G*D&<-Q.=MVA
M+I?N[3W33U-U8BN=^;7B-<0"W4GK.0[L\#E3H*;!B YZX3N&4V23+#RXWR)2
M,6EJ0=ITE)B4F"FOD0]IZ-2I23(8Z8VQWK \Q@?LNBG(N^RA"-2_::HJ,27I
M><W5*[4)3S<-) @5!)%79.$(C9>$\6#2?_S&NWC/C$L3^&?JP.R::>8HX:F^
MX3-?"_QW2%!F/>S*MJO*V'S%_^M#OV*3<N\L$J.H?;S6Z;XGN_;+?@$VPYW.
MAV9.EMD.$F9P\AE*&U\]'$\#A/TK?S!EC*U>RE!)K>N?C:,LX@,AF[I!> 34
MG;B?EFRHS[D==QU1O7(/A-3,<Q!CK,Z?!Y)1@*5\R2*JP1_4I^4"MRQ[_=R8
M3OP)!3>>"O.#*'A$ZK$LHN%'0C&B(R9$ECZ)ZAD6;8@J=(L115>3LM8H7O[-
M/99>+J0_=Z+)S;+(E, V7-76,NQ8Z:+E\[V7^W+$"DH5(\? [9.D66MAW)_H
MM*O1*WT]$2<@2S>@E,2W^4Y>1GB'@>@T.F8X=Z5>E)3O#O!M$64\WQI[<DB_
M\>NH1+)U2:?_?BZ9TX1[9+JD1,3>>[]/$OELK14QK(C35<:G#.5\GX2#R44;
M_VU/EJY9<$3M2I1H.65PSTS\QS3_\)?(]>1T)RD'>*2CN=)T&5PTD53FV2@Y
M<'Y<<^%-U8(B5R;URZ(J66QR73J+\RL9U<R=JP@U@,8_YV9#/6J;.MS2>47E
MF(A=N07E7F6VN"CQJG%3UZ(I@"+;-MOA\G$5P]RV/>_7EG==M>3 W:^Y?=UN
MT-;H7^ZN/_H(9[$P+&*NIY8$NVN,AAZQOL_^JGE[."K%@9FCK-6/WW;OA)MR
M7J&*[:%QV70=JLZ=W[/WAKV,]*-XA$&4#;$=6"-;EGW= ,=Q$ZL[ *D0VO$-
M""R4^)=OK=9+68FN7E 3X!\*S@H(%0:X8P5/C>%*$7G/Y*&8\=SWS"9&_(*<
M%RT0UT3K.#,GN4E*&>:8;(UC.*:)NLN7\R+S1X4R1NVHU+IYOL]O%,\G,!X=
MF,QDK!XTZTT>UGJY>B?%MO'$"$ !)U^VXW0'GK',PTP4P]UOC%6FK&HR7['5
M!&B[0BYG/W  [?XOY.7[4,+5:3Y$4P*$C7S8WK .)X)]B:?9D/-$L+X7"\K2
MK$M6R@X_)PL3F85=#NI-?>000#@%YIUUKU0,HYB8>$BB)4MOCDSKG)VGBRGR
MIN\PC+@^P.R2)IWZ?<LJ7ZCX^!UVY4H$W D?1Q;[R=OCX M-G! _6:1"N?"!
MOZU&C$K?RWD-A/9L=2LENE9!R0:AE!,!1)@<!Y_ LXV$WX=K!E1_%-(*RKF/
M YF1?\(\/B$Q[3L4:^IC.+0+J'M &/,;/3YL35"_&F7/IJ C =;;E#\+;]T!
M.H2D%?WR,F$ R&SG'^#*TQ*1LL+7%=1N1YP;T.SU40P0#7^4U6RU_,JVN&MC
MA=EOBK?O )S4%.%4F*=9)!BJ##1HN %",+4R_"EV4ZTD*FZ]N?<-PE=*FHHU
MH;$XR."\!$3&OZ0I@^_)@4G2+;=7S3DSQ" >_H![&X9^V:3[N'+^X\NO(:EZ
M/) ;[@,>C&?R[*FP)?.!($F&3@9D)E\%QG(3S!;+BE)*ANO<?:0]L[KQH;O6
MA4XAD&0)3H#B#SE5;8W0.T>]^J+;SGZ+Q;UD+U+^EW(^,+I\7MDM2Q7+DD\'
MH)_NQXULR?Y^X#5IVHU@'9F\ V (_Q*C_PS6&@.B-7$R_?3'^85;2;[P/G+[
MC4,1_1W-=^84SIFGCJ_.TB-HUO"6/HM&).@9((LDH^F%[?HH,>NE:7/4<Z4A
MS%1)JQNNT=!K)KA]IBCE>2)&I2./6[HMQ9_E-]XC[; \ONX1S_C[P;SJIB>=
M^A/ FI]#+AX"$;_FGN>9ZK7%?[:EB7GQ]HI2O.VZR)D#,Q,5^(D%Q1?-FT/R
M):8(3EXQZ0=:C;2M^A&ABNE<[]:[R;T[;RG_Y&83!YE%0HPT[VS6T)KM:2R_
M.04/U(\0.]S'Y SX^Q(C);9LN<:)5+:WEW#+M[J[@#RN@L('0<^;I!S/&MB:
MGA,^+R<R:]1A2R]L5DG46=4*EJ6G6X/A[GL&DO$A\-YWD7 R[OS4K^-?8E 1
MX7.KMMU3S\+W*5432?&@(:Q2: O0/3:1ID(%1,)-E_;&*8X9Q D53^"%G"U&
M@1Z!7("+#C!)[_)3C^IFZ.O@."KO=-(+?3CZ47L%6D>5E &JMQ7K"22_GT+M
M54ULFPJ$S>(8$WL+]T@+'\3SP&"L[/ $_=+:4XQ!Y>27YE_/'7"1HU*-NHVW
MJYDI'*0Y>=)WFS*+EM[H.2SK$I9:L1T=3F._U*^ZL+_IOB[\F?,]&*V)S:O.
M#E/*%+XZI.<>:'D",=>:D+3V]7)[_#,#AK//_1/)@9^U"9#!!Z@,H"BB'21X
MNQO\=^2P018Q^("+E4X)IZ@F[G5.YIIJ_8^&E4,&)WM[9C=TN8]>PX5P3>)<
MN7J3J<5_"IX4C.$0H!A>)6LA%XP-.D1ID5P,X33"R_%K/;4-:O#@WC73"\ I
M=18'W0,.S&[%T%-^M-&10X#^I7@"W73:!@/V@41@M.6,^^[K-NS5S-,_"_KB
M\X(GN7;CMT<AI^3 8WCD"3\EI&& \S=OJG!$$*G)\8@_=T$#<KE IE-HT@^V
M4DP:=29  PS*85 Q+8D!,Z0 O,\[,O!W%)&YJ6D5AS8I<5*QSC*/6JA,ED"J
M_OGR,(':9WO+S=<<= !R"ITIS'O8?]N=I]AJ[31TWXE_]*4/\ZC4/+2%<DI(
M2N^W<5]-26JW[^/QF'?:6/<V(DOO@=)H.UCW9Q^I,3^I^S08=SVCWQ%MZB4?
M62J,.YHDIJU\"C=NZ\'-Q?W'% !'N#MO62"*.M--IDX>X,>[,V^283[G7/;R
M[&R*6[+T.BC!SK3+GA!K[%+?C(<8,JN,^FIK9<_7)]NY;;G6M8@7?=<;Z;).
M >-!+S1Q8B $'0VI7S=\2P8C:KJ.K!@ZFJ%I#B$).%NJ_S,"(TR[]G:'L@S2
MZ+BWGS928I*>O7W$IRSV"X1 9\ -&/"DFMQ8DY1$PK1)'&#=# 2\U_)E&6\6
M(_+86>)2M"=7;XI->GFW9N<IB.7NF?QGY'6"G3G1ND3ZDZ[B/*TT:<0HI-A)
M1J4:RBL]L2S55:*P(JJA<B[EVZYG-)-(#^NRIP)"]DPZ_9C"0=;AZVBE1[^O
MFSDP1_V,G3#[UV:3A+F&<5U]X[C')4'^V?9&6%IEU?Q/@ AR:Y_I&\NUC/*R
M?./YZC4S6K"?CPX[VI)B)B*5DC)X"= 5JHF3!,E42+YZ;E6!J'G%/F#AZ*,_
M%D!EX2=EISSZ>_9"_Q%[AYAM'%M=,YF0(I?G"5QNDN=!1D&WPQ-G>0(HX"B>
MZL#(#5U_R/SCX_HAU4<;*NK+6>JUPSL LM(J-NF%_WY0J5J"Q&SI02L1XS2B
M9FJM_N&;KE2Q$8<6&+)XIM?05,DD/,'2N==$$R?=02_-YVFMM^1#8[/7O[I#
MX7W7)?5H_74".MEA)Z)0O4E.8!-"K&3V#D 0-KQ9M;""^_KK8J-;^LQH:!.1
M_9KFX2.<E L;3.HL@DR1)(-KIB(A\6,L=BHX'_)I1K8IQ/$2K")&OQG.VA\3
M4CV+6)[O];5G:RKYG !F;IH_6,/2<&.97_$F57+M VX'B9GC*M!(64R_3.IW
M?DC:PUV ?I%O*#.?#[(;BN8^_. J[7!XXH1AL#O_.O59\-<'U*B94HA^AR;:
MFLT@EVA;4*#M5#R+X/*L]D'(.\??@C\>BE'#1="?UHV)W-H50/:?OU*&C<JD
M^)@U?F\OWX/;.C^/-?/ :3>VRS>=S5[527Q,!+!1+C+8"R0^Q+YF5OLM5\*G
MX,S]"?6F!T0G85<*!F\\5T3D.'U[TLR])#P*- 1)\$BX=($HN7[NND3M,*S^
M$GQ)KK."A_6:XL+GW1@.YX9!V#K$GVW+("&0*WF=+]ZR8,ZNRF@A5YN:99!C
M$\D][M3"T.Y7 ]RFKA:G]2BA9T*^H6>LK0Y7QHCVQ++R:,LB,B<4<"*>(W-]
M8PGM1LW&'#;Q%@@F$6[21?F#"B9+9SHZGNB*DY:/@6)1:9T0/U//I]!-1IV$
M7$T<HC4B)LE7Q2V-I6;<2G-'.7S$4ISSKROL5QXYQOPBI4[_V(N959[\!JW4
M )X2?)J=$AN\$#)LAXY>RZBI=TXC'6'\@D%@609PGN%+:Z5\VA06'(Q/UEG@
M4[41SZ!<M(_9.?\VJC%NCI6W-BZ\T11GK;L\TM:%ZHOD,=_D4^Z,M-78ZK0)
M4X)55E=U3RA@]QI[;8&(6_&A=^*H('";-B3Y+SEA9MPLE/KG1$;YXTN2[/*#
MC@!B:>J5VY0=1_$];4A(^P]00TKS9A*VG;DSU5D6 =BI8'%79*\PUXEXO/-D
MV&[OV=Q+J\AW$0G H]"]J-$926EA-3H>R14>/FD'1+:]S,_Y#YZ9ME]_6'J5
M >P3J-[%S'Z#Q,I=*U4 +,\Q+V9SH>VMR"G]^1.)'#$2&C F.;#/3]9SRL-8
MC:[5BWQN**.'FT43F4Y/V5#1\O'B]Y<?%U8L<5(EXY(OU^R$)Y(>DP[!/% 3
ME3E(H4I3>=[3.\#\8V;\(A.+((D,:3?I;X2E O7/Y;VWJXHZ))501D:*4GT?
M'C'VR-"<U&4;9!E\?B_;5JZJB52NFS:[G/GUDB4=EB8$W$Y+7BZ(_0KER/[<
M\^5A#:@&R8O(Z-A_;L8*%OB\V6J6XKFRMJFU?U"DZLSZQ9*=SD5[$4)O7M,O
M%7L^%QJ:IED_8H?Y%576 L-.3YP3(6V=P:;5UX;:A/I)@;=+51J!?3UNP=J*
MJ[ZO\E5!SNMZ"7XC#C$!@"_846JJ_@TBKWWM,*'^SWO^K.NE/!X7;I@7UWW?
MJQ4U@^)Y9@C)43D:MXP1WVO;,V5K#>4]1 R:*M,^^,CRT,13Z Y !C&3\M:\
M^"AN>06/^PP<AAQM,\\[ZVLOS ;YER0@H)<:E%;&G2\XWGVTZ<%!> 4BX4;V
M:ZE'5Z-V$=PI)R4^:<$6#?51^S,N3BXTARLQ8S@4;"TE=P \6DH,,4:FRL%'
MIT4!U L+I@L.20Y,9H'26E\E@I--RU-6-VS]SQH;X=5*$K0618MH+/\:Y5]\
M8<7]&?L/W#*K@=]6(;QEUZK%O#],,[V0)WNFVS^B+DW;K E%3DK-"=$*,B0:
M0M^=!+; 0RZF/.-XW^U^.G<^N&>#K_ S'TTU96'Z5\JZS%*73\I63,#:HR9Z
M22T?&Z3;2DY=!G;N_J+?D^][9B(H'D^'5QC?>3%N1.7!F]IU!RA9F ^B7!L4
MG6.7U?A,=7B]WQI7\;3>DA M<C66?C("@H^[&PBI"C@!:#V$S;NDZ3Z9!6O]
M9"G"-AX;P\%$*?2^B1J8,&")M-(6^74'\,GP*E[(FRX5.:L8=2>5F2'&H4<4
M>2!GU%X-4C9\2F>1X>">J.:[QJ7??Q&MFDA8#&!W= N6I>7=K%7LGME>QV7B
M95#Z)ESUG57KH.$82XLQ,&TVSY&]<TOBL]?D$MY3,W2)8OM[CWYA*L=0"VW5
M?(DQG'2(MIJ<8M-[6[  7]M7<YPG)<7H0%L/I]*E%Q?V3ZK($FMDA8M$@ZCY
M<E-[3HSQ<(8P=H0KUE8(N[-R0Y6WE0Y3G8P \(T[P 4YW^W'.I*J7K=<NXJ!
M[(0EVI"5J%,P2%7-\DWJ@,)\I5<IY/H)QDM[RB\"3NQ?Q YDJ<Q$)DL/W8U%
M/V+%IAJT<4D=(,:5P<P8Z@%&\#([@8/'B0N-V+@#;1MC,[%Y=0B$$K!/*PHP
M.%7^Z\\0U'BQ^OGS#1:X\ Z.@CDNNIP-40]JK2Y:-(F)0<TW-H,ZN(N6">K8
MC]BI+BJ@(6^0FC53J9=G.X<Z'$S*5-T \_C.1!&8<&-%5YO;GN'9+7F=ZNYV
MZM: @L(X3.47@"HOBW#8"CQ>CG,C*-,W2X+L@>34UI$P<X[*M7G!7S?54.I5
MRJEC?N0.CE[+39U4.IM/2RWWP<XB<J(=IH52]NVOB%I"UQ%]+'65R$NE[+1^
M:IR;_5_?D6]AEB+GE"W.['4EHM(DX>LO6)\#SW3GQ0[N+3D5M0T#V=KFJ6'A
MT4:X4BM*<:?70R^NM9PB<K[=T"F1U6#[U-2OU2$*>=<3.R)\7 PO81^9FB'6
M']\3H@HUT2=9Q"_!3ELHJ?11;$0CA_@1+'G8IW6(]U/YN$G-U]4:Q%3JV>\_
MA_?!GU@/-WQ>9#U(LJ3][*R6GF.*'LW=1]=&YF-3O(\R-H*,VF0@M.7=GJF'
M;C1[-,0'AUY&F\V9^D,5J2P>N*E/2A)@QR1K"'6 (M7??,DB7/G4( 6;VZR#
MD.8M*EF(T\Y:EW9,VLUJ*8@+/,-$%E:K40M!:%C!;4F!$M.,I"'WH/]\S=\4
MU^= X]'^<"2&<GM#TG>JA?]V?O+PMU/65 4-W]9+CAUD>8@ADJTFQ\^)-_?Q
M+-;F#SJ05 NMJON^,)'B(6G\*G<48(O?*MD(,;%\OF,CD)QY/2N_<?7^_5I>
MW,"RD!ZFIQ@.='<;Z9$3_9X:]P>XK3?/'D3#2M,#G7&SM*>SPQP4YO @@!/S
MF%M41GKZ5?*DAP0/OW'*J9PLY=V)='3\R*%Y'3_2\!YYZ?DVW%35OS+]PM=A
M)GM5C,\OO.;+*U8N<A%!6=JGC5(;^U"W41#X@7)OZH5PCC4M2V_28_FE,X.^
MT3)W[6NI*]TA+TJO[X8L,IP+>DY^Q%7[*(>')A&Y\KJ.TDB,(,ESM:2;)N-"
M\IJ/KJSO6MPL,<H-#4WS:[V=^PF91D<2I>4]]0,PC_FE9^T]&;^$U-?LB!>=
MC&+U6MDFV5_OY>^CLPA;/UWRILWEU=F1YAZGA[-D(GX>R*<I-LS-#CAMVD-%
MXJ#RC:]C$X:,CTMFGT4>;D:<>+ <9Y%(H4UTA;PW'<TSEIOM/8A8Y%#@J6 ;
MD30EI>4LS-Z97&1SQ9B?JG^!BD@[$P;/B;"7-I+,=.5)(S>\2FE)B3J+6/$7
M%!8B'$'&JVT\Z"T3O$CK%O<QQ>KYM7RSV_1'FOU??AB6+:HE5Z,("?>^;O,[
M0*C((JARWT*6YHU?W4D6(0G6GIX.VTG20DY]8H_2>;FBSC&XM28;@<U"Z2 "
M?Q]UNL3P,EY)69=*]$MW_(:!3VHP.&]A9:D!+W5=[5=+ND409[MUCFC0PI"2
MTD^W=)MZ(BU+<QS9"O]VB$"\"G1[5E6"9Y ^O]& UGAU5OD[1,W#G% >+/"S
MA"/1E0,S==JJ07!W-S$WBEG,D!BX7>90TQ [O9TY[ 3ZT'=!1)N>R=TPY4>!
M?9K1Q,VHS&A:C"ZN67Z08-;IXNM_%DPZ4+YXO^I_(QO?JZ F-K2D?MKTS:RU
M:5K23BV&X+E1A3:QBUDC6\N50K#ZF+Z==$IL%MJ,[K%OY'DD:T:M0#? VRK-
MISQM0Q6LXFO]D7/.TK^^!U!6R,N+<(IP47O.D_@%#W^)>PQQB$'D.OT^&?_M
MEC$=]PM5I)^/8P[=3CIUDE2019"X#(7]3"ORJ_V/B+<*HGYUZU\WB)[V0=)>
M$3A&T5L3!4^!RW>TD$-&X? '62.8\NF$6L40!UY5S:H&6V!9^C.J@^ HP :B
M48RGR?3]&215)L%__#>W_KH= S)^!QTN<#&SG;U6"$>(.1FVV84#NBW0'3*'
MJ@M@<6^LM3" XZZKBJ0H 3"-- ;SA"+,I1R=R.X1UT&6A51E0);W]"R!2[^'
M$E/(WG#U_*42#W"9MZF"+YH6F\R]3DSN)P3I=&M)WCYIT&40B$!R>SE<XG^H
MX*EX+C;PHYT<V.TGU5I+(UYCJYOZG/RCRSSBE/_1W,_E7E"C7Q(MH&E&:C:(
M9"'S0*/IBM-5%2 (A:D@A3R][@ ?&NNNWK1M"E!E$5MV*CL%;OC6>SPLO34?
M8#T9I7A<4V'D][*6)H!<N"FLPWV48M;A%C?N7.O*(WU]W@^;YP&$W-X,-VH
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M4CO?BFX(?3.*V!:US[S4Q[/ABA^7,NFG/L,\+8F#/5V24< BUBO+@3GSP8/
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M"GN(ZU$_".)< ?D$0 _HMJ8TJPB##F,FP8@;OL,N9W.Y7S[8#L=W@,=[ J!
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MJE5_]%GD@?_!Q#415H6?1!0GB[5_P18+]/C/)Q__11DR_KS4Y=<QX9T4&V4
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M/1';TRLJXRKJI-7$HC3RR/OER_=.F=SS_9M/RA6UH9T4E3RVQ<'=)C@L0M5
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M_\U/8DEQ(4H>V_3OJAE*<945+ <691&\K?Y<_7\<I*[OQY=OZ$\M2A8]-,H
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M"NLC#=GY6&E$(^V&]4+DECQ##WN1VK<</QX!,)%[74O,5'^>J"F]72UE[+#
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M8I!S_!?>H@^ J74NLF5PV#H:46#[VIB8!SNJ\=Z+T 4CN'B!(KO#[(;_=E0
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MM"3.N<2NV>  G2;(.2YWGZ?3T"(#$A#PMU.?_@^O^MT%_0:/C"EIAD(\1[[
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M%!<[#P8?5R#*^Z: X_>'4C,-IW4GZ<J4HSZ->@ \%&D3U7F#5A&!!^\$:(&
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M^/=>S(Q>]&A:\K]QJF2IL<;O+<Q*W0*N(R[;/Y44L[=JG,?*CE#;\#"RQDZ
M7J_F(O@V?)U4JPUOS^,_,H#+N/C<WY-W0M( KM5%2QLS:1J?JF^:C.S3#3C?
M3?'-QYX3G5GWI;L&XX+OE920$\E&/RHUY:D;4AOF(PE*'"1%A A-\0#%LU7(
MHE(41_3DD=:^?4%PIQ.8CF=^<@L#)>)>0QE@NR_+D/OQ\;.M835^[8\ HGO]
M+(WC!X8[:<PS4:0&\;YI#-&1W=(#( -5L93A$08_F+$33UY\TGV_]2S\1%:)
M&6K-0F=YO:HIL;*F@K(, 6V4Y3+/=<4C#QHP\SJ) J,J _%+@A@O)6_VB8WY
M-U&KB61L%M/FQ&! ^+QB1?[F2.5S>AH_%! 1=^^(@WFMU5)>$WPM J5D]*UL
M>XDBPS,B,0M-<YH: BR?OHZLF8#:?AIMJL3"VVRQJ#'HQN\3E->&*P6/,Z(A
M[0+3N NZOAI*G%+-%KX-6<J;Y7>GD$/]$A4KMU+;G6K[;4GZXKM75FEUMC'.
MM(M2@# ?D\M+B_RQ4XH<B6^$L4\HQ!^\5\2Y';RO\M@$GTDUQ8M&KW#SSO9#
M+<C-$0'#$Q'3:*R/N9': ?7NE$+3QI- >VO%TJ&2^BD'C+A4AVPY;[+<(L/R
MVM$PEA;QS+I4!U%D:F<1E/4MP/T4.' "BH)EJZFQ6[#0W;K]"'\#. >'OKFC
MMK7!K*$G;^L9HHVJWK"HO'-AL"5=H9-2?R&RW/IRD37@%.(ZJ](^FXNK5&^M
M/*2Z2O\ZQZ2N_#U5^9L;MG/N+/.;KY7=8G3A"P1FPQ\UNV_[F!!P,62^L[_E
M+X<'Z]1/[)@DAMH79FV-4@]C#BFTO0%6:>6@3 H=K+$X."-NC+T=QFGORLQC
MY/.U-2\796*S3L_A?6U_OW+T1]+XQQ$/=5*Y=S-2!CD<"!Q./$A(BX=;K;?Y
MN#*=U+X-"TLS(PVH1W8@9@TT;BD+;E$J4#&B*J47,F75)5H1$:&SL1C]I=%^
M]#Z)M^> F5O69Y-9VDK<Q.> 0-+V8^](-Y+_+U\Y_/_E]URZDQ<CQV2ZHM!
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M!G+8@(.G0B<G1;-JNA@I!4&<J=/)&]X#3?=I#V42-ARH8PJ@)>+M1PEB]T>
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MWRVY+NPW#@Z[AJKJ]VI /U#5^#I..6PU>*2@)B)Q(:TIQ;-2W0R*S_J/:C*
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MS>CLR/74D7F?5M*#\D6U&:S@HB'+CUDEU>KOZJ DY&+PJY&+OGHJAB?*@3H
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MZ?"%VV+.O:LFG5)\T;ZN8I^YZL^T4/-^-[4LKO_<N'$?7KU<X5MR1<#DYCG
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M=MVJ:,2L_F>NF+9R!P1A2VRW4Z0SHM\3_-" J;.( IQRMW!4MO^<?&@8VMH
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MI'"]8:CW%:!,92#Y5TH(3#-_(R[F=R*KL+.]U<(#?Y<2^Y5OK1U,YN,_. V
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M;ZW\3?TI298N\G0!@PG7K@+Q2&^OFP$RCR3OF 5VR?*NSPOO-:4L!,&"":\
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MWN)CKJ*,\BD#)W-[F=^^G@'-%AM'B]M%^/E6'CL%X+@&S-\9X:4.$J2-%F]
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M&YEWUMUWBVPJ^VFW+=%HZS@HP R;2SHANJ.3+I6IKU+=*^2KH0IR1/0D *T
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MFY9;^Y5C%VF,JNB&[0R"@Y*=3%L%:KVROB&5>HKV;"-2>0JWOXZ'FT,<-8(
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MMGY)TD'#1ZZ9ANQ.6.? \:A.52!,ZH-3E=?+M%',$F57F/ I;Q)#55RV26X
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MPN;&?K%0=*$J1S]4F0-JWK\#FBE4K$R2?Q(7U7J+;Q-R3ZC;Y;&>%OFM&*.
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M\P\@EED]JL0A+2(LI;CYR.!5I5P;-$N/SH Y'X7GH\L544N?GM(GK'=H(ZX
M;>&1]-KOCY:G5Z@^LH$/%[L\A51];*E9/=(R$?U!S9?%^2^&!3HUGJ!UJ,-]
MR6<W3^P-I@V\$7.EM$,KC<;7[+A&@K]0^-KU6UBK:%> FPP3?D$BTB^'988E
M7U%L;3O7ZRL\KY9->!F%Q3S_FEJ6-I(2_IU+-6&C5L>C^@UX][;L)<A*!<70
M>W.GY=CC'D<:[-=_9*DGHXOW3U%*G=,)RK[,+!  SSGW=!,G7X,-IWF4QK.R
M'<5]V^_KFI-1E'Q4SNV?V#&^/38G#:JTJHP4%-)-?-+BYP3^YB7+()3&9[8A
M)?=.\)UH7N3ZY?+%>J,+CDX/S%O(#*)+:;5@V%BS;K"3/L\F*2.JF-K":>$W
M.%+_3F)-XDQ5]HZO(LGR&X;G21$#-QF@FL/" GPI]R SW\C//Z2-CY.@%UY7
M.OIRVE21S_L]HN1392$@*-O*_J2K/<1?#1D^OWT2PLZVG.9-YA AENOIPQ]V
M5T2WU=H(35&_K=#,62:5#,V 1DJS B&:"\Q2R+LL3'NBEI%0)L6:78B^875=
M1>$'&?CL0Z+4QDA?.;T)>^]6N=XSN&:&N^]^YYE"<FWXC@"ZJWAI-CUY=P[[
M]P87_!+:%15;V4)'$R$FZ+XN^W+X?W=QB2_(E8G614D'WZWR4ME)6%W1DK!/
MCJ%U':?^\YF]JNVT2K3E,SK+5A09S.?9T_TG\61Z)T!BJ<H(>A(#>T7W6 =K
M\&?H"%SFKO!#-UG*(7CE>OPNT)1(^23629ST^_H/CTMX.@3#  M09?3DQF<*
MR5Z%60?Z[,0?\>PL!?&:0FV6VQ6XSOL\P?"?GXD*S))^[2FPW->7.IF6)2\C
M P76]7;WW7#T :[AE!_('!4.X675%;Q<E=!CY&.2SFZ(3FV>UP2*AIX.7P%N
M%^NA-GQ=#@V)AR\+=;HV- 93Q:XO&D\K#T0C-?7@)^H'95EKV>=J'U&Y+TY'
M4<1:%9=C%VM7@$!-",A%3/",/4P,RH+SAY[8M5XV+<Y1P(,7C#*-/K0_!\UE
MCG--+^63YF@11="RYS^U2ZX ?ZICCQ6F"X):BV"@NO34[T+I._FKQE+#UWHF
M9W$\J\J_>Y+]>_&;:W5,J+$26K4\[_4?(1PJ#R1> 7"@L>0/KFWRCI'2GSB#
MK+5(K^V*X >">PS\TE.%KI6A/Y3=@W>Z1G+^JYC^@U-E_]&IP3^<6DM/]2&5
MB[+\W:LE7U(@\[Q]ROGH%> GU/ A;OS#N+/Q=]\=YRA4%W7Y"X0_@&L*SXK>
MEF_[NW'H7Q%_5W3^T\\_$O53K^6(V6(@_2?"&[Q(XQ)9I1L.N\8R!!T:E;0\
MEXJT$W$!UVD"T-Z&IC__-5KF^'_0OHY2YH(98G%>> H?=E:]9@7H#YQUKZGB
M_ <D/J12UR8#_]#[GK(7=H%U7\P>")R495LW=FF<?:>4Z#7$A]XL,(=_B.;'
MT/COM#C(_[VX7^E(=)T^_#^B_6<PM?Z=&+_#)"ESG/K#:L(%\Z69[Q2C;^45
MX'<TRS+$EG<@W[TR_I,Z_S&DX%]#^AL4_U&O^1_UE!'5NE*LSQQVGWFSP@P=
M;US'(G+]0)_UU7?M#_VC?P%E\'^2 M'?B0K]@ZB_5A^<7VMMXBP.-/"U&N'*
MTTUC&4U]_W,D:.8[U7VN(3FY-@K\1Z!5?J3A+T)G_?3*A_!GM5?Z44569N>-
MRE89$8G8L,9DV:&.TK=5]]** _21V3=J]\CJXL9SK)3Q;Y+'"XKDABTP)8C6
M0*B\\U+])=: ,12=!&&5JD:3S;"2<2_?_$VMQ[$/V?YQM_!(0=J:Q]4_CTPW
MY'_]_KV8_\);YJA84\ONYZ!WL#P3]2]]M:SD2W4-*-'L!MCOWN2E]J*ZQI/9
MC68*\%\&Y/7D 6\7=]E>".+G2CJ<Q.=18X_X4?\R('N#YL? <>6/#EG!C>E?
MOP"0=$)E%ED'K5Y*JJ O_.B$=3>/A_G\E_<']3'0XBP*@QEH=X2CLB&VMWL%
MN$',5WT6F'&KX)>7;(_)YM1&:>/$Y %SWC:+ =G]U)'Y_2Z/)VI6L7)&>1M=
M%X:,%-V3I]TP)X"#%QXV(OG1);OFTD\65.2ZJ/&\I).\[)XDH9>$1P8T0W'F
M:Q06ROL,(JT5*0[Z$F58C1W"SK4I$;N:L*/>R9SZQF?E*?BQ4<@R-=A*:*5"
MGA;ZDO#J1(/R?&G\R5GDGD+/@S;:NJ\H9OIB4[;P:@I84YH0A4Z3,D/*Y>BF
M%HK>NFXUN-2&9.+H1B]\610:2%S]%?6(3GCEF5AHE!>LNC/K4W]^40U&5,;Y
M2'-=$(HQ\ORI2S&$^_'\F!F/S90V]DC5A0))J; 043P<C9T8:RN@IP2$L0[)
M:T]0GTX(R4+LCM2SG/=ZU7-J)IB:"(A8]>LDIHBUB9'.3!M.6=4U9$P]0'/O
M$%J(#H$JLO<IY'\AQ-B7]M)^O)#LT<"S&&XH/:P<QW-O$JB_($3N38Z[[W/2
MT[(YI.:9TT5-*7T<N" $X6AA*;;F"7T5@T:V^)Y9[,X4T)?#'XI9IV,JG!4G
M-O*1#^=Q61/Q1+AWN>8S\>/2XGFI,;EYV4Q7C1A2W%L=6MOOFX@L]-U;SR7V
M*-8%8_W'NV]_-H/8 %WUZB>5"R0]P\G4NCE]6/SW2O"+D:AA&S0A!C5=X/C1
M\R<S^.Y+=DFF]Y?.*8(13B25J=%\".*5Y@7]\*_+31)+,=7+8HOZ34]M[)XC
M5B?H&B28"0=&=:X F%]!EM;IG,O!GNLHMD]7@%:6^PP6V*?JR<.W:0FE:0-*
MCU*U6RN,#8P?O&.7P1Z"V?GS*7H9[N&--W;LD\V9=HZJ(&FEWF^V5+RHWN^\
MX3/N?2?HP_SM$IJ'8S$Y S>7TJ"YC2M*#0D'A.T4 XUFBT^=VYLD"#^M+HML
M?@H:U3[7XR5=IRN[DT%Q< 6@[C@N"ZG:8ZCG5K%5'VED:86E?S4'00U.LV2^
MQ+\!AUSP4U4/+:(> BE6 CVL;6S'M=3?WDZ7_Z ]!NTG?08=OW=*G?*8B6AI
M#YR]EZ>1YB-F9L;N26O=T7#N&L>>^O"@X<P+H_N1/95:5/&*1ES2#LT=F 7L
M0L3&PS[PE3/&2FUZ* UW>EL/ +I9LRL:0#QJ>98'GL!U^E9I=6> Z"Z7$6BA
M@J8V;_:Q_W22?03ATRQ/+DD-3_Y@/M62-?LIEAM] 8]FB9=G>,:.&OD[GQRK
M&&6UB2K=3A,HIKUY(?%1(7< :?G5CPSFUCY&*BHX:J;K^EI_1;U[)26A"3*F
MBC3L54?FZPP)RUB9G. (&G :QWDZI!TI=YP-ACJ+*$VL;C.S/7S-8"/\ZA+8
M/"R,_9IJ:'9*_H3;[W:20!?QHW9J$MAU3\/IU%^C,S#V$O.>JZS#>(Q<L5RA
MN]&$@E#@0:ZXQ 70JRT^H:K.,[SG^7L:1TP/CI9:H^WEZIK83_KO"FX=ESEI
M?OZ\KG'HMJ-TYBI<O^ \<9QPLW%TA_@EABVE'$0,8V/4>@9?/XE=,^\51KJD
MH4PH;^5XI7ZXN8J<9'0I2\<%CI-'-E!;E"9&W](^.V BB_KEE_@O,CY6IB70
MR.WVA-#(? OL*.!;1&=MJ37X:#EU(".<BO4S%<WX-BD7I"F0&R'F!C[=;0,;
M@-/#CHB#EK/HM,58S'CA7:;-;U<AEK"ZP0GJM&V&:E^-0&'MVQ,S32AA&_KM
M;CH&T*T=Y4;/^ #A)X(BC3F?BE_<#>AW+RVV/4DG9-!YQ%5[_;2V6)O3Q'*K
MD=VENHD.YBVPX.4EG6K[\MW<;T9)]]U*TSMGF-/EH-";WLU/';LR2K';X,;?
M9GB /LX>*>GL<@)G3D8Q"\74+$;580-NJBNX]+@.BL52M[SU8EEM^<CIJL #
M9P+CW>Q$A&$KH@\V*59B0)9LI>,8.3=NIZT21XHF0]P)#:! KVP'*U9_UX0!
M["'-*T"H,MOP2&G235R5-$'OUN"ZC["=U:QO$QMX\^+]SGFN+W9:BA[[%%CZ
M4M74UR2^6'3E%-3:#FQ7GB^HJDO_4%Y4<9GDS!^VYT14HK&DRIX5M;9\2/UR
M5Q?*;[_!Y=&5SH%-UX@M]7[Y\)#?>%-H+VS/T*TE08_C0HE7886 L+[W '#)
M,B:,7FQ@/4,=!(QE8>1TSQ\5]Q0B0XGL.4^(;$/?\\=^JL&27N/1<EZW"XW<
M+LNJB0P6DN!U;U8:N9"T=Y[\1)_"ON1[!4CUV*)PK9@#W16/F>;KR$Y#\YFR
MH"XR;4Q<+AK:%9;(W[2?G#9^N,',_%K;JE3[<[7>22C%DH*W7^<6]A<O[6SW
M,!!/JY/L5[5AMU+TN<FR"0X/\@/CYD8-$HCK+3$7GK'* EL;UAN&W3125!^)
M5^N:HU<^[94\H69+^CR]:;C27-AE^K+]XY3GG:.%)@%)MEC2CY-UO3BD'!\C
MQF8U.M]#H^WJN8VM,+>7;O<EJ2.U(ZK#O27G0?>VQE[?^T;ZV:1FH1'G<]V%
M7EF0MG. MU7ETMGM8'7$='KH87&!4AO3>0E7C.+YIYIL\Y(VE=I:F-' KF)C
MA.0#RN!'4 >QNWPV7N)-%5$S1T^^?,E?%NE7020#::CVU"P3_,'X/$N/&)RT
M4)R"J0J*@(C3F),3(O X7\7-G>$*GP+@!%:D73%E7#QW[>O;P 9$="C='F-$
M@M5)+:YH7 >R:H,#J<W5?M/"LA.P=)1WP1)F2-_*K>PH?Z-/W%9H'+*\I.#)
MJ(L,7/1*Q3J#L=C5C# Y(0\,80D%[&4Y,DZ$^#/L3D;JB_?!L#A[J?K*L//Q
M5IJ9HTQ$<+NH;<)EJCWR_7U2C+$NC6'U:1[\]CI8H^EBS6'WKHHD/0<B[;38
MB Y^-'C;6)?;D'6=2T55.TU)"/:H_?H)ZIZI;.Y$ESD9+80;MJ-(V_'Q40A:
MVK>:R!1;]#2FH,([KO5"Z50;$R5&9-'JE8G/EATU U\C/1?;^5$D@M63*MV!
MG^J5GUX C1<,^RN;\,RKG;]J^^%I(43Z5+T%D[T*SB_,XU /0(^KYSC(JQI>
M5]0L+-!7GL]I.["V,H&EGP+,&X3F4QO;11G&^.Y&+P6_<8"''7H<?>.C]&![
M/Z-I3H:12;3ZR5+!BRIU,'+76VK!?,0Y_V:(?9^TC %%<GN"YVY 1M3ECI:E
M)&#N\8[/9B02A+-.(U*OT,%D&(H97$RQZ\LV\PQ%Y*X:T+U3@_Y!7EM5$0_(
M&,*73FBP,7/+QU@Q18:.<0&?+W@.>&G13L%;K:T78=U+?[^;/E=SI,2B'*GJ
M:(&IT&E/&74D,U\5[%"PMLW*[\@X&?00W=ZC6$$K($LDN!5A?;?K?D.B_*U3
M6>IB=>VQ^1'G==L5$V(LZ_"9)]&Y;8G37YFPK5=JQ2B,IC;32.O#;K[2^NI9
M2$SH>K,X]M#037</LE5FQ10$XV>)-ZH1'1_NMX.LC[07<L9S^[[A:'1LQN*@
MJQ[)KTPFZ/M4_J"F3 ,8@H/)FG-I#?Y8YO,%##G].+R4<GGTPG_7@*-MD+*_
MU)K?-2$"/2>RTLN\ZD*Y2-I<X3661'J2AGF#Q^J'-E'!H T&R\Q$OY8@07!B
MH\N&NM%.<EK7'L:LON6]&5T#5ANR'99!89:"S8E.?R<?QDR*!O&8.)$HEN:]
MU$/^-/0T#9<'8P2#L :99Q5C74'LMF\L?,)T/F%M\*P_&ZZD)A21_.S+/';4
M7E]1NYS%BI'X>:'6#09=0?I=U\>W]]I]1B?J=H,F\I)$H^F*<MSD;WI'W/."
MIUMKS=HBBX9E!*+99[E3-&UX0_4ZTI+S]:Q[BSK7/=]_OCD%X%LC6#49U%NX
M8+DYS-807NQ/7_Z4]1MCO>RD(Q;US4R_L[]MH_-OWD('4& !9J+GX,$4%V#,
M*V59X)\ E9-V6]W8.3UVZ0#8Z5N#GX_0TEGBH+_5T"IZ)RWE/9UG*+<2[J5=
M?X!;Y/A%AKPLDS>:YUR0@-UM>Y47S?>'EX]YQ'&DU)O&MIV1)U/RQ4>\:V7S
M8/CV[;;>33  *F5"2[)>[+"4A&]@NWT*FU)G&&:-^?C:])U$QDU;U"%(+U7Y
M"PM]._C=R.&!<QN=,/@@#]F/\4:]1]CA1-%. 5^MJ($@=J/SSHA%Z4H$_-WU
MP^!Z ,H]_7SNNA>'DX=_N@#:#="[?-:\'W,$]ADTZB<O>W#=01S%OM@3.VG)
M1I&^H#UHOP+,8D47P%$J9_VBJV7F_\J,S!CP"L#D8Y[N!*_0I+\"1%>=:<>#
M_A <4]B+(N ",>R+U5F>1?JV?"_.[/?BA@%7@/A'/SXJ_\/L$<45X NM;O[4
MT=8P>)\6:<@)&B2\ GA3B,T[MUP!A)4O$==F0,OX):,[GL>6_1[X%^R)8JNA
M5X F/%I$G<D5(.T1"LGK(]V\'PRS.A'QXL/LN9SVD/E+BMLXXJ/@8L_W,#?X
MSK%AA2<BGO3GY<K]'C<NS/TU\!E^KHCQ"P+:6_].AWC-&X)_L8XTO$M[^A*T
M^^%W&*W3G<9?BZWC'!4+E%'91;PC1_=X%'VLJ'"-=]8/O#\H_W#[GYKZPS=C
MU;*+S']G8D,7BO1HDU!Y#14H4F&R*X#:M1^JDGM1-WOZ'GVX')498SG&AZCO
M>-'\3P#XPVO1;.-3R4W>\[1&,(^1Y"]^_&+PK\ D',9%H<MB?Y; 1Y5._L!1
MS&GT\CN4/]VYD1ZKMM+PF[>5'Z['=R?^%WGVCU%=\^<Y-DHG_7SIEY+$3CV+
M=<NHKM/1A9_<?,W GD+0KZ7]K!S_MKHH#>S^Q?PO%C?XK@"QHA7*M9O\CT[P
MI&HOA\KH$Q99[TEK]PA? 3Y9F2'[;S *?_B^?H-HIO''[Y3\RO/?L/8MFV_I
MKWS\C\&VAG:=(4$S9<Q_%5*0@^S!Z8Y<2H]=W0%?T^3C]PB_'OSTZ;/8<NC/
M]2#^5\A6]#TE&'N_RD@@1]%H-Y0O]__RNK%VN0DJ"NS*0O;<MC@10ZX7_K/8
M=OY?50_=&K$ZWK7H;I;N5]>WA5#_6]\!$A#E$2^._M&^75/I9Z-V\9\GY+H2
M>2)S2R5;1?FK]T270V4=X/3$<(NPE<);Z@FLD9E\#YW9B*;':@N8]/[];]V,
MZYC0QGYY0_;@Q\2'8IG,HJI4/3^V7X=K-/C%-BCR?GZ!(<IQ]#+]Q?=)$$-_
M_[;Q[S],D5\W$X'>^8?O,0#@7V=XO!L9H0!TPBZ$+$HEEZ?:<XX9M&S2 VGZ
MGUL)['=)=;@XJU2*F\Y:BEF/Z@T;6YJ^=8#57N+,+^D1C<C9L(]<VHML-F0E
M)-*X7P'P[G_018UPH\X%!I@-W>:G! ]C&OMJN0Z[2^>F)XNW>)CL7HRFN6<;
M]LUQ%&9G&.NGV%T\N,,J55!+Q\D5H7EZP='TA=(YMB"::K&4Q=MX(@UC_73$
MIVGTZ<&HF)[;RT/.7>%'-@42-PP*7$/L98M\Z1'"@D<EKB.B=!)^-<>E.;,3
M9;I#OKRSVY3<#L>_7:SKN'$YB^%(YEJ9MT0AR_UN%@'G$B%Y;A4?OFAO$&EK
MP%7H@JPT'J_)Y4L)JUT!BNUGY7ULV>,%MEE:G\232J_'"G<A0R!X0#G4^">@
MS;EF$)YE#Z\#;O>\3".#-J<BJE3*+C-GO+/ZZ2PN$HL6;Z;A>-_G(![@ J$E
M<M<4EK%;>H%4?J$MP39V]PI0$J>]834\2%6<.,5YG'>$'C'B?1.L!3Y6Z0_Y
M:@;PTO2AG._3>Y)QXKH_G[+\41#N\'"ZX=$]^2*?6WG4TGV@WE9?9^,"Y_*V
M66^^MR=:AL_DG)C?2718\?_&$#?4XRA?]D9;Q<[F[0X/HXB3>!-4Y)'R@)\%
M89FW0#4\-W+U YU8W4T(3C3ZQ/1:@%+ZG2+.6]0LN:3'O\TI)9T-V6V3EJR)
M41BR4MLZQ(L"2"@\*L+F0I"?.^RL4+0DGL")^.D:LZ<0S>9*I\#46V<CT.U*
M"WQN]!VKG<"Q^1(4I<3K8KX+[NV8*"5,,0VD&TEA41>(M_8]S_Z2<^FXW;9A
M5<F:<@:?"4%4Y8-/D,C"2JBLPG6'T3J^/IOZ93^D=UN+3%BK@KN@E^JV81OY
M(%%:1N539;P+H8"V!$6^RL0I1W%J8)UFJ[\*]*B(2RL5C3HT7\8%8W9C6:LK
M,[_F7DQ<A]/ZO (#;%*#H S<_]Y!G\W'&@+-%_?A4?/)XN#H.R"U@%#;4K-J
MC)5$'GV8#)H@,^/KL)K%G1_E>%7WUN:3K!P#!\03PZF#L\^6S$O]^AQ]Z$--
MT97X/D&=Y3F$?]3:P$&\[926]@6+D /D"F!UVMS4+=#A)C;Q!'2P1[NJGE-(
MMR.-*R+%6=ZYF8Z_=?0!-]J?U[W-+ UJAR*X.3-Q<^F#TS-1K0YG9:\WD= 5
M\9G?QEJ&2N?:["#4Z(6]H%9:HM'.$^65D $-@I'235'23S#6^!D=^*W(?&HN
MO7R52O4 ^P":0^3.7.*"@&934+@EM9*;(J*P//+E0:]T<UO86-/P?-,GD@&L
M8;TXC&I71(H<=^$)+[_]UY7H@+'.C^1ROX'NL("41DU';;1NWF6.E@<=1Z9?
M7#Q:5>*O:I$D'\7.[+_!!17#E2B8":]HSS"ATN!R5^)QK#"H!FOG2=F%;ZJG
M* 73' :H5-I^R+RPE'V-!Y2FR$NQX7^CQC7RL8%G3K9!P'&_Y=$LPSMLB$NP
M2B5VTG4E9+O,3BT6O.=E'@G%+N)R*;M#K;<@@)O[S+5#2 ,QII?VX9C\9HL!
M8=@:M^ 8O@^0TL9C6'\(K*?WV6'BD9_Z\RB-ZF2<^P( 3]A,8 ;U_=H#A5T!
M8:W\X\@TT.*\F*!#8Y4*_XL $8%\!_*3)MK*AN:PO6SC)SSOOI;:M8O=F8/O
MC'@L]3R[V7U8VF=-$F'/?C<=\F*DL[ Q!?,HPX*2UF_>.4HHX8 ^.BM&KRXZ
MF+YN]/T ^K)THQ_$;IM2[!2I/) 3MC-C%K*L)=KIQWT?<=:1RY?T9MDA15L@
M]X(_0'Y,;__6DPJJE-N[^]AZXE^F[UA]GWZT"I_%,VF"D:J^-^C+,5D<*=N<
M 53 WV0&V?-W1(B*L)3%+Y")P;J+CPJ:*]]< 587Q ;2SM#:IRX$]2%\;U[7
ML-TE:R%^&-WV=6NKJ;/"=_412]BVZ#0P<L;3#,Z+W#%-OC0(FY5GQW*-R=1;
M)T%I-EC7;D8=92]E"#/E"Q?>VW&]+:+XG .2Z,!-Y37TN67<F_IU@6$X5/P#
M_L*-(OZW#VI3:?8NYE+1;V_<R307G+IF@$*OA^C2EUG)9T/\G-!F',FB=9")
MVKU[G.+$"JTS-\/;A.)GE-^]E[U1E]M0[3I1\?BZ_5ZJ"2-(8M#$AOE-:47J
MF$2,J>G+,+PF1U,?4X'#BOC)A]!GO[? PJ"N=E J[AW3"QP@\8&A;@Q.><\$
MBQ'\^7[4.JV7&0 ,"W//(P^3,MU64\%=8;M@6[:&N(_$]ZR'92^ T/214>Y+
ML7[J& [KADXS^M*31J_5UQ3E&:0-6_R-]<23.GOGHH6D*(!*+\3-R'*&A-%M
MLO1[;$LH'F/=7IRIZVRN5 ]*1:,Y+ 0!Z6UTASY\I?#:P":P0<S,=*G$;\"4
M.?H>W<?7^^V".^#<[/R%POG%JBO+,!IV+AO:T)(9(OSRT^.<&E9Z 4#8)IUB
M")$KT08F@.WO&W'-_-KUKO:6NP+<K_J^? %)P$D'P%759UA-P^'Z[S^]2?_#
MSR ]ZDC.>9O*@\LC^O%7+&#Q(W2^5O>9<^4QWE4HL&#A-</[KER (Y@]N)1\
MOE''-;B--E&[[%LP23?#^=>5!A[YM*>/WA+!7[Y6 QASGL%KK+J>J*9.UOR^
MZ.7CF[R5*MC@"XEA]AVS<W4#SE =4ZY=K?RD;5]J^6Y94_+5?4@S1?N!941Y
MH?G44UJ]OF1E\.9GM<G?1$V?W3C9%B=7GC]7GQ-*[@\8O%N9>;Y*#E$.U(N=
MB'[+JN?*NGFW1V3SGJ*O,?+YHY' RG0K][[[OF2ET?--D4_"YS8IO0(G^>/Y
MWPI2 !*ZK@#[; :@&N"*U14 W@QK N]= ?[:P&/PJ,R-N9I>N,_E-(::2-6H
M<;C-G"S[^AFIM8]+FBDK/##Q91A3UKPYT?6A1C>(J8-(U;X"5_7'.;*L[^<"
M_T$X0E6*%(>SX_H2.XEIV#\[QR5%9,#:^M- ]C_3_:_LJ?YKW:Q_XN3O<E+?
MS]W^47C;WX+YX= _<?)WN5\#3-JDQ0(M'AN?*'JZA?+M;B7:-WM'L?2A< O/
M7^53V?"M&;$/,XQEWI/L95HWYDH$D:=UDB(MQ$P7O=*A!0D/R4[XUJHJ(/UU
M\LWM/$:J^>Y&*/UV[8BB@!ZZ1K7.R2U83,?E$$O(.EM4W,^'7ZVBDMF]/5J8
M']N=6!7!7ZK$]_F_A=:/F\?Y  ]_S/XML&D>]^7C^VL@.+8R%@VS:T8OR7>M
MP%9T?ZQM)^S_-W. _]A0&KHJ1M!@]21T6>>;V39AU6>?I_V>7.M&M'MV"K71
M!A5CK21! OQ<APNY.S$*YJYU^$'LML[=N^R[JSQ?ZLM3_,'>=9H76J3#4X:R
M*CZ=TQ]&JKP%BB:F+4D^,03@D TNJUGS#QE8:8OJWR!64I[7%&%_KDR/]!PU
M=G^[+]0O_3(F/9;'"URVP%];M7?4F-J4+1;#> NM9E.FK9ZH<8\-M3HYB.JS
MIB70?YC>GLRG/<4IEIA7'7+&8[;PUL"*PJ>DJGHTFV#@CM!X*D6_B^(-/D-Y
M4!7WDDE8^"(+BQ5)!DWVV7@S^KJJKFY+H7"&-& ZW9K>QO;>-YVU(QO&]0;&
MC]"Q0D$FRI8E\((O-3+H7&%/^$PZUXDA>?+V*[YU[;H4TCJK&+(W]P!X'A;1
MSDF5_4I=!N7J8_$L\MORNP6Z?&8YR,+"Z;QXO1&W$*8!E7,-&A(8I32"Q[J:
MGUOAL6KDQ;Y$41./1?)GU:D77/1EH(P"5MX>/E!@*Q,:>U$^^E<*ME=#ML/Y
M<P6[#>:,8V6VRU&,*[R2'5IC1_6S&,@L2O,:#XBYB:C3*)_7/.:AZX30^D'J
MAV><$B4<(2K5(<+&%C;F.+$NK#+6ME^L'K!43@KUJ\NB1D9G-4D_,%GV,A<N
MYGI< =HFO2!.VLW5M<TU+.24'NM&Q:Q8O2T+V',YF,I+P+XF@NYF1,R&]Y'I
MQ5J8P3:Z[\:;=6&S+,5<=ST/^N9T3RR3;RNULT$SYKGSY[6[?.0OPD>=O"AV
MFACJHF\9OCJ2O"@>%"5=CYEVM]Z7_H#A>@7P R=NY#JF=9?-';B!%NO#=5UN
M39!-F=@N)"]:L6\)6UE8$5]LXD9E!NWJ*0=OO/.6JE><LJ4:]:4+3.ZJNE4?
M0'?#NCE6P8-Z9)U@:JJS2N^WSN=BG!@O:Z\ X3ANN5;'U20G%3+T]RBM#HEA
M5B3V2,\-A<*'6 +Z?#T7YK4*C??&AQ"ZS7&/;>_"'5-/4FWF<6R>S:HG3K^[
M,]26QC+L2V/M=I80-!=_*9M@LK3*V'#ML5+CZ*&AF*JT%5N"J<OV2&-TJR_]
M:-D%#Q%LIQ@J^IHZ4JOGPSC9%8!(6,HC9SU#UW:*IZ;,5+\)&XY5/8],3>?&
M1&NJ*05J5C?#V>S"])+,XIX$#38ZB>&Z>/!&.OHP;L4*)0;R<>GG:1PKDC31
M7V;UME>]I5S/E@ME1?N\J7L&RRZPI%A)Y-WLR=</UHSA>8?%,U'FK?F-/^1P
M>1HN-E#?2-@JZ"1CX\4 9/"7P#A>"+/9GWK4&"VPMUU:GL^6!\&;6F"<&+DO
MC*^W51GIR.;4,L1*6)VRQA,%'48VM<YLMB5P?<FV[I2]*.[VQ3\H,= 76GDZ
MA8D54C_S@.U>S%8:Q4C.*&LYZ[Y\G]QIOZ,Q"0G0YNZT_E0OD;_?J:*GO!\1
MVDC#ZL(YQP7=5NVJ_4*>9Q1E(LWM:D7UMKN*;H6*J]VUYVU\F0O1]Q3G&C'9
M%I-RT\R92[K2/(A3$9/BI&G4GVIE3N.<PD"=>#<V%@8&=HA8/WYDB_I\NZY.
MB,YJXPW22Z(6QDN[C5.\WKZ?AT";<]#QI=CSV4X/V_$6*) ?")M4[>DI[6WQ
MS*UW?T9G@$ZE8^(;MR*HE,Y>OR>_@<)@G&880(V)14VC>9.:>4N(C-'>-:DP
M?.92'1,;4Q\%5#>J;QHZZN7*,U(0K*5,<)517=?Q9?]-<8]BYN[7IU)8D%N/
M$%WAF3ZRY&Q+8BS\$N^YY(48!-:^[5)X1_-%*-]OBUNIO71JRYLS,.);Z@U!
MJKB7!BC7!>V,")B:J :3%1RYXN1,O0<M)^6RL1.LN><'/*@;;Y#SL7  V9M%
M/2L>A+KX\@[G#U\\$HXQ'FSB?:@O#.=#3$A= 7X;55DM@5P4UR/3VE $.*77
M)K*,;YO21F8G(KW(FQ#C[2>>OT$>3V4[W6'!;V7<V.TBC7>T)FS@ZM:4=E]C
M49_O3" >#,R/RVW!O>ZM^;5*[-VYY']U2S_]LV991 (B!@E3@(AUPH[+K0E+
MV.<XI[ODMR"59MXVYN5C%ASD6@XQ 5'0#F_IY[5[EUFVG:^H4,1K:91O\>_H
ME53T/>E^.EA8&-Q2J#:U\Q+71E/GHL.CE+:#AMJ=E8,#-?W4)TD%_T:]EUQ'
M?Z43AS0Y<?CB$TW$](R2F*NUA4\7WB ?TN&U0VGN4&US2JSK;2=MWX??IBV;
M:$/GFE)?B6/->1[((6PZ[;! R\6:NQ%;8O,TZ,)[%^N#"K<I*[ ZG]@!(L4W
MG'P^8MVW)1=AR46\/LXN1AHM&0L5BK<8-\L?-&\ES\\E*SX;D;;,-N>^?UBF
MB#"OMRA :NDL3'QB>,5]OE!D;*FPE>8R?YYDW*$=#P?'HIX[FMR8&5_WI1U>
M"=;DAYU\4+">8X<+XVK'6M8Y;J1QC]'-5G,C0+>/(^F.)Z4KWK;*88-U(E2:
MB#IA$%)AS2+1Y*Q!5EUNFZ?HZP:@-@X2Y:*<*GBI]]%]TV(%G?K:<;L)2MF(
MX:)WGVF.5JHJ#)#J70L*B7U<BHRRN=1'&_>0SB+9>D.3ZA_Z^-4ZPWA^XUNL
M$Z^O17Y@C#TY2+8O\T^7/Y'=N;>H1,CR6A>MW]W5GPX_0OV>^^0C7BFO8TK?
M18OL#1IBH(V@$_7%193 NI''O(^9.N(DDJ(5M:'[X ,E3KH:\!LT6',TI?QS
MAX=QN^+#AGH1HWXGNJ<]QJ9R0@JJ>GN"QB':U3R6T<=R$\)XD^_.M(40(T*1
MZFUP0D.COMWJ0H$.@[KWNDW4/4Y.,?1,FX=\V*VZ1.YZBVS1\8'YG+8?GN[B
MS4Q-N7?NCQRHI7='1G'/;E,<B9#*Q+@HB^)\RZEZ;2))@P7L%A8RJ8N.*EN<
MCHA?16$ )P_#"W@#%452R&7G?)C+=C*%"FD<%KULO-HF:L<.SPMSWO+49K-U
M+1M*18?8-)C.(V7KW&WOSK]-H0K;>!4TJ)&V +,I)3,),)(I1JJK(J)#%].Z
MW+[FO7N%UL48ZRD5W4^33!L8<<PE>S(Z;R9R!@>OET\K+YXZPYM3/I,!>(S&
M\T6W[_#;[E'LI5)(B1&;"RQZ#A]O<50XP7FI"0X#36Q?)>FLKHJP$"YP1. '
M'J8.._$FXB!3M(&T3*)QRV+DARP0R1=A*],XI\]?X9=:O_H2M=R,L^;F>1QY
MF>GA(]C+Q !P)P[/1#8=R.X9@.]D\L@1WB-(7#I:J-L-/FLL1Z0P#Q!GT7**
M%/>3*B6WIQ.*CK_):<-Q;/LZ/CG[Z6L<8GI'8=%CIZ3!S@:#_X#AWGO9:7]8
M_;G/O<=YU5Z&TF9T@+Z,"!J6@2:ZSK+%8K)J^UL8*+Y-7\JAYHII"^VI,HJ1
MZ%;_"QG%-[GWI<S>8]TJ7,]0+Z#X9WL)<37\0Y?-%OD!)6&#0I2P8>^& ;:R
MSK-R"A:N__[3[9M__6'0TY67-O#G&E:0;R^\G'9D>77XM$P8/K_G98WK?' _
MN(KI!C[AV@1'<&;8PJ12%?LKU2]GX%W>4.%IP4>WB0B&7,L>-2%V(Z >#Q0&
M>3M+2YRV@##G8C?HZ$(@:C^" M#X>S\1_6'H0\/2S.#,' *ZO,\9'+ER4@ 5
M5,]'[M-F\VA?SX4RYD  FM]CRPS<::,!EC626T&J2+KKQP6DMAXE=2?FZB5X
M@[WI^RBK[UIQH&Z;;#TAD[1^2O0%2RHVR@>..LU&$0\$7 %$-Z\ WG!3*6,8
M\Q6 2_0+=938+Q>^3YA=E;@"I+M< 9J '[.B2S11YC3_$Z%Q9Z1'9G*\NFT-
M^CETZF71HPM?_I'HDO&?DD 4<>>_O\R_"64CLC>)04G!GX+-HJ\ @4X95X#!
MNBO +!_N%>#.(>^+\!]B507LH/'A(W!S7]LWR?*>+L2F!!/^MVO \J\ K;5#
MH-5IT"YX\R5M/=&9:+GV::(7D^O3[Z@+XE^<EUT>R/P)<&EKV/]4(/)7@7K\
MUW>Z[GYWD8N[H-J \'(B_1>TX(J/+KPY8)#;_VO._"D0W?HKRG]Z,.X%"@93
MQO?7(4#UABWKFFRB!Y>*M+K%%WTBL4)4\#^C^1OA:'5^EP#]*TK^CR0*S)%N
MF8\-],L>G4,G-;^O5?=GTN-I[SA3X1]^S[(5:-Y@3>Q@I_FDWV7S1(KM?\F9
M?R4A=L'2C[]-Z3M0<P5P+0']2:OUYN4=B.I1V$_N=?U".+$__74E^C<*=/0C
M=I_IZ(2[+%Z"'R!=,GE-DG]4@M*?:]I= 8J(?,S+#CB/5;8<FQ&ESK2G)\;G
M*]%_TL,PD,CGY<_K#E> ?Z- 1O+\2M"G3LRZ_6M2-6I=XV2,?S[VAZ03[?]+
M7P(0JQ)=%UX_!+!S_TSB"[$[AT\&;*[37-C\%YM(+O4WM;AD8-97 )[O%9?V
MUS;(\A^:G:^^__Y4]I!\Y]K(=:OU[#7VU@_>Z3NA"D8SS]_^V=@J_\)*U5_=
M8_FK'8WPH6^K\PV[61FH+2)+!K%'R\TM24E)_6;U,(N"0*);Y?&8JJRIIOD5
M(#H$!;4N&D0UB4$ >M2_?F\.T% '%5G'?Q\U5;FA#RJZL+8.^C%L^M>K4#D%
M.?&[!C[+A0D99QK\M![6ID,^_S\:,/WCCM^AT3QJ R6CH P9'XMP9%XF0NN3
MF.L5LNCCEB].KV-X"J&,Q)H!8D%[,4W?2IK H$0BXHO.N\%@VR3'T<G*HBV/
MTWX9!\2J0NT8YE*0.I, =A_?-P7F#D(A9W3&VH-%0VK;ICX+.H-%6Z8-ZMN>
MZ7Z\V[JJMGI:MT97>4/G<,BV??L^#= ?W@-O/D@R#Y%-Q9=_>Z)6]3&B89_9
M?U=^[I7</(O,Z$@?KS]10%O*GGIS4,GRZ,B )GL8)S\5^"6RXH4Y>I\)_C-I
MS#>23D1[M^CMOW@%O,"E-FXY%FPLTG]!VZOJEUFNMN9+7#&TW7?7EBLFLN0;
ML?6!\<=//N_E^3TY&./Q/+]XFW8/*K81<=PW]^D*>,-08[6 1UAM&%E]JAG)
MWT8BZ-SY6G&?=L'I@[[HR^WI-.82BE1(WS:16I#+!EIVP:U"J_(-+0A&X-MJ
MPWSB02M1P&BEURY4GYRXI^=TD&_(6A!:E42:;-^AX=:A-BJLF;<QZN'Z/L$N
M%Z?N#C@<@K2=- CHJ;'X%G&7DC@I#XFC/#+G;@/6E-G@!Z^7EBY6^N?&OLMX
M-:?%5A;)&UZ?7M$A8,43\3+Z/L\;%-6ZJU[PY /N4+D>4=.L\WE8 LB]6IT<
MM\CQSH&A?])S(]/SFGZ3GD5%&J'F"N$EA123,(XAX2_]<^$R+$U6W49^7ZS
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MB?" ^SK= _IA&4U,HT:*X?1/A/P[T*N"^+K:4ME7U4A'/(),KC.L#57&LIJ
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M+1CF8&@[V78V<TL>'WM<0$ZVFWP,1O&).2-SAL?&P=%*+&B91[U99JLULN(
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M2"LVHU-:\?9*UPN*/H+88#,9H:0H@F_<3!H,*(H+]-W[D--=H<D4INU&9?@
MZ3^_A(O.7;Q:GW*A,_;%.9IS4,V*"UY*1/>FK^'?F2/%B=_)!>\"! DFI _^
MT(Z87 Z=-!'.3MR(.56P;=B#=B3^B)F"ZVU."O./560GKO) ]&4GC?%@Z-X\
MS*KXZ4K\?J,BSED3%R+@I_8M:L ,)-\,,A&#66'O-\J4W:;6$Y-<YRGW<N,?
MVA<G_*W13""Z-JRU;2> ,_9_*O^G\G\J_Z?R_U\JK^4URPR.O(^7/!)XL]O6
M0\A"U2O@D@-^ 4\)WG$J4IP*[(T3;B[/WR\R^?VG:[7$)-DN%Z>K4U4L]TF;
MPTHW0-=IB4"Q?<+CIG0F*O55 0>^,5XSHG& BR/N9!)QR+M&\07=G23NLF=W
M8ICK1'5%B3WR!*7G."Z;Z\ BB,]3CHV7>=\M ,LR#^L'QE/M%X\(1GBY<=N\
M=6V4\!&L3CM^ T^@,]MT43HQ8G;DW-7P$93+<$KF@^L='_3  2F2=\$QK9=C
M2Q9SM&1B:M]Y$ &4A03R-+C;ZL\/%+@.LJ4CBGW7NV_ZJ/-8$J82P!R@T"..
MMJ]VHL&&Z6>!X:(HANX28IP,+ONK=SR.H\9>G,:+6L6QJM;TG;+%G_*ZA2OG
ML(FL,_0'?7A\8SNO&[D+0(NG0S>(G)N%MS:V>M+=*BL16J^J?&&LE@CY1YCI
M?+/1+D @&ELJEX(W&K4,V1XO%?)=%<XUIJW02G'R1G& A3?'=@$;S<#%HHQ=
MP$00MG+J\*KBSAL1H0*%#6*D=C=DI6$7@*V*:J6Q"VAAPFZ7JYJ,W^9V<WD<
M.X_I]NB@VPG4O=RS%,L1KW;ZEC29T<TQP!\JAOZ*AH-N/)#*\5Q,5,ECZZYZ
MMTFN&P"V!L3Z#_4SY7/ETB@>_6".L?.NKW N,T'W-'U_!=7E+I'E"/1F\N\*
M,#[$&9PX#CK[ 6>MV+OP4#]LO97P%K2#\,Z*+E <V!N,-V-#_.1GJMDQ5)OO
M4;T/H7N(\E&3>VG^Z$YXV#=/')PVMB6&=0I6?7</] <?BUO,Z*;#)/X-?H(,
M\1(*4SX:9=J0:T#/V<-((89M_RT &?L :"LH,_KA\Q'0=7#UP?FYT5'VUY3+
M&/H2_Q8/_ CV?0\,_^@DB>+0^A:2]BX8^Q6P]L/1%$31$178P/D7 'W_ ( #
M-G\@R-?SMS6GTF,IV@48^J"Y>N.^1;&,+Z07\9OR]?X>_3\B("YLE"BB&,A2
MKAQ=HLMRV+Y&(^B:W#]%P$\AF&^_"U#YR4,YPOYJQO+S$='KIO*8\_]@B/[;
MD>;S0\S8.RD9C,'%ZOPP5Q5OST,2V"S^PP;^M1SS1%_I1?@.*C^!E.BR81R
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M1EP/X?*5^A-%J7JU3^KN!2&4S"U>EIP">[7SK$;7=3=8;#>'U@4-%J"44VK
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M-F1[AN'0QII7#)/U6K5)U+,J!IYCQAAGJI7U)R01TB12K9+W^I 2#%Y?,TJ
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M%,JQC[D ?!S*/06>Y2^RMF$]L-^/UTL57*5$D'TGR)?6Q]QM?XN$_U"0TA"
M)KI-YQFYOI RHZR.JMBJI:@],N=P6VW('KX2?88T>P2M 8G&YJF6\8)KNQ\
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M_PBA_[A(,&Z ^_&>OYS*MC^53,3Q8Q+3N@# I@G,&-\2Y)G1^ZEFC?_[J5,
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M^DA7==P5\R83[D\?QPA3..0&!P.6">$]&ZY)CILE$_&IV"1:*^>@BGDR87O
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MG?:*C&OG=#JHLO!TTO.Q7LH<W=,RH=P@;P28RYP^VIH;%+0I-FZ8<UG$+)_
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M<,7<.3+4.&K^+8Z,I+F18*HE25-*E^G<Z_+4NDZG3%2B)N8'$@X8YZH0NMM
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MO^<>>E;$W3H&B_E***X@'B5?^L[-P4<B$6=WL'D7%,6()V[7YPXVVHBHDOW
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MCN\/%H6=U!UG-WC&-4/[2^>TU]9K>E^L+XH_\@RWS>-B#[5Y&1C+KL/&':=
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M^[<S4./\&J@^C2-729'B+T#6-&\\0F +B&OPXZ/T2+75%XIV!S>O$_HN$C;
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M.HOPN$1(LSK6V@E8)4#Z.=I/.(>G):G(Y4=1J/D'):<Q(::\$#Z5BI!D89&
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M/&\>-T^P94#HEXWX,<VP^/'YUG$&N(#:)LPJSH#XM8.>W>6\@]4S((YBB.'
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M2AN"]NQ+RCP*2^&%D0&N?U8,_VP$:IX*%LV7J\L%@9 [7=2F7X;[Q\Z LM\
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M_P,H3D4O9VV5QW,N^;.I<]$QUSB,< 3#LLSA)510/\I,E"Q],%AW Z'ODY-
M-@:X>>['"<N;/<LX$[M/6?5:DWW+ML>XX:Y#! -'ES'8BK[<NI ./O"9$OZY
MDJ!FS(_#BGH>EVAZZ<35=S]?W.M=!_L,I6WA+M(DOU&_T7WG0%G^BHZ\)25[
MFJF6B ?/I(>]>'7+5%6EG>V,K%L&%[HT3U+ERMMEUJ\=[&^_EUX=I@%N;05/
M[)F-,Y71FTNU?]',UOU\2BTT8'<E.-1RZ0OF;M)ZG</KV-#6VJ=KG[KEW?K%
M38\DS\4I P@BS4X;3U@FBN/T-.FPRNP,OVY-1;5T2&_U6;,>JA_7VGP20WVC
M^M/_D *B7M3^WI93TIK@#;TQ_S'13EP:X#C_XH&UOA2,8,"ZCFOQJ[FD[@Q'
MM#J_+?=#U+S>APQ4;<$6LZP.R@7,D^VAFLA*7V<5:M[S>\6G1$W[>O1$X,'P
M%AB%2"9Y;Q?UDYM=O;WR!?K7$JHZ[)Q%SEYW<7V3 LMS*\'=-+T!:E#1KI&*
M?H]+)^ZQBN7AKO3MNQXZI3K@8<S6,ZU &F^3>&.@NZ/NO/LW W#Y%+^+4:QX
M%8NBF%1*#Y>R0YQO48G)76WXT2^26!\:RZ"XF@#F^R -BS/;<MM5S^A[HU58
MA:G3#^"?,];%.QH3&GR4S4N141=RCA1"<!Q))+7C9I95G%8/FQ$TG=XQCSM3
MB-F_ 3TZ!2R3\7;8#OP31\O1&LGL!UTE!'#:08<//G>D9#KKKWQFAV,[Q^?;
MK7NN/+V8&1SIK[@^)H"(M+E>L>0G_@8@)SQH)R_=A^SKS)TM0LH=>Z3&&N"]
MHF:8DYV94 -#8WK:_)9'ENEY]F0T909>X0 /8N_#1Q6K8TX:54_I *?'ZK);
M:PR4VEQ5XT-$S3R["V\XOJ]95BOE)(SK!:W7^\AO'G^8L^WH*R:A(G\[:/6B
MJ2-AR6UZYB<A9V]3RKJX2I#P?&<(CV.%Q07D U9OAM="_%%M[_/'$EUY2V)G
M.%BDH:=CJ# N;IL^<>.;HU+>R.";?H :E,?[2YN!O7$YG#)*]4-XIU%9KZ7=
MY=J:E#:43V[?M>HGZ<EOP/&R[NYIWE6=@(G ST:,^0 143(\2Z[55UJ;?'PO
MC&NY8KQ^;[F(K=":GCWNN1]V;<V$!JO05-\HL\^:ZDJ<Q80 ]"T^WE$F5,!Y
MG:O5U0_PYOU:IFLEV[*N::^"QII7MFRIBL1:\!Z: :/$%'@.R9]O^;&]^X[<
M)VP)IOQ)*=@\L(>70-TA%0<X/;C-0BIE^JAA&-T?RF/5VZ?KE_OCVUA!2O&X
MIU]9]F+_UC/6.C\N53P=*^!Q=3YIC+>%+2R?_1UE&.7I*WK8QJ8+NR1[CL]%
M:N+=%"V:X$Q%5AXFNL;6B!%7.KM3W;;U$ZS;@5,/FY/;,[HQEI#2!^+HA^@P
MI(UW4."QNRC#S(]\#GF'+./(N-:T@@J/FO7O[_ANX_,"NCT$^IT%E3Z;EMSG
MJ5DW:4&^,0!#VS](VF(=/&161^)K'6QZ(P.NT?#ZW]P1PFG?.>7:Z65D:*Z(
M85LV5JH)I#C\!EBUY6E(/ ?GK71%[+29>TPB9MTPOZ0"]6NU@S@J^P277P7P
MLS$44OH?%)2&[%[7-,S NI1]7TDF,WXT6,8>'G"WJV(]EXHP+[9</IE;16$N
M<=B41\\@##KY!K8HG'B'3A0L1:R"6+A\7RO?TO2:^KCM>M0U=_\%]95'$:<@
MM2LAG^ZU)9_B-<S7+<'7L=O%^<\U./?;>-C+U$&?9(ME/9''\#R H?4 +]/"
M5B-/JP5,I1 > CIWN3*,".[F4Y_$3'ES@K7UMIE;OF^SKF$VW3(+ /@3B&1R
MZN8!=X1LSSM:?IJ ?3>!;/3<Q[XTVZ!2>4$[D4;-5A*Y%=6(L<8X/6_""X_<
MKRH7N(<>>4FJ7Z3W&MB;3B#V'[7D4=([19(H\+O0+L,!UUX,<4,U]!_(@U;5
M#P!_ :?_(D6M6%5?$^0OHIMK'H$*X$B3]M4@5LOS51X-L]PJ7=F5\T?.X0<^
M3"6*KCBQJ\3#1+C#HHE=APR6?X*B%Y(  :G:^<84MAW*8[ ,1$)BN(=D3(F-
MFT00P=:MB_/6/^=&G^>)"0$W5@RQ+\!,WWE0UQ?P%^@"X*2'*LR)R.V>V*R_
M7W!&!U0*]0JN%WAO@5>LYQ:I!G!X'4$DFZXD,C@PKX9XNO3UCP3GZ[G?.',[
M](4FB<A4&" ?\7$.BQ2LO(FG78GWN@"1O"_()_F+M7PZ'&V*;46KWP"E&LH1
MY@8I,'\_P'4)?\)2&#JYCCO47S[1@<H7SW'EX/E4EC%]D^?K$4&;)\AAZ/:M
M*Z\BX$9X!NIX&93Q"$W\&VQ4^Z"6E:3T-,:\PXXZ'!0.J-^C=6PR"QQ!D*WB
MA!8LN*2SG2#MV_8FD)XRGN94&ECA:;7XUG[9M9A>##JBAYV"A9W:2^'I]3#7
MZ B%I,AT.OUP&NK;V=!VH ="_R8,&2C@S8L*\E$KIO::(7XDQL<JX4R\'-UU
MIPZK>\46@E$W#8TLP6-1C)6BQLX@DNXX8+>1$AQFOR=\X^?=#NCINX6$'BRW
M2'AB!VNH2Q&&"1&2SUA,^S$([^#O3W/)0%ZZI)EV&Z$D$M@0:V<>71TUE/&L
M]<]*A/Q\S;X7($)%19"/7C$5I(>S3M5FC[&\<9+ESA&(40]J3*O\[&MUART<
MIX @0?KI)1O1U8VF^XYOKQO_UQ,"H&/Y]P]7^BB4S(-G2,<9ABH(Q:XBK[CQ
M7F94Q5L]YXK"]GIY:=AIUC,J5&V-05A^BX%JWF_R]K,Q*#L^B!MX:'6TAFXY
M-^&A9222P-]B>2D^:D+9(OB_'Q8%*#'PP7"E[0MK5S0D&?HDI"[ZY/&D%-R'
M;[$AZAVE^-3)O0_T/02NV.MM.XP+MM6M'\N;DE;6-D?M()J=\B[D'FK[V\VR
MG/KOY^Y]P;.T>.%83E<.(*CVAF2<JDF3>1"@_=7Z%UVKK8[1M]\ 56QC*818
MTD\Z&A]B&7"G6]AY>NYG(>G*=;/) B2H8[ U-["X;,%LDM#]9T&=5[_P\ L1
M'26Y"5W_M.C(;BG9?MQ^CSM(BEQC%*7;VYT/5?IUP*7/F$VH: RNQ&]@VEZ6
MV(?BIM@A^P*GML18XUSO"FUM[[((RS4LDD5DKQ<\1D0^L\"U2:(+D>J.WWYV
MH:;RM2[\J^;#4.GPZ0$9($')!A]0L)K_ 3/\LMV\+_XKYJB-76$X_VK5$!>$
M9:+8YHF&!>J.QO!*QNXZX+BM;X(/V=WK\C< PYKVUZ7(PZ?NSXC6D<C7-X6P
MQ7^)&)AF=T,'#+'&Z/<:GJXK3'5L_D+^D+95UZZMXMV$OY[B)L;YYB7VJC&7
M0;<2V:F"TJ[6#'0ZH,+2SY_-*:)E<F4AB;<\WKV$F1O0PMDSXE8&?NI;'.#R
MM,R?[@A$HS#,H]X*J1*]$ MC%6O ZD%J*^[)_($A\)( 4,PUPQ$J\W!%]?+L
M/VC5NL/70Z,<S#[C4:0V/Y51R2VL7Y[_7)C-(W@%2VPB6@<\%D!(+M/)6,[Y
MWAG=46_HDE>,\D>A3#9.7F6B_(*SA#RN.QN1P&3R.UDFZ\U*1J370OI]JBL+
M]Q;3H<(,61(GP]41869]15;63'53ZC>P<&3D%&(>$Y.+0)%VIJ571U[^?:4(
MXR^I> 'C=8(8KVO=O\PP:": <*(,^E&&^JT#OEGUS0I3^A=W<8<+> (:12="
MN+2,7Q2NCQKQX#X_FZRZ@&OG/U14A( V)%!%/^>C2-W!D/;]1%T2AGR@.R[M
MF@5!G#8CDHYS!^/++*QNN+C\?[I![Y4UG=[42?V*0>UJ9(4U:>+,V\B$CR "
M/B_XBBTP<] OD=N3)P0&5A\1:V=_^.W(-GI5OY!ZK?>KF^_)<G(*WFU^@3VU
M@,V ^A"9>SN9*Z^U^FYAZ+J0HLY6U W41*'C)U-G[;6(]-HY<1PKZJC^.H:]
MY@8.R9[?*;N%@!RYY>O!= 7*YAL0P?D?JR8NH6?$6=;%EGGJ(0X8.=RMH9!>
M'.#05\![@E$&2LZ5\)V;LK24(.X3<98@6L(U-RGG*;,6W&1>?FVX9TN:+'Z-
M%$-VKOD  8D-)C;NFFJ57E1.SY(*8;1"7=U1&+IA"NJKU?F.S/+NXDEJ57.&
M^;H+$/%X49!-A9TM+7'Z!_J,:X3TXGO6D=O#2IR?=JN\2'L58I\KU+5MA:P)
MM$40"RQU#&AVF]+A@=1&3=Q ]+@\L,7\ )-K%QWU?DDE4[\H48+.151D%)&G
M'!&KD'9.>75UEX-RH25Q3SE!0\@/18#S@WO0#YNM1,&?48PGQLI6.2_I[)6R
M 0_.%@.1HU[:CR $8N)GAL5L='T,>,MS27M"ME% SY4NGQ=:Q=H.'A:K+K')
M>87=]4 2SHO,;UZ^=M8USX=GRXE->KNZ@3U<YG@OU2.4+C#-/M^\-%EA?PII
M'NJG;&E<,[2 I7M_?E+XK6RODD3TV*RV_ G3")9K-)4XL'GXP+J8#I:NX$-5
M6'E^O(O4J$1LKV@B,-(':'PTS84-_ 50U$GOUO5)\]%*=ZCNN-G/J?#ETVZ$
MVB9_L,V^1OA\\R[DPI"C>2WF"SH]3-37X/*3#QB-S*\+G1?GD(01C6<YI)BP
MR5+Y2*U+K_(.V\R/5=;T>RUA1WZPY_&/ T3GYX7D74,H@E4CM=#+-AY9Y,Y.
MA/-#2^"N= 59:Q'J;:ZZ,TMW!6XK"/0DL04.\KB!8Z,;OKQ@N :&$1>;Z^+<
M<Y+ 50FAS)EWXNH)RW54%SQM#2G8@\11.Y&QB+3UMJ?QWJZ)3ZTA#E#@V]G>
MVP;W.SS'F"PG>;_WQ40]R1@D(X*F=GAH8&M&L35#OY"0))R-EJ 76TZM.9=,
M*AA*C-_T.XKWR.\XYPF>VUX=?&R,W3U7YIEC?37.2@^;(HHTVQ;AT>!?;-RU
MWUPAOT9(-.IA9$;^3AQ?-"E[9B 4=8/,60X"F-@$(:$:TVMQ3$LQ?9GSP;0L
M.8HW.&-@#L<-HXME*M;6?BS'F,D$$4=]_5AQ8G:%.K9J0A3%W '[S;O$5+W>
M5,!U>*^E, YG,P/VILCS<^0I?C:ZUT+WLFM#.DV80C^M\V2%5NVY2%+=RBB>
M)KYJ0K\KC(8(/K&7"LU;!Q+96VY@:M&]WXJR=U&8LX/3#6]Z?G<A4Y@4'Y;R
MMK;N.^6V#5]%<>]B\.*RR%BE<#T!'3=0&GQ^T]!0LN^[0Q[T52Y(X;R],+58
MUB-CE.)GM+7NR /1L6;3Y]#D7O*]0AW,R9&-9[07NV[\9'/#5%47LS;B04V:
MFV, :_G5V(*$CXO=>.D,PC1)"...&KU4RBLXQI?""0)J2T227@,#A8&&CSZ7
M!N9K.Q=:53YX)I[../<KE(#F22,(#^T/X@]F 1RV;3R6MM:.,#'))LE/)=_N
MC2=(B!YYI$\]*\9'L_)XWCYJR#,8QYB(?7%,(GC!66WG%5&WF23Y)4F1I^H'
M5@4Q@>45M)S-K(N,Z,H2ZF(1/V;Z3\,[H,9%,7)+LU78JK,;;1%"-)!>;J#<
M**B^NC9^F>-21J#4W0]C]LQ&=)C25.)G4%9(XRDMV-L]J>,H,BVOZ/C-PR>;
M@Q6'?@<+& AOM\LQ_DGBKJH#$[;&N6E6CM<"*#'NU\6+RFQ[">AB=*V&B3*8
M@EX"7A#>)^[%Z[U:#IAR)^5V];ISDN#Z&;F^;S&G:(/AQQ9#L'0?0<1KWX-^
M5+I*=1R<YAAD96LXWM/V\&=1W!'<;8L<%V -# *[GRR[ OFY@1'FF^GR0E_V
MHQR&^(O9VH3L4E*\$AW/LM[W8![!N\!#,=HX%+GZ-&*[JZ&P(%+Q8HN+U?QJ
MEL1<;?_6UINJ=^=^J;0)FRM@'2D2/#B-9=OGZ +N=3TY0CI&69)C/<[@(2H<
MX*CU@XZBV8I:,))3EZ@(/&2V3<02KA92ZK, ."/3KZ^G2];>9XKQLM:3P$%]
M7#!&S2 $[*9W$7IFU,13T=%P6LWM!2J>E#2.#&*2/,/;+%II/42*VJ EW8SK
M8 V,!W1]K0"PCO6HW.'S?.K K=%H4>%O>KQIIA[&I_F"+I0V]FVAX@;M[=8$
MN7N7U/9R &/5IQ_)[S^LC"G@.TO5;LHKZG[(K*DE[[+)2IK2,K]M\;=B24FB
ME:%SX]\*X#0Z%\UHJ)7@M.="%3*OL++PHM8E*6G\M,N'A6#];AS_Z$B,T-$5
M)5Y*Q *6=5^\H1DZ_W/P#)< <6J.:Y,(V\Z8Z3*MT7D+!>RK1(0=?\E '@[E
M(H=U!G[5!8QV3+'8_]AL2#2E)*_:U&![(C)UWZW!8)59L#"TSE\/^/"MGW(D
MTJ$28QN$_\ 6<L)M//F:5NIHJ8RPX[-M65C;Q5>6WICB"H0D[#-V,EW(<:-0
M"#TLZ7:O6PIA9L45QCJX1//)TJZ-S]S5;7:DF1G 4TX;%0U;(IJ:DR_Y.(8(
MG4*D]"-;W)-$Q!2@KE34J3L7S33G:8NK1$76]*P@$3-H@-H7U$<(Y5&3]=0+
M+_::>$P66L"*3KYKK&W-VN*X&LD!GY=&;((I</M,G6JKS5ZBUD <7AGPII"G
MSY)(1@]7-6$<X%S4+>AL^=7(=<R*O>VZ4,>#=F+>GF/8"0$OH1_2?J$9E97)
M<DB3%QG@>*:KZ_ND&YRK)]W3-(000'^H3UPW4U&Y$6!DI]?ZK*C:?"Z5Z6QC
M].&!^+HRW6&"DTL))H!_YQPM]"OJ3.89YDA&%A-8\7RW,MV9>QHC36__HB+9
M5#P>1'H=02FVYN 7$L")&/*C<P:6W/3K&?)HPSE+5/M0+)8JV $R& 1136-?
M9.4Z3/.WF4+D*+YG4FYO G\BU<LV(;\MMO>APR$E;:ZK0]N3:1H27@ OYW&]
M0T<I%DW-1DYC25\\K'Z[DZS"E39=6()8).?Z?_#B?X%P47LYFDB@4.BJFJ%G
M1WJ9>.Y16G#[$F9\LYKW%9@438)Z 8_<)WHGZ!B<T@(?=;UN4XWV/"$XMR(O
M4[Z-V9>CX85LP?R"*PO^S,!C9Z9?3.=G(Z%S^I>[P6@IZZ"YK^^REM>X;\@L
ML7QRP+'6LX6!0F%C3O2,7H%,K&1HEN>KGJ.O5]&E<<A9+6$D9VP_-5_!H"V5
M0<-A*A'_(>]#-44L'G<D=#+9>E/R<0"KM;0X^37-3@ICT)A?$0ZP:TF_-]NZ
M,6[]]<=>SN2S!%U];!/7DG5(]O.*;))HF[:T;\[2$19B&OM[]WZ=VNK  396
M'&21X%<H;Y/_POKE&'CD@JBK,$Y"6L\2SG8I'/@[!.K+"8L6VW6_ 10^I)V6
MD6W>Z50\XQZ?#A9XW3X7%CVHI/)K[3CK9S.3@PUJ/Y$:%#)&BA+-;GZ=>*_1
MX#Q4*#?57("$I_A)/G/3LZR]6!-@J#;%P?""KEY?ES8N."XMRPKGPZO(CH.+
M66U-6C[FQIJ^=P:1&KL^*F-:F9S@O6JP6&4XT[I!#%6\L-'>^6@UE<ODMJ&M
MDH4^2_489W+ ]'9;JJ[EHW$RNZ;7!Q5$O)S1YZKMO&(0%YS,89.+0-4[V+0"
MHX(5RQ&M5ST[5Q^UBX$6+WDZ QH+13:Z4/\Z:Y DDU6YZ#3Y]DJ]QOFHSE#\
MJO"QR&K0'FR%2TM,*#./P+QU6)!@)&RX:_1'<R,*#VV$6&*<FGOW']IQY6^%
M@JA\"II9(.:!><DB6!SDY(:VXWH)O8(^*:2.P>[864EEJ QPQOQ0>!) (1ST
M+U.3=/BEIW _,9VA#:RT(J2M1OWL?3F.A]Q:/>Y%1&\4R,\3X[C9BO)YK.+U
MJI(2/,"SC<&M13%I;,3GB[E)AHO^7$69E<,QWQO>VP\R(YKI)-^L.WPYETY$
M)XP-V&9QM29!-37I8^$4K0LXP#R[5D--D6!%19B_G@HPM=8-MYPOE,6C5\+8
MUJW7/YIA:HIT*C85"<O&8.[T)N 9%:H@/FURHSEW!KMS67QV\Z_+1>&(M#.S
MJX<N>WCU3-CS\J<X'/8+WKVMZ?"=Z>,Z#@=L_2+NI;3R:NW!UVD?,!D>HB(I
MF[$J2/KTAL/300K7-QC\IT>D_5QVG,^4L8 =\9&PKN2M=G:9GY&'P:+JVL9]
M\_5-7JD'MF:M!XG.%H7'D;-^%34#(ZXI'&$("K[M%D<NH*BXG\D%=NPWH,'0
M  5\F!WDD"^EWEG@A1=J9.T+,T&';QH#IV'2Z^71?/64M)9Q7>&J$@!@AV<G
M^1OBDY<$F-Q_9OTN%\?<S<D^B+N;4FU-:)>.PV9*Z\0G0.)994DE8E4_'LD'
M0GK]6J3$E6#@^Z2QX3=?X]5 WHWJ ?[R8TQKOO"\!#FR5F1W7&%M7\\"L,';
MZG%\QG;^0\7J:5ONJR\F@(>MKZHN;,4_)45C_]S+ :--MU4XJ^81G8.^^^N"
M'S;MV"KS-M/>GW1XBOT.![B'YZB[[A$_=9"WB_8X4Q2=Y"TW9SA]<F;8:AB?
MV0?[/>W4QD5("($%%<1Q%FZZ$%INMW=%'6;WH(* ]]$H8:BUQ93"/%;PF0.2
M*6%O2U+.A".'J^$ */FSU%?8^=!PUB^80*R"F&DPFDUS<K3Z#LM)F:8E0],6
MF3NB5YUH*/4$R0;&VZPUHA-C<5UQ;_CU6D9">!WWBI'EK3V#3YO)"XQG6O@-
MJ#F5RFCAW-HU?]M-%-N\UVXVZ]$(^@WP)I[W;0SE?K1\V@EV=QNJ<.  _0U>
MB[\XUY8?U:*\;P[C0/Y)DD[U 0;/P!>7^IK:7Q.3*Z =A.%Q;^)SZHO$. F&
M']:L&&B'Y\K[U$Q-I/PYP"X&7[S!>"OW3F:N94E\DUFJ"IM[.X/&^V3KIA!C
MHI#-J06(;[[NT:LR8<.3 T>U]X?)#UZV@>R=XB \>!:8/PM8EE5T"W6/'D\V
M\4=RDF5EQ/NP#4SSUJ*_ ;+U4-#5-JJTC[,,P9[;]')AA9.-:GXUN3VP-DZ+
M1X!;P"6&<1IFU9Y?976O'7E6LK8V*IX_!6V!,ML S?)8+'T7=9^_GYUH\T.R
M",R<V<1YD$!%]4PZ(;,5KA3@,/RO:N4 /T'1#&8:8/-#PZ_YBS!/@>C5I'Z)
M+1=>W9ND[<BWT9R^ -R5?E-4=>'2;"'BA'#;O:_PU]ZTH-Y5%<2,MFV#B^?R
MAB 7CNXK_L,X_0*=!D*>PHS^[,\2I/=[=<5_%BQ%&"RR42N\-L"6G(W%*S_G
MM3\Q:Y%0*_7N)YJ6Y34W1!^QL8HG35@:?23_)(W?$QT82^KLSA8Z(P_-PB3I
M1CSCHTM;/H=S&BS2LYM,_( @_&#<4-DF9.0NEDG-U-J)FV=KBUO^EC^1,;I+
M'<9(7O9?5!R\M*FVCY_?]K[SM&G\@/&E9$?;X#TI72W4SJ;[F^EZNT:E,XB8
M-6@+@],T7N2MNZD*A!J2)W(LZ$\0L:9T-=G1_.GMKJJ)8M?\3A9N^QR;L2>+
M[HH=7P,[QJZ\_:;U\YNC'0D;5JK4")C7Q'XNP%",Z+,JBB#%CSM7M#1:4D,\
ML_+6Y1:QSTWZPL54J"-C\)HIW5Z1TY)><BQC=$[T"L1S*YELD/DDVT(T.(JW
M#;O'(()E^]O.,-O*>@I/:G$B^E(ICL@YIDXLJRHCM#IG]@P.^(\[\W/1<>4'
M6G=O>*>YJV6^,S&>(W"H%@6QP;E=BG':T=QG(\_REN4H6SJR[-24M[HS849;
M3O&6;'D_OY4YW0DA,J?'E=F/7)"NLE _0C(KYH^L/!5AHD6C>C]59>\W2"2/
MMF(OI'UZ$0X0)>L6:=]==4>'=!WYU1]H#MW+RW;69GF>B:/1&7.LMQP!+EM3
M.)[$,Q>*V9Y*T;3!T!3)V5_C7,RU>H)8:"Y\H@2M"?U<!@"?AK5H$4GUIO.D
M'\EI-H;$W0XS?"11 )7FICEN)%L[T]9XS40&4Y-!GG3O;57?<KU^GMW^EK>+
MJEAVXVX=%.<G P4DN>1;(CE-U^6FY_6G<<6KBO8V=+(KPN3\3P<POP$!3Q*\
M)7L]9]3A&65-W<(+[FF;MN1SW+Z"6R?;I$:(5HP Z^K97<\?Y,D@B1:8KEMN
M0&.";];2[J^#*N$Z"+BO1F]5PI.:,?^3)E4QST'CZY_GW.9YJ-H8Z*GE!_:.
MN)&*E++Q!=HY+X UF.\SC_;T?H/.>SUQ)W*V+$6W7Y@U'8W5G/JKPN/D<'8G
M>C](T=ODZ2P%LKR#4^\/CR$W&8IH^8Y9V2JP^Y IP:! :=U+%LH!T[F;HJO%
MS9WM\RHCHZ1^!\Q[;[7Z>3:=UW5\\.GD7N& WNGK"LUK)#:J]F3V//JR2,TO
M;>+>]&]G>'>%9"<+7)?-8D0:0PG'!\]>#<KMYYQ''6''^OT4H8?%?M<Z7T]4
MH70J/_R.=R9)<Y*$2TOMN];\-;ALUIORJ9,1A@-"%BK,Y6AJ7=+KP''[&86-
M=+'\H"[*6:&Z:7;C<[XTOC9*5S;*5U3<6?$DO=U/ITA/UC7MOP$Q IVK8B/-
MOP%P!W>Z4HD7$(QU[LC]2%>>Z=4!T\8X1+5\9,#EHMUNS?FO:N%WH1I#@_-1
M$AISK%4V++:GI!S4%N^#CIB,GI@\7!3E%F%;7'HNSI1C>O&L2W4F-$["N=4'
M"P ?1 N*[\W[')>5G:DOY(DZQ[R,:\@&D#RNQEESW'&"3G.EXWXN6%;=FVVK
M7[!4+,>L26.7;,_7DD_QD'"8-H:/3JC?Z9%O!0B*P1]C62WK_^3#*@)\Z^:9
MTE>\]9:E(>O)GS</96:U*:]V;O0FWF#ET&UD_WRR3O4$"@=<>6.6>42<\)5Y
M4JL6NC'&+6Y]LV]3+>. B JLF6&_NH.=8"JKG[G)1%U=T>V;Z:5U2]+_E#'O
MXH?0_JCA[N1,D2CD.)L&^.'#4:2OH[-WNKMGWOVS56OU;/?MI;^+63(N W+)
M#P8ZE0O.QK?TL./SMO)]?-KQ*VO#6%WOX=57M2 -]>654?[$*>CFGY,D[/:J
MQF8/[OA&3<E7R(VE! ES-B&L5QJS51%/9U0EJXBZ@$;ODB-1PO,M"&1-[LPU
M4<V3Z7OX4./%QX:T^??V=D7Q4BH'%QNH7W6OT?Q[%4L/7H,0SRI^?1@ZB]0B
MM/!JN^BV8]$B8R/*MQA IX<I;"]OZDC:A]*&B)961\TE\\A'N7<OE-I1&^'[
M<*$K\]0)LQ4O'=TE^&96P@TR+@Z198HIG"?GIO$\8;,N)($M5J(+ SB^@]-!
MYP618A:QGJ6?:B)C&7$N8A8K-]\TIF@3=9S'<^8VFIX7%HC&V14**]K7@TPG
M0"5?W\W9[T1)EJXP/F]-1UO <O7$E-^'JEJGLM'(J XOONK>:V0E/EQG^ZCQ
M&U#^5KF3Q[][F60@@KAG.[*6>)OD*",V4W[@U?%(7SXVB*1EIUATKM>C['WK
M-,^QIWSCDBGCETF"RD,/@)<VS[8B\&:-6?K5\R7)B.-Z /^0L*53VLWW=(I'
M?K3:+$%'>=N*(VR6J+%XWJ75 *3\YGMO;]HDNU+_&: ZQ:"^9V7T6<_L*^[%
M;'URZD92*'!82=Y#]^".J[E*YMS_*5S0_-D1=W1X4VA^JK ><&9)T.*U8++Y
MR#=[3<0DBT!*WY,&2'G_&Q"K./A8OY?&FE"J:.[IE!(O1>5FJDG9+J$27,E,
M^]FK9D,;T;SH^,&U?;STW6D"EU'@]3C ^/O]WA8:HY".J4L2>Q7EI96(4'^'
M5)5%\H*[-@H38$MF"*:AZ)REZUN(2R\$@!+8/%S&NRQ:XNAKHUBZ,DCDTY]'
M/(7H"I=E\^K^L9=G\ ETP3'%G"=III5RG^@D4#E"S4!8\H-#;S+2A]MUU&,G
M$I;9P 4SXPI$ZM?!R.!H>ROTV)RE]3,IK^L0(I6PI;-5WR(_C)%>GPI+9B53
M%Z5E69$'YH 9^,[%;1*G<I_>G7+7DEE^:U\O-4V+J)IE 4,]Q[8W_>;4NN@S
M#; &@[*:\H*KNTJWV]K74=B97QN+=AIBU[II'1(^;:O1YL"*S.8UUGP^4.)?
MO#AZZT_+Y EKNS2IK N([KFUA@BI9]$R_O)V8MP=:/;(@FULQVK,&$&R>9Q;
M44;1^PTP-^BE0V.J996N-QS>7/.#(+.0]VU2=:TU!HT#+(X)R[\;UUO:?PCA
M!!IG) P6&%JDC0^4^'H7#GH+Q_[DY#?7(X6W@7C(J\9HA5R93!(.1.Q^G/JH
M;BF*!S6Y@%N('ZRA:XR#"1Y (E9!((DNX0MYHJ2]6DTA]G;6#(V$KP[<0CEN
MSC<;S9/^"'EUGO0\$'_K+"4><XK%ST-W2ULB*&'#W"<7BGJ"WXT#5%=HA[9!
MN&=HQF*E\:F0O3*\YV* X%6P1ZAZ].[HT*M1[/ERG0/=QM#3 MZX5#5#V<5V
MI+)UK&E7(A&ER\O? *%"\NM^@)MK-\3*G6F;ME&;D@,N*O(.IO5HVTY8Q)4N
M7/$<<91]*%,H#;#+(M90[PU>2>I(%<Y) L3H)K-A'>$]*+:7CHT*-%VF=N^3
M,!5/7:.DDW">$B".DV_'>/6%=C?.SZ-06_E-I;#0XQ]Q@0@2+.\>["-M"?=V
M]U11&MY'SVF=#3"Y%^LQIRRPOQH<H8JA;!'[86NOOK#1VA(53QT5&]A13_9$
MY;ZL^6-O?78B6ND+R/'G% +6?:<JM$T,8VDWCN91.Q'_7*:"Z7A-N6=OYM:[
M*$T C[7<.R&\8(N%2V6V#JQ*^UVDLI=>8P!XHKLO,2<LU^#X/8^FS7*8JF3"
M A;]<1#%MVP<-27E-24]U:CBFI60/X$57YJ$)$Y-*/:)#KYA' 3%0^E8=HZF
MJ;X!.S\<#R@^(%I'%\PC6QZ:A2/PU4,S!A\'F.HM6IL]:%(B\J.&.2)%BHHX
M0ZM6STJ?8IZ4R#LEF"K*8%?$65>4ZGQWOB!W&?P._:!KDO0&.%T/H5-[5 SG
M^HRI&:#_Y8_7'V97#]R],AK1(0M^^%G6/$]FIK76_9VM> 1P4E3;5Y6-LN>5
M>5SKPWZON.R6D;<KM)31CQK<I 900#)=.C[?) &F;&'U$+^] 7ZS>"#5B0V9
MO5<=ZXT0B1>$T+N$6I9E&33FY0CFU<?N;)QCH4LLLS$<TW1@])7HQ7,792,,
MC%GSS<P[7)U"Q/,W8ND,K%K;-X=/"+JIC.]53Y</4C"+#:.A<%PIX/P-Z-6M
MF(CR+GJ5;EWSP\8-5^RS2WWC^0<5>7+Y8G&._1)^'*"WPH+Y@C"D86ER<5-*
M>U!Q;M4\?%N4Q*)SR0LOG8YS%9.";KV56061;)MHB:7!OT 8<W^/8?BI+'KJ
M29W_0GO1MK*HZ7/%VF^ 5ZLG;/BQL&KVVKI5'$222"Y<2D6+\=Y$*Z5OZD@6
M(SZN:SIXZ1B$?^D1<EBU%WUZNX74ZQ/ *KVO7YTG=V59+33<'D;&ZYS%% 1U
M0=.]1+*M9%$H:-)1!?2[B>+-F$Y??VI(&N5UGK0"S+8Z)==P9KPN0F@+[2.\
M6NYUI(">2O8\STD./1W/\WC+LG$O&7UNJ(4-TG?(PIG#ED_KMHWY\N0YUHP#
M7+RGTDC7FJ)J^A+_<T#9Z] Z[5P_R3G?XC? K)E,]-++N.7O_Y?^UXB!XP74
MT^#4_?,#T*KR_[ZP1X-?\,_[Y+&2_\,M+CDE5K=>&OJFJZ.$#]79*-?:0F11
M=0)ZC-\E$\[ R7<<>GW4P;TE!Y( 14E:2PM ?AZW60"RKL)T&D"7?ER:>1C5
MENH;,H(L-Y &-\I\RY;WU_4R>#5O!&,-H?+[D5N+#:DMM(S0*PW0+.EL,BB(
M^1N0<M IN%P-9;E!<<U:EG0QBI4$Z.;G\2@]:M3/]J2G:O(1HZ8!6B5-)ZL.
M;T^PAAW"/SPVBUC+Z@F&())'A@-<<5+SN %U:F:14S#3.G?+<\F9E-+.@GEB
M(&7=--^WZ^L+)YPR;YC-';-1-#3E_]@[%#K>$/=!656K]@6ITUJ, UAP4@NR
MX?IQS&K/ZLM(1#^$;[E(.P?#W62C$2IH6IZ=G%3X33-_-!EP)Y1'DUI1#9IX
MZ2ZQJ@)?KC9CELH\W9.>;UAV9 $CQY@Y4&!M:\7Z(>F==!YIDC[$7SEPC<[[
M$V9SE\ QB-!%PT%/VA%YE A!B@!.2_$W(+PNDW>GV]F5V DV,'\*80Z_W)H-
MUQ+O,FRC+2KC&C _1!X9],(B0?X?+ 8'1B9TE6[]6FH\25*:;(^& LW"<TS+
MEHY01^TYF]7$N\N6LF$B53-FIF#4IO]!\XEU_[$Y_)UHZ?M9< !J:M/_C&EI
M6/[Y='9BW9\-2.&Z]'\_3_-_(8F9;T_R6Z^NT80G-K@P+X/6 _@L*MD4+FRA
ML[EK8$:IC=<C2\>J^A[+$K[4O*^I2Y HI5@B51"=)1WX_#$-&VO"50GK*C(*
MK<#VA*LT4 9?*\IH&QN;A/D H32F2&@;V)UD1=K$BN;=Q)Y)>)C'!;94VJ7%
MG#[N*+U -OI6^&:YL*6[J\T"FWD#I:A$PKBV/['^BBQQHY9%\JECJ[_PHPJB
M?SN?[2K789JK9\1++NA/) UGI=B*RS]97&%]1B33: N?@<26+.H$QA_4!9S2
MET-@]6)TZJ_P@ MGQ2)H:@M/<@^N([JZ?;1-)E'-_0"7Z] "QP8_3M=H<7_[
MG9'L6 &!4I.!NSP\K"6@F?+#6!K@9)=]9(#.E.ZQN40#7B7;$/D*3;HOH7<K
MX#9@A$83.;,6_& 0F7I*W0BE>"U3K(>Z_Q%$DHG;U1C-NN.6M3PFDIME0%<@
M7WS_B]XVQ]NB+U[.+?@N&WTM4[L$)E-?L]RC3,^LWK[&4SQ?*>I,/\6$.7Y9
MZK)RGBH.]*;X7T6/<DX.I=P =C8?-DM/CJ14:%:.LN[T;-V*+^^J! R\BHC@
MW-$_Q0=@=&MBC&Z19:&X-=-(T)Y)O*)!;L!KUX+_:O1"8\$!2JC,;$#?&1ME
M1C7Y6JTZAFUKZ =H)/[[5^T)QZ!U8%_%Z2+J3P*#)KJ)*G#LH-AWU>0]Q5VX
M//^]$V/_/PF&\-(_RDG0XOR34_.DA/XWZV$_WA!!81K5=((#+A!:1-<;=U),
M^;XTS:_#&+%KYXQB(1T4S0T-4%M6@MU'IDWO+#P>8C&LZWMAZF2._"BQ>&PB
M##U-#&3=[X=99',\G;4-/_-7RWYH3,$?=T:T1)6UC9LVS"D+Y0GTVZ_[R&*"
M%U=[WQ@UF:K)7=.VQ6AT_)H]G^N+7YV\#<0X=7.<;Q5ADP?_!H3 J(2.?1R-
MC/;  2[=IVS!>7&[Z<M]IFX&!"!X;]7<?/U<NP09-+?'>LX)F-C=CM/WW&@Z
M?0)OM9HVJ4TMYE%,5NFN7M071'C$,@DM#S7!:"C<9J.?=:\+-BV<KL\?S<U(
M3HYAHT"B\_S?I)O2C V^"J)M4]]<+RHN^KP\(V#:U##X,(A_II^S7<9PUL;A
MB-8D]+"A@HCB?&'WLR >S(3H+3,Y]DN5QU[O8G/N"9-G+ZMH;)?8)-9QW)F4
M[$(T/>]>[DJQ/3AX'A]^T7,O[[PPSATOJ-ZZV>1#M'9<',=B-#W,;T!W<R5K
M$;8R"I;G%?*CUX+J1:!43.^[,MR-2XQZV?-HEBR\&"=<(6E5U2>#J/SSO3FU
MI4F ]TL>LOEQ\W-=$SRTEF 1X%=_L)"VE[IQALHRPL$13(377&X/[T$DU33%
M8D=;$SFB*4OC.6[V9#!EAYYDSI+Q;F4%(Q/O&(0:NK7V($^\H(6>;+>(L8O9
M+W^!IP61EIL]/?E \2&>J_N&)ZCRODQ^3I@ /<42EJBGE?>',#&R777AFHZ'
MM$+T!^,!F6B.%^QO'U%) UZ#M8GD1'?P/6Z_P(O).[\I*"A_-0N1)0S(-K^7
M]/P-B*2,7;?@CXH&3B"VO[^@ML^_[U6&5FZ9U2^]IB,8>!,@J,BTE30,Q9K5
MK+- B2Q9^@CF)14%QV J%LKEO"5F&-3=\-$NT_5HU9D]N?9(395+]LTW0>52
M>7H[>R;,YVY> J;"LSEEI(=MFA&EZRT^YG-3R-%"?5J\Z[>XEQ^8\4C1;F^0
MJ?Y?[9I[.-,+'\!_<V^YA"VBN<PE6C@)N2VKCON9)FRDR<PR,7++HE-N=6P6
MD>I0:JGE+C)"$C$CA)E[Q9!+XB#7]PRO?]Y_WC_>?\[SO._S/L_YX_/O]_E^
MG^_W^WRO,G4WC\_/<:BWO^3$YLZJ#V.:MRE3IWTCNFSZWSX18'_;>B!(OSQ'
M*UU"^$<\PDCJ+X4$$@?8W1G&"=/FIOW4RL_7U22PFO4?+7: ./K4">/!\T?N
MQR2Y*CDX7FPH5-D!FA$PY\;RV?YO\^%$*1QA+DY/Y(_$.F?=^+$#H:/&T,B#
M/_@JZ?6&HY5E=:F-G?E?'WY (G2GT0_0&[^4&-_AL4/9VZ8^[9SL<\+C#UW(
M:<-9X$(QZT?=DA4;$1<2FRW]\$VC^2NF#R>,E!L%020=YXX=( SBG]VR@2:$
M!0B6>_7Q"QV@%=/X)1_>."SB#/\7B@[;^<=8@+HI<"9@Z=(WQ(967_!C9=U@
MQ*8_]F7*=9W;H/EF^:NYI+/5YU=+Y;@QJP_HD5LV+CS?0,-P=^%SWW'6@$E;
M+G_%_)"=7^Z1I5X6$',CT1I]8USO:\:WOJ<HN\^M."UHH] SVU.(9HFE9QZH
M%?T>-!B<ZT#!P.,Y5]5;8E63I\KX EH.X4Z%[V[DNDY(1FU<8Q2?OJKUZ$_<
ML;%114>FT$:I9-?4U:E\ZF_CXK?RQEI-_HRZ4JNWK[1I /*;T^-V@<>K=E7)
M=,P];@U3YL"VT056H8]!RJ\/#T4H=YZ>&%7%XZD^7[XU6]+ &:C5O%&O_ U7
M/7G8B"HC8KC\#X/G-C*$4(-Z+TAZVB6@CR=TBPI;W%3'W'S?7"@*_;//K>7X
M=G02>]/W(HKWVL7*_>ZE_NRT]V]B@WQ;R*Y8VV&J1?$.(&^KN>CRN\C1$T%A
M:024&E>@X-UD9IOJ2+MQCSJ:/'^#O6U4F?G*G,;2B L:%,*E%COO:"1^W564
MRJ6M0G@GC$PG9[;/?G#4=&3*&*EMX+;EG:THWBXU]YRJ//=/Q./!0B>\U?O[
M;F4_#/UM :*%;LW+@U3.-6(0Y=GL9:L*LSW#]JZ>V[J+GZ?22*RLZ$*XAM\S
M\]W68OW4!LN@OPAVGR69Z6^COS<>:VV[M'^Y"6-6M9\QB.'DR%J\M$FPPMN?
MK]CWJ3T"KIC0QO!XN'4Q*&U?>V"4256YO<)8X;0)J-=;Z/+$@_<'?-FAEO&3
M)FYP #&F#KGT&J>2Y(:HM<%J+&&HAK#AC_E*'5&D.T7&$S8&^$6)IZ$!)XI(
MEJ\Z!L%FC\DB>3>O>>?/*M7&5<9/DZ*)][1!U0.%5'6N%@?N.<G@6J,K;WVZ
M4FHD>%M]"!>=/)EEH;7US.V:T>V)I9"7F:0+R/+T>91:JWZ@N,%?>A;X*TC4
MR*F-G,//2JA6:V>8P5S+Z7/?5%,\2XGZQI)N@W1@J=UA%6;X<V7O@L+X%Y1$
MYYNLB(5+.;?N1L&FF(:E8M++"J*)7=#O9>1^['*H T:=I3C3CY-[*SCUI9HI
M)_.&C3Y:<BCJR)O4JV,# :47N 6</%N2[#H^:9Y[$+M.NZ:S]6+-;TB>2*,1
M>*^#V=[.#A/-^F_=1<)0:B2#EH)?D7W% _+>MO*'H7>GKB-M_3E$C>Z7@L'.
M3.'FRX '=J^R0TV?HG>EZO5\3X#NT^WE^\59.+<MF'3M.;>5H:, P3BBPCB7
ML[^R^OJ2E!0_/5]^X%9UE!$QZS.BDZF TB3SF<JB4'<R%G29TIVV3A;MTO@L
M1RMY[J_IJ2>VA9 PT)U"8C>Z+FLJ6!DO=&D,5)C=(R\P_/!MW>,/3Z21K"2H
MF/11"*A5:,WK9. R2,GW&MNLU?3X78/6A+6BI XCM@12_,K:6H^WG8(V^%FW
M>S1V_WJBHEU):A8$U$!-Q*C4+!?/.[I;I>3#"D)6O0,6,X:T-3[MDVAD#$3O
M%B$1J -&=(#.(%]!&&5-ZE[/!$W7PWJG4IHO!20_$M>Z/'MFR>R)R;;.#1TI
M]8"0A+>P8*9778_*+>[YLY69<L>S>PJN$<V9<A8\4ZDC=7K];K8I-_%O7(S1
MA, 8?,.[LL"GE!>396*1T+DSN9YU]83X8RL%.T#%_&O-Y0?ZK1,L(%S-^"38
MJYI!\5(T5UOM.5T\DD494X\YN?P#5QK,K$55P,LDM>#9M917#JE:^+9U%TN,
M>#W_?Q3*_V^(72STF:VJ30BNH?E?.'7X,P24IGYS)7DD?(B;OMU:HEX^LJF&
MHHGY$\FB4"0$E%P/[9FX0F)?>)*OX5>S QRPC\T+E"'E#E4<J=M7*'L,WV?2
M4K(>9P*:W@&DA?IF-!*2,QD;<LAWFD&D?X^2V7N&S_V'.YC+!V7W@"6=S@%=
M93W!)AQ.,?CQQH&B#OJ$M#%2QI(.M#QY7XOL;'CL_+.A+%6$?:(QV*#^(]QU
M_U$V"$MF@M>JL&NNR6,,>&K#6?S@R!?NJ_&?YF9LO7+CX E?$.3F,#T/&) ;
M1"W5TC^,*/@FU;D[]?IQ!&@UU2=LG=S-K*Z3]'=A+X;/%Q:7%1U>49[%SC#!
M"C-KQR#&J&*WA4E9_?48CYP5-70S>(X1+GX^-\ZXV-J"-5M\;GC((RT<5(3+
M)KU@QAL2O""1K461&/$]D4%[GGH^?WTJI=LW##M^RQSN.8')?P: ,^A PA1O
M;W5'1$MI7H5TO_5UF6Y!]0]>9_2T]03TG2T05H_LN<@76JU9F6_*/C^<VL#W
M45HD95JBWXU00#E(5.E@/I(\0@?\,5QI@A:J4!*0WLU?['JZ\@(<YS;(Z*/K
MB<*[FE3022V>!AB; J"OAMWN3,,Z:F)),V&\4E>4% 04/_RTAIVPH'5P"5'P
MO<ETUX_Q2HF1#B'6DQ7XS2X-O\H7O?-Y<:>UG8@PI8,>V7HBSP+OWPZF=#CY
MV331 WG!V=W#ORNUV33%X\A,Z910Z5GLG3I7;R U_"3'\ZY]^7TH;>PL/5Q"
M?'< U*(K"QCV*@)4@TC%@A#YPN?CQ>HJ^SNKVF!^;MPQ"AMFUI-X.DB9T#T/
M]9L[4_DVI?TQ-&I%PZ-03U27VQ3CDZ,9&TO"(ELE4M[)!.)>[[7N_^#OQ@<0
MY^A 5^+/O?.?ZK SQ7:R0+YBDZ5[-"6RZH,.,<,.X4,'\BBLH>&098+'YP'1
M$H.JK,! A+.T4RI7.[Z_I.<_7NS_6TC9_MMR[F_^YE]([@S]$U!+ P04
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ML,$%7U$L,'Z!OR@6\!]14>[\Y.IUU<)"C>FD?;*9']OC<1!S26/C7UG,I:I
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M9ZMLGE9?D&I^UO4+KX*#*A,&=$4I_?RY_]4!3*W;AL(-5/[@^. 5@YM'5XL
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M$=>CIT6E (^9%^#B:?;($%FBJ#]W13\T?S5-W&ITB:+BURSV,%%3X>%A#_;
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M;&TR)W<A:YGAN*__IS7WQ,98B.:/W:=.(:/=TG#WH[Y.E^H=3SD=? )2H_P
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M2A@Y3*JW*_8I#PGFXOP S<N7QY/]=?JB[N/KAYS,V7_Y'>XM-9$_<E8D-%?
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MNH'5<J?,OOSM"@.#,M;X@$AL6._V5_BG;L9O31JSA"7 M:;IZC:P5J>IY3M
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MMTSF)E[8-I)*G3FO?"2X/=>8RXJW9#]@<5G$&7V0DMG!MH 0>/#1T%R .H$
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MI\B_&^5%6?85&&<(<B 8-"5-B5FDCP-ZO )BKDF?IG;KE3_\&9T^H")L$8^
M=82.+1;%&;OM115,Y*52?GJ+WRM81D-4,?D&F56TI((99;8>E'FO"/,ZVVE,
M<<#^E(Q)0QA;(V(R6LBH.X#>I. .,**HO>:IT >'R(0??GN%0,-4(%O' 0G
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M>P5MG/S46W0U9]WB;!QC4;2<_&6;NIC3L>P>-_[S#P:27SH)&.VXB&715&4
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MF77[% JN!89>:2L;,9M5+WQQ\W^8/.MV>C*>7B3&5JA&A(8:)/N\UBHQ7K)
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MB%Q>%K'W>2,_BSH8FE5)O-W)K#AX8.?RO4GVJ#!"&SY*J%IDRW^N$XIE^8W
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MHCG%W!UDUL/"C]B8:J$ X\(J+BUD@=X]6_W,M)5!ZN6(\IJ^WDU4AA9WO/%
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MK'OD6H.25(\!2:3U9'DY++;.INT$"]^YE1OW5>SQ/SNO/-#2/2PSD3S08'8
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M\2X4KI&+/<8/YBSV!->6LIN$=^%'S](_?<ZGE^N"Q?J^@5D_8E/S?B(]O31
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M>76_[Z]R7$EKM [LPHY[.N8L2]"Y^27TS^IT@$Q:S!WH#M,:DG(O/_H N$&
MU64OP.>DF0B*7QWT'?)[Y@R:V&,K^(_F>*;^ *B:6[ZU\R#Z7;+^SN8:EF'7
MV+D@PQ6R]W;YTDN4%/CG7MH3:1::/U>)8)"GYY3^@Z&_MM6FV*M/H$.VHN O
M<58=]KRP.FJDCQ]K9K#2^$0V1G:=HCYMQ,"3B^BSQAN#A"5C2'6_UJ\291M
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MET*%;YB]U%)NDY1E]VONDVP0,DQ(]R"!KH6"[#Y]5\( 1$1?9<6S <16 Z(
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MEC8?D;IG3\<(>YNR^H32.[P;CC+PY509,T4:%BH7@1'6WZ]]L]H(;LFZ%J^
MG?77Q)\T",6WH[MI6;V)=NK8N]E@\)8P@,MCPC->KY,!MPX[5S9M WQJ98$'
MN69]Q^K<I(::"$,WCU7ZF@+]!I]?$[M4BLG:.^6Z->H4Z=CUY$&6ISB&CR>
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MU"(-IY2!\1FSTW6EGJ2? UH6(N7S')HLR:W#[M)]8R($F7//K\&URZEH1-M
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M[&DYI(!>C+6%*WQ@H>C=A)A=S'J<9?;E 8\8PW"5[Q7MJ;B8P8B]D6IA9.T
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MA+!ZY]S5=US6LT^$^J<'0>7P41&8YE>9!<+O4W@K^CCO)MU_Y,BKX?FB'0P
MO,>C2KC.$:P'I10KW?W"/0.N2AV21/*W#Z /ZG [,!Z>+6OQL+33$T+;Y.S*
M$Y^*F+L4W#XT=]+Y%&"#U_,#]]G6J#=O(\&R(!STYF-*^BO]5I_OD_@M67?
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M1-P,59Y=$OES$HN<FLPLY$_D?P'_?PQD\Y4V]E'Z=W.P_XORU_TFG;._Q/7
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M#^](_1C%9J.'74?"TTX13G*/]A[@WF LT;1\(QW02'2DN;7.K&CU#M3,!L>
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M?-0$RM+.::$2M!9)+<%)JZQ+O99XK<H8&T/!54L(+56I&I5O!@RH6ZD3FW<
M[O['>KA&=F]V<#9ZFOQX,T*WI'4/%_6=T5FG*W<[!+4F\$.\6RXG__0S;8]>
MX+@E^-HYQ6M1<K"IY4>6!$68:Y=DG,M%V#5*H<75<EU-2*_UH!3D+6S O]XQ
MDK:Q-5 996C46\(-$60Y><N;*)MGCEKO1>!LVI9PQ:0EI-8:2]K'(<30T$*#
M0*4G?FT:XJ^%EM+Z>7%B8P VUJ%<!Q;^Q).*A>K]+/*^LWV[X9R7Q5@2HT#E
M=8ZN"(0;;C5?L\C^C8OF0$X^[)P2\@Y&T+Z71M#/M57WOB/0K*?8B_J:I[:Q
M&70@:<]'\U5E?!CSV1H><7N]D__!1IESTADX?G9^>4T@ Q9X8)FL7,NN+8.Q
MFM5D"FF[<=P=<[\UL[5]$#$QY2X.^Y21L;# N4^PWD?77FLG17F5%GPML-IW
M"FTHXWE[X,-8MCR%LKJ S4VP2QBJFQW-U,<U.+&(@*R8#(\OW@'RGY[-<5 1
M-&A7+^%";S0/!<9Q1]+7W/"_HLRY"TU80R4Q]&]R0BG:V;?&,!H_D6LWJD=L
M691,RHDW6USIMB]2U0Q_L3=^0"]ZW8&?1[J.=)?T\[U 8K/N-DR6]L<1F][B
M10I-U4V5X0<;[\C--A3U[.ID2X56#D,]LLRQ\'8K:BG:M4REZ#F=(_A,UIXE
MV'F;,GDZ[,]&=N )R<*@5; WL?+Y8./76SEJ\*UVG]*?YWV",^P1*C*+ EMP
M=^ZIG,273*K%[_; P-&I9# O(K#MNMN&Z9,PI<_C1@NV".AJXMOT.^!)A=&+
M;JC'O15#]+EMT6<ZY01,8(WY"%O08*,*K.)2X'7=&.D"906IS$(ZOGUWO4%X
M;K+ *)A(_3+@K4MIW@^O8R4!@JM=R>CBD&8RD+U4C&324&2]C/R^._<*GM);
M6-.&/US8A9Z1<7H8\[LS\:T,V1W@?@>([DKPW@'%?C<KUX5>..[B$U^6" 7F
M1V09G[R5O2AI"5XD&!>3&J'67JA.M65%2X.)*0KY. 2/FR2A^"# Z]>D+F31
M:V8?ZSY09:5T-FA!W,5@T,'0#V+D(U%,RD_;2SXW<R+4[)BO:Y+L^2[#=(T@
M\L"VF K\Q=CK)-8#KU&AAR+A17P=5,6+W#"BQ5"G%TPBF+-UX=PK!N4>KFG6
M1"^ITAIE<MRDTX(XK;X0Y[*7MOG3/8N6HA=&O.Y[TSP^2ZL8;2S&9@P^Q1G"
M1G -X\[KEDN$JT./_!.JIZRXO@^QQT:1NFIP$ 0D369\+G+;;/OVJ^-+.GY>
M5[U';AIL5:.B^^N*;/>:'N0'Y)+:ZR!6*PN1T*8E1(=%)5W)7\%>Z(NIIXG9
MGH:V:T _=3OA0%WH8O)9&G#=^!\5#_,4G+9+/6B1+Y*\=AVX/=!Q+?GS 9#[
M;R7/C/'F6!JT*F9)='CUN&X)ZY6UCI7&[=DP1A[<(-WJ8!GZ<J#]TNI4H"!K
MFBLYM]U"9)HG*7S=3G+12'6'%-&"P @@^=?+QX)O]I^YCA7$$#U8*P%<2,<O
M)E,98QV*!RDC[D-D8//VW;EW0#9Q7;+MT <#UY5#!]V@NLE9C'>V^3(6IP,L
MMV+*+HM.:)MG><-*GV](5&0__/9:95U51_^!I9>7]@_!F,;3&GCLO/L7G'<
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M2]M4&3HWJGK<:/IVEAY3&NC]^I+VN^6B/_SW?M[GJ8].( #"A&0@,YM NJ1
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MZ 9567-Q'S4OVN0FJ%8ZN\%P<#RA$[BGX:<^27<_TVC!X<?X9RZ4P'.A6:G
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M_E^$]+M-A1-2X-7W5#!4-0+;)YYOFLES=%G3-&WZU*68OZX*%,?CIC'IQ-J
MP8GD/E^VT4V&_T)%S!_)"P<%ZP]F>U_WL!=K047D[A',<59,1P6JD04%*$8J
MB-,'^-!8GCP4>7F%V\>@QR*E3U"Y)B7ZCZ&@V9!LD'.N*/B'4*A_ZLUCZYS6
M+5<IMQN?*NB5 C)X!=V7<PB4=_>1G.08EI6*D<WS7S'E_4N?2B ZM7=6_W<R
M^1+Q]8RLN;V,.9O,*SA*8OS+$.CX'LUF>WPP;>KG"E,UO'PLO68?3_YUS\*3
M$ <[%RPT0UST$7)\?VO*[ ;_LRB\)D6(U&;*2N^38/;G/:@*:[1.KWK(O5]_
MZI0$$X>7EMR'>5P#B.6O =4@D])KP(63Y-4FXM_O\?@T7[FIN"1<S3B@;^6!
M:8[.K86C?)9NGFX(1=C59N0'L/^F;@CN-K:4!:7%_@5ZKDPYSM"#1D$?H5Q%
M]$BE!"MQ\E Y(!;J/\W8#Y_OX,;+' )59Y4E&/3E>+U--$98ILMFOQRX![N+
MF7$*;7*6]C-&2XPO_#([L*?BP-XZ_CQS<FT'*OSP8XP+YKK&8 GU[:=DS;VK
M,LE5$;]$4&-(@(7[/)E+?JU+I!3PZ\62[_V_^\/%3AQ=H\N$2FX,A"\-R)8B
M(F1-I VK(+<WIME-&M]Q12$+T48+UN1-OY3><,.2TP!^?[KXS.3>-JFG:Z<B
M>&YI90ZKWL.%'=W82#Y ?[7@J;?K-TYG)9S*RFI>'1'@U4[V3'^D:U^AS;:R
M$O8=+  U6'[Z^21I(-CDL$) UV5P 1ADG_4E4PZ4&MU8-N*MIU.TE>(B?G%2
MM\KW%EPR^H 'F\Q+0J[J]@;+O2%'K^QU^2$NQLQ)W2M5[B]',+O7:[C$:)A1
MQX11-W,X_/_'+7.H[WWIU$EX'1>!_SK4"F)"OT%)'E1%G34>2F)B]_2?'J+^
M_^WS]Y-0D1_M4EX)Z5Y5W9^[> 0OD'*B;+Q+]NL7[!^_L%T#WKLV\UZ),)\2
M#P*QE,4/9O^M>9_82U?/=H.A3GD,?K-] @.-N1+*UBG'R1@B^P_BD=7/#!(T
MY<^0&VD=@]K7['T&S,D,M8;*71_-<[,G'.&_8W/V5IW U7WBT 1P0!H@Q$'<
MA3HG!@KR[*' 1)N<EQLUU$3[+)[X$KP$W0(>=M>J5_=>D8Z.U^RNV;],[N(P
M/.M!SE%PR#R.V<^G_:))7;5[YZ-[N1Y![K.]A2>O<9JL>(B.@_CD7)S?%&Q"
M(=133$1N]^":O4'-A"*>] V'FW!< QX<$-BXG@6EA3;MB^42B\L-USH(H.SB
M[@KZF1VB/NA##35"3$U-35PB,/H6T5Z8O*8R(W^Z>_=EG<ZIGAZ'8_(]JJS7
MU>55@6VWVTBIO^ISWPIC-$NC>^@XDM4!F*2ZY4S+?O$\390Q^BRHZ//Q*R]V
M=^Z'*HUAG_2T0[_L&"$<@%RKMJ)NURE6^52)7PY9HFD$JRP)[5;8\=]E YR]
M^$(LAJTF7\W!8WO\@B.B76I<T=KTVVQ<BSM9M&D'P7LS^N(/NHE\3,07/<BY
M\@^1Y9$LZY!V-:9RC\;I7_I6E41TZ$ !8:NJ,6/ED L@C+_,/X#7:.]>14@V
M%L+J%Z\^R+X,ZDF<:N&N^A3)<$:P*ED@E^,P8OQP>@^"&"ZQ-_X\GVG^VE ,
M1Y5F"$I [B?[;PI4?E.5IIL*S9H/]@H.73J<\MKNK^/;A+N7(*R7O(VJ8A(4
M5G<(XI.R@I[H=!T-S$EF!"&096QX!-F SH;?\_'GJ 9)S%%KUX22>FN*&"$.
M^B-F-S%J1C6?Y*I5!8#Z#R;YO=BVY-51-]:'^ZHZ%!TW=<71-43N82&P/]77
M3,/(3J=$I"RU'/.M%(#-[2:/<('>@@QM>D)D^CQYX]\.]-W">('FE.1?(Y,W
M>>)?(YA<U6)UC]B&9^'U /.ZYK.=Q&)]TP(9[,;'4IZ]SVZ%V @19XJ'K:L+
M-F(\FC+6Q#T7B2*%?8M[I>\KRAZ@G^DJ5?EN:OY<369O0<G5R75F?QU>/E:H
M71H1\8"];9TG$9IZXDQ1$89_IJ.K+-=L&N:GO$OI5W 0LLF;I:]V:L\$O%FW
MIO>IB#C I>_=W5;N?-:FV(D]<5/H:A?.WJE,]')JDO-:R4F&;SWN%BY;NR<W
MT;UD%#:Y'N5XQ]QFY6U8 N+S:T!($YE+U$0R/N! CO21YWK2J_[<MBU;K?=@
MN^*I:X#1F-AN4),2:U(F>_^)<.,QSU24)4.JXQ:L3A6% 8%K4XC(\\G!D[[A
M)%?V7>RK2IRLX3Y:I\<6^*',/K>'[= V2QLB?1TG_61AL8#$T%!D2JQ:)*?$
MW'S'&(WA+;9.I.A1>BV] A8]SCY/?KH'SH1]PU%?YT@P3]0:<8;P+QL5FKCH
M4"4#E3/BTG \C/F>=5X#?%F%'NDY0\"[+2<A;EF.VQL@+?K@13S:@>5$TY$5
M0-H$PE>R_3P+K)-W)&@KROB!R9_\;4J=8V>2B04'-^,4R^I*Q0B6_?$%[ ];
MP(!#9]H/.Z!2MSQCNC-O#*)&:]RNQ6:K9M-,>#M%&W#B-7<-.!$YB%9[4SH?
MV Q-@H. Z?F*S?,G=D^4,7;&&Q]7;?LQ,%H$KSX4]KS#M0QIKQWD4YLCLE;3
MP(6EU^@^F1 =@  .9IZO&!6P[)1#[ *T'DT:\6QDTX4!L*'JJ+$'8P!J%M;
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M4FVHED#=-->->^KKO:2RWDZG))]-\])N HY:BWMJ7!UO[%9.5TPE^EO"3QQ
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ML3K0'DGWL[S9F/-.3'^,![MO6M7L,WD#NB_)=[?,7M=X-UD];,-;RV.AY<!
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MC-:_M?192*W3<//#^_8U.7:NSRIO9"'KW3*NUJ(O0595@FDIGICU4#^#X@T
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MKU2BBR1N"&I(A9;,-R&@SO/IY\&7^;J,V90'ZA73D+LV]>LR[$MQA&?I9?3
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MJ^T/.KH2:8\]+XXR.<[[Z+;\%3M"?=M;H( F^/U6Y'1,U05#!]_ZQ(9ND#C
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M^<32$)YZ >ZX]DV_ 32VT4Q5BAP<X5X=@YHN0_K/UNBIQ=<N#R++CG=+5VX
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M]L/[M66!RG<%5PNE\Z9>7!A7AT$&/N8Y?PE[A.=Y)G:F'G5:1I$SMLP8+B$
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MC:;XTDOBXL/30 =;^QEFYISG2YC^N@^C"Q=:=LQ^S62IL\W]G#J!F?S+WB:
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M6P7"(MP=H?O&996;R;O^3.W]Q/UJ!A%ML:',=%:X4IDUA6E[.D*H%SA;!R=
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MHGU9B_NH&#I$+QNR]:6\+<%' Z.T<@VER!_S5[+N[<I^2]UKV7B, O1"*_I
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MF<UL<I2;@\3DC6D_SS+N^CT;%3QD/-*MBX*TT3&8R/O\'8;Z1MB]]V' U40
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M''\_KG ?S_:?#-%<@R)VZ1.HAWSEY0.P;'$C]:-9 /CS/$_<"]B_:_Q69^.
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M[VM[[B"AIY:Q-<AXPC,L+-C-X-,WDBW_ &QU+NU\&SR&:MFY1N#6VNN)S&>
MN&!]K/UA)N6VY$]$.F86;9LAAP]%[H:SN&0DX02B/YGY1IQX\[!OX+<^AK4O
MS!^YF@ENABE80]MDV]T^ZS#,L>*?\=)@QP!NB/S10[MPD8G8'R0G-!-O+!30
M%"Z0-T"ZF:I+L44GVLHA_LSURZI_ '+'8*;)6Y9[)DOB%:&AK^U5A()+<$"
M5ZH2\8^$EP>:AO@"A K0P:B++A+,X!OQ^/%ZSW>VFL16)]\/IJN@7/V^\\*P
MB$CXA_-1%]J$.F4_T?&'Q/VW4OL))0?Q\K)**W&U1SR(Y"W8"TSW5T4BD$[>
M![&B+!.9+]8C!E%&7CP!>J==L063)\=;G9%G&LEJC+^ERK 7_O"ZP^)YK9.O
M6&*,?<@W6E>_UNQ;$C-.<WM3K<>8#WJ0#/!KHBT^U4#%Y]>,$OM>ZJ4*,+^5
MQ4X17 R54NH'GTX*1?,V4KRG!3C+X$#B-^CQP<Y\26<(92E(./K6"+P69MUA
MNA!NFTZ'(?]Z"E%N:3A-[]AJ.M,@VSN3ZPV_T<:%S["D,YF/=RN5ERQK9DPV
MU G/6I2T^ZI0[_816-PX@IP.#X_L'7U*GDI'ADJEB+TP6(ZC](]9OV?#P/[(
M([\US93P+UMH;./0]YZ8(2\'.DYWP6%JV7N7>,]6;' T ?:B]TBEC<Y4;^]J
MQ\S8<F7FUA8#Y>^4<9ME!42*I]+Y&S2B\%2SN8CC4V&"YB7S"!NHIU+KM(MD
M6_8U'PWE\D8YYJ]Q\V0[HV_(^V<9K_D_R=*1FO4DUA9K#R)5DN.N:D@G&_9N
M-4J1*UVQQ]1;MTL >L[[$]4#KZ*:O7N"+G.-;<%!V@@VSXD'I)STXE#A"KE2
M#?@A\%#"<+\*J-QJP%(43"^GWKMJS-=XEA'S,)D.>C,MC?(34?Y6 (!G)97*
M>]$0E>D76[%47WU29'2?ULBI?7X7%,W +?'\] 2X9&D>:#3-. .'(L 4O:4Z
M0]52(;W2+*?;X>!J1).W.X.W@$*HZ,E#K6CZ+1<M?XW>97(FO#^3+;\%79T<
MTH0<4>%G&E__3$#V0H"O6F8EL=W*%]6GE,V*!/+6GP^WH1%?K===7I GYYWK
M_K!Y?SOBGG.?AG5([Q3UX^RV?VU/=R&1+_PR8UIA':TQV6:WTH3-<&]0LYY(
MH^:'.GISLO0G0Y?2MW;[,V[^=*@4M4I1N+W2<ZF]P-FSN)@WVN(+"8["X'^
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M+UJ4JEL4X4-SI#48S-)J[!U=Q6T#*,T,H_Q#AG5$,I*"V++JG=4[M^!S]ZV
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M?TI278=H:GUBAJ9 R57=NX- )AGO^NYJ9]:7+^U99HSDIE3,=J-!&HI]A;_
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MI.0/I>F')-M<;@_>*^S;Z$LX.FBMP#W' ADI2MW+S6E8[>TIN8DT(0%*\Z
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MYN+E/J\>>A<?F8N;V+/?_R4.M?,&+"L>_EW0XDNX=OZ$A0M]B?/)?X/JVVH
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M9;B,3*I%RO5&!]):* _,E=;'B=5*NG86E]0$>KY]=_:]:,?7SM*:7(M9&_Y
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MZN\RIX44XW*R%%;])PU-=R*K"ZAJZ6W2VW;[KP'T^VT<L 19XZ*WXC'#7*:
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M?A#M[5'0PYT0?LCHHNJT]12J44/,N$(/&\V.9MC,I\GH\Y,E:1^%N^A-?+X
MTY*X?2+:,U*4/E;DT$;),1@E<Q\SF(5;>A0&.6&IFNT]V"7O C&@%AVJJ5/I
MBI,4[2ZSB6O J_QI@]!?J 46%R +WP>6=-V((2KI DIW4KS%- *O^@3FNR 4
MM/F)8[>44/@\Y")7^K@0?G\7?:LGGC/MM^+CA'NX2F<>G4QB.54Y:&AOD%3O
M7^#;:\#K!JIV.1W2Z"*L5*]1"%.;A:VV.NP ]8!.M3CG#[;/\6J,5K!N9BGG
M#N($?@WH_[9MVR4U;V8=Y_4;TP[9MC3!O!GL8,$211Z&-0T@E3@$XCK$S<W
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MJX7V0-Y$NTJ<J9C5*Q4*T.5&_:2SN[PO'9L/J46,HV(3JKDS^AIP)&A"2*I
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M*'1O2FV903@Y5 ;-+-"0-N[B2LCT:9E6]/XPWZR^H7%JNH3% LJ_"N:S*#!
MWP3LCD05&E_S5,?/IVDPD20>>1"L[EF/'IR<DD&3$-L'G];JGK@LIHST4\F%
M3HC2G,S+:>6V&NAYEH!:%R1O 9_3]F$CQ9IU .Q-*,&Y^KA ,V.O@Z>K<L$<
MDZ20^KW:TB FIIA]SWVJ?<NC,$=D:^OW&L?JX.&@=?;Y!&8!(U?]SJ?L#*3
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M:I9<*,S+Q\$45]F),[=X8& G=^2WFD7U>9'9A#V- LF#M9@"EWA?9?B6,X7
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M9F\[S_O'=$J"5W+8H*P(N(G&9DS<X-]7'O/NIN6IX;MG;/C, 4CN!S9DAS$
ME6V5;;\^N/<U1!8$;;:AD>8@:/6:.E#,2,QU4R&V&88;W_&,WWPUBQ_Y^^U#
MJ4XZ>,N)[?)F$FN46=07+I+ ^[:]:!9/N=]@T$)R1-B6B#EN40E,-:3MQ>D#
M:X^84[*&[HNS2B6@HM#ZT3YJ5$_ =?OWEL<*TW?:K% GN\AMERMP(DIDYNFX
M4,3>\_!76 Z[>V@T,=1(XR?+M5M)-R^5LE'2;:.E0LB4AVL3ET0UY1GC5!HV
M#R^HFD'YN'!LFSH?^(<T@2+T](=,[Q>VGW017:5%K+-F^0\)W=S7A>XT\])8
M[ZK#I[L!9C'9)R-:>DL-!7;)@4&\,E=9MJ#PCR!2RH[LRY.GU!41ZU+I6WLP
MWX'0N%0ONDVAS1*ZR26>IL#NEW=F)Q9(TW3V9L:9CFX7XB7[@86BLE'/Y6^+
MG%]<9EQE2P<@F\V.S.G7&#ECVV&:2+_U(RZ]B=2B*#W-WF.N7[Y:N:0^;Y-_
M99"?\M+W*2)@C\!3OD3E R3C]8GZEV'>M!D2!6"2_8Z;_M*2-Y6"R9'G#LA7
M@JI7:^V7(S).:]ED"WUM9E%4TY^!>(R/SNY^%DQY_*QON<<QBQ]1D\6R:&)*
MPV>/!QQC_5&@!!354\XWV)7A@JDJ_SHS?#BX.3J919EP&TAV K-M?=,)&%]:
M>D/F:DF#*HM#.JV7"$:]6%HJ.2WL(KFH\-D(#:W _S7]@:0CVIB^2K=4K<0X
M;FQ'(SU*RBQZ5PUN'U'V!%*=;Q[BP71B&S,C];!K6V!_LEE>=&$+1V'=(=S]
METY!7>DB+5\-WVZ /A@#>%0C?Y2QH+PS$'V73T]6I$E].VK /G)Z?I<6_SAO
M'4(!2_Q!QVSG2@"]_(XV3VN_C*6%C]P=O>QIXQ7[TOGVTTU&UO1Q"<,<)>BX
MF.+T;F/>:O'W^NK?GI3I& #+78?K*]!H6\ ?8['E):F(3?V(U ='5/B-9R,^
M9*$2=I8;CV-8'^!>:VWN#RH**"G=(Q5,CUC9U9*A ">ZT\U&N_9-^_))D$=^
MQ[8MSVV'_6D.&>>]#W45.RC=.[B=(L$-343,9B9==T@]BZ);J%P*5]L*/@3]
M[',BECKR%N'H?9]$=#ZW74F97RJ7<P25!KSNER3E\=P-;6-7-;VS<*!&-=_W
MM2\#+(\!  4#*+4"'%1L:=;*9!9F!:.9TL&-2T8&!;#\!/D#:*F*0H]G07:D
M4*9T3RZ7EV%>O'( OR-?6D0/@U@;@OT&F&]'1^*HI>(!UH#O=L3K,!YQ;747
M)6J@V&::<F1%;%2T/'R8:33=+!)?/D<I!UJC6.P5XP]^MHD[Z;835))_JN3Y
MBD84X)%]X!H7\L&;JADX,GR]$D1F:D29O2"%AZ"QB]H.?"7Y57,]#1::Q- <
M;.R<FRV]]U2S-K6G+LZ-;R\NP: @N_OVOI+CK("7NFE2A]"@9_O&8YN9G2[%
ML10VDB&4]$3C_H>#QOSI*$LC8N%W'? :2PU$LQA)X/;A5!L+I#_) ZG-U@4B
M'BF*.5+*7^0*I&"4UL]^V+ZEU(+B*JR5D="D<-?F+Z*BY6DKXH%[_%F!_"UK
M,UP#:#*_F[%_-(D]+J88P,HSVQ LOKIL[*)":\8NR=#!1@GKJE=4=FU).ZM4
MH"W)0D@#Y(SS+)L8TM]L=P8KPP":)IFP;:C5*@;0%X0!'-,B5(D@ _+9!^='
M'A@ 8AUT$]*BT0DY46>[;J4&K6N>$6, =*JZ"$M4!-CX>#;%E[-!WE?!M_P5
M/SN6]_G1GC-20OIKW=!'OK?Y*\O6"\U&>B&L5-P_/6A@+S1O"XCZ&D7"G:<B
MI#+*;VU<ZR;LG\4%5G3RJ]8ZZSGTD#(HR=Q\:M/\Z=S EK:%LMRLKNRY32\L
ML<HX&<JR34N^7Y:FK$L[VD)AGYH-/YZN\/W JI8$->P[K9C=< @WG^2>&9T>
MQ!8*SQAI=90PO"5-)L+(D'5^AZ[D2!=$*:AK07[ 5V(/?44/J"A1R33XJ&KV
M,8_]O?M2/SSELW'WB]MFM<QNNWY.9V6/E]FD-?H6>%]8Q?FAV[YDFX>DPJKZ
M/#(MW[X2SXVX7JX^$F0W89V!B+US;%96>;J1*0?T\;J?4J76+*H*U7//+M+5
MD[;$4Q-)V"%\X00]E*+!ELAZ#. .XV!+=@_X.KD>=%$PS)U\[/Y$:OJ D7A7
MUU><Z<O@0,Q$)3F1-&&"AP=K8D+%PHLV/DA?;SIZ'>TVAY+"UB;9V0/;Z+_B
M(B.MPTW1U:PI',MD9!X;EY3;8 "-75,-$ 8Y#2->A#Y:5EG\=O7V*[@&'.FK
MC;TR004#P(;3 IAEC')H:0'#Q][#QU"?[=J7BWWU"Y^7K-]\K4K19)&J%0Z!
M;.':H8]LFD+4BV*]H;O.3F7#S6D%GCH(XY"FQ 7C,+;)0KOOI=4OQAPYL^HF
MD'E]1W8X2X&J"5))!)&_=^"K4/-D DY[7&&&D/HV2FM5K^*1TI'+/!#'^8B/
MP':@9]*T/QN>_4+!CO=(!M/*!/MG7!O JVLM*'LE?E:L%KV1;LXD6SQ.*M Y
MMU*=/T2=3%I97#S\((81OAKSARQ<&7;J&XW6V<T9\;D3^_/!:X(<X/J*"#QX
M)JJ47K978*O:?BDOSTW(%DL?*.QKD-H+Z$?L1KA56^ 28Y(R&<V<2SK7@R:[
MWIPC8-+&8UN?S/M'SP'SVUFJ-EN0==O]9H$:^[.=1M C7YF6V2>VC]G?.;63
M:"8T>(,EN8&60@51EF&%>4M#\, :(WZ.3PKOD7C>%JT>?9 3CJ5;&>=V4E]F
MH72(]4I?[9S)ZS/)PU+$*@J: E+3_\@IZ_FU8*);/2**S24$*>U&:VS<.8S+
M__E;5LML)?%5WJOVYHE:T-$]G:$(]Z4#2:[93VWL5C_TR@R5MI6CP7BGJHPA
M&:6G'48;75K0&.[HE.Z4$I,<@\%=0([Q,.T)68CV#]4-)[% =>$AVO1>HY<I
MW06N1Y(Z/X>E_KAD<34B/=:+Q@6K!0_KO'YR2[*K>7X2;*R/%3ZRJ3",Z_+5
M"9[L?N-+7T"!BP07>[ZY$&\GG;^RRW[^ G9>OAK&\%CL.*X). S?#FWU6@WR
M-7195PJM:HMJR5Q]8=\;;5QNDFC:\@8]6.U@X0-SQ%:S2LK5KJA'#!;X,J)H
M-J2?W25+[S[?I1.6:O)XO$>TE='7UMAMA=PNW/\\XVG HVI5(&06 =.3J(N&
M91)T/J:B$C!:^\VI(62\284*J?ESO8%ED50=UP]^"0K6@;S:W"]86P[_\U1=
MGI96[RFO@%CL5M=\YF77GZM'G]I"FJ#;:$9(?ZKYF= 4.-,8^>-<K 1%"(>$
M,9Z(=*"1Z(^M"=(?FNBK^0!X!UA:]@32OTEPLWD%O:#G) >%/@T/D9:#'F-W
MV9W4$6ED/+UD;UQQ0UW2T>ZS39,/M@1J2(<\XZH/A20743)>P6=4;:0(JT:^
M:B:%%F^&%G"^#NK].&N]=G/Z0 )=A8 &MZ2>@F*$'7^2O,I!;K5(#(6O:/:;
M.I]#4:6?H66,:?7^0-M9*E+)J.'(=0!10EI$+^A!^3D/WV_7U954PJO/$EJ5
MP6EX%R4O\UQHC 5)4V$'B@[$MVVW)+FY9;R650$(K7?^/ K]5V^M1[PK@XL4
M4$(?^G^B]RP)"K!TG%SBN1M,^(AR/SVL\9G;$_<*Q@ZT8'K7\PO:(,O!Y8%/
MJ-KTB&Z3W)P6)=5Y+7M]@27;STB8<Y75@QR3QJ5(?Z"%<?CUG8XF\:@)T^.-
MEEG]Z5HR>EL%"O(7H8Z$7[Y=EL._VD!S,Z;C.6MU&D[ZM$=GUX$EM!*7!&AO
M<H/5'K(K&AYT^TRK4F<3TYZ>H'M7Z <:=.UV.P5HRPR+A3[7,W/>T$*> 7)M
MB9J'EJ5(?;3,C4.!U6JWY?>LI].Q ;IHRK]*P>*^/G4E?V'2XU.Q37C>+ON1
M241O_*)A\1S+PFL4UUP>G#*LOZC?2.[2-A@9OFZ;+JEZ8S2BQ/7R\HGK)X2>
M/PTRF\3=VJXL/OK+7>D!H4.P&^=DE"+OU$;1$)'(\('JYW\R2$TI2GB+QM6G
MB\,GDD3O;;)@""5%Z'3;3[1KOB,?=,V5YSD&T-/V[$8_CQ U\EMU5J3<>J)\
M8UM;A8-6Q?4X$3A_D,7Q_?5:*HP'P/[-;G'?@*I3O_](J&SNF8BU)E.,[VSE
M;33+CY>#W^1JBH'KWL=)?FNK#V&_"5?>^^UU->813BNZY*Z4<[$1R?K%^)72
M]DRYIRD/_ZBC&C)).'A= 5)"YN4K667;IPQ^O2\KD&"P&^%KS1:>:R<@']EB
M9F])<V1P!G<S.&(QL^:$;S=96':Y+V^,K/P -X&#?/G5V]A>=<4NS3;/-*8@
MVMZN2^%8242JR7CM*JQAV\%RLTF4YJQ3K_;+>S4!O;;3+?3E7656[RD<C80(
MNR2VB!TB?5]F,4^\T[D]\[)"_C$2-2D^0!-.+?!7/!#FFIN%451I4CRZS'5Z
MN3?E[".PYRUMY&&.,%9)?F+__NUR'VN933NE7?Q=?>J@:#F"9Q\;9NXWNV\+
M7YP=^23[LR*C#5].$')7$*NV\]0V]N@CG4H.O"O2N6?SD[1QE!CD>[PRHU/+
M/!?U3PON#ZH.CZ"XC([R]N/VQ3Z]C#N+>L5&;YOWB/I];HD#,Z>*%MO8KY.Q
M",@)^8_KM#,'0DA_HP/:A_@T^_\QI(4!+'\0@_3&;6.9)V3+_I_:>ZGGOVOO
MNG^U]\5_T]ZS@]O_[]J[\88P*@8,DJET&6_?(K7$  S 5^ 07UELNA[L[M4>
M>PNC LK;#Z'8+LUS=4WCC 2$8-5/__O></:V$3X(E2B-;6*Y5K']KAH;MHR#
M U2Q5/T!!C"KJ M9/",!SY]+3OP+"7VV:0 #>%)Y8P9*\M2.PP"84>U_95TQ
M3\:0HF\?A<,/00]XLOYT7#H]&:*C/<4 @OBYQ4;./KWB#I#;->KPL*_7CG^S
M^30%N$XUXQT:@%*^".NJ>7UIR>A3TL/]6(M],.K<Q-!Y1'//YU9KBC=GLGQE
MQR5L$N:T .DAI=37$G;Q4M_\![,=Z_MB\.5&_!U^GC/_T,KWHB]E'"<#NK2*
M?VG9GAA9E.#J@Y%G+S\:(LZ7O@*W5WAG*U&O-_@*%^6U[EV9N 1D)2WZOH1W
MI\EFLRSWOJV_-TA^:3MZ?J,40^KYTU#"+#AAA.%*M&)8D$.V)5&HKA=H+JPL
M2M^6 ,\=UG^6,CFP2YZLU0$<7T ^>EOU9M52P1$491.2CA"03INF/=X<2,>"
MKN["97>9%VQA479XHAWGYQ-H1[FA@G-S&J\)T-51+":^32SR56E5. #'VZ/2
M&PM%L6\AYT/7X%%U.;>BP_'6$V""8^SNKU/CMW/R++\^.(WG$)S!7/"M?D9R
MS<B%\Z(2TV.N?T,*?+:,#S1NQXWNMI^H6_X-T#6X309= %H&TH3\.N.Z=]$J
M-RX#W,FT3$"9[Q=B #_+(.O&J' $-L[@<K)_T]P=4%S8I)$"71^<[T]A $XQ
ME5<93EC^:NFDA+V4/D!!2=X*=_?6%JTHN'I^>BOCLX%EZ=AD=+D&!QP:GZAA
M;UN9?<"U2H66#+W)GFCE]NA2_;75Y<#\\VP?#T+.Q/WJ[F[[U.PO0" .P9-+
MX*E4J87QP^&+JX?E^27T+@E&Z>M_PMUCYPOJ*M[Q=[],?A)O^\F=P8W"G-25
MF4R;ST[^+%R%R66OL W2S+B  3Q@EK]:93?>-<P.;V-=5#"[N):FBNO%C28L
M921%\4KVYMQ6>1:\J4,.T*M KL^I;1S(5+0XK?U"M17+$S^Z@LBY5]$/^I_B
MLC()((FWI6CW%K2K'=SH#\K>T7W"<XD$PPZN7;VSTH6J/WN4X,[-!H6=,][Q
M3!DYF<N-I[@PD7UH7T"C$5%33SR4G)L^=][^'\T_O^J=/3[9"05BSN(!%AFU
M*F1.KM(GV@,'SG?.#:R-V=2^,H8JT^6"+4G^-+,-9^4Y2D".D^;<;3%.83FG
MW#UO_-J]M(YUZ\ ,O"<9V@X]C%>46]?:X"XR$@,]T6E[#ZX';SB."6'&4- )
MS\!9#M?'1*\*JE;*(]/_E+1]#;%!]/XK:8/^(6DCT&YL/6-75']?U\^M1)NV
MF6$ PZ)LG3%7."/GC(/%OMA&+88'='N!ULJ!YZ%?N?C)G91C )$0Q&X1!M"V
M.I@!6FVO^(E%J1$,( 1RPLE[ZRHT?U$AL)Z-@F([-D-2=[>><+1@JPK4^(X$
M9.,2Y3_GI^Q-%13B*^QPA@YLN<0.072P0XS__B420ZWVY0^FJECP$E</)XC:
M40J^75Q:VW(?\2$QPO]5$&7X]$U1#C%7/#)A7<%_H@D6:2@%5UN=25WG#2>?
MF^\S+[V3RU<C.FKK7>%6(NMJM)C'[MQI+R"'S7O"N^$8@ 05^JHTP5.IB_+T
M2H":V=>2Y%4Q+YI][_MBM9["KD(T120X8T&Z!+G8W>DE_,-^*VLH*RF)4VLK
MHU2AAUEA-,U:QC +4;3XVM:<XN7<B])U][,>O=(%O]RY.6F;;'>6!<X1KQ\>
MENIS[+E0Z?_6_\SPWV3L!TW*A=5F,REA>I0'.#U:X[X"A5:DS#IO^\VH/]79
M?H06B+*?K+YV+EO">AB7VM06; K[^;0MPCM&^HN6H .1M1C)'Z&@=]&'-?'S
M&_5695JL>4-^1-O@AED95\Z?#[R_&-3EP$]?35EZ;=>;,&=DP@*NP&"9!R4B
MXCUS+-1#KDZ.J!?PW[XU#P4@L]*&#_>T[Q6ELP2\97'/N.]T#N/D&*Q50*E_
MU-RHD[T;MW;+]K;A]/?'.,;E$\[CRIQY6T="![5,@@].>IKJ;JS;PRMY:E#M
MJI2\/4HQ8&-(#\V#>$<56Y5D:*K"P'+4LZ2X*!C2]!T")^R 7.!K=3TIM#9_
MGS*-!SH_GZ.C&8\C>@C>*W5)B.$YH^)L[7_^>[VUWHKM%>)[Q]U&"Z3E^H\;
M] BK2_9YTIR:"M"2+'B.A7#(]7W]! ]/S=AOY'3;6.2'+-N771UZ+].][8]R
MW+YFQ!L+_1I7T$QKS5I;I_J%7;] Z.S,R^NHC.1Z=@8.*EOB75@; ])_8ITM
MA$C[K2C!<$4IM&$J0ROWMU*0?O,;T[]?M6/+/_P1SIMC8;*L#VR481]4\XCX
MOJ2A;4[*)5\S#I,:,0MF&G54L?D=5UXE:,]?3BAXP/%RL1DO7ELTW0%G[V7]
MD!>PV6O0F7^>,<D5VJR)\XN$V(UB6U1UPP,?2!_X0PA":IVVL'$"F#MNH9W-
M#1OH6>&F5=;-D$;QP ^EM&D QQ)=>M[& 3623!"QA;FKK[V&]6 %&6MN&5VN
M_\'>>T<UU:W[PK$+"(@0I DH38B ] X*T@4,)2"]2 T=0B\*TCL(*+WWA!XZ
M2 U%0""$#A*:]- [7-[W_<X^>WQW[^_<<<>]XXSSG?W''"-KS"<K:S[S*;_?
M7$_F%.(&/F=7??@<_!%PJZQ@V4\D^(=C5D5:1FA":,?/A:UFJF.7I4F9&OL?
MCO8'9!($YT)T[+<_'UXLN51=\_[W)?%UW](K@HP3DG,F5B%]=I8/WX _H212
M=3O9@6$V#17#R*Z[I;]FJ'52E-QM%3^%%QLG9Q]SROS<"N@/YV;TK_,:DY(V
M0!;V75O;H4/39@%8&OC-Z&TL8[Q"?3'KAHSE_KM[($_<4?O1"&^ECOCRY?HO
M#1)<9?NLV5MNF_T]0E<R2!^I!HB51T"!V-EITL"O2HG6B!U>/BW1[*KYBNSY
M=P"QE39(2%G--:[.BDT$[_UI7I!1R2NCQL_<:0O^)Y@(LC@'UU?#'CPAB?.N
M07J?M!AI6QKY?)5QY/ZY Y4Z4_P[%\O=B+3042Q;M3FS9.Z="A(-C5?O $\^
M%GGDQ=N4:#6E3B8$G'YTT+0HB;.<(1_VH#CE#'2> =251<2YM9M6ZI"!W^0L
M;K5>FVU(R;&FXICML[139M=@(SEKX^H7F\_*D3INKTE*7RFI2 L(\6;-!@MI
M;/'+8;0FJ+?*6DM $O<L#H63K1Y*8N<K$]A1?"W2)"E922KV#BI.I)TM?Q6P
MJN PLZ#2AP;2W'=E=!_*-GF,A9JX>XDYQQ2:,7R\XY[>KB2^.]6A:2=655Y(
M0Z[K6BKU8#/P6[^&SR&+.0PWV#[&32D^L+;AZ./#MI7X2X]8+M4<B10WO#RS
M!0[C:R^XA<+?]XS/J/FYEGUZ10$ B.!'+D]2UU)11G._;+VM7@5A2K$9;.<D
MFA;R?3H:TG.R>MA"V"ABO8:=Z8M<VM/S!M9@H-K3/P8G)(_*XWWG9P3 %3J*
M80Y++*\:U9SMB"Q/\;FU9+I+'%];8YJ M,.0I>8 Q^+9+O[J^50! XND2V:G
MAVWSY9I5F\)SBI4Z.AJ@1_NWE^%#\@/*HO#?XAJ> 49KEZ3#U0T%6YS&KK'B
M9(&H)EOP&]/G#9WCURX0/3G9:6X;+7D_PN.6ZD\G?WTIK JUF[\B>KDB$CCN
MLSKII W.%MZU8E3.RD/TM@#S([<-JI!A=WIMNC><]$-^1=!;BM,@(Q))N;VN
M -I[=GAN=N]VR.OY")48M;YL4W]:1YM,-I63/0NX!7!&-.JB6;O\/&U-)#E4
M871@]#4%0KT#2Y/=H/DI*TP6 _QRR,#W0^]<%'>PT?\".5@7J3SV'8$(K55/
M$7]L;'H=1NW;YPV"CE9ZO9N3^ZTL9^_\K*KKP&!0;G_.Q9#F7^ZJ\9S%.; H
M@.(/*T38H:[3M^Z%M//HP/$L*S.NJ?=-^(;<=W"<0M0.PYIP^BW1[7FQ'(%$
M[1*>#.</ #^Q]<K:8]/YU47.13F*E/2TNM+/2 %(XFE(;4TL?>]+/8<T* 94
M2JEMCSBA#,!WB.?[$>DDCY,)R1Y@KJX1-Z3H0Z[]]OOX$D!6I?E@A;6A9WHU
M7-U9TI#$#W0/@K.-@"LP-M3TW0C/G-+9!U/V$NVXW ,RF3G<FK<+>O/MI7S-
MR ^^IAPW$X6A&V=/FJ>/;)6LAS2%#\S@K/P*^??7HK^6*$';//1;1)T,.@9V
M$*-/RSMMP6!*!8X=%]:<T6]J2B/P_6**C4WU$M:CUT+%SF!YY,SX,#)(HN"8
M1V:4$[*U]MA2??'A.+S!TVW34,N80IKB9FY62CXK2*#LBZJKC$MAEA;TX8EF
M=) !N/5\/>E/IZ\HDY/8S$1,AM9""N]8]';TIIC6"XEP!NG3EL>;ADX<E1ZE
M/ZO_BI6+9K0"RKZZR[JO/I"SLB,2R17N(@F\;1A^ 4T?]0)F07G<:UQ0;A0G
M1)._+7+_'#M-5D[)P%,?\F-G^;C; =ZB[7I$<?--/-)*R'=WKL<.!6NR'3!?
MC_VM99MP#C.(0 ,7&%<RP]ZYR#',^BNPT^Z/H1/]-?0[N3D0R/IM^N"Q#.;\
MZQ0>TW_;J6NH-[17YCX#7^_,N0#N8#J"8:K69=\+?[V@.$"^?=Z%^5UXC2R0
MN.T*0-3EB)-#7=93K5GS]NEQWPG$7./83R@^QU GN*HO:6VV,M?$'34T;X.2
MZL3F5A91Y$NW903X7;+R;R3"0=6+ [?>/'_[HRNM*735AWAH'P:KJF%PHT\0
M$@V'' !+BD=C*^.>JOJYRGT?\7J28RF0;E45@-%=8:K405=!'%-RMED<OZ@[
MOY8F4P]7Z!_E)131"NIM_/ARP+&1;J#J=SXY=NOSL&>*>@M!H^ *Z+;_Y:1:
MYK'1?"U.J3&@93W7Q1DR]QX.=>(6BQ?O5'S"/Z;\6=KF45:4K=4,&80=N=7_
MJ#RDQ.TZM'Z(5/S];4)\BQJ8;VI.&% Q]?W:ZV]:=9)-+XZ!//"D69P(-'&1
M<?!9IM&-%[L9WY^6:V,28MYKHVP '0[AS_G$R(1Z<LGW7V7%U0U8^=P?@D&/
MFAH")EVZY+P@YP_AC:P/3.Z' F7+"I]GJ7V)5=I@(DO]&7Z+5>UG.-6*3BL5
MR,K [J7$)$_*-B(RE$%(=MZ%.M0SYNN7]B6ZAG#(;?'[0X9HI7U[P10DUO7H
M+Q$S(M8M9K:$[)R)->0FX?33T4!BFDN81ZA\U=:GG"/!PN;'QRY2\7[20BM'
M@:6K:;=^5A5B/#W-]NZY6(>N%L#UGQ5#'#^PO5->)537 #P'$+55PGR)5R<7
M)47&73\ZWO]U"2N4_I"#W0JSY#-SN'?MA.')G[GO7.=-J*4/_A!OB%>?CDG#
M165]/17HO3%;S_N>Z,+7UI&^&CBSB)(9[ZRMN]R&#XJ-D3:;SY!5BA:M),\V
M 6FC8L#DE"3Y)A(%5I'L5%J\(9F\R:#H*X"%V;2.+R4B0&84X$RC.O0FG]5+
M>0&L:)@5RB9CLNY#->+U>LF[F=\7M#5?#N%-I1UY4TF.E%.EEV\56M<FTW#J
M2TPX)8C7G__#2JY!%F"%!2<3YE"(S&3DL*6LB6MI<GYPL^/5[\=DI]"+KE,-
M!<?XNJ]?5,=/+K_?/0ZY;WA?0(P8/5:R)D%<]439+ GJ\HBKAVT<N,Q/9;I[
M_BI0S?)EN.Z*RTCXA[&&L>R(XN>]',29/4%^EGL<^4]-<7/MAXXOPFR7QNJ\
M0M?F P49\*CNO'L)H"A\7BH.,Y<(F5X+9W@2#;F.'^/KY,L$W5*%6X(2J19#
MJLEA]=3RQ7_!!]TE^FB/2]QH'W%0_=UTX7Y@Y6.UF+H*4%%6M5M2_Y_*%1FW
M>M:5"98L^ WH!(]60<6LQJ=FGUH,OB,"28;V\*<.V3"7_(#3M1]2D<F(4$R0
M'?29I9;\YA?>+/,[H5RX1W\K="0K7;2NKK2@3J/$;)7J24+0+:D/X<$SKX4*
MJDNOD^FI3.).9?" )F'H6%:DNY.3 7BW6"L[=Y6_7BRCNE*R_%8*:5*3-%FR
MS8P?9(BB?C!@O\E#;O:4V27J>EJT(2[VXSKLC8 _HDP)6&E R;$FXYHS?(C)
M*0"CN=,Z-#F]<7OM1WN-NU,27U=8H+^N28"@>LH3[ :K)/<,S5L#@D;A(,[;
M$:MG[7K\W[+&5Q^Z\]M_-E#K.5^7#"W$%%XK$IQ/L>$7^KPD[#^;,OU7;%2O
MC/RX60O)+!R+[LC_DZW\KAM0<EUZQ,[LT?0$ZH7_\5<GS=]YR3JWY+>XGV<'
M<M%<9S$ OC>9ZO]4X)17$4C!\"Q5&B 3\XRFZ%-2[']^P=4_:C<YF5].^3TX
M15?]G]C_[_]B [:YU: JCITTSQZ]BN2_VS/H\?T*$%#G< 40C_&I'GT M.Q4
M ,F8L.'"*LWA8'W%*P"!X\*E][,+B[\3\WU7.FZ@E3]]4 3J\9VWU?4=S#&
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MNRN WN.3,;6%EN/SL%7=ZO1S7YWK2"I]"4,?;U]*/#N%D%Z^\#&+.:;LUG3
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M,*&0VBZJ?ICVK+$"DZX>SI)V,B!+,UP89-,7;UL21!7"Y+-BGF?)/>.6K)K
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M$D4)AER)B2,X_SVHRD,ETOFX:I!0>TKJ$NXHN_#N>&O8L_3!JC%%7_1CP2N
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MV26WJ(!=+PBAF19ESJ#>V[H"K,8CUWXIU^FR'WG4@4Y70+S\/Q=2=#?^G0&
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M9J;?B?"<#<FN,MDH-5T:Y"[T\T</@WGC)>BE8$)W^7F.FEZWC+TK*[,N\!S
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M<..F$L9/W)%"E:"@,R6$^R">SS"&Z & K@=D$;W4S%7(=VW\V'SSNE2S0WZ
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M@QY^::]$4GMX6S+02K*H<ZDV_AK7NE=A@N(4)CUD!O'<\SUW@DA;!%95-2J
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MY&^9?2BR<W_SS?^99?_<WO?'O8D (5MX27TMO(&S*7%'R,"3,T[N7^"$I@!
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M0[3M5L.\X_P,*W#'J+[PV3N?JW-O QH-PTIF4"!T>9,2L@ !Z?SJ_HHD36U
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M+.6"7P%+6,2_7F64MY/Y1NG%V!+9<0UQ4'(&,G=]N5DEEBY^;PFYU2/11Z_
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MNH+H*V>H=JA11*UO]Q2[R?&?DM_Q&BCP;G@S6K\D9DAJ>YR%-5,1X5XG5L=
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M>E.5KZM[G^ZNEYV4/3DZO#G$\ZGG_>WL-\)O+]Y$8T$ST-?V$!2@"VOOOGL
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MOY"=]Y]%0*C;Y];/U_< DZEO5W+MXD]T9^$#J>I*MNY[$G'EHCL/K\8S J
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MO-E@NW<X#',/G-S.Z^'28'_=4?0#=:!_9.0KOD4F]/&_=Z3V/U/H?W7LOE>
MJQG_Z7H0*97HAZ 9[9_?_?6WA5'U06;[S_,+__3\%@9]D$&Q_XV_4O]=495
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M](/S;9E;_;)!F!V\Q^[*J(5S>F_!+^+=\/EZ-(S]))H[>94_&T6;A)V9\J/
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M-)\L#^/K4: \*Z#FG*<9$X<J+<S8,8Q!5M4JXG_NZ*AI7%QB511]=G E3WE
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MK91\+CJXC"T>'P<<:G@"CWD5QZH)F6G]ZC+:KH-SW-<NCN8Z/Z:]CN'9*>;
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MWC ^-"SSH8/OBV"!.R6P$ 6*=6&R195+)-SNB1+\6'R8)'&B7F]P]G,IL*S
MB:0W@-9R+5.\+H>A!\;JH5+4(!!]0.:7U971G<0P)4/DL:H+Q^@4FOD)1A]H
MJ4@_(<DZETOH_/+G"3?-1U9::)&:2(?% NN;LA/ R?V!*/W%LZ+[TV8'E*N=
M:I3GM(5NCT8<CI,'M1B1FQ?0N&1L,Z? 5="@)\8V(!'3$O+B=T4>;$;(A'P9
M1$21=MO$D5_<CBDK]@)-!Q<O]=(9=B*\-E1'VM+-JD;N/BBM#NF24 &,YZ9
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M<P4MWL1-X1 ,%S?H?XM'2J./P(1U1>!]PCDBJ%WLQ^MXVQ97.)#I];B^5O)
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M3IR&D'D?,2)3)IJ=4E+43[ O68PKD@'*K(X0Z^N^@R$_.HN5+4^6A3S14(_
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MA+'PRQ]C :%VL+0Q=P>K?EC!U8E=]"*^KKT_<.P=_KH0JF,(XIZ1R>^;6JI
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M=\D([RDS00C+<B&(7YK!;X:Q97!*E3[*"-O#/$IM9$<UNW.=V4?@N_04;;L
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M=AC:*GM].8Y@P>-(\(GN&5HRCU/>F6M+V@2ATNRLSMNZB7O*+-->C>^A22"
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MVO[+.S\,^4;Z8=\BSI&DZ6HX.9]W9;(VI=']@4<Y(T9W9E;\?]>9_9O!7S'
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M)%.7G8=9E]QDK9L.?]_(P>MDC/GC&A<A4.F(-1=R?8]F@LHQOF4]26LC=<W
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M5L\AS!;[ M>"AW7I74O"2\\NVS,SXSNU P%/8MLPKL>U=>.CJ^MO$CER[/>
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M?7O>;^D(;L6?X9"?,D6WR1>T%#NS^3>ZT:Y6)_3,F3]-=4[IR;WA)T4\[O>
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M%%M<A863I<R_YP@KDTA6MF-5UHIQ#96N^=;%DX$@(U!@8SFPPV-AS$H,>]*
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M2M(M[XF\7Z"MO6S1!>;!@__I+I?;X6&"4P*]SD.FR1W"DF"4@YLL)JWHB<P
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MP"A;7W*%#+'?"T_@#=D*%;W[O>BK5,S_G<K]_T/X>?=TW1TCL6CY5.;@CXS
M%P$M8HV_C_MV$/$OD2-Y/_9<Z>(8":RDAW=Q62>.5(WN<&.AW6%C_4LT6&$N
M=]H7^_[J&(#7\@W]_746T;&'22A8(T=;(G](_Y&U?XF:1?G3&ZD?DR]]R<R)
M3GB;GY%#0J:M?P$[8/YM9-F,_O,S=E$S=5K2L.ZGG1E]$.N)YG_(S;^&H?X-
MX7\(PF_KUW*]I3_@!53" 0B\2CY%3*3G_\,5;G\_?S__^<=W0R1@3!PSMT 8
MP)7I+X.C!#_K(\B>86)9%0YEY)]#7WIA&9%]UJ%;S[P!1PF-BJ0D\Z#>(#W3
M-@F9UY99O:YALWLAYQL>G8F0OYPO/]0+W<:8OS*&!F3> )ZX<?JMU!.>]KYF
M:*Y#N@'D'TY?3^,XG2DN-$!]#6\ %M*/Y#8F="J,0!-.TR]'"J*GQ@[=P(,.
MXP+(PC;Q)BV]\.+UDC5JQL^2O\8]*H!@81WE;]CHSK#Z\=8M@*F)6]@?<VP_
MO0&X%)>]%)Z_?X0N:NN2U!>?96]=A4\X17I]3&@:<C':9VFE^&VPJDYV57:2
M:.4%?ZGHU0;?(.%IWJ>9N:S#M+LD(4;>L6O7M[3LBU<><P6V=[2@W@V/%[SA
MR(9I=[2T[W*J>N^('!PYEVLG8ES!(=^)(7<,5[\3OS/\6\C?0OZ30K*<<RH<
M=FCB[Y+D%<A./%DZ2E^?X JR^@-N2<6"/78>MX8]XI[*OZO*=6?8(BO'_)\)
M.N&9!J]N:?(G'VX =5HK=T3<A)%K.U<RO [1[T31NUIAFW!'_%XKMD)M_["F
MB/XMY&\A_\N$4,:S<S[6FKM+(OM:O#HD8BPBRPBO?3V1\8U&Q/<*6TB/=94J
M(SMWG'UZ6VG7+UC_&L#_E4(DC 62H[\>%5C=-17@/MF)Y*5CUL^,*^Q\?]#^
MO/VKH/Z7"!GREP^&57#>#X'F@^Y);7=>9.9QLQ]V7JZ[\IKC=0C]D:#A_[5_
MC#\4$MGE:53VPR.B]S] C1C*V;G5<DAI^#_(-OZ_L#)_(N1-'&Z:*MN=)BI;
M_MTVP!<.@CWFW_9OD_Q2UZO&7L_-)-:7?B_KJ[^\.G\+^5O(?[^07*TE54:L
M)1N/%^LD-P"E!D%YSH,@[I#4 &JXGY-TZ!HW@&N>YS< A_S1GUOE0-:\(=QG
M5C< XL^JUS45!Q!I"/,_!+=_+.A!H$PM9+^;,V)B^V5K7-X4Y-+]^E[VN-1;
M5(ZJA#Q0M :MV6GX?97U"/631/9!^I6G&4MF'9FKZ&UN9D1JZM'8.C> SS;5
MLQV^NT<)E'9T5- 1 ':H0,LGEY$J[N"."BW0&/MXD49M]XH$C(Z+MX;]PEM*
MUVG=)Z8DE*TQ+\>8RH*Y"KJ%]T5J" ,7!NU=Q=(N7I90J2,:HHUX=3@ZVJ-'
MY<>PL$\L8ANJI[6> PLUFYB_T5ZK<>TJ7]K> $AT[B:R\SJ\F=V8*HRQ];.9
M8,=\MQX17-WOM+XGC=W%^86-W!F-@&J?_EW:^G@%^Y.K=R<B*/$N3.W6VLNS
M8Q!K>WWZ! 3>A$,6S"9"'S:R-L.4?'?5UBF=L+;>+OCKK_KQ@Y6QTY,\K<9A
M-L+._-YV@;+H3H$*#:.+FAG!)D&D$:$/'A_==[&,@0#/:UW!]$_[[9&8J1]K
MMI[K!#?16RKV\#=BO2ZR<$/73S$;?U&0]$9?(7_^M0#[T>5FT!Y&@@7TRD.Q
M84Q?\K/?PV+;C^Q4VEO<!$D99R%2HR,)FK&3?GN6V#D6;#4TW>OYT"BI??8Q
MK4,=0Z@VR7SS->.PR9"2)ME!NA6>(<#+.<NL,.21FUQ%PS-"DF/\)?A,<8!\
M3W-'IAG.;.)G:R34>K+(!4R>>-_I5A?W^<_+$BCA-4F)7K7''Z\ISC[E>_(F
M?IKV[\_.;T#RI+^4@A>$#;ET&NS9P>#%O4;M1>EE2DB_CX=7"-ZD>SDNY]=;
M]IE<5\E\/-R-::\OI "(DQ[O\YZEBQXAKW+9*8\/OM("M2,^\]VCYY/&4][%
MGI32QX@$6:[N%EF-PUI=8<G8W7@J;$E!K*#I)&)Z>;5/CWNX\JW\SZ5W<E*%
M3QAQNPSZL<VML-9U/$ >"],?\K?M'S-<,.]@HSV"^@=#>?O1)%3TPG:V26A%
M7HH,L,3W#ET*9FT^D\1/[]HFG .L5$%P0!Z3? ]#MFQWPRVR@V40J3B?5Z(@
MM%\C[4O'1B_@T)Q^ZZKDN\JV*4$T=44&0[6Y12)%G1E%>&'8=/K;7>BVFLEJ
M_=7V.#A7:ONAD>7S>S' XAG1E6EC[''LF<JC_%D;#^1-YJG),UMI2= ",_LN
M;0J L5]#1F;!</J8UZ!#O.*P8/45?#*=U]LH2:G]UQ&YTDLM-EXR73W,H'?[
M.R$Y#UEK.ORM%LL45X5([2\?O%['G,.J&V<=9X=DZ-)Z4G<\:OED1S9LXXA(
M,*E^GEFFGRY<O[- VB],YP64@1BBTDK;)/0#,+#9EG/,ZJG/DIRM<CB2@$!2
MDI>7'_5P+$Z>B::MOZ4<*@/RU+C&7O9]43,:&[6^ >QY C&FE@O2#%0Z%]SG
MM/3<KF?&5#*@V[KRX^E#;KSF$5B*MC55BKO"4S.TCC&G ^MCF5#;#TU-K-$<
M>V88('O+A53]4,$"6(E]LD0*/X6]DR+S,)UFK <*:NR8!2"*IGHB#Q0G#Y72
M&JMO\!^I(S8E8QUXF5NTBT>LR,O+0WG"D,I1).JL;1_GBZ@OJ0W8T[ZAZ;O&
MUA UR=#:Y' *VB&/B%Y<G@V[W,P;W=JJ5<[$-:J=QK+H^2+8QZTH74KS;,HI
M2ZRVZH"X]D.]T[<.?HG)#6::5OM9C#8WH<QU/FQ_X26N9SW>^"@0F:AME8U.
MBV<-<P]ASJ$?:KQ?1<H+R_W9LO4'VA[?X+.&<I3';P"A+N[4Q@-/)5(K*X.G
MX..%W@N&FVFT[\M>!L;,'[<UA&4^>+!_XCM+KPI?OZ"QJ%GH_D)R;8?4B52[
MIZOQJ^I[)Y#2WA$?CI@5*UM5Y<'^"E;LTOF22I8?V@V@&09*!1L5E,RM=[W:
M0XT6N^5R$@&EXU=_K2D>U74,&*&"@NFEE8]&XZ2;\=![G2!>NQT^95P[GQL&
MY^9)^>=89Q&H7I\%$>20+# X2A)60H,=,/@^;+ H[UKI#6_K0!>:V[W)(N0D
M\R:F.0- L8.-V ]\WB2AEBE7:3Y^]LBK;N2=UBHA%;KTY"/2ZJ&R0-[7LUDE
MH2^HFHA6$JZJC*_2QPCT#L>YM,Y58R[9*B-:=$B26DIJ+? 2,E15X3.DY@]4
M=AJ^>IP_)B>>.*KCT"@9)7A5'LH4LJLW%N1TVG(EP4N"[W)M=?P&[K9A=A_]
MPJ,-!;\<L] 9:R;51WUF2X4M/X]&A="1.T9^&E!:QW<#V')$S>W]I!?OX5LV
M<2F4)NCF#7KAU<6-LV_UX<3*=E%R]4,2.V^&M8Q"<36.:,6&RW9P!!!_="3%
M,&(GW&5(% (\ ,Y;<CPL--QEL=:A6>1]<Y;TJG28KEVCC\W9>AH JR$D6C=2
MC]N&'ZJ.I""RC<H."].)SC/E$R)>LE\0Y&Q#+!FI0@$H0<*9K!FA,P=?7O@/
M<>Z']DST.AEI^/E90KWPA22NOR0RP\?=EW(^CY_=!P^,V'^&?86*61HNC#0_
MIU"WMH*(?_R])8,0TZ<]OFO)"CR?M! M$1RWZ5ZR#UC2T8W-L1;'/U=X'N3,
M>3ZNJ6]N0:M?P<+:ADE@:&]6]C;5.)XR-?9/C?/_Y5$KN0&$9%^7Z>2KWP Z
M1CPT%":>JFSLS%H:/6:^A[4G+7PRK?MME_#J6$<1FC<=N?]@*+\'$+JOUF!5
M<P-(W-7YR,@S*+-*6\3N4+1#:%%V2]N_6R[E7CY^[=IQMQ3,[ZI^]]JUCO"7
M^,I725<+[J OIRCE4S> ?J>[16%\T[?^"._B#: ^K^5ZWO'V?2ZD8O;VJV/:
M!?]%TS&$=.:W*-D7%I#+TY#K<PC*A?O\Y:D+WX\46[>L$#=U1"M_%2W_*W3"
MDXN&;SM'[K\@F;P!S!&.U8:\^<DJ;;N\X7"._V*CEG_[U.-P=NT7SORW65/+
M '8F6/C)2'3:PF.UUN-TU,EC>N<&L%HS^ MC#Y,;@!-?V9*KW\\(OV6%\L(-
MX!?=17^DN<V"K^?C8?],=HF>>)QZ_X-2RCF[VX\_D6X_7:4XRVMZ^XORD1L<
M[PVW4=Z)+X]?"-VRWKX!_#EOV7^?N3F=]O>#WL=AG</JX'[7[)BMH,@5^":"
M;$?BTR(OD*=N6@01?<DU"-UG8?=)4]XT)>W]1KV V8)';4V3GYG"PZMO?<3T
MY#^8G7AJ)7L#T)G?P0%3S+.9_.Z=!FJXQAY F?MGTQOWEL?/WY\KOZBQOT[A
M\\I1ZM#3%T93_K^>+JY<0P]6IIX-4<F);@P GTYOBDO<YD)]:63KK3_,].\V
MJOXW/8 -FLS *X6K![:DV07Q#,>21^A1"JE\ 93Y$K\NS K88*$K#0O.K\PQ
M34;F:.;#J1JT1YS,Y*<=BL93-9:>JRE?39*P5UI9V>G\J*0<*B^,3G['&BO^
M%Z=\=/OGZJE,_D<),X>0 !>"-+"F!IU/7I_<99.KK79B0N9TD[XYSA1;F('<
M6_FF-N 3%'FQA[R/N4%OJE8): ;L<><)U'2F-5BF10*P.P1[=6N'&);.XK+,
M:"S;ASB74"CT9"5VWO!2-F9T83+Q: -Y3WWL$4&F/1'B!.BB"J >_@6T<?X%
MW1:#<F;$C%H@NR/L6%UN!.R W&CS:H@9QAS96*D[?\NA:4EK8:WY<#BCPZ>C
M@AUG-EYJ=_:N]CYQ\)?6@A?D=M,BMN^2-+10)+A>+AG?'S /?=/]!4*#8]GP
MM?^)MC9PRJUBS!&I3X&/4=JEC1C&]R'\IG2>3S_/WG*%O[VVS:+\R&)XWY#4
M=H5UXL/C?-/2(-?&>J+JZJ&C=2OSK(NN3XZ]+FL ))B E[!(3QZ>9G1Q)RI:
MI9WYM<V158S82XK36B3KK84C+07,G<4MY!S?^K=%_NGU_C'=T^/8G05? 7"
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M?NF:H9 3W-C\9W/9>0[:&KEW4].*=._0-7<KQL*CKB_<@50?EH\;$!)J%G*
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M1L:&CQ^9"XUG]D=V1C[E*MG^H%LYT$5NG3?!)2SXMNY:),.VHF^'08%.6<%
MMG:*2NI=?9A,T9(8]V>.6%]W)4IP<?;LOD:XM0\ 3,FF-L-L>5+>Q0,)_<SD
M-^^06;DZ\TD&A1K6L.NI9T,0,B/&<TJ4S,HE\W@A!%"1CC=A/ V;@LYY3^+$
M2YVAEP*G:W3(K!5C!B]08XC0B!0,F#)7TRVHL?)\^:-7F1\IVO#.SGA5HX5M
M'T5/U-2.8NVVOJ[!GP]O'"(T;*=0GJCE11F;0-?@>_12C/1\VY]+\)"%3 0V
MKD\H1?7HK @HW67WW)(@U!4OD?/U(#M="-3NY>Y^65X4-:;3A\?H1] !0X%4
M,S]?)31 B8)/I[OTMQ=2V9^J.,(8G7IL-;D+$8,S\G#F]&\T->7,$]6,_FSL
M8D$6^H Q)PP_>TN+K,\.%/R%W"LH.\DW,-CI--"0O8T/UOB:,GXI?:Z@[ A6
M70W>D[BNGZH4F4+*^ ZRDS\Y;)+,7R@1C]"*V"JVNL,<=QZ:/3HN@6IG\VMP
M)ZR-?K4'I6B!!T??-YY24G./O\J3=#'RXQOE D3W5KZ+SNS,"D29U7!IR)P%
M!74= +]0:KFBS7M9RT>A*4@SP7M0?OQ I@33^O+5M[Y$J!!H1BJJ,X@3&NO5
M6%1*519T%@ T>-)@'LP:&(4E/QDZ9BQ'CCA[Y-9N':_=^P[?CNC8)98-R(RB
MXR*52G()Q/JZY3(A=7 !:E2)3=Z9,[$)S+RV@9-(U\.%&AGZ42C]J9=.*X6#
M6P N:BJ,:$I=WW/_L>T5Y>&GNF_A[YNB.S3(LW**&N-/+>M>ZO7G@JE9Q([]
MD@&;D5W/,;T@A\@]TH)U1WS#5M8B6./G3:"LQEJ-4Y]IBB-X2&P7.0T$+A5+
M_MT&HX?4%[O,P3*=$DY_<@.V^$37>"T7]^.=9ZHY;3B:=#:"57K<$"QH;2@T
MS; M+%X,Y UR:GE*4E!B ^5JM)GPNY$F+!D:)9V?L[YH? >.)2JCTL2,#APU
MUM/8'.$<1F8[&WV\<R6YV3.=5M3'= _PC#@WECZY2/O>Q^3"]A@J;6XH&.-@
MK?KYH2PSP+$"1/>N;CIO:JU&K3&1S16]S'WZD$Z\8AQH5A4\Q$G:)FR=-'%'
M;^F>$,HB)'IA:9B,;\K1A%DB^4D7U#B_TJ/1^ 02-6R?5H7,$Z:<.90\&LQU
MZ%8Z\AV0T.^UF]Y'6%QJ9 N5&NMNE55(L9_/9RF>\E-S]C(;?5=]K;Y1%!WK
M%QN6_,B$SM?I\<%FC0X-]@#EX% &3#^HQNZ&/V]/$]]QL9U<CC-1]HZ<79/K
M&N%,)D+2'WFTJ3<TK,V$KBI&>M2PFD9@X!QS.L55!,!,_?SFRCR0:_3YK"YM
MDA6^M-2H4&6/W9'R<OA0V'8(X,3C&'-/1?'SZ"K4NO#Y$&_*+6/;B7D E *9
M);)D/C)9VBR\":T,*DNEE:R+]O1)R?.GB,Z9'N41*'3B[6L7B>: 5%*5BL$K
M@ZYA]/?-!&SSD>S>NP.PFM)FQER@-2]QB<8@Q/494/J<^F,A(KC7I95LRN;3
M=AU8H]Y9TN054FR(78B0O=':-\H@F?0MF$'3,WD4<GMY3!)%3$NP9H*KT@(]
M^/#MH$\SZL>']8&,=\4"W] 4<CBPOZ_IL\9,Z<5!-U$6MR*R+',[0S20D]'K
M4@$JV,&T>9/XEN8G!\_J1;88TS)(6KJEH:8^>1HHIS[W8G2):%BR#,$H!4<I
M20 /3N0O>9Z^6:: Z[5]M>,FL;#9^%9B=JI;B6[?Z\#HX[!-M.5'1/P\R&D4
M2R>QYMH>6UA&V*JW/$O+&FP&O4,%<S@&[&L.(4V-/;8-YD+JW5UY)L2;KQ?Z
M]2"N,;5,%E8E0BU99@5UL'#W_CHI3OE)QW?%]:2T',?S;>48*VJ<R\2*WF40
M&DGPMA+"!\8=!"G$%/%X4\(R@MS'3_3IZF,XF@5"M?-DIQ4O4CX:C5IQN;R!
M=,)2'W7<R2-IJ[8.8VOC17KWQT:5=F>^$D4\$/CYTYT^E7J_K3"9RD.) #!?
MIA0_PF MUMW\^NEJ:OQ CZT^PERN38XK?4[;AE2(ZCKGF8;"963)@>&DJ8=L
MHD$,-AH%B[!UD6S\6H2^WQ3;: L*!\O-FYQE*W:#H4]Y,)KY\AWZT,Y&-<[E
M'^!!\K,MX]MU'4-_#OK,9Q9"K+D+%C@[E3I^QBR'\ M^?FX,!*]DK/3=D+4D
M3_L&Z_?2*_H70Q:M2.-<<I7.=I^$-M=(Z/ST, _C""X<@(NTB!Q"T_-B7"5T
MP>?^3C)<01,3XY*%T3EOTK=+@<TGT"2O;/%<15OB"32-=V<,#HP?0P#;M3YH
M%O/3.4IZP.+'0=C;N9J3WA0@C_<M$0^+@0:H_W65@C.7$CJ-U\E^U^55BH&"
M69[4]6*ZM;3<"3@R1T=W86Z>0=+!D?(*'K*8Y<O7[TV(L"6!.X#?\]1MZJ9C
M6EA[/QFO76$N*_4#M:M_.D/)=7)20B,/7Q-^F!MB2.0^9RE?CWA?$I8$(8S6
M$AIB-"H-4C?"^_#FQL5PN<(I1]]5X+NP/\Y\ID5_SJT$TGE/7)*<,)=PR"$U
MSGE5N,=H%0+8*O7$R)S361)'C2EQE2<6$XS63.@24!HGD>89_)2(;7P%;<%%
MZM]MPZHAXSFWS:HE_TB:3Q<R$= )E&R%L)23584.N-IYGH\"'\CG<%IY4)?4
MAZ=[<I"H'RPEH+1[Q%#GO$)@>$\J3]&KM*0< Y4^VKJ"3"P.BB 1XJ S70P:
M/IL.!Q WQ&TMG.7B"GID;6I9*OZ"XFBKCCX32Z*OVBKT.W=04B[)ND,>;9>Q
MX7G1/0!3B),WV.D-SA$%"TP;(\K#O-:E&V4*14X,#3T75UG^88G(05*1N*OU
MKB63??Y@=8Y=H&S[8-\#^KM\[@%Z*;^FO?A0O+!%:HV[14_95NX!,V9WSAJ#
MDB%'O+:^,Y-]".NQ4XIN=Y:4"T;K4A>Y>@T9G"6,-R767E0'[H$+J#\XQ+?H
M*H0+JZPU\C#M)9XM+A31"<OD(3RZ>>"6FAJ:#71&]!L_,^1GB+],..@;Q/ V
MZT7-LN9/-O,[,U<?^/"[]5".<(]B&N@N%5B'JJ,:S' MT%:UC-LRFS5&X%NJ
M!_V<57/5! /UPWDR+):M%Y_)[#GPE>+,2)8.M*9K<'IR-=W(&M:/F))JFCL;
MP[1J+4T80U^P"HML^TS4>^&L,7,WR7W#PN%'HJV9Z59=0 3!G-+FES49U!.C
M:\Z+2I^\]SXV>BLKK=*SE6)<N ^)[6$+ZJ%( O23Q^NOBU7//:J;:36Q[>;'
MN!0[!F+O$7L20%PNCHKM'!;B&D86W2<GKGH'M_H5A%1A;W7[.OW."E22QW6+
M)8\TZDYJP5FQTL9>6XJXIH.'^R'>&9F[T-.%VZ(;FJZR=2+]X(DZKENKE0\-
MS8TQ1]-0F21CF9E'[F95\LE>YSTM-PG*O<K>H(&-#*MT]_":8Z-Y85[&?2!?
M0^.4[6M;YC@<0$G*(3-3#2+7S<=[.Q$^YL+=9@1*:&6(P?U5RO(8QWA,@^Z;
M7<RUIDN8$14RFTBJ1DWJKSAMG/<S[#M9(7OL3Q^TA@\/BQ))*PD<#QKLGDM8
MP^1M,@J\E&.<FN+J9S&^+F,<$B):A30[M[:^K8A05R0IAGZ1Q2RQ[_VN]AF
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M#<9 1,::\"N0APJT=3##MEW$SMTL&DY\N@R=&&AF]8GO)%BLWX<V4GQE5RP
MH?UZ%9BLJ?R%S'VZB8LYZ=O)?B>QZ(5P6>'%NVNE3\''>G5-)1)9NS%Z\NW8
M; '334^'3C";ZY9Q(2&@03XZ!I^GH;WIN$UP(79I&W?PG4XP20<5U:ZB:::S
MT&A7 B3A'H![<"Y88<S+<$1%=V0_4;<@IT@"ZM*J;?."Z[PK?9JQ1KV:/&CP
M!!1!03&?K=O;C78/D-$Z\?5BE)(;EN[09YG*%]#KF7)5RI*F!@$J-LY+;J64
MJ^'<6QFKAU(#N686VS&//KK3KZKS'VAVS7O[E<]1L.RM8<MW%8,_44S4'#2_
M+C  \=S!=,PC8-K+)E\C9(1"OH<K=N,#>8(:=>$D;%F:G["?UEF@Y"/B:1N<
M,_NAUUD5[] TT(]#=D2(S>]>/'9P<*U57+>6-3UAWJQYD1#5#5">FO0F7U"P
M7M/*2N<)[\J(FUY8)GB[$K9A<</KH+$^0"/3?]SW'FZ &M<"K>FNK-.12T1Z
MN8@R1-';P@J+R"C4MV03CK/CLO\13LU^"T,:*.><,6R:*F?>/KD(=GOT]7DJ
M"DK&8)Y..,6[MQ)O$S_? &2$%=S,PU2.N]/Y(6/>$P,FE=_TV<=F-$^NW$Q/
M?LARYUP<E#C0?HJQ3H&G@4MS0(T4V+L7,7I25"\:I?C[O&M57-_JQ'E:K@Z)
M/K5\4FI1Q'S$O*1V</=*D5NN^VIHOY5XC'4ER-70[:RD'!<$,8"CQ@_G0%5Z
MC)@&NUYY[WH]*5TR$.= /)<38+VR A[9+3G&>-<*6!NEL4:*;F3TW0-TT>_\
M&;]./W3;+SI=G@]-3G%%6 R<"3E__F)':0=\A;?H&/BBFEUU <^Z6P#S3 #?
M[U/=T>G;L5^^6(E&R>1-R'30MHW"ASE:XTY]CQ>_4G^VI6:/^,U+ZS='C(-"
M'^UJ5D@LKTJ 3C/*7:DEH(&;_>\3WI2+>\3QM;$(JRO4>'\BO02,(ZM8S9?\
M%&0@0:E);@5A9AL<[F0GS;[/BMQ[0(K FO+G;AEST$*LG^"%Y0;%KQJ\FNYE
MX!.Q4P9=*:V(+NZ=&NJRCA8LN=YEREB%:AT,]'O M_AEE6?D$II(JXQ-:0\#
MO2S7P=98EC3&)Y1["A303EQ7#/,Y#%70('2),I9^ZY*\Z<F^QNPN-;V:;"H9
MK<>OV.PXI>*Z12'!,:J@)]$YLTR=&.MM.S[Q84\@^DICI+A('Q$SU#7_*>$9
M9<LB'<5RCYGX;7'>#J\^D0T+3#9]C4=@'57ZT5UM>8F%.SC --.@PYQIJYL]
M&MN!4W7LR=G4@["E88!)IL32U*B^Q#[Y]+P&6?#@S^[YN*MF3"9+0?K%?"3K
MDO&8>T"/"*^-:<VO4AM8$%NK&=86*7F\L1)<81AR$9'AN-8 E)6C5D$5;Z("
M3.Z@6ZYN3A*(0>X&#6U",.O)BC/+&-?R(MUR00ZB=8Q2IP4BJLZ*5H?6DI5,
M]%DAAG\84^[!SECO$(E_7]9V Z*;R--#"U%35N<6W)QT^E4VA_$UJE)Y!;E
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MQ(QP:X6\N;W)V8XGU_J$;NG*?0E]<+6\ WR!ZU$\;>VY>5U!$]VJHLC+HGO
M10UF(7,,V8ACAM5/:T'!N?.F_B/F')XZBRVF,QHWPM)[ $#"U<7V7&=G3G\M
M(-.V"W?2)C BH ?B.(O05&JHB^KCLC<E=$:K3],Q@'X/Z;3V2'JL-2&KYD/8
MQST'FN#]_]K[RJ XNR;1(23!W5U#@ D0W"6X$PBNP648".Z!D&"#>W!W&-S=
M'8+#8,'=W2_O^^WWW??;JJVM6UOW[M;>_=%53TV=[NGGG'Y.R^GN$]]^FVQ7
M8&8A#7#9K$^2DU'83":G5A7]5B&8'T$CIWE"6TN.43M9G/U^Z$R<D$6M?_V3
MT>/$E*>8ERUYWCLLT4(U5?-\J$LW3.TRUF5]KNMT;DDW>QR\_8,4[D //\W#
M-M<U327J4NV;B>JL02MNP^Y+]@6K)>*9$OP]Y:A3V.D'Y**05T+5B^2O03^F
MUN.[6J@FLJK\$L='#+EA"(Q+F0T/ZFO[,.M#H<L.@KTPQHB$KKTEFN;PCXWU
ME?6&Z"F4,E1DM,-.X5"=;ENC?:E;962ANN$OM^8_./7$9*).H&M!1Z]O:!QI
MUQT++P,^UDX4_VX*FMM_ZV9B[8WT6Z51C/]!3A<RG,AR8V&\4-VV<-VJQH>?
MQY,PMMH8JA9P7+ +E#V]<0([XYCY6WCZ$$MLDTSL:=:>I.V#C28&NS8?J7%(
M(_A^+;;M.QX1M@-AG>\I%7RB,+\:+Y48N%8L+:UWOG";?[U%4U;<;#_<6GF^
M@DO)%KY"QE/80EX7T#GMH&U5V *JE Y9.X(?>]Y'2!Q<9^3].;QN%IH!1SO*
M[=#JX8VBFY!4,Z7H,#1[&%T"_W64Y2'3SP_\"32H/"\:T#X]X'1-SY!K'*[U
M\Y J.^/3U9]D:BN1?OI0U7='4$H'-7#-A4VM^@$\ A0>#=*A(-F&\FE.]2DG
MG4!#Z85BKJ'W VUK=OL?\FW?=7UEOE,;*D)+ZI!57':9?:;%UW>OE<>5PCG1
MA]O1;F(@*?C*@3@OV-;LA/P[V$9[B>$0N2\K"PID5F!:KYIB?G=@ZCH\\/Z+
M?27&$4NUQ5X\%RP^T)/E$K/"C?WQ//VNE<5=X[.[:'*ZT&35Y%WP>9ZZ+]RD
MA@+!;<XM\J:4LAZ'P6[\-I Q1]P+5UDSYA^^ZN!UK<YX1EG#>"GS*D0K<][_
M,]^,LF9BZ0\.-/N] [[4^%=#L_">/ELO? 2,4#AJ#)@I</Q"O*8(!.#T)U8^
MA*-IP=M=AD<_V!S,MQ*// '\P+^? +< K2? \MM[4$9Y6?7$NZS*2C_#VD!#
M&GV?CZ\2__4MK+"_'6?-R'_%X:[#BORN%NJ7X;4)8UIJ=(.2K,;5YEO /-'R
M%@28[['SR/9^IJF>!/B7E%3+%8U6SY>A]M-FY;+# F@#C&<.JN[DV#:7$->8
M[><UB#BVRJHBKYJKK)=RW$K9I^\-O0@"'>-T_'UAJXMO7"=/AEW<72 <S2K[
ML'EY^<YKZ6ZD#"L0862TH8C&!*D*B:L6%^%D_@&D_P2\,"V$WUI?:Q_52ZX6
M\!$T;'2B7_JL@M\TG^GW;U7O2>JF.M]^A'TPGGD5F\^+?W+R."P_EI7;\U'U
MDKH>3-"C;7(9%Z%DW[/SR^8=S]L]G7CW[I38(?PS7FREQU)XWCS'5U,2$C (
MX!QWU]()J2DMGJB4:5) ;!4##_1IIP&'Q+5DMD@^_'OD148CW*Z0ZE?SA'*7
M\-5>CKF2].1P/EI/QP5VR.][ED)72*]JO-RT,;MD0G<GETS;?1'=$Z#K*^6)
M?S57RLH,U[&. ^WVM?%\,[,)OJ JM1\,]]5Y_OCX$@-*-GVQ>P1O*>OXO<PJ
M!AKH_0[QU=&T,]Q;\_[^G?&2'7W:R0,A&MT=XI 0<*ZY*PHYA'4\S 3?/*L"
M6*#Q<<#]NRAU3Z.R:/@'?;?5T*^GMD26#5PI+K3\R4%-K7EX*2NM6+NU.'MV
MHRZT:69^$)-SRC4.!V!8;V%%$70:\'UVDG5N7EPF#'$RM4[[!/SBJ">54F>P
M45#2+&Q)I1'%!\-;]N >:W6O1,4C%*@69-12385.PA^*+ /IM26UQ#X(%2U-
MQ^5[%UP]^5XP5,K%/LXY2E=:1+I'AG--B/SD,G>)(\$V+V)6A@%"^?70H1M=
MYE7X9S!S^UAD"17CHF3[L S8U-;<FNEW$#;5F$A;KL$N5P.XH+X^@E:LV6TK
MN,F&',Q^1WXHKF%/2]AC :84)'K'1!/MKM-3LDN0&+L:)F\K8>W85PQ*P]ZY
M54LI;TX.(N>DI>]?5ZOC;$0)?MT$^?PKOU^P6Q!0_Z:*+;D?F_4*=ZJR1A*U
M3)+0D0J$\HB3@F(-OHR;?RM64\/,J<.OPU(CQQ9H%V'/F[F-PH)KCZF'%[@3
MJ52LQ]_MKEC  (']/H+GL0N9*E*PZKG<7%TB<F!J!$=@A9!7Z<%ER&MFB<I2
M%PA^ 2;.5%^__74A/G&8P S.['=Z)/>RO"1^:$G+A T7+&*/1V2,\O)D;J.=
M6=J8GLG3FSQ>\A:0<T0B\_E_FH5TDS.-$R.9X]3&X_IR@9N'M1IFSN_X\9H2
M5:AL G#UX+[24W]S[B9./U>&6,?%G=:Y44D:_HHM7A3K@NDGX-KK#HE$O,B0
M5*(19/0"ZI1/&UF^6W^'^]OWO<4O-$P (?P+R%DI&0A6ZG_QP+=+1%9L0*UY
M=GKZA?$J7$!&*&DE/W5 -)Y;)G @]4./I0-E^?R8;G-JO6WFMGJ4U4R4#$=^
ML3W;0KCLY/C]ASP05N/<<!U5YVM"ZI1?Q#'JKWI#JG1 E> W_4OH2/ T9R4H
MPT8]/<,V>2GB\FR(O,,$(@:990<"2KF[QR,U&@A#JD;PJ.2QWU?(S.SH2IFS
M/,_$4'V85]';(<P^A_E0NWN[#$G<I+A.TA<$D,GZ:6NPM?JIEH^?_X=1;6:?
M5@FC.=>X3C7_3X;,.YBD-*'9R1K<*PH>NJTGG _-^XQ4*D)Z-[."^0WP+9D0
M!I^_7\SW!ZC-/ '"7]ZJ,3Y;]R>_TV03'(D9U+DAWNNZSTX]E.4^U'H*S6SX
M HUN=4KH/+(BO.N3!^))*'FOAE+ ]&V,"QCW2^&-;)BDI,>,GLMJ LVU'M/^
MQ*M&1].0K2A)H.QHAP;7(URPF/'=ADC]:(Z)W/'CX>F@3%E]>TUU2JJ(],TW
M/'P+\U2D=XX6Q9R:S/ +S1U-Z5R*&'3-&#U?6>JBY2<H)^8'P1_411[><QO5
M7+ $\+V\E2_3L8R0LMN(J& \2VP7QJ@F*447 ]M1Z32R%=G\]G4.\T[!MW G
M'85P>"P"=7]U3TV,D/7K#2?;Z2$$"K 4[[:\#;OMFO\Y/4V);_"1P?Q8*=!)
M9P^E1-+9V'INO@D3:*Y_?!7H=^_B+G%>=QK'Y5.&_)YOO Q*@7$O]N:\-M%T
MX7VO YA!;(,9KOOSO4E=@OEXR3?;R@%O5P3%ZFE7E@YP>DGWU+QM4WWTD+-@
MY:3:*,&U-@:NI=GB;.^S2U$4*054,ULEDY+)WCY8J8LZ),1>$,TN!\"U;=8+
M$X)V<F9G=[0YLKBQ&9%PC^'62C[:OKQN>,3*6;9R\#9_F ;_CC.0-VH0=&C#
MOTI$RZE..(66(%?(9L4!)8O1K4XN2E]:<;'WN\Y@#OOL'NI$V74+W:ZI3]U[
M.>7.+PHX[Q<THDJR\:OM>;_:2^S) #,WVS\JM(JC$G+S]I<,&J HV:[IA.H(
MUW])=]B1'4)7ZFR(JS0M !%_&IJHPM^4#GH3YJ#[T%+K/-.ZXZ(1-^/[43H6
MTAMRIA\$6D'I\Y0IL$+A%V<&WU<YT3 Z3-</2[5I+V67F#L7??$7D5BK6T(8
MC_UI87Y]"?/8.R!?L;D*.A63? *PK*C??X3EQ,#(X\%NU,U=W^1L!:=K.-,"
MKL1$QP\X=A)EK'']F+XUTN76'<<5>'ME+BY2+&D-D3U:'[]FF/L66@(M6*ES
MG-6_U' KI5EPB6X7!!JLOBYR,EPEH^.A,Y'!C -<W!3I]#SB)W7A8S[$B<9C
M2E?0"4HX1%VS=Q%7'Z:Y%(S(S4.)7'SY-OU_HC8T3 EHK-8[%GGDUM96BYO1
M=VNNJX"TZ6I!O_=F66S5Q<,]@,"-P'-.;\UCLQ+0L_ZUWM9 ?1-!'T?6KOK;
M?6J0!6EW?%OCEY7&Z2!G1QEB%V9]YA"R$&#L</1;S)O!PQ0Q*J8K5T[8-CXW
MGW,D6O5"KE:$YXBB@VYM  >9M]SQ^JUU5(PC_V>G+XJL>MP!3+;[YYJ&DWF6
MAS%DA[VT4^+R*TW@=-V%ZP0G!<;-Q=),-3HDDF3T9'6;R%7_[UTG'TIGI5XM
M#0&S78<=]1F/]3-<H*$.4HVNT,O"BA< 2L?-RO-E.*N&N$;\@E6&N26L'RIB
MR$G\(8N-UP$YG04*N1SL-X.Q;VWQ-F%ZAQD(H1<R''N:6^82M'PV;<,>[Y:(
MQS82#DF4?HS,#:XESPBOI"'I6BR]G>0DPCB$8JE)>J%Q)1DZOKY\ CQB%MT-
M_L2&[6!=WH!J0]118<.[]V_\[T:]JRA86!I3'?1#BV9#Y:0;*K?-0M*%$DI9
MR>%.4!MPMBL6V& T&._\2;\=B-7A7I"!-(10Q\S%OIST-QY@X,O!Z9"_F'K9
M$-)FT'=2]1GQD';0_ZA;QQL!A/](5%Y9V11I4CMR;?^B/^W3QVN/-FY65Y_=
MJ\@W6:\ $E@+2&1/ &)UEQ>YWZ!*(+M5WJ %HU21[\>K^3HZ>[?Q <(K=-S[
MI93HY<4_6#;T]"-_%WQ.TB1@NFN<(XNYZ)$$(@O#7R>.C%5ILF2#.9*!<8#\
M6Y5*>/:N5)8I&T^F]&4=F8T%&><3+G1X,-FN3@)G*,JG<1O]2QG\@S5TOWYX
M)YL]80S:>*FQ_7?KM%HCX_4\1'TE3!X=&GQ)EG3L3P#R<!)NX<4\,P2U B7.
MZI"H^=P;P&]CSE7MO"#.K9/8'T<6ZA8;_#B&-ZW(5XD]#<<'U=.UX$)^"J[%
M6OINU=BNGRW$DRQ.3/1*WABQ7*M<![UX&T\ + XWSE**N?FN>9.PL4U]CX)A
M#PE[EZ_$J=ZDL#W*QTU^E\"0V_&HAC*:?B>RKWHRCDDD0\&#8C4B7@[Z)6YK
MS=SB];43-M0)N:<?-Z1((1TGW)V?\EWCF-1[4>(6*0GQYEL#.(JR<&N=6>6^
M!!;J!0@@R[ VDG\JTEN6.\$'AC(2KD?)Z;6;Z89H@%?Z[\68<XL*M+2E7J-K
M<[07E[BT)PZZ1CH)DG]"GVTJK_9I*VJ@BU[=YN19;VV)/.AQ8?CBG8/$[S>T
M#)D^[GV(KJ#5'9AKNX36' Z,*"$2ZF76GI7XVKZU6%=3(KXV6^NB[NWG.26M
M=#C0AOD'X.>M+._W]VHZOS[GZ;&<5T>([DI\ OAS'%4^Q$W?R=%0C7&OHU]P
M!UV0*"BM3%751 ;^"J\/,4YL$2!90Y'[E#UOT#=-X:1;]Y(EEU5;XPF GDV.
M'BQ='5%5*&3.\S)Y<BYD?*KXW?)*U<CE";[.>S&\=5+DHN,PM]SCKDP5:1GG
M7"]6+81V?:;F*CVA+?54(%LC*?![[/F.?L#* S8:O&S8 +KSM_KR00KMG**Z
M4&WZS.)_LRI>6?<)T)O=>CA9C3=Z[R[W>(!BYRC K_($B(CM?7#DG-?1Z^!
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M@RST<99:9;WNI6!3%ZK(512JW;[W2FLJVCMQ<9%L$LAHG2\/B#B*+U&2PQ)
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MNEH,96XF+J6H5J]N2?D]@#<O^A^C(A!Z_<=VN#S]9WO):Y8.C=7O?.ZH<$)
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M6(B]TVI/;&^I<*2\;R#KS5G'[R8",=Q>.>I/J[5F'9T_.K?M/88Q0#_8"[O
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M 2M'Z*M19!*"&-;Y<-=',<H._V?D&V,#N9<WG:E 5CGUBQ1##Z8WR!FV-SN
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M4(O%I$AOOZKJZ'$)_%81-!\86EE38J#F_W!5P/LYW[A:,BFPP7+(*X/>@34
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M1HK."5'!"WJMK_84F=K]!>FSC*?M+5RC/2MB9#>6P-60Q"B?14?K.N*EWW]
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M)_H!:8&#^))]DL-ND]C29&SW(M0:OJ^'#!)]7+S\VI,82MC#.=;@SI['I\/
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M1WWZ9:IJ/Y:R(Z.B)/P'>?6H[_/I7SH$OGK(ULA'H*H?<[-2G;@P.,/!H
M3J[1 '^+W[O<K2NS;)W>>;W@I#[.82<W\[GIRZNH-/I8DD;!GP ]2_VS'J%[
MWL>1'Z"EPV8WC&J#CT5GI!5,(^+9@R6XE?D\ZG M)9Y-W [D0C_NS6)"O:_S
M8]2-T^APA(WKP*!HTS40!+O-D<$42937P4(3T:%L7%M%6?)^K_"D!E5(\+:,
MZ6DA   #/W DS)HV1%>R^-!$GVT9J^,)MJ@72DKOF'A(.XZ6CI.^"B1XM>>(
MG1B(CS"S: =%IBYR:<A(%A-QM%;4'N8V<]PQ#.%>T5YKMSYM?>.^:ATHH?,?
M^3._287_[-T!@7^;FRS,TC^FQ9@;%4TS@C]"2[+_W;N<.']]VP2,\\IA&6U2
ML- +/E,926=/*'^N-,*JQ_ S#Q)&S_!"8I#*Y3_ D [C9\U[%F75.FNW6?@*
MHZ!6?KWK]SB?6!;AJUU<AOF PZOU:M!V^2_/"H;"V,;@#0UU"97EV!3#&Y\L
M)T_N-"7]"=3$1*'ECB3F\8'FIWOY\E%)(!X-[3@X S@PC5T%%B\DSQ7W"!,Z
MN_NL=M]=9&9M8UV]:>5TKI%7K/C9#8(PB)OYR'_"\!UN[&R7E68C&'?I]&,?
M/ZDE8]&-%BFW#@Z6P+&\KQW0(+GS>](*HQ61<X_0?DY?Q#YYV<F<C% \J9[7
MH\5Q-0J49!^A1^ D9<D*85*[VEKHX!7E:L7[&LR0.J;L@QL?])>S70->-7U>
MO428&W;_Z8S.?WVL_P-K###X*_M_\^ST7V$S_):63D5&O?;VX%1BJT##<@C,
M*"U.4Q "ZX)AW)*6[]B*!3K5?U+ +^+RAL<7Z\:^4^%U7O,7+I>[WQJG748>
M6_P/\!$%EA&44]<!U  ^]<'=03[)SRU:4Y^Q@ODLF2>VF$(:)S$XKTRY]T(&
M%98=UD16:'?L3X!Z>YY+_<T-'\; D=BS[MP>OK:*Q_'^@Q_WQBXM[H2O9#4T
M-W&<69LC.5F#L,4T.N6(,4U5QY7 >QXMON(30.DK-?&,NFUZ]I6FG1NN%[Y
MFF$_P7G?9U<)#@\I"D#F<&7]@QOBDE$G6@O)'YT[R;M'PEMK;/GY39KV+T:-
M?EXVF7BX3!S&6K4;3*?"CSS,62L:J[-ZX+N[4WL<&C<I:-^^OT@@$8IY"N1X
ME-TK;L98^>GLQR;XB>'OO8^%A>^,6JL\FO-)(+&4<247$E#'+_@=GOT1X(-9
MBR8KX6'(GD[]JAID24^:38&RB$NV_,@!G:CDJXK2Y<Q,EEZ&9?T_L6Q__3E$
M'"4(AN+?%5]9>@.Q8(9&/VKX?LL=-MSIW8U;'BC35D>/&\:8C,U$-N-X_Q)<
M8*<O=2?5J= N96S.:*ZP+U>Q(WY=0Q*2I0')TO*%HTS:4Y?(?8T(8F1$(1YB
MU/,@B,E%X91K_MM95V(!<F?\>;I'0(_?"/P:B'&X<('S.!CSI\ #W+SHE7(E
M.X+AKMH&"6H<P<+#"L 6SSKHKXZ^:/M?KN6 ?E_\,U_W7ZG*@=(!\2?>A8G7
M &%*[0MQX\VSH.2QI1,'B1\H1P5%&4A37&!B8I:/#NZ%#G(CMF19TZ1NMUI-
MP6JB\)5Z23CDE@050)-9IABLM$$[_G)*RKS2AB_RLQI>EWBBH+T18QKE_;7
M[8,4G7=^XT]6F0S>0 >//:X!,Q\XR8C^U4BCTTD<6]+5Z4/P?&H.R&3,EXL\
M$@&FV!;+%0DQU/2$3N.\ZE\GD !(!:Q>K<*Z^W?-C5#1%M]EF%$&'5?LZG(3
MEDZVVZ14FJ$V@[QM@+_^#"1 3+[QI&8E#RV,$C9.[<)I-X?<\#0@/WC#QT<D
MW/&3(4O2TU5MX ='LHRK8.V/7[O42BBSS :^2B>\'?L*C\!Z$(LFKO.3<--=
M9\(>Y\Y"%> QLBA>1A(A[7PFEL>4%+K GI\-02'K!UC4\0+GA>J7J=5"9;A
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M&I_<R) OV1ZO>\!CH[84)%$/MZ+RQLED8^:5+C=Y%RP//<N%B'S0*#:$9O%
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MQJ2R[ J;W@G&Q[LU>[XBS_? KBU;<25NHEHW2OZSY+__^X5VTXE_?T!Z<U.
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M38:SK4'O$J"%@C]S')6-] P)R _)&ACYQ(J%07;$,I-\?;CBS5;BWO" /E\
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M)DZD'M1EG#R "SD6BF\:;]8SXEN%7R5O;AQ^T@L!_%AI.X,^!9S#8A10K1>
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M70(J?7R>7\NA2Y4GRE;FIH%B,'K..9;E FJ1A/P]Q7(VYF_'R3JLN<_RB7$
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M\/'I7;M]8E";/OW%T,DK3FBTF,UY+,V^_626_CAV'?PI2+]K^GMN2\$VZ8)
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M2?JN)\15"4GA7>IG.RJOP8#>KOA&M_N+ORGNX)3(H%T=:K;N5^+]: , JP0
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MG,9M;=#M$%9T#]]YYJ:Y>?^C]4(480<?09'V?3,_TV7)]6SVZR]AMTTJV_E
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M-(8Q:,PNXELDU'$SVR=;.<_$!$_(7SJYG^B(:+([/8#QEQUODTCT+]8AFVP
MRL#A7-I021Q 'CR^S/5>MGN&WWKZQ<,TU_1Y%5EK.SK'VQ&]B^L'[3W^."!:
M7@3-VQU\#P<XAM@-/Y.W?&5(-GB]W[D'POUJ9Y$JGG2FGUJ78.6;44\N 3JB
MU)?. !; L)[9WB#!&-#_BSXX5%N:%Z[*3!I/NFX+K?[765C+!/M6J$2M +/>
MNG#-TAN/[H</4DI0@+JD%-Q)2.U39X#5M>KR9'G)#E$%V@.?]&N7KJBS7K%C
MDSZ^VF!UN\'8U@?/.Y\TA &CBH+"<NB,&A*<+P>A3,[4O>3:L&S;=#F_>^X-
ME:'NYCD.#O.LQ0@6%3[1)T1[+ED$MM=R\I,DKG]ZDR+<!]BG6JFAP:NJ&?D/
MVU""R25;RKZTZ!6'4"3YM*Y%9:X.V.=6T0-@7P>,84%!XRUE8A&I-R<M2$@6
M8JJL-BYZJZKSD<._NM6/<<9#BS%2^<9HLZY#?X',*A)- YY<&Y?[G.GWN:<J
MN>/)?0%WTZ?_(O% !Z709_K2?R,OM%DXN._M@X [!R3I^WJ<@:$<-A]@A(L-
M?4OF;4L'&IM1T\MF3V)MH@B3FE/4.^Y0DZ9HK (R,\D8W<;Q9OO7RJ^#\D*2
MGZE\+8!I>K-7E4!=KE?617=^O*)?-Y1I9DV^UMYZ<1)#4/"$!/1Q42.JJ<FK
M:U%R-XC:%AY@W\"9^[PY!-[6_60H2%40'SWX\('R>L64%;LK-66!<06>1I+1
M1]"3:ZH75-A_1)[VH12B1-OH'#P=&9M9G9NSWPA"J&"PZ'>DV)<42FQ?C#(P
M>NC"L\.L=06"#@J>0SB5%L4R^N7=7SK2L/11]Q!_7<\=CP\@9+D10?IP.IA9
M>^8P#IAO_*6JJ,[):ED#E(0IM#&O6$IN%&CXL9UCH\L%T6;(.NREH&4V%#CH
M7?>,6<ZRVE?YD:8]8'$W:7TWQ(. @7_K/^_D2#.P%4(IRUOH&SZD6O^A5/8D
M^AEGLLN]_1W&ZRE7N,)NZ SB2['%?1U+D.>JEQ=&[D6LW,[3FA24;1#CC7'!
ML[35Z[_''LO,4](@Q:6]JS;(@ZU9=25QP &7L-#/XJ9D<;,CIR\V53AO6,E0
M1%EL[%OAI4A0P6;S(>:_>UA9:K?B_\A;@SB,+OY$.>;TW(ERC.4@7L\Y\KXQ
MUZ-CI0UMYL@.0H/54$768EEGL>9*SDG%W4A#X\[T&VK+3&$,+'YX_A&*E_Y>
MF?+R9_+ROJ;ONXY86>JCONHUY0;XL:5KGM35W]^/HYA[F*217(5/-T[N^6T)
MH$D,0HR1?<Y(,5E!1]RL;DQD@N<>2BYY@!CT/(0)%1+4$&9R5@9U$;<F=]??
MK]5['@ZA41]5")G?FJ_?[ YEPKM*'HS4]6W:"\TERE-.&9R<#C#;N\KI'U:?
MO"C9-]IO=G> .91 /Z&9 K1%?::W$'_P*A7L^;X2)EAFDSNFK9%C0-EY3<].
M=7^@8[8GMH/%CY[KW8[_QW?V\!WR(Z.VH/3:9-'R<-##1W<&@$I)P#Y%,9](
MC-],:Z)T>LU@BI_/VGZVRN)6Y;6'5*'&8=G@OLIB/M<O!S*2>WP"JTTUJ3)7
MPI4NBQ,1D$I*LB5V-N?!QZ+X,0'W P/6KK)]\"+Y;&[2=<64Q(&BZN$E:,:>
MJ^PNEG84T3V#CH!@>"QL=% 9D3OYM97-3TVV,DVA DR)3ZN$\^E5058?6<@E
M9?+<"*IOW^Z0E3!$F9L-,8_?#%M+$2<M>VG[,Z'^RW_C6A(O?L_1PP[]IEL<
M2XUL+2BS$/BT<UF BM,/IGU)&-3[D4<$)I+:$^A8CN[K#K[F[>QDW-1T XY)
M#ZKDO3A/W%NO(CG&1OYZ:IS@_7<<T+N"YR P(5!PY;5TO6&BMM+9\>+CRLG.
M NJB2HUW<]]@Q $[- @Y)49^.IWJR=M)D.N)\UR&9"D&%43A0D*Z1YNO9%W>
M&L]:/O!)GILUU?'QNN*MC'=?[>$%;6H/-Y!")."BA"+H-9RYI)W+,ZW9"Y_2
M". H9MM,NZ<,N4<HM[VM$&W)7H_2Z3J%&C>;6VA=TH"IC7X:85( 0/7%#T&]
M[O.M@<BV=BN:;9>4K3>L3^[WE[<&:O#BZZE>UD]2:F<?3,Y=OV2EB?94K$36
M17_Y9B%F2YM>=$>V=W%8@V]8I_B>#CTS$D"$0BY]HI6_ACS]^*28+VKR\X6?
ME=[8T\(.2$&;'# E9J,8R%RN:[5T7=P:!9X>C(_HWIQ,F)4( *HCX):2)?7\
MQD(-VO0GZ! \XU95;=X9MQKL4F^[GW%+_ O SJ(^F)J:C;R^3H71''?%B@XA
M6EQ(FEH$=91I,UBJU8_GW6 =G=F48VQCPV\-[#?*BS[E0Z X( J&##D%>XV=
MH" X@.4%EE'FQUT$V8S"7K<"QKLE/ Y X0"TPQX!#AB7.)-CV\Y6(VJ^/.1$
M$0W5?U_V4% TQT/3K"B3(74PQD453Z@_@X,M-VWG3$@9A>(+!BH@H'5H#HN:
M"+T:*W'G*YJS3]6+%F_&9EP19^.-C$?^$NT#S*@A$N=FU%M]ZI'+!5=^/:%_
M8M*1>7E!=9P^YQ,1 >?>R2+Y=<LY%2 0!4^<&\7R>S $ZH38"#R#CB+G--G]
M8CX]3K,H"4CR[,472?XF=P:<C'%$YP2M3KV;%+W&\<2@44=>8TZ"_C)9Y#P]
M#5?,W5$W:E0_QX!H""Q8:K+0.QU+=E-\.?#-+(AX>"'VHG@=<ZA(-3A4"%^N
M_(>[@3AJ.H/L\%<;K0<]]+^\I29Y*GMLUQA.?C/%C<C:O<GM^(45TB<&P_>E
M<3K1QR&LTV\XZ_E]WOJ+R1[Q[KD@.4A!/B0?(W6B[.ND_Y7*O"9/)=GC3JO3
MK[/N84\M.F Z3.YA,]PT6YDNI:^VQ7?<"[=H,\9YOSCRWS<Q$ =U\*B/$JXM
M&G6D>6I]J.%GA)>)MMS8[?762N!Z.T)%TR_)I2[9SQQ #)R,QAVOP3-ZE[Q/
M>FA-N6-?A6\M?[?BD2GGY$SN;\<S9YLWJ.A;PJ,;>$AJ-/[MCW$C-CD35F.^
M)9(X.A<[&4W,FQ(0M83]+%N)5[GE!EJE&F<\[NJ#LHJ54[Q,9R36>#%+1S"F
MH=Z8A"]Y_#0T-*'ASD _ASM>''#0QA)X_V=1%''#M1,S?08R5V>>QS%1\X9J
MFTYN*U?Q,,UA24XCHN7SRI86>HO;C(:9WX,QVOP<7AFN)>D>PM*K,/?X^'7?
M'!=?JT[IF7BQ7RHFOKS\->-.NL=+%4#J^.7#NZHT+:-"(%E=@@7D[]1)*_'/
MC7RQ'6QT6)MF$[*^.71BT:CY3G)4 AR_^N@;S9745UTO'*:E+9K4QTW,^ER9
MU)7N%14HG9TOX/$[@\#K5Y^E71)<IK];YCG:@.4/8=,TL9K6I$GYI*OD09'F
M_Y);D>(MTU)8LDL=8^2P-TKD"^EF*Y%"J.ZPCLJ=^Y+$ZD###X438V(/7Q&0
MT)'?J-@A[J>R#4P9[HN$0QG:9>A3BE+4LX/;UA:&VFI,9Q.K3*%/;[:_7% ]
M[4X9>B=CQL'3S^%F*?Q.[C4[]@WVV7$(DBPK9&]YJ57G5&1A'0<,0;FQ7.V,
M_GTQ8ORF"$>!74Z8,+QUM&R V8SD4L=5);TJEN';86KW[CG,?C[.VVK[G)>!
M X"Y.NSISH_N[^5:=3"5^R$("T^MR?(:WJBZ]SLO4XSU_0R8Q"^R08XWJW=C
M#2!+.1,EB5>[\?,^8:%(.5B6*UX=2LT]$%9%"EWJ-B KR;](BC\EQ8-O$U_R
MO(=2%;2)P@AG]8KKFVP)#;Q>Z,TJR%4G?)24/U>IKBW^F*PS(?_*!_;+[Z:0
M@K :+29SU@NHS_LU,<A:QHA:O6,(,0GK6_?0OCT;I[M](]LT0^CM]D:K1%&1
MN\&R;V+VIS,<&@)\Y/I*LDG+ [W9*$!#_XQ\*T^+X3^3W*Q\8F055QZBQ*8W
M?9(Q8^]<3MHE9%Y*R>0MAO5J:B#?PV^B51'.GA;UB7HHKJX&":9GTQ3=Z\76
M)#*VNQXBHP0>R\_^D*P8SS!6Z/O+TI/PUO>DCJ7&+PC3PL,\HO/XZG25!O2T
M07SD$BZL2C8HB-6X;%!!>2+EK@]R;5'50/75&F4GQ04/,(PF@BJ%/F<DV4H_
M%NX476=B(](;MT=_M^%.++'Z%HAG5NXP[^8^#HACO)@8%QBTZORGO$</;F+-
MG.TN4]M9!RD#?OUK26K4H,^,AF]L2C][?\]]YLDRDM/I&F<@*X2UCDA26J=0
M6K\S>/Q>.<\(K8#R%R12XLO()"]WAZ0Q?P$M\.*9J(K4? C3;U^FRC^^>4JG
MR HZT0H9+L4!KB$GJBW8YK\*[ %H>M +B)!H62I7:0N+/L^2RU2L.23W51]>
M _7WQU.T;S3&)S'1ETV^.\B!:*+(LP\96Q[3U9:F5MF.3BHQ/3TP[)"\&R[2
MD4\N""?;C/*"0I:M'#(HS1_X2. [6SK]FBX3RWU/^Z,*)P]SI>++(@9H@)<=
M=GQFAC:/S":*2%S-ITB%=,U!9IRWGT!.WE:_[_4KIS/5--5]-62>OUG&U;-Q
MJ?F3<?;U%#!1IE"?0Y<[@R0X27&MO  [;OIP9H4TH5N+7I-DMHR+5/MFSL1=
MW^U&E6T8Z+LN@0D2T;NB@W:"]SO;[*\YRS/$+&I;JE!*;7YXEECKBZC$BN.
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M$8JL*P@9JPN^FD.,']O$7J98OS7K3J'PC)J-,7,=5/UBP\$PXL?:AE)3)IQ
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MQZQ5&!S3"M?OGG5T3OP[\W&!U,#<&RF)3V3QJP'^,$ _&;@T<P"\@H("S#P
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M.%\;U)NP3<(A^E&-/OAO%OW6+U>=[48;L'F]?F6_\OLI[KBV#S-7@PT5KG[
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M[M<V^MUX__U8EZ MTZ3\4_GLKSB;Y+\:\JLA_VT:XC??\)*!!&755%OU"8Y
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MWZ.-6X]SFZ?L&;%=AWV$Y&+"(3K6)$RSD)A^68G%\VTF4I7W1+MMC*2>-^?
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M>7.F%',+\9 O;('%5^R\I>U.KE^=@]7L!7!M6CG?HB:N/^MY,>4V1H<D02M
M_RFLJK,;<Q+6^3WF#\(ABQG/,C.T/=DSUTD2F+]Q[ LH>KQ:-#5O@? @B WZ
M,_I4*\,<-,4Y76O,T!"+/$F"N.WBG(\D,5%/=*Y]>1*%,ZMQ_RI"FC$#X+?P
ME$/9+0]3ZGVK$YDSWR+0=*Z U=34C!<2A L]J?9MG*Q6J^K:XGU.<Y"/C-<O
M"=8=XBY/PYU9AM;6&O$N-ZMVSC"I+K.;1!%_"125ZPQ>$R?_GC;&B']ZUVK%
MK783NW>SUF[E&M>DR=Y,V"'"];OVI27PPFKKG.SYHY]=[&].-"\H$FW,&M'
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M4'RD2A\3:(5PT_*G;SS-79JB!M.9WI5C&#H@IKFT'PV[S]&,I]:^=[K88T[
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M$JML(-@#M!5OG4V>H1P-)&.GR &>H1Y%AS4J#7U,KNI'97JE8LJJ-ESH?ND
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M8^7<[/+SJM#4&XR^[A$S.':#M]\+:NY)170F?YK_("TM<W^YX!VR(YD");=
M*O=-<J*]O5?@,7XB-4(B4\-R9BIQ&L8)]]_7U^I45?MQ,,8IA;D3SK-2/D4(
MSQ?LGH!AXTN(@Y$@L1"UE^R \'#8S/=^3#?CR^=$9GI"+EU&"O!*ZKZZF Q=
M_$XK)+\5@I#YCV_VW_%Z_&@1^M..R)RR3C*=^W#Z;I7_X"2XPB'"-6H53D_U
M+M6RQ6]4K'_-Y/_BF=RF/$?YM&&S6%W=4/LCS2W'PO+*+U:.]8JIA"J(:-'C
M8V/0D_<[K<Z>[D*.R8N2"7A7WOMZG=LX[5K$Y^[J@G;6SEXY"&J<:U<0%1D%
M+(L]-7%$'(',\;X)>(&IQY!5"_",S"D862%><\C3Z;0C$&GJ\YR)@Z-@MGU7
M4S>&94>*JL#C,"WH+0X<[<#S'VM;P",\P#U\;L3LP&"39N4W*KW5YD+'<C0?
M+* N^(A:*9$#X%6Y(]Z8WT=B=*:OB_)\'?92*+ \&=CT94&)[Z%3B#%F335Y
M&;%[9.O8?J]4MJVM:^EZK[/\NR_.ZJ.*-JXQ;3E*TYZSS)A8ODHB4#2N?XXQ
MA2H$,31#\G/>X/$:3G )F&3C<#<[^';+Z*S0:Q2?M0TR &J F^]?T$,H8_L.
ML%<4OU6%ISW>3I=:+3L?(6O3- .@MH"YGOQG0_'I02&<MWK9CN"LTO!70C9<
MS&(3&8:JK#<0B$I"N]!PJ57 B;UO]4/(62K5M4O\V^V[@[H4)2(:F5OH87SH
MH0""&,X?CA) +@I[,LD]1_$T)W955J?<LBN?M%F?<P&)3(G\2<NB"GHA(0:)
MTI_U:%G\5YPZUO0=??_OG.1:X^-6+FF.XST,3S^'">S>83;L&T9"]A'"!>?^
MX3NB?U -5))_$E(HN/=_RAOZRIRN1BRNG3*/2H<USX!,DSO-,Q@(&(%94=N!
MOA'P^:Z/S+&$/3MP-9<(4BPLIP-PB87PNK@D/=K)="Z 7\POUV%[^(,4:<D0
M4[#D^0U<O)8\'>31*BQRFOAP(-.%].T8I6=CB$=.5>J!D_@M!R?T_-T%@SI>
M&.H7]2-IP 1H>W'?0,SZ6.$73YGY)X,S?Q!AX0P6N\C&E]W=MVW/OFARI]<-
M<>=3!R*-P82*K_N9J&O>Y7THW#T+(O64HZ6-2$U=ZCX*P(&>1PO+]P=#>D+]
M,942\G\E*%P<H6#W-SKU^-W6W\*#8L*E-"S4*=T]I4="(8=N>'@GZ5>0F6UX
MJWZ91/J8,FY1W[2YE!'VW,?J:F6 JSO:ZQT0[[/ YM^JO#4[E6^S+)SZZ0&E
M3DN!5PTIQ\<,A JU!B48&<#%.$B*2R'D&86^5LG=23;(Q.8S6X70U,H23CA&
MDA!%LPK7[-KUO_$.^,;^B]1C'?$OTXY+UX2H=:ZE-P"5C<,+):K#Y%!SD>5)
MIDF06S30/SC2@/PH4\Y7PL3LE6 CQ<"U%E$<Y0,\!HC.YMU=E)92RJC)C9:L
MXM.R,8CA20S>>3]P>,S:3.V*Q2I7SDO*98KQ;F8Q] B@[5CPQ_4JW<3S8RZI
MPAI.)\=SMWBBJ_LLOD:S)<^X@PH5O> >FE%]ASSX0 ?# ,?^57W1I! 96RGT
MZ_.<5[D[$RQYHCPW^@@3FJ2-J[$R3?HP>< '[$*W9[6GH>*%'TQ>!#Y]+14G
M*MJCF&?0VA-/1(MK;"^M.H-4_]^FIW4:(]^>LLX(8TY/3^KU.C"J#WQF$#O$
M%L1)"B(CLQW=E$5&^L)<++C=\716G\3<?O58ZFR]<M>^I\]OSN$+I<ULL*^B
M.*V_R]]<B;^U<?S=!-_M"W,V'S^2-?EBFQ.#-]X3K#D2^Z9'M7*RP#'6>RX#
MG&,DT;$H)DQ?LI].L.)!_+TN_7 -+UXBW2W2(=:^\&618[OTR,+5__'R6#4_
M_<H%:2:)-W9;LA]7^%B_2<_=Z"C>UY))P\BKI==#<YW"7=V/HK'4J-S3;B5T
MP2M%B4D8_Z"#NB?BJ)C'H%_4H42QF&4HJ+5'\"_@UOAZA3GC3)LC&=(3M'KB
M2,YG<K9$F*>;<]5"K!4K1])<(A.7(0-$ATP@[W"I/)3)>@,OE5OP!#8 6-,&
MD"C\9_1K,UUF&SO'VPZK;:#3D(+._$M,?7O3I99$0/=7$[ VQ7M-S(O+GBY'
MTQI!!0G"/+0V0F8]7U$0%#_) T@E20$@+PQ04X3^4?5:FD^1#GQGC[( ;0W3
MX:6<[U": 88:@HJ&$A$E'5<Y@/6K_K?7:[Z_V>:HGX_Q;Z4#U_MJ/SJ"_J05
M_SC3WSKQ_C63OV;RUTS^/3,A>EO[2*O5ALPHNJ,DWS8;P>]YXK^"D?3'R.)I
MJ4*S'>A@BB$;X&YU8HDF]1N":3EZVE)7,+@WM@WO/$PJ<K-J2Z,8,!N:'_3Y
ME%3YJ>9#3.\BQV2!ZQT):204%M)P=$"$2W-\U<,U<)T3LL=N6R]OAME='='5
M(M8*B8E6N+>'Y?%5"8XR_T+P/?:<YT<"I6>'T;H"YR>&K5E$YPP39/KF':=>
MK?;"3)$B-^#ZV@J8+/VN9JZY;I%32\=]FU\&M,WGS+ U 6D9&F;HWB _,&1C
MZW,'_O7!<RH!62&R;,&;#=4R=WTP@-74@&"NC?D$()$V.AYA_;@HP?CMBBOY
MXUP;JH\O6ZP3F2AOGAL$^(,7<,$+&B]6:- J^M&%)T0(=C:F7N1."#2.%MV"
M%X4:5#.QB77OH_.A8]MC>4CG%%K4WJZ=L'P>E!..>4(LGY_(P.YOCX'+ W,[
MN-V^)L+[Y787S4.X;ZZ"MS.ODG/*JU%# %MITL26P10"\_-;O6/#(B8T/V<6
MM+@CVJ9+TI)(7E18L*I_NR/3R8E>-E&Q,3$+[W5;E&6F$6^^S4HO,>G:N;#Y
ME%E+WGE;M+A5SF3SC:?2GTIF7ZF)H?)Q<U)B(GTOBFO2Q[;VPDW24'!FS'VK
M5W=[.$=@=H*X[Q,:%'/7G2$*N@VL<:[;[ L+++7LBG(/KS(&FTQ(+QC<Q8R4
M%A=F1DJ'.WC;Y7G=WEX8+G6/*4K'A&Y <,A#)YR^];1.4SI<GI9.[35/A2#R
M>)[N4OD:@V"$\I>;4"WP?&Y/N/OW_79CN,HCWT!U5VJ2G;B'S^_C)PWL)V^D
MS"10)NY&MC.8=+DT]^\XP7*ROE#;17CT)5@8FKJ" FZ=!#B[NKOB13BCJC/C
M4T>$@RC\2*=< ;6[@ L-VI/1\N(@'YJJEUEFGD[VZ/C2H[HY2EV400[I7OMK
MNCG_D9OX R>/AO@?/E $B?\/H%+*J2G<J^'F]J E,:[,644N72PO7IG0#B O
MP;LK)U0,2D.]0Z#/J#&]OP?J] 5\#:S2MV-'9"+NJ,0?S?16YPS:/FX2VC#
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M-IIU@!X!&5**>X8QB$>6[][G7O. )NKIUU8>+B5+SRBBN#([D\/#(U/ZU0S
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M^.X:TYK[$1GGD'=ZU#.^D%-090M^$^238>[WK3GD+R/^TW@) F+Q2[@*J^(
MM%+>RNQXAV 1 R5\DILXT+(O] EJ6G3]"$"J@L7U92U$X_(IALZ+.V@X! U*
MA:Z9FFBZN8DD:0D?07Z4RK.BX5"TEO^*XHE F5I"3Q5?2]]B7^%I7;^+T\?=
MD)8F3)K,@V&K89DURM](@MB %4[?E 'U-_%7;%QMDW5=D2)Q_3("%F0#@D*
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M/PDX3\9,.D^\Y(V+H:V .X(KD$,F%LK6UBIX.3+CVSSS=*K?K7,3+,SMHHT
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MC=NI4?<QZBI?(A$ZU ()WL**.,/2LL\BE^YGV7PBZ6JZH &$L.T,EYQH5#O
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M]-MMYSLGYRF>7>41<4\7%YV&)P]-(_K.<SA)5=@"1J;Y/&"I/S?:VSYHTY
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M[I]V53R8K^>4#8V$D\^#B7K=^$/2IB]/TODHB/4?1W^V(8C.F\'=L&C@ZB.
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M$.@"%%E_='0&?$O-_URY1?FQK!)Y)TMRF$5=6?- +:!]T/'J49:,/_!"]']
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M7G=?>.(MX_MYOY[*LHZY?'?_O=9 *[%T2L*]/#;-N+%:P]!P&NJ._8*X&V=
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M> ;48]^#^@0<$)]7Q44FPL%G@/PUI],SH/D,:,LZ P(<MA$GN*6]QV< ^1G
MF$+^Z&.=9<VV<B"$%%4L/_#N?A(IKS5W1<+2T=P-GM:G]\1MB'%X4J.&1F9>
MU=AMSRON<A35#M_P2-^EN9;13^\\"^+DP5,]Y2)OX!YD8_VAO56POM<M*2BX
M.5M2&L&TE"3/** "XH<Q<)&WU<D,GW*MZCJ5'QCR94XLT)#<&B"3Q OV9TM,
MHG$!&]]<VED]D+\\]66P []OH/()08:&[5W 4V$.$3%]J=\\84(MV//IJBSH
MYBW[2Z0!K(\79DE\/W4Y7G?KV(F@A+NAPDN7%$WY&15SW((O]8NP*V$E,PL
MH2.YN9+ON'D:#KYXKZ9?8>TIJ%%=]_Z^A[+UQ=N-CO@J]]2%E67GO/\L>:7
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M@+TP;*>,3(E,:K1R!5P\ZB\ZI#-RI7J$>TS;3]*7?[/#_(&T#RC<,%RU_0X
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MY/2(?OU1Z-5Z],GY6Q:]&-&*V9;3XH,8C4^PGJV'29TLM+8I3UKU6>Q9TI\
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MA(A?"<P[\=--XC.H?E<@LX%IZ&.9%R);;Y@''-;Y7IT!_OHHQ&G@#";7Z Q
MT6[MG1-6O.?3ZX>PFV9:8\?0;@BY"UE+EER<><L0OV1/CU1A/M*5__?OB/_?
MW/Z;9UR*@&Y=8?'0^D)Q?8GOYL@=NP!8RZLQMM#LV5EO!''1OU^OW^V_\VUU
MR><0P:>,VS7W(3.VM3L"I^U"GTLM5!8G*CY$E;57D'VB+]R;G3=ME+V"]07M
M39>D#L=.VP\*1 Y9[=Z6/P]-]@!)3B2]7P&E? Q&U=-X]8T+A'V2"8_(Z,PE
M-(HV\+'G>!45L6]A3<<P*>(MT3%)9@GZQE/ MPUMOT;76I7FKKV?F' 7LZDS
M"6E228<\=D6J.*HV\/EYXW1>J-7R)N:M/=FO>YMI.#.MNC@^WC)XYUAU/)C(
MU*>S@2#=$4%6FF>BN<V(#FFEBTJ=JBE_!.&8NF:SNQ.:E%WJ&FAKWQP3&DDV
M$+PCHS%OTY46/T[NL_]>5S&,)3RC8[NED<%/.(J)U%O 484S4J[5F14'_?8C
M^G1:L9CJX2H%1\G!?<J*"_CZA,<K]/,0UK<@3C:6=!I=[CG$JRH"?ZKC#1M7
M9YG@6X?7OQF(9K!S/A:O)WRYCS-&)66!?="<MA,#1;7(RO87W%#S8+C&YKN_
M8:K/1=+SZ5-C#SY-Y!G@RDV_:IV;<B&X .%IEV$U*GX8[>925B0Z*#O@\M%7
M;];1'N>[87)SGK7N$!R_C@.EN&!Y:'=MC)RP7,T CDGE_F1CA)Q(O+XPSP4J
M^5BCH'^2]J+ZKB)R0/3J_L4''<>W1L$6T_*<O-5Z&YRXU'Z];$^JZ@// +H]
M$Y9)A,4;KD%G&__6DGP&<R#QAUW;',T%>6#'(9((8 U2I&U%)\\Q2XE]3@+W
M[^74>K20!2]U]7D77C4'OG)S7%>PX&)V>/_!)P4[L,B]WE=:^956'] %\LG-
M5;$'\^9+AES;AJ8@RU@8%95&E_*A6S>/3"MVED'G!!E6INEW.>OBW&RC!]2:
MK:UL=U47N779Y0DKYYUB#9>3R(0P."C>WCG:I<(R1OC!2!4BYK/JI%W\%]+$
MK Y#&FB+4R)JP%LZF"<700L+F&E*HANZT9T^Q9*FV&06(=39=$5.8K)5R:'-
M$99"&LS7 $5FU*]B YBN^#/@68')MLDK.X@VTL/HV>[MTR_'.L;T)&U*0LO$
M+:\-;1="S6AYG7J OTH8<?3B1H>DP#0%ZT9&7>^/I6DXD<86WWY")4;ML?U*
MXQZ+#V>&HS#\;W_G\P30X)UZ9KAC/_SR)]5TO6^=.28-2-L+=SB#.7MTO>CC
M<4F\*QC8$GUY0,,\!4S;]1ND']>D/NJM,3Y/D'@[S%$A?D'/1_(,T'/)EG^?
M*L&9^#[E:6VT-S%//AC9^^J&!BW6T5J[BGL]C;J2LFTE=-'D*OP5>E<!_+9\
M.7'/[)%0'^!*HQN_.D-O=FQ6!--H>E@0E+>Q:&E16Z)$88>C3CD,=KV?1/!$
M_ *I(1J!0BBBIMH/W'SOBNN,&1K<1L;=(^J-P]BRRW%1D',S )$X*Z\USU-M
M:BQ28:9?PH_T%ZO45 5)\]*KOW*_?F_HC\NQ'-:C[90$DP!6L!(V@*ER3]F-
MK2\^SNRUL<[\(<WUONT'O.%;5ZA_HP)&6;*7A:_BO)!=(-IICO1^*V)B?.KK
MS-LTU2P(XYV;HUTF'+*0OO8EFQ_+,@ST)"\ EE;:>2^>DP\E1DP//%C =V/T
M**JYRB_,*E)R@E=[1@1$*BP AZ@*YI% GU-)R[IKPYP#!;D+ W;+CF7()2K%
MJ_,7ZXD5HM5Q#)D!,A4:G%6L+LFA< ]3I'AYD9I:K>[#:F5K(^%6\:[9J])O
MR+2%*WJ(5N6DU0&I+K[>P3G%S2@W:[HPN" TT&;+G&)B^N2S=!9H-O'V6H1@
MF3"9UQ-[FH0];)"86VO2(O7TY4&422];TL:W:[.^1-QQ6CF59>V,Q11 IT3#
MO(RBPRDQNC(#O=5ZWXK1^)TK":7^C4%#(^&<2V0YA1R;],U^U:Y9[>[ WNWS
MY >^^!&(6_IW]SE+G8/#\;+/+G1%@X]W66EL01TM+Q4[#3<?AW4Y^"54ICQC
MY1RB-!\IN7CW,@/1SJCF?]XI"+U"V-GA-!%> 4S^$O560JDQBGT0GO@9:^OJ
M['4M[LJ KF_I0D1,1+7H6]Q99 U1@Y(,LF#T'!AL.9J07AL:%RGO?E"4&XUO
MH:W]:!E$K(*HC@EU/K]^I.AF$BZ+'7*J8:Z!W.<+PP6S]N4X5RA;*9?YZDG4
M?/'E#$DBU>7/AUPW#&UR$-#O_%Z3WSE,["[SG=4H0R8??KG$,R!7^D%*3W\B
M98]ZGXAQIQP>UC]M+[<P9@:? >6EU>_J151B[L%$W_@7O*Z[!7?[$/%E8K?'
M7?@Z_0H@'<S7O6\7*NSY6:^&&WE-MV7D8*=$9'J<DU#<.Y-P-:(ZNQ=4Q.2#
MGP^'HNL_HC?GCR&-5][E/!>XEF[?S8.[W.TE3I%"14@0$^JM<C[H^8@68Y'^
M&J$E94_^G:G+:?$!(P-32S%=ZODW?2F=VI9Y*WLAS, +K("SY$$Z"(J"&_Z%
M@\MEI8.8]]'J\_"Z1\\7E6[.?CCE3%P.CYW$FA/:9HPD"C][KGYCPW9IZ\L
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M'>[.ET2A! ;?9\AR:ZY".PE+].QPR51>EXL 7X1I.QW:"$EW-MA,DU&![^;
MP764VT->L-+!0^MR?S&<':I""@UN,N)( N6#KB-%0/E_L??>45%MR[[P(H,D
M07)60%!RD!Q5DFP!47)2 <DY9P3)&014LH* "$AL<A!HDM!(SM#=9&CH!H1&
MFNZ'YXWQW;WW^?:Y]WW?O>.=/_88U!_,L;K66'/6K/I5U9Q5A%?G%_K<W.C<
MNVD)DV4F;[]_&0ZP 22.2 BMO\CYXY.8B1=(1#$9>^E< [OE?6<>3S*3Y#T[
M6KE/J4W#=AYP+Z-*]/NP:ZHEK?Z6PP];VDA'$K;GB-5)#0R8GO>XKX\11*9+
M6#*OIL1;WD!6)[MZ<[)6#_OY->Z8I,NL@=[&XJM[A']?+1OD(23[@M K)MCZ
MR?\/XV&+ ]Z68I>43QJ"+OZT$0 XEA^=@*5)B3%M/_8\\]-7.W%Z7A>@NZ%U
M&'UOQC/"BJ @]7A'((5BEX7DJTRP-+2;,+!EGA?T[J9['$\BX7C%FBCXC,TZ
M[6745D,!G%JZ5YD^F!M:AD$YE>[/N%UQ)ECC?<J5K\-&ST65@L@\C@=ZD)VO
MO*U(MAV>?9C3("6M$%Q7S?*4.-*<'6:K"Z)8!62JV2Z*,)PE<P[3'+PUC1'3
M.V9U;M[7$]SFR:-3Y9_"W6_/R0R[K6'>MV/;JGL-QS :Z)Q2^R]:[. 8:.FY
M3F7<2RUAUALRO]EJ/I=B7U*AO+%N%H&WZ.\84!E,7FSN)#Y(@7)(;5_+3C1(
M>Z72G KBBLS-.'AWB ,B_#+\Z\!*HJB\'\5QBCU]1&TQ\OH2Z<\)@<\&^H".
M1)=RK]=VOOPOO0)S.R>R"-OZ6*U\D1NVEN_(>4*?<;G?U%0XXN#L>,&/5Q%&
M:K:)[5.M@I;6XI^&E.QG,S?QON9?R'%D]F&(48PG,SUE>[;9(=.9 F:B :#F
M1,SW&G8#]P=X$Z?!@=1ZU<#%V[ -ATNXH7M1J<*! RSQD'58'49PY\D%#BAQ
ML/RGD7\\9(2*Z6><?V",UNU)'^BX,;5$PTP\P:;31SS#0^3[+#R@BR+T<?W,
M)Z/1=P:1_ILG22BVN!"_8E:>/(5A]<>W:#[-YU7UD&JZS'5S%VY2 (HI71U$
MXQB2H@1RO(U%K>C65I^>19G]$#H;:)!=,T_^^S9(+R>! F>EV>@TRF+6D;;U
M@9OACM;;W,CA.&80?C]?D<QYS[M-)5K_4^.8/M R'NK.P4)5Y7J^O%._7]J\
MYNQ!8@VS;9<OQ2RWJ^Q0.![B^ ]U*/[E/%N^_*.U_K.Q?H*W\ZX^>VQK9GS;
MO5^I,.OPSF=]-H$ANKW' ZN-)(]^T$/0G%TG2C3C<+]X^21/;Y$R1^'@0;M,
MY'@H,GQ!FHJ$'4]9C.?'K[8"F*!+X.6WVEI J^%"R)+WNJ8MFXR! \KTV8PI
M0B*QB'"3550LPT*C&P<TAGTM&U-:VCQ;?HPX.FH=/N(<!H?%O%AJ;X2S/:_!
M\J2@'_X8$8'NYWD=,1OB !/[*BDFH<? +:;K;Q,B/N32WU4G?;:=JGH)@@U/
M4!H4-%R:\*2[G_B9 +PNP+>02A>6$ML)94+[5*QHB&3[\%B]:!20?HVU*>"W
M4?3CYT7*GE'KO ?'K.Z&R$.GLJ/XSJXS)%"NOARDS=IXRAQ]MUE8IANOPZ*8
MP@LK>A1\#V7T58DE!<+0$HKP17[L4KIKB$^V!NW6![:P<U::A9=^.JN9?R4"
MELQT0R6MGR7JB9XH0! .("R98;I$., Q=.RG\S)[_4ON^G.I#Q4#2:^2507$
MEA)A&@;ZC,S.^PJNCC\ZZ71A]I(@-_(Y!Y#12^::$'FN@>XKGSY0&+NRM0#N
MGNI./0HT*.U>2WK4R&@DW.?,=?]D25M<@RWK2 S0'!5E4:!GY@E_*<7^B2X\
MA%.-3H\D//1;YY$D#E@HQ4Y7A_UAEUQN"16VL#Y.FK"O8LA=HXYD*^$=S8X1
M9T.W6YA!);V!P'T][56O0XX\-0]HGK4*6H,Z&B/#E6)D=K_QZ/XH#4]:^#N#
MX&BF%>Y$3U'1=H8ZS+,-= RL^E7P'<Y\(>^+>03T87CPJ\^$UP9[(HKQOE_4
M=J2I,(4R(I,35B^$!"6#^*%X]+:Y9>*CZJ$.K,S666[/<@$2>GA!O?*E%122
MZ^EME!HS7=+V==E_)>9RKNH^3N+,YDIDQL?L@BEX;=0YDXF.G^>,Q0'7O!$,
M9-Q-8YC+SW28JA&]Q=MCHT&66$ZAWM-:AE=L7N&N(I]"J7NG^J5W0M(+D^OY
M0N*,;>FH^%K16$9QAK6K7NDA1Y962)U#-P;_?C"'1$=]&E^3?R$H==-1W?,W
ME7#Z^$\J9&!_$G1RB,0?(?#F']%M&<%W!>M"D?A@]D];GVNR6T"V"=]>&)AH
MC+#2MJW*/%XIO3?>U!F^? ,[C_9A3ZP]:!DO<7I!+74J5O!.BOM3%9F*7.A!
MBNH._2IGG0AF1/ED&P<TE!&L['8I,80-?D7/8%<ZCRL%_O0__^4#U-K(]N0\
M&*61E3T\VW RE\Q5RMKY 7ZQ(YD,JX$V&V8$0N!8M4Z']U<7,7<'L.3&@U6.
M2C?0D2%LVSZ?E@8I/_WV;=D<B+YNOBJWZ4B=G<)'T,1:P.IS,A;*;"7X\ :D
MK&46/!3?13(8,K=%X0CGYKM$GG(I)/;D4#<2!]/;GY\A7*9L#^?>FCX^TNP"
MR0@;G^R.>1=2_B$_\'M$.77PX\_?'8.4CKB<80R$!AT]3A9L4O9@1EJ"X2AT
MN/7Z\[ADW]M%\^ZZ'DUEYGZ7<EZ ,;]4.C!. L>9B065=YE1'\Q5 ]9?J-'@
MKXN3\FHNBFH!C7NT1-98B+(S#HARXIL/Q@%\YW>M:L^:%]81O^U!D <K$TD+
MK1L-2@*.UZRVW?VY-?*5$8B07BW.?&LQLRI3+;;PT+ME0QJ&1%]8"8T<BK:F
M0SG&]NH3".><'&A[WP(,_8;. /FU=!U9GG= 2N^[124VY'3)9\CZZSI0P%V%
M"#%NO,./\+&Z9QHDZ3)WAC$"8QL36&:3>I"^<%$%]PXC8]SUM'FM9A,)+F[_
MAV\'N&\'KF7HPB YGW' 5]G5)@7417L9=0-3(_6QL?LA9N1[M$$TB3SIB5*:
M"MUQY>W^^^.(XQ'Q>7DG>>\Y.DV91YA!/IZ,P<N_:CKTS&HG6@OC!3U7Q!\G
MGCYXGEF=*R7U-8J>-YN=SK;+V6:5?Q PJML5^7PS%P?,NAL/!\^1GVSGRTQ$
M1LO3)SR%KY]=PHTK9S#..*P44KK7+!N5EZQ_Y&0^+^BQ_ES9O9MKU$#)61C6
M+&Y']:V+8#OP+P.9DZ_Q5CG)E=>@P4XXP&WEIV'FKV7_X\ Q7C;LH2LGE;^3
M_K3=X9#)0EL1ARI36OC98X\MDR\?(@?96.!8=H? K#ADE"N"5GXDZ!$H^\FW
MVKJ$G#@C[Z!AFD$K(;-4<3*(%V=?@;0)#GCEU>T> #\/TN-T%'/FW/H"73_+
M^4!104'E2[,7<B-<5ID S='_5<[<%:7A4:43]8-2#?)6\+"#17?Y*NL+:!>\
MD&^#)U_DOP3.3ZY<HJ(X;NRU$"]M=%"I.09LT#EM*I 43?ZDZXHZZ8OGJV6;
M1'II$4R <S#GN1WF=A(!8CDL;UUI15F^K5,,TV:']G596' 5 PO$(EU+<0!9
M/X+H\ZX(=8'UAWDMEV<*#UMDD.?TH#(\4'1>N"PT6:*>!N'^%P:PFO /F.@@
MS-JM?'M&BC'M+ OT2%+B)DR:&Y_)QE.<;-M2 \FIEZ.K2^-_&^N_?*#1[L7!
M)\CL1^?!DDJJYCT:8KN&'W#R $D=57#HWG'GDN'!A< #X)=+>-8*N4022O2_
MEO'(KV 3&_Q+(6U"DD&@><[>3K+=6C6>GR'O-22OOOU2+?C8+15O=/Q)+[EU
MOAP\I7 W![61 QW1[9Y!H4L^)&@G*?0W64>_C+FRY:Z#R07P1GU7-PD)]/O-
MQW^P4RFZ3F/))/MCOPDG(%0BY1.N)35UCWHD7O6(1T$BQ19W"F@Q3C#Y6\4N
MQ#"8K?KU*3N_-RVBA$\S?]M4J'XC<Y848#R!T5Z5E_%A=JGNA#+,2)'@V\9:
M+=AHTF :W6[E2:S(V %I+1W9:#=8)S6Z]"M*JW!!]6DC#A#\Z?R@_,3HN1:3
M'IZ^YSU  G*7%&"/^GV](G^2KY S&2N62SM[BLTL^>4Q_&$ "+IP_RD2@9V"
M+9GU6?+51\#U@^H8WB0O.YJ:@GN&;!^GIHNQ#I(D+;KP1OW29LIP:I+M4/&Q
M?<F+N_/$;]][-[;X@Q3K<I]-KM$,Z*MP^XKZ5_-?O%.:N\B#"6'#9H-G%2KG
M#C'?E"[:0=;#H[+@Q9-J#70:3&1/EWS8UDX$H_/#[9A2G#!G*&TC]=5B)49>
MFGBP:X" *\U(@02J&<R\NDO)3/C"?R)D,BYE^;?%YE$\;F5^'CO',D5^@L)\
M?Q>7]::FK$M/D7R0)_'24QSDR0<(V@-6NK>*)^M#K,", @G5-(ZT.LUYQ?:K
MZK?8[J>2#-Q[^?+TP4] .-ARL@JA0"*<5RJ85.;D1[-MV'WW:7WIAJ&@.P&7
M#^1Y3^FC60<Y9SFI).N2A?HDHLPV7U3]*X;;\737PHG=%8D C0];TX'L.0OS
M?"."U1X>$G@= ;GK:\&7JG;KTD\$ &H!]!ETP*=5B$CRG&E?0<LK4*@RDY1V
MD*K?CCU S:6X!BJNHPXO,.\(&MA;<R+ERM^RMO'Z]EQ]S4Z0/A:N_#5$9M=*
MSC^[OY/V$EL14VKW9F7E/RZ*E_?78PTH?!Q#H^DGQR!O?-2J9+G.=7N,I!/M
M]#!''5F55K(HZ:*8^5KJ4-(F4S"6+BV52ER1R-$P-.;S'#KF7NW4'F=(Y:+V
M;9L((T6#+YH45*K,JQ$"=R]]2ZSK$08'0*)^B0GF$OSB@((KEUYE<@"T 90%
M@QE#(WA$>-)%#=0(>-+] :H?FV$D[S/TO_\(8S*O$FY3*].2V_!-^_"2J=B#
M5H7S.A4QR9+ %M","M)OK4>RM?CFUDH552YJE)@1D46,%[PUKNFB>#FCF$"5
MI_&L>/O+UOR=Y&S7<4D&0]0">/RJ\2=^/1V N>N8#F\0S=H=-H>UB\7<<R#L
M$)SD=<IYFQ#0:;N46G._7YY>#R'#U[3X1%C@OV9I XD"5OI<[CI="%,3VA_U
M7[17-\5Q'WU[(> SK,6=2CU@P*RYT]5(\#0>&+[(#YW# 5>F=>O/L+HGKSIM
MC[Q P_-OYPJ@*YVEK""_$1O'^0+,3>7ZZ)0/;T(G/OJ'!;_ZNI#Y@N9 7(*?
MR(,K[DJZ^EH_BL:R\U_:9-0_J2^4<M1^!Q6Z#@8AD !GI7?.[UF?:].K]MR^
M#1+<N,7H,1KFA5&Q";+]CV7ZA\Z+#[MD<^62#>>%0. _#?SB2YW84G!2VJM,
MC!;>8)^W.?4]E=9NY?![>RM66(6B20\3O1GVY0[B!XR3 \/^R7S8&J[("G&H
MGVTT/Q.)B:))*"X#($,FH*O^9SJB3.'4;M6$Z J%93QT>R$:/&["!9JDT3_C
M>@Z1ZQWB)3);[TX$ Q #""&!90PT)1Y[#<400XF9;T_.=E\1G,X&:;&"X66L
ML8MMR)[J&D)J'O1*]2QZQ1(YF@+=2#]Q/^QG*Y)2DQB\T?M>VIF$]?VSIN".
MQ( NDG'OWQ<I^4^,]FN\@Q\]6QWDYT8)/F[T_OGCY$E:^]],G\L'E#LXL5+?
MRM2YJ]GKQL,A[5&?1;_X2(4-!R0J<):@A^\U3?P@MV=Y$3<^OPU;/!GUB'F<
MJG%="TB:[8:U?3BQ/[<[\8L%74[]LZ.GAR"[X2/1\Y.3I101F4U6K_EV3IA&
M;&>-@HA09FXG2GZJ<TQR@-;MML:[N]<\0<B]158^ BZ*"#5S)&?4=:1=Y&=)
M&YJW\(>G^C>5 R0\-V4($S&%:7F?"H\+J2+^+V\]CI0/)EN^;F[V!9*U[7V]
MWXC/-KRRTY" H&XAX'ZIXA2JX9LQUZ?WZNDF]JR;4+PC6XV-3[BT>>39<WW6
MZ1O3^U\-RK(FAWB>'7#7I7WFB@@J2DJ#B,6QIN5^,>1.O$01Q_#*X&V8%0=&
M$ZG1RW1'A-;4-$ GFA\!57'9>*G#IG9]<<L883VZ=Q;T.KSB5V0$6BGEPOJU
M13W;_7O]B:'>PL#W]">U7/KJ*C(#Q_3E)C\YZNQ@[%3#1E]"3D >@N7I9.8_
M#+NY1&4)[2)(*Z\ _V_ 0&!E"U_VKQIIYV$XXA]J:TQAGGDVM: 8BGAVW\ZK
M)Q,^3^O5 H)?R3!Q>E<7XF_V(1[L3W1Y;L][#LQ'@SPX,IWI;I(_"+5]W@^(
MDYB?",KYL$=G?.SY8#\M9]&J.69BUN_&JJGZO*Q(50:P(QC3(^%;=;MTQ>W.
M\KE1E,6TZ#J]S"K7%T(;%]F^=_NNL>T9W*M?S8=[Z#55H[RZ?UK%!E-66.FZ
MX#L:,B1Y$&UFOJ6[3_YZ@"N3V[V;!W_ABR;]%OUF&'T#6?5QDP+-!PCGR4D'
MC"<%(O:F<D:()UE%^?H36^X*_%G*"'X"D9. 2[@G8*(TL7FF/$][D3TRNB+B
M:/<B+"84F^NZM'(GK<(Q#/D&.\ZBE/SL7.<M].+P&KFKP1N-MH%OA?2]$3RW
MM5@S.'O5 K$Q'TS00?=JQP6OV586:]/: &;L)E\ 01TMF;5TI]X_NX:]6,86
MM#P,DJ!  6$Q?8 #G&I2$((&)!1EGQ;KWA1;],M>0%!X:8C,_X!OW_<5&"]%
MAK.7?,2Z=SK5PB%+C+<QQ8';+0DDO%WB/_JD$?[%&RIN%.6X<R>/6AM%E7O"
MTOZ*L;$RH]9F=%R5]?6E),@\BY#HKKS2@_*+%PSFA%:T/\=J=L611M\,^1C@
M[@MNNY:N8<Y&D=$EB0<KP#\>'KD&*XB7?/TNX+/S\ZQY$X,'X$,>Z*,W-N&]
M9*2$&4FS!V8XH)XSUI7[^_$*V?;PIH7C>$P6?VP ,WWV<^=N9?FT"+%O-EX9
M%C%?5TC,_36^[OE8+3NU)%;ZE#T8Y?%<0Y:@LKK6U@K>YD:H5LN@+V$U'_EJ
M];D'#A@'%5+[?:D!34CN.I'+8%K-C+.8'GO(/U*Y(AX@ _A4LZ(FJB-"Y=!.
M?7CP:(BQ;JWEQOH'"G5NNPQE?C6CJ)JQ-[7NH8XG0TCJ>2>LK=MYT*4G*XEW
M</Q_6A?VDCC"_MB?6(DL;/#Z6"<"C@,T!O6#-<<4#& X@'K9/TP[1CUB% H7
M\O'Q$WECH!E,.BUX:_%#WDB7@@TR6/KR.2@U]1PZ[$F,>O[HTIJ C]/E8_1Q
MP4SS@F*+_7G#W6PVGGC+1GS5NZ<SIA_\K7LHF:>O$+>U>Z\P9%_S]F-G,>3T
M5,(! 5\^Y.E>*XWE'=M(Z*&V9BCE&\BPK"-\Q5$%&"[V?.%F6]MD4KKNA/2#
MY:44G"@SJ[IM#DV,K.WX:6UHK@0LD U?KN]@(;4;LC]:LI-TRWV;Y3Z'05MP
MG;2(0'[59BM;:/BE8M.Z%#2.M!,A4Y3;AZ 0WC7M[:L,5^OMV?L)TC^IJT!D
MV57I8=<P/.@Z'S>A]OXD^*4[69PV6&$AWI(607HK@A1AD5^QFN?W$"UBNYI'
M%'R^C6D-JDAI(!TG\A/_[:Q+B$/K8:'K[24J4BY&)2J'(VJR)?_XGZ3_2#M*
M?1"]RC14(39;F*[-9V1^DI'R>.M?]6G^@O$HVK6\CIS,8J%JO9GB;ZZ<'Q[)
M!< 4A^YQ"8$$FV4(GT:H =Z9JQR2WQ$_+N6AY[M#-=#B5F>QO*'OCF+P)-UT
M8GK_&P7%NF[PC!WT0@1VDNE&E+E? TW8HI\RW=BVR_). 3SJN3P!O@U9GEQ0
MJ1;4C= $[7IX9/!N)T378E+4[8Y H70GP;H*,7<*]W6-W_#2Z=WQ)O^<A]T2
MR$959L?=":'6^WZL[2(PW%'OY-?<WI+V6]!A9>RT1,%KI!^5[ET2+C;E/V6Z
M?B2<[X9(Z#1WMF4,-S3$?7Q[DM% 1]M/D!%._> H+ I+A8H)E]RNSRD[EA]F
MWN_KSA(83->LI;>*I*'^6DX@,.H9 "]$O_VXV[(9L?F]39EJM_*N,6+]S2+I
M_:L9V;[[PR_KR]9B%#A>$8BL;A2((O-F8JL+DX7N]4K7.4K@X25^JF./)^.I
M]?&!.,C\4(HSV!-T.1Z1F_\ZJBP\/<T;3;>H,ZF'GYBO [ [%:"FLA/N*%+,
M^NOL@(=@P9]/_<1;%+2V.2;=WAP=>8! //0 9$:D2L$A( CZD%971.?A],_E
M,CK11)KHQAA92C$2BL78[OU>O&D'4X/DN)*%[7>V];[3OMNU_*GN'\[2=7ZU
M$>/+L"2SOI3O_+=V['DQB87U#2GRUR,?M_RC0"C9RW0MC'T'6AZE^ZOC-0X
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M4AK-KN[',^60F*Y0+I12C5L8BN1)35M=_>MAE_?;J"_U*PTJ?D+18; S,\5
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M*I$%X6(HR#(AOM\']W\>E!#*%EV550@/KZN/9*=.F8SYQ(6\)^L#U>A>ICO
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MTP"Q4O*;M+.K>_/VI>:FF)A;+ WX^#M)8RRG[91#079DD;Q'?!1ATC700K%
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MP4ZKI62[S?3PI&^K5U'"#J=!=9Z'//Y*-.E/\Y_@[:/&"-:W@K9 :'Z>P7=
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MJU\)Z:*7D7'0""A3E0GZX<;\D_)S/7Q"WXAJW2/*%><7<XC/JW/]XMF.!\_
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MEVJAWZ"A.A\4*SV+JY I4PM"RK5#;GAE%8?TI@FUZ0_P *]\TJYK<624.8)
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M1  (S%-N\XWCT\+5"W>[6K>>RZ:Z59$[8( +5M@]>0>\V(S9/Y;"T?L-;N)
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MVEM]\QMCD8+++"Z85=RO5SU]FSNZ'8?[\_9[,6?OG=KM[H DO3M -^K;;<$
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MIAF2!W1K:FU[\ZP[/EHWPY)'*T*>1_O'&(<.0A[:#L&7NU*G_;VU/6RL:.\
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M[0-5>;1@[9DR["L%+'QE7>"DCMIYJZ$%;4\BNO)1Y=J-_O;$J4%3J%I5(T<
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M3RI;6\OS1*_PE>]:!G,K@T6J^U^ZW++N?+$56P:.PUWX!3W\9JX(O$.!Y4E
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M#<Z\(D:FL%R9 QJ]5$!#0<%$[B6Y>H"',()$!J.8I&HY%N9YJ=$9&6:?@IC
M8)\-)HF1*#ACGD&,5VK;>\]@AP-=*/'@N1;\X 48UB2>8=$N<V0]VD,0NO6'
ME:.0MHEU 3+OR]__:K9GT7M&!7^BUEU0W[B]^]@3CK]NU?HYK@_R\'? 4!I
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MPV(P"V:KZ&- TE&#=MBS309MV\%P:(O/A(]T2$&#K +9:D6#[)I!]DR#[+I
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M0>' "L(3X??4WH6X+Q^V2W)Z6C,4E[^U9M":06N&'&H&//; 8%T\ 4'9_=T
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M'#0#SPM#9R+2Q@9X >X;[LKGR087N./,)($\@#(0>1<OL'UQ?K'%NC@5S._
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M %A@!'+5*_NGU;.*_%M,UTN+57*V$6O.)];TFS]-*M6)>R#C=[,>%XU"2I?
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M'CX.;,BS7>.WYD--MO;Z?O6P&VZ95J69,F(9^:X8XWUA5B#80M5Y)FN@$TK
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MQ>3)U@D]K2P?&1-2QT2'^BVL9<5<3*C]=Y.J7S JQYB**5S[Z #O 7E62GV
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M%VH7%)-GBTQ[O-@*$F4.)]-/<WQH>6RS7'@L[$E$#H@OEHC$L=#=1-&"RF'
M!8.PE:323)@A]4([,4[)B!"L.#\Z[..@G!R568BRF_CMW^#9AN5$K$LE#V$]
M$/,B%E+Y ]'!G7!+14TX394 X=A4;DON3!&;(\.@Y=2%54X5=G8%0!.=5($X
M83-4(A8*(T%1Z^PD2,M9XAIC[#C2'RI$+=.;L5$Q,?;D(,'X>6.# &UOF\H.
MF<@>N_+S="Y('\:-)!,^"%WQB6EKT!CW$2/544W[H?"H\KS(@3/P]/8HT",Z
MF")A[@30A#FG5N+<<]')I,A'JZ'*2Z\[1D70\L/U=]& \I0'E3ZR?>PT\^G[
MWQ);[D7(6FQ_55ZVW JJH,)\'MNVM3L5<,9>FHK()=^F8GCJ310 4)4,A,U=
M/<J9ZERKL%]%1>(DCFF'K@G049A]:(SY,FH618P(JC>"&Z9#5).1U=0IWTE?
M&' RJ353H#G-"$S&?>+L%]I^D?I*(5I$,BP'!@6.NUZCPEV69MT4V.$FON0+
MD#93GI5\A#P#1?:9EC-0%:!1?6+4(%IL1!1G)R773!:*DA#\PQ(!J3BHT\/R
M49&'L[ " 0F&A@(-GLD0<V<>BSM/JW2E"(J(<@)5 ?>6"'<*2TT%Y&5O[ZXZ
MZ$"P2;C2\"+0%K J.*/$;E79E'M</T:ZMBX3Z$YH>NS&:Q*3#YP118#'">W!
M9#!:51.@92_WY(M541P2%A;("ENI3&3E)Z;O9E8N@C_UHF*(B2+%5/V%*+A!
M\L%,(L\<S;KHAD'@J8-K>JYACP;#OKMG_1_VWG2[;2S)%GX5K.J;W?97I%*2
MY\I[[UJR/);':SF=O?H?2!Z22($ "X-DUM-_L2/B3" IR4X[32E1/[(LB03.
M&'/L;5!ER!GUT&QSQ%E"KX:_!S-WVE*C^XR'0=M-3GSCJ%XD6?QY65INL 7-
M\TR\9JCU(<(]=,38+,5]QO*2%T93-G)5Q>LC62C^N@*+[X$T(T&;;\J;1"/,
MEC)!.J1P1C<.U590\*M923\.3G*2T@6OLU3X55;+<I8N%BEJ<5LXI(LL'>@)
M#2PQ_:O/R_JC-&X;$Z]]ZH?@TO V,5*OBDF%'#K./;[*I0\D[*#D"]-6%OV*
M[_P35W]=&^_*ZI(-_#D0N1*NA=ZQ6F(@M?3FVDMK$]]BO"SHW4!T+V8<6F"D
M^[1NI"4:F6Q<0QK=57TB5W?-B^5!"+C;2P90F\9U!T]L#8/'6G'C5!I+*<]
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M9\D;- '@FR_*>HE<<O*>%G>TXI/" <]WS!B0'),<0I/=,0E:&FN1I=*?RT5
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MYY'+ ZQ]>Y/>NRBAP:F!S@<P9L&3VC270O"'ZG1AD*E1N'OZ-0!6-\\&"[
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MOU;DI*Y4P19@:GOB <$\Q&G'!G.\V%7 !UWS39F;<#SA-OU]^R'X>W0$+$*
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M[/..C7 GERWBAMZQL7&2UB:S!W'\M6/]P8OD*%"Q8W-(2@0%=VQ0H=DDO>?
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M^$XUXR7D"E56VHO@E4EXM_6E&\3"+"]'_& '5$-NF5DZ-'&5&#I6^*Y ?]#
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M5OP-8&L4\H8 1L/A):;"R<3#9\X#71%O0ME%3P-3648/!$L15 QC*9D #KL
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MDQR]HK<KPI[K[BI3$0QWQJCGJ=R;0=/@=$> ]6-?7O'5/%R7!F?J"('9C\%
M<P5@4-QBQXYR'Z%V5R89 &G*RDC8(Y/8PN%J,5TMI>E2"U'F&P10Z09RML4Y
M/X$2U_(P&0-=EY??M#14RF*'VK<IN&_ 7S-/U91E@@^W6'<5 [_KU]U=42,#
M5I+#ONBE7MK-E$F['RN)KD4^/0<60^>C8F3"'9^ZE7XY2LD)3B!*/6,$1YZ:
M0XQ0%JP$^E2I+#X)3N6T@Q,MFF%0$&'BDP=\23F;Q^ZO^M*34*^<+8XWV?@F
MWV/L\J&?/4J[!]QM=HM[D5P03)6A$/) =$<C@T?DD4HB;-F;66Q#C2V\^7)A
MW]:X <1X/_98J6/?1V.9'/J@?3? /(FE(SC)%XT#K(B3JBI2J>OO%D[_RN%O
M@"GLS6RCH4-Y["6UN!56G*[JW\D0]2F^,W9LZNH= J/@?R75R:O+,'1E=#V
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M5T,I8@SCPW]V);-#?=<5I5O<@+F/,<>D\/LK!_UJB%;_.?:D:Y6BY(;%G&C
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M];!5?6*R6DT"OAC@5V0B_+2CB?0A$,(6:$F6I@)VJ3TVZ;'ET+X"#3+\%R/
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M:FSLIP!^7DQY@CJ9B$)^:6H>6_)"<#(.N1#A3&5#UJI9JV:M>H9:]3O.WX]
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MPHFD.P@9 <P7F!7+JAX-69QC8>1.H"_BUL$E(3-_6^UMH+'USU.1YPK?H?^
M*B\0R>?$Q\7>BJQ/LC[)^N0,]<GWPAT(&0^>VC*$@F)/@/]*O^D9>751F/"'
M)!=:6[3EX0_[<557:Y]"L>8WFEJAS1&)RV&0X=K-QG!(I;MKAX0)4?+A"G6D
MK7!50SJ'BYY,>73[EEF!I1V//[3OBO5 ZF,"]!I:!VEA/&S2HC_T@]MA4B@
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MJFUH)T":S8REZN.(P54Z,0_Y-/D7VM6GBTE_6&.N+>D :.&"6;<"0XO,;$)
M1)>\N>4Y5MUZW/5<\'7$+Y=VQ>,W[R-96O*TA')L--HKFG@8\83!BT[P[*B#
M</'K(>RD8F#WX $1!Y:.NSO($Z:3IL^N O]9,E7ZPZ'5'6,$F%8,"KS$FQ+'
MOHMWL\9.C):?9K"K_@KS.G*:^'),-S=VM9G.:KUMVS[FC.25 <YD63_L5UV
M ?,J^(KAV ?V:UX_(899&".LT<#/4O.E9%I+(8M1:J9,%W/^<<,<<<\1]QQQ
M/\.(.T< JIVX.TOO 1DQ]EU;BZ6S?!S #MO0OCQ=>DEG@ @":>U:<3ESC_\G
M=&:SM,_2/DO[BY7V<!"7_(<?F+ VP<=\B%:2>T'OR"FN&J6$G"&L%^D_H1R>
M^J19^E_N&<[2/TO_+/W/5/J+J"=!G<CQ943NI5)=LR+OR2_"PO>4T9#K/K1K
M;,\S]G]21IF%_$4>U2SDLY#/0OY,A7PSHFQ HC3; A65KD-^;-T+/H#!',\(
M]< WR'5$3*OR(2@NGRCJ\:^??B#J\31Q,W]2?]HD8RF<=>3YW?2L([..S#KR
M#'7DI,K'L\\DU#,1',,\=H-6+(DJ/2X@*#I:J%O-=UNDC4MTC<1 0V9<\1)_
M>EK]E3QI&BF3*J=!*B^KLJ*=4-_L;Q4T?Y&]K,N]!UF#9 V2-<@9:A!I_+CM
MG/;D:('F"3RV#+?V29VM+)6S5,Y2^4RELN,J9Q*]RRC?H$78;/$OT<G!N8D2
M79,TO>+6<7,I:";O)$42_5-Y3*3U4G_G4.U?K ]<)1R'TGKNI;..JBSE+_BL
M9BF?I7R6\N<JY:TY4!NA04(BV!$18,2B?U?5=8P5D>7QY9ZJ+(^S/,[R^$SE
M\3Q.S,IQ-=%B/ZYJ#J/O]KGLYZ*/4A;"60AG(7Q10EBK-Q]L <\B^7(/5A;)
M621GD7S6(CGJHT4;[;Z0FGO I"C"?,\P+?A'@CT?(18#$:D!DIO '\XAS7N0
MXH#*4@W5K92CJ'+0.I1V'!A0T,I/P@>S*KC< YU5058%616<M2K@%*($K*<H
MNG-POHV Y#! 4I;,EWN^LF3.DCE+YC.5S%**O926U;V"PGGD60,C9V#EKCT4
MM<"E,FS9J<J^3 YRL0<NB^HLJK.H/D-1'6$-+&HC( @=.'5QWX]5:F*?0"Y0
M0%#-1W[B!"+?M0NIF&&X7X:Q!3S#*:8'PRK&=Z#ZH *5PX))1)H[UPW5+( R
M!Y;N&]?UVVHO?%JN'PQ)-2;'\+C)956/ R"!TP8I0:[M78P+#LA0B6PYVGX:
M4:E K9TOP71*WZ5HO4><&%/^BPE5AS U EJ?)N8)'P2MPE!\ESH.#N@M"G0
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M/#;4AP@1#(9"0V[L_>PD:<'-M-''L/&:<#'UY291M6@8\Z\&3_7"](NRT$L
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MS%K]*F5SUNJS5I^U^@5J=1U(86VVPO>]?O=Q03\ R,L% !>@^$\+9JK*&!R
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MKU&C\B4L'1IN%R>I">:UM OESK-TQ!:B7@[PD%1UAM YD5S=>!<ORU-H6:7
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M>[PG),<64B,%A+GKXW>$,HAR7GB4<;D6N*MYT50I7WT4/E0/^#D]C0Q.'XK
M[*5:1(!^ AJ"=</_U8_%JA*S&G>D9ODHT;[0$ZZ'I6[3)Y5Q8R8_%)W38H/G
MK9G6".>W(J\$_8Y',=[H&ZI,,L6V3"1)/\F>B[/3]%]W+*ENNJOHQ>P[+4?.
MK(_5V-4=4V JH1OHC0T)*ALBKD#XV"!H#F5&\HP?:0 W&KZ9RS-[K9](F%CA
M(07B2*-$_P560I4DCK=7T^-/PT>R1VO!CT.!($?M2Q&PN(W+'@66/NS)TTR*
M O8A?PQ_IA(KNI$\=9<70X&=WMR17.-@*V'05\$M]"TJ@>Q%<SK895CQK]Y\
MRWO)\=%[;GL(T1$KEJ_>?[M,Y4M.'E;P\?,B[HBQ!CVJS![CQW#O_VF4EFF+
ML[0&"KWEN*?P46; ,V,.B3$-P>4_E2/SF;6!_&9N _EGI\NELSMT6XGV@[P'
M/D5.A.XD@7KLZJ;S_5X/3+W#0P3T61/+)T-DI.=JS">S>NE7&NF_%]:!<'$=
M$9?6,J+9C0M[JOT%2E)2.K^PAS,E;79_R/QQU^16F,P3<TAJD[P =CP'F9H?
M]KD4MQKG79>=)Z(-Q;9.8R*N:J^*82R:<0I5.[]826@KANV<#8J($[T89WGA
M0C%"$KX</L;[2TH=WH&F53@!Q6$XYS;9Q=8 <X4^,^A"KF Y^!&Q1W=D-B8B
M*Z2>@Z2<^>M]GT[6>+JM3A8I%B!#?4L\4EH.'JX!GUJ^[HI68"%D(+>J(QL;
M#*1V W'^5,ML[!G3*X7L9R^(]R,3G/'U 5@_^>;L"RK%8/50WI#DZE7]9;B3
M[RE"M-0V8MXHPV7=>SP0R<I]0V.?>,;+T%?[)#[$I-56YZ10<CP_[?.$5J K
M\#NB[TPN9@F+WW=\?3IP++3D+A1DN1L^<W"SL<AYHQZS28MJ#YL4@=%VAN@,
M_V\'XCB?5S:9=H'A^Z6$:KXLC]$"NBE*/+V8R6<'3>H2!T20P^LNL!EZ/U\"
MC3QH@D+]D<C+["BBJ4X.=_H[QU0^2;W.ZW5W0(/ VK>^^J)(O[<^]A_ZY_/!
MD<U\:J3ZER]>ID-V]&CHA/,1J.D#M]^G&[8/W'D2'\3&-%CB3WC:;GR/N7]E
M+=3(K$?+;8$.'7;AD/5OVA#^/.1HEN7S(\6 'KT&MZ, 02!]$7Q5(GFA']>!
M1'Q_5VMS3F@4B%D-I7@R<7-/!32Y9K:Y?S'VKXUHB[QM7+'U&_2CJXX85$!#
MFK10^$D."*P8E$%[X%(2O3_Z[('*R41R)+)GAF8XTX%2H#C5>N,B]*_;\5F7
MK0AE+<K^G$:ZXF(WEHCQ+F@'7^65)7Q.&])_A 5DOC!V!/Q,;>2T/#>5R+@/
M*YZT1A8VK<T]O]JMVOC&3(QR.PBZ)E2OI@,[UKLR&8F!/$YRDE8>JP2ZU\\(
M^\.KXC[R3=\ZW9<"* CN:NMONV:Y<+F_XB_]O;R-&XV3&CN*S=4#J%;ON_?9
M>HVTG^&X?UU*QH><K$R&=[2!BY81A3I563R@0'M/3FY-QHXG#FA1?LH]F65=
M2.M#/^&WI*B=5,5?A]PC2?:[E]^]TTO=5M_KOWZC.=Y&*N[1!V9R>.D3;+U
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M&]H$83H65UF3-[$@&^I:$7H@ %[X@$RJ<NY#+E@S$>="U8WT8&W&<FDBK9Q
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M(5@(&"Q)U&5"A1B:#5:K00^#@(<%2BK%^0EP$3C  GBZ#9D#'_B@+^5F\9<
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M=K98^'#Q/H*R%;D< %H3>!Y\KVP+Z"7 J6\"9+D=36Y2+@DFT7)-FP,BXQG
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M+2AS3RED3DH,,:;(G %]&0,825)TT]MS[<!;;]/E/$.*:1:J&4MC"MJ0!<L
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M/<\4L66ANX^H0F;/* 6E>=-']$NTU,AG%"V6]JE-B"0LQXD>*H6ZUF?QRQ]
M.16(%F= E#,NX>HK!I/] ?:Q!C1D<0KZ90@1VB0(V(*2K1\&>!/M(40D 5V.
MQOYUX+2(TA8AL<=N1@H@V6'&.L/1(%4)?A0/.,Z@5'F]D;8OU\B!%]X47 P
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M(S-BFDW29'X[<[]KPK\*HMB4C@I;@S@+TL#RI(6P#. L1!,SN9')U/'BSHD
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MR4^L61UED.-6[<+DV;15)BI$MGYIW@E61R;87JXNAJYO::[:E/.':$LZZIW
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MJJ'L5! )++'I+*J 5[T>%TN^6/+%DE^@):?(NRKW)07I:?OSMJR40^4PM-U
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MJ7!W_5W>=4-+]\B8NMFOAAQ@%N88;?VB.S0,J0=QOZMS:0WC+2!"Q<UFP F
MU_170TLO1Q2AV7D3N1\ZCOI4X7J="@RK?O/:;<$WBLUBOB^*E8- ^1//=]IJ
M^\L<V3K/V U#73J/5;U948BOH?I*CT(2QNX)3$KF9_+:TOJ&$X&.KS>3->8+
M;R"Z;(EG5[RJ%5KP"\UP;8S6E0^1F4#O*2?P56P#Q%*3_!Q=)_ [/0U2E8<D
M=2&4;MJ2SCK89YW;#&PN-^5#Z7_E%T_%V\PO'F_[ ;%UY3\DE1<G"4T;K#K1
M-W2N9""N6E?YH(!TE8-D3#N"4(8SAF1VK]VV?>]XMV#)MN[@XR\](*X0OG7<
M]-)L-GX-/9(">;*8\I;W"<O!%V6'\]61Q].;L6;H_!(8ZONZ>82(DY]T%92%
M _F0DU]4:!?JK],6(%D^:73A5X>W-B'42%[G+ 8\1E+IXDBN,%H?$>^MRRRY
M_LWJ[0E=>9D0"RMOR5SMZ=-N%'8_+:65L0DQ&18;IHQ9-6EX.7[=LM&-P:L(
MU#.;6\O0ES51LI$1HDD233!<\N#:F+:)^0*_S@:VZOH@,EC>LG(*@8"3_JX8
M/+:A/ 15_M@-99],QJ;*Z=:\<_'7:]^4MV$:*VI4WB;LV*<)4(7ONEM%N1R=
MMD#"K3:X6U7@Z^8NZ.WQ+"O?R"!@(N%4(=I@O."J'O9KFK=M$HO;2#]HR5%K
MME_>U!.NB2I>.G9NUT./%(XRC?3-'V5NEZK*A>6&EZK*4E59JBH76%4YDXD)
M1'LQ/4AI!F/5N0=[<EAXS)'K"+D:!!(+2NIZU^!BO1?KO5CO"[3>41]3S#!2
M4GR.@^E]S#E3HP;;'\ZT0.[HT\CY/4=I>395OMCTZUV9BTU?;/IBTZ_'ID-"
M;96OWI;=_>I+/\X#Y\@H=?-U"84#^N<[4-O='8$">OOEU^\RRIO5:?%=RS?Y
M:N\*X5E=W0V4V&F&GHR_5"K!212B_B3S0^4BRZ.-SF9_)4H"9=PE0?A<N3@]
M V-Y0':TH<PP=#^]!6<N)T[^NRJJ-J-.Y%#7I"SRXFRN=\LLSF9Q-HNSN4QG
MPRX!!6GO:LB=[)S_157"4C+^LMUK7M]8^:73X;J7UF*4%Z.\&.4+-,JC*CCK
MWU#)^_^!-@;&W9MR\BQ:.-_L2O< ;$++(+&<#RT"%1!V58&-14[6H<IGBN.H
MHBL<3-L!Z;8I&'*":,CFX0S"&=XV@&]=/=X@ >X"=)Z=D6U-VR5'P)NM('-F
MODH$\6-8V--(,#IHCK%[A(<[+D" "S6=2]"Q!!U+T'&!04?9^?.?ENY7_+ "
M[R3$LY(6*MKK,*R];2[[A?WDBI?48HP78[P8XTLTQMS+QCT,5*,/+0[:S["8
MW>M=/(O97<SN8G8OT.RJ]L),7_9B;Z]WU2SV=K&WB[V]8'L+PAWA3EA$##Z:
MU;/8W<7N+G;W NUNZ[;4;4T82ZYZ4EZAD);@2C";W Q/?"0&DFG_O"TK;O0=
M%BM]Q6MML=*+E5ZL] 5::4D"C]G/+-#$\%PPHUGMGS:%7RSJCA_'8EO,]&*F
M%S-]@6::V,1 G5,XD")9NB@ROMY\"S]169=]R5U<BH!C4C)&TC?M8IJO<H$M
MIGDQS8MIOD#3?!A: K49.OB<2.5^&.J?I I@!OYCX&;_[<+-_B_@9O]VK;T(
MS(,>>Q-FJLIG^/J(F+5VJQ_\*:XK^/BW*AK_!V*\V[N\9FSFHS.<WTK*C"^O
M?_I]T8IM[WSMK.N_R*3<#;E_F-ZYR<RHP(08(=.S,GM_V*GCS#2@B[^B^'$K
M1+H(.RNB37]JQN<>G7DZ224E,B\ZD?U@ZJZY*RFIL*X4XO7US^%^S$G#(T/G
M#C6**$/P'8W*'.]DRIUKVG&H"21OQXT?EI^LK /7<+).#5^MIK8-_4V6YD:X
M4:>D<:A)L:0#36:Y7WNWX53(P[+GA$=D9E) ]+R_ZEN0&]\F U3XZ>E6)!>\
MRO>-?^OT.=%D!&_TT%0/(R9M%F))=&R$]9L9O[M545(_&#TB]4/QB]R!(H):
M<(CO@1]/&%2)I=]FBQ)F9Q=*KD+K \3AB (H[U:3CPESD+!(SRTN%5A!.]:4
M:CN=T#FS0[(!7;-W/#N9S :D9&2/@2!<:8_:.S=N,NK >40+PA)N&R+K$US5
M5]ZU];V+1,'0">C3#1C+.&'DS5)^>W*2TE7<##U(062?0 P"!F6BOF#W_)RD
M O5[,47)HY!.2R<8,X^#:%T?/VR^T5J)5GZ.ASS1.!D3W<]\(7D%2T%+][>D
MM:R\E&%/4HLAAHIOTLG;#YWI*F2#39Q:TM7(>A:]81@?T483R;EKX2_,)+&4
MR%SCW,AR)V]2UJQ=SN)0?D)X7/& _X64!7B";?/=U'*+2DE/&TX75O!VK:-.
MD2*(E1C="%9Y<5'C1:F=E0_XC._5RU,;IBO.[L_+CA!E:T*IJFD/WEJOBG:X
M6Q&+_@#CBQ"\W_FST-U.5897Q,!\)Y)>L''/H7W.0)*L'MF5V.C>(,(G4[-K
M9!L::@U30G!";E%4>,@#=,VFA.0*%MF3#TG/.'D]ZX5D\MV/_A==^>#7R)6'
MF=_YY^ 6V&_YQ;^@%[^EP$.#(1IL#'X8&S-BY)EXL&@1E/XT>U=NQ,,Q]T9/
M/IZ:7HE J2@[EW=.2?Q*'75:'6Q+:5H<S7>-O=<U/,?N1^I,EGN2'V5EB X!
MCPB9Q6#Y'C\^>#N#+YN08NYI8>SG'RT:".@ ^#=",W>75Y%T'I=EW57_7..K
MP^C%D!&?V>5=LL[L@))\&VC$6<Q&&-!9V[OUKPL!"_5,JO:JSQZ'L>2[@ 3+
M7#Y;C:@5R8;U%<^4/)+^U2SR()/G#W%='']='10S:>P:CP'692>1'-M1$B</
M/I*5ZW(?-<W.3OBK:"BI0>G(3/#Q^^ARHN7R#^WC-IH:I5C?E.UFV'=HK?<?
MP(A %+W;-8^B%1#CQ 'A:BO&WPX6R[*;6;-&@(*^SUY^^EG<-:ZCG$S9[<BM
MK/YL+<][L3Q?V'F1:>N2O4.KWJ]$-Y'K8V$"Q-=&$D1F!ANNH_=@VUR56_?"
MWYQB[9HKK[*^/Y:8\91C^E"G(S-JXX>6GC7=Z^)]*K(^+&G'$HYV5^*<%-;J
MNFWR0LXYN,[(DN(\$C[--BRYAZXJ%CDH'(ME.K,7M6X#DCMC3Q[SS@IF%H[.
MRO2*I#^&AX?D2?"D2F$W4&1(I$DD@D1& J>L]'!)V]?)YJV=*_ !Y5HR<=TI
MRS^26'LTD_G/CB?8K8@04MU$1:<T\Z&AY-AN7G?LAE>C"3(9G<2/4%:CIH-+
M0_B-(HSBNJ6U6'O+*Q0A]*E)(F<<9K&)U6OC3!<D6LO](1=Q-N4DN?((ZO:T
M?!JM-\DGL$&)VJLP)(%#,AR1_$;L_>%(%5NC^KLW0TW;R*',/QSI[SR,CDR<
M;N%45ZKO8P38TDQ6G&#6ZS(3GF8JAFZ2IIB<= *O?C"$JAW$ZH)W>5M4T/;:
MDO(2WES?E%2P6KA*J/Y1$L=;3!HU^J(DE6C;ZR4Q@&_(H[$W?!\^_RU9+I<I
MM<MW[]Z\_Y;EG#1>:6)696:IB[TE^UN53M)Q^ ,SFG;F[,<*=/5VZ"20+6N\
M_:&E_<#KO8(Z 5A+B:<Z+_=\$M:!X:=AL"K3"<D@G]F+\XRK>=$<:#16>27'
M9?_TYL5.3Z >S9^X F[,6I(593/H%<::IS_ZR0(9:YB0%((+B*X19(@92N/W
M[%M1$%0GS$:I^ESG;[OA<-P_.&NN KN@4D Y5)3@X&9FF^T_W@ER?Z(=E*BZ
MQ7<AP:8, 6]9;RDCRX,0WEK"!3C*LBV8Q$F2*R&MJ+Y65L#-ZON9(^UZ*$FR
MT]9(^*GYO7R RN<6PL_%YZ-!8'EK(A6J:Q:=H@-856F0*1,(,=Q1MB,5QCRQ
M5CYR >C?_<PBXQ7$!"?!#;_H4[RB([4?6CG-V"I&X39E%_5 _4YZ03O)ARCY
M475?N0Q41S6O4 :B='M,!HSHU6P)_7JCCO>:)K%FD=14D7/MCT%!6\R,'</-
MZ7'W=LO;D^H8N.5PG.K@:26JWS4K0X5=!,^&8R<N(B?VTD3ZW>K.NXD61Y"6
M;!/2.)-I1;Y5GF<ETI?T 3UX<'IZ'&_RO<+]X>NA+>BR&78]J'\B?S/*68\X
M];PE]9/O3P&-GU@?UDGE;2X/C>BG<&,WI:_I-!7%9I8"K\+[-W)Y9Z9"(AUU
M(D?-=K,P,SXBH\;GS>,D!V_\:8Z]P>6LX*N@@3U !M9PG+,J(Z5ZZ"#HI_XO
M\8:VLL("EN,IC D6OPD?Z!7YTB0-RWK#3->+WR5:N>U=7I?_T'01&8#"B</"
M&C1ZM!@UCH0URQ(7K/\7S24+=.88'=*8;$L]P\3O^$?&:U6463&AB:SYK^(W
M0YHK\-#[Q_"N^T6Z3\0E&^;&>*SW>TA&1*:M\:Z$SK%5U3RNOL8N:LV*.#3>
M\K(X=GA.<MFQ!M:YOA?:>[_^H4<J'VPYIJ.('J4-E:;4OW. $^[YQC\O9]&^
M&"F-^O##WY->9.XZ0FWI[=2+N"KI^(,71%@33T!:#F)^+KONPVY(-T" (H0\
M[HF%/MJXFHG%5)[98.'ZO*C_P8>S$#UM\VXWFZ,X\4KIQ3%[0=Z>/L\U)LGD
M[45_/IQ2N$)\R$OY]5.OB8 ]O67)F(XX7 WJ)N;?]'::%EWG77G2=(Q&5$X;
M6AJ7 /6,HCI=,M'2O/8\X]MDI-=TIK"F><8L8\3$)PP'#'T4$Q7Y>G-$S^#*
MFL%N\FSBN6?N0X#,3W__IRXD!4V-!/JTMOI0=@O+Z(7B2A=$]H+(7A#9%XC(
MSE=:^M5,%T=/!#"0.):D@I9&Q>M=08OM76SO8GLOT/:2D%HFB3T@_.J0;T+G
M.)T_\G8A=+[B%;38WL7V+K;W FVOJ6-'#-[!;2BYK2"?Q?!>[_)9#.]B>!?#
M>X&&EXJ<+T+,NTA67O=B6<SL8F87,WN!9K:6UC*"%[:E5*YK0#@?"/!Q)RB/
MCUS!,G:@GBF5IZT-H9S(PI:V)!D0S1-D"$K1J*T3*J@;]HI $1I ;=$7> #W
MKC*>F*FH!' $?M>F!?"A0X,"'4BRV,*CUXPNE$#FJR+O\W".D<)H@I;1=A]Z
MV(#(')6\]1EP,=,BX?]TA^[#"#,",JEU$-1D9.5IT!6:A0%G4^1:1Y@EZIKK
M_"KLN%Q\9)S*3.5_MGI?'S,:\Z%.  %:_B?XR*8YX'?YGN#GF72$Z",0MHR?
M8JBG3]$%G(\!C#P"E&:APU2P)N"7/S(&?%8'_%AXJOF&3I9+=4SHVRE+V99@
MO$!173N@X+:3+>!?7CHRP@KA379'*S?20'"/#PTS _H3L(F%_:SV])!AY2JV
M1A )NJ<VS8L XL&6"VT[VY(0"W5 *A]7.W]!@P#D?J&JO">4C+0&)#O)_Y%V
M7'B?LHMHP>GJ)[N@#ZG[!+BCB&O$?N<F<]OV:6]Z[>OAM66]F$%&*NYLZPJ"
M43**L8_XNHU@,N_:?.\-P-TL9B\+H#S_1GYFB,\C0CE;\_<1:(^!<VS9$Z#>
MS>H;OP#\1!%D4!!KU$]Y!M;8F)4"*&(G;"-S8,)YD"&6H!\1Z@_VNX'@1[N\
MJEQ])W XAE-E('AAYP:17T&J<MT ;:VQCU(_-.,Z_ OI5]%<F (LY2^=:Q_*
M#;?=!+P8+6BTY?F?(U*/JAJ,YZ32AO_VYIA@5I\[>M3-QJPJ(]0I_#)[77):
M[-%N.R@/DP7)Y$WE-BER*'#E*$*1O?:+I[UVT@0T<MK!4_.W3;\M;>ZG'+/+
M-SMYH<X1SP[UUC!D:J:9[T/ A6Q["4_W/6PDW1D'W#6%E HUU]XYH8_AEA0T
M8$GC5_/"QZ!UL_?OIU0S8$U"TV=#@#\_>M3#Y.97XJFH9>K9T\450=&V8T8<
MBC88!0J,C\!(@EE'J4]"VUQF(+<5F*6^'%H?W43V'6GT/O@-L&G+ Z_TI&D/
M*]X0[B2(5C^Y?=M4 (.RV+N]MUR_=G<-L:4"GXNUF5S#@J=IZ_;Y/<?"9'LY
M[J'H&!TFXNXWSC\J[,^4B2H)Q;W]"-,^"2Y#.X0AUF*&HO@.\PUENMY-O]68
M94EV'+%?N3,&=+RCA2(@A*;<XJLD,9/P]FF,ZH>$NHSS-2AM'HCC!X; /RUR
MG:/*$:@R'N)C;Z_Z_=)>]<L\Q5NWX>:&N[*K\H"?L 13M$5I2=(B=C\Z[XB+
MYK%^S G8["TEF #(4(9^5]M9-8U,SFQ/<ZPW; 3<EL*," @$?"@YTXCXT;1L
M"04-Q>[N 7'\#(/<BMM V"\ &NZ'EIO=*K])"C]5_G0&*B2+*3\SS]Q+#&L-
MSCGM6C5'A^[8]6Y/MHBVGITNF:-1HVCGJFJVZ4AM'<5G2;_"+8)\/B.\V'O?
M)[U X8!C.'HH,JXZAWQ"%BF![)D0G5A$>,'V==_ ._++X6J3ES.,%#@Y%=X]
MTYC@O!+8-<W7$%AEU,)-4:S_&_J#8R>6CP)ST2#:<!3<F*]KK!#.=&X4<%!O
MD'<0[1%,/6OG1DYIVVP&I=S@]D:_0:1_2K^0QOVVRVN?_T ^T"P*X7(G/B$Y
M;O"JH@OQ24C.]-)CY7=\/7 KLI^$9RTOX2*9'E(E9U3XP (/F/?"B1(.9^,6
M.3,/'!N'&:+7:AZQ-9)T@!WZV'GD[1AM+&&L"R/ *UR[XZCK/7(S<$\<4P;(
M,-"]= (D"Q%CNXS/R3B (!*J$5(E9^SDU&Q.TZ$7+%FO<I:4$$P96*6#B./]
M]!LIR0:O@Z75XT(+&TM)<"D)+B7!"RP)IKV93QXZ%_3;]:ZDQ08O-GBQP1=H
M@R?GS!Y93LN?KKQ<U+^>E^UBJQ=;?8GCL]CJQ5;_/V6KF>()I=8'5P_"$63J
M(8&E/2F(+*;Y>A?88IH7T[R8Y@LTS93*0-(=Z>K\1\UX"]^W+?(?\N/29'+=
MBVDQPXL97LSPA9KA<65SDQ\(]_&1]Y6\KE=?Y^UFQZ;ILY>?OLQ6MZ]N5VNW
M(=;M*G],2O[O45%E6GKZ6"EDL($S<5KES;2$/"F_QWIL!B"%?^(1((!H^0"M
M</4.=5O2&@-L,Z=&#M+1:/.!X>KY>NC\A;S/6N'5">E6;T8:90I@'96MQ\^C
M-7\4B,O] 23J\,XH.CABI:W-A0)&('S:0/&4?8IAU\S;*IAI4A'J<V!V&!VM
MD(]'(DZ.SU@"[T]/!M  "&]3T"(A- 04KFCPF]7WT/1\G!39'RG$4(F'.N
M3E!C]CM_^X K4+4E8!+\= EA,$"Y=2(8$6@(Z.5X5:6LI?,@IA1\D3R3,J,S
MXD6%12- :<HB? :3")[:/.@@$/;E#0%(F,]:UG?K?'26<^O0.6B(XOZ!2P!5
M+)FYI;)_F=YDB<.6.&R)PRXP#B.9@+H>\HJT.TA=C;BL02GMF!>Y/JY$54.
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M@11$7I$H ^&F44YBG#)UBG)SYBZO($)4;_WA!#]XMU/Q[_Q!P(^FX[Q@6?\
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MBZ@&QE7+<J<9:4:3H)K"LA#L,-&22>>=QUS*/(FYX"C32!(/2#X=*D+C&H;
MO:.30MGMF9T<>H2S66N[Z]F#()'7/YW"2P9&12>+!M%FB%62 P^'<4Q%$E"4
M?K)G8+KTB9QEGL0,EP_YYBB9!-G4GRCJ80+I"\!8LKN%OU#W*QG+T3-W)QX:
M&7%^!M3;W(]<F]_QJ:%UFD2/F.IU. TST(@M>H(;PZB-GRRQD?8]Q_['X$VS
MN)MC?/R#'Y6.3FHQD(C"DX6C$H!_03:4[,H13"C.=?9QXU.>0;C^2X <'W!
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MF'2N]#[F@:,&JB6\(*<S[(%1%4>LQEU[7BF1(H<V6/!&4+%BSUTW%XG[W7T
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M\+65E%I]Z//?RH>A J<A7@J2#LR,L#/-27@)^VQ9 $S8$F9/'JUIBPZG7QF
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M'/401R=5#PN([. ![/\?%7WLU85#K0 <>]A8JXGL@G2N=%E,J<-C@FW_:<I
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M#=)*F5EMSJ UU,2ODUC%^/!RE!0QY9M,ZP<&-ZJG$SNK#O,()XJ2"<U0.1V
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MAJ3N-CM!S0N\[=ZT6=K<DA:MJ&^DX#6-N+9C5[EMIHTP %?RQ5YVVK=*P@V
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M(*H(R9S+R2"9P35HEL/W==A(S!".2PU4H3)[9G!\UTFJL.97JRQ!783EJ"/
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M5*_T%-<=FJP$ \BIBEUUDJIKFERUL8JH[,&X=)>&MM9Q7.S=\&I)M7;@E!Z
M<+$"BT" BINCL7)&8I"(I%Q"TK?<6F$3I."F)^S7;E?)D#"=44;NB@]M &2^
MNT^;@SVWP0$5NE,5KJWJ-K6WHV0<UJH[6CE_H5MGNE#?",[=^B)S(;_JZC"W
MSC-()_C#EI7#U:?LS[!I4X/?9DN-ZZI !PV.]W^P#[W.Z6&3'"Q)]([9HO8(
ME2V"QHJ*W +LJS0ARYLGC3<E!'J5;7&H:QH #@/7(2O/^'^M0]GL\D[9Y)2O
M,3E_[/[$_YCQ)!N>;U%KB<I ZH(NN1*S"7<[G@?<QH\'M[W()CM$ :HP6507
M!B[<4>WO,#G(FLZ$TH61"PMR B]9C;$S@IL"GY!AQ++ L!S88L!VVG86K%]1
MV_J3JIAPRB:%<R:X:W(]4?'4>1^3DJG<\M%%#T;8VMQ])]T[P;^ 5Z^5\78L
MH"(>(L=63 2G2/ \J;>,RP0+#W6VD4J*/2*&(SJ!VB0V-9"<: U/LEYR8-_S
M:ECIDOGC8+][MG25:%+WX"Z/,"9X3UYI;:J\R5T.Y;O.,=%Z?YMM7K8DY]VE
MO4V0B%VC3<GKC'+36.C(N$N>F]0-9<@1.F<BD&U@7* (-'4Q)S+39B/HN67^
MI?768-^-54%%RH /-RC&#3'P._>JS+;4BZN"LX@T]M68@OUH+]-!M^9N[-RF
MC?NY1+)$,5IWY/^F"M-:RI.PFE5\EW"$6Q&]@'ERN*XVP-,T;U6UBH$;49FN
MRX>IDP@5:8 E:Z/Y)@WER]1Q1%GGN[-,7HCZQ3"0-&Q=SM#2L%4:MDK#UHVY
M.8_<L)5=%!/L-U0:OW K!0VU)005;HB&69)+@B:AV[^1=%7R1!L-L,KL=RD\
MD8R7I6>0:9,7K&:S5EUCBX'$-_/YH8@ZE=;610H?2*=@F>":E[E1Z[Z> Z=M
M50VJ-8K)A(?-O3H".@(Z CH>@@[G%SHQW879C393'Y.G==DJ-&>#U*9T/;PX
M0.9 ;#:?BH07"2\2WD,)_Y7NH*T?T^!FA@,NQ7?[26<;(U)QBDF@XGAURR-&
MB1N:R[7LR^[](EOZ8_.\S&>-X]9T!#>U+)C?NC"A9J56[77"+K.-[9EKQDO<
MFNCHN3_^73OWVTXDR. XFMQ_N"(ZZ$=%,87GW7 4&ZL)WKTV,;2Z?(1[$D5?
MB&(X$99K9?+!0",13'_FZ NI(TE&!7OSN?CV<4[UUZ;[WF_KX$\QQIAZI 8#
M%6,7QI#=#K;MC\)*/SQN?,H_#D_/.J>M7N\A_/)XOW/8;@"/7_['_DQ;^- V
M=H=+@H,&WK%C?<%#48$URS&D_@> 4N>H_:&Z,E=]F22%:K7CM<$80_Y3$Z=N
MDQ_?PGQ!CAQG1?,[PE$K="YF/4>/OYJ/%'H:FT:_SGFT+P2\8)B08\F\&7X
MXAZ%)G9E'U O?Y6O'^[7(LIA@I5>?$ 9"TMYCE,8L!X .<_NRO3(+-7RIN9X
MM_L@!Y-R9AG(F-UNISO/@C-/;)[ 7SJ9X^4V@R(![ (7/&2E<SQJ2:FE"UKI
M65U>T@4&P_(B2Z+%6S/UJ/A$+)PP#Z4H[@#;B=J]:;5(V!H7X#UIP(%-L]HJ
MJ[2IX>449YX]V+H#AM4-[^-S;=E*LB"-<</4&$ZC,>5?VO#_Z0&=R.'IH0TI
M7EIK_ .WIPTN\IBT@.[9Z5/N*SS&L'M,R?!1'<ROYTL,<^K/9OV_S?@?3A"O
M ]F<O5%_N>D>T(9?9)Y)H?9,>CE)?;?[7?V7-LPVI6B+V#%TB(XO,(2?Y+JT
MCS-,0 (G^E+7U-N4;,JD,#V"PUNV:W=+B;(:CXR5-,HKZE=C*O1$?=J^E>L,
MZZ?TIO;)QS_,%;_P,48EC>]0P/''^TQ79_S2)$^HWA1]*G W<Q JE#I3*+6'
M,MT$<3O!%6PLA9\Y[X,&!4S0P\-3/5A(T)6(;KB_LZW'H[XN"]G&3+5Q*PZ!
MXWY&;JN=_K 2BL*_01HUF24S T0;U0=9\;X28I%T8+%5+Z.?<TPZ;BKVYV&@
M+5YF9U=0G@^R)Y4M6>789-/PT"2#L*XZB(658ULR;&25R1+@MMV-^&^]WW9(
MM)!,0SM8)V@60I.2B,LQZ2W0AL0-L]FJ E,@CYD':*-L>\IV5YHS?]_Y9PE5
M#LUV%*!I+JW18DUS@4'%G<VQ!ZSI(>!48-/0&E.QA+4V1:*X>3P55P>S4GBF
M\"9D6[O)'671CM.[DM@Q><D=W0E>H_"IZT$6F(>S^(0-:XS>T^",:\_,JMFL
MJ4QRZ@\?<1W9?$OZQEYTRFEI&:9B#,M12#C.:_%NU5$K![ 9VI1BWZ/43G1$
M<Y_6,5"%+<KE:I2/\/Z+RF3[_'?>XQE5<&@@MT_($OYX\=_GI"J,\[ANCHE?
MO<@+(.YU4L"2SQ-0(3ZH-%&F+\1+6Q=CID=->325:4IS<?[AY17_IBU/Z<1-
M#WTS8</LWO:0)<65!Y/0@ UK P2L_N.BW1X(K?!Z3(*5HN4X8\\\F8!SV6-G
MS%D %Z>,RYA9R#7S1"*5!9]-34#G70/8<-=.&XJ="5^(E+9&#"VBN$&#4JMT
MP!B!5+')9:3IX-:M7DRGR"TL;M?1[Z4FK-"*R6]_T)].S:B;V=O(J?L;"QO@
MGZG34E%H[?5(^MB,>.<8<-/.1!O;<N)W,,XCY)1FL,Q?53SDGKBZB2)B[P##
MSK9ERS#->SQ1XCJA!)$!5_R;(T:]/JXE$BI2&D0K"5SG\&V+B=E^,/@%8'S;
M[ H[EMSD11K?H-"G)BF@UXZHS376P8%DNE8+OH@G8W+IN1C.Z'Z6Z^V1_ 5"
M3,=)OV[79*;8*MO-;*8S14*G ^_1-!7,ZJ'4<,N^VR(5S@ZKBHPEJ_LBQI9V
M4XX&Y$SNOCOR)P&J-K7K=Y[_AOMV9V>1."/4;#4TGJC5&DCYH%1=8P?6O<\Z
ML"33'@I;161<\&NX$KF#1K#UZ_3JV:IK$Q)8D-6TX:(#7V1O KMMV1PWE3MN
M;R.,0:")%SGGU,-)G!&=I#/7MMV.8>%9QL"B8$KUS=TG:]1<B*9EGJ,\SDVG
M:0]T,OT=R1BR/7O"9B3>U^VPGMA$?>2(U^ ?M;*4FUE-RMTJZ7FPE!S';T5H
M>8?WTL:,\(DT#TJ]9D:_R+-A04>3S>@OZ!0E!:$UB=>NMI'Y"PU_,W.P4;[)
MMJ9(U8R=VM2"X)'6C0W<1G>HCAI79?/I6L4Q<^JL7\<=!F%>3\X*DGS&7X.,
MPQT]6<MAO<NQ%"(J$FJZ'2"?D'[3S%MB9QFK5-CUT\[):MR*4=WH+Z;N$@,>
M/84U=]QQ)U:Z7R0]!D+N/X/]95+K!%J4<VF<K8TNW)#5-"D$WLJ1-?'87)_*
MB?5T6QNI9K?61JR-YLZ)@R/EU!Y,UJ3T'?J.18Y!RUOB6A&+&J)PJ2XA)SR:
MEX]2) >3@/9)OACJK6HTVDS= ,6L5' L*-SF;$63Z<@R:_;51PD*<YKGG^N!
MS;5$H)'QYFC<;UM0QXGJSLTV;:M4Q,E0S1?PJ0L\*LUDK(7ZBVTUX/0Z 1SF
MSGDCI6;[6LW!UL/@Q'/ OAS,C$:%-56ZI)ESZ+;#]I&FTT%%Q6:-!Q [DYK?
M >EMRQ1"ZD%T#2($;VCC+^RA'=76QNIF0[:A ?*N":)?YVE56^VVL]MFP_;'
MT6HY C,-,#B:Y[A=6U-C[J*>)1&??\5XZ5"!)+=;H(GZ0"M+D/5C^\ [6R?7
M;S8R#A]1V3ZVE$;?<$?3/ SXT!T-; 1>\ZQ1WCPJSF\ 4:-8.1TQ\MKCRA[=
MNC6TTS9CGN%XZ'>:?$;TK]L'+ER+<P1U3RP:5=GT3:NS.+AJNJC'_;%0*^ =
MS25B$F) A[UL3H\^- OJ1FXSLM6TQ6N+*M-R>&9SZ-1I7R;RM=QYDSR76'\V
M731=,YF[E+)%-=_Z\V"_#KZ]4( U^(3?S/3)"R>Z]CJZ:1^M;5#;H,!,HY8-
METEPFE10SQH2^5XY]&BC/24!)3?,Q,FFB@N?W9!DF=O^J(]"D'88<.XI\)(1
M7)>R::^(S0JQ"4']8'>Q5+Y)3?M-@[JZL+16H> &]Y*LCIC:G@I.!)*,"T73
MAIUR=?OA ?6&9\\H;Q);?7/-$+LQVQIK:Q)ZX\2@$Z3FA]0PB *EP>(WHXLY
MM3KCHGU0+-3:)+1I,(VL:LR]9#O!^2HG8>P,/&TLW*4^N:A@T?#S9K:ZNR/6
MF>KC;H19#X@Z2&IV6;PW[."UVKE3O-><&  &!J"'BE;#Y+.].+35LCFTB(K(
M#;#HCWE!)5NU(032W11@D1ANB#C!]NMA$"<Q?O.GH'O\PRQR+8JZFTX9IKL'
MNDI &K,+R+2S:%^A.5;GN0"H[H;$9+61FB_L5!+\B+#)$P2:3I<TFW=L.^BQ
MU+FS:0E%>V)FH2\42X4O/3WJ'/W@P)Z3Y7A+'M!/1&X23LH %BGU&%_GIK-T
MG/Q4]\C(*8P&7A'O3:("T'%@6N@;#0F;L=3CINVPO=E#1/TE8=\4E>-79EST
M=96BA#')*E@2GM/0@[KI1!.*MT$!TE#H4D7I\F:C>+8_YT7]K6%R;=J0T?>;
M$),59,A*,8BNJ6E25B\E<EH/I]-MCQ\?2,NO[[.*JWP\"]5TH4TSF#CO5Z;=
M1>9@*KH_&G<WB(X]RZB&2<W5,08<-B*M2$W&:2[]OZN$W>WXMHK:71-N@+Q%
M%Q>E/;4_=V,=>PP:A!\8^+7*O4G9">L^09."6Z]CL=1X4FH[/+#57X:4\TD:
ML;I<J'%NPA&VMWZK(? 6]+1ZW]#YP?H>H>>B;_6F[*^--$_UB/0,7[G<$[I-
M419WAS;2/F!I3RVK*:QE[$D;M3> RVV7^",L81MFBG."D;QF(U8\9OG!ID=.
MW%.2/AH^E^U(P9L4O$G!FX<%;]%\9SL:-(U.+*50K>?&^RX<4V8,-?^CQ"B3
MT;2H@3^[%Y2FX< V?ZD_2M3 *: S Q*D8\7F,JF(=Q'O(MY]%._8+Z]/?OAD
MMNGS(&^IU:A.3W(=F1F*ME,E-=-#+U;*+AIKSLV+>VE*L=FL*$)<A+@(<0^%
M.#<5XC36V]I:8TM:'%^**K?)K#%A=Y#:JABW<N:7:NVU"]S%AMJ!3IE1%/B:
M?0EZ\VQZ6X%$PA'%%%XK;.C(_-KLH-T]VIW@LLT]-#Z:) 77%>LXLMR"SD?W
M =[MVVNW^2Z:PASKY"O:4^9,0LK2* OY Y.2QT*9,% =N\DG=3R(PJTCE>U9
M#^_BB(T[OXZ#,?B"\411BJ6-?):**C+ SL3_+4Q?7EPL' <F">3IM<V,-WDA
M"UR,[JL:/WGK6=JXM9<>)[99;R@\Z^/FGOG.80TXC:$_RG-MII!S$HG3$=DV
MZ;?IH/94J:,[6-YVN%)]/,;C;KSZD4W(H5O(Y'.CPGDQF]*WL)]^D]^R4MN4
MK4AQN4BC9*Q-74"LQIP;3*=F@AAM7K6#($E2<E$L7^LZ418K_7B$(CQ&#Z;.
M0+561+7/;[9YE)6NPRGFL>VZ,#AW-0U:9?[5IB?7OWL4>6ASWVP1'(7R+7%O
MHRFE)*@($Y(HU)&;,L,T11%CLGR;<CK@#S?(,INZJ]L?;07'NT?'J^=(+44-
MLU^;^C_+OQ&.O6<KL37L@@+6-K6Z3@A?PN;N84I@QE/558P^,?K$Z//0Z/OS
M'NC#JKHJ;,H2)<+1'/$(=V?3SMU/S4QC5%R'E> \ULC64/Q= 5R$]P>S5O:)
M00&KYK>R/-EDM/NC/"J3&)@,6C]&-O5UF.<Q)FR7(UO9&IG$R-;G,>$@Q]FM
M4UN]&IO$O8146DSDL]:&V5Z/;0'.7*QMU )K>)";:*:IZ?-N^I#89O'](D%7
M*=6*8O.9!.>+8?>L+&\6HJQZG-?UM,Z"Z^1#6P^+94Q5!N<'I[ZB02S0ZIF
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M]ZW-?LWXP46S(#=@;N=#9D%.@_PFDT&0O@Z"/.F<[O: I+E!D-/@'3+LFJ=
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MU3#^9C/O6_C;1M-H<JLQ:N-(;+E^*U+-+/X[E0EA7AKH#HC61;UM=FBSLKA
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M&#_((  C ".W0P!FZV@G +.>AA^/F(OA.07^I$>I.(BN51$-59!5XYXJ@GS
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M>^B)_QJE4=97P=5(J3)X$961C[.P$',DE?![M,^[$QZD&F#]=#I;"<AWNQ+
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MK13[X2[?2VW:UQ64[:ZWC?78<N:T*D*=-B=YTZX_K<M'5<(>I9N\GM8,OYR
MB)^H>F(%C4I:@B;4M06^C>Z2 A_</&89_K1*-0EW*GY&NSQX[D1"5YOIM'NT
M]6NO%BRI;6<8P\64+X,",_M58^WP8+XQH74K+:E^@%.6B,.,)\H1)&"-4<<8
M5*=)=K;>T6A],[I3TU(@,[/C+]^^P ;9=29'W=36J2+CDE;F-]8*&H7#VMW&
MP6D:EIN2.#;&%WJW,C3E07<K\@A%8)VO4JOW[&%@YR7=".,Y8G^\*]D+-03
MS+;"D/MH)K;86NC_B?IP\.KK;;8E#^:QU!?_$R)3@=TR)DS%]M(:Q1+[S8W+
MSIQSW4"0_>KLE[JM#'9QD,4,1.Q%_<^]/*N'QEEBXJ)L)V:NOD>@3\B5RC9C
MW7 ]H4&0]#4S(\ODV;K%MD!??*VRVB.78K>>8?;9"=Z@"+=R!-DV-*LQ'0.H
M9SAHKZE-;)Z:IHN@8,+-[*.-TJO@BN[!U<!,<UC2'OEH7$8V#:K_LJ6O+&3-
M&$+V/E'Z%=RI]JZT^KM2U*D@:OE&Z0CI:"*M\[Z-7G,X]IKI;9P^6>. ZQZC
MXPT3-7)\5&"\.49ZSIA;]BJ7:JY4>)D_.RYJRQ14I0P/O3&CN=PVNLZ3QD8%
M:!D:,"#;E)S;<Z?7"7XU!?,)CS%<]'BJ&J[C5_-!D%ML:)[KSH3'''#'<Q"5
M1**H\<B%3DZ<\:3#!\:VY;1!)HS3::LG-H$!<@32@'G;\LL8.<:_7<?8\+=_
M@V5K,\^3@6(>PM3Q1-<L9+S8-"PJ*F+C-2E4*UL<UV8B+%S$3'TTK.ML(6&-
M487]^$&@4?][.!S;PCXB0J$GJ)[2XPIIWB72&#V8-7X81RD'V1JE8F[M[B)!
M^?F2C"O4O5/%G;21/4+^>3$7M*A*1T8VB%H&&EN6;][]%OGF?O>M7XJ0WW45
M%SE@0$2) \%[8#P%<'"W7K(!([$O6W.->! #2H,_<6Y[\"^.-+\KAE%F8TOU
MV*X&+A&I$A/];\[)]#\(?KPZ_W!E4.DB_Q\;(/J)!#<?)>GRM8T =D\YXF6\
M1X]-W'@-@C] 5X!WT_ R9X18Q+_AX1W&]'I)DR RD+!.I4_SQC?HG?JK @D;
M)]P,*"35-+%M/&!';VF0X#GUWXK"X&6%4^C9X:*3J#5<GKK0:%X6SKVW'4AP
M;#T-SFR4]PL00$"8#)_ L:4XG]"0D,+.R5:MD45I= .+*]#WC"V=AR8D3KTN
MX0A <=8M&\]JX_^/O2]M;MO*TOXK*(]GVJF"V*)V)=.I<I2XQ]U).V4[2;T?
M0?*21 P";"R2V;_^/=M=L)"B%EL@=>=#3TR1P%W.OCS'W7 M9IQC"M7,N>6]
MFT$J&"8[@&6G$AL$\CG W!:K-3MGW!V52S6B$<[QDZ)RRB__'ZB_:X00ZK@
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M'#5D8.C"!B@ITIUKWU!3&<;%:\_FV#D[GV;1&N>Z)3$&P1N6/!A,I;#DC_F
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M4\236$)=M>-TJO<2C@S7"Y[.PLO#86?!4W<^W\UA.25,U#502_%-*_@ZC@9
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MN@25<*!2;"S^48T5UH^QQW(\#(.CPZ,A7'226(W$TZB746ZG*=_VB$,[,MF
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M#O&Z92>O[>S>.2_/6L]=!'KEXSFD'QSBE<].7MNKD][=VW-S;+[I13OP<ZK
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M/O1DO<9HVRB%B*2;)3MMBG8NJ#.L"=^$1R^C1%\!!4B1Z.Q;LU$2SR(AT':
M=1,Q=5.-A$F[J$63Q:3.)=IBA6]L+PK7<D-[.6WMU<6P>U_ <?3  HX=L/S^
MMUA&J5[VT]F?%06\WH!1CF3]'HW\G)@ S%!<X?>[;8U^S (,UX$\4L$\ L7%
M63641)A1@R^!G  ?JJIER9'O* .D<[D5\Q_'!8&MX7/Q#C$_E"2@*2L47<9M
MHDB&O#+-=/P0?K)$&T'D%.HU9&[X)7J3]"/Y1>DL-$I79I$D%G0TDES00? '
M>(89_093%O Y[$#_.BA )L13V 057_!#JC1!QQ!?5Z5EG.!*LU$)3AU\958E
MXL/14B4YQ1ER62W<%BU*3J0='#7[EW5]2K,;T @*\T-Y$$]#..&XX!!L-@9_
M=A"\Q9SL).;\WHW26Z&249V(@7TYVTE6]8+ +$W18 $Y:@KA=)%>+<?J%"*0
M6![#AG.,)F""%A\# AY33^11<Z(V;&5I&V5_<!2A9&_5I\Y#A/L.UYP6W2#=
M.SPILU6&Y'3+C<ZC$E=')V:7*%_&[>-RI\S,^AQUE4&[1M"FW>&/X&2#7AUS
M24:Z:I<8.HPA;YB"N,BCN,!'J"EL3;3C5L6']:LNJM&?0K-,@ERRT4F%ZXC-
MDHLY$9?L7<*M)9]%?;O<%$J\A3+P]3H22C%B#AY#3E0,\P>R 1 0F"VEJM]1
MJK!>I!H5)7X#L_CV4J8B;-<0K5PO61FZ8(1IQ"6&&F/0*PTS.*]%'F'NI5O]
M5H3Y)+[6XIR-!NQNX<88CC1Q=\W?7AR^('F'_3.P'O-OZ<RA?^M>'^['&6,I
MZ[)0W^K_^"[0'5B',MFC!70$JL0\AK_,:J/=N[.VSXK6O[%X\VQ;Y2+=/%%5
M9MLKF@1L1]B]G-.W1I/=O32THZNJO^?3I;QERW]I[/DO#SK,#>;29BMAHL92
M5\TO_*'5DD8;>:I-B8G5VMN6KT?"N3@Z.OO.L=76$-"^<D[M[-;<;B<E=)]^
MO9?OQ?=&UZZKV7+C%%BSI.V"FI'@6@^BQ]3GF#W)MD)SGEC.LT81+OQ4>@A^
M?_?VQX-6]T!DN@>:BO=__NOTLD4HU";8:A+T^J%G5.[U@]</7C_T4#\LLU)I
M2WN3[[?&=_$R>7<IR\MD+Y.]3.ZA3"8Y#+;R)"[&V356HUN3W8W#>'&\3T3E
MQ;$7QUX<]U <JP(%8ES,@Z@C%!^GTSPJRKSBRGO*H8PQ&880"M1GM2D&CYU-
MMIV6@!JV3E*162YEI0K>L]J0 _.*87?)VRL&KQB\8NBA8M!V.B:>DY7N\C"R
M%W.8DRB?2,]^=./-\QVF)2^%O13V4KB'4AA[>=#L#8-$7:L\FBE=>*0K>CI+
MW()EEI?3+/%YQ5VF+2^5O53V4KF'4GD>Y\K4CX1-),EB'&/6<1J/'7@6$,L%
MEA,F5"=;+5% KTT[7AP-S[]K5;5*>6='P207>7I1O[L$ZT6]%_5>U/=0U(.@
M<Y$!0]WP)D6$L"2PR04I&W?*$KE8%83(1GW'6O)[^;R[5.;ELY?/7C[W4#YS
M0Y%3-Y*H&8II@3'4:4DVPDU+3AW=M-UF1:(:?^C%]4X2G1?77EQ[<=U#<4W9
M1%6J;2=A;"-]=Q7LXS7J'0:!88PCTUEJ^U8GCIZJ 9117^U();&ZEN96MY\5
M)ZZ5W,6$'<*S**>&)3QT+LA9<6I7VJ=( \K$E"P=JYP;7A$8K*,S-LL=)TA"
M68/@_[(;S%#4UE5KI<+EA[P)Q#$ 9E($),A]^C7XO]LP&AO[ %V99S?<?1]-
MI_ YG1P&X?@W&DVTJ."O%)WC=NG4\>T*.$4@]=D\@+/$80 E PW ?09#C64"
M!S;'TJ0$KD!#$!H8*@S>:;QMYX!*^)AWQD#;%G6E6@J(2ANY1V* !:5W)/[G
M[-@-(#H[( 9JW%@-JR?)@# W'!3!GQ/(Q"2TU5?Z.J,D4=<Q56<5%?R)J,SV
MQ_/V"#L <5@6=!PI]K=7BZ4^8CA<+.8BG 6Z.T50V7FNQJ4!)L!O$*@#WO-U
M%"=$"AHGVZ#E!44&[(6(.2!P$!V (;#A9+D7FP<BP%(1:6]:M3K]L "M%7Z%
M^Z1A 7@_R J8?4-,3V6@)RH05UD%)Q47GS1.@WQ1I@#5&_I+&H310"AH!7$W
M=-!CD[@@4Q![(1Y.E6I<17/6^!X]V,K!#9^8@P-^3J*5QE?28L4.FVBL6V2U
MIO..-LG] ]Y%+%(=9S?D9E%76)),%)S8A)'K@80P])_E+I_Y3OZ>6C?>+_!^
M@?<+>N@7H((!-<;@;6P'X$=ZU,]UEC!N=;A=&S]I. -8PQ!-K;+QPK=^[B6I
M>B'OA;P7\CT5\CAM<,P.2F/.JOC"UIWU,GAW*<G+8"^#O0SNJ0QFJ[H] MOV
M;DK6E/".BT*'CKV9O$^$YD6T%]%>1/=41*<58OYS@&,>X60=E6,>;5SHQ(64
ME;<;YV],J!XS=31H+U=>4.\NN7E![06U%]0]%-2-,@0'2H4JP[ES,Z"YX&I&
MQ84.%FP1!DD\5FDA)14RQ;F5%Z:A(C-)/^JX.)R*5)>;H#FGY&O?MGE_6JG[
MIV:I#5=AE 55D<23&"Y"1BC(7#>O0':7#;P"\0K$*Y >*A NJT%,<!*UN120
M<?D;EK"K9:EG(]+P#SV?1D^L\5)Y=VG+2V4OE;U4[JE45E22#J(W-.4BH2Y%
M)8,_Q+Y.&:<>3:YA>]&,I]8G$57R8I#=^6<1357)HY?-9PJKD:,QHR"ZX9P"
M'8(R5Q&71'LIO[NTZJ6\E_)>RO=5RNO2=QP(QR-\HK+$>(<(:@[@?(J31/E&
M_KV@*B^/O3SV\KBG\KA[(.I(43U*5XO^'1M$G=O8BT'<QP\<Q-U-A@_;I2MB
MO0+L'QM[!>@5H%> .Z4 M\%*D*YB*>QT>L*QQXD?O1C%J9J82>(Q=ZK+\\8)
M/-U'FG:8/+U@]X+="_9>"W:GD17[6)<1U]TC$ ?^?Y#Q!0&!X#]T_1!7YJNI
M8O 50G]'I$G<ZAKP]W$2Q8LZ[D=<QC.N)Q(5(X5$656"/E"F?LA^T:N"W25H
MKPJ\*O"JH*>J@"LV,34\5O%2H)T(MH>D<)2H@C 0P&[/LU64$*90EH8;*H \
M4N7.$IP7U5Y4>U'=0U'M@L,EL2[S-X7Z./&NB@E=,:%(39FMFV1J S 8=]ES
M4,L?U#A"Z+XH238,=T4$._"!\.>(I%=0\11^?VMTGX;S O\LE!Z$@A!^!I*/
M$//@U6E6-J#RV&O2B'FIPE;G*!=\18T9F*P"@UFZ-9#?YLFV--A6(16%\M^\
M2$0]C,9S@EJ$GTWC4JAN$/R6EG'"'AKL0!$D(*-M1H7L+YBI5%$%L0L$JE^?
MP[?32C%L**,C$@0FP50RT"(A<V(AA(.$*5%#LS&$PD,NF$X5NJY%R/B<@G9)
M'S2;7&S["Y!$C&\C[_.OL'/;_^+VIA"@Y"0+\,((5Q)/$X\Y+@FL\C-(#02W
M9!!(7!7!7 Z"CXS/B%] @$^$FH3-YE&,Y&A!,36NG]XD_@:M+G=_V(B3POF6
M<2<&*1'?#1QW,8^7Y(3G0%KZRHLR&W^:9PE8186!'IW$254B?F.]A<>0KGT\
MT0&[[@J."%8TD?//396@@O-7=)2TS6@":RT4T&H$-P-7N\)UY,C4!8.[XOGA
M7 J[M$'P8^WJ&&92@VV&L@J*5P01EJASXQ"]3Z]N#*8H_!P^3L"H+:63"<\B
MC\=E!^)L&7V"K0+U\72DL:81:EVBAJ4JYU'2]K[P]'$YGQA$EB^/*G?@*U7.
M# 4R/J%H"AST=0RB$ GB[;23 (A<S/5O0Z]K:97#\,MY!-)OK*J21-4RRDND
M#</41,6P>U 5<0KW"7P&"KHB>ULN2;1'J<;S%!31C,A,@"B%=W%E*EI0C6FA
MHAR.#+A[ED<+6F 7<"A\#']/2UD]^1%"> :)%=D,Z',:7<,9"*1H90ZO#C5Z
MRU%:[FE(!9)Q4F1E3F6D#-8L/GL">G05,B'A%F$SBE0G+!<ED*J)TQH8:7[K
M:"Q[$O:\=9,T-^M1Q\4:@:U%R4U6)3)*X 8/@OEP_;. (Z]O@42]V+K&0'3T
M")CWSOK]OLK\"C[.14^^&R42&03"NB)Q;'L2\8MPT2"2@' W[/?L_MOE/2#S
MQ^.[',##MRL[-#M^T/Z>W$#[H%3PKZQ4['A>AATNB'O2VD/=>.-AL.[H",=Z
M^%WP,R(1%V+ZWOY.>H5\VRYV>+CM:M^+4?YKA/'PUT9]Z05HF&YRH@Z_PU>0
M3(!M%%E";#\)WA@,[P\&PYM^ /L1#4B1?'P)O_;MVS!X"]_D?UWP6\ 8?9VF
M>##O%4&E?R%Y\)48Y''8_,G9X UBH*,M368)V=16+[EY&NVC<%*%IYWCB!D&
M1U(3TF_<TH% V9GY8AX+<)(Q#&U6GFQ<U*VH?2UL>42V UE*:/2VWX.:"/,Z
M;($NP3>RR.%V%%E(CT[B3V@1PK/8B@[0\\EI<!F;BZ@<T5@4X+U1!>L%IV<
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M:1N(Y2K_]YMOKOA@8/;#^F#"!6-H)U6@7@>[E#Y94C*B:?'5_BT,_ :$?^_
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ME-TD9*!B#3,W\L?//6_&S$+;<5:3H_.+S]N2HH_]H=H:]-5^&\W[M!QP*W*
M9$&R(-G(2+^0LP_X-?_S^(0PEZ2^!_X&S/4"HCPHLR[??AN /DGY%U'@/E2W
M%-@3[ GV!'N&[*FW$H);A;'GZVW)KW6O;:S;]SN:JG?R*]R#:FN,\J!: D8
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MI5I"F&9K6ZG\R\L #JFWEJK#04]MM_+K+ 5^U!H_4 : N !=_-ZP\TPHRVR
M;[G=)(3>$ JHFF\"M>FB=OEF0#!0L *V0!DH-*'/4Q:%'J*!L:.V^M@147-:
MHG ";L6.J')PGM!]*0W.J]:P"#0'F@/-@>:4T'Q(!<UI=R@"N@'==8?N\LV
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M8 >PUQW8RS<#@H&"%7!>DH%E$^I]U%@VOZ;!V$RGG@Z&)>:Z1$$%#(NM4^5
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M0,$*J)5E8-R$QEI%&/<0C6*ZJK5Q>YZ:CQ-%'U Q]EN50_^$"%A5T+]J+68
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MU@B"[3YNIM-%\ T[S(0LR;8=)C'\QDWSJODGD!O(#>3.![D3FB)E(G>.37!
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M:<=ZMW\?)N0'LR^_K!CPX(J5#)2)XT&'D&9&@FM^Y:8GX1X*_?O5S1)QD0T
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MI6H[#$&D8 70"^@%P0%ZJ9WM0"\4K !Z ;T@.$ OM;-=T^FEG/D8!R]54C'
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MVFGE=XT+4%%OJ !-PO>;:@709 ::3*A4E4"3.]2UT39&W06IH@.8$;[?5"N
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M%9"=9-AS)V3]-YQTKZ0I(]L,(?++ @X+KS^WU=X@O_O$P(-ZXP&X$+[?5"N
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M8PNA&5>W8^%FHQ0-*T XCJQI$" 4K !R@.\WU0H@![*F08!0L +( ;[?5"N
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M9[W)V)UUQ60\6BNZB%S'.Y/K8Z!MI^68Y1GF?XU;1RZM[GT#2]R3-57.R@?
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M-J+4^CJ-_T[A%>KFJJ!3/A/J'8V,322I\Y;*QO_[%WSTUY;SSR1.4V3EGA!
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MMA_3-4_7@K?]&>VV*'L".1_L'+DE1Y)UGZE YWPB0/4O1KPE/@E2TN3< N_
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M2U_AJ<H$DY6!IFK7D.5V'*[2L;12="6MZ'D ,T^&("B9*U*:9 *;OPH2N Z
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MHBWGS-P^CO(KGL+T!I>0%OEICDYOXT/2OH!DX_"*LB[^C .L4-.CX\BE@"D
M&#-.1?E>Y'-.=DVLF&;E40X#3F"=QW1!TB=12FV0%Z;6YF"R^+&,4YE>82A^
M6(:62D_YM9O@@':!XWBHH8;*_M7^@C3G<>YZ]GNQ^R"50%27 F=$'*'Z$%"
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MJ46OF?"TNB7YGK[Q'I6D<Z6:%Y'MG"_*=Z.D%2,LP.L2I!*0 Z9\P *!CRX
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M/=EEG_<=G]=J%U^<WJDN3<_BF#U?%&^(G1!CGA'G#M,X2^#,B>XU?\8OYQ
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MV._TANEI'HB9$^NSH4A*<8V%^UTD2(WX%RKMFL?73A8[;@CX[69(EFF<)Q[
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MXY1^XNW]Y]\&DU?XGG3U$^<R#WP4D;C,V<5Y<>LD9<',<ZZ#;+[^:W DN3)
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M7):',A@7,)X-1Y2Q16*X>"LI/&6(2N(XQ-#PJMG%@G\CYU3AE)J*,+[F[40
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MZ_<&LTES.)B(9G_DC9O3MC]L^E.W/1*]47<RZYQJ DNOY3"25/];:*,7"L*
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M9K'_^8+!BK,#Q%F_?51Q=ENJ-[S/BK.Z(8T-3M< "$7]MI[;3,:S_B7#T<U
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MYT>.5'+(W_ !L;@:<,;&23>JW.[2GTGD)>^PHZ33]JD PM )8)?_@FV,9#A
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M4C-2OP2I^\>N<BC5+=^,S_J" N.S-J1@?&9\9GP^3%G"U;'+$C8 :/W;+#)
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M;SOXS7/'7/<75MX8X/2Y>8L%_*519<8VQK9RLSYCFY9DV0';YFZ_VG-,>!W
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M<O!5>!> +]\^SLAHV&8D:L9U'(W\0%T683S&CFUZL'P1HI0[X0@[D<-7 R%
M:3T)UQ@Y(C #:S2E2=JI!,D=@RW%ZP3LY(5 E^2^!?EUV++_Q/8CS8!N4X#]
M@I<!*$2"OC',Z(/;BQN@VJBK+0 LJJU@P<8+Q$WR%&R&ZUC;\.A6':[P[@@
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M_D=2)[_-3E041O5BA1]R-PT/=#W\88@/#Y$CY+AYBB??2V=)9+:-%7GWGX/
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MYO35;_WZ[!T)DFCPQU"I2_G!A,XI)N<*/9HZJ;7D:%7%$ Z=[9+AAQ6$FFM
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MX_ZP*IL1D ) S2"?3.HV56,W@HL93?#G_/K3Y<9A8N>&SAC@0>: <;\=&6U
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MIV9;M7GF+IR:!05(,S$B'S06S05_%#2;'([!IR,S,LP 8<X,?0\X=&I8(HA
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MP,9A7TPO'H(BC@,T V_\\<3TIA7C\^>;"@R3-#\#!1A-Y1M??_4C(7]LU-_
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M6L! @I(>06W<TR99UG!!ER"W0QYT%PX<82;.$UR;^/5*WYEC5$D9Y(E8-G,
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MM:7[[A?N=Q%.F#]!69P>))L1NL500F+DG\"<MIY)1"Q3&"NJ8(N8X]'^#X4
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MIE1M6;REXSC6A"8<ZI56:+8QHL7'D<HSD?>7L3A64D/_+"J5V4L\89 WJ:B
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M,,(L#R\+3H"MA9T7;8E4B$!K;9P26S[L/.I-U'EO*-&@G2R[+1-A4%.UR !
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MP$+PJ)6MF$$H@'HM?$+/>EQS!-K 4,#0I?>"2M9%Q4N<5GOO@L2L<G;9.$-
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M$KHIYM,P!@J=L\#\'6XPF\> [X8WT'M0+_Y=NY*(/6+'-OM@NIX-P@7TC7P
MEF#[#ITX]&AO^$R@@P]7YX<?'CY23S(.'KWR+:;"]V8IA62/K@.(=T_@30ZG
MKJYL":'K KK3C[./.FQ>#_\62O=G1FR&*FP4$1V61'_TEY:YLEY Z'3@"WR&
M2PJ;/42W%TLO20K*_C+Y[L.=;&Q/V>HOE$+!-P'E-F+R$0@@(6R=:Q\$A#_:
MH8(-_Y2?*3N;U#U3]C?&ZB^;;Z![;.,WQW;=4\#D(G")+_+FR-+>=G26[+/M
M&"[97+W;V DLS130Q4",=**?H+LP-WP0VKL"!AC5LJH65_-JOMHMI_GKUKGJ
M>"*V_. $.]S"@>LO06']Z.MKV. ;W7K67X"OO[*(3)0NNY%SX\GB7\9JX_U+
MF\Z'QF2Z[,\6XW%_/%W.^OK*F/774S)=J?I$TQ<C:B5DX)0Z+P-4?-NF!_Q8
M'4G&,MUD0$V"@J JC$FK\@></)>!<>9 OO'^R?MJ;Y[80.;=M[$O8\?-O09)
M?0+%>/*Q>]-VV 6[(7!\S!KH7E@U/-)EFM+9<83K?ZH+W9X"8/3]]@_X01?T
MC$S* S)-.#A_L_0-SH\[<8"0+V Z'2R:G!?37L]F7:WTI\E9OF<>WQ=MXEW2
MZ5,KZ<.!<9H, ^/4T6"><S*:;()_)D8!<H+)!X;QOCJ^J%U23+KH#=[XGNO!
M+1PDO?$A!HT,)VA2KR&D(*0@I"1S@2Y:XUYS1]E%[Y$YFY2/HG'KQ6Z3!J"4
M?QR3H(;8>2&)FN*Z?+G9/G\()YBRU"U]LZ)N=>H5#^9"*R.U1QTU,_G"G\SJ
M.<UAP"2(6)@YM[$_YL=)P"<M9FM6YU4$RAVZF(O*;ZD0LIO6%K+[]!_?]%Z^
M;%S/\>F+[@V-D-X]Z!L1S M#$MP+4S&0MQ?/8+&1[[=_[()YL[P8'HW?&;8G
MWG#U;CZ?]]0YYL1()\ZRZB+$9L3F9M(7I6,1PO)QL)R?=3JOKT-F<80.G%K"
M[<,\(]0Q$B:OG@V\-<#G@8J%--()=1N:3QWOWU!'@UDV6C=#>78:B8RMIM N
MPI)WV:X!IVP70VT?-&U*>ASJ&_65:\_$TX=/9;-D-]3(\SR,Y[/>>*;59MR@
MRKEPE8,(B^(NDV,!P55:O\&BOB;5)7&V,>=!-A!K5^]&@\D,@58V$>]&EH2,
M7H1_,$>??&XT-''072F=17_J $JW[9Q7%;P(]8W?S+5NN*:4UXN@SK3>:)1L
MUBF?L'=,Y[R6CP.(KBCI,CD0$%CE=2#4-Z"C),3*Z4"8#M0I8JQL(BY1&L*Y
M6Q#(Z%7X;#MK N)G_+JB]196<VD*\E2/MM P.J5_LTB]:,=5F!RLT@J7]W;;
MRJKBOCAC4F>HDN7U8(Q&D]Y8J\^#45N!:E'@Z)2^JNS60$AO,4[@F9 R@Z(P
M5I=BS47C]7%>D?J&@!5%;A^6(*M+1),GIP(5%"9:2,Z$@NTHYO)Y%3%NA"6O
M<J@M.?B$=:\G*0Z9GS%I]4SM*$H[0^;366^AJAAJDDV<9=5%B,TH[C*Y-#"G
M0U[OQ:A+S2327193[/0DG5!+E,71L3(0;";1"JL&"\XNG UHVE3R%YPQ1_4\
MS22*CZ+;]QO,QHO>;#&2)AZ#*D=RE8,(B^(ND]\ P55>OT%BON3%-Y/(!F+M
MZITZ4+%KDW0BWHT<!QF]"-A,H@TF#KHK+YP-:.=4JL:8GS&G\SS-)*I[$4:+
M26\XP>P#Z>0:FTD@NG9#TC'Q0$JV'.= F'2NF<1!!\)\,*_/4X^:1SX' C:3
MP&82:!AA,XGF59@<K,)F$J=S7YPQJ?-LS22J>S#FHYZF3:2)SF!9*O:20$3'
M,]&"! KL)7%FI\@9AV_+T$OBH$=D-M#J*\Q !=42-XG$>1:2,Z%@+XF%?$Y%
M#!MA+PDYU)8<?,)>$J>I#3ECSNJ9>DF4]H6H/76TZ(VU.<::9!-H6;41HC.*
MNTQ.#4SJD-=_<<91WLUWDTAS6F@##=,XI!-JB=(X.E8'@MTD6F'58,79A;,!
M39M*'H,S)JF>I9N$-A01%S!?2H_DZ$V&\DSD0(TCN<9!@$5QE\EM@-@JK]O@
MC+.[Y6@F<0"'64O*,79MDD[$NY'D(*,3 9M)M,'$06_EA;,![9QJU1AG3.H\
M2S.)(YP(T_&\-QKAU'3IY!J;22"Z=D/2,>] 2K8<YT XX_1L.9I)''8@:(/A
M&#%6-A&7* L!FTE@,XD+,8RPF41K7!/83*)I_E5Q7YPQI_-<S22.\&!,9KW9
M1)XT"*Q+Q682B.AX)EJ00('-),[J% &,ZU0SB<,>D?%@/$/0;H702Y1G<<A-
M8MC^TB**-C@YCDO#F6(=)K1A4Y[& U;7^;C55JNKT;83A[B%CA:)>%FP-44M
M_.RJ:9?EB#ECENQYVE>4][Z,I]/>?%S?I+6:$*<XW* 20VN@"]8 '@PI<U .
M^6"JLZ:K0%W !W/&<>2--\3(2$69(%R7E70NS8T#AO"[_.KI0!UXU3"?RFT^
MMM=?RISB^'*X^( M2D#^TI9 'ZAMTQ1/= GCP61<:A5UD_A/HCSJ+\H]/9$*
M'!U7\6P01>]!(8];RWXAL!A]8RB&Z9"59SO,O0+'',[KXU;?O+ _PD=V[X:_
M.\32J5,&1-8SX27O0?>4K6,_F091F$HR%)<X3^:*L.=%OP_.%G&BK_Q__V<.
M&NVMF_B@?N\0II^49Q/6^Q5V\*?M_'"55U]MCW!FJ</7 ^6C[\"I8]_Y0G1'
M(? ((_01\3>*5J3SGO),.#7@+:5O1-JPL2'4937HY@=HYT^":REZ=-=4:!ZT
M1)Z7O1LMAKW%,)E:SRD>"%NJY'#>4]GA\F#[3F'^\Z_?%X([(!X!YL(_%=AZ
MQO$5YV)K\>D5?9>L*&N? :%<LJG@*0 DOC@"ELC82!!P8Z<8('LO<"WD@GH&
MI0GG!/[6WYT5(Z[3W -*31LR)4TY/:#@E0%6:@O0ZCKFW8]OLD>)08^X[BI_
M*60BQP0TT5<ED(%;KF_2Y36T<)D0N7>VIUO1OW^P70\4T3\)/'UEWV^ ,L;N
MF_B']N7W;+9P'_;LKG0J!].K=\-!EJ8&3EN4B$!Z?^.$^P 9@N?TEW0G3&$'
MFU;(3_HS";4Y2"_7]M0.,%WV]Y7XPY*^+?Q*&RX(BJX\B_M"7^<7!F7+SC)=
MP5]CEE>4@XFBMI-QD&N6S[8C7J+O4\\51-[7*Z )J :X>J<.YOMV*><?4Q #
MY6;-&: _P@7&ZU4Y)(G$N]8<DLV/8CJ][C,2' 60^LAI"/1XH..9 :/#.QYU
M<T/U>J4#D/#&RWT BK*DN/PO#L@_P\ *(I^HXVF1R!>V9/:E?GBX9+8W3FF[
MQ6E=3/ZCMDRM9T!-9!C)?@:J6IN9QV XT [!P"$+<%[& N0VG F4,E='VH1E
M_!6ZP\2%>6'2I6 X49--\E8/Q/ M<K-FI'VP+;A5NOPJ02^*P=?>.,QAY][!
MBMY;\,X##$UA"@&HV%+WL^.35*\<)?-4?CL;+LL@8)9E/[-+!G6V*:[_"*N&
M1[JIWIEG3D&%:H,GH.J;#$$[M6L.'BF<@GS9W*W*5-J*6!9UG,*>PM^%2Y;]
M'EOH&]WW[+?"*;L"6NA;E[P)?GBK<,?M8B@*PB7JN#,'#7"*.G5IXA\WON=Z
M .=4-M,G"LWD2U,9+,;GX4D'0[M8SRLY&R:#N8;M!,HZ3=5$J/:#I;ONS5I8
M*\)8B:C#?//SU@,;G+I-N>U#C5Q8,U@^49^$^/Z=KWA6>JC/K#?3U-YPCE-]
MI!-$B8K^3VC#9-;W2\.'X,X!=V3BK$Q7RID$:+5@&U.YK9;3L0&MEBKE^9H:
MQGHW/]XP=\L7U_6)P=,PN-N,N>'<0 -^"A3@J>R7(U(81CUM4E_G(M09IZBC
M;[@:3Q@K338MDH8O$:-F:SK-M4B.VB^-M3NX##OG'&5XV,Y(<E9Q6PC;&9W"
M7AJ5MY>8;I7/6AK->Y.Y/'T>L:O!Z4THB5U DM,_/XPUE^^:@0ZA9OL^9M:W
M=TIUR<JGN)54G5<7;2)5L) 2535-!<)*6T3J#"RB14^3J$$C^I!D;>N$CJ13
M1,?0E20-\J(KJ35&$KJ2FN9?%5?21+K06_$RTS.83NA0NGR'TB%3JH,=,O.]
M3(NF6Y*G&%:-,JJ%AE6CKB=LE=D27A9T3V&KS!.XL!+5Z4VYL/+ML/\2QS9T
M]X$*\EQ3M;?2N*ZP6Q9VRVKRW'^ 4T$;6:T(,=QHWXJU8S^&GBIF93T'_JL2
MG5K41="IA?6A<DB%@G4UT:/AFUCO9UBCT ;!K>]03?G!NUN\+<)H,DAVU(OW
M1:A6?:\F6AI4WTQV5L-^CP?U\%YZP'B7-C QGXCUTO:6.A6@;!%Q,J2BF,N]
M#N5JIT_:?TH;UK'F\_;,TM1:UEP\FR>QYJ\%VE0E^U:%FH]I,),ML5R_JH0N
MI#_I!WH_A0VN@AY0U=J\:8DN94<8:>>2[$1KNJ/6?![)KC.>6TFRBS1@.R#9
M]FYE R4T<>@2S8VO\T]G-*<83Q,M2KYL5O8CN=-_?C3=E66[OD/JZ#^AB/40
MX]K;/?Q?QFKC_6LV&8TGP_6H/QH2TA^OUFI?'Z^'_>%,'Y*UNEI/5\O,!A;Y
M;4("6U'@U-*VC-(85Q70U-% X=HA^2^GM *D)CD=1!+7M5T'$?XE[PFLA.Q8
M!_]Q/7-UO:$M86#;FSMJ=)^(C[ ^SD=CK2_5T43K3];&!/@X4?O+]7327Q%U
M.!V.5&VV&+>]$0GO5T:5/YP-5UDRPBL>Y2%M*P2XP%N5N,HK<P, 8/LN'$WW
M=3<ZD,RK=R"IYS8^F0W&YQG9G7[][JR?+W"?CQJGOCP.<R M;!6H3QN!->]Q
M'<-ELEBH.]-YN@)2$Z<.[VD"D8\*?51E&Z CNP7\DW;B_I1^"6C<O7@.MZ$<
M[)"H&81$<"*/0D,TD0%--!G 1%4'LVGY\%VWX>:8X9\R!=4;2V>4@XWRZ<9,
MQIV> TW2'%5BZ\^2!"E?W;:P476AZD+555%U-583+67NMQQL*>Y$@)TU47,B
MG J7Y'O^8W [2 9$Y*OV8<AS2827M:P*>P1(,M$XFT7#8I#?[=SJ0V5OZ5F"
M6F+<!P_+_P[:D>8)?N#Q<^#)S98X+#W#W0O?$S<(X%=-6NN/0*28@/4/5;4%
MB8:CJW<+K3=6Y9E$C)JE4IV;'"Q"E,6S@"B+*'M*E$VDQ)T*90_5'91&V>FD
MI\V34QOE$]N.-=]!$$4011!%$&TSWRJ :*(Z[V0@>J#>K?Q5==P;:R,$4=D$
ML%#'E<,^]\O(VI.&(Z+X0S%YI<DKZJ%_78N+_G(2_-IH#)TC%ZSI5"]I#I&L
MK(H;1=BY+HM_Y<VB1)U_!;-(J-ZC'/BAQ3-JQ\PG5!U2J0[$6#D5-QZ4UK *
M,?9DOH?%F4"VJ/\^XJ0?RM,>7\H\/VG$KK+;'J'U,O4U0FMK6(70>BIH'67T
M]*D?6NOTZFN]T;"^R#CBKN2>_GJ:WZ=[^L_7K[M!'OP>R;87_OU&D^X/F$2=
MX$>+TQNP9?K%I$!@M_03V%-J#?;4IY^P/."-N=&=ER\>>72_VAMJ6SFV9<%'
MO]#:2.)Z9\WX'\WFK4BC0 W6FH1&- /0#+B40X1F )H!$3,@T8^[*3.@[I*$
MN40E"6T9JH*PCK N 1X@K".L(ZP?!>N)D16-P7JM11+3WDQ;(*RW0FK3XBE-
MSTFC2XA/2DO\GM_DBRXI.G=J__?()JJONFYNJ..I(,"#$^QPJ]^3_M(A^H^^
MOH8-OM&M9_W%O5)^9?G%T6$KL>DJ)0:<')J08AB3Y7(\T?JSX735'QM3O;^<
MKQ?]T4*=S19DK2UFRZL#*SE^1,>IQ:WXS)I)<JC<;AS*;NQD,!H%]/.GGUNR
M<<E[LB%KTZMM%$J+1P=^"0.&RBO"J4/K@AA]*+Y4&XU%2>F:+IN.0K^ 3T(!
M),!9*(TTKY\.9IB>UF!R8$Y^4W<GB<LW&&6A%<M%ZTQS4YR,(A4[Y)N,TBRX
M2*W>$&FD885T;;:QRW9)MC8Y,P6!IA&":X/AL<?D]#<;.3F%^J[M;,6!*,V?
M(CGU79<X@'JL[6S%Z2A2LD7^Z2C,L7"YL=X/OD-%[DW&V6B(ZMR'T"W?0-,D
MQ\:S+6#2L!#R(Y^:YE/'>JW*R -^C4$,00S!<X$8TD(^(88TS@/$$,00/!>(
M(:WE4^<QI)G!#Z=S)ZJCP4QN'GPFH!-TJ])!.%W(I,,.Q08#51U3/Y5+.4_9
MUW):@ D77819O@9SO%_1(Z(D0K4E:GB.Z9(4+9_\+W%L0W<?Z(&>:ZKV5IH&
ME'C$Y=:T7;ZHHO COB&^E<&W29WXEM/^!_&M5<(DJ:9%?$/A1WQ#?"N&;]-:
M\>UP'QS$MU8)T^4GG,KO(;[U=(_(U_4,7<08H9+<OCYQ0+?;=D:%9GV)UD_"
MT& :[GIC_&ZO:G87[UKJ3:3IIH>'6TA08_UP\=XL%=6[)O>RL@%!K0JH)>;-
M'P]J>2WB=Z/E$=1DDR $-02U+LJ]K&Q 4*L":HGY[C6 6DZ#= 0U>26HAI&Q
M+6M<*+];6,QXQNZ%K;=!3AFMJF5$^R6I,EE9%2L1.HI;%VW+E#9EQL.LZ#;7
MGQW,3I:RP9(T$B9?3SF$5<ET-<)J:UB%L'HB6$V,53\&5B\B*1IA55X%@; J
M#2L05B^ 50BK)X+5Q)CRHV#U$G*Q$5;;D*!]9O>\-AN,)G)SYL[V=$M9\>/;
M^.1WM'OD#5'7U)R^XWI/#EX6Z_2%EE/].0OCQ"AX83IE3!*^M+1RM).D3,M#
MST,+M#8B\.7P$A&X,03.:@16!8%;F ./"(P(C B,"(P(C C<$ )GM2JKA,#M
M2]A'!)8\BS]3:5SZX,"/9$W@)!K5)@=BH^\3(&13),=)$"U@$D[L: >?.E:(
M)R,/NEQ?CAB"YP(QI.5\0@QIG >((8@A>"X00UK+I\YC"/:%;M/D0&P+?5DA
MM\ZK'SG8@,W&*I0\)<9/!+$2H>!.D+][GLHG/.Z7?=R[?&E%X>^X\"/65<&Z
MQ 2$&K N+U.6"4H_#GH;_]&P/?'&:"[/;('P)YN82:H!$/Y0^#LK_ A_5> O
M,2NA#OB3H<D%'G?)',OR)JK*[U@^-' 0\U3ELS4PJG7A;$!;HX*MD1AA$=@:
ML1D6K74NXZ&_[$./MVL4_LX*/R)>!<2;)"8=U(9XM;J8-15!4#9ADU0/( BB
M\'=6^!$$JX!@8BY!?2"8TP^A% C.$0-EDS59<IIQTF&]DPZQA[(T6'F._E'8
M'DIR5N'LB!.9/HG9$6%TG2O0UOJZL2W4Y>H)[,XH#2L072^ 58BN)T+7Q'B!
M&M!5BKF'B*Z7JR<07:5A!:+K!; *T?5$Z)H8'5 'NM;IL!\OZG/9(^*VP8]?
MS^!*'(FX/Q+1$">[X8&BZ,^7.?:-\R NAY<X#Z(IJRH<!['Y$1I4&9;45]*"
M0 #.DKY<_8&N"FE8@;#<!5XB+#<%R]/Z8+EH9O[.D:$.AXC'K1 LQ&/$8\3C
MSO 2\;@I/)[5B,<%8PX[/)X,IXC'K1"L%A0(&+:_M(BB#9I YF:XP@^JXND_
ME5>$G]77RI*?5@E+!AKE4 MM)YE&3L=XUTG;Z2_RL;&2V52-DQ=M-I6?-CU)
MM/,[085!Q%"2/O\B4[=W2D>\EC#9$5%7%G6-J(NHBZA[A+,BT=?NE U]=NB[
MF"'\MD*BI"TX0 R617DC!B,&(P97Q^!IHM/>*<L3HJ&"$8)P%<6O-J[X1:3@
M5T\'ZL"KAOE4;O.QO?Y2YKC$E\/%YZO_2!QS%8B^^#44\>%$3?AV;E</Q/ M
M<K,.0F0@[M>N2SR7=M4R]:5IF9Y)W#NZQ3M8[GO+7OTHY_LA(.Q;JF\<GZ1*
M!R6'MDW3/U$"C0>3<2D:U2T =P\$]OVXA;=L/%?Q'G2/_>Z8+H'?^!_US0M+
MD)V]=94-\<+""!;+T!EE%?C<1[(BCTOB<"Z.U)Y"Z:7H&T.A]CNEKVNZGF*O
MV3>O;<NRG^&T*J_,#;QB^RZ\U7W]AO*_ 9&#1PIA9[(OU,7?KD"'KHAE484
MBPU_%ZJ&_1Y;Z!O=]^RW0MG 0;?TK4O>!#^\5;A"F@U%O\A$3.Y,P=/I=# >
M-Y@QT]J;1UUE/9BNE,$)6!QL'%@QO9(@W64T'"QRSDE QTQ3= 6$)TX=MFB4
M 4O;,H[C9%6V7;M4B2?T?>/9(.<PW>3@0/$4CX[ B=0:#;%%%DZ$V*+)@"VT
MI6E=N92= 1]ZJ4"D:1!IFDCN'Q]Y2DY_E9&34:CO6L]7ZCM!?2>A97W:Y.G,
M0R0L[<N-8'U,NA??5)KR>;J(UJ"STUZ:HG@!U.A4F%=*)FG%X!T9U32C.C\Q
MI7D>L#L-8@AB"!X+Q) V,JKS&-),M\X3W@OEG[#UE7B*O26.[M&\$<MV766E
M.\X+?/!9=PQ7OF8)W;TI-MIMI%.JJ7+*[^DXP%$<TW7+I>MFS@0-,QAO N7W
M.^B^#U'5EY._F-<+,[.?N#J<]":C^HIJ\-1?MO+M\+T691\1#Q&O%.)ECH(\
M%O'R!U5E(MYLWAO-$/"DDZX.1&;EOX'?>O;J!ZL*(1M7IP=#OGI#O'.C.U!N
MZ_O4[G,T0\J9(9DS,T,S!'X(7A.ELQ\B.O!Z8XA*6O?V07?(>]TE1O0-'VPW
MK[M4=7NE-UTLI*FW10TAMX; ^SG*?E=E']&Q$CIFSKP\&SH><9N?]R:C^AI7
MHX:0[#*/X?0CF'"S"Z43.).*M6N.(9^W"V_UZ&*4VV[!X()<=DO:5,F4N )5
M?9&V0*>ZIH][VF2,4079Q$K2(X_7=)3]KLH^PETEN$N;UG@DW!UQ[Q[UYG.$
M.^G$"H/H$C#A(]DZ<&*8[XOU1]0?;<<S_XOQ]+:9(N@/O' VH"E2Q11)&U09
MFB+!"U$M>+TQKB,Z\'1W<%6;8S! -@&3]/#C'1QEOZNRC\!7"?CFIP2^(V[C
M6F\XUA#X9!,PC()+P 0XG\H*CJ7I8=2[328(^@0OG UH@E0Q01)S%].R]3XP
M?7=L 7DDRVY1W[4:S_5EGVN\5J/L=U7V$=.J8-HL,<>P#DS+&"F,F":S[&#\
M6@(F7*]6CD\,+ -OJYF!#KP+9P.:&57,C/S^:X4+W3X];BW[A<3^?-0->S9%
M_[UT(B;I\<<;-LI^5V4?H:\2].4W8CL=].5=Q&>S"4*?;"*&H6L)F,"*.5R6
M0FY[#\11='$SQTKN=EHGZ">\<#:@=5+%.AD=2JOC2A ,D!NJ H5O\KB"[DC&
M^$3%((!L B3IX<9K-\I^5V4?@:T2L(U/!FQYE^KQ9(3 )IL R1+=CMV@#TUC
M9]O:Z@Z0\K)OVNP(-N5TBMR;S\",2S9#SC%<-(TU.+92(E;%1XP>Q2XT9V+F
MS"1_G O5HR>;5=8;J_)T0B^D&*(Z&Y7#F7G#+NR(J)*J:434UK *$?54B#JM
M 5'SZ\;_2QS;T-T'*F%S3=7>(HBV0IYD"<*?VU^@S0:CB=RLN;,]W8(CQT^K
MXND_%9V=UZ:<;.A$D-^)OF,-I6DJ@*)-U!)>QFVBT_(3C::8T33+-9I^<VSW
M="/3M4E/'<M3/(@VE+SZ QT1LG "4;D+O$14;@R5YS6@\A$M\!;CWF):7R$!
M@G(;'!L2E_E+SH&/4<]%I)S@3<:!:8@/'2XF:(KB!>"SX[I* B85M'.Z;<-(
MR;G.ISPVSX,.)_(CJ."Q.#FH(*,00V2\+;8M#-Z"M/F]">/,ANS;Z[X/OV \
MO!4F@12>=W2L2\XJ3 $LQK]7Y1WGASJZ1\H!:;D@\.;:@77<DT?8^LDBW*/>
M;%1?HCVZTD\I<*\QM(T BP#;>E8AP)X*8.>'VLL? ;!'34_71O+4YR/ %@;8
M;M3KMS/_OH:F>%C)+PO0-AJ*0*.I);S$=+_FK*K,;OI?-BO[D<1MJW9X*K":
M44I/!78#N'Q-CJA\.;Q$5&X.E3,;_9=&96G<&XC*DKLW).[Q+SGQOQ)/IAX"
MF(8O%=$Q%Z\=?,)D_%,4%,Y'N06%$5,&-.GIZOW5WG@H3SX$YH7*K0\Z7%Z
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MA3WCD$3OT;C%!AX^$[=B2<D,NP--VWC@'_!P#42=CH?M0H)5)_+(-I,!GA"
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MC&<;Z/83VX I-C$.,-^^@R>6BO.BY3=QAD:^.)Y9ADH\QCB.Q3"5*HG3]D8
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M6Y56>W==^FBV4V"CP$:F7@(U4&#;*+ MM-[)%=AVN+C9K#3;NV-_:;938*/
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MGC%G!64C4CA_X68DS.IT8-@P5HE>1P#,3'L$@3T(P1</8'YSO\+._&J<21D
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MD)CU23I[I'_XMNBK_[H8BU%Z ",'(J%-)[@VB- &,0N3AFE;878?31EP$J9
ME?2UR2R&2ZOL<CIG*Z (3/'PFDE0KR2YE ]O9_LRZ1H9TKW+W4HXICBG0B?L
M@0V :PZ-%^$T+.8EIT."U\!DBP> .3RP#OCB,\3;@;B_@"N8K<F9F%Q:/; T
MJUG;59J5-R-92+.V7I+90Y(B!'!Y=_[SOG-_^LO)U3_.N_>75_=GE]V3?]R>
MG_\\O[KKWO]Q>??+_<GI*2!BP'YR:G6J"%'<!QB8+4'*F1U,9D$@W=F):2+U
M9> O0-CQ1T%YPQ<N;-< 6 .S<+K24RUVQG %?UOW"FIGK"EC.+D_O;ZZN[W^
MT;V_N;T^/3_[_?:\.Z/_DZI<:/$<Z;5N?,_DX#6G+F@S'>XSESU_,IS8,8"O
MG5KEJC<MMK'^-%SPE''0PNF*@0S3$QMSC40*N,YS.K!Y/Y6<7/?[MHD9" ##
MT_-K"7SE1=-)/7/1!5S$I72YA,&3#-KE@5COP0!I345NID4^FH@<$R?4S5)2
M6JY2B9B.:9!>^_KZ#2OB2NTKWMB*5Q#!H]U&3@RSM;IQI#4_\D\)].V"&'Q
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MI'(@LY>$+3QGJ=AB+G$$OS+\R9"FEP8)31](M;W$\DF(6Y&TF1BUQ0#$6SZ
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M[%"$/QGRL,HN(A^75BHQFD>2)UE;F?G", K"&3( *]PF#_230HX G(\IGA:
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M<SE+RWBF!,_Y<.1X8]$-Z/6^0#=&Z-OF(^MZGGO4'<!3'BJ,]_O<%/?ZF>I
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MM69;RKOG66,AZD$X=."'_P]02P,$%     @ =8%D4F;YZW8M'P  <68!  \
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MLA;(B9O1^SD"5N^ 6_Z(I:5R*40HWRGNI!X=D1HTYF.71"NY)48W[^CVG9@
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MP,*&;"U/Y^Q<'N$>W@5!:FD  !K*V'GY.W&$7)NEPW3@>0_[8'U^8.(S$H!
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M@&D^+?71U1M^K/(0<$[LP#PY57W#/UKMMI'H&_[17H>,9-]PBWM22?8-_S3
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M6631H#1R>1;=$?:["AX-2H^7YU&JLE6P2%C#_\O[+0X!DC^S;](O&,6W9'K
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M4/J8 ]SXW0D]ILNO@D*C6+273!T E7I"V?-;6XVA#"8:9VG$\+,KZG&71%Y
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MS+GPU=[3JL8/)!5BRUO'OAI%4B1RFC=:-=V:1,BJ% @E;R1\6[.TN<4N*AF
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M>Z1/[]UL!3/L5__81GSU\9__=2N"9/'77:G5=UD<TF^$/H;.8N;!61+?!0T
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M>7X@HI$DY1SO=CAE[9=-$^<>8FY2J4[BOK<IQ1HQ%I?)L\Y$;"E9" ,V."\
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MM[1*R3M"4E^G>^.)OCY-(\/4XN$E!I5]*O>L5W\A]^KG86?^6&,&+C95\%*
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M!I]H#^UGR%>0K N'U6G:!5X5'CXJAR3.0"RZO;K&>1[(#2;:D&)3M2X%/C2
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M1D->3I(1(]Y^]V-KD\AI<4I4BGBZQ=EI'H5Z?94SX^G.3RV 6KJA=.6RI3B
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MQ*GJG#=K&D?[A_&[3XH7LPSNF()MQ&M3]#8,L:YE):<P_&8$E:.AIUM782*
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MO'Z[/%^#&+0A.: >MMA(Q8O $1U!6)X$XO[(N0+*%A"^U!UM=@3>$RX_1N@
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MC">HF0+!%=1L@>!KLQ+]$9-A;'M(8]J;XM.>(),6-]$+71U57%L>I&"TZC=
MT<OZ;X,?.'"&8,\YSK_ JP(15E-<F'#(@6L0"]O54N]O@KI>0C "-V,O,>ZM
M/T990FF>DWE%$K,9*>U4A>@DY!Y_2!!)+G$*]1Q8EZB1$>DQ\>+FI0A@(\M
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M!..S%_&]7'Q1:_7'FI7U[I0I:_?^5G*@)U:R39(3&RAP>=@)Y.Q$<QCNY\I
MCG<?[=!8N#&T]S7+ I=U!A@;^7Q[)1+@,M&#094!E0],?=+!8,WK G]./T<9
M;<^V@:OXOP]\0>[\L#O03I#/8E%,)Z;XE,+<POQ)Y>,*FOBP$1<(@PVQJI<D
M?>3C/SUSN:D$H <NDT""T@3&AZ>#\^LU--18DI8"F1 4"$F!+"J@LO)D")32
M B8NJ.4%M<" 2SQQ_%L]1PEBFL79781@_7*K!S)YB39:<4R%FKF9C%-W"G?%
MCIW*HPQEZ'\N>0:R0:8!)-97Z10]KNHMM7ZI+,X@CA)UL1DXPL3O#NZ(P89Y
M9E$5Z\Z=725U+P;7COU>2TC]]**+B.8V\.X)PN*:.I_!-:']-"S:@O70]-!C
MEW,"C!4H>87A6:/H8%6-A8H$&@)AGI+QKA?6+QT?HN(6#%^EY$MSC/[2\C&M
MA8O'B'LX.#-Y?L@R>MXYSV&A=]U$YY-&-18=E+Q4Q @^(&*,YJ]Y&=(]'M9,
M6'INU (()7,NMI4JWD1&7=+.5<[Z/DF)?R<1,N\^T4O"/+CUD'1O,A6CX)I1
MC &#%;45* BH7__SY%[L7NLM,8U5&M_![#G9).GC>MNAA/R>O'7>_2?];,TM
M7W.T7<HQC9\&LOKNQ7"P3V"^)B,1<:02C!T3J42C:Q^=I@.8>/U_GNE(Y3G.
M]I@6+-*ZGWJ%1O]0Y0@AB^WB(<(^RCL%.\ JH>X4RO@G+0=0P@MKJ2]H;- (
M+$X.6'XDBC>>&_8];':I<"<Q+S/$FE4PD\01'/"HBH+3>>.*[%KA;B:,/@5'
M/3+/-6VL#Y#1@51WQMCUM'G8.Z;FWEAJ'BQS"&/T&0 !CZLG/(6C3EW/,QUL
MON,Y&>H><9;\RH*U?CJF0LT5'EW4?3I$(*F8!F"]SM&ONO#!Z7&>)L/95AEQ
M!I/'] ?\#+.4"D?31GTW&B1CL=#53];#2@9G!FINX RG<2!>I (4UM!<P*"@
M7CS8G&8F3_F4QC!#M.J4)7BL(EHWO>JG80Y''TWW#E)SXCDN;^86AGN,HH-5
M-18J$F@(A'E2L:X7UE]G'Z+B%@Q?:^!+<XS^)>TQK86+QXA[S+-JO'J$Z>;%
M9KFXCX)%D74G1?=.(0W;=WN<YI@=( QLF7@$(*RFMC#!$![!65BM!$]7_GUM
MUZY+B;#?<N'K:9IYC=0-7X?;WDL'?,V:\&OWS;\F QKYP7B2,T7-7:W5#F=%
M\BN_1NN,'L;3&O"T:;L[;S3&RY%+XR)"PJ4K"?AUXT2&$U#Q93>#A>&^QH@/
M'$52T_;2T$4M8&O?;6_(-G$&9\/'5N=PY(TX50OC'S*<YY_2#$:(2OP#R:7/
M(#%9>!]]<>C=J@R]&86: .Z']JXX4#,'E'LH&;-3DU$/#SK(?!7FH1%(:K$
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M.&5MM@X1 M?)UOJ:ACG>WR3S!#<*.<TRAL5A^*M(<%K@TS(2Z*[>+D,12G9
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M&6DTV7R'/65YKV0W!EBL[8L*6%WL&1PKB&JT@O$%U;S3@DX@>U)8KOP'-DO
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M459P11/1B?VU<M+"[Q'NXS0E GN,DG#*<Z8$AR2Y&:B0DA[)D)VRPA*&F5Q
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M_^_UI=D'S\%LVAH+H&C"RDR.R@3)\"I$_B>ZK/>B]WA9JIG'01#VN,]!>C
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MV(0J#J/9@@X'HTCJ'2^Y,8JXZM1+CM1H!<OZ++-E.M2KBAR*O4@3OXL07Y'
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M[/Z,QYVC,Q =D'^K$&P ^>[TL_*R#?%K8&!YP7'A5/I8UD;:Q;&#)?A.VF;
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M#DDL!7=)=F4JX7YC\9]D7EM\\9E)D]8QWT=@?+K(L(:-FB@AH.?N!P85R_0
M!IU_!X'AS^T(0?S:U)+24D<G2:XZ9P?3V^)G44) :RY=<D\.MOAHHG(:W<P
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M%YF?8<XIBJRJM8FIWUGV?,^I+"1O9:BJXON>V.OG$&X"\Z<-F.1LL,A- G*
M:7X%<Q ; 5_,/?+M\&?':W?F,4'A/](K^Y7,SU>6MXSL/K#SHDU] =P)3D66
MN,I91#+$V6;&:\Y\$4U\XP=9QI2,WIIVT2/S;HCO$S+=$*8HW&4T^@7Q9YZ]
MP<JY6E)H;/=I)>?43X-QIA%=V$8Q=BERHG7SY<EK*7B\Q]T?Q%ZN@*T)6+)P
MAMA-DHGB>V U.5F8I<+3[GS&]X1%:>W^D:T#JFD#GK;^&</62U_(;TF#!<T1
M4JD'SN _]U%0G6I55DZY#?[5\:NPO1-2](I2PI>$8U/,7"1BW83K]%1)HBO=
MAFS%)$Q*<H?NMM!N5P$\#_\*+8]<48K;H364I)L3/=+=%9V3FRZNK!EKO[F-
M@!#=$3B2<GM64BJ5?-O5+HVOO[NPY:8;]9 :&EFVMQ)C&2$Y<U]IN<,SQ3Y=
M//EQK]CI<P":G<ROW<O7V8H%*K/0[SUT=JUD4:[(1L-(^]X:G\#FYTY1R=FH
MWR[2QLE\I.5<\A;#J .8_4P'GW<>A8T6;.\<*WI-2BO-(.&MIJ/?&I8ZEY)G
MK@W^#T2$_"QRA/04:_=#+WHU($'@D.1F/"/VBVB)8E%*>G3LTG*N"/(D\X_T
MR)L@>:_A0,7^ULE/B[WR/-(H9TG8!2I)6*HUWRY+_> Q^P;9R5",5 ,.'RSW
MPB9+7*W_\L_Q5C50F<?>Y@.O$HJC>C)X&P.D_A_4^P% PV3)/)6=,/N-Y6YQ
M[6 $B;75KND![L(67#3!"B,SRT<4ZJ_ZNFUNGUQ_0V;VPB9S\88.-01:XWE7
M?W(W-J8Y5LG'#<[U'_0Y]-SOEN];LU4(6E*B%6@M)3V:*KJ(QE>U,/8NX+M[
M5%'I:A;8+@OE--#[Y(*&RX?@YN8<M2=R7TG)U#.;/H#^ OL'+4'SG^+UC0/4
M@8Z?T+'<<,'@9!48$UF,A05'<FR*HR8&H=.F.)?. UF&[IR>6XZ]H)YK6Z@M
M4_%]:_J)+)DT_T98#='-BA7\0>K4<@*MZ]3LH%)Z-4^@+9['1J=RO VOT:DJ
M^1A[6B\MCSW82O2D*J.@@WOF4XLO0=0E,OT?2PAH:9FX$RX'/* [,=<0PEMW
M]F)!/&:+G)'@)R%N9#E^"^TY\SI=NY?PS[/@C(#B(1-W/ED$Q'ND&WOVY<,I
MSB!4,) >WUT40SG9;!P[+O<<O[J>A^L0S +[A<2<1H:!+6<JR8_13P3P72CE
M1M#RNC*+XG= N,%1<^>6-_>?-G,X=*>L1PUBSR,):FS>-X_SH_!3*?Y>RZJD
M!>_]*^K=DI\<U3N/NO#'&<F7^A19'1SAMBR'PYV_"TS98<W9Q)D]>+I=S1!W
MP1"EUMEZ(8Q ,5IZ7D/)QK+G2? ;>T6(*\3&E53B)V2\U,!0U3'+;$;/C71/
MZ"HJ7<T"*_S*:4C8D1YL7>I%R[M8V#/B^>GCY1T%/8][!$'0TW-SLO<'E_&/
ME9#HA/]<H5R9&7 B6NY0Q &:RV_$)1X8CW!'F*]MU_:CPG4@/!/Y(M&8'D=8
MCPT^MJX7FTGCUZ_<8SFFCW0]&1T(5W#!L^8Q;:DE"7=>854.""JXE /H9RU\
M+.3:<9J'&4;(2;3C-+RE-;X=)TY5#Z!_M<R)K3#DAM/&NLX@KL(KW[[:3(T@
M>OVAV#L;!\[8(MPR![/\0CZ4MM:U;HT:M/(GTTS)CW!F43E7'&]V;6RM2,P1
M%??4FM[[&NW_%D0OWXO>3-T@\1HBNO]RKSD<2S,O$I)Z%OGJ9WH3XV:OK+3N
M@3B%[[V9FD3H>9VB(P(X;&9>+J3=37+!(Z:W4584OM,(Z9P*-[3'DK)@,:HL
M-HY#/FKZK,.P.EYR*!V1Q>)/,[B5Q,JF>'TT4R>)Q1KON0:+ Z(Y4&9*0(G;
M<R;8W?1>QL7) +0@%8'O$S/]5&7I&K0P821%P]#&9G5H[*?V<#1&&4)KD[3V
M98J9;K?Z)#=:FX"7XO39W#-6G\!(ZW(K.4QF6CK23\<5N;'[1]!</YE(GG$]
M9KD#^<5,$P"7:4XE\N13!+^:*=)D$"RN@9"VRS,T($8&J5RI"M/[T4N*_O*:
M(GMR_]0\P(0KL]2@=2CQ3SZ8N<$0]7@.8V\K*@AQU,;KT.%U:+\6U/YY-,^K
M65]#B];6]N)MKLT\@V*UT6AUT38.DIE'3M:P$BG/QUN$F[G!T$*^ONZBZ>V)
M&^C%P^*9O)>LF2<3J0R%RY^FN W2MK^I:L:++'7+D30SLZ<)DKSX,>]6/.ZW
M Y3J:EMSZ(QM*"X+74V-\Q0Y]3>E#65Q+"],;1N$8*;6/<=NB'$TE9A5-SG@
MP)GI6FRD63-M+5*</IIIY#; *=.DA*,TZLW,W5.@!0U';E2;AP]Q31H/<5R_
MCKBF.S+7IRJ%Z=/)"-/AM:"^O1B';[Q5\5U6TF&.@_5Q!(O[V5"= CF&H[K(
M8"C2%I)#-VH$ 5&WU_(SQ>[SJ"8.Y%QIVU>.V:@;.&9"/7PY=*.F.)1R->V9
M.72C@D!!5V&O?!X51J4_+M>#?8?<>T/CUI0A]P=A=UPRG[S 3Y>P#]FK8O:R
M<9(!\V34(Q@P60E!]AQV#X<Y.?E9,$?QR,7C/HYWUC9YW8G"+![I-$+$SP4"
M9-RC[PVM_J'8J"ZT<MZ_5VY4PPEXID>)7L9$W!G4Z7[+0J9<%AXU9(E/[\I^
M)?/SE>4M21:KT8@6L@2K01SUA1"(&?3*+>KW'T8W D>S))SQGMCKYQ!F-7_:
M 'DW2/3R(WU<V=[\(*[G_?@ 7@]I'!]U9]E@U&1_)0OC>&,Y?(:KPM*?+C(_
MR^ X/I?7;\>D'DW\J)1ZPK(@CJ_IQ2!FG*X;VXMXCK0WT/HGL;PLA..]1,"R
M_M.QWSFG&=C&]\P,;+N'N0MKZ]\Q0![I'P *8'A+ WM&0",#AK8+VS-"E./X
MX70T= [4R9/KD1G#9_[DSJ@;/WZ",1EZLQ5@-WUVDK#F;*W<6-ED<!T-R*:X
M3MTKV_,#,.5MN/KZEK?-PCL>_\;P/A#V>R7XCE?RQOA&MZ 2>#5<UO_M;0Y=
MF."/^-^B?V(?WI/%&_;?I_OKO2%<RPU^_"1^\-N,KM_NVAV]#:Q7ZM+U-AZ4
M-\'AJ!Z"^C!;D7GHD.DB]30>Q,VQ==B+CF/M=5@=-&>W#L5ME^Z!A3]UL1!O
M1]]>;W@7IOSV90#O?4 20V9')K>#^X&SAJ92I8&06;BJVT>5DM#1%*MD<)DV
M6+6D.IS/+75G<?E^!3/*$D.W5+NA[I*9K8=;%H.X$)D.T3Y7!O6Y-,X/*^H%
M"H 6H*,?Z5PNDRS0.4)HG'/2& =O^>=C2T"-N=9-6@*6+R&OL&'LM;%V^^/S
M$=^],S/N2<5>$Y#&O*>1L9=I<=U6G\N9:EC>!,7,PZIB^]5;71Q%8UT-PA9L
M_>;+6M*\D8>9Y[;Q_A.^9W$DS0R>P-Y=,0GM[]2["'?% 'XOB'3JB3>+=SJ8
M+B)DDJABI?XJL4%Z[Y&JF8:&6TN2Y^>C;B29CW3<K'ZW/)L5*)'BM>!C_7=L
M+--%7^O@.AU.YIY:\''G8KU\0J6"/$9[*%W4A0 J.$,<'[/M B%\BG Y47_S
MH8'E]%'C\W>5<\M?L="\*^HEL677[LP)YZSBPW< "<@P HFR:_\Q2Q$_O;<C
MU,U8NVK<9:K(JT=.08N;%P"^<NC/E(?)# SR",(X6T3*Q2M.='1E']/]&K&P
MICNXY0]0J:G&3WZ+_N[R^GM]4;_A>FUYV^GB*@S@%Y,&7WL J56OV/'ZKSZ%
M9Z1=/?I[+*7<A$1>7U:0[/"=_VBB7(IR0E,6GMQYDK),YI>O,_C57=@KYAXM
M-4#G<Y?<G.(T^S3#J",PRU.X M70QG0/!NC3W-N<=H]G3$.OM1E'M/LVXT<8
MN+5%3HCW;LX_:6LS9J3[--];L+ >?Q+G):XGB;J"RX\Q7F"/Z0(KO\YC"))B
MB%,9TJ:/>;C(QOK(](BO3K"-S1L.K9GA3-U &]G*'%JS7^.T07MP^^+XCKI,
M";[MAHCF'DJ-A;3<'<3Q'1693 ADJ^&W/2E4UA*&%0YFCJEZ1=5M>$1A:1-_
M5QG><J[=!?76$1,2KS'2U'OR]H+G'YL[=N>13;S3V#,.B$5W*>YZK_X>G\<&
MR,+I8Z5L+L@+<>@FJ7/#8COOK8#%4B7'8E=I7(A'";H2O"-*] ARC:"HPSN$
MJH8E[AM"D-W5ZFFT.B5%T;*5Y=#K(T!3%<_EM?'VR[HUF8/H&!WN.E"+5Z",
M\;.6HXM>/:FRZT)K)D6Y#?[5\2O!7ZZ=DQ ON:^ZW,&\(+)JV5E.&HUSI-_M
M>:(LF9T;M=:-,VV3Q,4_[& E(7SD2'>X8KN*/#Z3$(KE3@5M-;;(7E,;>0-D
MCXPJG596#;*)#BNCJ6/_?+-L]X;Z_M1]L%AT\5X_TK09*6;7B%+4,3L8>T;(
M/-JI!=QD^ZUBIH@BJV.>B2F0V5\L]0Q?5Z6:#OH,166F 8U<=HG00W0- 95V
M0E%1\:860Q%--,_2C.%'5[,3ST+?=IF3<@8GP(_N_LRL [G&?Y"*N!/,WL12
MEK4?DM)U/*FB1/DGQR*M*I:Q"'!6A9(!T;.])3]3M':%40'!N%8JRF<A1$G9
M/7BOD9N_;T$VO Y7DU8U@_-,W<3XKMJ,[2)ZP_"Q-%R3:]</+,>)?&G2"U%$
M!,U5(Z-2SGHLD@A) >7I8@$'UQ.58OG/],>8)Z)2/L(\)8"OT%?97E((P6H2
MTNM8U:$6M;)5A#19MWM.+FG;MI2*'GE9X=K'2<A*0CKF\D <H+G\!C=LSW*
MD<D<U+[-G@]9(I7$I$0I=JC9;G*5D>756886_GS#%?,?Q'*"U8WUS))_OQ-V
M3D4/==G74GR<V?1A9C,'+IJ)_*=H#BYHN'P(;F[.48/GOM+CB:BWZ<5G(4-5
MR^TOTPW@AG'.C&C*VF6B;GH55+J:Q>351IW[<AIZHN,=X(?&LG/B@=Q91K8%
M?H?544*?V7/X9WL&]JH'1FM4=L-Q=OCL3"#4<<80E+@E!W<>77K6SB<6.9]P
MLJZ2A(27(J*5.ABE^1(AI&.OWE+65  D%HO'F/]7Z$=A2GBI44VGNYE@)4<5
M%?1N^7=JN\'Y]/?KBY.OF:/,7!NIY2AW[*0HXWVV#@P.EH*?6 J6&R[ @@H9
M.*RTFN5NL>H?1Q)_EU^O0[B1;V$$%%L%WZ''OG0>R#)TY_3<<NP%]5S;0O%0
M\;W$^?&]('-VX&^'YP9^].=WZY6%$(JS6?!1:[S%X8U(WO8_:HNW>Z:(<9SM
M?=(J7Z(B[^"#>I[\'5,^F?VVI"]O_6#C 5,G7Z(__<K^E&4(?O;G^42(E=VO
MM@4,G"PF";\1IG4W*V:QB.NX&@*M\1R 17 X*&9Q*PC("58Z=6?4H<MM;/5A
M+[\U-#IW ^'M<R%R.N8%,-(U21=<_O970ZC#N6 MN4HR$D\72:1C%%B-VO;%
MG^I ,AOIA=X)!1]KYOD1N,2N>N'G$@UI+(_,'XCW8L^(+V>BU]#0@67&8\"\
M4W"WL?A/,DA)^+[0I+7L'6!\NLBPAMX]Q02DG+-_4.^'?V.O;;C6\PX.\14'
M[:X5(=9EB"I:NM00ZO()';EG*LEH>0Y*BY.6L.*?;??^A<5RH5Z'Y ;H< U1
MG:W$:76>2"@\7=IX]7AY$3,;K*LY/510#@REW+F(3*W';*<%.&J?AHC:@5:E
M*&N 8_?%:.R4G=\2VV__Y)X:BV.U[4P;6/Z\N,<'HW>B[&V+BEP7.8AFBT)U
MQ[G($;!_F#\8BV*5$Z48HYS*?6^VVJA3L\5..]YY[)W1Z"@[A95.V/W3^,E8
M-$4<VO68Y4[H9[/5J=B3QMYE0N QAJ-GMA[%7"EJWN52R+Z,GH!*H5?SYKHO
M[KX8AZ/8FS6M?4_G^\W,(RH6CT S41$<$;.-,B4G,!/2LG?B3LS#K3CDAQ8$
M'.V0.#DU<P>5!671PK"P%(WW9IKQ=6CL!_!Q-,S4[\+RMCH&,X7)<+L;;3GN
MA\VF,!FNJS PX8*>4P2_FBF=U/A+I2+@=]">GIHIZI3[;ZK2(?:M*W-?1@02
M2VH1.[S;G!JJ:U%I150X$XK#9K;N1<!6G=C& 3/S#JU&AV"2%U-$/XY:N011
MT:Q5#J790E"9%BY/9][7P>8^:-8FA=>@E=._'\V6BP*E #*(80H9< 3'^]U.
MC^1J6J0@?37;7L$&KN6KCNR0>G\Z(I5%JK!(3 J6X6>O[9C<&U[_)X7TD]D*
M0;BJ4C9R7+ J%,?0[.YH,AC6E M+H?NL/"Z\9SV09,"K*AJ7(O=UW'19W2%0
M-7 'W8=W@]2Y9=!5%X),03LQ^_XO<TY+JGERR$;=6G!$><G6%"CUG?".&:BR
MVKHI7(8^WTO"55<8F<,V[C+!BT)QW6L.I'+3XXB--ER-]!3##X-,B$0B6%,<
MGX.IW"]PW!M2J#E"BI[A+SM([%3VQT@A'CT$^><*9&>5%$OU&0S'?=B+FNZD
M8'T9K[H9J)"-DSB*9ON=D2A6]<=*(?LZWGT+W'H5?<YVR'T\&3=;_J$6T?HN
M!7+T*N2 %&V3R#$<#9?Z:TJ=P^:CX5&/#5 L[IO*@1O-%T&7345_7([FUQ'-
MW$4/V5XY!?/CN#4%MV9YM^T4S$_CSLSLS%P7]A2GSZ-)(W:=8Q >8/?E9,0.
MA=TY7:]9S%H4BP^TLUB.9J&H\(LO?7OQ'%DU\G64?/4&=EJ5:/ZT ?KIXUX9
MJI\,+_ZGZ'4E>N6[ QOHD3ZN;"^'XACR(7K*BQY,_W3L=\YI%L[Q%EAW"P1C
MW([362/[!VSR?Q++RV(XNA7W,*R(LKRW N:=343EX:O?I]&SD[L,1D!-%U>A
M.V>)B-&9SB"FX_K\;V]S@ '+/^)_B_Z)?7A/%F_8?Y_NK_>&<"TW^/&3^,%O
M,[I^NZO._S:P7JE+U]MXT O;GSG4#SWR$-#9CQ5U8'X^<_[!09SO(A:NW07U
MUDEF>6#9S@ZPXN+_]T#YSX:4X_W@V^L-+Z.>WS\,CKT/2!*QN".3VT*MHJ*E
MK^9Z3=V(K:A:JC\- S^PHDVZCUU=5\TJ.GHZA!YP<.W[H5AG\%H2FOD'P3+U
MHK)?\]\M)V11%1$_DG,I)]?)NDS"8 4R[J^&:Y,EHZ4E!!OZGFP27VB:*,Z2
MC9A$3]GAOQ-+^1/,-)N,H@4%RR$^6PO;9R%3S+-Y10BJN4<I"7Q+H7VPV+OQ
M/0ELT)"7KRRT)BX%DXQS$96&B4V5Z!B(\*Q@D [V9H;'+$/QN6FP&VOH=G<*
M^;%0=N0*2*+WYQ.8#MY/,.< *F8#1/>X_9T_78!)!_^\>RD0W)12E/5TA>>O
MZ4Q[LCBWZ2(CO#$K(T!,K@V9_P FV".]"Y\=>_:TH>Y5Z#B7K\2;V3Z,D*(+
M5MHT,K_9[R;2-K77Q(]3*\-J.6T9*^C.B^,[T99(!1%M$B,>/2^T;LG/Z)_P
M4E& HA;KRK%\?[J(6,K?/T7LJF("^$[-KV06LA36\Y5EPS7&!1$$J^W.[ WL
M67[MP;5O1A+M7!K@NQFV,#@:A7AP%._[GV@YQZR(D\W"VJYLN'7/X-P=M&3
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M4?#@; TE2*Q8%AV^9"D7LX,))6M325(A6Z#%T+.>O>[H KO&@$P!5U^)IV^
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M,W(,6-:?V<ERZ9$EZ-[#'$9].#=@\AC6('-0N\.XE(D_'?N=<R22H=](2D2
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MERNU*<CNKX9QENT0R(=@.PJ"1[^O8/LV#_H="=WXP)CPW>?_F Y;GH%]36Z
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MLHGK*TB)F[")BVFXDG)'DJ4/!ZN8OS6(YZVMAVT8PZYMSK83S[K&IC1UE:,
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MN=ZLJ7,/I1Y*$%BC'!AWN,2AD+A-<HLHM+3(II<P@,9WL^,>M4SO =>3O[F
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MW._"$;%RO1FGTZQE!**LOR7]&]1_.V-]/JC ^&Q)FQJ8HJRV+XP!T_\ZQ[A
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M@6^ G6786K,,F3XBX1HL&JXK;C1I&<='?1LRA*K:='?4R@WSFJDUQ(+I20,
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MR@-[ !OO]*PA]>XN:8IW%49K?)+A R39'R^,"=D+,I?N F\'\S#>*&>\75.
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M.6>Q@*E*_8V%R$XY+>"&3#!AY)U\S#\U>1Z/%1FLB<NM&48?TYJ$LNO\?._
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M'5N.[ F!Q:QC2V2_5E=7/?4\5',9016]R*F;/_:$)ZSL@3S9E? G2>LMX(C
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MYU;!-0?<TFQ<WQ#L@D;=O^O]KV]E!+_XWZ*.7?Z/J6.7_Y;Z#U!+ P04
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M+#D/TXMR>R.P@.E%@UOM@[;X$@:5#WA$<681-2#O-)<13ZD@OW!)X2M\>SL
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MB2R&-@%;%["^#KC,M9B2%* 141W17H@Y;.>(:5:Z!F:(7>JJCA*9  ' :@6
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M.&9XS;]5MHZY6:$,+UU/8N+0A>[>?TX-)=ZM&BT^S;2<X@/0WU!+ P04
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MFL+I];5OG*8,;_FWRM;+;UDHPPO8?W2YNUV'Y9>6ME=^T/D'4$L! A0#%
M  @ =8%D4NF0WO'8K ( V) # !8              ( !     &=T;#(Q<F=C
M8FIM-3 P,# P,2YJ<&=02P$"% ,4    " !U@612NU423,4L P FT@, %@
M            @ $,K0( 9W1L,C%R9V-B:FTU,# P,# R+FIP9U!+ 0(4 Q0
M   ( '6!9%*.1$FI"R,# .W* P 6              "  07:!0!G=&PR,7)G
M8V)J;34P,# P,#,N:G!G4$L! A0#%     @ =8%D4C:.]&RAQ@$ @%H" !8
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M<F=C8FIM-3 P,# P-RYJ<&=02P$"% ,4    " !U@612H-)ZTI3. 0!XI (
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M,#(P,3(S,2YX<V102P$"% ,4    " !U@612;CXLLTH5   T6 $ $P
M        @ &S_"4 ;FLM,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( '6!
M9%*YET\!@DP  #4]!0 3              "  2X2)@!N:RTR,#(P,3(S,5]D
M968N>&UL4$L! A0#%     @ =8%D4NGB>[5%O   9T + !,
M ( !X5XF &YK+3(P,C Q,C,Q7VQA8BYX;6Q02P$"% ,4    " !U@612QDEY
M \]X   K!@D $P              @ %7&R< ;FLM,C R,#$R,S%?<')E+GAM
M;%!+ 0(4 Q0    ( '6!9%*RTY[8B9H  )#\ P 1              "  5>4
M)P!N:RUE>#$P,S5?-#,S+FAT;5!+ 0(4 Q0    ( '6!9%)\V#7U&0,  %T5
M   /              "  0\O* !N:RUE>#(Q,5\Q,"YH=&U02P$"% ,4
M" !U@612:07,KR8%  ">-0  #@              @ %5,B@ ;FLM97@R,S%?
M-RYH=&U02P$"% ,4    " !U@612'(O:US()  "-5P  #@
M@ &G-R@ ;FLM97@S,3%?."YH=&U02P$"% ,4    " !U@612_:E]I3\)  "H
M5P  #@              @ $%02@ ;FLM97@S,3)?-BYH=&U02P$"% ,4
M" !U@612(>AZ S\$  !Q$@  #@              @ %P2B@ ;FLM97@S,C%?
M.2YH=&U02P$"% ,4    " !U@612W7(#+#<$  !!$@  #P
K@ ';3B@ ;FLM97@S,C)?,3$N:'1M4$L%!@     : !H GP8  #]3*     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
